PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, PZ; Polovitskaya, MM; Jentsch, TJ				Zhou, Pingzheng; Polovitskaya, Maya M.; Jentsch, Thomas J.			LRRC8 N termini influence pore properties and gating of volume-regulated anion channels (VRACs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; chloride channel; biophysics; electrophysiology; membrane transport; ICl; swell; ICl; vol; swelling-activated chloride channel; VSOAC; VSOR; amino-terminus; N-terminus	1ST EXTRACELLULAR LOOP; LEUCINE-RICH REPEAT; GAP-JUNCTION CHANNEL; CALHM ION CHANNELS; LINING RESIDUES; CHLORIDE CHANNELS; CELL-VOLUME; ESSENTIAL COMPONENT; CHARGE SELECTIVITY; MOLECULAR IDENTITY	Volume-regulated anion channels (VRACs) are crucial for cell volume regulation and have various roles in physiology and pathology. VRACs were recently discovered to be formed by heteromers of leucine-rich repeat-containing 8 (LRRC8) proteins. However, the structural determinants of VRAC permeation and gating remain largely unknown. We show here that the short stretch preceding the first LRRC8 transmembrane domain determines VRAC conductance, ion permeability, and inactivation gating. Substituted-cysteine accessibility studies revealed that several of the first 15 LRRC8 residues are functionally important and exposed to a hydrophilic environment. Substituting glutamate 6 with cysteine decreased the amplitudes of swelling-activated I-Cl,I-vol currents, strongly increased iodide-over-chloride permeability, and markedly shifted the voltage dependence of channel inactivation. Importantly, these effects were reversed by 2-sulfonatoethyl methanethiosulfonate, which restores the negative charge at this amino acid position. Cd2+-mediated blocking of I-Cl,I-vol in cysteine variants suggested that the LRRC8 N termini come close together in the multimeric channel complex and might form part of the pore. We propose a model in which the N termini of the LRRC8 subunits line the cytoplasmic portion of the VRAC pore, possibly by folding back into the ion permeation pathway.	[Zhou, Pingzheng; Polovitskaya, Maya M.; Jentsch, Thomas J.] Leibniz Forschungsinst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Zhou, Pingzheng; Polovitskaya, Maya M.; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Jentsch, Thomas J.] Charite, Neurocure Cluster Excellence, D-10117 Berlin, Germany; [Polovitskaya, Maya M.] Free Univ Berlin, Fac Biol Chem & Pharm, Grad Program, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de		Polovitskaya, Maya/0000-0002-8144-9824; Jentsch, Thomas/0000-0002-3509-2553	European Research Council [294435, 740537]; Deutsche Forschungsgemeinschaft [JE 164/12-1, SFB 740 TPC05]; NeuroCure Cluster of Excellence; Alexander von Humboldt Foundation	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure Cluster of Excellence; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by European Research Council Advanced Grants 294435 "Cytovolion" and 740537 "Volsignal" and Deutsche Forschungsgemeinschaft Grants JE 164/12-1, SFB 740 TPC05, and NeuroCure Cluster of Excellence (to T.J.J.) and by a stipend from the Alexander von Humboldt Foundation (to P.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Cahalan M D, 1988, Soc Gen Physiol Ser, V43, P281; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; De Jesus-Perez JJ, 2016, J GEN PHYSIOL, V147, P25, DOI 10.1085/jgp.201511424; Deneka D, 2018, NATURE, V558, P254, DOI 10.1038/s41586-018-0134-y; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fatehi M, 2009, J MEMBRANE BIOL, V228, P151, DOI 10.1007/s00232-009-9167-3; Gaitan-Penas H, 2016, BIOPHYS J, V111, P1429, DOI 10.1016/j.bpj.2016.08.030; Gradogna A, 2017, J PHYSIOL-LONDON, V595, P6719, DOI 10.1113/JP274795; HAZAMA A, 1988, J PHYSIOL-LONDON, V402, P687, DOI 10.1113/jphysiol.1988.sp017229; Hernandez-Carballo CY, 2010, PFLUG ARCH EUR J PHY, V460, P633, DOI 10.1007/s00424-010-0842-0; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; JACKSON PS, 1994, AM J PHYSIOL-CELL PH, V267, pC1203, DOI 10.1152/ajpcell.1994.267.5.C1203; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02664-0; Kronengold J, 2003, CELL COMMUN ADHES, V10, P193, DOI 10.1080/15419060390264325; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Kubota K, 2004, FEBS LETT, V564, P147, DOI 10.1016/S0014-5793(04)00332-1; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Lee CC, 2014, J BIOL CHEM, V289, P17124, DOI 10.1074/jbc.M114.571257; Linsdell Paul, 2015, BioMolecular Concepts, V6, P191, DOI 10.1515/bmc-2015-0013; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Lutter D, 2017, J CELL SCI, V130, P1122, DOI 10.1242/jcs.196253; Ma ZM, 2016, PFLUG ARCH EUR J PHY, V468, P395, DOI 10.1007/s00424-015-1757-6; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Noskov SY, 2006, BIOPHYS CHEM, V124, P279, DOI 10.1016/j.bpc.2006.05.033; Oh S, 2008, J PHYSIOL-LONDON, V586, P2445, DOI 10.1113/jphysiol.2008.150805; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 2006, CONTRIB NEPHROL, V152, P9, DOI 10.1159/000096285; Oshima A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13681; Pedersen SF, 2015, ACTA PHYSIOL, V213, P868, DOI 10.1111/apha.12450; Pedersen SF, 2016, PFLUG ARCH EUR J PHY, V468, P371, DOI 10.1007/s00424-015-1781-6; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sabirov RZ, 2000, PFLUG ARCH EUR J PHY, V439, P315, DOI 10.1007/s004240050945; Schober AL, 2017, J PHYSIOL-LONDON, V595, P6939, DOI 10.1113/JP275053; Srinivas M, 2018, BBA-BIOMEMBRANES, V1860, P192, DOI 10.1016/j.bbamem.2017.04.024; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Stuhlmann T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04353-y; Syeda R, 2016, CELL, V164, P499, DOI 10.1016/j.cell.2015.12.031; Tanis JE, 2017, AM J PHYSIOL-CELL PH, V313, pC173, DOI 10.1152/ajpcell.00318.2016; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Ullrich F, 2016, J BIOL CHEM, V291, P17040, DOI 10.1074/jbc.M116.739342; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; Voets T, 1997, J GEN PHYSIOL, V110, P313, DOI 10.1085/jgp.110.3.313; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	59	19	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13440	13451		10.1074/jbc.RA118.002853	http://dx.doi.org/10.1074/jbc.RA118.002853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29925591	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000443375500008
J	Lee, JM; Han, HS; Jung, YS; Harris, RA; Koo, SH; Choi, HS				Lee, Ji-Min; Han, Hye-Sook; Jung, Yoon Seok; Harris, Robert A.; Koo, Seung-Hoi; Choi, Hueng-Sik			The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB COACTIVATOR CRTC2; HEPATIC GLUCONEOGENESIS; HETERODIMER PARTNER; KEY REGULATOR; TORC2; PGC-1; DISRUPTION; ZHANGFEI; REGION; LIVER	Under fasting conditions, activation of several hepatic genes sets the stage for gluconeogenesis in the liver. cAMP response element-binding protein (CREB), CREB-regulated transcription coactivator 2 (CRTC2), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) are essential for this transcriptional induction of gluconeogenic genes. PGC-1insight that may help inform potential therapeutic approaches targeting PGC-l alpha-mediated regulation of hepatic glucose metabolism. induction is mediated by activation of a CREB/CRTC2 signaling complex, and recent findings have revealed that small heterodimer partner-interacting leucine zipper protein (SMILE), a member of the CREB/ATF family of basic region-leucine zipper (bZIP) transcription factors, is an insulin-inducible corepressor that decreases PGC-1 alpha expression and abrogates its stimulatory effect on hepatic gluconeogenesis. However, the molecular mechanism whereby SMILE suppresses PGC-1a expression is unknown. Here, we investigated SMII.E's effects on the CREB/CRTC2 signaling pathway and glucose metabolism. We found that SMILE significantly inhibits CREB/ CRTC2-induced PGC-1 alpha expression by interacting with and disrupting the CREB/CRTC2 complex. Consequently, SMILE decreased PGC-1 alpha-induced hepatic gluconeogenic gene expression. Furthermore, SMILE inhibited CREB/CRTC2-induced phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) gene expression by directly repressing the expression of these genes and by indirectly inhibiting the expression of PGC-1 alpha via CREB/CRTC2 repression. Indeed, enhanced gluconeogenesis and circulating blood glucose levels in mice injected with an adenovirus construct containing a constitutively active CRTC2 variant (CRTC2-S171A) were significantly reduced by WT SMILE, but not by leucine zipper-mutated SMILE. These results reveal that SMILE represses CREB/CRTC2-induced PGC-1 alpha expression, an insight that may help inform potential therapeutic approaches targeting PGC-1 alpha-mediated regulation of hepatic glucose metabolism.	[Lee, Ji-Min; Jung, Yoon Seok; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Sch Biol Sci & Technol, Gwangju 500757, South Korea; [Lee, Ji-Min; Jung, Yoon Seok; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Gwangju 500757, South Korea; [Han, Hye-Sook; Koo, Seung-Hoi] Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, 145 Anam Ro, Seoul 136713, South Korea; [Harris, Robert A.] Univ Kansas, Dept Biochem & Mol Biol, Med Ctr, Kansas City, KS 66160 USA	Chonnam National University; Chonnam National University; Korea University; University of Kansas; University of Kansas Medical Center	Choi, HS (corresponding author), Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Sch Biol Sci & Technol, Gwangju 500757, South Korea.; Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Gwangju 500757, South Korea.; Koo, SH (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, 145 Anam Ro, Seoul 136713, South Korea.	koohoi@korea.ac.kr; hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	National Research Foundation of Korea (NRF) by National Creative Research Initiatives [20110018305]; National Research Foundation of Korea [2015R1A2A1A01006687, 2017M3A9D5A01052447, 2015R1A5A1009024]; Korea University, Seoul, Korea	National Research Foundation of Korea (NRF) by National Creative Research Initiatives; National Research Foundation of Korea(National Research Foundation of Korea); Korea University, Seoul, Korea	This work was supported through the National Research Foundation of Korea (NRF) by National Creative Research Initiatives Grant 20110018305 (to H.-S.C) and National Research Foundation of Korea Grants 2015R1A2A1A01006687, 2017M3A9D5A01052447, and 2015R1A5A1009024 to (S.-H.K). The work was also supported by a grant from Korea University, Seoul, Korea (to S.-H.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lee JM, 2016, DIABETES, V65, P62, DOI 10.2337/db15-0249; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Misra J, 2011, J BIOL CHEM, V286, P41972, DOI 10.1074/jbc.M111.274514; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wu XL, 1998, J BIOL CHEM, V273, P20820, DOI 10.1074/jbc.273.33.20820; WYNSHAWBORIS A, 1986, J BIOL CHEM, V261, P9714; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077256	24	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13125	13133		10.1074/jbc.RA118.002196	http://dx.doi.org/10.1074/jbc.RA118.002196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29950523	hybrid, Green Published			2022-12-28	WOS:000442730200013
J	Yang, J; Park, KW; Cho, S				Yang, Jiwon; Park, Keun Woo; Cho, Sunghee			Inhibition of the CD36 receptor reduces visceral fat accumulation and improves insulin resistance in obese mice carrying the BDNF-Val66Met variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BDNF VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR VAL66MET; MICROVASCULAR COMPLICATIONS; GENETIC VARIANT; ASIAN-AMERICANS; INFLAMMATION; EXPRESSION; ASSOCIATION; MACROPHAGE; ATHEROSCLEROSIS	Obesity-induced metabolic dysfunctions increase the risk for vascular diseases, including type II diabetes and stroke. Managing obesity is of interest to address the worldwide health problem; however, the role of genetic variability in human obesity development and specific targets for obesity-related metabolic disease have not been thoroughly studied. A SNP in the brain-derived neurotropic factor (BDNF) gene that results in the substitution of a valine with a methionine at codon 66 (Val66Met) occurs with a high frequency in humans. This study addressed the effect of genetic variability in developing obesity and the efficacy of the inhibition of cluster of differentiation 36 (CD36), a multifunctional receptor implicated in obesity and insulin resistance, in WT mice and mice with the BDNF Val66Met variant. CD36 inhibition by salvionolic acid B (SAB) in diet-induced obese WT mice reduced visceral fat accumulation and improved insulin resistance. The benefit of SAB was abrogated in CD36 knockout mice, showing the specificity of SAB. In addition, mice with the Val66Met variant in both alleles (BDNFM/M) fed a high-fat diet exhibited extreme obesity with increased CD36 gene and protein levels in macrophages. Chronic SAB treatment in BDNFM/M mice significantly decreased visceral fat accumulation and improved insulin resistance. Notably, the effect of SAB was greater in the extremely obese BDNFM/M mice compared with the WT mice. The study demonstrated a link between BDNF Val66Met and elevated CD36 expression and suggested that CD36 inhibition may be a potential strategy to improve metabolic dysfunctions and to normalize risk factors for vascular diseases in the obese population.	[Yang, Jiwon; Park, Keun Woo; Cho, Sunghee] Burke Med Res Inst, White Plains, NY 10605 USA; [Cho, Sunghee] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA	Cornell University	Cho, S (corresponding author), Burke Med Res Inst, Weill Cornell Med, Feil Family Brain & Mind Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	suc2002@med.cornell.edu			NHLBI NIH HHS [R01 HL082511] Funding Source: Medline; NINDS NIH HHS [R01 NS095359, R01 NS077897] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095359, R01NS077897] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alkhatatbeh MJ, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.1; Bao Y, 2012, ATHEROSCLEROSIS, V223, P152, DOI 10.1016/j.atherosclerosis.2012.05.006; Beckers S, 2008, MOL GENET METAB, V95, P110, DOI 10.1016/j.ymgme.2008.06.008; Castro AVB, 2014, ARQ BRAS ENDOCRINOL, V58, P600, DOI 10.1590/0004-2730000003223; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Handberg A, 2010, J CLIN ENDOCR METAB, V95, P1939, DOI 10.1210/jc.2009-2002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; King GL, 2012, DIABETES CARE, V35, P1181, DOI 10.2337/dc12-0210; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Mou ZY, 2015, CELL REP, V13, P1073, DOI 10.1016/j.celrep.2015.09.065; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Peng JH, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0393-0; Pentti K, 2009, EUR J ENDOCRINOL, V160, P979, DOI 10.1530/EJE-09-0151; Pivac N, 2009, CROAT MED J, V50, P43, DOI 10.3325/cmj.2009.50.43; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Qin LY, 2014, J NEUROSCI, V34, P2493, DOI 10.1523/JNEUROSCI.4140-13.2014; Qin LY, 2011, J NEUROSCI, V31, P775, DOI 10.1523/JNEUROSCI.4547-10.2011; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Sampson MJ, 2003, ATHEROSCLEROSIS, V167, P129, DOI 10.1016/S0021-9150(02)00421-5; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Skledar M, 2012, PROG NEURO-PSYCHOPH, V36, P136, DOI 10.1016/j.pnpbp.2011.08.003; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Szmuilowicz ED, 2009, NAT REV ENDOCRINOL, V5, P553, DOI 10.1038/nrendo.2009.166; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vanesvki F, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00037; Vroegrijk IOCM, 2013, OBESITY, V21, P2037, DOI 10.1002/oby.20354; Wang L, 2010, J BIOMOL SCREEN, V15, P239, DOI 10.1177/1087057109359686; Woo MS, 2016, J BIOL CHEM, V291, P23654, DOI 10.1074/jbc.M116.750018; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	49	23	24	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13338	13348		10.1074/jbc.RA118.002405	http://dx.doi.org/10.1074/jbc.RA118.002405			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29914985	Green Published, hybrid			2022-12-28	WOS:000442730200030
J	Li, JZ; Fu, XQ; Cao, SB; Li, J; Xing, S; Li, DY; Dong, Y; Cardin, D; Park, HW; Mauvais-Jarvis, F; Zhang, HT				Li, Jianzhuo; Fu, Xueqi; Cao, Subing; Li, Jing; Xing, Shu; Li, Dongying; Dong, Yan; Cardin, Derrick; Park, Hee-Won; Mauvais-Jarvis, Franck; Zhang, Haitao			Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; microtubule; plasma membrane; kinesin; heat shock protein (HSP); HSP27; KIF5B; prostate cancer; steroid hormone receptor; type I nuclear receptor	PROSTATE-CANCER CELLS; NON-GENOMIC ACTIONS; STEROID-HORMONES; LIPID RAFTS; MICRODOMAINS; TRANSPORT; SURVIVAL; VARIANT; DYNEIN; MODEL	The androgen receptor (AR) is a ligand-activated nuclear receptor that plays a critical role in normal prostate physiology, as well as in the development and progression of prostate cancer. In addition to the classical paradigm in which AR exerts its biological effects in the nucleus by orchestrating the expression of the androgen-regulated transcriptome, there is considerable evidence supporting a rapid, nongenomic activity mediated by membrane-associated AR. Although the genomic action of AR has been studied in depth, the molecular events governing AR transport to the plasma membrane and the downstream AR signaling cascades remain poorly understood. In this study, we report that AR membrane transport is microtubule-dependent. Disruption of the function of kinesin 5B (KIF5B), but not of kinesin C3 (KIFC3), interfered with AR membrane association and signaling. Co-immunoprecipitation and pulldown assays revealed that AR physically interacts with KIF5B and that androgen enhances this interaction. Furthermore, we show that heat shock protein 27 (HSP27) is activated by membrane-associated AR and that HSP27 plays an important role in mediating AR-mediated membrane-to-nuclear signal transduction. Together, these results indicate that AR membrane translocation is mediated by the microtubule cytoskeleton and the motor protein KIF5B. By activating HSP27, membrane-associated AR potentiates the transcriptional activity of nuclear AR. We conclude that disruption of AR membrane translocation may represent a potential strategy for targeting AR signaling therapeutically in prostate cancer.	[Li, Jianzhuo; Fu, Xueqi; Xing, Shu] Jilin Univ, Sch Life Sci, Changchun 130012, Jilin, Peoples R China; [Li, Jing] Jilin Univ, Sch Med, Changchun 130012, Jilin, Peoples R China; [Li, Jianzhuo; Li, Dongying; Cardin, Derrick; Zhang, Haitao] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA; [Cao, Subing; Dong, Yan] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, New Orleans, LA 70112 USA; [Park, Hee-Won] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Mauvais-Jarvis, Franck] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Li, Jianzhuo; Cao, Subing; Li, Dongying; Dong, Yan; Cardin, Derrick; Zhang, Haitao] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Mauvais-Jarvis, Franck] Southeast Louisiana Vet Hlth Care Syst, New Orleans, LA 70119 USA; [Li, Dongying] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	Jilin University; Jilin University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; US Food & Drug Administration (FDA)	Zhang, HT (corresponding author), 1430 Tulane Ave, New Orleans, LA 70112 USA.	hzhang@tulane.edu	Li, Dongying/AAB-9232-2019	Li, Dongying/0000-0003-0721-2500; Dong, Yan/0000-0003-1622-5354	American Cancer Society [RSG-14-016-01-CCE, DOD W81XWH-12-1-0275, W81XWH-14-1-0480]; Louisiana Cancer Research Consortium Fund; Tulane University Carol Lavin Bernick Faculty Grants; National Institutes of Health [R01 DK074970, DK107444]; Department of Veterans Affairs Merit Review Award [BX003725]; NATIONAL CANCER INSTITUTE [R01CA188609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074970, R01DK107444] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003725] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Louisiana Cancer Research Consortium Fund; Tulane University Carol Lavin Bernick Faculty Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by American Cancer Society Grants RSG-14-016-01-CCE, DOD W81XWH-12-1-0275, and W81XWH-14-1-0480; Louisiana Cancer Research Consortium Fund; and the Tulane University Carol Lavin Bernick Faculty Grants (to H. Z.). This work was also supported by National Institutes of Health Grants R01 DK074970 and DK107444 (to F.M.-J.) and Department of Veterans Affairs Merit Review Award BX003725. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahrens-Fath I, 2005, FEBS J, V272, P74, DOI 10.1111/j.1432-1033.2004.04395.x; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Deng Q, 2017, CELL PHYSIOL BIOCHEM, V43, P223, DOI 10.1159/000480343; Deng Q, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/3985916; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Garza-Contreras J, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0109-17.2017; Gelfand VI, 2001, METH MOL B, V164, P191; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Harrell JM, 2004, J BIOL CHEM, V279, P54647, DOI 10.1074/jbc.M406863200; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; Katsogiannou M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00346; Konda JD, 2017, MOL ONCOL, V11, P599, DOI 10.1002/1878-0261.12042; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Moreno-Altamirano MMB, 2007, IMMUNOLOGY, V120, P536, DOI 10.1111/j.1365-2567.2006.02531.x; Navarro G, 2016, CELL METAB, V23, P837, DOI 10.1016/j.cmet.2016.03.015; Nishiyama T, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.03.007; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Notini AJ, 2005, J MOL ENDOCRINOL, V35, P547, DOI 10.1677/jme.1.01884; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Robitaille H, 2010, J INVEST DERMATOL, V130, P74, DOI 10.1038/jid.2009.185; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tan MHE, 2015, ACTA PHARMACOL SIN, V36, P3, DOI 10.1038/aps.2014.18; Thadani-Mulero M, 2012, CANCER RES, V72, P4611, DOI 10.1158/0008-5472.CAN-12-0783; Voll EA, 2014, ONCOTARGET, V5, P2648, DOI 10.18632/oncotarget.1917; Yang X, 2011, J BIOL CHEM, V286, P36152, DOI 10.1074/jbc.M111.265124; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Zarif JC, 2015, ONCOTARGET, V6, P6862, DOI 10.18632/oncotarget.3119; Zhang GY, 2015, ONCOTARGET, V6, P23358, DOI 10.18632/oncotarget.4396; Zhuang LY, 2002, CANCER RES, V62, P2227; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	41	13	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12719	12729		10.1074/jbc.RA118.003075	http://dx.doi.org/10.1074/jbc.RA118.003075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934310	Green Published, hybrid			2022-12-28	WOS:000442203500006
J	Hua, XT; Li, BB; Song, L; Hu, CM; Li, XY; Wang, DD; Xiong, Y; Zhao, P; He, HW; Xia, QY; Wang, F				Hua, Xiaoting; Li, Binbin; Song, Liang; Hu, Cuimei; Li, Xianyang; Wang, Dandan; Xiong, Ying; Zhao, Ping; He, Huawei; Xia, Qingyou; Wang, Fei			Stimulator of interferon genes (STING) provides insect antiviral immunity by promoting Dredd caspase-mediated NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC GMP-AMP; CYTOSOLIC-DNA; BOMBYX-MORI; INTRACELLULAR DNA; TRANSCRIPTION FACTOR; PATHWAY; DROSOPHILA; PROTEIN; ADAPTER; SENSOR	The antiviral cGMP-AMP (cGAMP)-stimulator of interferon genes (STING) pathway is well characterized in mammalian cells. However, whether this pathway also plays a role in insect antiviral immunity is unknown. In this study, we found that cGAMP is produced in silkworm (Bombyx mori) cells infected with nucleopolyhedrovirus (NPV). In searches for STING-related sequences, we identified BmSTING, a potential cGAMP sensor in B. mori. We observed that BmSTING overexpression effectively inhibits NPV replication in silkworm larvae, whereas dsRNA-mediated BmSTING knockdown resulted in higher viral load. Cleavage and nuclear translocation of BmRelish, a NF-B-related transcription factor, was also observed when BmSTING was overexpressed and was enhanced by cGAMP stimulation or viral infection of B. mori larvae. Moreover, we identified a caspase-8-like protein (BmCasp8L) as a BmSTING-interacting molecule and as a suppressor of BmSTING-mediated BmRelish activation. Interestingly, cGAMP stimulation decreased BmCasp8L binding to BmSTING and increased BmRelish activity. Of note, an interaction between death-related ced-3/Nedd2-like caspase (BmDredd) and BmSTING promoted BmRelish cleavage for efficient antiviral signaling and protection of insect cells from viral infection. Our findings have uncovered BmSTING as a critical mediator of antiviral immunity in the model insect B. mori and have identified several BmSTING-interacting proteins that control antiviral defenses.	[Hua, Xiaoting; Li, Binbin; Song, Liang; Hu, Cuimei; Li, Xianyang; Wang, Dandan; Xiong, Ying; Zhao, Ping; He, Huawei; Xia, Qingyou; Wang, Fei] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Zhao, Ping; He, Huawei; Xia, Qingyou] Southwest Univ, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	He, HW; Xia, QY; Wang, F (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	hehuawei@swu.edu.cn; xiaqy@swu.edu.cn; fwangswu@gmail.com			State Key Program of National Natural Science of China [31530071]; Natural Science Foundation of China [31672495, 31572465]; Chongqing Research Program of Basic Research and Frontier Technology [CSTC2014JCYJA80010, CSTC2015JCYJBX0035]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Research Program of Basic Research and Frontier Technology	This work was supported by State Key Program of National Natural Science of China Grant 31530071, Natural Science Foundation of China Grants 31672495 and 31572465, and Chongqing Research Program of Basic Research and Frontier Technology CSTC2014JCYJA80010 and CSTC2015JCYJBX0035. The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Dong ZM, 2016, J PROTEOME RES, V15, P1435, DOI 10.1021/acs.jproteome.5b00943; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guo R, 2015, APPL MICROBIOL BIOT, V99, P5175, DOI 10.1007/s00253-015-6634-x; Hua XT, 2016, INSECT SCI, V23, P297, DOI 10.1111/1744-7917.12210; Huang LL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4001; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jiang Y, 2017, PROTEIN CELL, V8, P83, DOI 10.1007/s13238-016-0303-4; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099200; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Ma XJ, 2015, INSECT BIOCHEM MOLEC, V63, P144, DOI 10.1016/j.ibmb.2015.06.009; Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Moreno-Habel DA, 2012, J INVERTEBR PATHOL, V110, P92, DOI 10.1016/j.jip.2012.02.007; O'Reilly D., 1992, BACULOVIRUS EXPRESSI, P69; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Paradkar PN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002823; Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109; Qian WL, 2017, J BIOL CHEM, V292, P12460, DOI [10.1074/jbc.M117.775130, 10.1074/jbc.m117.775130]; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tatsuke T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092313; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	46	40	43	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11878	11890		10.1074/jbc.RA117.000194	http://dx.doi.org/10.1074/jbc.RA117.000194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29875158	Green Published, hybrid			2022-12-28	WOS:000440134500020
J	Yuan, L; Singh, D; Buescher, JL; Arikkath, J				Yuan, Li; Singh, Dipika; Buescher, James L.; Arikkath, Jyothi			A role for proteolytic regulation of -catenin in remodeling a subpopulation of dendritic spines in the rodent brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catenin; proteolysis; calpain; neuron; dendritic spine; -catenin; neural development	REPEAT PROTEIN/DELTA-CATENIN; DELTA-CATENIN; HIPPOCAMPAL-NEURONS; SYNAPSE MORPHOGENESIS; CALPAIN; PLASTICITY; CELLS; FAMILY; ACIDIFICATION; LOCALIZATION	Neural wiring and activity are essential for proper brain function and behavioral outputs and rely on mechanisms that guide the formation, elimination, and remodeling of synapses. During development, it is therefore vital that synaptic densities and architecture are tightly regulated to allow for appropriate neural circuit formation and function. -Catenin, a component of the cadherin-catenin cell adhesion complex, has been demonstrated to be a critical regulator of synaptic density and function in the developing central neurons. In this study, we identified forms of -catenin that include only the N-terminal (DcatNT) or the C-terminal (DcatCT) regions. We found that these -catenin forms are differentially expressed in different regions of the male mouse brain. Our results also indicated that in rat primary cortical culture, these forms are generated in an activity-dependent manner by Ca2+-dependent and calpain-mediated cleavage of -catenin or in an activity-independent but lysosome-dependent manner. Functionally, loss of the domain containing the calpain-cleavage sites allowing for generation of DcatCT and DcatNT perturbed the density of a subpopulation of dendritic protrusions in rat hippocampal neurons. This subpopulation likely included protrusions that are either in transition toward becoming mature mushroom spines or in the process of being eliminated. By influencing this subpopulation of spines, proteolytic processing of -catenin can likely regulate the balance between mature and immature dendritic protrusions in coordination with neural activity. We conclude that by undergoing cleavage, -catenin differentially regulates the densities of subpopulations of dendritic spines and contributes to proper neural circuit wiring in the developing brain.	[Yuan, Li; Arikkath, Jyothi] Univ Nebraska Med Ctr, Munroe Meyer Inst, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Yuan, Li; Singh, Dipika; Buescher, James L.; Arikkath, Jyothi] Univ Nebraska Med Ctr, Munroe Meyer Inst, Dev Neurosci, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Arikkath, J (corresponding author), Univ Nebraska Med Ctr, Munroe Meyer Inst, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Arikkath, J (corresponding author), Univ Nebraska Med Ctr, Munroe Meyer Inst, Dev Neurosci, Omaha, NE 68198 USA.	jyothi.arikkath@unmc.edu			Munroe-Meyer Institute; Alzheimer's Association; Nebraska Research Initiative; National Institutes of Health Institutional Development Award (IDeA) from NIGMS [5P20GM103471-10]; Nebraska EPSCoR [EPS-1004094]; National Institutes of Health [1R03MH110726-01]; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH110726] Funding Source: NIH RePORTER	Munroe-Meyer Institute; Alzheimer's Association(Alzheimer's Association); Nebraska Research Initiative; National Institutes of Health Institutional Development Award (IDeA) from NIGMS; Nebraska EPSCoR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by Startup Funds from the Munroe-Meyer Institute, grants from the Alzheimer's Association, The Nebraska Research Initiative, National Institutes of Health Institutional Development Award (IDeA) 5P20GM103471-10 from NIGMS, Nebraska EPSCoR Grant EPS-1004094, and National Institutes of Health Grant 1R03MH110726-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a graduate student fellowship from the University of Nebraska Medical Center.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Amini M, 2013, J NEUROSCI, V33, P5773, DOI 10.1523/JNEUROSCI.4247-12.2013; Arikkath J, 2008, J NEUROSCI, V28, P7047, DOI 10.1523/JNEUROSCI.0451-08.2008; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Bai G, 2011, NEURON, V72, P9, DOI 10.1016/j.neuron.2011.09.012; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Belcaro C, 2015, GENE, V565, P146, DOI 10.1016/j.gene.2015.03.054; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Gu DM, 2011, J BIOL CHEM, V286, P23178, DOI 10.1074/jbc.M110.167544; Gu DM, 2009, J CELL SCI, V122, P4049, DOI 10.1242/jcs.031948; Haggie PM, 2009, J BIOL CHEM, V284, P7681, DOI 10.1074/jbc.M809161200; Harris D. C., 2010, QUANTITATIVE CHEM AN; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Kawamura Y, 1999, NEUROSCI LETT, V277, P185, DOI 10.1016/S0304-3940(99)00875-7; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Markham NO, 2014, MOL BIOL CELL, V25, P2592, DOI 10.1091/mbc.E13-08-0492; Martinez JA, 2010, APOPTOSIS, V15, P1480, DOI 10.1007/s10495-010-0526-4; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Ochiishi T, 2008, MOL CELL NEUROSCI, V39, P499, DOI 10.1016/j.mcn.2008.06.002; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; PAPA M, 1995, J NEUROSCI, V15, P1; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Seong E, 2015, CELL ADHES MIGR, V9, P202, DOI 10.4161/19336918.2014.994919; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Suresh A, 2017, CEREB CORTEX, V27, P4244, DOI 10.1093/cercor/bhx128; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Valcu M, 2011, NAT METHODS, V8, P104, DOI 10.1038/nmeth0211-104; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yuan L, 2017, SEMIN CELL DEV BIOL, V69, P70, DOI 10.1016/j.semcdb.2017.05.027; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	43	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11625	11638		10.1074/jbc.RA118.001966	http://dx.doi.org/10.1074/jbc.RA118.001966			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29875160	Green Published, hybrid			2022-12-28	WOS:000439449700030
J	Ciossani, G; Overlack, K; Petrovic, A; in 't Veld, PJH; Koerner, C; Wohlgemuth, S; Maffini, S; Musacchio, A				Ciossani, Giuseppe; Overlack, Katharina; Petrovic, Arsen; in 't Veld, Pim J. Huis; Koerner, Carolin; Wohlgemuth, Sabine; Maffini, Stefano; Musacchio, Andrea			The kinetochore proteins CENP-E and CENP-F directly and specifically interact with distinct BUB mitotic checkpoint Ser/Thr kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kinetochore; centromere; mitosis; checkpoint control; microtubule; Bub1; BubR1; CENP-E; CENP-F; spindle assembly checkpoint	SPINDLE ASSEMBLY CHECKPOINT; ACCURATE CHROMOSOME SEGREGATION; APICAL NUCLEAR MIGRATION; LIGHT INTERMEDIATE CHAIN; MICROTUBULE CAPTURE; DYNEIN RECRUITMENT; HUMAN-CELLS; ROUGH DEAL; ANALYTICAL ULTRACENTRIFUGATION; STRUCTURAL-ANALYSIS	The segregation of chromosomes during cell division relies on the function of the kinetochores, protein complexes that physically connect chromosomes with microtubules of the spindle. The metazoan proteins, centromere protein E (CENP-E) and CENP-F, are components of a fibrous layer of mitotic kinetochores named the corona. Several of their features suggest that CENP-E and CENP-F are paralogs: they are very large (comprising approximate to 2700 and 3200 residues, respectively), contain abundant predicted coiled-coil structures, are C-terminally prenylated, and are endowed with microtubule-binding sites at their termini. Moreover, CENP-E contains an ATP-hydrolyzing motor domain that promotes microtubule plus end-directed motion. Here, we show that both CENP-E and CENP-F are recruited to mitotic kinetochores independently of the main corona constituent, the Rod/Zwilch/ZW10 (RZZ) complex. We identified specific interactions of CENP-F and CENP-E with budding uninhibited by benzimidazole 1 (BUB1) and BUB1-related (BUBR1) mitotic checkpoint Ser/Thr kinases, respectively, paralogous proteins involved in mitotic checkpoint control and chromosome alignment. Whereas BUBR1 was dispensable for kinetochore localization of CENP-E, BUB1 was stringently required for CENP-F localization. Through biochemical reconstitution, we demonstrated that the CENP-E/BUBR1 and CENP-F/BUB1 interactions are direct and require similar determinants, a dimeric coiled-coil in CENP-E or CENP-F and a kinase domain in BUBR1 or BUB1. Our findings are consistent with the existence of structurally similar BUB1/CENP-F and BUBR1/CENP-E complexes, supporting the notion that CENP-E and CENP-F are evolutionarily related.	[Ciossani, Giuseppe; Overlack, Katharina; Petrovic, Arsen; in 't Veld, Pim J. Huis; Koerner, Carolin; Wohlgemuth, Sabine; Maffini, Stefano; Musacchio, Andrea] Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany; [Musacchio, Andrea] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Univ Str, D-45141 Essen, Germany	Max Planck Society; University of Duisburg Essen	Musacchio, A (corresponding author), Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	andrea.musacchio@mpi-dortmund.mpg.de	Veld, Pim J. Huis in 't/AAJ-9030-2020; Körner, Carolin/AAT-7799-2020	Veld, Pim J. Huis in 't/0000-0003-0234-6390; Musacchio, Andrea/0000-0003-2362-8784; Petrovic, Arsen/0000-0003-4448-4230; Ciossani, Giuseppe/0000-0001-5293-4292	Max Planck Society; European Research Council (ERC) Advanced Investigator Grant RECEPIANCE [669686]; European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant [675737]	Max Planck Society(Max Planck Society); European Research Council (ERC) Advanced Investigator Grant RECEPIANCE(European Research Council (ERC)); European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant	This work was supported by the Max Planck Society, European Research Council (ERC) Advanced Investigator Grant RECEPIANCE (Proposal 669686), and European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant Agreement 675737. The authors declare that they have no conflicts of interest with the contents of this article.	Aebi U., 2006, CELL BIOL LAB HDB, P242, DOI 10.1016B978-012164730-8/50152-0; Akera T, 2015, NAT CELL BIOL, V17, P1124, DOI 10.1038/ncb3219; Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; Baffet AD, 2015, DEV CELL, V33, P703, DOI 10.1016/j.devcel.2015.04.022; Barisic M, 2010, MOL BIOL CELL, V21, P1968, DOI 10.1091/mbc.E09-04-0356; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basto R, 2004, CURR BIOL, V14, P56, DOI 10.1016/j.cub.2003.12.025; Berto A, 2018, EMBO REP, V19, DOI 10.15252/embr.201744742; Bolhy S, 2011, J CELL BIOL, V192, P855, DOI 10.1083/jcb.201007118; Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Breit C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144673; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Caldas GV, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150160; CASIANO CA, 1993, J CELL SCI, V106, P1045; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Cheerambathur DK, 2013, SCIENCE, V342, P1239, DOI 10.1126/science.1246232; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Civril F, 2010, STRUCTURE, V18, P616, DOI 10.1016/j.str.2010.02.014; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Earnshaw WC, 2015, NAT REV MOL CELL BIO, V16, P443, DOI 10.1038/nrm4001; Feng J, 2006, CHROMOSOMA, V115, P320, DOI 10.1007/s00412-006-0049-5; Gama JB, 2017, J CELL BIOL, V216, P943, DOI 10.1083/jcb.201610108; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Holland AJ, 2015, MOL BIOL CELL, V26, P1845, DOI 10.1091/mbc.E14-11-1560; Holt SV, 2005, J CELL SCI, V118, P4889, DOI 10.1242/jcs.02614; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Hu DJK, 2013, CELL, V154, P1300, DOI 10.1016/j.cell.2013.08.024; Huis In 't Veld P. J., 2016, ELIFE, V5; Hussein D, 2002, J CELL SCI, V115, P3403; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; JOKELAINEN PT, 1967, J ULTRA MOL STRUCT R, V19, P19, DOI 10.1016/S0022-5320(67)80058-3; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Krenn V, 2012, J CELL BIOL, V196, P451, DOI 10.1083/jcb.201110013; Kuhn J, 2017, J CELL BIOL, V216, P1533, DOI 10.1083/jcb.201611104; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; LIAO H, 1994, SCIENCE, V265, P394, DOI 10.1126/science.8023161; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Magidson V, 2015, NAT CELL BIOL, V17, P1134, DOI 10.1038/ncb3223; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Matson DR, 2014, J CELL BIOL, V205, P541, DOI 10.1083/jcb.201307137; MCEWEN BF, 1993, J CELL BIOL, V120, P301, DOI 10.1083/jcb.120.2.301; Mische S, 2008, MOL BIOL CELL, V19, P4918, DOI 10.1091/mbc.E08-05-0483; Mosalaganti S, 2017, J CELL BIOL, V216, P961, DOI 10.1083/jcb.201611060; Moudgil DK, 2015, J CELL BIOL, V208, P881, DOI 10.1083/jcb.201412085; Musacchio A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010005; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Musinipally V, 2013, J MOL BIOL, V425, P4427, DOI 10.1016/j.jmb.2013.07.027; Overlack K, 2017, CURR BIOL, V27, P2915, DOI 10.1016/j.cub.2017.08.033; Overlack K, 2015, ELIFE, V4, DOI 10.7554/eLife.05269; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Raaijmakers JA, 2018, CELL REP, V22, P1424, DOI 10.1016/j.celrep.2018.01.034; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Schafer-Hales K, 2007, MOL CANCER THER, V6, P1317, DOI 10.1158/1535-7163.MCT-06-0703; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Silio V, 2015, DEV CELL, V35, P600, DOI 10.1016/j.devcel.2015.11.012; Simoes PA, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212159; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; van Hooff JJE, 2017, EMBO REP, V18, P1559, DOI 10.15252/embr.201744102; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Volkov VA, 2015, J CELL BIOL, V209, P813, DOI 10.1083/jcb.201408083; Weissmann F, 2016, P NATL ACAD SCI USA, V113, pE2564, DOI 10.1073/pnas.1604935113; Williams BC, 1996, J CELL BIOL, V134, P1127, DOI 10.1083/jcb.134.5.1127; Wojcik E, 2001, NAT CELL BIOL, V3, P1001, DOI 10.1038/ncb1101-1001; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Wynne DJ, 2015, J CELL BIOL, V210, P899, DOI 10.1083/jcb.201506020; Yamamoto TG, 2008, J CELL BIOL, V183, P187, DOI 10.1083/jcb.200805185; Yang ZY, 2005, MOL CELL BIOL, V25, P4062, DOI 10.1128/MCB.25.10.4062-4074.2005; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zhang G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8162; ZHU XL, 1995, J BIOL CHEM, V270, P19545, DOI 10.1074/jbc.270.33.19545; ZHU XL, 1995, MOL CELL BIOL, V15, P5017; Zhu XL, 1999, MOL CELL BIOL, V19, P1016	102	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10084	10101		10.1074/jbc.RA118.003154	http://dx.doi.org/10.1074/jbc.RA118.003154			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29748388	Green Published, hybrid			2022-12-28	WOS:000437096700013
J	Kuwabara, MF; Wasano, K; Takahashi, S; Bodner, J; Komori, T; Uemura, S; Zheng, J; Shima, T; Homma, K				Kuwabara, Makoto F.; Wasano, Koichiro; Takahashi, Satoe; Bodner, Justin; Komori, Tomotaka; Uemura, Sotaro; Zheng, Jing; Shima, Tomohiro; Homma, Kazuaki			The extracellular loop of pendrin and prestin modulates their voltage-sensing property	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; molecular motor; electrophysiology; anion transport; cell motility; electromotility; SLC26	OUTER HAIR CELL; ENLARGED VESTIBULAR AQUEDUCT; NONSYNDROMIC HEARING-LOSS; MOTOR PROTEIN; GUINEA-PIG; MOTILITY; MUTATIONS; TRANSPORTER; DEPENDENCE; ZEBRAFISH	Pendrin and prestin belong to the solute carrier 26 (SLC26) family of anion transporters. Prestin is unique among the SLC26 family members in that it displays voltage-driven motor activity (electromotility) and concurrent gating currents that manifest as nonlinear cell membrane electrical capacitance (nonlinear capacitance (NLC)). Although the anion transport mechanism of the SLC26 proteins has begun to be elucidated, the molecular mechanism of electromotility, which is thought to have evolved from an ancestral ion transport mechanism, still remains largely elusive. Here, we demonstrate that pendrin also exhibits large NLC and that charged residues present in one of the extracellular loops of pendrin and prestin play significant roles in setting the voltage-operating points of NLC. Our results suggest that the molecular mechanism responsible for sensing voltage is not unique to prestin among the members of the SLC26 family and that this voltage-sensing mechanism works independently of the anion transport mechanism.	[Kuwabara, Makoto F.; Komori, Tomotaka; Uemura, Sotaro; Shima, Tomohiro] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Wasano, Koichiro; Takahashi, Satoe; Zheng, Jing; Homma, Kazuaki] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, 303 E Chicago Ave, Chicago, IL 60611 USA; [Bodner, Justin] Depaul Univ, Chicago, IL 60614 USA; [Zheng, Jing; Homma, Kazuaki] Northwestern Univ, Hugh Knowles Ctr Clin & Basic Sci Hearing & Its D, Chicago, IL 60608 USA	University of Tokyo; Northwestern University; Feinberg School of Medicine; DePaul University; Northwestern University	Shima, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.; Homma, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, 303 E Chicago Ave, Chicago, IL 60611 USA.	tomohiro.shima@bs.s.u-tokyo.ac.jp; k-homma@northwestern.edu	Wasano, Koichiro/AAY-1414-2020	Homma, Kazuaki/0000-0002-4440-2277; Wasano, Koichiro/0000-0001-7335-3622; Bodner, Justin/0000-0001-7369-7724	National Institutes of Health [DC014553]; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology Grant [JPMJCR14W1]; Ministry of Education, Culture, Sports, Science and Technology, Japan [15K18514, 17K15100]; Hugh Knowles Center; University of Tokyo; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC014553, R56DC011813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency, Core Research for Evolutional Science and Technology Grant; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hugh Knowles Center; University of Tokyo; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health Grant DC014553 (to K. H.); Japan Science and Technology Agency, Core Research for Evolutional Science and Technology Grant JPMJCR14W1 (to S. U.); Ministry of Education, Culture, Sports, Science and Technology, Japan Grants 15K18514 (to T. S.) and 17K15100 (to T. K.); and the Hugh Knowles Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Ashmore J. F, 1990, NEUROSCI RES       S, V12, pS39, DOI DOI 10.1016/0921-8696(90)90007-P; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Beurg M, 2013, NEURON, V79, P69, DOI 10.1016/j.neuron.2013.05.018; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chai YC, 2013, AM J MED GENET A, V161, P2226, DOI 10.1002/ajmg.a.36068; Chang YN, 2017, BIOL CHEM, V398, P165, DOI 10.1515/hsz-2016-0254; Dai P, 2009, PHYSIOL GENOMICS, V38, P281, DOI 10.1152/physiolgenomics.00047.2009; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Deak L, 2005, J PHYSIOL-LONDON, V563, P483, DOI 10.1113/jphysiol.2004.078857; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Geertsma ER, 2015, NAT STRUCT MOL BIOL, V22, P803, DOI 10.1038/nsmb.3091; Gorbunov D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4622; Grandori R, 1997, PROTEIN ENG, V10, P1099, DOI 10.1093/protein/10.9.1099; Homma K, 2013, J BIOL CHEM, V288, P2452, DOI 10.1074/jbc.M112.411579; Homma K, 2011, J BIOL CHEM, V286, P2297, DOI 10.1074/jbc.M110.185694; Homma K, 2010, BBA-BIOMEMBRANES, V1798, P1029, DOI 10.1016/j.bbamem.2010.02.001; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Keller JP, 2014, J NEUROSCI, V34, P1325, DOI 10.1523/JNEUROSCI.4020-13.2014; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim M, 2011, INT J PEDIATR OTORHI, V75, P1538, DOI 10.1016/j.ijporl.2011.09.002; Kowarz E, 2015, BIOTECHNOL J, V10, P647, DOI 10.1002/biot.201400821; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Mistrik P, 2012, J PHYSIOL-LONDON, V590, P5597, DOI 10.1113/jphysiol.2012.241448; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D., 2006, NOVART FDN SYMP, V273, P261; Oliver D., 2006, NOVART FDN SYMP, V273, P253; Oliver Dominik, 2006, Novartis Found Symp, V273, P244; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Schaechinger TJ, 2011, EMBO J, V30, P2793, DOI 10.1038/emboj.2011.202; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sloan-Heggen CM, 2016, HUM GENET, V135, P441, DOI 10.1007/s00439-016-1648-8; Sloan-Heggen CM, 2015, J MED GENET, V52, P823, DOI 10.1136/jmedgenet-2015-103389; Tan XD, 2012, J CELL SCI, V125, P1039, DOI 10.1242/jcs.097337; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054388; Tang J, 2011, J BIOL CHEM, V286, P31014, DOI 10.1074/jbc.M111.259564; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Yao GD, 2013, ACTA OTO-LARYNGOL, V133, P833, DOI 10.3109/00016489.2013.777160; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049984	52	11	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9970	9980		10.1074/jbc.RA118.001831	http://dx.doi.org/10.1074/jbc.RA118.001831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29777056	hybrid, Green Published			2022-12-28	WOS:000437096700004
J	Arshad, N; Cresswell, P				Arshad, Najla; Cresswell, Peter			Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						major histocompatibility complex (MHC); antigen presentation; antigen processing; protein export; tumor immunology; immunotherapy; calreticulin; myeloproliferative neoplasms; peptide-loading complex; protein secretion	MAJOR HISTOCOMPATIBILITY COMPLEX; MUTANT MYELOPROLIFERATIVE NEOPLASMS; THROMBOPOIETIN RECEPTOR; CANCER-IMMUNOTHERAPY; SOMATIC MUTATIONS; HLA-B; MOLECULES; TAPASIN; CELLS; MECHANISM	Major histocompatibility complex-I-(2)m dimers (MHC-I) bind peptides derived from intracellular proteins, enabling the immune system to distinguish between normal cells and those expressing pathogen-derived or mutant proteins. The peptides bind to MHC-I in the endoplasmic reticulum (ER), and this binding is facilitated by the peptide loading complex (PLC), which contains calreticulin (CRT). CRT associates with MHC-I via a conserved glycan present on MHC-I and recruits it to the PLC for peptide binding. Somatic frameshift mutations in CRT (CRT-FS) drive the proliferation of a subset of myeloproliferative neoplasms, which are chronic blood tumors. All CRT-FS proteins have a C-terminal sequence lacking the normal ER-retention signal and possessing a net negative charge rather than the normal positive charge. We characterized the effect of CRT-FS on antigen presentation by MHC-I in human cells. Our results indicate that CRT-FS cannot mediate CRT's peptide loading function in the PLC. Cells lacking CRT exhibited reduced surface MHC-I levels, consistent with reduced binding of high-affinity peptides, and this was not reversed by CRT-FS expression. CRT-FS was secreted and not detectably associated with the PLC, leading to poor MHC-I recruitment, although CRT-FS could still associate with MHC-I in a glycan-dependent manner. The addition of an ER-retention sequence to CRT-FS restored its association with the PLC but did not rescue MHC-I recruitment or its surface expression, indicating that the CRT-FS mutants functionally compromise the PLC. MHC-I down-regulation permits tumor cells to evade immune surveillance, and these findings may therefore be relevant for designing effective immunotherapies for managing myeloproliferative neoplasms.	[Arshad, Najla; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Cresswell, Peter] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Arshad, N; Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA.	najla.arshad@yale.edu; peter.cresswell@yale.edu	Arshad, Najla/H-9453-2019	Arshad, Najla/0000-0001-5553-311X	National Institutes of Health Grant [RO1-AI097206]; CRI Irvington Postdoctoral Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097206] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRI Irvington Postdoctoral Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant RO1-AI097206 (to P.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the CRI Irvington Postdoctoral Fellowship Program.	Al-Akhrass H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01172-5; Araki M, 2017, CANCER SCI, V108, P1907, DOI 10.1111/cas.13327; Araki M, 2016, BLOOD, V127, P1307, DOI 10.1182/blood-2015-09-671172; Barkal AA, 2018, NAT IMMUNOL, V19, P76, DOI 10.1038/s41590-017-0004-z; BARNSTABLE CJ, 1978, BRIT MED BULL, V34, P241, DOI 10.1093/oxfordjournals.bmb.a071504; Beatty GL, 2015, CLIN CANCER RES, V21, P687, DOI 10.1158/1078-0432.CCR-14-1860; Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Byrne JC, 2013, J IMMUNOL, V190, P5207, DOI 10.4049/jimmunol.1300057; Cathro HP, 2010, CANCER IMMUNOL IMMUN, V59, P465, DOI 10.1007/s00262-009-0765-9; Chachoua I, 2016, BLOOD, V127, P1325, DOI 10.1182/blood-2015-11-681932; Cooper A, 2006, J BIOL CHEM, V281, P16563, DOI 10.1074/jbc.M601418200; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Dierssen JWF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-33; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Elf S, 2016, CANCER DISCOV, V6, P368, DOI 10.1158/2159-8290.CD-15-1434; Everett MW, 2007, J IMMUNOL, V179, P7646, DOI 10.4049/jimmunol.179.11.7646; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbati MR, 2016, AM J HEMATOL, V91, P211, DOI 10.1002/ajh.24245; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guo D., 2015, J INTEGRATIVE BIOINF, V12, P35; Han LJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0275-0; Hermouet S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/145293; Hofmann S, 2011, CURR CANCER DRUG TAR, V11, P72, DOI 10.2174/156800911793743682; Holmstrom MO, 2018, LEUKEMIA, V32, P429, DOI 10.1038/leu.2017.214; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Jiang JS, 2017, SCIENCE, V358, P1064, DOI 10.1126/science.aao5154; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Li J, 2018, BLOOD, V131, P649, DOI 10.1182/blood-2017-09-806356; Liu CZ, 2010, BBA-MOL CELL RES, V1803, P544, DOI 10.1016/j.bbamcr.2010.03.001; Liu HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002690; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Nagler E, 2017, TRANSL CANCER RES, V6, P86, DOI 10.21037/tcr.2017.02.14; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Panter MS, 2012, J BIOL CHEM, V287, P31172, DOI 10.1074/jbc.M112.387704; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Patel U, 2017, CL LYMPH MYELOM LEUK, V17, pS62, DOI 10.1016/j.clml.2017.02.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietra D, 2016, LEUKEMIA, V30, P431, DOI 10.1038/leu.2015.277; Pocanschi CL, 2011, J BIOL CHEM, V286, P27266, DOI 10.1074/jbc.M111.258467; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Shide K, 2017, LEUKEMIA, V31, P1136, DOI 10.1038/leu.2016.308; Sim ACN, 2013, SCI REP-UK, V3, DOI 10.1038/srep03232; Stahlschmidt W, 2014, J BIOL CHEM, V289, P4906, DOI 10.1074/jbc.M113.535211; STAM NJ, 1986, J IMMUNOL, V137, P2299; Theocharides APA, 2016, BLOOD, V127, P3253, DOI 10.1182/blood-2016-02-696310; Thomas C, 2017, SCIENCE, V358, P1060, DOI 10.1126/science.aao6001; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108	60	41	41	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9555	9569		10.1074/jbc.RA118.002836	http://dx.doi.org/10.1074/jbc.RA118.002836			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29769311	Green Published, hybrid			2022-12-28	WOS:000436102300001
J	Davis, I; Yang, Y; Wherritt, D; Liu, AM				Davis, Ian; Yang, Yu; Wherritt, Daniel; Liu, Aimin			Reassignment of the human aldehyde dehydrogenase ALDH8A1 (ALDH12) to the kynurenine pathway in tryptophan catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aldehyde dehydrogenase; 2-aminomuconate semialdehyde dehydrogenase; tryptophan catabolism; retinal metabolism; NAD biosynthesis; biodegradation; serotonin; neurological disease; kynurenine pathway; retinal dehydrogenase	SEMIALDEHYDE DECARBOXYLASE ACMSD; NAD BIOSYNTHESIS; IDENTIFICATION; DEGRADATION; EXPRESSION; MECHANISM; CATALYSIS; SEQUENCE; RING	The kynurenine pathway is the primary route for l-tryptophan degradation in mammals. Intermediates and side products of this pathway are involved in immune response and neurodegenerative diseases. This makes the study of enzymes, especially those from mammalian sources, of the kynurenine pathway worthwhile. Recent studies on a bacterial version of an enzyme of this pathway, 2-aminomuconate semialdehyde (2-AMS) dehydrogenase (AMSDH), have provided a detailed understanding of the catalytic mechanism and identified residues conserved for muconate semialdehyde recognition and activation. Findings from the bacterial enzyme have prompted the reconsideration of the function of a previously identified human aldehyde dehydrogenase, ALDH8A1 (or ALDH12), which was annotated as a retinal dehydrogenase based on its ability to preferentially oxidize 9-cis-retinal over trans-retinal. Here, we provide compelling bioinformatics and experimental evidence that human ALDH8A1 should be reassigned to the missing 2-AMS dehydrogenase of the kynurenine metabolic pathway. For the first time, the product of the semialdehyde oxidation by AMSDH is also revealed by NMR and high-resolution MS. We found that ALDH8A1 catalyzes the NAD(+)-dependent oxidation of 2-AMS with a catalytic efficiency equivalent to that of AMSDH from the bacterium Pseudomonas fluorescens. Substitution of active-site residues required for substrate recognition, binding, and isomerization in the bacterial enzyme resulted in human ALDH8A1 variants with 160-fold increased K-m or no detectable activity. In conclusion, this molecular study establishes an additional enzymatic step in an important human pathway for tryptophan catabolism.	[Davis, Ian; Yang, Yu; Wherritt, Daniel; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Davis, Ian] Univ Texas San Antonio, San Antonio, TX USA; [Davis, Ian] Georgia State Univ, Atlanta, GA 30303 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University System of Georgia; Georgia State University	Liu, AM (corresponding author), Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA.	Feradical@utsa.edu	Liu, Aimin/C-1572-2017; Wherritt, Daniel/AAY-6852-2020	Liu, Aimin/0000-0002-4182-8176; Wherritt, Daniel/0000-0002-8616-9864; Yang, Yu/0000-0001-5305-2435; Davis, Ian/0000-0002-1566-4972	National Institutes of Health [G12MD007591]; National Science Foundation [1625963]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108988, R01GM107529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107985] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER; Division Of Chemistry [1625963] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Dr. Wendell Griffith for assisting with MS analysis. The mass spectrometry facility was sponsored by National Institutes of Health Grant G12MD007591. The NMR spectrometer is a shared instrument sponsored by the National Science Foundation under Award 1625963.	Ananieva Elitsa, 2015, World J Biol Chem, V6, P281, DOI 10.4331/wjbc.v6.i4.281; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; Colabroy KL, 2005, J AM CHEM SOC, V127, P840, DOI 10.1021/ja0446395; Davis I, 2015, EXPERT REV NEUROTHER, V15, P719, DOI 10.1586/14737175.2015.1049999; Fukuoka SI, 2002, J BIOL CHEM, V277, P35162, DOI 10.1074/jbc.M200819200; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; He ZQ, 1998, J BACTERIOL, V180, P4591, DOI 10.1128/JB.180.17.4591-4595.1998; Huo L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6935; Huo L, 2015, PROTEINS, V83, P178, DOI 10.1002/prot.24722; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; Huo L, 2012, BIOCHEMISTRY-US, V51, P5811, DOI 10.1021/bi300635b; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2007, J AM CHEM SOC, V129, P9278, DOI 10.1021/ja073648l; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Lima WC, 2009, MOL BIOL EVOL, V26, P399, DOI 10.1093/molbev/msn261; Lin M, 2000, J BIOL CHEM, V275, P40106, DOI 10.1074/jbc.M008027200; Muraki T, 2003, APPL ENVIRON MICROB, V69, P1564, DOI 10.1128/AEM.69.3.1564-1572.2003; NISHINO SF, 1993, APPL ENVIRON MICROB, V59, P2520, DOI 10.1128/AEM.59.8.2520-2525.1993; NISHIZUKA Y, 1965, J BIOL CHEM, V240, P733; Park J, 2013, J BIOL CHEM, V288, P15760, DOI 10.1074/jbc.M113.460428; Pellicciari R, 2018, J MED CHEM, V61, P745, DOI 10.1021/acs.jmedchem.7b01254; Phillips RS, 2017, BIOORG MED CHEM LETT, V27, P1705, DOI 10.1016/j.bmcl.2017.02.080; Phillips RS, 2014, ARCH BIOCHEM BIOPHYS, V544, P69, DOI 10.1016/j.abb.2013.10.020; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; WHITMAN CP, 1991, J AM CHEM SOC, V113, P3154, DOI 10.1021/ja00008a052; Wogulis M, 2008, BIOCHEMISTRY-US, V47, P1608, DOI 10.1021/bi701172v; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang Y, 2016, J BIOL CHEM, V291, P26252, DOI 10.1074/jbc.M116.759712	34	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9594	9603		10.1074/jbc.RA118.003320	http://dx.doi.org/10.1074/jbc.RA118.003320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29703752	hybrid, Green Published			2022-12-28	WOS:000436102300004
J	Hamlin, AN; Chinnarasu, S; Ding, YY; Xian, XD; Herz, J; Jaeschke, A; Hui, DY				Hamlin, Allyson N.; Chinnarasu, Sivaprakasam; Ding, Yinyuan; Xian, Xunde; Herz, Joachim; Jaeschke, Anja; Hui, David Y.			Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein receptor; liver metabolism; lipoprotein receptor-related protein (LPR); fibrosis; cholesterol metabolism; inflammation	FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; MICE; INFLAMMATION; EXPRESSION; GENE; LRP	Reduced low-density lipoprotein receptor-related protein-1 (LRP1) expression in the liver is associated with poor prognosis of liver cirrhosis and hepatocellular carcinoma. Previous studies have shown that hepatic LRP1 deficiency exacerbates palmitate-induced steatosis and toxicity in vitro and also promotes high-fat diet-induced hepatic insulin resistance and hepatic steatosis in vivo. The current study examined the impact of liver-specific LRP1 deficiency on disease progression to steatohepatitis. hLrp1(+/+) mice with normal LRP1 expression and hLrp1(-/-) mice with hepatocyte-specific LRP1 inactivation were fed a high-fat, high-cholesterol (HFHC) diet for 16 weeks. Plasma lipid levels and body weights were similar between both groups. However, the hLrp1(-/-) mice displayed significant increases in liver steatosis, inflammation, and fibrosis compared with the hLrp1(+/+) mice. Hepatocyte cell size, liver weight, and cell death, as measured by serum alanine aminotransferase levels, were also significantly increased in hLrp1(-/-) mice. The accelerated liver pathology observed in HFHC-fed hLrp1(-/-) mice was associated with reduced expression of cholesterol excretion and bile acid synthesis genes, leading to elevated immune cell infiltration and inflammation. Additional in vitro studies revealed that cholesterol loading induced significantly higher expression of genes responsible for hepatic stellate cell activation and fibrosis in hLrp1(-/-) hepatocytes than in hLrp1(+/+) hepatocytes. These results indicate that hepatic LRP1 deficiency accelerates liver disease progression by increasing hepatocyte death, thereby causing inflammation and increasing sensitivity to cholesterol-induced pro-fibrotic gene expression to promote steatohepatitis. Thus, LRP1 may be a genetic variable that dictates individual susceptibility to the effects of dietary cholesterol on liver diseases.	[Hamlin, Allyson N.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Metab Dis Res Ctr, Cincinnati, OH 45237 USA; [Chinnarasu, Sivaprakasam; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Metab Dis Res Ctr, Cincinnati, OH 45237 USA; [Ding, Yinyuan; Xian, Xunde; Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurotherapeut, Dallas, TX 75390 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Metab Dis Res Ctr, Dept Pathol, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	huidy@ucmail.uc.edu	Xian, Xunde/B-9490-2012; Chinnarasu, Sivaprakasam/AAU-4373-2020	Xian, Xunde/0000-0003-3059-1254; COJANDARAJ, Dr LOUIS/0000-0002-5264-6546; Ding, Yinyuan/0000-0003-4918-8457	National Institutes of Health Grants [RO1 DK074932, R37 HL63762, RO1 NS093382, 1RF1 AG053391]; Consortium for Frontotemporal Dementia Research; Bright Focus Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK074932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG053391] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; Bright Focus Foundation(BrightFocus Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants RO1 DK074932 (to D.Y.H.) and R37 HL63762, RO1 NS093382, and 1RF1 AG053391 (to J.H.) and by the Consortium for Frontotemporal Dementia Research and the Bright Focus Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basford JE, 2011, J BIOL CHEM, V286, P13079, DOI 10.1074/jbc.M111.229369; Day CP, 2011, CLIN MED, V11, P176, DOI 10.7861/clinmedicine.11-2-176; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ding YY, 2016, EBIOMEDICINE, V7, P135, DOI 10.1016/j.ebiom.2016.04.002; Ferrell JM, 2016, J LIPID RES, V57, P1144, DOI 10.1194/jlr.M064709; Hamlin AN, 2016, J BIOL CHEM, V291, P16610, DOI 10.1074/jbc.M116.717744; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Huang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032775; Ioannou GN, 2009, HEPATOLOGY, V50, P175, DOI 10.1002/hep.22941; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kneeman JM, 2012, THER ADV GASTROENTER, V5, P199, DOI 10.1177/1756283X11430859; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Machado MV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060857; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; NISHINA PM, 1993, J LIPID RES, V34, P1413; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xian XD, 2017, ELIFE, V6, DOI 10.75549/eLife.29292; Zhang J, 2017, EBIOMEDICINE, V15, P173, DOI 10.1016/j.ebiom.2016.12.016; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006853	29	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9674	9684		10.1074/jbc.RA118.001952	http://dx.doi.org/10.1074/jbc.RA118.001952			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29752404	hybrid, Green Published			2022-12-28	WOS:000436102300012
J	Iyer, GR; Singh, S; Kaur, I; Agarwal, S; Siddiqui, MA; Bansal, A; Kumar, G; Saini, E; Paul, G; Mohmmed, A; Chitnis, CE; Malhotra, P				Iyer, Gayatri R.; Singh, Shailja; Kaur, Inderjeet; Agarwal, Shalini; Siddiqui, Mansoor A.; Bansal, Abhisheka; Kumar, Gautam; Saini, Ekta; Paul, Gourab; Mohmmed, Asif; Chitnis, Chetan E.; Malhotra, Pawan			Calcium-dependent phosphorylation of Plasmodium falciparum serine repeat antigen 5 triggers merozoite egress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoproteomics; plasmodium; posttranslational modification (PTM); protein phosphorylation; malaria; CDPK1; merozoites egress; Plasmodium falciparum; SERA5	MALARIA PARASITE DEVELOPMENT; PROTEIN-KINASE; CYSTEINE PROTEASE; HOST ERYTHROCYTE; ARTEMISININ RESISTANCE; LIFE-CYCLE; SERA5; INHIBITION; EXPRESSION; IDENTIFICATION	The human malaria parasite Plasmodium falciparum proliferates in red blood cells following repeated cycles of invasion, multiplication, and egress. P. falciparum serine repeat antigen 5 (PfSERA5), a putative serine protease, plays an important role in merozoite egress. However, regulation of its activity leading to merozoite egress is poorly understood. In this study, we show that PfSERA5 undergoes phosphorylation prior to merozoite egress. Immunoprecipitation of parasite lysates using anti-PfSERA5 serum followed by MS analysis identified calcium-dependent protein kinase 1 (PfCDPK1) as an interacting kinase. Association of PfSERA5 with PfCDPK1 was corroborated by co-sedimentation, co-immunoprecipitation, and co-immunolocalization analyses. Interestingly, PfCDPK1 phosphorylated PfSERA5 in vitro in the presence of Ca2+ and enhanced its proteolytic activity. A PfCDPK1 inhibitor, purfalcamine, blocked the phosphorylation and activation of PfSERA5 both in vitroas well as in schizonts, which, in turn, blocked merozoite egress. Together, these results suggest that phosphorylation of PfSERA5 by PfCDPK1 following a rise in cytosolic Ca2+ levels activates its proteolytic activity to trigger merozoite egress.	[Iyer, Gayatri R.; Singh, Shailja; Kaur, Inderjeet; Agarwal, Shalini; Siddiqui, Mansoor A.; Bansal, Abhisheka; Kumar, Gautam; Saini, Ekta; Paul, Gourab; Mohmmed, Asif; Chitnis, Chetan E.; Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, Malaria Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Singh, Shailja; Chitnis, Chetan E.] Inst Pasteur, Dept Parasites & Insect Vectors, 25-28 Rue Doctor Roux, F-75015 Paris, France; [Singh, Shailja] Jawaharlal Nehru Univ, Special Ctr Mol Med, Delhi, India; [Agarwal, Shalini] Jawaharlal Nehru Univ, Sch Life Sci, Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Chitnis, CE; Malhotra, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.; Chitnis, CE (corresponding author), Inst Pasteur, Dept Parasites & Insect Vectors, 25-28 Rue Doctor Roux, F-75015 Paris, France.	chetan.chitnis@pasteur.fr; pawanmal@gmail.com	Bansal, Abhisheka/ABC-7871-2020	Bansal, Abhisheka/0000-0002-2959-8494; Chitnis, Chetan/0000-0002-8773-9865; Kaur, Inderjeet/0000-0001-8778-1396; Saini, Ekta/0000-0001-5701-6108; Agarwal, Shalini/0000-0002-5526-6872; Iyer, Gayatri/0000-0002-8100-0832	Department of Biotechnology, Government of India [BT/01/CEIB/11/V/01]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India (BT/01/CEIB/11/V/01). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal S, 2013, CELL MICROBIOL, V15, P910, DOI 10.1111/cmi.12086; Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Azevedo MF, 2013, BIOCHEM J, V452, P433, DOI 10.1042/BJ20130124; Bansal A, 2013, J BIOL CHEM, V288, P1590, DOI 10.1074/jbc.M112.411934; BZIK DJ, 1988, MOL BIOCHEM PARASIT, V30, P279, DOI 10.1016/0166-6851(88)90097-7; Collins CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006453; Dua M, 2001, MOL BIOCHEM PARASIT, V116, P95, DOI 10.1016/S0166-6851(01)00306-1; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; HADLEY T, 1983, EXP PARASITOL, V55, P306, DOI 10.1016/0014-4894(83)90027-9; Hanspal M, 2002, BLOOD, V100, P1048, DOI 10.1182/blood-2002-01-0101; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Kanodia S, 2014, BBA-GEN SUBJECTS, V1840, P2765, DOI 10.1016/j.bbagen.2014.04.013; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kaur I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35432; Kiefer MC, 1996, MOL BIOCHEM PARASIT, V78, P55, DOI 10.1016/S0166-6851(96)02607-2; Korde R, 2008, J MED CHEM, V51, P3116, DOI 10.1021/jm070735f; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Le Bonniec S, 1999, J BIOL CHEM, V274, P14218, DOI 10.1074/jbc.274.20.14218; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; LYON JA, 1986, J IMMUNOL, V136, P2245; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Palacpac NMQ, 2011, VACCINE, V29, P5837, DOI 10.1016/j.vaccine.2011.06.052; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Soni S, 2005, BLOOD CELL MOL DIS, V35, P201, DOI 10.1016/j.bcmd.2005.05.006; Stallmach R, 2015, MOL MICROBIOL, V96, P368, DOI 10.1111/mmi.12941; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	41	17	18	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9736	9746		10.1074/jbc.RA117.001540	http://dx.doi.org/10.1074/jbc.RA117.001540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29716996	hybrid, Green Published			2022-12-28	WOS:000436102300018
J	Keable, SM; Zadvornyy, OA; Johnson, LE; Ginovska, B; Rasmussen, AJ; Danyal, K; Eilers, BJ; Prussia, GA; LeVan, AX; Raugei, S; Seefeldt, LC; Peters, JW				Keable, Stephen M.; Zadvornyy, Oleg A.; Johnson, Lewis E.; Ginovska, Bojana; Rasmussen, Andrew J.; Danyal, Karamatullah; Eilers, Brian J.; Prussia, Gregory A.; LeVan, Axl X.; Raugei, Simone; Seefeldt, Lance C.; Peters, John W.			Structural characterization of the P1+ intermediate state of the P-cluster of nitrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidation-reduction (redox); metalloprotein; nitrogenase; enzyme structure; computational biology; nitrogen fixation; nitrogen reduction; P-cluster of MoFe protein; poised states; redox mediators; redox-dependent ligand exchange; [8Fe-7S] cluster	MOLECULAR-ORBITAL METHODS; MOFE-PROTEIN; FE PROTEIN; BASIS-SETS; ELECTRON-TRANSFER; REDOX STATE; MECHANISM; SUBSTRATE; ENERGY; APPROXIMATION	Nitrogenase is the enzyme that reduces atmospheric dinitrogen (N-2) to ammonia (NH3) in biological systems. It catalyzes a series of single-electron transfers from the donor iron protein (Fe protein) to the molybdenum-iron protein (MoFe protein) that contains the iron-molybdenum cofactor (FeMo-co) sites where N-2 is reduced to NH3. The P-cluster in the MoFe protein functions in nitrogenase catalysis as an intermediate electron carrier between the external electron donor, the Fe protein, and the FeMo-co sites of the MoFe protein. Previous work has revealed that the P-cluster undergoes redox-dependent structural changes and that the transition from the all-ferrous resting (P-N) state to the two-electron oxidized P2+ state is accompanied by protein serine hydroxyl and backbone amide ligation to iron. In this work, the MoFe protein was poised at defined potentials with redox mediators in an electrochemical cell, and the three distinct structural states of the P-cluster (P2+, P1+, and P-N) were characterized by X-ray crystallography and confirmed by computational analysis. These analyses revealed that the three oxidation states differ in coordination, implicating that the P1+ state retains the serine hydroxyl coordination but lacks the backbone amide coordination observed in the P2+ states. These results provide a complete picture of the redox-dependent ligand rearrangements of the three P-cluster redox states.	[Keable, Stephen M.; Eilers, Brian J.; Prussia, Gregory A.; LeVan, Axl X.; Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Zadvornyy, Oleg A.; Raugei, Simone; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99163 USA; [Johnson, Lewis E.; Ginovska, Bojana; Raugei, Simone; Seefeldt, Lance C.; Peters, John W.] Pacific Northwest Natl Lab, Richland, WA 99352 USA; [Rasmussen, Andrew J.; Danyal, Karamatullah; Seefeldt, Lance C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Johnson, Lewis E.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	Montana State University System; Montana State University Bozeman; Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Utah System of Higher Education; Utah State University; University of Washington; University of Washington Seattle	Peters, JW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99163 USA.; Seefeldt, LC (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	lance.seefeldt@usu.edu; jw.peters@wsu.edu	Zadvornyy, Oleg/P-5294-2019	Zadvornyy, Oleg A./0000-0002-5374-6856	United States Department of Energy (DOE), Office of Science, Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; DOE's Office of Biological and Environmental Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy (DOE), Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE's Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, is supported by the United States Department of Energy (DOE), Office of Science, Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). Computer resources were provided by the W. R. Wiley Environmental Molecular Sciences Laboratory, a DOE Office of Science User Facility, located at Pacific Northwest National Laboratory and sponsored by DOE's Office of Biological and Environmental Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; BURGESS BK, 1980, BIOCHIM BIOPHYS ACTA, V614, P196, DOI 10.1016/0005-2744(80)90180-1; Chan JM, 1999, BIOCHEMISTRY-US, V38, P5779, DOI 10.1021/bi982866b; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Danyal K, 2015, BIOCHEMISTRY-US, V54, P2456, DOI 10.1021/acs.biochem.5b00140; Danyal K, 2011, BIOCHEMISTRY-US, V50, P9255, DOI 10.1021/bi201003a; Danyal K, 2010, J AM CHEM SOC, V132, P13197, DOI 10.1021/ja1067178; Duval S, 2013, P NATL ACAD SCI USA, V110, P16414, DOI 10.1073/pnas.1311218110; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Kelly CP, 2006, J PHYS CHEM B, V110, P16066, DOI 10.1021/jp063552y; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Lanzilotta WN, 1997, BIOCHEMISTRY-US, V36, P12976, DOI 10.1021/bi9715371; Lanzilotta WN, 1998, BIOCHEMISTRY-US, V37, P11376, DOI 10.1021/bi980048d; Li L, 2013, J CHEM THEORY COMPUT, V9, P2126, DOI 10.1021/ct400065j; LINDAHL PA, 1988, J BIOL CHEM, V263, P19412; LOWE DJ, 1993, BIOCHEM J, V292, P93, DOI 10.1042/bj2920093; Lowery TJ, 2006, P NATL ACAD SCI USA, V103, P17131, DOI 10.1073/pnas.0603223103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Pitera JW, 2001, BIOPHYS J, V80, P2546, DOI 10.1016/S0006-3495(01)76226-1; Rupnik K, 2012, J AM CHEM SOC, V134, P13749, DOI 10.1021/ja304077h; Sarma R, 2010, J INORG BIOCHEM, V104, P385, DOI 10.1016/j.jinorgbio.2009.11.009; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; TITTSWORTH RC, 1993, J AM CHEM SOC, V115, P9763, DOI 10.1021/ja00074a050; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang ZY, 2011, METHODS MOL BIOL, V766, P9, DOI 10.1007/978-1-61779-194-9_2; Yoo SJ, 2000, J AM CHEM SOC, V122, P4926, DOI 10.1021/ja000254k	40	25	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9629	9635		10.1074/jbc.RA118.002435	http://dx.doi.org/10.1074/jbc.RA118.002435			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29720402	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000436102300007
J	Park, S; Cui, J; Yu, WS; Wu, L; Carmon, KS; Liu, QYJ				Park, Soohyun; Cui, Jie; Yu, Wangsheng; Wu, Ling; Carmon, Kendra S.; Liu, Qingyun J.			Differential activities and mechanisms of the four R-spondins in potentiating Wnt/-catenin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; stem cells; 7-helix receptor; Wnt signaling; beta-catenin (-catenin); LGR4; LGR5; organoids; R-spondin	HIGH-AFFINITY LIGAND; STEM-CELLS; VASCULAR DEVELOPMENT; R-SPONDIN-4 RSPO4; CRYSTAL-STRUCTURE; CANCER CELLS; COLON-CANCER; LGR5; RECEPTORS; COMPLEX	The four R-spondins (RSPO1-4) strongly potentiate Wnt signaling and play critical roles in normal development, adult stem cell survival, and cancer development and aggressiveness. All four RSPOs have been suggested to potentiate Wnt signaling by binding to three related receptors, i.e. leucine-rich repeat-containing, G protein-coupled receptors 4, 5, and 6 (LGR4/5/6), and then inducing the clearance of two E3 ubiquitin ligases (RNF43 and ZNRF3) that otherwise would ubiquitinate Wnt receptors for degradation. Here, we show that RSPO1-4 have differential dependence on LGRs in potentiating Wnt/-catenin signaling and that RSPO2 can enhance this pathway without any LGR. LGR4 knockout (LGR4KO) in HEK293 cells completely abrogated the Wnt/-catenin signaling response to RSPO1 and RSPO4 and strongly impaired the response to RSPO3. RSPO2, however, retained robust activity albeit with decreased potency. Complete rescue of RSPO1-4 activity in LGR4KO cells required the seven-transmembrane domain of LGR4. Furthermore, an RSPO2 mutant with normal binding affinity to ZNRF3 but no or little binding to LGR4 or LGR5 still potentiated Wnt/-catenin signaling in vitro, supported the growth of intestinal organoids ex vivo, and stimulated intestinal crypt growth in vivo. Mechanistically, RSPO2 could increase Wnt receptor levels in the absence of any LGR without affecting ZNRF3 endocytosis and stability. These findings suggest that RSPO1-4 use distinct mechanisms in regulating Wnt and other signaling pathways, which have important implications for understanding the pleiotropic functions of RSPOs and LGRs in both normal and cancer development.	[Park, Soohyun; Yu, Wangsheng; Wu, Ling; Carmon, Kendra S.; Liu, Qingyun J.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, 1825 Pressler St, Houston, TX 77030 USA; [Park, Soohyun; Yu, Wangsheng; Wu, Ling; Carmon, Kendra S.; Liu, Qingyun J.] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Cui, Jie] Wntrix Inc, Houston, TX 77021 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Liu, QYJ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, 1825 Pressler St, Houston, TX 77030 USA.	Qingyun.liu@uth.tmc.edu		park, soohyun/0000-0001-9847-9985	Cancer Prevention and Research Institute of Texas [RP160235, RP170245]; Janice D. Gordon endowment for bowel cancer research	Cancer Prevention and Research Institute of Texas; Janice D. Gordon endowment for bowel cancer research	This work was supported in part by Cancer Prevention and Research Institute of Texas Grants RP160235 and RP170245 and the Janice D. Gordon endowment for bowel cancer research (to Q.J.L). Q.J.L. is a cofounder of Wntrix, and J.C. is a full-time employee of Wntrix.	Aoki M, 2008, DEV GROWTH DIFFER, V50, P85, DOI 10.1111/j.1440-169x.2007.00978.x; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bergmann C, 2006, AM J HUM GENET, V79, P1105, DOI 10.1086/509789; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Carmon KS, 2017, J BIOL CHEM, V292, P14989, DOI 10.1074/jbc.M117.786798; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chartier C, 2016, CANCER RES, V76, P713, DOI 10.1158/0008-5472.CAN-15-0561; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130348; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lebensohn AM, 2018, ELIFE, V7, DOI 10.7554/eLife.33126; Moad HE, 2013, BIOCHEMISTRY-US, V52, P7295, DOI 10.1021/bi401090h; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Peng WC, 2013, CELL REP, V3, P1885, DOI 10.1016/j.celrep.2013.06.009; Ren ZM, 2018, BLOOD, V131, P982, DOI 10.1182/blood-2017-07-797050; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Warner ML, 2015, MOL PHARMACOL, V87, P410, DOI 10.1124/mol.114.095133; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Xie Y, 2013, EMBO REP, V14, P1120, DOI 10.1038/embor.2013.167; Xu JG, 2015, J BIOL CHEM, V290, P2455, DOI 10.1074/jbc.M114.599134; Xu K, 2013, STRUCTURE, V21, P1683, DOI 10.1016/j.str.2013.07.001; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Yi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078144; Zebisch M, 2015, J STRUCT BIOL, V191, P149, DOI 10.1016/j.jsb.2015.05.008; Zebisch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3787	43	43	45	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9759	9769		10.1074/jbc.RA118.002743	http://dx.doi.org/10.1074/jbc.RA118.002743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29752411	Green Published, hybrid			2022-12-28	WOS:000436102300020
J	Abe, K; Sunagawa, N; Terada, T; Takahashi, Y; Arakawa, T; Igarashi, K; Samejima, M; Nakai, H; Taguchi, H; Nakajima, M; Fushinobu, S				Abe, Koichi; Sunagawa, Naoki; Terada, Tohru; Takahashi, Yuta; Arakawa, Takatoshi; Igarashi, Kiyohiko; Samejima, Masahiro; Nakai, Hiroyuki; Taguchi, Hayao; Nakajima, Masahiro; Fushinobu, Shinya			Structural and thermodynamic insights into beta-1,2-glucooligosaccharide capture by a solute-binding protein in Listeria innocua	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; CYCLIC-BETA-GLUCANS; MOLECULAR-DYNAMICS; EVOLUTIONARY CONSERVATION; STRUCTURE VALIDATION; PERIPLASMIC GLUCANS; ACTIVE-TRANSPORT; MALTOSE; OLIGOSACCHARIDES; RECOGNITION	beta-1,2-Glucans are bacterial carbohydrates that exist in cyclic or linear forms and play an important role in infections and symbioses involving Gram-negative bacteria. Although several beta-1,2-glucan-associated enzymes have been characterized, little isknownabouthow beta-1,2-glucan and its shorter oligosaccharides (Sop n s) are captured and imported into the bacterial cell. Here, we report the biochemical and structural characteristics of the Sop n -binding protein (SO-BP, Lin1841) associated with the ATP-binding cassette (ABC) transporter from the Grampositive bacterium Listeria innocua. Calorimetric analysis revealed that SO-BP specifically binds to Sop n s with a degree of polymerization of 3 or more, with K d values in the micromolar range. The crystal structures of SO-BP in an unliganded open formandin closedcomplexeswithtri-, tetra-, andpentaoligosaccharides (Sop 3-5) were determined to a maximum resolution of 1.6 A. The binding site displayed shape complementarity to Sop n, which adopted a zigzag conformation. We noted that water-mediated hydrogen bonds and stacking interactions play a pivotal role in the recognition of Sop 3-5 by SO-BP, consistent with its binding thermodynamics. Computational free-energy calculations and a mutational analysis confirmed that interactions with the third glucose moiety of Sop n s are significantly responsible for ligand binding. A reduction in unfavorable changes in binding entropy that were in proportion to the lengths of the Sop n s was explained by conformational entropy changes. Phylogenetic and sequence analyses indicated that SO-BP ABC transporter homologs, glycoside hydrolases, and other related proteins are co-localized in the genomes of several bacteria. This study may improve our understanding of bacterial beta-1,2-glucan metabolism and promote the discovery of unidentified beta-1,2-glucan-associated proteins.	[Abe, Koichi; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Abe, Koichi; Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Sunagawa, Naoki; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Takahashi, Yuta; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Igarashi, Kiyohiko] VTT Tech Res Ctr Finland, FI-02044 Espoo, Vtt, Finland; [Taguchi, Hayao; Nakajima, Masahiro] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Niigata University; VTT Technical Research Center Finland; Tokyo University of Science	Fushinobu, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Terada, Tohru/W-2956-2019; Nakajima, Masahiro/J-3566-2019; Igarashi, Kiyohiko/E-6799-2016; Arakawa, Takatoshi/K-9739-2013	Fushinobu, Shinya/0000-0003-1346-6435; Terada, Tohru/0000-0002-7091-0646; Nakajima, Masahiro/0000-0002-3182-0859; Igarashi, Kiyohiko/0000-0001-5152-7177; Arakawa, Takatoshi/0000-0001-6496-5440; Taguchi, Hayao/0000-0001-5270-581X; Sunagawa, Naoki/0000-0002-0382-6671	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED); JSPS-KAKENHI [15H02443, 26660083]	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED) and by JSPS-KAKENHI Grants 15H02443 and 26660083 (to S. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe K., 2015, J APPL GLYCOSCI, V62, P47, DOI [DOI 10.5458/JAG.JAG, 10.5458/jag.jag.JAG-2014_011, DOI 10.5458/JAG.JAG.JAG-2014_011]; Abe K, 2017, J BIOL CHEM, V292, P7487, DOI 10.1074/jbc.M116.762724; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; ANDRE I, 1995, NEW J CHEM, V19, P331; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; Barnett CB, 2008, J PHYS CHEM B, V112, P15450, DOI 10.1021/jp8067409; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D. A., 2017, AMBER 2017; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DOWD MK, 1992, CARBOHYD RES, V233, P15, DOI 10.1016/S0008-6215(00)90917-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ejby M, 2016, J BIOL CHEM, V291, P20220, DOI 10.1074/jbc.M116.746529; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Medrano FJ, 2014, ACTA CRYSTALLOGR F, V70, P564, DOI 10.1107/S2053230X14006578; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MANDELS M, 1962, J BACTERIOL, V83, P400, DOI 10.1128/JB.83.2.400-408.1962; MAO B, 1982, J BIOL CHEM, V257, P1131; Medintz IL, 2006, CURR OPIN BIOTECH, V17, P17, DOI 10.1016/j.copbio.2006.01.002; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakajima M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42671; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pereira CS, 2006, BIOPHYS J, V90, P4337, DOI 10.1529/biophysj.106.081539; Peric-Hassler L, 2010, CARBOHYD RES, V345, P1781, DOI 10.1016/j.carres.2010.05.026; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; Rao V. S. R., 1998, CONFORMATION CARBOHY; Schmidt S, 2010, RAPID COMMUN MASS SP, V24, P2009, DOI 10.1002/rcm.4605; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; TALAGA P, 1994, J BACTERIOL, V176, P6538, DOI 10.1128/JB.176.21.6538-6544.1994; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Terada T, 2012, J PHYS CHEM B, V116, P6810, DOI 10.1021/jp2125558; Terwilliger TC, 2013, ACTA CRYSTALLOGR D, V69, P2244, DOI 10.1107/S0907444913017770; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7; van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101	68	15	15	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8812	8828		10.1074/jbc.RA117.001536	http://dx.doi.org/10.1074/jbc.RA117.001536			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29678880	Green Published, hybrid			2022-12-28	WOS:000434941900008
J	Fang, C; Li, T; Li, Y; Xu, GJ; Deng, QW; Chen, YJ; Hou, YN; Lee, HC; Zhao, YJ				Fang, Cheng; Li, Ting; Li, Ying; Xu, Guan Jie; Deng, Qi Wen; Chen, Ya Jie; Hou, Yun Nan; Lee, Hon Cheung; Zhao, Yong Juan			CD38 produces nicotinic acid adenosine dinucleotide phosphate in the lysosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acid adenine dinucleotide phosphate (NAADP); CD38; lysosome; endocytosis; single-domain antibody (sdAb, nanobody)	CYCLIC ADP-RIBOSE; INOSITOL TRISPHOSPHATE; CA2+ MOBILIZATION; ANTIGEN CD38; CELLS; NAADP; CALCIUM; CYCLASE; INTERNALIZATION; RECEPTOR	Nicotinic acid adenosine dinucleotide phosphate (NAADP) is a Ca2+-mobilizing second messenger that regulates a wide range of biological activities. However, the mechanism of its biogenesis remains controversial. CD38 is the only enzyme known to catalyze NAADP synthesis from NADP and nicotinic acid. CD38-mediated catalysis requires an acidic pH, suggesting that NAADP may be produced in acidic endolysosomes, but this hypothesis is untested. In this study, using human cell lines, we specifically directed CD38 to the endolysosomal system and assessed cellular NAADP production. First, we found that nanobodies targeting various epitopes on the C-terminal domain of CD38 could bind to cell surface-localized CD38 and induce its endocytosis. We also found that CD38 internalization occurred via a clathrin-dependent pathway, delivered CD38 to the endolysosome, and elevated intracellular NAADP levels. We also created a CD38 variant for lysosome-specific expression, which not only withstood the degradative environment in the lysosome, but was also much more active than WT CD38 in elevating cellular NAADP levels. Supplementing CD38-expressing cells with nicotinic acid substantially increased cellular NAADP levels. These results demonstrate that endolysosomal CD38 can produce NAADP in human cells. They further suggest that CD38's compartmentalization to the lysosome may allow for its regulation via substrate access, rather than enzyme activation, thereby providing a reliable mechanism for regulating cellular NAADP production.	[Fang, Cheng; Li, Ting; Li, Ying; Xu, Guan Jie; Deng, Qi Wen; Chen, Ya Jie; Hou, Yun Nan; Lee, Hon Cheung; Zhao, Yong Juan] Peking Univ, Shenzhen Grad Sch, Lab Cytophysiol, State Key Lab Chem Oncogen,Key Lab Chem Genom, Shenzhen 518055, Peoples R China	Peking University; University Town of Shenzhen	Lee, HC; Zhao, YJ (corresponding author), Peking Univ, Shenzhen Grad Sch, Lab Cytophysiol, State Key Lab Chem Oncogen,Key Lab Chem Genom, Shenzhen 518055, Peoples R China.	leehoncheung@gmail.com; zhaoyj@pkusz.edu.cn	Zhao, Yongjuan/AAS-9919-2021; Lee, Hon Cheung/C-4329-2009	Zhao, Yong Juan/0000-0003-4564-1912; Deng, Qiwen/0000-0002-4153-1778	National Science Foundation of China [31571438, 31470815]; Shenzhen Governments [JCYJ20160608091848749, JCYJ20170412150609690]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Governments	This work was supported by National Science Foundation of China Grants 31571438 (to Y. J. Z.) and 31470815 (to H. C. L.) and Shenzhen Governments Grants JCYJ20160608091848749 (to Y. J. Z.) and JCYJ20170412150609690 (to H. C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Antonelli A, 2001, DIABETES, V50, P985, DOI 10.2337/diabetes.50.5.985; Bahn A, 2008, J BIOL CHEM, V283, P16332, DOI 10.1074/jbc.M800737200; Bruzzone S, 2001, FASEB J, V15, P10; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Deaglio S, 1998, J IMMUNOL, V160, P395; Dutta Dipannita, 2012, Cell Logist, V2, P203; Elkin SR, 2016, WIEN MED WOCHENSCHR, V166, P196, DOI 10.1007/s10354-016-0432-7; Fumey W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14112-6; FUNARO A, 1990, J IMMUNOL, V145, P2390; Funaro A, 1998, J IMMUNOL, V160, P2238; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Gao Y, 2007, MOL CELL BIOCHEM, V295, P1, DOI 10.1007/s11010-006-9265-9; Gopal E, 2007, PHARM RES-DORDR, V24, P575, DOI 10.1007/s11095-006-9176-1; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R., 2013, MESSENGER, V2, P96; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Gul R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149125; Guse AH, 2013, CURR TOP MED CHEM, V13, P2978, DOI 10.2174/15680266113136660212; Horenstein AL, 1998, BIOCHEM J, V330, P1129; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Kontani K, 1996, J BIOL CHEM, V271, P1534; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; KUMAGAI MA, 1995, J EXP MED, V181, P1101, DOI 10.1084/jem.181.3.1101; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Li T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27055; Lin WK, 2017, J BIOL CHEM, V292, P13243, DOI 10.1074/jbc.M117.789347; Liu J, 2017, P NATL ACAD SCI USA, V114, P8283, DOI 10.1073/pnas.1703718114; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Moreschi I, 2006, BIOCHEM BIOPH RES CO, V345, P573, DOI 10.1016/j.bbrc.2006.04.096; OREILLY DS, 1984, J CLIN PATHOL, V37, P1358, DOI 10.1136/jcp.37.12.1358; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; Terdoslavich Michela, 2012, Drug Metab Lett, V6, P165; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Yabuuchi H, 1998, PHARMACEUT RES, V15, P411, DOI 10.1023/A:1011920213991; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379; Zhao YJ, 2012, ACTA BIOCH BIOPH SIN, V44, P719, DOI 10.1093/abbs/gms044; Zocchi E, 1999, FASEB J, V13, P273, DOI 10.1096/fasebj.13.2.273; Zocchi E, 1996, FEBS LETT, V396, P327, DOI 10.1016/0014-5793(96)01125-8	49	26	26	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8151	8160		10.1074/jbc.RA118.002113	http://dx.doi.org/10.1074/jbc.RA118.002113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632067	Green Published, hybrid			2022-12-28	WOS:000433224600020
J	Haglund, E; Nguyen, L; Schafer, NP; Lammert, H; Jennings, PA; Onuchic, JN				Haglund, Ellinor; Nguyen, Lannie; Schafer, Nicholas Peter; Lammert, Heiko; Jennings, Patricia Ann; Onuchic, Jose Nelson			Uncovering the molecular mechanisms behind disease-associated leptin variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; leptin; obesity; protein misfolding; protein structure; Bioinactive hormone; Congenital-leptin Deficiency; Pierced Lasso Topology	EARLY-ONSET OBESITY; MISSENSE MUTATION; PERIPHERAL ACTIONS; BINDING DOMAIN; GENE-MUTATIONS; DEFICIENCY; PROTEIN; PATHOPHYSIOLOGY; HYPOGONADISM; DYSFUNCTION	The pleiotropic hormone leptin has a pivotal role in regulating energy balance by inhibiting hunger and increasing energy expenditure. Homozygous mutations found in the leptin gene are associated with extreme obesity, marked hyperphagia, and impaired immune function. Although these mutations have been characterized in vivo, a detailed understanding of how they affect leptin structure and function remains elusive. In the current work, we used NMR, differential scanning calorimetry, molecular dynamics simulations, and bioinformatics calculations to characterize the effects of these mutations on leptin structure and function and binding to its cognate receptor. We found that mutations identified in patients with congenital leptin deficiency not only cause leptin misfolding or aggregation, but also cause changes in the dynamics of leptin residues on the receptor-binding interface. Therefore, we infer that mutation-induced leptin deficiency may arise from several distinct mechanisms including (i) blockade of leptin receptor interface II, (ii) decreased affinity in the second step of leptin's interaction with its receptor, (iii) leptin destabilization, and (iv) unsuccessful threading through the covalent loop, leading to leptin misfolding/aggregation. We propose that this expanded framework for understanding the mechanisms underlying leptin deficiency arising from genetic mutations may be useful in designing therapeutics for leptin-associated disorders.	[Haglund, Ellinor; Schafer, Nicholas Peter; Lammert, Heiko; Onuchic, Jose Nelson] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA; [Onuchic, Jose Nelson] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Onuchic, Jose Nelson] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Onuchic, Jose Nelson] Rice Univ, Dept Biosci, Houston, TX 77005 USA; [Nguyen, Lannie; Jennings, Patricia Ann] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Rice University; Rice University; Rice University; Rice University; University of California System; University of California San Diego	Haglund, E; Onuchic, JN (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.; Onuchic, JN (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.; Onuchic, JN (corresponding author), Rice Univ, Dept Chem, Houston, TX 77005 USA.; Onuchic, JN (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.; Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ellinorh@rice.edu; pajennings@ucsd.edu; jonuchic@rice.edu		Schafer, Nicholas/0000-0001-9789-2516	Center for Theoretical Biological Physics; National Science Foundation (NSF) [PHY-1427654]; NSF [MCB-1241332, PHY-161407, CHE-1614101]; Welch Foundation [C-1792]; NIGMS, National Institutes of Health [R01 GM44557]; D. R. Bullard-Welch Chair at Rice University [C-0016]; Div Of Molecular and Cellular Bioscience [1241332] Funding Source: National Science Foundation	Center for Theoretical Biological Physics; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); D. R. Bullard-Welch Chair at Rice University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Center for Theoretical Biological Physics, sponsored by National Science Foundation (NSF) Grant PHY-1427654, and NSF Grants MCB-1241332, PHY-161407, and CHE-1614101. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by Welch Foundation Grant C-1792.; Supported by NIGMS, National Institutes of Health, Grant R01 GM44557 and the D. R. Bullard-Welch Chair at Rice University, Grant C-0016.	Altawil AS, 2016, CLIN MED INSIGHTS-PE, V10, P115, DOI 10.4137/CMPed.S40432; Baratta Mario, 2002, Med Sci Monit, V8, pRA282; Baxter EL, 2013, P NATL ACAD SCI USA, V110, P948, DOI 10.1073/pnas.1208286110; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Blazer DG, 2006, GENES BEHAV SOCIAL E; Boute N, 2004, BIOCHIMIE, V86, P351, DOI 10.1016/j.biochi.2004.06.005; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; Carpenter B, 2012, STRUCTURE, V20, P487, DOI 10.1016/j.str.2012.01.019; Chekhranova M K, 2008, Bioorg Khim, V34, P854; CONNOLLY ML, 1980, BIOPOLYMERS, V19, P1167, DOI 10.1002/bip.1980.360190606; Dabrowski-Tumanski P, 2016, NUCLEIC ACIDS RES, V44, pW383, DOI 10.1093/nar/gkw308; Dickie M. M., 1957, MOUSE NEWS LETT, V17, P52; Elias CF, 2013, CELL MOL LIFE SCI, V70, P841, DOI 10.1007/s00018-012-1095-1; Farooqi IS, 2014, J ENDOCRINOL, V223, pT63, DOI 10.1530/JOE-14-0480; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fatima W, 2011, INT J PEDIATR OBES, V6, P419, DOI 10.3109/17477166.2011.608431; Fietta P, 2005, Minerva Med, V96, P65; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; Fong TM, 1998, MOL PHARMACOL, V53, P234, DOI 10.1124/mol.53.2.234; Fruhbeck G, 2002, NUTR REV, V60, pS47, DOI 10.1301/002966402320634931; Fruhbeck G, 2001, P NUTR SOC, V60, P301, DOI 10.1079/PNS200196; Funcke Jan-Bernd, 2014, Mol Cell Pediatr, V1, P3, DOI 10.1186/s40348-014-0003-1; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gibson WT, 2004, J CLIN ENDOCR METAB, V89, P4821, DOI 10.1210/jc.2004-0376; Gierut AM, 2017, BIOINFORMATICS, V33, P3819, DOI 10.1093/bioinformatics/btx493; Gong DW, 1996, J BIOL CHEM, V271, P3971; Haglund E, 2017, J PHYS CHEM B, V121, P706, DOI 10.1021/acs.jpcb.6b11506; Haglund E, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/35/354107; Haglund E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003613; Haglund E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045654; Hong CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015333; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Khan S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-56; Kratzsch J, 2002, HORM RES, V57, P127, DOI 10.1159/000057963; LEIBEL RL, 1993, CRIT REV FOOD SCI, V33, P351, DOI 10.1080/10408399309527632; LEIBEL RL, 1990, WORLD REV NUTR DIET, V63, P90; Mancour LV, 2012, MOL CELL, V48, P655, DOI 10.1016/j.molcel.2012.09.003; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; Moharana K, 2014, STRUCTURE, V22, P866, DOI 10.1016/j.str.2014.04.012; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; Muoio DM, 2002, BEST PRACT RES CL EN, V16, P653, DOI 10.1053/beem.2002.0223; Murphy R., 2006, MISBEHAVING PROTEINS, P331; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Niemyska W, 2016, SCI REP-UK, V6, DOI 10.1038/srep36895; Niv-Spector L, 2010, MOL GENET METAB, V100, P193, DOI 10.1016/j.ymgme.2010.02.015; Noel JK, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004794; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Peelman F, 2014, J ENDOCRINOL, V223, pT9, DOI 10.1530/JOE-14-0264; Pigeyre M, 2016, CLIN SCI, V130, P943, DOI 10.1042/CS20160136; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Saeed S, 2012, MOL GENET METAB, V106, P121, DOI 10.1016/j.ymgme.2012.03.001; Shabana, 2016, BIOL RES, V49, DOI [10.1186/S40659-016-0082-7, 10.1186/s40659-016-0082-7]; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Thakur S, 2014, CLIN GENET, V86, P391, DOI 10.1111/cge.12289; Verploegen SABW, 1997, FEBS LETT, V405, P237, DOI 10.1016/S0014-5793(97)00192-0; Wabitsch M, 2017, EUR J ENDOCRINOL, V176, P315, DOI 10.1530/EJE-16-0821; Wabitsch M, 2015, J CLIN ENDOCR METAB, V100, P3227, DOI 10.1210/jc.2015-2263; Wabitsch M, 2015, NEW ENGL J MED, V372, P48, DOI 10.1056/NEJMoa1406653; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	70	5	5	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12919	12933		10.1074/jbc.RA118.003957	http://dx.doi.org/10.1074/jbc.RA118.003957			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29950524	hybrid, Green Published			2022-12-28	WOS:000442203500023
J	Silva-Aguiar, RP; Bezerra, NCF; Lucena, MC; Sirtoli, GM; Sudo, RT; Zapata-Sudo, G; Takiya, CM; Pinheiro, AAS; Dias, WB; Caruso-Neves, C				Silva-Aguiar, Rodrigo Pacheco; Bezerra, Nathalia C. F.; Lucena, Miguel C.; Sirtoli, Gabriela M.; Sudo, Roberto T.; Zapata-Sudo, Gisele; Takiya, Christina M.; Pinheiro, Ana Acacia S.; Dias, Wagner Barbosa; Caruso-Neves, Celso			O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; proteinuria; hypertension; kidney; endocytosis; O-linked N-acetylglucosamine (O-GlcNAc); megalin; SHR	N-ACETYLGLUCOSAMINE; RECEPTOR MEGALIN; GLCNAC; ALBUMINURIA; TRANSFERASE; FILTRATION; TRANSPORT; DISEASE; TARGET; STRESS	Hypertensive individuals are at greater risk for developing chronic kidney disease (CKD). Reducing proteinuria has been suggested as a possible therapeutic approach to treat CKD. However, the mechanisms underlying the development of proteinuria in hypertensive conditions are incompletely understood. Cardiac and vascular dysfunction is associated with changes in the O-GlcNAcylation pathway in hypertensive models. We hypothesized that O-GlcNAcylation is also involved in renal damage, especially development of proteinuria, associated with hypertension. Using the spontaneously hypertensive rat (SHR) model, we observed higher renal cortex O-GlcNAcylation, glutamine-fructose aminotransferase (GFAT), and O-GlcNAc transferase (OGT) protein expression, which positively correlated with proteinuria. Interestingly, this was observed in hypertensive, but not pre-hypertensive, rats. Pharmacological inhibition of GFAT decreased renal cortex O-GlcNAcylation, proteinuria, and albuminuria in SHR. Using a proximal tubule cell line, we observed that increased O-GlcNAcylation reduced megalin surface expression and albumin endocytosis in vitro, and the effects were correlated in vivo. Moreover, megalin is O-GlcNAcylated both in vitro and in vivo. In conclusion, our results demonstrate a new mechanism involved in hypertension-associated proteinuria.	[Silva-Aguiar, Rodrigo Pacheco; Bezerra, Nathalia C. F.; Lucena, Miguel C.; Sirtoli, Gabriela M.; Takiya, Christina M.; Pinheiro, Ana Acacia S.; Dias, Wagner Barbosa; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; [Sudo, Roberto T.; Zapata-Sudo, Gisele] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Desenvolvimento Farm, BR-21941902 Rio De Janeiro, Brazil; [Caruso-Neves, Celso] Inst Nacl Ciencia & Tecnol Med Regenerat INCT Reg, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, CCS, Bloco C,Sala 34, BR-21941902 Rio De Janeiro, RJ, Brazil.	caruso@biof.ufrj.br	Caruso-Neves, Celso/C-4014-2013; Dias, Wagner/B-1401-2016; Zapata-Sudo, Gisele/AAG-8790-2020; Takiya, Christina/AAU-5959-2021; Silva-Aguiar, Rodrigo Pacheco/AAH-7924-2020	Caruso-Neves, Celso/0000-0002-2415-7753; Takiya, Christina/0000-0002-8019-628X; Silva-Aguiar, Rodrigo Pacheco/0000-0003-1975-8033; Pinheiro, Ana Acacia/0000-0002-3894-1645; Dias, Wagner/0000-0002-8378-8846	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant [471771/2013-9]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants [E-26/201.197/2014, E-26/202.950/2016, APQ1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants	This work was supported by the following Brazilian funding agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant 471771/2013-9 (to C. C. N.) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants E-26/201.197/2014 and E-26/202.950/2016 (to C. C. N.) and APQ1 (to W. B. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; Barnes JW, 2015, CIRCULATION, V131, P1260, DOI 10.1161/CIRCULATIONAHA.114.013878; Bay AEP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11550; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Carrero JJ, 2017, KIDNEY INT, V91, P244, DOI 10.1016/j.kint.2016.09.037; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Carson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099771; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; D'Amico G, 2003, KIDNEY INT, V63, P809, DOI 10.1046/j.1523-1755.2003.00840.x; De S, 2014, MEMBRANES-BASEL, V4, P333, DOI 10.3390/membranes4030333; Degrell P, 2009, LIFE SCI, V84, P389, DOI 10.1016/j.lfs.2009.01.007; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Geng F, 2012, J CELL SCI, V125, P2615, DOI 10.1242/jcs.096735; Gianesello L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13789-z; Hilgers RHP, 2012, AM J PHYSIOL-HEART C, V303, pH513, DOI 10.1152/ajpheart.01175.2011; Hirano M, 2017, BBA-GEN SUBJECTS, V1861, P3106, DOI 10.1016/j.bbagen.2016.10.015; Hu JC, 2017, FREE RADICAL BIO MED, V103, P121, DOI 10.1016/j.freeradbiomed.2016.12.032; Koral K, 2014, AM J PHYSIOL-RENAL, V307, pF1380, DOI 10.1152/ajprenal.00454.2014; Landgraf SS, 2011, AM J PHYSIOL-RENAL, V300, pF499, DOI 10.1152/ajprenal.00384.2010; Lima VV, 2009, HYPERTENSION, V53, P166, DOI 10.1161/HYPERTENSIONAHA.108.116798; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Martinez MR, 2017, BIOCHEM SOC T, V45, P237, DOI 10.1042/BST20160153; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mori KP, 2017, J AM SOC NEPHROL, V28, P278, DOI 10.1681/ASN.2015101168; Nagai M, 2003, MOL BIOL CELL, V14, P4984, DOI 10.1091/mbc.E03-06-0385; Oki T, 1999, GENOMICS, V57, P227, DOI 10.1006/geno.1999.5785; Ono S, 2017, NEPHROL DIAL TRANSPL, V32, P1477, DOI 10.1093/ndt/gfw463; Park MJ, 2014, J BIOL CHEM, V289, P13519, DOI 10.1074/jbc.M113.530139; Peruchetti DB, 2014, J BIOL CHEM, V289, P16790, DOI 10.1074/jbc.M114.549717; Queiroz-Madeira EP, 2010, BBA-BIOMEMBRANES, V1798, P360, DOI 10.1016/j.bbamem.2009.06.018; Ronco C, 2014, NEPHROL DIAL TRANSPL, V29, P958, DOI 10.1093/ndt/gft457; Russo LM, 2009, J AM SOC NEPHROL, V20, P489, DOI 10.1681/ASN.2008050503; Schiessl IM, 2016, J AM SOC NEPHROL, V27, P731, DOI 10.1681/ASN.2014111125; Sun J, 2017, KIDNEY INT REP, V2, P721, DOI 10.1016/j.ekir.2017.02.012; Theilig F, 2007, J AM SOC NEPHROL, V18, P1824, DOI 10.1681/ASN.2006111266; Udani S, 2011, NAT REV NEPHROL, V7, P11, DOI 10.1038/nrneph.2010.154; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; Wang XY, 2009, CURR OPIN NEPHROL HY, V18, P412, DOI 10.1097/MNH.0b013e32832f5775; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x; Zafir A, 2013, STEM CELLS, V31, P765, DOI 10.1002/stem.1325; Zeng QH, 2016, P NATL ACAD SCI USA, V113, P9333, DOI 10.1073/pnas.1606801113	48	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12749	12758		10.1074/jbc.RA118.001746	http://dx.doi.org/10.1074/jbc.RA118.001746			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29954945	Green Published, hybrid			2022-12-28	WOS:000442203500009
J	Thomas, A; Ramananda, Y; Mun, K; Naren, AP; Arora, K				Thomas, Andrew; Ramananda, Yashaswini; Mun, KyuShik; Naren, Anjaparavanda P.; Arora, Kavisha			AC6 is the major adenylate cyclase forming a diarrheagenic protein complex with cystic fibrosis transmembrane conductance regulator in cholera	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; chloride transport; cyclic AMP (cAMP); cholera toxin; cystic fibrosis transmembrane conductance regulator (CFTR); adenylate cyclase (adenylyl cyclase)	INTESTINAL ION-TRANSPORT; CHLORIDE CHANNEL; CFTR; TOXIN; CAMP; COMPARTMENTALIZATION; PATHOPHYSIOLOGY; RESISTANCE; DOMAIN; CELLS	The World Health Organization(WHO) has reported a worldwide surge in cases of cholera caused by the intestinal pathogen Vibrio cholerae, and, combined, such surges have claimed several million lives, mostly in early childhood. Elevated cAMP production in intestinal epithelial cells challenged with cholera toxin (CTX) results in diarrhea due to chloride transport by a cAMP-activated channel, the cystic fibrosis transmembrane conductance regulator (CFTR). However, the identity of the main cAMP-producing proteins that regulate CFTR in the intestine and may be relevant for secretory diarrhea is unclear. Here, using RNA-Seq to identify the predominant AC isoform in mouse and human cells and extensive biochemical analyses for further characterization, we found that the cAMP-generating enzyme adenylate cyclase 6 (AC6) physically and functionally associates with CFTR at the apical surface of intestinal epithelial cells. We generated epithelium-specific AC6 knockout mice and demonstrated that CFTR-dependent fluid secretion is nearly abolished in AC6 knockout mice upon CTX challenge in ligated ileal loops. Furthermore, loss of AC6 function dramatically impaired CTX-induced CFTR activation in human and mouse intestinal spheroids. Our finding that the CFTR-AC6 protein complex is the key mediator of CTX-associated diarrhea may facilitate development of antidiarrheal agents to manage cholera symptoms and improve outcomes.	[Thomas, Andrew; Ramananda, Yashaswini; Mun, KyuShik; Naren, Anjaparavanda P.; Arora, Kavisha] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pulm Med, 3333 Burnet Ave,MLC 2021, Cincinnati, OH 45229 USA; [Ramananda, Yashaswini] Univ Illinois, Dept Biomed Sci, Chicago, IL 60607 USA	Cincinnati Children's Hospital Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Naren, AP; Arora, K (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pulm Med, 3333 Burnet Ave,MLC 2021, Cincinnati, OH 45229 USA.	anaren@cchmc.org; kavisha.arora@cchmc.org			National Institutes of Health [DK080834, DK093045]; Cystic Fibrosis Foundation [ARORA16F0]; NAREN [14XX0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL113229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093045, P30DK117467, R01DK080834, P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NAREN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK080834 and DK093045 (to A. P. N.) and Cystic Fibrosis Foundation Grants ARORA16F0 (to K. A.) and NAREN 14XX0 (to A. P. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arora K, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93686; Arora K, 2014, BIOCHEMISTRY-US, V53, P4169, DOI 10.1021/bi401263h; Arora K, 2013, PFLUG ARCH EUR J PHY, V465, P1397, DOI 10.1007/s00424-013-1280-6; Bozoky Z, 2017, P NATL ACAD SCI USA, V114, pE2086, DOI 10.1073/pnas.1613546114; Cheepala S, 2013, ANNU REV PHARMACOL, V53, P231, DOI 10.1146/annurev-pharmtox-010611-134609; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Chey WD, 2012, AM J GASTROENTEROL, V107, P1702, DOI 10.1038/ajg.2012.254; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dessauer CW, 2017, PHARMACOL REV, V69, P93, DOI 10.1124/pr.116.013078; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Finkelstein R. A., 1996, MED MICROBIOLOGY; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Melis N, 2014, BRIT J PHARMACOL, V171, P3716, DOI 10.1111/bph.12726; Moon C, 2015, J BIOL CHEM, V290, P11246, DOI 10.1074/jbc.M114.605410; Pasyk S, 2015, PROTEOMICS, V15, P447, DOI 10.1002/pmic.201400218; Sabbatini ME, 2013, J PHYSIOL-LONDON, V591, P3693, DOI 10.1113/jphysiol.2012.249698; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	30	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12949	12959		10.1074/jbc.RA118.003378	http://dx.doi.org/10.1074/jbc.RA118.003378			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29903911	Green Published, hybrid			2022-12-28	WOS:000442203500029
J	Yang, Y; Kong, SY; Zhang, YN; Melo-Cardenas, J; Gao, BX; Zhang, YS; Zhang, DD; Zhang, B; Song, JX; Thorp, E; Zhang, KZ; Zhang, JP; Fang, DY				Yang, Yi; Kong, Sinyi; Zhang, Yana; Melo-Cardenas, Johanna; Gao, Beixue; Zhang, Yusi; Zhang, Donna D.; Zhang, Bin; Song, Jianxun; Thorp, Edward; Zhang, Kezhong; Zhang, Jinping; Fang, Deyu			The endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls a critical checkpoint in B cell development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lymphocyte; unfolded protein response (UPR); ubiquitin ligase; ubiquitin; protein turnover; pre-BCR	SHOCK-PROTEIN GP96; TOLL-LIKE RECEPTORS; LIGHT-CHAIN; PRE-BCR; TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATION; AUTOIMMUNE-DISEASE; MASTER CHAPERONE; TRANSMEMBRANE 5; DEGRADATION	Humoral immunity involves multiple checkpoints that occur in B cell development, maturation, and activation. The pre-B-cell receptor (pre-BCR) is expressed following the productive recombination of the immunoglobulin heavy-chain gene, and sSignalsing through the pre-BCR are required for the differentiation of pre-B cells into immature B cells. However, the molecular mechanisms controlling the pre-BCR expression and signaling strength remain undefined. Herein, we probed the role of the endoplasmic reticulum-associated, stress-activated E3 ubiquitin ligase HMG-CoA reductase degradation 1 (Hrd1) in B cell differentiation. Using mice with a specific Hrd1 deletion in pro-B cells and subsequent B cell developmental stages, we showed that the E3 ubiquitin ligase Hrd1 governs a critical checkpoint during B cell development. We observed that Hrd1 is required for degradation of the pre-BCR complex during the early stage of B cell development. As a consequence, loss of Hrd1 in the B cell lineage resulted in increased pre-BCR expression levels and a developmental defect in the transition from large to small pre-B cells. This defect, in turn, resulted in reduced fewer mature B cells in bone marrow and peripheral lymphoid organs. Our results revealed a novel critical role of Hrd1 in controlling a critical checkpoint in B cell-mediated immunity and suggest that Hrd1 may functioning as an E3 ubiquitin ligase of the pre-BCR complex.	[Yang, Yi; Zhang, Jinping] Soochow Univ, Inst Biol, Suzhou 215123, Jiangsu, Peoples R China; [Yang, Yi; Zhang, Jinping] Soochow Univ, Inst Med Sci, Suzhou 215123, Jiangsu, Peoples R China; [Yang, Yi; Kong, Sinyi; Zhang, Yana; Melo-Cardenas, Johanna; Gao, Beixue; Zhang, Yusi; Thorp, Edward; Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA; [Zhang, Yana] Guangzhou Women & Childrens Med Ctr, Dept Otolaryngol Head & Neck Surg, Guangzhou 510623, Guangdong, Peoples R China; [Zhang, Donna D.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Zhang, Bin] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol,Dept Med, Chicago, IL 60611 USA; [Song, Jianxun] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 16801 USA; [Zhang, Kezhong] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Dept Immunol & Microbiol, Detroit, MI 48201 USA	Soochow University - China; Soochow University - China; Northwestern University; Feinberg School of Medicine; University of Arizona; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Wayne State University	Zhang, JP (corresponding author), Soochow Univ, Inst Biol, Suzhou 215123, Jiangsu, Peoples R China.; Zhang, JP (corresponding author), Soochow Univ, Inst Med Sci, Suzhou 215123, Jiangsu, Peoples R China.; Fang, DY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j_pzhang@suda.edu.cn; fangd@northwestern.edu	zhang, jin/GXV-9154-2022	Zhang, Kezhong/0000-0002-6062-235X; Melo-Cardenas, Johanna/0000-0002-5122-3349	National Institutes of Health [AI079056, AI108634, AR006634]; National Natural Science Foundation of China (NSFC) [81600784, 31270939, 81471526, 81771667]; Training Program of the Major Research Plan in regional immunology of the National Natural Science Foundation of China [91442110]; Natural Science Foundation of Jiangsu Province [BK20170349]; postdoctoral foundation of China; Social development project of Jiangsu Province Grant [BE2016676]; Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139812, R01HL122309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI079056, R01AI108634, R01AI079056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026845, P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Training Program of the Major Research Plan in regional immunology of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); postdoctoral foundation of China(China Postdoctoral Science Foundation); Social development project of Jiangsu Province Grant; Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health R01 Grants AI079056, AI108634, and AR006634 (to D. F.) and National Natural Science Foundation of China (NSFC) Grants 81600784 (to Y. Z.) 31270939, 81471526, and 81771667, Training Program of the Major Research Plan in regional immunology of the National Natural Science Foundation of China Grant 91442110,; Natural Science Foundation of Jiangsu Province Grant BK20170349, a postdoctoral foundation of China grant (to Y. Y.), Social development project of Jiangsu Province Grant BE2016676 (to Y. Y.), and the Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brouns GS, 1996, J BIOL CHEM, V271, P19272, DOI 10.1074/jbc.271.32.19272; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Fujita H, 2015, EMBO J, V34, P1042, DOI 10.15252/embj.201489897; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Ji YW, 2016, CELL REP, V16, P2630, DOI 10.1016/j.celrep.2016.08.003; Kawano Y, 2012, MOL CELL BIOL, V32, P4462, DOI 10.1128/MCB.00531-12; Keren Z, 2004, J BIOL CHEM, V279, P13418, DOI 10.1074/jbc.M311970200; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Kong SY, 2016, P NATL ACAD SCI USA, V113, P10394, DOI 10.1073/pnas.1606742113; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Levine MH, 2000, P NATL ACAD SCI USA, V97, P2743, DOI 10.1073/pnas.050552997; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; NISHIMOTO N, 1991, P NATL ACAD SCI USA, V88, P6284, DOI 10.1073/pnas.88.14.6284; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Thaxton JE, 2014, J IMMUNOL, V192, P5679, DOI 10.4049/jimmunol.1302755; Ubelhart R, 2010, NAT IMMUNOL, V11, P759, DOI 10.1038/ni.1903; van Loo PF, 2007, IMMUNITY, V27, P468, DOI 10.1016/j.immuni.2007.07.018; Wu S, 2012, J BIOL CHEM, V287, P19896, DOI 10.1074/jbc.M112.343848; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Wu TD, 2014, GENE DEV, V28, P708, DOI 10.1101/gad.238246.114; Yang H, 2014, J EXP MED, V211, P2467, DOI 10.1084/jem.20140283; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang YL, 2015, J CLIN INVEST, V125, P859, DOI 10.1172/JCI79014; Zheng H, 2001, J IMMUNOL, V167, P6731, DOI 10.4049/jimmunol.167.12.6731; Zhou AX, 2015, CIRC RES, V116, P1736, DOI 10.1161/CIRCRESAHA.116.305602	45	13	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12934	12944		10.1074/jbc.RA117.001267	http://dx.doi.org/10.1074/jbc.RA117.001267			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29907570	Green Published, hybrid			2022-12-28	WOS:000442203500024
J	Skotnicova, P; Sobotka, R; Shepherd, M; Hajek, J; Hrouzek, P; Tichy, M				Skotnicova, Petra; Sobotka, Roman; Shepherd, Mark; Hajek, Jan; Hrouzek, Pavel; Tichy, Martin			The cyanobacterial protoporphyrinogen oxidase HemJ is a new b-type heme protein functionally coupled with coproporphyrinogen III oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosynthesis; heme; cyanobacteria; enzyme purification; membrane protein; coproporphyrinogen III oxidase; HemJ; protoporphyrinogen IX oxidase; Synechocystis sp; PCC 6803	ESCHERICHIA-COLI; PHOTOSYSTEM-II; TETRAPYRROLE BIOSYNTHESIS; GENE-EXPRESSION; PCC 6803; COMPLEX; PORPHYRIN; DISCOVERY; OXIDATION; SEQUENCE	Protoporphyrinogen IX oxidase (PPO), the last enzyme that is common to both chlorophyll and heme biosynthesis pathways, catalyzes the oxidation of protoporphyrinogen IX to protoporphyrin IX. PPO has several isoforms, including the oxygen-dependent HemY and an oxygen-independent enzyme, HemG. However, most cyanobacteria encode HemJ, the least characterized PPO form. We have characterized HemJ from the cyanobacterium Synechocystis sp. PCC 6803 (Synechocystis 6803) as a bona fide PPO; HemJ down-regulation resulted in accumulation of tetrapyrrole precursors and in the depletion of chlorophyll precursors. The expression of FLAG-tagged Synechocystis 6803 HemJ protein (HemJ.f) and affinity isolation of HemJ.f under native conditions revealed that it binds heme b. The most stable HemJ.f form was a dimer, and higher oligomeric forms were also observed. Using both oxygen and artificial electron acceptors, we detected no enzymatic activity with the purified HemJ.f, consistent with the hypothesis that the enzymatic mechanism for HemJ is distinct from those of other PPO isoforms. The heme absorption spectra and distant HemJ homology to several membrane oxidases indicated that the heme in HemJ is redox-active and involved in electron transfer. HemJ was conditionally complemented by another PPO, HemG from Escherichia coli. If grown photoautotrophically, the complemented strain accumulated tripropionic tetrapyrrole harderoporphyrin, suggesting a defect in enzymatic conversion of coproporphyrinogen III to protoporphyrinogen IX, catalyzed by coproporphyrinogen III oxidase (CPO). This observation supports the hypothesis that HemJ is functionally coupled with CPO and that this coupling is disrupted after replacement of HemJ by HemG.	[Skotnicova, Petra; Sobotka, Roman; Hajek, Jan; Hrouzek, Pavel; Tichy, Martin] Czech Acad Sci, Inst Microbiol, Ctr Algatech, Trebon 37981, Czech Republic; [Skotnicova, Petra; Sobotka, Roman; Hajek, Jan; Hrouzek, Pavel; Tichy, Martin] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Shepherd, Mark] Univ Kent, RAPID Grp, Sch Biosci, Canterbury CT2 7NZ, Kent, England	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Kent	Tichy, M (corresponding author), CAS, Ctr Algatech, Inst Microbiol, Novohradska 237, Trebon 37981, Czech Republic.	tichym@alga.cz	Skotnicová, Petra/J-6875-2014; Skotnicová, Petra/Y-5866-2019; Tichy, Martin/B-6545-2008; Sobotka, Roman/J-3077-2014	Skotnicová, Petra/0000-0002-6077-0256; Skotnicová, Petra/0000-0002-6077-0256; Tichy, Martin/0000-0003-2814-1959; Hrouzek, Pavel/0000-0002-2061-0266; Shepherd, Mark/0000-0002-7472-2300; Sobotka, Roman/0000-0001-5909-3879	Czech Science Foundation [P501/12/G055]; Czech Ministry of Education Projects [LO1416, LM2015055]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education Projects	This work was supported by Project P501/12/G055 of the Czech Science Foundation and by Czech Ministry of Education Projects LO1416 and LM2015055. The authors declare that they have no conflicts of interest with the contents of this article.	Boynton TO, 2011, APPL ENVIRON MICROB, V77, P4795, DOI 10.1128/AEM.00171-11; Boynton TO, 2009, BIOCHEMISTRY-US, V48, P6705, DOI 10.1021/bi900850y; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Buinska L., 2018, PLANT PHYSIOL, V176, P2931; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Czarnecki O, 2012, J EXP BOT, V63, P1675, DOI 10.1093/jxb/err437; Dailey HA, 1996, J BIOL CHEM, V271, P8714, DOI 10.1074/jbc.271.15.8714; Dailey HA, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00048-16; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; ELDER GH, 1978, BIOCHEM J, V169, P215, DOI 10.1042/bj1690215; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Gomelsky M, 1996, J BACTERIOL, V178, P1946, DOI 10.1128/jb.178.7.1946-1954.1996; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; Hobbs C, 2016, BIOCHEM J, V473, P3997, DOI 10.1042/BCJ20160696; JACOBS NJ, 1981, ARCH BIOCHEM BIOPHYS, V211, P305, DOI 10.1016/0003-9861(81)90458-6; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kahlon S, 2006, MICROBIOL-SGM, V152, P647, DOI 10.1099/mic.0.28510-0; Kato K, 2010, P NATL ACAD SCI USA, V107, P16649, DOI 10.1073/pnas.1000771107; KENNEDY GY, 1970, COMP BIOCHEM PHYSIOL, V36, P21, DOI 10.1016/0010-406X(70)90647-X; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Knoppova J, 2014, PLANT CELL, V26, P1200, DOI 10.1105/tpc.114.123919; Kobayashi K, 2014, GENOME BIOL EVOL, V6, P2141, DOI 10.1093/gbe/evu170; Komenda J, 2010, BBA-BIOENERGETICS, V1797, P566, DOI 10.1016/j.bbabio.2010.02.006; Kopecna J, 2015, PLANT PHYSIOL, V169, P1307, DOI 10.1104/pp.15.01150; Krynicka V, 2014, MOL MICROBIOL, V94, P609, DOI 10.1111/mmi.12782; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Lermontova I, 2006, PLANT J, V48, P499, DOI 10.1111/j.1365-313X.2006.02894.x; Li T, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-13; Lim, 2010, HIGH PERFORMANCE LIQ; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lu PL, 2014, P NATL ACAD SCI USA, V111, P1813, DOI 10.1073/pnas.1323931111; Ma JZ, 2012, BIOINFORMATICS, V28, pI59, DOI 10.1093/bioinformatics/bts213; Mann NH, 2000, FEBS LETT, V479, P72, DOI 10.1016/S0014-5793(00)01871-8; Masoumi A, 2008, MICROBIOL-SGM, V154, P3707, DOI 10.1099/mic.0.2008/018705-0; Medlock AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135896; MILLER MJ, 1988, J BIOL CHEM, V263, P5235; Mobius K, 2010, P NATL ACAD SCI USA, V107, P10436, DOI 10.1073/pnas.1000956107; Narita S, 1996, GENE, V182, P169, DOI 10.1016/S0378-1119(96)00545-8; Nishimura K., 1995, DNA RES, V2, P1, DOI 10.1093/dnares/2.1.1; NORDMANN Y, 1983, J CLIN INVEST, V72, P1139, DOI 10.1172/JCI111039; Phillips JD, 2004, J BIOL CHEM, V279, P38960, DOI 10.1074/jbc.M406050200; Pilny J., 2015, BIO-PROTOCOL, V5, pe1390; Rand K, 2010, BIOL CHEM, V391, P55, DOI 10.1515/BC.2010.006; Sarian FD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148358; SASARMAN A, 1993, CAN J MICROBIOL, V39, P1155, DOI 10.1139/m93-174; SASARMAN A, 1979, J GEN MICROBIOL, V113, P297, DOI 10.1099/00221287-113-2-297; Schmitt C, 2005, HUM MOL GENET, V14, P3089, DOI 10.1093/hmg/ddi342; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; Shepherd M, 2005, ANAL BIOCHEM, V344, P115, DOI 10.1016/j.ab.2005.06.012; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stadnichuk I, 1998, PLANT SCI, V136, P11, DOI 10.1016/S0168-9452(98)00088-0; Summerfield TC, 2011, MICROBIOL-SGM, V157, P301, DOI 10.1099/mic.0.041053-0; Wang S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005324; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zhang CX, 2017, NUCLEIC ACIDS RES, V45, pW291, DOI 10.1093/nar/gkx366	57	12	12	3	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12394	12404		10.1074/jbc.RA118.003441	http://dx.doi.org/10.1074/jbc.RA118.003441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29925590	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000441408500007
J	Murillo-de-Ozores, AR; Rodriguez-Gama, A; Bazua-Valenti, S; Leyva-Rios, K; Vazquez, N; Pacheco-Alvarez, D; De La Rosa-Velazquez, IA; Wengi, A; Stone, KL; Zhang, JH; Loffing, J; Lifton, RP; Yang, CL; Ellison, DH; Gamba, G; Castaneda-Bueno, M				Rafael Murillo-De-Ozores, Adrian; Rodriguez-Gama, Alejandro; Bazua-Valenti, Silvana; Leyva-Rios, Karla; Vazquez, Norma; Pacheco-Alvarez, Diana; De La Rosa-Velazquez, Inti A.; Wengi, Agnieszka; Stone, Kathryn L.; Zhang, Junhui; Loffing, Johannes; Lifton, Richard P.; Yang, Chao-Ling; Ellison, David H.; Gamba, Gerardo; Castaneda-Bueno, Maria			C-terminally truncated, kidney-specific variants of the WNK4 kinase lack several sites that regulate its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; hypertension; membrane transport; protein phosphatase; phosphoprotein phosphatase 1 (PP1); proteolysis; serine; threonine protein kinase; pseudohypoaldosteronism; Ste20-related proline; alanine-rich kinase; WNK lysine-deficient protein kinase 4	PROTEIN PHOSPHATASE 1; BLOOD-PRESSURE; NA+ CHANNEL; COTRANSPORTER; SPAK; ACTIVATION; PHOSPHORYLATION; UBIQUITINATION; HYPERTENSION; HOMEOSTASIS	WNK lysine-deficient protein kinase 4 (WNK4) is an important regulator of renal salt handling. Mutations in its gene cause pseudohypoaldosteronism type II, mainly arising from overactivation of the renal Na+/Cl- cotransporter (NCC). In addition to full-length WNK4, we have observed faster migrating bands (between 95 and 130 kDa) in Western blots of kidney lysates. Therefore, we hypothesized that these could correspond to uncharacterized WNK4 variants. Here, using several WNK4 antibodies and WNK4(-/-) mice as controls, we showed that these bands indeed correspond to short WNK4 variants that are not observed in other tissue lysates. LC-MS/MS confirmed these bands as WNK4 variants that lack C-terminal segments. In HEK293 cells, truncation of WNK4's C terminus at several positions increased its kinase activity toward Ste20-related proline/alanine-rich kinase (SPAK), unless the truncated segment included the SPAK-binding site. Of note, this gain-of-function effect was due to the loss of a protein phosphatase 1 (PP1)-binding site in WNK4. Cotransfection with PP1 resulted in WNK4 dephosphorylation, an activity that was abrogated in the PP1-binding site WNK4 mutant. The electrophoretic mobility of the in vivo short variants of renal WNK4 suggested that they lack the SPAK-binding site and thus may not behave as constitutively active kinases toward SPAK. Finally, we show that at least one of the WNK4 short variants may be produced by proteolysis involving a Zn2+-dependent metalloprotease, as recombinant full-length WNK4 was cleaved when incubated with kidney lysate.	[Rafael Murillo-De-Ozores, Adrian] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 14080, DF, Mexico; [Rodriguez-Gama, Alejandro; Bazua-Valenti, Silvana; Vazquez, Norma; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 14080, DF, Mexico; [Leyva-Rios, Karla; Pacheco-Alvarez, Diana] Univ Panamer, Escuela Med, Mexico City 03920, DF, Mexico; [De La Rosa-Velazquez, Inti A.] Univ Nacl Autonoma Mexico, Genom Lab, RAI, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14080, DF, Mexico; [Wengi, Agnieszka; Loffing, Johannes] Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; [Wengi, Agnieszka; Loffing, Johannes] Univ Zurich, Swiss Natl Ctr Competence Res Kidney Control Home, CH-8057 Zurich, Switzerland; [Stone, Kathryn L.] Yale Univ, Sch Med, MS & Prote Resource, WM Keck Biotechnol Resource Lab, New Haven, CT 06510 USA; [Zhang, Junhui; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lifton, Richard P.] Rockefeller Univ, Lab Human Genet & Genom, New York, NY 10065 USA; [Yang, Chao-Ling; Ellison, David H.] Oregon Hlth & Sci Univ, Dept Med, Div Nephrol & Hypertens, Portland, OR 97239 USA; [Yang, Chao-Ling; Ellison, David H.] Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA; [Gamba, Gerardo; Castaneda-Bueno, Maria] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14080, DF, Mexico; [Gamba, Gerardo] Escuela Med & Ciencias Salud, Tecnol Monterrey, Monterrey 64710, Nuevo Leon, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Panamericana - Ciudad de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; University of Zurich; University of Zurich; Yale University; Yale University; Rockefeller University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Tecnologico de Monterrey	Castaneda-Bueno, M (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14080, DF, Mexico.	mcasta85@yahoo.com.mx	Loffing, Johannes/ABG-9973-2020; CASTANEDA-BUENO, MARIA/GYR-1202-2022; , David/X-5730-2019	Rodriguez Gama, Alejandro/0000-0003-3257-5549; Loffing, Johannes/0000-0002-9415-6588; Pacheco-Alvarez, Diana/0000-0001-5454-9267	National Institutes of Health [DK51496]; Conacyt [23, 257726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK51496 (to G.G., C.-L.Y., and D.H.E.) and Conacyt Grants 23 (to G.G.) and 257726 (to M.C.-B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argaiz ER, 2018, AM J PHYSIOL-RENAL, V315, pF734, DOI 10.1152/ajprenal.00145.2018; Arvaniti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26235; Bazua-Valenti S, 2015, J AM SOC NEPHROL, V26, P1781, DOI 10.1681/ASN.2014050470; Beynon R., 2000, PROTEOLYTIC ENZYMES, P105; Castaneda-Bueno M, 2017, P NATL ACAD SCI USA, V114, pE879, DOI 10.1073/pnas.1620315114; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Chavez-Canales M, 2014, HYPERTENSION, V64, P1047, DOI 10.1161/HYPERTENSIONAHA.114.04036; Correa LM, 2000, DEV BIOL, V225, P124, DOI 10.1006/dbio.2000.9825; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Frenette-Cotton R, 2018, J CELL PHYSIOL, V233, P396, DOI 10.1002/jcp.25899; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; Grimm PR, 2017, J AM SOC NEPHROL, V28, P2598, DOI 10.1681/ASN.2016090948; Ishizawa K, 2016, BIOCHEM BIOPH RES CO, V480, P745, DOI 10.1016/j.bbrc.2016.10.127; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Koumangoye R, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13479; Krishnan N, 2012, MOL CELL BIOL, V32, P4306, DOI 10.1128/MCB.00382-12; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Lin DH, 2012, AM J PHYSIOL-RENAL, V303, pF110, DOI 10.1152/ajprenal.00676.2011; Lobbestael E, 2013, BIOCHEM J, V456, P119, DOI 10.1042/BJ20121772; Markadieu N, 2014, J BIOL CHEM, V289, P29273, DOI 10.1074/jbc.M114.604009; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Naraine MK, 2017, FASEB J, V31; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2014, J BIOL CHEM, V289, P17680, DOI 10.1074/jbc.M113.540518; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4020, DOI 10.1073/pnas.0611727104; San-Cristobal P, 2008, AM J PHYSIOL-RENAL, V295, pF1199, DOI 10.1152/ajprenal.90396.2008; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Terker AS, 2015, CELL METAB, V21, P39, DOI 10.1016/j.cmet.2014.12.006; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Villa F, 2007, EMBO REP, V8, P839, DOI 10.1038/sj.embor.7401048; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xiao YX, 2015, ANAL BIOCHEM, V477, P95, DOI 10.1016/j.ab.2014.11.006; Yang CL, 2007, BIOCHEM BIOPH RES CO, V353, P535, DOI 10.1016/j.bbrc.2006.11.151; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Zhang C., 2016, AM J PHYSIOL-RENAL, V312, pF622	47	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12209	12221		10.1074/jbc.RA118.003037	http://dx.doi.org/10.1074/jbc.RA118.003037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29921588	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000440803200019
J	Pedrote, MM; de Oliveira, GAP; Felix, AL; Mota, MF; Marques, MD; Soares, IN; Iqbal, A; Norberto, DR; Gomes, AMO; Gratton, E; Cino, EA; Silva, JL				Pedrote, Murilo M.; de Oliveira, Guilherme A. P.; Felix, Adriani L.; Mota, Michelle F.; Marques, Mayra de A.; Soares, Iaci N.; Iqbal, Anwar; Norberto, Douglas R.; Gomes, Andre M. O.; Gratton, Enrico; Cino, Elio A.; Silva, Jerson L.			Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; protein aggregation; p53; amyloid; cancer; tumor suppressor; fluorescence spectroscopy; hydrostatic pressure; molten globule	TUMOR-SUPPRESSOR P53; WILD-TYPE P53; MUTANT P53; HIGH-PRESSURE; DESIGNED PEPTIDE; STRUCTURAL BASIS; PROTEIN; MECHANISM; RESCUE; INTERMEDIATE	The functionality of the tumor suppressor p53 is altered in more than 50% of human cancers, and many individuals with cancer exhibit amyloid-like buildups of aggregated p53. An understanding of what triggers the pathogenic amyloid conversion of p53 is required for the further development of cancer therapies. Here, perturbation of the p53 core domain (p53C) with subdenaturing concentrations of guanidine hydrochloride and high hydrostatic pressure revealed native-like molten globule (MG) states, a subset of which were highly prone to amyloidogenic aggregation. We found that MG conformers of p53C, probably representing population-weighted averages of multiple states, have different volumetric properties, as determined by pressure perturbation and size-exclusion chromatography. We also found that they bind the fluorescent dye 4,4-dianilino-1,1-binaphthyl-5,5-disulfonic acid (bis-ANS) and have a native-like tertiary structure that occludes the single Trp residue in p53. Fluorescence experiments revealed conformational changes of the single Trp and Tyr residues before p53 unfolding and the presence of MG conformers, some of which were highly prone to aggregation. p53C exhibited marginal unfolding cooperativity, which could be modulated from unfolding to aggregation pathways with chemical or physical forces. We conclude that trapping amyloid precursor states in solution is a promising approach for understanding p53 aggregation in cancer. Our findings support the use of single-Trp fluorescence as a probe for evaluating p53 stability, effects of mutations, and the efficacy of therapeutics designed to stabilize p53.	[Pedrote, Murilo M.; de Oliveira, Guilherme A. P.; Felix, Adriani L.; Mota, Michelle F.; Marques, Mayra de A.; Soares, Iaci N.; Iqbal, Anwar; Norberto, Douglas R.; Gomes, Andre M. O.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Programa Biol Estrutural,Inst Bioquim Med Leopold, BR-21941901 Rio De Janeiro, RJ, Brazil; [de Oliveira, Guilherme A. P.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA 92697 USA; [Cino, Elio A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil	Universidade Federal do Rio de Janeiro; University of Virginia; University of California System; University of California Irvine; Universidade Federal de Minas Gerais	de Oliveira, GAP; Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Programa Biol Estrutural,Inst Bioquim Med Leopold, BR-21941901 Rio De Janeiro, RJ, Brazil.; de Oliveira, GAP (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	gaugusto@bioqmed.ufrj.br; jerson@bioqmed.ufrj.br	SILVA, JERSON Lima/GRF-1442-2022; de Oliveira, Guilherme A. P./O-1192-2013; Norberto, Douglas/AAV-6754-2020; Silva, Jerson/J-8984-2014; Gomes, Andre M.O./C-4009-2014; Marques, Mayra/AAN-3130-2021	SILVA, JERSON Lima/0000-0001-9523-9441; de Oliveira, Guilherme A. P./0000-0002-0063-5888; Silva, Jerson/0000-0001-9523-9441; Gomes, Andre M.O./0000-0003-1052-8004; Marques, Mayra/0000-0002-4131-4634; Pedrote, Murilo/0000-0001-6744-9572; Gratton, Enrico/0000-0002-6450-7391	National Council of Technological and Scientific Development; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro Grant [E-26/201.817/2015]; Pew Charitable Trusts Foundation; National Institutes of Health [P41-GM103540, P50-GM076516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Council of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro Grant; Pew Charitable Trusts Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Council of Technological and Scientific Development and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (to J.L.S.). This work was also aided by the Cancer Foundation and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro Grant E-26/201.817/2015 (to G.A.P.d.O. and J.L.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a doctoral fellowship from the National Council of Technological and Scientific Development.; Recipient of a fellowship from the Pew Charitable Trusts Foundation.; Supported in part by National Institutes of Health Grants P41-GM103540 and P50-GM076516.	Acharya N, 2016, J PHYS CHEM LETT, V7, P173, DOI 10.1021/acs.jpclett.5b02545; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Baldwin RL, 2010, PROTEINS, V78, P2725, DOI 10.1002/prot.22803; Basse N, 2010, CHEM BIOL, V17, P46, DOI 10.1016/j.chembiol.2009.12.011; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Borgohain G, 2018, J MOL LIQ, V251, P378, DOI 10.1016/j.molliq.2017.12.054; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Canning P, 2012, J MOL BIOL, V423, P515, DOI 10.1016/j.jmb.2012.08.005; Ceru S, 2008, FEBS LETT, V582, P203, DOI 10.1016/j.febslet.2007.12.002; Cho SS, 2008, P NATL ACAD SCI USA, V105, P118, DOI 10.1073/pnas.0709376104; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; Cino EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32535; Costa DCF, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023614; Das A, 2009, J PHYS CHEM B, V113, P12816, DOI 10.1021/jp906350s; Dasgupta A, 2014, J PHYS CHEM B, V118, P6380, DOI 10.1021/jp410019f; de Oliveira GAP, 2017, BIOPHYS CHEM, V231, P20, DOI 10.1016/j.bpc.2017.03.007; de Oliveira GAP, 2015, P NATL ACAD SCI USA, V112, pE2775, DOI 10.1073/pnas.1500352112; De Smet F, 2017, J PATHOL, V242, P24, DOI 10.1002/path.4872; Enthart A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26707; Friedler A, 2004, J MOL BIOL, V336, P187, DOI 10.1016/j.jmb.2003.12.005; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Ghosh S, 2017, CELL DEATH DIFFER, V24, P1784, DOI 10.1038/cdd.2017.105; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; James NG, 2011, ANAL BIOCHEM, V410, P70, DOI 10.1016/j.ab.2010.11.011; Jha SK, 2014, P NATL ACAD SCI USA, V111, P4856, DOI 10.1073/pnas.1315453111; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Joerger AC, 2015, STRUCTURE, V23, P2246, DOI 10.1016/j.str.2015.10.016; Karamanos TK, 2016, J AM CHEM SOC, V138, P6271, DOI 10.1021/jacs.6b02464; Kovachev PS, 2017, J BIOL CHEM, V292, P9345, DOI 10.1074/jbc.M116.762096; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Malacrida L, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/4/047001; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Munoz V, 2016, CURR OPIN STRUC BIOL, V36, P58, DOI 10.1016/j.sbi.2015.12.001; Neumaier S, 2014, J MOL BIOL, V426, P2520, DOI 10.1016/j.jmb.2014.04.022; Reiner A, 2010, P NATL ACAD SCI USA, V107, P4955, DOI 10.1073/pnas.0910001107; Roche J, 2012, P NATL ACAD SCI USA, V109, P6945, DOI 10.1073/pnas.1200915109; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Silva JL, 2018, ACCOUNTS CHEM RES, V51, P181, DOI 10.1021/acs.accounts.7b00473; Silva JL, 2014, CHEM REV, V114, P7239, DOI 10.1021/cr400204z; Skora L, 2010, J AM CHEM SOC, V132, P9223, DOI 10.1021/ja100453e; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Wang GZ, 2017, P NATL ACAD SCI USA, V114, pE2634, DOI 10.1073/pnas.1700308114; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2437, DOI 10.1073/pnas.1500243112; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; Yang J, 2001, J AGR FOOD CHEM, V49, P3236, DOI 10.1021/jf001226o; Yang-Hartwich Y, 2015, ONCOGENE, V34, P3605, DOI 10.1038/onc.2014.296; Zhou RH, 2011, J PHYS CHEM B, V115, P1323, DOI 10.1021/jp105160a	53	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11374	11387		10.1074/jbc.RA118.003285	http://dx.doi.org/10.1074/jbc.RA118.003285			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29853637	Green Published, hybrid			2022-12-28	WOS:000439449700009
J	Grudnik, P; Kaminski, MM; Rembacz, KP; Kuska, K; Madej, M; Potempa, J; Dawidowski, M; Dubin, G				Grudnik, Przemyslaw; Kaminski, Marcin M.; Rembacz, Krzysztof P.; Kuska, Katarzyna; Madej, Mariusz; Potempa, Jan; Dawidowski, Maciej; Dubin, Grzegorz			Structural basis for ADP-dependent glucokinase inhibition by 8-bromo-substituted adenosine nucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; enzyme inhibitor; glucose metabolism; crystal structure; X-ray crystallography; 8-bromo-adenosine monophosphate; 8-bromo-AMP; ADP-dependent glucokinase; reactive oxygen species; T cell activation	ACTIVATED PROTEIN-KINASE; T-CELL-ACTIVATION; CRYSTAL-STRUCTURES; AMP; EXPRESSION; MITOCHONDRIA; SPECIFICITY; GLYCOLYSIS; FAMILY; SITES	In higher eukaryotes, several ATP-utilizing enzymes known as hexokinases activate glucose in the glycolysis pathway by phosphorylation to glucose 6-phosphate. In contrast to canonical hexokinases, which use ATP, ADP-dependent glucokinase (ADPGK) catalyzes noncanonical phosphorylation of glucose to glucose 6-phosphate using ADP as a phosphate donor. Initially discovered in Archaea, the human homolog of ADPGK was described only recently. ADPGK's involvement in modified bioenergetics of activated T cells has been postulated, and elevated ADPGK expression has been reported in various cancer tissues. However, the physiological role of ADPGK is still poorly understood, and effective ADPGK inhibitors still await discovery. Here, we show that 8-bromo-substituted adenosine nucleotide inhibits human ADPGK. By solving the crystal structure of archaeal ADPGK in complex with 8-bromoadenosine phosphate (8-Br-AMP) at 1.81 angstrom resolution, we identified the mechanism of inhibition. We observed that 8-Br-AMP is a competitive inhibitor of ADPGK and that the bromine substitution induces marked structural changes within the protein's active site by engaging crucial catalytic residues. The results obtained using the Jurkat model of activated human T cells suggest its moderate activity in a cellular setting. We propose that our structural insights provide a critical basis for rational development of novel ADPGK inhibitors.	[Grudnik, Przemyslaw; Rembacz, Krzysztof P.; Kuska, Katarzyna; Madej, Mariusz; Potempa, Jan; Dubin, Grzegorz] Jagiellonian Univ Krakow, Fac Biochem Biophys & Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland; [Grudnik, Przemyslaw; Madej, Mariusz; Potempa, Jan; Dubin, Grzegorz] Jagiellonian Univ Krakow, Malopolska Ctr Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland; [Kaminski, Marcin M.] St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Dawidowski, Maciej] Warsaw Med Univ, Fac Pharm, Banacha 1 St, PL-02097 Warsaw, Poland	Jagiellonian University; Jagiellonian University; St Jude Children's Research Hospital; Medical University of Warsaw	Grudnik, P (corresponding author), Jagiellonian Univ Krakow, Fac Biochem Biophys & Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland.; Dubin, G (corresponding author), Jagiellonian Univ Krakow, Malopolska Ctr Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland.; Kaminski, MM (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	przemyslaw.grudnik@uj.edu.pl; marcin.kaminski@stjude.org; grzegorz.dubin@uj.edu.pl	Kaminski, Marcin/L-6974-2015; Potempa, Jan/AAA-6850-2021; Grudnik, Przemyslaw/AAV-7097-2020; Dubin, Grzegorz/J-8168-2014; Dawidowski, Maciej/U-9307-2017	Kaminski, Marcin/0000-0002-9026-0185; Grudnik, Przemyslaw/0000-0002-7157-0014; Dubin, Grzegorz/0000-0002-5535-5760; Dawidowski, Maciej/0000-0002-7262-5718; Potempa, Jan/0000-0002-3600-7461	Ministry of Science and Higher Education	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	We thank Urszula Nowak for help during the initial phase of the project, Klaudia Wo from the MCB Structural Biology Core Facility for help in crystallization, and Helmholtz-Zentrum Berlin for the allocation of beamtime. The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alba G, 2004, FEBS LETT, V573, P219, DOI 10.1016/j.febslet.2004.07.077; Rivas-Pardo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066687; Brenner C, 1997, NAT STRUCT BIOL, V4, P231, DOI 10.1038/nsb0397-231; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hughes TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4571; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaminski MM, 2013, ARCH IMMUNOL THER EX, V61, P367, DOI 10.1007/s00005-013-0235-0; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Lee KE, 2016, CANCER DISCOV, V6, P256, DOI 10.1158/2159-8290.CD-15-0822; Ludlow RF, 2015, P NATL ACAD SCI USA, V112, P15910, DOI 10.1073/pnas.1518946112; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merino F, 2008, FEBS J, V275, P4033, DOI 10.1111/j.1742-4658.2008.06544.x; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Richter JP, 2016, J BIOL CHEM, V291, P3694, DOI 10.1074/jbc.M115.679902; Richter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065267; Richter S, 2012, MOL CELL BIOCHEM, V364, P131, DOI 10.1007/s11010-011-1212-8; Robak T, 2011, EXPERT OPIN INV DRUG, V20, P343, DOI 10.1517/13543784.2011.554822; Ronimus RS, 2004, BIOCHEM BIOPH RES CO, V315, P652, DOI 10.1016/j.bbrc.2004.01.103; Seidel SAI, 2012, ANGEW CHEM INT EDIT, V51, P10656, DOI 10.1002/anie.201204268; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; SHOHAM M, 1980, J MOL BIOL, V140, P1, DOI 10.1016/0022-2836(80)90353-8; Sparta KM, 2016, J APPL CRYSTALLOGR, V49, P1085, DOI 10.1107/S1600576716004416; Tokarz P, 2018, PROTEIN SCI, V27, P790, DOI 10.1002/pro.3377; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu DY, 2014, NUCLEIC ACIDS RES, V42, P3607, DOI 10.1093/nar/gkt1382; Xu RX, 2004, J MOL BIOL, V337, P355, DOI 10.1016/j.jmb.2004.01.040; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024	43	4	4	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11088	11099		10.1074/jbc.RA117.001562	http://dx.doi.org/10.1074/jbc.RA117.001562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784881	hybrid, Green Published			2022-12-28	WOS:000438882800021
J	Hossain, D; Barbosa, JAF; Cohen, EA; Tsang, WY				Hossain, Delowar; Barbosa, Jeremy A. Ferreira; Cohen, Eric A.; Tsang, William Y.			HIV-1 Vpr hijacks EDD-DYRK2-DDB1(DCAF1) to disrupt centrosome homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centrosome; centriole; ubiquitin ligase; human immunodeficiency virus (HIV); viral protein; microtubule; Cep78; CP110	E3 UBIQUITIN LIGASE; HUMAN-IMMUNODEFICIENCY-VIRUS; DEFICIENCY-SYNDROME AIDS; HUMANIZED MICE; CELL-CYCLE; INHIBITS TELOMERASE; PROTEIN-INTERACTION; GENE-TRANSCRIPTION; DEGRADATION; DAMAGE	Viruses exploit the host cell machinery for their own profit. To evade innate immune sensing and promote viral replication, HIV type 1 (HIV-1) subverts DNA repair regulatory proteins and induces G(2)/M arrest. The preintegration complex of HIV-1 is known to traffic along microtubules and accumulate near the microtubule-organizing center. The centrosome is the major microtubule-organizing center in most eukaryotic cells, but precisely how HIV-1 impinges on centrosome biology remains poorly understood. We report here that the HIV-1 accessory protein viral protein R (Vpr) localized to the centrosome through binding to DCAF1, forming a complex with the ubiquitin ligase EDD-DYRK2-DDB1(DCAF1) and Cep78, a resident centrosomal protein previously shown to inhibit EDD-DYRK2-DDB1(DCAF1). Vpr did not affect ubiquitination of Cep78. Rather, it enhanced ubiquitination of an EDD-DYRK2-DDB1(DCAF1) substrate, CP110, leading to its degradation, an effect that could be overcome by Cep78 expression. The down-regulation of CP110 and elongation of centrioles provoked by Vpr were independent of G(2)/M arrest. Infection of T lymphocytes with HIV-1, but not with HIV-1 lacking Vpr, promoted CP110 degradation and centriole elongation. Elongated centrioles recruited more -tubulin to the centrosome, resulting in increased microtubule nucleation. Our results suggest that Vpr is targeted to the centrosome where it hijacks a ubiquitin ligase, disrupting organelle homeostasis, which may contribute to HIV-1 pathogenesis.	[Hossain, Delowar; Barbosa, Jeremy A. Ferreira; Cohen, Eric A.; Tsang, William Y.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Hossain, Delowar; Cohen, Eric A.; Tsang, William Y.] McGill Univ, Div Expt Med, Montreal, PQ H4A 3J1, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Tsang, William Y.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal	Tsang, WY (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.; Tsang, WY (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ H4A 3J1, Canada.; Tsang, WY (corresponding author), Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada.	william.tsang@ircm.qc.ca		Tsang, William/0000-0002-1584-616X	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to W. Y. T.) and a grant from the Canadian Institutes of Health Research (CIHR) (to E. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonso PV, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-27; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Barbelanne M, 2015, HUM MOL GENET, V24, P2185, DOI 10.1093/hmg/ddu738; Barbelanne M, 2013, HUM MOL GENET, V22, P2482, DOI 10.1093/hmg/ddt100; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Bolton DL, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-17; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Bregnard C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00176; Chang F, 2004, MOL BIOL CELL, V15, P1793, DOI 10.1091/mbc.E03-09-0691; Chen D, 2002, EMBO J, V21, P6801, DOI 10.1093/emboj/cdf683; Coffin JM, 1997, RETROVIRUSES INTERAC; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Das A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006791; Dave VP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-128; de Mareuil J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-5; Dumas A, 2015, J CELL BIOL, V211, P359, DOI 10.1083/jcb.201503124; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Forget J, 1998, J MOL BIOL, V284, P915, DOI 10.1006/jmbi.1998.2206; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Fregoso OI, 2016, MBIO, V7, DOI 10.1128/mBio.01433-16; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Gaynor EM, 2001, EXP CELL RES, V267, P243, DOI 10.1006/excr.2001.5247; Gerard FCA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089195; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hossain D, 2017, EMBO REP, V18, P632, DOI 10.15252/embr.201642377; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2016, P NATL ACAD SCI USA, V113, pE3921, DOI 10.1073/pnas.1605023113; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kim K, 2013, MOL CELL, V52, P459, DOI 10.1016/j.molcel.2013.09.017; Kim K, 2012, MOL CELL BIOL, V32, P783, DOI 10.1128/MCB.06037-11; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lahouassa H, 2016, P NATL ACAD SCI USA, V113, P5311, DOI 10.1073/pnas.1600485113; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lukic Z, 2014, J VIROL, V88, P13613, DOI 10.1128/JVI.02219-14; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Minemoto Y, 1999, BIOCHEM BIOPH RES CO, V258, P379, DOI 10.1006/bbrc.1999.0640; Mullee LI, 2016, CHROMOSOME RES, V24, P35, DOI 10.1007/s10577-015-9503-7; Nakagawa T, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-22; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Sabo Y, 2013, CELL HOST MICROBE, V14, P535, DOI 10.1016/j.chom.2013.10.012; Sato K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004453; Sato K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003812; Sato K, 2012, J VIROL, V86, P5000, DOI 10.1128/JVI.07062-11; Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Watanabe N, 2000, EXP CELL RES, V258, P261, DOI 10.1006/excr.2000.4908; Watkins RL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-125; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Zamborlini A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-63; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7; ZHAO LJ, 1994, J BIOL CHEM, V269, P15577; Zhou XH, 2017, J BIOL CHEM, V292, P21117, DOI 10.1074/jbc.M117.798801; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	69	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9448	9460		10.1074/jbc.RA117.001444	http://dx.doi.org/10.1074/jbc.RA117.001444			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29724823	Green Published, hybrid			2022-12-28	WOS:000435441400028
J	Martin-Garrido, A; Biesiadecki, BJ; Salhi, HE; Shaifta, Y; dos Remedios, CG; Ayaz-Guner, S; Cai, WX; Ge, Y; Avkiran, M; Kentish, JC				Martin-Garrido, Abel; Biesiadecki, Brandon J.; Salhi, Hussam E.; Shaifta, Yasin; dos Remedios, Cristobal G.; Ayaz-Guner, Serife; Cai, Wenxuan; Ge, Ying; Avkiran, Metin; Kentish, Jonathan C.			Monophosphorylation of cardiac troponin-I at Ser-23/24 is sufficient to regulate cardiac myofibrillar Ca2+ sensitivity and calpain-induced proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						troponin; phosphorylation; protein kinase D (PKD); calpain; cardiac muscle; cardiomyocyte; Ca2+ sensitivity; myofibril; sarcomere	BINDING-PROTEIN-C; FAILING HUMAN HEART; KINASE-D; PHOSPHORYLATION SITE; MYOFILAMENT FUNCTION; MYOSIN; MYOCARDIUM; AFFINITY; MUSCLE; CARDIOMYOPATHY	The acceleration of myocardial relaxation produced by -adrenoreceptor stimulation is mediated in part by protein kinase A (PKA)-mediated phosphorylation of cardiac troponin-I (cTnI), which decreases myofibrillar Ca2+ sensitivity. Previous evidence suggests that phosphorylation of both Ser-23 and Ser-24 in cTnI is required for this Ca2+ desensitization. PKA-mediated phosphorylation also partially protects cTnI from proteolysis by calpain. Here we report that protein kinase D (PKD) phosphorylates only one serine of cTnI Ser-23/24. To explore the functional consequences of this monophosphorylation, we examined the Ca2+ sensitivity of force production and susceptibility of cTnI to calpain-mediated proteolysis when Ser-23/24 of cTnI in mouse cardiac myofibrils was nonphosphorylated, mono-phosphorylated, or bisphosphorylated (using sequential incubations in -phosphatase, PKD, and PKA, respectively). Phos-tag gels, Western blotting, and high-resolution MS revealed that PKD produced >90% monophosphorylation of cTnI, primarily at Ser-24, whereas PKA led to cTnI bisphosphorylation exclusively. PKD markedly decreased the Ca2+ sensitivity of force production in detergent-permeabilized ventricular trabeculae, whereas subsequent incubation with PKA produced only a small further fall of Ca2+ sensitivity. Unlike PKD, PKA also substantially phosphorylated myosin-binding protein-C and significantly accelerated cross-bridge kinetics (k(tr)). After phosphorylation by PKD or PKA, cTnI in isolated myofibrils was partially protected from calpain-mediated degradation. We conclude that cTnI monophosphorylation at Ser-23/24 decreases myofibrillar Ca2+ sensitivity and partially protects cTnI from calpain-induced proteolysis. In healthy cardiomyocytes, the basal monophosphorylation of cTnI may help tonically regulate myofibrillar Ca2+ sensitivity.	[Martin-Garrido, Abel; Shaifta, Yasin; Avkiran, Metin; Kentish, Jonathan C.] Kings Coll London, British Heart Fdn Ctr Excellence, Sch Cardiovasc Med & Sci, London SE1 7EH, England; [Biesiadecki, Brandon J.; Salhi, Hussam E.] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [dos Remedios, Cristobal G.] Univ Sydney, Discipline Anat & Histol, Bosch Inst, Sydney, NSW 2006, Australia; [Ayaz-Guner, Serife; Cai, Wenxuan; Ge, Ying] Univ Wisconsin, Dept Cell & Regenerat Biol, Pharmacol Training Program, Madison, WI 53705 USA; [Ge, Ying] Univ Wisconsin, Dept Chem, Pharmacol Training Program, Madison, WI 53705 USA; [Cai, Wenxuan] Univ Wisconsin, Dept Mol & Cellular, Pharmacol Training Program, Madison, WI 53705 USA; [Ge, Ying] Univ Wisconsin, Human Prote Program, Madison, WI 53705 USA; [Martin-Garrido, Abel] Univ Cambridge, Div Cardiovasc Med, Cambridge CB2 0QQ, England	University of London; King's College London; University System of Ohio; Ohio State University; University of Sydney; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Avkiran, M; Kentish, JC (corresponding author), Kings Coll London, St Thomas Hosp, British Heart Fdn Ctr Res Excellence, Rayne Inst, London SE1 7EH, England.	metin.avkiran@kcl.ac.uk; jon.kentish@kcl.ac.uk	AYAZ-GUNER, Serife/ABE-6237-2020; Ayaz-Guner, Serife/K-4139-2019	Ayaz-Guner, Serife/0000-0002-1052-0961; Cai, Wenxuan/0000-0001-7117-2449; Avkiran, Metin/0000-0003-2392-6343	British Heart Foundation [PG/11/100/29211, RE/13/2/30182]; National Institutes of Health [R01 HL109810, R01 HL096971, S10OD018475, R01 HL114940]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096971, R01HL114940, R01HL109810] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018475] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by British Heart Foundation grants PG/11/100/29211 and RE/13/2/30182 (to J. K. and M. A) and National Institutes of Health Grants R01 HL109810, R01 HL096971, and S10OD018475 (to Y. G.) and R01 HL114940 to (B. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Cuello F, 2011, J BIOL CHEM, V286, P5300, DOI 10.1074/jbc.M110.202713; DILISA F, 1995, BIOCHEM J, V308, P57, DOI 10.1042/bj3080057; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Fitzsimons DP, 2001, J PHYSIOL-LONDON, V530, P263, DOI 10.1111/j.1469-7793.2001.0263l.x; Fukuda N, 2004, CURR VASC PHARMACOL, V2, P135, DOI 10.2174/1570161043476357; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Gross SM, 2016, PHYSIOL GENOMICS, V48, P377, DOI 10.1152/physiolgenomics.00112.2015; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Hinken AC, 2007, PHYSIOLOGY, V22, P73, DOI 10.1152/physiol.00043.2006; Jensen BC, 2011, J MOL CELL CARDIOL, V51, P518, DOI 10.1016/j.yjmcc.2010.11.014; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Layland J, 2004, J PHYSIOL-LONDON, V556, P835, DOI 10.1113/jphysiol.2004.061176; Martell A. E., 1974, CRIT STABILITY CONST, V1, P270; McDonough JL, 1999, CIRC RES, V84, P9; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00315; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731; van der Velden J, 2011, PFLUG ARCH EUR J PHY, V462, P155, DOI 10.1007/s00424-011-0960-3; van Dijk SJ, 2012, CIRC-HEART FAIL, V5, P36, DOI 10.1161/CIRCHEARTFAILURE.111.963702; Wijnker PJM, 2015, J MOL CELL CARDIOL, V82, P93, DOI 10.1016/j.yjmcc.2015.03.006; Wijnker PJM, 2013, AM J PHYSIOL-HEART C, V304, pH260, DOI 10.1152/ajpheart.00498.2012; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Zachariou M, 1996, J PHYS CHEM-US, V100, P12680, DOI 10.1021/jp9601476; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; Zhuo SQ, 1997, PROTEIN ENG, V10, P1445, DOI 10.1093/protein/10.12.1445	40	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8588	8599		10.1074/jbc.RA117.001292	http://dx.doi.org/10.1074/jbc.RA117.001292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29669813	hybrid, Green Published			2022-12-28	WOS:000434205700022
J	Miyanokoshi, M; Yokosawa, T; Wakasugi, K				Miyanokoshi, Miki; Yokosawa, Takumi; Wakasugi, Keisuke			Tryptophanyl-tRNA synthetase mediates high-affinity tryptophan uptake into human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; tryptophan; amino acid transport; interferon; indoleamine-pyrrole 2; 3-dioxygenase (IDO1); tryptophanyl-tRNA synthetase; mutagenesis	HUMAN INDOLEAMINE 2,3-DIOXYGENASE; AMINO-ACID TRANSPORTER; INTERFERON-GAMMA; CRYSTAL-STRUCTURE; ANGIOSTATIC ACTIVITY; DENDRITIC CELLS; ACTIVE-SITE; HUMAN TRPRS; PROTEIN; IDENTIFICATION	The tryptophan (Trp) transport system has a high affinity and selectivity toward Trp, and has been reported to exist in both human and mouse macrophages. Although this system is highly expressed in interferon- (IFN-)-treated cells and indoleamine 2,3-dioxygenase 1 (IDO1)-expressing cells, its identity remains incompletely understood. Tryptophanyl-tRNA synthetase (TrpRS) is also highly expressed in IFN--treated cells and also has high affinity and selectivity for Trp. Here, we investigated the effects of human TrpRS expression on Trp uptake into IFN--treated human THP-1 monocytes or HeLa cells. Inhibition of human TrpRS expression by TrpRS-specific siRNAs decreased and overexpression of TrpRS increased Trp uptake into the cells. Of note, the TrpRS-mediated uptake system had more than hundred-fold higher affinity for Trp than the known System L amino acid transporter, promoted uptake of low Trp concentrations, and had very high Trp selectivity. Moreover, site-directed mutagenesis experiments indicated that Trp- and ATP-binding sites, but not tRNA-binding sites, in TrpRS are essential for TrpRS-mediated Trp uptake into the human cells. We further demonstrate that the addition of purified TrpRS to cell culture medium increases Trp uptake into cells. Taken together, our results reveal that TrpRS plays an important role in high-affinity Trp uptake into human cells.	[Miyanokoshi, Miki; Wakasugi, Keisuke] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan; [Yokosawa, Takumi; Wakasugi, Keisuke] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Wakasugi, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.; Wakasugi, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	wakasugi@bio.c.u-tokyo.ac.jp	Wakasugi, Keisuke/AAQ-1642-2020	Wakasugi, Keisuke/0000-0002-8408-5616	Kurata Memorial Hitachi Science and Technology Foundation Kurata Grant; Smoking Research Foundation research grant; Japan Society for the Promotion of Science (JSPS) KAKENHI [21570129, 26440047, 17K07329, 16J09853]	Kurata Memorial Hitachi Science and Technology Foundation Kurata Grant; Smoking Research Foundation research grant; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Kurata Memorial Hitachi Science and Technology Foundation Kurata Grant (to K.W.), the Smoking Research Foundation research grant (to K.W.), and Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 21570129, 26440047, and 17K07329 (to K.W.) and 16J09853 (to M.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn YH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.191; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bhutia YD, 2015, BBA-BIOMEMBRANES, V1848, P453, DOI 10.1016/j.bbamem.2014.10.021; Brown JR, 1997, J MOL EVOL, V45, P9, DOI 10.1007/PL00006206; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; dePouplana LR, 1996, P NATL ACAD SCI USA, V93, P166, DOI 10.1073/pnas.93.1.166; DOUBLIE S, 1995, STRUCTURE, V3, P17, DOI 10.1016/S0969-2126(01)00132-0; Ewalt KL, 2005, BIOCHEMISTRY-US, V44, P4216, DOI 10.1021/bi048116l; Ewalt KL, 2002, BIOCHEMISTRY-US, V41, P13344, DOI 10.1021/bi020537k; FLECKNER J, 1995, CYTOKINE, V7, P70, DOI 10.1006/cyto.1995.1009; FLECKNER J, 1991, P NATL ACAD SCI USA, V88, P11520, DOI 10.1073/pnas.88.24.11520; FROLOVA LY, 1991, GENE, V109, P291, DOI 10.1016/0378-1119(91)90624-K; Johnson JD, 2002, FEMS MICROBIOL LETT, V216, P111, DOI 10.1111/j.1574-6968.2002.tb11423.x; Kapoor M, 2008, J BIOL CHEM, V283, P2070, DOI 10.1074/jbc.M706028200; Kise Y, 2004, NAT STRUCT MOL BIOL, V11, P149, DOI 10.1038/nsmb722; KISSELEV L, 1993, TRENDS BIOCHEM SCI, V18, P263, DOI 10.1016/0968-0004(93)90178-P; Kisselev L L, 1979, Methods Enzymol, V59, P234; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; Kudo Y, 2003, AM J OBSTET GYNECOL, V188, P719, DOI 10.1067/mob.2003.156; Kudo Y, 2001, J PHYSIOL-LONDON, V535, P207, DOI 10.1111/j.1469-7793.2001.00207.x; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; Lee CW, 2015, ONCOTARGET, V6, P21979, DOI 10.18632/oncotarget.4273; Littlejohn TK, 2003, J BIOL CHEM, V278, P29525, DOI 10.1074/jbc.M301700200; Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Matsunaga T, 2002, SCAND J IMMUNOL, V56, P593, DOI 10.1046/j.1365-3083.2002.01179.x; Miyanokoshi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03477; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Nakamoto T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24750; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Paley EL, 2011, J ALZHEIMERS DIS, V26, P263, DOI 10.3233/JAD-2011-110176; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; REANO A, 1993, J INVEST DERMATOL, V100, P775, DOI 10.1111/1523-1747.ep12476463; RUBIN BY, 1991, J BIOL CHEM, V266, P24245; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Seymour RL, 2006, J LEUKOCYTE BIOL, V80, P1320, DOI 10.1189/jlb.1205727; Shaw AC, 1999, ELECTROPHORESIS, V20, P984, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<984::AID-ELPS984>3.0.CO;2-R; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Silk JD, 2011, J IMMUNOL, V187, P1617, DOI 10.4049/jimmunol.1000815; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; TOLSTRUP AB, 1995, J BIOL CHEM, V270, P397, DOI 10.1074/jbc.270.1.397; Turpaev KT, 1996, EUR J BIOCHEM, V240, P732, DOI 10.1111/j.1432-1033.1996.0732h.x; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wakasugi K, 2005, BIOCHEMISTRY-US, V44, P225, DOI 10.1021/bi048313k; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wakasugi K, 2007, BIOCHEMISTRY-US, V46, P11291, DOI 10.1021/bi7012068; Wakasugi K, 2010, BIOCHEMISTRY-US, V49, P3156, DOI 10.1021/bi1000239; Wakasugi K, 2010, FEBS LETT, V584, P229, DOI 10.1016/j.febslet.2009.11.073; Xu F, 2001, NUCLEIC ACIDS RES, V29, P4125, DOI 10.1093/nar/29.20.4125; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yang XL, 2007, STRUCTURE, V15, P793, DOI 10.1016/j.str.2007.05.009; Yang XL, 2006, EMBO J, V25, P2919, DOI 10.1038/sj.emboj.7601154; Yang XL, 2004, TRENDS BIOCHEM SCI, V29, P250, DOI 10.1016/j.tibs.2004.03.002; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	66	22	24	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8428	8438		10.1074/jbc.RA117.001247	http://dx.doi.org/10.1074/jbc.RA117.001247			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666190	hybrid, Green Published			2022-12-28	WOS:000434205700008
J	Badawy, SMM; Okada, T; Kajimoto, T; Hirase, M; Matovelo, SA; Nakamura, S; Yoshida, D; Ijuin, T; Nakamura, S				Badawy, Shaymaa Mohamed Mohamed; Okada, Taro; Kajimoto, Taketoshi; Hirase, Mitsuhiro; Matovelo, Shubi Ambwene; Nakamura, Shunsuke; Yoshida, Daisuke; Ijuin, Takeshi; Nakamura, Shun-ichi			Extracellular -synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingosine-1-phosphate (S1P); lipid raft; signal transduction; -synuclein (-synuclein); ganglioside	AGGREGATED ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; GANGLIOSIDE GM1; LEWY BODIES; SPHINGOSINE-1-PHOSPHATE; EXOSOMES; MUTATION; INTERNALIZATION; TRIPLICATION; LOCALIZATION	-Synuclein (-Syn)-positive intracytoplasmic inclusions, known as Lewy bodies, are thought to be involved in the pathogenesis of Lewy body diseases, such as Parkinson's disease (PD). Although growing evidence suggests that cell-to-cell transmission of -Syn is associated with the progression of PD and that extracellular -Syn promotes formation of inclusion bodies, its precise mechanism of action in the extracellular space remains unclear. Here, as indicated by both conventional fractionation techniques and FRET-based protein-protein interaction analysis, we demonstrate that extracellular -Syn causes expulsion of sphingosine 1-phosphate receptor subtype 1 (S1P(1)R) from the lipid raft fractions. S1P(1)R regulates vesicular trafficking, and its expulsion involved -Syn binding to membrane-surface gangliosides. Consequently, the S1P(1)R became refractory to S1P stimulation required for activating inhibitory G-protein (G(i)) in the plasma membranes. Moreover, the extracellular -Syn also induced uncoupling of the S1P(1)R on internal vesicles, resulting in the reduced amount of CD63 molecule (CD63) in the lumen of multivesicular endosomes, together with a decrease in CD63 in the released exosomes from -Syn-treated cells. Furthermore, cholesterol-depleting agent-induced S1P(1)R expulsion from the rafts also resulted in S1P(1)R uncoupling. Taken together, these results suggest that extracellular -Syn-induced expulsion of S1P(1)R from lipid rafts promotes the uncoupling of S1P(1)R from G(i), thereby blocking subsequent G(i) signals, such as inhibition of cargo sorting into exosomal vesicles in multivesicular endosomes. These findings help shed additional light on PD pathogenesis.	[Badawy, Shaymaa Mohamed Mohamed; Okada, Taro; Kajimoto, Taketoshi; Hirase, Mitsuhiro; Matovelo, Shubi Ambwene; Nakamura, Shunsuke; Yoshida, Daisuke; Ijuin, Takeshi; Nakamura, Shun-ichi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Biochem, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan	Kobe University	Nakamura, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Biochem, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan.	snakamur@kobe-u.ac.jp		Okada, Taro/0000-0001-5183-9402; Nakamura, Shun-ichi/0000-0002-2704-6557	Ministry of Education, Culture, Sports, Science and Technology of Japan; Nakatani Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatani Foundation	This work was supported by a Grant-in-Aid for challenging Exploratory Research (to S.-i. N.), a Grant-in-Aid for Scientific Research (C) (to T. O.), a Grant-in-Aid for Scientific Research (C) (to T. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Technology Development Research Grant from the Nakatani Foundation (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Baba M, 1998, AM J PATHOL, V152, P879; Badawy SMM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16457-4; Bae EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5755; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fantini J, 2011, J MOL BIOL, V408, P654, DOI 10.1016/j.jmb.2011.03.009; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; Kajimoto T, 2018, J BIOL CHEM, V293, P245, DOI 10.1074/jbc.M117.808733; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Maguire-Zeiss KA, 2006, BIOCHEM BIOPH RES CO, V349, P1198, DOI 10.1016/j.bbrc.2006.08.127; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Ohno Y, 2009, GENES CELLS, V14, P911, DOI 10.1111/j.1365-2443.2009.01319.x; Okada T, 2016, SCI REP-UK, V6, DOI 10.1038/srep37810; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Park SM, 2002, BLOOD, V100, P2506, DOI 10.1182/blood.V100.7.2506; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SUGANO K, 1978, FEBS LETT, V89, P321, DOI 10.1016/0014-5793(78)80246-4; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Takeda A, 1998, AM J PATHOL, V152, P367; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang LC, 2017, SECUR COMMUN NETW, DOI 10.1155/2017/4842694; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	41	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8208	8216		10.1074/jbc.RA118.001986	http://dx.doi.org/10.1074/jbc.RA118.001986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632069	Green Published, hybrid			2022-12-28	WOS:000433224600025
J	Hori, Y; Hashimoto, T; Nomoto, H; Hyman, BT; Iwatsubo, T				Hori, Yukiko; Hashimoto, Tadafumi; Nomoto, Hidetoshi; Hyman, Bradley T.; Iwatsubo, Takeshi			Role of apolipoprotein E in -amyloidogenesis: Isoform-specific effects on protofibril to fibril conversion of A in vitro and brain A deposition in vivo (vol 290, pg 15163, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Hori Y, 2015, J BIOL CHEM, V290, P15163, DOI 10.1074/jbc.M114.622209	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7267	7267		10.1074/jbc.AAC118.003576	http://dx.doi.org/10.1074/jbc.AAC118.003576			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29752420	hybrid, Green Published			2022-12-28	WOS:000432174500021
J	Liu, YF; Paz, K; Herschkovitz, A; Alt, A; Tennenbaum, T; Sampson, SR; Ohba, M; Kuroki, T; LeRoith, D; Zick, Y				Liu, Yan-Fang; Paz, Keren; Herschkovitz, Avia; Alt, Addy; Tennenbaum, Tamar; Sampson, Sanford R.; Ohba, Motoi; Kuroki, Toshio; LeRoith, Derek; Zick, Yehiel			RETRACTION: Insulin stimulates PKC -mediated phosphorylation of insulin receptor substrate-1 (IRS-1): A self-attenuated mechanism to negatively regulate the function of IRS proteins. (Retraction of Vol 276, Pg 14459, 2001)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022; Zick, Yehiel/K-1479-2012					Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200	1	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7264	7264		10.1074/jbc.W118.003466	http://dx.doi.org/10.1074/jbc.W118.003466			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29752417	Green Published, hybrid			2022-12-28	WOS:000432174500018
J	Martemyanov, KA; Garcia-Marcos, M				Martemyanov, Kirill A.; Garcia-Marcos, Mikel			Making useful gadgets with miniaturized G proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ACTIVATION	G protein-coupled receptors (GPCRs) relay information from extracellular stimuli to intracellular responses in a wide range of physiological and pathological processes, but understanding their complex effects in live cells is a daunting task. In this issue of JBC, Wan et al. repurpose mini G proteinspreviously used as affinity tools for structural studiesto develop a suite of probes to visualize GPCR activation in live cells. The approach is expected to revolutionize our understanding of the spatiotemporal control and mechanisms of GPCR signaling.	[Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33453 USA; [Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Scripps Research Institute; Boston University	Garcia-Marcos, M (corresponding author), Boston Univ, 72 E Concord St,Rm K206, Boston, MA 02118 USA.	mgm1@bu.edu			NIDA, National Institutes of Health [DA026405]; NIGMS, National Institutes of Health [R01GM112631, R01GM108733]; American Cancer Society [RSG-13-362-01-TBE]; Karin Grunebaum Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108733, R01GM112631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405] Funding Source: NIH RePORTER	NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); Karin Grunebaum Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIDA, National Institutes of Health Grant DA026405.r Supported by NIGMS, National Institutes of Health Grants R01GM112631 and R01GM108733, American Cancer Society Grant RSG-13-362-01-TBE, and the Karin Grunebaum Cancer Research Foundation.	Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Nehme R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175642; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975	10	1	1	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7474	7475		10.1074/jbc.H118.002879	http://dx.doi.org/10.1074/jbc.H118.002879			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29752421	Green Published, hybrid			2022-12-28	WOS:000432174500038
J	Baker, PJ; Masters, SL				Baker, Paul J.; Masters, Seth L.			Caspase substrates won't be defined by a four-letter code	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							COMBINATORIAL APPROACH; PROTEASE; SPECIFICITIES; GSDMD	Inflammatory cell death can be mediated by the murine caspase-1 and -11. Genetic and cell biological data point to conflicting conclusions whether these caspases cleave the same substrates or use distinct mechanisms to mediate inflammation and cell death. Peptide screening and biochemical analysis by Gonzales Ramirez et al. now suggest caspase-11 specificity may be determined outside the known substrate motif and identifies substrates cleaved preferentially by caspase-1, providing new opportunities to uniquely target inflammatory caspases.	[Baker, Paul J.; Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Div Inflammat, Parkville, Vic 3052, Australia; [Baker, Paul J.; Masters, Seth L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Masters, SL (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	masters@wehi.edu.au	Masters, Seth L/N-2886-2013	Masters, Seth L/0000-0003-4763-576X; Baker, Paul J./0000-0002-3642-2366	National Health and Medical Research Council [1144282, 1142354, 1099262]; Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute-Wellcome International Research Scholarship; Glaxosmithkline	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute-Wellcome International Research Scholarship; Glaxosmithkline(GlaxoSmithKline)	This work was supported by National Health and Medical Research Council Grants 1144282, 1142354, and 1099262, The Sylvia and Charles Viertel Foundation, a Howard Hughes Medical Institute-Wellcome International Research Scholarship, and Glaxosmithkline.	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Poreba M, 2017, NAT PROTOC, V12, P2189, DOI 10.1038/nprot.2017.091; Poreba M, 2015, CHEM REV, V115, P12546, DOI 10.1021/acs.chemrev.5b00434; Ramirez MLG, 2018, J BIOL CHEM, V293, P7058, DOI 10.1074/jbc.RA117.001329; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907	10	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7068	7069		10.1074/jbc.H118.002802	http://dx.doi.org/10.1074/jbc.H118.002802			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29728534	Green Published, hybrid			2022-12-28	WOS:000431487300038
J	Brenke, JK; Popowicz, GM; Schorpp, K; Rothenaigner, I; Roesner, M; Meininger, I; Kalinski, C; Ringelstetter, L; R'kyek, O; Jurjens, G; Vincendeau, M; Plettenburg, O; Sattler, M; Krappmann, D; Hadian, K				Brenke, Jara K.; Popowicz, Grzegorz M.; Schorpp, Kenji; Rothenaigner, Ina; Roesner, Manfred; Meininger, Isabel; Kalinski, Cedric; Ringelstetter, Larissa; R'kyek, Omar; Juerjens, Gerrit; Vincendeau, Michelle; Plettenburg, Oliver; Sattler, Michael; Krappmann, Daniel; Hadian, Kamyar			Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; RHEUMATOID-ARTHRITIS; DRUG DISCOVERY; FREQUENT HITTERS; UBIQUITIN; ACTIVATION; MALT1; CELLS; IDENTIFICATION; OPPORTUNITIES	Constitutive NE-kappa B signaling represents a hallmark of chronic inflammation and autoimmune diseases. The E3 ligase TNF receptor-associated factor 6 (TRAF6) acts as a key regulator bridging innate immunity, pro-inflammatory cytokines, and antigen receptors to the canonical NF-kappa B pathway. Structural analysis and point mutations have unraveled the essential role of TRAF6 binding to the E2-conjugating enzyme ubiquitin-conjugating enzyme E2 N (Ubc13 or UBE2N) to generate Lys63-linked ubiquitin chains for inflammatory and immune signal propagation. Genetic mutations disrupting TRAF6-Ubc13 binding have been shown to reduce TRAF6 activity and, consequently, NE-kappa B activation. However, to date, no small-molecule modulator is available to inhibit the TRAF6-Ubc13 interaction and thereby counteract NF-kappa B signaling and associated diseases. Here, using a high-throughput small-molecule screening approach, we discovered an inhibitor of the TRAF6 -Ubc13 interaction that reduces TRAF6-Ubc13 activity both in vitro and in cells. We found that this compound, C25-140, impedes NF-kappa B activation in various immune and inflammatory signaling pathways also in primary human and murine cells. Importantly, C25-140 ameliorated inflammation and improved disease outcomes of autoimmune psoriasis and rheumatoid arthritis in preclinical in vivo mouse models. Hence, the first-in-class TRAF6-Ubc13 inhibitor C25-140 expands the toolbox for studying the impact of the ubiquitin system on immune signaling and underscores the importance of TRAF6 E3 ligase activity in psoriasis and rheumatoid arthritis. We propose that inhibition of TRAF6 activity by small molecules represents a promising novel strategy for targeting autoimmune and chronic inflammatory diseases.	[Brenke, Jara K.; Schorpp, Kenji; Rothenaigner, Ina; Ringelstetter, Larissa; Hadian, Kamyar] Helmholtz Zentrum Munchen, Assay Dev & Screening Platform, Inst Mol Toxicol & Pharmacol, D-85764 Neuherberg, Germany; [Popowicz, Grzegorz M.; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Struct Biol, D-85764 Neuherberg, Germany; [Meininger, Isabel; Vincendeau, Michelle; Krappmann, Daniel] Helmholtz Zentrum Munchen, Res Unit Cellular Signal Integrat, Inst Mol Toxicol & Pharmacol, D-85764 Neuherberg, Germany; [Kalinski, Cedric] Helmholtz Zentrum Munchen, Innovat Management, D-85764 Neuherberg, Germany; [R'kyek, Omar; Juerjens, Gerrit; Plettenburg, Oliver] Helmholtz Zentrum Munchen, Inst Med Chem, D-85764 Neuherberg, Germany; [Vincendeau, Michelle] Helmholtz Zentrum Munchen, Inst Virol, D-85764 Neuherberg, Germany; [Popowicz, Grzegorz M.; Sattler, Michael] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, D-85747 Garching, Germany; [Roesner, Manfred] Mroe Consulting, D-65817 Eppstein, Germany; [R'kyek, Omar; Juerjens, Gerrit; Plettenburg, Oliver] Leibnitz Univ Hannover, Inst Organ Chem, D-30167 Hannover, Germany; [Meininger, Isabel] AbbVie Deutschland GmbH, D-65189 Wiesbaden, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Leibniz University Hannover; AbbVie	Hadian, K (corresponding author), Helmholtz Zentrum Munchen GmbH, Inst Mol Toxicol & Pharmacol, Assay Dev & Screening Platform, D-85764 Neuherberg, Germany.	kamyar.hadian@helmholtz-muenchen.de	Hadian, Kamyar/B-6314-2013; Vincendeau, Michelle/AAD-4320-2022; Krappmann, Daniel/AAT-4354-2021; Sattler, Michael/A-2407-2012; Krappmann, Daniel/ABF-4038-2021; Plettenburg, Oliver/AAY-8083-2020	Hadian, Kamyar/0000-0001-8727-2575; Krappmann, Daniel/0000-0001-7640-3234; Sattler, Michael/0000-0002-1594-0527; Krappmann, Daniel/0000-0001-7640-3234; 	Life Science Foundation;  [SFB 1054]	Life Science Foundation; 	This work was supported by grants from the Life Science Foundation (to K. H.) and the SFB 1054 project A04 (to D. K.). A patent for the clinical use of C25-140 has been published by the European patent office.	Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brenke JK, 2016, J BIOMOL SCREEN, V21, P596, DOI 10.1177/1087057116639992; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Gul S, 2014, EXPERT OPIN DRUG DIS, V9, P1393, DOI 10.1517/17460441.2014.954544; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Isaacs JD, 2015, NAT REV RHEUMATOL, V11, P627, DOI 10.1038/nrrheum.2015.138; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kelly PN, 2015, J EXP MED, V212, P2189, DOI 10.1084/jem.20151074; Kliza K, 2017, NAT METHODS, V14, P504, DOI [10.1038/NMETH.4228, 10.1038/nmeth.4228]; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Landre V, 2014, ONCOTARGET, V5, P7988, DOI 10.18632/oncotarget.2431; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Meininger I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11292; Namjou B, 2012, ARTHRITIS RHEUM-US, V64, P1960, DOI 10.1002/art.34361; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Olson MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14246; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pulvino M, 2012, BLOOD, V120, P1668, DOI 10.1182/blood-2012-02-406074; Schorpp K, 2016, J BIOMOL SCREEN, V21, P965, DOI 10.1177/1087057116641935; Schorpp K, 2014, J BIOMOL SCREEN, V19, P715, DOI 10.1177/1087057113516861; Scott DC, 2017, NAT CHEM BIOL, V13, P850, DOI 10.1038/nchembio.2386; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sokka T, 2008, MOD RHEUMATOL, V18, P228, DOI 10.1007/s10165-008-0056-x; Strickson S, 2013, BIOCHEM J, V451, P427, DOI 10.1042/BJ20121651; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tanaka Y, 2013, MOD RHEUMATOL, V23, P415, DOI 10.1007/s10165-012-0799-2; Toubi E, 2004, AUTOIMMUNITY, V37, P183, DOI 10.1080/08916930410001704944; Vincendeau M, 2016, SCI REP-UK, V6, DOI 10.1038/srep18934; Visser K, 2009, ANN RHEUM DIS, V68, P1094, DOI 10.1136/ard.2008.092668; Walsh MC, 2015, IMMUNOL REV, V266, P72, DOI 10.1111/imr.12302; Wang HQ, 2015, MOL MED REP, V11, P2761, DOI 10.3892/mmr.2014.3104; Weber E, 2017, SLAS DISCOV, V22, P316, DOI 10.1177/1087057116681408; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wavers-de Boer K, 2012, ANN RHEUM DIS, V71, P1472, DOI 10.1136/annrheumdis-2011-200736; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zarzycka B, 2015, J CHEM INF MODEL, V55, P294, DOI 10.1021/ci500631e; Zhu LJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3866; Zotti T, 2012, J CELL PHYSIOL, V227, P1280, DOI 10.1002/jcp.24011	54	36	37	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13191	13203		10.1074/jbc.RA118.002649	http://dx.doi.org/10.1074/jbc.RA118.002649			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29950522	Green Published, hybrid			2022-12-28	WOS:000442730200018
J	Kefalas, G; Jouvet, N; Baldwin, C; Estall, JL; Larose, L				Kefalas, George; Jouvet, Nathalie; Baldwin, Cindy; Estall, Jennifer L.; Larose, Louise			Peptide-based sequestration of the adaptor protein Nck1 in pancreatic cells enhances insulin biogenesis and protects against diabetogenic stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); diabetes; adaptor protein; insulin synthesis; insulin secretion; lipotoxicity; cell therapy; adaptor protein Nck; cell-penetrating peptide; diabetes; PERK	ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-HOMEOSTASIS; PERK EIF2AK3; BETA-CELLS; DEPENDENT ACTIVATION; SH2/SH3 ADAPTERS; KINASE PAK1; OBESE MICE; SURVIVAL; TRANSLATION	One feature of diabetes is the failure of pancreatic cells to produce insulin, but the molecular mechanisms leading to this failure remain unclear. Increasing evidence supports a role for protein kinase R-like endoplasmic reticulum kinase (PERK) in the development and function of healthy pancreatic cells. Previously, our group identified the adaptor protein Nck1 as a negative regulator of PERK. Indeed, we demonstrated that Nck1, by directly binding PERK autophosphorylated on Tyr(561), limits PERK activation and signaling. Accordingly, we found that stable depletion of Nck1 in cells promotes PERK activation and signaling, increases insulin biosynthesis, and improves cell viability in response to diabetes-related stresses. Herein, we explored the therapeutic potential of abrogating the interaction between Nck and PERK to improve -cell function and survival. To do so, we designed and used a peptide containing the minimal PERK sequence involved in binding Nck1 conjugated to the cell-permeable protein transduction domain from the HIV protein TAT. In the current study, we confirm that the synthetic TAT-Tyr(P)(561) phosphopeptide specifically binds the SH2 domain of Nck and prevents Nck interaction with PERK, thereby promoting basal PERK activation. Moreover, we report that treatment of cells with TAT-Tyr(P)(561) inhibits glucolipotoxicity-induced apoptosis, whereas it enhances insulin production and secretion. Taken together, our results support the potential of sequestering Nck using a synthetic peptide to enhance basal PERK activation and create more robust cells.	[Kefalas, George; Baldwin, Cindy; Larose, Louise] McGill Univ, Hlth Ctr, Res Inst, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada; [Kefalas, George; Estall, Jennifer L.; Larose, Louise] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H4A 3J1, Canada; [Jouvet, Nathalie; Baldwin, Cindy; Estall, Jennifer L.] Inst Rech Clin Montreal, 110 Ave Pins O, Montreal, PQ H2W 1R7, Canada	McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Larose, L (corresponding author), McGill Univ, Hlth Ctr, Res Inst, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.; Estall, JL (corresponding author), Inst Rech Clin Montreal, 110 Ave Pins O, Montreal, PQ H2W 1R7, Canada.	jennifer.estall@ircm.qc.ca; louise.larose@mcgill.ca		Estall, Jennifer/0000-0002-9838-1440	Canadian Institutes of Health Research Project [PJT-148771, PJT-374589]	Canadian Institutes of Health Research Project(Canadian Institutes of Health Research (CIHR))	This work is supported by Canadian Institutes of Health Research Project Grants PJT-148771 (to J. L. E.) and PJT-374589 (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Borroto A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2140; Cardin E, 2007, FEBS J, V274, P5865, DOI 10.1111/j.1742-4658.2007.06110.x; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Chen J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005648; Chen M, 1998, J BIOL CHEM, V273, P25171, DOI 10.1074/jbc.273.39.25171; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dusseault J, 2016, DIABETES, V65, P2652, DOI 10.2337/db15-1559; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gandin V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11127; Gao Y, 2012, MOL CELL BIOL, V32, P5129, DOI 10.1128/MCB.01009-12; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Harding HP, 2012, J BIOL CHEM, V287, P44338, DOI 10.1074/jbc.M112.428987; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Julier C, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-29; Kebache S, 2004, J BIOL CHEM, V279, P9662, DOI 10.1074/jbc.M310535200; Kebache S, 2002, P NATL ACAD SCI USA, V99, P5406, DOI 10.1073/pnas.082483399; Labelle-Cote M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-443; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; Latreille M, 2011, AM J PHYSIOL-ENDOC M, V300, pE423, DOI 10.1152/ajpendo.00088.2010; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; Lussier G, 1997, J BIOL CHEM, V272, P2688, DOI 10.1074/jbc.272.5.2688; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Masuda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131012; Morris DC, 2017, MOL BIOL CELL, V28, P3500, DOI 10.1091/mbc.E17-02-0106; Mukherjee C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001933; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Roy E, 2010, J IMMUNOL, V185, P7518, DOI 10.4049/jimmunol.1000008; Roy E, 2010, P NATL ACAD SCI USA, V107, P15529, DOI 10.1073/pnas.1009743107; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Wang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099684; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; Yamani L, 2015, CELL SIGNAL, V27, P2555, DOI 10.1016/j.cellsig.2015.09.016; Yamani L, 2014, MOL BIOL CELL, V25, P702, DOI 10.1091/mbc.E13-09-0511; Yu QJ, 2015, P NATL ACAD SCI USA, V112, P15420, DOI 10.1073/pnas.1516362112; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	47	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12516	12524		10.1074/jbc.RA118.002728	http://dx.doi.org/10.1074/jbc.RA118.002728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29941454	Green Published, hybrid			2022-12-28	WOS:000441408500017
J	Sudom, A; Talreja, S; Danao, J; Bragg, E; Kegel, R; Min, XS; Richardson, J; Zhang, ZQ; Sharkov, N; Marcora, E; Thibault, S; Bradley, J; Wood, S; Lim, AC; Chen, H; Wang, SL; Foltz, IN; Sambashivan, S; Wang, ZL				Sudom, Athena; Talreja, Santosh; Danao, Jean; Bragg, Eric; Kegel, Rob; Min, Xiaoshan; Richardson, Jason; Zhang, Zhongqi; Sharkov, Nikolai; Marcora, Edoardo; Thibault, Steve; Bradley, Jodi; Wood, Steve; Lim, Ai-Ching; Chen, Hang; Wang, Songli; Foltz, Ian N.; Sambashivan, Shilpa; Wang, Zhulun			Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; neuroinflammation; X-ray crystallography; lipid-binding protein; scavenger receptor; TREM2; R47H; neurodegeneration; microglia; antibody; myeloid cell; structure; triggering receptor expressed on myeloid cells 2	BINDS; PHOSPHATIDYLSERINE; CLEAVAGE; SUSTAINS; IMPAIRS; LIGAND; MICE	Triggering receptor expressed on myeloid cells 2 (TREM2) is an immune receptor expressed on the surface of microglia, macrophages, dendritic cells, and osteoclasts. The R47H TREM2 variant is a significant risk factor for late-onset Alzheimer's disease (AD), and the molecular basis of R47H TREM2 loss of function is an emerging area of TREM2 biology. Here, we report three high-resolution structures of the extracellular ligand-binding domains (ECDs) of R47H TREM2, apo-WT, and phosphatidylserine (PS)-bound WT TREM2 at 1.8, 2.2, and 2.2 , respectively. The structures reveal that Arg(47) plays a critical role in maintaining the structural features of the complementarity-determining region 2 (CDR2) loop and the putative positive ligand-interacting surface (PLIS), stabilizing conformations capable of ligand interaction. This is exemplified in the PS-bound structure, in which the CDR2 loop and PLIS drive critical interactions with PS via surfaces that are disrupted in the variant. Together with in vitro and in vivo characterization, our structural findings elucidate the molecular mechanism underlying loss of ligand binding, putative oligomerization, and functional activity of R47H TREM2. They also help unravel how decreased in vitro and in vivo stability of TREM2 contribute to loss of function in disease.	[Sudom, Athena; Talreja, Santosh; Danao, Jean; Bragg, Eric; Kegel, Rob; Min, Xiaoshan; Sharkov, Nikolai; Marcora, Edoardo; Thibault, Steve; Lim, Ai-Ching; Chen, Hang; Wang, Songli; Sambashivan, Shilpa; Wang, Zhulun] Amgen Inc, Amgen Discovery Res, San Francisco, CA 94080 USA; [Richardson, Jason; Zhang, Zhongqi; Bradley, Jodi; Wood, Steve] Amgen Inc, Amgen Discovery Res, Thousand Oaks, CA 91320 USA; [Foltz, Ian N.] Amgen Inc, Amgen Discovery Res, Burnaby, BC V5A 1V7, Canada; [Kegel, Rob] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Sharkov, Nikolai] NGM Biopharmaceut, San Francisco, CA 94080 USA; [Marcora, Edoardo] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Marcora, Edoardo] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chen, Hang] Denali Therapeut, San Francisco, CA 94080 USA	Amgen; Amgen; Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sudom, A; Wang, ZL (corresponding author), Amgen Inc, Amgen Discovery Res, San Francisco, CA 94080 USA.; Sambashivan, S (corresponding author), Proneurotech Inc, San Francisco, CA 94080 USA.	asudom@amgen.com; shilpashivan@gmail.com; zwang@amgen.com		Marcora, Edoardo/0000-0002-3829-4927	United States Department of Energy at the Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]	United States Department of Energy at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	We thank Fernando Garces and Sheree Johnstone for critical reading of the manuscript. We also thank Roman Shimanovich for some liposome preparations. X-ray diffraction experiments were performed on beamline 5.0.2 at the Advanced Light Source with support from the United States Department of Energy under Contract DE-AC03-76SF00098 at the Lawrence Berkeley National Laboratory.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Chen QX, 2013, AM J RESP CRIT CARE, V188, P201, DOI 10.1164/rccm.201211-1967OC; Cheng QW, 2018, J BIOL CHEM, V293, P12620, DOI 10.1074/jbc.RA118.001848; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Iborra S, 2015, IMMUNOBIOLOGY, V220, P175, DOI 10.1016/j.imbio.2014.09.013; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Kober DL, 2014, PROTEIN EXPRES PURIF, V96, P32, DOI 10.1016/j.pep.2014.01.015; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Read CB, 2015, J IMMUNOL, V194, P1417, DOI 10.4049/jimmunol.1402303; Schlepckow K, 2017, EMBO MOL MED, V9, P1356, DOI 10.15252/emmm.201707672; Shah B, 2014, J AM SOC MASS SPECTR, V25, P999, DOI 10.1007/s13361-014-0858-3; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; Tietjen GT, 2014, P NATL ACAD SCI USA, V111, pE1463, DOI 10.1073/pnas.1320174111; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhang ZQ, 2010, ANAL CHEM, V82, P10194, DOI 10.1021/ac102359u; Zhang ZQ, 2009, ANAL CHEM, V81, P8354, DOI 10.1021/ac901193n; Zhao YJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.200	33	54	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12634	12646		10.1074/jbc.RA118.002352	http://dx.doi.org/10.1074/jbc.RA118.002352			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29794134	Green Published, hybrid			2022-12-28	WOS:000441408500027
J	Cruz, JM; Hupper, N; Wilson, LS; Concannon, JB; Wang, Y; Oberhauser, B; Patora-Komisarska, K; Zhang, YY; Glass, DJ; Trendelenburg, AU; Clarke, BA				Cruz, Joseph M.; Hupper, Nicole; Wilson, Liz S.; Concannon, John B.; Wang, Yuan; Oberhauser, Berndt; Patora-Komisarska, Krystyna; Zhang, Yunyu; Glass, David J.; Trendelenburg, Anne-Ulrike; Clarke, Brian A.			Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; DNA REARRANGEMENTS; UBIQUITIN LIGASES; CONTROLLED-TRIAL; CLENBUTEROL; POPULATION; ATROPHY; PATHOPHYSIOLOGY; DIFFERENTIATION; PREVALENCE	Facioscapulohumeral muscular dystrophy (FSHD) is among the most prevalent of the adult-onset muscular dystrophies. FSHD causes a loss of muscle mass and function, resulting in severe debilitation and reduction in quality of life. Currently, only the symptoms of FSHD can be treated, and such treatments have minimal benefit. The available options are not curative, and none of the treatments address the underlying cause of FSHD. The genetic, epigenetic, and molecular mechanisms triggering FSHD are now quite well-understood, and it has been shown that expression of the transcriptional regulator double homeobox 4 (DUX4) is necessary for disease onset and is largely thought to be the causative factor in FSHD. Therefore, we sought to identify compounds suppressing DUX4 expression in a phenotypic screen using FSHD patient-derived muscle cells, a zinc finger and SCAN domain-containing 4 (ZSCAN4)-based reporter gene assay for measuring DUX4 activity, and similar to 3,000 small molecules. This effort identified molecules that reduce DUX4 gene expression and hence DUX4 activity. Among those, beta(2)-adrenergic receptor agonists and phosphodiesterase inhibitors, both leading to increased cellular cAMP, effectively decreased DUX4 expression by >75% in cells from individuals with FSHD. Of note, we found that cAMP production reduces DUX4 expression through a protein kinase A-dependent mode of action in FSHD patient myotubes. These findings increase our understanding of how DUX4 expression is regulated in FSHD and point to potential areas of therapeutic intervention.	[Cruz, Joseph M.; Hupper, Nicole; Wilson, Liz S.; Zhang, Yunyu; Trendelenburg, Anne-Ulrike; Clarke, Brian A.] Novartis Inst Biomed Res, Musculoskeletal Dis, 181 Massachusetts Ave, Cambridge, MA 02139 USA; [Concannon, John B.; Wang, Yuan; Glass, David J.] Novartis Inst Biomed Res, Chem Biol & Therapeut, Cambridge, MA 02139 USA; [Oberhauser, Berndt; Patora-Komisarska, Krystyna] Novartis Inst Biomed Res, Global Discovery Chem, CH-4056 Basel, Switzerland	Novartis; Novartis; Novartis	Clarke, BA (corresponding author), Novartis Inst Biomed Res, Musculoskeletal Dis, 181 Massachusetts Ave, Cambridge, MA 02139 USA.	Brian.Clarke@novartis.com	Glass, David/AAI-3910-2021; Glass, David/C-4782-2012	Glass, David/0000-0001-6187-4164				Badrinarayan P, 2013, CURR PHARM DESIGN, V19, P4714, DOI 10.2174/1381612811319260005; Block GJ, 2013, HUM MOL GENET, V22, P4661, DOI 10.1093/hmg/ddt314; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brand T, 2017, CELL SIGNAL, V40, P156, DOI 10.1016/j.cellsig.2017.09.015; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Campbell AE, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0134-x; Ceci R, 2011, HORM METAB RES, V43, P702, DOI 10.1055/s-0031-1285867; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cox ME, 2000, J BIOL CHEM, V275, P13812, DOI 10.1074/jbc.275.18.13812; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; Flanigan KM, 2001, NEUROMUSCULAR DISORD, V11, P525, DOI 10.1016/S0960-8966(01)00201-2; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Hagg A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23042; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Himeda CL, 2014, MOL CELL BIOL, V34, P1942, DOI 10.1128/MCB.00149-14; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Huichalaf C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115278; Jones TI, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-23; Kissel JT, 2001, NEUROLOGY, V57, P1434, DOI 10.1212/WNL.57.8.1434; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; MALTIN CA, 1989, BIOCHEM J, V261, P965, DOI 10.1042/bj2610965; MALTIN CA, 1993, AM J PHYSIOL, V265, pE176, DOI 10.1152/ajpendo.1993.265.1.E176; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Mostacciuolo ML, 2009, CLIN GENET, V75, P550, DOI 10.1111/j.1399-0004.2009.01158.x; MUMMERY CJ, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003278; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; PADBERG GW, 1995, MUSCLE NERVE, pS81, DOI 10.1002/mus.880181315; Pannerec A, 2016, AGING-US, V8, P712, DOI 10.18632/aging.100926; Payan CA, 2009, ARCH PHYS MED REHAB, V90, P1094, DOI 10.1016/j.apmr.2008.12.027; Sharma Chandramohan, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2013-203411; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Statland Jeffrey M, 2015, J Neuromuscul Dis, V2, P291; Tan HN, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0276-0; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; TYLER FH, 1950, ANN INTERN MED, V32, P640, DOI 10.7326/0003-4819-32-4-640; van der Kooi EL, 2004, NEUROLOGY, V63, P702, DOI 10.1212/01.WNL.0000134660.30793.1F; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wang Y, 2016, CELL CHEM BIOL, V23, P862, DOI 10.1016/j.chembiol.2016.05.016; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26	44	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11837	11849		10.1074/jbc.RA118.002633	http://dx.doi.org/10.1074/jbc.RA118.002633			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29899111	Green Published, hybrid			2022-12-28	WOS:000440134500017
J	Ong, SC; Belgi, A; van Lierop, B; Delaine, C; Andrikopoulos, S; MacRaild, CA; Norton, RS; Haworth, NL; Robinson, AJ; Forbes, BE				Ong, Shee Chee; Belgi, Alessia; van Lierop, Bianca; Delaine, Carlie; Andrikopoulos, Sofianos; MacRaild, Christopher A.; Norton, Raymond S.; Haworth, Naomi L.; Robinson, Andrea J.; Forbes, Briony E.			Probing the correlation between insulin activity and structural stability through introduction of the rigid A6-A11 bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; POTENTIAL-ENERGY SURFACE; BIOLOGICAL-ACTIVITY; POLYMERIZATION PATTERN; MOLECULAR-DYNAMICS; DIABETES-MELLITUS; DISULFIDE BONDS; KINETIC TRAP; B-CHAIN; PH 7.0	The development of fast-acting and highly stable insulin analogues is challenging. Insulin undergoes structural transitions essential for binding and activation of the insulin receptor (IR), but these conformational changes can also affect insulin stability. Previously, we substituted the insulin A6-A11 cystine with a rigid, non-reducible C=C linkage ("dicarba" linkage). A cis-alkene permitted the conformational flexibility of the A-chain N-terminal helix necessary for high-affinity IR binding, resulting in surprisingly rapid activity in vivo. Here, we show that, unlike the rapidly acting Lys(B28)Pro(B29) insulin analogue (KP insulin), cis-dicarba insulin is not inherently monomeric. We also show that cis-dicarba KP insulin lowers blood glucose levels even more rapidly than KP insulin, suggesting that an inability to oligomerize is not responsible for the observed rapid activity onset of cis-dicarba analogues. Although rapid-acting, neither dicarba species is stable, as assessed by fibrillation and thermodynamics assays. MALDI analyses and molecular dynamics simulations of cis-dicarba insulin revealed a previously unidentified role of the A6-A11 linkage in insulin conformational dynamics. By controlling the conformational flexibility of the insulin B-chain helix, this linkage affects overall insulin structural stability. This effect is independent of its regulation of the A-chain N-terminal helix flexibility necessary for IR engagement. We conclude that high-affinity IR binding, rapid in vivo activity, and insulin stability can be regulated by the specific conformational arrangement of the A6-A11 linkage. This detailed understanding of insulin's structural dynamics may aid in the future design of rapid-acting insulin analogues with improved stability.	[Ong, Shee Chee; Delaine, Carlie; Forbes, Briony E.] Flinders Univ South Australia, Coll Med & Publ Hlth, Bedford Pk, SA 5042, Australia; [Belgi, Alessia; van Lierop, Bianca; Haworth, Naomi L.; Robinson, Andrea J.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Andrikopoulos, Sofianos] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [MacRaild, Christopher A.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Haworth, Naomi L.] Australian Natl Univ, Res Sch Chem, Acton, ACT 2601, Australia; [Haworth, Naomi L.] Deakin Univ, Sch Life & Environm Sci, Waurn Ponds, Vic 3216, Australia	Flinders University South Australia; Monash University; University of Melbourne; Monash University; Australian National University; Deakin University	Forbes, BE (corresponding author), Flinders Univ South Australia, Coll Med & Publ Hlth, Bedford Pk, SA 5042, Australia.	briony.forbes@flinders.edu.au	Forbes, Briony/R-1838-2019; Haworth, Naomi L/G-5254-2011	Haworth, Naomi L/0000-0002-3299-3137; Forbes, Briony/0000-0003-4360-9927; Norton, Raymond/0000-0001-8893-0584; Robinson, Andrea/0000-0003-3859-1312	Australian postgraduate scholarship; Australian National Health and Medical Research Council; National Health and Medical Research Council Project [APP1069328]; Australian Research Council [LP12020200792]	Australian postgraduate scholarship(Australian Government); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Supported by an Australian postgraduate scholarship.; Recipient of fellowship support from the Australian National Health and Medical Research Council.; Supported by National Health and Medical Research Council Project Grant APP1069328 and Australian Research Council Grant LP12020200792.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Banting FG, 2007, INDIAN J MED RES, V125, pA251; Bonnesen C, 2010, CELL BIOL TOXICOL, V26, P293, DOI 10.1007/s10565-009-9142-x; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; Campbell RK, 1996, ANN PHARMACOTHER, V30, P1263, DOI 10.1177/106002809603001111; Case DA, 2014, AMBER 14; Chang SG, 2003, MOL CELLS, V16, P323; Chen Y, 2004, BIOCHEMISTRY-US, V43, P9225, DOI 10.1021/bi049710y; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Dai Y, 1996, BBA-PROTEIN STRUCT M, V1296, P63, DOI 10.1016/0167-4838(96)00054-4; De Meyts P, 2015, BIOESSAYS, V37, P389, DOI 10.1002/bies.201400190; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; GANDERTON RH, 1992, BIOCHEM J, V288, P195, DOI 10.1042/bj2880195; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haworth NL, 2007, MOL SIMULAT, V33, P475, DOI 10.1080/08927020701361876; Haworth NL, 2010, AUST J CHEM, V63, P379, DOI 10.1071/CH09456; Hossain MA, 2015, ORG BIOMOL CHEM, V13, P10895, DOI 10.1039/c5ob01539a; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JEFFREY PD, 1976, BIOCHEMISTRY-US, V15, P4660, DOI 10.1021/bi00666a018; Jensen M., 2000, THESIS; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lawrence M. C., 2015, RECEPTOR TYROSINE KI, P163; Liu Y, 2004, J BIOCHEM, V135, P1, DOI 10.1093/jb/mvg134; Ludwig DB, 2011, BIOTECHNOL BIOENG, V108, P2359, DOI 10.1002/bit.23188; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mathieu C, 2017, NAT REV ENDOCRINOL, V13, P385, DOI 10.1038/nrendo.2017.39; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; Menting JG, 2016, NAT STRUCT MOL BIOL, V23, P916, DOI 10.1038/nsmb.3292; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MILTHORPE BK, 1977, BIOCHIM BIOPHYS ACTA, V495, P195, DOI 10.1016/0005-2795(77)90376-2; Pandyarajan V, 2012, CURR DIABETES REP, V12, P697, DOI 10.1007/s11892-012-0318-z; Papaioannou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144058; Phillips Nelson B, 2012, J Diabetes Sci Technol, V6, P277; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; SCHILLING RJ, 1991, PHARMACEUT RES, V8, P721, DOI 10.1023/A:1015893832222; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; SOOS MA, 1989, BIOCHEM J, V263, P553, DOI 10.1042/bj2630553; SOOS MA, 1989, P NATL ACAD SCI USA, V86, P5217, DOI 10.1073/pnas.86.14.5217; van Dam EM, 2005, MOL ENDOCRINOL, V19, P1067, DOI 10.1210/me.2004-0413; van Lierop B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16876-3; van Lierop BJ, 2011, AUST J CHEM, V64, P806, DOI 10.1071/CH11090; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Wong N, 2011, ENDOCRINOLOGY, V152, P3690, DOI 10.1210/en.2011-0288; Woods R Jeremy, 2012, J Diabetes Sci Technol, V6, P265; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	64	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11928	11943		10.1074/jbc.RA118.002486	http://dx.doi.org/10.1074/jbc.RA118.002486			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29899115	Green Published, hybrid			2022-12-28	WOS:000440134500024
J	White, MD; Kamps, JJAG; East, S; Kearney, LJT; Flashman, E				White, Mark D.; Kamps, Jos J. A. G.; East, Samuel; Kearney, Leah J. Taylor; Flashman, Emily			The plant cysteine oxidases from Arabidopsis thaliana are kinetically tailored to act as oxygen sensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE-FACTOR; END RULE PATHWAY; ETHYLENE RESPONSE FACTORS; HYDROXYLASE DOMAIN 2; LOW INTERNAL OXYGEN; PROLYL 4-HYDROXYLASES; ANAEROBIC STRESS; RESONANCE; RAP2.2; ASSAY	Group VII ethylene response factors (ERF-VIIs) regulate transcriptional adaptation to flooding-induced hypoxia in plants. ERF-VII stability is controlled in an O-2-dependent manner by the Cys/Arg branch of the N-end rule pathway whereby oxidation of a conserved N-terminal cysteine residue initiates target degradation. This oxidation is catalyzed by plant cysteine oxidases (PCOs), which use O-2 as cosubstrate to generate Cys-sulfinic acid. The PCOs directly link O-2 availability to ERF-VII stability and anaerobic adaptation, leading to the suggestion that they act as plant O-2 sensors. However, their ability to respond to fluctuations in O-2 concentration has not been established. Here, we investigated the steady-state kinetics of Arabidopsis thaliana PCOs 1-5 to ascertain whether their activities are sensitive to O-2 levels. We found that the most catalytically competent isoform is AtPCO4, both in terms of responding to O-2 and oxidizing AtRAP2.2/2,12 (two of the most prominent ERF-VIIs responsible for promoting the hypoxic response), which suggests that AtPCO4 plays a central role in ERF-VII regulation. Furthermore, we found that AtPCO activity is susceptible to decreases in pH and that the hypoxia-inducible AtPCOs 1/2 and the noninducible AtPCOs 4/5 have discrete AtERF-VII substrate preferences. Pertinently, the AtPCOs had K-m(app)(O2)values in a physiologically relevant range, which should enable them to sensitively react to changes in O-2 availability. This work validates an O-2-sensing role for the PCOs and suggests that differences in expression pattern, ERF-VII selectivity, and catalytic capability may enable the different isoforms to have distinct biological functions. Individual PCOs could therefore be targeted to manipulate ERF-VII levels and improve stress tolerance in plants.	[White, Mark D.; Kamps, Jos J. A. G.; East, Samuel; Kearney, Leah J. Taylor; Flashman, Emily] Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England	University of Oxford	White, MD; Flashman, E (corresponding author), Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	mark.white@chem.ox.ac.uk; emily.flashman@chem.ox.ac.uk		Taylor-Kearney, Leah/0000-0001-7530-7670; Flashman, Emily/0000-0002-4169-4278; White, Mark/0000-0002-1431-0339	Biotechnology and Biological Sciences Research Council (UK) [BB/M024458/1]; BBSRC [BB/M024458/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council (UK) New Investigator Grant BB/M024458/1 (to E. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Borisjuk L, 2009, NEW PHYTOL, V182, P17, DOI 10.1111/j.1469-8137.2008.02752.x; Bui LT, 2015, PLANT SCI, V236, P37, DOI 10.1016/j.plantsci.2015.03.008; Dao JH, 2009, ANAL BIOCHEM, V384, P213, DOI 10.1016/j.ab.2008.09.052; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Gasch P, 2016, PLANT CELL, V28, P160, DOI 10.1105/tpc.15.00866; Geigenberger P, 2000, BIOL CHEM, V381, P723, DOI 10.1515/BC.2000.093; Gibbs DJ, 2016, NEW PHYTOL, V211, P1188, DOI 10.1111/nph.14105; Gibbs DJ, 2015, PLANT PHYSIOL, V169, P23, DOI 10.1104/pp.15.00338; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Giuntoli B, 2018, PLANT PHYSIOL, V176, P1143, DOI 10.1104/pp.17.01225; Gout E, 2001, PLANT PHYSIOL, V125, P912, DOI 10.1104/pp.125.2.912; Hancock RL, 2017, ACS CHEM BIOL, V12, P1011, DOI 10.1021/acschembio.6b00958; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Ho QT, 2010, J EXP BOT, V61, P2745, DOI 10.1093/jxb/erq108; Imsand EM, 2012, ARCH BIOCHEM BIOPHYS, V521, P10, DOI 10.1016/j.abb.2012.03.006; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Mendiondo GM, 2016, PLANT BIOTECHNOL J, V14, P40, DOI 10.1111/pbi.12334; Myllyharju J, 2013, ACTA PHYSIOL, V208, P148, DOI 10.1111/apha.12096; Ober ES, 1996, J EXP BOT, V47, P447, DOI 10.1093/jxb/47.3.447; Rolletschek H, 2007, J EXP BOT, V58, P3171, DOI 10.1093/jxb/erm154; Schmidt RR, 2018, PLANT PHYSIOL, V176, P1131, DOI 10.1104/pp.17.01394; Staby L, 2017, BIOCHEM J, V474, P2509, DOI 10.1042/BCJ20160631; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; Tarhonskaya H, 2014, BIOCHEM J, V463, P363, DOI 10.1042/BJ20140779; van Dongen JT, 2015, ANNU REV PLANT BIOL, V66, P345, DOI 10.1146/annurev-arplant-043014-114813; van Dongen JT, 2003, PLANT PHYSIOL, V131, P1529, DOI 10.1104/pp.102.017202; Vartapetian BB, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; Vicente J, 2017, CURR BIOL, V27, P3183, DOI 10.1016/j.cub.2017.09.006; Wang FF, 2017, PLANT CELL PHYSIOL, V58, P1126, DOI 10.1093/pcp/pcx079; Weits DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4425; White MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14690; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Zhao Y, 2012, NEW PHYTOL, V195, P450, DOI 10.1111/j.1469-8137.2012.04160.x	41	49	49	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11786	11795		10.1074/jbc.RA118.003496	http://dx.doi.org/10.1074/jbc.RA118.003496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29848548	Green Published, hybrid			2022-12-28	WOS:000440134500013
J	Pedrosa, AG; Francisco, T; Bicho, D; Dias, AF; Barros-Barbosa, A; Hagmann, V; Dodt, G; Rodrigues, TA; Azevedo, JE				Pedrosa, Ana G.; Francisco, Tania; Bicho, Diana; Dias, Ana F.; Barros-Barbosa, Aurora; Hagmann, Vera; Dodt, Gabriele; Rodrigues, Tony A.; Azevedo, Jorge E.			Peroxisomal monoubiquitinated PEX5 interacts with the AAA ATPases PEX1 and PEX6 and is unfolded during its dislocation into the cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); peroxisome; ubiquitin; protein sorting; protein translocation; PEX1; PEX5; PEX6	PROTEIN IMPORT PATHWAY; TARGETING SIGNAL; PTS1 RECEPTOR; SACCHAROMYCES-CEREVISIAE; CYCLING RECEPTOR; DIHYDROFOLATE-REDUCTASE; BIOGENESIS DISORDERS; CONSERVED CYSTEINE; AMINO-ACID; MACHINERY	PEX1 and PEX6 are two members of the ATPases associated with diverse cellular activities (AAA) family and the core components of the receptor export module of the peroxisomal matrix protein import machinery. Their role is to extract monoubiquitinated PEX5, the peroxisomal protein-shuttling receptor, from the peroxisomal membrane docking/translocation module (DTM), so that a new cycle of protein transportation can start. Recent data have shown that PEX1 and PEX6 form a heterohexameric complex that unfolds substrates by processive threading. However, whether the natural substrate of the PEX1-PEX6 complex is monoubiquitinated PEX5 (Ub-PEX5) itself or some Ub-PEX5-interacting component(s) of the DTM remains unknown. In this work, we used an established cell-free in vitro system coupled with photoaffinity cross-linking and protein PEGylation assays to address this problem. We provide evidence suggesting that DTM-embedded Ub-PEX5 interacts directly with both PEX1 and PEX6 through its ubiquitin moiety and that the PEX5 polypeptide chain is globally unfolded during the ATP-dependent extraction event. These findings strongly suggest that DTM-embedded Ub-PEX5 is a bona fide substrate of the PEX1-PEX6 complex.	[Pedrosa, Ana G.; Francisco, Tania; Bicho, Diana; Dias, Ana F.; Barros-Barbosa, Aurora; Rodrigues, Tony A.; Azevedo, Jorge E.] Univ Porto, i3S, Rua Alfredo Allen 208, P-4200135 Porto, Portugal; [Pedrosa, Ana G.; Francisco, Tania; Bicho, Diana; Dias, Ana F.; Barros-Barbosa, Aurora; Rodrigues, Tony A.; Azevedo, Jorge E.] Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Porto, Portugal; [Pedrosa, Ana G.; Dias, Ana F.; Rodrigues, Tony A.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4200135 Porto, Portugal; [Hagmann, Vera; Dodt, Gabriele] Univ Tubingen, Interfak Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Eberhard Karls University of Tubingen	Azevedo, JE (corresponding author), Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Porto, Portugal.	jazevedo@ibmc.up.pt	Francisco, Tânia/AAK-9920-2020; Bicho, Diana/M-2454-2017; Azevedo, Jorge E/A-4113-2008; Barros-Barbosa, AR/L-1321-2014; Rodrigues, Tony/K-1141-2014	Francisco, Tânia/0000-0003-3571-5164; Bicho, Diana/0000-0002-9095-7134; Azevedo, Jorge E/0000-0001-7714-5302; Barros-Barbosa, AR/0000-0003-4484-4427; Pedrosa, Ana G/0000-0001-8887-2046; Rodrigues, Tony/0000-0003-2311-8258; Dias, Ana Filipa/0000-0002-6667-1961	FEDER (Fundo Europeu de Desenvolvimento Regional), through COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020; Portuguese funds through Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior [POCI-01-0145-FEDER-007274, PTDC/BEX-BCM/2311/2014]; Portuguese funds through Norte 2020-Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S" [NORTE-01-0145-FEDER-000008]; Fundacao para a Ciencia e Tecnologia; Programa Operacional Potencial Humano do QREN; Fundo Social Europeu	FEDER (Fundo Europeu de Desenvolvimento Regional), through COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020; Portuguese funds through Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior; Portuguese funds through Norte 2020-Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S"; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano do QREN; Fundo Social Europeu	This work was funded by FEDER (Fundo Europeu de Desenvolvimento Regional), through COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior in the framework of the projects "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274) and "The molecular mechanisms of peroxisome biogenesis" (PTDC/BEX-BCM/2311/2014), and through Norte 2020-Programa Operacional Regional do Norte, under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S" (NORTE-01-0145-FEDER-000008). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Humano do QREN, and Fundo Social Europeu.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Bailey ME, 2015, BIOPHYS J, V109, P2546, DOI 10.1016/j.bpj.2015.11.011; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Bhogal MS, 2016, J BIOL CHEM, V291, P2460, DOI 10.1074/jbc.M115.686501; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Blok NB, 2015, P NATL ACAD SCI USA, V112, pE4017, DOI 10.1073/pnas.1500257112; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Ciniawsky S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8331; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; Dias AF, 2017, J BIOL CHEM, V292, P15287, DOI 10.1074/jbc.M117.805044; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; Dorman G, 2016, CHEM REV, V116, P15284, DOI 10.1021/acs.chemrev.6b00342; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Francisco T, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700047; Francisco T, 2013, J BIOL CHEM, V288, P29151, DOI 10.1074/jbc.M113.487140; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Galland N, 2007, BBA-MOL CELL RES, V1773, P521, DOI 10.1016/j.bbamcr.2007.01.006; Gardner BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02474-4; Gardner BM, 2015, J MOL BIOL, V427, P1375, DOI 10.1016/j.jmb.2015.01.019; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Goto S, 2011, PLANT CELL, V23, P1573, DOI 10.1105/tpc.110.080770; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12836; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; Islinger M, 2010, BBA-MOL CELL RES, V1803, P881, DOI 10.1016/j.bbamcr.2010.03.013; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Jardim A, 2000, J BIOL CHEM, V275, P13637, DOI 10.1074/jbc.275.18.13637; Johjima A, 2015, J BIOL CHEM, V290, P11762, DOI 10.1074/jbc.M114.614768; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Junker JP, 2005, BIOPHYS J, V89, pL46, DOI 10.1529/biophysj.105.072066; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Kragler F, 1998, P NATL ACAD SCI USA, V95, P13336, DOI 10.1073/pnas.95.22.13336; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyata N, 2012, TRAFFIC, V13, P168, DOI 10.1111/j.1600-0854.2011.01298.x; Monroe N, 2016, J MOL BIOL, V428, P1897, DOI 10.1016/j.jmb.2015.11.004; Neuhaus A, 2014, J BIOL CHEM, V289, P437, DOI 10.1074/jbc.M113.499707; Nordgren M, 2015, AUTOPHAGY, V11, P1326, DOI 10.1080/15548627.2015.1061846; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Popov-Celeketic D, 2011, EMBO REP, V12, P542, DOI 10.1038/embor.2011.72; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; Rodrigues TA, 2016, NAT PROTOC, V11, P2454, DOI 10.1038/nprot.2016.147; Rodrigues TA, 2014, MOL CELL BIOL, V34, P2917, DOI 10.1128/MCB.01727-13; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; Tamura S, 2014, J BIOL CHEM, V289, P24336, DOI 10.1074/jbc.M114.588038; Tan DY, 2016, FEBS J, V283, P986, DOI 10.1111/febs.13569; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17229, DOI 10.1074/jbc.270.29.17229; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Walter C, 2001, AM J HUM GENET, V69, P35, DOI 10.1086/321265; Wanders RJA, 2014, BIOCHIMIE, V98, P36, DOI 10.1016/j.biochi.2013.08.022; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	78	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11553	11563		10.1074/jbc.RA118.003669	http://dx.doi.org/10.1074/jbc.RA118.003669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29884772	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000439449700024
J	Ulaganathan, T; Banin, E; Helbert, W; Cygler, M				Ulaganathan, ThirumalaiSelvi; Banin, Ehud; Helbert, William; Cygler, Miroslaw			Structural and functional characterization of PL28 family ulvan lyase NLR48 from Nonlabens ulvanivorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate processing; catalysis; crystal structure; substrate specificity; bacteria; algae; substrate binding; ulvan lyase; -jelly roll fold; PL28 family	SUBSTRATE RECOGNITION; ALGINATE LYASE; POLYSACCHARIDE; ENZYMES; ENVIRONMENT; FEATURES	Ulvan is a complex sulfated polysaccharide present in the cell wall of green algae of the genus Ulva (Chlorophyta). The first ulvan-degrading polysaccharide lyases were identified several years ago, and more were discovered through genome sequencing of marine bacteria. Ulvan lyases are now grouped in three polysaccharide lyase (PL) families in the CAZy database, PL24, PL25, and PL28. The recently determined structures of the representative lyases from families PL24 and PL25 show that they adopt a seven-bladed -propeller fold and utilize the His/Tyr catalytic mechanism. No structural information is yet available for PL28 ulvan lyases. NLR48 from Nonlabens ulvanivorans belongs to PL28 together with its close paralog, NLR42. Biochemical studies of NLR42 have revealed that it can cleave ulvan next to both uronic acid epimers. We report the crystal structure of ulvan lyase NLR48 at 1.9- resolution. It has a -jelly roll fold with an extended, deep, and positively charged substrate-binding cleft. Putative active-site residues were identified from the sequence conservation pattern, and their role was confirmed by site-directed mutagenesis. The structure of an inactive K162M mutant with a tetrasaccharide substrate showed the substrate occupying the - subsites. Comparison with lyases from other PL families with -jelly roll folds supported assignment of the active site and explained its ability to degrade ulvan next to either epimer of uronic acid. NLR48 contains the His/Tyr catalytic machinery with Lys(162) and Tyr(281) playing the catalytic base/acid roles.	[Ulaganathan, ThirumalaiSelvi; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Banin, Ehud] Bar Ilan Univ, Fac Life Sci, IL-5290002 Ramat Gan, Israel; [Helbert, William] CNRS, Ctr Rech Macromol Vegetales CERMAV, BP53, F-38000 Grenoble 9, France; [Helbert, William] Grenoble Alpes Univ, BP53, F-38000 Grenoble 9, France; [Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada	University of Saskatchewan; Bar Ilan University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca		Cygler, Miroslaw/0000-0003-4579-1881	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Kevin Voth for comments. We acknowledge the Protein Characterization and Crystallization Facility, College of Medicine, University of Saskatchewan for access to the crystallization robot. Research described in this paper was performed using beamline 08ID-1 at the Canadian Light Source synchrotron, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collen PN, 2011, J BIOL CHEM, V286, P42063, DOI 10.1074/jbc.M111.271825; Cunha L, 2016, MAR DRUGS, V14, DOI 10.3390/md14030042; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dong S, 2014, J BIOL CHEM, V289, P29558, DOI 10.1074/jbc.M114.584573; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foran E, 2017, ALGAL RES, V25, P39, DOI 10.1016/j.algal.2017.04.036; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2014, CURR OPIN STRUC BIOL, V28, P87, DOI 10.1016/j.sbi.2014.07.012; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han YH, 2009, J BIOL CHEM, V284, P34019, DOI 10.1074/jbc.M109.025338; Hehemann JH, 2014, CURR OPIN STRUC BIOL, V28, P77, DOI 10.1016/j.sbi.2014.07.009; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konno N, 2009, FEBS LETT, V583, P1323, DOI 10.1016/j.febslet.2009.03.034; Kopel M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00793-14; Kopel M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01257-14; Kopel M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01081-14; Kopel M, 2016, J BIOL CHEM, V291, P5871, DOI 10.1074/jbc.M115.673947; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Melcher RLJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44115; Michel G, 2013, WOODH PUB SER BIOMED, P429, DOI 10.1533/9781908818355.3.429; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Popa EG, 2015, CRIT REV BIOTECHNOL, V35, P410, DOI 10.3109/07388551.2014.889079; Shalaby EA, 2011, PLANT SIGNAL BEHAV, V6, P1338, DOI 10.4161/psb.6.9.16779; Sudha PN, 2014, ADV FOOD NUTR RES, V73, P145, DOI 10.1016/B978-0-12-800268-1.00008-1; Ulaganathan T, 2018, J BIOL CHEM, V293, P4026, DOI 10.1074/jbc.RA117.001642; Ulaganathan T, 2017, ACS CHEM BIOL, V12, P1269, DOI 10.1021/acschembio.7b00126	34	19	21	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11564	11573		10.1074/jbc.RA118.003659	http://dx.doi.org/10.1074/jbc.RA118.003659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29875159	Green Published, hybrid			2022-12-28	WOS:000439449700025
J	Yang, Y; Liu, FG; Liu, AM				Yang, Yu; Liu, Fange; Liu, Aimin			Adapting to oxygen: 3-Hydroxyanthrinilate 3,4-dioxygenase employs loop dynamics to accommodate two substrates with disparate polarities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dioxygenase; iron; enzyme structure; oxygen binding; crystal structure; conformational change; Extradiol dioxygenase; hydrophobicity; Nonheme iron enzyme; Oxygen activation; Tryptophan-kynurenine pathway	CRYSTAL-STRUCTURE; X-RAY; TRYPTOPHAN; MECHANISM; PATHWAY; 3-HYDROXYANTHRANILATE-3,4-DIOXYGENASE; IDENTIFICATION; KETOGLUTARATE; KYNURENINES; DEGRADATION	3-Hydroxyanthranilate 3,4-dioxygenase (HAO) is an iron-dependent protein that activates O-2 and inserts both oxygen atoms into 3-hydroxyanthranilate (3-HAA). An intriguing question is how HAO can rapidly bind O-2, even though local O-2 concentrations and diffusion rates are relatively low. Here, a close inspection of the HAO structures revealed that substrate- and inhibitor-bound structures exhibit a closed conformation with three hydrophobic loop regions moving toward the catalytic iron center, whereas the ligand-free structure is open. We hypothesized that these loop movements enhance O-2 binding to the binary complex of HAO and 3-HAA. We found that the carboxyl end of 3-HAA triggers changes in two loop regions and that the third loop movement appears to be driven by an H-bond interaction between Asn(27) and Ile(142). Mutational analyses revealed that N27A, I142A, and I142P variants cannot form a closed conformation, and steady-state kinetic assays indicated that these variants have a substantially higher K-m for O-2 than WT HAO. This observation suggested enhanced hydrophobicity at the iron center resulting from the concerted loop movements after the binding of the primary substrate, which is hydrophilic. Given that O-2 is nonpolar, the increased hydrophobicity at the iron center of the binary complex appears to be essential for rapid O-2 binding and activation, explaining the reason for the 3-HAA-induced loop movements. Because substrate binding-induced open-to-closed conformational changes are common, the results reported here may help further our understanding of how oxygen is enriched in nonheme iron-dependent dioxygenases.	[Yang, Yu; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Liu, Fange] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Pennsylvania; Pennsylvania Medicine	Liu, AM (corresponding author), Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA.; Liu, FG (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	liufg@pennmedicine.upenn.edu; Feradical@utsa.edu	; Liu, Aimin/C-1572-2017	Yang, Yu/0000-0001-5305-2435; Liu, Aimin/0000-0002-4182-8176	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, DE-AC02-76SF00515]; National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108988, P41GM103393, R01GM107529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107985] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Drs. Tadhg P. Begley and Steven E. Ealick for providing the HAO expression plasmid. We are indebted to Ian Davis for constructive discussions and manuscript editing. We thank the staff scientists at the sections 19 and 22 beamlines of the Advanced Photon Source (APS), Argonne National Laboratory and the beamline 9-2 of the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory. Use of the APS and SSRL is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contracts DE-AC02-06CH11357 and DE-AC02-76SF00515, respectively. The SSRL facility is additionally supported by National Institutes of Health Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boechi L, 2013, J BIOL CHEM, V288, P6754, DOI 10.1074/jbc.M112.426056; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho JH, 2009, J BIOL CHEM, V284, P34321, DOI 10.1074/jbc.M109.031054; Cohen J, 2007, BIOPHYS J, V93, P3591, DOI 10.1529/biophysj.107.108712; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; Colabroy KL, 2005, BIOCHEMISTRY-US, V44, P7623, DOI 10.1021/bi0473455; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; DEVILLOTA ED, 1981, BRIT J ANAESTH, V53, P1325, DOI 10.1093/bja/53.12.1325; Dilovic I, 2009, BIOPOLYMERS, V91, P1189, DOI 10.1002/bip.21167; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Erlandsen H, 2000, BIOCHEMISTRY-US, V39, P2208, DOI 10.1021/bi992531+; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khare D, 2010, P NATL ACAD SCI USA, V107, P14099, DOI 10.1073/pnas.1006738107; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Li XW, 2006, PROTEIN SCI, V15, P761, DOI 10.1110/ps.051967906; Liu FG, 2015, J BIOL CHEM, V290, P15621, DOI 10.1074/jbc.M115.650259; Muraki T, 2003, APPL ENVIRON MICROB, V69, P1564, DOI 10.1128/AEM.69.3.1564-1572.2003; O'Brien JR, 2003, BIOCHEMISTRY-US, V42, P5547, DOI 10.1021/bi0341096; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERUTZ MF, 1966, J MOL BIOL, V21, P199, DOI 10.1016/0022-2836(66)90088-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Volner A, 2003, J BIOL INORG CHEM, V8, P121, DOI 10.1007/s00775-002-0395-6; Zhang Y, 2005, BIOCHEMISTRY-US, V44, P7632, DOI 10.1021/bi047353l	31	8	8	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10415	10424		10.1074/jbc.RA118.002698	http://dx.doi.org/10.1074/jbc.RA118.002698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29784877	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000437828400001
J	Yuan, L; Wang, HY; Liu, Q; Wang, Z; Zhang, MS; Zhao, Y; Liang, K; Chen, LY; Xu, T; Xu, PY				Yuan, Lin; Wang, Huiyu; Liu, Qi; Wang, Zhe; Zhang, Mingshu; Zhao, Yan; Liang, Kuo; Chen, Liangyi; Xu, Tao; Xu, Pingyong			Etoposide-induced protein 2.4 functions as a regulator of the calcium ATPase and protects pancreatic -cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; pancreatic islet; cell metabolism; calcium ATPase; apoptosis; ATPase sarcoplasmic; endoplasmic reticulum Ca2+-transporting 2; etoposide-induced protein 2; 4; glucose tolerance	AUTOPHAGY; KINASE; EXPRESSION; APOPTOSIS; EI24; ACTIVATION; P53	Calcium homeostasis is essential for maintaining the viability and function of pancreatic cells and plays a key role in preventing the development of diabetes. Decreased levels of ATPase sarcoplasmic/endoplasmic reticulum Ca2+-transporting 2 (ATP2a2), the main calcium pump in cells, are often found in individuals with diabetes and in diabetic animal models. However, the regulators of ATP2a2 and the molecular mechanisms responsible for controlling ATP2a2 activity remain unclear. Etoposide-induced protein 2.4 (Ei24) is also down-regulated in cells of diabetic individuals, whereas the effect of decreased Ei24 level on -cell function is not clarified. Here, using Cre-LoxP and CRISPR/Cas9-based genomic knockout (KO) approaches to generate pancreatic cell-specific Ei24 KO mice and pancreatic -cell lines, we found that Ei24 regulates ATP2a2 activity. Specifically, we observed that Ei24 binds to ATP2a2 through Ei24 residues 293-299, which we named here the ATP2a2-interacting region (AIR). Loss of Ei24 inactivated ATP2a2, disrupted calcium homeostasis, and deactivated the calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2)-AMP-activated protein kinase (AMPK) pathway. Elevation of calcium concentration in the endoplasmic reticulum or agonist-induced AMPK activation rescued pancreatic -cell survival and improved glucose tolerance of Ei24 KO mice. Our findings indicate that targeting the Ei24-ATP2a2 interaction to increase ATP2a2 activity can protect pancreatic cells and improve glucose homeostasis in diabetic models, suggesting that Ei24 could potentially serve as a target to prevent or manage diabetes.	[Yuan, Lin; Wang, Huiyu; Liu, Qi; Wang, Zhe; Zhang, Mingshu; Xu, Pingyong] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Zhao, Yan; Xu, Tao] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Liu, Qi; Wang, Zhe; Zhang, Mingshu; Xu, Tao; Xu, Pingyong] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100101, Peoples R China; [Liang, Kuo] Capital Med Univ, XuanWu Hosp, Dept Gen Surg, Beijing 100053, Peoples R China; [Xu, Pingyong] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing Key Lab Cardiometab Mol Med, Inst Mol Med, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital Medical University; Peking University	Xu, PY (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China.; Xu, T (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Xu, T; Xu, PY (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100101, Peoples R China.	xutao@ibp.ac.cn; pyxu@ibp.ac.cn	王, 慧玉/GPX-6583-2022	王, 慧玉/0000-0001-7855-9769	National Key R&D Program of China [2016YFA0501500]; National Basic Research Program [2013CB910103]; National Natural Science Foundation of China [31421002, 31401174, 21778069]; Chinese Academy of Sciences [XDA12030201, XDB08030203]; CAST; Beijing Natural Science Foundation [7182063]; Beijing Health System High Level Health Technical Personnel Grant [2014-3-058]	National Key R&D Program of China; National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); CAST; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Health System High Level Health Technical Personnel Grant	This work was supported by National Key R&D Program of China Grant 2016YFA0501500; National Basic Research Program Grant 2013CB910103; National Natural Science Foundation of China Grants 31421002, 31401174, and 21778069; Project of the Chinese Academy of Sciences Grants XDA12030201 and XDB08030203; Young Elite Scientist Sponsorship Program by CAST; Beijing Natural Science Foundation Grant 7182063; and Beijing Health System High Level Health Technical Personnel Grant 2014-3-058. The authors declare that they have no conflicts of interest with the contents of this article.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; de Juan-Sanz J, 2017, NEURON, V93, P867, DOI 10.1016/j.neuron.2017.01.010; Devkota S, 2016, AUTOPHAGY, V12, P2038, DOI 10.1080/15548627.2016.1217371; Devkota S, 2012, INT J BIOCHEM CELL B, V44, P1887, DOI 10.1016/j.biocel.2012.06.034; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Johnson JD, 2010, ADV EXP MED BIOL, V654, P447, DOI 10.1007/978-90-481-3271-3_19; Kang S, 2016, J BIOL CHEM, V291, P5185, DOI 10.1074/jbc.M115.705012; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Lehar SM, 1996, ONCOGENE, V12, P1181; Liang K, 2014, PROTEIN CELL, V5, P783, DOI 10.1007/s13238-014-0075-7; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Mork CN, 2007, FEBS LETT, V581, P5440, DOI 10.1016/j.febslet.2007.10.046; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Sundararaman A, 2016, J BIOL CHEM, V291, P14410, DOI 10.1074/jbc.M116.731257; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yuan K, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0166-2; Yuan L, 2013, STEM CELLS DEV, V22, P2384, DOI 10.1089/scd.2012.0717; Zarain-Herzberg A, 2014, CELL CALCIUM, V56, P302, DOI 10.1016/j.ceca.2014.09.005; Zhao X, 2001, CELL DEATH DIFFER, V8, P878, DOI 10.1038/sj.cdd.4400894; Zhao XS, 2005, CANCER RES, V65, P2125, DOI 10.1158/0008-5472.CAN-04-3377; Zhao YG, 2012, J BIOL CHEM, V287, P42053, DOI 10.1074/jbc.M112.415968	28	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10128	10140		10.1074/jbc.RA118.002399	http://dx.doi.org/10.1074/jbc.RA118.002399			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769309	Green Published, hybrid			2022-12-28	WOS:000437096700016
J	Pflanz, NC; Daszkowski, AW; Cornelison, GL; Trudell, JR; Mihic, SJ				Pflanz, Natasha C.; Daszkowski, Anna W.; Cornelison, Garrett L.; Trudell, James R.; Mihic, S. John			An intersubunit electrostatic interaction in the GABA(A) receptor facilitates its responses to benzodiazepines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; GABA receptor; electrostatics; electrophysiology; Xenopus; cysteine-mediated cross-linking; Cys-loop receptor; benzodiazepines; ionotropic receptor; sedative	AGONIST BINDING; ANXIOLYTIC PROPERTIES; GAMMA(2) SUBUNIT; GLYCINE RECEPTOR; A RECEPTORS; ACID; MODULATION; CHANNEL; SITE; ACTIVATION	Benzodiazepines are positive allosteric modulators of the GABA(A) receptor (GABA(A)R), acting at the - subunit interface to enhance GABA(A)R function. GABA or benzodiazepine binding induces distinct conformational changes in the GABA(A)R. The molecular rearrangements in the GABA(A)R following benzodiazepine binding remain to be fully elucidated. Using two molecular models of the GABA(A)R, we identified electrostatic interactions between specific amino acids at the - subunit interface that were broken by, or formed after, benzodiazepine binding. Using two-electrode voltage clamp electrophysiology in Xenopus laevis oocytes, we investigated these interactions by substituting one or both amino acids of each potential pair. We found that Lys(104) in the (1) subunit forms an electrostatic bond with Asp(75) of the (2) subunit after benzodiazepine binding and that this bond stabilizes the positively modified state of the receptor. Substitution of these two residues to cysteine and subsequent covalent linkage between them increased the receptor's sensitivity to low GABA concentrations and decreased its response to benzodiazepines, producing a GABA(A)R that resembles a benzodiazepine-bound WT GABA(A)R. Breaking this bond restored sensitivity to GABA to WT levels and increased the receptor's response to benzodiazepines. The (1) Lys(104) and (2) Asp(75) interaction did not play a role in ethanol or neurosteroid modulation of GABA(A)R, suggesting that different modulators induce different conformational changes in the receptor. These findings may help explain the additive or synergistic effects of modulators acting at the GABA(A)R.	[Pflanz, Natasha C.; Daszkowski, Anna W.; Cornelison, Garrett L.; Mihic, S. John] Univ Texas Austin, Inst Neurosci, Dept Neurosci, Div Pharmacol & Toxicol,Waggoner Ctr Alcohol & Ad, Austin, TX 78712 USA; [Pflanz, Natasha C.; Daszkowski, Anna W.; Cornelison, Garrett L.; Mihic, S. John] Univ Texas Austin, Inst Cell & Mol Biol, Dept Neurosci, Div Pharmacol & Toxicol,Waggoner Ctr Alcohol & Ad, Austin, TX 78712 USA; [Trudell, James R.] Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Stanford University	Mihic, SJ (corresponding author), Univ Texas Austin, Inst Neurosci, Dept Neurosci, Div Pharmacol & Toxicol,Waggoner Ctr Alcohol & Ad, Austin, TX 78712 USA.; Mihic, SJ (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Dept Neurosci, Div Pharmacol & Toxicol,Waggoner Ctr Alcohol & Ad, Austin, TX 78712 USA.	mihic@austin.utexas.edu			National Institutes of Health [F31DA042564]; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA042564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Ruth L. Kirschstein National Research Service Award F31DA042564 (to N.C.P.) from the National Institute on Drug Abuse.	Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Amato A, 1999, J PHYSIOL-LONDON, V517, P35, DOI 10.1111/j.1469-7793.1999.0035z.x; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Buhr A, 1997, P NATL ACAD SCI USA, V94, P8824, DOI 10.1073/pnas.94.16.8824; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Ci SQ, 2008, PROTEIN J, V27, P71, DOI 10.1007/s10930-007-9109-9; Downing SS, 2005, BRIT J PHARMACOL, V145, P894, DOI 10.1038/sj.bjp.0706251; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Gielen MC, 2012, J NEUROSCI, V32, P5707, DOI 10.1523/JNEUROSCI.5663-11.2012; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hanson SM, 2011, BRIT J PHARMACOL, V162, P673, DOI 10.1111/j.1476-5381.2010.01073.x; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Langer S.Z., 1992, EUR NEUROPSYCHOPHARM, V2, P232, DOI DOI 10.1016/0924-977X(92)90081-I; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McCracken ML, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00045; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MIHIC SJ, 1994, J BIOL CHEM, V269, P32768; Morris HV, 2006, EUR J NEUROSCI, V23, P2495, DOI 10.1111/j.1460-9568.2006.04775.x; NEWLAND CF, 1991, J PHYSIOL-LONDON, V432, P203, DOI 10.1113/jphysiol.1991.sp018382; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; STUDY RE, 1981, P NATL ACAD SCI-BIOL, V78, P7180, DOI 10.1073/pnas.78.11.7180; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2014, DAWN REPORT BENZODIA; Todorovic J, 2010, P NATL ACAD SCI USA, V107, P7987, DOI 10.1073/pnas.1001845107; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Venkatachalan SP, 2012, J BIOL CHEM, V287, P6714, DOI 10.1074/jbc.M111.316836; Wallner M, 2014, NEUROCHEM RES, V39, P1118, DOI 10.1007/s11064-014-1243-0; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Yoluk O, 2013, BIOPHYS J, V105, P640, DOI 10.1016/j.bpj.2013.06.037	36	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8264	8274		10.1074/jbc.RA118.002128	http://dx.doi.org/10.1074/jbc.RA118.002128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29622679	Green Published, hybrid			2022-12-28	WOS:000433224600030
J	Jamsheer, KM; Shukla, BN; Jindal, S; Gopan, N; Mannully, CT; Laxmi, A				Jamsheer, Muhammed K.; Shukla, Brihaspati N.; Jindal, Sunita; Gopan, Nandu; Mannully, Chanchal Thomas; Laxmi, Ashverya			The FCS-like zinc finger scaffold of the kinase SnRK1 is formed by the coordinated actions of the FLZ domain and intrinsically disordered regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PHOSPHORYLATION; HUMAN INTERACTOME; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; BINDING REGIONS; LAND PLANTS; LIFE-SPAN; EVOLUTION; AMPK; SEQUENCE	The SNF1-related protein kinase 1 (SnRK1) is a heterotrimeric eukaryotic kinase that interacts with diverse proteins and regulates their activity in response to starvation and stress signals. Recently, the FCS-like zinc finger (FLZ) proteins were identified as a potential scaffold for SnRK1 in plants. However, the evolutionary and mechanistic aspect of this complex formation is currently unknown. Here, in silico analyses predicted that FLZ proteins possess conserved intrinsically disordered regions (IDRs) with a propensity for protein binding in the N and C termini across the plant lineage. We observed that the Arabidopsis FLZ proteins promiscuously interact with SnRK1 subunits, which formed different isoenzyme complexes. The FLZ domain was essential for mediating the interaction with SnRK1 alpha subunits, whereas the IDRs in the N termini facilitated interactions with the beta and beta gamma subunits of SnRK1. Furthermore, the IDRs in the N termini were important for mediating dimerization of different FLZ proteins. Of note, the interaction of FLZ with SnRK1 was confined to cytoplasmic foci, which colocalized with the endoplasmic reticulum. An evolutionary analysis revealed that in general, the IDR-rich regions are under more relaxed selection than the FLZ domain. In summary, the findings in our study reveal the structural details, origin, and evolution of a land plant-specific scaffold of SnRK1 formed by the coordinated actions of IDRs and structured regions in the FLZ, proteins. We propose that the FLZ, protein complex might be involved in providing flexibility, thus enhancing the binding repertoire of the SnRK1 hub in land plants.	[Jamsheer, Muhammed K.; Shukla, Brihaspati N.; Jindal, Sunita; Mannully, Chanchal Thomas; Laxmi, Ashverya] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India; [Gopan, Nandu] Jawaharial Nehru Ctr Adv Sci Res, Jakkur 560064, Bengaluru, India; [Mannully, Chanchal Thomas] Vellore Inst Technol, Vellore 632014, Tamil Nadu, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Vellore Institute of Technology	Laxmi, A (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India.	ashverya_laxmi@nipgr.ac.in	Jindal, Sunita/AAO-5556-2020	Gopan, Nandu/0000-0002-7227-3441; Jindal, Sunita/0000-0002-0318-2204; Jamsheer K, Muhammed/0000-0002-2135-8760	Department of Biotechnology, Government of India [BT/PR8001/BRB/10/1211/2013, BT/PR12855/BPA/118/87/2015]; National Institute of Plant Genome Research; University Grants Commission, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute of Plant Genome Research; University Grants Commission, Government of India(University Grants Commission, India)	This work was supported in part by Project Grant BT/PR8001/BRB/10/1211/2013 from the Department of Biotechnology, Government of India, and a Core Grant from the National Institute of Plant Genome Research. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a research fellowship from the University Grants Commission, Government of India.; Recipients of research fellowships from the National Institute of Plant Genome Research.; Recipient of Research Fellowship BT/PR12855/BPA/118/87/2015 from the Project Grant from the Department of Biotechnology, Government of India.	Afek A, 2011, J MOL BIOL, V409, P439, DOI 10.1016/j.jmb.2011.03.056; Ahrens J, 2016, MOL BIOL EVOL, V33, P2248, DOI 10.1093/molbev/msw092; Ahrens JB, 2017, CELL MOL LIFE SCI, V74, P3163, DOI 10.1007/s00018-017-2559-0; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bitrian M, 2011, PLANT J, V65, P829, DOI 10.1111/j.1365-313X.2010.04462.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Broeckx T, 2016, J EXP BOT, V67, P6215, DOI 10.1093/jxb/erw416; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Chen XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067120; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dobrenel T, 2016, ANNU REV PLANT BIOL, V67, P261, DOI 10.1146/annurev-arplant-043014-114648; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Emanuelle S, 2015, PLANT J, V82, P183, DOI 10.1111/tpj.12813; Erce MA, 2013, MOL CELL PROTEOMICS, V12, P3184, DOI 10.1074/mcp.M113.031500; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gao JJ, 2012, BIOCOMPUT-PAC SYM, P94; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Glab N, 2017, PLANT J, V89, P1031, DOI 10.1111/tpj.13445; Goldstein RA, 2008, CURR OPIN STRUC BIOL, V18, P170, DOI 10.1016/j.sbi.2008.01.006; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harper TM, 2018, J BIOL CHEM, V293, P13778, DOI 10.1074/jbc.R117.794438; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; He YH, 2004, PLANT MOL BIOL, V54, P1, DOI 10.1023/B:PLAN.0000028730.10834.e3; Heilbronn LK, 2005, PLOS MED, V2, P721, DOI 10.1371/journal.pmed.0020231; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Hu JF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004508; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jamsheer KM, 2018, PLANT J, V94, P232, DOI 10.1111/tpj.13854; Jamsheer KM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00746; Jamsheer KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134328; Jamsheer KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099074; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kato H, 2018, J EXP BOT, V69, P291, DOI 10.1093/jxb/erx267; Kramer EM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00869; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malhis N, 2015, BIOINFORMATICS, V31, P1738, DOI 10.1093/bioinformatics/btv060; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI [10.1093/bioinformatics/btn575, 10.1093/bioinformatics/btp666]; Minina EA, 2013, AGING CELL, V12, P327, DOI 10.1111/acel.12048; Nagulapalli M, 2016, NUCLEIC ACIDS RES, V44, P1591, DOI 10.1093/nar/gkv1135; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nietzsche M, 2016, CURR PLANT BIOL, V5, P36, DOI 10.1016/j.cpb.2015.10.004; Nietzsche M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00054; Nukarinen E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31697; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Peng ZL, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv585; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Ramon M, 2013, PLANT J, V75, P11, DOI 10.1111/tpj.12192; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Roustan V, 2016, J EXP BOT, V67, P3897, DOI 10.1093/jxb/erw211; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schaefer C, 2010, BIOINFORMATICS, V26, P625, DOI 10.1093/bioinformatics/btq012; Schepetilnikov M, 2013, EMBO J, V32, P1087, DOI 10.1038/emboj.2013.61; Sharifpoor S, 2012, GENOME RES, V22, P791, DOI 10.1101/gr.129213.111; Shaw AJ, 2011, AM J BOT, V98, P352, DOI 10.3732/ajb.1000316; Shi SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038772; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Winter DL, 2015, PROTEOMICS, V15, P2166, DOI 10.1002/pmic.201400521; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yan J, 2016, MOL BIOSYST, V12, P697, DOI 10.1039/c5mb00640f; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	88	20	37	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13134	13150		10.1074/jbc.RA118.002073	http://dx.doi.org/10.1074/jbc.RA118.002073			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29945970	Green Published, hybrid			2022-12-28	WOS:000442730200014
J	Leighton, PLA; Kanyo, R; Neil, GJ; Pollock, NM; Allison, WT				Leighton, Patricia L. A.; Kanyo, Richard; Neil, Gavin J.; Pollock, Niall M.; Allison, W. Ted			Prion gene paralogs are dispensable for early zebrafish development and have nonadditive roles in seizure susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodevelopment; zebrafish; prion disease; transcription activator-like effector nuclease; TALEN; PrPC; excitotoxicity; neurodegeneration; gene editing; neural hyperactivity; targeted mutagenesis	ALZHEIMERS-DISEASE; LATERAL-LINE; NEURITE OUTGROWTH; CELL-MIGRATION; PROTEIN; EXPRESSION; RECEPTOR; PRP; LACKING; MICE	Normally folded prion protein (PrPC) and its functions in healthy brains remain underappreciated compared with the intense study of its misfolded forms (prions, PrPSc) during the pathobiology of prion diseases. This impedes the development of therapeutic strategies in Alzheimer's and prion diseases. Disrupting the zebrafish homologs of PrPC has provided novel insights; however, mutagenesis of the zebrafish paralog prp2 did not recapitulate previous dramatic developmental phenotypes, suggesting redundancy with the prp1 paralog. Here, we generated zebrafish prp1 loss-of-function mutant alleles and dual prp1(-/-);prp2(-/-) mutants. Zebrafish prp1(-/-) and dual prp1(-/-);prp2(-/-) mutants resemble mammalian Prnp knockouts insofar as they lack overt phenotypes, which surprisingly contrasts with reports of severe developmental phenotypes when either prp1 or prp2 is knocked down acutely. Previous studies suggest that PrPC participates in neural cell development/adhesion, including in zebrafish where loss of prp2 affects adhesion and deposition patterns of lateral line neuromasts. In contrast with the expectation that prp1's functions would be redundant to prp2, they appear to have opposing functions in lateral line neurodevelopment. Similarly, loss of prp1 blunted the seizure susceptibility phenotypes observed in prp2 mutants, contrasting the expected exacerbation of phenotypes if these prion gene paralogs were serving redundant roles. In summary, prion mutant fish lack the overt phenotypes previously predicted, and instead they have subtle phenotypes similar to mammals. No evidence was found for functional redundancy in the zebrafish prion gene paralogs, and the phenotypes observed when each gene is disrupted individually are consistent with ancient functions of prion proteins in neurodevelopment and modulation of neural activity.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Alberta, Ctr Prion & Prot Folding Dis, Edmonton, AB T6G 2E9, Canada	University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, CW Biol Sci Ctr 405, Edmonton, AB T6G 2E9, Canada.	ted.allison@ualberta.ca			Alberta Prion Research Institute-Alberta Innovates BioSolutions; Alzheimer Society of Alberta; Northwest Territories; Alzheimer Society of Canada; Alberta Innovates Health Solutions	Alberta Prion Research Institute-Alberta Innovates BioSolutions; Alzheimer Society of Alberta; Northwest Territories; Alzheimer Society of Canada; Alberta Innovates Health Solutions	This work was supported in part by operating grants from the Alberta Prion Research Institute-Alberta Innovates BioSolutions and the Alzheimer Society of Alberta and the Northwest Territories (to W. T. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by studentships from Alzheimer Society of Canada and Alberta Innovates Health Solutions.	Allison WT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102223; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Bayes A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14613; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Bertani I, 2017, J NEUROSCI, V37, P10278, DOI 10.1523/JNEUROSCI.1301-17.2017; Bhinder G., 2012, NEUROMETHODS, P71; Brethour D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40313; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carulla P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11971; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Daude N, 2012, PRION, V6, DOI 10.4161/pri.21867; Daude N, 2012, P NATL ACAD SCI USA, V109, P9035, DOI 10.1073/pnas.1202130109; deCarvalho TN, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00098; Ehsani S, 2012, PRION, V6, P317, DOI 10.4161/pri.20196; Ehsani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026800; Ehsani S, 2011, PROG NEUROBIOL, V93, P405, DOI 10.1016/j.pneurobio.2010.12.001; Fleisch VC, 2013, NEUROBIOL DIS, V55, P11, DOI 10.1016/j.nbd.2013.03.007; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hernandez-Rapp J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04881; Huc-Brandt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113331; Kaiser DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051305; Komiya Yuko, 2008, Organogenesis, V4, P68; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Leighton PLA, 2018, BIOL OPEN, V7, DOI 10.1242/bio.025734; Leighton PLA, 2016, J ALZHEIMERS DIS, V54, P3, DOI 10.3233/JAD-160361; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Malaga-Trillo E, 2016, PRION, V10, P352, DOI 10.1080/19336896.2016.1221873; Malaga-Trillo E, 2011, BBA-MOL BASIS DIS, V1812, P402, DOI 10.1016/j.bbadis.2010.09.013; Malaga-Trillo E, 2009, PRION, V3, P129, DOI 10.4161/pri.3.3.9651; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Mehrabian M, 2016, ASN NEURO, V8, DOI 10.1177/1759091416679074; Mehrabian M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133741; Mehrabian M, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00053; Miesbauer M, 2006, BIOCHEM BIOPH RES CO, V341, P218, DOI 10.1016/j.bbrc.2005.12.168; Nourizadeh-Lillabadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013573; Ochs K, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00063; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; Parrie LE, 2018, DEV BIOL, V438, P23, DOI 10.1016/j.ydbio.2018.03.012; Reimann RR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005401; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Ryan NS, 2016, LANCET NEUROL, V15, P1326, DOI 10.1016/S1474-4422(16)30193-4; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; Salta E, 2014, VIRUSES-BASEL, V6, P4398, DOI 10.3390/v6114398; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Schmitz M, 2014, MOL NEUROBIOL, V50, P923, DOI 10.1007/s12035-014-8655-3; Sempou E, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0076-5; Shum EY, 2016, CELL, V165, P382, DOI 10.1016/j.cell.2016.02.046; Singh S. K., 2010, J PROTEOM BIOINFORM, V3, P135, DOI DOI 10.4172/JPB.1000132; Solis GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070327; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Striebel JF, 2013, PRION, V7, P280, DOI 10.4161/pri.25738; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V294, P912, DOI 10.1016/S0006-291X(02)00546-6; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Villablanca EJ, 2006, DEV DYNAM, V235, P1578, DOI 10.1002/dvdy.20743; Vossel KA, 2017, LANCET NEUROL, V16, P311, DOI 10.1016/S1474-4422(17)30044-3; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wieser HG, 2006, CLIN NEUROPHYSIOL, V117, P935, DOI 10.1016/j.clinph.2005.12.007; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Young R, 2009, FEBS LETT, V583, P3296, DOI 10.1016/j.febslet.2009.09.027; Yu GH, 2009, MOL REPROD DEV, V76, P3, DOI 10.1002/mrd.20960; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018	81	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12576	12592		10.1074/jbc.RA117.001171	http://dx.doi.org/10.1074/jbc.RA117.001171			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903907	Green Published, hybrid			2022-12-28	WOS:000441408500022
J	Pourfarjam, Y; Ventura, J; Kurinov, I; Cho, A; Moss, J; Kim, IK				Pourfarjam, Yasin; Ventura, Jessica; Kurinov, Igor; Cho, Ahra; Moss, Joel; Kim, In-Kwon			Structure of human ADP-ribosyl-acceptor hydrolase 3 bound to ADP-ribose reveals a conformational switch that enables specific substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; conformational change; structural biology; substrate specificity; hydrolase; ARH3; PARP1	39-KDA POLY(ADP-RIBOSE) GLYCOHYDROLASE; PAR POLYMER; CELL-DEATH; PROTEIN; ADP-RIBOSYLHYDROLASE-3; PURIFICATION; COMPLEXES; MECHANISM; INSIGHTS; FEATURES	ADP-ribosyl-acceptor hydrolase 3 (ARH3) plays important roles in regulation of poly(ADP-ribosyl)ation, a reversible post-translational modification, and in maintenance of genomic integrity. ARH3 degrades poly(ADP-ribose) to protect cells from poly(ADP-ribose)-dependent cell death, reverses serine mono(ADP-ribosyl)ation, and hydrolyzes O-acetyl-ADP-ribose, a product of Sirtuin-catalyzed histone deacetylation. ARH3 preferentially hydrolyzes O-linkages attached to the anomeric C1 of ADP-ribose; however, how ARH3 specifically recognizes and cleaves structurally diverse substrates remains unknown. Here, structures of full-length human ARH3 bound to ADP-ribose and Mg2+, coupled with computational modeling, reveal a dramatic conformational switch from closed to open states that enables specific substrate recognition. The glutamate flap, which blocks substrate entrance to Mg2+ in the unliganded closed state, is ejected from the active site when substrate is bound. This closed-to-open transition significantly widens the substrate-binding channel and precisely positions the scissile 1-O-linkage for cleavage while securing tightly 2- and 3-hydroxyls of ADP-ribose. Our collective data uncover an unprecedented structural plasticity of ARH3 that supports its specificity for the 1-O-linkage in substrates and Mg2+-dependent catalysis.	[Pourfarjam, Yasin; Ventura, Jessica; Cho, Ahra; Kim, In-Kwon] Univ Cincinnati, Dept Chem, 301 Clifton Ct, Cincinnati, OH 45221 USA; [Kurinov, Igor] Cornell Univ, Dept Chem & Chem Biol, Northeastern Collaborat Access Team, Adv Photon Source NE CAT APS, Argonne, IL 60439 USA; [Moss, Joel] NHLBI, Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA	University System of Ohio; University of Cincinnati; Cornell University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, IK (corresponding author), Univ Cincinnati, Dept Chem, 301 Clifton Ct, Cincinnati, OH 45221 USA.	in-kwon.kim@uc.edu		Kim, In-Kwon/0000-0002-2779-9735	National Institutes of Health [P41 GM103403, S10OD021527]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work used NE-CAT beamlines (National Institutes of Health Grant P41 GM103403) and an Eiger 16M detector on 24-ID-E beam line (National Institutes of Health Grant S10OD021527) at the APS (United States Department of Energy Grant DE-AC02-06CH11357).	Abplanalp J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02253-1; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Beck C, 2014, EXP CELL RES, V329, P18, DOI 10.1016/j.yexcr.2014.07.003; Berthold CL, 2009, P NATL ACAD SCI USA, V106, P14247, DOI 10.1073/pnas.0905906106; Bieche I, 2013, INT J CANCER, V133, P2791, DOI 10.1002/ijc.28304; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; BRAUN SA, 1994, EUR J BIOCHEM, V220, P369, DOI 10.1111/j.1432-1033.1994.tb18633.x; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finch KE, 2012, ACS CHEM BIOL, V7, P563, DOI 10.1021/cb200506t; Fontana P, 2017, ELIFE, V6, DOI 10.7554/eLife.28533; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; HATAKEYAMA K, 1986, J BIOL CHEM, V261, P4902; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kasamatsu A, 2011, J BIOL CHEM, V286, P21110, DOI 10.1074/jbc.M111.237636; Kim IK, 2015, J BIOL CHEM, V290, P3775, DOI 10.1074/jbc.M114.624718; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Li XD, 2009, J MOL BIOL, V390, P737, DOI 10.1016/j.jmb.2009.05.031; Mashimo M, 2013, P NATL ACAD SCI USA, V110, P18964, DOI 10.1073/pnas.1312783110; Megnin-Chanet F, 2010, CELL MOL LIFE SCI, V67, P3649, DOI 10.1007/s00018-010-0490-8; MIWA M, 1974, J BIOL CHEM, V249, P3475; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; NORDLUND S, 1984, BIOCHIM BIOPHYS ACTA, V791, P21, DOI 10.1016/0167-4838(84)90276-0; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palazzo L, 2018, ELIFE, V7, DOI 10.7554/eLife.34334; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Tucker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050889; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	45	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12350	12359		10.1074/jbc.RA118.003586	http://dx.doi.org/10.1074/jbc.RA118.003586			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29907568	Green Published, hybrid			2022-12-28	WOS:000441408500004
J	Kowalski, E; Geng, S; Rathes, A; Lu, R; Li, LW				Kowalski, Elizabeth; Geng, Shuo; Rathes, Allison; Lu, Ran; Li, Liwu			Toll-interacting protein differentially modulates HIF1 and STAT5-mediated genes in fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; inflammation; gene expression; innate immunity; signal transduction	AUTOPHAGIC CLEARANCE; INFLAMMATION; HYPOXIA; DISEASE; BINDING; MACROPHAGES; RESPONSES; ALPHA	Toll-interacting protein (Tollip) deficiency has been implicated in complex inflammatory and infectious diseases whose mechanisms are poorly understood. Comparing the gene expression profiles of WT and Tollip-deficient murine embryonic fibroblasts, we observed here that Tollip deficiency selectively reduces the expression of the inflammatory cytokines interleukin 6 (IL-6), IL-12, and tumor necrosis factor (TNF) but potentiates the expression of fatty acid-binding protein 4 (FABP4) in these cells. We also observed that expression of hypoxia-inducible factor 1- (HIF1) is reduced, whereas that of signal transducer and activator of transcription 5 (STAT5) is elevated, in Tollip-deficient cells, correlating with the decreased expression of inflammatory cytokines and increased expression of FABP4 in these cells. We further found that the coupling of ubiquitin to ER degradation (CUE) domain of Tollip is required for stimulating HIF1 activity, because Tollip CUE-domain mutant cells exhibited reduced levels of HIF1 and selected cytokines. Tollip is known to mediate autophagy and lysosome fusion, and herein we observed that Tollip's autophagy function is required for modulating STAT5 and FABP4 expression. Bafilomycin A, an inhibitor of lysosome fusion, enhanced STAT5 and FABP4 expression in WT fibroblasts, whereas torin 2, an activator of autophagy, reduced STAT5 and FABP4 expression in Tollip-deficient fibroblasts. Taken together, our study reveals that Tollip differentially modulates HIF1 and STAT5 expression in fibroblasts, potentially explaining the complex and context-dependent contribution of Tollip to disease development.	[Kowalski, Elizabeth; Geng, Shuo; Rathes, Allison; Lu, Ran; Li, Liwu] Virginia Tech, Dept Biol Sci & Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Tech, Dept Biol Sci, 162 Life Sci 1 Bldg,907 Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu	lu, ran/HHC-8613-2022		National Institutes of Health [R01 AI136386, HL115835]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI136386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants R01 AI136386 and HL115835 (to L.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agardh HE, 2013, J CELL MOL MED, V17, P303, DOI 10.1111/jcmm.12011; Andreasen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023999; Ankem G, 2011, BIOCHEM J, V435, P597, DOI 10.1042/BJ20102160; Baker B, 2015, J BIOL CHEM, V290, P6670, DOI 10.1074/jbc.M114.611442; Bertsch S, 2011, SHOCK, V35, P266, DOI 10.1097/SHK.0b013e3181fd068c; Chen KQ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004078; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Chmiest D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13476; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Ferreira JV, 2013, AUTOPHAGY, V9, P1349, DOI 10.4161/auto.25190; Hu FL, 2014, ANN RHEUM DIS, V73, P928, DOI 10.1136/annrheumdis-2012-202444; Huang C, 2016, CLIN EXP ALLERGY, V46, P1549, DOI 10.1111/cea.12793; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Jaber N, 2013, ANN NY ACAD SCI, V1280, P48, DOI 10.1111/nyas.12026; Kalliolias GD, 2010, J IMMUNOL, V185, P7047, DOI 10.4049/jimmunol.1001290; Kasivisvanathan V, 2011, CURR VASC PHARMACOL, V9, P333, DOI 10.2174/157016111795495602; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sohn C, 2015, ARTHRITIS RHEUMATOL, V67, P86, DOI 10.1002/art.38871; Spath GF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000381; Steen KA, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00282-16; Suojalehto H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127003; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Xu HL, 2016, MOL ENDOCRINOL, V30, P325, DOI 10.1210/me.2015-1301; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	37	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12239	12247		10.1074/jbc.RA118.003382	http://dx.doi.org/10.1074/jbc.RA118.003382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29921584	Green Published, hybrid			2022-12-28	WOS:000440803200021
J	Kritsiligkou, P; Rand, JD; Weids, AJ; Wang, XM; Kershaw, CJ; Grant, CM				Kritsiligkou, Paraskevi; Rand, Jonathan D.; Weids, Alan J.; Wang, Ximeng; Kershaw, Chris J.; Grant, Chris M.			Endoplasmic reticulum (ER) stress-induced reactive oxygen species (ROS) are detrimental for the fitness of a thioredoxin reductase mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); thioredoxin; peroxiredoxin; reactive oxygen species (ROS); redox regulation	UNFOLDED PROTEIN RESPONSE; YEAST SACCHAROMYCES-CEREVISIAE; YAP-1 TRANSCRIPTIONAL REGULATION; CHRONOLOGICAL LIFE-SPAN; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; GLUTATHIONE-REDUCTASE; SIGNAL-TRANSDUCTION; TSA1 PEROXIREDOXIN; REDOX REGULATION	The unfolded protein response (UPR) is constitutively active in yeast thioredoxin reductase mutants, suggesting a link between cytoplasmic thiol redox control and endoplasmic reticulum (ER) oxidative protein folding. The unique oxidative environment of the ER lumen requires tight regulatory control, and we show that the active UPR depends on the presence of oxidized thioredoxins rather than arising because of a loss of thioredoxin function. Preventing activation of the UPR by deletion of HAC1, encoding the UPR transcription factor, rescues a number of thioredoxin reductase mutant phenotypes, including slow growth, shortened longevity, and oxidation of the cytoplasmic GSH pool. This is because the constitutive UPR in a thioredoxin reductase mutant results in the generation of hydrogen peroxide. The oxidation of thioredoxins in a thioredoxin reductase mutant requires aerobic metabolism and the presence of the Tsa1 and Tsa2 peroxiredoxins, indicating that a complete cytoplasmic thioredoxin system is crucial for maintaining ER redox homeostasis.	[Kritsiligkou, Paraskevi; Rand, Jonathan D.; Weids, Alan J.; Wang, Ximeng; Kershaw, Chris J.; Grant, Chris M.] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England; [Kritsiligkou, Paraskevi] German Canc Res Ctr, Div Redox Regulat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	University of Manchester; Helmholtz Association; German Cancer Research Center (DKFZ)	Grant, CM (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Div Mol & Cellular Funct, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	chris.grant@manchester.ac.uk	Kritsiligkou, Paraskevi/W-9399-2019	Kritsiligkou, Paraskevi/0000-0003-2452-141X; Kershaw, Christopher/0000-0001-6625-7894; Grant, Chris/0000-0002-0616-6576	Biotechnology and Biological Sciences Research (BBSRC) Council [BB/M020770/1, BB/P005594/1]; BBSRC; BBSRC [BB/P005594/1, BB/M020770/1] Funding Source: UKRI; MRC [MR/L011840/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research (BBSRC) Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Biotechnology and Biological Sciences Research (BBSRC) Council Project Grants BB/M020770/1 and BB/P005594/1 (to C. M. G.) and a BBSRC funded studentship (to A. J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044278; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Brandes N, 2013, ELIFE, V2, DOI 10.7554/eLife.00306; Brown JD, 2013, CELL REP, V5, P1425, DOI 10.1016/j.celrep.2013.10.036; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Costello J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0559-z; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Deponte M, 2015, BIOL CHEM, V396, P401, DOI 10.1515/hsz-2014-0280; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Ellgaard L, 2018, TRENDS BIOCHEM SCI, V43, P32, DOI 10.1016/j.tibs.2017.10.006; GAN ZR, 1991, J BIOL CHEM, V266, P1692; Garrido EO, 2002, MOL MICROBIOL, V43, P993, DOI 10.1046/j.1365-2958.2002.02795.x; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Izawa S, 1999, J BIOL CHEM, V274, P28459, DOI 10.1074/jbc.274.40.28459; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kimata Y, 2006, GENES CELLS, V11, P59, DOI 10.1111/j.1365-2443.2005.00921.x; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Leichert LI, 2015, BIOL CHEM, V396, P389, DOI 10.1515/hsz-2014-0314; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Machado AK, 1997, J BIOL CHEM, V272, P17045, DOI 10.1074/jbc.272.27.17045; Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; Morgan B, 2016, NAT CHEM BIOL, V12, P437, DOI [10.1038/NCHEMBIO.2067, 10.1038/nchembio.2067]; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; MULLER EGD, 1991, J BIOL CHEM, V266, P9194; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Netto LES, 2016, MOL CELLS, V39, P65, DOI 10.14348/molcells.2016.2349; Ocampo A, 2011, MECH AGEING DEV, V132, P315, DOI 10.1016/j.mad.2011.06.007; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Pearson GD, 1998, J BIOL CHEM, V273, P5431, DOI 10.1074/jbc.273.10.5431; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Pincus D, 2014, P NATL ACAD SCI USA, V111, P14800, DOI 10.1073/pnas.1409588111; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Poet GJ, 2017, EMBO J, V36, P693, DOI 10.15252/embj.201695336; Ragu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108123; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Sideri TC, 2010, P NATL ACAD SCI USA, V107, P6394, DOI 10.1073/pnas.1000347107; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Stocker S, 2018, ANTIOXID REDOX SIGN, V28, P558, DOI 10.1089/ars.2017.7162; Swalwell H, 2012, FREE RADICAL BIO MED, V52, P626, DOI 10.1016/j.freeradbiomed.2011.11.019; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Trotter EW, 2005, EUKARYOT CELL, V4, P392, DOI 10.1128/EC.4.2.392-400.2005; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Weids AJ, 2014, J CELL SCI, V127, P1327, DOI 10.1242/jcs.144022; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200	76	20	20	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					11984	11995		10.1074/jbc.RA118.001824	http://dx.doi.org/10.1074/jbc.RA118.001824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29871930	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000440803200002
J	Sharma, S; Arunachalam, PS; Menon, M; Ragupathy, V; Satya, RV; Jebaraj, J; Aralaguppe, SG; Rao, C; Pal, S; Saravanan, S; Murugavel, KG; Balakrishnan, P; Solomon, S; Hewlett, I; Ranga, U				Sharma, Shilpee; Arunachalam, Prabhu S.; Menon, Malini; Ragupathy, Viswanath; Satya, Ravi Vijaya; Jebaraj, Joshua; Aralaguppe, Shambhu Ganeshappa; Rao, Chaitra; Pal, Sreshtha; Saravanan, Shanmugam; Murugavel, Kailapuri G.; Balakrishnan, Pachamuthu; Solomon, Suniti; Hewlett, Indira; Ranga, Udaykumar			PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); infectious disease; viral DNA; viral protein; viral replication; Gag; HIV-1C; NGS; PTAP duplication; Replication advantage	IMMUNODEFICIENCY-VIRUS TYPE-1; LONG TERMINAL REPEAT; PRIMER-BINDING SITE; LATE DOMAIN; DRUG-NAIVE; IN-VIVO; ANTIRETROVIRAL THERAPY; VIRAL PARTICLES; SOUTH-AFRICA; SEQUENCE	HIV-1 subtype C (HIV-1C) may duplicate longer amino acid stretches in the p6 Gag protein, leading to the creation of an additional Pro-Thr/Ser-Ala-Pro (PTAP) motif necessary for viral packaging. However, the biological significance of a duplication of the PTAP motif for HIV-1 replication and pathogenesis has not been experimentally validated. In a longitudinal study of two different clinical cohorts of select HIV-1 seropositive, drug-naive individuals from India, we found that 8 of 50 of these individuals harbored a mixed infection of viral strains discordant for the PTAP duplication. Conventional and next-generation sequencing of six primary viral quasispecies at multiple time points disclosed that in a mixed infection, the viral strains containing the PTAP duplication dominated the infection. The dominance of the double-PTAP viral strains over a genetically similar single-PTAP viral clone was confirmed in viral proliferation and pairwise competition assays. Of note, in the proximity ligation assay, double-PTAP Gag proteins exhibited a significantly enhanced interaction with the host protein tumor susceptibility gene 101 (Tsg101). Moreover, Tsg101 overexpression resulted in a biphasic effect on HIV-1C proliferation, an enhanced effect at low concentration and an inhibitory effect only at higher concentrations, unlike a uniformly inhibitory effect on subtype B strains. In summary, our results indicate that the duplication of the PTAP motif in the p6 Gag protein enhances the replication fitness of HIV-1C by engaging the Tsg101 host protein with a higher affinity. Our results have implications for HIV-1 pathogenesis, especially of HIV-1C.	[Sharma, Shilpee; Arunachalam, Prabhu S.; Menon, Malini; Jebaraj, Joshua; Aralaguppe, Shambhu Ganeshappa; Rao, Chaitra; Pal, Sreshtha; Ranga, Udaykumar] Jawaharlal Nehru Ctr Adv Sci Res, HIV AIDS Lab, Bengaluru 56006, India; [Ragupathy, Viswanath; Hewlett, Indira] US FDA, Off Blood Review & Res, Ctr Biol Evaluat & Res, Div Emerging & Transmission Transmitted Dis,Lab M, Silver Spring, MD 20993 USA; [Satya, Ravi Vijaya] GRAIL Inc, Menlo Pk, CA 94025 USA; [Saravanan, Shanmugam; Murugavel, Kailapuri G.; Balakrishnan, Pachamuthu; Solomon, Suniti] Y R Gaitonde Ctr AIDS Res & Educ, Chennai 600113, Tamil Nadu, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); US Food & Drug Administration (FDA)	Ranga, U (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, HIV AIDS Lab, Bengaluru 56006, India.	udaykumar@jncasr.ac.in	Saravanan, Shanmugam/GOG-9024-2022; Sharma, Shilpee/AAA-8379-2022; Aralaguppe, Shambhu/AAU-4474-2020; Ragupathy, Viswanath/ABA-3444-2021; Balakrishnan, Pachamuthu/ABV-6282-2022	Saravanan, Shanmugam/0000-0002-5991-8022; Balakrishnan, Pachamuthu/0000-0002-1710-9155; Sharma, Shilpee/0000-0003-4645-9442; Rao, Chaitra/0000-0002-2834-7458	Department of Science and Technology, Government of India [DST/INT/SAFR/MEGA-P(5)/2011]; Jawaharlal Nehru Centre for Advanced Scientific Research	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India))	This work was supported in part by Grant DST/INT/SAFR/MEGA-P(5)/2011 from Department of Science and Technology, Government of India (to U.R.), and intramural funds from Jawaharlal Nehru Centre for Advanced Scientific Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and the Food and Drug Administration (FDA).	Abraha Awet, 2005, Methods Mol Biol, V304, P355; Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Bachu M, 2012, J BIOL CHEM, V287, P44714, DOI 10.1074/jbc.M112.397158; Bachu M, 2012, AIDS RES HUM RETROV, V28, P1362, DOI 10.1089/aid.2011.0388; Bano AS, 2009, J GEN VIROL, V90, P2768, DOI 10.1099/vir.0.011080-0; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bilodeau PS, 1999, J VIROL, V73, P9764, DOI 10.1128/JVI.73.12.9764-9772.1999; Boullosa J, 2014, VIRUSES-BASEL, V6, P2495, DOI 10.3390/v6062495; Brumme ZL, 2003, ANTIVIR THER, V8, P91; Cao J, 2008, J VIROL, V82, P495, DOI 10.1128/JVI.01096-07; Chang SY, 1999, AIDS RES HUM RETROV, V15, P1591, DOI 10.1089/088922299309892; Chang SY, 1999, AIDS RES HUM RETROV, V15, P1703, DOI 10.1089/088922299309748; CHECROUNE F, 1995, J ACQ IMMUN DEF SYND, V10, P1; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chopera DR, 2012, J VIROL, V86, P13423, DOI 10.1128/JVI.02171-12; Colgrove RC, 2005, AIDS RES HUM RETROV, V21, P191, DOI 10.1089/aid.2005.21.191; de Arellano ER, 2006, AIDS REV, V8, P9; De Baar MP, 2000, AIDS RES HUM RETROV, V16, P499; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Dettenhofer M, 1999, J VIROL, V73, P4696, DOI 10.1128/JVI.73.6.4696-4704.1999; Flys T, 2005, AIDS RES HUM RETROV, V21, P739, DOI 10.1089/aid.2005.21.739; Fun A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-63; Gallego O, 2003, HIV CLIN TRIALS, V4, P372, DOI 10.1310/X618-KWKJ-WCTQ-LQ2L; Gallego O, 2003, J CLIN MICROBIOL, V41, P1245, DOI 10.1128/JCM.41.3.1245-1247.2003; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Guimaraes AP, 2008, AIDS RES HUM RETROV, V24, P967, DOI 10.1089/aid.2008.0020; Hahn S, 2011, J IMMUNOL, V186, P5706, DOI 10.4049/jimmunol.1003764; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2005, AIDS RES HUM RETROV, V21, P886, DOI 10.1089/aid.2005.21.886; Ibe S, 2003, MICROBIOL IMMUNOL, V47, P71, DOI 10.1111/j.1348-0421.2003.tb02788.x; Josephs TM, 2017, BIOL CHEM, V398, P1027, DOI 10.1515/hsz-2016-0305; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lastere S, 2004, ANTIVIR THER, V9, P221; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Marlowe N, 2004, AIDS RES HUM RETROV, V20, P1119, DOI 10.1089/aid.2004.20.1119; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martins AN, 2016, J VIROL, V90, P768, DOI 10.1128/JVI.01640-15; Martins AN, 2011, AIDS RES HUM RETROV, V27, P687, DOI [10.1089/AID.2010.0282, 10.1089/aid.2010.0282]; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Neogi U, 2016, AIDS RES HUM RETROV, V32, P80, DOI [10.1089/aid.2015.0266, 10.1089/AID.2015.0266]; Neogi U, 2011, AIDS RES HUM RETROV, V27, P1249, DOI [10.1089/aid.2011.0078, 10.1089/AID.2011.0078]; Neogi U, 2009, INDIAN J EXP BIOL, V47, P424; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Ntale RS, 2012, J VIROL, V86, P12013, DOI 10.1128/JVI.00539-12; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters S, 2001, J VIROL, V75, P9644, DOI 10.1128/JVI.75.20.9644-9653.2001; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Prescher J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004677; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Resh MD, 2005, AIDS REV, V7, P84; Rossi AH, 2013, AIDS RES HUM RETROV, V29, P1056, DOI [10.1089/aid.2012.0311, 10.1089/AID.2012.0311]; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sharma S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2184-4; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Simon V, 2003, NAT REV MICROBIOL, V1, P181, DOI 10.1038/nrmicro772; Song YH, 2007, ARCH VIROL, V152, P1553, DOI 10.1007/s00705-007-0973-6; Sood V, 2008, AIDS, V22, P1683, DOI 10.1097/QAD.0b013e3282f56114; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Swanstrom R., 1997, P263; Tamiya S, 2004, J VIROL, V78, P12030, DOI 10.1128/JVI.78.21.12030-12040.2004; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	81	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11687	11708		10.1074/jbc.M117.815829	http://dx.doi.org/10.1074/jbc.M117.815829			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29773649	Green Published, hybrid			2022-12-28	WOS:000440134500004
J	Hsu, AT; Lupancu, TJ; Lee, MC; Fleetwood, AJ; Cook, AD; Hamilton, JA; Achuthan, A				Hsu, Amy T.; Lupancu, Tanya J.; Lee, Ming-Chin; Fleetwood, Andrew J.; Cook, Andrew D.; Hamilton, John A.; Achuthan, Adrian			Epigenetic and transcriptional regulation of IL4-induced CCL17 production in human monocytes and murine macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon regulatory factor (IRF); STAT transcription factor; signal transduction; epigenetics; monocyte; macrophage; chemokine; cytokine; dendritic cell; interleukin	COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; ALTERNATIVE ACTIVATION; GM-CSF; GENE-EXPRESSION; IN-VIVO; INFLAMMATION; POLARIZATION; DIFFERENTIATION	Interleukin 4 (IL4) is generally viewed as a Th2 cytokine capable of polarizing macrophages into an anti-inflammatory phenotype, whereas granulocyte macrophage-colony-stimulating factor (GM-CSF) is often viewed as a proinflammatory cytokine with part of this function due to its action on monocytes/macrophages. Paradoxically, these two cytokines act additively to enhance the in vitro differentiation of dendritic cells from precursors such as monocytes. One up-regulated marker of an IL4-polarized M2 macrophage is the chemokine (C-C motif) ligand 17 (CCL17), which we have recently reported to be induced by GM-CSF in monocytes/macrophages in an interferon regulatory factor 4 (IRF4)-dependent manner. In this study, we report that IL4 also induces CCL17 production by acting through IRF4 in human monocytes and murine macrophages. Furthermore, evidence is presented that IL4 up-regulates IRF4 expression at the epigenetic level by enhancing the expression and activity of jumonji domain-containing protein 3 (JMJD3) demethylase. Intriguingly, silencing the signal transducer and activator of transcription 6 (STAT6) gene led to a decrease in not only CCL17 formation, but also in that of its upstream regulators, JMJD3 and IRF4. Moreover, IL4 treatment of human monocytes resulted in an increased association of STAT6 to the promoter regions of the CCL17, IRF4, and JMJD3 genes. Thus, despite their vastly different functions, IL4 and GM-CSF appear to share elements of a common signaling pathway in regulating CCL17 production in human monocytes and murine macrophages.	[Hsu, Amy T.; Lupancu, Tanya J.; Lee, Ming-Chin; Fleetwood, Andrew J.; Cook, Andrew D.; Hamilton, John A.; Achuthan, Adrian] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; [Hamilton, John A.] Univ Melbourne, Australian Inst Musculoskeletal Sci AIMSS, St Albans, Vic 3021, Australia; [Hamilton, John A.] Western Hlth, St Albans, Vic 3021, Australia	Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Achuthan, A (corresponding author), Royal Melbourne Hosp, 4th Fl,Clin Sci Bldg, Parkville, Vic 3050, Australia.	aaa@unimelb.edu.au	Achuthan, Adrian/K-7281-2015; Fleetwood, Andrew/AAB-4743-2019; Achuthan, Adrian/S-3931-2019	Achuthan, Adrian/0000-0003-3640-2338; Fleetwood, Andrew/0000-0002-6803-3533; Achuthan, Adrian/0000-0003-3640-2338; Lee, Kevin Ming-Chin/0000-0002-6609-3524; Hsu, Amy/0000-0002-9873-0719	National Health and Medical Research Council of Australia; Research Grant Support Scheme from the University of Melbourne	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Research Grant Support Scheme from the University of Melbourne	This work was supported by grants from the National Health and Medical Research Council of Australia (to J. A. H. and A. D. C), and a Research Grant Support Scheme from the University of Melbourne (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Achuthan A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0332-4; Achuthan A, 2016, J CLIN INVEST, V126, P3453, DOI 10.1172/JCI87828; Alferink J, 2003, J EXP MED, V197, P585, DOI 10.1084/jem.20021859; Borriello F, 2015, EUR J IMMUNOL, V45, P2042, DOI 10.1002/eji.201445303; Bowdridge S, 2010, NAT IMMUNOL, V11, P879, DOI 10.1038/ni1010-879; CHEUNG DL, 1992, BLOOD, V79, P1972; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P821, DOI 10.1016/j.imbio.2010.05.031; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; HAMILTON JA, 1992, IMMUNOLOGY, V76, P566; HAMILTON JA, 1994, J LEUKOCYTE BIOL, V55, P355; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton JA, 2017, NAT REV DRUG DISCOV, V16, P53, DOI 10.1038/nrd.2016.231; Hamilton JA, 2015, EXPERT REV CLIN IMMU, V11, P457, DOI 10.1586/1744666X.2015.1024110; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; Hayashida S, 2011, J DERMATOL SCI, V61, P180, DOI 10.1016/j.jdermsci.2010.10.013; Hemmerle T, 2014, P NATL ACAD SCI USA, V111, P12008, DOI 10.1073/pnas.1402783111; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lehtonen A, 2002, J LEUKOCYTE BIOL, V71, P511; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Liddiard K, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-45; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; MUI ALF, 1995, J LEUKOCYTE BIOL, V57, P799, DOI 10.1002/jlb.57.5.799; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Semnani RT, 2011, INFECT IMMUN, V79, P3957, DOI 10.1128/IAI.05191-11; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Vento-Tormo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0863-2; Weigel BJ, 2002, BLOOD, V100, P4169, DOI 10.1182/blood-2002-04-1063; Weiss M, 2015, P NATL ACAD SCI USA, V112, P11001, DOI 10.1073/pnas.1506254112; Wirnsberger G, 2006, EUR J IMMUNOL, V36, P1882, DOI 10.1002/eji.200635972	43	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11415	11423		10.1074/jbc.RA118.002416	http://dx.doi.org/10.1074/jbc.RA118.002416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871928	Green Published, hybrid			2022-12-28	WOS:000439449700012
J	Klychnikov, OI; Shamorkina, TM; Weeks, SD; van Leeuwen, HC; Corver, J; Drijfhout, JW; van Veelen, PA; Sluchanko, NN; Strelkov, SV; Hensbergen, PJ				Klychnikov, Oleg I.; Shamorkina, Tatiana M.; Weeks, Stephen D.; van Leeuwen, Hans C.; Corver, Jeroen; Drijfhout, Jan W.; van Veelen, Peter A.; Sluchanko, Nikolai N.; Strelkov, Sergei V.; Hensbergen, Paul J.			Discovery of a new Pro-Pro endopeptidase, PPEP-2, provides mechanistic insights into the differences in substrate specificity within the PPEP family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-DIFFICILE; STRUCTURAL BASIS; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; PROTEASES; SORTASE; IDENTIFICATION; ENDOPROTEASE; DEGRADATION; PEPTIDES	Pro-Pro endopeptidases (PPEPs) belong to a recently discovered family of proteases capable of hydrolyzing a Pro-Pro bond. The first member from the bacterial pathogen Clostridium difficile (PPEP-1) cleaves two C. difficile cell-surface proteins involved in adhesion, one of which is encoded by the gene adjacent to the ppep-1 gene. However, related PPEPs may exist in other bacteria and may shed light on substrate specificity in this enzyme family. Here, we report on the homolog of PPEP-1 in Paenibacillus alvei, which we denoted PPEP-2. We found that PPEP-2 is a secreted metalloprotease, which likewise cleaved a cell-surface protein encoded by an adjacent gene. However, the cleavage motif of PPEP-2, PLPPVP, is distinct from that of PPEP-1 (VNPPVP). As a result, an optimal substrate peptide for PPEP-2 was not cleaved by PPEP-1 and vice versa. To gain insight into the specificity mechanism of PPEP-2, we determined its crystal structure at 1.75 resolution and further confirmed the structure in solution using small-angle X-ray scattering (SAXS). We show that a four-amino-acid loop, which is distinct in PPEP-1 and -2 (GGST in PPEP-1 and SERV in PPEP-2), plays a crucial role in substrate specificity. A PPEP-2 variant, in which the four loop residues had been swapped for those from PPEP-1, displayed a shift in substrate specificity toward PPEP-1 substrates. Our results provide detailed insights into the PPEP-2 structure and the structural determinants of substrate specificity in this new family of PPEP proteases.	[Klychnikov, Oleg I.; Weeks, Stephen D.; Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, B-3000 Leuven, Belgium; [Shamorkina, Tatiana M.; van Veelen, Peter A.; Hensbergen, Paul J.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, POB 9600, NL-2300 RC Leiden, Netherlands; [van Leeuwen, Hans C.; Corver, Jeroen] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 Leiden, Netherlands; [Drijfhout, Jan W.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 Leiden, Netherlands; [Sluchanko, Nikolai N.] Russian Acad Sci, Fed Res Ctr Biotechnol, AN Bach Inst Biochem, Moscow 119071, Russia; [Sluchanko, Nikolai N.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Biophys, Moscow 119991, Russia	KU Leuven; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Hensbergen, PJ (corresponding author), Leiden Univ, Med Ctr, Ctr Prote & Metabol, POB 9600, NL-2300 RC Leiden, Netherlands.	P.Hensbergen@lumc.nl	Klychnikov, Oleg I./AAN-6167-2020; Weeks, Stephen/N-4813-2019; Sluchanko, Nikolai/R-4110-2016; Weeks, Stephen D/G-6150-2017; Drijfhout, Jan Wouter/ABA-6318-2021	Klychnikov, Oleg I./0000-0002-0383-9237; Weeks, Stephen/0000-0002-1360-0852; Sluchanko, Nikolai/0000-0002-8608-1416; Weeks, Stephen D/0000-0002-1360-0852; Drijfhout, Jan Wouter/0000-0003-4808-5296; Shamorkina, Tatiana/0000-0002-4191-6061; Corver, Jeroen/0000-0002-9262-5475; Hensbergen, Paul/0000-0002-3193-5445; van Veelen, Peter/0000-0002-7898-9408	Department of Pharmaceutical and Pharmacological Sciences of KU Leuven	Department of Pharmaceutical and Pharmacological Sciences of KU Leuven	This work was supported in part by funds from the Department of Pharmaceutical and Pharmacological Sciences of KU Leuven. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balog CIA, 2010, MOL CELL PROTEOMICS, V9, P667, DOI 10.1074/mcp.M900537-MCP200; Banerjee G, 2017, BIOTECHNOL GENET ENG, V33, P119, DOI 10.1080/02648725.2017.1408256; Bondt A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27955; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Chen AGY, 2011, RNA, V17, P1967, DOI 10.1261/rna.2757311; Corver J, 2017, MOL MICROBIOL, V105, P663, DOI 10.1111/mmi.13736; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; Donahue EH, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0219-1; Aguilar JGD, 2018, FOOD RES INT, V103, P253, DOI 10.1016/j.foodres.2017.10.044; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Friebe S, 2016, TOXINS, V8, DOI 10.3390/toxins8030069; Grady EN, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0603-7; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Heirbaut M, 2016, ARCH BIOCHEM BIOPHYS, V610, P41, DOI 10.1016/j.abb.2016.10.002; Hensbergen PJ, 2015, FEBS LETT, V589, P3952, DOI 10.1016/j.febslet.2015.10.027; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Hiemstra HS, 1997, P NATL ACAD SCI USA, V94, P10313, DOI 10.1073/pnas.94.19.10313; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Janesch B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076566; Kasana RC, 2011, CRIT REV MICROBIOL, V37, P262, DOI 10.3109/1040841X.2011.577029; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Kirk JA, 2017, MICROB BIOTECHNOL, V10, P76, DOI 10.1111/1751-7915.12372; Klein T, 2018, CHEM REV, V118, P261, DOI 10.1021/acs.chemrev.7b00120; Krishnan V, 2013, ACTA CRYSTALLOGR D, V69, P1073, DOI 10.1107/S0907444913004642; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Marshall NC, 2017, MOL CELL PROTEOMICS, V16, pS161, DOI 10.1074/mcp.O116.066456; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Peltier J, 2015, J BIOL CHEM, V290, P24453, DOI 10.1074/jbc.M115.665091; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rey M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30980; Rubino JT, 2016, J BIOL INORG CHEM, V21, P185, DOI 10.1007/s00775-015-1319-6; Schacherl M, 2015, STRUCTURE, V23, P1632, DOI 10.1016/j.str.2015.06.018; Schradert CU, 2017, MOL CELL PROTEOMICS, V16, P1162, DOI 10.1074/mcp.M116.066803; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tack GJ, 2013, WORLD J GASTROENTERO, V19, P5837, DOI 10.3748/wjg.v19.i35.5837; Talamantes D, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0538-6; Tonry JH, 2012, CELL MICROBIOL, V14, P1219, DOI 10.1111/j.1462-5822.2012.01791.x; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; van Leeuwen HC, 2014, FEBS LETT, V588, P4325, DOI 10.1016/j.febslet.2014.09.041; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Vergnolle N, 2016, GUT, V65, P1215, DOI 10.1136/gutjnl-2015-309147; Walden M, 2015, ELIFE, V4, DOI 10.7554/eLife.06638; Wang YC, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0802-8; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Yang YH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004169; Yiallouros I, 2000, FEBS LETT, V484, P224, DOI 10.1016/S0014-5793(00)02163-3	61	5	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11154	11165		10.1074/jbc.RA118.003244	http://dx.doi.org/10.1074/jbc.RA118.003244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794027	Green Published, hybrid			2022-12-28	WOS:000438882800027
J	van Eijk, M; Rynkiewicz, MJ; Khatri, K; Leymarie, N; Zaia, J; White, MR; Hartshorn, KL; Cafarella, TR; van Die, I; Hessing, M; Seaton, BA; Haagsman, HP				van Eijk, Martin; Rynkiewicz, Michael J.; Khatri, Kshitij; Leymarie, Nancy; Zaia, Joseph; White, Mitchell R.; Hartshorn, Kevan L.; Cafarella, Tanya R.; van Die, Irma; Hessing, Martin; Seaton, Barbara A.; Haagsman, Henk P.			Lectin-mediated binding and sialoglycans of porcine surfactant protein D synergistically neutralize influenza A virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host-pathogen interaction; innate immunity; influenza virus; collectin; N-linked glycosylation; sialic acid; antiviral agent; structural biology; drug design; viral immunology; porcine immunology; pulmonary defense; recombinant protein; surfactant protein D	CARBOHYDRATE-RECOGNITION DOMAIN; COLLISION-INDUCED DISSOCIATION; STRUCTURAL-CHARACTERIZATION; ANTIINFLUENZA ACTIVITY; ANTIVIRAL ACTIVITY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; IMMUNE-RESPONSE; N-GLYCOSYLATION; LUNG	Innate immunity is critical in the early containment of influenza A virus (IAV) infection, and surfactant protein D (SP-D) plays a crucial role in the pulmonary defense against IAV. In pigs, which are important intermediate hosts during the generation of pandemic IAVs, SP-D uses its unique carbohydrate recognition domain (CRD) to interact with IAV. An N-linked CRD glycosylation provides interactions with the sialic acid-binding site of IAV, and a tripeptide loop at the lectin-binding site facilitates enhanced interactions with IAV glycans. Here, to investigate both mechanisms of IAV neutralization in greater detail, we produced an N-glycosylated neck-CRD fragment of porcine SP-D (RpNCRD) in HEK293 cells. X-ray crystallography disclosed that the N-glycan did not alter the CRD backbone structure, including the lectin site conformation, but revealed a potential second nonlectin-binding site for glycans. IAV hemagglutination inhibition, IAV aggregation, and neutralization of IAV infection studies showed that RpNCRD, unlike the human analogue RhNCRD, exhibits potent neutralizing activity against pandemic A/Aichi/68 (H3N2), enabled by both porcine-specific structural features of its CRD. MS analysis revealed an N-glycan site-occupancy of >98% at Asn-303 of RpNCRD with complex-type, heterogeneously branched and predominantly (2,3)-sialylated oligosaccharides. Glycan-binding array data characterized both RpNCRD and RhNCRD as mannose-type lectins. RpNCRD also bound Lewis(Y) structures, whereas RhNCRD bound polylactosamine-containing glycans. The presence of the N-glycan in the CRD increases the glycan-binding specificity of RpNCRD. These insights increase our understanding of porcine-specific innate defense against pandemic IAV and may inform the design of recombinant SP-D-based antiviral drugs.	[van Eijk, Martin; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Rynkiewicz, Michael J.; Cafarella, Tanya R.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [White, Mitchell R.; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Khatri, Kshitij; Leymarie, Nancy; Zaia, Joseph] Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA; [van Die, Irma] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 HZ Amsterdam, Netherlands; [Hessing, Martin] U Prot Express BV, Life Sci Incubator, Utrecht Sci Pk,Yalelaan 62, NL-3584 CM Utrecht, Netherlands	Utrecht University; Boston University; Boston University; Boston University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Eijk, M (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands.	m.vaneijk@uu.nl	Khatri, Kshitij/I-7013-2019; Haagsman, Henk P/F-8919-2010; Zaia, Joseph/U-7850-2019	Khatri, Kshitij/0000-0002-6592-869X; Zaia, Joseph/0000-0001-9497-8701; Rynkiewicz, Michael/0000-0002-4717-5700	National Institutes of Health from NIGMS [GM62116]; NATIONAL CANCER INSTITUTE [U01CA221234] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM104603] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010724] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the Protein-Glycan Interaction Core (Emory University School of Medicine, Atlanta, GA) of the Consortium for Functional Glycomics (supported by National Institutes of Health Grant GM62116 from NIGMS) for performing the glycan array analysis.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Appelmelk BJ, 1997, TRENDS MICROBIOL, V5, P70, DOI 10.1016/S0966-842X(96)10084-6; Berg T, 2000, BBA-PROTEIN STRUCT M, V1543, P159, DOI 10.1016/S0167-4838(00)00184-9; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Clark HW, 2016, INFECT IMMUN, V84, P1585, DOI 10.1128/IAI.01239-15; CONBOY JJ, 1992, J AM SOC MASS SPECTR, V3, P804, DOI 10.1016/1044-0305(92)80003-4; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch E, 2011, J BIOL CHEM, V286, P40681, DOI 10.1074/jbc.M111.300673; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Crouch EC, 2006, AM J RESP CELL MOL, V35, P84, DOI 10.1165/rcmb.2005-0462OC; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Goh BC, 2013, BIOCHEMISTRY-US, V52, P8527, DOI 10.1021/bi4010683; GONZALEZ J, 1992, ANAL BIOCHEM, V205, P151, DOI 10.1016/0003-2697(92)90592-U; HAAGSMAN HP, 1991, BIOCHEM J, V275, P273, DOI 10.1042/bj2750273; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1993, J IMMUNOL, V151, P6265; Hartshorn KL, 2003, AM J PHYSIOL-LUNG C, V285, pL1066, DOI 10.1152/ajplung.00057.2003; Hartshorn KL, 2002, BIOCHEM J, V366, P87, DOI 10.1042/BJ20011868; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Hillaire MLB, 2014, VIRUS RES, V181, P22, DOI 10.1016/j.virusres.2013.12.032; Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; JOHNSON RS, 1987, ANAL CHEM, V59, P2621, DOI 10.1021/ac00148a019; Khatri K, 2016, MOL CELL PROTEOMICS, V15, P1895, DOI 10.1074/mcp.M116.058016; Khatri K, 2014, J PROTEOME RES, V13, P4347, DOI 10.1021/pr500506z; Leth-Larsen R, 1999, BIOCHEM J, V343, P645, DOI 10.1042/0264-6021:3430645; Morlot C, 2007, ACTA CRYSTALLOGR D, V63, P961, DOI 10.1107/S0907444907035470; MUNAKATA H, 1982, BIOCHEM BIOPH RES CO, V108, P1401, DOI 10.1016/S0006-291X(82)80062-4; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng WC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732191; Nikolaidis NM, 2014, AM J PHYSIOL-LUNG C, V306, pL1036, DOI 10.1152/ajplung.00035.2014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Reiding KR, 2014, ANAL CHEM, V86, P5784, DOI 10.1021/ac500335t; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Seaton BA, 2010, INNATE IMMUN-LONDON, V16, P143, DOI 10.1177/1753425910368716; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294; Tripathi S, 2015, INNATE IMMUN-LONDON, V21, P73, DOI 10.1177/1753425913508992; van Eijk M, 2004, AM J RESP CELL MOL, V30, P871, DOI 10.1165/rcmb.2003-0355OC; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; van Eijk M, 2002, AM J RESP CELL MOL, V26, P739, DOI 10.1165/ajrcmb.26.6.4520; van Eijk M, 2000, J IMMUNOL, V164, P1442, DOI 10.4049/jimmunol.164.3.1442; van Eijk M, 2012, J BIOL CHEM, V287, P26666, DOI 10.1074/jbc.M112.368571; van Eijk M, 2011, J BIOL CHEM, V286, P20137, DOI 10.1074/jbc.M111.224469; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; World Health Organization, 2016, INFL SEAS	55	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10646	10662		10.1074/jbc.RA117.001430	http://dx.doi.org/10.1074/jbc.RA117.001430			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29769321	Green Published, hybrid			2022-12-28	WOS:000437828400022
J	Kytidou, K; Beekwilder, J; Artola, M; van Meel, E; Wilbers, RHP; Moolenaar, GF; Goosen, N; Ferraz, MJ; Katzy, R; Voskamp, P; Florea, BI; Hokke, CH; Overkleeft, HS; Schots, A; Bosch, D; Pannu, N; Aerts, JMFG				Kytidou, Kassiani; Beekwilder, Jules; Artola, Marta; van Meel, Eline; Wilbers, Ruud H. P.; Moolenaar, Geri F.; Goosen, Nora; Ferraz, Maria J.; Katzy, Rebecca; Voskamp, Patrick; Florea, Bogdan I.; Hokke, Cornelis H.; Overkleeft, Herman S.; Schots, Arjen; Bosch, Dirk; Pannu, Navraj; Aerts, Johannes M. F. G.			Nicotiana benthamiana -galactosidase A1.1 can functionally complement human -galactosidase A deficiency associated with Fabry disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; plant; human; enzyme inhibitor; glycolipid; fluorescence; protein expression; enzyme purification; enzyme structure; -galactosidase; enzyme-replacement therapy; Fabry disease; glycosphingolipids; Nicotiana benthamiana; homologue; lysosomal storage disorder; recombinant enzyme; glycosphingolipid	HUMAN ALPHA-GALACTOSIDASE; ACTIVITY-BASED PROBES; ENZYME REPLACEMENT THERAPY; GLYCOSYL HYDROLASES; BETA-GLUCOSIDASES; AGALSIDASE-ALPHA; GAUCHER-DISEASE; MELON FRUIT; QUANTIFICATION; PURIFICATION	alpha-Galactosidases (EC 3.2.1.22) are retaining glycosidases that cleave terminal -linked galactose residues from glycoconjugate substrates. -Galactosidases take part in the turnover of cell wall-associated galactomannans in plants and in the lysosomal degradation of glycosphingolipids in animals. Deficiency of human -galactosidase A (-Gal A) causes Fabry disease (FD), a heritable, X-linked lysosomal storage disorder, characterized by accumulation of globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3). Current management of FD involves enzyme-replacement therapy (ERT). An activity-based probe (ABP) covalently labeling the catalytic nucleophile of -Gal A has been previously designed to study -galactosidases for use in FD therapy. Here, we report that this ABP labels proteins in Nicotiana benthamiana leaf extracts, enabling the identification and biochemical characterization of an N. benthamiana -galactosidase we name here A1.1 (gene accession ID GJZM-1660). The transiently overexpressed and purified enzyme was a monomer lacking N-glycans and was active toward 4-methylumbelliferyl--d-galactopyranoside substrate (K-m = 0.17 mm) over a broad pH range. A1.1 structural analysis by X-ray crystallography revealed marked similarities with human -Gal A, even including A1.1's ability to hydrolyze Gb3 and lyso-Gb3, which are not endogenous in plants. Of note, A1.1 uptake into FD fibroblasts reduced the elevated lyso-Gb3 levels in these cells, consistent with A1.1 delivery to lysosomes as revealed by confocal microscopy. The ease of production and the features of A1.1, such as stability over a broad pH range, combined with its capacity to degrade glycosphingolipid substrates, warrant further examination of its value as a potential therapeutic agent for ERT-based FD management.	[Kytidou, Kassiani; van Meel, Eline; Ferraz, Maria J.; Katzy, Rebecca; Aerts, Johannes M. F. G.] Leiden Inst Chem, Dept Med Biochem, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Artola, Marta; Florea, Bogdan I.; Overkleeft, Herman S.] Leiden Inst Chem, Dept Bioorgan Synth, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Voskamp, Patrick; Pannu, Navraj] Leiden Inst Chem, Dept Biophys Struct Chem, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Moolenaar, Geri F.; Goosen, Nora] Leiden Inst Chem, Dept Cloning & Prot Purificat Facil, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Beekwilder, Jules; Wilbers, Ruud H. P.; Schots, Arjen; Bosch, Dirk] Wageningen Univ & Res, Plant Sci Grp, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [Hokke, Cornelis H.] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Parasitol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University; Leiden University; Leiden University; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Aerts, JMFG (corresponding author), Leiden Inst Chem, Dept Med Biochem, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.	j.m.f.g.aerts@lic.leidenuniv.nl	Wilbers, Ruud/O-1844-2019; Aerts, Johannes/A-1028-2009; Florea, Bogdan I./AAM-9975-2020; Artola, Marta/AAI-3603-2021; Hokke, Cornelis Hendrik/AAQ-4712-2021; Schots, Arjen/ABF-8014-2020; Beekwilder, Jules/A-6802-2011	Wilbers, Ruud/0000-0003-1149-9268; Aerts, Johannes/0000-0001-8168-2565; Artola, Marta/0000-0002-3051-3902; Hokke, Cornelis Hendrik/0000-0003-3545-7804; Schots, Arjen/0000-0002-6036-7088; Florea, Bogdan Iulius/0000-0001-7114-2266; Katzy, Rebecca Elisabeth/0000-0002-4188-5795; Beekwilder, Jules/0000-0003-3238-4427; Ferraz, Maria Joao/0000-0002-5765-9645	NWO ZonMW [91116025]	NWO ZonMW(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work was supported by NWO ZonMW Grant 91116025. The authors declare that they have no conflicts of interest with the contents of this article.	AERTS JMFG, 1986, CLIN CHIM ACTA, V158, P155, DOI 10.1016/0009-8981(86)90231-7; Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Arends M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182379; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; Blom D, 2003, AM J HUM GENET, V72, P23, DOI 10.1086/345309; CARCHON H, 1975, CARBOHYD RES, V41, P175, DOI 10.1016/S0008-6215(00)87017-2; Carmi N, 2003, PLANT J, V33, P97, DOI 10.1046/j.1365-313X.2003.01609.x; Chandrasekar B, 2014, MOL CELL PROTEOMICS, V13, P2787, DOI 10.1074/mcp.O114.041616; Chien SF, 2008, PLANT MOL BIOL REP, V26, P213, DOI 10.1007/s11105-008-0035-6; Choi L, 2015, NEUROSCI LETT, V594, P163, DOI 10.1016/j.neulet.2015.01.084; Daldoul S, 2012, ACTA PHYSIOL PLANT, V34, P891, DOI 10.1007/s11738-011-0887-5; Desnick R. J., 1995, METAB MOL BASIS INHE; Eng C, 2007, MOL GENET METAB, V92, pS20, DOI 10.1016/j.ymgme.2007.08.044; Ferraz MJ, 2016, FEBS LETT, V590, P716, DOI 10.1002/1873-3468.12104; Ferraz MJ, 2014, BBA-MOL CELL BIOL L, V1841, P811, DOI 10.1016/j.bbalip.2013.11.004; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Gao ZF, 1999, PLANT PHYSIOL, V119, P979, DOI 10.1104/pp.119.3.979; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; HAIBACH F, 1991, BIOCHEM BIOPH RES CO, V181, P1564, DOI 10.1016/0006-291X(91)92117-3; HAMERS MN, 1977, HUM GENET, V36, P289, DOI 10.1007/BF00446279; HENRISSAT B, 1995, BIOCHEM J, V311, P350, DOI 10.1042/bj3110350; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Jiang JB, 2016, ACS CENTRAL SCI, V2, P351, DOI 10.1021/acscentsci.6b00057; Jiang JB, 2015, CHEM SCI, V6, P2782, DOI 10.1039/c4sc03739a; Kallemeijn WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170268; Kallemeijn WW, 2014, J BIOL CHEM, V289, P35351, DOI 10.1074/jbc.M114.593376; Kim WD, 2002, PHYTOCHEMISTRY, V61, P621, DOI 10.1016/S0031-9422(02)00368-0; Kizhner T, 2015, MOL GENET METAB, V114, P259, DOI 10.1016/j.ymgme.2014.08.002; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kytidou K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01026; Lenders M, 2016, J AM SOC NEPHROL, V27, P256, DOI 10.1681/ASN.2014121226; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Maranville E, 2000, ARCH BIOCHEM BIOPHYS, V373, P225, DOI 10.1006/abbi.1999.1532; Marques ARA, 2016, J LIPID RES, V57, P451, DOI 10.1194/jlr.M064923; Marraccini P, 2005, PLANT PHYSIOL BIOCH, V43, P909, DOI 10.1016/j.plaphy.2005.08.010; MATHEW CD, 1987, PHYTOCHEMISTRY, V26, P1299, DOI 10.1016/S0031-9422(00)81798-7; Mirzaian M, 2017, CLIN CHIM ACTA, V466, P178, DOI 10.1016/j.cca.2017.01.014; Mirzaian M, 2016, CLIN CHIM ACTA, V459, P36, DOI 10.1016/j.cca.2016.05.017; Motabar Omid, 2010, Curr Chem Genomics, V4, P67, DOI 10.2174/1875397301004010067; MURALI R, 1994, J MOL BIOL, V239, P578, DOI 10.1006/jmbi.1994.1397; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rezende RM, 2017, SEMIN IMMUNOL, V30, P3, DOI 10.1016/j.smim.2017.07.004; Sakuraba H, 2006, J HUM GENET, V51, P180, DOI 10.1007/s10038-005-0342-9; Sanchez-Nino MD, 2015, HUM MOL GENET, V24, P5720, DOI 10.1093/hmg/ddv291; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Shen JS, 2016, J INHERIT METAB DIS, V39, P293, DOI 10.1007/s10545-015-9886-9; SWEELEY CC, 1963, J BIOL CHEM, V238, P3148; Westerhof LB, 2014, PLANT BIOTECHNOL J, V12, P1333, DOI 10.1111/pbi.12251; Westerhof LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046460; Wilbers RHP, 2017, SCI REP-UK, V7, DOI 10.1038/srep45910; Willems LI, 2014, EUR J ORG CHEM, V2014, P6044, DOI 10.1002/ejoc.201402589; Willems LI, 2014, CHEM-EUR J, V20, P10864, DOI 10.1002/chem.201404014; Willems LI, 2014, J AM CHEM SOC, V136, P11622, DOI 10.1021/ja507040n; Witte MD, 2011, ORG BIOMOL CHEM, V9, P5908, DOI 10.1039/c1ob05531c; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Wu L, 2017, NAT CHEM BIOL, V13, P867, DOI 10.1038/nchembio.2395; Zha HG, 2012, ANN BOT-LONDON, V109, P735, DOI 10.1093/aob/mcr321; ZHU A, 1995, BBA-PROTEIN STRUCT M, V1247, P260, DOI 10.1016/0167-4838(94)00228-9; ZHU A, 1994, GENE, V140, P227, DOI 10.1016/0378-1119(94)90548-7	62	12	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10042	10058		10.1074/jbc.RA118.001774	http://dx.doi.org/10.1074/jbc.RA118.001774			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29674318	Green Published, hybrid			2022-12-28	WOS:000437096700010
J	Chiu, YH; Yang, MR; Wang, LJ; Chen, MH; Chang, GD; Chen, HW				Chiu, Yueh-Ho; Yang, Ming-Ren; Wang, Liang-Jie; Chen, Ming-Hon; Chang, Geen-Dong; Chen, Hungwen			New insights into the regulation of placental growth factor gene expression by the transcription factors GCM1 and DLX3 in human placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						placenta; gene transcription; growth factor; transcription factor; acetylation; DLX3; GCM1; MTF1; PGF; trophoblast	FACTOR-I MTF-1; HUMAN TROPHOBLAST; CELL-DIFFERENTIATION; MISSING 1; PREECLAMPSIA; HYPOXIA; STIMULATION; CONTRIBUTES; MECHANISMS; SYNCYTIN	Expression of placental growth factor (PGF) is closely associated with placental perfusion in early pregnancy. PGF is primarily expressed in placental trophoblasts, and its expression decreases in preeclampsia, associated with placental hypoxia. The transcription factors glial cells missing 1 (GCM1) and metal-regulatory transcription factor 1 (MTF1) have been implicated in the regulation of PGF gene expression through regulatory elements upstream and downstream of the PGF transcription start site, respectively. Here, we clarified the mechanism underlying placenta-specific PGF expression. We demonstrate that GCM1 up-regulates PGF expression through three downstream GCM1-binding sites (GBSs) but not a previously reported upstream GBS. Interestingly, we also found that these downstream GBSs also harbor metal-response elements for MTF1. Surprisingly, however, we observed that MTF1 is unlikely to regulate PGF expression in the placenta because knockdown or overexpression of GCM1, but not MTF1, dramatically decreased PGF expression or reversed the suppression of PGF expression under hypoxia, respectively. We also demonstrate that another transcription factor, Distal-less homeobox 3 (DLX3), interacts with the DNA-binding domain and the first transactivation domain of GCM1 and that this interaction inhibits GCM1-mediated PGF expression. Moreover, the GCM1-DLX3 interaction interfered with CREB-binding protein-mediated GCM1 acetylation and activation. In summary, we have identified several GBSs in the PGF promoter that are highly responsive to GCM1, have demonstrated that MTF1 does not significantly regulate PGF expression in placental cells, and provide evidence that DLX3 inhibits GCM1-mediated PGF expression. Our findings revise the mechanism for GCM1- and DLX3-mediated regulation of PGF gene expression.	[Chiu, Yueh-Ho; Wang, Liang-Jie; Chen, Hungwen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Yang, Ming-Ren; Chen, Ming-Hon; Chang, Geen-Dong; Chen, Hungwen] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei 106, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Chen, HW (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.	hwchen@gate.sinica.edu.tw	Chen, Hungwen/AAC-1394-2022	Chen, Hungwen/0000-0001-7928-0006	Ministry of Science and Technology [103-2311-B-001-024, 106-2311-B-001-013]; Academia Sinica, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by Ministry of Science and Technology Grants 103-2311-B-001-024 and 106-2311-B-001-013 and Academia Sinica, Taiwan (to H.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Baumwell S, 2007, NEPHRON CLIN PRACT, V106, pC72, DOI 10.1159/000101801; Benirschke K., 2001, PATHOLOGY HUMAN PLAC, P42; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cerdeira AS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006585; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chang M, 2008, BIOL REPROD, V78, P841, DOI 10.1095/biolreprod.107.065599; Chau K, 2017, J HUM HYPERTENS, V31, P782, DOI 10.1038/jhh.2017.61; Cheong ML, 2016, MOL CELL BIOL, V36, P197, DOI 10.1128/MCB.00655-15; Chui A, 2012, J MOL MED, V90, P273, DOI 10.1007/s00109-011-0836-1; Cramer M, 2005, BIOL CHEM, V386, P865, DOI 10.1515/BC.2005.101; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; Depoix C, 2011, REPROD SCI, V18, P219, DOI 10.1177/1933719110389337; Dewerchin M, 2014, EXPERT OPIN THER TAR, V18, P1339, DOI 10.1517/14728222.2014.948420; Dube A, 2011, BIOCHEM CELL BIOL, V89, P562, DOI [10.1139/O11-063, 10.1139/o11-063]; GEHRING WJ, 1990, TRENDS GENET, V6, P323, DOI 10.1016/0168-9525(90)90253-3; Gobble RM, 2009, PLACENTA, V30, P869, DOI 10.1016/j.placenta.2009.08.003; Green CJ, 2001, CANCER RES, V61, P2696; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Keryer G, 1998, J CELL SCI, V111, P995; Khaliq A, 1996, GROWTH FACTORS, V13, P243, DOI 10.3109/08977199609003225; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; Li S, 2017, J CELL PHYSIOL, V232, P2900, DOI 10.1002/jcp.25752; Li S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02120-5; Makris A, 2016, HYPERTENSION, V67, P1263, DOI 10.1161/HYPERTENSIONAHA.116.07286; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nishimoto F, 2009, ENDOCRINOLOGY, V150, P1801, DOI 10.1210/en.2008-0949; Schreiber J, 1998, NUCLEIC ACIDS RES, V26, P2337, DOI 10.1093/nar/26.10.2337; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Spradley FT, 2016, HYPERTENSION, V67, P740, DOI 10.1161/HYPERTENSIONAHA.115.06783; Wang LJ, 2012, MOL CELL BIOL, V32, P3707, DOI 10.1128/MCB.00223-12; Welch PC, 2006, AM J OBSTET GYNECOL, V194, P1625, DOI 10.1016/j.ajog.2006.01.012; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Yang CS, 2005, J BIOL CHEM, V280, P10083, DOI 10.1074/jbc.M413986200; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhang H, 2003, CURR BIOL, V13, P1625, DOI 10.1016/j.cub.2003.08.054	38	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9801	9811		10.1074/jbc.RA117.001384	http://dx.doi.org/10.1074/jbc.RA117.001384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743241	Green Published, hybrid			2022-12-28	WOS:000436102300023
J	Freund, JR; Mansfield, CJ; Doghramji, LJ; Adappa, ND; Palmer, JN; Kennedy, DW; Reed, DR; Jiang, PH; Lee, RJ				Freund, Jenna R.; Mansfield, Corrine J.; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Reed, Danielle R.; Jiang, Peihua; Lee, Robert J.			Activation of airway epithelial bitter taste receptors by Pseudomonas aeruginosa quinolones modulates calcium, cyclic-AMP, and nitric oxide signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cilia; mucosal immunology; lung; protein kinase A (PKA); G protein-coupled receptor (GPCR); air-liquid interface; airway surface liquid; chronic rhinosinusitis; mucociliary clearance	UPPER RESPIRATORY-INFECTION; NONPOLYPOID CHRONIC RHINOSINUSITIS; QUORUM-SENSING MOLECULE; SEROUS ACINAR-CELLS; G-PROTEIN; IN-VITRO; FLUID SECRETION; SWEET TASTE; CILIARY MOTILITY; CYSTIC-FIBROSIS	Bitter taste receptors (taste family 2 bitter receptor proteins; T2Rs), discovered in many tissues outside the tongue, have recently become potential therapeutic targets. We have shown previously that airway epithelial cells express several T2Rs that activate innate immune responses that may be important for treatment of airway diseases such as chronic rhinosinusitis. It is imperative to more clearly understand what compounds activate airway T2Rs as well as their full range of functions. T2R isoforms in airway motile cilia (T2R4, -14, -16, and -38) produce bactericidal levels of nitric oxide (NO) that also increase ciliary beating, promoting clearance of mucus and trapped pathogens. Bacterial quorum-sensing acyl-homoserine lactones activate T2Rs and stimulate these responses in primary airway cells. Quinolones are another type of quorum-sensing molecule used by Pseudomonas aeruginosa. To elucidate whether bacterial quinolones activate airway T2Rs, we analyzed calcium, cAMP, and NO dynamics using a combination of fluorescent indicator dyes and FRET-based protein biosensors. T2R-transfected HEK293T cells, several lung epithelial cell lines, and primary sinonasal cells grown and differentiated at the air-liquid interface were tested with 2-heptyl-3-hydroxy-4-quinolone (known as Pseudomonas quinolone signal; PQS), 2,4-dihydroxyquinolone, and 4-hydroxy-2-heptylquinolone (HHQ). In HEK293T cells, PQS activated T2R4, -16, and -38, whereas HHQ activated T2R14. 2,4-Dihydroxyquinolone had no effect. PQS and HHQ increased calcium and decreased both baseline and stimulated cAMP levels in cultured and primary airway cells. In primary cells, PQS and HHQ activated levels of NO synthesis previously shown to be bactericidal. This study suggests that airway T2R-mediated immune responses are activated by bacterial quinolones as well as acyl-homoserine lactones.	[Freund, Jenna R.; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lee, Robert J.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mansfield, Corrine J.; Reed, Danielle R.; Jiang, Peihua] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Monell Chemical Senses Center	Lee, RJ (corresponding author), Hosp Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, 5th Fl,Ste A,3400 Spruce St, Philadelphia, PA 19104 USA.	rjl@pennmedicine.upenn.edu	Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686; Freund, Jenna/0000-0001-8264-8318	National Institutes of Health [R03DC013862, R01DC016309, P30DC011735, S10OD018125]; Cystic Fibrosis Foundation [LEER16G0]; Department of Otorhinolaryngology at the University of Pennsylvania; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC016309, R03DC013862, P30DC011735] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Department of Otorhinolaryngology at the University of Pennsylvania; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by National Institutes of Health Grants R03DC013862 and R01DC016309, Cystic Fibrosis Foundation Grant LEER16G0, and the Department of Otorhinolaryngology at the University of Pennsylvania (to R.J.L.). Genotyping of patient samples was supported by National Institutes of Health Grants P30DC011735 and S10OD018125 (to D.R.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdalla MY, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00176-17; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P783, DOI 10.1002/alr.21803; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P356, DOI 10.1002/alr.21675; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P25, DOI 10.1002/alr.21666; Adappa ND, 2014, INT FORUM ALLERGY RH, V4, P3, DOI 10.1002/alr.21253; Adappa ND, 2013, INT FORUM ALLERGY RH, V3, P184, DOI 10.1002/alr.21140; An SS, 2017, CELL SIGNAL, V41, P82, DOI 10.1016/j.cellsig.2017.02.002; Bedford FL, 2011, PERCEPTION, V40, P1265, DOI 10.1068/p7119; Behrens M, 2018, CHEM BIOL DRUG DES, V91, P422, DOI 10.1111/cbdd.13089; Blalock JE, 2007, BRAIN BEHAV IMMUN, V21, P23, DOI 10.1016/j.bbi.2006.09.004; Blalock JE, 2005, J INTERN MED, V257, P126, DOI 10.1111/j.1365-2796.2004.01441.x; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Calfee MW, 2005, INFECT IMMUN, V73, P878, DOI 10.1128/IAI.73.2.878-882.2005; Cantone E, 2018, LARYNGOSCOPE, V128, pE339, DOI 10.1002/lary.27175; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Cohen SP, 2012, J BIOL CHEM, V287, P41706, DOI 10.1074/jbc.M112.423806; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Diggle SP, 2006, CHEM BIOL, V13, P701, DOI 10.1016/j.chembiol.2006.05.006; Dimova S, 2005, TOXICOL IN VITRO, V19, P107, DOI 10.1016/j.tiv.2004.07.003; Doerner JF, 2015, ELIFE, V4, DOI 10.7554/eLife.11066; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; Dzaman Karolina, 2016, Otolaryngol Pol, V70, P13, DOI 10.5604/00306657.1209438; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Ferencik M, 1997, Bratisl Lek Listy, V98, P187; Ferre S, 2015, TRENDS PHARMACOL SCI, V36, P145, DOI 10.1016/j.tips.2015.01.002; Fowler CJ, 1997, CLIN CHIM ACTA, V265, P247, DOI 10.1016/S0009-8981(97)00139-3; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Gahbauer S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00494; Gaida MM, 2016, ONCOTARGET, V7, P12623, DOI 10.18632/oncotarget.7206; Gaida MM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw004; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Gruber JD, 2016, PEERJ, V4, DOI 10.7717/peerj.1495; Guina T, 2003, P NATL ACAD SCI USA, V100, P2771, DOI 10.1073/pnas.0435846100; Ha DG, 2011, J BACTERIOL, V193, P6770, DOI 10.1128/JB.05929-11; Hansch GM, 2014, J APPL BIOMATER FUNC, V12, P21, DOI 10.5301/jabfm.5000204; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hariri BM, 2017, J BIOL CHEM, V292, P8484, DOI [10.1074/jbc.M116.771949, 10.1074/jbc.m116.771949]; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P261, DOI 10.2500/ajra.2016.30.4331; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; HINGLEY ST, 1986, INFECT IMMUN, V51, P254, DOI 10.1128/IAI.51.1.254-262.1986; Holban AM, 2014, VIRULENCE, V5, P303, DOI 10.4161/viru.27571; HOON MA, 1995, BIOCHEM J, V309, P629, DOI 10.1042/bj3090629; Hotterbeekx A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00106; Huang WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23450; JAIN B, 1995, AM J PHYSIOL-LUNG C, V268, pL911, DOI 10.1152/ajplung.1995.268.6.L911; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; KANTHAKUMAR K, 1993, INFECT IMMUN, V61, P2848, DOI 10.1128/IAI.61.7.2848-2853.1993; Karaman R, 2016, CHEM BIOL DRUG DES, V88, P66, DOI 10.1111/cbdd.12734; Kim DW, 2017, AM J RESP CELL MOL, V56, P762, DOI 10.1165/rcmb.2016-0373OC; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Kuhn C, 2013, METHOD CELL BIOL, V117, P229, DOI 10.1016/B978-0-12-408143-7.00013-X; Kuhn C, 2010, CHEM SENSES, V35, P395, DOI 10.1093/chemse/bjq027; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; Langan KM, 2015, CURR OPIN INFECT DIS, V28, P547, DOI 10.1097/QCO.0000000000000217; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33221; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Lee RJ, 2015, CURR OPIN ALLERGY CL, V15, P14, DOI 10.1097/ACI.0000000000000120; Lee RJ, 2014, J MOL MED, V92, P1235, DOI 10.1007/s00109-014-1222-6; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476; Lee RJ, 2013, AM J RHINOL ALLERGY, V27, P283, DOI 10.2500/ajra.2013.27.3911; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Li F, 2013, MOL HUM REPROD, V19, P349, DOI 10.1093/molehr/gat009; Lin JS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14888; Lin S, 2000, J BIOL CHEM, V275, P17979, DOI 10.1074/jbc.275.24.17979; Liu AMF, 2003, J BIOMOL SCREEN, V8, P39, DOI 10.1177/1087057102239665; Liu YC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01226; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; Maniscalco M, 2007, INFLAMM RES, V56, P58, DOI 10.1007/s00011-006-6111-1; Marcinkiewicz J, 1997, IMMUNOPHARMACOLOGY, V37, P35, DOI 10.1016/S0162-3109(96)00168-3; Maurer S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00369; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; MCLAUGHLIN SK, 1994, PHYSIOL BEHAV, V56, P1157, DOI 10.1016/0031-9384(94)90360-3; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; McMahon DB, 2018, FASEB J, V32, P155, DOI 10.1096/fj.201700114RRR; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mfuna Endam L, 2014, INT FORUM ALLERGY RH, V4, P200, DOI 10.1002/alr.21275; Miyamoto S, 2000, BRIT J PHARMACOL, V130, P650, DOI 10.1038/sj.bjp.0703358; Mody SM, 2000, MOL PHARMACOL, V57, P13; Morales-Soto N, 2018, J BIOL CHEM, V293, P9544, DOI 10.1074/jbc.RA118.002605; Odaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100252; Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455; Ozeck M, 2004, EUR J PHARMACOL, V489, P139, DOI 10.1016/j.ejphar.2004.03.004; Paczkowski JE, 2017, J BIOL CHEM, V292, P4064, DOI 10.1074/jbc.M116.770552; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Pydi SP, 2014, J BIOL CHEM, V289, P25054, DOI 10.1074/jbc.M114.576975; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Reen FJ, 2011, FEMS MICROBIOL ECOL, V77, P413, DOI 10.1111/j.1574-6941.2011.01121.x; Robbins RA, 1997, AM J RESP CRIT CARE, V155, P268, DOI 10.1164/ajrccm.155.1.9001323; Rom DI, 2017, RHINOLOGY, V55, P90, DOI [10.4193/Rhino16.181, 10.4193/Rhin16.181]; Sandau MM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0170-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; SISSON JH, 1995, AM J PHYSIOL-LUNG C, V268, pL596, DOI 10.1152/ajplung.1995.268.4.L596; Sisson JH, 1999, ALCOHOL CLIN EXP RES, V23, P1528, DOI 10.1111/j.1530-0277.1999.tb04677.x; Sisson JH, 2009, ALCOHOL CLIN EXP RES, V33, P610, DOI 10.1111/j.1530-0277.2008.00875.x; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Storch U, 2017, PFLUG ARCH EUR J PHY, V469, P725, DOI 10.1007/s00424-017-1975-1; Stout SL, 2007, J HISTOCHEM CYTOCHEM, V55, P433, DOI 10.1369/jhc.6A7089.2007; Tan J, 2012, J CHEM INF MODEL, V52, P1875, DOI 10.1021/ci300133a; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Tashiro Y, 2013, MICROBES ENVIRON, V28, P13, DOI 10.1264/jsme2.ME12167; Thomas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07256-y; Tipton KA, 2015, MOL MICROBIOL, V96, P670, DOI 10.1111/mmi.12963; Verbeurgt C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181302; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; WEIGENT DA, 1995, J LEUKOCYTE BIOL, V58, P137, DOI 10.1002/jlb.58.2.137; Wen XX, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0183-9; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; Wolfle U, 2016, MOLECULES, V21, DOI 10.3390/molecules21030306; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Woodworth BA, 2007, AM J RHINOL, V21, P533, DOI 10.2500/ajr.2007.21.3068; Workman AD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00624; Workman AD, 2018, J ALLER CL IMM-PRACT, V6, P1078, DOI 10.1016/j.jaip.2017.09.014; Workman AD, 2017, INT FORUM ALLERGY RH, V7, P770, DOI 10.1002/alr.21966; Yamamoto K, 2013, SEMIN CELL DEV BIOL, V24, P240, DOI 10.1016/j.semcdb.2012.08.005; Yan CH, 2017, AM J RHINOL ALLERGY, V31, P85, DOI 10.2500/ajra.2017.31.4424; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhao KQ, 2012, FASEB J, V26, P3178, DOI 10.1096/fj.11-202184	139	54	54	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9824	9840		10.1074/jbc.RA117.001005	http://dx.doi.org/10.1074/jbc.RA117.001005			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29748385	hybrid, Green Published			2022-12-28	WOS:000436102300025
J	Posner, MG; Upadhyay, A; Ishima, R; Kalli, AC; Harris, G; Kremerskothen, J; Sansom, MSP; Crennell, SJ; Bagby, S				Posner, Mareike G.; Upadhyay, Abhishek; Ishima, Rieko; Kalli, Antreas C.; Harris, Gemma; Kremerskothen, Joachim; Sansom, Mark S. P.; Crennell, Susan J.; Bagby, Stefan			Distinctive phosphoinositide- and Ca2+-binding properties of normal and cognitive performance-linked variant forms of KIBRA C2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); crystallography; phosphoinositide; molecular dynamics; analytical ultracentrifugation; calcium-binding protein; Alzheimer disease; -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor; AMPAR); Hippo pathway; membrane trafficking; C2 domain; human cognition; KIBRA; WWC protein family	MOLECULAR-DYNAMICS; STRUCTURE VALIDATION; ALZHEIMERS-DISEASE; MEMBRANE-BINDING; CA2+ BINDING; FORCE-FIELD; MEMORY; ASSOCIATION; POLYMORPHISM; PROTEINS	Kidney- and brain-expressed protein (KIBRA), a multifunctional scaffold protein with around 20 known binding partners, is involved in memory and cognition, organ size control via the Hippo pathway, cell polarity, and membrane trafficking. KIBRA includes tandem N-terminal WW domains, a C2 domain, and motifs for binding atypical PKC and PDZ domains. A naturally occurring human KIBRA variant involving residue changes at positions 734 (Met-to-Ile) and 735 (Ser-to-Ala) within the C2 domain affects cognitive performance. We have elucidated 3D structures and calcium- and phosphoinositide-binding properties of human KIBRA C2 domain. Both WT and variant C2 adopt a canonical type I topology C2 domain fold. Neither Ca2+ nor any other metal ion was bound to WT or variant KIBRA C2 in crystal structures, and Ca2+ titration produced no significant reproducible changes in NMR spectra. NMR and X-ray diffraction data indicate that KIBRA C2 binds phosphoinositides via an atypical site involving -strands 5, 2, 1, and 8. Molecular dynamics simulations indicate that KIBRA C2 interacts with membranes via primary and secondary sites on the same domain face as the experimentally identified phosphoinositide-binding site. Our results indicate that KIBRA C2 domain association with membranes is calcium-independent and involves distinctive C2 domain-membrane relative orientations.	[Posner, Mareike G.; Upadhyay, Abhishek; Crennell, Susan J.; Bagby, Stefan] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Ishima, Rieko] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Kalli, Antreas C.] Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England; [Kalli, Antreas C.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Harris, Gemma] Rutherford Appleton Lab, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Kremerskothen, Joachim] Univ Hosp Munster, Internal Med D, Dept Nephrol Hypertens & Rheumatol, D-48149 Munster, Germany; [Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Bath; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Leeds; University of Leeds; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Munster; University of Oxford	Bagby, S (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bsssb@bath.ac.uk	Posner, Mareike/AGK-4002-2022	Posner, Mareike/0000-0002-3156-3071; Bagby, Stefan/0000-0003-2302-9511; Kalli, Antreas/0000-0001-7156-9403; Harris, Gemma/0000-0002-4587-4620	Biotechnology and Biological Sciences Research Council [BB/J008176/1]; BBSRC [BB/J008176/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/J008176/1. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashraf A, 2015, INT J BIOCHEM CELL B, V69, P20, DOI 10.1016/j.biocel.2015.10.001; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Coudevylle N, 2008, J BIOL CHEM, V283, P35918, DOI 10.1074/jbc.M804094200; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Dai H, 2004, NAT STRUCT MOL BIOL, V11, P844, DOI 10.1038/nsmb817; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duning K, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.49; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrer-Orta C, 2017, P NATL ACAD SCI USA, V114, pE5343, DOI 10.1073/pnas.1702542114; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Heitz FD, 2016, NEUROBIOL LEARN MEM, V135, P100, DOI 10.1016/j.nlm.2016.07.028; Hermann A, 2018, HEPATOLOGY, V67, P1546, DOI 10.1002/hep.29647; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Johannsen S, 2008, NEUROSCIENCE, V155, P1165, DOI 10.1016/j.neuroscience.2008.06.054; Kalli AC, 2014, BIOCHEM SOC T, V42, P1418, DOI 10.1042/BST20140144; Kawai E, 2015, NEUROMOL MED, V17, P170, DOI 10.1007/s12017-015-8348-8; Khanal P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21828-6; Kremerskothen J, 2005, J NEUROCHEM, V92, P597, DOI 10.1111/j.1471-4159.2004.02888.x; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Ling JJ, 2018, NEUROSCI LETT, V662, P77, DOI 10.1016/j.neulet.2017.08.057; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Meliambro K, 2017, J BIOL CHEM, V292, P21137, DOI 10.1074/jbc.M117.819029; Milnik A, 2012, AM J MED GENET B, V159B, P958, DOI 10.1002/ajmg.b.32101; Montaville P, 2008, PROTEIN SCI, V17, P1025, DOI 10.1110/ps.073326608; Montaville P, 2007, J BIOL CHEM, V282, P5015, DOI 10.1074/jbc.M606746200; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Ochoa WF, 2002, J MOL BIOL, V320, P277, DOI 10.1016/S0022-2836(02)00464-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Picas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6647; Piras IS, 2017, HIPPOCAMPUS, V27, P784, DOI 10.1002/hipo.22731; Posner MG, 2009, FEBS J, V276, P4012, DOI 10.1111/j.1742-4658.2009.07110.x; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tracy TE, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600224; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Vogt-Eisele A, 2014, J NEUROCHEM, V128, P686, DOI 10.1111/jnc.12480; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wennmann DO, 2014, MOL BIOL EVOL, V31, P1710, DOI 10.1093/molbev/msu115; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Willsey AJ, 2017, NEURON, V94, P486, DOI 10.1016/j.neuron.2017.04.024; Wilson KE, 2016, GENES-BASEL, V7, DOI 10.3390/genes7060023; Yamamoto E, 2016, STRUCTURE, V24, P1421, DOI 10.1016/j.str.2016.06.002; Yoshihama Y, 2011, CURR BIOL, V21, P705, DOI 10.1016/j.cub.2011.03.029; Yoshihama Y, 2009, BIOSCI BIOTECH BIOCH, V73, P147, DOI 10.1271/bbb.80564; Zhang L, 2014, CELL SIGNAL, V26, P1392, DOI 10.1016/j.cellsig.2014.02.023; Zhang NNN, 2017, CEREB CORTEX, V27, P4797, DOI 10.1093/cercor/bhw276	72	4	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9335	9344		10.1074/jbc.RA118.002279	http://dx.doi.org/10.1074/jbc.RA118.002279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29724824	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000435441400019
J	Kolsch, A; Hejazi, M; Stieger, KR; Feifel, SC; Kern, JF; Muh, F; Lisdat, F; Lokstein, H; Zouni, A				Koelsch, Adrian; Hejazi, Mahdi; Stieger, Kai R.; Feifel, Sven C.; Kern, Jan F.; Mueh, Frank; Lisdat, Fred; Lokstein, Heiko; Zouni, Athina			Insights into the binding behavior of native and non-native cytochromes to photosystem I from Thermosynechococcus elongatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION-CENTER; FLASH KINETIC-ANALYSIS; FAST-ELECTRON TRANSFER; PLASTOCYANIN; PROTEIN; C(6); ELECTROSTATICS; COMPLEX; PEROXIDASE; CRYSTALLIZATION	The binding of photosystem I (PS I) from Thermosynechococcus elongatus to the native cytochrome (cyt) c(6) and cyt c from horse heart (cyt c(HH)) was analyzed by oxygen consumption measurements, isothermal titration calorimetry (ITC), and rigid body docking combined with electrostatic computations of binding energies. Although PS I has a higher affinity for cyt c(HH) than for cyt c(6), the influence of ionic strength and pH on binding is different in the two cases. ITC and theoretical computations revealed the existence of unspecific binding sites for cyt c(HH) besides one specific binding site close to P 700. Binding to PS I was found to be the same for reduced and oxidized cyt c(HH). Based on this information, suitable conditions for cocrystallization of cyt c(HH) with PS I were found, resulting in crystals with a PS I: cyt c(HH) ratio of 1: 1. A crystal structure at 3.4-angstrom resolution was obtained, but cyt c(HH) cannot be identified in the electron density map because of unspecific binding sites and/or high flexibility at the specific binding site. Modeling the binding of cyt c 6 to PS I revealed a specific binding site where the distance and orientation of cyt c(6) relative to P-700 are comparable with cyt c 2 from purple bacteria relative to P-870. This work provides new insights into the binding modes of different cytochromes to PS I, thus facilitating steps toward solving the PS I-cyt c costructure and a more detailed understanding of natural electron transport processes.	[Koelsch, Adrian; Hejazi, Mahdi; Zouni, Athina] Humboldt Univ, Biophys Photosynth, Inst Biol, Philippstr 13, D-10115 Berlin, Germany; [Stieger, Kai R.; Feifel, Sven C.; Lisdat, Fred] Univ Appl Sci Wildau, Inst Appl Life Sci, Biosyst Technol, Hochschulring 1, D-15745 Wildau, Germany; [Kern, Jan F.] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Mueh, Frank] Johannes Kepler Univ Linz, Dept Theoret Biophys, Inst Theoret Phys, Altenberger Str 69, A-4040 Linz, Austria; [Lokstein, Heiko] Charles Univ Prague, Dept Chem Phys & Opt, Ke Karlovu 3, CZ-12116 Prague 2, Czech Republic	Humboldt University of Berlin; University of Applied Sciences Wildau; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Johannes Kepler University Linz; Charles University Prague	Kolsch, A; Zouni, A (corresponding author), Humboldt Univ, Biophys Photosynth, Inst Biol, Philippstr 13, D-10115 Berlin, Germany.	koelscha@hu-berlin.de; athina.zouni@hu-berlin.de	Lokstein, Heiko/AAK-1930-2021; Lokstein, Heiko/P-2788-2019; Kern, Jan/G-2586-2013	Lokstein, Heiko/0000-0001-6739-4612; Kern, Jan/0000-0002-7272-1603	Bundesministerium fur Bildung and Forschung (BMBF), Germany [031A154B]; Deutsche Forschungsgemeinschaft through the cluster of excellence "Unifying Concepts in Catalysis" [E2/E3]; Czech Science Foundation (Grantova Agentura Ceske Republiky) [P501/12/G055]	Bundesministerium fur Bildung and Forschung (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft through the cluster of excellence "Unifying Concepts in Catalysis"(German Research Foundation (DFG)); Czech Science Foundation (Grantova Agentura Ceske Republiky)	This work was supported in part by the Bundesministerium fur Bildung and Forschung (BMBF), Germany (Biotechnologie 2020+, Project 031A154B) and the Deutsche Forschungsgemeinschaft through the cluster of excellence "Unifying Concepts in Catalysis" coordinated by the Technische Universitat Berlin (Project E2/E3). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Czech Science Foundation (Grantova Agentura Ceske Republiky) Grant P501/12/G055.	Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Axelrod HL, 2002, J MOL BIOL, V319, P501, DOI 10.1016/S0022-2836(02)00168-7; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bernal-Bayard P, 2015, BBA-BIOENERGETICS, V1847, P1549, DOI 10.1016/j.bbabio.2015.09.006; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Diaz-Moreno I, 2005, J BIOL CHEM, V280, P7925, DOI 10.1074/jbc.M412422200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Drepper F, 1996, BIOCHEMISTRY-US, V35, P1282, DOI 10.1021/bi951471e; El-Mohsnawy E, 2010, BIOCHEMISTRY-US, V49, P4740, DOI 10.1021/bi901807p; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fromme P, 1998, BBA-BIOENERGETICS, V1365, P175, DOI 10.1016/S0005-2728(98)00059-0; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Golub M, 2017, PHOTOSYNTH RES, V133, P163, DOI 10.1007/s11120-017-0342-6; Guergova-Kuras M, 2001, P NATL ACAD SCI USA, V98, P4437, DOI 10.1073/pnas.081078898; HAEHNEL W, 1989, J CELL BIOL, V108, P1397, DOI 10.1083/jcb.108.4.1397; HATANAKA H, 1993, BIOCHIM BIOPHYS ACTA, V1141, P45, DOI 10.1016/0005-2728(93)90187-K; HERVAS M, 1994, BBA-BIOENERGETICS, V1184, P235, DOI 10.1016/0005-2728(94)90228-3; HERVAS M, 1992, EUR J BIOCHEM, V203, P115, DOI 10.1111/j.1432-1033.1992.tb19835.x; HERVAS M, 1995, BIOCHEMISTRY-US, V34, P11321, DOI 10.1021/bi00036a004; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lubner CE, 2011, P NATL ACAD SCI USA, V108, P20988, DOI 10.1073/pnas.1114660108; MALMGREN L, 1978, BRAIN RES, V153, P477, DOI 10.1016/0006-8993(78)90333-5; Mazor Y, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.14; MOSER CC, 1988, BIOCHEMISTRY-US, V27, P2450, DOI 10.1021/bi00407a031; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Muh F, 2005, BBA-BIOENERGETICS, V1708, P219, DOI 10.1016/j.bbabio.2005.03.005; Mukherjee D, 2011, J COLLOID INTERF SCI, V358, P477, DOI 10.1016/j.jcis.2011.03.070; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Navarro JA, 2000, PHOTOSYNTH RES, V65, P63, DOI 10.1023/A:1006404621724; Nguyen K, 2017, PHOTOSYNTH RES, V131, P79, DOI 10.1007/s11120-016-0300-8; Nowaczyk MM, 2016, NAT CHEM BIOL, V12, P990, DOI 10.1038/nchembio.2240; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Pettigrew GW, 2003, BIOCHEMISTRY-US, V42, P2046, DOI 10.1021/bi027125w; POULOS TL, 1987, J BIOL CHEM, V262, P13881; Proux-Delrouyre V, 2003, J AM CHEM SOC, V125, P13686, DOI 10.1021/ja0363819; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; Shimada S, 2017, EMBO J, V36, P291, DOI 10.15252/embj.201695021; Sommer F, 2004, J BIOL CHEM, V279, P20009, DOI 10.1074/jbc.M313986200; Sommer F, 2002, J BIOL CHEM, V277, P6573, DOI 10.1074/jbc.M110633200; Stieger KR, 2016, J MATER CHEM A, V4, P17009, DOI 10.1039/c6ta07141d; Stieger KR, 2016, NANOSCALE, V8, P10695, DOI 10.1039/c6nr00097e; Stieger KR, 2014, PHYS CHEM CHEM PHYS, V16, P15667, DOI 10.1039/c4cp00935e; Utschig LM, 2011, J AM CHEM SOC, V133, P16334, DOI 10.1021/ja206012r; van Thor JJ, 1999, BIOCHEMISTRY-US, V38, P12735, DOI 10.1021/bi9903502; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; Zygadlo A, 2005, BBA-BIOENERGETICS, V1708, P154, DOI 10.1016/j.bbabio.2005.02.003	59	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9090	9100		10.1074/jbc.RA117.000953	http://dx.doi.org/10.1074/jbc.RA117.000953			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29695502	Green Published, hybrid			2022-12-28	WOS:000434941900030
J	Damasceno, FC; Condeles, AL; Lopes, AKB; Facci, RR; Linares, E; Truzzi, DR; Augusto, O; Toledo, JC				Damasceno, Fernando Cruvinel; Condeles, Andre Luis; Bueno Lopes, Angelica Kodama; Facci, Romulo Rodrigues; Linares, Edlaine; Truzzi, Daniela Ramos; Augusto, Ohara; Toledo, Jose Carlos, Jr.			The labile iron pool attenuates peroxynitrite-dependent damage and can no longer be considered solely a pro-oxidative cellular iron source	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitric oxide; nitrosative stress; nitrosylation; oxidative stress; superoxide ion; chelatable iron pool; Fenton; hydrogen peroxide; labile iron pool; peroxynitrite	NITRIC-OXIDE; CHELATABLE IRON; HYDROGEN-PEROXIDE; COMPLEX-FORMATION; FERRIC IRON; ISONICOTINOYL HYDRAZONE; MANGANESE PORPHYRINS; SUPEROXIDE-DISMUTASE; MEDIATED OXIDATION; CARBON-DIOXIDE	The ubiquitous cellular labile iron pool (LIP) is often associated with the production of the highly reactive hydroxyl radical, which forms through a redox reaction with hydrogen peroxide. Peroxynitrite is a biologically relevant peroxide produced by the recombination of nitric oxide and superoxide. It is a strong oxidant that may be involved in multiple pathological conditions, but whether and how it interacts with the LIP are unclear. Here, using fluorescence spectroscopy, we investigated the interaction between the LIP and peroxynitrite by monitoring peroxynitrite-dependent accumulation of nitrosated and oxidized fluorescent intracellular indicators. We found that, in murine macrophages, removal of the LIP with membrane-permeable iron chelators sustainably accelerates the peroxynitrite-dependent oxidation and nitrosation of these indicators. These observations could not be reproduced in cell-free assays, indicating that the chelator-enhancing effect on peroxynitrite-dependent modifications of the indicators depended on cell constituents, presumably including LIP, that react with these chelators. Moreover, neither free nor ferrous-complexed chelators stimulated intracellular or extracellular oxidative and nitrosative chemistries. On the basis of these results, LIP appears to be a relevant and competitive cellular target of peroxynitrite or its derived oxidants, and thereby it reduces oxidative processes, an observation that may change the conventional notion that the LIP is simply a cellular source of pro-oxidant iron.	[Damasceno, Fernando Cruvinel; Condeles, Andre Luis; Bueno Lopes, Angelica Kodama; Facci, Romulo Rodrigues; Toledo, Jose Carlos, Jr.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil; [Facci, Romulo Rodrigues; Linares, Edlaine; Truzzi, Daniela Ramos; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Toledo, JC (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil.	toledo@ffclrp.usp.br	Damasceno, Fernando Cruvinel/P-7029-2019; Toledo, Jose C/J-4360-2015; Linares, Edlaine/AAR-8753-2020; Truzzi, Daniela R/B-2540-2014; Augusto, Ohara/D-3839-2012	Damasceno, Fernando Cruvinel/0000-0002-3814-2712; Linares, Edlaine/0000-0001-8164-3013; Truzzi, Daniela R/0000-0003-4421-9621; Augusto, Ohara/0000-0002-7220-4286; Toledo Junior, Jose Carlos/0000-0003-0818-0846	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/00550-2, 2013/07937-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2010/00550-2 and 2013/07937-8. The authors declare that they have no conflicts of interest with the contents of this article.	Alamdari DH, 2005, FREE RADICAL BIO MED, V39, P1362, DOI 10.1016/j.freeradbiomed.2005.06.023; AUGUSTO O, 1994, ARCH BIOCHEM BIOPHYS, V310, P118, DOI 10.1006/abbi.1994.1147; Balavoine GGA, 1997, NITRIC OXIDE-BIOL CH, V1, P507, DOI 10.1006/niox.1997.0153; Balcerczyk A, 2007, FREE RADICAL RES, V41, P563, DOI 10.1080/10715760601175353; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bonini MG, 2001, J BIOL CHEM, V276, P9749, DOI 10.1074/jbc.M008456200; Bonini MG, 1999, J BIOL CHEM, V274, P10802, DOI 10.1074/jbc.274.16.10802; Breuer W, 1996, FEBS LETT, V382, P304, DOI 10.1016/0014-5793(96)00190-1; Breuer W, 1997, FEBS LETT, V403, P213, DOI 10.1016/S0014-5793(97)00056-2; Briviba K, 1998, CHEM RES TOXICOL, V11, P1398, DOI 10.1021/tx980086y; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Carballal S, 2014, BBA-GEN SUBJECTS, V1840, P768, DOI 10.1016/j.bbagen.2013.07.005; Coddington JW, 1999, J AM CHEM SOC, V121, P2438, DOI 10.1021/ja982887t; Collins HL, 2002, J IMMUNOL, V168, P3458, DOI 10.4049/jimmunol.168.7.3458; Crow JP, 2000, FREE RADICAL BIO MED, V28, P1487, DOI 10.1016/S0891-5849(00)00249-5; Damasceno FC, 2014, FREE RADICAL BIO MED, V77, P270, DOI 10.1016/j.freeradbiomed.2014.09.012; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; DUBOIS JE, 1992, INORG CHEM, V31, P853, DOI 10.1021/ic00031a030; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Espey MG, 2002, P NATL ACAD SCI USA, V99, P11127, DOI 10.1073/pnas.152157599; Exner M, 2000, CHEM RES TOXICOL, V13, P287, DOI 10.1021/tx990201k; Feelisch M., 1996, METHODS NITRIC OXIDE, P455; Ferrer-Sueta G, 2002, METHOD ENZYMOL, V349, P23, DOI 10.1016/S0076-6879(02)49318-4; Ferrer-Sueta G, 1999, CHEM RES TOXICOL, V12, P442, DOI 10.1021/tx980245d; Ferrer-Sueta G, 2006, FREE RADICAL BIO MED, V41, P503, DOI 10.1016/j.freeradbiomed.2006.04.028; Fritsche G, 2001, J INFECT DIS, V183, P1388, DOI 10.1086/319860; Furtmuller PG, 2005, BIOCHEM BIOPH RES CO, V337, P944, DOI 10.1016/j.bbrc.2005.09.138; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Gerasimov OV, 1999, INORG CHEM, V38, P4317, DOI 10.1021/ic990384y; Goldstein S, 1997, NITRIC OXIDE-BIOL CH, V1, P417, DOI 10.1006/niox.1997.0142; GOLDSTEIN S, 1995, INORG CHEM, V34, P4041, DOI 10.1021/ic00120a006; HAMED MY, 1983, INORG CHIM A-BIOINOR, V80, P237, DOI 10.1016/S0020-1693(00)91289-1; HAMED MY, 1983, INORG CHIM A-BIOINOR, V78, P1, DOI 10.1016/S0020-1693(00)86480-4; HAMED MY, 1983, INORG CHIM A-BIOINOR, V80, P115, DOI 10.1016/S0020-1693(00)91271-4; Herold S, 2003, CHEM RES TOXICOL, V16, P390, DOI 10.1021/tx025595l; ISCHIROPOULOS H, 1995, FEBS LETT, V364, P279, DOI 10.1016/0014-5793(95)00307-U; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Li Q, 2014, J BIOL CHEM, V289, P19917, DOI 10.1074/jbc.M114.569764; Li Q, 2009, NITRIC OXIDE-BIOL CH, V21, P69, DOI 10.1016/j.niox.2009.04.001; Lobysheva II, 1999, BIOCHEMISTRY-MOSCOW+, V64, P153; Lomonosova EE, 1998, FREE RADICAL BIO MED, V24, P522, DOI 10.1016/S0891-5849(97)00295-5; Lu CY, 2005, J BIOL INORG CHEM, V10, P732, DOI 10.1007/s00775-005-0019-z; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; Martins D, 2015, FREE RADICAL BIO MED, V85, P138, DOI 10.1016/j.freeradbiomed.2015.04.010; Masumoto H, 1996, CHEM RES TOXICOL, V9, P262, DOI 10.1021/tx950115u; Masumoto K, 1996, FEBS LETT, V398, P179, DOI 10.1016/S0014-5793(96)01237-9; MCDONALD CC, 1965, J AM CHEM SOC, V87, P3319, DOI 10.1021/ja01093a007; Meczynska S, 2008, HEMOGLOBIN, V32, P157, DOI 10.1080/03630260701699821; OTTOLENGHI M, 1968, J PHYS CHEM-US, V72, P593, DOI 10.1021/j100848a600; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Pantopoulos K., 1995, BIOL NITRIC OXIDE EN, P24; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; PONKA P, 1979, BIOCHIM BIOPHYS ACTA, V586, P278, DOI 10.1016/0304-4165(79)90100-4; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sergent O, 1997, HEPATOLOGY, V25, P122, DOI 10.1002/hep.510250123; SHI MM, 1994, J BIOL CHEM, V269, P26512; Shimanovich R, 2001, ARCH BIOCHEM BIOPHYS, V387, P307, DOI 10.1006/abbi.2000.2247; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Simunek T, 2005, J MOL CELL CARDIOL, V39, P345, DOI 10.1016/j.yjmcc.2005.05.008; Spasojevic I, 2007, FREE RADICAL BIO MED, V42, P1193, DOI 10.1016/j.freeradbiomed.2007.01.019; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Toledo JC, 2011, FREE RADICAL BIO MED, V50, P1032, DOI 10.1016/j.freeradbiomed.2011.02.020; Trujillo M, 2008, METHOD ENZYMOL, V441, P173, DOI 10.1016/S0076-6879(08)01210-X; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j	72	13	14	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8530	8542		10.1074/jbc.RA117.000883	http://dx.doi.org/10.1074/jbc.RA117.000883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29661935	Green Published, hybrid			2022-12-28	WOS:000434205700017
J	Py, B; Gerez, C; Huguenot, A; Vidaud, C; Fontecave, M; de Choudens, SO; Barras, F				Py, Beatrice; Gerez, Catherine; Huguenot, Allison; Vidaud, Claude; Fontecave, Marc; de Choudens, Sandrine Ollagnier; Barras, Frederic			The ErpA/NfuA complex builds an oxidation-resistant Fe-S cluster delivery pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron-sulfur protein; Escherichia coli (E; coli); oxidative stress; isoprenoid; protein-protein interaction; metal ion-protein interaction	IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; MONOTHIOL GLUTAREDOXINS; ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; 4FE-4S CLUSTERS; IN-VIVO; PROTEINS; MATURATION; BIOGENESIS	Fe-S cluster-containing proteins occur in most organisms, wherein they assist in myriad processes from metabolism to DNA repair via gene expression and bioenergetic processes. Here, we used both in vitro and in vivo methods to investigate the capacity of the four Fe-S carriers, NfuA, SufA, ErpA, and IscA, to fulfill their targeting role under oxidative stress. Likewise, Fe-S clusters exhibited varying half-lives, depending on the carriers they were bound to; an NfuA-bound Fe-S cluster was more stable (t(1/2) = 100 min) than those bound to SufA (t(1/2) = 55 min), ErpA (t(1/2) = 54 min), or IscA (t(1/2) = 45 min). Surprisingly, the presence of NfuA further enhanced stability of the ErpA-bound cluster to t(1/2) = 90 min. Using genetic and plasmon surface resonance analyses, we showed that NfuA and ErpA interacted directly with client proteins, whereas IscA or SufA did not. Moreover, NfuA and ErpA interacted with one another. Given all of these observations, we propose an architecture of the Fe-S delivery network in which ErpA is the last factor that delivers cluster directly to most if not all client proteins. NfuA is proposed to assist ErpA under severely unfavorable conditions. A comparison with the strategy employed in yeast and eukaryotes is discussed.	[Py, Beatrice; Huguenot, Allison; Barras, Frederic] Inst Microbiol Mediterranee, F-13009 Marseille, France; [Py, Beatrice; Huguenot, Allison; Barras, Frederic] CNRS, UMR 7283, LCB, 31 Chemin Joseph Aiguier, F-13009 Marseille, France; [Py, Beatrice; Huguenot, Allison; Barras, Frederic] Aix Marseille Univ, F-13007 Marseille, France; [Gerez, Catherine; de Choudens, Sandrine Ollagnier] Univ Grenoble Alpes, F-38400 St Martin Dheres, France; [Gerez, Catherine; de Choudens, Sandrine Ollagnier] CNRS, UMR 5249, LCBM, F-38054 Grenoble, France; [Gerez, Catherine; de Choudens, Sandrine Ollagnier] CEA, DRF, BIG, CBM,BioCat, F-38054 Grenoble, France; [Vidaud, Claude] CEA, DRF, BIAM, F-30200 Marcoule, France; [Fontecave, Marc] Paris Sci & Lettres PSL Res Univ, Univ Paris 06, UPMC, CNRS,Lab Chim Proc Biol,UMR 8229,Coll France, F-75252 Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite	Py, B (corresponding author), CNRS, UMR 7283, LCB, Inst Microbiol Mediterranee, 31 Chemin Joseph Aiguier, F-13009 Marseille, France.; Barras, F (corresponding author), Inst Pasteur, Dept Microbiol, 25-28 Rue Dr Roux, F-75015 Paris, France.	py@imm.cnrs.fr; barras@imm.cnrs.fr	VIDAUD, Claude/AGX-9878-2022	Ollagnier de Choudens, Sandrine/0000-0002-0080-6659; Barras, Frederic/0000-0003-3458-2574	CNRS; ANR (FeStress); Institut Universitaire de France; CEA; Aix-Marseille Universite; Universite Joseph Fourier	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (FeStress)(French National Research Agency (ANR)); Institut Universitaire de France; CEA(French Atomic Energy Commission); Aix-Marseille Universite; Universite Joseph Fourier	This work was supported by grants from CNRS, ANR (FeStress), the Institut Universitaire de France, CEA, Aix-Marseille Universite, and the Universite Joseph Fourier. The authors declare that they have no conflicts of interest with the contents of this article.	Alhebshi A, 2012, MOL BIOL CELL, V23, P3582, DOI 10.1091/mbc.E12-05-0413; Andreini C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171279; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balk J, 2014, ANNU REV PLANT BIOL, V65, P125, DOI 10.1146/annurev-arplant-050213-035759; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Beilschmidt LK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15124; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Blanc B, 2015, BBA-MOL CELL RES, V1853, P1436, DOI 10.1016/j.bbamcr.2014.12.009; Boutigny S, 2013, J BIOL CHEM, V288, P14200, DOI 10.1074/jbc.M113.460360; Boyd ES, 2014, BIOCHEMISTRY-US, V53, P5834, DOI 10.1021/bi500488r; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Boyd JM, 2008, J BACTERIOL, V190, P4596, DOI 10.1128/JB.00262-08; Brancaccio D, 2014, J AM CHEM SOC, V136, P16240, DOI 10.1021/ja507822j; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FLINT DH, 1993, J BIOL CHEM, V268, P25547; Gao HY, 2013, BIOCHEMISTRY-US, V52, P6633, DOI 10.1021/bi4007622; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Grawert T, 2004, J AM CHEM SOC, V126, P12847, DOI 10.1021/ja0471727; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAGEN KS, 1981, J AM CHEM SOC, V103, P4054, DOI 10.1021/ja00404a013; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; MALKIN R, 1966, BIOCHEM BIOPH RES CO, V23, P822, DOI 10.1016/0006-291X(66)90561-4; Mashruwala AA, 2015, MOL MICROBIOL, V95, P383, DOI 10.1111/mmi.12860; Melber A, 2016, ELIFE, V5, DOI 10.7554/eLife.15991; Milner-White EJ, 2005, ORIGINS LIFE EVOL B, V35, P19, DOI 10.1007/s11084-005-4582-7; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Ollagnier-de Choudens S, 2003, J BIOL CHEM, V278, P17993, DOI 10.1074/jbc.M300285200; Pelzer W, 2000, FEBS LETT, V476, P134, DOI 10.1016/S0014-5793(00)01711-7; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rivasseau C, 2009, PLANT CELL ENVIRON, V32, P82, DOI 10.1111/j.1365-3040.2008.01903.x; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; SANDS RH, 1960, BIOCHEM BIOPH RES CO, V3, P47, DOI 10.1016/0006-291X(60)90101-7; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Vinella D, 2013, MOL MICROBIOL, V87, P493, DOI 10.1111/mmi.12135; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Vogel A., 2000, VOGELS TXB QUANTITAT; Wolff M, 2003, FEBS LETT, V541, P115, DOI 10.1016/S0014-5793(03)00317-X	57	19	19	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7689	7702		10.1074/jbc.RA118.002160	http://dx.doi.org/10.1074/jbc.RA118.002160			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29626095	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000437256500019
J	Goldstone, DC; Baker, EN				Goldstone, David C.; Baker, Edward N.			Stress control for a well-structured life	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TYPHIMURIUM	Aerobic life brings with it a need to respond to external redox stress in ways that preserve key processes. Suppressor of copper sensitivity (Scs) proteins contribute to this response in some bacteria, but have poorly defined molecular functions. Furlong et al. now demonstrate that two Scs proteins from Proteus mirabilis provide a redox relay functionally equivalent to, but structurally distinct from, the Dsb proteins that orchestrate disulfide bonding in Escherichia coli, emphasizing the wide prevalence of this mechanism in bacteria.	[Goldstone, David C.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand	University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz		Goldstone, David/0000-0003-0069-9408				Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Furlong EJ, 2018, J BIOL CHEM, V293, P5793, DOI 10.1074/jbc.RA118.001860; Furlong EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16065; Goldstone DC, 2016, ACTA CRYSTALLOGR D, V72, P40, DOI 10.1107/S2059798315021488; Gupta SD, 1997, J BACTERIOL, V179, P4977, DOI 10.1128/jb.179.16.4977-4984.1997; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Heller WT, 2010, ACTA CRYSTALLOGR D, V66, P1213, DOI [10.1107/S0907444910017658, 10.1107/S090744491001]; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Shepherd M, 2013, ANTIOXID REDOX SIGN, V19, P1494, DOI 10.1089/ars.2012.4939; Williamson JA, 2015, NAT STRUCT MOL BIOL, V22, P809, DOI 10.1038/nsmb.3099	10	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5806	5807		10.1074/jbc.H118.002699	http://dx.doi.org/10.1074/jbc.H118.002699			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29678889	hybrid, Green Published			2022-12-28	WOS:000430497300005
J	Courtade, G; Forsberg, Z; Heggset, EB; Eijsink, VGH; Aachmann, FL				Courtade, Gaston; Forsberg, Zarah; Heggset, Ellinor B.; Eijsink, Vincent G. H.; Aachmann, Finn L.			The carbohydrate-binding module and linker of a modular lytic polysaccharide monooxygenase promote localized cellulose oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLOBIOSE DEHYDROGENASE; THERMOMONOSPORA-FUSCA; HYDROLYTIC EFFICIENCY; NMR-SPECTROSCOPY; PROTEIN DYNAMICS; CHEMICAL-SHIFT; ENZYMES; DOMAIN; DEGRADATION; SUBSTRATE	Lytic polysaccharide monooxygenases (LPMOs) are copper-dependent enzymes that catalyze the oxidative cleavage of polysaccharides such as cellulose and chitin, a feature that makes them key tools in industrial biomass conversion processes. The catalytic domains of a considerable fraction of LPMOs and other carbohydrate-active enzymes (CAZymes) are tethered to carbohydrate-binding modules (CBMs) by flexible linkers. These linkers preclude X-ray crystallographic studies, and the functional implications of these modular assemblies remain partly unknown. Here, we used NMR spectroscopy to characterize structural and dynamic features of full-length modular ScLPMO10C from Streptomyces coelicolor. We observed that the linker is disordered and extended, creating distance between the CBM and the catalytic domain and allowing these domains to move independently of each other. Functional studies with cellulose nanofibrils revealed that most of the substrate-binding affinity of full-length ScLPMO10C resides in the CBM. Comparison of the catalytic performance of full-length ScLPMO10C and its isolated catalytic domain revealed that the CBM is beneficial for LPMO activity at lower substrate concentrations and promotes localized and repeated oxidation of the substrate. 'taken together, these results provide a mechanistic basis for understanding the interplay between catalytic domains linked to CBMs in LPMOs and CAZymes in general.	[Courtade, Gaston; Aachmann, Finn L.] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, NOBIPOL, Sem Saelands Vei 6-8, N-7491 Trondheim, Norway; [Forsberg, Zarah; Eijsink, Vincent G. H.] NMBU Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, N-1432 AS, Norway; [Heggset, Ellinor B.] RISE PFI AS, Hogskoleringen 6b, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Life Sciences	Aachmann, FL (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, NOBIPOL, Sem Saelands Vei 6-8, N-7491 Trondheim, Norway.	finn.l.aachmann@ntnu.no	Forsberg, Zarah/AAM-2395-2020; Heggset, Ellinor/J-4335-2016; Aachmann, Finn Lillelund/G-4136-2015	Heggset, Ellinor/0000-0001-8876-8898; Eijsink, Vincent/0000-0002-9220-8743; Courtade, Gaston/0000-0002-1644-3223; Aachmann, Finn Lillelund/0000-0003-1613-4663	NTNU Norwegian University of Science and Technology; OXYMOD project; Norwegian NMR Platform; FRIPRO project; Research Council of Norway [269408, 226244, 262853]	NTNU Norwegian University of Science and Technology; OXYMOD project; Norwegian NMR Platform; FRIPRO project; Research Council of Norway(Research Council of Norway)	This work was supported by SO funds from NTNU Norwegian University of Science and Technology and by the OXYMOD project, the Norwegian NMR Platform, and an FRIPRO project, all funded by Research Council of Norway Grants 269408, 226244, and 262853, respectively. The authors declare that they have no conflicts of interest with the contents of this article.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Amore A, 2017, P NATL ACAD SCI USA, V114, P13667, DOI 10.1073/pnas.1714249114; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brun E, 1997, BIOCHEMISTRY-US, V36, P16074, DOI 10.1021/bi9718494; CALZA RE, 1985, BIOCHEMISTRY-US, V24, P7797, DOI 10.1021/bi00347a044; Courtade G, 2017, BIOMOL NMR ASSIGN, V11, P257, DOI 10.1007/s12104-017-9759-2; Courtade G, 2017, CARBOHYD RES, V448, P212, DOI 10.1016/j.carres.2017.02.003; Courtade G, 2016, P NATL ACAD SCI USA, V113, P5922, DOI 10.1073/pnas.1602566113; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Czjzek M, 2017, METHODS MOL BIOL, V1588, P239, DOI 10.1007/978-1-4939-6899-2_19; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forsberg Z, 2018, J BIOL CHEM, V293, P1397, DOI 10.1074/jbc.M117.817130; Forsberg Z, 2016, J BIOL CHEM, V291, P7300, DOI 10.1074/jbc.M115.700161; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; FUSHMAN D, 1994, J BIOMOL NMR, V4, P61, DOI 10.1007/BF00178336; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Gomes TCF, 2012, J COMPUT CHEM, V33, P1338, DOI 10.1002/jcc.22959; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harreither W, 2011, APPL ENVIRON MICROB, V77, P1804, DOI 10.1128/AEM.02052-10; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Johansen KS, 2016, BIOCHEM SOC T, V44, P143, DOI 10.1042/BST20150204; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; MCGINNIS K, 1993, BIOCHEMISTRY-US, V32, P8157, DOI 10.1021/bi00083a015; ONG E, 1994, J BACTERIOL, V176, P999, DOI 10.1128/JB.176.4.999-1008.1994; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Poon DKY, 2007, J BIOL CHEM, V282, P2091, DOI 10.1074/jbc.M609670200; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Sheldon RA, 2016, J MOL CATAL A-CHEM, V422, P3, DOI 10.1016/j.molcata.2016.01.013; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Takashima T, 2018, CARBOHYD RES, V458, P52, DOI 10.1016/j.carres.2018.02.004; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	62	62	62	2	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13006	13015		10.1074/jbc.RA118.004269	http://dx.doi.org/10.1074/jbc.RA118.004269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29967065	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000442730200003
J	Hu, WX; Wang, ZM; Zheng, HJ				Hu, Wenxin; Wang, Zhiming; Zheng, Hongjin			Mitochondrial accumulation of amyloid beta (A beta) peptides requires TOMM22 as a main A beta receptor in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						yeast; mitochondria; amyloid- (A); electron microscopy (EM); chromatography; protein-protein interaction; Ni-NTA conjugated nanogold; protein import; Tom22	TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; IMPORT; TOM22; RECOGNITION; DYSFUNCTION; PREPROTEIN; NEURONS; NEURODEGENERATION	Mitochondrial accumulation of intracellular beta-amyloid (A beta) peptides is present in the brains of individuals with Alzheimer's disease (AD) as well as in related mouse models of AD. This accumulation is extremely toxic because A beta disrupts the normal functions of many mitochondrial proteins, resulting in significant mitochondrial dysfunction. Therefore, understanding the mitochondrial accumulation of A beta is useful for future pharmaceutical design of drugs to address mitochondrial dysfunction in AD. However, the detailed molecular mechanism of this accumulation process remains elusive. Here, using yeast mitochondria, we present direct experimental evidence suggesting that A beta is specifically recognized by translocase of outer mitochondrial membrane subunit 22 (Tom22 in yeast; TOMM22 in human), a noncanonical receptor within the mitochondrial protein import machinery, and that this recognition is critical for A beta accumulation in mitochondria. Furthermore, we found that residues 25-42 in the A beta peptide mediate the specific interaction with TOMM22. On the basis of our findings, we propose that cytosolic A beta is recognized by TOMM22; transferred to another translocase subunit, TOMM40; and transported through the TOMM channel into the mitochondria. Our results not only confirm that yeast mitochondria can be used as a model to study mitochondrial dysfunction caused by A beta peptides in AD but also pave the way for future studies of the molecular mechanism of mitochondrial A beta accumulation.	[Hu, Wenxin; Wang, Zhiming; Zheng, Hongjin] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Mail Stop 8101, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Zheng, HJ (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Mail Stop 8101, Aurora, CO 80045 USA.	hongjin.zheng@ucdenver.edu			Boettcher Foundation Webb-Waring Biomedical Research Award	Boettcher Foundation Webb-Waring Biomedical Research Award	This work was supported by the Boettcher Foundation Webb-Waring Biomedical Research Award (to H.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Agostinho P, 2015, J ALZHEIMERS DIS, V45, P329, DOI 10.3233/JAD-142730; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; BROOKSBANK BWL, 1984, DEV BRAIN RES, V16, P37, DOI 10.1016/0165-3806(84)90060-9; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cenini G, 2016, MOL BIOL CELL, V27, P3257, DOI 10.1091/mbc.E16-05-0313; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Crouch PJ, 2008, INT J BIOCHEM CELL B, V40, P181, DOI 10.1016/j.biocel.2007.07.013; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; DuBoff B, 2013, TRENDS NEUROSCI, V36, P325, DOI 10.1016/j.tins.2013.03.002; Hernandez-Zimbron LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042344; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hansson Petersen C. A., 2008, P NATL ACAD SCI USA, V105, P13145, DOI DOI 10.1073/PNAS.0806192105; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Neupert W, 2015, J MOL BIOL, V427, P1135, DOI 10.1016/j.jmb.2015.02.001; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Pinho CM, 2014, BBA-BIOENERGETICS, V1837, P1069, DOI 10.1016/j.bbabio.2014.02.007; Poduslo JF, 2012, BIOCHEMISTRY-US, V51, P3993, DOI 10.1021/bi300275g; Rimmer KA, 2011, J MOL BIOL, V405, P804, DOI 10.1016/j.jmb.2010.11.017; Saitoh T, 2011, BIOCHEMISTRY-US, V50, P5487, DOI 10.1021/bi200470x; Schmidt C, 2008, MOL PSYCHIATR, V13, P953, DOI 10.1038/sj.mp.4002077; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Selfridge JE, 2013, NEUROBIOL DIS, V51, P3, DOI 10.1016/j.nbd.2011.12.057; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Sirk D, 2007, J NEUROCHEM, V103, P1989, DOI 10.1111/j.1471-4159.2007.04907.x; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; YAMAGUCHI H, 1992, ACTA NEUROPATHOL, V85, P15, DOI 10.1007/BF00304629; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200	47	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12681	12689		10.1074/jbc.RA118.002713	http://dx.doi.org/10.1074/jbc.RA118.002713			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29925587	hybrid, Green Published			2022-12-28	WOS:000442203500003
J	Kummarapurugu, AB; Afosah, DK; Sankaranarayanan, NV; Gangji, RN; Zheng, S; Kennedy, T; Rubin, BK; Voynow, JA; Desai, UR				Kummarapurugu, Apparao B.; Afosah, Daniel K.; Sankaranarayanan, Nehru Viji; Gangji, Rahaman Navaz; Zheng, Shuo; Kennedy, Thomas; Rubin, Bruce K.; Voynow, Judith A.; Desai, Umesh R.			Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deoxyribonuclease (DNase); protease; cystic fibrosis; neutrophil; heparin; mucus; CF sputum; neutrophil elastase; competitive inhibition; DNA; ODSH	LUNG; INFLAMMATION; SECRETIONS; CLEARANCE; PROTEASES; CHILDREN	Cystic fibrosis (CF) is a multifactorial disease in which dysfunction of protease-antiprotease balance plays a key role. The current CF therapy relies on dornase , hypertonic saline, and antibiotics and does not address the high neutrophil elastase (NE) activity observed in the lung and sputum of CF patients. Our hypothesis is that variants of heparin, which potently inhibit NE but are not anticoagulant, would help restore the protease-antiprotease balance in CF. To realize this concept, we studied molecular principles governing the effectiveness of different heparins, especially 2-O,3-O-desulfated heparin (ODSH), in the presence of sputum components and therapeutic agents. Using sputa from CF patients and an NE activity assay, we found that heparins are ineffective if used in the absence of dornase. This is true even when mucolytics, such as DTT or N-acetylcysteine, were used. Computational modeling suggested that ODSH and DNA compete for binding to an overlapping allosteric site on NE, which reduces the anti-NE potential of ODSH. NE inhibition of both DNA and ODSH is chain length-dependent, but ODSH chains exhibit higher potency per unit residue length. Likewise, ODSH chains exhibit higher NE inhibition potential compared with DNA chains in the presence of saline. These studies suggest fundamental differences in DNA and ODSH recognition and inhibition of NE despite engaging overlapping sites and offer unique insights into molecular principles that could be used in developing antiprotease agents in the presence of current treatments, such as dornase and hypertonic saline.	[Kummarapurugu, Apparao B.; Zheng, Shuo; Rubin, Bruce K.; Voynow, Judith A.] Virginia Commonwealth Univ, Childrens Hosp Richmond, POB 980315, Richmond, VA 23298 USA; [Afosah, Daniel K.; Sankaranarayanan, Nehru Viji; Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Afosah, Daniel K.; Sankaranarayanan, Nehru Viji; Gangji, Rahaman Navaz; Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23298 USA; [Kennedy, Thomas] Tulane Univ, Med Ctr, New Orleans, LA 70112 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Tulane University	Voynow, JA (corresponding author), Virginia Commonwealth Univ, Childrens Hosp Richmond, POB 980315, Richmond, VA 23298 USA.; Desai, UR (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23298 USA.	Judith.voynow@vcuhealth.org; urdesai@vcu.edu	Afosah, Daniel/GSD-8459-2022; Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597; Navaz Gangji, Rahaman/0000-0002-8160-3473	National Institutes of Health [HL107152]; CFF Research Grant [VOYNOW15IO]; Commonwealth Health Research Board Grant [236-14-14]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFF Research Grant; Commonwealth Health Research Board Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL107152 (to U. R. D.) and CFF Research Grant VOYNOW15IO and Commonwealth Health Research Board Grant 236-14-14 (to J. A. V.). T. K. invented the chemical entity ODSH, was the scientific founder of Cantex Pharmaceuticals, and owns stock in Cantex. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Horani RA, 2013, J MED CHEM, V56, P867, DOI 10.1021/jm301338q; BELORGEY D, 1995, FEBS LETT, V361, P265, DOI 10.1016/0014-5793(95)00173-7; Bennett WD, 2015, J APPL PHYSIOL, V118, P1483, DOI 10.1152/japplphysiol.00404.2014; Boothello RS, 2015, METHODS MOL BIOL, V1229, P335, DOI 10.1007/978-1-4939-1714-3_27; Cantin AM, 1998, AM J RESP CRIT CARE, V157, P464, DOI 10.1164/ajrccm.157.2.9608033; CHERNICK WS, 1959, PEDIATRICS, V24, P739; Elias JA, 2015, FISHMANS PULMONARY D, P757; Gray RD, 2015, ANTIBIOTICS-BASEL, V4, P62, DOI 10.3390/antibiotics4010062; Griffin KL, 2014, AM J RESP CELL MOL, V50, P684, DOI 10.1165/rcmb.2013-0338RC; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Henry BL, 2007, J BIOL CHEM, V282, P31891, DOI 10.1074/jbc.M704257200; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kelly E, 2008, EXPERT OPIN THER TAR, V12, P145, DOI 10.1517/14728222.12.2.145 ; Kummarapurugu AB, 2018, AM J RESP CELL MOL, V58, P126, DOI 10.1165/rcmb.2017-0250LE; Markart P, 2010, J AEROSOL MED PULM D, V23, P161, DOI 10.1089/jamp.2009.0780; NADZIEJKO C, 1994, AM J RESP CELL MOL, V11, P103, DOI 10.1165/ajrcmb.11.1.7912511; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; Paranjape SM, 2018, PAEDIATR RESPIR REV, V25, P64, DOI 10.1016/j.prrv.2017.03.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsey BW, 2017, AM J RESP CRIT CARE, V195, P1092, DOI 10.1164/rccm.201702-0266ED; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; REDINI F, 1988, BIOCHEM J, V252, P515, DOI 10.1042/bj2520515; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sankaranarayanan NV, 2014, GLYCOBIOLOGY, V24, P1323, DOI 10.1093/glycob/cwu077; Sankaranarayanan NV, 2015, METHODS MOL BIOL, V1229, P289, DOI 10.1007/978-1-4939-1714-3_24; Sankarayanarayanan NV, 2017, ANGEW CHEM INT EDIT, V56, P2312, DOI 10.1002/anie.201609541; SEGEL IH, 1975, ENZYME KINETICS, P125; Sharma L, 2014, J IMMUNOTOXICOL, V11, P260, DOI 10.3109/1547691X.2013.839587; Sly PD, 2013, NEW ENGL J MED, V368, P1963, DOI 10.1056/NEJMoa1301725; Spencer JL, 2006, BIOCHEMISTRY-US, V45, P9104, DOI 10.1021/bi060338r; Taggart C, 2000, J BIOL CHEM, V275, P27258; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Twigg MS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/293053; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; van Zundert G. C., 2016, J MOL BIOL, V428, P720; Voynow JA, 1999, AM J PHYSIOL-LUNG C, V276, pL835; Voynow JA, 2008, INT J BIOCHEM CELL B, V40, P1238, DOI 10.1016/j.biocel.2008.03.003; Weldon S, 2009, J IMMUNOL, V183, P8148, DOI 10.4049/jimmunol.0901716; Xia BY, 2005, GLYCOBIOLOGY, V15, P747, DOI 10.1093/glycob/cwi061; Zheng S, 2017, AM J RESP CELL MOL, V56, P90, DOI 10.1165/rcmb.2016-0069OC	41	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12480	12490		10.1074/jbc.RA118.002644	http://dx.doi.org/10.1074/jbc.RA118.002644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903912	hybrid, Green Published			2022-12-28	WOS:000441408500014
J	Lu, GD; Jia, ZY; Zu, QQ; Zhang, JX; Zhao, LB; Shi, HB				Lu, Guangdong; Jia, Zhenyu; Zu, Qingquan; Zhang, Jinxing; Zhao, Linbo; Shi, Haibin			Inhibition of the cyclophilin A-CD147 interaction attenuates right ventricular injury and dysfunction after acute pulmonary embolism in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; Western blot; cardiomyopathy; biotechnology; thrombosis; acute pulmonary embolism; CD147; cyclophilin A; EMMPRIN; right ventricular dysfunction; heart disease	ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; EARLY BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; SYSTOLIC FUNCTION; OXIDATIVE STRESS; CYCLOSPORINE-A; MATRIX; CD147; THROMBOEMBOLISM	Acute pulmonary embolism (APE)-induced inflammation contributes to cardiomyocyte injury and dysfunction in the right ventricle (RV) of the heart. The interactions of cyclophilin A with its ligand extracellular matrix metalloproteinase inducer (EMMPRIN or CD147) may be involved in this inflammatory process. To this end, here we induced APE by intravenous injections of microspheres in Sprague-Dawley rats. We found that after the APE, cyclophilin A and CD147 levels increased synchronously in RV tissue following APE and peaked at 24 h. The cyclophilin A inhibitor cyclosporine A attenuated the APE-induced cyclophilin A levels, and a monoclonal antibody of CD147 (anti-CD147) abrogated the elevation of CD147 in the RV but not the increase of cyclophilin A. Importantly, treatment with cyclosporine A, anti-CD147, or both attenuated APE-induced increases in RV systolic pressure, plasma cardiac troponin-I (cTnI) concentrations, the RV/left ventricle diameter ratio, and the Tei index, measured by echocardiography 24 h after APE induction. These beneficial effects were associated with reduced RV neutrophil infiltration and prevention of matrix metalloproteinase 9 (MMP-9) and MMP-2 activation. These findings suggested that inhibiting the cyclophilin A-CD147 interaction attenuates APE-associated RV cardiomyocyte injury and dysfunction by suppressing inflammation. We further proposed that cyclophilin A and CD147 might participate in APE-induced pathological processes by partly activating the ERK1/2 kinase-nuclear factor-B pathway. We conclude that the cyclophilin A-CD147 interaction may represent a potential therapeutic target for managing APE.	[Lu, Guangdong; Jia, Zhenyu; Zu, Qingquan; Zhang, Jinxing; Zhao, Linbo; Shi, Haibin] Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Shi, HB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Nanjing 210029, Jiangsu, Peoples R China.	shihb@njmu.edu.cn			National Natural Science Foundation of China [81271678]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81271678. The authors declare that they have no conflicts of interest with the contents of this article.	Beauchesne PR, 2007, DRUG DEV IND PHARM, V33, P211, DOI 10.1080/03639040601155665; Cau SBA, 2013, CARDIOVASC DRUG THER, V27, P259, DOI 10.1007/s10557-013-6458-9; Cuadrado I, 2016, THERANOSTICS, V6, P545, DOI 10.7150/thno.13352; Dahhan T, 2016, CARDIOVASC ULTRASOUN, V14, DOI 10.1186/s12947-016-0087-y; Dai YX, 2014, BRAIN RES, V1556, P67, DOI 10.1016/j.brainres.2014.01.052; Dang BQ, 2015, CRIT CARE MED, V43, pE369, DOI 10.1097/CCM.0000000000001146; Dawar FU, 2017, J LEUKOCYTE BIOL, V102, P989, DOI 10.1189/jlb.3RU0317-090RR; Dawar FU, 2017, J LEUKOCYTE BIOL, V101, P823, DOI 10.1189/jlb.3RU1116-477R; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Fortuna GM, 2007, INT J CARDIOL, V114, P22, DOI 10.1016/j.ijcard.2005.11.109; Heinzmann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124606; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jin R, 2017, STROKE, V48, P3356, DOI 10.1161/STROKEAHA.117.018839; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Jones AE, 2003, AM J PHYSIOL-LUNG C, V284, pL1072, DOI 10.1152/ajplung.00283.2002; Kalt DA, 2017, LAB MED, V48, pE62, DOI 10.1093/labmed/lmx056; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Konstantinides SV, 2016, J AM COLL CARDIOL, V67, P976, DOI 10.1016/j.jacc.2015.11.061; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Lalu MM, 2005, EUR HEART J, V26, P27, DOI 10.1093/eurheratj/ehi007; Malesevic M, 2013, J MED CHEM, V56, P7302, DOI 10.1021/jm4007577; Neto-Neves EM, 2013, J CELL MOL MED, V17, P1588, DOI 10.1111/jcmm.12163; Neto-Neves EM, 2011, CRIT CARE MED, V39, P349, DOI 10.1097/CCM.0b013e3181fa3dfe; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Park JH, 2008, INT J CARDIOL, V125, P319, DOI 10.1016/j.ijcard.2007.02.030; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Ramachandran S, 2012, PROTEOMICS, V12, P2808, DOI 10.1002/pmic.201100586; Satoh K, 2014, CIRC RES, V115, P738, DOI 10.1161/CIRCRESAHA.115.304563; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Seizer P, 2014, CARDIOVASC RES, V102, P17, DOI 10.1093/cvr/cvu035; Seizer P, 2011, ARTERIOSCL THROM VAS, V31, P1377, DOI 10.1161/ATVBAHA.111.225771; Seko Y, 2004, BIOCHEM BIOPH RES CO, V317, P162, DOI 10.1016/j.bbrc.2004.03.021; Shimokawa H, 2016, CIRC RES, V118, P352, DOI 10.1161/CIRCRESAHA.115.306532; Sousa-Santos O, 2012, N-S ARCH PHARMACOL, V385, P685, DOI 10.1007/s00210-012-0748-9; Souza-Costa DC, 2007, CRIT CARE MED, V35, P239, DOI 10.1097/01.CCM.0000251638.67104.C3; Sun SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102541; Watts JA, 2006, J MOL CELL CARDIOL, V41, P296, DOI 10.1016/j.yjmcc.2006.05.011; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Zhang WC, 2017, TRANSPLANTATION, V101, P2862, DOI 10.1097/TP.0000000000001941	39	12	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12199	12208		10.1074/jbc.RA118.002845	http://dx.doi.org/10.1074/jbc.RA118.002845			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29914983	Green Published, hybrid			2022-12-28	WOS:000440803200018
J	Ma, L; Sun, L; Jin, X; Xiong, SD; Wang, JH				Ma, Li; Sun, Li; Jin, Xia; Xiong, Si-Dong; Wang, Jian-Hua			Scaffold attachment factor B suppresses HIV-1 infection of CD4(+) T cells by preventing binding of RNA polymerase II to HIV-1's long terminal repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral transcription; virology; virus; HIV; host-pathogen interaction	HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL TRANS-INFECTION; MESSENGER-RNA; LATENT HIV-1; GENE-EXPRESSION; CAPTURE HIV-1; SAF-B; PROTEIN; TRANSCRIPTION; INHIBITION	The 5 end of the HIV, type 1 (HIV-1) long terminal repeat (LTR) promoter plays an essential role in driving viral transcription and productive infection. Multiple host and viral factors regulate LTR activity and modulate HIV-1 latency. Manipulation of the HIV-1 LTR provides a potential therapeutic strategy for combating HIV-1 persistence. In this study, we identified an RNA/DNA-binding protein, scaffold attachment factor B (SAFB1), as a host cell factor that represses HIV-1 transcription. We found that SAFB1 bound to the HIV-1 5 LTR and significantly repressed 5 LTR-driven viral transcription and HIV-1 infection of CD4(+) T cells. Mechanistically, SAFB1-mediated repression of HIV-1 transcription and infection was independent of its RNA- and DNA-binding capacities. Instead, by binding to phosphorylated RNA polymerase II, SAFB1 blocked its recruitment to the HIV-1 LTR. Of note, SAFB1-mediated repression of HIV-1 transcription from proviral DNA maintained HIV-1 latency in CD4(+) T cells. In summary, our findings reveal that SAFB1 binds to the HIV-1 LTR and physically interacts with phosphorylated RNA polymerase II, repressing HIV-1 transcription initiation and elongation. Our findings improve our understanding of host modulation of HIV-1 transcription and latency and provide a new host cell target for improved anti-HIV-1 therapies.	[Ma, Li; Xiong, Si-Dong] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215006, Peoples R China; [Ma, Li; Xiong, Si-Dong] Soochow Univ, Inst Med Sci, Suzhou 215006, Peoples R China; [Ma, Li; Sun, Li; Jin, Xia; Wang, Jian-Hua] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China	Soochow University - China; Soochow University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Wang, JH (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	jh_wang@sibs.ac.cn			Chinese Academy of Sciences [QYZDB-SSW-SMC059, YZ201649]; Natural Science Foundation of China [81572001]; National Grant Program on Key Infectious Disease Grant [2018ZX10301101-003-002]; Natural Science Foundation of China-National Institutes of Health [81561128009]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grant Program on Key Infectious Disease Grant; Natural Science Foundation of China-National Institutes of Health	This work was supported by Key Project of the Chinese Academy of Sciences Grant QYZDB-SSW-SMC059 and Instrument Developing Project of the Chinese Academy of Sciences Grant YZ201649, the Natural Science Foundation of China Grant 81572001, the National Grant Program on Key Infectious Disease Grant 2018ZX10301101-003-002, and Natural Science Foundation of China-National Institutes of Health Joint Grant 81561128009 (to J.-H. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfonso-Parra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010248; Altmeyer M, 2013, MOL CELL, V52, P206, DOI 10.1016/j.molcel.2013.08.025; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cary DC, 2016, J CLIN INVEST, V126, P448, DOI 10.1172/JCI80565; Debril MB, 2005, J MOL ENDOCRINOL, V35, P503, DOI 10.1677/jme.1.01856; Ding DL, 2013, VIROLOGY, V440, P182, DOI 10.1016/j.virol.2013.02.022; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Drakouli S, 2017, FEBS J, V284, P2482, DOI 10.1111/febs.14141; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Francis AC, 2011, CURR MED CHEM, V18, P2904; Garee JP, 2010, J CELL BIOCHEM, V109, P312, DOI 10.1002/jcb.22420; Gordon H, 2013, RNA BIOL, V10, P1714, DOI 10.4161/rna.26542; Hakre S, 2011, CURR OPIN HIV AIDS, V6, P19, DOI 10.1097/COH.0b013e3283412384; Jean-Philippe J, 2014, BBA-GENE REGUL MECH, V1839, P251, DOI 10.1016/j.bbagrm.2014.02.002; Jiang AP, 2016, J VIROL, V90, P2928, DOI 10.1128/JVI.03008-15; Jiang AP, 2015, J VIROL, V89, P8050, DOI 10.1128/JVI.01021-15; Li C, 2017, J VIROL, V91, DOI 10.1128/JVI.01830-16; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Lin JJ, 2008, J BIOL CHEM, V283, P29681, DOI 10.1074/jbc.M802076200; Liu HW, 2015, NUCLEIC ACIDS RES, V43, P3605, DOI 10.1093/nar/gkv246; Lusic M, 2015, J MOL BIOL, V427, P688, DOI 10.1016/j.jmb.2014.07.022; Ma L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099535; Mahmoudi T, 2012, TRANSCR-AUSTIN, V3, P171, DOI 10.4161/trns.20541; Hernandez-Hernandez JM, 2013, NUCLEIC ACIDS RES, V41, P5704, DOI 10.1093/nar/gkt285; Margolis David M, 2010, Curr HIV/AIDS Rep, V7, P37, DOI 10.1007/s11904-009-0033-9; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; McManamy Mary E. Manson, 2014, Antiviral Chemistry & Chemotherapy, V23, P145, DOI 10.3851/IMP2551; Melnik S, 2011, NAT METHODS, V8, P963, DOI [10.1038/NMETH.1705, 10.1038/nmeth.1705]; Mukhopadhyay NK, 2014, ONCOGENE, V33, P3235, DOI 10.1038/onc.2013.294; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Norman M, 2016, BIOCHEM J, V473, P4271, DOI 10.1042/BCJ20160649; OBRIEN MC, 1995, BIOCHEM BIOPH RES CO, V207, P903, DOI 10.1006/bbrc.1995.1271; Oesterreich S, 1997, J CELL BIOCHEM, V67, P275, DOI 10.1002/(SICI)1097-4644(19971101)67:2<275::AID-JCB13>3.0.CO;2-E; Omura Y, 2009, BMB REP, V42, P232, DOI 10.5483/BMBRep.2009.42.4.232; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Rafati H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001206; Ren XX, 2016, J BIOL CHEM, V291, P4580, DOI 10.1074/jbc.M115.706135; Renz A, 1996, NUCLEIC ACIDS RES, V24, P843, DOI 10.1093/nar/24.5.843; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Schwartz C, 2017, BIOCHEM PHARMACOL, V146, P10, DOI 10.1016/j.bcp.2017.07.001; Sun WW, 2018, MBIO, V9, DOI 10.1128/mBio.02408-17; Symons J, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-016-0325-2; Tian RR, 2012, ANTIVIR RES, V95, P57, DOI 10.1016/j.antiviral.2012.04.011; Townson SM, 2004, J BIOL CHEM, V279, P26074, DOI 10.1074/jbc.M313726200; Valente ST, 2006, MOL CELL, V23, P597, DOI 10.1016/j.molcel.2006.07.021; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Wolf D, 2008, CELL HOST MICROBE, V4, P398, DOI 10.1016/j.chom.2008.08.013; Woolaway K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-28; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	51	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12177	12185		10.1074/jbc.RA118.002018	http://dx.doi.org/10.1074/jbc.RA118.002018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29887524	Green Published, hybrid			2022-12-28	WOS:000440803200016
J	Racz, B; Varadi, A; Kong, J; Allikmets, R; Pearson, PG; Johnson, G; Cioffi, CL; Petrukhin, K				Racz, Boglarka; Varadi, Andras; Kong, Jian; Allikmets, Rando; Pearson, Paul G.; Johnson, Graham; Cioffi, Christopher L.; Petrukhin, Konstantin			A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug design; drug development; drug discovery; pharmacokinetics; pharmacology; molecular pharmacology; retinoid-binding protein; retinal degeneration; retinal metabolism; retina; age-related macular degeneration; lipofuscin; RBP4; Stargardt disease; visual cycle	PIGMENT EPITHELIAL-CELLS; MACULAR DEGENERATION; VITAMIN-A; COMPLEMENT ACTIVATION; FUNDUS AUTOFLUORESCENCE; LIPOFUSCIN ACCUMULATION; POTENTIAL TREATMENT; GEOGRAPHIC ATROPHY; NIGHT BLINDNESS; RPE LIPOFUSCIN	A primary pathological defect in the heritable eye disorder Stargardt disease is excessive accumulation of cytotoxic lipofuscin bisretinoids in the retina. Age-dependent accumulation of lipofuscin in the retinal pigment epithelium (RPE) matches the age-dependent increase in the incidence of the atrophic (dry) form of age-related macular degeneration (AMD) and therefore may be one of several pathogenic factors contributing to AMD progression. Lipofuscin bisretinoid synthesis in the retina depends on the influx of serum retinol from the circulation into the RPE. Formation of the tertiary retinol-binding protein 4 (RBP4)-transthyretin-retinol complex in the serum is required for this influx. Herein, we report the pharmacological effects of the non-retinoid RBP4 antagonist, BPN-14136. BPN-14136 dosing in the Abca4(-/-) mouse model of increased lipofuscinogenesis significantly reduced serum RBP4 levels and inhibited bisretinoid synthesis, and this inhibition correlated with a partial reduction in visual cycle retinoids such as retinaldehydes serving as bisretinoid precursors. BPN-14136 administration at doses inducing maximal serum RBP4 reduction did not produce changes in the rate of the visual cycle, consistent with minimal changes in dark adaptation. Abca4(-/-) mice exhibited dysregulation of the complement system in the retina, and BPN-14136 administration normalized the retinal levels of proinflammatory complement cascade components such as complement factors D and H, C-reactive protein, and C3. We conclude that BPN-14136 has several beneficial characteristics, combining inhibition of bisretinoid synthesis and reduction in retinaldehydes with normalization of the retinal complement system. BPN-14136, or a similar compound, may be a promising drug candidate to manage Stargardt disease and dry AMD.	[Racz, Boglarka; Varadi, Andras; Kong, Jian; Allikmets, Rando; Petrukhin, Konstantin] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Pearson, Paul G.] Pearson Pharma Partners, Westlake Village, CA 91361 USA; [Johnson, Graham] NuPharmAdvise LLC, Sanbornton, NH 03269 USA; [Cioffi, Christopher L.] Albany Coll Pharm & Hlth Sci, Dept Basic & Clin Sci, Albany, NY 12208 USA; [Cioffi, Christopher L.] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA	Columbia University; Columbia University; Albany College of Pharmacy & Health Sciences; Albany College of Pharmacy & Health Sciences	Petrukhin, K (corresponding author), Columbia Univ, Med Ctr, Dept Ophthalmol, 635 West 165th St,Box 27, New York, NY 10032 USA.	kep4@cumc.columbia.edu	Allikmets, Rando/ABD-4533-2021	Varadi, Andras/0000-0001-5591-377X; Petrukhin, Konstantin/0000-0002-5545-6924	NEI [P30 EY019007]; Research to Prevent Blindness (New York, NY); NATIONAL EYE INSTITUTE [P30EY019007, R24EY019861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS074476] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Theresa Swayne and Laura Munteanu for the assistance with confocal microscopy. Research facilities were supported by NEI Grant P30 EY019007 (Core Support for Vision Research) and by unrestricted funds from Research to Prevent Blindness (New York, NY) to the Department of Ophthalmology, Columbia University.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Bavik C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124940; Baylor DA, 1998, EYE, V12, P521, DOI 10.1038/eye.1998.140; BERNI R, 1992, FEBS LETT, V308, P43, DOI 10.1016/0014-5793(92)81046-O; Biesalski HK, 2007, VITAM HORM, V75, P117, DOI 10.1016/S0083-6729(06)75005-1; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; Brandstetter C, 2015, J BIOL CHEM, V290, P31189, DOI 10.1074/jbc.M115.671180; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Chichili GR, 2005, INVEST OPHTH VIS SCI, V46, P3562, DOI 10.1167/iovs.05-0089; Cioffi CL, 2015, J MED CHEM, V58, P5863, DOI 10.1021/acs.jmedchem.5b00423; Cioffi CL, 2014, J MED CHEM, V57, P7731, DOI 10.1021/jm5010013; Cohen SM, 2009, TOXICOL SCI, V111, P4, DOI 10.1093/toxsci/kfp131; DELAEY JJ, 1995, RETINA-J RET VIT DIS, V15, P399, DOI 10.1097/00006982-199515050-00005; Delori F. C., 1995, RETINAL PIGMENT EPIT, V62, P37; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Dobri N, 2013, INVEST OPHTH VIS SCI, V54, P85, DOI 10.1167/iovs.12-10050; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1691; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Farjo KM, 2012, MOL CELL BIOL, V32, P5103, DOI 10.1128/MCB.00820-12; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Gibbs D, 2009, INVEST OPHTH VIS SCI, V50, P4386, DOI 10.1167/iovs.09-3471; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Jaakson K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/humu.10263; KENEL MF, 1988, TERATOGEN CARCIN MUT, V8, P1, DOI 10.1002/tcm.1770080102; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kolesnikov AV, 2017, P NATL ACAD SCI USA, V114, pE9675, DOI 10.1073/pnas.1712405114; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mata NL, 2013, RETINA-J RET VIT DIS, V33, P498, DOI 10.1097/IAE.0b013e318265801d; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; Petrukhin K, 2007, EXPERT OPIN THER TAR, V11, P625, DOI 10.1517/14728222.11.5.625; Petrukhin Konstantin, 2013, Drug Discov Today Ther Strateg, V10, pe11; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Radu RA, 2014, J BIOL CHEM, V289, P9113, DOI 10.1074/jbc.M114.548669; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Roberts LJ, 2012, MOL VIS, V18, P280; Samuel W, 2006, J CELL PHYSIOL, V209, P854, DOI 10.1002/jcp.20774; SCHAFFER EM, 1993, J NUTR, V123, P1497, DOI 10.1093/jn/123.9.1497; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; Smith T, 2016, JAMA OPHTHALMOL, V134, P824, DOI 10.1001/jamaophthalmol.2016.1466; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P8325, DOI 10.1167/iovs.13-13214; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Vogel S, 2002, BIOCHEMISTRY-US, V41, P15360, DOI 10.1021/bi0268551; vonRuckmann A, 1997, INVEST OPHTH VIS SCI, V38, P478; Walia S, 2009, OPHTHALMIC GENET, V30, P63, DOI 10.1080/13816810802695550; Weber BHF, 2014, DTSCH ARZTEBL INT, V111, DOI 10.3238/arztebl.2014.0133; Wolf G, 1999, NUTR REV, V57, P258; WOLF G, 1995, NUTR REV, V53, P98; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou J, 2009, INVEST OPHTH VIS SCI, V50, P1392, DOI 10.1167/iovs.08-2868	71	23	23	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11574	11588		10.1074/jbc.RA118.002062	http://dx.doi.org/10.1074/jbc.RA118.002062			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871924	hybrid, Green Published			2022-12-28	WOS:000439449700026
J	Plouffe, SW; Lin, KC; Moore, JL; Tan, FE; Ma, SH; Ye, Z; Qiu, YJ; Ren, B; Guan, KL				Plouffe, Steven W.; Lin, Kimberly C.; Moore, Jerrell L., III; Tan, Frederick E.; Ma, Shenghong; Ye, Zhen; Qiu, Yunjiang; Ren, Bing; Guan, Kun-Liang			The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEAD; MICE; TRANSCRIPTION; DEGRADATION; DEFECTS; TARGETS	The Hippo pathway plays an important role in regulating tissue homeostasis, and its effectors, the transcriptional co-activators Yes-associated protein (YAP) and WW domain-containing transcription regulator 1 (WWTR1 or TAZ), are responsible for mediating the vast majority of its physiological functions. Although YAP and TAZ are thought to be largely redundant and similarly regulated by Hippo signaling, they have developmental, structural, and physiological differences that suggest they may differ in their regulation and downstream functions. To better understand the functions of YAP and TAZ in the Hippo pathway, using CRISPR/Cas9, we generated YAP KO, TAZ KO, and YAP/TAZ KO cell lines in HEK293A cells. We evaluated them in response to many environmental conditions and stimuli and used RNA-Seq to compare their transcriptional profiles. We found that YAP inactivation has a greater effect on cellular physiology (namely, cell spreading, volume, granularity, glucose uptake, proliferation, and migration) than TAZ inactivation. However, functional redundancy between YAP and TAZ was also observed. In summary, our findings confirm that the Hippo pathway effectors YAP and TAZ are master regulators for multiple cellular processes but also reveal that YAP has a stronger influence than TAZ.	[Plouffe, Steven W.; Lin, Kimberly C.; Moore, Jerrell L., III; Ma, Shenghong; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Plouffe, Steven W.; Lin, Kimberly C.; Moore, Jerrell L., III; Ma, Shenghong; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Tan, Frederick E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Qiu, Yunjiang] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Ye, Zhen; Qiu, Yunjiang; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Qiu, Yunjiang/AAC-1395-2019	Qiu, Yunjiang/0000-0002-0539-9714	National Institutes of Health [R35CA196878, R01GM51586, R01DE015964]; NATIONAL CANCER INSTITUTE [R35CA196878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35CA196878, R01GM51586, and R01DE015964 (to K.-L.G.). K.-L.G. is a co-founder of and has an equity interest in Vivace Therapeutics, Inc. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Dai YY, 2017, J THORAC DIS, V9, P2246, DOI 10.21037/jtd.2017.07.18; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Kaan HYK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02219-9; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lin KC, 2017, NAT CELL BIOL, V19, P996, DOI 10.1038/ncb3581; Liu XF, 2016, CELL REP, V14, P1169, DOI 10.1016/j.celrep.2015.12.104; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Santucci M, 2015, J MED CHEM, V58, P4857, DOI 10.1021/jm501615v; Sebe-Pedros A, 2012, CELL REP, V1, P13, DOI 10.1016/j.celrep.2011.11.004; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216	28	121	123	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11230	11240		10.1074/jbc.RA118.002715	http://dx.doi.org/10.1074/jbc.RA118.002715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29802201	Green Published, hybrid			2022-12-28	WOS:000438882800033
J	Orth, K				Orth, Kim			My winding trail while fulfilling my love for science and family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						microbiology; type III secretion system (T3SS); signal transduction; post-translational modification (PTM); enzyme mechanism; acetylation; AMPylation; YopJ		My winding path toward a career in science was awkward, like an adolescent finding an identity. It did not follow a classic course; it had many interruptions, complications, and challenges. It also involved a bit of luck and extremely supportive colleagues, mentors, and family, including my husband, children, and in-laws. I was inspired to tell my story here because I met a young woman interviewing in 2018 for graduate school who is growing up with the same complicated family expectations, social challenges, love for science, and desire to be a scientist as I had four decades ago. Her future is uncertain, because her chosen academic path is not encouraged by those around her. We, as a society, must find ways to encourage, promote, enable, and give strength to those who want to follow their dreams, despite facing many challenges in their lives. Here are some things I learned on my career path that I hope might be helpful for others.	[Orth, Kim] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	Welch Foundation [I-1561]; Once Upon A Time Foundation; Health and Human Services; National Institutes of Health Grant from NIGMS [R01 GM115118]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM115118] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Once Upon A Time Foundation; Health and Human Services; National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Welch Foundation Grant I-1561, Once Upon A Time Foundation, Health and Human Services, National Institutes of Health Grant R01 GM115118 from NIGMS, and Howard Hughes Medical Institute. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.		0	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10435	10437		10.1074/jbc.AW118.003225	http://dx.doi.org/10.1074/jbc.AW118.003225			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29643182	hybrid, Green Published			2022-12-28	WOS:000437828400003
J	Azumaya, CM; Sierra-Valdez, F; Cordero-Morales, JF; Nakagawa, T				Azumaya, Caleigh M.; Sierra-Valdez, Francisco; Cordero-Morales, Julio F.; Nakagawa, Terunaga			Cryo-EM structure of the cytoplasmic domain of murine transient receptor potential cation channel subfamily C member 6 (TRPC6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; transient receptor potential channels (TRP channels); cryo-electron microscopy; membrane protein; calcium channel; kidney; electrophysiology; glomerulosclerosis; vasoconstriction; TRPC6; purification	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ION-CHANNEL; ELECTRON CRYOMICROSCOPY; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; ACTIVATION; PAIN	The kidney maintains the internal milieu by regulating the retention and excretion of proteins, ions, and small molecules. The glomerular podocyte forms the slit diaphragm of the ultrafiltration filter, whose damage leads to progressive kidney failure and focal segmental glomerulosclerosis (FSGS). The canonical transient receptor potential 6 (TRPC6) ion channel is expressed in the podocyte, and mutations in its cytoplasmic domain cause FSGS in humans. In vitro evaluation of disease-causing mutations in TRPC6 has revealed that these genetic alterations result in abnormal ion channel gating. However, the mechanism whereby the cytoplasmic domain modulates TRPC6 function is largely unknown. Here, we report a cryo-EM structure of the cytoplasmic domain of murine TRPC6 at 3.8 resolution. The cytoplasmic fold of TRPC6 is characterized by an inverted dome-like chamber pierced by four radial horizontal helices that converge into a vertical coiled-coil at the central axis. Unlike other TRP channels, TRPC6 displays a unique domain swap that occurs at the junction of the horizontal helices and coiled-coil. Multiple FSGS mutations converge at the buried interface between the vertical coiled-coil and the ankyrin repeats, which form the dome, suggesting these regions are critical for allosteric gating modulation. This functionally critical interface is a potential target for drug design. Importantly, dysfunction in other family members leads to learning deficits (TRPC1/4/5) and ataxia (TRPC3). Our data provide a structural framework for the mechanistic investigation of the TRPC family.	[Azumaya, Caleigh M.; Nakagawa, Terunaga] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Sch Med, Ctr Struct Biol, Nashville, TN 37232 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Sierra-Valdez, Francisco; Cordero-Morales, Julio F.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Cordero-Morales, JF (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA.; Nakagawa, T (corresponding author), 702 Light Hall, Nashville, TN 37232 USA.	jcordero@uthsc.edu; terunaga.nakagawa@vanderbilt.edu		Cordero Morales, Julio/0000-0002-6505-5403; Sierra-Valdez, Francisco J/0000-0002-7803-9701	National Institutes of Health [S10RR031634]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125629, T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	EM data collections using FEI Polara and FEI TF20 were conducted at the Center for Structural Biology's Molecular CryoEM facility at Vanderbilt University. We thank Dr. Scott Collier and Dr. Elad Binshtein for their support at the facility. We thank Dr. James Fitzpatrick and Michael Rau for providing access and facilitating data collection using the Titan Krios at the Washington University Center for Cellular Imaging, Washington University at St. Louis Medical School. This work was conducted in part using the Central Processing Unit and Graphical Processing Unit resources of the Advanced Computing Center for Research and Education (ACCRE) at Vanderbilt University. We used Distributed Online Research Storage (DORS) system supported by the National Institutes of Health Grant S10RR031634 (to Jarrod Smith). We acknowledge the use of SBGrid-supported software (22). We thank Dr. Vasquez for experimental advice and critically reading the manuscript, and Dr. Efren Garcia Maldonado and Dr. Erkan Karakas for advice during model construction.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Broker-Lai J, 2017, EMBO J, V36, P2770, DOI 10.15252/embj.201696369; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dietrich A, 2014, HANDB EXP PHARMACOL, V222, P157, DOI 10.1007/978-3-642-54215-2_7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duan J., 2018, BIORXIV282715, DOI [10.1101/282715, DOI 10.1101/282715]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; Fan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36852; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Madej MG, 2018, PFLUG ARCH EUR J PHY, V470, P213, DOI 10.1007/s00424-018-2107-2; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mottl AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-104; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Santin S, 2009, NEPHROL DIAL TRANSPL, V24, P3089, DOI 10.1093/ndt/gfp229; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Tang QL, 2018, CELL RES, V28, P746, DOI 10.1038/s41422-018-0038-2; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Urban N, 2017, BRIT J PHARMACOL, V174, P4099, DOI 10.1111/bph.13977; Vinayagam D, 2018, ELIFE, V7, DOI 10.7554/eLife.36615; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	48	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10381	10391		10.1074/jbc.RA118.003183	http://dx.doi.org/10.1074/jbc.RA118.003183			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29752403	Green Published, hybrid			2022-12-28	WOS:000437096700035
J	Steiger, D; Yokota, T; Li, J; Ren, SX; Minamisawa, S; Wang, YB				Steiger, DeAnna; Yokota, Tomohiro; Li, Jin; Ren, Shuxun; Minamisawa, Susumu; Wang, Yibin			The serine/threonine-protein kinase/endoribonuclease IRE1 protects the heart against pressure overload-induced heart failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); cardiomyocyte; cardiomyopathy; heart failure; signal transduction	ENDOPLASMIC-RETICULUM STRESS; P38 MAP KINASES; ER STRESS; CELL-DEATH; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; RESPONSE PATHWAY; GENE-EXPRESSION; TRANSGENIC MICE; QUALITY-CONTROL	Heart failure is associated with induction of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). The serine/threonine protein kinase/endoribonuclease IRE1 is a key protein in ER stress signal transduction. IRE1 activity can induce both protective UPR and apoptotic downstream signaling events, but the specific role for IRE1 activity in the heart is unknown. A major aim of this study was to characterize the specific contribution of IRE1 in cardiac physiology and pathogenesis. We used both cultured myocytes and a transgenic mouse line with inducible and cardiomyocyte-specific IRE1 overexpression as experimental models to achieve targeted IRE1 activation. IRE1 expression induced a potent but transient ER stress response in cardiomyocytes and did not cause significant effects in the intact heart under normal physiological conditions. Furthermore, the IRE1-activated transgenic heart responding to pressure overload exhibited preserved function and reduced fibrotic area, associated with increased adaptive UPR signaling and with blunted inflammatory and pathological gene expression. Therefore, we conclude that IRE1 induces transient ER stress signaling and confers a protective effect against pressure overload-induced pathological remodeling in the heart. To our knowledge, this report provides first direct evidence of a specific and protective role for IRE1 in the heart and reveals an interaction between ER stress signaling and inflammatory regulation in the pathologically stressed heart.	[Steiger, DeAnna; Yokota, Tomohiro; Li, Jin; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Steiger, DeAnna; Yokota, Tomohiro; Li, Jin; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Steiger, DeAnna; Yokota, Tomohiro; Li, Jin; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Minamisawa, Susumu] Jikei Univ, Sch Med, Dept Cell Physiol, Tokyo 1058461, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Jikei University	Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu		Minamisawa, Susumu/0000-0003-4728-2116; Yokota, Tomohiro/0000-0003-2540-3810; Wang, Yibin/0000-0003-0852-0767	National Institutes of Health [HL103205, HL070079]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Vehicle Racing Commemorative Foundation; Jikei University Graduate Research Fund; MEXT Supported Program for the Strategic Research Foundation at Private Universities; National Institutes of Health Ruth L. Kirschstein National Research Service Award [F31 AG038156]; UCLA-Waseda Brain Circulation fellowship award from the Japanese Ministry of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103205, R01HL070079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG038156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Jikei University Graduate Research Fund; MEXT Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA-Waseda Brain Circulation fellowship award from the Japanese Ministry of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants HL103205 and HL070079 (to Y.W.) and additional funding from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S.M.), the Vehicle Racing Commemorative Foundation (to S.M.), The Jikei University Graduate Research Fund (to S.M.), and the MEXT Supported Program for the Strategic Research Foundation at Private Universities (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Ruth L. Kirschstein National Research Service Award F31 AG038156.; Supported by a UCLA-Waseda Brain Circulation fellowship award from the Japanese Ministry of Science and Technology.	Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Briot A, 2014, DEV CELL, V31, P707, DOI 10.1016/j.devcel.2014.11.023; Bulleid NJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013219; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cool AR, 2009, J MOL CELL CARDIOL, V46, P225, DOI 10.1016/j.yjmcc.2008.10.013; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Ishikawa T, 2006, GENESIS, V44, P143, DOI 10.1002/gene.20192; Isodono K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009746; IWAKI K, 1990, J BIOL CHEM, V265, P13809; JANERO DR, 1991, J CELL PHYSIOL, V149, P347, DOI 10.1002/jcp.1041490302; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li MX, 2005, CIRCULATION, V111, P2494, DOI 10.1161/01.CIR.0000165117.71483.0C; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Lu G, 2013, MOL METAB, V2, P405, DOI 10.1016/j.molmet.2013.07.005; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Mitchell S, 2006, PHYSIOL GENOMICS, V25, P50, DOI 10.1152/physiolgenomics.00224.2005; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Ota A, 2012, J BIOL CHEM, V287, P6266, DOI 10.1074/jbc.M111.331264; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Petrich BG, 2003, FASEB J, V17, P749, DOI 10.1096/fj.02-0438fje; Prins D, 2009, CAN J PHYSIOL PHARM, V87, P419, DOI [10.1139/Y09-032, 10.1139/y09-032]; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Stadtman ER, 2004, CURR MED CHEM, V11, P1105, DOI 10.2174/0929867043365341; Streicher JM, 2010, CIRC RES, V106, P1434, DOI 10.1161/CIRCRESAHA.109.213199; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zhang C, 2001, BIOCHEM BIOPH RES CO, V289, P718, DOI 10.1006/bbrc.2001.6044; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	63	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9652	9661		10.1074/jbc.RA118.003448	http://dx.doi.org/10.1074/jbc.RA118.003448			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29769316	Green Published, hybrid			2022-12-28	WOS:000436102300010
J	Stowell, JAW; Wagstaff, JL; Hill, CH; Yu, MM; McLaughlin, SH; Freund, SMV; Passmore, LA				Stowell, James A. W.; Wagstaff, Jane L.; Hill, Chris H.; Yu, Minmin; McLaughlin, Stephen H.; Freund, Stefan M. V.; Passmore, Lori A.			A low-complexity region in the YTH domain protein Mmi1 enhances RNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; intrinsically disordered protein; mRNA decay; meiosis; protein-nucleic acid interaction; nuclear magnetic resonance (NMR); deadenylation; exosome specificity factor; YT521-B homology; YTH domain	MESSENGER-RNA; STRUCTURAL BASIS; M(6)A RNA; RECOGNITION; ELIMINATION; SYSTEM; MECHANISM; PROMOTES; REVEALS; PROGRAM	Mmi1 is an essential RNA-binding protein in the fission yeast Schizosaccharomyces pombe that eliminates meiotic transcripts during normal vegetative growth. Mmi1 contains a YTH domain that binds specific RNA sequences, targeting mRNAs for degradation. The YTH domain of Mmi1 uses a noncanonical RNA-binding surface that includes contacts outside the conserved fold. Here, we report that an N-terminal extension that is proximal to the YTH domain enhances RNA binding. Using X-ray crystallography, NMR, and biophysical methods, we show that this low-complexity region becomes more ordered upon RNA binding. This enhances the affinity of the interaction of the Mmi1 YTH domain with specific RNAs by reducing the dissociation rate of the Mmi1-RNA complex. We propose that the low-complexity region influences RNA binding indirectly by reducing dynamic motions of the RNA-binding groove and stabilizing a conformation of the YTH domain that binds to RNA with high affinity. Taken together, our work reveals how a low-complexity region proximal to a conserved folded domain can adopt an ordered structure to aid nucleic acid binding.	[Stowell, James A. W.; Wagstaff, Jane L.; Hill, Chris H.; Yu, Minmin; McLaughlin, Stephen H.; Freund, Stefan M. V.; Passmore, Lori A.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Freund, SMV; Passmore, LA (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	smvf@mrc-lmb.cam.ac.uk; passmore@mrc-lmb.cam.ac.uk		Hill, Chris H/0000-0001-7037-0611; Passmore, Lori/0000-0003-1815-3710	European Research Council under the European Union's Seventh Framework Programme/ERC [261151]; Medical Research Council [MC_U105192715]; MRC [MC_U105192715] Funding Source: UKRI	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Starting Grant Agreement 261151 (to L. A. P.) and Medical Research Council Grant MC_U105192715 (to L. A. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Calabretta S, 2015, TRENDS BIOCHEM SCI, V40, P662, DOI 10.1016/j.tibs.2015.08.012; Chatterjee D, 2016, RNA, V22, P1011, DOI 10.1261/rna.056515.116; Clery A, 2017, METHODS, V118, P137, DOI 10.1016/j.ymeth.2017.03.004; Coey CT, 2016, NUCLEIC ACIDS RES, V44, P10248, DOI 10.1093/nar/gkw768; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cremona N, 2011, MOL BIOL CELL, V22, P66, DOI 10.1091/mbc.E10-05-0448; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hautbergue GM, 2008, P NATL ACAD SCI USA, V105, P5154, DOI 10.1073/pnas.0709167105; Haynes C, 2006, NUCLEIC ACIDS RES, V34, P305, DOI 10.1093/nar/gkj424; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Jarvelin AI, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0132-3; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Keating KS, 2012, ACTA CRYSTALLOGR D, V68, P985, DOI 10.1107/S0907444912018549; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Kilchert C, 2015, CELL REP, V13, P2504, DOI 10.1016/j.celrep.2015.11.026; Langer A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3099; Li J, 2017, ELIFE, V6, DOI 10.7554/eLife.30688; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Monaco S, 2013, J APPL CRYSTALLOGR, V46, P804, DOI 10.1107/S0021889813006195; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Neelamraju Y, 2015, J PROTEOMICS, V127, P61, DOI 10.1016/j.jprot.2015.04.031; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Shen HH, 2007, NAT STRUCT MOL BIOL, V14, P597, DOI 10.1038/nsmb1263; Shichino Y, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140022; Smet-Nocca C, 2008, BIOCHEMISTRY-US, V47, P6519, DOI 10.1021/bi7022283; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Stowell JAW, 2016, CELL REP, V17, P1978, DOI 10.1016/j.celrep.2016.10.066; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Theler D, 2014, NUCLEIC ACIDS RES, V42, P13911, DOI 10.1093/nar/gku1116; Ukleja M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10433; Vassilenko KS, 2002, BBA-PROTEIN STRUCT M, V1594, P168, DOI 10.1016/S0167-4838(01)00303-X; Wang CY, 2016, NUCLEIC ACIDS RES, V44, P969, DOI 10.1093/nar/gkv1382; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Welte T, 2014, BIOPHYS J, V106, p18A, DOI 10.1016/j.bpj.2013.11.156; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	62	9	9	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9210	9222		10.1074/jbc.RA118.002291	http://dx.doi.org/10.1074/jbc.RA118.002291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29695507	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000435441400007
J	Choi, H; Chaiyamongkol, W; Doolittle, AC; Johnson, ZI; Gogate, SS; Schoepflin, ZR; Shapiro, IM; Risbud, MV				Choi, Hyowon; Chaiyamongkol, Weera; Doolittle, Alexandra C.; Johnson, Zariel I.; Gogate, Shilpa S.; Schoepflin, Zachary R.; Shapiro, Irving M.; Risbud, Makarand V.			COX-2 expression mediated by calcium-TonEBP signaling axis under hyperosmotic conditions serves osmoprotective function in nucleus pulposus cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MEDULLARY INTERSTITIAL-CELLS; ELEMENT-BINDING PROTEIN; INTERVERTEBRAL DISC; CYCLOOXYGENASE-2 EXPRESSION; TRANSCRIPTION FACTOR; HYPERTONIC STRESS; EPITHELIAL-CELLS; CONTRIBUTES; SURVIVAL	The nucleus pulposus (NP) of intervertebral discs experiences dynamic changes in tissue osmolarity because of diurnal loading of the spine. TonEBP/NFAT5 is a transcription factor that is critical in osmoregulation as well as survival of NP cells in the hyperosmotic milieu. The goal of this study was to investigate whether cyclooxygenase-2 (COX-2) expression is osmoresponsive and dependent on TonEBP, and whether it serves an osmoprotective role. NP cells up-regulated COX-2 expression in hyperosmotic media. The induction of COX-2 depended on elevation of intracellular calcium levels and p38 MAPK pathway, but independent of calcineurin signaling as well as MEK/ERK and JNK pathways. Under hyperosmotic conditions, both COX-2 mRNA stability and its proximal promoter activity were increased. The proximal COX-2 promoter (-1840/+123 bp) contained predicted binding sites for TonEBP, AP-1, NF-kappa B, and C/EBP-beta. While COX-2 promoter activity was positively regulated by both AP-1 and NF-kappa B, AP-1 had no effect and NF-kappa B negatively regulated COX-2 protein levels under hyperosmotic conditions. Onthe other hand, TonEBPwas necessary for both COX-2 promoter activity and protein up-regulation in response to hyperosmotic stimuli. Ex vivo disc organ culture studies using hypomorphic TonEBP(+/-) mice confirmed that TonEBP is required for hyperosmotic induction of COX-2. Importantly, the inhibition of COX-2 activity under hyperosmotic conditions resulted in decreased cell viability, suggesting that COX-2 plays a cytoprotectiveandhomeostatic role inNPcells for their adaptation to dynamically loaded hyperosmotic niches.	[Choi, Hyowon; Chaiyamongkol, Weera; Doolittle, Alexandra C.; Johnson, Zariel I.; Gogate, Shilpa S.; Schoepflin, Zachary R.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Choi, Hyowon; Chaiyamongkol, Weera; Doolittle, Alexandra C.; Johnson, Zariel I.; Gogate, Shilpa S.; Schoepflin, Zachary R.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell Biol & Regenerat Med, Philadelphia, PA 19107 USA; [Chaiyamongkol, Weera] Prince Songkla Univ, Dept Orthopaed Surg, Fac Med, Hat Yai 90110, Thailand	Jefferson University; Jefferson University; Prince of Songkla University	Risbud, MV (corresponding author), Thomas Jefferson Univ, 1025 Walnut St,Ste 511 Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu		Choi, Hyowon/0000-0003-4935-4849	NIAMS, National Institutes of Health [R01AR055655, R01AR064733, T32AR052273, F30AR066506]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064733, F30AR066506, R01AR055655, T32AR052273] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by NIAMS, National Institutes of Health Grants R01AR055655 and R01AR064733, and T32AR052273 (to Z. I. J. and A. C. D.), and F30AR066506 (to Z. R. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Binch ALA, 2016, MATRIX BIOL, V52-54, P355, DOI 10.1016/j.matbio.2016.01.005; Breyer MD, 2001, CURR OPIN NEPHROL HY, V10, P89, DOI 10.1097/00041552-200101000-00014; Chen J, 2005, J BIOL CHEM, V280, P16354, DOI 10.1074/jbc.M411134200; Cheng HF, 2002, J BIOL CHEM, V277, P45638, DOI 10.1074/JBC.m206040200; Cheng HF, 2000, J CLIN INVEST, V106, P681, DOI 10.1172/JCI10318; Choi H., 2018, MATRIX BIOL; Coon D, 2007, J ENDODONT, V33, P432, DOI 10.1016/j.joen.2006.12.001; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Favale NO, 2009, BIOCHEM BIOPH RES CO, V381, P301, DOI 10.1016/j.bbrc.2008.12.189; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Gajghate S, 2009, J BONE MINER RES, V24, P992, DOI [10.1359/JBMR.090103, 10.1359/jbmr.090103]; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gogate SS, 2012, J BONE MINER RES, V27, P1106, DOI 10.1002/jbmr.1571; Hao CM, 1999, AM J PHYSIOL-RENAL, V277, pF352, DOI 10.1152/ajprenal.1999.277.3.F352; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Hiyama A, 2009, J BIOL CHEM, V284, P9824, DOI 10.1074/jbc.M807081200; Irarrazabal CE, 2008, J BIOL CHEM, V283, P2554, DOI 10.1074/jbc.M703490200; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Johnson ZI, 2017, J BIOL CHEM, V292, P17561, DOI 10.1074/jbc.M117.790378; Johnson ZI, 2016, J BIOL CHEM, V291, P26686, DOI 10.1074/jbc.M116.757732; Johnson ZI, 2014, MATRIX BIOL, V40, P10, DOI 10.1016/j.matbio.2014.08.014; Kim NH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.61; Kim SH, 2009, CARCINOGENESIS, V30, P753, DOI 10.1093/carcin/bgp066; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; Kusama K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132017; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee YS, 2013, FREE RADICAL RES, V47, P422, DOI 10.3109/10715762.2013.784965; Libert S, 2016, MOL VIS, V22, P100; Madonna R, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0342-4; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; Moeckel GW, 2003, J BIOL CHEM, V278, P19352, DOI 10.1074/jbc.M302209200; Nahm O, 2002, AM J PHYSIOL-CELL PH, V282, pC49, DOI 10.1152/ajpcell.00267.2001; Norregaard R, 2015, KIDNEY RES CLIN PRAC, V34, P194, DOI 10.1016/j.krcp.2015.10.004; Ogata S, 2006, BIOCHEM BIOPH RES CO, V351, P808, DOI 10.1016/j.bbrc.2006.10.098; Peskar BM, 2001, J PHYSIOLOGY-PARIS, V95, P3, DOI 10.1016/S0928-4257(01)00003-1; Rim JS, 1998, J BIOL CHEM, V273, P20615, DOI 10.1074/jbc.273.32.20615; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Rishud M. V., 2018, MATRIX BIOL; Shehzad A, 2015, BMB REP, V48, P109, DOI 10.5483/BMBRep.2015.48.2.081; Shin HJ, 2014, CELL DEATH DIFFER, V21, P1095, DOI 10.1038/cdd.2014.29; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Tian Y, 2016, MATRIX BIOL, V50, P39, DOI 10.1016/j.matbio.2015.11.008; Tsai TT, 2007, J BONE MINER RES, V22, P965, DOI 10.1359/JBMR.070322; Tsai TT, 2006, J BIOL CHEM, V281, P25416, DOI 10.1074/jbc.M601969200; van Dijk B, 2015, J ORTHOP RES, V33, P1724, DOI 10.1002/jor.22946; Wang H, 2015, AM J PHYSIOL-RENAL, V308, pF140, DOI 10.1152/ajprenal.00471.2014; Yan Y, 2006, J CELL SCI, V119, P2985, DOI 10.1242/jcs.03014; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Zhang DY, 2008, MOL CANCER RES, V6, P165, DOI 10.1158/1541-7786.MCR-07-0181	53	21	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8969	8981		10.1074/jbc.RA117.001167	http://dx.doi.org/10.1074/jbc.RA117.001167			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29700115	Green Published, hybrid			2022-12-28	WOS:000434941900020
J	O'Neill, S; Mathis, M; Kovacic, L; Zhang, SS; Reinhardt, J; Scholz, D; Schopfer, U; Bouhelal, R; Knaus, UG				O'Neill, Sharon; Mathis, Magalie; Kovacic, Lidija; Zhang, Suisheng; Reinhardt, Jurgen; Scholz, Dimitri; Schopfer, Ulrich; Bouhelal, Rochdi; Knaus, Ulla G.			Quantitative interaction analysis permits molecular insights into functional NOX4 NADPH oxidase heterodimer assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NADPH oxidase maturation; reactive oxygen species (ROS); genetic disease; dimerization; protein-protein interaction; NanoBit; NOX complex; NOX4; p22(phox); NanoLuc; hydrogen peroxide (H2O2)	PROTEIN-PROTEIN INTERACTION; FLAVOCYTOCHROME B(558); P22(PHOX) SUBUNIT; B-LOOP; INHIBITORS; CELLS; IDENTIFICATION; LOCALIZATION; MUTAGENESIS; MATURATION	Protein-protein interactions critically regulate many biological systems, but quantifying functional assembly of multipass membrane complexes in their native context is still challenging. Here, we combined modeling-assisted protein modification and information from human disease variants with a minimal-size fusion tag, split-luciferase-based approach to probe assembly of the NADPH oxidase 4 (NOX4)-p22(phox) enzyme, an integral membrane complex with unresolved structure, which is required for electron transfer and generation of reactive oxygen species (ROS). Integrated analyses of heterodimerization, trafficking, and catalytic activity identified determinants for the NOX4-p22(phox) interaction, such as heme incorporation into NOX4 and hot spot residues in transmembrane domains 1 and 4 in p22(phox). Moreover, their effect on NOX4 maturation and ROS generation was analyzed. We propose that this reversible and quantitative protein-protein interaction technique with its small split-fragment approach will provide a protein engineering and discovery tool not only for NOX research, but also for other intricate membrane protein complexes, and may thereby facilitate new drug discovery strategies for managing NOX-associated diseases.	[O'Neill, Sharon; Kovacic, Lidija; Zhang, Suisheng; Scholz, Dimitri; Knaus, Ulla G.] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [O'Neill, Sharon; Kovacic, Lidija; Zhang, Suisheng; Knaus, Ulla G.] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Mathis, Magalie; Reinhardt, Jurgen; Schopfer, Ulrich; Bouhelal, Rochdi] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Kovacic, Lidija] Novartis Pharmaceut, Elm Pk Business Campus,Merr Rd, Dublin 4, Ireland	University College Dublin; University College Dublin; Novartis	Knaus, UG (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 4, Ireland.	ulla.knaus@ucd.ie			Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by a grant from the Science Foundation Ireland (to U.G.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Beaumerl S, 2014, BIOCHEM J, V464, P425, DOI 10.1042/BJ20140555; Borbely G, 2010, J MED CHEM, V53, P6758, DOI 10.1021/jm1004368; Campion Y, 2009, J INNATE IMMUN, V1, P556, DOI 10.1159/000231977; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gaggini F, 2011, BIOORGAN MED CHEM, V19, P6989, DOI 10.1016/j.bmc.2011.10.016; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hayes P, 2015, CELL MOL GASTROENTER, V1, P489, DOI 10.1016/j.jcmgh.2015.06.005; Hecker L, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2015.12.45; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hirano K, 2015, ANTIOXID REDOX SIGN, V23, P358, DOI 10.1089/ars.2014.6202; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson HM, 2010, J BIOL CHEM, V285, P10281, DOI 10.1074/jbc.M109.084939; Jaquet V, 2011, BRIT J PHARMACOL, V164, P507, DOI 10.1111/j.1476-5381.2011.01439.x; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Luxen S, 2009, J CELL SCI, V122, P1238, DOI 10.1242/jcs.044123; Magnani F, 2017, P NATL ACAD SCI USA, V114, P6764, DOI 10.1073/pnas.1702293114; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meijles DN, 2012, COMPUT BIOL CHEM, V39, P6, DOI 10.1016/j.compbiolchem.2012.05.001; Nakano Y, 2008, J CLIN INVEST, V118, P1176, DOI 10.1172/JCI33835; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; Petronio MS, 2013, MOLECULES, V18, P2821, DOI 10.3390/molecules18032821; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Prior KK, 2016, J BIOL CHEM, V291, P7045, DOI 10.1074/jbc.M115.710772; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Strengert M, 2014, ANTIOXID REDOX SIGN, V20, P2695, DOI 10.1089/ars.2013.5353; Stynen B, 2012, MICROBIOL MOL BIOL R, V76, P331, DOI 10.1128/MMBR.05021-11; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; Vlachantoni D, 2011, HUM MOL GENET, V20, P322, DOI 10.1093/hmg/ddq467; von Lohneysen K, 2012, J BIOL CHEM, V287, P8737, DOI 10.1074/jbc.M111.332494; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	51	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8750	8760		10.1074/jbc.RA117.001045	http://dx.doi.org/10.1074/jbc.RA117.001045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29674345	Green Published, hybrid			2022-12-28	WOS:000434941900003
J	Blain-Hartung, M; Rockwell, NC; Moreno, MV; Martin, SS; Gan, F; Bryant, DA; Lagarias, JC				Blain-Hartung, Matthew; Rockwell, Nathan C.; Moreno, Marcus V.; Martin, Shelley S.; Gan, Fei; Bryant, Donald A.; Lagarias, J. Clark			Cyanobacteriochrome-based photoswitchable adenylyl cyclases (cPACs) for broad spectrum light regulation of cAMP levels in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenylate cyclase (adenylyl cyclase); cyanobacteria; phototransduction; optogenetics; photoreceptor; signal transduction; biliprotein; biliverdin; cAMP; linear tetrapyrrole; photoswitch	C-DI-GMP; PHOTO-DYNAMICS; CYCLIC-AMP; SIGNAL-TRANSDUCTION; CELLULAR CAMP; RED-LIGHT; DOMAIN; PHOTOACTIVATION; PHOTORECEPTORS; BIOSYNTHESIS	Class III adenylyl cyclases generate the ubiquitous second messenger cAMP from ATP often in response to environmental or cellular cues. During evolution, soluble adenylyl cyclase catalytic domains have been repeatedly juxtaposed with signal-input domains to place cAMP synthesis under the control of a wide variety of these environmental and endogenous signals. Adenylyl cyclases with light-sensing domains have proliferated in photosynthetic species depending on light as an energy source, yet are also widespread in nonphotosynthetic species. Among such naturally occurring light sensors, several flavin-based photoactivated adenylyl cyclases (PACs) have been adopted as optogenetic tools to manipulate cellular processes with blue light. In this report, we report the discovery of a cyanobacteriochrome-based photoswitchable adenylyl cyclase (cPAC) from the cyanobacterium Microcoleus sp. PCC 7113. Unlike flavin-dependent PACs, which must thermally decay to be deactivated, cPAC exhibits a bistable photocycle whose adenylyl cyclase could be reversibly activated and inactivated by blue and green light, respectively. Through domain exchange experiments, we also document the ability to extend the wavelength-sensing specificity of cPAC into the near IR. In summary, our work has uncovered a cyanobacteriochrome-based adenylyl cyclase that holds great potential for the design of bistable photoswitchable adenylyl cyclases to fine-tune cAMP-regulated processes in cells, tissues, and whole organisms with light across the visible spectrum and into the near IR.	[Blain-Hartung, Matthew; Rockwell, Nathan C.; Moreno, Marcus V.; Martin, Shelley S.; Lagarias, J. Clark] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Gan, Fei; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Gan, Fei] Scripps Res Inst, 5202 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman; Scripps Research Institute	Lagarias, JC (corresponding author), 1 Shields Ave, Davis, CA 95616 USA.	jclagarias@ucdavis.edu	Lagarias, John Clark/L-3139-2013	Lagarias, John Clark/0000-0002-2093-0403; Blain-Hartung, Matthew/0000-0001-6756-0035; Gan, Fei/0000-0003-1670-5251	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy [DOE DE-FG02-09ER16117]; National Science Foundation [MCB-1613022]; National Institutes of Health, NIGMS [T32-GM07377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy Grant DOE DE-FG02-09ER16117 (to J. C. L.), National Science Foundation Grant MCB-1613022 (to D. A. B.), and National Institutes of Health, NIGMS Grant T32-GM07377 (to M. B.-H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Bhaya D, 2004, MOL MICROBIOL, V53, P745, DOI 10.1111/j.1365-2958.2004.04160.x; Blain-Hartung M, 2017, BIOCHEMISTRY-US, V56, P6145, DOI 10.1021/acs.biochem.7b00734; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Cann MJ, 2003, J BIOL CHEM, V278, P35033, DOI 10.1074/jbc.M303025200; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Enomoto G, 2015, P NATL ACAD SCI USA, V112, P8082, DOI 10.1073/pnas.1504228112; Enomoto G, 2014, J BIOL CHEM, V289, P24801, DOI 10.1074/jbc.M114.583674; Freer LH, 2012, J PHYS CHEM B, V116, P10571, DOI 10.1021/jp302637u; Fushimi K, 2017, PHOTOCHEM PHOTOBIOL, V93, P903, DOI 10.1111/php.12764; Fushimi K, 2017, PHOTOCHEM PHOTOBIOL, V93, P681, DOI 10.1111/php.12732; Fushimi K, 2016, BIOCHEMISTRY-US, V55, P6981, DOI 10.1021/acs.biochem.6b00940; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gordillo FJL, 2004, J PLANT PHYSIOL, V161, P211, DOI 10.1078/0176-1617-00953; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Ho MY, 2017, CURR OPIN PLANT BIOL, V37, P24, DOI 10.1016/j.pbi.2017.03.006; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; JORGENSEN BB, 1986, APPL ENVIRON MICROB, V51, P408; Karsten U, 1996, SYST APPL MICROBIOL, V19, P285, DOI 10.1016/S0723-2020(96)80054-3; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; Kobayashi M, 2004, DEV GENES EVOL, V214, P503, DOI 10.1007/s00427-004-0432-2; Kyriakakis P, 2018, ACS SYNTH BIOL, V7, P706, DOI 10.1021/acssynbio.7b00413; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Lim S, 2014, PHOTOCH PHOTOBIO SCI, V13, P951, DOI 10.1039/c3pp50442e; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Lindner R, 2017, J MOL BIOL, V429, P1336, DOI 10.1016/j.jmb.2017.03.020; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; Muller K, 2013, MOL BIOSYST, V9, P596, DOI 10.1039/c3mb25590e; Mulder DT, 2015, MOL MICROBIOL, V95, P678, DOI 10.1111/mmi.12895; Narikawa R, 2015, BIOCHEM BIOPH RES CO, V461, P390, DOI 10.1016/j.bbrc.2015.04.045; Ohki M, 2017, P NATL ACAD SCI USA, V114, P8562, DOI 10.1073/pnas.1704391114; Ohki M, 2016, P NATL ACAD SCI USA, V113, P6659, DOI 10.1073/pnas.1517520113; OHMORI K, 1993, PLANT CELL PHYSIOL, V34, P169; Ohmori M, 2004, PHOTOCH PHOTOBIO SCI, V3, P503, DOI 10.1039/b401623h; Okamoto S, 2004, PHOTOCHEM PHOTOBIOL, V80, P429, DOI 10.1562/0031-8655(2004)080&lt;0429:APPATT&gt;2.0.CO;2; Okkotsu Y, 2013, J BACTERIOL, V195, P5499, DOI 10.1128/JB.00726-13; Oliveira MC, 2015, J MOL BIOL, V427, P415, DOI 10.1016/j.jmb.2014.11.012; Omoregie EO, 2004, APPL ENVIRON MICROB, V70, P2119, DOI 10.1128/AEM.70.4.2119-2128.2004; Ong NT, 2018, ACS SYNTH BIOL, V7, P240, DOI 10.1021/acssynbio.7b00289; Penzkofer A, 2014, J PHOTOCH PHOTOBIO A, V287, P19, DOI 10.1016/j.jphotochem.2014.04.017; Penzkofer A, 2013, CHEM PHYS, V412, P96, DOI 10.1016/j.chemphys.2012.12.015; Penzkofer A, 2011, CHEM PHYS, V387, P25, DOI 10.1016/j.chemphys.2011.05.028; Penzkofer A., 2014, TRENDS APPL SPECTROS, V11, P39; Penzkofer A, 2016, DYES PIGMENTS, V135, P102, DOI 10.1016/j.dyepig.2016.05.037; Penzkofer A, 2015, J PHOTOCH PHOTOBIO B, V153, P90, DOI 10.1016/j.jphotobiol.2015.08.027; Raffelberg S, 2013, BIOCHEM J, V455, P359, DOI 10.1042/BJ20130637; Ramakrishnan P, 2016, ACS SYNTH BIOL, V5, P733, DOI 10.1021/acssynbio.6b00068; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2017, J PLANT PHYSIOL, V217, P57, DOI 10.1016/j.jplph.2017.05.022; Rockwell NC, 2016, BIOCHEMISTRY-US, V55, P3907, DOI 10.1021/acs.biochem.6b00299; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P9667, DOI 10.1021/bi3013565; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Ryu MH, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00014-17; Ryu MH, 2014, P NATL ACAD SCI USA, V111, P10167, DOI 10.1073/pnas.1324301111; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shemetov AA, 2017, CELL CHEM BIOL, V24, P758, DOI 10.1016/j.chembiol.2017.05.018; Shenoy AR, 2004, FEBS LETT, V561, P11, DOI 10.1016/S0014-5793(04)00128-0; Shin AY, 2014, FEBS LETT, V588, P2964, DOI 10.1016/j.febslet.2014.05.050; SMITH G, 1981, FEMS MICROBIOL LETT, V11, P175; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Terauchi K, 1999, PLANT CELL PHYSIOL, V40, P248, DOI 10.1093/oxfordjournals.pcp.a029534; Huynh TN, 2015, MICROBIOL-SGM, V161, P1504, DOI 10.1099/mic.0.000092; Uda Y, 2017, P NATL ACAD SCI USA, V114, P11962, DOI 10.1073/pnas.1707190114; YANG JK, 1983, J BIOL CHEM, V258, P3750; Yoshikawa S, 2005, PHOTOCH PHOTOBIO SCI, V4, P727, DOI 10.1039/b417212d	84	45	45	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8473	8483		10.1074/jbc.RA118.002258	http://dx.doi.org/10.1074/jbc.RA118.002258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29632072	Green Published, hybrid			2022-12-28	WOS:000434205700012
J	Herschkovitz, A; Liu, YF; Ilan, E; Ronen, D; Boura-Halfon, S; Zick, Y				Herschkovitz, Avia; Liu, Yan-Fang; Ilan, Erez; Ronen, Denise; Boura-Halfon, Sigalit; Zick, Yehiel			RETRACTION: Common inhibitory serine sites phosphorylated by IRS-1 kinases, triggered by insulin and inducers of insulin resistance. (Retraction of Vol 282, Pg 18018, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Zick, Yehiel/K-1479-2012; liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022					Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7266	7266		10.1074/jbc.W118.003468	http://dx.doi.org/10.1074/jbc.W118.003468			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29752419	Green Published, hybrid			2022-12-28	WOS:000432174500020
J	Katsuno, Y; Qin, J; Oses-Prieto, J; Wang, HJ; Jackson-Weaver, O; Zhang, TW; Lamouille, S; Wu, J; Burlingame, A; Xu, J; Derynck, R				Katsuno, Yoko; Qin, Jian; Oses-Prieto, Juan; Wang, Hongjun; Jackson-Weaver, Olan; Zhang, Tingwei; Lamouille, Samy; Wu, Jian; Burlingame, Alma; Xu, Jian; Derynck, Rik			Arginine methylation of SMAD7 by PRMT1 in TGF-beta-induced epithelial-mesenchymal transition and epithelial stem-cell generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; DRUG-RESISTANCE; MIGRATION; RECEPTOR; GROWTH; ZEB1; EMT; DIFFERENTIATION; TUMORIGENICITY; PROLIFERATION	The epithelial-to-mesenchymal transdifferentiation (EMT) is crucial for tissue differentiation in development and drives essential steps in cancer and fibrosis. EMT is accompanied by reprogramming of gene expression and has been associated with the epithelial stem-cell state in normal and carcinoma cells. The cytokine transforming growth factor beta (TGF-beta) drives this program in cooperation with other signaling pathways and through TGF-beta-activated SMAD3 as the major effector. TGF-beta-induced SMAD3 activation is inhibited by SMAD7 and to a lesser extent by SMAD6, and SMAD6 and SMAD7 both inhibit SMAD1 and SMAD5 activation in response to the TGF-beta-related bone morphogenetic proteins (BMPs). We previously reported that, in response to BMP, protein arginine methyltransferase 1 (PRMT1) methylates SMAD6 at the BMP receptor complex, thereby promoting its dissociation from the receptors and enabling BMP-induced SMAD1 and SMAD5 activation. We now provide evidence that PRMT1 also facilitates TGF-beta-signaling by methylating SMAD7, which complements SMAD6 methylation. We found that PRMT1 is required for TGF-beta-induced SMAD3 activation, through a mechanism similar to that of BMP-induced SMAD6 methylation, and thus promotes the TGF-beta-induced EMT and epithelial stem-cell generation. This critical mechanism positions PRMT1 as an essential mediator of TGF-beta-signaling that controls the EMT and epithelial cell stemness through SMAD7 methylation.	[Katsuno, Yoko; Wang, Hongjun; Lamouille, Samy; Xu, Jian; Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Katsuno, Yoko; Wang, Hongjun; Lamouille, Samy; Xu, Jian; Derynck, Rik] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Oses-Prieto, Juan; Burlingame, Alma] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Derynck, Rik] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Derynck, Rik] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Qin, Jian; Jackson-Weaver, Olan; Zhang, Tingwei; Wu, Jian; Xu, Jian] Univ Southern Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Xu, Jian] Univ Southern Calif, Dept Biochem & Mol Med, Keck Sch Med, Los Angeles, CA 90033 USA; [Katsuno, Yoko] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Qin, Jian] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan 430060, Hubei, Peoples R China; [Wang, Hongjun] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20852 USA; [Zhang, Tingwei] Virginia Tech, Caril Res Inst, Roanoke, VA 24016 USA; [Zhang, Tingwei] Virginia Tech, Sch Med, Roanoke, VA 24016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Southern California; University of Southern California; University of Tokyo; Wuhan University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Xu, J (corresponding author), Univ Southern Calif, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 106, Los Angeles, CA 90033 USA.; Derynck, R (corresponding author), Univ Calif San Francisco, Broad Ctr Regenerat Med & Stem Cell Res, 35 Med Ctr Way,RMB 1027, San Francisco, CA 94143 USA.	xujian@usc.edu; rik.derynck@ucsf.edu	Wu, Jian/H-9404-2019; Xu, Jian/AAE-1415-2019	Wu, Jian/0000-0002-9272-5732; Zhang, Tingwei/0000-0003-2173-4663; Jackson-Weaver, Olan/0000-0002-0545-0647	Biomedical Research Technology Program of the National Institutes of Health National Center for Research Resources [5P41RR001614-29]; NIGMS, National Institutes of Health [8 P41 GM103481-29]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA136690, R01CA063101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026468, T90DE021982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	Biomedical Research Technology Program of the National Institutes of Health National Center for Research Resources; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The MS analysis was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at University of California San Francisco (A.L. Burlingame, Director) supported by the Biomedical Research Technology Program of the National Institutes of Health National Center for Research Resources under Grant 5P41RR001614-29; NIGMS, National Institutes of Health Grant 8 P41 GM103481-29; and the Howard Hughes Medical Institute.	Avasarala S, 2015, J BIOL CHEM, V290, P13479, DOI 10.1074/jbc.M114.636050; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Chuang CY, 2017, ONCOL REP, V38, P1115, DOI 10.3892/or.2017.5737; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19874; Gou YC, 2018, MECH DEVELOP, V152, P13, DOI 10.1016/j.mod.2018.05.001; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hashimoto M, 2016, J BIOL CHEM, V291, P2237, DOI 10.1074/jbc.M115.684514; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Itoh F, 2014, SEMIN CELL DEV BIOL, V32, P98, DOI 10.1016/j.semcdb.2014.05.017; Krampert M, 2010, MOL CELL BIOL, V30, P3685, DOI 10.1128/MCB.00434-09; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liao HW, 2015, J CLIN INVEST, V125, P4529, DOI 10.1172/JCI82826; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Muthusamy BP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002325; Nakai K, 2018, BREAST CANCER-TOKYO, V25, P74, DOI 10.1007/s12282-017-0790-z; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Shia WJ, 2012, BLOOD, V119, P4953, DOI 10.1182/blood-2011-04-347476; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Tang SY, 2010, DEV BIOL, V344, P233, DOI 10.1016/j.ydbio.2010.05.004; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu PL, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022087; Xu PL, 2014, MOL CELL, V56, P723, DOI 10.1016/j.molcel.2014.11.027; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhang T, 2018, J DENT RES, V97, P810, DOI 10.1177/0022034518755688; Zheng SS, 2013, MOL CELL, V52, P37, DOI 10.1016/j.molcel.2013.08.039; Zhou WZ, 2016, TUMOR BIOL, V37, P2613, DOI 10.1007/s13277-015-4098-3	43	42	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13059	13072		10.1074/jbc.RA118.002027	http://dx.doi.org/10.1074/jbc.RA118.002027			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29907569	hybrid, Green Published			2022-12-28	WOS:000442730200008
J	Menade, M; Kozlov, G; Trempe, JF; Pande, H; Shenker, S; Wickremasinghe, S; Li, XL; Hojjat, H; Dicaire, MJ; Brais, B; McPherson, PS; Wong, MJH; Young, JC; Gehring, K				Menade, Marie; Kozlov, Guennadi; Trempe, Jean-Francois; Pande, Harshit; Shenker, Solomon; Wickremasinghe, Sihara; Li, Xinlu; Hojjat, Hamed; Dicaire, Marie-Josee; Brais, Bernard; McPherson, Peter S.; Wong, Michael J. H.; Young, Jason C.; Gehring, Kalle			Structures of ubiquitin-like (Ubl) and Hsp90-like domains of sacsin provide insight into pathological mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; structural biology; neurodegenerative disease; molecular chaperone; biophysics; ARSACS disease; sacsin protein; Hsp90; TRAP1; X-ray crystallography	RECESSIVE SPASTIC ATAXIA; X-RAY SOLUTION; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; PROTEIN SACSIN; ARSACS; SYSTEM; REFINEMENT; CHAPERONE; DEFECTS	Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disease that is caused by mutations in the SACS gene. The product of this gene is a very large 520-kDa cytoplasmic protein, sacsin, with a ubiquitin-like (Ubl) domain at the N terminus followed by three large sacsin internal repeat (SIRPT) supradomains and C-terminal J and HEPN domains. The SIRPTs are predicted to contain Hsp90-like domains, suggesting a potential chaperone activity. In this work, we report the structures of the Hsp90-like Sr1 domain of SIRPT1 and the N-terminal Ubl domain determined at 1.55- and 2.1-angstrom resolutions, respectively. The Ubl domain crystallized as a swapped dimer that could be relevant in the context of full-length protein. The Sr1 domain displays the Bergerat protein fold with a characteristic nucleotide-binding pocket, although it binds nucleotides with very low affinity. The Sr1 structure reveals that ARSACS-causing missense mutations (R272H, R272C, and T201K) disrupt protein folding, most likely leading to sacsin degradation. This work lends structural support to the view of sacsin as a molecular chaperone and provides a framework for future studies of this protein.	[Menade, Marie; Kozlov, Guennadi; Trempe, Jean-Francois; Pande, Harshit; Shenker, Solomon; Wickremasinghe, Sihara; Li, Xinlu; Hojjat, Hamed; Wong, Michael J. H.; Young, Jason C.; Gehring, Kalle] McGill Univ, McGill Ctr Struct Biol, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Dicaire, Marie-Josee; Brais, Bernard; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Trempe, Jean-Francois] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Rm 473, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Brais, Bernard/Y-3910-2019; Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation (NSF); NIGMS, National Institutes of Health (NIH) via NSF [DMR-0225180]; National Center for Research Resources (NCRR), NIH [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NIGMS, National Institutes of Health (NIH) via NSF; National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Tin Pan for technical assistance. Data were acquired at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS). CHESS is supported by the National Science Foundation (NSF) and NIGMS, National Institutes of Health (NIH) via NSF Award DMR-0225180, and the MacCHESS resource is supported by National Center for Research Resources (NCRR), NIH Award RR-01646.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Anderrson JF, 2011, J MOL BIOL, V411, P870, DOI 10.1016/j.jmb.2011.06.016; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Baets J, 2010, NEUROLOGY, V75, P1181, DOI 10.1212/WNL.0b013e3181f4d86c; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Blumkin L, 2015, EUR J PAEDIATR NEURO, V19, P472, DOI 10.1016/j.ejpn.2015.02.005; BOUCHARD JP, 1978, CAN J NEUROL SCI, V5, P61, DOI 10.1017/S0317167100024793; Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; Bradshaw TY, 2016, HUM MOL GENET, V25, P3232, DOI 10.1093/hmg/ddw173; Criscuolo C, 2015, J NEUROL, V262, P2755, DOI 10.1007/s00415-015-7911-4; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Grynberg M, 2003, TRENDS BIOCHEM SCI, V28, P224, DOI 10.1016/S0968-0004(03)00060-4; Guernsey DL, 2010, J NEUROL SCI, V288, P79, DOI 10.1016/j.jns.2009.09.034; Kamionka M, 2004, PROTEIN SCI, V13, P2370, DOI 10.1110/ps.04824304; Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884; Lariviere R, 2015, HUM MOL GENET, V24, P727, DOI 10.1093/hmg/ddu491; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137298; Liu L, 2016, J NEUROL SCI, V362, P111, DOI 10.1016/j.jns.2016.01.026; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; MATSUMURA M, 1984, J BACTERIOL, V160, P413, DOI 10.1128/JB.160.1.413-420.1984; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Richter AM, 2004, NEUROGENETICS, V5, P165, DOI 10.1007/s10048-004-0179-y; Romano A, 2013, HUM MUTAT, V34, P525, DOI 10.1002/humu.22269; Seo YH, 2015, ARCH PHARM RES, V38, P1582, DOI 10.1007/s12272-015-0636-1; Shrestha L, 2016, CELL CHEM BIOL, V23, P158, DOI 10.1016/j.chembiol.2015.12.006; Sung N, 2016, ACTA CRYSTALLOGR D, V72, P904, DOI 10.1107/S2059798316009906; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takado Y, 2007, MOVEMENT DISORD, V22, P748, DOI 10.1002/mds.21365; Thiffault I, 2013, CAN J NEUROL SCI, V40, P61, DOI 10.1017/S0317167100012968; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vermeer S, 2008, NEUROGENETICS, V9, P207, DOI 10.1007/s10048-008-0131-7; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7	49	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12832	12842		10.1074/jbc.RA118.003939	http://dx.doi.org/10.1074/jbc.RA118.003939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29945973	Green Published, hybrid			2022-12-28	WOS:000442203500016
J	Taguchi, Y; Lu, L; Marrero-Winkens, C; Otaki, H; Nishida, N; Schatzl, HM				Taguchi, Yuzuru; Lu, Li; Marrero-Winkens, Cristobal; Otaki, Hiroki; Nishida, Noriyuki; Schatzl, Hermann M.			Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrPSc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; prion disease; protein crosslinking; protein misfolding; protein structure; protein conformation; prion conversion; prion protein	CREUTZFELDT-JAKOB-DISEASE; CODON 219; BETA-2-ALPHA-2 LOOP; TRANSGENIC MICE; NMR STRUCTURE; TRANSMISSION; MUTATION; POLYMORPHISM; AGGREGATION; BRIDGES	Prions are composed solely of the pathological isoform (PrPSc) of the normal cellular prion protein (PrPC). Identification of different PrPSc structures is crucially important for understanding prion biology because the pathogenic properties of prions are hypothesized to be encoded in the structures of PrPSc. However, these structures remain yet to be identified, because of the incompatibility of PrPSc with conventional high-resolution structural analysis methods. Previously, we reported that the region between the first and the second alpha-helix (H1 similar to H2) of PrPC might cooperate with the more C-terminal side region for efficient interactions with PrPSc. From this starting point, we created a series of PrP variants with two cysteine substitutions (C;C-PrP) forming a disulfide-crosslink between H1 similar to H2 and the distal region of the third helix (Ctrm). We then assessed the conversion capabilities of the C;C-PrP variants in N2a cells infected with mouse-adapted scrapie prions (22L-ScN2a). Specifically, Cys substitutions at residues 165, 166, or 168 in H1 similar to H2 were combined with cysteine scanning along Ctrm residues 220-229. We found that C;C-PrPs are expressed normally with glycosylation patterns and subcellular localization similar to WT PrP, albeit differing in expression levels. Interestingly, some C;C-PrPs converted to protease-resistant isoforms in the 22L-ScN2a cells, but not in Fukuoka1 prion-infected cells. Crosslink patterns of convertible C;C-PrPs indicated a positional change of H1 similar to H2 toward Ctrm in PrPSc-induced conformational conversion. Given the properties of the C;C-PrPs reported here, we propose that these PrP variants may be useful tools for investigating prion strain-specific structures and structure-phenotype relationships of PrPSc.	[Taguchi, Yuzuru; Lu, Li; Marrero-Winkens, Cristobal; Schatzl, Hermann M.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada; [Taguchi, Yuzuru; Nishida, Noriyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Cellular & Mol Biol, Nagasaki 8528523, Japan; [Lu, Li; Marrero-Winkens, Cristobal; Schatzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB, Canada; [Otaki, Hiroki] Nagasaki Univ, Grad Sch Biomed Sci, Ctr Bioinformat & Mol Med, Nagasaki 8528523, Japan	University of Calgary; Nagasaki University; University of Calgary; Nagasaki University	Taguchi, Y (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada.; Taguchi, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Cellular & Mol Biol, Nagasaki 8528523, Japan.; Schatzl, HM (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	ytaguchi@nagasaki-u.ac.jp; hschaetz@ucalgary.ca	Otaki, Hiroki/N-1540-2019	Otaki, Hiroki/0000-0002-0556-8434; Schatzl, Hermann/0000-0003-4972-8740	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health [R01 NS076853-01A1]; Alberta Innovates Health Solutions (AIHS) [201200002, 201600010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates Health Solutions (AIHS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health Grant R01 NS076853-01A1 and Alberta Innovates Health Solutions (AIHS) Grants 201200002 and 201600010. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Angers R, 2014, P NATL ACAD SCI USA, V111, P11169, DOI 10.1073/pnas.1404739111; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; Bett C, 2012, FASEB J, V26, P2868, DOI 10.1096/fj.11-200923; Biljan I, 2012, BIOCHEM J, V446, P243, DOI 10.1042/BJ20111940; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Giachin G, 2013, MOLECULES, V18, P9451, DOI 10.3390/molecules18089451; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Ishibashi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137958; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Knowles TPJ, 2006, BIOPHYS J, V91, P1494, DOI 10.1529/biophysj.106.081653; Kurt TD, 2014, J BIOL CHEM, V289, P10660, DOI 10.1074/jbc.M114.549030; Lukic A, 2010, ARCH NEUROL-CHICAGO, V67, P1021, DOI 10.1001/archneurol.2010.184; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Ohhashi Y, 2018, P NATL ACAD SCI USA, V115, P2389, DOI 10.1073/pnas.1715483115; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Saijo E, 2016, J VIROL, V90, P4905, DOI 10.1128/JVI.00088-16; Saverioni D, 2013, J BIOL CHEM, V288, P27972, DOI 10.1074/jbc.M113.477547; Seno H, 2000, ACTA NEUROPATHOL, V99, P125, DOI 10.1007/PL00007415; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; Shindoh R, 2009, J VIROL, V83, P3852, DOI 10.1128/JVI.01740-08; Shirai T, 2014, STRUCTURE, V22, P560, DOI 10.1016/j.str.2013.12.019; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Striebel JF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002275; Taguchi Y, 2013, PRION, V7, P452, DOI 10.4161/pri.27500; Taguchi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003466; Tamguney G, 2013, J GEN VIROL, V94, P443, DOI 10.1099/vir.0.045989-0; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Vazquez-Fernandez E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005835; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Zahn R, 2003, J MOL BIOL, V326, P225, DOI 10.1016/S0022-2836(02)01332-3	46	2	2	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12730	12740		10.1074/jbc.RA117.001633	http://dx.doi.org/10.1074/jbc.RA117.001633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934306	hybrid, Green Published			2022-12-28	WOS:000442203500007
J	Lu, M; He, XW				Lu, Min; He, Xiangwei			Ccp1 modulates epigenetic stability at centromeres and affects heterochromatin distribution in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone chaperone; centromere; heterochromatin; yeast; epigenetic stability; fission yeast	FISSION YEAST CENTROMERES; CENP-A; HISTONE H3; CHROMATIN INTEGRITY; NUCLEOSOME DYNAMICS; MESSENGER-RNAS; BUDDING YEAST; PROTEIN; KINETOCHORE; COMPLEX	Distinct chromatin organization features, such as centromeres and heterochromatin domains, are inherited epigenetically. However, the mechanisms that modulate the accuracy of epigenetic inheritance, especially at the individual nucleosome level, are not well-understood. Here, using ChIP and next-generation sequencing (ChIP-Seq), we characterized Ccp1, a homolog of the histone chaperone Vps75 in budding yeast that functions in centromere chromatin duplication and heterochromatin maintenance in fission yeast (Schizosaccharomyces pombe). We show that Ccp1 is enriched at the central core regions of the centromeres. Of note, among all histone chaperones characterized, deletion of the ccp1 gene uniquely reduced the rate of epigenetic switching, manifested as position effect variegation within the centromeric core region (CEN-PEV). In contrast, gene deletion of other histone chaperones either elevated the PEV switching rates or did not affect centromeric PEV. Ccp1 and the kinetochore components Mis6 and Sim4 were mutually dependent for centromere or kinetochore association at the proper levels. Moreover, Ccp1 influenced heterochromatin distribution at multiple loci in the genome, including the subtelomeric and the pericentromeric regions. We also found that Gar2, a protein predominantly enriched in the nucleolus, functions similarly to Ccp1 in modulating the epigenetic stability of centromeric regions, although its mechanism remained unclear. Together, our results identify Ccp1 as an important player in modulating epigenetic stability and maintaining proper organization of multiple chromatin domains throughout the fission yeast genome.	[He, Xiangwei] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	He, XW (corresponding author), Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China.	xhe@zju.edu.cn			National 973 Plan for Basic Research Grant [2015CB910602]; National Natural Science Foundation of China (NSFC) [31628012]	National 973 Plan for Basic Research Grant; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National 973 Plan for Basic Research Grant 2015CB910602 (to X. H.) and National Natural Science Foundation of China (NSFC) Grant 31628012 (to X. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Allshire RC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018770; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bassett EA, 2012, DEV CELL, V22, P749, DOI 10.1016/j.devcel.2012.02.001; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Buttrick GJ, 2011, CHROMOSOME RES, V19, P393, DOI 10.1007/s10577-011-9185-8; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Clement C, 2015, NAT STRUCT MOL BIOL, V22, P587, DOI 10.1038/nsmb.3067; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dong QH, 2016, MOL CELL, V64, P79, DOI 10.1016/j.molcel.2016.08.022; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Gao Q, 2010, P NATL ACAD SCI USA, V107, P13330, DOI 10.1073/pnas.1004887107; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; GULLI MP, 1995, NUCLEIC ACIDS RES, V23, P1912, DOI 10.1093/nar/23.11.1912; Gurard-Levin ZA, 2014, ANNU REV BIOCHEM, V83, P487, DOI 10.1146/annurev-biochem-060713-035536; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Hayashi A, 2006, MOL BIOL CELL, V17, P5173, DOI 10.1091/mbc.E06-05-0388; Henikoff S, 2012, GENETICS, V190, P1575, DOI 10.1534/genetics.111.137711; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jin QW, 2007, MOL BIOL CELL, V18, P2924, DOI 10.1091/mbc.E06-09-0853; Infante JJ, 2012, METHODS MOL BIOL, V833, P63, DOI 10.1007/978-1-61779-477-3_5; Keck KM, 2011, TRAFFIC, V12, P826, DOI 10.1111/j.1600-0854.2011.01202.x; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim S, 2015, J CELL BIOL, V208, P181, DOI 10.1083/jcb.201407074; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Li WZ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006900; Link Andrew J, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5606; Link Andrew J, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5607; Liu TY, 2016, P NATL ACAD SCI USA, V113, pE2822, DOI 10.1073/pnas.1523295113; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Sadeghi L, 2014, NAT STRUCT MOL BIOL, V21, P236, DOI 10.1038/nsmb.2776; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Selth LA, 2009, MOL CELL BIOL, V29, P4220, DOI 10.1128/MCB.01882-08; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Sicard H, 1998, MOL BIOL CELL, V9, P2011, DOI 10.1091/mbc.9.8.2011; Sugiyama T, 2013, NUCLEIC ACIDS RES, V41, P6674, DOI 10.1093/nar/gkt363; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2011, METHODS MOL BIOL, V725, P15, DOI 10.1007/978-1-61779-046-1_2; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Xue YM, 2013, MOL CELL BIOL, V33, P1645, DOI 10.1128/MCB.01121-12; Yao JH, 2013, J BIOL CHEM, V288, P19184, DOI 10.1074/jbc.M113.471276; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	74	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12068	12080		10.1074/jbc.RA118.003873	http://dx.doi.org/10.1074/jbc.RA118.003873			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29899117	hybrid, Green Published			2022-12-28	WOS:000440803200008
J	Wang, S; Ren, SW; Bai, RX; Xiao, PH; Zhou, Q; Zhou, Y; Zhou, ZG; Niu, YY; Ji, WZ; Chen, YC				Wang, Shuang; Ren, Shuaiwei; Bai, Raoxian; Xiao, Puhao; Zhou, Qin; Zhou, Yin; Zhou, Zhigang; Niu, Yuyu; Ji, Weizhi; Chen, Yongchang			No off-target mutations in functional genome regions of a CRISPR/Cas9-generated monkey model of muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gel electrophoresis; gene knockout; gene mapping; gene therapy; gene silencing; gene transfer; genetic disease; CRISPR; Cas9; efficiency; nonhuman primate; off-target; safety	CYNOMOLGUS MONKEY; CRISPR-CAS9; GENERATION; CELLS; GENE	CRISPR/Cas9 is now widely used in biomedical research and has great potential for clinical applications. However, the safety and efficacy of this gene-editing technique are significant issues. Recent reports on mouse models and human cells have raised concerns that off-target mutations could hamper applying the CRISPR technology in patients. The high similarities of nonhuman primates to humans in genome content and organization, genetic diversity, physiology, and cognitive abilities have made these animals ideal experimental models for understanding human diseases and developing therapeutics. Off-target mutations of CRISPR/Cas9 have been analyzed in previous studies of nonhuman primates, but no report has investigated genome-wide off-target effects in living monkeys. Here, we used rhesus monkeys in which a genetic disorder mimicking Duchenne muscular dystrophy had previously been produced with CRISPR/Cas9. Using whole-genome sequencing to comprehensively assess on- and off-target mutations in these animals, we found that CRISPR/Cas9-based gene editing is active on the expected genomic sites without producing off-target modifications in other functional regions of the genome. These findings suggest that the CRISPR/Cas9 technique could be relatively safe and effective in modeling genetic disease in nonhuman primates and in future therapeutic research of human diseases.	[Wang, Shuang; Ren, Shuaiwei; Bai, Raoxian; Xiao, Puhao; Zhou, Qin; Zhou, Yin; Zhou, Zhigang; Niu, Yuyu; Ji, Weizhi; Chen, Yongchang] Kunming Univ Sci & Technol, Inst Primate Translat Med, Yunnan Key Lab Primate Biomed Res, Kunming 650500, Yunnan, Peoples R China; [Wang, Shuang; Ren, Shuaiwei; Bai, Raoxian; Xiao, Puhao; Zhou, Qin; Zhou, Yin; Zhou, Zhigang; Niu, Yuyu; Ji, Weizhi; Chen, Yongchang] Yunnan Prov Acad Sci & Technol, Kunming 650051, Yunnan, Peoples R China	Kunming University of Science & Technology	Ji, WZ; Chen, YC (corresponding author), Kunming Univ Sci & Technol, Inst Primate Translat Med, Kunming 650500, Yunnan, Peoples R China.	wji@lpbr.cn; chenyc@lpbr.cn			National Key Research and Development Program of China [2018YFA0107902, 2016YFA010401]; National Natural Science Foundation of China [U1602224]; Basic Research Project of Yunnan Province [2015FA037]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Yunnan Province	This work was supported by National Key Research and Development Program of China Grants 2018YFA0107902 and 2016YFA010401, National Natural Science Foundation of China Grant U1602224, and Basic Research Project of Yunnan Province Grant 2015FA037. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KR, 2018, NAT METHODS, V15, P512, DOI 10.1038/s41592-018-0011-5; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Cui YQ, 2018, CELL RES, V28, P383, DOI 10.1038/cr.2018.10; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2014, J BIOL CHEM, V289, P4594, DOI 10.1074/jbc.R113.488247; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Zhao H, 2017, CELL RES, V27, P1293, DOI 10.1038/cr.2017.95	14	23	24	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11654	11658		10.1074/jbc.AC118.004404	http://dx.doi.org/10.1074/jbc.AC118.004404			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29941452	Green Published, hybrid			2022-12-28	WOS:000440134500001
J	Cui, W; Yoneda, R; Ueda, N; Kurokawa, R				Cui, Wei; Yoneda, Ryoma; Ueda, Naomi; Kurokawa, Riki			Arginine methylation of translocated in liposarcoma (TLS) inhibits its binding to long noncoding RNA, abrogating TLS-mediated repression of CBP/p300 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fused in sarcoma (FUS); long noncoding RNA (long ncRNA; lncRNA); post-translational modification (PTM); RNA-protein interaction; cyclin D1; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); histone acetylase; histone; RNA; gene expression; CBP; HAT activity; lncRNA; p300; TLS	SARCOMA PROTEIN; PRMT1; TRANSCRIPTION; METHYLTRANSFERASES; RECOGNITION; PEPTIDE	Translocated in liposarcoma (TLS) is an RNA-binding protein and a transcription-regulatory sensor of DNA damage. TLS binds promoter-associated noncoding RNA (pncRNA) and inhibits histone acetyltransferase (HAT) activity of CREB-binding protein (CBP)/E1A-binding protein P300 (p300) on the cyclin D1 (CCND1) gene. Although post-translational modifications of TLS, such as arginine methylation, are known to regulate TLS's nucleocytoplasmic shuttling and assembly in stress granules, its interactions with RNAs remain poorly characterized. Herein, using various biochemical assays, we confirmed the earlier observations that TLS is methylated by protein arginine methyltransferase 1 (PRMT1) in vitro. The arginine methylation of TLS disrupted binding to pncRNA and also prevented binding of TLS to and inhibition of CBP/p300. This result indicated that arginine methylation of TLS abrogates both binding to pncRNA and TLS-mediated inhibition of CBP/p300 HAT activities. We also report that an arginine residue within the Arg-Gly-Gly domain of TLS, Arg-476, serves as the major determinant for binding to pncRNA. Either methylation or mutation of Arg-476 of TLS significantly decreased pncRNA binding and thereby prevented a pncRNA-induced allosteric alteration in TLS that is required for its interaction with CBP/p300. Moreover, unlike WT TLS, an R476A TLS mutant did not inhibit CCND1 promoter activity in luciferase reporter assays. Taken together, we propose the hypothesis that arginine methylation of TLS regulates both TLS-nucleic acid and TLS-protein interactions and thereby participates in transcriptional regulation.	[Cui, Wei; Yoneda, Ryoma; Ueda, Naomi; Kurokawa, Riki] Saitama Med Univ, Res Ctr Genom Med, Div Gene Struct & Funct, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan	Saitama Medical University	Kurokawa, R (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Gene Struct & Funct, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan.	rkurokaw@saitama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT); KAKENHI from JSPS to MEXT of Japan [22390057, 25293073, 18K06939]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI from JSPS to MEXT of Japan	This work was supported in part by a grant-in-aid for "Support Project of Strategic Research Center in Private Universities" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to Saitama Medical University Research Center for Genomic Medicine and by KAKENHI from JSPS to MEXT of Japan (KibanB Grants 22390057 and 25293073, KibanC Grant 18K06939). The authors declare that they have no conflicts of interest with the contents of this article.	Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Belyanskaya LL, 2001, J BIOL CHEM, V276, P18681, DOI 10.1074/jbc.M011446200; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Brooke GN, 2011, CANCER RES, V71, P914, DOI 10.1158/0008-5472.CAN-10-0874; Burdach J, 2012, TRENDS BIOCHEM SCI, V37, P199, DOI 10.1016/j.tibs.2012.02.001; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Du K, 2011, BIOCHEM BIOPH RES CO, V404, P991, DOI 10.1016/j.bbrc.2010.12.097; Fujimoto K., 2013, CELL BIOL, V1, P18, DOI [10.11648/j.cb.20130102.11, DOI 10.11648/J.CB.20130102.11]; Fujimoto K, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-77; Hung CJ, 2009, PROTEIN J, V28, P139, DOI 10.1007/s10930-009-9174-3; Jobert L, 2009, EXP CELL RES, V315, P1273, DOI 10.1016/j.yexcr.2008.12.008; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Morettin A, 2015, MUTAGENESIS, V30, P177, DOI 10.1093/mutage/geu039; Ozdilek BA, 2017, NUCLEIC ACIDS RES, V45, P7984, DOI 10.1093/nar/gkx460; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Scaramuzzino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061576; Takahama K, 2013, CHEM BIOL, V20, P341, DOI 10.1016/j.chembiol.2013.02.013; Takahama K, 2011, FEBS J, V278, P988, DOI 10.1111/j.1742-4658.2011.08020.x; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049267; Yang L., 2015, THESIS; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yoneda R, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0068-8; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou Yueqin, 2014, Rare Dis, V2, pe29515, DOI 10.4161/rdis.29515	33	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10937	10948		10.1074/jbc.RA117.000598	http://dx.doi.org/10.1074/jbc.RA117.000598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784880	hybrid, Green Published			2022-12-28	WOS:000438882800008
J	DeColli, AA; Nemeria, NS; Majumdar, A; Gerfen, GJ; Jordan, F; Meyers, CLF				DeColli, Alicia A.; Nemeria, Natalia S.; Majumdar, Ananya; Gerfen, Gary J.; Jordan, Frank; Meyers, Caren L. Freel			Oxidative decarboxylation of pyruvate by 1-deoxy-d-xyulose 5-phosphate synthase, a central metabolic enzyme in bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						decarboxylase; oxygen binding; oxidation-reduction (redox); thiamine; enzyme mechanism; pyridoxal phosphate; DXP synthase; oxidative decarboxylation; oxygenase	COLI 1-DEOXY-D-XYLULOSE-5-PHOSPHATE SYNTHASE; ACETOLACTATE SYNTHASE; THIAMIN DIPHOSPHATE; DEPENDENT ENZYMES; SUBSTRATE-BINDING; DXP SYNTHASE; BIOSYNTHESIS; INTERMEDIATE; MECHANISM; OXIDOREDUCTASE	The underexploited antibacterial target 1-deoxy-d-xyluose 5-phosphate (DXP) synthase catalyzes the thiamin diphosphate (ThDP)-dependent formation of DXP from pyruvate and d-glyceraldehyde 3-phosphate (d-GAP). DXP is an essential intermediate in the biosynthesis of ThDP, pyridoxal phosphate, and isoprenoids in many pathogenic bacteria. DXP synthase catalyzes a distinct mechanism in ThDP decarboxylative enzymology in which the first enzyme-bound pre-decarboxylation intermediate, C2-lactyl-ThDP (LThDP), is stabilized by DXP synthase in the absence of d-GAP, and d-GAP then induces efficient LThDP decarboxylation. Despite the observed LThDP accumulation and lack of evidence for C2-carbanion formation in the absence of d-GAP, CO2 is released at appreciable levels under these conditions. Here, seeking to resolve these conflicting observations, we show that DXP synthase catalyzes the oxidative decarboxylation of pyruvate under conditions in which LThDP accumulates. O-2-dependent LThDP decarboxylation led to one-electron transfer from the C2-carbanion/enamine to O-2, with intermediate ThDP-enamine radical formation, followed by peracetic acid formation en route to acetate. Thus, LThDP formation and decarboxylation and DXP formation were studied under anaerobic conditions. Our results support a model in which O-2-dependent LThDP decarboxylation and peracetic acid formation occur in the absence of d-GAP, decreasing the levels of pyruvate and O-2 in solution. The relative pyruvate and O-2 concentrations then dictate the extent of LThDP accumulation, and its buildup can be observed when [pyruvate] > [O-2]. The finding that O-2 acts as a structurally distinct trigger of LThDP decarboxylation supports the hypothesis that a mechanism involving small molecule-dependent LThDP decarboxylation equips DXP synthase for diverse, yet uncharacterized cellular functions.	[DeColli, Alicia A.; Meyers, Caren L. Freel] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Majumdar, Ananya] Johns Hopkins Univ, Sch Med, Dept Chem, Baltimore, MD 21205 USA; [Nemeria, Natalia S.; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Gerfen, Gary J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Johns Hopkins University; Johns Hopkins University; Rutgers State University Newark; Rutgers State University New Brunswick; Yeshiva University; Albert Einstein College of Medicine	Meyers, CLF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	cmeyers@jhmi.edu		Freel Meyers, Caren/0000-0003-1458-0897	National Institutes of Health [R01 GM084998]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084998, T32GM008763, R15GM116077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM084998 (to C.L.F.M). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABELL LM, 1991, BIOCHEMISTRY-US, V30, P7883, DOI 10.1021/bi00246a002; Applied Photophysics, 2012, US MAN SX20 STOPP FL; Bartee D, 2015, CHEMBIOCHEM, V16, P1771, DOI 10.1002/cbic.201500119; Basta LAB, 2014, FEBS J, V281, P2820, DOI 10.1111/febs.12823; Battistini MR, 2016, PROTEIN EXPRES PURIF, V120, P16, DOI 10.1016/j.pep.2015.12.003; Brammer LA, 2011, J BIOL CHEM, V286, P36522, DOI 10.1074/jbc.M111.259747; Brammer LA, 2009, ORG LETT, V11, P4748, DOI 10.1021/ol901961q; Bunik Victoria I, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P307; BURGHAUS O, 1992, MEAS SCI TECHNOL, V3, P765, DOI 10.1088/0957-0233/3/8/013; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Eubanks LM, 2003, BIOCHEMISTRY-US, V42, P1140, DOI 10.1021/bi0205303; Gonzalez-James OM, 2010, J AM CHEM SOC, V132, P6896, DOI 10.1021/ja101775s; Kluger R, 2015, ACCOUNTS CHEM RES, V48, P2843, DOI 10.1021/acs.accounts.5b00306; Laber B, 1999, FEBS LETT, V449, P45, DOI 10.1016/S0014-5793(99)00393-2; Mansoorabadi SO, 2006, BIOCHEMISTRY-US, V45, P7122, DOI 10.1021/bi0602516; Morris F, 2013, CHEMBIOCHEM, V14, P1309, DOI 10.1002/cbic.201300187; Mundle SOC, 2009, J AM CHEM SOC, V131, P11638, DOI 10.1021/ja902686h; Nemeria NS, 2018, FREE RADICAL BIO MED, V115, P136, DOI 10.1016/j.freeradbiomed.2017.11.018; Nemeria NS, 2017, FREE RADICAL BIO MED, V108, P644, DOI 10.1016/j.freeradbiomed.2017.04.017; Nemeria NS, 2016, BIOCHEMISTRY-US, V55, P1135, DOI 10.1021/acs.biochem.5b01300; Nemeria NS, 2014, J BIOL CHEM, V289, P29859, DOI 10.1074/jbc.M114.591073; Patel H, 2012, J AM CHEM SOC, V134, P18374, DOI 10.1021/ja307315u; Pierce E, 2017, BIOCHEMISTRY-US, V56, P2824, DOI 10.1021/acs.biochem.7b00222; Putt KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079218; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Sanders S, 2017, ACS INFECT DIS, V3, P467, DOI 10.1021/acsinfecdis.6b00168; Schloss J. V., 1996, BIOCH PHYSL THIAMIN, P580; Schorken U, 1998, BBA-PROTEIN STRUCT M, V1385, P229, DOI 10.1016/S0167-4838(98)00071-5; Smith JM, 2014, J ANTIBIOT, V67, P77, DOI 10.1038/ja.2013.105; Smith JM, 2012, MEDCHEMCOMM, V3, P65, DOI 10.1039/c1md00233c; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Sung MG, 2015, BIOPROC BIOSYST ENG, V38, P517, DOI 10.1007/s00449-014-1291-5; Tittmann K, 2005, BIOCHEMISTRY-US, V44, P13291, DOI 10.1021/bi051058z; TSE JMT, 1993, BIOCHEMISTRY-US, V32, P10398, DOI 10.1021/bi00090a015; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Zhou JY, 2017, P NATL ACAD SCI USA, V114, P9355, DOI 10.1073/pnas.1619981114	36	7	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10857	10869		10.1074/jbc.RA118.001980	http://dx.doi.org/10.1074/jbc.RA118.001980			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784878	Green Published, hybrid			2022-12-28	WOS:000438882800002
J	Wattenberg, BW				Wattenberg, Binks W.			The long and the short of ceramides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HELA-CELLS; SYNTHASES; APOPTOSIS; STRESS	The sphingolipid ceramide is not only a precursor of more complex sphingolipids, but also a potent signaling molecule. Specific ceramide species have distinct cellular functions, and each ceramide synthase therefore has particular roles in cells and organisms. Tidhar and colleagues, utilizing two ceramide synthases differing widely in fatty acid specificity, have identified a short amino acid sequence that is critical for this specificity. This work represents a crucial first step in the understanding of both the enzymology and the biology driving the diverse functions of ceramide.	[Wattenberg, Binks W.] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Virginia Commonwealth University	Wattenberg, BW (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.	brian.wattenberg@vcuhealth.org			National Institutes of Health [1R01HL131340]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant 1R01HL131340. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ferreira NS, 2017, J BIOL CHEM, V292, P7588, DOI 10.1074/jbc.M117.785345; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Law BA, 2018, FASEB J, V32, P1403, DOI 10.1096/fj.201700300R; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Rana MS, 2018, SCIENCE, V359, P176, DOI 10.1126/science.aao6326; Sassa T, 2012, BBA-MOL CELL BIOL L, V1821, P1031, DOI 10.1016/j.bbalip.2012.04.008; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Tidhar R, 2018, J BIOL CHEM, V293, P9912, DOI 10.1074/jbc.RA118.001936; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271	10	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9922	9923		10.1074/jbc.H118.003522	http://dx.doi.org/10.1074/jbc.H118.003522			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29934368	Green Published, hybrid			2022-12-28	WOS:000436102300033
J	Dite, TA; Langendorf, CG; Hoque, A; Galic, S; Rebello, RJ; Ovens, AJ; Lindqvist, LM; Ngoei, KRW; Ling, NXY; Furic, L; Kemp, BE; Scott, JW; Oakhill, JS				Dite, Toby A.; Langendorf, Christopher G.; Hoque, Ashfaqul; Galic, Sandra; Rebello, Richard J.; Ovens, Ashley J.; Lindqvist, Lisa M.; Ngoei, Kevin R. W.; Ling, Naomi X. Y.; Furic, Luc; Kemp, Bruce E.; Scott, John W.; Oakhill, Jonathan S.			AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; RATIONAL DESIGN; CANCER; AUTOPHAGY; SUBUNIT; ULK1; PHOSPHORYLATION; METABOLISM; COMPLEXES; MECHANISM	Inhibition of the metabolic regulator AMP-activated protein kinase (AMPK) is increasingly being investigated for its therapeutic potential in diseases where AMPK hyperactivity results in poor prognoses, as in established cancers and neurodegeneration. However, AMPK-inhibitory tool compounds are largely limited to compound C, which has a poor selectivity profile. Here we identify the pyrimidine derivative SBI-0206965 as a direct AMPK inhibitor. SBI-0206965 inhibits AMPK with 40-fold greater potency and markedly lower kinase promiscuity than compound C and inhibits cellular AMPK signaling. Biochemical characterization reveals that SBI-0206965 is a mixed-type inhibitor. A co-crystal structure of the AMPK kinase domain/SBI-0206965 complex shows that the drug occupies a pocket that partially overlaps the ATP active site in a type IIb inhibitor manner. SBI-0206965 has utility as a tool compound for investigating physiological roles for AMPK and provides fresh impetus to small-molecule AMPK inhibitor therapeutic development.	[Dite, Toby A.; Hoque, Ashfaqul; Ovens, Ashley J.; Ling, Naomi X. Y.; Oakhill, Jonathan S.] Univ Melbourne, St Vincents Inst Med Res, Metab Signalling Lab, Fitzroy, Vic 3065, Australia; [Langendorf, Christopher G.; Galic, Sandra; Ngoei, Kevin R. W.; Kemp, Bruce E.; Scott, John W.] Univ Melbourne, St Vincents Inst Med Res, Prot Chem & Metab Unit, Fitzroy, Vic 3065, Australia; [Rebello, Richard J.; Furic, Luc] Peter MacCallum Canc Ctr, Prostate Canc Translat Res Lab, Melbourne, Vic 3000, Australia; [Rebello, Richard J.; Furic, Luc] Monash Univ, Biomed Discovery Inst, Canc Program, Clayton, Vic 3800, Australia; [Rebello, Richard J.; Furic, Luc] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Lindqvist, Lisa M.] Walter & Eliza Hall Inst Med Res, Cell Signalling & Cell Death Div, Parkville, Vic 3052, Australia; [Furic, Luc] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Kemp, Bruce E.; Scott, John W.; Oakhill, Jonathan S.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic 3000, Australia	St. Vincent's Institute of Medical Research; University of Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; Peter Maccallum Cancer Center; Monash University; Monash University; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center; University of Melbourne; Australian Catholic University	Oakhill, JS (corresponding author), St Vincents Inst Med Res, Metab Signalling Lab, Fitzroy, Vic 3065, Australia.	joakhill@svi.edu.au	Kemp, Bruce/G-9602-2019; Furic, Luc/F-4886-2012; Oakhill, Jonathan S/F-5724-2011; Scott, John W/AAA-2676-2021; Rebello, Richard/W-4687-2019; Scott, John W/P-1170-2018; Galic, Sandra/C-6098-2014; Hoque, Ashfaqul/AAL-8462-2020	Kemp, Bruce/0000-0001-6735-5082; Furic, Luc/0000-0002-1893-9812; Oakhill, Jonathan S/0000-0002-9475-1440; Scott, John W/0000-0002-1896-9798; Rebello, Richard/0000-0001-6271-6678; Scott, John W/0000-0002-1896-9798; Galic, Sandra/0000-0002-7611-5619; Hoque, Ashfaqul/0000-0003-2384-2983; Langendorf, Christopher/0000-0002-9049-5283; Ling, Naomi/0000-0001-6240-4092; Ovens, Ashley/0000-0001-5711-6555	Australian Research Council (ARC); Cancer Australia; National Health and Medical Research Council (NHMRC); Jack Brockhoff foundation [JBF-4206]; Victorian Government's Operational Infrastructure Support Program; Department of Health and Human Services acting through the Victorian Cancer Agency [MCRF16007]	Australian Research Council (ARC)(Australian Research Council); Cancer Australia; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Jack Brockhoff foundation; Victorian Government's Operational Infrastructure Support Program; Department of Health and Human Services acting through the Victorian Cancer Agency	This work was supported by grants from the Australian Research Council (ARC), Cancer Australia, the National Health and Medical Research Council (NHMRC), and the Jack Brockhoff foundation (Grant JBF-4206, 2016). The authors declare that they have no conflicts of interest with the contents of this article.; An NHMRC Early Career Research Fellow. Supported in part by the Victorian Government's Operational Infrastructure Support Program.; Supported by the Department of Health and Human Services acting through the Victorian Cancer Agency (MCRF16007).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BDOLAH A, 1968, J BACTERIOL, V96, P1144, DOI 10.1128/JB.96.4.1144-1149.1968; Blanc J, 2013, ANTI-CANCER AGENT ME, V13, P731, DOI 10.2174/1871520611313050008; Bricogne G., 2011, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davidson W, 2004, BIOCHEMISTRY-US, V43, P11658, DOI 10.1021/bi0495073; Dessauer CW, 1999, TRENDS PHARMACOL SCI, V20, P205, DOI 10.1016/S0165-6147(99)01310-3; Dite TA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00628-y; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fryer LGD, 2002, FEBS LETT, V531, P189, DOI 10.1016/S0014-5793(02)03501-9; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Ghani U, 2010, BIOORGAN MED CHEM, V18, P4042, DOI 10.1016/j.bmc.2010.04.021; Handa N, 2011, ACTA CRYSTALLOGR D, V67, P480, DOI 10.1107/S0907444911010201; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Jeon SM, 2015, ARCH PHARM RES, V38, P346, DOI 10.1007/s12272-015-0549-z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Langendorf CG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10912; Lee Y, 2016, BIOCHEM BIOPH RES CO, V469, P515, DOI 10.1016/j.bbrc.2015.12.015; Lesuisse D, 2011, BIOORG MED CHEM LETT, V21, P2224, DOI 10.1016/j.bmcl.2011.03.003; Liang JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8926; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Liu YJ, 2015, J NEUROGENET, V29, P50, DOI 10.3109/01677063.2015.1067203; Marmor S, 2001, BIOCHEMISTRY-US, V40, P12207, DOI 10.1021/bi015567m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; PATEL MS, 1972, BIOCHEM J, V128, P677, DOI 10.1042/bj1280677; Popovics P, 2015, EXPERT OPIN THER TAR, V19, P617, DOI 10.1517/14728222.2015.1005603; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Ross FA, 2017, CELL CHEM BIOL, V24, P813, DOI 10.1016/j.chembiol.2017.05.021; Ross FA, 2016, BIOCHEM J, V473, P189, DOI 10.1042/BJ20150910; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott JW, 2015, CHEM BIOL, V22, P705, DOI 10.1016/j.chembiol.2015.05.011; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Tang F, 2017, ONCOL REP, V37, P3449, DOI 10.3892/or.2017.5635; Thomson JM, 2007, ANTIMICROB AGENTS CH, V51, P1577, DOI 10.1128/AAC.01293-06; Vijayan RSK, 2015, J MED CHEM, V58, P466, DOI 10.1021/jm501603h; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; WESTMARK PR, 1993, J AM CHEM SOC, V115, P3416, DOI 10.1021/ja00062a003; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	64	66	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8874	8885		10.1074/jbc.RA118.003547	http://dx.doi.org/10.1074/jbc.RA118.003547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29695504	Green Published, hybrid			2022-12-28	WOS:000434941900012
J	Weinhaupl, K; Brennich, M; Kazmaier, U; Lelievre, J; Ballell, L; Goldberg, A; Schanda, P; Fraga, H				Weinhaupl, Katharina; Brennich, Martha; Kazmaier, Uli; Lelievre, Joel; Ballell, Lluis; Goldberg, Alfred; Schanda, Paul; Fraga, Hugo			The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); Mycobacterium tuberculosis; natural product; antibiotic action; antibiotic resistance; small-angle X-ray scattering (SAXS); protease; chaperone	SMALL-ANGLE SCATTERING; CASEINOLYTIC PROTEASE; NMR-SPECTROSCOPY; ADAPTER PROTEIN; MACROMOLECULES; STABILITY; BEAMLINE; SAXS; PLUS; BM29	Mycobacterium tuberculosis can remain dormant in the host, an ability that explains the failure of many current tuberculosis treatments. Recently, the natural products cyclomarin, ecumicin, and lassomycin have been shown to efficiently kill Mycobacterium tuberculosis persisters. Their target is the N-terminal domain of the hexameric AAA+ ATPase ClpC1, which recognizes, unfolds, and translocates protein substrates, such as proteins containing phosphorylated arginine residues, to the ClpP1P2 protease for degradation. Surprisingly, these antibiotics do not inhibit ClpC1 ATPase activity, and how they cause cell death is still unclear. Here, using NMR and small-angle X-ray scattering, we demonstrate that arginine-phosphate binding to the ClpC1 N-terminal domain induces millisecond dynamics. We show that these dynamics are caused by conformational changes and do not result from unfolding or oligomerization of this domain. Cyclomarin binding to this domain specifically blocked these N-terminal dynamics. On the basis of these results, we propose a mechanism of action involving cyclomarin-induced restriction of ClpC1 dynamics, which modulates the chaperone enzymatic activity leading eventually to cell death.	[Weinhaupl, Katharina; Schanda, Paul; Fraga, Hugo] Univ Grenoble Alpes, CEA, CNRS, IBS, 71 Ave Martyrs,CS 10090, F-38044 Grenoble 9, France; [Brennich, Martha] European Mol Biol Lab, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France; [Kazmaier, Uli] Saarland Univ, Inst Organ Chem, Campus C4-2, D-66123 Saarbrucken, Germany; [Lelievre, Joel; Ballell, Lluis] GlaxoSmithKline, Dis Developing World Discovery Performance Unit, Severo Ochoa 2, Madrid 28760, Spain; [Goldberg, Alfred] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Fraga, Hugo] Univ Porto, Dept Biomed, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal; [Fraga, Hugo] Univ Porto, I3S, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); Saarland University; GlaxoSmithKline; Harvard University; Harvard Medical School; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Schanda, P (corresponding author), Univ Grenoble Alpes, CEA, CNRS, IBS, 71 Ave Martyrs,CS 10090, F-38044 Grenoble 9, France.; Fraga, H (corresponding author), Univ Porto, Dept Biomed, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.; Fraga, H (corresponding author), Univ Porto, I3S, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.	paul.schanda@ibs.fr; hfraga@med.up.pt	Fraga, Hugo/X-4850-2019; Kazmaier, Uli/D-2947-2018; Schanda, Paul/A-5975-2010	Fraga, Hugo/0000-0001-7677-4086; Schanda, Paul/0000-0002-9350-7606; Weinhaupl, Katharina/0000-0002-9552-9876; Ballell, Lluis/0000-0002-3029-1860	FRISBI [ANR-10-INSB-05-02]; GRAL within the Grenoble Partnership for Structural Biology [ANR-10-LABX-4901]; Tres Cantos Open Lab Foundation; NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	FRISBI; GRAL within the Grenoble Partnership for Structural Biology; Tres Cantos Open Lab Foundation; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work used the platforms of the Grenoble Instruct Center (UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-4901) within the Grenoble Partnership for Structural Biology. We thank Dr. Caroline Mas for valuable advice. Dr. Goldberg's laboratory received grants from the Tres Cantos Open Lab Foundation and NIGMS, National Institutes of Health. We thank the ESRF for beam time at BM29.	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Ashiotis G, 2015, J APPL CRYSTALLOGR, V48, P510, DOI 10.1107/S1600576715004306; Barbie P, 2016, ORG BIOMOL CHEM, V14, P6055, DOI 10.1039/c6ob00801a; Barbie P, 2016, ORG LETT, V18, P204, DOI 10.1021/acs.orglett.5b03292; Bouvignies G, 2012, J PHYS CHEM B, V116, P14311, DOI 10.1021/jp311109u; Brennich ME, 2017, JOVE-J VIS EXP, DOI 10.3791/54861; Brennich ME, 2016, J APPL CRYSTALLOGR, V49, P203, DOI 10.1107/S1600576715024462; Carroni Marta, 2017, Elife, V6, DOI 10.7554/eLife.30120; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Franco R, 2017, J AM CHEM SOC, V139, P1065, DOI 10.1021/jacs.6b12089; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gao W, 2015, ANTIMICROB AGENTS CH, V59, P880, DOI 10.1128/AAC.04054-14; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Hart KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12965; He LC, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601625; Ishibashi M, 2005, PROTEIN EXPRES PURIF, V42, P1, DOI 10.1016/j.pep.2005.03.028; Ishikawa T, 2004, J STRUCT BIOL, V146, P180, DOI 10.1016/j.jsb.2003.11.018; Jung IP, 2017, INT J BIOL MACROMOL, V101, P348, DOI 10.1016/j.ijbiomac.2017.03.126; Kar NP, 2008, FEBS J, V275, P6149, DOI 10.1111/j.1742-4658.2008.06738.x; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2007, EMBO J, V26, P2061, DOI 10.1038/sj.emboj.7601655; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Lo JH, 2001, PROTEIN SCI, V10, P551, DOI 10.1110/ps.41401; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shukla D, 2010, J PHYS CHEM B, V114, P13426, DOI 10.1021/jp108399g; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Trentini DB, 2016, NATURE, V539, P48, DOI 10.1038/nature20122; Vagenende V, 2013, ACS CHEM BIOL, V8, P416, DOI 10.1021/cb300440x; Vasudevan D, 2013, J BIOL CHEM, V288, P30883, DOI 10.1074/jbc.M113.493767; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Yee M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02342-16; Zhang SW, 2017, J ADV CERAM, V6, P1, DOI 10.1007/s40145-016-0209-x; Zhang Y, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0023-2013; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	48	20	21	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8379	8393		10.1074/jbc.RA118.002251	http://dx.doi.org/10.1074/jbc.RA118.002251			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29632076	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000434205700005
J	St Amand, MM; Bond, MR; Riedy, J; Comly, M; Shiloach, J; Hanover, JA				St Amand, Melissa M.; Bond, Michelle R.; Riedy, Julia; Comly, Marcella; Shiloach, Joseph; Hanover, John A.			A genetic model to study O-GlcNAc cycling in immortalized mouse embryonic fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-GlcNAc transferase (OGT); (O-GlcNAc); fibroblast; glycogen synthase kinase 3 (GSK3); tauopathy; Tau protein (Tau); protein phosphorylation	RNA-POLYMERASE-II; N-ACETYLGLUCOSAMINE; INSULIN-RESISTANCE; X-CHROMOSOME; IN-VIVO; PHOSPHORYLATION; TRANSFERASE; TAU; GLYCOSYLATION; STRESS	O-GlcNAcylation is an abundant posttranslational protein modification in which the monosaccharide O-GlcNAc is added to Ser/Thr residues by O-GlcNAc transferase and removed by O-GlcNAcase. Analyses of O-GlcNAc-mediated signaling and metabolic phenomena are complicated by factors including unsatisfactory inhibitors and loss-of-function cell lines lacking identical genetic backgrounds. In this work, we generated immortalized WT, Oga knockout, and Ogt floxed allele (Ogt floxed) mouse embryonic fibroblast (MEF) cell lines with similar genetic backgrounds. These lines will facilitate experiments and serve as a platform to study O-GlcNAc cycling in mammals. As a test paradigm, we used the immortalized MEF lines to investigate how changes in O-GlcNAcylation affected pathological phosphorylation of the tau protein. The activity of glycogen synthase kinase 3 (GSK3), a kinase that phosphorylates tau, decreases when expressed in Oga knockout MEFs compared with WT cells. Phosphorylation at Thr(231) in recombinant, tauopathy-associated tau with a proline-to-leucine mutation at position 301 (P301L) was altered when expressed in MEFs with altered O-GlcNAc cycling. In aggregate, our data support that O-GlcNAc cycling indirectly affects tau phosphorylation at Thr(231), but tau phosphorylation was highly variable, even in genetically stable, immortalized MEF cells. The variable nature of tau phosphorylation observed here supports the need to use cells akin to those generated here with genetically defined lesions and similar backgrounds to study complex biological processes.	[St Amand, Melissa M.; Riedy, Julia; Shiloach, Joseph] NIDDK, Biotechnol Unit, NIH, Bethesda, MD 20892 USA; [St Amand, Melissa M.; Bond, Michelle R.; Comly, Marcella; Hanover, John A.] NIDDK, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hanover, JA (corresponding author), NIDDK, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA.	johnh@bdg8.niddk.nih.gov		Hanover, John/0000-0002-3154-9878	Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060102, ZIADK060103, ZIADK060101] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NIDDK, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Chow CY, 2016, NAT REV GENET, V17, P63, DOI 10.1038/nrg.2015.9; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olivier-Van Stichelen S, 2017, J BIOL CHEM, V292, P6076, DOI 10.1074/jbc.M116.774042; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	39	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13673	13681		10.1074/jbc.RA118.004059	http://dx.doi.org/10.1074/jbc.RA118.004059			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29954943	Green Published, hybrid			2022-12-28	WOS:000443375500026
J	Limi, S; Senecal, A; Coleman, R; Lopez-Jones, M; Guo, P; Polumbo, C; Singer, RH; Skoultchi, AI; Cvekl, A				Limi, Saima; Senecal, Adrien; Coleman, Robert; Lopez-Jones, Melissa; Guo, Peng; Polumbo, Christina; Singer, Robert H.; Skoultchi, Arthur, I; Cvekl, Ales			Transcriptional burst fraction and size dynamics during lens fiber cell differentiation and detailed insights into the denucleation process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING ENZYME; GENE-EXPRESSION REGULATION; MESSENGER-RNA SYNTHESIS; ALPHA-B-CRYSTALLIN; SINGLE-CELL; REGULATORY NETWORKS; MAMMALIAN-CELLS; POLYMERASE-II; A-CRYSTALLIN; EYE LENS	Genes are transcribed in irregular pulses of activity termed transcriptional bursts. Cellular differentiation requires coordinated gene expression; however, it is unknown whether the burst fraction (i.e. the number of active phases of transcription) or size/intensity (the number of RNA molecules produced within a burst) changes during cell differentiation. In the ocular lens, the positions of lens fiber cells correlate precisely with their differentiation status, and the most advanced cells degrade their nuclei. Here, we examined the transcriptional parameters of the beta-actin and lens differentiation-specific alpha-, beta-, and gamma-crystall in genes by RNA fluorescent in situ hybridization (FISH) in the lenses of embryonic day (E) E12.5, E14.5, and E16.5 mouse embryos and newborns. We found that cellular differentiation dramatically alters the burst fraction in synchronized waves across the lens fiber cell compartment with less dramatic changes in burst intensity. Surprisingly, we observed nascent transcription of multiple genes in nuclei just before nuclear destruction. Nuclear condensation was accompanied by transfer of nuclear proteins, including histone and nonhistone proteins, to the cytoplasm. Although lens-specific deletion of the chromatin remodeler SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (Smarca5/Snf2h) interfered with denucleation, persisting nuclei remained transcriptionally competent and exhibited changes in both burst intensity and fraction depending on the gene examined. Our results uncover the mechanisms of nascent transcriptional control during differentiation and chromatin remodeling, confirm the burst fraction as the major factor adjusting gene expression levels, and reveal transcriptional competence of fiber cell nuclei even as they approach disintegration.	[Limi, Saima; Cvekl, Ales] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Senecal, Adrien; Coleman, Robert; Lopez-Jones, Melissa; Guo, Peng; Polumbo, Christina; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Singer, Robert H.; Skoultchi, Arthur, I] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Singer, Robert H.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cvekl, A (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ales.cvekl@einstein.yu.edu		Cvekl, Ales/0000-0002-3957-789X	National Institutes of Health from NCI [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126045, T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA047729] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Shalev Itzkovitz for the critical reading of the manuscript. We are grateful to Dr. Usha Andley for advice. We thank the Analytical Imaging core facility for their services. The imaging was conducted in the Analytical Imaging Facility, which is funded by National Institutes of Health Grant P30CA013330 from NCI.	Akinduro O, 2016, J INVEST DERMATOL, V136, P1460, DOI 10.1016/j.jid.2016.03.016; Alvarez-Saavedra M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5181; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Battich N, 2015, CELL, V163, P1596, DOI 10.1016/j.cell.2015.11.018; Brennan LA, 2018, EXP EYE RES, V174, P173, DOI 10.1016/j.exer.2018.06.003; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Caveney PM, 2017, ACS SYNTH BIOL, V6, P334, DOI 10.1021/acssynbio.6b00189; Chaffee BR, 2014, DEVELOPMENT, V141, P3388, DOI 10.1242/dev.106005; Chen WV, 2001, BBA-GENE STRUCT EXPR, V1519, P30, DOI 10.1016/S0167-4781(01)00201-9; Cho WK, 2016, ELIFE, V5, DOI 10.7554/eLife.13617; Corrigan AM, 2016, ELIFE, V5, DOI 10.7554/eLife.13051; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Cvekl A, 2017, TRENDS GENET, V33, P677, DOI 10.1016/j.tig.2017.08.001; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; Dahm R, 1998, EUR J CELL BIOL, V75, P237, DOI 10.1016/S0171-9335(98)80118-0; den Engelsman J, 2004, EUR J BIOCHEM, V271, P4195, DOI 10.1111/j.1432-1033.2004.04359.x; Dluhosova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087448; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Eliscovich C, 2017, P NATL ACAD SCI USA, V114, pE1875, DOI 10.1073/pnas.1621440114; Erdel F, 2011, FEBS J, V278, P3608, DOI 10.1111/j.1742-4658.2011.08282.x; Fischer H, 2011, J INVEST DERMATOL, V131, P1208, DOI 10.1038/jid.2011.13; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; GORING DR, 1993, DEV DYNAM, V196, P143, DOI 10.1002/aja.1001960208; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027; He S, 2016, DEVELOPMENT, V143, P1937, DOI 10.1242/dev.135285; Hendy O, 2017, MOL BIOL CELL, V28, P3360, DOI 10.1091/mbc.E17-06-0408; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; KARASEK J, 1988, J INVEST DERMATOL, V91, P243, DOI 10.1111/1523-1747.ep12470372; Kiefer CM, 2011, BLOOD, V118, P6200, DOI 10.1182/blood-2011-06-363101; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Pietrowski D, 1997, BIOL CHEM, V378, P1183; PIETROWSKI D, 1994, GENE, V144, P171, DOI 10.1016/0378-1119(94)90375-1; Precht P, 2010, MOL IMMUNOL, V47, P2038, DOI 10.1016/j.molimm.2010.04.009; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rowan S, 2017, EXP EYE RES, V156, P72, DOI 10.1016/j.exer.2016.02.011; Sala A, 2011, EMBO J, V30, P1766, DOI 10.1038/emboj.2011.98; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Senecal A, 2014, CELL REP, V8, P75, DOI 10.1016/j.celrep.2014.05.053; Singh SK, 2016, GENE DEV, V30, P2527, DOI 10.1101/gad.285692.116; Sun J, 2015, MOL VIS, V21, P955; Sun J, 2015, NUCLEIC ACIDS RES, V43, P6827, DOI 10.1093/nar/gkv589; Tantale K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12248; van Bavel CC, 2009, MOL IMMUNOL, V47, P511, DOI 10.1016/j.molimm.2009.08.009; van den IJssel P, 2003, EXP CELL RES, V287, P249, DOI 10.1016/S0014-4827(03)00092-2; Vera M, 2016, ANNU REV GENET, V50, P267, DOI 10.1146/annurev-genet-120215-034854; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; Wolf L, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-88; Woo AJ, 2011, BLOOD, V118, P3684, DOI 10.1182/blood-2011-03-341446; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zenklusen D, 2010, METHOD ENZYMOL, V470, P641, DOI 10.1016/S0076-6879(10)70026-4; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhao BB, 2016, DEV CELL, V36, P498, DOI 10.1016/j.devcel.2016.02.001	70	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13176	13190		10.1074/jbc.RA118.001927	http://dx.doi.org/10.1074/jbc.RA118.001927			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29959226	hybrid, Green Published			2022-12-28	WOS:000442730200017
J	Desguin, B; Fellner, M; Riant, O; Hu, J; Hausinger, RP; Hols, P; Soumillion, P				Desguin, Benoit; Fellner, Matthias; Riant, Olivier; Hu, Jian; Hausinger, Robert P.; Hols, Pascal; Soumillion, Patrice			Biosynthesis of the nickel-pincer nucleotide cofactor of lactate racemase requires a CTP-dependent cyclometallase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial metabolism; nickel; lactic acid; natural product biosynthesis; protein structure; cyclometalation; lactate racemase; pincer complex	CONTROLLED GENE-EXPRESSION; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; PROTEIN; BINDING; SYSTEM; TRANSFORMATION	Bacterial lactate racemase is a nickel-dependent enzyme that contains a cofactor, nickel pyridinium-3,5-bisthiocarboxylic acid mononucleotide, hereafter named nickel-pincer nucleotide (NPN). The LarC enzyme from the bacterium Lactobacillus plantarum participates in NPN biosynthesis by inserting nickel ion into pyridinium-3,5-bisthiocarboxylic acid mononucleotide. This reaction, known in organometallic chemistry as a cyclometalation, is characterized by the formation of new metal-carbon and metal-sulfur sigma bonds. LarC is therefore the first cyclometallase identified in nature, but the molecular mechanism of LarC-catalyzed cyclometalation is unknown. Here, we show that LarC activity requires Mn2+-dependent CTP hydrolysis. The crystal structure of the C-terminal domain of LarC at 1.85 resolution revealed a hexameric ferredoxin-like fold and an unprecedented CTP-binding pocket. The loss-of-function of LarC variants with alanine variants of acidic residues leads us to propose a carboxylate-assisted mechanism for nickel insertion. This work also demonstrates the in vitro synthesis and purification of the NPN cofactor, opening new opportunities for the study of this intriguing cofactor and of NPN-utilizing enzymes.	[Desguin, Benoit; Hols, Pascal; Soumillion, Patrice] Catholic Univ Louvain, Inst Life Sci, B-1348 Louvain La Neuve, Belgium; [Riant, Olivier] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain La Neuve, Belgium; [Fellner, Matthias; Hu, Jian; Hausinger, Robert P.] Michigan State Univ, Dept Biochem & Mol Genet, E Lansing, MI 48824 USA; [Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Hausinger, Robert P.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Hols, Pascal] Fond Natl Rech Sci, Liege, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Michigan State University; Michigan State University; Michigan State University; Fonds de la Recherche Scientifique - FNRS	Desguin, B (corresponding author), BBGM ISV, Croix Sud 4-5 Bte L7-07-06, B-1348 Louvain La Neuve, Belgium.	benoit.desguin@uclouvain.be	riant, olivier/AAU-3567-2021; Fellner, Matthias/AFL-6357-2022; Fellner, Matthias/AAG-6443-2022	Fellner, Matthias/0000-0003-3192-6984; Fellner, Matthias/0000-0003-3192-6984; Hausinger, Robert/0000-0002-3643-2054; Desguin, Benoit/0000-0002-5004-6918; riant, olivier/0000-0003-4852-6469	National Science Foundation [CHE-1516126]; Fond National de la Recherche Scientifique; Belgian French Community Actions de Recherche Concertees Programme	National Science Foundation(National Science Foundation (NSF)); Fond National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian French Community Actions de Recherche Concertees Programme	This work was supported by National Science Foundation Grant CHE-1516126 (to R. P. H. and J. H.) and by Fond National de la Recherche Scientifique and Belgian French Community Actions de Recherche Concertees Programme (to P. S. and P. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht M, 2010, CHEM REV, V110, P576, DOI 10.1021/cr900279a; ARCHIBALD F, 1986, CRC CR REV MICROBIOL, V13, P63, DOI 10.3109/10408418609108735; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caliskan N, 2015, TRENDS BIOCHEM SCI, V40, P265, DOI 10.1016/j.tibs.2015.03.006; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Desguin B, 2016, P NATL ACAD SCI USA, V113, P5598, DOI 10.1073/pnas.1600486113; Desguin B, 2015, SCIENCE, V349, P66, DOI 10.1126/science.aab2272; Desguin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4615; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fellner M, 2017, P NATL ACAD SCI USA, V114, P9074, DOI 10.1073/pnas.1704967114; Fujishiro T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7895; Fujishiro T, 2014, FEBS LETT, V588, P2789, DOI 10.1016/j.febslet.2014.05.059; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; Orzel L, 2008, CHEM-EUR J, V14, P9419, DOI 10.1002/chem.200800991; Palanca C, 2017, ENV MICROBIOL REP, V9, P290, DOI 10.1111/1758-2229.12533; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sigel R.K.O., 2007, NICKEL ITS SURPRISIN, P109; Sparta KM, 2016, J APPL CRYSTALLOGR, V49, P1085, DOI 10.1107/S1600576716004416; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Zhang GY, 2009, APPL ENVIRON MICROB, V75, P1080, DOI 10.1128/AEM.01416-08; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zheng ZJ, 2016, NUCLEIC ACIDS RES, V44, pD301, DOI 10.1093/nar/gkv1124	34	19	19	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12303	12317		10.1074/jbc.RA118.003741	http://dx.doi.org/10.1074/jbc.RA118.003741			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29887527	hybrid, Green Published			2022-12-28	WOS:000441408500001
J	Fernandez-de Gortari, E; Espinoza-Fonseca, LM				Fernandez-de Gortari, Eli; Espinoza-Fonseca, L. Michel			Structural basis for relief of phospholamban-mediated inhibition of the sarcoplasmic reticulum Ca2+-ATPase at saturating Ca2+ conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium ATPase; calcium; sarcoplasmic reticulum (SR); membrane transport; molecular dynamics; cardiac muscle; inhibition mechanism; phospholamban; SERCA	PARTICLE MESH EWALD; CALCIUM-PUMP; MOLECULAR-DYNAMICS; MONOMERIC PHOSPHOLAMBAN; CONFORMATIONAL SWITCH; CRYSTAL-STRUCTURES; BINDING SITES; PHOSPHORYLATION; PROTEIN; SARCOLIPIN	Sarcoplasmic reticulum Ca2+-ATPase (SERCA) is critical for cardiac Ca2+ transport. Reversal of phospholamban (PLB)-mediated SERCA inhibition by saturating Ca2+ conditions operates as a physiological rheostat to reactivate SERCA function in the absence of PLB phosphorylation. Here, we performed extensive atomistic molecular dynamics simulations to probe the structural mechanism of this process. Simulation of the inhibitory complex at superphysiological Ca2+ concentrations ([Ca2+] = 10 mm) revealed that Ca2+ ions interact primarily with SERCA and the lipid headgroups, but not with PLB's cytosolic domain or the cytosolic side of the SERCA-PLB interface. At this [Ca2+], a single Ca2+ ion was translocated from the cytosol to the transmembrane transport sites. We used this Ca2+-bound complex as an initial structure to simulate the effects of saturating Ca2+ at physiological conditions ([Ca2+](total) approximate to 400 m). At these conditions, approximate to 30% of the Ca2+-bound complexes exhibited structural features consistent with an inhibited state. However, in approximate to 70% of the Ca2+-bound complexes, Ca2+ moved to transport site I, recruited Glu(771) and Asp(800), and disrupted key inhibitory contacts involving the conserved PLB residue Asn(34). Structural analysis showed that Ca2+ induces only local changes in interresidue inhibitory interactions, but does not induce repositioning or changes in PLB structural dynamics. Upon relief of SERCA inhibition, Ca2+ binding produced a site I configuration sufficient for subsequent SERCA activation. We propose that at saturating [Ca2+] and in the absence of PLB phosphorylation, binding of a single Ca2+ ion in the transport sites rapidly shifts the equilibrium toward a noninhibited SERCA-PLB complex.	[Fernandez-de Gortari, Eli; Espinoza-Fonseca, L. Michel] Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Espinoza-Fonseca, LM (corresponding author), Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	lmef@umich.edu		Espinoza-Fonseca, L. Michel/0000-0002-7356-5681	NIGMS, National Institutes of Health Grant [R01GM120142]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120142] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM120142 (to L. M. E.-F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Akin BL, 2012, J BIOL CHEM, V287, P7582, DOI 10.1074/jbc.M111.334987; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; BALKE CW, 1994, J PHYSIOL-LONDON, V474, P447, DOI 10.1113/jphysiol.1994.sp020036; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; CARUGO O, 1993, J CHEM SOC DALTON, P2127, DOI 10.1039/dt9930002127; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Simone A, 2013, BIOCHEMISTRY-US, V52, P6684, DOI 10.1021/bi400517b; Deng H, 2006, PROTEINS, V64, P34, DOI 10.1002/prot.20973; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; Dudev T, 1999, J PHYS CHEM A, V103, P8093, DOI 10.1021/jp991575p; Dudev T, 2004, J PHYS CHEM B, V108, P4546, DOI 10.1021/jp0310347; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; Espinoza-Fonseca LM, 2015, BIOCHEM BIOPH RES CO, V463, P37, DOI 10.1016/j.bbrc.2015.05.012; Espinoza-Fonseca LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095979; Espinoza-Fonseca LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026936; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandez-De Gortari E, 2017, PHYS CHEM CHEM PHYS, V19, P10153, DOI 10.1039/c7cp00243b; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Ha KN, 2007, J BIOL CHEM, V282, P37205, DOI 10.1074/jbc.M704056200; HOVEMADSEN L, 1993, AM J PHYSIOL, V264, pC677, DOI 10.1152/ajpcell.1993.264.3.C677; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; James ZM, 2012, BIOPHYS J, V103, P1370, DOI 10.1016/j.bpj.2012.08.032; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kekenes-Huskey PM, 2012, PROTEIN SCI, V21, P1429, DOI 10.1002/pro.2129; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kirschenlohr HL, 2000, BIOCHEM J, V346, P385, DOI 10.1042/0264-6021:3460385; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; Metcalfe EE, 2005, BIOCHEMISTRY-US, V44, P4386, DOI 10.1021/bi047571e; Espinoza-Fonseca LM, 2015, BIOPHYS J, V108, P1697, DOI 10.1016/j.bpj.2015.03.004; Mintz E, 1997, BBA-BIOENERGETICS, V1318, P52, DOI 10.1016/S0005-2728(96)00132-6; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; NAYAL M, 1994, P NATL ACAD SCI USA, V91, P817, DOI 10.1073/pnas.91.2.817; Norimatsu Y, 2017, NATURE, V545, P193, DOI 10.1038/nature22357; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pal TK, 2008, J MOL GRAPH MODEL, V27, P20, DOI 10.1016/j.jmgm.2008.02.001; Paterlini MG, 2005, BIOPHYS J, V88, P3243, DOI 10.1529/biophysj.104.054460; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sabbah HN, 2014, ESC HEART FAIL, V1, P94, DOI 10.1002/ehf2.12013; Sande JB, 2002, CARDIOVASC RES, V53, P382, DOI 10.1016/S0008-6363(01)00489-8; SASAKI T, 1992, J BIOL CHEM, V267, P1674; Smolin N, 2015, J PHYS CHEM B, V119, P1407, DOI 10.1021/jp511433v; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; Sugita Y, 2010, P NATL ACAD SCI USA, V107, P21465, DOI 10.1073/pnas.1015819107; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; Weber W, 2000, J PHYS CHEM B, V104, P3668, DOI 10.1021/jp9937757; WENDTGALLITELLI MF, 1991, J PHYSIOL-LONDON, V435, P349, DOI 10.1113/jphysiol.1991.sp018514; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Zamoon J, 2005, P NATL ACAD SCI USA, V102, P4747, DOI 10.1073/pnas.0406039102; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5	81	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12405	12414		10.1074/jbc.RA118.003752	http://dx.doi.org/10.1074/jbc.RA118.003752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29934304	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000441408500008
J	Jamilloux, Y; Lagrange, B; Micco, A; Bourdonnay, E; Provost, A; Tallant, R; Henry, T; Martinon, F				Jamilloux, Yvan; Lagrange, Brice; Di Micco, Antonia; Bourdonnay, Emilie; Provost, Angelina; Tallant, Remy; Henry, Thomas; Martinon, Fabio			A proximity-dependent biotinylation (BioID) approach flags the p62/sequestosome-1 protein as a caspase-1 substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; inflammation; autophagy; caspase-1 (CASP1); proteomics; proteolytic enzyme	INFLAMMASOME ACTIVATION; CELL-DEATH; SELECTIVE AUTOPHAGY; AIM2 INFLAMMASOME; IN-VITRO; INFECTION; CLEAVAGE; RECRUITMENT; SECRETION; MUTATION	The inflammasome is a major component of the innate immune system, and its main function is to activate caspase-1, a cysteine protease that promotes inflammation by inducing interleukin-1 (IL-1) maturation and release into the extracellular milieu. To prevent uncontrolled inflammation, this complex is highly regulated. When it is assembled, the inflammasome is insoluble, which has long precluded the analysis of its interactions with other proteins. Here we used the proximity-dependent biotinylation assay (BioID) to identify proteins associated with caspase-1 during inflammasome activation. Using the BioID in a cell-free system in which the inflammasome had been activated, we found that a caspase-1-biotin ligase fusion protein selectively labeled 111 candidates, including the p62/sequestosome-1 protein (p62). Using co-immunoprecipitation experiments, we demonstrated that p62 interacts with caspase-1. This interaction promoted caspase-1-mediated cleavage of p62 at Asp-329. Mechanistic and functional analyses revealed that caspase-1-mediated cleavage of p62 leads to loss of its interaction with the autophagosomal protein microtubule-associated protein 1 light chain 3 (LC3B). Strikingly, overexpression of a p62 N-terminal fragment generated upon caspase-1 cleavage decreased IL-1 release, whereas overexpression of p62's C-terminal portion enhanced IL-1 release, by regulating pro-IL1 levels. Overall, the overexpression of both fragments together decreased IL-1 release. Taken together, our results indicate that caspase-1-mediated p62 cleavage plays a complex role in balancing caspase-1-induced inflammation.	[Jamilloux, Yvan; Lagrange, Brice; Di Micco, Antonia; Bourdonnay, Emilie; Provost, Angelina; Tallant, Remy; Henry, Thomas; Martinon, Fabio] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Jamilloux, Yvan; Lagrange, Brice; Di Micco, Antonia; Bourdonnay, Emilie; Provost, Angelina; Tallant, Remy; Henry, Thomas; Martinon, Fabio] Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, Ctr Int Rech Infectiol, CNRS,INSERM,UMR5308,U1111, F-69007 Lyon, France; [Jamilloux, Yvan; Lagrange, Brice; Di Micco, Antonia; Bourdonnay, Emilie; Provost, Angelina; Tallant, Remy; Henry, Thomas; Martinon, Fabio] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Hop Croix Rousse, Dept Internal Med, F-69004 Lyon, France	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Henry, T (corresponding author), Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, Ctr Int Rech Infectiol, CNRS,INSERM,UMR5308,U1111, F-69007 Lyon, France.; Martinon, F (corresponding author), Dept Biochem, Rm F404,Ch Boveresses 155,CP 51, CH-1066 Epalinges, Switzerland.	thomas.henry@inserm.fr; fabio.martinon@unil.ch	Martinon, Fabio/A-5575-2009; Jamilloux, Yvan/F-6601-2019; Henry, Thomas/G-3160-2013; Bourdonnay, Emilie/P-3115-2019	Martinon, Fabio/0000-0002-6969-822X; Jamilloux, Yvan/0000-0001-5249-3650; Henry, Thomas/0000-0002-0687-8565; Bourdonnay, Emilie/0000-0002-3579-5478; Lagrange, Brice/0000-0002-4131-5995	Fondation Innovations en Infectiologie; Foundation for the Development of Internal Medicine in Europe; Groupama Foundation; EC Seventh Framework Programme (FP7) Grants [311542, 281996]; Societe Nationale Francaise de Medecine Interne; poste d'accueil from INSERM	Fondation Innovations en Infectiologie; Foundation for the Development of Internal Medicine in Europe; Groupama Foundation; EC Seventh Framework Programme (FP7) Grants; Societe Nationale Francaise de Medecine Interne; poste d'accueil from INSERM	This work was supported by Fondation Innovations en Infectiologie, the Foundation for the Development of Internal Medicine in Europe, and the Groupama Foundation (to Y. J.), EC Seventh Framework Programme (FP7) Grants 311542 (to T. H.) and 281996 (to F. M.); the Societe Nationale Francaise de Medecine Interne, and by a poste d'accueil from INSERM (to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Bagnis Claude, 2009, V515, P151, DOI 10.1007/978-1-59745-559-6_10; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Chae JJ, 2015, ARTHRITIS RHEUMATOL, V67, P563, DOI 10.1002/art.38961; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; Cronan JE, 2005, J NUTR BIOCHEM, V16, P416, DOI 10.1016/j.jnutbio.2005.03.017; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Di Micco A, 2016, P NATL ACAD SCI USA, V113, pE4671, DOI 10.1073/pnas.1602419113; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Harris J, 2017, MOL IMMUNOL, V86, P10, DOI 10.1016/j.molimm.2017.02.013; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Jamilloux Y, 2016, METHODS MOL BIOL, V1417, P207, DOI 10.1007/978-1-4939-3566-6_14; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu T, 2016, CELL REP, V16, P1988, DOI 10.1016/j.celrep.2016.07.019; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Luschen S, 1998, BIOCHEM BIOPH RES CO, V253, P92, DOI 10.1006/bbrc.1998.9754; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Ohtsuka S, 2014, EUR J IMMUNOL, V44, P1084, DOI 10.1002/eji.201344091; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saitoh T, 2016, J ALLERGY CLIN IMMUN, V138, P28, DOI 10.1016/j.jaci.2016.05.009; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi J, 2014, CELL DEATH DIFFER, V21, P1432, DOI 10.1038/cdd.2014.58; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JY, 2013, AUTOPHAGY, V9, P1591, DOI 10.4161/auto.26059; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 2001, J CELL BIOL, V152, P1115, DOI 10.1083/jcb.152.5.1115; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; Wang LJ, 2012, MOL CELL PROTEOMICS, V11, P1230, DOI 10.1074/mcp.M112.020594; Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011; Wurzer B, 2015, ELIFE, V4, DOI 10.7554/eLife.08941; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	47	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12563	12575		10.1074/jbc.RA117.000435	http://dx.doi.org/10.1074/jbc.RA117.000435			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29929983	Green Published, hybrid			2022-12-28	WOS:000441408500021
J	Zheng, WL; Lu, Y; Tian, SY; Ma, FG; Wei, YJ; Xu, SS; Li, Y				Zheng, Weili; Lu, Yi; Tian, Siyu; Ma, Fengge; Wei, Yijuan; Xu, Shuangshuang; Li, Yong			Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; dimerization; X-ray crystallography; drug discovery; receptor structure-function; translation regulation; structural biology; structural model; transcriptional coactivator; FXR RXR heterodimer	RETINOID-X-RECEPTOR; LIGAND-BINDING DOMAINS; BILE-ACIDS; CRYSTAL-STRUCTURE; AGONIST; ALPHA; IDENTIFICATION; COACTIVATORS; ACTIVATION; DISEASE	Farnesoid X receptor (FXR) is a member of the family of ligand-activated nuclear receptors. FXR plays critical roles in maintaining many metabolic pathways, including bile acid regulation and glucose and lipid homeostasis, and forms a heterodimeric complex with the retinoid X receptor (RXR). Despite the important roles of the FXR/RXR heterodimerization in human physiology, the molecular basis underlying the FXR/RXR interaction is still uncertain in the absence of a complex structure. Here, we report the heterodimeric structure of FXR and RXR in the presence of an FXR agonist (WAY-362450), RXR agonist (9-cis-retinoic acid), and a peptide derived from a steroid receptor coactivator (SRC2), revealing both unique and conserved modes for FXR heterodimerization. We found that the dimerization with RXR induced allosteric conformational changes on the coactivator-binding site of FXR. These changes enhanced the transcriptional activity of FXR by promoting the coactivator binding, thus suggesting a structural basis for the functional permissiveness of the FXR/RXR heterodimer complex. Furthermore, sequence analyses together with functional mutagenesis studies indicated that the helix H10 largely responsible for the dimerization is highly conserved and also critical for the FXR transcriptional activity. Our findings highlight the important roles of RXR heterodimerization in the nuclear receptor signaling, providing a potential framework to develop pharmaceutical agents in treating FXR/RXR-related diseases.	[Zheng, Weili; Lu, Yi; Tian, Siyu; Ma, Fengge; Wei, Yijuan; Xu, Shuangshuang; Li, Yong] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China	Xiamen University	Li, Y (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China.; Zheng, WL (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	weilizheng1116@gmail.com; yongli@xmu.edu.cn	Zheng, Weili/J-6754-2019	Zheng, Weili/0000-0003-4644-0127; Lu, Yi/0000-0002-6504-9548	National Natural Science Foundation of China [31470726, 31770814, U1405220]; 111 Project of Ministry of Education of China [B06016]; National Science Foundation of China [J1310027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project of Ministry of Education of China(Ministry of Education, China - 111 Project); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31470726, 31770814, and U1405220; 111 Project of Ministry of Education of China Grant B06016; and National Science Foundation of China for Fostering Talents in Basic Research Grant J1310027. The authors declare that they have no conflicts of interest with the contents of this article.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chao EY, 2008, J MED CHEM, V51, P5758, DOI 10.1021/jm800612u; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez EJ, 2018, PHARMACOL THERAPEUT, V183, P152, DOI 10.1016/j.pharmthera.2017.10.014; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Jin LH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2924; Kojetin DJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9013; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Ohno T, 2012, CANCER LETT, V323, P215, DOI 10.1016/j.canlet.2012.04.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pavlin MR, 2014, J BIOL CHEM, V289, P24771, DOI 10.1074/jbc.M114.575423; Putcha BDK, 2012, P NATL ACAD SCI USA, V109, P6084, DOI 10.1073/pnas.1119852109; Rizzo G, 2005, MOL PHARMACOL, V68, P551, DOI 10.1124/mol.105.012104; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; Wallace BD, 2013, J MOL BIOL, V425, P2561, DOI 10.1016/j.jmb.2013.04.012; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042; Yamada S, 2014, EXPERT OPIN THER PAT, V24, P443, DOI 10.1517/13543776.2014.880692; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	36	19	20	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12535	12541		10.1074/jbc.RA118.004188	http://dx.doi.org/10.1074/jbc.RA118.004188			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29934308	hybrid, Green Published			2022-12-28	WOS:000441408500019
J	Clancy, JW; Sheehan, CS; Tricarico, CJ; D'Souza-Schorey, C				Clancy, James W.; Sheehan, Cohn S.; Tricarico, Christopher J.; D'Souza-Schorey, Crislyn			Aberrant endocytosis leads to the loss of normal mitotic spindle orientation during epithelial glandular morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; epithelial cell; cell biology; cell polarity; cell sorting; membrane trafficking; morphogenesis; epithelial cyst; endocytosis; mitotic spindle; ARF6; extracellular signal regulated kinase; glandular epithelium; receptor internalization; cadherin; GTPase; cMet receptor	BREAST-CANCER INVASION; ARF6 ACTIVATION; SIGNALING PATHWAY; RAB35; RECEPTOR; CELLS; CDC42; ENDOSOMES; PROTEINS; ADHESION	Epithelial cells form tissues with many functions, including secretion and environmental separation and protection. Glandular epithelial tissues comprise cysts and tubules that are formed from a polarized, single-epithelial cell layer surrounding a central, fluid-filled lumen. The pathways regulating key processes in epithelial tissue morphogenesis such as mitotic spindle formation are incompletely understood, but are important to investigate, as their dysregulation is a signature of epithelial tumors. Here, we describe a signaling axis that manifests in a defect in mitotic spindle orientation during epithelial growth and cystogenesis. We found that activation of the small GTPase ADP-ribosylation factor 6 (ARF6) results in the sustained internalization of cell-surface components such as the cMet receptor and the cell-adhesion molecule E-cadherin. The spindle orientation defect arising from elevated levels of ARF6-GTP required an increase in cMet endocytosis, but was independent of E-cadherin internalization or elevated extracellular signal-regulated kinase (ERK) activity resulting from internalized receptor signaling on endosomes. Misorientation of the mitotic spindle resulted in the development of epithelial cysts with structural abnormalities, the most conspicuous of which was the presence of multiple intercellular lumens. Abnormal mitotic spindle orientation was necessary but insufficient to disrupt glandular development, as blocking the strong prosurvival signal resulting from ERK hyperactivation yielded structurally normal cysts despite continued manifestation of spindle orientation defects. Our findings highlight a previously unknown link between ARF6 activation, cMet receptor internalization, and mitotic spindle orientation during epithelial glandular morphogenesis.	[Clancy, James W.; Sheehan, Cohn S.; Tricarico, Christopher J.; D'Souza-Schorey, Crislyn] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	D'Souza-Schorey, C (corresponding author), Box 369,Galvin Life Sci Bldg, Notre Dame, IN 46556 USA.	cdsouzas@nd.edu		Clancy, James/0000-0001-7967-1111	NCI, National Institutes of Health [R01CA115316]; NATIONAL CANCER INSTITUTE [R01CA115316] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health, Grant R01CA115316 (to C.D.-S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Benard V, 2002, METHOD ENZYMOL, V345, P349; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Hu ZZ, 2013, EXP CELL RES, V319, P1932, DOI 10.1016/j.yexcr.2013.05.028; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Miyamotoa Y, 2014, MOL BIOL CELL, V25, P1532, DOI 10.1091/mbc.E13-10-0600; Monteleon CL, 2012, MOL BIOL CELL, V23, P4495, DOI 10.1091/mbc.E12-03-0246; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Pellon-Cardenas O, 2013, MOL CELL BIOL, V33, P2963, DOI 10.1128/MCB.01698-12; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Sangar F, 2014, ONCOGENE, V33, P2758, DOI 10.1038/onc.2013.211; Tushir JS, 2010, MOL BIOL CELL, V21, P2355, DOI 10.1091/mbc.E09-09-0824; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	42	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12095	12104		10.1074/jbc.RA117.001640	http://dx.doi.org/10.1074/jbc.RA117.001640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29903910	Green Published, hybrid			2022-12-28	WOS:000440803200010
J	Hager, NA; Krasowski, CJ; Mackie, TD; Kolb, AR; Needham, PG; Augustine, AA; Dempsey, A; Szent-Gyorgyi, C; Bruchez, MP; Bain, DJ; Kwiatkowski, AV; O'Donnell, AF; Brodsky, JL				Hager, Natalie A.; Krasowski, Collin J.; Mackie, Timothy D.; Kolb, Alexander R.; Needham, Patrick G.; Augustine, Andrew A.; Dempsey, Alison; Szent-Gyorgyi, Christopher; Bruchez, Marcel P.; Bain, Daniel J.; Kwiatkowski, Adam V.; O'Donnell, Allyson F.; Brodsky, Jeffrey L.			Select -arrestins control cell-surface abundance of the mammalian Kir2.1 potassium channel in a yeast model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin ligase; calcineurin; arrestin; vacuole; Saccharomyces cerevisiae; protein trafficking (Golgi); endocytosis; inward rectifying channel; protein adaptor; protein quality control; vacuole; yeast	GAP1 PERMEASE UBIQUITYLATION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; INTRACELLULAR TRAFFICKING; FUNCTIONAL EXPRESSION; REGULATE ENDOCYTOSIS; STRESS CONDITIONS; PLASMA-MEMBRANE; GLOBAL ANALYSIS; GENE DELETION	Protein composition at the plasma membrane is tightly regulated, with rapid protein internalization and selective targeting to the cell surface occurring in response to environmental changes. For example, ion channels are dynamically relocalized to or from the plasma membrane in response to physiological alterations, allowing cells and organisms to maintain osmotic and salt homeostasis. To identify additional factors that regulate the selective trafficking of a specific ion channel, we used a yeast model for a mammalian potassium channel, the K+ inward rectifying channel Kir2.1. Kir2.1 maintains potassium homeostasis in heart muscle cells, and Kir2.1 defects lead to human disease. By examining the ability of Kir2.1 to rescue the growth of yeast cells lacking endogenous potassium channels, we discovered that specific -arrestins regulate Kir2.1 localization. Specifically, we found that the Ldb19/Art1, Aly1/Art6, and Aly2/Art3 -arrestin adaptor proteins promote Kir2.1 trafficking to the cell surface, increase Kir2.1 activity at the plasma membrane, and raise intracellular potassium levels. To better quantify the intracellular and cell-surface populations of Kir2.1, we created fluorogen-activating protein fusions and for the first time used this technique to measure the cell-surface residency of a plasma membrane protein in yeast. Our experiments revealed that two -arrestin effectors also control Kir2.1 localization. In particular, both the Rsp5 ubiquitin ligase and the protein phosphatase calcineurin facilitated the -arrestin-mediated trafficking of Kir2.1. Together, our findings implicate -arrestins in regulating an additional class of plasma membrane proteins and establish a new tool for dissecting the trafficking itinerary of any membrane protein in yeast.	[Hager, Natalie A.; Krasowski, Collin J.; O'Donnell, Allyson F.] Duquesne Univ, Dept Biol Sci, 600 Forbes Ave, Pittsburgh, PA 15282 USA; [Mackie, Timothy D.; Kolb, Alexander R.; Needham, Patrick G.; Augustine, Andrew A.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Dempsey, Alison; Szent-Gyorgyi, Christopher; Bruchez, Marcel P.] Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA; [Bain, Daniel J.] Univ Pittsburgh, Dept Geol & Environm Sci, Pittsburgh, PA 15260 USA; [Kwiatkowski, Adam V.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	O'Donnell, AF (corresponding author), Duquesne Univ, Dept Biol Sci, 600 Forbes Ave, Pittsburgh, PA 15282 USA.; Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	odonne15@duq.edu; jbrodsky@pitt.edu	Bain, Daniel J/G-3055-2013	Hager, Natalie/0000-0002-7140-7380; O'Donnell, Allyson/0000-0003-0966-288X; Bain, Daniel/0000-0003-1979-7016	National Institutes of Health [R01 HL127711, R01 GM075061, P30 DK079307, U54-GM103529]; National Science Foundation (NSF) MCB CAREER Grant [1553143]; NSF EAR-IF [0948366]; Shurl and Kay Curci Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529, R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) MCB CAREER Grant(National Science Foundation (NSF)); NSF EAR-IF(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Shurl and Kay Curci Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL127711 (to A. V. K.), R01 GM075061 (to J. L. B. and A. F. O.), P30 DK079307 (to J. L. B.), and U54-GM103529 (to A. D., C. S.-G., and M. P. B). This work also was supported by National Science Foundation (NSF) MCB CAREER Grant 1553143 (to A. F. O.) and NSF EAR-IF 0948366 (to D. J. B.), a Pilot Grant from P30 DK079307 (to A. F. O.), and a grant from the Shurl and Kay Curci Foundation (to M. P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai T, 2002, CIRCULATION, V105, P2592, DOI 10.1161/01.CIR.0000019906.35135.A3; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Boeckstaens M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4101; Brachmann CB, 1998, YEAST, V14, P115; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Chen H, 1998, FEBS LETT, V422, P307, DOI 10.1016/S0014-5793(98)00028-3; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Crapeau M, 2014, J BIOL CHEM, V289, P22103, DOI 10.1074/jbc.M114.582320; Curran J, 2014, CIRC RES, V115, P68, DOI 10.1161/CIRCRESAHA.115.304149; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; de Boer TP, 2010, ACTA PHYSIOL, V199, P243, DOI 10.1111/j.1748-1716.2010.02108.x; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Foote C, 2006, J CELL BIOL, V173, P615, DOI 10.1083/jcb.200510161; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Herrador A, 2013, J BIOL CHEM, V288, P16206, DOI 10.1074/jbc.C113.452250; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Ho HC, 2017, MOL BIOL CELL, V28, P1271, DOI 10.1091/mbc.E17-01-0008; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Minear S, 2011, EUKARYOT CELL, V10, P1574, DOI 10.1128/EC.05163-11; Nakamura RL, 1998, METHOD ENZYMOL, V293, P89; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; O'Donnell AF, 2015, MOL CELL BIOL, V35, P939, DOI 10.1128/MCB.01183-14; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; O'Donnell AF, 2012, MOL CELL BIOL, V32, P4506, DOI 10.1128/MCB.01176-12; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; O'Donnell BM, 2017, J BIOL CHEM, V292, P12813, DOI 10.1074/jbc.M117.786376; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; Picones A, 2001, BIOPHYS J, V81, P2035, DOI 10.1016/S0006-3495(01)75853-5; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Pratt CP, 2015, BIOCONJUGATE CHEM, V26, P1963, DOI 10.1021/acs.bioconjchem.5b00409; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Prosser DC, 2016, JOVE-J VIS EXP, DOI 10.3791/54587; Prosser DC, 2015, J CELL SCI, V128, P4220, DOI 10.1242/jcs.175372; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Shiwarski DJ, 2017, MOL BIOL CELL, V28, P2202, DOI 10.1091/mbc.E17-01-0030; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Starita LM, 2012, PROTEOMICS, V12, P236, DOI 10.1002/pmic.201100166; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Szent-Gyorgyi C, 2013, J MOL BIOL, V425, P4595, DOI 10.1016/j.jmb.2013.08.014; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Tan R, 2017, MOL CELL, V65, P818, DOI 10.1016/j.molcel.2017.01.015; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Tristani-Firouzi M, 2010, PFLUG ARCH EUR J PHY, V460, P289, DOI 10.1007/s00424-010-0820-6; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; VOLLAND C, 1994, FOLIA MICROBIOL, V39, P554, DOI 10.1007/BF02814106; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yan Q, 2015, ORG BIOMOL CHEM, V13, P2078, DOI 10.1039/c4ob02309a; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	94	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11006	11021		10.1074/jbc.RA117.001293	http://dx.doi.org/10.1074/jbc.RA117.001293			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784874	hybrid, Green Published			2022-12-28	WOS:000438882800014
J	Del Poggetto, E; Toto, A; Aloise, C; Di Piro, F; Gori, L; Malatesta, F; Gianni, S; Chiti, F; Bemporad, F				Del Poggetto, Edoardo; Toto, Angelo; Aloise, Chiara; Di Piro, Francesco; Gori, Ludovica; Malatesta, Francesco; Gianni, Stefano; Chiti, Fabrizio; Bemporad, Francesco			Stability of an aggregation-prone partially folded state of human profilin-1 correlates with aggregation propensity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); protein folding; protein misfolding; aggregation; amyloid; neurodegenerative disease; profilin; ALS; Lou Gehrig Disease; protein dynamics; protein self-assembly	AMYOTROPHIC-LATERAL-SCLEROSIS; INTERMEDIATE STATE; TRANSITION-STATES; PROTEIN; FRUSTRATION; MUTATIONS; BETA(2)-MICROGLOBULIN; IDENTIFICATION; DEGENERATION; MECHANISM	A set of missense mutations in the gene encoding profilin-1 has been linked to the onset of familial forms of ALS (fALS), also known as Lou Gehrig's disease. The pathogenic potential of these mutations is linked to the formation of intracellular inclusions of the mutant proteins and correlates with the mutation-induced destabilization of its native, fully folded state. However, the mechanism by which these mutations promote misfolding and self-assembly is yet unclear. Here, using temperature-jump and stopped-flow kinetic measurements, we show that, during refolding, WT profilin-1 transiently populates a partially folded (PF) state endowed with hydrophobic clusters exposed to the solvent and with no detectable secondary structure. We observed that this conformational state is marginally stable at neutral pH but becomes significantly populated at mildly acidic pH. Interestingly, the fALS-associated mutations did not cause a change in the refolding mechanism of profilin-1, but induced a stabilization of the PF state. In the presence of preformed profilin-1 aggregates, the PF state, unlike the unfolded and folded states, could interact with these aggregates via nonspecific hydrophobic interactions and also increase thioflavin-T fluorescence, revealing its amyloidogenic potential. Moreover, in the variants tested, we found a correlation between conformational stability of PF and aggregation propensity, defining this conformational state as an aggregation-prone folding intermediate. In conclusion, our findings indicate that mutation-induced stabilization of a partially folded state can enhance profilin-1 aggregation and thereby contribute to the pathogenicity of the mutations.	[Del Poggetto, Edoardo; Aloise, Chiara; Di Piro, Francesco; Gori, Ludovica; Chiti, Fabrizio; Bemporad, Francesco] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Viale GB Morgagni 50, I-50134 Florence, Italy; [Toto, Angelo; Malatesta, Francesco; Gianni, Stefano] Sapienza Univ Rome, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Gianni, Stefano] CNR, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Gianni, Stefano] CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	University of Florence; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Fondazione Cenci Bolognetti; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Bemporad, F (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Viale GB Morgagni 50, I-50134 Florence, Italy.	francesco.bemporad@unifi.it	Malatesta, Francesco/AAT-4757-2020; Toto, Angelo/AAV-9598-2021	Toto, Angelo/0000-0002-4620-3677; Bemporad, Francesco/0000-0002-0643-6249; Chiti, Fabrizio/0000-0002-1330-1289; Del Poggetto, Edoardo/0000-0002-3648-4399	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetto di Interesse "Invecchiamento"; Programma per Giovani Ricercatori "Rita Levi Montalcini" 2010; Sapienza University of Rome [C26A155S48, B52F16003410005, RP11715C34AEAC9B]	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetto di Interesse "Invecchiamento"(Ministry of Education, Universities and Research (MIUR)); Programma per Giovani Ricercatori "Rita Levi Montalcini" 2010; Sapienza University of Rome	This work was supported in part by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetto di Interesse "Invecchiamento" (to S. G.) and Programma per Giovani Ricercatori "Rita Levi Montalcini" 2010 (to F. B.) and Sapienza University of Rome, Grants C26A155S48, B52F16003410005, and RP11715C34AEAC9B (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alkam D, 2017, CELL MOL LIFE SCI, V74, P967, DOI 10.1007/s00018-016-2372-1; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Boopathy S, 2015, P NATL ACAD SCI USA, V112, P7984, DOI 10.1073/pnas.1424108112; Brettle M, 2015, NEUROSCI LETT, V609, P223, DOI 10.1016/j.neulet.2015.09.034; Chen Y, 2013, ADV POROUS MATER, V1, P34, DOI 10.1166/apm.2013.1006; Chi CN, 2007, FEBS LETT, V581, P1109, DOI 10.1016/j.febslet.2007.02.011; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Del Poggetto E, 2016, BIOL CHEM, V397, P927, DOI 10.1515/hsz-2016-0154; Del Poggetto E, 2015, ACS CHEM BIOL, V10, P2553, DOI 10.1021/acschembio.5b00598; Del Poggetto E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12332; Ferreiro DU, 2018, CURR OPIN STRUC BIOL, V48, P68, DOI 10.1016/j.sbi.2017.09.006; Finsterer J, 2014, EUR J MED GENET, V57, P103, DOI 10.1016/j.ejmg.2014.01.002; Freischmidt A, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0214-y; Geierhaas CD, 2008, PROTEIN ENG DES SEL, V21, P215, DOI 10.1093/protein/gzm092; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Gianni S, 2014, P NATL ACAD SCI USA, V111, P14141, DOI 10.1073/pnas.1405233111; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Parra RG, 2016, NUCLEIC ACIDS RES, V44, pW356, DOI 10.1093/nar/gkw304; Heidarsson PO, 2014, P NATL ACAD SCI USA, V111, P13069, DOI 10.1073/pnas.1401065111; Honda RP, 2015, STRUCTURE, V23, P1735, DOI 10.1016/j.str.2015.07.001; Ingre C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.009; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Karamanos TK, 2016, J AM CHEM SOC, V138, P6271, DOI 10.1021/jacs.6b02464; Krobath H, 2012, J MOL BIOL, V422, P705, DOI 10.1016/j.jmb.2012.06.020; Kullmann JA, 2012, NEUROSCIENCE, V223, P355, DOI 10.1016/j.neuroscience.2012.07.055; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; Matsukawa K, 2016, J BIOL CHEM, V291, P23464, DOI 10.1074/jbc.M116.729152; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Rennella E, 2017, BIOCHEMISTRY-US, V56, P692, DOI 10.1021/acs.biochem.6b01263; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sen Mojumdar S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01996-1; Smith BN, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.10.032; Stoppini M, 2015, J BIOL CHEM, V290, P9951, DOI 10.1074/jbc.R115.639799; Tanaka Y, 2016, PRION, V10, P283, DOI 10.1080/19336896.2016.1207033; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yang CX, 2016, P NATL ACAD SCI USA, V113, pE6209, DOI 10.1073/pnas.1605964113	45	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10303	10313		10.1074/jbc.RA118.002087	http://dx.doi.org/10.1074/jbc.RA118.002087			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29760185	Green Published, hybrid			2022-12-28	WOS:000437096700028
J	Ko, TP; Lai, SJ; Hsieh, TJ; Yang, CS; Chen, Y				Ko, Tzu-Ping; Lai, Shu-Jung; Hsieh, Tung-Ju; Yang, Chia-Shin; Chen, Yeh			The tetrameric structure of sialic acid-synthesizing UDP-GlcNAc 2-epimerase from Acinetobacter baumannii: A comparative study with human GNE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inhibitor; hydrolase; catalysis; protein crystallization; oligomer; inhibition mechanism; catalytic mechanism; hydrolytic enzyme; inhibitor design; N-acetyl neuraminic acid; protein oligomer	MECHANISM; CRYSTALLOGRAPHY; BIOSYNTHESIS; ENZYME; SYSTEM	Sialic acid presentation on the cell surface by some pathogenic strains of bacteria allows their escape from the host immune system. It is one of the major virulence factors. Bacterial biosynthesis of sialic acids starts with the conversion of UDP-GlcNAc to UDP and ManNAc by a hydrolyzing 2-epimerase. Here, we present the crystal structure of this enzyme, named NeuC, from Acinetobacter baumannii. The protein folds into two Rossmann-like domains and forms dimers and tetramers as does the epimerase part of the bifunctional UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE). In contrast to human GNE, which showed only the closed conformation, the NeuC crystals contained both open and closed protomers in each dimer. Substrate soaking changed the space group from C222(1) to P2(1)2(1)2(1). In addition to UDP, an intermediate-like ligand was seen bound to the closed protomer. The UDP-binding mode in NeuC was similar to that in GNE, although a few side chains were rotated away. NeuC lacks the CMP-Neu5Ac-binding site for allosteric inhibition of GNE. However, the two enzymes as well as other NeuC homologues (but not SiaA from Neisseria meningitidis) appear to be common in tetrameric organization. The revised two-base catalytic mechanism may involve His-125 (Glu-134 in GNE), as suggested by mutant activity analysis.	[Ko, Tzu-Ping; Lai, Shu-Jung] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Hsieh, Tung-Ju] China Med Univ, Res Ctr Tumor Med Sci, Taichung 404, Taiwan; [Yang, Chia-Shin; Chen, Yeh] Hungkuang Univ, Dept Biotechnol, Taichung 433, Taiwan	Academia Sinica - Taiwan; China Medical University Taiwan; Hungkuang University	Chen, Y (corresponding author), Hungkuang Univ, Dept Biotechnol, Taichung 433, Taiwan.	chyeah6599@sunrise.hk.edu.tw	Lai, Shu-Jung/G-8875-2019	Lai, Shu-Jung/0000-0001-7653-8147	Taiwan Protein Project [MOST106-0210-01-15-04, MOST107-0210-01-1902]	Taiwan Protein Project	This work was supported by Taiwan Protein Project Grants MOST106-0210-01-15-04 and MOST107-0210-01-1902). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bull C, 2014, BBA-REV CANCER, V1846, P238, DOI 10.1016/j.bbcan.2014.07.005; Chen SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23274; Chen SC, 2014, PROTEINS, V82, P1519, DOI 10.1002/prot.24516; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Chou WK, 2003, J AM CHEM SOC, V125, P2455, DOI 10.1021/ja021309g; DeLano W. L, 2016, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghaderi D, 2007, J MOL BIOL, V369, P746, DOI 10.1016/j.jmb.2007.03.037; Gunawan J, 2005, J BIOL CHEM, V280, P3555, DOI 10.1074/jbc.M411942200; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2015, TOP CURR CHEM, V366, P97, DOI 10.1007/128_2013_464; Hwang TS, 2002, BIOCHEM BIOPH RES CO, V295, P167, DOI 10.1016/S0006-291X(02)00620-4; Krapp S, 2003, J MOL BIOL, V334, P625, DOI 10.1016/j.jmb.2003.09.080; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Li YH, 2012, APPL MICROBIOL BIOT, V94, P887, DOI 10.1007/s00253-012-4040-1; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Mosimann SC, 2001, J BIOL CHEM, V276, P8190, DOI 10.1074/jbc.M007235200; Murkin AS, 2004, BIOCHEMISTRY-US, V43, P14290, DOI 10.1021/bi048606d; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Tanner ME, 2005, BIOORG CHEM, V33, P216, DOI 10.1016/j.bioorg.2005.01.005; Vann WF, 2004, J BACTERIOL, V186, P706, DOI 10.1128/JB.186.3.706-712.2004	29	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10119	10127		10.1074/jbc.RA118.001971	http://dx.doi.org/10.1074/jbc.RA118.001971			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764940	Green Published, hybrid			2022-12-28	WOS:000437096700015
J	Su, HB; Zhang, Z; Liu, ZJ; Peng, BZ; Kong, C; Wang, HH; Zhang, Z; Xu, Y				Su, Haibo; Zhang, Zhen; Liu, Zijian; Peng, Baozhou; Kong, Cong; Wang, Honghai; Zhang, Zhi; Xu, Ying			Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2-dependent maturation of dendritic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; tuberculosis; dendritic cell; antigen processing; PE; PPE proteins; tuberculosis; TLR; Toll-like receptor; tuberculosis vaccine; helper T cell response; CD4(+) T cell	NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; IMMUNE-RESPONSES; NLRP3 INFLAMMASOME; PROTECTIVE EFFICACY; VACCINE CANDIDATE; MULTIGENE FAMILY; IN-VIVO; MACROPHAGES; ACTIVATION	Targeting of Mycobacterium tuberculosis (MTB) PE/PPE antigens that induce type 1 helper T cell (Th1) and Th17 responses represents a crucial strategy for the development of tuberculosis (TB) vaccines. However, only a few PE/PPE antigens induce these responses. Here, we sought to determine how the cell wall-associated antigen PPE60 (Rv3478) activates dendritic cell (DC) maturation and T-cell differentiation. We observed that PPE60 induces DC maturation by augmenting the protein expression of cluster of differentiation 80 (CD80) and CD86 and major histocompatibility complex (MHC) class I and MHC class II on the cell surface. PPE60 also stimulated the production of tumor necrosis factor- (TNF), interleukin (IL)-1, IL-6, IL-12p70, and IL-23p19 but not IL-10. This induction was mediated by Toll-like receptor 2 (TLR2) and followed by activation of p38, c-Jun N-terminal kinase (JNK), and NF-B signaling. PPE60 enhanced MHC-II expression and promoted antigen processing by DCs in a TLR2-dependent manner. Moreover, PPE60-stimulated DCs directed naive CD4(+) T cells to produce IFN-, IL-2, and IL-17A, expanding the Th1 and Th17 responses, along with activation of T-bet and RAR-related orphan receptor C (RORt) but not GATA-3. Moreover, PPE60 activated the NLRP3 inflammasome followed by caspase-1-dependent IL-1 and IL-18 synthesis in DCs. Of note, pharmacological inhibition of NLRP3 activation specifically attenuated IFN- and IL-17A secretion into the supernatant from CD4(+) T cells cocultured with PPE60-activated DCs. These findings indicate that PPE60 induces Th1 and Th17 immune responses by activating DCs in a TLR2-dependent manner, suggesting PPE60's potential for use in MTB vaccine development.	[Su, Haibo; Liu, Zijian; Peng, Baozhou] GMU, GIBH, Joint Sch Life Sci, 195 Dongfengxi Rd, Guangzhou 510000, Guangdong, Peoples R China; [Kong, Cong; Wang, Honghai; Xu, Ying] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China; [Su, Haibo; Zhang, Zhen; Zhang, Zhi] Guangdong Second Prov Gen Hosp, 466 Xingang Rd, Guangzhou 510220, Guangdong, Peoples R China	Fudan University	Xu, Y (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.; Zhang, Z (corresponding author), Guangdong Second Prov Gen Hosp, 466 Xingang Rd, Guangzhou 510220, Guangdong, Peoples R China.	yalw135@126.com; yingxu2520@fudan.edu.cn			National Natural Science Foundation of China [31600747]; youth innovation talents program of the education department of Guangdong province through University Innovation Strong School Project [2016KQNCX141, Q17024049]; National Science and Technology Major Project [2018ZX10731301-004, 2018ZX10302302-002]; Guangzhou Science and Technology Innovation Committee [201804010317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); youth innovation talents program of the education department of Guangdong province through University Innovation Strong School Project; National Science and Technology Major Project; Guangzhou Science and Technology Innovation Committee	This work was supported by National Natural Science Foundation of China Grant 31600747, the youth innovation talents program of the education department of Guangdong province through University Innovation Strong School Project Grants 2016KQNCX141 and Q17024049, National Science and Technology Major Project 2018ZX10731301-004 and 2018ZX10302302-002, and Guangzhou Science and Technology Innovation Committee Grant 201804010317. The authors declare that they have no conflicts of interest with the contents of this article.	Ade N, 2007, TOXICOL SCI, V99, P488, DOI 10.1093/toxsci/kfm178; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Basu S, 2018, MICROB PATHOGENESIS, V114, P219, DOI 10.1016/j.micpath.2017.11.044; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Brennan MJ, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00969-16, 10.1128/iai.00969-16]; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Derrick SC, 2013, VACCINE, V31, P4641, DOI 10.1016/j.vaccine.2013.07.032; Dona V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057517; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; Forsyth KS, 2016, CURR OPIN IMMUNOL, V40, P123, DOI 10.1016/j.coi.2016.03.003; Jacobo REG, 2014, CELL IMMUNOL, V289, P167, DOI 10.1016/j.cellimm.2014.03.010; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Gopalakrishnan A, 2016, CURR OPIN IMMUNOL, V42, P76, DOI 10.1016/j.coi.2016.06.003; Jang S, 2008, J LEUKOCYTE BIOL, V84, P1264, DOI 10.1189/jlb.1107742; Kaufmann SHE, 2012, CURR OPIN BIOTECH, V23, P900, DOI 10.1016/j.copbio.2012.03.007; Khubaib M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00719; Kim WS, 2016, IMMUNOBIOLOGY, V221, P440, DOI 10.1016/j.imbio.2015.11.006; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Kupz A, 2016, J CLIN INVEST, V126, P2109, DOI 10.1172/JCI84978; Lewinsohn DA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01262; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Mourik BC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00294; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nieuwenhuizen NE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00121; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Saini NK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.133, 10.1038/nmicrobiol.2016.133]; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sato K, 1998, CLIN EXP IMMUNOL, V112, P63; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Sayes F, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005770; Sia JK, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/747543; Su HB, 2015, ONCOTARGET, V6, P38517, DOI 10.18632/oncotarget.5956; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Vordermeier HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040890; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Windish HP, 2011, VACCINE, V29, P7842, DOI 10.1016/j.vaccine.2011.07.094; Xu Y, 2015, J MOL MED, V93, P645, DOI 10.1007/s00109-014-1243-1; Yuk JM, 2014, CLIN EXP VACCINE RES, V3, P155, DOI 10.7774/cevr.2014.3.2.155	57	24	26	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10287	10302		10.1074/jbc.RA118.001696	http://dx.doi.org/10.1074/jbc.RA118.001696			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29739853	Green Published, hybrid			2022-12-28	WOS:000437096700027
J	Tachibana, K; Yuzuriha, T; Tabata, R; Fukuda, S; Maegawa, T; Takahashi, R; Tanimoto, K; Tsujino, H; Nunomura, K; Lin, BZ; Matsuura, Y; Tanaka, T; Hamakubo, T; Sakai, J; Kodama, T; Kobayashi, T; Ishimoto, K; Miyachi, H; Doi, T				Tachibana, Keisuke; Yuzuriha, Tomohiro; Tabata, Ryotaro; Fukuda, Syohei; Maegawa, Takashi; Takahashi, Rika; Tanimoto, Keiichi; Tsujino, Hirofumi; Nunomura, Kazuto; Lin, Bangzhong; Matsuura, Yoshiharu; Tanaka, Toshiya; Hamakubo, Takao; Sakai, Juro; Kodama, Tatsuhiko; Kobayashi, Tadayuki; Ishimoto, Kenji; Miyachi, Hiroyuki; Doi, Takefumi			Discovery of peroxisome proliferator-activated receptor (PPAR alpha) activators with a ligand-screening system using a human PPAR-expressing cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peroxisome proliferator-activated receptor (PPAR); triglyceride; cell biology; transcription regulation; drug screening; chemical screening system; dyslipidemia; ligand; nuclear receptor; Tet-off system	RESPONSE ELEMENT; LIPID-METABOLISM; MICE; GENE; STEATOHEPATITIS; AGONISTS; LIVER; CARBOHYDRATE; SUPERFAMILY; MECHANISM	Peroxisome proliferator-activated receptor (PPAR) is a ligand-activated transcription factor that belongs to the superfamily of nuclear hormone receptors. PPAR is mainly expressed in the liver, where it activates fatty acid oxidation and lipoprotein metabolism and improves plasma lipid profiles. Therefore, PPAR activators are often used to treat patients with dyslipidemia. To discover additional PPAR activators as potential compounds for use in hypolipidemic drugs, here we established human hepatoblastoma cell lines with luciferase reporter expression from the promoters containing peroxisome proliferator-responsive elements (PPREs) and tetracycline-regulated expression of full-length human PPAR to quantify the effects of chemical ligands on PPAR activity. Using the established cell-based PPAR-activator screening system to screen a library of >12,000 chemical compounds, we identified several hit compounds with basic chemical skeletons different from those of known PPAR agonists. One of the hit compounds, a 1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid derivative we termed compound 3, selectively up-regulated PPAR transcriptional activity, leading to PPAR target gene expression both in vitro and in vivo. Of note, the half-maximal effective concentrations of the hit compounds were lower than that of the known PPAR ligand fenofibrate. Finally, fenofibrate or compound 3 treatment of high fructose-fed rats having elevated plasma triglyceride levels for 14 days indicated that compound 3 reduces plasma triglyceride levels with similar efficiency as fenofibrate. These observations raise the possibility that 1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid derivatives might be effective drug candidates for selective targeting of PPAR to manage dyslipidemia.	[Tachibana, Keisuke; Yuzuriha, Tomohiro; Tabata, Ryotaro; Fukuda, Syohei; Maegawa, Takashi; Takahashi, Rika; Tanimoto, Keiichi; Tsujino, Hirofumi; Nunomura, Kazuto; Lin, Bangzhong; Kobayashi, Tadayuki; Ishimoto, Kenji; Doi, Takefumi] Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan; [Yuzuriha, Tomohiro] Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan; [Matsuura, Yoshiharu] Osaka Univ, Res Inst Microbial Dis, Dept Mol Virol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Tanaka, Toshiya; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan; [Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan; [Sakai, Juro] Univ Tokyo, Res Ctr Adv Sci & Technol, Div Metab Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan; [Miyachi, Hiroyuki] Univ Tokyo, Drug Discovery Initiat, Lead Explorat Unit, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	Osaka University; Setsunan University; Osaka University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Tachibana, K; Doi, T (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	nya@phs.osaka-u.ac.jp; doi@phs.osaka-u.ac.jp		Sakai, Juro/0000-0003-4043-1035	JSPS KAKENHI [15H02896, 16K13044, 18H03190]; Lydia O'Leary Memorial Pias Dermatological Foundation; Takeda Science Foundation; Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) - Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED) [17am0101084j0001, JP18am0101123, JP18am0101084, JP18am0101085]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Lydia O'Leary Memorial Pias Dermatological Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) - Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by JSPS KAKENHI Grants 15H02896, 16K13044, and 18H03190; Lydia O'Leary Memorial Pias Dermatological Foundation; Takeda Science Foundation; the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) funded by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); and the Japan Agency for Medical Research and Development (AMED) under Grants 17am0101084j0001, JP18am0101123, JP18am0101084, and JP18am0101085. The authors declare that they have no conflicts of interest with the contents of this article.	Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Ban S, 2011, BIOORGAN MED CHEM, V19, P3183, DOI 10.1016/j.bmc.2011.03.064; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Dubois V, 2017, J CLIN INVEST, V127, P1202, DOI 10.1172/JCI88894; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; Feng L, 2016, DIABETOLOGIA, V59, P1276, DOI 10.1007/s00125-016-3912-9; Fruchart JC, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-26; Fruchart JC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-82; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HERTZ R, 1995, J BIOL CHEM, V270, P13470, DOI 10.1074/jbc.270.22.13470; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; LEE SST, 1995, MOL CELL BIOL, V15, P3012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Markt P, 2007, J COMPUT AID MOL DES, V21, P575, DOI 10.1007/s10822-007-9140-0; Miyamoto T, 1997, J BIOL CHEM, V272, P7752, DOI 10.1074/jbc.272.12.7752; MIYATA KS, 1993, J BIOL CHEM, V268, P19169; Nakshatri H, 1998, NUCLEIC ACIDS RES, V26, P2491, DOI 10.1093/nar/26.10.2491; Nomura M, 2003, J MED CHEM, V46, P3581, DOI 10.1021/jm0205144; Park J, 1997, J LIPID RES, V38, P2529; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Raza-Iqbal S, 2015, J ATHEROSCLER THROMB, V22, P754, DOI 10.5551/jat.28720; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tachibana K, 2013, J BIOCHEM, V154, P265, DOI 10.1093/jb/mvt050; Tachibana K, 2009, BIOCHEM BIOPH RES CO, V389, P501, DOI 10.1016/j.bbrc.2009.09.018; Tachibana K, 2008, PPAR RES, V2008, DOI 10.1155/2008/102737; Tachibana K, 2008, FEBS LETT, V582, P3884, DOI 10.1016/j.febslet.2008.10.027; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a	38	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10333	10343		10.1074/jbc.RA118.002077	http://dx.doi.org/10.1074/jbc.RA118.002077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764933	Green Published, hybrid			2022-12-28	WOS:000437096700031
J	Giguere, N; Pacelli, C; Saumure, C; Bourque, MJ; Matheoud, D; Levesque, D; Slack, RS; Park, DS; Trudeau, LE				Giguere, Nicolas; Pacelli, Consiglia; Saumure, Caroline; Bourque, Marie-Josee; Matheoud, Diana; Levesque, Daniel; Slack, Ruth S.; Park, David S.; Trudeau, Louis-Eric			Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Parkinson disease; dopamine; parkin; PTEN-induced putative kinase 1 (PINK1); axon; bioenergetics; mitochondria; cell culture	OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; AXONAL ARBORIZATION; NULL MICE; DJ-1; PINK1; SUSCEPTIBILITY; VULNERABILITY; DEGENERATION	Many mutations in genes encoding proteins such as Parkin, PTEN-induced putative kinase 1 (PINK1), protein deglycase DJ-1 (DJ-1 or PARK7), leucine-rich repeat kinase 2 (LRRK2), and -synuclein have been linked to familial forms of Parkinson's disease (PD). The consequences of these mutations, such as altered mitochondrial function and pathological protein aggregation, are starting to be better understood. However, little is known about the mechanisms explaining why alterations in such diverse cellular processes lead to the selective loss of dopamine (DA) neurons in the substantia nigra (SNc) in the brain of individuals with PD. Recent work has shown that one of the reasons for the high vulnerability of SNc DA neurons is their high basal rate of mitochondrial oxidative phosphorylation (OXPHOS), resulting from their highly complex axonal arborization. Here, we examined whether axonal growth and basal mitochondrial function are altered in SNc DA neurons from Parkin-, Pink1-, or DJ-1-KO mice. We provide evidence for increased basal OXPHOS in Parkin-KO DA neurons and for reduced survival of DA neurons that have a complex axonal arbor. The surviving smaller neurons exhibited reduced vulnerability to the DA neurotoxin and mitochondrial complex I inhibitor MPP+, and this reduction was associated with reduced expression of the DA transporter. Finally, we found that glial cells play a role in the reduced resilience of DA neurons in these mice and that WT Parkin overexpression rescues this phenotype. Our results provide critical insights into the complex relationship between mitochondrial function, axonal growth, and genetic risk factors for PD.	[Giguere, Nicolas; Saumure, Caroline; Bourque, Marie-Josee; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ H4T 1J4, Canada; [Giguere, Nicolas; Saumure, Caroline; Bourque, Marie-Josee; Matheoud, Diana; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ H4T 1J4, Canada; [Trudeau, Louis-Eric] Univ Montreal, Fac Med, Cent Nervous Syst Res Grp GRSNC, Montreal, PQ H4T 1J4, Canada; [Pacelli, Consiglia] Univ Foggia, Dept Clin & Expt Med, I-71122 Foggia, Italy; [Matheoud, Diana] CRCHUM, Montreal, PQ H2X 0A9, Canada; [Levesque, Daniel] Univ Montreal, Fac Pharm, Montreal, PQ H4T 1J4, Canada; [Levesque, Daniel; Trudeau, Louis-Eric] GRUM, Montreal, PQ H3C 3J7, Canada; [Slack, Ruth S.; Park, David S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1M 8M5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Foggia; Universite de Montreal; Universite de Montreal; University of Ottawa	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol & Physiol, CP 6128, Montreal, PQ H3T 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Trudeau, Louis-Eric/AAE-4782-2020; PACELLI, CONSIGLIA/J-9032-2016	Trudeau, Louis-Eric/0000-0003-4684-1377; Park, David/0000-0002-4490-3784; PACELLI, CONSIGLIA/0000-0003-4915-5823	Krembil Foundation; Brain Canada Foundation; Canadian Institutes of Health Research; Parkinson Society Canada	Krembil Foundation; Brain Canada Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson Society Canada	This work was supported in part by a grant from the Krembil Foundation and the Brain Canada Foundation (to R.S., D.P., and L.-E.T.), the Canadian Institutes of Health Research, and by a pilot project grant from Parkinson Society Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Aguiar AS, 2013, NEUROTOX RES, V24, P280, DOI 10.1007/s12640-013-9389-0; Akundi RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016038; Benskey MJ, 2015, NEUROTOXICOLOGY, V46, P1, DOI 10.1016/j.neuro.2014.11.004; Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135; Burman JL, 2012, P NATL ACAD SCI USA, V109, P10438, DOI 10.1073/pnas.1120688109; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cao X, 2017, AGING CELL, V16, P1180, DOI 10.1111/acel.12654; Casarejos MJ, 2006, J NEUROCHEM, V97, P934, DOI 10.1111/j.1471-4159.2006.03777.x; Damiano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099898; De Rosa P, 2015, CLIN CHIM ACTA, V449, P68, DOI 10.1016/j.cca.2015.04.042; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; Franco-Iborra S, 2015, CURR BIOL, V25, pR797, DOI 10.1016/j.cub.2015.07.062; Gauthier J, 1999, BRAIN RES, V834, P228, DOI 10.1016/S0006-8993(99)01573-5; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Haque ME, 2012, J BIOL CHEM, V287, P23162, DOI 10.1074/jbc.M112.346437; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Heo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032629; Hung H C, 1996, Brain Res Mol Brain Res, V41, P14; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Lee Y, 2017, CELL REP, V18, P918, DOI 10.1016/j.celrep.2016.12.090; Lev N, 2013, J MOL NEUROSCI, V50, P542, DOI 10.1007/s12031-013-9984-9; Luk KC, 2013, J NEUROCHEM, V125, P932, DOI 10.1111/jnc.12160; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; Mullett SJ, 2009, NEUROBIOL DIS, V33, P28, DOI 10.1016/j.nbd.2008.09.013; Nakajima K, 2001, BRAIN RES, V916, P76, DOI 10.1016/S0006-8993(01)02866-9; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Pacelli C, 2011, BBA-MOL BASIS DIS, V1812, P1041, DOI 10.1016/j.bbadis.2010.12.022; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Parent M, 2006, J NEURAL TRANSM-SUPP, P85; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Perez FA, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-71; Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332; Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034; Pissadaki EK, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00013; Rappold PM, 2010, NEUROTHERAPEUTICS, V7, P413, DOI 10.1016/j.nurt.2010.07.001; Ren Y, 2015, STEM CELLS, V33, P68, DOI 10.1002/stem.1854; Rousseaux MWC, 2012, P NATL ACAD SCI USA, V109, P15918, DOI 10.1073/pnas.1205102109; Shaltouki A, 2015, STEM CELL REP, V4, P847, DOI 10.1016/j.stemcr.2015.02.019; Solano RM, 2008, J NEUROSCI, V28, P598, DOI 10.1523/JNEUROSCI.4609-07.2008; Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112; Thomas B, 2007, NEUROBIOL DIS, V26, P312, DOI 10.1016/j.nbd.2006.12.021; Yamano K, 2016, EMBO REP, V17, P300, DOI 10.15252/embr.201541486; Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	54	26	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9580	9593		10.1074/jbc.RA117.000499	http://dx.doi.org/10.1074/jbc.RA117.000499			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29700116	Green Published, hybrid			2022-12-28	WOS:000436102300003
J	Molina, LCP; Pinto, NA; Torres, NI; Gonzalez-Cota, AL; Luque, GM; Balestrini, PA; Romarowski, A; Krapf, D; Santi, CM; Trevino, CL; Darszon, A; Buffone, MG				Puga Molina, Lis C.; Pinto, Nicolas A.; Torres, Nicolas I.; Gonzalez-Cota, Ana L.; Luque, Guillermina M.; Balestrini, Paula A.; Romarowski, Ana; Krapf, Dario; Santi, Celia M.; Trevino, Claudia L.; Darszon, Alberto; Buffone, Mariano G.			CFTR/ENaC-dependent regulation of membrane potential during human sperm capacitation is initiated by bicarbonate uptake through NBC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sperm; bicarbonate; epithelial sodium channel (ENaC); fertilization; sodium transport; Capacitation; ENaC; human sperm; membrane potential; NBC	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; SODIUM-BICARBONATE; FERTILIZING-CAPACITY; INTRACELLULAR SODIUM; CARBONIC-ANHYDRASES; CHANNEL REGULATION; MOLECULAR-CLONING; CHLORIDE CHANNEL; HYPERPOLARIZATION	To fertilize an egg, sperm must reside in the female reproductive tract to undergo several maturational changes that are collectively referred to as capacitation. From a molecular point of view, the HCO3 -dependent activation of the atypical soluble adenylyl cyclase (ADCY10) is one of the first events that occurs during capacitation and leads to the subsequent cAMP-dependent activation of protein kinase A (PKA). Capacitation is also accompanied by hyperpolarization of the sperm plasma membrane. We previously reported that PKA activation is necessary forCFTR(cystic fibrosis transmembrane conductance regulator channel) activity and for the modulation of membrane potential (Em). However, the main HCO3 transporters involved in the initial transport and the PKA-dependent Em changes are not well known nor characterized. Here, we analyzed how the activity of CFTR regulates Em during capacitation and examined its relationship with an electrogenic Na / HCO3 cotransporter (NBC) and epithelial Na channels (ENaCs). We observed that inhibition of both CFTR and NBC decreased HCO3 influx, resulting in lower PKA activity, and that events downstream of the cAMP activation of PKA are essential for the regulation of Em. Addition of a permeable cAMP analog partially rescued the inhibitory effects caused by these inhibitors. HCO3 also produced a rapid membrane hyperpolarization mediated by ENaC channels, which contribute to the regulation of Em during capacitation. Altogether, we demonstrate for the first time, that NBC cotransporters and ENaC channels are essential in the CFTR-dependent activation of the cAMP/ PKA sig-naling pathway and Em regulation during human sperm capacitation.	[Puga Molina, Lis C.; Pinto, Nicolas A.; Torres, Nicolas I.; Luque, Guillermina M.; Balestrini, Paula A.; Romarowski, Ana; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, C1425FQB, Buenos Aires, DF, Argentina; [Gonzalez-Cota, Ana L.; Santi, Celia M.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Krapf, Dario] UNR, CONICET, Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina; [Trevino, Claudia L.; Darszon, Alberto] UNAM, Inst Biotechnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Washington University (WUSTL); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universidad Nacional Autonoma de Mexico	Buffone, MG (corresponding author), Vuelta Obligado 2490,C1425FQB, RA-1428 Buenos Aires, DF, Argentina.	mgbuffone@ibyme.conicet.gov.ar	Puga Molina, Lis del Carmen/AFE-9171-2022; Puga Molina, Lis del Carmen/AAE-9765-2022; Luque, Guillermina/M-9237-2019; torres, nicolas/AAE-4849-2019	Puga Molina, Lis del Carmen/0000-0001-7937-4918; Puga Molina, Lis del Carmen/0000-0001-7937-4918; Luque, Guillermina/0000-0002-2745-8236; Krapf, Dario/0000-0001-7607-1954; Balestrini, Paula Ania/0000-0002-9351-1226; Gonzalez Cota, Ana L./0000-0002-1643-5805; Pinto, Nicolas Alejandro/0000-0001-9992-5692; Torres, Nicolas/0000-0001-6501-185X; Darszon, Alberto/0000-0002-2502-0505	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2015-2294, PICT 2015-3164]; CONACyT-Mexico Fronteras de la Ciencia 71; DGAPA/UNAM [IN203116, IN205516]; National Institutes of Health [R01 HD069631]; Consejo Nacional de Ciencia y Tecnologia postdoctoral fellowship [EPE-2017 291231]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069631] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONACyT-Mexico Fronteras de la Ciencia 71; DGAPA/UNAM(Universidad Nacional Autonoma de Mexico); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by Agencia Nacional de Promocion Cientifica y Tecnologica Grants PICT 2015-2294 (to M.G.B.) and PICT 2015-3164 (to D.K.), CONACyT-Mexico Fronteras de la Ciencia 71 (to A.D. and C.T.), DGAPA/UNAM Grants IN203116 (to C.T.) and IN205516 (to A.D.), and National Institutes of Health Grants R01 HD069631 (to C.M.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Consejo Nacional de Ciencia y Tecnologia postdoctoral fellowship EPE-2017 291231.	AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Baron S, 2005, J AM SOC NEPHROL, V16, P3490, DOI 10.1681/ASN.2005010075; Berdiev BK, 2009, MOL BIOSYST, V5, P123, DOI 10.1039/b810471a; Brenker C, 2014, ELIFE, V3, DOI 10.7554/eLife.01438; Briel M, 1998, J PHYSIOL-LONDON, V508, P825, DOI 10.1111/j.1469-7793.1998.825bp.x; Brown SG, 2016, HUM REPROD, V31, P1147, DOI 10.1093/humrep/dew056; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; Buffone MG, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117911; Calzada L, 1997, ARCH ANDROLOGY, V38, P151, DOI 10.3109/01485019708987892; Chavez JC, 2014, J BIOL CHEM, V289, P32266, DOI 10.1074/jbc.M114.607556; Ch'en FT, 2008, BRIT J PHARMACOL, V153, P972, DOI 10.1038/sj.bjp.0707667; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chavez JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094037; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Diao RY, 2013, REPRODUCTION, V146, P637, DOI 10.1530/REP-13-0146; Escoffier J, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127266; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Geng YY, 2017, J BIOL CHEM, V292, P8978, DOI 10.1074/jbc.M117.776013; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Gunaratne HJ, 2006, GENE, V375, P37, DOI 10.1016/j.gene.2006.02.005; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; HINTON BT, 1981, J REPROD FERTIL, V61, P59, DOI 10.1530/jrf.0.0610059; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V246, P535, DOI 10.1006/bbrc.1998.8658; Jensen LJ, 1999, BIOL REPROD, V60, P573, DOI 10.1095/biolreprod60.3.573; Jose O, 2015, BIOCHEM BIOPH RES CO, V468, P713, DOI 10.1016/j.bbrc.2015.11.021; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kong XB, 2009, INT J ANDROL, V32, P330, DOI 10.1111/j.1365-2605.2008.00864.x; Kunzelmann K, 2003, PFLUG ARCH EUR J PHY, V445, P504, DOI 10.1007/s00424-002-0958-y; Li CY, 2010, HUM REPROD, V25, P317, DOI 10.1093/humrep/dep406; Li P, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0114-17.2017; Linares-Hernandez L, 1998, BBA-BIOMEMBRANES, V1372, P1, DOI 10.1016/S0005-2736(98)00035-2; Lopez-Gonzalez I, 2014, MOL HUM REPROD, V20, P619, DOI 10.1093/molehr/gau029; Luconi M, 2005, BIOL REPROD, V72, P22, DOI 10.1095/biolreprod.104.032490; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Mannowetz N, 2011, INT J ANDROL, V34, P153, DOI 10.1111/j.1365-2605.2010.01067.x; Mannowetz N, 2013, ELIFE, V2, DOI 10.7554/eLife.01009; Mansell SA, 2014, MOL HUM REPROD, V20, P392, DOI 10.1093/molehr/gau003; McPartlin LA, 2009, BIOL REPROD, V81, P199, DOI 10.1095/biolreprod.108.074880; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Patrat C, 2002, BIOL REPROD, V66, P1775, DOI 10.1095/biolreprod66.6.1775; Molina LCP, 2017, J CELL PHYSIOL, V232, P1404, DOI 10.1002/jcp.25634; Rode B, 2012, HUM MOL GENET, V21, P1287, DOI 10.1093/hmg/ddr558; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Sanchez G, 2006, MOL HUM REPROD, V12, P565, DOI 10.1093/molehr/gal062; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Sassani P, 2002, AM J PHYSIOL-CELL PH, V282, pC408, DOI 10.1152/ajpcell.00409.2001; Soleimani M, 2001, J MEMBRANE BIOL, V183, P71, DOI 10.1007/s00232-001-0055-8; Sorum B, 2015, CELL, V163, P724, DOI 10.1016/j.cell.2015.09.052; Stival C, 2016, ADV ANAT EMBRYOL CEL, V220, P93, DOI 10.1007/978-3-319-30567-7_5; Stival C, 2015, J BIOL CHEM, V290, P18855, DOI 10.1074/jbc.M115.640326; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Torres-Flores V, 2008, J ANDROL, V29, P63, DOI 10.2164/jandrol.107.003368; VISHWAKARMA P, 1962, FERTIL STERIL, V13, P481; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wandernoth PM, 2015, J BIOL CHEM, V290, P29202, DOI 10.1074/jbc.M115.698597; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	68	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9924	9936		10.1074/jbc.RA118.003166	http://dx.doi.org/10.1074/jbc.RA118.003166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743243	Green Published, hybrid			2022-12-28	WOS:000436102300034
J	Hilton, JK; Salehpour, T; Sisco, NJ; Rath, P; Van Horn, WD				Hilton, Jacob K.; Salehpour, Taraneh; Sisco, Nicholas J.; Rath, Parthasarathi; Van Horn, Wade D.			Phosphoinositide-interacting regulator of TRP (PIRT) has opposing effects on human and mouse TRPM8 ion channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transient receptor potential channels (TRP channels); phosphoinositide; membrane protein; nuclear magnetic resonance (NMR); ion channel; electrophysiology; channel modulation; phosphoinositide regulator of TRP	ANKYRIN REPEAT DOMAIN; ELECTRON CRYOMICROSCOPY; HAIR-CELLS; COLD; RECEPTOR; ACTIVATION; MECHANISM; MENTHOL; SUBUNIT; BINDING	Transient receptor potential melastatin 8 (TRPM8) is a cold-sensitive ion channel with diverse physiological roles. TRPM8 activity is modulated by many mechanisms, including an interaction with the small membrane protein phosphoinositide-interacting regulator of TRP (PIRT). Here, using comparative electrophysiology experiments, we identified species-dependent differences between the human and mouse TRPM8-PIRT complexes. We found that human PIRT attenuated human TPRM8 conductance, unlike mouse PIRT, which enhanced mouse TRPM8 conductance. Quantitative Western blot analysis demonstrates that this effect does not arise from decreased trafficking of TRPM8 to the plasma membrane. Chimeric human/mouse TRPM8 channels were generated to probe the molecular basis of the PIRT modulation, and the effect was recapitulated in a pore domain chimera, demonstrating the importance of this region for PIRT-mediated regulation of TRPM8. Moreover, recombinantly expressed and purified human TRPM8 S1-S4 domain (comprising transmembrane helices S1-S4, also known as the sensing domain, ligand-sensing domain, or voltage sensing-like domain) and full-length human PIRT were used to investigate binding between the proteins. NMR experiments, supported by a pulldown assay, indicated that PIRT binds directly and specifically to the TRPM8 S1-S4 domain. Binding became saturated as the S1-S4:PIRT mole ratio approached 1. Our results have uncovered species-specific TRPM8 modulation by PIRT. They provide evidence for a direct interaction between PIRT and the TRPM8 S1-S4 domain with a 1:1 binding stoichiometry, suggesting that a functional tetrameric TRPM8 channel has four PIRT-binding sites.	[Hilton, Jacob K.; Salehpour, Taraneh; Sisco, Nicholas J.; Rath, Parthasarathi; Van Horn, Wade D.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Hilton, Jacob K.; Salehpour, Taraneh; Sisco, Nicholas J.; Rath, Parthasarathi; Van Horn, Wade D.] Arizona State Univ, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85281 USA; [Hilton, Jacob K.; Salehpour, Taraneh; Sisco, Nicholas J.; Rath, Parthasarathi; Van Horn, Wade D.] Arizona State Univ, Magnet Resonance Res Ctr, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Van Horn, WD (corresponding author), Virginia G Piper Ctr Personalized Diagnost, Sch Mol Sci, Biodesign Inst, Magnet Resonance Res Ctr, POB 871604, Tempe, AZ 85281 USA.	wade.van.horn@asu.edu	Van Horn, Wade/GSN-2667-2022; Sisco, Nicholas J/ABE-3039-2021	Van Horn, Wade/0000-0002-2493-5578; Sisco, Nicholas J/0000-0003-2091-868X	Bisgrove Early Career Award from the Science Foundation Arizona [R01GM112077]; National Institutes of Health [R01GM112077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112077] Funding Source: NIH RePORTER	Bisgrove Early Career Award from the Science Foundation Arizona; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Bisgrove Early Career Award from the Science Foundation Arizona and National Institutes of Health Grant R01GM112077 (to W.V.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Almeida MC, 2012, J NEUROSCI, V32, P2086, DOI 10.1523/JNEUROSCI.5606-11.2012; Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Bai JP, 2011, AM J PHYSIOL-CELL PH, V300, pC435, DOI 10.1152/ajpcell.00449.2010; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3501; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding Z, 2008, EUR J PHARMACOL, V578, P201, DOI 10.1016/j.ejphar.2007.09.030; Duan JJ, 2018, P NATL ACAD SCI USA, V115, P2377, DOI 10.1073/pnas.1722038115; Gao XF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8650; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Gavva NR, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-36; Gkika D, 2015, J CELL BIOL, V208, P89, DOI 10.1083/jcb.201402076; Gracheva EO, 2015, CURR OPIN NEUROBIOL, V34, P67, DOI 10.1016/j.conb.2015.01.021; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Guo W, 2016, PURINERG SIGNAL, V12, P489, DOI 10.1007/s11302-016-9515-6; Hilton JK, 2015, BIOCHEMISTRY-US, V54, P2401, DOI 10.1021/acs.biochem.5b00071; Janssens A, 2011, J PHYSIOL-LONDON, V589, P4827, DOI 10.1113/jphysiol.2011.216523; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Knowlton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025894; Kroncke BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501228; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; Martinez-Espinosa PL, 2014, J GEN PHYSIOL, V144, P275, DOI 10.1085/jgp.201411253; Matos-Cruz V, 2017, CELL REP, V21, P3329, DOI 10.1016/j.celrep.2017.11.083; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Patel KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020559; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peng DG, 2014, BIOCHEMISTRY-US, V53, P2032, DOI 10.1021/bi500102w; Quallo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8150; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; Rath P, 2016, BIOCHEMISTRY-US, V55, P114, DOI 10.1021/acs.biochem.5b00931; Rohacs T, 2014, HANDB EXP PHARMACOL, V223, P1143, DOI 10.1007/978-3-319-05161-1_18; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; Sun J, 2014, HYPERTENSION, V63, P1354, DOI 10.1161/HYPERTENSIONAHA.113.02573; Sun XH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00063; Survery S, 2016, J BIOL CHEM, V291, P26899, DOI 10.1074/jbc.M116.743443; Tang M, 2016, ACTA PHARMACOL SIN, V37, P98, DOI 10.1038/aps.2015.110; Tang ZX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3179; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Velisetty P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27652; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CM, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0054-x; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Yang F, 2015, NAT CHEM BIOL, V11, P518, DOI [10.1038/NCHEMBIO.1835, 10.1038/nchembio.1835]; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zhou JH, 2015, BIOPHYS J, V108, P2658, DOI 10.1016/j.bpj.2015.04.024	58	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9423	9434		10.1074/jbc.RA118.003563	http://dx.doi.org/10.1074/jbc.RA118.003563			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29724821	hybrid, Green Published			2022-12-28	WOS:000435441400026
J	Cooke, M; Zhou, XL; Casado-Medrano, V; Lopez-Haber, C; Baker, MJ; Garg, R; Ann, J; Lee, J; Blumberg, PM; Kazanietz, MG				Cooke, Mariana; Zhou, Xiaoling; Casado-Medrano, Victoria; Lopez-Haber, Cynthia; Baker, Martin J.; Garg, Rachana; Ann, Jihyae; Lee, Jeewoo; Blumberg, Peter M.; Kazanietz, Marcelo G.			Characterization of AJH-836, a diacylglycerol-lactone with selectivity for novel PKC isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase C (PKC); phorbol ester; diacylglycerol; lipid signaling; ligand-binding protein; C1 domain; cPKC; diacylglycerol lactone; nPKC; protein kinase activation; cell signaling; second messenger; cytoskeleton	PROTEIN-KINASE-C; PHORBOL ESTER BINDING; CONFORMATIONALLY CONSTRAINED ANALOGS; PROSTATE-CANCER CELLS; INDUCED APOPTOSIS; DOWN-REGULATION; TUMOR PROMOTION; DAG-LACTONES; MOUSE SKIN; DELTA	Diacylglycerol (DAG) is a key lipid second messenger downstream of cellular receptors that binds to the C1 domain in many regulatory proteins. Protein kinase C (PKC) isoforms constitute the most prominent family of signaling proteins with DAG-responsive C1 domains, but six other families of proteins, including the chimaerins, Ras-guanyl nucleotide-releasing proteins (RasGRPs), and Munc13 isoforms, also play important roles. Their significant involvement in cancer, immunology, and neurobiology has driven intense interest in the C1 domain as a therapeutic target. As with other classes of targets, however, a key issue is the establishment of selectivity. Here, using [H-3]phorbol 12,13-dibutyrate ([H-3]PDBu) competition binding assays, we found that a synthetic DAG-lactone, AJH-836, preferentially binds to the novel PKC isoforms PKC and PKCE relative to classical PKC and PKCII. Assessment of intracellular translocation, a hallmark for PKC activation, revealed that AJH-836 treatment stimulated a striking preferential redistribution of PKCE to the plasma membrane relative to PKC. Moreover, unlike with the prototypical phorbol ester phorbol 12-myristate 13-acetate (PMA), prolonged exposure of cells to AJH-836 selectively down-regulated PKC and PKCE without affecting PKC expression levels. Biologically, AJH-836 induced major changes in cytoskeletal reorganization in lung cancer cells, as determined by the formation of membrane ruffles, via activation of novel PKCs. We conclude that AJH-836 represents a C1 domain ligand with PKC-activating properties distinct from those of natural DAGs and phorbol esters. Our study supports the feasibility of generating selective C1 domain ligands that promote novel biological response patterns.	[Cooke, Mariana; Casado-Medrano, Victoria; Lopez-Haber, Cynthia; Baker, Martin J.; Garg, Rachana; Kazanietz, Marcelo G.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA; [Zhou, Xiaoling; Blumberg, Peter M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ann, Jihyae; Lee, Jeewoo] Seoul Natl Univ, Coll Pharm, Lab Med Chem, Seoul 08826, South Korea	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU)	Kazanietz, MG (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Casado-Medrano, Victoria/ABE-6429-2021; Baker, Martin/AAM-8426-2020; zhou, xuan/GZA-8157-2022; Cooke, Mariana/V-1375-2019; Cooke, Mariana/ABD-5051-2021; Baker, Martin James/AAO-1650-2020; Garg, Rachana/AAQ-9518-2020	Casado-Medrano, Victoria/0000-0002-6929-4559; Baker, Martin/0000-0002-9743-6294; Lee, Jeewoo/0000-0002-7832-6719; Ann, Jihyae/0000-0002-5043-8014; Garg, Rachana/0000-0002-7808-1053; Lopez Haber, Cynthia/0000-0001-9106-543X; Cooke, Mariana/0000-0001-9300-8447	National Institutes of Health [ES026023, CA189765, CA196232]; National Research Foundation of Korea for the Global Core Research Center [2011-0030001]; Intramural Research Program of the National Institutes of Health, Center for Cancer Research, NCI [Z1A BC 005270]; NATIONAL CANCER INSTITUTE [ZIABC005270, R01CA189765, Z01BC005270, R01CA196232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea for the Global Core Research Center(National Research Foundation of Korea); Intramural Research Program of the National Institutes of Health, Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants ES026023, CA189765, and CA196232 (to M.G.K.); by National Research Foundation of Korea for the Global Core Research Center Grant 2011-0030001; and in part by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, NCI Project Z1A BC 005270. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ann J, 2015, EUR J MED CHEM, V90, P332, DOI 10.1016/j.ejmech.2014.11.025; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; Bogi K, 1998, CANCER RES, V58, P1423; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Cooke M, 2017, MOL CARCINOGEN, V56, P1531, DOI 10.1002/mc.22617; Duan D, 2008, J MED CHEM, V51, P5198, DOI 10.1021/jm8001907; Durgan J, 2007, FEBS LETT, V581, P3377, DOI 10.1016/j.febslet.2007.06.035; Elhalem E, 2017, BIOORGAN MED CHEM, V25, P2971, DOI 10.1016/j.bmc.2017.03.022; Garcia LC, 2014, BIOORGAN MED CHEM, V22, P3123, DOI 10.1016/j.bmc.2014.04.024; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Garg R, 2017, CELL REP, V19, P375, DOI 10.1016/j.celrep.2017.03.042; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HANNUN YA, 1986, J BIOL CHEM, V261, P9341; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; HENNINGS H, 1987, CARCINOGENESIS, V8, P1343, DOI 10.1093/carcin/8.9.1343; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kashiwagi M, 2002, J BIOCHEM, V132, P853, DOI 10.1093/oxfordjournals.jbchem.a003297; Kazanietz MG, 2017, CANCER RES, V77, P5445, DOI 10.1158/0008-5472.CAN-17-1456; KAZANIETZ MG, 1992, J BIOL CHEM, V267, P20878; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; Kedei N, 2014, J MED CHEM, V57, P5356, DOI 10.1021/jm500417b; Kim H, 2016, J CELL BIOCHEM, V117, P647, DOI 10.1002/jcb.25314; Lum MA, 2013, J BIOL CHEM, V288, P13093, DOI 10.1074/jbc.M112.437061; Marquez VE, 2003, ACCOUNTS CHEM RES, V36, P434, DOI 10.1021/ar020124b; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Nacro K, 2000, J MED CHEM, V43, P921, DOI 10.1021/jm9904607; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Ohashi N, 2017, BIOCONJUGATE CHEM, V28, P2135, DOI 10.1021/acs.bioconjchem.7b00299; Okhrimenko H, 2005, J BIOL CHEM, V280, P23643, DOI 10.1074/jbc.M501374200; OLIVIER AR, 1992, J CELL PHYSIOL, V152, P240, DOI 10.1002/jcp.1041520204; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Pu YM, 2009, J BIOL CHEM, V284, P1302, DOI 10.1074/jbc.M804796200; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Russo P, 2016, MAR DRUGS, V14, DOI 10.3390/md14010005; SHARKEY NA, 1984, P NATL ACAD SCI-BIOL, V81, P607, DOI 10.1073/pnas.81.2.607; SZALLASI Z, 1993, CANCER RES, V53, P2507; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	52	9	12	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8330	8341		10.1074/jbc.RA117.000235	http://dx.doi.org/10.1074/jbc.RA117.000235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29636415	Green Published, hybrid			2022-12-28	WOS:000434205700002
J	Gu, WD; Hong, XC; Le Bras, A; Nowak, WN; Bhaloo, SI; Deng, JC; Xie, Y; Hu, YH; Ruan, XZ; Xu, QB				Gu, Wenduo; Hong, Xuechong; Le Bras, Alexandra; Nowak, Witold N.; Bhaloo, Shirin Issa; Deng, Jiacheng; Xie, Yao; Hu, Yanhua; Ruan, Xiong Z.; Xu, Qingbo			Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mesenchymal stem cells (MSCs); vascular smooth muscle cells; cell differentiation; microRNA mechanism; transforming growth factor beta (TGF-); tissue engineering; umbilical cord mesenchymal stem cells	GROWTH-FACTOR-BETA; NEOINTIMAL FORMATION; MIRNA-ASTERISK; MODULATION; PHENOTYPE; MECHANISM; THERAPY; DISEASE; INJURY; GENES	Tissue-engineered vascular grafts with long-term patency are greatly needed in the clinical settings, and smooth muscle cells (SMCs) are a critical graft component. Human mesenchymal stem cells (MSCs) are used for generating SMCs, and understanding the underlying regulatory mechanisms of the MSC-to-SMC differentiation process could improve SMC generation in the clinic. Here, we found that in response to stimulation of transforming growth factor-1 (TGF1), human umbilical cord-derived MSCs abundantly express the SMC markers -smooth muscle actin (SMA), smooth muscle protein 22 (SM22), calponin, and smooth muscle myosin heavy chain (SMMHC) at both gene and protein levels. Functionally, MSC-derived SMCs displayed contracting capacity in vitro and supported vascular structure formation in the Matrigel plug assay in vivo. More importantly, SMCs differentiated from human MSCs could migrate into decellularized mouse aorta and give rise to the smooth muscle layer of vascular grafts, indicating the potential of utilizing human MSC-derived SMCs to generate vascular grafts. Of note, microRNA (miR) array analysis and TaqMan microRNA assays identified miR-503 and miR-222-5p as potential regulators of MSC differentiation into SMCs at early time points. Mechanistically, miR-503 promoted SMC differentiation by directly targeting SMAD7, a suppressor of SMAD-related, TGF1-mediated signaling pathways. Moreover, miR-503 expression was SMAD4-dependent. SMAD4 was enriched at the miR-503 promoter. Furthermore, miR-222-5p inhibited SMC differentiation by targeting and down-regulating ROCK2 and SMA. In conclusion, MSC differentiation into SMCs is regulated by miR-503 and miR-222-5p and yields functional SMCs for use in vascular grafts.	[Gu, Wenduo; Hong, Xuechong; Le Bras, Alexandra; Nowak, Witold N.; Bhaloo, Shirin Issa; Deng, Jiacheng; Xie, Yao; Hu, Yanhua; Xu, Qingbo] Kings Coll London, Sch Cardiovasc Med & Sci, British Heart Fdn Ctr, London SE5 9NU, England; [Ruan, Xiong Z.] Chongqing Med Univ, Ctr Lipid Res, Key Lab Mol Biol Infect Dis, Minist Educ,Dept Infect Dis,Affiliated Hosp 2, Chongqing, Peoples R China; [Ruan, Xiong Z.] UCL, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England	University of London; King's College London; Chongqing Medical University; University of London; University College London	Ruan, XZ (corresponding author), Chongqing Med Univ, Ctr Lipid Res, Key Lab Mol Biol Infect Dis, Minist Educ,Dept Infect Dis,Affiliated Hosp 2, Chongqing, Peoples R China.; Ruan, XZ (corresponding author), UCL, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.; Xu, QB (corresponding author), Kings Coll London, Sch Cardiovasc Med & Sci, Kings BHF Ctr, 125 Coldharbour Lane, London SE5 9NU, England.	x.ruan@ucl.ac.uk; qingbo.xu@kcl.ac.uk	Ruan, Xiong Zhong/GZA-5963-2022	Ruan, Xiong Zhong/0000-0001-5199-4971; Le Bras, Alexandra/0000-0001-7898-4618; Gu, Wenduo/0000-0002-3859-3150; Deng, Jiacheng/0000-0002-3216-3774; Nowak, Witold/0000-0002-1526-3511	British Heart Foundation [RG/14/6/31144]; National Nature Science Foundation of China [81390354]	British Heart Foundation(British Heart Foundation); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by British Heart Foundation Grant RG/14/6/31144 and the National Nature Science Foundation of China Grant Number 81390354. The authors declare that they have no conflicts of interest with the contents of this article.	Abu Kasim NH, 2015, J TISSUE ENG REGEN M, V9, pE252, DOI 10.1002/term.1663; Adams B, 2007, TRENDS CARDIOVAS MED, V17, P246, DOI 10.1016/j.tcm.2007.08.005; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bhayani MK, 2012, MUTAT RES-FUND MOL M, V731, P14, DOI 10.1016/j.mrfmmm.2011.10.014; Campagnolo P, 2015, BIOMATERIALS, V60, P53, DOI 10.1016/j.biomaterials.2015.04.055; Caporali A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9024; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen WX, 2013, TUMOR BIOL, V34, P1361, DOI 10.1007/s13277-013-0750-y; Chen YK, 2013, ARTERIOSCL THROM VAS, V33, P1844, DOI 10.1161/ATVBAHA.113.300902; Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Guo L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/907420; Guo L, 2012, GENE, V511, P187, DOI 10.1016/j.gene.2012.09.066; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Kan X, 2016, MOL MED REP, V13, P4315, DOI 10.3892/mmr.2016.5048; Karamariti E, 2013, CIRC RES, V112, P1433, DOI 10.1161/CIRCRESAHA.111.300415; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim MR, 2009, STEM CELLS, V27, P191, DOI 10.1634/stemcells.2008-0363; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lee A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02852-4; Lee MS, 2011, JACC-CARDIOVASC INTE, V4, P831, DOI 10.1016/j.jcin.2011.05.014; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Lo Furno D, 2018, J CELL PHYSIOL, V233, P3982, DOI 10.1002/jcp.26192; Maguire EM, 2017, ARTERIOSCL THROM VAS, V37, P2026, DOI 10.1161/ATVBAHA.117.309196; Mah SM, 2010, CRIT REV EUKAR GENE, V20, P141, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.40; Matsushita R, 2016, ONCOTARGET, V7, P28460, DOI 10.18632/oncotarget.8668; Merlet E, 2013, CARDIOVASC RES, V98, P458, DOI 10.1093/cvr/cvt045; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Reid G, 2016, EPIGENOMICS-UK, V8, P1079, DOI 10.2217/epi-2016-0035; Rothuizen TC, 2016, TISSUE ENG PART C-ME, V22, P923, DOI [10.1089/ten.tec.2016.0173, 10.1089/ten.TEC.2016.0173]; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Shende P, 2017, BIOMED PHARMACOTHER, V91, P693, DOI 10.1016/j.biopha.2017.04.126; Togliatto G, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000376; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang C, 2010, TISSUE ENG PT A, V16, P1201, DOI 10.1089/ten.TEA.2009.0303; Wong MM, 2015, JOVE-J VIS EXP, DOI 10.3791/52565; Xu J, 2013, MOL BIOSYST, V9, P217, DOI 10.1039/c2mb25360g; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhao Y, 2008, TRENDS GENET, V24, P323, DOI 10.1016/j.tig.2008.04.004; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065153; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007	56	37	40	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8089	8102		10.1074/jbc.RA118.001739	http://dx.doi.org/10.1074/jbc.RA118.001739			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29643181	Green Published, hybrid			2022-12-28	WOS:000433224600015
J	Litke, C; Bading, H; Mauceri, D				Litke, Christian; Bading, Hilmar; Mauceri, Daniela			Histone deacetylase 4 shapes neuronal morphology via a mechanism involving regulation of expression of vascular endothelial growth factor D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone deacetylase (HDAC); epigenetics; dendrite; hippocampus; calcium; neuronal morphology; nucleo-cytoplasmic shuttling; synaptic activity; VEGFD	SYNAPTIC PLASTICITY; NUCLEAR ACCUMULATION; HDAC4; PHOSPHORYLATION; SURVIVAL; BINDING; TRANSLOCATION; FAMILY; DEATH; CREB	Nucleo-cytoplasmic shuttling of class IIa histone deacetylases (i.e. HDAC4, -5, -7, and -9) is a synaptic activity- and nuclear calcium-dependent mechanism important for epigenetic regulation of signal-regulated gene expression in hippocampal neurons. HDAC4 in particular has been linked to the regulation of genes important for both synaptic structure and plasticity. Here, using a constitutively nuclear-localized, dominant-active variant of HDAC4 (HDAC4 3SA), we demonstrate that HDAC4 accumulation in the nucleus severely reduces both the length and complexity of dendrites of cultured mature hippocampal neurons, but does not affect the number of dendritic spines. This phenomenon appeared to be specific to HDAC4, as increasing the expression of HDAC3 or HDAC11, belonging to class I and class IV HDACs, respectively, did not alter dendritic architecture. We also show that HDAC4 3SA decreases the expression of vascular endothelial growth factor D (VEGFD), a key protein required for the maintenance of dendritic arbors. The expression of other members of the VEGF family and their receptors was not affected by the nuclear accumulation of HDAC4. VEGFD overexpression or administration of recombinant VEGFD, but not VEGFC, the closest VEGFD homologue, rescued the impaired dendritic architecture caused by the nuclear-localized HDAC4 variant. These results identify HDAC4 as an epigenetic regulator of neuronal morphology that controls dendritic arborization via the expression of VEGFD.	[Litke, Christian; Bading, Hilmar; Mauceri, Daniela] Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, Dept Neurobiol, INF 364, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Mauceri, D (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, Dept Neurobiol, INF 364, D-69120 Heidelberg, Germany.	Mauceri@nbio.uni-heidelberg.de	Mauceri, Daniela/C-4969-2014	Mauceri, Daniela/0000-0003-1225-4633; Litke, Christian/0000-0001-9403-4233	Deutsche Forschungsgemeinschaft [SFB1158, FOR2325]; FRONTIER grant from the Heidelberg University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FRONTIER grant from the Heidelberg University	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB1158 and FOR2325 (to D. M. and H. B.) and FRONTIER grant from the Heidelberg University (to D. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ageta-Ishihara N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3532; Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bading H, 2017, J EXP MED, V214, P569, DOI 10.1084/jem.20161673; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Baloyannis SJ, 2009, J NEUROL SCI, V283, P153, DOI 10.1016/j.jns.2009.02.370; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Bryant DT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11630-1; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Gu X, 2018, J CELL PHYSIOL, V233, P673, DOI 10.1002/jcp.25927; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hemstedt TJ, 2017, J NEUROSCI, V37, P6946, DOI 10.1523/JNEUROSCI.2345-16.2017; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Kassis H, 2015, STROKE, V46, P1909, DOI 10.1161/STROKEAHA.115.009046; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Mauceri D, 2015, J BIOL CHEM, V290, P23039, DOI 10.1074/jbc.M115.654962; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; Mellstrom B, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0204-8; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlumm F, 2013, J BIOL CHEM, V288, P8074, DOI 10.1074/jbc.M112.432773; Segal M, 2010, EUR J NEUROSCI, V31, P2178, DOI 10.1111/j.1460-9568.2010.07270.x; Shen XT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0124-15.2016; SHOLL DA, 1953, J ANAT, V87, P387; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Wu QM, 2017, MOL NEUROBIOL, V54, P6970, DOI 10.1007/s12035-016-0199-2; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan H, 2016, NEUROBIOL DIS, V91, P182, DOI 10.1016/j.nbd.2016.03.004; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	50	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8196	8207		10.1074/jbc.RA117.001613	http://dx.doi.org/10.1074/jbc.RA117.001613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632070	hybrid, Green Published			2022-12-28	WOS:000433224600024
J	Sen, S; Das, C				Sen, Sabyasachi; Das, Chandrima			Managing the sugar factory: A new feather in the cap for nuclear factor Y	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GLUCONEOGENESIS	Gluconeogenesis in the liver converts lipids and several other noncarbohydrate precursors into glucose, ensuring that blood sugar levels are maintained at healthy levels, especially during fasting. Effective regulation of gluconeogenesis is therefore critical for maintaining systemic metabolic homeostasis. Zhang and colleagues have discovered that the ubiquitous transcriptional regulator nuclear factor Y (NF-Y) confers cAMP responsiveness to key gluconeogenic genes and up-regulates hepatic glucose production. The study expands our understanding of transcriptional regulation of hepatic gluconeogenesis and also presents critical insights into the function of NF-Y in the liver.	[Sen, Sabyasachi; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India	Saha Institute of Nuclear Physics	Das, C (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India.	chandrima.das@saha.ac.in	Das, Chandrima/AAI-7398-2021	Das, Chandrima/0000-0002-8117-2810	Biomolecular Assembly, Recognition, and Dynamics (BARD) Research Grant from the Department of Atomic Energy (DAE), Government of India [12-RD-SIN-5.04-0103]	Biomolecular Assembly, Recognition, and Dynamics (BARD) Research Grant from the Department of Atomic Energy (DAE), Government of India	This work was supported by Biomolecular Assembly, Recognition, and Dynamics (BARD) Research Grant 12-R&D-SIN-5.04-0103 from the Department of Atomic Energy (DAE), Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Bedford DC, 2011, CELL METAB, V14, P219, DOI 10.1016/j.cmet.2011.06.010; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Liu YL, 2017, MOL CELL BIOCHEM, V426, P47, DOI 10.1007/s11010-016-2879-7; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Sen S, 2017, J BIOL CHEM, V292, P20362, DOI 10.1074/jbc.M117.786863; TAPPY L, 1995, DIABETES METAB, V21, P233; Zhang YJ, 2018, J BIOL CHEM, V293, P7894, DOI 10.1074/jbc.RA117.000508	9	2	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7905	+		10.1074/jbc.H118.002885	http://dx.doi.org/10.1074/jbc.H118.002885			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29777018	Green Published, hybrid			2022-12-28	WOS:000437256500037
J	Nguyen-Tu, MS; Xavier, GD; Leclerc, I; Rutter, GA				Nguyen-Tu, Marie-Sophie; Xavier, Gabriela da Silva; Leclerc, Isabelle; Rutter, Guy A.			Transcription factor-7-like 2 (TCF7L2) gene acts downstream of the Lkb1/Stk11 kinase to control mTOR signaling, cell growth, and insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreatic islet; insulin secretion; cell growth; liver kinase B1 (LKB1); T-cell factor (TCF); pancreatic cell; TCF7L2	PEUTZ-JEGHERS-SYNDROME; BETA-CELLS; GLUCOSE-HOMEOSTASIS; LKB1; MASS; MICE; EXPRESSION; EXPANSION; IDENTITY; RISK	Variants in the transcription factor-7-like 2 (TCF7L2/TCF4) gene, involved in Wnt signaling, are associated with type 2 diabetes. Loss of Tcf7l2 selectively from the cell in mice has previously been shown to cause glucose intolerance and to lower cell mass. Deletion of the tumor suppressor liver kinase B1 (LKB1/STK11) leads to cell hyperplasia and enhanced glucose-stimulated insulin secretion, providing a convenient genetic model for increased cell growth and function. The aim of this study was to explore the possibility that Tcf7l2 may be required for the effects of Lkb1 deletion on insulin secretion in the mouse cell. Mice bearing floxed Lkb1 and/or Tcf7l2 alleles were bred with knockin mice bearing Cre recombinase inserted at the Ins1 locus (Ins1Cre), allowing highly cell-selective deletion of either or both genes. Oral glucose tolerance was unchanged by the further deletion of a single Tcf7l2 allele in these cells. By contrast, mice lacking both Tcf7l2 alleles on this background showed improved oral glucose tolerance and insulin secretion in vivo and in vitro compared with mice lacking a single Tcf7l2 allele. Biallelic Tcf7l2 deletion also enhanced cell proliferation, increased cell mass, and caused changes in polarity as revealed by the rosette-like arrangement of cells. Tcf7l2 deletion also increased signaling by mammalian target of rapamycin (mTOR), augmenting phospho-ribosomal S6 levels. We identified a novel signaling mechanism through which a modifier gene, Tcf7l2, lies on a pathway through which LKB1 acts in the cell to restrict insulin secretion.	Imperial Coll London, Imperial Ctr Translat & Expt Med, Dept Med, Sect Cell Biol & Funct Genom, London W12 0NN, England; Imperial Coll London, Imperial Ctr Translat & Expt Med, Div Diabet Endocrinol & Metab, Pancreat Islet & Diabet Consortium,Dept Med, London W12 0NN, England	Imperial College London; Imperial College London	Rutter, GA (corresponding author), Imperial Coll London, Hammersmith Hosp Campus, DuCane Rd, London W12 0NN, England.	g.rutter@imperial.ac.uk		Rutter, Guy/0000-0001-6360-0343; da Silva Xavier, Gabriela/0000-0002-0678-012X; Leclerc, Isabelle/0000-0003-0044-7921	Medical Research Council (MRC) Program [MR/J0003042/1, MR/N00275X/1, MR/L020149/1]; Wellcome Trust [WT098424AIA]; Royal Society Wolfson Research Merit Awards; Diabetes UK Project Grants [BDA11/0004210, BDA/15/0005275]; MRC [MR/L020149/1, MR/K001981/1, MR/N00275X/1] Funding Source: UKRI	Medical Research Council (MRC) Program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society Wolfson Research Merit Awards(Royal Society of London); Diabetes UK Project Grants; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council (MRC) Program Grants MR/J0003042/1, MR/N00275X/1, and MR/L020149/1 (DIVA); Wellcome Trust Senior Investigator Grant WT098424AIA; Royal Society Wolfson Research Merit Awards; and Diabetes UK Project Grants BDA11/0004210 and BDA/15/0005275 (to G. A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Boardman LA, 1998, ANN INTERN MED, V128, P896, DOI 10.7326/0003-4819-128-11-199806010-00004; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cruciani-Guglielmacci C, 2017, MOL METAB, V6, P340, DOI 10.1016/j.molmet.2017.01.009; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Fu A, 2015, DIABETOLOGIA, V58, P1513, DOI 10.1007/s00125-015-3579-7; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Habener J. F., 2014, ISLETS OF LANGERHANS, P391; Heni M, 2010, DIABETES, V59, P3247, DOI 10.2337/db10-0674; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kahn SE, 2009, DIABETOLOGIA, V52, P1003, DOI 10.1007/s00125-009-1321-z; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Liu K, 2014, TUMOR BIOL, V35, P995, DOI 10.1007/s13277-013-1133-0; Ma YM, 2010, ONCOL REP, V23, P1569, DOI 10.3892/or_00000797; Mehta ZB, 2016, AM J PHYSIOL-ENDOC M, V311, pE488, DOI 10.1152/ajpendo.00074.2016; Mezza T, 2014, DIABETES, V63, P994, DOI 10.2337/db13-1013; Mitchell RK, 2017, J BIOL CHEM, V292, P8892, DOI 10.1074/jbc.M117.784629; Mitchell RK, 2015, HUM MOL GENET, V24, P1390, DOI 10.1093/hmg/ddu553; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Muncan V, 2007, EMBO REP, V8, P966, DOI 10.1038/sj.embor.7401071; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Rutter GA, 2015, DIABETOLOGIA, V58, P31, DOI 10.1007/s00125-014-3405-7; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Swisa A, 2015, J BIOL CHEM, V290, P20934, DOI 10.1074/jbc.M115.639237; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; Xavier GD, 2012, DIABETOLOGIA, V55, P2667, DOI 10.1007/s00125-012-2600-7; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Zeggini E, 2007, DIABETOLOGIA, V50, P1, DOI 10.1007/s00125-006-0507-x; Zhou YD, 2014, HUM MOL GENET, V23, P6419, DOI 10.1093/hmg/ddu359	49	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14178	14189		10.1074/jbc.RA118.003613	http://dx.doi.org/10.1074/jbc.RA118.003613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29967064	Green Published, hybrid			2022-12-28	WOS:000444070700038
J	Bortnov, V; Annis, DS; Fogerty, FJ; Barretto, KT; Turton, KB; Mosher, DF				Bortnov, Valeriu; Annis, Douglas S.; Fogerty, Frances J.; Barretto, Karina T.; Turton, Keren B.; Mosher, Deane F.			Myeloid-derived growth factor is a resident endoplasmic reticulum protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-ISOMERASE; INTERACTION NETWORK; IDENTIFICATION; DRAFT; MAP	Human myeloid-derived growth factor (MYDGF, also known as C19orf10) is named based on its identification as a secreted monocyte/macrophage-derived mediator of cardiac repair following myocardial infarction in mice. Homologs of MYDGF, however, are present in organisms throughout and outside of the animal kingdom, some of which lack hematopoietic and circulatory systems. Moreover, the UPF0556 protein domain, which defines these homologs, lacks a known structure. As a result, the functions and properties of MYDGF are unclear. Our current work was initiated to test whether MYDGF is present in secretory vesicles of eosinophils, as it was recently reported to be abundant in these cells. However, we could not demonstrate secretion and unexpectedly discovered that MYDGF co-localizes with P4HB in the nuclear envelope, which comprises the bulk of endoplasmic reticulum (ER) in eosinophils, and with P4HB and RCAS1 in Golgi. We noted a ubiquitous C-terminal sequence BXEL (B, basic; X, variable residue; E, Glu; L, Leu) that has the potential to retain human MYDGF and its homologs in the ER. To test the functionality of this sequence, we expressed full-length human MYDGF or MYDGF lacking the C-terminal Glu-Leu residues in monolayers of human embryonic kidney 293 (HEK293) cells. Full-length MYDGF accumulated in cells whereas truncated MYDGF appeared in the medium. These observations reveal that MYDGF resides in the ER and the Golgi and provide a new framework for investigating and understanding this intriguing protein.	[Bortnov, Valeriu; Annis, Douglas S.; Fogerty, Frances J.; Barretto, Karina T.; Turton, Keren B.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA; [Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	dfmosher@wisc.edu		Bortnov, Valeriu/0000-0002-1159-7338; Turton, Keren/0000-0001-9064-6523	University of Wisconsin-Madison Department of Biochemistry Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125390] Funding Source: NIH RePORTER	University of Wisconsin-Madison Department of Biochemistry Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Elle Grevstad for help in obtaining and processing microscopy data. Microscopy was performed at the University of Wisconsin- Madison Biochemistry Optical Core, which was established with support from the University of Wisconsin-Madison Department of Biochemistry Endowment.	ANDRES DA, 1991, J BIOL CHEM, V266, P14277; Bailey MJ, 2011, IMMUNOL CELL BIOL, V89, P283, DOI 10.1038/icb.2010.92; Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151; Cavalier-Smith T, 2015, MOL PHYLOGENET EVOL, V83, P293, DOI 10.1016/j.ympev.2014.08.011; Cavalier-Smith T, 2014, MOL PHYLOGENET EVOL, V81, P71, DOI 10.1016/j.ympev.2014.08.012; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Dias FF, 2014, J HISTOCHEM CYTOCHEM, V62, P450, DOI 10.1369/0022155414531437; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Han ST, 2014, AM J RESP CELL MOL, V50, P654, DOI 10.1165/rcmb.2013-0181OC; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Korf-Klingebiel M, 2015, NAT MED, V21, P140, DOI 10.1038/nm.3778; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Maddison DR, 2007, ZOOTAXA, P19, DOI 10.11646/zootaxa.1668.1.4; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MAYENO AN, 1992, J LEUKOCYTE BIOL, V51, P172, DOI 10.1002/jlb.51.2.172; Mosher DF, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00159; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Owusu BY, 2018, J CELL COMMUN SIGNAL, V12, P289, DOI 10.1007/s12079-017-0426-2; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Riley BE, 2004, J BIOL CHEM, V279, P42290, DOI 10.1074/jbc.M406284200; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Shao SC, 2017, SCIENCE, V355, P298, DOI 10.1126/science.aah6130; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Straub C, 2009, PROTEOM CLIN APPL, V3, P1151, DOI 10.1002/prca.200900043; Sunagozaka H, 2011, INT J CANCER, V129, P1576, DOI 10.1002/ijc.25830; Tulin EE, 2003, J IMMUNOL, V170, P1593, DOI 10.4049/jimmunol.170.3.1593; Tulin EE, 2001, J IMMUNOL, V167, P6338, DOI 10.4049/jimmunol.167.11.6338; Wang P, 2004, CELL MOL LIFE SCI, V61, P2405, DOI 10.1007/s00018-004-4256-z; Weeraphan C, 2012, TALANTA, V99, P294, DOI 10.1016/j.talanta.2012.05.054; Weiler T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2145; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wilkerson EM, 2016, J PROTEOME RES, V15, P1524, DOI 10.1021/acs.jproteome.6b00006; Zhou JS, 2017, BLOOD, V130, P817, DOI 10.1182/blood-2016-12-755587	39	13	16	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13166	13175		10.1074/jbc.AC118.002052	http://dx.doi.org/10.1074/jbc.AC118.002052			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29954947	hybrid, Green Published			2022-12-28	WOS:000442730200016
J	Mehra, S; Ghoshn, D; Kumar, R; Mondal, M; Gadhe, LG; Das, S; Anoop, A; Jha, NN; Jacob, RS; Chatterjee, D; Ray, S; Singh, N; Kumar, A; Maji, SK				Mehra, Surabhi; Ghoshn, Dhiman; Kumar, Rakesh; Mondal, Mrityunjoy; Gadhe, Laxmikant G.; Das, Subhadeep; Anoop, Arunagiri; Jha, Narendra N.; Jacob, Reeba S.; Chatterjee, Debdeep; Ray, Soumik; Singh, Nitu; Kumar, Ashutosh; Maji, Samir K.			Glycosaminoglycans have variable effects on alpha-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CIRCULAR-DICHROISM SPECTRA; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; IN-VITRO; ALZHEIMERS-DISEASE; PROTEIN; MUTATION; PEPTIDES; TOXICITY	Parkinson's disease is mainly a sporadic disorder in which both environmental and cellular factors play a major role in the initiation of this disease. Glycosaminoglycans (GAG) are integral components of the extracellular matrix and are known to influence amyloid aggregation of several proteins, including alpha-synuclein (alpha-Syn). However, the mechanism by which different GAGs and related biological polymers influence protein aggregation and the structure and intercellular spread of these aggregates remains elusive. In this study, we used three different GAGs and related charged polymers to establish their role in alpha-Syn aggregation and associated biological activities of these aggregates. Heparin, a representative GAG, affected alpha-Syn aggregation in a concentration-dependent manner, whereas biphasic alpha-Syn aggregation kinetics was observed in the presence of chondroitin sulfate B. Of note, as indicated by 2D NM R analysis, different GAGs uniquely modulated alpha-Syn aggregation because of the diversity of their interactions with soluble alpha-Syn. Moreover, subtle differences in the GAG backbone structure and charge density significantly altered the properties of the resulting amyloid fibrils. Each GAG/polymer facilitated the formation of morphologically and structurally distinct alpha-Syn amyloids, which not only displayed variable levels of cytotoxicity but also exhibited an altered ability to internalize into cells. Our study supports the role of GAGs as key modulators in alpha-Syn amyloid formation, and their distinct activities may regulate amyloidogenesis depending on the type of GAG being up- or down-regulated in vivo.	[Mehra, Surabhi; Ghoshn, Dhiman; Kumar, Rakesh; Mondal, Mrityunjoy; Gadhe, Laxmikant G.; Das, Subhadeep; Anoop, Arunagiri; Jha, Narendra N.; Jacob, Reeba S.; Chatterjee, Debdeep; Ray, Soumik; Singh, Nitu; Kumar, Ashutosh; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Das, Subhadeep] Indian Inst Technol, IITB Monash Res Acad, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Maji, SK (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	samirmaji@iitb.ac.in	Arunagiri, Anoop/P-2528-2018; JHA, NARENDRA NATH/ABI-3727-2020; Maji, Samir K. K./B-9640-2019	Arunagiri, Anoop/0000-0001-9839-1860; JHA, NARENDRA NATH/0000-0002-1734-7663; Maji, Samir K. K./0000-0002-9110-1565; Chatterjee, Dr. Debdeep/0000-0001-8153-8651; Jacob, Reeba/0000-0002-0676-834X; Mondal, Mrityunjoy/0000-0003-2973-4633; Mehra, Surabhi/0000-0003-1777-673X; Das, Subhadeep/0000-0003-1870-8456	DBT-Neuroscience, Government of India [BT/PR14344Med/30/501/2010]; DBT-Basic Sciences [BT/PR13359/BRB/10/752/2009]; Council of Scientific and Industrial Research, India [37(1648)/15/EMRII]; University Grants Commission (Govt. of India)	DBT-Neuroscience, Government of India; DBT-Basic Sciences; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (Govt. of India)(University Grants Commission, India)	This work was supported by Grant BT/PR14344Med/30/501/2010 from DBT-Neuroscience, Government of India; Grant BT/PR13359/BRB/10/752/2009 from DBT-Basic Sciences; and Grant 37(1648)/15/EMRII from the Council of Scientific and Industrial Research, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of a fellowship from the University Grants Commission (Govt. of India). Both authors contributed equally to this work.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Avila CL, 2014, J BIOL CHEM, V289, P13838, DOI 10.1074/jbc.M113.544288; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DEWITT DA, 1994, BRAIN RES, V656, P205, DOI 10.1016/0006-8993(94)91386-2; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; El-Agnaf OMA, 2002, BIOCHEM SOC T, V30, P559; Ellett LJ, 2015, GLYCOBIOLOGY, V25, P745, DOI 10.1093/glycob/cwv014; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Ghosh D, 2017, INT J BIOL MACROMOL, V100, P37, DOI 10.1016/j.ijbiomac.2016.10.021; Ghosh D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09228; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hegde ML, 2010, FRONT BIOSCI-LANDMRK, V15, P418, DOI 10.2741/3628; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Iannuzzi C, 2015, MOLECULES, V20, P2510, DOI 10.3390/molecules20022510; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jendresen CB, 2015, J BIOL CHEM, V290, P5053, DOI 10.1074/jbc.M114.600569; Jha NN, 2013, BIOCHEMISTRY-US, V52, P8800, DOI 10.1021/bi401398k; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Karlsson M, 2001, Methods Mol Biol, V171, P159; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Madine J, 2013, BIOCHEMISTRY-US, V52, P8984, DOI 10.1021/bi401231u; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; MORITA H, 1995, CONTRIB NEPHROL, V112, P83; Morris AM, 2009, BIOPHYS CHEM, V140, P9, DOI 10.1016/j.bpc.2008.11.003; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; PERRY G, 1992, BRAIN RES, V579, P350, DOI 10.1016/0006-8993(92)90074-J; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Saric A, 2014, P NATL ACAD SCI USA, V111, P17869, DOI 10.1073/pnas.1410159111; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; SNOW AD, 1987, LAB INVEST, V56, P120; SNOW AD, 1990, LAB INVEST, V63, P601; Solomon JP, 2011, BIOCHEMISTRY-US, V50, P2486, DOI 10.1021/bi101905n; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Timmer NM, 2010, NEUROSCI RES, V66, P380, DOI 10.1016/j.neures.2009.12.012; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; VANGOOL D, 1993, DEMENTIA, V4, P308, DOI 10.1159/000107338; Vieira TCRG, 2014, FASEB J, V28, P2667, DOI 10.1096/fj.13-246777; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Wang PP, 2014, PROTEIN PEPTIDE LETT, V21, P1048, DOI 10.2174/0929866521666140626095145; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wolf H, 2015, J VIROL, V89, P9853, DOI 10.1128/JVI.01276-15; Yoneda H, 2014, J RECEPT SIG TRANSD, V34, P21, DOI 10.3109/10799893.2013.845788; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang LJ, 2001, J BIOL CHEM, V276, P28806, DOI 10.1074/jbc.M100204200	74	30	30	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					12975	12991		10.1074/jbc.RA118.004267	http://dx.doi.org/10.1074/jbc.RA118.004267			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29959225	Green Published, hybrid			2022-12-28	WOS:000442730200001
J	Sugiki, T; Egawa, D; Kumagai, K; Kojima, C; Fujiwara, T; Takeuchi, K; Shimada, I; Hanada, K; Takahashi, H				Sugiki, Toshihiko; Egawa, Daichi; Kumagai, Keigo; Kojima, Chojiro; Fujiwara, Toshimichi; Takeuchi, Koh; Shimada, Ichio; Hanada, Kentaro; Takahashi, Hideo			Phosphoinositide binding by the PH domain in ceramide transfer protein (CERT) is inhibited by hyperphosphorylation of an adjacent serine-repeat motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI-APPARATUS REQUIRES; ENDOPLASMIC-RETICULUM; LIPID TRAFFICKING; START DOMAINS; TRANSPORT; PHOSPHORYLATION; SPHINGOMYELIN; ASSOCIATION; ACTIVATION; COMPLEX	Sphingolipids such as ceramide are important constituents of cell membranes. The ceramide transfer protein (CERT) moves ceramide from the endoplasmic reticulum to the Golgi apparatus in a nonvesicular manner. Hyperphosphorylation of the serine-repeat motif (SRM) adjacent to the pleckstrin homology (PH) domain of CERT down-regulates the inter-organelle ceramide transport function of CERT. However, the mechanistic details of this down-regulation remain elusive. Using solution NMR and binding assays, we herein show that a hyperphosphorylation-mimetic CERT variant in which 10 serine/threonine residues of SRM had been replaced with glutamate residues (the 10E variant) displays an intramolecular interaction between SRM and positively charged regions of the PH domain, which are involved in the binding of this domain to phosphatidylinositol 4-monophosphate (PI4P). Of note, the binding of the PH domain to PI4P-embedded membranes was attenuated by the SRM 10E substitutions in cell-free assays. Moreover, the 10E substitutions reduced the Golgi-targeting activity of the PH-SRM construct in living cells. These results indicate that hyperphosphorylated SRM directly interacts with the surface of the PH domain in an intramolecular manner, thereby decreasing the PI4P-binding activity of the PH domain. In light of these findings, we propose that the hyperphosphorylation of SRM may trigger the dissociation of CERT from the Golgi apparatus, resulting in a functionally less active conformation of CERT.	[Sugiki, Toshihiko; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sugiki, Toshihiko] JBiC, Koto Ku, Tokyo 1358073, Japan; [Sugiki, Toshihiko; Takeuchi, Koh; Shimada, Ichio; Takahashi, Hideo] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan; [Sugiki, Toshihiko; Kojima, Chojiro; Fujiwara, Toshimichi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Egawa, Daichi; Kumagai, Keigo; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Kojima, Chojiro] Yokohama Natl Univ, Grad Sch, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Kojima, Chojiro] Yokohama Natl Univ, Fac Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Takahashi, Hideo] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University; National Institute of Infectious Diseases (NIID); Yokohama National University; Yokohama National University; Yokohama City University	Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan.; Takahashi, H (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hanak@nih.go.jp; hidtak@yokohama-cu.ac.jp	Kojima, Chojiro/AFV-4592-2022; Takeuchi, Koh/B-4971-2010; Kumagai, Keigo/AAG-1385-2021	Takeuchi, Koh/0000-0002-6227-4627; Hanada, Kentaro/0000-0003-1383-2781; Kumagai, Keigo/0000-0002-1663-2905	METI; NEDO, MEXT Scientific Research on Innovative Areas [17H06417]; Platform Project for Supporting Drug Discovery and Life Science Research; AMED; AMED-CREST from AMED of Japan [JP17gm0910005j0003]	METI; NEDO, MEXT Scientific Research on Innovative Areas; Platform Project for Supporting Drug Discovery and Life Science Research; AMED(Japan Agency for Medical Research and Development (AMED)); AMED-CREST from AMED of Japan	This work was primarily supported by METI and NEDO, MEXT Scientific Research on Innovative Areas Grant 17H06417 (to K.H.) and in part by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED and AMED-CREST from AMED under Grant JP17gm0910005j0003 of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Amata I, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00181; Keldysh M V, 1978, Kosm Biol Aviakosm Med, V12, P83; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Bolduc D, 2013, ELIFE, V2, DOI 10.7554/eLife.00691; Capasso S, 2017, EMBO J, V36, P1736, DOI 10.15252/embj.201696048; Charruyer A, 2008, J BIOL CHEM, V283, P16682, DOI 10.1074/jbc.M800799200; Chiapparino A, 2016, PROG LIPID RES, V61, P30, DOI 10.1016/j.plipres.2015.10.004; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Goto A, 2016, J BIOL CHEM, V291, P1336, DOI 10.1074/jbc.M115.682997; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Hurlock AK, 2014, TRAFFIC, V15, P915, DOI 10.1111/tra.12187; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Mandell DJ, 2007, J AM CHEM SOC, V129, P820, DOI 10.1021/ja063019w; Midzak A, 2014, TRAFFIC, V15, P895, DOI 10.1111/tra.12177; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Prashek J, 2017, J BIOL CHEM, V292, P14217, DOI 10.1074/jbc.M117.780007; Prashek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079590; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Sugiki T, 2009, PROTEIN SCI, V18, P1115, DOI 10.1002/pro.92; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Tatsuta T, 2014, TRENDS CELL BIOL, V24, P44, DOI 10.1016/j.tcb.2013.07.011; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200	36	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11206	11217		10.1074/jbc.RA118.002465	http://dx.doi.org/10.1074/jbc.RA118.002465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29848549	Green Published, hybrid			2022-12-28	WOS:000438882800031
J	Balasuriya, N; Kunkel, MT; Liu, XG; Biggar, KK; Li, SSC; Newton, AC; O'Donoghue, P				Balasuriya, Nileeka; Kunkel, Maya T.; Liu, Xuguang; Biggar, Kyle K.; Li, Shawn S. -C.; Newton, Alexandra C.; O'Donoghue, Patrick			Genetic code expansion and live cell imaging reveal that Thr-308 phosphorylation is irreplaceable and sufficient for Akt1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; protein kinase B (PKB); protein phosphorylation; cell biology; cell signaling; enzyme; aminoacyl tRNA synthetase; transfer RNA (tRNA); genetic code expansion; phosphomimetics; phosphoseryl-tRNA synthetase (SepRS); tRNASep; activation loop; hydrophobic motif	PROTEIN-KINASE-B; RICTOR-MTOR COMPLEX; SIGNALING PATHWAY; SPATIOTEMPORAL DYNAMICS; HYDROPHOBIC DOMAIN; ESCHERICHIA-COLI; ACTIVATION LOOP; UP-REGULATION; TUMOR-GROWTH; LUNG-CANCER	The proto-oncogene Akt/protein kinase B (PKB) is a pivotal signal transducer for growth and survival. Growth factor stimulation leads to Akt phosphorylation at two regulatory sites (Thr-308 and Ser-473), acutely activating Akt signaling. Delineating the exact role of each regulatory site is, however, technically challenging and has remained elusive. Here, we used genetic code expansion to produce site-specifically phosphorylated Akt1 to dissect the contribution of each regulatory site to Akt1 activity. We achieved recombinant production of full-length Akt1 containing site-specific pThr and pSer residues for the first time. Our analysis of Akt1 site-specifically phosphorylated at either or both sites revealed that phosphorylation at both sites increases the apparent catalytic rate 1500-fold relative to unphosphorylated Akt1, an increase attributable primarily to phosphorylation at Thr-308. Live imaging of COS-7 cells confirmed that phosphorylation of Thr-308, but not Ser-473, is required for cellular activation of Akt. We found in vitro and in the cell that pThr-308 function cannot be mimicked with acidic residues, nor could unphosphorylated Thr-308 be mimicked by an Ala mutation. An Akt1 variant with pSer-308 achieved only partial enzymatic and cellular signaling activity, revealing a critical interaction between the -methyl group of pThr-308 and Cys-310 in the Akt1 active site. Thus, pThr-308 is necessary and sufficient to stimulate Akt signaling in cells, and the common use of phosphomimetics is not appropriate for studying the biology of Akt signaling. Our data also indicate that pThr-308 should be regarded as the primary diagnostic marker of Akt activity.	[Balasuriya, Nileeka; Liu, Xuguang; Biggar, Kyle K.; Li, Shawn S. -C.; O'Donoghue, Patrick] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [O'Donoghue, Patrick] Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada; [Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of California System; University of California San Diego	O'Donoghue, P (corresponding author), Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada.; Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu; patrick.odonoghue@uwo.ca		O'Donoghue, Patrick/0000-0002-9500-8640	Natural Sciences and Engineering Research Council of Canada [RGPIN 04282-2014]; Canada Foundation for Innovation [229917]; Ontario Research Fund [229917]; Canada Research Chairs [950-229917]; Canadian Cancer Society Research Institute Innovation [704324]; Canadian Breast Cancer Foundation; National Institutes of Health [R03 CA178524, R35 GM122523, R01 GM43154]; Ontario Graduate Scholarship; Banting Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R03CA178524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R35GM122523] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Cancer Society Research Institute Innovation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Banting Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN 04282-2014 (to P. O.), Canada Foundation for Innovation Grant 229917 (to P. O.), Ontario Research Fund Grant 229917 (to P. O.), Canada Research Chairs 950-229917 (to P. O.), the Canadian Cancer Society Research Institute Innovation Grant 704324 (to P. O. and S. L.), the Canadian Breast Cancer Foundation (to S. L.), and National Institutes of Health Grants R03 CA178524 (to M. T. K.) and R35 GM122523 and R01 GM43154 (to A. C. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of an Ontario Graduate Scholarship.; Recipient of a Banting Postdoctoral Fellowship.	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andjelkovic M, 1999, MOL CELL BIOL, V19, P5061; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Antal CE, 2014, BIOCHEM SOC T, V42, P1477, DOI 10.1042/BST20140172; Antal CE, 2013, MOL CELL PROTEOMICS, V12, P3498, DOI 10.1074/mcp.R113.029819; Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Dissmeyer N, 2011, METHODS MOL BIOL, V779, P93, DOI 10.1007/978-1-61779-264-9_6; Ebner M, 2017, MOL CELL, V65, P416, DOI 10.1016/j.molcel.2016.12.028; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Fabbro D, 1999, PROTEIN EXPRES PURIF, V17, P83, DOI 10.1006/prep.1999.1102; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; George S, 2016, FEBS LETT, V590, P1530, DOI 10.1002/1873-3468.12182; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Hassan B, 2013, SURG ONCOL CLIN N AM, V22, P641, DOI 10.1016/j.soc.2013.06.008; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; Iacovides DC, 2013, MOL CELL PROTEOMICS, V12, P3210, DOI 10.1074/mcp.M112.023119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Klein S, 2005, PROTEIN EXPRES PURIF, V41, P162, DOI 10.1016/j.pep.2005.01.003; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kunkel Maya T, 2009, Curr Protoc Chem Biol, V1, P17; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lee S, 2013, ANGEW CHEM INT EDIT, V52, P5771, DOI 10.1002/anie.201300531; Liao Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07962-7; Lippa B, 2008, BIOORG MED CHEM LETT, V18, P3359, DOI 10.1016/j.bmcl.2008.04.034; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; LoRusso PM, 2016, J CLIN ONCOL, V34, P3803, DOI 10.1200/JCO.2014.59.0018; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Massihnia D, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0371-1; Munoz C, 2013, J MEMBRANE BIOL, V246, P189, DOI 10.1007/s00232-012-9520-9; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Parker L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100631; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Reuveni H, 2002, BIOCHEMISTRY-US, V41, P10304, DOI 10.1021/bi0202530; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Steichen JM, 2012, J BIOL CHEM, V287, P14672, DOI 10.1074/jbc.M111.335091; Tang H, 2016, ONCOL REP, V36, P900, DOI 10.3892/or.2016.4901; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; Tobisawa T, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0621-6; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; TSUTAKAWA SE, 1995, J BIOL CHEM, V270, P26807, DOI 10.1074/jbc.270.45.26807; Turowec JP, 2010, METHOD ENZYMOL, V484, P471, DOI [10.1016/S0076-6879(10)84023-6, 10.1016/B978-0-12-381298-8.00023-X]; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Warsi J, 2015, CELL PHYSIOL BIOCHEM, V37, P2454, DOI 10.1159/000438598; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Xiao J, 2017, ONCOL REP, V37, P2513, DOI 10.3892/or.2017.5484; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang YW, 2016, ONCOTARGET, V7, P59388, DOI 10.18632/oncotarget.10673; Zhang XL, 2006, J BIOL CHEM, V281, P13949, DOI 10.1074/jbc.M601384200; Zhuo DX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065679	68	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10744	10756		10.1074/jbc.RA118.002357	http://dx.doi.org/10.1074/jbc.RA118.002357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29773654	Green Published, hybrid			2022-12-28	WOS:000437828400029
J	de Lange, T				de Lange, Titia			What I got wrong about shelterin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						telomere; shelterin; Ras-related protein 1 (Rap1); POT1; TIN2; t-loop; TRF1 (TERF1; telomeric repeat binding factor 1); TRF2 (TERF2; telomeric repeat binding factor 2)	TELOMERE LENGTH; BINDING-PROTEIN; YEAST TELOMERES; DNA-SEQUENCE; TRF1; CHROMATIN; COMPLEX; RAP1; POT1; END	The ASBMB 2018 Bert and Natalie Vallee award in Biomedical Sciences honors our work on shelterin, a protein complex that helps cells distinguish the chromosome ends from sites of DNA damage. Shelterin protects telomeres from all aspects of the DNA damage response, including ATM and ATR serine/threonine kinase signaling and several forms of double-strand break repair. Today, this six-subunit protein complex could easily be identified in one single proteomics step. But, it took us more than 15 years to piece together the entire shelterin complex, one protein at a time. Although we did a lot of things right, here I tell the story of shelterin's discovery with an emphasis on the things that I got wrong along the way.	[de Lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10065 USA.	delange@rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NCI [R35CA210036]; NIA [RO1 AG016642]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R35CA210036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Outstanding Investigator Award R35CA210036 from NCI and Grant RO1 AG016642 from NIA and a grant from the Breast Cancer Research Foundation. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; GOTTSCHLING DE, 1984, CELL, V38, P501, DOI 10.1016/0092-8674(84)90505-1; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; LIPPS HJ, 1982, P NATL ACAD SCI-BIOL, V79, P2495, DOI 10.1073/pnas.79.8.2495; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; MCKAY SJ, 1992, NUCLEIC ACIDS RES, V20, P1387, DOI 10.1093/nar/20.6.1387; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	38	6	6	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10453	10456		10.1074/jbc.AW118.003234	http://dx.doi.org/10.1074/jbc.AW118.003234			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29794139	Green Published, hybrid			2022-12-28	WOS:000437828400006
J	Selvan, N; George, S; Serajee, FJ; Shaw, M; Hobson, L; Kalscheuer, V; Prasad, N; Levy, SE; Taylor, J; Aftimos, S; Schwartz, CE; Huq, AM; Gecz, J; Wells, L				Selvan, Nithya; George, Stephan; Serajee, Fatema J.; Shaw, Marie; Hobson, Lynne; Kalscheuer, Vera; Prasad, Nripesh; Levy, Shawn E.; Taylor, Juliet; Aftimos, Salim; Schwartz, Charles E.; Huq, Ahm M.; Gecz, Jozef; Wells, Lance			O-GlcNAc transferase missense mutations linked to X-linked intellectual disability deregulate genes involved in cell fate determination and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification; glycosyltransferase; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); O-linked N-acetylglucosamine (O-GlcNAc); genetic disease; enzyme kinetics; transcriptomics; intellectual disability; RNA-seq; XLID	N-ACETYLGLUCOSAMINE; STEM-CELLS; GLOBAL IDENTIFICATION; IN-VIVO; GLCNACYLATION; OGT; DROSOPHILA; HCFC1; PHOSPHORYLATION; TRANSCRIPTION	It is estimated that approximate to 1% of the world's population has intellectual disability, with males affected more often than females. OGT is an X-linked gene encoding for the enzyme O-GlcNAc transferase (OGT), which carries out the reversible addition of N-acetylglucosamine (GlcNAc) to Ser/Thr residues of its intracellular substrates. Three missense mutations in the tetratricopeptide (TPR) repeats of OGT have recently been reported to cause X-linked intellectual disability (XLID). Here, we report the discovery of two additional novel missense mutations (c.775 G>A, p.A259T, and c.1016 A>G, p.E339G) in the TPR domain of OGT that segregate with XLID in affected families. Characterization of all five of these XLID missense variants of OGT demonstrates modest declines in thermodynamic stability and/or activities of the variants. We engineered each of the mutations into a male human embryonic stem cell line using CRISPR/Cas9. Investigation of the global O-GlcNAc profile as well as OGT and O-GlcNAc hydrolase levels by Western blotting showed no gross changes in steady-state levels in the engineered lines. However, analyses of the differential transcriptomes of the OGT variant-expressing stem cells revealed shared deregulation of genes involved in cell fate determination and liver X receptor/retinoid X receptor signaling, which has been implicated in neuronal development. Thus, here we reveal two additional mutations encoding residues in the TPR regions of OGT that appear causal for XLID and provide evidence that the relatively stable and active TPR variants may share a common, unelucidated mechanism of altering gene expression profiles in human embryonic stem cells.	[Selvan, Nithya; George, Stephan; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Serajee, Fatema J.; Huq, Ahm M.] Wayne State Univ, Dept Pediat, Detroit, MI 48201 USA; [Serajee, Fatema J.; Huq, Ahm M.] Wayne State Univ, Dept Neurol, Detroit, MI 48201 USA; [Shaw, Marie; Gecz, Jozef] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA 5006, Australia; [Hobson, Lynne] Womens & Childrens Hosp, Adelaide, SA 5006, Australia; [Kalscheuer, Vera] Max Planck Inst Mol Genet, Res Grp Dev & Dis, D-14195 Berlin, Germany; [Prasad, Nripesh; Levy, Shawn E.] HudsonAlpha Inst Biotechnol, Genom Serv Lab, Huntsville, AL 35806 USA; [Taylor, Juliet; Aftimos, Salim] Auckland City Hosp, Genet Hlth Serv New Zealand Northern Hub, Auckland 1142, New Zealand; [Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Gecz, Jozef] South Australian Hlth & Med Res Inst, Adelaide, SA 5006, Australia	University System of Georgia; University of Georgia; Wayne State University; Wayne State University; University of Adelaide; Womens & Childrens Hospital Australia; Max Planck Society; HudsonAlpha Institute for Biotechnology; Auckland City Hospital; Greenwood Genetic Center; South Australian Health & Medical Research Institute (SAHMRI)	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	lwells@ccrc.uga.edu	Gecz, Jozef/X-3469-2019	Gecz, Jozef/0000-0002-7884-6861; Wells, Lance/0000-0003-4956-5363; Kalscheuer, Vera/0000-0001-6898-3259	W. M. Keck Foundation; National Institutes of Health Grant from NIGMS [P41GM103490]; South Carolina Department of Disabilities and Special Needs (SCDDSN); National Institutes of Health Grant from NINDS [RO1N5073854]; National Health and Medical Research Council of Australia [APP1091593, APP1041920]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); South Carolina Department of Disabilities and Special Needs (SCDDSN); National Institutes of Health Grant from NINDS; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the W. M. Keck Foundation (to L. W.), National Institutes of Health Grant P41GM103490 from NIGMS (to L. W.), a grant from the South Carolina Department of Disabilities and Special Needs (SCDDSN) (to C. E. S.), National Institutes of Health Grant RO1N5073854 from NINDS (to C. E. S.), and National Health and Medical Research Council of Australia Grants APP1091593 and APP1041920 (to J. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bhuiyan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136636; Bouazzi H, 2015, CLIN CASE REP, V3, P604, DOI 10.1002/ccr3.301; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Deng RP, 2014, PROTEOMICS, V14, P1020, DOI 10.1002/pmic.201300144; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Guo HB, 2017, J BIOL CHEM, V292, P4123, DOI 10.1074/jbc.M116.763201; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Jolly LA, 2015, HUM MOL GENET, V24, P3335, DOI 10.1093/hmg/ddv083; Kapuria V, 2016, GENE DEV, V30, P960, DOI 10.1101/gad.275925.115; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Kenwrick S, 2004, DEV DYNAM, V229, P289, DOI 10.1002/dvdy.10440; Koufaris C, 2016, BIOMED REP, V4, P215, DOI 10.3892/br.2015.559; Kvarnung M, 2017, ADV EXP MED BIOL, V1031, P39, DOI 10.1007/978-3-319-67144-4_3; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Mariappa D, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150234; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Nairn AV, 2010, METHOD ENZYMOL, V479, P73, DOI 10.1016/S0076-6879(10)79004-2; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Niranjan TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116454; Okuyama R, 2003, J NEUROCHEM, V86, P1271, DOI 10.1046/j.1471-4159.2003.01939.x; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Selvan N, 2017, NAT CHEM BIOL, V13, P882, DOI 10.1038/nchembio.2404; Selvan N, 2015, J BIOL CHEM, V290, P11969, DOI 10.1074/jbc.M114.628750; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sherry ST, 1999, GENOME RES, V9, P677; Simandi Z, 2018, MOL CELL ENDOCRINOL, V471, P51, DOI 10.1016/j.mce.2017.07.033; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sun GQ, 2010, ADV DRUG DELIVER REV, V62, P1299, DOI 10.1016/j.addr.2010.08.003; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Vaidyanathan K, 2017, J BIOL CHEM, V292, P8948, DOI 10.1074/jbc.M116.771030; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Willems AP, 2017, J BIOL CHEM, V292, P12621, DOI 10.1074/jbc.M117.790097; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]	52	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10810	10824		10.1074/jbc.RA118.002583	http://dx.doi.org/10.1074/jbc.RA118.002583			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29769320	Green Published, hybrid			2022-12-28	WOS:000437828400034
J	Mbonye, U; Wang, BL; Gokulrangan, G; Shi, WX; Yang, SC; Karn, J				Mbonye, Uri; Wang, Benlian; Gokulrangan, Giridharan; Shi, Wuxian; Yang, Sichun; Karn, Jonathan			Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); transcription elongation factor; bromodomain-containing protein 4 (BRD4); heat-shock protein 90 (Hsp90); 7SK snRNP; proteomics; post-translational modification (PTM); Cdc37; HIV latency; P-TEFb; super-elongation complex; Tat; CDK activation loop	IMMUNODEFICIENCY-VIRUS TRANSCRIPTION; NEGATIVE ELONGATION-FACTOR; RNA-POLYMERASE-II; 7SK SNRNP; CDK9/CYCLIN T1; TYPE-1 TAT; FACTOR-B; COMPLEX; HSP90; LATENCY	The HIV trans-activator Tat recruits the host transcription elongation factor P-TEFb to stimulate proviral transcription. Phosphorylation of Thr-186 on the activation loop (T-loop) of cyclin-dependent kinase 9 (CDK9) is essential for its kinase activity and assembly of CDK9 and cyclin T1 (CycT1) to form functional P-TEFb. Phosphorylation of a second highly conserved T-loop site, Ser-175, alters the competitive binding of Tat and the host recruitment factor bromodomain containing 4 (BRD4) to P-TEFb. Here, we investigated the intracellular mechanisms that regulate these key phosphorylation events required for HIV transcription. Molecular dynamics simulations revealed that the CDK9/CycT1 interface is stabilized by intramolecular hydrogen bonding of pThr-186 by an arginine triad and Glu-96 of CycT1. Arginine triad substitutions that disrupted CDK9/CycT1 assembly accumulated Thr-186-dephosphorylated CDK9 associated with the cytoplasmic Hsp90/Cdc37 chaperone. The Hsp90/Cdc37/CDK9 complex was also present in resting T cells, which lack CycT1. Hsp90 inhibition in primary T cells blocked P-TEFb assembly, disrupted Thr-186 phosphorylation, and suppressed proviral reactivation. The selective CDK7 inhibitor THZ1 blocked CDK9 phosphorylation at Ser-175, and in vitro kinase assays confirmed that CDK7 activity is principally responsible for Ser-175 phosphorylation. Mutation of Ser-175 to Lys had no effect on CDK9 kinase activity or P-TEFb assembly but strongly suppressed both HIV expression and BRD4 binding. We conclude that the transfer of CDK9 from the Hsp90/Cdc37 complex induced by Thr-186 phosphorylation is a key step in P-TEFb biogenesis. Furthermore, we demonstrate that CDK7-mediated Ser-175 phosphorylation is a downstream nuclear event essential for facilitating CDK9 T-loop interactions with Tat.	[Mbonye, Uri; Karn, Jonathan] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Wang, Benlian; Gokulrangan, Giridharan; Shi, Wuxian; Yang, Sichun] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wang, Benlian; Gokulrangan, Giridharan; Shi, Wuxian; Yang, Sichun] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Gokulrangan, Giridharan] Bristol Myers Squibb, Wallingford, CT 06492 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Bristol-Myers Squibb	Karn, J (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, 10900 Euclid Ave,LC4860, Cleveland, OH 44106 USA.	jonathan.karn@case.edu	Mbonye, Uri/AAG-8861-2020; Yang, Sichun/B-1608-2008	Mbonye, Uri/0000-0002-7694-0803; Yang, Sichun/0000-0002-1726-0576	National Institutes of Health Public Health Service [R01 DA043159, R01 DA036171, R01 DE025464, R01 AI120204, R33 AI110156]; American Foundation for AIDS Research (amfAR) [108266-51-RFRL, 108836-55-RGRL]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI120204, R33AI110156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043159, R01DA036171] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); American Foundation for AIDS Research (amfAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Public Health Service Grants R01 DA043159, R01 DA036171, R01 DE025464, R01 AI120204, and R33 AI110156 and American Foundation for AIDS Research (amfAR) Grants 108266-51-RFRL and 108836-55-RGRL (to the Karn laboratory). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ammosova Tatiana, 2011, PLoS One, V6, pe18985, DOI 10.1371/journal.pone.0018985; Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Bourgeois CF, 2002, MOL CELL BIOL, V22, P1079, DOI 10.1128/MCB.22.4.1079-1093.2002; Budhiraja S, 2013, J VIROL, V87, P1211, DOI 10.1128/JVI.02413-12; Budhiraja S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-52; Calderwood Stuart K, 2015, Subcell Biochem, V78, P103, DOI 10.1007/978-3-319-11731-7_5; Case DA, 2012, AMBER 12; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; Dow EC, 2010, J CELL PHYSIOL, V224, P84, DOI 10.1002/jcp.22096; FEINBERG MB, 1991, P NATL ACAD SCI USA, V88, P4045, DOI 10.1073/pnas.88.9.4045; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fisher Robert P, 2012, Genes Cancer, V3, P731, DOI 10.1177/1947601912473308; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Fukuyo Y, 2010, CANCER LETT, V290, P24, DOI 10.1016/j.canlet.2009.07.010; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gudipaty SA, 2015, MOL CELL BIOL, V35, P3810, DOI 10.1128/MCB.00226-15; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Jadlowsky JK, 2014, MOL CELL BIOL, V34, P1911, DOI 10.1128/MCB.01013-13; Joshi P, 2016, J BIOL CHEM, V291, P10332, DOI 10.1074/jbc.M116.717538; Keen NJ, 1996, P NATL ACAD SCI USA, V93, P2505, DOI 10.1073/pnas.93.6.2505; Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Kobbi L, 2016, P NATL ACAD SCI USA, V113, P12721, DOI 10.1073/pnas.1612331113; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Margolis DM, 2016, SCIENCE, V353, P362, DOI 10.1126/science.aaf6517; Marz M, 2009, MOL BIOL EVOL, V26, P2821, DOI 10.1093/molbev/msp198; Mbonye U, 2017, ANNU REV VIROL, V4, P261, DOI 10.1146/annurev-virology-101416-041646; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; Mbonye UR, 2015, PROTEOMICS, V15, P2078, DOI 10.1002/pmic.201500038; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; McNamara RP, 2013, CELL REP, V5, P1256, DOI 10.1016/j.celrep.2013.11.003; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Passinen S, 2001, EUR J BIOCHEM, V268, P5337, DOI 10.1046/j.0014-2956.2001.02467.x; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Prasanth KV, 2010, MOL BIOL CELL, V21, P4184, DOI 10.1091/mbc.E10-02-0105; Ramakrishnan R, 2012, J CELL PHYSIOL, V227, P609, DOI 10.1002/jcp.22760; Ramakrishnan R, 2009, J LEUKOCYTE BIOL, V86, P1345, DOI 10.1189/jlb.0509309; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schuller R, 2016, MOL CELL, V61, P305, DOI 10.1016/j.molcel.2015.12.003; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schulze-Gahmen U, 2016, ELIFE, V5, DOI 10.7554/eLife.15910; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siliciano JD, 2016, J CLIN INVEST, V126, P409, DOI 10.1172/JCI86047; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Suh H, 2016, MOL CELL, V61, P297, DOI 10.1016/j.molcel.2015.12.021; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tillotson B, 2010, J BIOL CHEM, V285, P39835, DOI 10.1074/jbc.M110.141580; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681	83	29	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10009	10025		10.1074/jbc.RA117.001347	http://dx.doi.org/10.1074/jbc.RA117.001347			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29743242	Green Published, hybrid			2022-12-28	WOS:000437096700007
J	Murthy, T; Bluemn, T; Gupta, AK; Reimer, M; Rao, S; Pillai, MM; Minella, AC				Murthy, Tushar; Bluemn, Theresa; Gupta, Abhishek K.; Reimer, Michael; Rao, Sridhar; Pillai, Manoj M.; Minella, Alex C.			Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; RNA splicing; chromatin; chromatin immunoprecipitation (ChiP); cyclin; cyclin-dependent kinase (CDK); phosphorylation; RNA splicing	CELL-DIFFERENTIATION; RING SIDEROBLASTS; CANCER GENES; HISTONE H1.4; BRANCH SITE; U2 SNRNP; PHOSPHORYLATION; SF3B1; TRANSCRIPTION; MUTATIONS	Splicing factor 3B1 (SF3B1) is a core splicing protein that stabilizes the interaction between the U2 snRNA and the branch point in the mRNA target during splicing. SF3B1 is heavily phosphorylated at its N terminus and a substrate of cyclin-dependent kinases (CDKs). Although SF3B1 phosphorylation coincides with splicing catalysis, the functional significance of SF3B1 phosphorylation is largely undefined. Here, we show that SF3B1 phosphorylation follows a dynamic pattern during cell cycle progression that depends on CDK activity. SF3B1 is known to interact with chromatin, and we found that SF3B1 maximally interacts with nucleosomes during G(1)/S and that this interaction requires CDK2 activity. In contrast, SF3B1 disassociates from nucleosomes at G(2)/M, coinciding with a peak in CDK1-mediated SF3B1 phosphorylation. Thus, CDK1 and CDK2 appear to have opposing roles in regulating SF3B1-nucleosome interactions. Importantly, these interactions were modified by the presence and phosphorylation status of linker histone H1, particularly the H1.4 isoform. Performing genome-wide analysis of SF3B1-chromatin binding in synchronized cells, we observed that SF3B1 preferentially bound exons. Differences in SF3B1 chromatin binding to specific sites, however, did not correlate with changes in RNA splicing, suggesting that the SF3B1-nucleosome interaction does not determine cell cycle-dependent changes to mRNA splicing. Our results define a cell cycle stage-specific interaction between SF3B1 and nucleosomes that is mediated by histone H1 and depends on SF3B1 phosphorylation. Importantly, this interaction does not seem to be related to SF3B1's splicing function and, rather, points toward its potential role as a chromatin modifier.	[Murthy, Tushar] Northwestern Univ, Driskill Grad Program, Chicago, IL 60611 USA; [Bluemn, Theresa; Reimer, Michael; Rao, Sridhar] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Bluemn, Theresa; Reimer, Michael; Rao, Sridhar; Minella, Alex C.] BloodCtr Wisconsin, Blood Res Inst, 8727 W Watertown Plank Rd, Milwaukee, WI 53213 USA; [Gupta, Abhishek K.; Pillai, Manoj M.] Yale Canc Ctr, Sect Hematol, New Haven, CT 06510 USA; [Gupta, Abhishek K.; Pillai, Manoj M.] Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA	Northwestern University; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Yale University; Yale University	Minella, AC (corresponding author), BloodCtr Wisconsin, Blood Res Inst, 8727 W Watertown Plank Rd, Milwaukee, WI 53213 USA.; Pillai, MM (corresponding author), Yale Canc Ctr, Sect Hematol, New Haven, CT 06510 USA.; Pillai, MM (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.	manoj.pillai@yale.edu; aminella@me.com		Minella, Alex/0000-0001-6693-3362; Bluemn, Theresa/0000-0003-1296-2461	National Institutes of Health [R01 HL098608, R01HL103040, R01HL133406]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098608, R01HL104070, R01HL133406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL098608 (to A. C. M.) and R01HL103040 and R01HL133406 (to M. M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boudrez A, 2002, J BIOL CHEM, V277, P31834, DOI 10.1074/jbc.M204427200; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez D, 2016, ELIFE, V5, DOI 10.7554/eLife.10288; Eto K, 2011, MOL CELL BIOCHEM, V355, P217, DOI 10.1007/s11010-011-0857-7; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hergeth SP, 2015, EMBO REP, V16, P1439, DOI 10.15252/embr.201540749; Herzel L, 2017, NAT REV MOL CELL BIO, V18, P637, DOI 10.1038/nrm.2017.63; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Kamieniarz K, 2012, GENE DEV, V26, P797, DOI 10.1101/gad.182014.111; Kesarwani AK, 2017, ONCOGENE, V36, P1123, DOI 10.1038/onc.2016.279; Kfir N, 2015, CELL REP, V11, P618, DOI 10.1016/j.celrep.2015.03.048; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee KY, 2012, J BIOL CHEM, V287, P11891, DOI 10.1074/jbc.M111.338467; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mupo A, 2017, LEUKEMIA, V31, P720, DOI 10.1038/leu.2016.251; Nuytten M, 2008, ONCOGENE, V27, P1449, DOI 10.1038/sj.onc.1210774; Obeng EA, 2016, CANCER CELL, V30, P404, DOI 10.1016/j.ccell.2016.08.006; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Strikoudis A, 2016, NAT CELL BIOL, V18, P1127, DOI 10.1038/ncb3424; Thompson BJ, 2015, J EXP MED, V212, P723, DOI 10.1084/jem.20150002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zheng YP, 2010, J CELL BIOL, V189, P407, DOI 10.1083/jcb.201001148; Zlotorynski E, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.44	55	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10220	10234		10.1074/jbc.RA118.001654	http://dx.doi.org/10.1074/jbc.RA118.001654			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764937	Green Published, hybrid			2022-12-28	WOS:000437096700022
J	Stival, C; Ritagliati, C; Xu, XR; Gervasi, MG; Luque, GM; Graf, CB; De la Vega-Beltran, JL; Torres, N; Darszon, A; Krapf, D; Buffone, MG; Visconti, PE; Krapf, D				Stival, Cintia; Ritagliati, Carla; Xu, Xinran; Gervasi, Maria G.; Luque, Guillermina M.; Baro Graf, Carolina; Luis De la Vega-Beltran, Jose; Torres, Nicolas; Darszon, Alberto; Krapf, Diego; Buffone, Mariano G.; Visconti, Pablo E.; Krapf, Dario			Disruption of protein kinase A localization induces acrosomal exocytosis in capacitated mouse sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sperm; fertilization; reproduction; protein kinase A (PKA); signal transduction	OPTICAL RECONSTRUCTION MICROSCOPY; MALE-FERTILITY; TYROSINE PHOSPHORYLATION; ANCHORING PROTEIN; MAMMALIAN SPERM; SRC KINASE; EGG WATER; MOTILITY; PKA; CAMP	Protein kinase A (PKA) is a broad-spectrum Ser/Thr kinase involved in the regulation of several cellular activities. Thus, its precise activation relies on being localized at specific subcellular places known as discrete PKA signalosomes. A-Kinase anchoring proteins (AKAPs) form scaffolding assemblies that play a pivotal role in PKA regulation by restricting its activity to specific microdomains. Because one of the first signaling events observed during mammalian sperm capacitation is PKA activation, understanding how PKA activity is restricted in space and time is crucial to decipher the critical steps of sperm capacitation. Here, we demonstrate that the anchoring of PKA to AKAP is not only necessary but also actively regulated during sperm capacitation. However, we find that once capacitated, the release of PKA from AKAP promotes a sudden Ca2+ influx through the sperm-specific Ca2+ channel CatSper, starting a tail-to-head Ca2+ propagation that triggers the acrosome reaction. Three-dimensional super-resolution imaging confirmed a redistribution of PKA within the flagellar structure throughout the capacitation process, which depends on anchoring to AKAP. These results represent a new signaling event that involves CatSper Ca2+ channels in the acrosome reaction, sensitive to PKA stimulation upon release from AKAP.	[Stival, Cintia; Ritagliati, Carla; Baro Graf, Carolina; Krapf, Dario] CONICET UNR, Lab Cell Signal Transduct Networks, Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina; [Xu, Xinran; Krapf, Diego] Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80523 USA; [Gervasi, Maria G.; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Luque, Guillermina M.; Torres, Nicolas; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Biol & Med Expt IBYME, C1428ADN, Buenos Aires, DF, Argentina; [Luis De la Vega-Beltran, Jose; Darszon, Alberto] UNAM, Inst Biotecnol IBT, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico; [Krapf, Diego] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Colorado State University; University of Massachusetts System; University of Massachusetts Amherst; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Universidad Nacional Autonoma de Mexico; Colorado State University	Krapf, D (corresponding author), Inst Biol Mol & Celular Rosario CONICET UNR, RA-2000 Rosario, SF, Argentina.; Krapf, D (corresponding author), UNR, Lab Especialidades Reprod, Fac Ciencias Bioquim & Farmaceut, Ocampo & Esmeralda, RA-2000 Rosario, SF, Argentina.	krapf@ibr-conicet.gov.ar	Luque, Guillermina/M-9237-2019; Stival, Cintia/AAM-2069-2021; torres, nicolas/AAE-4849-2019; Krapf, Diego/Y-2087-2019	Luque, Guillermina/0000-0002-2745-8236; Krapf, Diego/0000-0002-2833-5553; Torres, Nicolas/0000-0001-6501-185X; Darszon, Alberto/0000-0002-2502-0505; Baro Graf, Carolina/0000-0003-4490-9083; Gervasi, Maria Gracia/0000-0002-5468-2700; Krapf, Dario/0000-0001-7607-1954	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2014-2702, PICT 2015-3164, PICT 2015-2294]; Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico [IN205516]; Consejo Nacional de Ciencia y Tecnologia Fronteras [71]; National Science Foundation [1401432]; Eunice Kennedy Shriver National Institutes of Health, NICHD Grants [RO1 HD38082, HD44044]; National Institutes of Health [RO1TW008662]; Division Of Physics [1401432] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038082, R01HD044044] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW008662] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia Fronteras; National Science Foundation(National Science Foundation (NSF)); Eunice Kennedy Shriver National Institutes of Health, NICHD Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grants PICT 2014-2702 and PICT 2015-3164 (to Dario Krapf) and PICT 2015-2294 (to M.G.B.), Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico Grant IN205516 and Consejo Nacional de Ciencia y Tecnologia Fronteras 71 (to A.D.), National Science Foundation Grant 1401432 (to Diego Krapf), Eunice Kennedy Shriver National Institutes of Health, NICHD Grants RO1 HD38082 and HD44044 (to P.E.V.), and National Institutes of Health Grant RO1TW008662 (to M.G.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvau A, 2016, DEVELOPMENT, V143, P2325, DOI 10.1242/dev.136499; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; Buffone MG, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117911; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; Clouvel G, 2013, PROC SPIE, V8590, DOI 10.1117/12.2001986; Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Ernesto JI, 2015, J CELL BIOL, V210, P1213, DOI 10.1083/jcb.201412041; Escoffier J, 2007, J CELL PHYSIOL, V212, P753, DOI 10.1002/jcp.21075; Escoffier J, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127266; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Greenwald EC, 2011, J CARDIOVASC PHARM, V58, P462, DOI 10.1097/FJC.0b013e31822001e3; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hereng TH, 2012, J STRUCT BIOL, V178, P300, DOI 10.1016/j.jsb.2012.03.013; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hino T, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140400; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Izeddin I, 2012, OPT EXPRESS, V20, P4957, DOI 10.1364/OE.20.004957; Krapf D, 2007, DEV BIOL, V306, P516, DOI 10.1016/j.ydbio.2007.03.030; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; Krapf D, 2009, BIOL REPROD, V80, P311, DOI 10.1095/biolreprod.108.071076; Krapf D, 2016, PHYS CHEM CHEM PHYS, V18, P12633, DOI 10.1039/c6cp00937a; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XY, 2013, IUBMB LIFE, V65, P2, DOI 10.1002/iub.1111; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Marbouty M, 2015, MOL CELL, V59, P588, DOI 10.1016/j.molcel.2015.07.020; Muro Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135368; Newell AEH, 2008, CELL MOTIL CYTOSKEL, V65, P539, DOI 10.1002/cm.20279; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Romarowski A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136085; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Stival C, 2016, ADV ANAT EMBRYOL CEL, V220, P93, DOI 10.1007/978-3-319-30567-7_5; Stival C, 2015, J BIOL CHEM, V290, P18855, DOI 10.1074/jbc.M115.640326; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Torres-Flores V, 2011, HUM REPROD, V26, P2626, DOI 10.1093/humrep/der237; Torres-Quesada O, 2017, CELL SIGNAL, V37, P1, DOI 10.1016/j.cellsig.2017.05.012; Weigel AV, 2011, P NATL ACAD SCI USA, V108, P6438, DOI 10.1073/pnas.1016325108; Wertheimer E, 2013, J BIOL CHEM, V288, P35307, DOI 10.1074/jbc.M113.489476; Wojtal KA, 2006, MOL BIOL CELL, V17, P3638, DOI 10.1091/mbc.E06-03-0230	49	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9435	9447		10.1074/jbc.RA118.002286	http://dx.doi.org/10.1074/jbc.RA118.002286			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700114	Green Published, hybrid			2022-12-28	WOS:000435441400027
J	Papizan, JB; Vidal, AH; Bezprozvannaya, S; Bassel-Duby, R; Olson, EN				Papizan, James B.; Vidal, Alexander H.; Bezprozvannaya, Svetlana; Bassel-Duby, Rhonda; Olson, Eric N.			Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; proteostasis; cardiomyopathy; cardiac metabolism; skeletal muscle; Cullin-3; muscle damage; myopathy; protein degradation	RECESSIVE NEMALINE MYOPATHY; SPINAL MUSCULAR-ATROPHY; MYOFIBRILLAR MYOPATHY; CYCLIN-E; PROTEIN; PROTEOSTASIS; MUTATIONS; GENE; IDENTIFICATION; DEGRADATION	Control of protein homeostasis is an essential cellular process that, when perturbed, can result in the deregulation or toxic accumulation of proteins. Owing to constant mechanical stress, striated muscle proteins are particularly prone to wear and tear and require several protein quality-control mechanisms to coordinate protein turnover and removal of damaged proteins. Kelch-like proteins, substrate adapters for the Cullin-3 (Cul3)-RING ligase (CRL3) complex, are emerging as critical regulators of striated muscle development and function, highlighting the importance of Cul3-mediated proteostasis in muscle function. To explore the role of Cul3-mediated proteostasis in striated muscle, here we deleted Cul3 specifically in either skeletal muscle (SkM-Cul3 KO) or cardiomyocytes (CM-Cul3 KO) of mice. The loss of Cul3 caused neonatal lethality and dramatic alterations in the proteome, which were unique to each striated muscle type. Many of the proteins whose expression was significantly changed in the SkM-Cul3 KO were components of the extracellular matrix and sarcomere, whereas proteins altered in the CM-Cul3 KO were involved in metabolism. These findings highlight the requirement for striated muscle-specific CRL3 activity and indicate how the CRL3 complex can control different nodes of protein interaction networks in different types of striated muscle. Further identification of Cul3 substrates, and how these substrates are targeted, may reveal therapeutic targets and treatment regimens for striated muscle diseases.	[Papizan, James B.; Vidal, Alexander H.; Bezprozvannaya, Svetlana; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Hamon Ctr Regenerat Sci & Med, Senator Paul D Wellstone Muscular Dystrophy Coope, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Eric.olson@utsouthwestern.edu		Papizan, James/0000-0003-4257-6246; Vidal, Alexander/0000-0002-2805-3687	National Institutes of Health [AR-067294, HL-130253, DK-099653]; Robert A. Welch Foundation [1-0025]; Ruth L. Kirschstein NRSA F32 National Institutes of Health Training Grant [5F32HL123323-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Ruth L. Kirschstein NRSA F32 National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants AR-067294, HL-130253, and DK-099653 and Robert A. Welch Foundation Grant 1-0025 (to E. N. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Ruth L. Kirschstein NRSA F32 National Institutes of Health Training Grant 5F32HL123323-03.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Anderson DM, 2016, P NATL ACAD SCI USA, V113, pE4494, DOI 10.1073/pnas.1608423113; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Blondelle J, 2017, J MOL BIOL, V429, P1045, DOI 10.1016/j.jmb.2017.02.012; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Garg A, 2014, J CLIN INVEST, V124, P3529, DOI 10.1172/JCI74994; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; Gupta VA, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-11; Gupta VA, 2013, AM J HUM GENET, V93, P1108, DOI 10.1016/j.ajhg.2013.10.020; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Korovila I, 2017, REDOX BIOL, V13, P550, DOI 10.1016/j.redox.2017.07.008; Kulak NA, 2017, MOL CELL PROTEOMICS, V16, P694, DOI 10.1074/mcp.O116.065136; Lee YR, 2010, EMBO J, V29, P1748, DOI 10.1038/emboj.2010.62; Lehtokari VL, 2006, HUM MUTAT, V27, P946, DOI 10.1002/humu.20370; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Lo SC, 2006, MOL CELL BIOL, V26, P1235, DOI 10.1128/MCB.26.4.1235-1244.2006; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nam S, 2009, J BIOL CHEM, V284, P8192, DOI 10.1074/jbc.M808230200; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Papizan JB, 2017, J CLIN INVEST, V127, P3730, DOI 10.1172/JCI93445; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Ramirez-Martinez A, 2017, ELIFE, V6, DOI 10.7554/eLife.26439; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Sorimachi H, 2012, CARDIOVASC RES, V96, P11, DOI 10.1093/cvr/cvs157; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Uruno A, 2016, MOL CELL BIOL, V36, P1655, DOI 10.1128/MCB.01095-15; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang HL, 2013, CARDIOVASC RES, V98, P248, DOI 10.1093/cvr/cvt050; Zhu Y, 2017, BIOCHEM BIOPH RES CO, V484, P827, DOI 10.1016/j.bbrc.2017.01.182	56	19	19	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8802	8811		10.1074/jbc.RA118.002104	http://dx.doi.org/10.1074/jbc.RA118.002104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29653945	Green Published, hybrid			2022-12-28	WOS:000434941900007
J	Tretter, JY; Schorpp, K; Luxenburger, E; Trambauer, J; Steiner, H; Hadian, K; Gires, O; Niessing, D				Tretter, Jana Ylva; Schorpp, Kenji; Luxenburger, Elke; Trambauer, Johannes; Steiner, Harald; Hadian, Kamyar; Gires, Olivier; Niessing, Dierk			A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; EP-CAM; MONOCLONAL-ANTIBODY; COLON-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; ANTIGEN GA733-2; POOR-PROGNOSIS; EXPRESSION; GENE	Epithelial cell-adhesion molecule (EpCAM) is a transmembrane protein that regulates cell cycle progression and differentiation and is overexpressed in many carcinomas. The EpCAMinduced mitogenic cascade is activated via regulated intramembrane proteolysis (RIP) of EpCAM by ADAM and gamma-secretases, generating the signaling-active intracellular domain EpICD. Because of its expression pattern and molecular function, EpCAM is a valuable target in prognostic and therapeutic approaches for various carcinomas. So far, several immunotherapeutic strategies have targeted the extracellular domain of EpCAM. However, targeting the intracellular signaling cascade of EpCAM holds promise for specifically interfering with EpCAM's proliferation- stimulating signaling cascade. Here, using a yellow fluorescence protein-tagged version of the C-terminal fragment of EpCAM, we established a high-content screening (HCS) of a small-molecule compound library (n = 27,280) and characterized validated hits that target EpCAM signaling. In total, 128 potential inhibitors were initially identified, of which one compound with robust inhibitory effects on RIP of EpCAM was analyzed in greater detail. In summary, our study demonstrates that the development of an HCS for small-molecule inhibitors of the EpCAM signaling pathway is feasible. We propose that this approach may also be useful for identifying chemical compounds targeting other disorders involving membrane cleavagedependent signaling pathways.	[Tretter, Jana Ylva; Niessing, Dierk] German Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Struct Biol, D-85764 Neuherberg, Germany; [Schorpp, Kenji; Hadian, Kamyar] German Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Toxicol & Pharmacol, Assay Dev & Screening Platform, D-85764 Neuherberg, Germany; [Luxenburger, Elke; Gires, Olivier] Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, D-80539 Munich, Germany; [Trambauer, Johannes; Steiner, Harald] Ludwig Maximilians Univ Munchen, Biomed Ctr, Metab Biochem, D-80539 Munich, Germany; [Steiner, Harald] German Ctr Neurodegenerat Dis, D-81377 Munich, Germany; [Niessing, Dierk] Ulm Univ, Inst Pharmaceut Biotechnol, D-89081 Ulm, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Ulm University	Niessing, D (corresponding author), German Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Struct Biol, D-85764 Neuherberg, Germany.; Gires, O (corresponding author), Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, D-80539 Munich, Germany.; Niessing, D (corresponding author), Ulm Univ, Inst Pharmaceut Biotechnol, D-89081 Ulm, Germany.	Olivier.Gires@med.uni-muenchen.de; niessing@helmholtz-muenchen.de	Niessing, Dierk/M-4619-2014; Niessing, Dierk/AAE-4936-2022; Hadian, Kamyar/B-6314-2013	Niessing, Dierk/0000-0002-5589-369X; Niessing, Dierk/0000-0002-5589-369X; Hadian, Kamyar/0000-0001-8727-2575; Trambauer, Johannes/0000-0002-7173-1180	Wilhelm Sander Foundation [2015.019.1]	Wilhelm Sander Foundation	This work was supported by Wilhelm Sander Foundation Grant 2015.019.1. The authors declare that they have no conflicts of interest with the contents of this article.	ALBERTI S, 1994, P NATL ACAD SCI USA, V91, P5833, DOI 10.1073/pnas.91.13.5833; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Brunner A, 2008, J CLIN PATHOL, V61, P307, DOI 10.1136/jcp.2007.049460; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Chong JM, 2001, J BIOL CHEM, V276, P5804, DOI 10.1074/jbc.M008839200; Denzel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-402; Dolle L, 2015, AM J PHYSIOL-GASTR L, V308, pG233, DOI 10.1152/ajpgi.00069.2014; Du WQ, 2009, J CANCER RES CLIN, V135, P1277, DOI 10.1007/s00432-009-0569-5; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fields ALA, 2009, J CLIN ONCOL, V27, P1941, DOI 10.1200/JCO.2008.18.5710; Fong D., 2006, J CLIN PATHOL; Gerlach JC, 2018, J CELL PHYSIOL, V233, P4841, DOI 10.1002/jcp.26286; Gires O, 2008, ATLAS GENET CYTOGENE; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Groth A, 2012, CLIN CANCER RES, V18, P1028, DOI 10.1158/1078-0432.CCR-11-2767; Hachmeister M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071836; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kuan II, 2017, SCI REP-UK, V7, DOI 10.1038/srep41852; Liao MY, 2015, ONCOTARGET, V6, P24947, DOI 10.18632/oncotarget.4453; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Lund K, 2014, MABS-AUSTIN, V6, P1038, DOI 10.4161/mabs.28207; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Massoner P, 2014, BRIT J CANCER, V111, P955, DOI 10.1038/bjc.2014.366; Molina F, 1996, EUR J BIOCHEM, V240, P125, DOI 10.1111/j.1432-1033.1996.0125h.x; Munz M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-44; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Neighbors M, 2008, J IMMUNOTHER, V31, P644, DOI 10.1097/CJI.0b013e3181826d89; Ng CF, 2011, GENE, V481, P41, DOI 10.1016/j.gene.2011.04.005; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Oishi N, 2014, LIVER CANCER, V3, P71, DOI 10.1159/000343863; Park SY, 2016, ONCOL REP, V36, P197, DOI 10.3892/or.2016.4789; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ralhan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014130; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Riesenberg R, 2001, J HISTOCHEM CYTOCHEM, V49, P911, DOI 10.1177/002215540104900711; Sankpal NV, 2017, ONCOGENE, V36, P3706, DOI 10.1038/onc.2016.504; Sankpal NV, 2013, MOL CANCER RES, V11, P418, DOI 10.1158/1541-7786.MCR-12-0518; Sarrach S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20131-8; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schmohl JU, 2016, ONCOTARGET, V7, P73830, DOI 10.18632/oncotarget.12073; Schmoll HJ, 2009, J CLIN ONCOL, V27, P1926, DOI 10.1200/JCO.2008.20.6284; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; SEARS HF, 1982, LANCET, V1, P762; SEARS HF, 1984, J BIOL RESP MODIF, V3, P138; Spater D, 2014, DEVELOPMENT, V141, P4418, DOI 10.1242/dev.091538; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Spizzo G, 2002, INT J CANCER, V98, P883, DOI 10.1002/ijc.10270; STRNAD J, 1989, CANCER RES, V49, P314; SZALA S, 1990, P NATL ACAD SCI USA, V87, P3542, DOI 10.1073/pnas.87.9.3542; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Tsaktanis T, 2015, J BIOL CHEM, V290, P24574, DOI 10.1074/jbc.M115.662700; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Waldron NN, 2014, TARGET ONCOL, V9, P239, DOI 10.1007/s11523-013-0290-9; Went P, 2005, AM J SURG PATHOL, V29, P83, DOI 10.1097/01.pas.0000.146028.70868.7a; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Yanamoto S, 2007, ORAL ONCOL, V43, P869, DOI 10.1016/j.oraloncology.2006.10.010; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng XH, 2017, CANCER RES, V77, P482, DOI 10.1158/0008-5472.CAN-16-0842	71	2	2	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8994	9005		10.1074/jbc.RA118.002776	http://dx.doi.org/10.1074/jbc.RA118.002776			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29700109	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000434941900022
J	Bijvelds, MJC; Tresadern, G; Hellemans, A; Smans, K; Nieuwenhuijze, NDA; Meijsen, KF; Bongartz, JP; Ver Donck, L; de Jonge, HR; Schuurkes, JAJ; De Maeyer, JH				Bijvelds, Marcel J. C.; Tresadern, Gary; Hellemans, Ann; Smans, Karine; Nieuwenhuijze, Natascha D. A.; Meijsen, Kelly F.; Bongartz, Jean-Pierre; Ver Donck, Luc; de Jonge, Hugo R.; Schuurkes, Jan A. J.; De Maeyer, Joris H.			Selective inhibition of intestinal guanosine 3,5-cyclic monophosphate signaling by small-molecule protein kinase inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase G; PKG; drug discovery; signal transduction; intestinal epithelium; cyclic GMP; cGMP; CFTR; cystic fibrosis transmembrane conductance regulator; enterotoxigenic E; coli; ETEC; secretory diarrhea; vasodilator-stimulated phosphoprotein	TRANSMEMBRANE CONDUCTANCE REGULATOR; GUANYLYL CYCLASE-C; ION-TRANSPORT; IN-VITRO; CGMP; SECRETION; ACTIVATION; EXPRESSION; DWARFISM; MICE	The guanosine 3,5-cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII) serine/threonine kinase relays signaling through guanylyl cyclase C (GCC) to control intestinal fluid homeostasis. Here, we report the discovery of small-molecule inhibitors of cGKII. These inhibitors were imidazole-aminopyrimidines, which blocked recombinant human cGKII at submicromolar concentrations but exhibited comparatively little activity toward the phylogenetically related protein kinases cGKI and cAMP-dependent protein kinase (PKA). Whereas aminopyrimidyl motifs are common in protein kinase inhibitors, molecular modeling of these imidazole-aminopyrimidines in the ATP-binding pocket of cGKII indicated an unconventional binding mode that directs their amine substituent into a narrow pocket delineated by hydrophobic residues of the hinge and the C-helix. Crucially, this set of residues included the Leu-530 gatekeeper, which is not conserved in cGKI and PKA. In intestinal organoids, these compounds blocked cGKII-dependent phosphorylation of the vasodilator-stimulated phosphoprotein (VASP). In mouse small intestinal tissue, cGKII inhibition significantly attenuated the anion secretory response provoked by the GCC-activating bacterial heat-stable toxin (STa), a frequent cause of infectious secretory diarrhea. In contrast, both PKA-dependent VASP phosphorylation and intestinal anion secretion were unaffected by treatment with these compounds, whereas experiments with T84 cells indicated that they weakly inhibit the activity of cAMP-hydrolyzing phosphodiesterases. As these protein kinase inhibitors are the first to display selective inhibition of cGKII, they may expedite research on cGMP signaling and may aid future development of therapeutics for managing diarrheal disease and other pathogenic syndromes that involve cGKII.	[Bijvelds, Marcel J. C.; Nieuwenhuijze, Natascha D. A.; Meijsen, Kelly F.; de Jonge, Hugo R.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, POB 2040, NL-3000CA Rotterdam, Netherlands; [Tresadern, Gary; Smans, Karine; Bongartz, Jean-Pierre; Ver Donck, Luc] Janssen Res & Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Hellemans, Ann; Schuurkes, Jan A. J.; De Maeyer, Joris H.] Shire Movetis NV, Veedijk 58, B-2300 Turnhout, Belgium	Erasmus University Rotterdam; Erasmus MC; Johnson & Johnson; Janssen Pharmaceuticals; Shire Pharmaceuticals Limited	Bijvelds, MJC (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, POB 2040, NL-3000CA Rotterdam, Netherlands.	m.bijvelds@erasmusmc.nl		Tresadern, Gary/0000-0002-4801-1644; Bijvelds, Marcel/0000-0003-0814-188X	Movetis NV; Agency for Innovation by Science and Technology (IWT), Belgium	Movetis NV; Agency for Innovation by Science and Technology (IWT), Belgium(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by Movetis NV with support from the Agency for Innovation by Science and Technology (IWT), Belgium. The authors declare that they have no conflicts of interest with the contents of this article.	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Bijvelds MJC, 2015, J INFECT DIS, V212, P1806, DOI 10.1093/infdis/jiv300; Bijvelds MJC, 2009, GASTROENTEROLOGY, V137, P976, DOI 10.1053/j.gastro.2009.05.037; Burkhardt M, 2000, J BIOL CHEM, V275, P33536, DOI 10.1074/jbc.M005670200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cheung J, 2015, P NATL ACAD SCI USA, V112, P1374, DOI 10.1073/pnas.1424206112; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; DEJONGE HR, 1976, NATURE, V262, P590, DOI 10.1038/262590a0; DEJONGE HR, 1981, ADV CYCLIC NUCL PROT, V14, P315; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; ELHUSSEINI AED, 1995, J NEUROCHEM, V64, P2814; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; FORTE LR, 1992, AM J PHYSIOL, V263, pC607, DOI 10.1152/ajpcell.1992.263.3.C607; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; Gambaryan S, 2012, BRIT J PHARMACOL, V167, P826, DOI 10.1111/j.1476-5381.2012.02044.x; Gong R, 2011, SCIENCE, V333, P1642, DOI 10.1126/science.1207675; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hogenauer C, 2000, AM J HUM GENET, V67, P1422, DOI 10.1086/316911; JARCHAU T, 1994, P NATL ACAD SCI USA, V91, P9426, DOI 10.1073/pnas.91.20.9426; KAUFFMAN RF, 1987, J PHARMACOL EXP THER, V242, P864; Koltes JE, 2009, P NATL ACAD SCI USA, V106, P19250, DOI 10.1073/pnas.0904513106; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lawrence DW, 2002, AM J PHYSIOL-CELL PH, V282, pC1235, DOI 10.1152/ajpcell.00288.2001; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Medina JR, 2011, J MED CHEM, V54, P1871, DOI 10.1021/jm101527u; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pierce AC, 2008, J MED CHEM, V51, P1972, DOI 10.1021/jm701248t; POHLER D, 1995, FEBS LETT, V374, P419, DOI 10.1016/0014-5793(95)01168-E; Romi H, 2012, AM J HUM GENET, V90, P893, DOI 10.1016/j.ajhg.2012.03.022; SLICE LW, 1989, J BIOL CHEM, V264, P20940; Taylor MK, 2002, J BIOL CHEM, V277, P37242, DOI 10.1074/jbc.M202060200; Thiagarajah JR, 2004, GASTROENTEROLOGY, V126, P511, DOI 10.1053/j.gastro.2003.11.005; Tsuchida A, 2008, COMPARATIVE MED, V58, P560; Vaandrager AB, 2000, GASTROENTEROLOGY, V118, P108, DOI 10.1016/S0016-5085(00)70419-7; Vaandrager AB, 2005, FRONT BIOSCI-LANDMRK, V10, P2150, DOI 10.2741/1687; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; Valentino MA, 2011, J CLIN INVEST, V121, P3578, DOI 10.1172/JCI57925; Werner C, 2004, EUR J NEUROSCI, V20, P3498, DOI 10.1111/j.1460-9568.2004.03793.x; Wincott CM, 2014, NEUROBIOL LEARN MEM, V114, P32, DOI 10.1016/j.nlm.2014.04.007; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	44	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8173	8181		10.1074/jbc.RA118.002835	http://dx.doi.org/10.1074/jbc.RA118.002835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29653944	Green Published, hybrid			2022-12-28	WOS:000433224600022
J	Melkova, K; Zapletal, V; Jansen, S; Nomilner, E; Zachrdla, M; Hritz, J; Novacek, J; Zweckstetter, M; Jensen, MR; Blackledge, M; Zidek, L				Melkova, Katerina; Zapletal, Vojtech; Jansen, Severine; Nomilner, Erik; Zachrdla, Milan; Hritz, Jozef; Novacek, Jiri; Zweckstetter, Markus; Jensen, Malene R.; Blackledge, Martin; Zidek, Lukas			Functionally specific binding regions of microtubule-associated protein 2c exhibit distinct conformations and dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; RESIDUAL DIPOLAR COUPLINGS; DENSITY-FUNCTION-ANALYSIS; BACKBONE DYNAMICS; ALPHA-SYNUCLEIN; PROLINE-RICH; NMR ANALYSIS; PHOSPHORYLATION; TAU; DOMAIN	Microtubule-associated protein 2c (MAP2c) is a 49-kDa intrinsically disordered protein regulating the dynamics of microtubules in developing neurons. MAP2c differs from its sequence homologue Tau in the pattern and kinetics of phosphorylation by cAMP-dependent protein kinase (PKA). Moreover, the mechanisms through which MAP2c interacts with its binding partners and the conformational changes and dynamics associated with these interactions remain unclear. Here, we used NMR relaxation and paramagnetic relaxation enhancement techniques to determine the dynamics and long-range interactions within MAP2c. The relaxation rates revealed large differences in flexibility of individual regions of MAP2c, with the lowest flexibility observed in the known and proposed binding sites. Quantitative conformational analyses of chemical shifts, small-angle X-ray scattering (SAXS), and paramagnetic relaxation enhancement measurements disclosed that MAP2c regions interacting with important protein partners, including Fyn tyrosine kinase, plectin, and PKA, adopt specific conformations. High populations of polyproline II and alpha-helices were found in Fyn- and plectin-binding sites of MAP2c, respectively. The region binding the regulatory subunit of PKA consists of two helical motifs bridged by a more extended conformation. Of note, although MAP2c and Tau did not differ substantially in their conformations in regions of high sequence identity, we found that they differ significantly in long-range interactions, dynamics, and local conformation motifs in their N-terminal domains. These results highlight that the N-terminal regions of MAP2c provide important specificity to its regulatory roles and indicate a close relationship between MAP2c's biological functions and conformational behavior.	[Melkova, Katerina; Zapletal, Vojtech; Jansen, Severine; Nomilner, Erik; Zachrdla, Milan; Hritz, Jozef; Novacek, Jiri; Zidek, Lukas] Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno 62500, Czech Republic; [Melkova, Katerina; Zapletal, Vojtech; Jansen, Severine; Nomilner, Erik; Zachrdla, Milan; Zidek, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, Brno 62500, Czech Republic; [Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, Von Siebold Str 3a, D-37075 Gottingen, Germany; [Jensen, Malene R.; Blackledge, Martin] Univ Grenoble Alps, CNRS, CEA, F-38000 Grenoble, France; [Zachrdla, Milan] Ecole Normale Super, Dept Chim, 24 Rue Lhomond, F-75005 Paris, France	Masaryk University Brno; Masaryk University Brno; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Zidek, L (corresponding author), Masaryk Univ, Kamenice 5, CZ-62500 Brno, Czech Republic.	lzidek@chemi.muni.cz	Jansen, Severine/Q-6364-2019; Novacek, Jiri/AAQ-4739-2021; Zidek, Lukas/D-7112-2012; Hritz, Jozef/J-6887-2015; Novacek, Jiri/D-8551-2012; Zidek, Lukas/AAB-6109-2020	Novacek, Jiri/0000-0003-4013-3898; Zidek, Lukas/0000-0002-8013-0336; Hritz, Jozef/0000-0002-4512-9241; Novacek, Jiri/0000-0003-4013-3898; Zidek, Lukas/0000-0002-8013-0336	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX- 49-01]; Ministry of Education, Youth, and Sports of the Czech Republic (MEYS CR) [LM2015043]; CESNET [LM2015042]; CERIT Scientific Cloud by MEYS CR [LM2015085]; IT4Innovations National Supercomputing Center [LM2015070]; MEYS CR	FRISBI; GRAL; Ministry of Education, Youth, and Sports of the Czech Republic (MEYS CR); CESNET; CERIT Scientific Cloud by MEYS CR; IT4Innovations National Supercomputing Center; MEYS CR	This work used the platforms of the Grenoble Instruct Center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX- 49-01) within the Grenoble Partnership for Structural Biology (PSB). The CIISB research infrastructure project LM2015043 funded by the Ministry of Education, Youth, and Sports of the Czech Republic (MEYS CR) is gratefully acknowledged for the partial financial support of the measurements at the Josef Dadok National NMR Centre and Proteomics Core Facilities, CEITEC-Masaryk University. Computational resources were provided by CESNET (LM2015042) and the CERIT Scientific Cloud (LM2015085) under the program "Projects of Large Research, Development, and Innovations Infrastructures" funded by MEYS CR, and by the IT4Innovations National Supercomputing Center (LM2015070) under the program "Large Infrastructures for Research, Experimental Development, and Innovations" funded by MEYS CR. We thank G. Wiche for providing plasmids for protein expression, and M. Z. thanks E. Mandelkow and J. Biernat for useful discussions.	Abragam A., 1961, PRINCIPLES NUCLEAR M, P264; Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s; Barthe P, 1999, J BIOMOL NMR, V15, P271, DOI 10.1023/A:1008336418418; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernado P, 2009, BIOPHYS J, V97, P2839, DOI 10.1016/j.bpj.2009.08.044; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; BRANDT R, 1994, J BIOL CHEM, V269, P11776; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P333, DOI 10.1016/B978-012164491-8/50007-5; Dehmelt L, 2005, GENOME BIOL, V6; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eyal E, 2004, J COMPUT CHEM, V25, P712, DOI 10.1002/jcc.10420; Ferrage F, 2012, METHODS MOL BIOL, V831, P141, DOI 10.1007/978-1-61779-480-3_9; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Gotz F, 2016, BIOCHEM J, V473, P1881, DOI 10.1042/BCJ20160242; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; Guo Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030163; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; ISHIMA R, 1995, BIOCHEMISTRY-US, V34, P3162, DOI 10.1021/bi00010a005; ISHIMA R, 1995, J MAGN RESON SER B, V108, P73, DOI 10.1006/jmrb.1995.1104; Jalava NS, 2007, INT J DEV NEUROSCI, V25, P121, DOI 10.1016/j.ijdevneu.2006.12.001; Jansen S, 2017, J BIOL CHEM, V292, P6715, DOI 10.1074/jbc.M116.771097; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Kaderavek P, 2014, J BIOMOL NMR, V58, P193, DOI 10.1007/s10858-014-9816-4; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kazimierczuk K, 2008, J MAGN RESON, V192, P123, DOI 10.1016/j.jmr.2008.02.003; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kowalewski A., 2006, NUCL SPIN RELAXATION, P127; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Krizova H, 2004, J BIOMOL NMR, V28, P369, DOI 10.1023/B:JNMR.0000015404.61574.65; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Laurine E, 2003, J BIOL CHEM, V278, P29979, DOI 10.1074/jbc.M303242200; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Malmendal A, 2003, BIOCHEM BIOPH RES CO, V301, P136, DOI 10.1016/S0006-291X(02)02989-3; Marsh JA, 2008, J AM CHEM SOC, V130, P7804, DOI 10.1021/ja802220c; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Medina MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019420; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Nodet G, 2009, J AM CHEM SOC, V131, P17908, DOI 10.1021/ja9069024; Novacek J, 2014, J MAGN RESON, V241, P41, DOI 10.1016/j.jmr.2013.12.008; Novacek J, 2013, J BIOMOL NMR, V56, P291, DOI 10.1007/s10858-013-9761-7; OBAR RA, 1989, NEURON, V3, P639, DOI 10.1016/0896-6273(89)90274-2; Ortega E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197467; Ozenne V, 2012, J AM CHEM SOC, V134, P15138, DOI 10.1021/ja306905s; Ozenne V, 2012, BIOINFORMATICS, V28, P1463, DOI 10.1093/bioinformatics/bts172; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Redfield A., 1965, ADV MAGN RESON, V1, P1, DOI [10.1016/B978-1-4832-3114-3.50007-6, DOI 10.1016/B978-1-4832-3114-3.50007-6]; Reynolds JG, 2008, J BIOL CHEM, V283, P8070, DOI 10.1074/jbc.C700221200; Salmon L, 2010, J AM CHEM SOC, V132, P8407, DOI 10.1021/ja101645g; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schwalbe M, 2014, STRUCTURE, V22, P238, DOI 10.1016/j.str.2013.10.020; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Sibille N, 2012, PROTEINS, V80, P454, DOI 10.1002/prot.23210; Srb P, 2017, J BIOMOL NMR, V69, P133, DOI 10.1007/s10858-017-0138-1; Sundermann F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2590-9; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tie L, 2008, J PROTEOME RES, V7, P1704, DOI 10.1021/pr700711s; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Valencia RG, 2013, MOL BIOL CELL, V24, P768, DOI 10.1091/mbc.E12-06-0488; VIERECK C, 1989, J NEUROSCI, V9, P3547; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WANGSNESS RK, 1953, PHYS REV, V89, P728, DOI 10.1103/PhysRev.89.728; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; WILLE H, 1992, J BIOL CHEM, V267, P10737; Xie C, 2015, J NEUROCHEM, V135, P19, DOI 10.1111/jnc.13228; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zamora-Leon SP, 2005, J BIOL CHEM, V280, P1962, DOI 10.1074/jbc.M411380200; Zamora-Leon SP, 2001, J BIOL CHEM, V276, P39950, DOI 10.1074/jbc.M107807200	85	9	9	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13297	13309		10.1074/jbc.RA118.001769	http://dx.doi.org/10.1074/jbc.RA118.001769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29925592	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000442730200027
J	Rahnamoun, H; Hong, J; Sun, ZX; Lee, J; Lu, HB; Lauberth, SM				Rahnamoun, Homa; Hong, Juyeong; Sun, Zhengxi; Lee, Jihoon; Lu, Hanbin; Lauberth, Shannon M.			Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ENHANCERS; CHROMATIN ORGANIZATION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; CANCER; COMPLEX; METHYLATION; MLL3/MLL4; REVEALS; PROTEIN	Monomethylation of histone H3 lysine 4 (H3K4me1) is enriched at enhancers that are primed for activation and the levels of this histone mark are frequently altered in various human cancers. Yet, how alterations in H3K4m1 are established and the consequences of these epigenetic changes in tumorigenesis are not well understood. Using ChIP-Seq in human colon cancer cells, we demonstrate that mutant p53 depletion results in decreased H3K4me1 levels at active enhancers that reveal a striking colocalization of mutant p53 and the H3K4 monomethyltransferase MLL4 following chronic tumor necrosis factor alpha (TNF alpha) signaling. We further reveal that mutant p53 forms physiological associations and direct interactions with MLL4 and promotes the enhancer binding of MLL4, which is required for TNF alpha-inducible H3K4mel and histone H3 lysine 27 acetylation (H3K27ac) levels, enhancer-derived transcript (eRNA) synthesis, and mutant p53-dependent target gene activation. Complementary in vitro studies with recombinant chromatin and purified proteins demonstrate that binding of the MLL3/4 complex and H3K4me1 deposition is enhanced by mutant p53 and p300-mediated acetylation, which in turn reflects a MLL3/4-dependent enhancement of mutant p53 and p300-dependent transcriptional activation. Collectively, our findings establish a mechanism in which mutant p53 cooperates with MLL4 to regulate aberrant enhancer activity and tumor-promoting gene expression in response to chronic immune signaling.	[Rahnamoun, Homa; Hong, Juyeong; Sun, Zhengxi; Lee, Jihoon; Lu, Hanbin; Lauberth, Shannon M.] Univ Calif San Diego, Sect Mol Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Lauberth, SM (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	slauberth@ucsd.edu	Lee, Ji Hoon/AAV-5473-2021	Lee, Ji Hoon/0000-0002-7488-3999; Rahnamoun, Homa/0000-0002-0555-2328; Lauberth, Shannon/0000-0003-4131-8536; LEE, Ji-Hoon/0000-0002-4537-9638	Sidney Kimmel Foundation for Cancer Research [857A6A]; University of California Cancer Research Coordinating Committee [CRN-17-420616]; UCSD Cellular and Molecular Genetics Training Program through the National Institute of General Medical Sciences Institutional Grant [T32 GM007240]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	Sidney Kimmel Foundation for Cancer Research; University of California Cancer Research Coordinating Committee(University of California System); UCSD Cellular and Molecular Genetics Training Program through the National Institute of General Medical Sciences Institutional Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Sidney Kimmel Foundation for Cancer Research, Research Scholar Award 857A6A, and University of California Cancer Research Coordinating Committee Award CRN-17-420616 (to S. M. L.) and by the UCSD Cellular and Molecular Genetics Training Program through the National Institute of General Medical Sciences Institutional Grant T32 GM007240 (to H.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Aran D, 2013, CELL, V154, P11, DOI 10.1016/j.cell.2013.06.018; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bereczki O, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-57; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cho YW, 2012, METHODS MOL BIOL, V809, P465, DOI 10.1007/978-1-61779-376-9_30; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kurdistani SK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-156; Laptenko O, 2016, TRENDS BIOCHEM SCI, V41, P1022, DOI 10.1016/j.tibs.2016.08.011; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahnamoun H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01117-y; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Ryan RJH, 2015, CANCER DISCOV, V5, P1058, DOI 10.1158/2159-8290.CD-15-0370; Shinsky SA, 2015, J BIOL CHEM, V290, P25819, DOI 10.1074/jbc.M115.684142; Sigal A, 2000, CANCER RES, V60, P6788; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Wang CC, 2016, P NATL ACAD SCI USA, V113, P11871, DOI 10.1073/pnas.1606857113; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang SP, 2017, MOL CELL, V67, P308, DOI 10.1016/j.molcel.2017.06.028; Yan J, 2018, CELL RES, V28, P204, DOI 10.1038/cr.2018.1; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	51	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13234	13246		10.1074/jbc.RA118.003387	http://dx.doi.org/10.1074/jbc.RA118.003387			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29954944	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000442730200022
J	Younan, ND; Chen, KF; Rose, RS; Crowther, DC; Viles, JH				Younan, Nadine D.; Chen, Ko-Fan; Rose, Ruth-Sarah; Crowther, Damian C.; Viles, John H.			Prion protein stabilizes amyloid-beta (A beta) oligomers and enhances A beta neurotoxicity in a Drosophila model of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRUNCATED AMYLOID-BETA((11-40/42)); SYNAPTIC PLASTICITY; LOCOMOTOR-ACTIVITY; PLAQUE-FORMATION; IN-VIVO; TOXICITY; IMPAIRMENT; EXPRESSION; PEPTIDE; NEURODEGENERATION	The cellular prion protein (PrPC) can act as a cell-surface receptor for beta-amyloid (A beta) peptide; however, a role for PrPC in the pathogenesis of Alzheimer's disease (AD) is contested. Here, we expressed a range of A beta isoforms and PrPC in the Drosophila brain. We found that co-expression of A beta and PrPC significantly reduces the lifespan, disrupts circadian rhythms, and increases A beta deposition in the fly brain. In contrast, under the same conditions, expression of A beta or PrPC individually did not lead to these phenotypic changes. In vitro studies revealed that substoichiometric amounts of PrPC trap A beta as oligomeric assemblies and fragment-preformed A beta fibers. The ability of membrane-anchored PrPC to trap A beta as cytotoxic oligomers at the membrane surface and fragment inert A beta fibers suggests a mechanism by which PrPC exacerbates A beta deposition and pathogenic phenotypes in the fly, supporting a role for PrPC in AD. This study provides a second animal model linking PrPC expression with A beta toxicity and supports a role for PrPC in AD pathogenesis. Blocking the interaction of A beta and PrPC represents a potential therapeutic strategy.	[Younan, Nadine D.; Rose, Ruth-Sarah; Viles, John H.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England; [Chen, Ko-Fan] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, London WC1N 3BG, England; [Crowther, Damian C.] AstraZeneca, Neurosci IMED Biotech Unit, Granta Pk, Cambridge CB21 6GH, England	University of London; Queen Mary University London; University of London; University College London; AstraZeneca	Viles, JH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.; Crowther, DC (corresponding author), AstraZeneca, Neurosci IMED Biotech Unit, Granta Pk, Cambridge CB21 6GH, England.	damian.crowther@azneuro.com; j.viles@qmul.ac.uk	Rose, Ruth/AAW-3844-2020; Crowther, Damian/E-1703-2016	Rose, Ruth/0000-0001-6406-137X; Crowther, Damian/0000-0001-7791-1396	Wellcome Trust [093241/Z/10/Z]; Biotechnology and Biological Sciences Research Council [BB/M023877/1]; BBSRC [BB/D005027/1, BB/M023877/1] Funding Source: UKRI; MRC [G0700990] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 093241/Z/10/Z and Biotechnology and Biological Sciences Research Council Grant BB/M023877/1. The authors declare that they have no conflicts of interest with the contents of this article.	Bachhuber T, 2015, NAT MED, V21, P802, DOI 10.1038/nm.3885; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barritt JD, 2017, ANGEW CHEM INT EDIT, V56, P9816, DOI 10.1002/anie.201704618; Barritt JD, 2015, J BIOL CHEM, V290, P27791, DOI 10.1074/jbc.M115.684084; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bode DC, 2017, J BIOL CHEM, V292, P1404, DOI 10.1074/jbc.M116.762526; Bove-Fenderson E, 2017, J BIOL CHEM, V292, P16858, DOI 10.1074/jbc.M117.789990; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen KF, 2011, CURR BIOL, V21, P719, DOI 10.1016/j.cub.2011.03.049; Chen KF, 2014, DIS MODEL MECH, V7, P445, DOI 10.1242/dmm.014134; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; He J, 2013, J NEUROL SCI, V326, P89, DOI 10.1016/j.jns.2013.01.020; Hermann C, 2012, J COMP NEUROL, V520, P970, DOI 10.1002/cne.22742; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iraci N, 2015, VIRUS RES, V207, P62, DOI 10.1016/j.virusres.2014.10.015; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Johnson E, 1998, J NEUROGENET, V12, P1, DOI 10.3109/01677069809108552; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Long DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106068; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nieznanski K, 2014, ACS CHEM NEUROSCI, V5, P340, DOI 10.1021/cn500019c; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; Pinnock EC, 2016, J ALZHEIMERS DIS, V49, P645, DOI 10.3233/JAD-150482; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purro SA, 2018, BIOL PSYCHIAT, V83, P358, DOI 10.1016/j.biopsych.2017.11.020; Rahimi J, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0082-1; Resenberger UK, 2012, NEURODEGENER DIS, V10, P298, DOI 10.1159/000332596; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Sarell CJ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170158; Sarell CJ, 2013, PRION, V7, P359, DOI 10.4161/pri.26415; Scott-McKean JJ, 2016, NEUROBIOL DIS, V91, P124, DOI 10.1016/j.nbd.2016.03.001; Sowade RF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00579-4; Speretta E, 2012, J BIOL CHEM, V287, P20748, DOI 10.1074/jbc.M112.350124; Stokin GB, 2008, HUM MOL GENET, V17, P3474, DOI 10.1093/hmg/ddn240; Thackray AM, 2017, BIOCHEM J, V474, P3253, DOI 10.1042/BCJ20170462; Thackray AM, 2014, BIOCHEM J, V463, P31, DOI 10.1042/BJ20140129; Thackray AM, 2012, BIOCHEM J, V444, P487, DOI 10.1042/BJ20112141; Thackray AM, 2012, EXP MOL PATHOL, V92, P194, DOI 10.1016/j.yexmp.2012.01.005; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309; Younan ND, 2013, FASEB J, V27, P1847, DOI 10.1096/fj.12-222588; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	78	16	16	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13090	13099		10.1074/jbc.RA118.003319	http://dx.doi.org/10.1074/jbc.RA118.003319			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29887525	Green Published, hybrid			2022-12-28	WOS:000442730200010
J	Chan, EC; Ren, CG; Xie, ZH; Jude, J; Barker, T; Koziol-White, CA; Ma, M; Panettieri, RA; Wu, DQ; Rosenberg, HF; Druey, KM				Chan, Eunice C.; Ren, Chunguang; Xie, Zhihui; Jude, Joseph; Barker, Tolga; Koziol-White, Cynthia A.; Ma, Michelle; Panettieri, Reynold A.; Wu, Dianqing; Rosenberg, Helene F.; Druey, Kirk M.			Regulator of G protein signaling 5 restricts neutrophil chemotaxis and trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						regulator of G protein signaling; RGS; chemotaxis; neutrophil; inflammation; trafficking; GPCR; G protein-coupled receptor; leukocyte; innate immunity	RGS PROTEINS; TRANSENDOTHELIAL MIGRATION; ISCHEMIA-REPERFUSION; INFLAMMATION; ACTIVATION; ATHEROSCLEROSIS; EOSINOPHILS; INFECTION; TISSUE; CELLS	Neutrophils are white blood cells that are mobilized to damaged tissues and to sites of pathogen invasion, providing the first line of host defense. Chemokines displayed on the surface of blood vessels promote migration of neutrophils to these sites, and tissue- and pathogen-derived chemoattractant signals, including N-formylmethionylleucylphenylalanine (fMLP), elicit further migration to sites of infection. Although nearly all chemoattractant receptors use heterotrimeric G proteins to transmit signals, many of the mechanisms lying downstream of chemoattractant receptors that either promote or limit neutrophil motility are incompletely defined. Here, we show that regulator of G protein signaling 5 (RGS5), a protein that modulates G protein activity, is expressed in both human and murine neutrophils. We detected significantly more neutrophils in the airways of Rgs5(-/-) mice than WT counterparts following acute respiratory virus infection and in the peritoneum in response to injection of thioglycollate, a biochemical proinflammatory stimulus. RGS5-deficient neutrophils responded with increased chemotaxis elicited by the chemokines CXC motif chemokine ligand 1 (CXCL1), CXCL2, and CXCL12 but not fMLP. Moreover, adhesion of these cells was increased in the presence of both CXCL2 and fMLP. In summary, our results indicate that RGS5 deficiency increases chemotaxis and adhesion, leading to more efficient neutrophil mobilization to inflamed tissues in mice. These findings suggest that RGS5 expression and activity in neutrophils determine their migrational patterns in the complex microenvironments characteristic of inflamed tissues.	[Chan, Eunice C.; Xie, Zhihui; Barker, Tolga; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, NIH, Bethesda, MD 20892 USA; [Ma, Michelle; Rosenberg, Helene F.] NIAID, Inflammat Immunobiol Sect, NIH, Bethesda, MD 20892 USA; [Ren, Chunguang; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Jude, Joseph; Koziol-White, Cynthia A.; Panettieri, Reynold A.] Rutgers New Jersey Sch Med, Child Hlth Inst New Jersey, Rutgers Inst Translat Med & Sci, Newark, NJ 07103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yale University	Druey, KM (corresponding author), NIAID, NIH, 10 Ctr Dr,Rm 11N238A, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	ren, Chunguang/L-9609-2019; panettieri, reynold/AAG-9485-2019		Intramural Research Program, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000746, ZIAAI000943] Funding Source: NIH RePORTER	Intramural Research Program, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program, NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alqinyah M, 2018, CELL SIGNAL, V42, P77, DOI 10.1016/j.cellsig.2017.10.007; Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Arnold C, 2018, FASEB J, V32, P2021, DOI 10.1096/fj.201700384RR; Ayres-Sander CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060025; Balenga NA, 2014, J ALLERGY CLIN IMMUN, V134, P451, DOI 10.1016/j.jaci.2014.01.019; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Burn T, 2017, CELL MOL LIFE SCI, V74, P1871, DOI 10.1007/s00018-016-2444-2; Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12; Croft W, 2013, J BIOL CHEM, V288, P27327, DOI 10.1074/jbc.M113.497826; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; DOERSCHUK CM, 1993, J APPL PHYSIOL, V74, P3040, DOI 10.1152/jappl.1993.74.6.3040; Domachowske JB, 2000, J IMMUNOL, V165, P2677, DOI 10.4049/jimmunol.165.5.2677; Druey KM, 2017, ADV IMMUNOL, V136, P315, DOI 10.1016/bs.ai.2017.05.001; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Gane J, 2012, THORAX, V67, P553, DOI 10.1136/thoraxjnl-2011-200088; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Heusinkveld LE, 2017, EXPERT OPIN ORPHAN D, V5, P813, DOI 10.1080/21678707.2017.1375403; Hirano Y, 2016, BIOL CHEM, V397, P497, DOI 10.1515/hsz-2015-0309; Holdfeldt A, 2017, J LEUKOCYTE BIOL, V102, P871, DOI 10.1189/jlb.2A0317-086RR; Hwang IY, 2010, GENES IMMUN, V11, P384, DOI 10.1038/gene.2010.27; Hwang IY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060139; Hyun YM, 2017, J LEUKOCYTE BIOL, V102, P617, DOI 10.1189/jlb.1RU1216-521R; Kehrl JH, 2016, BIOCHEM PHARMACOL, V114, P40, DOI 10.1016/j.bcp.2016.04.005; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Laurent Paoline, 2017, Front Immunol, V8, P454, DOI 10.3389/fimmu.2017.00454; Lee JK, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0491-0; Lomakina EB, 2010, CELL MOL BIOENG, V3, P106, DOI 10.1007/s12195-009-0099-x; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Miyamoto-Matsubara M, 2010, ANN NY ACAD SCI, V1200, P112, DOI 10.1111/j.1749-6632.2010.05507.x; Muller WA, 2016, IMMUNOL REV, V273, P61, DOI 10.1111/imr.12443; Naumenko V, 2018, CELL TISSUE RES, V371, P505, DOI 10.1007/s00441-017-2763-0; Patel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7614; Percopo CM, 2017, J LEUKOCYTE BIOL, V101, P321, DOI 10.1189/jlb.3A0416-166R; Percopo CM, 2015, ANTIVIR RES, V121, P109, DOI 10.1016/j.antiviral.2015.07.001; Percopo CM, 2014, METHODS MOL BIOL, V1178, P257, DOI 10.1007/978-1-4939-1016-8_22; Percopo CM, 2011, VIROLOGY, V416, P26, DOI 10.1016/j.virol.2011.04.010; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Shankar SP, 2012, J IMMUNOL, V188, P6347, DOI 10.4049/jimmunol.1103781; Shen J, 2016, HUM PATHOL, V47, P121, DOI 10.1016/j.humpath.2015.09.013; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; Sprang SR, 2016, BIOPOLYMERS, V105, P449, DOI 10.1002/bip.22836; Surve CR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8163; Swamydas M., 2015, CURR PROTOC IMMUNOL, V110, P3, DOI DOI 10.1002/0471142735.im0320s110; Tamirisa P, 1999, CIRCULATION, V99, P441, DOI 10.1161/01.CIR.99.3.441; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Wang ZL, 2008, J CLIN INVEST, V118, P195, DOI 10.1172/JCI33139; Wang ZQ, 2016, BIOCHEM BIOPH RES CO, V473, P551, DOI 10.1016/j.bbrc.2016.03.114; Waugh JL, 2005, J COMP NEUROL, V481, P299, DOI 10.1002/cne.20372; Xie ZH, 2008, MOL CELL, V31, P660, DOI 10.1016/j.molcel.2008.06.024; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0; Yuan QY, 2017, CELL REP, V19, P2586, DOI 10.1016/j.celrep.2017.05.080; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565	60	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12690	12702		10.1074/jbc.RA118.002404	http://dx.doi.org/10.1074/jbc.RA118.002404			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29929985	Green Published, hybrid			2022-12-28	WOS:000442203500004
J	McGrath-Morrow, SA; Ndeh, R; Helmin, KA; Chen, SY; Anekalla, KR; Abdala-Valencia, H; D'Alessio, FR; Collaco, JM; Singer, BD				McGrath-Morrow, Sharon A.; Ndeh, Roland; Helmin, Kathryn A.; Chen, Shang-Yang; Anekalla, Kishore R.; Abdala-Valencia, Hiam; D'Alessio, Franco R.; Collaco, J. Michael; Singer, Benjamin D.			DNA methylation regulates the neonatal CD4(+) T-cell response to pneumonia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSE; RESOLUTION; INDUCTION; EXPRESSION; TOLERANCE; OUTCOMES; BET; LPS	Pediatric acute lung injury, usually because of pneumonia, has a mortality rate of more than 20% and an incidence that rivals that of all childhood cancers combined. CD4(+) T-cells coordinate the immune response to pneumonia but fail to function robustly among the very young, who have poor outcomes from lung infection. We hypothesized that DNA methylation represses a mature CD4(+) T-cell transcriptional program in neonates with pneumonia. Here, we found that neonatal mice (3-4 days old) aspirated with Escherichia coli bacteria had a higher mortality rate than juvenile mice (11-14 days old). Transcriptional profiling with an unsupervised RNA-Seq approach revealed that neonates displayed an attenuated lung CD4(+) T-cell transcriptional response to pneumonia compared with juveniles. Unlike neonates, juveniles up-regulated a robust set of canonical T-cell immune response genes. DNA methylation profiling with modified reduced representation bisulfite sequencing revealed 44,119 differentially methylated CpGs, which preferentially clustered around transcriptional start sites and CpG islands. A methylation difference-filtering algorithm detected genes with a high likelihood of differential promoter methylation regulating their expression; these 731 loci encoded important immune response and tissue-protective T-cell pathway components. Disruption of DNA methylation with the hypomethylating agent decitabine induced plasticity in the lung CD4(+) T-cell marker phenotype. Altogether, multidimensional profiling suggested that DNA methylation within the promoters of a core set of CD4(+) T-cell pathway genes contributes to the hyporesponsive neonatal immune response to pneumonia. These findings also suggest that DNA methylation could serve as a mechanistic target for disease-modifying therapies in pediatric lung infection and injury.	[McGrath-Morrow, Sharon A.; Ndeh, Roland; Collaco, J. Michael] Johns Hopkins Univ, Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD USA; [Helmin, Kathryn A.; Chen, Shang-Yang; Anekalla, Kishore R.; Abdala-Valencia, Hiam; Singer, Benjamin D.] Northwestern Univ Feinberg, Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [D'Alessio, Franco R.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Singer, Benjamin D.] Northwestern Univ Feinberg, Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA	Johns Hopkins University; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Northwestern University; Feinberg School of Medicine	Singer, BD (corresponding author), McGaw Pavil, Ste M 300, Chicago, IL 60611 USA.	benjamin-singer@northwestern.edu	Singer, Benjamin D./P-2392-2019; Chen, Shang-Yang/GXH-3516-2022	Singer, Benjamin D./0000-0001-5775-8427; Chen, Shang-Yang/0000-0002-6864-4713; Anekalla, Kishore/0000-0002-8366-5782	National Institutes of Health award [P30CA006973, P30AR053503]; Feinberg School of Medicine; Center for Genetic Medicine; Feinberg's Department of Biochemistry and Molecular Genetics; Office of the Provost; Northwestern Information Technology; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114800, K08HL128867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503] Funding Source: NIH RePORTER	National Institutes of Health award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feinberg School of Medicine; Center for Genetic Medicine; Feinberg's Department of Biochemistry and Molecular Genetics; Office of the Provost; Northwestern Information Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We acknowledge Dr. Alexander V. Misharin for the thoughtful review of this manuscript. We also acknowledge the Sidney Kimmel Cancer Center Experimental and Computational Genomics Core (supported by National Institutes of Health award P30CA006973), the Northwestern University RNA-Seq Center of the Pulmonary and Critical Care Medicine and Rheumatology Divisions, and the Johns Hopkins Bayview Flow Cytometry Core (supported by National Institutes of Health award P30AR053503). This research was supported in part through the computational resources and staff contributions provided by the Genomics Compute Cluster, which is jointly supported by the Feinberg School of Medicine, the Center for Genetic Medicine, and Feinberg's Department of Biochemistry and Molecular Genetics, the Office of the Provost, the Office for Research, and Northwestern Information Technology. The Genomics Compute Cluster is part of Quest, Northwestern University's high performance computing facility, with the purpose to advance research in genomics.	ABRAMOWICZ D, 1990, EUR J IMMUNOL, V20, P1647, DOI 10.1002/eji.1830200805; Cook Donald N, 2015, Nucl Receptor Res, V2; D'Alessio FR, 2016, AM J PHYSIOL-LUNG C, V310, pL733, DOI 10.1152/ajplung.00419.2015; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Duke T, 2005, ARCH DIS CHILD-FETAL, V90, P211, DOI 10.1136/adc.2003.048108; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Institute of Medicine (US) and National Research Council (US) National Cancer Policy Board, 2003, EP CHILDH CANC; Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Levy O, 2005, J ENDOTOXIN RES, V11, P113, DOI 10.1179/096805105X37376; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; McGrath-Morrow SA, 2017, CYTOKINE, V97, P108, DOI 10.1016/j.cyto.2017.06.002; McGrath-Morrow SA, 2015, AM J RESP CELL MOL, V52, P323, DOI 10.1165/rcmb.2014-0100OC; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Mock JR, 2014, MUCOSAL IMMUNOL, V7, P1440, DOI 10.1038/mi.2014.33; Obata Y, 2014, NAT IMMUNOL, V15, P571, DOI 10.1038/ni.2886; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; POWELL TJ, 1990, J IMMUNOL, V144, P854; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SCHURMANS S, 1990, J IMMUNOL, V145, P2465; Singer BD, 2016, AM J PHYSIOL-LUNG C, V310, pL796, DOI 10.1152/ajplung.00334.2015; Singer BD, 2015, AM J RESP CELL MOL, V52, P641, DOI 10.1165/rcmb.2014-0327OC; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Wang X, 2017, ONCOTARGET, V8, P56802, DOI 10.18632/oncotarget.18063; Zhang XM, 2017, NAT REV IMMUNOL, V17, P495, DOI 10.1038/nri.2017.54; Zhang Y, 2018, BRIEF BIOINFORM, V19, P374, DOI 10.1093/bib/bbw133; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zimmerman JJ, 2009, PEDIATRICS, V124, P87, DOI 10.1542/peds.2007-2462	42	28	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11772	11783		10.1074/jbc.RA118.003589	http://dx.doi.org/10.1074/jbc.RA118.003589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29866884	Green Published, hybrid			2022-12-28	WOS:000440134500010
J	Arndt, L; Dokas, J; Gericke, M; Kutzner, CE; Muller, S; Jeromin, F; Thiery, J; Burkhardt, R				Arndt, Lilli; Dokas, Janine; Gericke, Martin; Kutzner, Carl Elias; Mueller, Silvana; Jeromin, Franziska; Thiery, Joachim; Burkhardt, Ralph			Tribbles homolog 1 deficiency modulates function and polarization of murine bone marrow-derived macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; signal transduction; migration; phagocytosis; Janus kinase (JAK); STAT transcription factor; M1; M2; polarization	REGULATES HEPATIC LIPOGENESIS; SIGNALING PATHWAYS; GENE-EXPRESSION; C/EBP-ALPHA; IMMUNE-RESPONSES; ACTIVATION; TRIB1; RECEPTOR; INFLAMMATION; CELLS	Macrophages are essential for innate immunity and inflammatory responses and differentiate into various functional phenotypes. Tribbles homolog 1 (Trib1), a member of the mammalian Tribbles homolog pseudokinase family, has been implicated in regulation of cell differentiation, proliferation, and metabolism, but its role in macrophage biology has not been fully elucidated. Here, we investigated the consequences of Trib1 deficiency on macrophage functions and M1/M2 polarization. Bone marrow-derived macrophages (BMDMs) from Trib1-deficient (Trib1(-/-)) mice exhibited elevated phagocytic capacity, correlating with up-regulation of several scavenger receptors. Concomitantly, uptake of modified low-density lipoprotein was increased in Trib1(-/-) BMDMs. Trib1(-/-) macrophages also exhibited diminished migration in the presence of the chemokine MCP-1, associated with reduced expression of the MCP-1 receptor Ccr2. Furthermore, Trib1 deficiency attenuated the response of BMDMs to both M1 and M2 stimuli; induction of the M1-marker genes Il6, Il1b, and Nos2 upon LPS/IFN stimulation and of the M2-marker genes Cd206, Fizz1, and Arg1 upon IL-4 stimulation was reduced. Functionally, Trib1 deficiency decreased secretion of proinflammatory cytokines (IL-6, TNF, IL-1, and CXCL1) and reduced nitric oxide and reactive oxygen species production in M1-polarized macrophages. Supporting the attenuated M2 phenotype, IL-4-stimulated Trib1(-/-) macrophages secreted less IL-10 and TGF. Mechanistically, Trib1(-/-) BMDMs displayed lower levels of Janus kinase 1 (JAK1), resulting in reduced activation of LPS/IFN-mediated STAT1 signaling. Likewise, decreased levels of JAK1 along with lower activation of STAT6 and STAT3 were observed in M2-polarized Trib1(-/-) BMDMs. Our findings suggest that Trib1 extensively controls macrophage M1/M2 polarization via the JAK/STAT signaling pathway.	[Arndt, Lilli; Dokas, Janine; Kutzner, Carl Elias; Mueller, Silvana; Jeromin, Franziska; Thiery, Joachim; Burkhardt, Ralph] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Liebigstr 27, D-04103 Leipzig, Germany; [Gericke, Martin] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Thiery, Joachim; Burkhardt, Ralph] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Burkhardt, R (corresponding author), Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Liebigstr 27, D-04103 Leipzig, Germany.	ralph.burkhardt@medizin.uni-leipzig.de	Kutzner, Carl Elias/ABI-2268-2020; Gericke, Martin/AAI-8637-2020	Kutzner, Carl Elias/0000-0003-4053-2231; Burkhardt, Ralph/0000-0003-1924-1202	Deutsche Forschungsgemeinschaft, Collaborative Research Centre "Obesity Mechanisms" [SFB1052-B07]; Stiftung fur Pathobiochemie und Molekulare Diagnostik	Deutsche Forschungsgemeinschaft, Collaborative Research Centre "Obesity Mechanisms"(German Research Foundation (DFG)); Stiftung fur Pathobiochemie und Molekulare Diagnostik	This study was supported by Deutsche Forschungsgemeinschaft, Collaborative Research Centre "Obesity Mechanisms" Grant SFB1052-B07 (to R.B.) and a grant from Stiftung fur Pathobiochemie und Molekulare Diagnostik (to J. D. and R. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Bauer RC, 2015, J CLIN INVEST, V125, P3809, DOI 10.1172/JCI77095; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dhakal M, 2014, EUR J IMMUNOL, V44, P842, DOI 10.1002/eji.201343755; Douvris A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000884; Durzynska I, 2017, STRUCTURE, V25, P287, DOI 10.1016/j.str.2016.12.008; Eyers PA, 2017, TRENDS CELL BIOL, V27, P284, DOI 10.1016/j.tcb.2016.11.002; Guan HT, 2016, SCI REP-UK, V6, DOI 10.1038/srep32667; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Johnston J, 2015, BIOCHEM SOC T, V43, P1069, DOI 10.1042/BST20150095; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee B, 2014, AM J PHYSIOL-ENDOC M, V306, pE1144, DOI 10.1152/ajpendo.00002.2014; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy JM, 2015, STRUCTURE, V23, P2111, DOI 10.1016/j.str.2015.08.017; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohmori Y, 1998, J BIOL CHEM, V273, P29202, DOI 10.1074/jbc.273.44.29202; Ostertag A, 2010, DIABETES, V59, P1991, DOI 10.2337/db09-1537; Piras V, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00070; Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sung HY, 2007, J BIOL CHEM, V282, P18379, DOI 10.1074/jbc.M610792200; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Teupser D, 2008, ARTERIOSCL THROM VAS, V28, P2009, DOI 10.1161/ATVBAHA.108.175257; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wells CA, 2005, J LEUKOCYTE BIOL, V78, P9, DOI 10.1189/jlb.1204710; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Yamamoto M, 2007, J EXP MED, V204, P2233, DOI 10.1084/jem.20070183; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264; Yoshida A, 2013, BLOOD, V122, P1750, DOI 10.1182/blood-2012-12-476101; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20	42	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11527	11536		10.1074/jbc.RA117.000703	http://dx.doi.org/10.1074/jbc.RA117.000703			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29899113	Green Published, hybrid			2022-12-28	WOS:000439449700022
J	Fong, LK; Yang, MM; Chaves, RD; Reyna, SM; Langness, VF; Woodruff, G; Roberts, EA; Young, JE; Goldstein, LSB				Fong, Lauren K.; Yang, Max M.; Chaves, Rodrigo dos Santos; Reyna, Sol M.; Langness, Vanessa F.; Woodruff, Grace; Roberts, Elizabeth A.; Young, Jessica E.; Goldstein, Lawrence S. B.			Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid- clearance in human astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; amyloid precursor protein (APP); amyloid-beta (A); Alzheimer disease; cholesterol metabolism; induced pluripotent stem cell (iPS cell) (iPSC); lipoprotein receptor; lipoprotein metabolism	RECEPTOR-RELATED PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; PLURIPOTENT STEM-CELLS; BETA-SECRETASE CLEAVAGE; A-BETA; APOLIPOPROTEIN-E; CHOLESTEROL-METABOLISM; AXONAL-TRANSPORT; TRANSGENIC MICE; HUMAN PLASMA	Mounting evidence suggests that alterations in cholesterol homeostasis are involved in Alzheimer's disease (AD) pathogenesis. Amyloid precursor protein (APP) or multiple fragments generated by proteolytic processing of APP have previously been implicated in the regulation of cholesterol metabolism. However, the physiological function of APP in regulating lipoprotein homeostasis in astrocytes, which are responsible for de novo cholesterol biosynthesis and regulation in the brain, remains unclear. To address this, here we used CRISPR/Cas9 genome editing to generate isogenic APP-knockout (KO) human induced pluripotent stem cells (hiPSCs) and differentiated them into human astrocytes. We found that APP-KO astrocytes have reduced cholesterol and elevated levels of sterol regulatory element-binding protein (SREBP) target gene transcripts and proteins, which were both downstream consequences of reduced lipoprotein endocytosis. To elucidate which APP fragments regulate cholesterol homeostasis and to examine whether familial AD mutations in APP affect lipoprotein metabolism, we analyzed an isogenic allelic series harboring the APP Swedish and APP V717F variants. Only astrocytes homozygous for the APP Swedish (APP(Swe/Swe)) mutation, which had reduced full-length APP (FL APP) due to increased -secretase cleavage, recapitulated the APP-KO phenotypes. Astrocytic internalization of -amyloid (A), another ligand for low-density lipoprotein (LDL) receptors, was also impaired in APP-KO and APP(Swe/Swe) astrocytes. Finally, impairing cleavage of FL APP through -secretase inhibition in APP(Swe/Swe) astrocytes reversed the LDL and A endocytosis defects. In conclusion, FL APP is involved in the endocytosis of LDL receptor ligands and is required for proper cholesterol homeostasis and A clearance in human astrocytes.	[Fong, Lauren K.; Yang, Max M.; Chaves, Rodrigo dos Santos; Reyna, Sol M.; Langness, Vanessa F.; Woodruff, Grace; Roberts, Elizabeth A.; Young, Jessica E.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Young, Jessica E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Young, Jessica E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Fong, Lauren K.; Yang, Max M.; Chaves, Rodrigo dos Santos; Reyna, Sol M.; Langness, Vanessa F.; Woodruff, Grace; Roberts, Elizabeth A.; Goldstein, Lawrence S. B.] Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.; Goldstein, LSB (corresponding author), Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu	; Yang, Max/N-1982-2018	dos Santos Chaves, Rodrigo/0000-0003-0762-7634; Yang, Max/0000-0001-9808-0675	National Institutes of Health Predoctoral Training Grant [T32 GM008666]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/18028-9]; National Institutes of Health Grants from NIA [RF1 AG048083-01, 2P50 AG005131-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, RF1AG048083] Funding Source: NIH RePORTER	National Institutes of Health Predoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health Grants from NIA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in whole or part by National Institutes of Health Predoctoral Training Grant T32 GM008666; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 2013/18028-9, and National Institutes of Health Grants RF1 AG048083-01 and 2P50 AG005131-31 from NIA. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almenar-Queralt A, 2014, J NEUROSCI, V34, P3320, DOI 10.1523/JNEUROSCI.1503-13.2014; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Chen AK, 2008, ANAL CHEM, V80, P7437, DOI 10.1021/ac8011347; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; D'Antonio M, 2017, STEM CELL REP, V8, P1101, DOI 10.1016/j.stemcr.2017.03.011; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hass S, 1998, J BIOL CHEM, V273, P13892; Holtzman DM, 2011, SCI TRANSL MED, V3; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Knauer MF, 1996, BRAIN RES, V740, P6, DOI 10.1016/S0006-8993(96)00711-1; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Llorente-Cortes V, 2006, J MOL BIOL, V359, P950, DOI 10.1016/j.jmb.2006.04.008; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nicolas M, 2014, DEVELOPMENT, V141, P2543, DOI 10.1242/dev.108712; Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Ryan NS, 2016, LANCET NEUROL, V15, P1326, DOI 10.1016/S1474-4422(16)30193-4; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; TOPPER R, 1995, ACTA NEUROPATHOL, V89, P23; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang W, 2014, FASEB J, V28, P849, DOI 10.1096/fj.13-239301; Woodruff G, 2016, CELL REP, V17, P759, DOI 10.1016/j.celrep.2016.09.034; Woodruff G, 2013, CELL REP, V5, P974, DOI 10.1016/j.celrep.2013.10.018; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378; Yamakawa H, 2010, J BIOL CHEM, V285, P1634, DOI 10.1074/jbc.M109.066753; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Young JE, 2015, CELL STEM CELL, V16, P373, DOI 10.1016/j.stem.2015.02.004; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	78	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11341	11357		10.1074/jbc.RA117.000441	http://dx.doi.org/10.1074/jbc.RA117.000441			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858247	Green Published, hybrid			2022-12-28	WOS:000439449700007
J	Ho, PY; Li, H; Pavlov, TS; Tuerk, RD; Tabares, D; Brunisholz, R; Neumann, D; Staruschenko, A; Hallows, KR				Ho, Pei-Yin; Li, Hui; Pavlov, Tengis S.; Tuerk, Roland D.; Tabares, Diego; Brunisholz, Rene; Neumann, Dietbert; Staruschenko, Alexander; Hallows, Kenneth R.			beta(1)Pix exchange factor stabilizes the ubiquitin ligase Nedd4-2 and plays a critical role in ENaC regulation by AMPK in kidney epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); epithelial sodium channel (ENaC); ubiquitin ligase; sodium transport; 14-3-3 protein; kidney; -Pix	ACTIVATED PROTEIN-KINASE; NA+ CHANNEL; SODIUM-CHANNEL; BETA-PIX; FUNCTIONAL REGULATION; CELLULAR-ENERGY; C-CBL; PHOSPHORYLATION; INHIBITION; SERUM	Our previous work has established that the metabolic sensor AMP-activated protein kinase (AMPK) inhibits the epithelial Na+ channel (ENaC) by promoting its binding to neural precursor cell-expressed, developmentally down-regulated 4-2, E3 ubiquitin protein ligase (Nedd4-2). Here, using MS analysis and in vitro phosphorylation, we show that AMPK phosphorylates Nedd4-2 at the Ser-444 (Xenopus Nedd4-2) site critical for Nedd4-2 stability. We further demonstrate that the Pak-interacting exchange factor (1)Pix is required for AMPK-mediated inhibition of ENaC-dependent currents in both CHO and murine kidney cortical collecting duct (CCD) cells. Short hairpin RNA-mediated knockdown of (1)Pix expression in CCD cells attenuated the inhibitory effect of AMPK activators on ENaC currents. Moreover, overexpression of a (1)Pix dimerization-deficient mutant unable to bind 14-3-3 proteins (602-611) increased ENaC currents in CCD cells, whereas overexpression of WT (1)Pix had the opposite effect. Using additional immunoblotting and co-immunoprecipitation experiments, we found that treatment with AMPK activators promoted the binding of (1)Pix to 14-3-3 proteins in CCD cells. However, the association between Nedd4-2 and 14-3-3 proteins was not consistently affected by AMPK activation, (1)Pix knockdown, or overexpression of WT (1)Pix or the (1)Pix-602-611 mutant. Moreover, we found that (1)Pix is important for phosphorylation of the aforementioned Nedd4-2 site critical for its stability. Overall, these findings elucidate novel molecular mechanisms by which AMPK regulates ENaC. Specifically, they indicate that AMPK promotes the assembly of (1)Pix, 14-3-3 proteins, and Nedd4-2 into a complex that inhibits ENaC by enhancing Nedd4-2 binding to ENaC and its degradation.	[Ho, Pei-Yin; Li, Hui; Tabares, Diego; Hallows, Kenneth R.] Univ Southern Calif, Keck Sch Med, Dept Med, Div Nephrol & Hypertens, Los Angeles, CA 90033 USA; [Ho, Pei-Yin; Li, Hui; Tabares, Diego; Hallows, Kenneth R.] Univ Southern Calif, Keck Sch Med, USC UKRO Kidney Res Ctr, Los Angeles, CA 90033 USA; [Pavlov, Tengis S.] Henry Ford Hlth Syst, Div Hypertens & Vasc Res, Detroit, MI 48202 USA; [Pavlov, Tengis S.; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Tuerk, Roland D.; Neumann, Dietbert] Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Brunisholz, Rene] Swiss Fed Inst Technol, Funct Genom Ctr, CH-8097 Zurich, Switzerland; [Neumann, Dietbert] Maastricht Univ, Sch Cardiovasc Dis, Dept Pathol, NL-6200 MD Maastricht, Netherlands	University of Southern California; University of Southern California; Henry Ford Health System; Henry Ford Hospital; Medical College of Wisconsin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Maastricht University	Hallows, KR (corresponding author), USC, Keck Sch Med, USC UKRO Kidney Res Ctr, Div Nephrol & Hypertens, 2020 Zonal Ave,IRD 806, Los Angeles, CA 90033 USA.	hallows@usc.edu		Hallows, Kenneth/0000-0002-2964-2440; Neumann, Dietbert/0000-0002-4316-684X; Staruschenko, Alexander/0000-0002-5190-8356	NIDDK, National Institutes of Health [R01 DK075048]; NHLBI, National Institutes of Health [K99/R00 HL116603, R01 HL108880, R35 HL135749]; EU FP6 Contract [LSHM-CT-2004-005272]; Netherlands Organization for Scientific Research VIDI Grant [864.10.007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL116603, R00HL116603, R35HL135749, R01HL108880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EU FP6 Contract; Netherlands Organization for Scientific Research VIDI Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant R01 DK075048 (to K.R.H.); NHLBI, National Institutes of Health Grants K99/R00 HL116603 (to T.S.P.) and R01 HL108880 and R35 HL135749 (to A. S.); EU FP6 Contract LSHM-CT-2004-005272 (EXGENESIS) (to D.N. and R. D. T.); and Netherlands Organization for Scientific Research VIDI Grant 864.10.007 (to D. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almaca J, 2009, PFLUG ARCH EUR J PHY, V458, P713, DOI 10.1007/s00424-009-0660-4; Alzamora R, 2013, AM J PHYSIOL-RENAL, V305, pF943, DOI 10.1152/ajprenal.00303.2013; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Cammisotto PG, 2008, AM J PHYSIOL-RENAL, V294, pF881, DOI 10.1152/ajprenal.00373.2007; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chandran S, 2011, J BIOL CHEM, V286, P37830, DOI 10.1074/jbc.M111.293233; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Frank SR, 2012, CURR BIOL, V22, P1747, DOI 10.1016/j.cub.2012.07.011; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gleason CE, 2015, J CLIN INVEST, V125, P117, DOI 10.1172/JCI73935; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hallows KR, 2010, J BIOL CHEM, V285, P21671, DOI 10.1074/jbc.M109.084731; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Koh CG, 2001, J CELL SCI, V114, P4239; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee SH, 2001, J BIOL CHEM, V276, P25066, DOI 10.1074/jbc.M010892200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mount PF, 2005, AM J PHYSIOL-RENAL, V289, pF1103, DOI 10.1152/ajprenal.00458.2004; Mukherjee A, 2017, J BIOL CHEM, V292, P4152, DOI 10.1074/jbc.M117.776146; Nagaki K, 2006, BIOCHEMISTRY-US, V45, P6733, DOI 10.1021/bi052640q; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Pastor-Soler NM, 2012, CURR OPIN NEPHROL HY, V21, P523, DOI 10.1097/MNH.0b013e3283562390; Pavlov TS, 2010, J AM SOC NEPHROL, V21, P833, DOI 10.1681/ASN.2009080885; Peairs A, 2009, CLIN EXP IMMUNOL, V156, P542, DOI 10.1111/j.1365-2249.2009.03924.x; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00154; Staub O, 2005, J AM SOC NEPHROL, V16, P3167, DOI 10.1681/ASN.2005050454; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Stevens BM, 2014, STEM CELLS, V32, P1124, DOI 10.1002/stem.1644; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	70	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11612	11624		10.1074/jbc.RA118.003082	http://dx.doi.org/10.1074/jbc.RA118.003082			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858246	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000439449700029
J	Jennings, GK; Hsu, MH; Shock, LS; Johnson, EF; Hackett, JC				Jennings, Gareth K.; Hsu, Mei-Hui; Shock, Lisa S.; Johnson, Eric F.; Hackett, John C.			Noncovalent interactions dominate dynamic heme distortion in cytochrome P450 4B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; Raman spectroscopy; X-ray crystallography; heme; ultraviolet-visible spectroscopy; CYP4B1; heme distortion; hydrocarbon; resonance raman; regiochemistry; regioselectivity; omega-hydroxylation; substrate specificity	RESONANCE RAMAN-SPECTRA; PROTEIN COVALENT BONDS; OMEGA-HYDROXYLATION; PROSTHETIC HEME; RABBIT CYP4B1; P450 ENZYMES; ACID; METABOLISM; HEMOGLOBIN; MECHANISM	Cytochrome P450 4B1 (4B1) functions in both xenobiotic and endobiotic metabolism. An ester linkage between Glu-310 in 4B1 and the 5-methyl group of heme facilitates preferential hydroxylation of terminal () methyl groups of hydrocarbons (HCs) and fatty acids compared with -1 sites bearing weaker C-H bonds. This preference is retained albeit diminished 4-fold for the E310A mutant, but the reason for this is unclear. Here, a crystal structure of the E310A-octane complex disclosed that noncovalent interactions maintain heme deformation in the absence of the ester linkage. Consistent with the lower symmetry of the heme, resonance Raman (RR) spectroscopy revealed large enhancements of RR peaks for high-spin HC complexes of 4B1 and the E310A mutant relative to P450 3A4. Whereas these enhancements were diminished in RR spectra of a low-spin 4B1-N-hydroxy-N-(4-butyl-2-methylphenyl)formamidine complex, a crystal structure indicated that this inhibitor does not alter heme ruffling. RR spectra of Fe2+-CO HC complexes revealed larger effects of HC length in E310A than in 4B1, suggesting that reduced rigidity probably underlies increased E310A-catalyzed (-1)-hydroxylation. Diminished effects of the HC on the position of the Fe-CO stretching mode in 4B1 suggested that the ester linkage limits substrate access to the CO. Heme ruffling probably facilitates autocatalytic ester formation by reducing inhibitory coordination of Glu-310 with the heme iron. This also positions the 5-methyl for a reaction with the proposed glutamyl radical intermediate and potentially enhances oxo-ferryl intermediate reactivity for generation of the glutamyl radical to initiate ester bond formation and -hydroxylation.	[Jennings, Gareth K.; Shock, Lisa S.; Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Jennings, Gareth K.; Shock, Lisa S.; Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Jennings, Gareth K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Virginia Commonwealth University; Virginia Commonwealth University; Scripps Research Institute; University of California System; University of California San Diego	Johnson, EF (corresponding author), Scripps Res Inst, MEM 255,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Hackett, JC (corresponding author), Virginia Commonwealth Univ, Sch Med, 401 Coll St, Richmond, VA 23298 USA.	johnson@scripps.edu; john.hackett@vcuhealth.org	Hackett, John/J-3871-2019	Hackett, John/0000-0002-4923-2668	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM114168, R01GM031001] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health (including Grant P41GM103393).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auer M, 2014, J BIOL CHEM, V289, P31480, DOI 10.1074/jbc.M114.595157; Baer BR, 2005, BIOCHEMISTRY-US, V44, P13914, DOI 10.1021/bi051267j; Baer BR, 2005, CHEM RES TOXICOL, V18, P855, DOI 10.1021/tx0496993; Baer BR, 2007, BIOCHEMISTRY-US, V46, P11598, DOI 10.1021/bi701064b; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; BILLINGTON D, 1978, BIOCHEM PHARMACOL, V27, P2891, DOI 10.1016/0006-2952(78)90205-8; Borbulevych OY, 2014, ACTA CRYSTALLOGR D, V70, P1233, DOI 10.1107/S1399004714002260; BRESSLER R, 1969, PHARMACOL REV, V21, P105; Brogioni S, 2006, J RAMAN SPECTROSC, V37, P263, DOI 10.1002/jrs.1442; Cerda-Colon JF, 1998, J AM CHEM SOC, V120, P9312, DOI 10.1021/ja972654m; Chang TKH, 2006, DRUG METAB REV, V38, P627, DOI 10.1080/03602530600959433; Cheesman MJ, 2003, ARCH BIOCHEM BIOPHYS, V416, P17, DOI 10.1016/S0003-9861(03)00278-9; Chen ZC, 2003, BIOCHEMISTRY-US, V42, P2542, DOI 10.1021/bi027206s; Chen ZC, 2004, BIOCHEMISTRY-US, V43, P1798, DOI 10.1021/bi034920g; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; CZERWINSKI M, 1991, CANCER RES, V51, P4636; de Montellano PRO, 2008, DRUG METAB REV, V40, P405, DOI [10.1080/03602530802186439, 10.1080/03602530802186439 ]; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Dunford HB, 2000, REDOX REP, V5, P169, DOI 10.1179/135100000101535708; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088; Fisher MB, 1998, BIOCHEM BIOPH RES CO, V248, P352, DOI 10.1006/bbrc.1998.8842; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; Gottfried DS, 1996, J PHYS CHEM-US, V100, P12034, DOI 10.1021/jp9609489; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; He X, 2005, J BIOL CHEM, V280, P22697, DOI 10.1074/jbc.M502632200; Henne KR, 2001, BIOCHEMISTRY-US, V40, P12925, DOI 10.1021/bi011171z; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Hsu MH, 2017, J BIOL CHEM, V292, P5610, DOI 10.1074/jbc.M117.775494; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Huang LS, 2006, J BIOL CHEM, V281, P18983, DOI 10.1074/jbc.M602307200; Huang LS, 2006, ARCH BIOCHEM BIOPHYS, V446, P77, DOI 10.1016/j.abb.2005.11.011; Jennings GK, 2016, MOL PHARMACOL, V90, P42, DOI 10.1124/mol.116.103721; Johnson Amanda L, 2015, Adv Pharmacol, V74, P223, DOI 10.1016/bs.apha.2015.05.002; Joyce MG, 2004, J BIOL CHEM, V279, P23287, DOI 10.1074/jbc.M401717200; JUNG C, 1991, BIOCHIM BIOPHYS ACTA, V1076, P130, DOI 10.1016/0167-4838(91)90229-S; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIMURA S, 1981, BIOCHEMISTRY-US, V20, P4632, DOI 10.1021/bi00519a018; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Limburg J, 2005, BIOCHEMISTRY-US, V44, P4091, DOI 10.1021/bi047686i; Mak PJ, 2004, BIOPOLYMERS, V75, P217, DOI 10.1002/bip.20115; MANTHEY JA, 1986, J BIOL CHEM, V261, P6734; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Olea C, 2008, ACS CHEM BIOL, V3, P703, DOI 10.1021/cb800185h; Peng JT, 2010, ANAL CHIM ACTA, V683, P63, DOI 10.1016/j.aca.2010.08.033; Podstawka E, 2006, BIOPOLYMERS, V83, P455, DOI 10.1002/bip.20573; RETTIE AE, 1995, BIOCHEMISTRY-US, V34, P7889, DOI 10.1021/bi00024a013; ROBERTSON IGC, 1981, MOL PHARMACOL, V20, P662; SCHULZ H, 1983, BIOCHEMISTRY-US, V22, P1827, DOI 10.1021/bi00277a013; Shaik S, 2004, J AM CHEM SOC, V126, P11746, DOI 10.1021/ja047432k; Spiro T. G., 1988, BIOL APPL RAMAN SPEC, V3; Spiro TG, 2008, SMALLEST BIOMOLECULES: DIATOMICS AND THEIR INTERACTIONS WITH HEME PROTEINS, P95, DOI 10.1016/B978-044452839-1.50005-X; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; ThorntonManning J, 1996, J PHARMACOL EXP THER, V276, P21; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VARADARAJAN R, 1989, SCIENCE, V243, P69, DOI 10.1126/science.2563171; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Zbylut SD, 2002, J AM CHEM SOC, V124, P6751, DOI 10.1021/ja012578u; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737	62	11	13	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11433	11446		10.1074/jbc.RA118.004044	http://dx.doi.org/10.1074/jbc.RA118.004044			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858244	Green Published, hybrid			2022-12-28	WOS:000439449700014
J	Katagiri, Y; Morgan, AA; Yu, PP; Bangayan, NJ; Junka, R; Geller, HM				Katagiri, Yasuhiro; Morgan, Ashlea A.; Yu, Panpan; Bangayan, Nathanael J.; Junka, Radoslaw; Geller, Herbert M.			Identification of novel binding sites for heparin in receptor protein-tyrosine phosphatase (RPTP sigma): Implications for proteoglycan signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteoglycan; heparan sulfate; chondroitin sulfate; cell signaling; glycosaminoglycan; receptor tyrosine phosphatase; RPTP sigma	CHONDROITIN SULFATE PROTEOGLYCAN; PTP-SIGMA; IN-VIVO; LAR; DOMAINS; REGENERATION; INHIBITORS; EXTENSION; SYNDECAN; NEURONS	Receptor protein-tyrosine phosphatase RPTP sigma has important functions in modulating neural development and regeneration. Compelling evidence suggests that both heparan sulfate (HS) and chondroitin sulfate (CS) glycosaminoglycans (GAGs) bind to a series of Lys residues located in the first Ig domain of RPTP sigma. However, HS promotes and CS inhibits axonal growth. Mutation of these Lys residues abolished binding and signal transduction of RPTP sigma to CS, whereas HS binding was reduced, and signaling persisted. This activity was mediated through novel heparin-binding sites identified in the juxtamembrane region. Although different functional outcomes of HS and CS have been previously attributed to the differential oligomeric state of RPTP sigma upon GAG binding, we found that RPTP sigma was clustered by both heparin and CS GAG rich in 4,6-O-disulfated disaccharide units. We propose an additional mechanism by which RPTP sigma distinguishes between HS and CS through these novel binding sites.	[Katagiri, Yasuhiro; Morgan, Ashlea A.; Yu, Panpan; Bangayan, Nathanael J.; Junka, Radoslaw; Geller, Herbert M.] NHLBI, Lab Dev Neurobiol, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Yu, Panpan] Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Minist Educ, Joint Int Res Lab CNS Regenerat, Guangzhou 510632, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Jinan University	Katagiri, Y (corresponding author), NHLBI, Lab Dev Neurobiol, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	katagiry@helix.nih.gov	Yu, Panpan/M-5718-2019	Morgan, Ashlea/0000-0002-3235-2567	Division of Intramural Research, NHLBI, National Institutes of Health; Mizutani Foundation for Glycoscience; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006021] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI, National Institutes of Health; Mizutani Foundation for Glycoscience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Intramural Research, NHLBI, National Institutes of Health, and the Mizutani Foundation for Glycoscience. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Biersmith BH, 2011, J MOL BIOL, V408, P616, DOI 10.1016/j.jmb.2011.03.013; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Briani C, 1998, J NEUROIMMUNOL, V84, P117, DOI 10.1016/S0165-5728(97)00209-9; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Doody KM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4616; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Krueger NX, 2003, MOL CELL BIOL, V23, P6909, DOI 10.1128/MCB.23.19.6909-6921.2003; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Lee HS, 2016, BIOORG MED CHEM LETT, V26, P87, DOI 10.1016/j.bmcl.2015.11.026; Ohtake Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37152; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Takahashi H, 2013, TRENDS NEUROSCI, V36, P522, DOI 10.1016/j.tins.2013.06.002; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Thelin MA, 2013, FEBS J, V280, P2431, DOI 10.1111/febs.12214; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Won SY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00327; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yi JH, 2014, EXP NEUROL, V255, P12, DOI 10.1016/j.expneurol.2014.02.007; Yu PP, 2018, TRENDS NEUROSCI, V41, P47, DOI 10.1016/j.tins.2017.10.005; Yu PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059285	28	16	16	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11639	11647		10.1074/jbc.RA118.003081	http://dx.doi.org/10.1074/jbc.RA118.003081			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29880643	hybrid, Green Published			2022-12-28	WOS:000439449700031
J	Ravindra, KC; Ahrens, CC; Wang, Y; Ramseier, JY; Wishnok, JS; Griffith, LG; Grodzinsky, AJ; Tannenbaum, SR				Ravindra, Kodihalli C.; Ahrens, Caroline C.; Wang, Yang; Ramseier, Julie Y.; Wishnok, John S.; Griffith, Linda G.; Grodzinsky, Alan J.; Tannenbaum, Steven R.			Chemoproteomics of matrix metalloproteases in a model of cartilage degeneration suggests functional biomarkers associated with posttraumatic osteoarthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS; matrix metalloproteinase (MMP); osteoarthritis; peptidase; protein engineering; osteoarthritis; matrix metalloproteinase (MMP); ADAMTS; protein engineering; peptidase	IN-SITU ZYMOGRAPHY; SYNOVIAL FIBROBLASTS; MECHANICAL INJURY; PROTEASE ACTIVITY; BOVINE CARTILAGE; TISSUE INHIBITOR; GENE-EXPRESSION; COLLAGENASE; STROMELYSIN; ENDOMETRIOSIS	Active matrix metalloproteases (MMPs) play a significant role in the pathogenesis of many diseases including osteoarthritis (OA), which involves progressive proteolytic degradation of cartilage. Clinical success of OA interventions that target MMPs has been limited by a lack of information about the presence and activity of specific disease-related proteases. We therefore developed a chemoproteomics approach based on MS to characterize the release and activity of MMPs in an in vitro model of the early inflammatory phase of posttraumatic OA (PTOA). We designed and synthesized chemical activity-based probes (ABPs) to identify active MMPs in bovine cartilage explants cultured for 30 days with the proinflammatory cytokine, interleukin-1. Using these probes in an activity-based protein profiling-multidimensional identification technology (ABPP-MudPIT) approach, we identified active MMP-1, -2, -3, -7, -9, -12, and -13 in the medium after 10 days of culture, the time at which irreversible proteolysis of the collagen network in the explant was detected using proteolytic activation of FRET-quenched MMP substrates. Total MMP levels were quantified by shotgun proteomics, which, taken with ABPP-MudPIT data, indicated the presence of predominantly inactive MMPs in the culture medium. The selectivity of the ABPP-MudPIT approach was further validated by detection of specific endogenous MMPs activated de novo with 4-aminophenylmurcuric acetate. The utility of the new ABPP-MudPIT approach for detecting molecular biomarkers of PTOA disease initiation and potential targets for therapeutics motivates possible application in other diseases involving MMP activity.	[Ravindra, Kodihalli C.; Wang, Yang; Ramseier, Julie Y.; Wishnok, John S.; Griffith, Linda G.; Grodzinsky, Alan J.; Tannenbaum, Steven R.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Tannenbaum, Steven R.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Ahrens, Caroline C.; Griffith, Linda G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Griffith, Linda G.] MIT, Ctr Gynepathol Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Grodzinsky, Alan J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Grodzinsky, Alan J.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tannenbaum, SR (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tannenbaum, SR (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	srt@mit.edu		Griffith, Linda/0000-0002-1801-5548	National Institutes of Health NIAMS Grant [AR060331]; National Science Scholarship, Agency for Science, Technology and Research, Singapore; National Institutes of Health [R01EB010246]; John and Karine Begg Fund; National Research Foundation; Singapore Infectious Disease IRG, Singapore-MIT Alliance for Research and Technology (SMART); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010246] Funding Source: NIH RePORTER	National Institutes of Health NIAMS Grant; National Science Scholarship, Agency for Science, Technology and Research, Singapore; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John and Karine Begg Fund; National Research Foundation; Singapore Infectious Disease IRG, Singapore-MIT Alliance for Research and Technology (SMART); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health NIAMS Grant AR060331 (to A. J. G.), National Science Scholarship, Agency for Science, Technology and Research, Singapore (to W. Y.), National Institutes of Health Grant R01EB010246 (to L. G. G.), the John and Karine Begg Fund (to L. G. G.), the National Research Foundation, and the Singapore Infectious Disease IRG, Singapore-MIT Alliance for Research and Technology (SMART). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Caescu C., 2010, BIOCHEM J, V424, P79; Chen CH, 2013, J AM CHEM SOC, V135, P1645, DOI 10.1021/ja307866z; CHIN JR, 1985, J BIOL CHEM, V260, P2367; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Dickinson SC, 2003, MATRIX BIOL, V22, P267, DOI 10.1016/S0945-053X(03)00034-9; Dozin B, 2002, MATRIX BIOL, V21, P449, DOI 10.1016/S0945-053X(02)00028-8; Freije JR, 2003, J CHROMATOGR A, V1009, P155, DOI 10.1016/S0021-9673(03)00920-8; Gartner CA, 2007, J PROTEOME RES, V6, P1482, DOI 10.1021/pr060605f; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; He Y, 2013, MATRIX BIOL, V32, P143, DOI 10.1016/j.matbio.2012.12.001; Kellogg BA, 2011, BIOCONJUGATE CHEM, V22, P717, DOI 10.1021/bc100480a; Keow JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043434; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Levin JI, 2004, CURR TOP MED CHEM, V4, P1289, DOI 10.2174/1568026043387935; Levy DE, 1998, J MED CHEM, V41, P199, DOI 10.1021/jm970494j; Li Y, 2015, OSTEOARTHR CARTILAGE, V23, P266, DOI 10.1016/j.joca.2014.11.006; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; Miller MA, 2016, CANCER DISCOV, V6, P382, DOI 10.1158/2159-8290.CD-15-0933; Miller MA, 2013, P NATL ACAD SCI USA, V110, pE2074, DOI 10.1073/pnas.1222387110; Miller MA, 2011, INTEGR BIOL-UK, V3, P422, DOI 10.1039/c0ib00083c; Milner JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2034; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Mungall BA, 2001, J BIOCHEM BIOPH METH, V47, P169, DOI 10.1016/S0165-022X(00)00126-3; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Niphakis MJ, 2014, ANNU REV BIOCHEM, V83, P341, DOI 10.1146/annurev-biochem-060713-035708; OKADA Y, 1992, LAB INVEST, V66, P680; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Ravindra KC, 2015, CHEM RES TOXICOL, V28, P1903, DOI 10.1021/acs.chemrestox.5b00105; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Stevens AL, 2009, MOL CELL PROTEOMICS, V8, P1475, DOI 10.1074/mcp.M800181-MCP200; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; VINCENTI MP, 1994, ARTHRITIS RHEUM, V37, P1115, DOI 10.1002/art.1780370802; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yan SJ, 2003, VET PATHOL, V40, P227, DOI 10.1354/vp.40-3-227; Zeitvogel A, 2001, AM J PATHOL, V159, P1839, DOI 10.1016/S0002-9440(10)63030-1	44	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11459	11469		10.1074/jbc.M117.818542	http://dx.doi.org/10.1074/jbc.M117.818542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29794029	Green Published, hybrid			2022-12-28	WOS:000439449700016
J	Du, H; Leng, JP; Wang, PC; Li, L; Wang, YS				Du, Hua; Leng, Jiapeng; Wang, Pengcheng; Li, Lin; Wang, Yinsheng			Impact of tobacco-specific nitrosamine-derived DNA adducts on the efficiency and fidelity of DNA replication in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA replication; DNA polymerase; mutagenesis; carcinogenesis; DNA adduct; DNA alkylation; N-nitrosamine; translesion synthesis; translesion synthesis polymerase	TRANSLESION SYNTHESIS POLYMERASES; TANDEM MASS-SPECTROMETRY; LUNG-CANCER; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; MUTAGENIC PROPERTIES; ESCHERICHIA-COLI; NEVER-SMOKERS; REV1 PROTEIN; IN-VIVO; REPAIR	The tobacco-derived nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N-nitrosonornicotine (NNN) are known human carcinogens. Following metabolic activation, NNK and NNN can induce a number of DNA lesions, including several 4-(3-pyridyl)-4-oxobut-1-yl (POB) adducts. However, it remains unclear to what extent these lesions affect the efficiency and accuracy of DNA replication and how their replicative bypass is influenced by translesion synthesis (TLS) DNA polymerases. In this study, we investigated the effects of three stable POB DNA adducts (O-2-POB-dT, O-4-POB-dT, and O-6-POB-dG) on the efficiency and fidelity of DNA replication in HEK293T human cells. We found that, when situated in a double-stranded plasmid, O-2-POB-dT and O-4-POB-dT moderately blocked DNA replication and induced exclusively TA (approximate to 14.9%) and TC (approximate to 35.2%) mutations, respectively. On the other hand, O-6-POB-dG slightly impeded DNA replication, and this lesion elicited primarily the GA transition (approximate to 75%) together with a low frequency of the GT transversion (approximate to 3%). By conducting replication studies in isogenic cells in which specific TLS DNA polymerases (Pols) were deleted by CRISPR-Cas9 genome editing, we observed that multiple TLS Pols, especially Pol and Pol , are involved in bypassing these lesions. Our findings reveal the cytotoxic and mutagenic properties of specific POB DNA adducts and unravel the roles of several TLS polymerases in the replicative bypass of these adducts in human cells. Together, these results provide important new knowledge about the biological consequences of POB adducts.	[Du, Hua; Leng, Jiapeng; Wang, Pengcheng; Li, Lin; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022	Wang, Pengcheng/0000-0003-4581-983X	National Institutes of Health [R01 ES025121]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R01 ES025121. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Carlson ES, 2016, CHEM RES TOXICOL, V29, P2194, DOI 10.1021/acs.chemrestox.6b00384; CRESPI CL, 1991, CARCINOGENESIS, V12, P1197, DOI 10.1093/carcin/12.7.1197; Delaney JC, 2008, CHEM RES TOXICOL, V21, P232, DOI 10.1021/tx700292a; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; GERSON SL, 1988, CANCER RES, V48, P5368; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gowda ASP, 2016, CHEM RES TOXICOL, V29, P303, DOI 10.1021/acs.chemrestox.5b00468; Gowda ASP, 2012, CHEM RES TOXICOL, V25, P1195, DOI 10.1021/tx200483g; Guengerich FP, 2003, BIOCHEMISTRY-US, V42, P10965, DOI 10.1021/bi034937z; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Guza R, 2010, ACS SYM SER, V1041, P73; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Jasti VP, 2011, CHEM RES TOXICOL, V24, P1833, DOI 10.1021/tx200435d; Kotandeniya D, 2013, BIOCHEMISTRY-US, V52, P4075, DOI 10.1021/bi4004952; Lao YB, 2006, CHEM RES TOXICOL, V19, P674, DOI 10.1021/tx050351x; Lawrence CW, 2002, DNA REPAIR, V1, P425, DOI 10.1016/S1568-7864(02)00038-1; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leng JP, 2017, ANAL CHEM, V89, P9124, DOI 10.1021/acs.analchem.7b01857; Li L, 2009, CHEM RES TOXICOL, V22, P1464, DOI 10.1021/tx9001572; Liu D, 2013, J MOL CELL BIOL, V5, P204, DOI 10.1093/jmcb/mjs061; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Pauly GT, 2002, CHEM RES TOXICOL, V15, P165, DOI 10.1021/tx0101245; PETERSON LA, 1993, CANCER RES, V53, P2780; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pustovalova Y, 2016, BIOCHEMISTRY-US, V55, P2043, DOI 10.1021/acs.biochem.5b01282; RONAI ZA, 1993, CARCINOGENESIS, V14, P2419, DOI 10.1093/carcin/14.11.2419; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shopland DR, 1995, ENVIRON HEALTH PERSP, V103, P131, DOI 10.2307/3432300; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; TAKESHITA M, 1994, NUCLEIC ACIDS RES, V22, P1897, DOI 10.1093/nar/22.10.1897; Urban AM, 2012, CHEM RES TOXICOL, V25, P2167, DOI 10.1021/tx300245w; Wang LJ, 1999, CHEM RES TOXICOL, V12, P127, DOI 10.1021/tx980251+; Wang PC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv941; Weerasooriya S, 2015, DNA REPAIR, V35, P63, DOI 10.1016/j.dnarep.2015.09.023; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; You CJ, 2015, NAT PROTOC, V10, P1389, DOI 10.1038/nprot.2015.094; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; Yousefzadeh MJ, 2013, DNA REPAIR, V12, P1, DOI 10.1016/j.dnarep.2012.10.004; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Zhai QQ, 2014, NUCLEIC ACIDS RES, V42, P10529, DOI 10.1093/nar/gku748; Zhai QQ, 2014, CARCINOGENESIS, V35, P2002, DOI 10.1093/carcin/bgu085	45	22	23	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11100	11108		10.1074/jbc.RA118.003477	http://dx.doi.org/10.1074/jbc.RA118.003477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789427	Green Published, hybrid			2022-12-28	WOS:000438882800022
J	Tillet, E; Ouarne, M; Desroches-Castan, A; Mallet, C; Subileau, M; Didier, R; Lioutsko, A; Belthier, G; Feige, JJ; Bailly, S				Tillet, Emmanuelle; Ouarne, Marie; Desroches-Castan, Agnes; Mallet, Christine; Subileau, Mariela; Didier, Robin; Lioutsko, Anna; Belthier, Guillaume; Feige, Jean-Jacques; Bailly, Sabine			A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); angiogenesis; vascular biology; blood; liver; heterodimer	KINASE 1 ALK1; TGF-BETA; GROWTH; SPECIFICITY; RECEPTORS; FAMILY; IDENTIFICATION; ACTIVATION; COMPLEXES; SIGNALS	Bone morphogenetic protein 9 (BMP9) and BMP10 are the two high-affinity ligands for the endothelial receptor activin receptor-like kinase 1 (ALK1) and are key regulators of vascular remodeling. They are both present in the blood, but their respective biological activities are still a matter of debate. The aim of the present work was to characterize their circulating forms to better understand how their activities are regulated in vivo. First, by cotransfecting BMP9 and BMP10, we found that both can form a disulfide-bonded heterodimer in vitro and that this heterodimer is functional on endothelial cells via ALK1. Next, we developed an ELISA that could specifically recognize the BMP9-BMP10 heterodimer and which indicated its presence in both human and mouse plasma. In addition to using available Bmp9-KO mice, we generated a conditional Bmp10-KO mouse strain. The plasma from Bmp10-KO mice, similarly to that of Bmp9-KO mice, completely lacked the ability to activate ALK1-transfected 3T3 cells or phospho-Smad1-5 on endothelial cells, indicating that the circulating BMP activity is mostly due to the BMP9-BMP10 heterodimeric form. This result was confirmed in human plasma that had undergone affinity chromatography to remove BMP9 homodimer. Finally, we provide evidence that hepatic stellate cells in the liver could be the source of the BMP9-BMP10 heterodimer. Together, our findings demonstrate that BMP9 and BMP10 can heterodimerize and that this heterodimer is responsible for most of the biological BMP activity found in plasma.	[Tillet, Emmanuelle; Ouarne, Marie; Desroches-Castan, Agnes; Mallet, Christine; Subileau, Mariela; Didier, Robin; Lioutsko, Anna; Belthier, Guillaume; Feige, Jean-Jacques; Bailly, Sabine] Univ Grenoble Alpes, INSERM, CEA, BIG Biol Canc & Infect, F-38000 Grenoble, France; [Didier, Robin] Univ Nice, INSERM, C3M, F-06200 Nice, France; [Lioutsko, Anna] Univ Paris Sud 11, IDMIT, INSERM, CEA, F-92260 Fontenay Aux Roses, France; [Belthier, Guillaume] Univ Montpellier, INSERM, CNRS, IGF, F-34090 Montpellier, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Tillet, E (corresponding author), CEA G, BCI, BIG, UMR1036, 17 Rue Martyrs, F-38054 Grenoble, France.	emmanuelle.tillet@cea.fr	Castan, Agnes/AAS-2580-2021; Feige, Jean-Jacques/M-8905-2017; Ouarné, Marie/ABB-2357-2021; Desroches-Castan, Agnes/AAA-4557-2019; bailly, sabine/G-3540-2013	Castan, Agnes/0000-0002-3301-9504; Feige, Jean-Jacques/0000-0002-1354-7692; Ouarné, Marie/0000-0003-4724-4363; bailly, sabine/0000-0003-1043-7030; Tillet, Emmanuelle/0000-0002-0076-8007; Subileau, Mariela/0000-0002-7759-8376	Fondation Maladies Rares (FMR)	Fondation Maladies Rares (FMR)	We thank Dr. D. Constam (Ecole Polytechnique Federale de Lausanne, Switzerland) for his gift of PCR3-furin plasmid, Dr. S. J. lee (Johns Hopkins University School of Medicine, Baltimore, MD) and Dr. T. Zimmers (Thomas Jefferson University, Philadelphia, PA) for providing Bmp9-KO mice, Dr. D. Metzger (IGBMC, Illkirch, France) for providing the Rosa26-CreER<SUP>T2</SUP> mouse, and the animal facility staff at Institut de Biosciences et Biotechnologies de Grenoble (BIG, Grenoble, France) for animal husbandry. We thank the Fondation Maladies Rares (FMR) for its financial support to the generation of Bmp10<SUP>lox/lox</SUP> mice.	Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Breitkopf-Heinlein K, 2017, GUT, V66, P939, DOI 10.1136/gutjnl-2016-313314; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Constam DB, 2014, SEMIN CELL DEV BIOL, V32, P85, DOI 10.1016/j.semcdb.2014.01.008; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; de Vinuesa AG, 2016, CYTOKINE GROWTH F R, V27, P65, DOI 10.1016/j.cytogfr.2015.12.005; Fuerer C, 2014, J BIOL CHEM, V289, P17854, DOI 10.1074/jbc.M114.550301; Guo J, 2012, CYTOKINE GROWTH F R, V23, P61, DOI 10.1016/j.cytogfr.2012.02.001; Hernandez Felicia, 2015, Hum Genome Var, V2, P15040, DOI 10.1038/hgv.2015.40; Herrera B, 2009, CANCER RES, V69, P9254, DOI 10.1158/0008-5472.CAN-09-2912; Hinck A. P., 2016, COLD SPRING HARBOR P, V8; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Isaacs MJ, 2010, MOL ENDOCRINOL, V24, P1469, DOI 10.1210/me.2009-0496; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; Jiang H, 2016, J BIOL CHEM, V291, P2954, DOI 10.1074/jbc.M115.683292; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kienast Y, 2016, J BIOL CHEM, V291, P3395, DOI 10.1074/jbc.M115.680009; Laux DW, 2013, DEVELOPMENT, V140, P3403, DOI 10.1242/dev.095307; Levet S, 2015, P NATL ACAD SCI USA, V112, pE3207, DOI 10.1073/pnas.1508386112; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Mahlawat P, 2012, BIOCHEMISTRY-US, V51, P6328, DOI 10.1021/bi300942x; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mottershead DG, 2015, J BIOL CHEM, V290, P24007, DOI 10.1074/jbc.M115.671487; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Tanaka C, 2007, GENE DEV, V21, P3272, DOI 10.1101/gad.1623907; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Valera E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011167; Wohl AP, 2016, J BIOL CHEM, V291, P12732, DOI 10.1074/jbc.M115.704734; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Zhao B, 2018, J BIOL CHEM, V293, P1579, DOI 10.1074/jbc.M117.809657; Zinski J., 2017, COLD SPRING HARBOR P, V2017, DOI 1101/cshperspect.a033274	57	64	65	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10963	10974		10.1074/jbc.RA118.002968	http://dx.doi.org/10.1074/jbc.RA118.002968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789425	Green Published, hybrid			2022-12-28	WOS:000438882800010
J	Clarke, SG				Clarke, Steven G.			The ribosome: A hot spot for the identification of new types of protein methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein methylation; post-translational modification (PTM); translation elongation factor; ribosome; ribosome structure; protein methyltransferase	SET DOMAIN METHYLTRANSFERASE; MASS-SPECTROMETRIC ANALYSIS; N-TERMINAL METHYLATION; ARGININE METHYLATION; SACCHAROMYCES-CEREVISIAE; S-ADENOSYLMETHIONINE; CYSTEINE METHYLTRANSFERASE; LYSINE METHYLATION; ESCHERICHIA-COLI; DNA-DAMAGE	Cellular physiology depends on the alteration of protein structures by covalent modification reactions. Using a combination of bioinformatic, genetic, biochemical, and mass spectrometric approaches, it has been possible to probe ribosomal proteins from the yeast Saccharomyces cerevisiae for post-translationally methylated amino acid residues and for the enzymes that catalyze these modifications. These efforts have resulted in the identification and characterization of the first protein histidine methyltransferase, the first N-terminal protein methyltransferase, two unusual types of protein arginine methyltransferases, and a new type of cysteine methylation. Two of these enzymes may modify their substrates during ribosomal assembly because the final methylated histidine and arginine residues are buried deep within the ribosome with contacts only with RNA. Two of these modifications occur broadly in eukaryotes, including humans, whereas the others demonstrate a more limited phylogenetic range. Analysis of strains where the methyltransferase genes are deleted has given insight into the physiological roles of these modifications. These reactions described here add diversity to the modifications that generate the typical methylated lysine and arginine residues previously described in histones and other proteins.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clarke, Steven G.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Clarke, SG (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Moffitt, Terrie E/D-5295-2011; caspi, avshalom/D-5294-2011	Moffitt, Terrie E/0000-0002-8589-6760; caspi, avshalom/0000-0003-0082-4600; Clarke, Steven/0000-0002-7303-6632	National Science Foundation [MCB-1714569]; National Institutes of Health [GM026020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB-1714569 and National Institutes of Health Grant GM026020. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afjehi-Sadat L, 2013, CURR OPIN CHEM BIOL, V17, P12, DOI 10.1016/j.cbpa.2012.12.023; Al-Hadid Q, 2016, RNA, V22, P489, DOI 10.1261/rna.054569.115; Al-Hadid Q, 2016, BIOCHEM BIOPH RES CO, V470, P552, DOI 10.1016/j.bbrc.2016.01.107; Al-Hadid Q, 2014, MOL CELL BIOL, V34, P2903, DOI 10.1128/MCB.01634-13; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Black JC, 2013, BIOPOLYMERS, V99, P127, DOI 10.1002/bip.22136; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Bonsignore LA, 2015, ONCOTARGET, V6, P12248, DOI 10.18632/oncotarget.3653; Bonsignore LA, 2015, MECH AGEING DEV, V146, P42, DOI 10.1016/j.mad.2015.03.012; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Castillo-Aguilera O., 2017, BIOMOLECULES, V7, pE3, DOI DOI 10.3390/BI0M7010003; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Chern MK, 2002, J BIOL CHEM, V277, P15345, DOI 10.1074/jbc.M111379200; Clarke S., 2006, PROTEIN METHYLTRANSF, V24, P1; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y; Demirci H, 2007, EMBO J, V26, P567, DOI 10.1038/sj.emboj.7601508; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; DOGNIN MJ, 1980, EUR J BIOCHEM, V112, P131, DOI 10.1111/j.1432-1033.1980.tb04995.x; Dong C, 2015, GENE DEV, V29, P2343, DOI 10.1101/gad.270611.115; Drozak J, 2015, J BIOL CHEM, V290, P17190, DOI 10.1074/jbc.M115.640037; Dzialo MC, 2014, J BIOL CHEM, V289, P30511, DOI 10.1074/jbc.M114.605527; Erce MA, 2013, PROTEOMICS, V13, P1059, DOI 10.1002/pmic.201200477; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Gratenstein K, 2005, GENOMICS, V85, P762, DOI 10.1016/j.ygeno.2005.02.010; Hamey JJ, 2018, TRENDS BIOCHEM SCI, V43, P211, DOI 10.1016/j.tibs.2018.01.004; Hamey JJ, 2016, MOL CELL PROTEOMICS, V15, P164, DOI 10.1074/mcp.M115.052449; Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Jakobsson ME, 2018, RNA BIOL, V15, P314, DOI 10.1080/15476286.2018.1440875; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Louie DF, 1996, J BIOL CHEM, V271, P28189, DOI 10.1074/jbc.271.45.28189; Low JKK, 2012, FEBS J, V279, P4423, DOI 10.1111/febs.12039; Lv FJ, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.37; Medvar B, 2016, PHYSIOL GENOMICS, V48, P502, DOI 10.1152/physiolgenomics.00031.2016; Meng FY, 2004, ANAL CHEM, V76, P2852, DOI 10.1021/ac0354903; Meskauskas A, 2010, NUCLEIC ACIDS RES, V38, P7800, DOI 10.1093/nar/gkq641; Mielecki D, 2015, MUTAT RES-REV MUTAT, V763, P294, DOI 10.1016/j.mrrev.2014.12.001; Migliori V, 2010, EPIGENOMICS-UK, V2, P119, DOI [10.2217/epi.09.39, 10.2217/EPI.09.39]; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Olsson I, 2007, EXP CELL RES, V313, P1778, DOI 10.1016/j.yexcr.2007.03.007; Petkowski JJ, 2013, BIOCHEM J, V456, P453, DOI 10.1042/BJ20131163; Petkowski JJ, 2012, BIOCHEMISTRY-US, V51, P5942, DOI 10.1021/bi300278f; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2008, J BIOL CHEM, V283, P15512; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Raposo AE, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0036-2; Rendon OZ, 2014, HUM MOL GENET, V23, P5159, DOI 10.1093/hmg/ddu239; Revenkova E, 1999, EMBO J, V18, P490, DOI 10.1093/emboj/18.2.490; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Richardson SL, 2015, J BIOL CHEM, V290, P11601, DOI 10.1074/jbc.M114.626846; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Sathyan KM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14678; Sayegh J, 2008, BIOCHEM BIOPH RES CO, V372, P811, DOI 10.1016/j.bbrc.2008.05.121; Schwalm EL, 2016, SCIENCE, V352, P309, DOI 10.1126/science.aad5367; Sengupta S, 2014, BBA-GEN SUBJECTS, V1840, P1861, DOI 10.1016/j.bbagen.2014.01.005; Shields KM, 2017, PROTEIN SCI, V26, P1639, DOI 10.1002/pro.3202; Shin HS, 2009, BIOCHEM BIOPH RES CO, V385, P273, DOI 10.1016/j.bbrc.2009.05.055; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343; Tooley JG, 2014, PROTEIN SCI, V23, P1641, DOI 10.1002/pro.2547; VANET A, 1994, MOL MICROBIOL, V14, P947, DOI 10.1111/j.1365-2958.1994.tb01330.x; Vlaming H, 2014, EMBO REP, V15, P1077, DOI 10.15252/embr.201438793; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P121; Wang CY, 2017, FEBS LETT, V591, P433, DOI 10.1002/1873-3468.12533; Webb KJ, 2011, J BIOL CHEM, V286, P18405, DOI 10.1074/jbc.M110.200410; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Wilson LJ, 2018, CANCER RES, V78, P15, DOI 10.1158/0008-5472.CAN-17-2291; Winter DL, 2018, J MOL BIOL, V430, P102, DOI 10.1016/j.jmb.2017.11.009; Wlodarski T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023168; Wu RX, 2015, GENE DEV, V29, P2337, DOI 10.1101/gad.270926.115; Wu ZR, 2017, FEBS J, V284, P2732, DOI 10.1111/febs.14056; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yang YZ, 2012, MOL CELL, V48, P487, DOI 10.1016/j.molcel.2012.11.007; Yao Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004522; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Yesselman JD, 2015, PROTEINS, V83, P403, DOI 10.1002/prot.24724; Young BD, 2012, BIOCHEMISTRY-US, V51, P5091, DOI 10.1021/bi300186g; Zhang G, 2015, ORG BIOMOL CHEM, V13, P4149, DOI 10.1039/c5ob00120j; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhang Y, 2016, J BIOL CHEM, V291, P20149, DOI 10.1074/jbc.M116.734079; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283	100	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10438	10446		10.1074/jbc.AW118.003235	http://dx.doi.org/10.1074/jbc.AW118.003235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29743234	Green Published, hybrid			2022-12-28	WOS:000437828400004
J	Knight, JM; Mandal, P; Morlacchi, P; Mak, G; Li, E; Madison, M; Landers, C; Saxton, B; Felix, E; Gilbert, B; Sederstrom, J; Varadhachary, A; Singh, MM; Chatterjee, D; Corry, DB; McMurray, JS				Knight, J. Morgan; Mandal, Pijus; Morlacchi, Pietro; Mak, Garbo; Li, Evan; Madison, Matthew; Landers, Cameron; Saxton, Brandon; Felix, Ed; Gilbert, Brian; Sederstrom, Joel; Varadhachary, Atul; Singh, Melissa M.; Chatterjee, Dev; Corry, David B.; McMurray, John S.			Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; STAT transcription factor; allergen; fungi; cytokine; peptidomimetic; SH2 domain; STAT5; STAT6	DOSE INHALED FLUTICASONE; INNATE LYMPHOID-CELLS; SIGNAL-TRANSDUCTION; CARNITINE HOMEOSTASIS; PHOSPHATASE SHP-1; INFLUENZA-VIRUS; ASTHMA; THERAPY; IL-4; INFLAMMATION	Asthma is a chronic inflammatory disease of the lungs and airways and one of the most burdensome of all chronic maladies. Previous studies have established that expression of experimental and human asthma requires the IL-4/IL-13/IL-4 receptor (IL-4R) signaling pathway, which activates the transcription factor STAT6. However, no small molecules targeting this important pathway are currently in clinical development. To this end, using a preclinical asthma model, we sought to develop and test a small-molecule inhibitor of the Src homology 2 domains in mouse and human STAT6. We previously developed multiple peptidomimetic compounds on the basis of blocking the docking site of STAT6 to IL-4R and phosphorylation of Tyr(641) in STAT6. Here, we expanded the scope of our initial in vitro structure-activity relationship studies to include central and C-terminal analogs of these peptides to develop a lead compound, PM-43I. Conducting initial dose range, toxicity, and pharmacokinetic experiments with PM-43I, we found that it potently inhibits both STAT5- and STAT6-dependent allergic airway disease in mice. Moreover, PM-43I reversed preexisting allergic airway disease in mice with a minimum ED50 of 0.25 g/kg. Of note, PM-43I was efficiently cleared through the kidneys with no long-term toxicity. We conclude that PM-43I represents the first of a class of small molecules that may be suitable for further clinical development against asthma.	[Knight, J. Morgan; Mak, Garbo; Li, Evan; Corry, David B.] Baylor Coll Med, Dept Med, 1 Baylor Plaza,BCM285, Houston, TX 77030 USA; [Knight, J. Morgan; Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Saxton, Brandon; Gilbert, Brian] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Madison, Matthew; Landers, Cameron; Corry, David B.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Li, Evan; Corry, David B.] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Mandal, Pijus; Morlacchi, Pietro; Felix, Ed; McMurray, John S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Sederstrom, Joel] Baylor Coll Med, Flow Cytometry Core Facil, Houston, TX USA; [Corry, David B.] Michael E Debakey Vet Affairs Ctr Translat Res In, Houston, TX 77030 USA; [Varadhachary, Atul; Singh, Melissa M.; Chatterjee, Dev] Fannin Innovat Studio & Atrapos Therapeut LLC, Houston, TX 77027 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Knight, JM; Corry, DB (corresponding author), Baylor Coll Med, Dept Med, 1 Baylor Plaza,BCM285, Houston, TX 77030 USA.	JMK@bcm.edu; dcorry@bcm.edu		Madison, Matthew/0000-0001-8143-7471; Landers, Cameron/0000-0002-1507-282X	National Institutes of Health [R41AI25007, R01 HL117181]; Veterans Affairs Office of Research and Development [I01BX002221, I01 CX001673]; American Asthma Foundation; Biology of Inflammation Center, Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI125007] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Office of Research and Development; American Asthma Foundation; Biology of Inflammation Center, Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study was funded by National Institutes of Health Grants R41AI25007 and R01 HL117181, Veterans Affairs Office of Research and Development Grants I01BX002221 and I01 CX001673, the American Asthma Foundation, and the Biology of Inflammation Center, Baylor College of Medicine. J.M.K., P. Mandal, P. Morlacchi, D.B.C., and Atrapos Therapeutics, LLC hold intellectual property rights in compound PM-43I. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed CMI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00183; Arima K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000567; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Board on Environmental Studies and Toxicology Division on Earth and Life Sciences National Research Council, 2014, REV FORM ASS NAT TOX; Brass EP, 2002, PHARMACOL REV, V54, P589, DOI 10.1124/pr.54.4.589; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; Cates C. J., 2012, COCHRANE DATABASE SY; Chang GH, 2013, AM J OTOLARYNG, V34, P743, DOI 10.1016/j.amjoto.2013.07.016; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Duerr CU, 2016, CYTOKINE, V87, P1, DOI 10.1016/j.cyto.2016.01.018; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fairfax AJ, 1999, THORAX, V54, P860, DOI 10.1136/thx.54.9.860; Gavino AC, 2016, ALLERGY, V71, P1684, DOI 10.1111/all.12937; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HALLER O, 1979, J EXP MED, V149, P601, DOI 10.1084/jem.149.3.601; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hao YH, 2014, INFECT IMMUN, V82, P5246, DOI 10.1128/IAI.01989-14; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Helman D, 1998, FEBS LETT, V441, P287, DOI 10.1016/S0014-5793(98)01555-5; Hoffmann F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00107; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Iwasaki A, 2017, NAT REV IMMUNOL, V17, P7, DOI 10.1038/nri.2016.117; Jia YY, 2013, BASIC CLIN PHARMACOL, V113, P431, DOI 10.1111/bcpt.12112; Kabata H, 2015, ALLERGOL INT, V64, P227, DOI 10.1016/j.alit.2015.03.004; Knight JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142212; Knight JM, 2014, J ALLERGY CLIN IMMUN, V133, P189, DOI 10.1016/j.jaci.2013.03.049; KNIGHT V, 1988, EUR J CLIN MICROBIOL, V7, P721, DOI 10.1007/BF01975037; Knight V, 1987, Infect Dis Clin North Am, V1, P441; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; LAVROV SV, 1968, NATURE, V217, P856, DOI 10.1038/217856a0; Leav BA, 2000, NEW ENGL J MED, V343, P586, DOI 10.1056/NEJM200008243430818; Lee SH, 2008, J IMMUNOL, V180, P4656, DOI 10.4049/jimmunol.180.7.4656; Losman JA, 1999, J IMMUNOL, V162, P3770; Mandal PK, 2015, J MED CHEM, V58, P8970, DOI 10.1021/acs.jmedchem.5b01321; Mandal PK, 2011, J MED CHEM, V54, P3549, DOI 10.1021/jm2000882; Mandal PK, 2009, ORG LETT, V11, P3394, DOI 10.1021/ol9012662; McDonald VM, 2017, RESPIROLOGY, V22, P53, DOI 10.1111/resp.12957; McMurray John S, 2012, JAKSTAT, V1, P263, DOI 10.4161/jkst.22682; Mitkus RJ, 2013, VACCINE, V31, P2738, DOI 10.1016/j.vaccine.2013.03.071; Miyata S, 1999, CLIN EXP ALLERGY, V29, P114; Morlacchi P, 2014, ACS MED CHEM LETT, V5, P69, DOI 10.1021/ml4003919; Patnaik A, 2002, CLIN CANCER RES, V8, P2142; Peter E, 2002, CLIN INFECT DIS, V35, pE54, DOI 10.1086/341971; Peters MC, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0651-4; PHALEN RF, 1984, INHALATION STUDIES F, P211; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Porter PC, 2014, J ALLERGY CLIN IMMUN, V134, P325, DOI 10.1016/j.jaci.2014.04.028; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; SCHLESINGER RB, 1985, J TOXICOL ENV HEALTH, V15, P197, DOI 10.1080/15287398509530647; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Tan HTT, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0650-5; Uehara Y, 2015, CIRC J, V79, P2523, DOI 10.1253/circj.CJ-15-0960; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077795; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Zhu JF, 2010, IMMUNOL CELL BIOL, V88, P244, DOI 10.1038/icb.2009.114	63	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10026	10040		10.1074/jbc.RA117.000567	http://dx.doi.org/10.1074/jbc.RA117.000567			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29739850	hybrid, Green Published			2022-12-28	WOS:000437096700008
J	Punch, EK; Hover, S; Blest, HTW; Fuller, J; Hewson, R; Fontana, J; Mankouri, J; Barr, JN				Punch, Emma K.; Hover, Samantha; Blest, Henry T. W.; Fuller, Jack; Hewson, Roger; Fontana, Juan; Mankouri, Jamel; Barr, John N.			Potassium is a trigger for conformational change in the fusion spike of an enveloped RNA virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virus entry; fusion protein; electron tomography; conformational change; potassium transport; ion channel; virus structure	HEMORRHAGIC-FEVER VIRUS; CRYSTAL-STRUCTURE; CRYOELECTRON TOMOGRAPHY; ELECTRON-MICROSCOPY; GLYCOPROTEIN; ENTRY; PH; BUNYAVIRUSES; CLATHRIN; PROTEIN	Many enveloped viruses enter cells through the endocytic network, from which they must subsequently escape through fusion of viral and endosomal membranes. This membrane fusion is mediated by virus-encoded spikes that respond to the dynamic endosomal environment, which triggers conformational changes in the spikes that initiate the fusion process. Several fusion triggers have been identified and include pH, membrane composition, and endosome-resident proteins, and these cues dictate when and where viral fusion occurs. We recently reported that infection with an enveloped bunyavirus requires elevated potassium ion concentrations [K+], controlled by cellular K+ channels, that are encountered during viral transit through maturing endosomes. Here we reveal the molecular basis for the K+ requirement of bunyaviruses through the first direct visualization of a member of the Nairoviridae family, namely Hazara virus (HAZV), using cryo-EM. Using cryo-electron tomography, we observed HAZV spike glycoproteins within infectious HAZV particles exposed to both high and low [K+], which showed that exposure to K+ alone results in dramatic changes to the ultrastructural architecture of the virion surface. In low [K+], the spikes adopted a compact conformation arranged in locally ordered arrays, whereas, following exposure to high [K+], the spikes became extended, and spike-membrane interactions were observed. Viruses exposed to high [K+] also displayed enhanced infectivity, thus identifying K+ as a newly defined trigger that helps promote viral infection. Finally, we confirmed that K+ channel blockers are inhibitory to HAZV infection, highlighting the potential of K+ channels as anti-bunyavirus targets.	[Punch, Emma K.; Hover, Samantha; Blest, Henry T. W.; Fuller, Jack; Fontana, Juan; Mankouri, Jamel; Barr, John N.] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Fontana, Juan; Mankouri, Jamel; Barr, John N.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Fuller, Jack; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England	University of Leeds; University of Leeds; Public Health England	Barr, JN (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.; Barr, JN (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	j.n.barr@leeds.ac.uk	Fontana, Juan/A-9138-2009	Fontana, Juan/0000-0002-9084-2927; Hover, Samantha/0000-0001-9190-5670; barr, john/0000-0002-9035-2039; Mankouri, Jamel/0000-0002-4325-3687	Wellcome Trust [108466/Z/15/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Microscopes were funded by the Wellcome Trust (108466/Z/15/Z). We also thank Dr. Emma L. Hesketh and Dr. Rebecca F. Thompson of The University of Leeds for cryo-EM data acquisition.	Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y; Apellaniz B, 2014, CHEM PHYS LIPIDS, V181, P40, DOI 10.1016/j.chemphyslip.2014.03.003; Battisti AJ, 2011, J VIROL, V85, P835, DOI 10.1128/JVI.01847-10; Bergeron E, 2007, J VIROL, V81, P13271, DOI 10.1128/JVI.01647-07; Bitto D, 2016, J BIOL CHEM, V291, P6412, DOI 10.1074/jbc.M115.691113; Bowden TA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003374; de Boer SM, 2012, J VIROL, V86, P13767, DOI 10.1128/JVI.01364-12; Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110; Dube M, 2016, J VIROL, V90, P6303, DOI 10.1128/JVI.00634-16; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Estrada-Pena A, 2013, J APPL MICROBIOL, V114, P278, DOI 10.1111/jam.12039; Freiberg AN, 2008, J VIROL, V82, P10341, DOI 10.1128/JVI.01191-08; Garrison AR, 2013, VIROLOGY, V444, P45, DOI 10.1016/j.virol.2013.05.030; Guardado-Calvo P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005813; Halldorsson S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02789-2; Halldorsson S, 2016, P NATL ACAD SCI USA, V113, P7154, DOI 10.1073/pnas.1603827113; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845; Hover S, 2016, J BIOL CHEM, V291, P3411, DOI 10.1074/jbc.M115.692673; Huiskonen JT, 2010, J VIROL, V84, P4889, DOI 10.1128/JVI.00057-10; Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Li S, 2016, CELL REP, V16, P278, DOI 10.1016/j.celrep.2016.06.039; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Sherman MB, 2009, VIROLOGY, V387, P11, DOI 10.1016/j.virol.2009.02.038; Shtanko O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004390; Simon M, 2009, J GEN VIROL, V90, P210, DOI 10.1099/vir.0.006387-0; Stauffer S, 2014, J VIROL, V88, P13029, DOI 10.1128/JVI.01430-14; SULEIMAN MNEH, 1980, LANCET, V2, P939; Surtees R, 2015, BMC STRUCT BIOL, V15, DOI 10.1186/s12900-015-0051-3; TALMON Y, 1987, J VIROL, V61, P2319, DOI 10.1128/JVI.61.7.2319-2321.1987; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Wang WM, 2015, J VIROL, V89, P11740, DOI 10.1128/JVI.01680-15; Willensky S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005948; Xiong QR, 2009, J STRUCT BIOL, V168, P378, DOI 10.1016/j.jsb.2009.08.016; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhu Y., 2018, J VIROL, V92	43	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9937	9944		10.1074/jbc.RA118.002494	http://dx.doi.org/10.1074/jbc.RA118.002494			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29678879	Green Published, hybrid			2022-12-28	WOS:000437096700001
J	Shahzad, MMK; Arevalo, JM; Armaiz-Pena, GN; Lu, CH; Stone, RL; Moreno-Smith, M; Nishimura, M; Lee, JW; Jennings, NB; Bottsford-Miller, J; Vivas-Mejia, P; Lutgendorf, SK; Lopez-Berestein, G; Bar-Eli, M; Cole, SW; Sood, AK				Shahzad, Mian M. K.; Arevalo, Jesusa M.; Armaiz-Pena, Guillermo N.; Lu, Chunhua; Stone, Rebecca L.; Moreno-Smith, Myrthala; Nishimura, Masato; Lee, Jeong-Won; Jennings, Nicholas B.; Bottsford-Miller, Justin; Vivas-Mejia, Pablo; Lutgendorf, Susan K.; Lopez-Berestein, Gabriel; Bar-Eli, Menashe; Cole, Steven W.; Sood, Anil K.			Stress effects on FosB and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis (vol 285, pg 35462, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Sood, Anoop Kumar/A-7344-2013	Sood, Anoop Kumar/0000-0001-5702-4108	NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA086862] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Shahzad MMK, 2010, J BIOL CHEM, V285, P35462, DOI 10.1074/jbc.M110.109579	1	5	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10041	10041		10.1074/jbc.AAC118.004299	http://dx.doi.org/10.1074/jbc.AAC118.004299			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29959278	Green Published, hybrid			2022-12-28	WOS:000437096700009
J	Macek, P; Cliff, MJ; Embrey, KJ; Holdgate, GA; Nissink, JWM; Panova, S; Waltho, JP; Davies, RA				Macek, Pavel; Cliff, Matthew J.; Embrey, Kevin J.; Holdgate, Geoffrey A.; Nissink, J. Willem M.; Panova, Stanislava; Waltho, Jonathan P.; Davies, Rick A.			Myc phosphorylation in its basic helix-loop-helix region destabilizes transient -helical structures, disrupting Max and DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered protein; Myc (c-Myc); protein phosphorylation; protein dynamic; protein-protein interaction; biophysics	PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; BURKITT-LYMPHOMA CELLS; COPY-NUMBER ALTERATION; C-MYC; TRANSCRIPTION FACTORS; GENE; KINASE; SET; THERMODYNAMICS	Myelocytomatosis proto-oncogene transcription factor (Myc) is an intrinsically disordered protein with critical roles in cellular homeostasis and neoplastic transformation. It is tightly regulated in the cell, with Myc phosphorylation playing a major role. In addition to the well-described tandem phosphorylation of Thr-52 and Ser-62 in the Myc transactivation domain linked to its degradation, P21 (RAC1)-activated kinase 2 (PAK2)-mediated phosphorylation of serine and threonine residues in the C-terminal basic helix-loop-helix leucine zipper (bHLH-LZ) region regulates Myc transcriptional activity. Here we report that PAK2 preferentially phosphorylates Myc twice, at Thr-358 and Ser-373, with only a minor fraction being modified at the previously identified Thr-400 site. For transcriptional activity, Myc binds E-box DNA elements, requiring its heterodimerization with Myc-associated factor X (Max) via the bHLH-LZ regions. Using isothermal calorimetry (ITC), we found that Myc phosphorylation destabilizes this ternary protein-DNA complex by decreasing Myc's affinity for Max by 2 orders of magnitude, suggesting a major effect of phosphorylation on this complex. Phosphomimetic substitutions revealed that Ser-373 dominates the effect on Myc-Max heterodimerization. Moreover, a T400D substitution disrupted Myc's affinity for Max. ITC, NMR, and CD analyses of several Myc variants suggested that the effect of phosphorylation on the Myc-Max interaction is caused by secondary structure disruption during heterodimerization rather than by a change in the structurally disordered state of Myc or by phosphorylation-induced electrostatic repulsion in the heterodimer. Our findings provide critical insights into the effects of PAK2-catalyzed phosphorylation of Myc on its interactions with Max and DNA.	[Macek, Pavel; Davies, Rick A.] AstraZeneca, IMED Discovery Sci, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Embrey, Kevin J.; Holdgate, Geoffrey A.] AstraZeneca, IMED Discovery Sci, Cambridge CB4 0WG, England; [Nissink, J. Willem M.] AstraZeneca, IMED Oncol, Cambridge CB4 0WG, England; [Cliff, Matthew J.; Panova, Stanislava; Waltho, Jonathan P.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Cliff, Matthew J.; Panova, Stanislava; Waltho, Jonathan P.] Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England; [Macek, Pavel] NMR Bio SAS, CS 10090, F-38044 Grenoble, France	AstraZeneca; AstraZeneca; AstraZeneca; University of Manchester; University of Manchester	Davies, RA (corresponding author), AstraZeneca, IMED Discovery Sci, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.; Macek, P (corresponding author), NMR Bio SAS, CS 10090, F-38044 Grenoble, France.	macek@nmr-bio.com; rick.davies@astrazeneca.com	Nissink, J. Willem M./C-1507-2010	Nissink, J. Willem M./0000-0003-2572-9140; Macek, Pavel/0000-0003-3774-7717; Cliff, Matthew/0000-0002-7482-0234; Panova, Stanislava/0000-0002-9331-5962; Waltho, Jonathan/0000-0002-7402-5492	Discovery Sciences grant from the AstraZeneca Post-Doctoral Programme; Bruker BioSpin; BBSRC [BB/K016245/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [974872, BB/K016245/1] Funding Source: researchfish	Discovery Sciences grant from the AstraZeneca Post-Doctoral Programme; Bruker BioSpin; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Discovery Sciences grant from the AstraZeneca Post-Doctoral Programme (to P. M.) and a student fellowship from Bruker BioSpin (to S. P.). The work described here was initiated as a project within AstraZeneca. K. J. E., R. A. D., G. A. H., and J. W. M. N. are current employees of AstraZeneca and may hold stock in the company. P. M. is a former employee of AstraZeneca and may hold stock in the company.	Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P2333, DOI 10.1021/bi0522551; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Dang CV, 1999, MOL CELL BIOL, V19, P1; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Fletcher JM, 2012, ACS SYNTH BIOL, V1, P240, DOI 10.1021/sb300028q; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gundry Rebekah L, 2009, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1025s88; Hart JR, 2014, P NATL ACAD SCI USA, V111, P12556, DOI 10.1073/pnas.1319488111; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Janes RW., 2009, MODERN TECHNIQUES CI, P183; Jung KC, 2005, BIOCHEM BIOPH RES CO, V334, P269, DOI 10.1016/j.bbrc.2005.06.088; Jung LA, 2017, ONCOGENE, V36, P1911, DOI 10.1038/onc.2016.354; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Krylov D., 2001, ELS, DOI [10.1038/npg.els.0003001, DOI 10.1038/NPG.ELS.0003001]; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; LANG JC, 1988, BRIT J CANCER, V58, P62; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Lienin SF, 1998, J AM CHEM SOC, V120, P9870, DOI 10.1021/ja9810179; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Meier-Andrejszki L, 2007, BIOCHEMISTRY-US, V46, P12427, DOI 10.1021/bi701081q; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Shi J, 2009, BIOORG MED CHEM LETT, V19, P6038, DOI 10.1016/j.bmcl.2009.09.044; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Uribesalgo I, 2011, NAT CELL BIOL, V13, P1443, DOI 10.1038/ncb2355; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wasylishen AR, 2013, CANCER RES, V73, P6504, DOI 10.1158/0008-5472.CAN-12-4063; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhao HT, 2015, J CO2 UTIL, V11, P10, DOI 10.1016/j.jcou.2014.11.004	55	11	13	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9301	9310		10.1074/jbc.RA118.002709	http://dx.doi.org/10.1074/jbc.RA118.002709			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29695509	Green Published, hybrid			2022-12-28	WOS:000435441400016
J	Mitsche, MA; Hobbs, HH; Cohen, JC				Mitsche, Michael A.; Hobbs, Helen H.; Cohen, Jonathan C.			Patatin-like phospholipase domain-containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets (vol 293, pg 6958, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NIDDK NIH HHS [R01 DK090066] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090066] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Mitsche MA, 2018, J BIOL CHEM, V293, P6958, DOI 10.1074/jbc.RA118.002333	1	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9232	9232		10.1074/jbc.AAC118.004058	http://dx.doi.org/10.1074/jbc.AAC118.004058			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29907731	Green Published, hybrid			2022-12-28	WOS:000435441400009
J	Li, HC; Zhang, PF; Zhang, QY; Li, CN; Zou, WG; Chang, ZJ; Cui, CP; Zhang, LQ				Li, Hongchang; Zhang, Pengfei; Zhang, Qiuyue; Li, Chaonan; Zou, Weiguo; Chang, Zhijie; Cui, Chun-Ping; Zhang, Lingqiang			WWP2 is a physiological ubiquitin ligase for phosphatase and tensin homolog (PTEN) in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMLINE MUTATIONS; TUMOR-SUPPRESSOR; AXON REGENERATION; COWDEN DISEASE; NUCLEAR PTEN; GENE; PTEN/MMAC1; BREAST; CANCER; STABILITY	The tumor suppressor phosphatase and tensin homolog (PTEN) plays a central role in regulating phosphatidylinositol 3-kinase (PI3K) signaling, and its gene is very frequently mutated in various human cancers. Numerous studies have revealed that PTEN levels are tightly regulated by both transcriptional and posttranslational modifications, with especially ubiquitylation significantly regulating PTEN protein levels. Although several ubiquitin ligases have been reported to mediate PTEN ubiquitylation in vitro, the ubiquitin ligase that promotes PTEN degradation in vivo has not been reported. Here we took advantage of specific knockout mouse models to demonstrate that WW domain-containing E3 ubiquitin protein ligase 2 (WWP2) promotes PTEN degradation under physiological conditions, whereas another ubiquitin ligase, carboxyl terminus of Hsp70-interacting protein (CHIP), had no such effect. WWP2 knockout mice exhibited reduced body size, elevated PTEN protein levels, and reduced phosphorylation levels of the serine/threonine kinase and PTEN target AKT. In contrast, we observed no elevation of PTEN protein levels in CHIP knockout tissues and mouse embryonic fibroblasts. Furthermore, PTEN protein levels in CHIP/WWP2 double knockout mice were very similar to those in WWP2 single knockout mice and significantly higher than in WT and CHIP knockout mice. Our results demonstrate that WWP2, rather than CHIP, is an ubiquitin ligase that promotes PTEN degradation in vivo. Considering PTEN's significant role in tumor development, we propose that WWP2 may be a potential target for fine-tuning PTEN levels in anticancer therapies.	[Li, Hongchang; Zhang, Pengfei; Zhang, Qiuyue; Li, Chaonan; Cui, Chun-Ping; Zhang, Lingqiang] Beijing Inst Life, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing 102206, Peoples R China; [Zhang, Lingqiang] Southern Med Univ, Shanghai Fengxian Cent Hosp Grad Training Base, Dept Gen Surg, Fengxian Hosp, Shanghai 201400, Peoples R China; [Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Chang, Zhijie] Tsinghua Univ, Sch Med, Dept Basic Med Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China	Southern Medical University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tsinghua University	Cui, CP; Zhang, LQ (corresponding author), Beijing Inst Life, 27 Taiping Rd, Beijing 100850, Peoples R China.	cui_chunping2000@aliyun.com; zhanglq@nic.bmi.ac.cn	Chang, Zhijie/AAH-8109-2019	Chang, Zhijie/0000-0003-1567-3227	National Natural Science Foundation of China [31330021]; Beijing Natural Science Foundation Project [Z151100003915083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Project(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (Grant 31330021) and Beijing Natural Science Foundation Project (Z151100003915083). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sutphen R, 1999, AM J MED GENET, V82, P290, DOI 10.1002/(SICI)1096-8628(19990212)82:4<290::AID-AJMG3>3.0.CO;2-0; Tawo R, 2017, CELL, V169, P470, DOI 10.1016/j.cell.2017.04.003; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	27	16	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8886	8899		10.1074/jbc.RA117.001060	http://dx.doi.org/10.1074/jbc.RA117.001060			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29685889	Green Published, hybrid			2022-12-28	WOS:000434941900013
J	Long, NE; Sullivan, BJ; Ding, HM; Doll, S; Ryan, MA; Hitchcock, CL; Martin, EW; Kumar, K; Tweedle, MF; Magliery, TJ				Long, Nicholas E.; Sullivan, Brandon J.; Ding, Haiming; Doll, Stephanie; Ryan, Michael A.; Hitchcock, Charles L.; Martin, Edward W., Jr.; Kumar, Krishan; Tweedle, Michael F.; Magliery, Thomas J.			Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN-FV; SCFV MULTIMERS; V-H; CANCER; EXPRESSION; STABILITY; DIABODIES; CC49; BIODISTRIBUTION; PROTEINS	Antibody (Ab) fragments have great clinical potential as cancer therapeutics and diagnostics. Their small size allows for fast clearance from blood, low immunoreactivity, better tumor penetration, and simpler engineering and production. The smallest fragment derived from a full-length IgG that retains binding to its antigen, the single-chain variable fragment (scF(V)), is engineered by fusing the variable light and variable heavy domains with a peptide linker. Along with switching the domain orientation, altering the length and amino acid sequence of the linker can significantly affect scF(V) binding, stability, quaternary structure, and other biophysical properties. Comprehensive studies of these attributes in a single scaffold have not been reported, making design and optimization of Ab fragments challenging. Here, we constructed libraries of 3E8, an Ab specific to tumor-associated glycoprotein 72 (TAG-72), a mucinous glycoprotein overexpressed in 80% of adenocarcinomas. We cloned, expressed, and characterized scF(V) s, diabodies, and higher-order multimer constructs with varying linker compositions, linker lengths, and domain orientations. These constructs dramatically differed in their oligomeric states and stabilities, not only because of linker and orientation but also related to the purification method. For example, protein L-purified constructs tended to have broader distributions and higher oligomeric states than has been reported previously. From this library, we selected an optimal construct, 3E8.G(4)S, for biodistribution and pharmacokinetic studies and in vivo xenograft mouse PET imaging. These studies revealed significant tumor targeting of 3E8.G(4)S with a tumor-to-background ratio of 29:1. These analyses validated 3E8.G(4)S as a fast, accurate, and specific tumor-imaging agent.	[Long, Nicholas E.; Sullivan, Brandon J.; Ryan, Michael A.; Magliery, Thomas J.] Ohio State Univ, Coll Med, Dept Chem & Biochem, Columbus, OH 43210 USA; [Long, Nicholas E.; Ryan, Michael A.] Ohio State Univ, Coll Med, Ohio State Biochem Program, Columbus, OH 43210 USA; [Ding, Haiming; Doll, Stephanie; Kumar, Krishan; Tweedle, Michael F.] Ohio State Univ, Coll Med, Lab Translat Res Imaging Pharmaceut, Wright Ctr Innovat Biomed Imaging,Dept Radiol, Columbus, OH 43210 USA; [Hitchcock, Charles L.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Martin, Edward W., Jr.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Magliery, TJ (corresponding author), Dept Chem & Biochem, 100 W 18th Ave, Columbus, OH 43210 USA.	magliery.1@osu.edu			Enlyton, Ltd.; National Institutes of Health [R01 GM083114]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083114, T32GM086252] Funding Source: NIH RePORTER	Enlyton, Ltd.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a research contract from Enlyton, Ltd. (to T. J. M. and M. F. T.). Protein stability studies were supported by National Institutes of Health Grant R01 GM083114 (to T. J. M.). N. E. L, B. J. S., C. L. H., E. W. M., and T. J. M. are inventors on patents related to this work that have been licensed by Enlyton, Ltd. E. W. M. and T. J. M. are officers of Enlyton, Ltd., and C. L. H., E. W. M., and T. J. M. are shareholders of Enlyton, Ltd. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALFTHAN K, 1995, PROTEIN ENG, V8, P725, DOI 10.1093/protein/8.7.725; Atwell JL, 1999, PROTEIN ENG, V12, P597, DOI 10.1093/protein/12.7.597; Bailey G. S., 1996, LODOGEN METHOD RADIO; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Cuesta AM, 2012, MABS-AUSTIN, V4, P226, DOI 10.4161/mabs.4.2.19140; DESPLANCQ D, 1994, PROTEIN ENG, V7, P1027, DOI 10.1093/protein/7.8.1027; Dolezal O, 2000, PROTEIN ENG, V13, P565, DOI 10.1093/protein/13.8.565; DORAI H, 1994, BIO-TECHNOL, V12, P890, DOI 10.1038/nbt0994-890; Durani V, 2012, PROTEIN EXPRES PURIF, V85, P9, DOI 10.1016/j.pep.2012.06.007; Goel A, 2001, J NUCL MED, V42, P1519; Goel A, 2000, CANCER RES, V60, P6964; Gong L, 2018, MOL IMAGING BIOL, V20, P47, DOI 10.1007/s11307-017-1096-4; Hitchcock C. L., 2017, CLIN SURG, V2, P1491; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; HUSTON JS, 1991, METHOD ENZYMOL, V203, P46; Julien S, 2012, BIOMOLECULES, V2, P435, DOI 10.3390/biom2040435; KING DJ, 1993, BIOCHEM J, V290, P723, DOI 10.1042/bj2900723; Kora A. A., 1997, PROTEIN ENG, V10, P423; Mammen JMV, 2007, AM J SURG, V194, P349, DOI 10.1016/j.amjsurg.2006.08.092; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moran N, 2011, NAT BIOTECHNOL, V29, P5, DOI 10.1038/nbt0111-5; PANTOLIANO MW, 1991, BIOCHEMISTRY-US, V30, P10117, DOI 10.1021/bi00106a007; Pavlinkova G, 1999, J NUCL MED, V40, P1536; PLUCKTHUN A, 1991, BIO-TECHNOL, V9, P545, DOI 10.1038/nbt0691-545; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shankar LK, 2006, J NUCL MED, V47, P1059; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tang Y, 1996, J BIOL CHEM, V271, P15682, DOI 10.1074/jbc.271.26.15682; Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Yoon SO, 2006, J BIOL CHEM, V281, P6985, DOI 10.1074/jbc.M511165200	34	11	14	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9030	9040		10.1074/jbc.RA118.002538	http://dx.doi.org/10.1074/jbc.RA118.002538			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29669811	hybrid, Green Published			2022-12-28	WOS:000434941900025
J	McAvoy, CZ; Siegel, A; Piszkiewicz, S; Miaou, E; Yu, MS; Nguyen, T; Moradian, A; Sweredoski, MJ; Hess, S; Shan, SO				McAvoy, Camille Z.; Siegel, Alex; Piszkiewicz, Samantha; Miaou, Emily; Yu, Mansen; Thang Nguyen; Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja; Shan, Shu-Ou			Two distinct sites of client protein interaction with the chaperone cpSRP43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; CHLOROPLAST SRP; POSTTRANSLATIONAL INTEGRATION; REPEAT PROTEINS; STRESS-PROTEINS; SUBSTRATE; BINDING; AGGREGATE; COMPLEX; ACTIVATION	Integral membrane proteins are prone to aggregation and misfolding in aqueous environments and therefore require binding by molecular chaperones during their biogenesis. Chloroplast signal recognition particle 43 (cpSRP43) is an ATP-independent chaperone required for the biogenesis of the most abundant class of membrane proteins, the light-harvesting chlorophyll a/b-binding proteins (LHCPs). Previous work has shown that cpSRP43 specifically recognizes an L18 loop sequence conserved amongLHCPparalogs. However, howcpSRP43 protects the transmembrane domains (TMDs) of LHCP from aggregation was unclear. In this work, alkylation-protection and site-specific cross-linking experiments found that cpSRP43 makes extensive contacts with all the TMDs in LHCP. Site-directed mutagenesis identified a class of cpSRP43 mutants that bind tightly to the L18 sequence but are defective in chaperoning full-length LHCP. These mutations mapped to hydrophobic surfaces on or near the bridging helix and the beta-hairpins lining the ankyrin repeat motifs of cpSRP43, suggesting that these regions are potential sites for interaction with the client TMDs. Our results suggest a working model for client protein interactions in this membrane protein chaperone.	[McAvoy, Camille Z.; Siegel, Alex; Piszkiewicz, Samantha; Miaou, Emily; Yu, Mansen; Thang Nguyen; Shan, Shu-Ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja] CALTECH, Proteome Explorat Lab, Pasadena, CA 91125 USA; [Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Piszkiewicz, Samantha] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Yu, Mansen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Thang Nguyen] Mt San Antonio Coll, Dept Chem, Walnut, CA 91789 USA; [Hess, Sonja] Medimmune Inc, Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; McGill University; AstraZeneca; Medimmune	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu		Yu, Mansen/0000-0002-1353-4154; Siegel, Alexander/0000-0003-3601-5178; Piszkiewicz, Samantha/0000-0003-4391-776X	Betty and Gordon Moore Foundation [94-3397785]; National Institutes of Health [R01 GM114390, 2 T32 GM 7616-36]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, R01GM114390] Funding Source: NIH RePORTER	Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Betty and Gordon Moore Foundation Grant 94-3397785 and National Institutes of Health Grant R01 GM114390 (to S.-o. S.) and by National Institutes of Health Training Grant 2 T32 GM 7616-36 (to C. Z. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrick D, 2008, CURR OPIN STRUC BIOL, V18, P27, DOI 10.1016/j.sbi.2007.12.004; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Cain P, 2011, BIOCHEM J, V437, P149, DOI 10.1042/BJ20110270; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DESHAIES RJ, 1988, TRENDS BIOCHEM SCI, V13, P384, DOI 10.1016/0968-0004(88)90180-6; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; Eichacker LA, 2001, BBA-MOL CELL RES, V1541, P120, DOI 10.1016/S0167-4889(01)00151-3; Falk S, 2010, J BIOL CHEM, V285, pLE25, DOI 10.1074/jbc.L110.160093; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Gao F, 2015, J BIOL CHEM, V290, P15462, DOI 10.1074/jbc.M114.624346; Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200; Horn R, 2002, J MOL BIOL, V318, P547, DOI 10.1016/S0022-2836(02)00115-8; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Jaru-Ampornpan P, 2013, J BIOL CHEM, V288, P13431, DOI 10.1074/jbc.M113.462861; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jonas-Straube E, 2001, J BIOL CHEM, V276, P24654, DOI 10.1074/jbc.M100153200; Kikani CK, 2010, J BIOL CHEM, V285, P41034, DOI 10.1074/jbc.M110.157594; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Liang FC, 2016, P NATL ACAD SCI USA, V113, pE1615, DOI 10.1073/pnas.1524777113; Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738; Mihara K, 1996, TRENDS CELL BIOL, V6, P104, DOI 10.1016/0962-8924(96)81000-2; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nguyen TX, 2013, J BIOL CHEM, V288, P13420, DOI 10.1074/jbc.M113.462812; Nguyen TX, 2011, BIOCHEMISTRY-US, V50, P7208, DOI 10.1021/bi200742a; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; Peracchi A, 1998, RNA, V4, P1332, DOI 10.1017/S1355838298980979; Peracchi A, 1998, BIOCHEMISTRY-US, V37, P14765, DOI 10.1021/bi980867y; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Reinsberg D, 2000, BIOCHEMISTRY-US, V39, P14305, DOI 10.1021/bi001365z; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Saraogi I, 2011, J AM CHEM SOC, V133, P14936, DOI 10.1021/ja206626g; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schunemann D, 2004, CURR GENET, V44, P295, DOI 10.1007/s00294-003-0450-z; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Thoma J, 2015, NAT STRUCT MOL BIOL, V22, P795, DOI 10.1038/nsmb.3087; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Wang P., 2018, P NATL ACAD SCI US; Wittelsberger A, 2008, CHEM BIOL DRUG DES, V71, P380, DOI 10.1111/j.1747-0285.2008.00646.x; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028	52	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8861	8873		10.1074/jbc.RA118.002215	http://dx.doi.org/10.1074/jbc.RA118.002215			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29669809	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000434941900011
J	Mygind, KJ; Storiko, T; Freiberg, ML; Samsoe-Petersen, J; Schwarz, J; Andersen, OM; Kveiborg, M				Mygind, Kasper J.; Stoeriko, Theresa; Freiberg, Marie L.; Samsoe-Petersen, Jacob; Schwarz, Jeanette; Andersen, Olav M.; Kveiborg, Marie			Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; sorting nexin (SNX); endocytosis; trafficking; shedding	ALPHA CONVERTING-ENZYME; INDUCED DOWN-REGULATION; METALLOPROTEASE-DISINTEGRIN; PROSTATE-CANCER; BREAST-CANCER; SECRETED FORM; ENDOCYTOSIS; CLATHRIN; RECEPTOR; INTEGRIN	ADAM9 is an active member of the family of transmembrane ADAMs (a disintegrin and metalloproteases). It plays a role in processes such as bone formation and retinal neovascularization, and importantly, its expression in human cancers correlates with disease stage and poor prognosis. Functionally, ADAM9 can cleave several transmembrane proteins, thereby shedding their ectodomains from the cell surface. Moreover, ADAM9 regulates cell behavior by binding cell-surface receptors such as integrin and membrane-type matrix metalloproteases. Because these functions are mainly restricted to the cell surface, understanding the mechanisms regulating ADAM9 localization and activity at this site is highly important. To this end, we here investigated how intracellular trafficking regulates ADAM9 availability at the cell surface. We found that ADAM9 undergoes constitutive clathrin-dependent internalization and subsequent degradation or recycling to the plasma membrane. We confirmed previous findings of an interaction between ADAM9 and the intracellular sorting protein, sorting nexin 9 (SNX9), as well as its close homolog SNX18. Knockdown of either SNX9 or SNX18 had no apparent effects on ADAM9 internalization or recycling. However, double knockdown of SNX9 and SNX18 decreased ADAM9 internalization significantly, demonstrating a redundant role in this process. Moreover, SNX9 knockdown revealed a nonredundant effect on overall ADAM9 protein levels, resulting in increased ADAM9 levels at the cell surface, and a corresponding increase in the shedding of Ephrin receptor B4, a well-known ADAM9 substrate. Together, our findings demonstrate that intracellular SNX9-mediated trafficking constitutes an important ADAM9 regulatory pathway.	[Mygind, Kasper J.; Stoeriko, Theresa; Freiberg, Marie L.; Samsoe-Petersen, Jacob; Schwarz, Jeanette; Kveiborg, Marie] Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Andersen, Olav M.] Aarhus Univ, Danish Res Inst Translat Neurosci DANDRITE Nord E, Dept Biomed, Ole Worms Alle 3, DK-8000 Aarhus C, Denmark; [Mygind, Kasper J.] PSL Res Univ, Inst Curie, CNRS, UMR144, 26 Rue Ulm, F-75005 Paris, France; [Stoeriko, Theresa] Humboldt Univ, Dept Biol, Fac Life Sci, Mol Parasitol, Philippstr 13,Haus 14, D-10115 Berlin, Germany; [Schwarz, Jeanette] Univ Hosp Schleswig Holstein, Inst Clin Chem, Campus Kiel,Arnold Heller Str 3, D-24105 Kiel, Germany; [Schwarz, Jeanette] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Campus Kiel,Arnold Heller Str 3, D-24105 Kiel, Germany	University of Copenhagen; Aarhus University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Humboldt University of Berlin; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Kveiborg, M (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	marie.kveiborg@sund.ku.dk	Kveiborg, Marie/AAM-3019-2020; Andersen, Olav/N-2777-2017	Kveiborg, Marie/0000-0002-1293-1019; Samsoe-Petersen, Jacob/0000-0001-9763-2175; Andersen, Olav/0000-0003-4226-3354; Storiko, Theresa/0000-0001-6253-5738	Danish Cancer Society; Lundbeck Foundation; Kobenhavns Universitets Fond for Kraeftforskning; Faculty of Health and Medical Sciences, University of Copenhagen	Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Kobenhavns Universitets Fond for Kraeftforskning; Faculty of Health and Medical Sciences, University of Copenhagen	The work was supported in part by The Danish Cancer Society, Lundbeck Foundation, and Kobenhavns Universitets Fond for Kraeftforskning. The authors declare that they have no conflicts of interest with the contents of this article. K. J. M. was supported by a Ph.D. fellowship from the Faculty of Health and Medical Sciences, University of Copenhagen.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; Bendris N., 2016, MOL BIOL CELL, DOI [10.1019/mbc.E16-02-0101, DOI 10.1019/MBC.E16-02-0101]; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Chan KM, 2012, DEV CELL, V22, P1176, DOI 10.1016/j.devcel.2012.04.014; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dombernowsky SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8518; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; English WR, 2012, BIOCHEM BIOPH RES CO, V421, P70, DOI 10.1016/j.bbrc.2012.03.113; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-179; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grutzmann R, 2004, BRIT J CANCER, V90, P1053, DOI 10.1038/sj.bjc.6601645; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Guo S, 2015, BBA-BIOMEMBRANES, V1848, P2101, DOI 10.1016/j.bbamem.2015.05.024; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Hotoda N, 2002, BIOCHEM BIOPH RES CO, V293, P800, DOI 10.1016/S0006-291X(02)00302-9; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Karadag A, 2006, BLOOD, V107, P3271, DOI 10.1182/blood-2005-09-3830; Linford A, 2012, DEV CELL, V22, P952, DOI 10.1016/j.devcel.2012.04.010; Lorenzen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35067; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Mao XY, 2011, AM J CANCER RES, V1, P604; Marcello E, 2013, J CLIN INVEST, V123, P2523, DOI 10.1172/JCI65401; Maretzky T, 2017, BIOCHEM J, V474, P1467, DOI 10.1042/BCJ20170075; Matthews AL, 2017, PLATELETS, V28, P333, DOI 10.1080/09537104.2016.1184751; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Monoranu CM, 2008, CANCER GENET CYTOGEN, V182, P18, DOI 10.1016/j.cancergencyto.2007.12.008; Nath D, 2000, J CELL SCI, V113, P2319; O'Shea C, 2003, INT J CANCER, V105, P754, DOI 10.1002/ijc.11161; Park J, 2010, J CELL SCI, V123, P1742, DOI 10.1242/jcs.064170; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shin N, 2007, J BIOL CHEM, V282, P28939, DOI 10.1074/jbc.M700283200; Shintani Y, 2004, CANCER RES, V64, P4190, DOI 10.1158/0008-5472.CAN-03-3235; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stautz D, 2012, TRAFFIC, V13, P1532, DOI 10.1111/j.1600-0854.2012.01405.x; Sun HS, 2003, BRIT J HAEMATOL, V122, P590, DOI 10.1046/j.1365-2141.2003.04419.x; Tao KS, 2010, JPN J CLIN ONCOL, V40, P645, DOI 10.1093/jjco/hyq030; Tseng HY, 2014, J MOL BIOL, V426, P3180, DOI 10.1016/j.jmb.2014.07.003; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Wong GE, 2001, J BIOL CHEM, V276, P24937, DOI 10.1074/jbc.M101637200; Wu G, 2016, MODERN PATHOL, V29, P359, DOI 10.1038/modpathol.2016.37; Zhou M, 2001, BIOCHEM BIOPH RES CO, V280, P574, DOI 10.1006/bbrc.2000.4155; Zigrino P, 2007, J BIOL CHEM, V282, P30785, DOI 10.1074/jbc.M701658200; Zigrino P, 2011, J BIOL CHEM, V286, P6801, DOI 10.1074/jbc.M110.168617; Zubel A, 2009, GYNECOL ONCOL, V114, P332, DOI 10.1016/j.ygyno.2009.05.005	61	6	6	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8077	8088		10.1074/jbc.RA117.001077	http://dx.doi.org/10.1074/jbc.RA117.001077			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29622675	Green Published, hybrid			2022-12-28	WOS:000433224600014
J	Suarez, J; Cividini, F; Scott, BT; Lehmann, K; Diaz-Juarez, J; Diemer, T; Dai, A; Suarez, JA; Jain, M; Dillmann, WH				Suarez, Jorge; Cividini, Federico; Scott, Brian T.; Lehmann, Kim; Diaz-Juarez, Julieta; Diemer, Tanja; Dai, Anzhi; Suarez, Jorge A.; Jain, Mohit; Dillmann, Wolfgang H.			Restoring mitochondrial calcium uniporter expression in diabetic mouse heart improves mitochondrial calcium handling and cardiac function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial metabolism; calcium; diabetes; pyruvate dehydrogenase complex (PDC); metabolomics; cardiomyocyte; mitochondrial calcium handling; mitochondrial calcium uniporter (MCU)	PERMEABILITY TRANSITION PORE; SENSITIVE K+ CHANNELS; SARCOPLASMIC-RETICULUM; REPERFUSION INJURY; O-GLCNACYLATION; ESSENTIAL COMPONENT; RODENT MODELS; GENE-TRANSFER; CA2+ RELEASE; RAT-HEART	Diabetes mellitus is a growing health care problem, resulting in significant cardiovascular morbidity and mortality. Diabetes also increases the risk for heart failure (HF) and decreased cardiac myocyte function, which are linked to changes in cardiac mitochondrial energy metabolism. The free mitochondrial calcium level ([Ca2+](m)) is fundamental in activating the mitochondrial respiratory chain complexes and ATP production and is also known to regulate pyruvate dehydrogenase complex (PDC) activity. The mitochondrial calcium uniporter (MCU) complex (MCUC) plays a major role in mediating mitochondrial Ca2+ import, and its expression and function therefore have a marked impact on cardiac myocyte metabolism and function. Here, we investigated MCU's role in mitochondrial Ca2+ handling, mitochondrial function, glucose oxidation, and cardiac function in the heart of diabetic mice. We found that diabetic mouse hearts exhibit altered expression of MCU and MCUC members and a resulting decrease in [Ca2+](m), mitochondrial Ca2+ uptake, mitochondrial energetic function, and cardiac function. Adeno-associated virus-based normalization of MCU levels in these hearts restored mitochondrial Ca2+ handling, reduced PDC phosphorylation levels, and increased PDC activity. These changes were associated with cardiac metabolic reprogramming toward normal physiological glucose oxidation. This reprogramming likely contributed to the restoration of both cardiac myocyte and heart function to nondiabetic levels without any observed detrimental effects. These findings support the hypothesis that abnormal mitochondrial Ca2+ handling and its negative consequences can be ameliorated in diabetes by restoring MCU levels via adeno-associated virus-based MCU transgene expression.	[Suarez, Jorge; Cividini, Federico; Scott, Brian T.; Diaz-Juarez, Julieta; Diemer, Tanja; Dai, Anzhi; Suarez, Jorge A.; Dillmann, Wolfgang H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lehmann, Kim; Jain, Mohit] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Lehmann, Kim; Jain, Mohit] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Diaz-Juarez, Julieta] Inst Nacl Cardiol, Dept Pharmacol, Juan Badiano 41, Tlalpan 14080, DF, Mexico	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dillmann, WH (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	wdillmann@ucsd.edu	Suarez, Jorge/AAS-7873-2021	Suarez, Jorge/0000-0002-2294-6329; Scott, Brian/0000-0002-1321-7204; Cividini, Federico/0000-0001-6312-6514	National Institutes of Health [HL066941]; Department of Veterans Affairs [BX001121]; P. Robert Majumder Charitable Foundation; University of California Institute for Mexico; United States (UC MEXUS)-Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CN 15-1489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); P. Robert Majumder Charitable Foundation; University of California Institute for Mexico; United States (UC MEXUS)-Consejo Nacional de Ciencia y Tecnologia (CONACYT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant HL066941, Merit Review Award BX001121 from the Department of Veterans Affairs, the P. Robert Majumder Charitable Foundation, University of California Institute for Mexico and the United States (UC MEXUS)-Consejo Nacional de Ciencia y Tecnologia (CONACYT) Grant CN 15-1489 (to W. H. D. and J. D. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404; Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Belke DD, 2007, AM J PHYSIOL-HEART C, V292, pH1755, DOI 10.1152/ajpheart.00884.2006; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Cividini F, 2016, J BIOL CHEM, V291, P26515, DOI 10.1074/jbc.M116.754481; Das A, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0486-5; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Diaz-Juarez J, 2016, AM J PHYSIOL-CELL PH, V311, pC1005, DOI 10.1152/ajpcell.00236.2016; ENTMAN ML, 1977, J MOL CELL CARDIOL, V9, P515, DOI 10.1016/S0022-2828(77)80367-2; Fang HF, 2012, HUM GENE THER METHOD, V23, P234, DOI 10.1089/hgtb.2012.105; Flarsheim CE, 1996, AM J PHYSIOL-HEART C, V271, pH192, DOI 10.1152/ajpheart.1996.271.1.H192; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Granatiero V, 2017, ADV EXP MED BIOL, V982, P25, DOI 10.1007/978-3-319-55330-6_2; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffin TM, 2016, BIOCHIMIE, V124, P74, DOI 10.1016/j.biochi.2015.10.013; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Ji LL, 2017, DIABETES, V66, P1586, DOI 10.2337/db16-1237; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Liu JC, 2016, CELL REP, V16, P1561, DOI 10.1016/j.celrep.2016.07.011; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lu XY, 2013, CIRC RES, V112, P424, DOI 10.1161/CIRCRESAHA.111.300501; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Makino A, 2011, AM J PHYSIOL-REG I, V300, pR1296, DOI 10.1152/ajpregu.00437.2010; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; NEELY J R, 1972, Progress in Cardiovascular Diseases, V15, P289, DOI 10.1016/0033-0620(72)90029-1; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pendin D, 2014, CELL CALCIUM, V55, P139, DOI 10.1016/j.ceca.2014.02.008; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; RANDLE PJ, 1963, LANCET, V1, P785; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RUTTER GA, 1989, BIOCHIM BIOPHYS ACTA, V1014, P263, DOI 10.1016/0167-4889(89)90222-X; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schilling JD, 2015, ANTIOXID REDOX SIGN, V22, P1515, DOI 10.1089/ars.2015.6294; Sloan RC, 2012, J MOL CELL CARDIOL, V52, P1009, DOI 10.1016/j.yjmcc.2012.02.009; Suarez J, 2004, AM J PHYSIOL-HEART C, V286, pH68, DOI 10.1152/ajpheart.00245.2003; Suarez J, 2013, AM J PHYSIOL-CELL PH, V304, pC248, DOI 10.1152/ajpcell.00039.2012; TANAKA Y, 1992, CARDIOVASC RES, V26, P409, DOI 10.1093/cvr/26.4.409; Tomar D, 2016, CELL REP, V15, P1673, DOI 10.1016/j.celrep.2016.04.050; Trost SU, 2000, ENDOCRINOLOGY, V141, P3057, DOI 10.1210/en.141.9.3057; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; WEISS JN, 1989, J GEN PHYSIOL, V94, P911, DOI 10.1085/jgp.94.5.911; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Yu LP, 2013, DIABETES, V62, P1833, DOI 10.2337/db12-1152; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	61	42	44	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8182	8195		10.1074/jbc.RA118.002066	http://dx.doi.org/10.1074/jbc.RA118.002066			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626093	hybrid, Green Published			2022-12-28	WOS:000433224600023
J	Tan, LX; Cho, KJ; Neupane, P; Capon, RJ; Hancock, JF				Tan, Lingxiao; Cho, Kwang-Jin; Neupane, Pratik; Capon, Robert J.; Hancock, John F.			An oxanthroquinone derivative that disrupts RAS plasma membrane localization inhibits cancer cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signaling; plasma membrane; Ras protein; GTPase Kras (KRAS); sphingolipid; cancer; endosome recycling; oxanthroquinone; sphingomyelin; trafficking	SMALL-MOLECULE INHIBITION; K-RAS; CAAX MOTIF; PROTEINS; TRAFFICKING; PALMITOYLATION; NANOCLUSTERS; ENDOSOMES; TARGETS	Oncogenic RAS proteins are commonly expressed in human cancer. To be functional, RAS proteins must undergo post-translational modification and localize to the plasma membrane (PM). Therefore, compounds that prevent RAS PM targeting have potential as putative RAS inhibitors. Here we examine the mechanism of action of oxanthroquinone G01 (G01), a recently described inhibitor of KRAS PM localization. We show that G01 mislocalizes HRAS and KRAS from the PM with similar potency and disrupts the spatial organization of RAS proteins remaining on the PM. G01 also inhibited recycling of epidermal growth factor receptor and transferrin receptor, but did not impair internalization of cholera toxin, indicating suppression of recycling endosome function. In searching for the mechanism of impaired endosomal recycling we observed that G01 also enhanced cellular sphingomyelin (SM) and ceramide levels and disrupted the localization of several lipid and cholesterol reporters, suggesting that the G01 molecular target may involve SM metabolism. Indeed, G01 exhibited potent synergy with other compounds that target SM metabolism in KRAS localization assays. Furthermore, G01 significantly abrogated RAS-RAF-MAPK signaling in Madin-Darby canine kidney (MDCK) cells expressing constitutively activated, oncogenic mutant RASG12V. G01 also inhibited the proliferation of RAS-less mouse embryo fibroblasts expressing oncogenic mutant KRASG12V or KRASG12D but not RAS-less mouse embryo fibroblasts expressing oncogenic mutant BRAFV600E. Consistent with these effects, G01 selectively inhibited the proliferation of KRAS-transformed pancreatic, colon, and endometrial cancer cells. Taken together, these results suggest that G01 should undergo further evaluation as a potential anti-RAS therapeutic.	[Tan, Lingxiao; Hancock, John F.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX 77030 USA; [Cho, Kwang-Jin] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Neupane, Pratik; Capon, Robert J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Wright State University Dayton; University of Queensland	Hancock, JF (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX 77030 USA.	john.f.hancock@uth.tmc.edu	Capon, Robert/G-9238-2012; Cho, Kwang-jin/AAI-4923-2020	Capon, Robert/0000-0002-8341-7754; Hancock, John/0000-0003-0542-4710; Tan, Lingxiao/0000-0001-9758-891X	NATIONAL CANCER INSTITUTE [R00CA188593] Funding Source: NIH RePORTER; NCI NIH HHS [R00 CA188593] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ariotti N, 2014, J CELL BIOL, V204, P777, DOI 10.1083/jcb.201307055; Cho KJ, 2016, MOL CELL BIOL, V36, P363, DOI 10.1128/MCB.00719-15; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; GHOSH RN, 1995, J CELL BIOL, V128, P549, DOI 10.1083/jcb.128.4.549; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Maekawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35762; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Papke B, 2017, SCIENCE, V355, P1158, DOI 10.1126/science.aam7622; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rodman JS, 2000, J CELL SCI, V113, P183; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rowinsky EK, 2006, J CLIN ONCOL, V24, P2981, DOI 10.1200/JCO.2006.05.9808; Salim AA, 2014, ORG BIOMOL CHEM, V12, P4872, DOI 10.1039/c4ob00745j; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; van der Hoeven D, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00373-17; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; Zhou M, 2016, J CELL BIOL, V214, P445, DOI 10.1083/jcb.201604061; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	41	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13696	13706		10.1074/jbc.RA118.003907	http://dx.doi.org/10.1074/jbc.RA118.003907			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29970615	Green Published, hybrid			2022-12-28	WOS:000443375500028
J	Nagappan-Chettiar, S; Johnson-Venkatesh, EM; Umemori, H				Nagappan-Chettiar, Sivapratha; Johnson-Venkatesh, Erin M.; Umemori, Hisashi			Tyrosine phosphorylation of the transmembrane protein SIRP: Sensing synaptic activity and regulating ectodomain cleavage for synapse maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodevelopment; synapse; hippocampus; tyrosine; phosphorylation; shedding; immunoglobulin superfamily; neural activity; synaptogenesis	DEPENDENT PROTEOLYTIC CLEAVAGE; CELL-ADHESION; HIPPOCAMPAL-NEURONS; NEGATIVE REGULATION; ALPHA; ACTIVATION; RAT; DIFFERENTIATION; CIRCUITS; SHP-2	Synapse maturation is a neural activity-dependent process during brain development, in which active synapses preferentially undergo maturation to establish efficient neural circuits in the brain. Defects in this process are implicated in various neuropsychiatric disorders. We have previously reported that a postsynaptic transmembrane protein, signal regulatory protein- (SIRP), plays an important role in activity-dependently directing synapse maturation. In the presence of synaptic activity, the ectodomain of SIRP is cleaved and released and then acts as a retrograde signal to induce presynaptic maturation. However, how SIRP detects synaptic activity to promote its ectodomain cleavage and synapse maturation is unknown. Here, we show that activity-dependent tyrosine phosphorylation of SIRP is critical for SIRP cleavage and synapse maturation. We found that during synapse maturation and in response to neural activity, SIRP is highly phosphorylated on its tyrosine residues in the hippocampus, a structure critical for learning and memory. Tyrosine phosphorylation of SIRP was necessary for SIRP cleavage and presynaptic maturation, as indicated by the fact that a phosphorylation-deficient SIRP variant underwent much less cleavage and could not drive presynaptic maturation. However, SIRP phosphorylation did not affect its synaptic localization. Finally, we show that inhibitors of the Src and JAK kinase family suppress neural activity-dependent SIRP phosphorylation and cleavage. Together, our results indicate that SIRP phosphorylation serves as a mechanism for detecting synaptic activity and linking it to the ectodomain cleavage of SIRP, which in turn drives synapse maturation in an activity-dependent manner.	[Nagappan-Chettiar, Sivapratha; Johnson-Venkatesh, Erin M.; Umemori, Hisashi] Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Nagappan-Chettiar, Sivapratha; Umemori, Hisashi] Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Umemori, H (corresponding author), Harvard Med Sch, Boston Childrens Hosp, 300 Longwood Ave,Ctr Life Sci 13074, Boston, MA 02115 USA.	hisashi.umemori@childrens.harvard.edu		Nagappan Chettiar, Sivapratha/0000-0003-4371-8090; Umemori, Hisashi/0000-0001-7198-2062	National Institutes of Health [R01-NS092578, R01-MH111647]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01-NS092578 and R01-MH111647 (to H. U.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Atapattu L, 2012, J CELL SCI, V125, P6084, DOI 10.1242/jcs.112631; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bemben MA, 2014, NAT NEUROSCI, V17, P56, DOI 10.1038/nn.3601; Bian Z, 2016, P NATL ACAD SCI USA, V113, pE5434, DOI 10.1073/pnas.1521069113; BROWNING MD, 1985, J NEUROCHEM, V45, P11, DOI 10.1111/j.1471-4159.1985.tb05468.x; Chia PH, 2013, J CELL BIOL, V203, P11, DOI 10.1083/jcb.201307020; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Dabrowski A, 2015, DEVELOPMENT, V142, P1818, DOI 10.1242/dev.115568; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Galbaugh T, 2010, MOL CANCER RES, V8, P1413, DOI 10.1158/1541-7786.MCR-10-0130; Hamada J, 2004, FEBS LETT, V557, P204, DOI 10.1016/S0014-5793(03)01493-5; Hashimoto K, 2013, CELL MOL LIFE SCI, V70, P4667, DOI 10.1007/s00018-013-1405-2; Holm CK, 2016, BIOCHEM BIOPH RES CO, V478, P268, DOI 10.1016/j.bbrc.2016.07.048; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Johnson-Venkatesh EM, 2010, EUR J NEUROSCI, V32, P181, DOI 10.1111/j.1460-9568.2010.07338.x; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lipska BK, 2002, J NEUROSCI, V22, P2835, DOI 10.1523/JNEUROSCI.22-07-02835.2002; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Londino JD, 2015, J BIOL CHEM, V290, P31113, DOI 10.1074/jbc.M115.682914; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Maruyama T, 2012, J NEUROCHEM, V121, P891, DOI 10.1111/j.1471-4159.2012.07748.x; Meyer F, 2012, NEUROPSYCHOPHARMACOL, V37, P2233, DOI 10.1038/npp.2012.74; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Nagappan-Chettiar S, 2017, NEUROSCI RES, V116, P60, DOI 10.1016/j.neures.2016.12.003; Nakahata Y, 2000, J NEUROCHEM, V74, P2436, DOI 10.1046/j.1471-4159.2000.0742436.x; Neznanov N, 2003, J BIOL CHEM, V278, P3809, DOI 10.1074/jbc.M210698200; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Niimura M, 2005, J NEUROCHEM, V92, P1377, DOI 10.1111/j.1471-4159.2005.02977.x; Ohnishi H, 2010, J NEUROSCI, V30, P10472, DOI 10.1523/JNEUROSCI.0257-10.2010; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Penzes P, 2013, J NEUROCHEM, V126, P165, DOI 10.1111/jnc.12261; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Stofega MR, 2000, J BIOL CHEM, V275, P28222; Stofega MR, 1998, J BIOL CHEM, V273, P7112, DOI 10.1074/jbc.273.12.7112; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Takada T, 1998, J BIOL CHEM, V273, P9234, DOI 10.1074/jbc.273.15.9234; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Terauchi A, 2016, ELIFE, V5, DOI 10.7554/eLife.12151; Terauchi A, 2015, J CELL SCI, V128, P281, DOI 10.1242/jcs.158337; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Toth AB, 2013, NAT NEUROSCI, V16, P1417, DOI 10.1038/nn.3516; Umemori H, 1999, ONCOGENE, V18, P7399, DOI 10.1038/sj.onc.1203152; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027; Zhao H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1131-2	60	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12026	12042		10.1074/jbc.RA117.001488	http://dx.doi.org/10.1074/jbc.RA117.001488			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29914984	Green Published, hybrid			2022-12-28	WOS:000440803200005
J	Niesteruk, A; Jonker, HRA; Richter, C; Linhard, V; Sreeramulu, S; Schwalbe, H				Niesteruk, Anna; Jonker, Hendrik R. A.; Richter, Christian; Linhard, Verena; Sreeramulu, Sridhar; Schwalbe, Harald			The domain architecture of PtkA, the first tyrosine kinase from Mycobacterium tuberculosis, differs from the conventional kinase architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE DETERMINATION; RESISTANT TUBERCULOSIS; ROTATIONAL DIFFUSION; DRUG DEVELOPMENT; CHEMICAL-SHIFTS; NMR-SPECTRA; PHOSPHORYLATION; PHOSPHATASE; RELAXATION; MEMBRANE	The discovery that MptpA (low-molecular-weight protein tyrosine phosphatase A) from Mycobacterium tuberculosis (Mtb) has an essential role for Mtb virulence has motivated research of tyrosine-specific phosphorylation in Mtb and other pathogenic bacteria. The phosphatase activity of MptpA is regulated via phosphorylation on Tyr(128) and Tyr(129). Thus far, only a single tyrosine-specific kinase, protein-tyrosine kinase A (PtkA), encoded by the Rv2232 gene has been identified within the Mtb genome. MptpA undergoes phosphorylation by PtkA. PtkA is an atypical bacterial tyrosine kinase, as its sequence differs from the sequence consensus within this family. The lack of structural information on PtkA hampers the detailed characterization of the MptpA-PtkA interaction. Here, using NMR spectroscopy, we provide a detailed structural characterization of the PtkA architecture and describe its intra- and intermolecular interactions with MptpA. We found that PtkA's domain architecture differs from the conventional kinase architecture and is composed of two domains, the N-terminal highly flexible intrinsically disordered domain (IDDPtkA) and the C-terminal rigid kinase core domain (KCDPtkA). The interaction between the two domains, together with the structural model of the complex proposed in this study, reveal that the IDDPtkA is unstructured and highly dynamic, allowing for a fly-casting-like mechanism of transient interactions with the rigid KCDPtkA. This interaction modulates the accessibility of the KCDPtkA active site. In general, the structural and functional knowledge of PtkA gained in this study is crucial for understanding the MptpA-PtkA interactions, the catalytic mechanism, and the role of the kinase-phosphatase regulatory system in Mtb virulence.	[Niesteruk, Anna; Jonker, Hendrik R. A.; Richter, Christian; Linhard, Verena; Sreeramulu, Sridhar; Schwalbe, Harald] Goethe Univ Frankfurt Main, Ctr Biomol Magnet Resonance BMRZ, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany; [Schwalbe, Harald] DFG Funded Cluster Excellence Macromol Complexes, Frankfurt, Germany	Goethe University Frankfurt	Schwalbe, H (corresponding author), Goethe Univ Frankfurt Main, Ctr Biomol Magnet Resonance BMRZ, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany.; Schwalbe, H (corresponding author), DFG Funded Cluster Excellence Macromol Complexes, Frankfurt, Germany.	schwalbe@nmr.uni-frankfurt.de	Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010	Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909; Linhard, Verena/0000-0002-0278-9792	DFG; European Commission (iNEXT) [653706]; Horizon 2020 program of the European Union; state of Hesse (BMRZ)	DFG(German Research Foundation (DFG)); European Commission (iNEXT)(European Commission); Horizon 2020 program of the European Union; state of Hesse (BMRZ)	This work was supported by DFG, the European Commission (iNEXT, Grant 653706, funded by the Horizon 2020 program of the European Union), and the state of Hesse (BMRZ). The authors declare that they have no conflicts of interest with the contents of this article.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chao JD, 2014, J BIOL CHEM, V289, P9463, DOI 10.1074/jbc.R113.520015; CHOW K, 1994, FEMS MICROBIOL LETT, V124, P203, DOI 10.1111/j.1574-6968.1994.tb07285.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Goddard T. D., 2002, SPARKY VERSION 3 105; Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Kusebauch U, 2014, P NATL ACAD SCI USA, V111, P9265, DOI 10.1073/pnas.1323894111; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Niesteruk A, 2018, FEBS LETT, V592, P1233, DOI 10.1002/1873-3468.13022; OSTROVSKY PC, 1995, GENE DEV, V9, P2034, DOI 10.1101/gad.9.16.2034; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; Parish T, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0010-2013; Pepio AM, 2001, J BIOL CHEM, V276, P3846, DOI 10.1074/jbc.M006339200; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Stehle T, 2012, J BIOL CHEM, V287, P34569, DOI 10.1074/jbc.M112.399261; Tjandra N, 1997, NAT STRUCT BIOL, V4, P443, DOI 10.1038/nsb0697-443; van den Boogaard J, 2009, ANTIMICROB AGENTS CH, V53, P849, DOI 10.1128/AAC.00749-08; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; VUISTER GW, 1994, J BIOMOL NMR, V4, P193; Wong D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18547-9; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Zhao X, 2002, J BIOL CHEM, V277, P4722, DOI 10.1074/jbc.M107803200; Zhou PF, 2015, BIOCHEM BIOPH RES CO, V467, P421, DOI 10.1016/j.bbrc.2015.09.124; Zhou PF, 2015, FEBS LETT, V589, P326, DOI 10.1016/j.febslet.2014.12.015; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	46	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11823	11836		10.1074/jbc.RA117.000120	http://dx.doi.org/10.1074/jbc.RA117.000120			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29884774	Green Published, hybrid			2022-12-28	WOS:000440134500016
J	Inoue-Mochita, M; Inoue, T; Kojima, S; Futakuchi, A; Fujimoto, T; Sato-Ohira, S; Tsutsumi, U; Tanihara, H				Inoue-Mochita, Miyuki; Inoue, Toshihiro; Kojima, Sachi; Futakuchi, Akiko; Fujimoto, Tomokazu; Sato-Ohira, Saori; Tsutsumi, Utako; Tanihara, Hidenobu			Interleukin-6-mediated trans-signaling inhibits transforming growth factor- signaling in trabecular meshwork cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin 6 (IL-6); interleukin 6 receptor (IL6R); transforming growth factor (TGF-B); eye; STAT3; signaling; signal transduction; aqueous humor; trabecular meshwork cell	MULTIPLE PROINFLAMMATORY CYTOKINES; EPITHELIAL-MESENCHYMAL TRANSITION; HUMOR OUTFLOW FACILITY; RHO KINASE INHIBITOR; OPEN-ANGLE GLAUCOMA; AQUEOUS-HUMOR; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; IL-6 RECEPTOR; SOLUBLE IL-6	Glaucoma is one of the major causes of blindness, and transforming growth factor-2 (TGF-2) has been found to be elevated in the aqueous humor of eyes with primary open-angle glaucoma (POAG). TGF-2 in aqueous humor causes the glaucoma-related fibrosis of human trabecular meshwork (HTM), suggesting an important role of TGF- in POAG pathogenesis. Here, we sought to elucidate the effects of IL-6 trans-signaling on TGF- signaling in HTM cells. Using a multiplex immunoassay, POAG patients decreased IL-6 levels and increased soluble IL-6 receptor (sIL-6R) levels compared with the controls. In in vitro experiments, we observed that the IL-6 level was increased in the conditioned medium of HTM cells after TGF-2 stimulation. To elucidate the relationship between TGF-2 and IL-6 in HTM cells, we conducted Western blotting and immunohistochemical analyses, and we noted that the combination of IL-6 and sIL-6R (IL6/sIL-6R) suppressed TGF--induced up-regulation of -smooth muscle actin in HTM cells, whereas IL-6 alone did not. This suggests that trans-signaling, not classic signaling, of IL-6 suppresses TGF--induced fibrosis of HTM. IL6/sIL-6R also suppressed TGF--mediated activation of myosin light chain 2 (MLC2), Smad2, and p38. Of note, these inhibitory effects of IL6/sIL-6R on TGF- were partly reduced by siRNA-mediated knockdown of STAT3. Moreover, IL-6/sIL-6R partly inhibited TGF--induced activation of the Smad-sensitive promoter detected with luciferase reporter gene assays and up-regulation of TGFRI and TGFRII, evaluated by quantitative real-time RT-PCR. Strikingly, overexpression of TGFRI and TGFRII diminished these inhibitory effects of IL-6/sIL-6R. We conclude that of IL-6-mediated trans-signaling potently represses TGF- signaling in HTM cells.	[Inoue-Mochita, Miyuki; Inoue, Toshihiro; Kojima, Sachi; Futakuchi, Akiko; Fujimoto, Tomokazu; Sato-Ohira, Saori; Tsutsumi, Utako; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, 1-1-1 Honjo, Kumamoto 8608556, Japan	Kumamoto University	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	noel@da2.so-net.ne.jp	Ogawa, Akiko/AAD-7683-2021	Fujimoto, Tomokazu/0000-0002-4867-1925; Inoue, Toshihiro/0000-0003-3769-7609	JSPS KAKENHI [26293375, 15K10872, 15K15636, 26462664]; Kowaand Merck Sharp and Dohme; Senju Pharmaceutical; Santen Pharmaceutical; Alcon Japan; Pfizer Japan; Kowa; Otsuka Pharmaceutical; Novartis Pharma	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kowaand Merck Sharp and Dohme; Senju Pharmaceutical; Santen Pharmaceutical; Alcon Japan(Novartis); Pfizer Japan(Pfizer); Kowa; Otsuka Pharmaceutical(Otsuka Pharmaceutical); Novartis Pharma	This work was supported by JSPS KAKENHI Grants 26293375, 15K10872, 15K15636, and 26462664. H. T. has received consulting fees from Kowaand Merck Sharp and Dohme; board membership fees from Senju Pharmaceutical, Santen Pharmaceutical, Alcon Japan, and Pfizer Japan; and research grants from Kowa, Senju Pharmaceutical, Santen Pharmaceutical, Alcon Japan, Pfizer Japan, and Otsuka Pharmaceutical. T. I. has received a research grant from Novartis Pharma.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Curnow SJ, 2004, J IMMUNOL, V173, P5290, DOI 10.4049/jimmunol.173.8.5290; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Gallucci RM, 2006, J INVEST DERMATOL, V126, P561, DOI 10.1038/sj.jid.5700109; Gonzalez JM, 2012, INVEST OPHTH VIS SCI, V53, P3395, DOI 10.1167/iovs.11-8570; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Han H, 2011, INVEST OPHTH VIS SCI, V52, P2889, DOI 10.1167/iovs.10-6640; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Inoue-Mochita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120774; JAMPEL HD, 1990, CURR EYE RES, V9, P963, DOI 10.3109/02713689009069932; Keller KE, 2014, J OCUL PHARMACOL TH, V30, P267, DOI 10.1089/jop.2013.0187; Laurenzana A, 2015, J MOL MED, V93, P783, DOI 10.1007/s00109-015-1266-2; Liton PB, 2009, MOL VIS, V15, P326; Liton PB, 2005, BIOCHEM BIOPH RES CO, V337, P1229, DOI 10.1016/j.bbrc.2005.09.182; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; LUST JA, 1992, CYTOKINE, V4, P96, DOI 10.1016/1043-4666(92)90043-Q; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Nakanishi H, 2004, AM J PATHOL, V165, P471, DOI 10.1016/S0002-9440(10)63312-3; Nishimoto N, 2000, INT IMMUNOL, V12, P187, DOI 10.1093/intimm/12.2.187; Ohira S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147080; Ohira S, 2015, INVEST OPHTH VIS SCI, V56, P3541, DOI 10.1167/iovs.14-15918; Pattabiraman PP, 2014, J CELL PHYSIOL, V229, P927, DOI 10.1002/jcp.24524; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Petrinovic-Doresic J, 1999, OCUL IMMUNOL INFLAMM, V7, P75, DOI 10.1076/ocii.7.2.75.4017; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sarkozi R, 2012, BIOCHEM BIOPH RES CO, V424, P801, DOI 10.1016/j.bbrc.2012.07.042; Seong GJ, 2009, MOL VIS, V15, P2123; Simon D, 2008, INVEST OPHTH VIS SCI, V49, P3988, DOI 10.1167/iovs.08-1953; Takahashi E, 2014, EXP EYE RES, V118, P72, DOI 10.1016/j.exer.2013.11.014; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tanihara H, 2013, JAMA OPHTHALMOL, V131, P1288, DOI 10.1001/jamaophthalmol.2013.323; Tanihara H, 2013, AM J OPHTHALMOL, V156, P731, DOI 10.1016/j.ajo.2013.05.016; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Tsuboi N, 2012, INVEST OPHTH VIS SCI, V53, P6702, DOI 10.1167/iovs.12-10376; Vyas B, 2010, ANN OTO RHINOL LARYN, V119, P350, DOI 10.1177/000348941011900513; Wang G, 2016, ONCOGENE, V35, P4388, DOI 10.1038/onc.2015.446; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379	42	17	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10975	10984		10.1074/jbc.RA118.003298	http://dx.doi.org/10.1074/jbc.RA118.003298			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29752408	hybrid, Green Published			2022-12-28	WOS:000438882800011
J	Rostovtseva, TK; Gurnev, PA; Hoogerheide, DP; Rovini, A; Sirajuddin, M; Bezrukov, SM				Rostovtseva, Tatiana K.; Gurnev, Philip A.; Hoogerheide, David P.; Rovini, Amandine; Sirajuddin, Minhajuddin; Bezrukov, Sergey M.			Sequence diversity of tubulin isotypes in regulation of the mitochondrial voltage-dependent anion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gating; tubulin; membrane protein; recombinant protein expression; protein engineering; protein-lipid interaction; mitochondrial transport; ion channel; permeability; membrane transport; beta-barrel channel; drift-diffusion model; engineered recombinant tubulin; peripheral membrane proteins; VDAC; C-terminal tail; gating charge; intrinsically disordered protein domains	III BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; ALPHA-TUBULIN; CANCER-CELLS; PHOSPHOLIPID-VESICLES; PROXIMITY LIGATION; ION-CHANNEL; IN-SITU; VDAC; MEMBRANE	The microtubule protein tubulin is a heterodimer comprising / subunits, in which each subunit features multiple isotypes in vertebrates. For example, seven -tubulin and eight -tubulin isotypes in the human tubulin gene family vary mostly in the length and primary sequence of the disordered anionic carboxyl-terminal tails (CTTs). The biological reason for such sequence diversity remains a topic of vigorous enquiry. Here, we demonstrate that it may be a key feature of tubulin's role in regulation of the permeability of the mitochondrial outer membrane voltage-dependent anion channel (VDAC). Using recombinant yeast /-tubulin constructs with -CTTs, -CTTs, or both from various human tubulin isotypes, we probed their interactions with VDAC reconstituted into planar lipid bilayers. A comparative study of the blockage kinetics revealed that either -CTTs or -CTTs block the VDAC pore and that the efficiency of blockage by individual CTTs spans 2 orders of magnitude, depending on the CTT isotype. -Tubulin constructs, notably 3, blocked VDAC most effectively. We quantitatively described these experimental results using a physical model that accounted only for the number and distribution of charges in the CTT, and not for the interactions between specific residues on the CTT and VDAC pore. Based on these results, we speculate that the effectiveness of VDAC regulation by tubulin depends on the predominant tubulin isotype in a cell. Consequently, the fluxes of ATP/ADP through the channel could vary significantly, depending on the isotype, thus suggesting an intriguing link between VDAC regulation and the diversity of tubulin isotypes present in vertebrates.	[Rostovtseva, Tatiana K.; Gurnev, Philip A.; Rovini, Amandine; Bezrukov, Sergey M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Transport, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA; [Hoogerheide, David P.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Sirajuddin, Minhajuddin] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Standards & Technology (NIST) - USA; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Rostovtseva, TK (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Transport, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov	Hoogerheide, David P./AAB-3753-2019; rovini, amandine/W-1703-2019	Hoogerheide, David P./0000-0003-2918-1469; Rovini, Amandine/0000-0003-0483-9092; Sirajuddin, Minhajuddin/0000-0001-5742-2130	National Science Foundation (NSF) [ACI-1053575]; NSF [ACI-1445606]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are indebted to Jeff Abramson and Lucie Bergdoll (David Geffen School of Medicine, UCLA) for fruitful discussions. This study used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation (NSF) Grant ACI-1053575. Specifically, it was the Bridges system supported by NSF Award ACI-1445606, at the Pittsburgh Super-computing Center (PSC).	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ambjornsson T, 2002, J CHEM PHYS, V117, P4063, DOI 10.1063/1.1486208; BANERJEE A, 1988, J BIOL CHEM, V263, P3029; BERNIERVALENTIN F, 1983, J CELL BIOL, V97, P209, DOI 10.1083/jcb.97.1.209; Bickel T, 2001, EUR PHYS J E, V4, P33, DOI 10.1007/s101890170140; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Bode CJ, 2003, EMBO REP, V4, P94, DOI 10.1038/sj.embor.embor716; Bretteville A, 2017, METHODS MOL BIOL, V1523, P297, DOI 10.1007/978-1-4939-6598-4_18; BURGOYNE RD, 1988, EMBO J, V7, P2311, DOI 10.1002/j.1460-2075.1988.tb03074.x; Camara AKS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00460; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Colombini M, 1996, Ion Channels, V4, P169; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Doi M., 1988, THEORY POLYMER DYNAM, P8; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Hoogerheide DP, 2018, BIOPHYS J, V114, P772, DOI 10.1016/j.bpj.2017.12.019; Hoogerheide DP, 2017, P NATL ACAD SCI USA, V114, pE3622, DOI 10.1073/pnas.1619806114; Hoogerheide DP, 2017, NANOSCALE, V9, P183, DOI 10.1039/c6nr08145b; Hoogerheide DP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.248301; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Johnson V, 2011, BIOCHEMISTRY-US, V50, P8636, DOI 10.1021/bi2005174; Kienzle P., 2011, BUMPS VERSION 080; KLAUSNER RD, 1981, J BIOL CHEM, V256, P5879; KUMAR N, 1981, J BIOL CHEM, V256, P5886; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Luduena RF, 2013, INT REV CEL MOL BIO, V302, P41, DOI 10.1016/B978-0-12-407699-0.00002-9; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Mariani M, 2015, GENE, V563, P109, DOI 10.1016/j.gene.2015.03.061; Minoura I, 2013, FEBS LETT, V587, P3450, DOI 10.1016/j.febslet.2013.08.032; Monge C, 2008, MOL CELL BIOCHEM, V318, P147, DOI 10.1007/s11010-008-9865-7; Monje-Galvan V, 2016, BBA-BIOMEMBRANES, V1858, P1584, DOI 10.1016/j.bbamem.2016.02.018; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Noskov SY, 2016, BBA-BIOMEMBRANES, V1858, P1778, DOI 10.1016/j.bbamem.2016.02.026; Noskov SY, 2013, BIOCHEMISTRY-US, V52, P9246, DOI 10.1021/bi4011495; Nystrom Nicholas A, 2015, P 2015 XSEDE C SCI A; PALMIERI F, 1989, J BIOENERG BIOMEMBR, V21, P417, DOI 10.1007/BF00762514; Pamula MC, 2016, J CELL BIOL, V213, P425, DOI 10.1083/jcb.201603050; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Redeker V, 2010, METHOD CELL BIOL, V95, P77, DOI 10.1016/S0091-679X(10)95006-1; Roll-Mecak A, 2015, SEMIN CELL DEV BIOL, V37, P11, DOI 10.1016/j.semcdb.2014.09.026; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2015, SPRINGER SER BIOPHYS, V18, P3, DOI 10.1007/978-3-319-20149-8_1; Rostovtseva TK, 2012, J BIOL CHEM, V287, P29589, DOI 10.1074/jbc.M112.378778; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; SCHATZ PJ, 1987, MOL CELL BIOL, V7, P3799, DOI 10.1128/MCB.7.10.3799; Sheldon KL, 2015, J BIOL CHEM, V290, P26784, DOI 10.1074/jbc.M115.678854; Shoshan-Barmatz V, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00154; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Ti SC, 2016, DEV CELL, V37, P72, DOI 10.1016/j.devcel.2016.03.003; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Valenstein ML, 2016, CELL, V164, P911, DOI 10.1016/j.cell.2016.01.019; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P292; Vemu A, 2016, J BIOL CHEM, V291, P12907, DOI 10.1074/jbc.C116.731133; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vrugt JA, 2009, INT J NONLIN SCI NUM, V10, P273, DOI 10.1515/IJNSNS.2009.10.3.273; Weinrich M, 2017, NANOSCALE, V9, P13291, DOI 10.1039/c7nr03926c; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033	72	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10949	10962		10.1074/jbc.RA117.001569	http://dx.doi.org/10.1074/jbc.RA117.001569			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29777059	Green Published, hybrid			2022-12-28	WOS:000438882800009
J	Wang, WH; Li, F; Xu, YM; Wei, JC; Zhang, YN; Yang, H; Gao, BX; Yu, GH; Fang, DY				Wang, Wenhui; Li, Fei; Xu, Yuanming; Wei, Juncheng; Zhang, Yana; Yang, Heeyoung; Gao, Beixue; Yu, Guohua; Fang, Deyu			JAK1-mediated Sirt1 phosphorylation functions as a negative feedback of the JAK1-STAT3 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Janus kinase (JAK); signal transduction; sirtuin 1 (SIRT1); STAT3; post-translational modification (PTM); JAK1; negative feedback	BREAST-CANCER CELLS; P53 ACETYLATION; LUNG-CANCER; DNA-DAMAGE; ACTIVATION; DEACETYLASE; TRANSFORMATION; TRANSCRIPTION; INHIBITION; EXPRESSION	The type III NAD-dependent histone deacetylase Sirt1 plays important roles in a variety of pathobiological functions through targeting either the acetylated histones or transcription factors. However, the molecular mechanisms underlying how the Sirt1 functions are regulated remain vague. Herein we identified that the Janus kinase 1 (JAK1) interacts with Sirt1 and catalyzes its phosphorylation at the tyrosine residues of 280 and 301, both of which are highly conserved and located in the histone deacetylase catalytic domain of Sirt1. IL-6 stimulation enhanced Sirt1 interaction with JAK1 and JAK1-mediated Sirt1 phosphorylation. Interestingly, JAK1-mediated Sirt1 phosphorylation did not alter Sirt1 deacetylase catalytic activity, but instead it is required for Sirt1 interaction with the downstream transcription factor STAT3. JAK1-mediated phosphorylation enhanced Sirt1 suppression of STAT3 acetylation and transcriptional activity. As a consequence, Sirt1 activation attenuates IL-6 activity in protecting cancer cells from chemotherapeutic drug-induced apoptosis. Our studies identify JAK1 as a previously unappreciated tyrosine kinase of Sirt1 and reveal a novel negative feedback of the JAK1-STAT3 pathway.	[Wang, Wenhui; Yu, Guohua] Wei Fang Peoples Hosp, Dept Oncol, Wei Fang 261041, Shandong, Peoples R China; [Wang, Wenhui; Li, Fei; Xu, Yuanming; Wei, Juncheng; Zhang, Yana; Yang, Heeyoung; Gao, Beixue; Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Zhang, Yana] Guangzhou Women & Childrens Med Ctr, Dept Otolaryngol Head & Neck Surg, Guangzhou 510623, Guangdong, Peoples R China	Northwestern University; Feinberg School of Medicine	Yu, GH (corresponding author), Wei Fang Peoples Hosp, Dept Oncol, Wei Fang 261041, Shandong, Peoples R China.; Fang, DY (corresponding author), 303 E Chicago Ave, Chicago, IL 60611 USA.	ghyry@126.com; fangd@northwestern.edu	xu, Yuanming/R-2226-2018; Wei, Juncheng/Q-1092-2019	xu, Yuanming/0000-0003-3137-5270; 	National Institutes of Health [R01 AI079056, AI108634, AR006634]; National Natural Science Foundation of China [81600784]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056, R01AI108634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI079056, AI108634, and AR006634 (to D. F.) and the National Natural Science Foundation of China Grant 81600784 (to Y. Z.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Conrad E, 2016, CELL DEATH DIFFER, V23, P110, DOI 10.1038/cdd.2015.75; Conze D, 2001, CANCER RES, V61, P8851; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Lau AW, 2014, AM J CANCER RES, V4, P245; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yan HQ, 2014, CANCER SCI, V105, P1220, DOI 10.1111/cas.12478; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	37	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11067	11075		10.1074/jbc.RA117.001387	http://dx.doi.org/10.1074/jbc.RA117.001387			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789426	hybrid, Green Published			2022-12-28	WOS:000438882800019
J	Nithianantham, S; McNally, FJ; Al-Bassam, J				Nithianantham, Stanley; McNally, Francis J.; Al-Bassam, Jawdat			Structural basis for disassembly of katanin heterododecamers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; microtubule-associated protein (MAP); microtubule; mitosis; meiosis; tubulin	MICROTUBULE-SEVERING ACTIVITY; SPASTIC PARAPLEGIA; AAA ATPASE; PROTEIN; COMPLEX; CRYSTALLOGRAPHY; SOFTWARE; QUALITY; SYSTEM; PHENIX	The reorganization of microtubules in mitosis, meiosis, and development requires the microtubule-severing activity of katanin. Katanin is a heterodimer composed of an ATPase associated with diverse cellular activities (AAA) subunit and a regulatory subunit. Microtubule severing requires ATP hydrolysis by katanin's conserved AAA ATPase domains. Whereas other AAA ATPases form stable hexamers, we show that katanin forms only a monomer or dimers of heterodimers in solution. Katanin oligomers consistent with hexamers of heterodimers or heterododecamers were only observed for an ATP hydrolysis-deficient mutant in the presence of ATP. X-ray structures of katanin's AAA ATPase in monomeric nucleotide-free and pseudo-oligomeric ADP-bound states revealed conformational changes in the AAA subdomains that explained the structural basis for the instability of the katanin heterododecamer. We propose that the rapid dissociation of katanin AAA oligomers may lead to an autoinhibited state that prevents inappropriate microtubule severing or that cyclical disassembly into heterodimers may critically contribute to the microtubule-severing mechanism.	[Nithianantham, Stanley; McNally, Francis J.; Al-Bassam, Jawdat] Univ Calif Davis, Dept Mol Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Al-Bassam, J (corresponding author), Univ Calif Davis, Dept Mol Cellular Biol, Davis, CA 95616 USA.	jawdat@ucdavis.edu			National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205, S10OD021527]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110283, R01GM079421, P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021527] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Advanced Photon Source and Drs. K. Rajashankar, J. Schuermann, and D. Neau of the Northeastern Collaborative Access Team (NE-CAT) for the use of the 24-IDC and IDE beam lines to collect all the X-ray diffraction data for our crystallo-graphic studies. We thank our graduate student, Brian D. Cook, for help with SEC-MALS. This work is based upon research conducted at the NE-CAT beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). The Eiger 16M detector on 24-ID-E beam line is funded by a NIH-ORIP HEI grant (S10OD021527). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bailey ME, 2015, BIOPHYS J, V109, P2546, DOI 10.1016/j.bpj.2015.11.011; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Han H, 2017, ELIFE, V6, DOI 10.7554/eLife.31324; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hu WF, 2014, NEURON, V84, P1240, DOI 10.1016/j.neuron.2014.12.017; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; Jiang K, 2017, NAT CELL BIOL, V19, P480, DOI 10.1038/ncb3511; Jiang K, 2014, DEV CELL, V28, P295, DOI 10.1016/j.devcel.2014.01.001; Joly N, 2016, DEVELOPMENT, V143, P3604, DOI 10.1242/dev.140830; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Mishra-Gorur K, 2014, NEURON, V84, P1226, DOI 10.1016/j.neuron.2014.12.014; Monroe N, 2017, ELIFE, V6, DOI 10.7554/eLife.24487; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Powell HR, 2013, ACTA CRYSTALLOGR D, V69, P1195, DOI 10.1107/S0907444912048524; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Srayko M, 2000, GENE DEV, V14, P1072; Su M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700325; Sun S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16064; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Taylor JL, 2012, J STRUCT BIOL, V179, P133, DOI 10.1016/j.jsb.2012.03.002; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wohlever ML, 2017, MOL CELL, V67, P194, DOI 10.1016/j.molcel.2017.06.019; Zehr E, 2017, NAT STRUCT MOL BIOL, V24, P717, DOI 10.1038/nsmb.3448	48	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10590	10605		10.1074/jbc.RA117.001215	http://dx.doi.org/10.1074/jbc.RA117.001215			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29752405	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000437828400018
J	Abou El Hassan, M; Huang, K; Xu, ZD; Yu, T; Bremner, R				Abou El Hassan, Mohamed; Huang, Katherine; Xu, Zhaodong; Yu, Tao; Bremner, Rod			Frequent interferon regulatory factor 1 (IRF1) binding at remote elements without histone modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone modification; interferon regulatory factor (IRF); STAT transcription factor; histone acetylase; interferon; transcription enhancer; gene regulation	GENE-EXPRESSION; ORDERED RECRUITMENT; ALPHA CISTROME; CIITA LOCUS; TRANSCRIPTION; ENHANCERS; ACTIVATION; DISTINCT; BRG1; ACETYLATION	Transcriptional activators bind DNA and recruit cofactors to modify chromatin. The extent to which these two events are separable is unclear. Here, using a custom ChIP tiling array to map chromatin modifications, we show that interferon--induced DNA binding of signal transducer and activator of transcription 1 (STAT1), typically associated with the transcription factor interferon regulatory factor 1 (IRF1), causes histone acetylation (H3ac, H4ac). In contrast, among IRF1 sites lacking concomitant STAT1 recruitment, only 25% underwent inducible histone acetylation, 31% exhibited constitutive histone acetylation, and 44% had no histone acetylation. These latter orphan sites also lacked other activating modifications (e.g. H3K4me1, H3K4me2) and were typically remote from transcription start sites. In these cases the closest gene was typically an IFN-inducible locus that did not respond to IFN in this setting. Orphan sites were detected in different cell types, suggesting broad relevance. Despite an atypical downstream response (i.e. no histone modifications), IRF1 binding depended on SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4 (SMARCA4 or BRG1), as is typical of active IRF1 enhancers. Although SMARCA4 permitted IRF1 access to the orphan sites, there was no corecruitment of the histone acetyltransferases CREB-binding protein (CBP) and p300. Orphan sites were constitutively unacetylated, and several were marked with repressive chromatin modifications (e.g. H3K27me3). In conclusion, although IRF1 can trigger enhanceosome formation independently of STAT1, its ability to do so depends on local chromatin cues.	[Abou El Hassan, Mohamed; Huang, Katherine; Xu, Zhaodong; Yu, Tao; Bremner, Rod] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Abou El Hassan, Mohamed] Queen Elizabeth Hosp, Prov Lab Serv, Clin Chem Div, Charlottetown, PE C1A 8T5, Canada; [Abou El Hassan, Mohamed] Dalhousie Univ, Fac Med, Dept Pathol, Halifax, NS B3H 4R2, Canada; [Bremner, Rod] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Bremner, Rod] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University; Dalhousie University; University of Toronto; University of Toronto	Bremner, R (corresponding author), Mt Sinai Hosp, Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	bremner@lunenfeld.ca	Bremner, Rod/I-6490-2012	Bremner, Rod/0000-0001-9184-7212	Krembil Foundation; Canadian Cancer Society Research Institute	Krembil Foundation; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by funding from the Krembil Foundation (to R. B.) and from the Canadian Cancer Society Research Institute (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abou El Hassan M, 2017, BMC MOL BIOL, V18, DOI 10.1186/s12867-017-0084-1; Abou El Hassan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126466; Bemer M, 2018, METHODS MOL BIOL, V1675, P205, DOI 10.1007/978-1-4939-7318-7_13; Carrascosa LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15366; Chow NA, 2014, CELL REP, V9, P1718, DOI 10.1016/j.celrep.2014.11.011; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eklund EA, 1999, J IMMUNOL, V163, P6095; El Hassan MA, 2015, J IMMUNOL, V194, P5007, DOI 10.4049/jimmunol.1403247; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Leung YT, 2015, EPIGENETICS-US, V10, P191, DOI 10.1080/15592294.2015.1009764; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Lupien M, 2009, MOL CELL BIOL, V29, P3413, DOI 10.1128/MCB.00020-09; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Negishi H, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028423; Ni ZY, 2008, NAT IMMUNOL, V9, P785, DOI 10.1038/ni.1619; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Suzuki K, 2017, ADV PROTEIN CHEM STR, V106, P71, DOI 10.1016/bs.apcsb.2016.08.002; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Zakharova N, 2003, J BIOL CHEM, V278, P43067, DOI 10.1074/jbc.M308166200; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	29	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10353	10362		10.1074/jbc.RA118.002889	http://dx.doi.org/10.1074/jbc.RA118.002889			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29748386	Green Published, hybrid			2022-12-28	WOS:000437096700033
J	Kurasawa, Y; Hu, HQ; Zhou, Q; Li, ZY				Kurasawa, Yasuhiro; Hu, Huiqing; Zhou, Qing; Li, Ziyin			The trypanosome-specific protein CIF3 cooperates with the CIF1 protein to promote cytokinesis in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cell division; cytokinesis; parasite; Trypanosoma brucei; Aurora B kinase; kinetoplastid; polo-like kinase; sleeping sickness; trypanosomiasis; CIF1; CIF2; CIF3	POLO-LIKE KINASE; CELL MORPHOGENESIS; INITIATION; SEGREGATION; EXPRESSION; FLAGELLUM; ROLES; RING	Cytokinesis, the terminal step in cell division, in the protist human pathogen Trypanosoma brucei occurs along the longitudinal axis from the anterior tip of the new flagellum attachment zone (FAZ) toward the posterior cell tip. This process is regulated by a signaling cascade composed of the Polo-like kinase homolog TbPLK, the Aurora B kinase homolog TbAUK1, and the trypanosome-specific CIF1-CIF2 protein complex. However, the regulatory mechanism and the signaling pathway for this unusual mode of cytokinesis remain poorly understood. Here, we report another trypanosome-specific protein assembly, the CIF1-CIF3 complex, and its essential role in cytokinesis initiation. Through biochemical and genetic approaches, we demonstrate that CIF3 interacts with CIF1 in a TbPLK-dependent manner and maintains CIF1 localization at the new FAZ tip. Conversely, CIF1 maintains CIF3 stability at the new FAZ tip. We further show that TbPLK is required for CIF3 localization and that CIF3 is necessary for targeting TbAUK1 to the new FAZ tip during anaphase. These results suggest that two trypanosome-specific CIF1-containing protein complexes cooperate with the evolutionarily conserved Polo-like kinase and Aurora B kinase to promote cytokinesis in T. brucei.	[Kurasawa, Yasuhiro; Hu, Huiqing; Zhou, Qing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/I-6223-2019; Zhou, Qing/A-8296-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [AI101437, AI118736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101437, R01AI118736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI101437 and AI118736. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; Cheffings TH, 2016, CURR BIOL, V26, pR719, DOI 10.1016/j.cub.2016.06.071; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hu HQ, 2017, J CELL SCI, V130, P4108, DOI 10.1242/jcs.207134; Hu HQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006146; Hu HQ, 2015, J BIOL CHEM, V290, P25012, DOI 10.1074/jbc.M115.674796; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Li Z, 2010, EUKARYOT CELL, V9, P705, DOI 10.1128/EC.00330-09; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Muller S, 2016, SEMIN CELL DEV BIOL, V53, P10, DOI 10.1016/j.semcdb.2015.10.037; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wickstead B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015020; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	26	18	18	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10275	10286		10.1074/jbc.RA118.003113	http://dx.doi.org/10.1074/jbc.RA118.003113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764941	Green Published, hybrid			2022-12-28	WOS:000437096700026
J	Marciano, G; Da Vela, S; Tria, G; Svergun, DI; Byron, O; Huang, DT				Marciano, Gabriele; Da Vela, Stefano; Tria, Giancarlo; Svergun, Dmitri I.; Byron, Olwyn; Huang, Danny T.			Structure-specific recognition protein-1 (SSRP1) is an elongated homodimer that binds histones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						analytical ultracentrifugation; small-angle X-ray scattering (SAXS); histone chaperone; oligomerization; histone; H2A-H2B; H3-H4; homodimer; SSRP1	SMALL-ANGLE SCATTERING; DNA-POLYMERASE ALPHA; N-TERMINAL DOMAIN; CHAPERONE FACT; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; NUCLEOSOME REORGANIZATION; CHROMATIN; REPLICATION; SPT16	The histone chaperone complex facilitates chromatin transcription (FACT) plays important roles in DNA repair, replication, and transcription. In the formation of this complex, structure-specific recognition protein-1 (SSRP1) heterodimerizes with suppressor of Ty 16 (SPT16). SSRP1 also has SPT16-independent functions, but how SSRP1 functions alone remains elusive. Here, using analytical ultracentrifugation (AUC) and small-angle X-ray scattering (SAXS) techniques, we characterized human SSRP1 and that from the amoeba Dictyostelium discoideum and show that both orthologs form an elongated homodimer in solution. We found that substitutions in the SSRP1 pleckstrin homology domain known to bind SPT16 also disrupt SSRP1 homodimerization. Moreover, AUC and SAXS analyses revealed that SSRP1 homodimerization and heterodimerization with SPT16 (resulting in FACT) involve the same SSRP1 surface, namely the PH2 region, and that the FACT complex contains only one molecule of SSRP1. These observations suggest that SSRP1 homo- and heterodimerization might be mutually exclusive. Moreover, isothermal titration calorimetry analyses disclosed that SSRP1 binds both histones H2A-H2B and H3-H4 and that disruption of SSRP1 homodimerization decreases its histone-binding affinity. Together, our results provide evidence for regulation of SSRP1 by homodimerization and suggest a potential role for homodimerization in facilitating SPT16-independent functions of SSRP1.	[Marciano, Gabriele; Huang, Danny T.] Univ Glasgow, Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland; [Marciano, Gabriele; Huang, Danny T.] Univ Glasgow, Inst Canc Sci, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland; [Da Vela, Stefano; Tria, Giancarlo; Svergun, Dmitri I.] European Mol Biol Lab, Hamburg Outstn, EMBL DESY, Notkestr 85, D-22607 Hamburg, Germany; [Byron, Olwyn] Univ Glasgow, Sch Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Tria, Giancarlo] Maastricht Univ, Multimodal Imaging Inst, Div Nanoscopy, POB 616, NL-6200 MD Maastricht, Netherlands	Beatson Institute; University of Glasgow; University of Glasgow; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Glasgow; Maastricht University	Marciano, G (corresponding author), Univ Glasgow, Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.; Marciano, G (corresponding author), Univ Glasgow, Inst Canc Sci, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	gabriele.marciano@bioch.ox.ac.uk; d.huang@beatson.gla.ac.uk	Huang, Danny/AAM-3631-2021	Huang, Danny/0000-0002-6192-259X; Svergun, Dmitri/0000-0003-0830-5696; Marciano, Gabriele/0000-0003-2720-652X; TRIA, Giancarlo/0000-0003-4736-471X; Byron, Olwyn/0000-0001-7857-4520	Cancer Research UK [A23278]	Cancer Research UK(Cancer Research UK)	This work was supported in part by Cancer Research UK Grant A23278. The authors declare that they have no conflicts of interest with the contents of this article.	Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Dam J, 2004, METHOD ENZYMOL, V384, P185; Fazly A, 2012, J BIOL CHEM, V287, P10753, DOI 10.1074/jbc.M112.347450; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hoffmann C, 2015, ACS CHEM BIOL, V10, P2753, DOI 10.1021/acschembio.5b00493; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Ikeda Y, 2011, DEV CELL, V21, P589, DOI 10.1016/j.devcel.2011.08.013; Kasai N, 2005, J BIOMOL NMR, V32, P83, DOI 10.1007/s10858-005-3662-3; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Kemble DJ, 2015, MOL CELL, V60, P294, DOI 10.1016/j.molcel.2015.09.008; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lambert SJ, 1999, ACTA CRYSTALLOGR D, V55, P1048, DOI 10.1107/S0907444999001912; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P99; Li YP, 2007, J BIOL CHEM, V282, P6936, DOI 10.1074/jbc.M603822200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marciano G, 2016, ACTA CRYSTALLOGR F, V72, P121, DOI 10.1107/S2053230X15024565; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Schlesinger MB, 2000, GENETICS, V155, P1593; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SMITH CA, 1988, BIOCHEM EDUC, V16, P104, DOI 10.1016/0307-4412(88)90075-1; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Svejstrup JQ, 2002, CURR OPIN GENET DEV, V12, P156, DOI 10.1016/S0959-437X(02)00281-2; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Tsunaka Y, 2016, GENE DEV, V30, P673, DOI 10.1101/gad.274183.115; Tsunaka Y, 2009, J BIOL CHEM, V284, P24610, DOI 10.1074/jbc.M109.001958; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Zeng SX, 2010, MOL CELL BIOL, V30, P935, DOI 10.1128/MCB.01379-09; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zhang W., 2015, SCI REPORTS, V5, P1, DOI DOI 10.1038/SREP10791; Zunder RM, 2012, P NATL ACAD SCI USA, V109, pE144, DOI 10.1073/pnas.1119095109	65	8	9	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10071	10083		10.1074/jbc.RA117.000994	http://dx.doi.org/10.1074/jbc.RA117.000994			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764934	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000437096700012
J	Fragiadaki, M; Zeidler, MP				Fragiadaki, Maria; Zeidler, Martin P.			Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; cancer biology; microRNA (miRNA); microRNA mechanism; cell proliferation; ANKHD1; ccRCC; clear cell; miR-29a; miRNA-binding	MICRORNA EXPRESSION PROFILE; PROMOTES; HIPPO; MASK; IDENTIFICATION; MIGRATION; REVEALS; PATHWAY; BIOGENESIS; ACTIVATION	Clear cell renal cell carcinoma (ccRCC) represents the most common kidney cancer worldwide. Increased cell proliferation associated with abnormal microRNA (miRNA) regulation are hallmarks of carcinogenesis. Ankyrin repeat and single KH domain 1 (ANKHD1) is a highly conserved protein found to interact with core cancer pathways in Drosophila; however, its involvement in RCC is completely unexplored. Quantitative PCR studies coupled with large-scale genomics data sets demonstrated that ANKHD1 is significantly up-regulated in kidneys of RCC patients when compared with healthy controls. Cell cycle analysis revealed that ANKHD1 is an essential factor for RCC cell division. To understand the molecular mechanism(s) utilized by ANKHD1 to drive proliferation, we performed bioinformatics analyses that revealed that ANKHD1 contains a putative miRNA-binding motif. We screened 48 miRNAs with tumor-enhancing or -suppressing activities and found that ANKHD1 binds to and regulates three tumor-suppressing miRNAs (i.e. miR-29a, miR-205, and miR-196a). RNA-immunoprecipitation assays demonstrated that ANKHD1 physically interacts with its target miRNAs via a single K-homology domain, located in the C terminus of the protein. Functionally, we discovered that ANKHD1 positively drives ccRCC cell mitosis via binding to and suppressing mainly miR-29a and to a lesser degree via miR-196a/205, leading to up-regulation in proliferative genes such as CCDN1. Collectively, these data identify ANKHD1 as a new regulator of ccRCC proliferation via specific miRNA interactions.	[Fragiadaki, Maria] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Acad Nephrol Unit, Hallamshire Tower, Sheffield S10 2RX, S Yorkshire, England; [Fragiadaki, Maria; Zeidler, Martin P.] Univ Sheffield, Bateson Ctr, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Fragiadaki, M (corresponding author), Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Acad Nephrol Unit, Hallamshire Tower, Sheffield S10 2RX, S Yorkshire, England.	m.fragiadaki@sheffield.ac.uk		Zeidler, Martin/0000-0003-2942-1135; Fragiadaki, Maria/0000-0002-1587-5577	Kidney Research UK Fellowship; Thomas-Berry and Simpson Fellowship; Cancer Research UK Senior Fellowship	Kidney Research UK Fellowship(Kidney Research UK (KRUK)); Thomas-Berry and Simpson Fellowship; Cancer Research UK Senior Fellowship	This work was supported by a Kidney Research UK Fellowship and a Thomas-Berry and Simpson Fellowship (to M.F.) and a Cancer Research UK Senior Fellowship (to M.P.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Avraham R, 2012, BIOCHEM SOC T, V40, P26, DOI 10.1042/BST20110623; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen JJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-169; Chen L, 2014, BMB REP, V47, P39, DOI 10.5483/BMBRep.2014.47.1.079; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Chen Z, 2014, ONCOL RES TREAT, V37, P658, DOI 10.1159/000368792; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dhyani A, 2015, EUR J CANCER, V51, P252, DOI 10.1016/j.ejca.2014.11.012; Fragiadaki M, 2017, KIDNEY INT, V91, P575, DOI 10.1016/j.kint.2016.10.039; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; He HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125672; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Hollingworth D, 2012, NUCLEIC ACIDS RES, V40, P6873, DOI 10.1093/nar/gks368; Karlsson P, 2015, P NATL ACAD SCI USA, V112, P14096, DOI 10.1073/pnas.1512865112; Li YF, 2016, MOL MED REP, V14, P560, DOI 10.3892/mmr.2016.5251; Lin S, 2016, J BIOL CHEM, V291, P15342, DOI 10.1074/jbc.M116.726067; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Ma WB, 2012, J BIOL CHEM, V287, P10189, DOI 10.1074/jbc.M111.303636; Machado-Neto JA, 2014, EXP CELL RES, V324, P137, DOI 10.1016/j.yexcr.2014.04.004; Mamoori A, 2016, BIOL CELL, V108, P51, DOI 10.1111/boc.201500062; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nishikawa R, 2015, FEBS LETT, V589, P2136, DOI 10.1016/j.febslet.2015.06.005; Piazzon N, 2012, J MOL CELL BIOL, V4, P398, DOI 10.1093/jmcb/mjs027; Sansores-Garcia L, 2013, CURR BIOL, V23, P229, DOI 10.1016/j.cub.2012.12.033; Sidor CM, 2013, CURR BIOL, V23, P223, DOI 10.1016/j.cub.2012.11.061; Smith RK, 2002, DEVELOPMENT, V129, P71; Tang W, 2014, BRIT J CANCER, V110, P450, DOI 10.1038/bjc.2013.724; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Traina F, 2006, BBA-MOL BASIS DIS, V1762, P828, DOI 10.1016/j.bbadis.2006.07.010; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; Xu L, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-17; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhao ZJ, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0513-x; Zhu MW, 2015, HUM MOL GENET, V24, P3272, DOI 10.1093/hmg/ddv081	45	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9570	9579		10.1074/jbc.RA117.000975	http://dx.doi.org/10.1074/jbc.RA117.000975			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29695508	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000436102300002
J	Mueller, JW; Idkowiak, J; Gesteira, TF; Vallet, C; Hardman, R; van den Boom, J; Dhir, V; Knauer, SK; Rosta, E; Arlt, W				Mueller, Jonathan W.; Idkowiak, Jan; Gesteira, Tarsis F.; Vallet, Cecilia; Hardman, Rebecca; van den Boom, Johannes; Dhir, Vivek; Knauer, Shirley K.; Rosta, Edina; Arlt, Wiebke			Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						steroid hormone; sulfotransferase; molecular docking; enzyme kinetics; protein-protein interaction; dehydroepiandrosterone; DHEAS; PAPS synthase; steroid sulfation pathway	PROTEIN-PROTEIN DOCKING; CYTOSOLIC SULFOTRANSFERASES; QUINARY STRUCTURE; CRYSTAL-STRUCTURE; LOCALIZATION; EXPRESSION; MUTATIONS; EVOLUTION; ENZYMES; DOMAIN	The high-energy sulfate donor 3-phosphoadenosine-5-phosphosulfate (PAPS), generated by human PAPS synthase isoforms PAPSS1 and PAPSS2, is required for all human sulfation pathways. Sulfotransferase SULT2A1 uses PAPS for sulfation of the androgen precursor dehydroepiandrosterone (DHEA), thereby reducing downstream activation of DHEA to active androgens. Human PAPSS2 mutations manifest with undetectable DHEA sulfate, androgen excess, and metabolic disease, suggesting that ubiquitous PAPSS1 cannot compensate for deficient PAPSS2 in supporting DHEA sulfation. In knockdown studies in human adrenocortical NCI-H295R1 cells, we found that PAPSS2, but not PAPSS1, is required for efficient DHEA sulfation. Specific APS kinase activity, the rate-limiting step in PAPS biosynthesis, did not differ between PAPSS1 and PAPSS2. Co-expression of cytoplasmic SULT2A1 with a cytoplasmic PAPSS2 variant supported DHEA sulfation more efficiently than co-expression with nuclear PAPSS2 or nuclear/cytosolic PAPSS1. Proximity ligation assays revealed protein-protein interactions between SULT2A1 and PAPSS2 and, to a lesser extent, PAPSS1. Molecular docking studies showed a putative binding site for SULT2A1 within the PAPSS2 APS kinase domain. Energy-dependent scoring of docking solutions identified the interaction as specific for the PAPSS2 and SULT2A1 isoforms. These findings elucidate the mechanistic basis for the selective requirement for PAPSS2 in human DHEA sulfation.	[Mueller, Jonathan W.; Idkowiak, Jan; Hardman, Rebecca; Dhir, Vivek; Arlt, Wiebke] Univ Birmingham, IMSR, Birmingham B15 2TT, W Midlands, England; [Mueller, Jonathan W.; Idkowiak, Jan; Arlt, Wiebke] Birmingham Hlth Partners, CEDAM, Birmingham B15 2TH, W Midlands, England; [Gesteira, Tarsis F.; Rosta, Edina] Kings Coll London, Dept Chem, London SE1 1DB, England; [Vallet, Cecilia; Knauer, Shirley K.] Univ Duisburg Essen, Dept Mol Biol 2, Ctr Med Biotechnol ZMB, D-45141 Essen, Germany; [van den Boom, Johannes] Univ Duisburg Essen, Dept Mol Biol 1, Ctr Med Biotechnol ZMB, D-45141 Essen, Germany	University of Birmingham; University of London; King's College London; University of Duisburg Essen; University of Duisburg Essen	Mueller, JW (corresponding author), Univ Birmingham, Coll Med & Dent Sci, IMSR, Birmingham B15 2TT, W Midlands, England.	j.w.mueller@bham.ac.uk	Arlt, Wiebke/B-6310-2009; Idkowiak, Jan/R-9990-2019; Knauer, Shirley K/E-7931-2012; Mueller, Jonathan Wolf/D-1632-2010	Arlt, Wiebke/0000-0001-5106-9719; Knauer, Shirley K/0000-0003-4321-0924; Vallet, Cecilia/0000-0002-9413-846X; Mueller, Jonathan Wolf/0000-0003-1212-189X; Idkowiak, Jan/0000-0001-9181-3995; Rosta, Edina/0000-0002-9823-4766	European Commission Marie Curie Fellowship [SUPA-HD 625451]; Wellcome Trust [092283]; ISSF award; Medical Research Council UK Research Training Fellowship [G1001964]; Biotechnology and Biological Sciences Research Council UK Grant [BB/N007700/1]; Society for Endocrinology Early Career Grant; BBSRC [BB/N007700/1] Funding Source: UKRI; EPSRC [EP/L000253/1, EP/M022609/1] Funding Source: UKRI; MRC [G1001964] Funding Source: UKRI	European Commission Marie Curie Fellowship(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); ISSF award; Medical Research Council UK Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council UK Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Society for Endocrinology Early Career Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Commission Marie Curie Fellowship SUPA-HD 625451 (to J. W. M.), Wellcome Trust Project Grant 092283 (to W. A.), ISSF award (to J. W. M.), Medical Research Council UK Research Training Fellowship G1001964 (to J. I.), the Biotechnology and Biological Sciences Research Council UK Grant BB/N007700/1 (to E. R.), and a Society for Endocrinology Early Career Grant (to J. W. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Barlow K. A., 2018, J PHYS CHEM B, DOI [10.1021/acs.jcpb.7b11367, DOI 10.1021/ACS.JCPB.7B11367]; Bernstein RM, 2012, AM J PHYS ANTHROPOL, V147, P389, DOI 10.1002/ajpa.22001; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chan KX, 2016, P NATL ACAD SCI USA, V113, pE4567, DOI 10.1073/pnas.1604936113; Cohen RD, 2017, PROTEIN SCI, V26, P403, DOI 10.1002/pro.3092; Coughtrie MWH, 2016, CHEM-BIOL INTERACT, V259, P2, DOI 10.1016/j.cbi.2016.05.005; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; FEHER T, 1977, ACTA ENDOCRINOL-COP, V85, P126; Fuda H, 2002, BIOCHEM J, V365, P497, DOI 10.1042/BJ20020044; Gesteira TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070880; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grum D, 2010, BIOCHEM BIOPH RES CO, V395, P420, DOI 10.1016/j.bbrc.2010.04.039; Herrero J, 2016, DATABASE OXFORD, V2016; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirschmann F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04539-2; Hudson Benjamin H, 2012, Adv Biol Regul, V52, P229; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kauffman FC, 2004, DRUG METAB REV, V36, P823, DOI 10.1081/DMR-200033496; Kalsch J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13058; Kessler D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-37; Knapp B, 2011, J COMPUT BIOL, V18, P997, DOI 10.1089/cmb.2010.0237; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lansdon EB, 2004, BIOCHEMISTRY-US, V43, P4356, DOI 10.1021/bi049827m; LIPMANN F, 1958, SCIENCE, V128, P575, DOI 10.1126/science.128.3324.575; Lu LY, 2009, DRUG METAB DISPOS, V37, P1083, DOI 10.1124/dmd.108.025395; Matena A, 2013, STRUCTURE, V21, P1769, DOI 10.1016/j.str.2013.07.016; MCCONKEY EH, 1982, P NATL ACAD SCI-BIOL, V79, P3236, DOI 10.1073/pnas.79.10.3236; Mueller JW, 2015, ENDOCR REV, V36, P526, DOI 10.1210/er.2015-1036; Mueller JW, 2013, FEBS J, V280, P3050, DOI 10.1111/febs.12252; Nagai N, 2004, J CELL SCI, V117, P3331, DOI 10.1242/jcs.01191; Noordam C, 2009, NEW ENGL J MED, V360, P2310, DOI 10.1056/NEJMoa0810489; Oostdijk W, 2015, J CLIN ENDOCR METAB, V100, pE672, DOI 10.1210/jc.2014-3556; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; Pedersen LC, 2000, FEBS LETT, V475, P61, DOI 10.1016/S0014-5793(00)01479-4; Rai BK, 2006, BIOINFORMATICS, V22, P2691, DOI 10.1093/bioinformatics/btl449; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Schroder E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029559; Schuler G, 2018, J STEROID BIOCHEM, V179, P55, DOI 10.1016/j.jsbmb.2017.10.006; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Sircar A, 2010, PROTEINS, V78, P3115, DOI 10.1002/prot.22765; Stelzer C, 2007, DEV DYNAM, V236, P1313, DOI 10.1002/dvdy.21137; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; van den Boom J, 2012, J BIOL CHEM, V287, P17645, DOI 10.1074/jbc.M111.325498; Wang T, 2016, BIOCHEMISTRY-US, V55, P4036, DOI 10.1021/acs.biochem.6b00401; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Weitzner B, 2009, PROTEINS, V75, P289, DOI 10.1002/prot.22347; Yang G, 2016, BIOCHEMISTRY-US, V55, P4583, DOI 10.1021/acs.biochem.6b00561	56	21	22	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9724	9735		10.1074/jbc.RA118.002248	http://dx.doi.org/10.1074/jbc.RA118.002248			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743239	Green Published, hybrid			2022-12-28	WOS:000436102300017
J	Prakash, D; Walters, KA; Martinie, RJ; McCarver, AC; Kumar, AK; Lessner, DJ; Krebs, C; Golbeck, JH; Ferry, JG				Prakash, Divya; Walters, Karim A.; Martinie, Ryan J.; McCarver, Addison C.; Kumar, Adepu K.; Lessner, Daniel J.; Krebs, Carsten; Golbeck, John H.; Ferry, James G.			Toward a mechanistic and physiological understanding of a ferredoxin:disulfide reductase from the domains Archaea and Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; stress; enzyme mechanism; disulfide; thioredoxin	METHANOSARCINA-ACETIVORANS; THIOREDOXIN REDUCTASE; FERREDOXINTHIOREDOXIN REDUCTASE; SPECTROSCOPIC CHARACTERIZATION; DISULFIDE REDUCTION; CATALYTIC MECHANISM; CLUSTER CHEMISTRY; 4FE-4S CLUSTER; SITE; METHANE	Disulfide reductases reduce other proteins and are critically important for cellular redox signaling and homeostasis. Methanosarcina acetivorans is a methane-producing microbe from the domain Archaea that produces a ferredoxin:disulfide reductase (FDR) for which the crystal structure has been reported, yet its biochemical mechanism and physiological substrates are unknown. FDR and the extensively characterized plant-type ferredoxin:thioredoxin reductase (FTR) belong to a distinct class of disulfide reductases that contain a unique active-site [4Fe-4S] cluster. The results reported here support a mechanism for FDR similar to that reported for FTR with notable exceptions. Unlike FTR, FDR contains a rubredoxin [1Fe-0S] center postulated to mediate electron transfer from ferredoxin to the active-site [4Fe-4S] cluster. UV-visible, EPR, and Mossbauer spectroscopic data indicated that two-electron reduction of the active-site disulfide in FDR involves a one-electron-reduced [4Fe-4S](1+) intermediate previously hypothesized for FTR. Our results support a role for an active-site tyrosine in FDR that occupies the equivalent position of an essential histidine in the active site of FTR. Of note, one of seven Trxs encoded in the genome (Trx5) and methanoredoxin, a glutaredoxin-like enzyme from M. acetivorans, were reduced by FDR, advancing the physiological understanding of FDR's role in the redox metabolism of methanoarchaea. Finally, bioinformatics analyses show that FDR homologs are widespread in diverse microbes from the domain Bacteria.	[Prakash, Divya; Walters, Karim A.; Kumar, Adepu K.; Krebs, Carsten; Golbeck, John H.; Ferry, James G.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Martinie, Ryan J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [McCarver, Addison C.; Lessner, Daniel J.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [McCarver, Addison C.] ImmunoVision Inc, 1820 Ford Ave, Springdale, AR 72764 USA; [Kumar, Adepu K.] Sardar Patel Renewable Energy Res Inst, Post Box 2,Near BVM Engn Coll, Vallabh Vidyanagar 388120, Gujarat, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Arkansas System; University of Arkansas Fayetteville	Ferry, JG (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	jgf3@psu.edu	Prakash, Divya/Z-5061-2019; Krebs, Carsten/D-4773-2009; Kiran Kumar, Dr. Adepu/AAD-2089-2019	Prakash, Divya/0000-0003-0080-2583; Krebs, Carsten/0000-0002-3302-7053; Kiran Kumar, Dr. Adepu/0000-0001-6612-1823; Martinie, Ryan/0000-0003-1257-2850	National Science Foundation Graduate Research Fellowship Program Grant [DGE1255832]; NASA Exobiology Grant [NNX12AR60G]; Arkansas Biosciences Institute, major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000; National Science Foundation [MCB-1613022, MCB-1359578]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-95ER20198 MOD16, DE-FG02-95ER20198 MOD17]; Person Endowment; Div Of Molecular and Cellular Bioscience [1359578] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship Program Grant; NASA Exobiology Grant(National Aeronautics & Space Administration (NASA)); Arkansas Biosciences Institute, major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000; National Science Foundation(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Person Endowment; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by National Science Foundation Graduate Research Fellowship Program Grant DGE1255832.; Supported by NASA Exobiology Grant NNX12AR60G and the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000.; Supported by National Science Foundation Grants MCB-1613022 and MCB-1359578 for the EPR spectroscopy and redox titrations, respectively.; Supported by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grants DE-FG02-95ER20198 MOD16 and 17 (90%) and the Person Endowment (10%). To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania 16802. Tel.: 814-863-5721; E-mail: jgf3@psu.edu.	Balsera M, 2013, PLANTA, V237, P619, DOI 10.1007/s00425-012-1803-y; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; Eidsness MK, 1999, BIOCHEMISTRY-US, V38, P14803, DOI 10.1021/bi991661f; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Fahey RC, 2013, BBA-GEN SUBJECTS, V1830, P3182, DOI 10.1016/j.bbagen.2012.10.006; Gilmore SP, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4036-4; Glauser DA, 2004, J BIOL CHEM, V279, P16662, DOI 10.1074/jbc.M313851200; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Jameson GNL, 2003, J AM CHEM SOC, V125, P1146, DOI 10.1021/ja029338e; Kumar AK, 2015, BIOCHEMISTRY-US, V54, P3122, DOI 10.1021/acs.biochem.5b00137; Lessner DJ, 2006, P NATL ACAD SCI USA, V103, P17921, DOI 10.1073/pnas.0608833103; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; McCarver AC, 2017, MICROBIOL-SGM, V163, P62, DOI 10.1099/mic.0.000406; McCarver AC, 2014, FEBS J, V281, P4598, DOI 10.1111/febs.12964; MCFARLAN SC, 1992, J BIOL CHEM, V267, P10561; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; MIDDLETON P, 1978, EUR J BIOCHEM, V88, P135, DOI 10.1111/j.1432-1033.1978.tb12430.x; Munck E., 2000, PHYS METHODS BIOINOR, P287; NEWMAN DJ, 1968, EUR J BIOCHEM, V7, P45, DOI 10.1111/j.1432-1033.1968.tb19571.x; ONATE YA, 1989, J BIOL CHEM, V264, P18386; ONDARZA RN, 1983, J MOL EVOL, V19, P371, DOI 10.1007/BF02101641; Pandelia ME, 2015, BBA-MOL CELL RES, V1853, P1395, DOI 10.1016/j.bbamcr.2014.12.005; Schurmann P, 1995, PHOTOSYNTH RES, V46, P309, DOI 10.1007/BF00020445; Sheehan R, 2015, J IND MICROBIOL BIOT, V42, P965, DOI 10.1007/s10295-015-1592-y; Staples CR, 1998, BIOCHEMISTRY-US, V37, P4612, DOI 10.1021/bi9729763; Susanti D, 2014, P NATL ACAD SCI USA, V111, P2608, DOI 10.1073/pnas.1324240111; Wagner T, 2017, SCIENCE, V357, P699, DOI 10.1126/science.aan0425; Walters EM, 2009, BIOCHEMISTRY-US, V48, P1016, DOI 10.1021/bi802074p; Walters EM, 2005, J AM CHEM SOC, V127, P9612, DOI 10.1021/ja051909q; Walters EM, 2004, PHOTOSYNTH RES, V79, P249, DOI 10.1023/B:PRES.0000017195.05870.61; Wei YF, 2015, BIOCHEMISTRY-US, V54, P7019, DOI 10.1021/acs.biochem.5b01092; Yenugudhati D, 2016, BIOCHEMISTRY-US, V55, P313, DOI 10.1021/acs.biochem.5b00823	37	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9198	9209		10.1074/jbc.RA118.002473	http://dx.doi.org/10.1074/jbc.RA118.002473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29720404	Green Published, hybrid			2022-12-28	WOS:000435441400006
J	Ul Husna, A; Wang, N; Cobbold, SA; Newton, HJ; Hocking, DM; Wilksch, JJ; Scott, TA; Davies, MR; Hinton, JC; Tree, JJ; Lithgow, T; McConville, MJ; Strugnell, RA				Ul Husna, Asma; Wang, Nancy; Cobbold, Simon A.; Newton, Hayley J.; Hocking, Dianna M.; Wilksch, Jonathan J.; Scott, Timothy A.; Davies, Mark R.; Hinton, Jay C.; Tree, Jai J.; Lithgow, Trevor; McConville, Malcolm J.; Strugnell, Richard A.			Methionine biosynthesis and transport are functionally redundant for the growth and virulence of Salmonella Typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						methionine; S-adenosylmethionine (SAM); biosynthesis; transporter; Salmonella enterica; peptidoglycan; in vivo infection; virulence	ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; S-ADENOSYLMETHIONINE; CONTAINING VACUOLE; ABC TRANSPORTER; IN-VITRO; GENE; METABOLISM; INFECTION; MUTANTS	Methionine (Met) is an amino acid essential for many important cellular and biosynthetic functions, including the initiation of protein synthesis and S-adenosylmethionine-mediated methylation of proteins, RNA, and DNA. The de novo biosynthetic pathway of Met is well conserved across prokaryotes but absent from vertebrates, making it a plausible antimicrobial target. Using a systematic approach, we examined the essentiality of de novo methionine biosynthesis in Salmonella enterica serovar Typhimurium, a bacterial pathogen causing significant gastrointestinal and systemic diseases in humans and agricultural animals. Our data demonstrate that Met biosynthesis is essential for S. Typhimurium to grow in synthetic medium and within cultured epithelial cells where Met is depleted in the environment. During systemic infection of mice, the virulence of S. Typhimurium was not affected when either de novo Met biosynthesis or high-affinity Met transport was disrupted alone, but combined disruption in both led to severe in vivo growth attenuation, demonstrating a functional redundancy between de novo biosynthesis and acquisition as a mechanism of sourcing Met to support growth and virulence for S. Typhimurium during infection. In addition, our LC-MS analysis revealed global changes in the metabolome of S. Typhimurium mutants lacking Met biosynthesis and also uncovered unexpected interactions between Met and peptidoglycan biosynthesis. Together, this study highlights the complexity of the interactions between a single amino acid, Met, and other bacterial processes leading to virulence in the host and indicates that disrupting the de novo biosynthetic pathway alone is likely to be ineffective as an antimicrobial therapy against S. Typhimurium.	[Ul Husna, Asma; Wang, Nancy; Newton, Hayley J.; Hocking, Dianna M.; Wilksch, Jonathan J.; Scott, Timothy A.; Davies, Mark R.; Tree, Jai J.; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3000, Australia; [Cobbold, Simon A.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Parkville, Vic 3052, Australia; [Hinton, Jay C.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Tree, Jai J.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Lithgow, Trevor] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Scott, Timothy A.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England; [Lithgow, Trevor] Australian Res Council, Canberra, ACT, Australia	University of Melbourne; University of Melbourne; University of Liverpool; University of New South Wales Sydney; Monash University; University of London; London School of Hygiene & Tropical Medicine	Wang, N; Strugnell, RA (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3000, Australia.	nancyw@unimelb.edu.au; rastru@unimelb.edu.au	Wang, Nancy/K-4949-2019; Wang, Nancy/C-1518-2016; Hinton, Jay C. D./B-2142-2008; Davies, Mark R/J-2128-2014; Lithgow, Trevor/H-5925-2017	Wang, Nancy/0000-0001-7623-1858; Hinton, Jay C. D./0000-0003-2671-6026; Davies, Mark R/0000-0001-6141-5179; Cobbold, Simon/0000-0002-9927-8998; Lithgow, Trevor/0000-0002-0102-7884; Strugnell, Richard/0000-0003-0614-5641; Scott, Timothy/0000-0001-7042-8609; Husna, Asma Ul/0000-0001-7740-9849; Tree, Jai/0000-0001-8233-0975; Newton, Hayley/0000-0002-9240-2001	Australian National Health and Medical Research Council Program (NHMRC) Program [606788]; International Postgraduate Research Scholarship in Australia	Australian National Health and Medical Research Council Program (NHMRC) Program(National Health and Medical Research Council (NHMRC) of Australia); International Postgraduate Research Scholarship in Australia	This work was supported by Australian National Health and Medical Research Council Program (NHMRC) Program Grant 606788 (to T.L. and R.A.S.). This work was also supported by an International Postgraduate Research Scholarship in Australia (to A.U.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Augustus AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-558; AYLING PD, 1972, J GEN MICROBIOL, V73, P127, DOI 10.1099/00221287-73-1-127; AYLING PD, 1979, J GEN MICROBIOL, V114, P227, DOI 10.1099/00221287-114-2-227; BANERJEE RV, 1989, J BIOL CHEM, V264, P13888; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Berney M, 2015, P NATL ACAD SCI USA, V112, P10008, DOI 10.1073/pnas.1513033112; Bertrand EM, 2013, LIMNOL OCEANOGR, V58, P1431, DOI 10.4319/lo.2013.58.4.1431; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bogard RW, 2012, MBIO, V3, DOI 10.1128/mBio.00236-12; Bourne CR, 2014, ANTIBIOTICS-BASEL, V3, P1, DOI 10.3390/antibiotics3010001; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Coates ARM, 2007, BRIT J PHARMACOL, V152, P1147, DOI 10.1038/sj.bjp.0707432; Cobbold SA, 2016, J INFECT DIS, V213, P276, DOI 10.1093/infdis/jiv372; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ejim LJ, 2004, INFECT IMMUN, V72, P3310, DOI 10.1128/IAI.72.6.3310-3314.2004; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; GONZALEZ JC, 1992, BIOCHEMISTRY-US, V31, P6045, DOI 10.1021/bi00141a013; Gordon MA, 2011, CURR OPIN INFECT DIS, V24, P484, DOI 10.1097/QCO.0b013e32834a9980; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Harada E, 2010, J BACTERIOL, V192, P2892, DOI 10.1128/JB.01535-09; Hernandez SB, 2015, ENVIRON MICROBIOL, V17, P1081, DOI 10.1111/1462-2920.12491; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jelsbak L, 2016, INFECT IMMUN, V84, P2076, DOI 10.1128/IAI.00182-16; JETER RM, 1984, J BACTERIOL, V159, P206, DOI 10.1128/JB.159.1.206-213.1984; KALAN EB, 1954, J BACTERIOL, V68, P293, DOI 10.1128/JB.68.3.293-298.1954; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; KATZEN HM, 1965, J BIOL CHEM, V240, P825; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; LISSNER CR, 1983, J IMMUNOL, V131, P3006; MANDELL GL, 1973, J CLIN INVEST, V52, P1673, DOI 10.1172/JCI107348; Mastroeni P., 2006, SALMONELLA INFECTION; MAXON ME, 1989, P NATL ACAD SCI USA, V86, P85, DOI 10.1073/pnas.86.1.85; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Morowitz MJ, 2011, SURG CLIN N AM, V91, P771, DOI 10.1016/j.suc.2011.05.001; Murima P, 2014, CHEM BIOL, V21, P1423, DOI 10.1016/j.chembiol.2014.08.020; Nairz M, 2009, CELL MICROBIOL, V11, P1365, DOI 10.1111/j.1462-5822.2009.01337.x; Neis EPJG, 2015, NUTRIENTS, V7, P2930, DOI 10.3390/nu7042930; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; Pitchandi P, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-29; PRATS R, 1989, J BACTERIOL, V171, P3740, DOI 10.1128/jb.171.7.3740-3745.1989; Raman SB, 2013, INFECT IMMUN, V81, P1430, DOI 10.1128/IAI.00743-12; Richardson AR, 2011, CELL HOST MICROBE, V10, P33, DOI 10.1016/j.chom.2011.06.004; RICHAUD C, 1993, J BIOL CHEM, V268, P26827; Rossi M, 2011, NUTRIENTS, V3, P118, DOI 10.3390/nu3010118; Shah DH, 2007, VET MICROBIOL, V119, P352, DOI 10.1016/j.vetmic.2006.09.002; SHAW NA, 1991, FEMS MICROBIOL LETT, V78, P127, DOI 10.1016/0378-1097(91)90145-Z; Sikora M, 2009, MICROBIOL-SGM, V155, P1858, DOI 10.1099/mic.0.026609-0; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Struck AW, 2012, CHEMBIOCHEM, V13, P2642, DOI 10.1002/cbic.201200556; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tuite NL, 2005, J BACTERIOL, V187, P4362, DOI 10.1128/JB.187.13.4362-4371.2005; TURNER SJ, 1993, INFECT IMMUN, V61, P5374, DOI 10.1128/IAI.61.12.5374-5380.1993; VAUDAUX P, 1979, ANTIMICROB AGENTS CH, V16, P743, DOI 10.1128/AAC.16.6.743; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	72	11	11	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9506	9519		10.1074/jbc.RA118.002592	http://dx.doi.org/10.1074/jbc.RA118.002592			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29720401	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000435441400033
J	Yamanaka, Y; Winardhi, RS; Yamauchi, E; Nishiyama, S; Sowa, Y; Yan, J; Kawagishi, I; Ishihama, A; Yamamoto, K				Yamanaka, Yuki; Winardhi, Ricksen S.; Yamauchi, Erika; Nishiyama, So-ichiro; Sowa, Yoshiyuki; Yan, Jie; Kawagishi, Ikuro; Ishihama, Akira; Yamamoto, Kaneyoshi			Dimerization site 2 of the bacterial DNA-binding protein H-NS is required for gene silencing and stiffened nucleoprotein filament formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); gene silencing; dimerization; transcription factor; gene regulation; bacterial chromatin; DNA compaction; H-NS; nucleoid-associated protein; transcription repression	NUCLEOID-STRUCTURING PROTEIN; ESCHERICHIA-COLI; FOREIGN DNA; TRANSCRIPTION FACTORS; IN-VITRO; DOMAIN; EXPRESSION; OLIGOMERIZATION; ORGANIZATION; RECOGNITION	The bacterial nucleoid-associated protein H-NS is a DNA-binding protein, playing a major role in gene regulation. To regulate transcription, H-NS silences genes, including horizontally acquired foreign genes. Escherichia coli H-NS is 137 residues long and consists of two discrete and independent structural domains: an N-terminal oligomerization domain and a C-terminal DNA-binding domain, joined by a flexible linker. The N-terminal oligomerization domain is composed of two dimerization sites, dimerization sites 1 and 2, which are both required for H-NS oligomerization, but the exact role of dimerization site 2 in gene silencing is unclear. To this end, we constructed a whole set of single amino acid substitution variants spanning residues 2 to 137. Using a well-characterized H-NS target, the slp promoter of the glutamic acid-dependent acid resistance (GAD) cluster promoters, we screened for any variants defective in gene silencing. Focusing on the function of dimerization site 2, we analyzed four variants, I70C/I70A and L75C/L75A, which all could actively bind DNA but are defective in gene silencing. Atomic force microscopy analysis of DNA-H-NS complexes revealed that all of these four variants formed condensed complexes on DNA, whereas WT H-NS formed rigid and extended nucleoprotein filaments, a conformation required for gene silencing. Single-molecule stretching experiments confirmed that the four variants had lost the ability to form stiffened filaments. We conclude that dimerization site 2 of H-NS plays a key role in the formation of rigid H-NS nucleoprotein filament structures required for gene silencing.	[Yamanaka, Yuki; Yamauchi, Erika; Nishiyama, So-ichiro; Sowa, Yoshiyuki; Kawagishi, Ikuro; Ishihama, Akira; Yamamoto, Kaneyoshi] Hosei Univ, Dept Frontier Biosci, 3-7-2 Kajino Cho, Tokyo 1848584, Japan; [Yamanaka, Yuki; Nishiyama, So-ichiro; Sowa, Yoshiyuki; Kawagishi, Ikuro; Ishihama, Akira; Yamamoto, Kaneyoshi] Hosei Univ, Res Ctr Micronano Technol, 3-11-15 Midori Cho, Tokyo 1840003, Japan; [Yamanaka, Yuki; Winardhi, Ricksen S.; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, 5A Engn Dr 1, Singapore 117411, Singapore; [Winardhi, Ricksen S.; Yan, Jie] Natl Univ Singapore, Dept Phys, 2 Sci Dr 3, Singapore 117542, Singapore; [Nishiyama, So-ichiro] Niigata Univ Pharm & Appl Life Sci, Fac Appl Life Sci, Akiha Ku, 265-1 Higashijima, Niigata, Niigata 9568603, Japan	Hosei University; Hosei University; National University of Singapore; National University of Singapore; Niigata University	Yamamoto, K (corresponding author), Hosei Univ, Dept Frontier Biosci, 3-7-2 Kajino Cho, Tokyo 1848584, Japan.; Yamamoto, K (corresponding author), Hosei Univ, Res Ctr Micronano Technol, Tokyo 1848584, Japan.	kanyamam@hosei.ac.jp	Yamanaka, Yuki/AAV-3504-2020; Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291; Yamanaka, Yuki/0000-0003-3479-9896; Sowa, Yoshiyuki/0000-0002-1691-2018	RCE in Mechanobiology; Alcohol and Education Research Council; MEXT Supported Program for the Strategic Research Foundation at Private Universities; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2013-T2-1-154]; National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore; Cooperative Research Program of the Network Joint Research Center for Materials and Devices; National Institutes of Health	RCE in Mechanobiology; Alcohol and Education Research Council; MEXT Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore(National Research Foundation, Singapore); Cooperative Research Program of the Network Joint Research Center for Materials and Devices; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an RCE in Mechanobiology, the National Institutes of Health, and the Alcohol and Education Research Council. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the MEXT Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017, to Hosei University.; Supported by the Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2013-T2-1-154) and the National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore.; Supported by the Cooperative Research Program of the Network Joint Research Center for Materials and Devices.	Ali SS, 2013, J BIOL CHEM, V288, P13356, DOI 10.1074/jbc.M113.455378; Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; Burton NA, 2010, J MOL BIOL, V401, P726, DOI 10.1016/j.jmb.2010.06.054; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Caramel A, 2000, MOL MICROBIOL, V36, P85, DOI 10.1046/j.1365-2958.2000.01827.x; Cordeiro TN, 2015, J BIOL CHEM, V290, P21200, DOI 10.1074/jbc.M114.630400; Desai SK, 2016, ELIFE, V5, DOI 10.7554/eLife.10747; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Donato GM, 1999, J BACTERIOL, V181, P941, DOI 10.1128/JB.181.3.941-948.1999; Dorman CJ, 2009, FRONT BIOSCI-LANDMRK, V14, P4103, DOI 10.2741/3515; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Gao YF, 2017, P NATL ACAD SCI USA, V114, P12560, DOI 10.1073/pnas.1716721114; Giangrossi M, 2014, BBA-PROTEINS PROTEOM, V1844, P339, DOI 10.1016/j.bbapap.2013.11.010; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Ishihama A, 2016, NUCLEIC ACIDS RES, V44, P2058, DOI 10.1093/nar/gkw051; Ishihama A, 2014, J BACTERIOL, V196, P2718, DOI 10.1128/JB.01579-14; Jauregui R, 2003, NUCLEIC ACIDS RES, V31, P6770, DOI 10.1093/nar/gkg882; Krin E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-273; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Qu Y, 2013, NUCLEIC ACIDS RES, V41, P5263, DOI 10.1093/nar/gkt249; Renault M, 2013, FEBS J, V280, P2916, DOI 10.1111/febs.12297; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; SHINDO H, 1995, FEBS LETT, V360, P125, DOI 10.1016/0014-5793(95)00079-O; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Ueda T, 2013, DNA RES, V20, P263, DOI 10.1093/dnares/dst008; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; van der Valk RA, 2017, ELIFE, V6, DOI 10.7554/eLife.27369; Walthers D, 2011, J BIOL CHEM, V286, P1895, DOI 10.1074/jbc.M110.164962; Williams RM, 1996, J BACTERIOL, V178, P4335, DOI 10.1128/jb.178.15.4335-4343.1996; Winardhi RS, 2015, BIOPHYS J, V109, P1321, DOI 10.1016/j.bpj.2015.08.016; Winardhi RS, 2014, J BIOL CHEM, V289, P13739, DOI 10.1074/jbc.M113.545954; Winardhi RS, 2012, NUCLEIC ACIDS RES, V40, P8942, DOI 10.1093/nar/gks669; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yamanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111962	48	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9496	9505		10.1074/jbc.RA117.001425	http://dx.doi.org/10.1074/jbc.RA117.001425			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29695505	hybrid, Green Published			2022-12-28	WOS:000435441400032
J	Yan, JY; Li, J; Hu, J; Zhang, L; Wei, CG; Sultana, N; Cai, XQ; Zhang, WJ; Cai, CL				Yan, Jianyun; Li, Jun; Hu, Jun; Zhang, Lu; Wei, Chengguo; Sultana, Nishat; Cai, Xiaoqiang; Zhang, Weijia; Cai, Chen-Leng			Smad4 deficiency impairs chondrocyte hypertrophy via the Runx2 transcription factor in mouse skeletal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondrocyte; chondrogenesis; development; SMAD transcription factor; signaling; bone; mouse; Chondrocyte differentiation; Chondrocyte hypertrophy; Endochondral bone formation; Runx2; Smad4	ENDOCHONDRAL BONE-DEVELOPMENT; GROWTH-PLATE CHONDROCYTES; II COLLAGEN GENE; CLEIDOCRANIAL DYSPLASIA; INDIAN-HEDGEHOG; MORPHOGENETIC PROTEIN; CBFA1-DEFICIENT MICE; FACTOR RECEPTOR-3; CRE RECOMBINASE; FACTOR-BETA	Chondrocyte hypertrophy is the terminal step in chondrocyte differentiation and is crucial for endochondral bone formation. How signaling pathways regulate chondrocyte hypertrophic differentiation remains incompletely understood. In this study, using a Tbx18:Cre (Tbx18(Cre/+)) gene-deletion approach, we selectively deleted the gene for the signaling protein SMAD family member 4 (Smad4(f/f)) in the limbs of mice. We found that the Smad4-deficient mice develop a prominent shortened limb, with decreased expression of chondrocyte differentiation markers, including Col2a1 and Acan, in the humerus at mid-to-late gestation. The most striking defects in these mice were the absence of stylopod elements and failure of chondrocyte hypertrophy in the humerus. Moreover, expression levels of the chondrocyte hypertrophy-related markers Col10a1 and Panx3 were significantly decreased. Of note, we also observed that the expression of runt-related transcription factor 2 (Runx2), a critical mediator of chondrocyte hypertrophy, was also down-regulated in Smad4-deficient limbs. To determine how the skeletal defects arose in the mouse mutants, we performed RNA-Seq with ChIP-Seq analyses and found that Smad4 directly binds to regulatory elements in the Runx2 promoter. Our results suggest a new mechanism whereby Smad4 controls chondrocyte hypertrophy by up-regulating Runx2 expression during skeletal development. The regulatory mechanism involving Smad4-mediated Runx2 activation uncovered here provides critical insights into bone development and pathogenesis of chondrodysplasia.	[Yan, Jianyun; Li, Jun; Hu, Jun; Zhang, Lu; Sultana, Nishat; Cai, Xiaoqiang; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Mindich Child Hlth & Dev Inst, One Gustave L Levy Pl, New York, NY 10029 USA; [Yan, Jianyun; Li, Jun; Hu, Jun; Zhang, Lu; Sultana, Nishat; Cai, Xiaoqiang; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, One Gustave L Levy Pl, New York, NY 10029 USA; [Yan, Jianyun] Southern Med Univ, Sino Japanese Cooperat Platform Translat Res Hear, Guangdong Prov Biomed Engn Technol Res Ctr Cardio, Lab Heart Ctr,Zhujiang Hosp,Heart Ctr, Guangzhou 510280, Guangdong, Peoples R China; [Yan, Jianyun] Southern Med Univ, Sino Japanese Cooperat Platform Translat Res Hear, Guangdong Prov Biomed Engn Technol Res Ctr Cardio, Dept Cardiol,Zhujiang Hosp,Heart Ctr, Guangzhou 510280, Guangdong, Peoples R China; [Wei, Chengguo; Zhang, Weijia] Icahn Sch Med Mt Sinai, Div Renal, New York, NY 10029 USA; [Wei, Chengguo; Zhang, Weijia] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Southern Medical University - China; Southern Medical University - China; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Cai, CL (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Mindich Child Hlth & Dev Inst, One Gustave L Levy Pl, New York, NY 10029 USA.; Cai, CL (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, One Gustave L Levy Pl, New York, NY 10029 USA.	chenleng.cai@mssm.edu	Yan, Jianyun/AAX-4510-2020	Yan, Jianyun/0000-0002-6962-1169	National Institutes of Health [1R01HL131735, 1R01HL095810, 1R56HL129807, 1K02HL094688]; American Heart Association [15GRNT25710153, 0855808D]; March of Dimes Foundation [5-FY07-642]; National Natural Science Foundation of China [81470488, 81770280, 81728004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL129807, T32HL007824, R01HL131735, R01HL095810, K02HL094688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes Foundation(March of Dimes); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants 1R01HL131735, 1R01HL095810, 1R56HL129807, and 1K02HL094688, American Heart Association Grants 15GRNT25710153 and 0855808D, and March of Dimes Foundation Grant 5-FY07-642 (to C. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Natural Science Foundation of China Grants 81470488, 81770280, and 81728004.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2007, MATRIX BIOL, V26, P224, DOI 10.1016/j.matbio.2006.12.002; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bond SR, 2011, J BONE MINER RES, V26, P2911, DOI 10.1002/jbmr.509; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai XQ, 2013, DEVELOPMENT, V140, P3176, DOI 10.1242/dev.092502; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Domowicz MS, 2009, DEV BIOL, V329, P242, DOI 10.1016/j.ydbio.2009.02.024; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; Jeon J, 2011, J BIOL CHEM, V286, P27206, DOI 10.1074/jbc.M111.218065; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Long FX, 2001, DEVELOPMENT, V128, P5099; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Saito A, 2014, MOL CELL, V53, P127, DOI 10.1016/j.molcel.2013.11.008; Salazar VS, 2013, J CELL SCI, V126, P4974, DOI 10.1242/jcs.131953; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shu B, 2011, J CELL SCI, V124, P3428, DOI 10.1242/jcs.083659; Shukunami C, 1999, INT J DEV BIOL, V43, P39; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; Yan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104503; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhang JH, 2005, DEV BIOL, V284, P311, DOI 10.1016/j.ydbio.2005.05.036; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	69	15	16	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9162	9175		10.1074/jbc.RA118.001825	http://dx.doi.org/10.1074/jbc.RA118.001825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29735531	Green Published, hybrid			2022-12-28	WOS:000435441400003
J	Kudlacek, ST; Premkumar, L; Metz, SW; Tripathy, A; Bobkov, AA; Payne, AM; Graham, S; Brackbill, JA; Miley, MJ; de Silva, AM; Kuhlman, B				Kudlacek, Stephan T.; Premkumar, Lakshmanane; Metz, Stefan W.; Tripathy, Ashutosh; Bobkov, Andrey A.; Payne, Alexander Matthew; Graham, Stephen; Brackbill, James A.; Miley, Michael J.; de Silva, Aravinda M.; Kuhlman, Brian			Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ANTIBODY; NEUTRALIZING ANTIBODIES; CONFORMATIONAL-CHANGES; PROTECTIVE EFFICACY; CRYSTAL-STRUCTURE; HIGHLY POTENT; EPITOPES; DOMAIN; IMMUNOGENICITY; STABILITY	The spread of dengue (DENV) and Zika virus (ZIKV) is a major public health concern. The primary target of antibodies that neutralize DENV and ZIKV is the envelope (E) glycoprotein, and there is interest in using soluble recombinant E (sRecE) proteins as subunit vaccines. However, the most potent neutralizing antibodies against DENV and ZIKV recognize epitopes on the virion surface that span two or more E proteins. Therefore, to create effective DENV and ZIKV vaccines, presentation of these quaternary epitopes may be necessary. The sRecE proteins fromDENVand ZIKV crystallize as native-like dimers, but studies in solution suggest that these dimers are marginally stable. To better understand the challenges associated with creating stable sRecE dimers, we characterized the thermostability of sRecE proteins from ZIKV and three DENV serotypes, DENV2-4. All four proteins irreversibly unfolded at moderate temperatures (46-53 degrees C). At 23 degrees C and low micromolar concentrations, DENV2 and ZIKV were primarily dimeric, and DENV3-4 were primarily monomeric, whereas at 37 degrees C, all four proteins were predominantly monomeric. We further show that the dissociation constant for DENV2 dimerization is very temperature-sensitive, ranging from < 1 mu M at 25 degrees C to 50 mu M at 41 degrees C, due to a large exothermic enthalpy of binding of similar to 79 kcal/mol. We also found that quaternary epitope antibody binding to DENV2-4 and ZIKV sRecE is reduced at 37 degrees C. Our observation of reduced sRecE dimerization at physiological temperature highlights the need for stabilizing the dimer as part of its development as a subunit vaccine.	[Kudlacek, Stephan T.; Tripathy, Ashutosh; Payne, Alexander Matthew; Kuhlman, Brian] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Premkumar, Lakshmanane; Metz, Stefan W.; Graham, Stephen; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Bobkov, Andrey A.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Brackbill, James A.; Miley, Michael J.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kuhlman, Brian] Univ N Carolina, Lineburger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Sanford Burnham Prebys Medical Discovery Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Kuhlman, B (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	bkuhlman@email.unc.edu	desilva, Aravinda/ABE-6260-2020; , PEP-MX Core/AGV-4051-2022; Metz, Stefan/J-1974-2019	desilva, Aravinda/0000-0003-3317-5950; Metz, Stefan/0000-0002-9249-2844; Kudlacek, Stephan/0000-0002-0029-9984; Payne, Alex/0000-0003-0947-0191	NIGMS, National Institutes of Health (NIH) [R01GM073960]; NIAID, NIH [U19 AI09784]; Centers for Disease Control and Prevention [00HVELJB-2017-04191]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570, R01GM073960] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health (NIH), Grant R01GM073960; NIAID, NIH Grant U19 AI09784; and Centers for Disease Control and Prevention Grant 00HVELJB-2017-04191. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5; Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439; COHEN J, 2017, SCIENCE, V80; Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021; Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; DELENDA C, 1994, ARCH VIROL, V139, P197, DOI 10.1007/BF01309465; Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651; Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15; Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178; Govindarajan D, 2015, VACCINE, V33, P4105, DOI 10.1016/j.vaccine.2015.06.067; Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722; Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00055-16, 10.1128/MMBR.00055-16]; Hsieh SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100641; KOSLYUCHENKO VA, 2016, NATURE, V533, P425; Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhlman B, 1998, BIOCHEMISTRY-US, V37, P1025, DOI 10.1021/bi972352x; Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025; Li J, 2018, STRUCTURE, V26, P51, DOI 10.1016/j.str.2017.11.017; Lim XX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14339; Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74; Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004; Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11; Manoff SB, 2015, VACCINE, V33, P7126, DOI 10.1016/j.vaccine.2015.09.101; MCDIS Y, 2004, NATURE, V427, P313; Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6; Metz SW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005071; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464; Nivarthi UK, 2017, J VIROL, V91, DOI 10.1128/JVI.02041-16; Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Scheiblhofer S, 2017, EXPERT REV VACCINES, V16, P479, DOI 10.1080/14760584.2017.1306441; Sergeev YV, 2004, BIOCHEMISTRY-US, V43, P415, DOI 10.1021/bi034617f; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 2016, J WKLY EPIDEMIOL REC, V91, P349; Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2015, CURR OPIN VIROL, V12, P109, DOI 10.1016/j.coviro.2015.04.006; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	55	14	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8922	8933		10.1074/jbc.RA118.002658	http://dx.doi.org/10.1074/jbc.RA118.002658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29678884	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000434941900016
J	Zhu, JH; Lu, XR; Feng, QP; Stathopulos, PB				Zhu, Jinhui; Lu, Xiangru; Feng, Qingping; Stathopulos, Peter B.			A charge-sensing region in the stromal interaction molecule 1 luminal domain confers stabilization-mediated inhibition of SOCE in response to S-nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES CRAC CHANNELS; CA2+ STORE; STIM1 COUPLES; ORAI1; OLIGOMERIZATION; GLUTATHIONYLATION; CYSTEINE; SENSOR; DEGRADATION; DEPLETION	Store-operated Ca2+ entry (SOCE) is a major Ca2+ signaling pathway facilitating extracellular Ca2+ influx in response to the initial release of intracellular endo/sarcoplasmic reticulum (ER/SR) Ca2+ stores. Stromal interaction molecule 1 (STIM1) is the Ca2+ sensor that activates SOCE following ER/SR Ca2+ depletion. The EF-hand and the adjacent sterile alpha-motif (EFSAM) domains of STIM1 are essential for detecting changes in luminal Ca2+ concentrations. Low ER Ca2+ levels trigger STIM1 destabilization and oligomerization, culminating in the opening of Orai1-composed Ca2+ channels on the plasma membrane. NOmediated S-nitrosylation of cysteine thiols regulates myriad protein functions, but its effects on the structural mechanisms that regulate SOCE are unclear. Here, we demonstrate that S-nitrosylation of Cys 49 and Cys 56 in STIM1 enhances the thermodynamic stability of its luminal domain, resulting in suppressed hydrophobic exposure and diminished Ca2+ depletion-dependent oligomerization. Using solution NMR spectroscopy, we pinpointed a structural mechanism for STIM1 stabilization driven by complementary charge interactions between an electropositive patch on the core EFSAM domain and the S-nitrosylated nonconserved region of STIM1. Finally, using live cells, we found that the enhanced luminal domain stability conferred by either Cys 49 and Cys 56 S-nitrosylation or incorporation of negatively charged residues into the EFSAM electropositive patch in the full-length STIM1 context significantly suppresses SOCE. Collectively, our results suggest that S-nitrosylation of STIM1 inhibits SOCE by interacting with an electropositive patch on the EFSAM core, which modulates the thermodynamic stability of the STIM1 luminal domain.	[Zhu, Jinhui; Lu, Xiangru; Feng, Qingping; Stathopulos, Peter B.] Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St N, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Feng, QP; Stathopulos, PB (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St N, London, ON N6A 5C1, Canada.	qingping.feng@schulich.uwo.ca; peter.stathopulos@schulich.uwo.ca		Stathopulos, Peter B./0000-0002-0536-6656; Feng, Qingping/0000-0001-9739-2765	Natural Sciences and Engineering Research Council of Canada [05239]; Canadian Foundation for Innovation/Ontario Research Fund [34113]; Canadian Institutes of Health Research [MOP-142383]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation/Ontario Research Fund(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 05239 (to P. B. S.), Canadian Foundation for Innovation/Ontario Research Fund Grant 34113 (to P. B. S.), and Canadian Institutes of Health Research Grant MOP-142383 (to Q. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Albertos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9669; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnett SD, 2017, CRIT REV BIOCHEM MOL, V52, P340, DOI 10.1080/10409238.2017.1304353; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bocedi A, 2004, BIOCHEM BIOPH RES CO, V315, P710, DOI 10.1016/j.bbrc.2004.01.113; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Cai ZJ, 2015, ARTERIOSCL THROM VAS, V35, P2366, DOI 10.1161/ATVBAHA.115.305796; Choi YJ, 2017, BBA-MOL CELL RES, V1864, P1054, DOI 10.1016/j.bbamcr.2016.11.015; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Collins HE, 2013, AM J PHYSIOL-HEART C, V305, pH446, DOI 10.1152/ajpheart.00104.2013; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Eichmann C, 2016, J MOL BIOL, V428, P3737, DOI 10.1016/j.jmb.2016.07.010; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feng JH, 2011, BIOSCI TRENDS, V5, P17, DOI 10.5582/bst.2011.v5.1.17; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; Gould N, 2013, J BIOL CHEM, V288, P26473, DOI 10.1074/jbc.R113.460261; Gui L, 2018, J MOL BIOL; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kohr MJ, 2014, J MOL CELL CARDIOL, V69, P67, DOI 10.1016/j.yjmcc.2014.01.010; Kumar R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44558; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li Y, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3592581; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu L, 2002, EUR J BIOCHEM, V269, P4277, DOI 10.1046/j.1432-1033.2002.03118.x; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8826; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Martinez-Ruiz A, 2013, ANTIOXID REDOX SIGN, V19, P1220, DOI 10.1089/ars.2012.5066; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Miao Y, 2013, ELIFE, V2, DOI 10.7554/eLife.00802; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Okamoto S, 2014, CELL REP, V8, P217, DOI 10.1016/j.celrep.2014.06.005; Pace C N, 1986, Methods Enzymol, V131, P266; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prins D, 2011, EMBO REP, V12, P1182, DOI 10.1038/embor.2011.173; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Renganathan M, 2002, J NEUROPHYSIOL, V87, P761, DOI 10.1152/jn.00369.2001; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sievers F, 2014, CURR PROTOC BIOINFOR, V48; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Takahashi H, 2007, NEURON, V53, P53, DOI 10.1016/j.neuron.2006.11.023; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2011, P NATL ACAD SCI USA, V108, P1337, DOI 10.1073/pnas.1015125108; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	73	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8900	8911		10.1074/jbc.RA117.000503	http://dx.doi.org/10.1074/jbc.RA117.000503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29661937	Green Published, hybrid			2022-12-28	WOS:000434941900014
J	Hendrickson, TL				Hendrickson, Tamara L.			Old enzymes versus new herbicides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The introduction of manmade chemicals, including the herbicide atrazine, into the environment has led to the emergence of microorganisms with new biodegradation pathways. Esquirol et al. demonstrate that the AtzE enzyme catalyzes a central step in atrazine degradation and that expression of AtzE requires coexpression of the small protein AtzG. Remarkably, AtzG and AtzE appear to have evolved from GatC and GatA, components of an ancient enzyme involved in indirect tRNA aminoacylation, providing an elegant demonstration of metabolic repurposing.	[Hendrickson, Tamara L.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Wayne State University	Hendrickson, TL (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	Tamara.Hendrickson@chem.wayne.edu						Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; de Souza ML, 1998, APPL ENVIRON MICROB, V64, P2323; Esquirol L, 2018, J BIOL CHEM, V293, P7880, DOI 10.1074/jbc.RA118.001996; Esquirol L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192736; Kerminen K, 2018, SCI TOTAL ENVIRON, V618, P1449, DOI 10.1016/j.scitotenv.2017.09.302; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Rathnayake UM, 2017, CURR OPIN CHEM BIOL, V41, P114, DOI 10.1016/j.cbpa.2017.10.009; Ruan BF, 2001, ACTA BIOCHIM POL, V48, P313; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; Skouloubris S, 2003, P NATL ACAD SCI USA, V100, P11297, DOI 10.1073/pnas.1932482100	10	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7892	+		10.1074/jbc.H118.002878	http://dx.doi.org/10.1074/jbc.H118.002878			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29777017	hybrid, Green Published			2022-12-28	WOS:000437256500035
J	Schaffer, C; Messner, P				Schaeffer, Christina; Messner, Paul			Carb loading takes proteins on a ride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						bacteria; glycobiology; post-translational modification (PTM); membrane transport; adhesin	GLYCOSYLTRANSFERASE	Cytoplasmic protein O-glycosylation in bacteria is often required for protein maturation, but the dependence of protein export on carbohydrate modifications is less understood. In the current issue of JBC, Chen et al. describe the mechanism for posttranslational modification of a Streptococcus gordonii adhesin and its delivery to the membrane, leading to the first comprehensive model featuring the interplay of glycosyltransferases and the translocation system.	[Schaeffer, Christina; Messner, Paul] Univ Bodenkultur Wien, NanoGlycobiol Unit, Dept NanoBiotechnol, Muthgasse 11, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Schaffer, C (corresponding author), Univ Bodenkultur Wien, NanoGlycobiol Unit, Dept NanoBiotechnol, Muthgasse 11, A-1190 Vienna, Austria.	christina.schaeffer@boku.ac.at	Messner, Paul/Q-5345-2017	Messner, Paul/0000-0002-3246-5801	Austrian Science Fund FWF [P24317-B22, P26836-B22, I-2875, W1224]	Austrian Science Fund FWF(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF, Projects P24317-B22, P26836-B22, I-2875, and W1224. The authors declare that they have no conflicts of interest with the contents of this article.	Chen Y, 2018, J BIOL CHEM, V293, P5360, DOI 10.1074/jbc.RA117.000963; Chen Y, 2016, P NATL ACAD SCI USA, V113, pE1190, DOI 10.1073/pnas.1600494113; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Schaffer C, 2017, FEMS MICROBIOL REV, V41, P49, DOI 10.1093/femsre/fuw036; Schwarz F, 2011, J BIOL CHEM, V286, P35267, DOI 10.1074/jbc.M111.277160; Seepersaud R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006558; Seepersaud R, 2012, J BACTERIOL, V194, P5564, DOI 10.1128/JB.01000-12; Varki A., 2017, ESSENTIALS GLYCOBIOL; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	10	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5374	5375		10.1074/jbc.H118.002411	http://dx.doi.org/10.1074/jbc.H118.002411			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29626108	Green Published, hybrid			2022-12-28	WOS:000429409300039
J	Scherer, AN; Anand, NS; Koleske, AJ				Scherer, Alexander N.; Anand, Neha S.; Koleske, Anthony J.			Cortactin stabilization of actin requires actin-binding repeats and linker, is disrupted by specific substitutions, and is independent of nucleotide state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; ARP2/3 COMPLEX; ADP-ACTIN; FLUORESCENCE MICROSCOPY; PHOSPHORYLATION SITES; DENDRITIC SPINE; CAPPING PROTEIN; CELL MOTILITY; BARBED-END; FILAMENTS	The actin-binding protein cortactin promotes the formation and maintenance of actin-rich structures, including lamellipodial protrusions in fibroblasts and neuronal dendritic spines. Cortactin cellular functions have been attributed to its activation of the Arp2/3 complex, which stimulates actin branch nucleation, and to its recruitment of Rho family GTPase regulators. Cortactin also binds actin filaments and significantly slows filament depolymerization, but the mechanism by which it does so and the relationship between actin binding and stabilization are unclear. Here we elucidated the cortactin regions that are necessary and sufficient for actin filament binding and stabilization. Using actin cosedimentation assays, we found that the cortactin repeat region binds actin but that the adjacent linker region is required for binding with the same affinity as fulllength cortactin. Using total internal reflection fluorescence microscopy to measure the rates of single filament actin depolymerization, we observed that cortactin -actin interactions are sufficient to stabilize actin filaments. Moreover, conserved charged residues in repeat 4 were necessary for high-affinity actin binding, and substitution of these residues significantly impaired cortactin-mediated actin stabilization. Cortactin bound actin with higher affinity than did its paralog, hematopoietic cell-specific Lyn substrate 1 (HS1), and the effects on actin stability were specific to cortactin. Finally, cortactin stabilized A DP-actin filaments, indicating that the stabilization mechanism does not depend on the actin nucleotide state. Together, these results indicate that cortactin binding to actin is necessary and sufficient to stabilize filaments in a concentration-dependent manner, specific to conserved residues in the cortactin repeats, and independent of the actin nucleotide state.	[Scherer, Alexander N.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Anand, Neha S.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Dept Neurosci, 333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Koleske, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA.; Koleske, AJ (corresponding author), Yale Univ, Dept Neurosci, 333 Cedar St, New Haven, CT 06520 USA.	anthony.koleske@yale.edu	Anand, Neha/AAK-4151-2021	Scherer, Alexander/0000-0003-0114-9272	NINDS, National Institutes of Health [NS089662, NS105640]; NIMH, National Institutes of Health [MH115939]; NIGMS, National Institutes of Health [F30GM119198]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F30GM119198, T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH115939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105640, R01NS089662] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grants NS089662 and NS105640 and NIMH, National Institutes of Health Grant MH115939 (to A.J.K.) and NIGMS, National Institutes of Health Award F30GM119198 (to A.N.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cherepanova O, 2006, J MOL BIOL, V356, P714, DOI 10.1016/j.jmb.2005.11.082; Citalan-Madrid AF, 2017, MUCOSAL IMMUNOL, V10, P1237, DOI 10.1038/mi.2016.136; Courtemanche N, 2015, J BIOL CHEM, V290, P4038, DOI 10.1074/jbc.M114.608117; Courtemanche N, 2013, BIOCHEMISTRY-US, V52, P6456, DOI 10.1021/bi400682n; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Ponce AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep29003; Hao JJ, 2005, J BIOL CHEM, V280, P37988, DOI 10.1074/jbc.M504552200; Helgeson LA, 2014, J BIOL CHEM, V289, P28856, DOI 10.1074/jbc.M114.587527; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Hering H, 2003, J NEUROSCI, V23, P11759; Hong NH, 2015, J CELL BIOL, V210, P753, DOI 10.1083/jcb.201412127; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Li X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16959-1; Liang X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00797-w; Lin YC, 2013, J NEUROSCI, V33, P1846, DOI 10.1523/JNEUROSCI.4284-12.2013; Lukoyanova N, 2002, CURR BIOL, V12, P383, DOI 10.1016/S0960-9822(02)00678-4; MacGrath SM, 2012, BIOCHEMISTRY-US, V51, P6644, DOI 10.1021/bi300722t; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Niedermayer T, 2012, P NATL ACAD SCI USA, V109, P10769, DOI 10.1073/pnas.1121381109; Oelkers JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019931; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pant K, 2006, J MOL BIOL, V359, P840, DOI 10.1016/j.jmb.2006.03.065; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rosenberg BJ, 2017, MOL BIOL CELL, V28, P1347, DOI 10.1091/mbc.E16-12-0885; Schmoller KM, 2011, J STRUCT BIOL, V173, P350, DOI 10.1016/j.jsb.2010.09.003; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Shekhar S, 2017, CURR BIOL, V27, P1990, DOI 10.1016/j.cub.2017.05.036; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Shvetsov A, 2009, CELL MOTIL CYTOSKEL, V66, P90, DOI 10.1002/cm.20328; Sinha S, 2016, J CELL BIOL, V214, P197, DOI 10.1083/jcb.201601025; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Thomas SG, 2017, PLATELETS, V28, P372, DOI 10.1080/09537104.2016.1235688; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; van Rossum AGSH, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-15; van Rossum AGSH, 2003, J BIOL CHEM, V278, P45672, DOI 10.1074/jbc.M306688200; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	60	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13022	13032		10.1074/jbc.RA118.004068	http://dx.doi.org/10.1074/jbc.RA118.004068			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29929984	hybrid, Green Published			2022-12-28	WOS:000442730200005
J	Whitley, MJ; Arjunan, P; Nemeria, NS; Korotchkina, LG; Park, YH; Patel, MS; Jordan, F; Furey, W				Whitley, Matthew J.; Arjunan, Palaniappa; Nemeria, Natalia S.; Korotchkina, Lioubov G.; Park, Yun-Hee; Patel, Mulchand S.; Jordan, Frank; Furey, William			Pyruvate dehydrogenase complex deficiency is linked to regulatory loop disorder in the alpha V138M variant of human pyruvate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIAMIN DIPHOSPHATE; E1 SUBUNIT; DEPENDENT ENZYMES; STRUCTURAL BASIS; PHOSPHORYLATION; CATALYSIS; FEATURES; INTERMEDIATE; INACTIVATION; IONIZATION	The pyruvate dehydrogenase multienzyme complex (PDHc) connects glycolysis to the tricarboxylic acid cycle by producing acetyl-CoA via the decarboxylation of pyruvate. Because of its pivotal role in glucose metabolism, this complex is closely regulated in mammals by reversible phosphorylation, the modulation of which is of interest in treating cancer, diabetes, and obesity. Mutations such as that leading to the alpha V138M variant in pyruvate dehydrogenase, the pyruvate-decarboxylating PDHc E1 component, can result in PDHc deficiency, an inborn error of metabolism that results in an array of symptoms such as lactic acidosis, progressive cognitive and neuromuscular deficits, and even death in infancy or childhood. Here we present an analysis of two X-ray crystal structures at 2.7-angstrom resolution, the first of the disease-associated human alpha V138M E1 variant and the second of human wildtype (WT) E1 with a bound adduct of its coenzyme thiamin diphosphate and the substrate analogue acetylphosphinate. The structures provide support for the role of regulatory loop disorder in E1 inactivation, and the alpha V138M variant structure also reveals that altered coenzyme binding can result in such disorder even in the absence of phosphorylation. Specifically, both E1 phosphorylation at alpha Ser-264 and the alpha V138M substitution result in disordered loops that are not optimally oriented or available to efficiently bind the lipoyl domain of PDHc E2. Combined with an analysis of alpha V138M activity, these results underscore the general connection between regulatory loop disorder and loss of E1 catalytic efficiency.	[Whitley, Matthew J.; Arjunan, Palaniappa; Furey, William] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA; [Nemeria, Natalia S.; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Korotchkina, Lioubov G.; Park, Yun-Hee; Patel, Mulchand S.] Univ Buffalo State Univ New York, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14203 USA; [Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rutgers State University Newark; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Furey, W (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA.	fureyw@pitt.edu	Whitley, Matthew/I-9531-2019	Whitley, Matthew/0000-0001-8830-7514; Furey, William/0000-0002-7788-0689	DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK080748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM116077, R01GM121469, R01GM061791, R01GM050380] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Baykal AT, 2006, BIOCHEMISTRY-US, V45, P7522, DOI 10.1021/bi060395k; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; Byron O, 2017, SUBCELL BIOCHEM, V83, P523, DOI 10.1007/978-3-319-46503-6_19; CHUN K, 1993, HUM MOL GENET, V2, P449, DOI 10.1093/hmg/2.4.449; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferriero R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004986; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; Jordan F, 2002, BIOORG CHEM, V30, P188, DOI 10.1006/bioo.2002.1249; Jordan F, 2014, BIOORG CHEM, V57, P251, DOI 10.1016/j.bioorg.2014.08.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Kerr D. S., 1996, ALPHA KETO ACID DEHY, P249; KOROTCHKINA LG, 1995, PROTEIN EXPRES PURIF, V6, P79, DOI 10.1006/prep.1995.1011; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; LIU TC, 1995, J BIOL CHEM, V270, P15545, DOI 10.1074/jbc.270.26.15545; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; Nemeria NS, 2016, BIOCHEMISTRY-US, V55, P1135, DOI 10.1021/acs.biochem.5b01300; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; Patel KP, 2012, MOL GENET METAB, V105, P34, DOI 10.1016/j.ymgme.2011.09.032; Paulikat M, 2017, BIOCHEMISTRY-US, V56, P1854, DOI 10.1021/acs.biochem.6b00984; Pei XY, 2008, STRUCTURE, V16, P1860, DOI 10.1016/j.str.2008.10.009; Pletcher J., 1982, THIAMIN 20 YEARS PRO, P454; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; Seyda A, 2000, BIOCHEM BIOPH RES CO, V270, P1068, DOI 10.1006/bbrc.2000.2551	32	8	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13204	13213		10.1074/jbc.RA118.003996	http://dx.doi.org/10.1074/jbc.RA118.003996			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29970614	Green Published, hybrid			2022-12-28	WOS:000442730200019
J	Hosford, CJ; Chappie, JS				Hosford, Christopher J.; Chappie, Joshua S.			The crystal structure of the Helicobacter pylori LlaJI.R1 N-terminal domain provides a model for site-specific DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RESTRICTION-ENDONUCLEASE; SHORT HISTORY; B3 DOMAIN; MCRBC; PROTEIN; RECOGNITION; ENZYME; MECHANISM; REVEALS; SYSTEM	Restriction modification systems consist of an endonuclease that cleaves foreign DNA site-specifically and an associated methyltransferase that protects the corresponding target site in the host genome. Modification-dependent restriction systems, in contrast, specifically recognize and cleave methylated and/or glucosylated DNA. The LlaJI restriction system contains two 5-methylcytosine (5mC) methyltransferases (LlaJI.M1 and LlaJI.M2) and two restriction proteins (LlaJI.R1 and LlaJI.R2). LlaJI.R1 and LlaJI.R2 are homologs of McrB and McrC, respectively, which in Escherichia coli function together as a modification-dependent restriction complex specific for 5mC-containing DNA. Lactococcus lactis LlaJI.R1 binds DNA site-specifically, suggesting that the LlaJI system uses a different mode of substrate recognition. Here we present the structure of the N-terminal DNA-binding domain of Helicobacter pylori LlaJI.R1 at 1.97- resolution, which adopts a B3 domain fold. Structural comparison to B3 domains in plant transcription factors and other restriction enzymes identifies key recognition motifs responsible for site-specific DNA binding. Moreover, biochemistry and structural modeling provide a rationale for how H. pylori LlaJI.R1 may bind a target site that differs from the 5-bp sequence recognized by other LlaJI homologs and identify residues critical for this recognition activity. These findings underscore the inherent structural plasticity of B3 domains, allowing recognition of a variety of substrates using the same structural core.	[Hosford, Christopher J.; Chappie, Joshua S.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Chappie, JS (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	chappie@cornell.edu	Chappie, Joshua S./AAV-6076-2021	Chappie, Joshua S./0000-0002-5733-7275	National Institutes of Health [P41 GM103403]; National Institutes of Health-ORIP HEI Grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120242, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-ORIP HEI Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank April Lee for assistance with initial crystallization experiments, the Northeastern Collaborative Access Team (NE-CAT) beamline staff at the Advanced Photon Source (APS) for assistance with remote X-ray data collection, Dr. Holger Sondermann for critical reading of the manuscript and use of his SEC-MALS instrument, Dr. John O'Donnell for assistance with SEC-MALS data analysis, and Dr. Eric Alani and Dr. Carol Manhart for guidance and assistance with filter binding experiments. This work is based upon research conducted at the NE-CAT beamlines (24-ID-C and 24-ID-E) under the General User Proposals GUP-51113 and GUP-41829 (PI: J. S. C). NE-CAT is funded by National Institutes of Health program project Grant P41 GM103403. The Pilatus 6M detector on 24-ID-C beam line is funded by National Institutes of Health-ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a U.S. Dept. of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bair CL, 2007, J MOL BIOL, V366, P779, DOI 10.1016/j.jmb.2006.11.049; Borgaro JG, 2013, NUCLEIC ACIDS RES, V41, P4198, DOI 10.1093/nar/gkt102; Cohen-Karni D, 2011, P NATL ACAD SCI USA, V108, P11040, DOI 10.1073/pnas.1018448108; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gast FU, 1997, BIOL CHEM, V378, P975, DOI 10.1515/bchm.1997.378.9.975; Golovenko D, 2014, NUCLEIC ACIDS RES, V42, P4113, DOI 10.1093/nar/gkt1368; Golovenko D, 2009, NUCLEIC ACIDS RES, V37, P6613, DOI 10.1093/nar/gkp699; Grazulis S, 2005, P NATL ACAD SCI USA, V102, P15797, DOI 10.1073/pnas.0507949102; Hendrickson WA, 2014, Q REV BIOPHYS, V47, P49, DOI 10.1017/S0033583514000018; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horton JR, 2014, NUCLEIC ACIDS RES, V42, P12092, DOI 10.1093/nar/gku871; Horton JR, 2014, NUCLEIC ACIDS RES, V42, P7947, DOI 10.1093/nar/gku497; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kazrani AA, 2014, NUCLEIC ACIDS RES, V42, P5929, DOI 10.1093/nar/gku186; King GJ, 2013, J BIOL CHEM, V288, P3198, DOI 10.1074/jbc.M112.438572; KRUGER T, 1995, EMBO J, V14, P2661, DOI 10.1002/j.1460-2075.1995.tb07264.x; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0; Mulligan EA, 2010, NUCLEIC ACIDS RES, V38, P1997, DOI 10.1093/nar/gkp1120; O'Driscoll J, 2005, MOL MICROBIOL, V57, P1532, DOI 10.1111/j.1365-2958.2005.04769.x; O'Driscoll J, 2004, APPL ENVIRON MICROB, V70, P5546, DOI 10.1128/AEM.70.9.5546-5556.2004; O'Driscoll J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-40; Panne D, 1999, J MOL BIOL, V290, P49, DOI 10.1006/jmbi.1999.2894; Panne D, 2001, EMBO J, V20, P3210, DOI 10.1093/emboj/20.12.3210; Pieper U, 2002, BIOCHEMISTRY-US, V41, P5236, DOI 10.1021/bi0156862; Pieper U, 2002, BIOCHEMISTRY-US, V41, P5245, DOI 10.1021/bi015687u; Pieper U, 1999, BIOL CHEM, V380, P1225, DOI 10.1515/BC.1999.155; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Raghavendra NK, 2012, FRONT BIOSCI-LANDMRK, V17, P1094, DOI 10.2741/3975; RALEIGH EA, 1986, P NATL ACAD SCI USA, V83, P9070, DOI 10.1073/pnas.83.23.9070; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Sasnauskas G, 2017, NUCLEIC ACIDS RES, V45, P9583, DOI 10.1093/nar/gkx634; Shao C, 2014, ACTA CRYSTALLOGR D, V70, P2477, DOI 10.1107/S139900471401606X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stewart FJ, 2000, J MOL BIOL, V298, P611, DOI 10.1006/jmbi.2000.3697; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Tamulaitiene G, 2014, NUCLEIC ACIDS RES, V42, P14022, DOI 10.1093/nar/gku1237; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Yamasaki K, 2013, TRENDS PLANT SCI, V18, P267, DOI 10.1016/j.tplants.2012.09.001; Yang XR, 2016, APPL MICROBIOL BIOT, V100, P2289, DOI 10.1007/s00253-015-7141-9; Zhou XYE, 2004, J MOL BIOL, V335, P307, DOI 10.1016/j.jmb.2003.10.030	53	4	4	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11758	11771		10.1074/jbc.RA118.001888	http://dx.doi.org/10.1074/jbc.RA118.001888			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29895618	Green Published, hybrid			2022-12-28	WOS:000440134500009
J	Jin, TC; Brefo-Mensah, E; Fan, WR; Zeng, WH; Li, YJ; Zhang, YZ; Palmer, M				Jin, Tengchuan; Brefo-Mensah, Eric; Fan, Weirong; Zeng, Weihong; Li, Yajuan; Zhang, Yuzhu; Palmer, Michael			Crystal structure of the Streptococcus agalactiae CAMP factor provides insights into its membrane-permeabilizing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; PORE-FORMING TOXIN; X-RAY-DIFFRACTION; ESCHERICHIA-COLI; DIPHTHERIA-TOXIN; GPI ANCHORS; FACTOR GENE; PROTEIN; EXPRESSION; DOMAIN	Streptococcus agalactiae is an important human opportunistic pathogen that can cause serious health problems, particularly among newborns and older individuals. S. agalactiae contains the CAMP factor, a pore-forming toxin first identified in this bacterium. The CAMP reaction is based on the co-hemolytic activity of the CAMP factor and is commonly used to identify S. agalactiae in the clinic. Closely related proteins are present also in other Gram-positive pathogens. Although the CAMP toxin was discovered more than a half century ago, no structure from this toxin family has been reported, and the mechanism of action of this toxin remains unclear. Here, we report the first structure of this toxin family, revealing a structural fold composed of 5 + 3-helix bundles. Further analysis by protein truncation and site-directed mutagenesis indicated that the N-terminal 5-helix bundle is responsible for membrane permeabilization, whereas the C-terminal 3-helix bundle is likely responsible for host receptor binding. Interestingly, the C-terminal domain inhibited the activity of both full-length toxin and its N-terminal domain. Moreover, we observed that the linker region is highly conserved and has a conserved DLXXXDXAT sequence motif. Structurally, this linker region extensively interacted with both terminal CAMP factor domains, and mutagenesis disclosed that the conserved sequence motif is required for CAMP factor's co-hemolytic activity. In conclusion, our results reveal a unique structure of this bacterial toxin and help clarify the molecular mechanism of its co-hemolytic activity.	[Jin, Tengchuan; Zeng, Weihong; Li, Yajuan] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Jin, Tengchuan; Zeng, Weihong; Li, Yajuan] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China; [Brefo-Mensah, Eric; Palmer, Michael] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Fan, Weirong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, South Campus, Shanghai 201400, Peoples R China; [Zhang, Yuzhu] USDA ARS, Hlth Proc Foods Res Unit, Western Reg Res Ctr, Albany, CA 94706 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Waterloo; Shanghai Jiao Tong University; United States Department of Agriculture (USDA)	Jin, TC (corresponding author), Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China.; Jin, TC (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	jint@ustc.edu.cn	Zhang, Yuzhu/C-3606-2014; Jin, Tengchuan/B-5883-2014	Zhang, Yuzhu/0000-0001-7882-5692; Jin, Tengchuan/0000-0002-1395-188X; Brefo-Mensah, Eric K./0000-0002-9747-0185	Fundamental Research Funds for the Central Universities Grant [WK2070000108, WK2070000097]; 100 Talents Programme of the Chinese Academy of Sciences; National Natural Science Fund for Young Scholars Grant [31600598]; China Postdoctoral Science Foundation Grant [2015M582007]; Tenth Batch Special Support of China Postdoctoral Science Foundation Grant [2015T100454]; Canadian Natural Sciences and Engineering Research Council (NSERC) Grant [250265-2013]	Fundamental Research Funds for the Central Universities Grant(Fundamental Research Funds for the Central Universities); 100 Talents Programme of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Fund for Young Scholars Grant; China Postdoctoral Science Foundation Grant(China Postdoctoral Science Foundation); Tenth Batch Special Support of China Postdoctoral Science Foundation Grant; Canadian Natural Sciences and Engineering Research Council (NSERC) Grant	Supported by Fundamental Research Funds for the Central Universities Grant WK2070000108 and by the 100 Talents Programme of the Chinese Academy of Sciences.; Supported by National Natural Science Fund for Young Scholars Grant 31600598, China Postdoctoral Science Foundation Grant 2015M582007, Tenth Batch Special Support of China Postdoctoral Science Foundation Grant 2015T100454, and Fundamental Research Funds for the Central Universities Grant WK2070000097.; Supported by Canadian Natural Sciences and Engineering Research Council (NSERC) Grant 250265-2013.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; Collins MD, 2000, INT J SYST EVOL MICR, V50, P1173, DOI 10.1099/00207713-50-3-1173; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Doxey AC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAGER RS, 1973, ANAL BIOCHEM, V53, P290, DOI 10.1016/0003-2697(73)90433-8; Ferguson M. A. J., 2015, ESSENTIALS GLYCOBIOL, P137; Gao J, 2017, CHEM COMMUN, V53, P6227, DOI 10.1039/c7cc03056h; Gase K, 1999, INFECT IMMUN, V67, P4725, DOI 10.1128/IAI.67.9.4725-4731.1999; Gatsogiannis C, 2016, NAT STRUCT MOL BIOL, V23, P884, DOI 10.1038/nsmb.3281; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grandjean F, 2007, PATHOL BIOL, V55, P407, DOI 10.1016/j.patbio.2007.07.008; Hagemans D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00056; Hensler ME, 2008, MICROB PATHOGENESIS, V44, P84, DOI 10.1016/j.micpath.2007.08.005; Herrmann LM, 1997, PROTEIN SCI, V6, P657; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang M, 1996, MICROB PATHOGENESIS, V20, P297, DOI 10.1006/mpat.1996.0028; Jin T, 2008, J AGR FOOD CHEM, V56, P8159, DOI 10.1021/jf801138q; Jin TC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40991; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kaul P, 1996, PROTEIN SCI, V5, P687; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Kinoshita T, 2016, J LIPID RES, V57, P4, DOI 10.1194/jlr.E065417; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lang SH, 2007, MED MICROBIOL IMMUN, V196, P1, DOI 10.1007/s00430-006-0021-2; Liu GJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-775; Liu L, 2014, J FISH DIS, V37, P1067, DOI 10.1111/jfd.12187; Malik Adeel, 2010, Advances in Bioinformatics, V2010, P436036, DOI 10.1155/2010/436036; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Mweu MM, 2014, PREV VET MED, V113, P219, DOI 10.1016/j.prevetmed.2013.10.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ren JH, 1999, BIOCHEMISTRY-US, V38, P976, DOI 10.1021/bi981576s; SCHNEEWIND O, 1988, INFECT IMMUN, V56, P2174, DOI 10.1128/IAI.56.8.2174-2179.1988; Shabayek S, 2010, INDIAN J MED MICROBI, V28, P320, DOI 10.4103/0255-0857.71821; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shome BR, 2012, TROP ANIM HEALTH PRO, V44, P1981, DOI 10.1007/s11250-012-0167-4; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; van Montfort BA, 2001, J BIOL CHEM, V276, P12756, DOI 10.1074/jbc.M010728200; van Pee K, 2017, ELIFE, V6, DOI 10.7554/eLife.23644; Verani J.R., 2010, PREVENTION PERINATAL; Wu XM, 2008, CARBOHYD RES, V343, P1718, DOI 10.1016/j.carres.2008.03.033; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zhao HY, 2014, J COMPUT CHEM, V35, P2177, DOI 10.1002/jcc.23730	56	9	9	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11867	11877		10.1074/jbc.RA118.002336	http://dx.doi.org/10.1074/jbc.RA118.002336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29884770	hybrid, Green Published			2022-12-28	WOS:000440134500019
J	Razidlo, GL; Burton, KM; McNiven, MA				Razidlo, Gina L.; Burton, Kevin M.; McNiven, Mark A.			Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-MESENCHYMAL TRANSITION; STATISTICAL-MODEL; STAT3; PROGRESSION; CYTOSKELETON; IL-6; RHO; CHEMORESISTANCE; INFLAMMATION; METASTASIS	Inflammation is a major driver of tumor progression and metastasis, although the mechanisms by which proinflammatory cytokines drive metastatic invasion are unknown. Interleukin-6 (IL-6) is a potent proinflammatory cytokine that is elevated in individuals with pancreatic cancer (PDAC), is required for PDAC progression in mice, and increases tumor cell invasion in vitro. Here, we provide insights into the mechanisms by which IL-6 activates tumor cell invasion. We found that IL-6 stimulation rapidly and robustly activates the small GTPase cell division cycle 42 (CDC42) in human PDAC cells and promotes the formation of premigratory filopodia. The CDC42 activation was required for IL-6-induced invasion as blocking CDC42 activity rendered the cells insensitive to IL-6's proinvasive effects. Loss of Janus kinase 2 (JAK2) or signal transducer and activator of transcription 3 (STAT3) prevented IL-6-mediated CDC42 activation, indicating that IL-6 activates CDC42 through both JAK2 and STAT3. However, the rapid activation of CDC42 suggested that this activation may be distinct from canonical STAT3-mediated transcriptional activation. Importantly, we observed an interaction between STAT3 and IQ motif-containing GTPase-activating protein 1 (IQGAP1), a scaffolding platform that binds CDC42. STAT3 colocalized with CDC42 and IQGAP1 at the plasma membrane, suggesting cross-talk between IL-6-mediated STAT3 signaling and CDC42 activation. These results suggest that IL-6 promotes metastatic invasion, at least partially, through CDC42 and that, along with its pleiotropic effects on tumor growth and progression, IL-6 signaling also activates proinvasive GTPase signaling, priming tumor cells for metastatic invasion.	[Razidlo, Gina L.; McNiven, Mark A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Razidlo, Gina L.; Burton, Kevin M.; McNiven, Mark A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Burton, Kevin M.] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Razidlo, GL (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	razidlo.gina@mayo.edu		Razidlo, Gina/0000-0002-9042-2738	National Institutes of Health NCI Cancer Center Support [5P30 CA15083-43C1]; NATIONAL CANCER INSTITUTE [P50CA102701, P30CA015083, R01CA104125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health NCI Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Dr. Micah Schott and members of the McNiven laboratory for technical support, helpful suggestions, and critical reading of the manuscript. We acknowledge the Mayo Clinic Medical Genome Facility-Proteomics Core and its supporting grant, National Institutes of Health NCI Cancer Center Support Grant 5P30 CA15083-43C1.	Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Choidas A, 1998, EUR J CELL BIOL, V77, P81, DOI 10.1016/S0171-9335(98)80075-7; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Huang C, 2011, NEOPLASMA, V58, P396, DOI 10.4149/neo_2011_05_396; Jacquemet G, 2017, J CELL BIOL, V216, P3387, DOI 10.1083/jcb.201704045; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim JH, 2009, J BIOL CHEM, V284, P35425, DOI 10.1074/jbc.M109.051516; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; MATSUGUCHI T, 1995, EMBO J, V14, P257, DOI 10.1002/j.1460-2075.1995.tb06999.x; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Nagathihalli NS, 2016, ONCOTARGET, V7, P65982, DOI 10.18632/oncotarget.11786; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Pal K, 2014, MOL CANCER THER, V13, P2264, DOI 10.1158/1535-7163.MCT-14-0291; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Selvaraj BT, 2012, J CELL BIOL, V199, P437, DOI 10.1083/jcb.201203109; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Socoro-Yuste N, 2016, BBA-MOL CELL RES, V1863, P2758, DOI 10.1016/j.bbamcr.2016.08.012; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Teng TS, 2009, J CELL SCI, V122, P4150, DOI 10.1242/jcs.057109; Toffali L, 2017, J IMMUNOL, V198, P708, DOI 10.4049/jimmunol.1600933; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; Wittchen ES, 2008, METHOD ENZYMOL, V443, P285, DOI 10.1016/S0076-6879(08)02014-4; Zhang YQ, 2013, CANCER RES, V73, P6359, DOI 10.1158/0008-5472.CAN-13-1558-T; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou Z, 2013, CIRCULATION, V127, P476, DOI 10.1161/CIRCULATIONAHA.112.132126	37	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11143	11153		10.1074/jbc.RA118.003276	http://dx.doi.org/10.1074/jbc.RA118.003276			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29853638	hybrid, Green Published			2022-12-28	WOS:000438882800026
J	Craig, PA				Craig, Paul A.			Lessons from my undergraduate research students	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						structure-function; enzyme; gel electrophoresis; chromatography; bioinformatics; computational biology; CURE; mentor-student relationship; protein function prediction; teaching lab; undergraduate research; mentor-student relationship		From very early on, my personal/professional life has been shaped by teachers in many different settings. Teaching and learning form a two-way street. In the process of teaching undergraduate students, particularly in the research lab, I have learned some profound lessons about the importance of listening to them, challenging them, giving them autonomy, and allowing them to enjoy success and to risk failure. I am now working with a team of faculty members to implement these lessons in a course-based undergraduate research experience in the biochemistry teaching laboratory. Our goal is to seek answers to the question How do students become scientists? and to implement those answers with our future students.	[Craig, Paul A.] Rochester Inst Technol, Sch Chem & Mat Sci, Rochester, NY 14623 USA	Rochester Institute of Technology	Craig, PA (corresponding author), Rochester Inst Technol, 1 Lomb Mem Dr,Gosnell Bldg,Rm 2116, Rochester, NY 14623 USA.	paul.craig@rit.edu		Craig, Paul/0000-0002-2085-7816	Rochester Institute of Technology; NIGMS, National Institutes of Health [R15GM078077]; National Science Foundation [0402408, 1503811, 1709170]; Direct For Education and Human Resources [1503699] Funding Source: National Science Foundation; Division Of Undergraduate Education [1503676, 1503811] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM078077] Funding Source: NIH RePORTER	Rochester Institute of Technology; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Rochester Institute of Technology, NIGMS, National Institutes of Health Grant R15GM078077, and by National Science Foundation Grants 0402408, 1503811, and 1709170. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman R. C., 2010, PROTEIN DATA BANK NE, V45, P5; Craig P., 2017, BASIL BIOCH AUTHENTI; Craig PA, 2003, BIOCHEM MOL BIOL EDU, V31, P151, DOI 10.1002/bmb.2003.494031020209; Craig PA, 2017, BIOCHEM MOL BIOL EDU, V45, P426, DOI 10.1002/bmb.21060; Dries DR, 2017, BIOCHEM MOL BIOL EDU, V45, P69, DOI 10.1002/bmb.20991; Fisher A, 2012, BIOCHEM MOL BIOL EDU, V40, P393, DOI 10.1002/bmb.20651; Furnham N, 2014, NUCLEIC ACIDS RES, V42, pD485, DOI 10.1093/nar/gkt1243; Grell L, 2006, BIOCHEM MOL BIOL EDU, V34, P402, DOI 10.1002/bmb.2006.494034062672; Hanson B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-87; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; LEVENSHT.VI, 1965, DOKL AKAD NAUK SSSR+, V163, P845; McKay Talia, 2015, Journal of Structural and Functional Genomics, V16, P43, DOI 10.1007/s10969-015-9194-5; Roosevelt T., 1910, COMMUNICATION	15	3	3	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10447	10452		10.1074/jbc.RA118.003722	http://dx.doi.org/10.1074/jbc.RA118.003722			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29743235	Green Published, hybrid			2022-12-28	WOS:000437828400005
J	Habtemichael, EN; Li, DT; Alcazar-Roman, A; Westergaard, XO; Li, MY; Petersen, MC; Li, HB; DeVries, SG; Li, E; Julca-Zevallos, O; Wolenski, JS; Bogan, JS				Habtemichael, Estifanos N.; Li, Don T.; Alcazar-Roman, Abel; Westergaard, Xavier O.; Li, Muyi; Petersen, Max C.; Li, Hanbing; DeVries, Stephen G.; Li, Eric; Julca-Zevallos, Omar; Wolenski, Joseph S.; Bogan, Jonathan S.			Usp25m protease regulates ubiquitin-like processing of TUG proteins to control GLUT4 glucose transporter translocation in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transporter type 4 (GLUT4); insulin; protein processing; adipocyte; membrane trafficking; protein translocation; proteolysis; kinesin; insulin resistance; ubiquitylation (ubiquitination)	DIET-INDUCED OBESITY; 3T3-L1 ADIPOCYTES; INSULIN ACTION; DEGRADATION SIGNAL; RECYCLING PATHWAY; STORAGE-VESICLES; SKELETAL-MUSCLE; ADIPOSE-TISSUE; CELL-SURFACE; INTERACTS	Insulin stimulates the exocytic translocation of specialized vesicles in adipocytes, which inserts GLUT4 glucose transporters into the plasma membrane to enhance glucose uptake. Previous results support a model in which TUG (Tether containing a UBX domain for GLUT4) proteins trap these GLUT4 storage vesicles at the Golgi matrix and in which insulin triggers endoproteolytic cleavage of TUG to translocate GLUT4. Here, we identify the muscle splice form of Usp25 (Usp25m) as a protease required for insulin-stimulated TUG cleavage and GLUT4 translocation in adipocytes. Usp25m is expressed in adipocytes, binds TUG and GLUT4, dissociates from TUG-bound vesicles after insulin addition, and colocalizes with TUG and insulin-responsive cargoes in unstimulated cells. Previous results show that TUG proteolysis generates the ubiquitin-like protein, TUGUL (for TUG ubiquitin-like). We now show that TUGUL modifies the kinesin motor protein, KIF5B, and that TUG proteolysis is required to load GLUT4 onto these motors. Insulin stimulates TUG proteolytic processing independently of phosphatidylinositol 3-kinase. In nonadipocytes, TUG cleavage can be reconstituted by transfection of Usp25m, but not the related Usp25a isoform, together with other proteins present on GLUT4 vesicles. In rodents with diet-induced insulin resistance, TUG proteolysis and Usp25m protein abundance are reduced in adipose tissue. These effects occur soon after dietary manipulation, prior to the attenuation of insulin signaling to Akt. Together with previous data, these results support a model whereby insulin acts through Usp25m to mediate TUG cleavage, which liberates GLUT4 storage vesicles from the Golgi matrix and activates their microtubule-based movement to the plasma membrane. This TUG proteolytic pathway for insulin action is independent of Akt and is impaired by nutritional excess.	[Habtemichael, Estifanos N.; Li, Don T.; Alcazar-Roman, Abel; Westergaard, Xavier O.; Li, Muyi; Petersen, Max C.; Li, Hanbing; DeVries, Stephen G.; Li, Eric; Julca-Zevallos, Omar; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA; [Li, Don T.; Julca-Zevallos, Omar; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Petersen, Max C.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Wolenski, Joseph S.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Li, Hanbing] Zhejiang Univ Technol, Inst Pharmacol, Dept Pharmaceut Sci, Hangzhou 310014, Zhejiang, Peoples R China	Yale University; Yale University; Yale University; Yale University; Zhejiang University of Technology	Bogan, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Li, Hanbing/W-3302-2019; Bogan, Jonathan S/A-1575-2010; Li, Don/F-5162-2018	Bogan, Jonathan S/0000-0001-6463-8466; Alcazar-Roman, Abel R./0000-0003-1668-1886; Li, Don/0000-0001-7547-4022	National Institutes of Health [P30 DK45735]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK115037, R01DK092661, F30DK104596, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Gerald Shulman, Dr. Nai-Wen Chi, Arielle Patterson, Vincent Calia-Bogan, and Roland Calia-Bogan for helpful discussions and assistance, and Dr. Gemma Marfany, Dr. Konstantin Kandror, and Dr. Gustav Lienhard for kindly sharing plasmids. This work used the Cell Biology Core of the Yale Diabetes Endocrinology Research Center (supported by National Institutes of Health Grant P30 DK45735) as well as services provided by the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University.	Belman JP, 2015, J BIOL CHEM, V290, P4447, DOI 10.1074/jbc.M114.603977; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bosch-Comas A, 2006, CELL MOL LIFE SCI, V63, P723, DOI 10.1007/s00018-005-5533-1; Brewer PD, 2016, J BIOL CHEM, V291, P773, DOI 10.1074/jbc.M115.694919; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Cui J, 2017, FASEB J, V31, P2533, DOI 10.1096/fj.201601103R; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Govers R, 2014, ADV CLIN CHEM, V66, P173, DOI 10.1016/B978-0-12-801401-1.00006-2; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Habtemichael EN, 2015, J BIOL CHEM, V290, P14454, DOI 10.1074/jbc.C115.639203; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Huang GR, 2013, MOL BIOL CELL, V24, P3115, DOI 10.1091/mbc.E12-10-0765; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Jun HS, 2008, OBESITY, V16, P1226, DOI 10.1038/oby.2008.220; Jung ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep08805; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Kawaguchi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45037; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-166; Lin DD, 2015, P NATL ACAD SCI USA, V112, P11324, DOI 10.1073/pnas.1509968112; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Liu SJ, 2017, CELL REP, V18, P1005, DOI 10.1016/j.celrep.2016.12.086; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Loffler MG, 2013, J BIOL CHEM, V288, P20135, DOI 10.1074/jbc.M113.458075; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Pan X, 2017, MOL BIOL CELL, V28, P1667, DOI 10.1091/mbc.E16-11-0777; Quan NH, 2017, FASEB J, V31, P4153, DOI 10.1096/fj.201700063R; Ren YJ, 2016, J BIOL CHEM, V291, P13206, DOI 10.1074/jbc.M116.718080; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Sebastian BM, 2005, AM J PHYSIOL-ENDOC M, V289, pE1077, DOI 10.1152/ajpendo.00296.2005; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2008, J BIOL CHEM, V283, P30311, DOI 10.1074/jbc.M805182200; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Valero R, 2001, GENOME BIOL, V2; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Xu DC, 2017, GENE DEV, V31, P1024, DOI 10.1101/gad.300889.117; Xu YK, 2016, J CELL SCI, V129, P2085, DOI 10.1242/jcs.174805; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Zhong HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080976; Zhong LL, 2016, DIABETOLOGIA, V59, P582, DOI 10.1007/s00125-015-3815-1	72	19	19	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10466	10486		10.1074/jbc.RA118.003021	http://dx.doi.org/10.1074/jbc.RA118.003021			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29773651	hybrid, Green Published			2022-12-28	WOS:000437828400008
J	Jimenez-Vicente, E; Yang, ZY; Ray, WK; Echavarri-Erasun, C; Cash, VL; Rubio, LM; Seefeldt, LC; Dean, DR				Jimenez-Vicente, Emilio; Yang, Zhi-Yong; Keith Ray, W.; Echavarri-Erasun, Carlos; Cash, Valerie L.; Rubio, Luis M.; Seefeldt, Lance C.; Dean, Dennis R.			Sequential and differential interaction of assembly factors during nitrogenase MoFe protein maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein assembly; nitrogenase; reductase; protein purification; electron paramagnetic resonance (EPR); MoFe protein; FeMo-cofactor; P-cluster; nitrogen fixation	IRON-MOLYBDENUM COFACTOR; IN-VITRO SYNTHESIS; AZOTOBACTER-VINELANDII NITROGENASE; KLEBSIELLA-PNEUMONIAE; NUCLEOTIDE-SEQUENCE; MUTATIONAL ANALYSIS; STRUCTURAL GENES; DELETION STRAIN; FIXATION; PURIFICATION	Nitrogenases reduce atmospheric nitrogen, yielding the basic inorganic molecule ammonia. The nitrogenase MoFe protein contains two cofactors, a [7Fe-9S-Mo-C-homocitrate] active-site species, designated FeMo-cofactor, and a [8Fe-7S] electron-transfer mediator called P-cluster. Both cofactors are essential for molybdenum-dependent nitrogenase catalysis in the nitrogen-fixing bacterium Azotobacter vinelandii. We show here that three proteins, NafH, NifW, and NifZ, copurify with MoFe protein produced by an A. vinelandii strain deficient in both FeMo-cofactor formation and P-cluster maturation. In contrast, two different proteins, NifY and NafY, copurified with MoFe protein deficient only in FeMo-cofactor formation. We refer to proteins associated with immature MoFe protein in the following as assembly factors. Copurifications of such assembly factors with MoFe protein produced in different genetic backgrounds revealed their sequential and differential interactions with MoFe protein during the maturation process. We found that these interactions occur in the order NafH, NifW, NifZ, and NafY/NifY. Interactions of NafH, NifW, and NifZ with immature forms of MoFe protein preceded completion of P-cluster maturation, whereas interaction of NafY/NifY preceded FeMo-cofactor insertion. Because each assembly factor could independently bind an immature form of MoFe protein, we propose that subpopulations of MoFe protein-assembly factor complexes represent MoFe protein captured at different stages of a sequential maturation process. This suggestion was supported by separate isolation of three such complexes, MoFe protein-NafY, MoFe protein-NifY, and MoFe protein-NifW. We conclude that factors involved in MoFe protein maturation sequentially bind and dissociate in a dynamic process involving several MoFe protein conformational states.	[Jimenez-Vicente, Emilio; Keith Ray, W.; Cash, Valerie L.; Dean, Dennis R.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Yang, Zhi-Yong; Seefeldt, Lance C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Echavarri-Erasun, Carlos; Rubio, Luis M.] UPM, Ctr Biotecnol & Genom Plantas, Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Campus Montegancedo UPM Pozuelo De Alarcon, Madrid 28223, Spain	Virginia Polytechnic Institute & State University; Utah System of Higher Education; Utah State University; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Politecnica de Madrid	Dean, DR (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	deandr@vt.edu	Rubio, Luis M./B-5827-2009; Echavarri-Erasun, Carlos/L-5820-2014; Yang, Zhiyong/E-7834-2013	Rubio, Luis M./0000-0003-1596-2475; Yang, Zhiyong/0000-0001-8186-9450; Echavarri-Erasun, Carlos/0000-0001-8363-5199; Dean, Dennis/0000-0001-8960-6196	Fralin Life Science Institute; Agricultural Experiment Station Hatch Program; McIntire-Stennis Program at Virginia Tech	Fralin Life Science Institute; Agricultural Experiment Station Hatch Program; McIntire-Stennis Program at Virginia Tech	Mass spectrometry resources used in this work are maintained in part through funding by the Fralin Life Science Institute, the Agricultural Experiment Station Hatch Program, and the McIntire-Stennis Program at Virginia Tech and are managed by Richard F. Helm.	ALLEN RM, 1993, J BIOL CHEM, V268, P23670; Barney BM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01534-17; BENNETT LT, 1988, MOL MICROBIOL, V2, P315, DOI 10.1111/j.1365-2958.1988.tb00034.x; BENNETT LT, 1988, J BIOL CHEM, V263, P1364; BISHOP PE, 1986, SCIENCE, V232, P92, DOI 10.1126/science.232.4746.92; BLANCO G, 1993, MOL MICROBIOL, V9, P869, DOI 10.1111/j.1365-2958.1993.tb01745.x; Broach RB, 2006, BIOCHEMISTRY-US, V45, P15039, DOI 10.1021/bi061697p; Buren S, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fnx274; BURGESS BK, 1980, BIOCHIM BIOPHYS ACTA, V614, P196, DOI 10.1016/0005-2744(80)90180-1; Chatterjee R, 1997, J BIOL CHEM, V272, P21604, DOI 10.1074/jbc.272.34.21604; CHISNELL JR, 1988, J BACTERIOL, V170, P27, DOI 10.1128/jb.170.1.27-33.1988; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2005, P NATL ACAD SCI USA, V102, P6291, DOI 10.1073/pnas.0501216102; Dilworth MJ, 1998, BIOCHEMISTRY-US, V37, P17495, DOI 10.1021/bi9812017; Dos Santos PC, 2011, METHODS MOL BIOL, V766, P81, DOI 10.1007/978-1-61779-194-9_6; Dos Santos PC, 2011, MOL MICROBIOL, V79, P1132, DOI 10.1111/j.1365-2958.2011.07541.x; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hamilton TL, 2011, J BACTERIOL, V193, P4477, DOI 10.1128/JB.05099-11; Hernandez JA, 2011, J BIOL CHEM, V286, P6321, DOI 10.1074/jbc.M110.168732; HOMER MJ, 1993, J BACTERIOL, V175, P4907, DOI 10.1128/JB.175.15.4907-4910.1993; HOMER MJ, 1995, J BIOL CHEM, V270, P24745, DOI 10.1074/jbc.270.42.24745; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; Hu Y, 2007, P NATL ACAD SCI USA, V104, P10424, DOI 10.1073/pnas.0704297104; Hu YL, 2004, J BIOL CHEM, V279, P54963, DOI 10.1074/jbc.M408983200; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; JOERGER RD, 1988, CRIT REV MICROBIOL, V16, P1, DOI 10.3109/10408418809104465; JOERGER RD, 1990, J BACTERIOL, V172, P3400, DOI 10.1128/jb.172.6.3400-3408.1990; JOERGER RD, 1988, J BACTERIOL, V170, P1475, DOI 10.1128/jb.170.4.1475-1487.1988; Kim S, 1996, J BIOL CHEM, V271, P9764, DOI 10.1074/jbc.271.16.9764; Magnuson JK, 1997, TETRAHEDRON, V53, P11971, DOI 10.1016/S0040-4020(97)00710-2; Moser J, 2013, P NATL ACAD SCI USA, V110, P2094, DOI 10.1073/pnas.1218303110; ORMEJOHNSON WH, 1972, P NATL ACAD SCI USA, V69, P3142, DOI 10.1073/pnas.69.11.3142; PAUL W, 1989, EUR J BIOCHEM, V178, P675, DOI 10.1111/j.1432-1033.1989.tb14497.x; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Ribbe MW, 2002, J BIOL CHEM, V277, P23469, DOI 10.1074/jbc.M202061200; RIVERAORTIZ JM, 1975, J BACTERIOL, V123, P537, DOI 10.1128/JB.123.2.537-545.1975; ROBERTS GP, 1978, J BACTERIOL, V136, P267, DOI 10.1128/JB.136.1.267-279.1978; ROBINSON AC, 1987, J BIOL CHEM, V262, P14327; Rubio LM, 2004, J BIOL CHEM, V279, P19739, DOI 10.1074/jbc.M400965200; Rubio LM, 2002, J BIOL CHEM, V277, P14299, DOI 10.1074/jbc.M107289200; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Rupnik K, 2012, J AM CHEM SOC, V134, P13749, DOI 10.1021/ja304077h; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Seefeldt LC, 2012, CURR OPIN CHEM BIOL, V16, P19, DOI 10.1016/j.cbpa.2012.02.012; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09; SHAH VK, 1994, J BIOL CHEM, V269, P1154; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; STRANDBERG GW, 1968, CAN J MICROBIOL, V14, P25, DOI 10.1139/m68-005; Vicente EJ, 2017, P NATL ACAD SCI USA, V114, P3009, DOI 10.1073/pnas.1701560114; WHITE TC, 1992, J BIOL CHEM, V267, P24007	54	23	23	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9812	9823		10.1074/jbc.RA118.002994	http://dx.doi.org/10.1074/jbc.RA118.002994			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29724822	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000436102300024
J	Platko, K; Lebeau, P; Austin, RC				Platko, Khrystyna; Lebeau, Paul; Austin, Richard C.			MAPping the kinase landscape of macrophage activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ARLTS1; CANCER	ARL11 is a tumor suppressor gene with established pro-apoptotic properties, but its function beyond this role is poorly understood. A new analysis of macrophage activation has identified ARL11 as a novel regulator of a mitogen-activated protein kinase (MAPK). These findings expand on the function of ARL11 beyond its tumor suppressor activity and highlight a novel role as a regulator of macrophage activation and inflammatory response.	[Platko, Khrystyna; Lebeau, Paul; Austin, Richard C.] McMaster Univ, St Josephs Healthcare Hamilton, Dept Med, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Platko, Khrystyna; Lebeau, Paul; Austin, Richard C.] Hamilton Ctr Kidney Res, Hamilton, ON L8N 4A6, Canada; [Austin, Richard C.] Hamilton Hlth Sci, Thrombosis & Atherosclerosis Res Inst TaARI, Hamilton, ON L8L 2X2, Canada; [Austin, Richard C.] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Austin, Richard C.] Heart & Stroke Fdn Ontario, Ottawa, ON, Canada; [Austin, Richard C.] St Josephs Healthcare, Div Nephrol, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Austin, RC (corresponding author), 50 Charlton Ave E,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca			Heart and Stroke Foundation of Ontario [T-6146]; Heart and Stroke Foundation of Canada [G-13-0003064, G-15-0009389]; Canadian Institutes of Health Research [74477]; St. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research Team Grant in Thromboembolism [FRN-79846]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); St. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research Team Grant in Thromboembolism(Canadian Institutes of Health Research (CIHR))	This work was supported in part by research grants from the Heart and Stroke Foundation of Ontario (T-6146), the Heart and Stroke Foundation of Canada (G-13-0003064 and G-15-0009389), and the Canadian Institutes of Health Research (74477) (to R.C.A.). Financial support from St. Joseph's Healthcare Hamilton and the Canadian Institutes of Health Research Team Grant in Thromboembolism (FRN-79846) is acknowledged. The authors declare that they have no conflicts of interest with the contents of this article.	Arya SB, 2018, J BIOL CHEM, V293, P9892, DOI 10.1074/jbc.RA117.000727; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Lioberas J, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00028; Siltanen S, 2008, EUR J HUM GENET, V16, P983, DOI 10.1038/ejhg.2008.43; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Yendamuri S, 2008, CANCER LETT, V264, P11, DOI 10.1016/j.canlet.2008.02.021; Yendamuri S, 2007, CANCER RES, V67, P7738, DOI 10.1158/0008-5472.CAN-07-1481	7	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9910	9911		10.1074/jbc.H118.003380	http://dx.doi.org/10.1074/jbc.H118.003380			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29934367	Green Published, hybrid			2022-12-28	WOS:000436102300031
J	Igarashi, A; Itoh, K; Yamada, T; Adachi, Y; Kato, T; Murata, D; Sesaki, H; Iijima, M				Igarashi, Atsushi; Itoh, Kie; Yamada, Tatsuya; Adachi, Yoshihiro; Kato, Takashi; Murata, Daisuke; Sesaki, Hiromi; Iijima, Miho			Nuclear PTEN deficiency causes microcephaly with decreased neuronal soma size and increased seizure susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase and tensin homolog (PTEN); phosphatidylinositide 3-kinase (PI 3-kinase); mouse genetics; brain; cell signaling; lipid signaling; PIP3 signaling; nucleus; mouse; genome editing	HAMARTOMA TUMOR SYNDROME; LOCALIZATION; PATHWAY; BRAIN; TUMORIGENESIS; MODELS; DRP1	Defects in phosphatase and tensin homolog (PTEN) are associated with neurological disorders and tumors. PTEN functions at two primary intracellular locations: the plasma membrane and the nucleus. At the membrane, PTEN functions as a phosphatidylinositol (3,4,5)-trisphosphate phosphatase and suppresses PI 3-kinase signaling that drives cell growth and tumorigenesis. However, the in vivo function of nuclear PTEN is unclear. Here, using CRISPR/Cas9, we generated a mouse model in which PTEN levels in the nucleus are decreased. Nuclear PTEN-deficient mice were born with microcephaly and maintained a small brain during adulthood. The size of neuronal soma was significantly smaller in the cerebellum, cerebral cortex, and hippocampus. Also, these mice were prone to seizure. No changes in PI 3-kinase signaling were observed. By contrast, the size of other organs was unaffected. Therefore, nuclear PTEN is essential for the health of the brain by promoting the growth of neuronal soma size during development.	[Igarashi, Atsushi; Itoh, Kie; Yamada, Tatsuya; Adachi, Yoshihiro; Kato, Takashi; Murata, Daisuke; Sesaki, Hiromi; Iijima, Miho] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Iijima, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	miijima@jhmi.edu			National Institutes of Health [GM084015, GM123266]; Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084015, R01GM123266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM084015 (to M. I.) and GM123266 (to H. S.) and the Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center (to M. I. and H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi Y, 2016, MOL CELL, V63, P1034, DOI 10.1016/j.molcel.2016.08.013; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chung JH, 2006, HUM MOL GENET, V15, P2553, DOI 10.1093/hmg/ddl177; Cupolillo D, 2016, NEUROPSYCHOPHARMACOL, V41, P1457, DOI 10.1038/npp.2015.339; DEDEYN PP, 1992, EPILEPSY RES, V12, P87, DOI 10.1016/0920-1211(92)90030-W; Dhir A., 2012, CURR PROT NEUROSCI, V58, p9.37.1, DOI [DOI 10.1002/0471142301.NS0937S58, 10.1002/0471142301.ns0937s58]; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Nguyen HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep12600; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Kreis P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00023; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Leslie NR, 2016, BIOCHEM SOC T, V44, P273, DOI 10.1042/BST20150224; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marino S, 2002, DEVELOPMENT, V129, P3513; Moncalero VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018857; Nardella C, 2011, CURR TOP MICROBIOL, V347, P135, DOI 10.1007/82_2010_62; Nguyen HN, 2014, ONCOGENE, V33, P5688, DOI 10.1038/onc.2013.507; Nguyen HN, 2015, ONCOGENE, V34, P3737, DOI 10.1038/onc.2014.293; Pilarski R, 2013, JNCI-J NATL CANCER I, V105, P1607, DOI 10.1093/jnci/djt277; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Sarnat HB, 2015, CELL TISSUE RES, V359, P279, DOI 10.1007/s00441-014-1988-4; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Veleva-Rotse BO, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00035; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Yamada T, 2016, AM J PATHOL, V186, P2798, DOI 10.1016/j.ajpath.2016.06.025; Yang M, 2017, ONCOGENE, V36, P3673, DOI 10.1038/onc.2016.493; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004	49	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9292	9300		10.1074/jbc.RA118.002356	http://dx.doi.org/10.1074/jbc.RA118.002356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29735527	Green Published, hybrid			2022-12-28	WOS:000435441400015
J	Michalski, MN; Williams, BO				Michalski, Megan N.; Williams, Bart O.			A quest for clarity in bone erosion: The role of sequestosome 1 in Paget's disease of bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MUTATION; P62; OSTEOCLASTOGENESIS; INCREASES; DOMAIN	Alterations in the SQSTM1 gene are a putative cause of Paget's disease of bone, yet results are conflicting about how these mutations impact osteoclasts, the cell type believed to be the main pathological contributor. In this issue of JBC, Zach et al. provide important new evidence that the protein encoded by SQSTM1, p62, negatively regulates osteoclastogenesis and demonstrate that aged p62-deficient mice develop bone phenotypes similar to those of Paget's disease. These findings help to clarify the role of this important protein and present new opportunities to interrogate bone biology.	[Michalski, Megan N.; Williams, Bart O.] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA	Van Andel Institute	Williams, BO (corresponding author), Van Andel Res Inst, 333 Bostwick NE, Grand Rapids, MI 49503 USA.	bart.williams@vai.org		Williams, Bart/0000-0002-5261-5301	NIAMS NIH HHS [R01 AR053293] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053293] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chang KH, 2014, CELL REP, V9, P2084, DOI 10.1016/j.celrep.2014.11.031; Daroszewska A, 2011, HUM MOL GENET, V20, P2734, DOI 10.1093/hmg/ddr172; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Galson Deborah L, 2014, J Bone Metab, V21, P85, DOI 10.11005/jbm.2014.21.2.85; Hiruma Y, 2008, HUM MOL GENET, V17, P3708, DOI 10.1093/hmg/ddn266; Kurihara N, 2007, J CLIN INVEST, V117, P133, DOI 10.1172/JCI28267; Rea SL, 2006, J BONE MINER RES, V21, P1136, DOI 10.1359/JBMR.060405; Tan A, 2014, QJM-INT J MED, V107, P865, DOI 10.1093/qjmed/hcu075; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960; Zach F, 2018, J BIOL CHEM, V293, P9530, DOI 10.1074/jbc.RA118.002449	10	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9542	9543		10.1074/jbc.H118.003689	http://dx.doi.org/10.1074/jbc.H118.003689			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29907733	Green Published, hybrid			2022-12-28	WOS:000435441400036
J	Shakeel, T; Gupta, M; Fatma, Z; Kumar, R; Kumar, R; Singh, R; Sharma, M; Jade, D; Gupta, D; Fatma, T; Yazdani, SS				Shakeel, Tabinda; Gupta, Mayank; Fatma, Zia; Kumar, Rakesh; Kumar, Raubins; Singh, Rahul; Sharma, Medha; Jade, Dhananjay; Gupta, Dinesh; Fatma, Tasneem; Yazdani, Syed Shams			A consensus-guided approach yields a heat-stable alkane-producing enzyme and identifies residues promoting thermostability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein engineering; structure-function; enzyme mechanism; enzyme mutation; molecular modeling; molecular dynamics; biofuel; aldehyde deformylating oxygenase; long-chain alkane; thermostable enzyme	CYANOBACTERIAL ALDEHYDE DECARBONYLASE; DEFORMYLATING OXYGENASE; SALT BRIDGES; ACID; BIOSYNTHESIS; SIMULATION; CONVERSION; STABILITY; INSIGHTS; DYNAMICS	Aldehyde-deformylating oxygenase (ADO) is an essential enzyme for production of long-chain alkanes as drop-in biofuels, which are compatible with existing fuel systems. The most active ADOs are present in mesophilic cyanobacteria, especially Nostoc punctiforme. Given the potential applications of thermostable enzymes in biorefineries, here we generated a thermostable (Cts)-ADO based on a consensus of ADO sequences from several thermophilic cyanobacterial strains. Using an in silico design pipeline and a metagenome library containing 41 hot-spring microbial communities, we created Cts-ADO. Cts-ADO displayed a 3.8-fold increase in pentadecane production on raising the temperature from 30 to 42 degrees C, whereas ADO from N. punctiforme (Np-ADO) exhibited a 1.7-fold decline. 3D structure modeling and molecular dynamics simulations of Cts- and Np-ADO at different temperatures revealed differences between the two enzymes in residues clustered on exposed loops of these variants, which affected the conformation of helices involved in forming the ADO catalytic core. In Cts-ADO, this conformational change promoted ligand binding to its preferred iron, Fe2, in the di-iron cluster at higher temperature, but the reverse was observed in Np-ADO. Detailed mapping of residues conferring Cts-ADO thermostability identified four amino acids, which we substituted individually and together in Np-ADO. Among these substitution variants, A161E was remarkably similar to Cts-ADO in terms of activity optima, kinetic parameters, and structure at higher temperature. A161E was located in loop L6, which connects helices H5 and H6, and supported ligand binding to Fe2 at higher temperatures, thereby promoting optimal activity at these temperatures and explaining the increased thermostability of Cts-ADO.	[Shakeel, Tabinda; Gupta, Mayank; Fatma, Zia; Kumar, Raubins; Singh, Rahul; Sharma, Medha; Yazdani, Syed Shams] Int Ctr Genet Engn & Biotechnol, Microbial Engn Grp, New Delhi 110067, India; [Kumar, Rakesh; Jade, Dhananjay; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Translat Bioinformat Grp, New Delhi 110067, India; [Shakeel, Tabinda; Gupta, Mayank; Fatma, Zia; Singh, Rahul; Sharma, Medha; Yazdani, Syed Shams] Int Ctr Genet Engn & Biotechnol, DBT ICGEB Ctr Adv Bioenergy Res, New Delhi 110067, India; [Fatma, Tasneem] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; DBT-ICGEB Centre for Advanced Bioenergy Research, New Delhi; Jamia Millia Islamia	Yazdani, SS (corresponding author), Int Ctr Genet Engn & Biotechnol, Microbial Engn Grp, New Delhi 110067, India.; Yazdani, SS (corresponding author), Int Ctr Genet Engn & Biotechnol, DBT ICGEB Ctr Adv Bioenergy Res, New Delhi 110067, India.	shams@icgeb.res.in	Gupta, Dinesh/C-1079-2009; Singh, Rahul/AAT-2337-2021	Gupta, Dinesh/0000-0002-7548-8835; Jade, Dhananjay/0000-0002-3009-5915	Department of Biotechnology, Government of India [BT/PB/Center/03/2011, BT/IN/INDO-UK/SuBB/21/SSY/2013, BT/BI/25/066/2012]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by Department of Biotechnology, Government of India, Grants BT/PB/Center/03/2011 and BT/IN/INDO-UK/SuBB/21/SSY/2013 (to S. S. Y.) and Grant BT/BI/25/066/2012 (to D. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar MK, 2013, P NATL ACAD SCI USA, V110, P87, DOI 10.1073/pnas.1216516110; Andre C, 2013, P NATL ACAD SCI USA, V110, P3191, DOI 10.1073/pnas.1218769110; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Bao LY, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0596-9; Buer BC, 2014, ACS CHEM BIOL, V9, P2584, DOI 10.1021/cb500343j; Buist PH, 2007, NAT PROD REP, V24, P1110, DOI 10.1039/b508584p; Case D. A., 2014, AMBER 14; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan CH, 2015, WORLD J EMERG MED, V6, P16, DOI 10.5847/wjem.j.1920-8642.2015.01.003; Damnjanovic J, 2014, BIOTECHNOL BIOENG, V111, P674, DOI 10.1002/bit.25149; Das D, 2014, ACS CHEM BIOL, V9, P570, DOI 10.1021/cb400772q; Das D, 2011, ANGEW CHEM INT EDIT, V50, P7148, DOI 10.1002/anie.201101552; DeLano W.L., 2002, PYMOL MOL GRAPH SYST; Dembitsky VM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1276, DOI 10.1023/A:1021309623541; DENNIS M, 1992, P NATL ACAD SCI USA, V89, P5306, DOI 10.1073/pnas.89.12.5306; Eser BE, 2011, BIOCHEMISTRY-US, V50, P10743, DOI 10.1021/bi2012417; Fatma Z, 2018, METAB ENG, V46, P1, DOI 10.1016/j.ymben.2018.01.002; Fatma Z, 2016, METAB ENG, V37, P35, DOI 10.1016/j.ymben.2016.04.003; GELPI E, 1968, SCIENCE, V161, P700, DOI 10.1126/science.161.3842.700; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Gunasekaran K, 2003, J MOL BIOL, V332, P143, DOI 10.1016/S0022-2836(03)00893-3; Hayashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122217; Howard TP, 2013, P NATL ACAD SCI USA, V110, P7636, DOI 10.1073/pnas.1215966110; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; Jia CJ, 2015, PROTEIN CELL, V6, P55, DOI 10.1007/s13238-014-0108-2; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; JONES JG, 1969, J GEN MICROBIOL, V59, P145, DOI 10.1099/00221287-59-2-145; Khara B, 2013, CHEMBIOCHEM, V14, P1204, DOI 10.1002/cbic.201300307; Knothe G, 2010, PROG ENERG COMBUST, V36, P364, DOI 10.1016/j.pecs.2009.11.004; Krebs C, 2011, CURR OPIN CHEM BIOL, V15, P291, DOI 10.1016/j.cbpa.2011.02.019; Kurtz DM, 1997, J BIOL INORG CHEM, V2, P159, DOI 10.1007/s007750050120; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Li N, 2011, J AM CHEM SOC, V133, P6158, DOI 10.1021/ja2013517; Liao H H, 1991, Protein Expr Purif, V2, P43, DOI 10.1016/1046-5928(91)90008-7; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lu XF, 2010, BIOTECHNOL ADV, V28, P742, DOI 10.1016/j.biotechadv.2010.05.021; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; Malabanan MM, 2010, CURR OPIN STRUC BIOL, V20, P702, DOI 10.1016/j.sbi.2010.09.005; Mamonova TB, 2013, BBA-PROTEINS PROTEOM, V1834, P854, DOI 10.1016/j.bbapap.2013.02.011; MCINNES AG, 1980, LIPIDS, V15, P609, DOI 10.1007/BF02534009; MERDINGER E, 1966, J BACTERIOL, V91, P1831, DOI 10.1128/JB.91.5.1831-1833.1966; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Olson DG, 2012, CURR OPIN BIOTECH, V23, P396, DOI 10.1016/j.copbio.2011.11.026; ORO J, 1966, SCIENCE, V154, P399, DOI 10.1126/science.154.3747.399; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; Papaleo E, 2007, J MOL GRAPH MODEL, V26, P93, DOI 10.1016/j.jmgm.2006.09.012; Paul B, 2013, J AM CHEM SOC, V135, P5234, DOI 10.1021/ja3115949; Paul M, 2014, J BIOMOL STRUCT DYN, V32, P928, DOI 10.1080/07391102.2013.799438; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shakeel T, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00034; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; SHIEA J, 1990, ORG GEOCHEM, V15, P223, DOI 10.1016/0146-6380(90)90001-G; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Speight J. G., 2016, HDB PETROLEUM REFINI; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Thomas AS, 2004, J AM CHEM SOC, V126, P2208, DOI 10.1021/ja039159c; Timilsina GR, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2012.0323; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Vinther JM, 2011, J AM CHEM SOC, V133, P271, DOI 10.1021/ja105388k; Wang Q, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0351-8; Wang Q, 2014, CHEM COMMUN, V50, P4299, DOI 10.1039/c4cc00591k; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waugh MW, 2014, BIOCHEMISTRY-US, V53, P5537, DOI 10.1021/bi5005766; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Westerlund-Karlsson A, 2002, BIOCHEM BIOPH RES CO, V296, P1072, DOI 10.1016/S0006-291X(02)02052-1; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Wintrode PL, 2003, J MOL BIOL, V327, P745, DOI 10.1016/S0022-2836(03)00147-5; Yu HR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41212; Zhang Jingjing, 2013, Biotechnol Biofuels, V6, P86, DOI 10.1186/1754-6834-6-86	83	13	13	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9148	9161		10.1074/jbc.RA117.000639	http://dx.doi.org/10.1074/jbc.RA117.000639			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29632075	Green Published, hybrid			2022-12-28	WOS:000435441400002
J	Etzl, S; Lindner, R; Nelson, MD; Winkler, A				Etzl, Stefan; Lindner, Robert; Nelson, Matthew D.; Winkler, Andreas			Structure-guided design and functional characterization of an artificial red light-regulated guanylate/adenylate cyclase for optogenetic applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; CRYSTAL-STRUCTURE; PHYTOCHROME; GENE; ELEGANS; BINDING; PHOTOACTIVATION; PHOTORECEPTORS; REARRANGEMENTS; TRANSDUCTION	Genetically targeting biological systems to control cellular processes with light is the concept of optogenetics. Despite impressive developments in this field, underlying molecular mechanisms of signal transduction of the employed photoreceptor modules are frequently not sufficiently understood to rationally design new optogenetic tools. Here, we investigate the requirements for functional coupling of red light-sensing phytochromes with non-natural enzymatic effectors by creating a series of constructs featuring the Deinococcus radiodurans bacteriophytochrome linked to a Synechocystis guanylate/adenylate cyclase. Incorporating characteristic structural elements important for cyclase regulation in our designs, we identified several red light-regulated fusions with promising properties. We provide details of one light-activated construct with low dark-state activity and high dynamic range that outperforms previous optogenetic tools in vitro and expands our in vivo toolkit, as demonstrated by manipulation of Caenorhabditis elegans locomotor activity. The full-length crystal structure of this phytochromelinked cyclase revealed molecular details of photoreceptoreffector coupling, highlighting the importance of the regulatory cyclase element. Analysis of conformationaldynamicsbyhydrogendeuterium exchange in different functional states enriched our understanding of phytochrome signaling and signal integration by effectors. We found that light-induced conformational changes in the phytochrome destabilize the coiled-coil sensoreffector linker, which releases the cyclase regulatory element from an inhibited conformation, increasing cyclase activity of this artificial system. Future designs of optogenetic functionalities may benefit from our work, indicating that rational considerations for the effector improve the rate of success of initial designs to obtain optogenetic tools with superior properties.	[Etzl, Stefan; Winkler, Andreas] Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria; [Lindner, Robert] Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany; [Nelson, Matthew D.] St Josephs Univ, Dept Biol, Philadelphia, PA 19131 USA	Graz University of Technology; Max Planck Society; Saint Joseph's University	Winkler, A (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	Andreas.Winkler@TUGraz.at	Nelson, Matthew/N-1462-2013	Nelson, Matthew/0000-0002-2085-8974; Winkler, Andreas/0000-0001-6221-9671	Austrian Science Fund (FWF) [P27124]; NAWI Graz; Austrian Science Fund Ph.D. program "DK Molecular Enzymology" Grant [W901]; NIGMS National Institutes of Health [R15GM122058]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM122058] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NAWI Graz; Austrian Science Fund Ph.D. program "DK Molecular Enzymology" Grant; NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Austrian Science Fund (FWF) Grant P27124 (to A. W.). This work was also supported by NAWI Graz. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Austrian Science Fund Ph.D. program "DK Molecular Enzymology" Grant W901.; Supported by the NIGMS National Institutes of Health Grant R15GM122058.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Anantharaman V, 2001, TRENDS BIOCHEM SCI, V26, P579, DOI 10.1016/S0968-0004(01)01968-5; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bjorling A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600920; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Burkhardt A, 2016, EUR PHYS J PLUS, V131, P1, DOI 10.1140/epjp/i2016-16056-0; Churgin MA, 2017, ELIFE, V6, DOI [10.7554/elife.26652, 10.7554/eLife.26652]; Davis MW, 1995, J NEUROSCI, V15, P8408; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; de Alda JAGO, 2000, J BACTERIOL, V182, P3839, DOI 10.1128/JB.182.13.3839-3842.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enomoto G, 2014, J BIOL CHEM, V289, P24801, DOI 10.1074/jbc.M114.583674; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gourinchas G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602498; Gushchin I, 2017, SCIENCE, V356, DOI 10.1126/science.aah6345; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleinboelting S, 2016, J BIOL CHEM, V291, P9776, DOI 10.1074/jbc.M115.708255; Kleinboelting S, 2014, FEBS J, V281, P4151, DOI 10.1111/febs.12913; Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111; Lindner R, 2017, J MOL BIOL, V429, P1336, DOI 10.1016/j.jmb.2017.03.020; Lindner R, 2014, J AM SOC MASS SPECTR, V25, P1018, DOI 10.1007/s13361-014-0850-y; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lupas AN, 2017, TRENDS BIOCHEM SCI, V42, P130, DOI 10.1016/j.tibs.2016.10.007; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Nelson M. D., 2011, OVERLAP EXTENSION PC, P459; Ohki M, 2016, P NATL ACAD SCI USA, V113, P6659, DOI 10.1073/pnas.1517520113; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ramos-Espiritu L, 2016, NAT CHEM BIOL, V12, P838, DOI [10.1038/NCHEMBIO.2151, 10.1038/nchembio.2151]; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Redemann S, 2011, NAT METHODS, V8, P250, DOI 10.1038/NMETH.1565; Ryu MH, 2014, P NATL ACAD SCI USA, V111, P10167, DOI 10.1073/pnas.1324301111; Saalau-Bethell SM, 2014, CHEMMEDCHEM, V9, P823, DOI 10.1002/cmdc.201300480; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Vercellino I, 2017, P NATL ACAD SCI USA, V114, pE9821, DOI 10.1073/pnas.1712621114; Winkler A, 2015, ACS CHEM BIOL, V10, P502, DOI 10.1021/cb500744m; Ziegler M, 2017, FEBS J, V284, P1204, DOI 10.1111/febs.14047	45	34	34	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9078	9089		10.1074/jbc.RA118.003069	http://dx.doi.org/10.1074/jbc.RA118.003069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29695503	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000434941900029
J	Liu, YP; Lan, WX; Wang, CX; Cao, CY				Liu, Yaping; Lan, Wenxian; Wang, Chunxi; Cao, Chunyang			A putative G-quadruplex structure in the proximal promoter of VEGFR-2 has implications for drug design to inhibit tumor angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIMERIC G-QUADRUPLEX; INTRAMOLECULAR G-QUADRUPLEX; HUMAN TELOMERE; K+ SOLUTION; IN-VIVO; DNA; REGION; RECEPTOR; SEQUENCE	Tumor angiogenesis is mainly regulated by vascular endothelial growth factor (VEGF) produced by cancer cells. It is active on the endothelium via VEGF receptor 2 (VEGFR-2). G-quadruplexes are DNA secondary structures formed by guanine-rich sequences, for example, within gene promoters where they may contribute to transcriptional activity. The proximal promoter of VEGFR-2 contains a G-quadruplex, which has been suggested to interact with small molecules that inhibit VEGFR-2 expression and thereby tumor angiogenesis. However, its structure is not known. Here, we determined its NMR solution structure, which is composed of three stacked G-tetrads containing three syn guanines. The first guanine (G(1)) is positioned within the central G-tetrad. We also observed that a noncanonical, V-shaped loop spans three G-tetrad planes, including no bridging nucleotides. A long and diagonal loop, which includes six nucleotides, connects reversal double chains. With a melting temperature of 54.51 degrees C, the scaffold of this quadruplex is stabilized by one G-tetrad plane stacking with one nonstandard bp, G(3)-C-8, whose bases interact with each other through only one hydrogen bond. In summary, the NMR solution structure of the G-quadruplex in the proximal promoter region of the VEGFR-2 gene reported here has uncovered its key features as a potential anticancer drug target.	[Liu, Yaping; Lan, Wenxian; Wang, Chunxi; Cao, Chunyang] Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Ctr Excellence Mol Synth, Shanghai Inst Organ Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China; [Liu, Yaping; Cao, Chunyang] Chinese Acad Sci, Collaborat Innovat Ctr Chem Life Sci, 345 Lingling Rd, Shanghai 200032, Peoples R China; [Lan, Wenxian; Wang, Chunxi; Cao, Chunyang] Univ Chinese Acad Sci, 19 A Yuquan Rd, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cao, CY (corresponding author), Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Ctr Excellence Mol Synth, Shanghai Inst Organ Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.; Cao, CY (corresponding author), Chinese Acad Sci, Collaborat Innovat Ctr Chem Life Sci, 345 Lingling Rd, Shanghai 200032, Peoples R China.; Cao, CY (corresponding author), Univ Chinese Acad Sci, 19 A Yuquan Rd, Beijing 100049, Peoples R China.	ccao@mail.sioc.ac.cn		Liu, Yaping/0000-0003-0375-0889	National Key Research and Development Program of China [2017YPE0108200, 2016YFA0502302]; Chinese Academy of Sciences Strategic Priority Research Program [XDB 20000000]; National Science Foundation of China [91753119, 21472229, 21778065]	National Key Research and Development Program of China; Chinese Academy of Sciences Strategic Priority Research Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China Grants 2017YPE0108200 and 2016YFA0502302; Chinese Academy of Sciences Strategic Priority Research Program Grant XDB 20000000; and National Science Foundation of China Grants 91753119, 21472229, and 21778065. The authors declare that they have no conflicts of interest with the contents of this article.	Amrane S, 2012, J AM CHEM SOC, V134, P5807, DOI 10.1021/ja208993r; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brunger A. T, 1993, X PLOR VERSION 31 SY; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Crnugelj M, 2003, J AM CHEM SOC, V125, P7866, DOI 10.1021/ja0348694; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; GLEAVE ME, 1993, CANCER RES, V53, P5300; Goddard T. D, 2009, SPARKY 3; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Kuryavyi V, 2010, STRUCTURE, V18, P73, DOI 10.1016/j.str.2009.10.015; Kuszewski J, 2000, J MAGN RESON, V146, P249, DOI 10.1006/jmre.2000.2142; LIOTTA LA, 1974, CANCER RES, V34, P997; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MARTINYBARON G, 1995, CURR OPIN BIOTECH, V6, P675, DOI 10.1016/0958-1669(95)80111-1; Marusic M, 2012, NUCLEIC ACIDS RES, V40, P6946, DOI 10.1093/nar/gks329; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; NICOSIA RF, 1994, AM J PATHOL, V145, P1023; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P3099, DOI 10.1002/anie.200806244; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Phan AT, 2002, J AM CHEM SOC, V124, P1160, DOI 10.1021/ja011977m; Phan AT, 2000, J BIOMOL NMR, V16, P175, DOI 10.1023/A:1008355231085; Piazza A, 2017, ELIFE, V6, DOI 10.7554/eLife.26884; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; Salvati E, 2014, NUCLEIC ACIDS RES, V42, P2945, DOI 10.1093/nar/gkt1289; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; Shirude PS, 2007, J AM CHEM SOC, V129, P7484, DOI 10.1021/ja070497d; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; WANG Y, 1993, J MOL BIOL, V234, P1171, DOI 10.1006/jmbi.1993.1668; Zhang N, 2005, J AM CHEM SOC, V127, P17277, DOI 10.1021/ja0543090; Zhang N, 2001, J MOL BIOL, V311, P1063, DOI 10.1006/jmbi.2001.4916	46	15	16	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8947	8955		10.1074/jbc.RA118.002666	http://dx.doi.org/10.1074/jbc.RA118.002666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29666187	hybrid, Green Published			2022-12-28	WOS:000434941900018
J	Parra, KJ; Hayek, SR				Parra, Karlett J.; Hayek, Summer R.			A lysosomal proton pump turns on when glucose runs out	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							VACUOLAR H+-ATPASE; COMPLEX; ACIDIFICATION	Vacuolar H+-ATPase (V-ATPase) is a glucose-responsive, ATP-driven proton pump that controls the acidity of cellular organelles. Increases in glucose stimulate V-ATPase assembly and activity, and glucose deprivation triggers rapid V-ATPase disassembly and inactivation in yeast. McGuire and Forgac describe the opposite phenomenon in mammalian cells, specifically that V-ATPase assembly and activation increases when glucose is lost, raising new questions about mammalian mechanisms of energy conservation.	[Parra, Karlett J.; Hayek, Summer R.] Univ New Mexico, Sch Med, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Parra, KJ (corresponding author), Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, MSC 08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu			American Heart Association [16GRNT27760020]; University of New Mexico Health Sciences Center	American Heart Association(American Heart Association); University of New Mexico Health Sciences Center	This work was supported in part by American Heart Association Grant 16GRNT27760020 (to K. J. P.) and the University of New Mexico Health Sciences Center. The authors declare that they have no conflicts of interest with the contents of this article.	Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; McGuire CM, 2018, J BIOL CHEM, V293, P9113, DOI 10.1074/jbc.RA117.001327; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Smardon AM, 2015, J BIOL CHEM, V290, P27511, DOI 10.1074/jbc.M115.667634; Weyandt Jamie D, 2017, Am Soc Clin Oncol Educ Book, V37, P825, DOI 10.14694/EDBK_175561; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014	10	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9124	9125		10.1074/jbc.H118.002950	http://dx.doi.org/10.1074/jbc.H118.002950			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29884762	Green Published, hybrid			2022-12-28	WOS:000434941900033
J	Ujfalusi, Z; Vera, CD; Mijailovich, SM; Svicevic, M; Yu, EC; Kawana, M; Ruppel, KM; Spudich, JA; Geeves, MA; Leinwand, LA				Ujfalusi, Zoltan; Vera, Carlos D.; Mijailovich, Srbolujub M.; Svicevic, Marina; Yu, Elizabeth Choe; Kawana, Masataka; Ruppel, Kathleen M.; Spudich, James A.; Geeves, Michael A.; Leinwand, Leslie A.			Dilated cardiomyopathy myosin mutants have reduced force-generating capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-I PHOSPHORYLATION; CROSS-BRIDGE CYCLE; CARDIAC MYOSIN; HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR-MECHANISM; MUSCLE-CONTRACTION; PROTEIN GENES; MUTATIONS; SKELETAL; ALPHA	Dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) can cause arrhythmias, heart failure, and cardiac death. Here, we functionally characterized the motor domains of five DCM-causing mutations in human beta-cardiac myosin. Kinetic analyses of the individual events in the ATPase cycle revealed that each mutation alters different steps in this cycle. For example, different mutations gave enhanced or reduced rate constants of ATP binding, ATP hydrolysis, or ADP release or exhibited altered ATP, ADP, or actin affinity. Local effects dominated, no common pattern accounted for the similar mutant phenotype, and there was no distinct set of changes that distinguished DCM mutations from previously analyzed HCM myosin mutations. That said, using our data to model the complete ATPase contraction cycle revealed additional critical insights. Four of the DCM mutations lowered the duty ratio (the ATPase cycle portion when myosin strongly binds actin) because of reduced occupancy of the force-holding A center dot M center dot D complex in the steady state. Under load, the A center dot M center dot D state is predicted to increase owing to a reduced rate constant for ADP release, and this effect was blunted for all five DCM mutations. We observed the opposite effects for two HCM mutations, namely R403Q and R453C. Moreover, the analysis predicted more economical use of ATP by the DCM mutants than by WT and the HCM mutants. Our findings indicate that DCM mutants have a deficit in force generation and force-holding capacity due to the reduced occupancy of the force-holding state.	[Ujfalusi, Zoltan; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Vera, Carlos D.; Leinwand, Leslie A.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Vera, Carlos D.; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Mijailovich, Srbolujub M.] IIT, Dept Biol, Chicago, IL 60616 USA; [Svicevic, Marina] Univ Kragujevac, Fac Sci, Kragujevac 34000, Serbia; [Yu, Elizabeth Choe] Stanford Univ, Dept Pediat Cardiol, Sch Med, Stanford, CA 94305 USA; [Kawana, Masataka; Ruppel, Kathleen M.; Spudich, James A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Ujfalusi, Zoltan] Univ Pecs, Sch Med, Dept Biophys, Szigeti St 12, H-7624 Pecs, Hungary	University of Kent; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Illinois Institute of Technology; University of Kragujevac; Stanford University; Stanford University; University of Pecs	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@Colorado.edu	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Svicevic, Marina/0000-0003-2791-3849; Vera, Carlos/0000-0003-1207-4878	MyoKardia, Inc.; National Institutes of Health [HL117138, GM33289]; British Heart Foundation [PG-175-30200]	MyoKardia, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation)	J. A. S. is a founder of and owns stock in MyoKardia, Inc. L A. L is a founder of, owns stock in, and has a sponsored research agreement with MyoKardia, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant HL117138.; Supported by National Institutes of Health Grant GM33289.; Supported by British Heart Foundation Grant PG-175-30200.	Adamek N, 2011, CELL MOL LIFE SCI, V68, P139, DOI 10.1007/s00018-010-0448-x; Adhikari AS, 2016, CELL REP, V17, P2857, DOI 10.1016/j.celrep.2016.11.040; Aksel T, 2015, CELL REP, V11, P910, DOI 10.1016/j.celrep.2015.04.006; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; Bloemink M, 2014, J BIOL CHEM, V289, P5158, DOI 10.1074/jbc.M113.511204; Bloemink MJ, 2013, J BIOL CHEM, V288, P27469, DOI 10.1074/jbc.M113.488130; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Daehmlow S, 2002, BIOCHEM BIOPH RES CO, V298, P116, DOI 10.1016/S0006-291X(02)02374-4; De La Cruz E.M, 2009, KINETIC EQUILIBRIUM; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Egelman E.H., 2012, COMPREHENSIVE BIOPHY, V4, P251; Fenn WO, 1923, J PHYSIOL-LONDON, V58, P0175; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Geeves MA, 2005, CELL MOL LIFE SCI, V62, P1462, DOI 10.1007/s00018-005-5015-5; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenberg MJ, 2014, BIOPHYS J, V107, pL41, DOI 10.1016/j.bpj.2014.11.005; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Huang J, 2009, BIOCHEMISTRY-US, V48, P11834, DOI 10.1021/bi901756n; Irving M, 2017, BIOPHYS J, V113, P2579, DOI 10.1016/j.bpj.2017.09.037; Kalabokis VN, 1997, BIOCHEMISTRY-US, V36, P15834, DOI 10.1021/bi971932r; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Liu C., 2018, 258020 BIORXIV; Lowey S, 2008, J BIOL CHEM, V283, P20579, DOI 10.1074/jbc.M800554200; McConnell BK, 2001, CIRC RES, V88, P383; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; Memo M, 2013, CARDIOVASC RES, V99, P65, DOI 10.1093/cvr/cvt071; Messer AE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00315; Mijailovich SM, 2017, BIOPHYS J, V112, P984, DOI 10.1016/j.bpj.2017.01.021; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Nag S, 2017, NAT STRUCT MOL BIOL, V24, P525, DOI 10.1038/nsmb.3408; Nag S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500511; Nyitrai M, 2003, BIOPHYS J, V85, P1053, DOI 10.1016/S0006-3495(03)74544-5; Parvari R, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/639250; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SMITH DA, 1995, BIOPHYS J, V69, P538, DOI 10.1016/S0006-3495(95)79927-1; Smith DA, 2014, J MUSCLE RES CELL M, V35, P295, DOI 10.1007/s10974-014-9391-z; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Spudich JA, 2015, BIOCHEM SOC T, V43, P64, DOI 10.1042/BST20140324; Sung JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8931; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Trivedi Darshan V, 2018, Biophys Rev, V10, P27, DOI 10.1007/s12551-017-0274-6; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Vikstrom KL, 1996, MOL MED, V2, P556, DOI 10.1007/BF03401640; Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193; Walklate J, 2016, J BIOL CHEM, V291, P10318, DOI 10.1074/jbc.M115.707489; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Westfall MV, 2002, CIRC RES, V91, P525, DOI 10.1161/01.RES.0000034710.46739.C0	59	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9017	9029		10.1074/jbc.RA118.001938	http://dx.doi.org/10.1074/jbc.RA118.001938			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29666183	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000434941900024
J	Martin, EM; Jackson, MP; Gamerdinger, M; Gense, K; Karamonos, TK; Humes, JR; Deuerling, E; Ashcroft, AE; Radford, SE				Martin, Esther M.; Jackson, Matthew P.; Gamerdinger, Martin; Gense, Karina; Karamonos, Theodoros K.; Humes, Julia R.; Deuerling, Elke; Ashcroft, Alison E.; Radford, Sheena E.			Conformational flexibility within the nascent polypeptide-associated complex enables its interactions with structurally diverse client proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; protein misfolding; protein cross-linking; chaperone; molecular chaperone; NAC native mass spectrometry (MS); nuclear magnetic resonance (NMR)	RIBOSOME-ASSOCIATED CHAPERONES; MOBILITY-MASS SPECTROMETRY; COLLISION CROSS-SECTIONS; ALPHA-SYNUCLEIN; NMR-SPECTROSCOPY; CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; NAC	As newly synthesized polypeptides emerge from the ribosome, it is crucial that they fold correctly. To prevent premature aggregation, nascent chains interact with chaperones that facilitate folding or prevent misfolding until protein synthesis is complete. Nascent polypeptide-associated complex (NAC) is a ribosome-associated chaperone that is important for protein homeostasis. However, how NAC binds its substrates remains unclear. Using native electrospray ionization MS (ESI-MS), limited proteolysis, NMR, and cross-linking, we analyzed the conformational properties of NAC from Caenorhabditis elegans and studied its ability to bind proteins in different conformational states. Our results revealed that NAC adopts an array of compact and expanded conformations and binds weakly to client proteins that are unfolded, folded, or intrinsically disordered, suggestive of broad substrate compatibility. Of note, we found that this weak binding retards aggregation of the intrinsically disordered protein -synuclein both in vitro and in vivo. These findings provide critical insights into the structure and function of NAC. Specifically, they reveal the ability of NAC to exploit its conformational plasticity to bind a repertoire of substrates with unrelated sequences and structures, independently of actively translating ribosomes.	[Martin, Esther M.; Jackson, Matthew P.; Karamonos, Theodoros K.; Humes, Julia R.; Ashcroft, Alison E.; Radford, Sheena E.] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Gamerdinger, Martin; Gense, Karina; Deuerling, Elke] Univ Konstanz, Inst Mol Microbiol, Dept Biol, D-78454 Constance, Germany; [Martin, Esther M.] MedImmune Ltd, Granta Pk, Cambridge CB21 6GH, England	University of Leeds; University of Konstanz; AstraZeneca; Medimmune	Radford, SE (corresponding author), Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk		Radford, Sheena/0000-0002-3079-8039; Humes, Julia/0000-0002-1407-7880; Gamerdinger, Martin/0000-0003-1483-8181	Wellcome Trust [094232/Z/10/Z]; Biotechnology and Biological Sciences Research Council (BBSRC) Research Equipment Initiative Grant [BB/E012558/1]; BBSRC Alert 14 Grant [BB/M012573/1]; University of Leeds; BBSRC [BB/M012573/1, BB/E012558/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC) Research Equipment Initiative Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Alert 14 Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Leeds; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the members of our laboratories for helpful discussions. We also thank Renate Schlomer and Nasir Khan for technical assistance. The Chirascan CD spectrometer and the Jeol electron microscope were purchased with funding from Wellcome Trust Grant 094232/Z/10/Z; the Synapt HDMS and Synapt HDMS G2Si mass spectrometers were purchased with funding from the Biotechnology and Biological Sciences Research Council (BBSRC) Research Equipment Initiative Grant BB/E012558/1 and BBSRC Alert 14 Grant BB/M012573/1, respectively. We also thank the University of Leeds for funding NMR instrumentation.	Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; BRENNER S, 1974, GENETICS, V77, P71; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Cabrita LD, 2016, NAT STRUCT MOL BIOL, V23, P278, DOI 10.1038/nsmb.3182; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Calabrese A. N., 2018, METHODS, V2018, pS1046, DOI [10.1016/j.ymeth.2018.1002.1020, DOI 10.1016/J.YMETH.2018.1002.1020]; Calabrese AN, 2015, METHODS, V89, P38, DOI 10.1016/j.ymeth.2015.02.018; Deckert A, 2016, P NATL ACAD SCI USA, V113, P5012, DOI 10.1073/pnas.1519124113; Devine PWA, 2017, J AM SOC MASS SPECTR, V28, P1855, DOI 10.1007/s13361-017-1689-9; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562; Gamerdinger M, 2015, SCIENCE, V348, P201, DOI 10.1126/science.aaa5335; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kogan GL, 2014, MOL BIOL+, V48, P189, DOI 10.1134/S0026893314020095; Konijnenberg A, 2013, BBA-PROTEINS PROTEOM, V1834, P1239, DOI 10.1016/j.bbapap.2012.11.013; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lambert W, 2013, CELL STRESS CHAPERON, V18, P75, DOI 10.1007/s12192-012-0360-4; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Liu YW, 2010, BIOCHEMISTRY-US, V49, P2890, DOI 10.1021/bi902050p; Marklund EG, 2015, STRUCTURE, V23, P791, DOI 10.1016/j.str.2015.02.010; Meng FC, 2017, CELL MOL LIFE SCI, V74, P3069, DOI 10.1007/s00018-017-2555-4; Min K, 2010, BIOTECHNIQUES, V48, P229, DOI 10.2144/000113365; Ott AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143457; Pashley CL, 2012, J MOL BIOL, V416, P300, DOI 10.1016/j.jmb.2011.12.041; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Radwan M, 2017, IUBMB LIFE, V69, P49, DOI 10.1002/iub.1597; Rand KD, 2009, ANAL CHEM, V81, P10019, DOI 10.1021/ac901897x; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Schiffrin B, 2016, NAT STRUCT MOL BIOL, V23, P786, DOI 10.1038/nsmb.3266; Sharma SK, 2017, CELL MOL LIFE SCI, V74, P617, DOI 10.1007/s00018-016-2340-9; Sinz A, 2015, PROTEIN SCI, V24, P1193, DOI 10.1002/pro.2696; Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107; Spreter T, 2005, J BIOL CHEM, V280, P15849, DOI 10.1074/jbc.M500160200; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Suss O, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00043; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LF, 2010, PROTEIN CELL, V1, P406, DOI 10.1007/s13238-010-0049-3; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Woods WS, 2007, J BIOL CHEM, V282, P34555, DOI 10.1074/jbc.M705283200; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Young LM, 2015, NAT CHEM, V7, P73, DOI [10.1038/nchem.2129, 10.1038/NCHEM.2129]; Zhang YX, 2014, NAT STRUCT MOL BIOL, V21, P1042, DOI 10.1038/nsmb.2908	61	18	20	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8554	8568		10.1074/jbc.RA117.001568	http://dx.doi.org/10.1074/jbc.RA117.001568			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29650757	Green Published, hybrid			2022-12-28	WOS:000434205700019
J	Thines, L; Deschamps, A; Sengottaiyan, P; Savel, O; Stribny, J; Morsomme, P				Thines, Louise; Deschamps, Antoine; Sengottaiyan, Palanivelu; Savel, Oksana; Stribny, Jiri; Morsomme, Pierre			The yeast protein Gdt1p transports Mn2+ ions and thereby regulates manganese homeostasis in the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						yeast; Golgi; calcium transport; manganese; membrane transport; transporter; Congenital Disorder of Glycosylation; GDT1; UPF0016	SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; PLASMA-MEMBRANE; PH HOMEOSTASIS; CALCIUM; GLYCOSYLATION; TMEM165; PMR1; IDENTIFICATION; BIOSYNTHESIS	The uncharacterized protein family 0016 (UPF0016) is a family of secondary ion transporters implicated in calcium homeostasis and some diseases. More precisely, genetic variants of the human UPF0016 ortholog transmembrane protein 165 (TMEM165) have been linked to congenital disorders of glycosylation (CDG). The Saccharomyces cerevisiae ortholog Gdt1p has been shown to be involved in calcium homeostasis and protein glycosylation. Moreover, plant and bacterial UPF0016 members appear to have putative roles in Mn2+ homeostasis. Here, we produced the yeast UPF0016 member Gdt1p in the bacterial host Lactococcus lactis. Using Mn2+-induced quenching of Fura-2-emitted fluorescence, we observed that Gdt1p mediates Mn2+ influx, in addition to its previously reported regulation of Ca2+ influx. The estimated K-m values of Gdt1p of 15.6 +/- 2.6 m for Ca2+ and 83.2 +/- 9.8 m for Mn2+ indicated that Gdt1p has a higher affinity for Ca2+ than for Mn2+. In yeast cells, we found that Gdt1p is involved in the resistance to high Mn2+ concentration and controls total Mn2+ stores. Lastly, we demonstrated that GDT1 deletion affects the activity of the yeast Mn2+-dependent Sod2p superoxide dismutase, most likely by modulating cytosolic Mn2+ concentrations. Taken together, we obtained first evidence that Gdt1p from yeast directly transports manganese, which strongly reinforces the suggested link between the UPF0016 family and Mn2+ homeostasis and provides new insights into the molecular causes of human TMEM165-associated CDGs. Our results also shed light on how yeast cells may regulate Golgi intraluminal concentrations of manganese, a key cofactor of many enzymes involved in protein glycosylation.	[Thines, Louise; Deschamps, Antoine; Sengottaiyan, Palanivelu; Savel, Oksana; Stribny, Jiri; Morsomme, Pierre] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium; [Thines, Louise] Fonds Format Rech Ind & Agr FRIA, Brussels, Belgium	Universite Catholique Louvain	Morsomme, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium.	pierre.morsomme@uclouvain.be	Morsomme, Pierre/AAD-9600-2019	Morsomme, Pierre/0000-0001-7780-7230; Stribny, Jiri/0000-0002-2449-3167	Fonds National de la Recherche Scientifique-FNRS [PDR-T.0206.16]; Communaute Francaise de Belgique-Actions de Recherches Concertees	Fonds National de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique-Actions de Recherches Concertees	This work was supported by grants from Fonds National de la Recherche Scientifique-FNRS Grant PDR-T.0206.16 and the Communaute Francaise de Belgique-Actions de Recherches Concertees. The authors declare that they have no conflicts of interest with the contents of this article.	ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Brandenburg F, 2017, PLANT PHYSIOL, V173, P1798, DOI 10.1104/pp.16.01895; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Colinet AS, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12729; Colinet AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24282; Demaegd D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100851; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Dulary E, 2018, BBA-GEN SUBJECTS, V1862, P394, DOI 10.1016/j.bbagen.2017.11.006; Fisher CR, 2016, J BACTERIOL, V198, P2810, DOI 10.1128/JB.00215-16; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Gandini C, 2017, NEW PHYTOL, V215, P256, DOI 10.1111/nph.14526; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; Page MM, 2010, J COMP PHYSIOL B, V180, P361, DOI 10.1007/s00360-009-0416-7; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Potelle S, 2017, BIOCHEM J, V474, P1481, DOI 10.1042/BCJ20160910; Potelle S, 2016, HUM MOL GENET, V25, P1489, DOI 10.1093/hmg/ddw026; Rayner JC, 1998, J BIOL CHEM, V273, P26836, DOI 10.1074/jbc.273.41.26836; ROMERO PA, 1989, J BIOL CHEM, V264, P1946; Schneider A, 2016, PLANT CELL, V28, P892, DOI 10.1105/tpc.15.00812; Snyder NA, 2017, G3-GENES GENOM GENET, V7, P3913, DOI 10.1534/g3.117.300339; Sorin A, 1997, J BIOL CHEM, V272, P9895; Striebeck A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130022; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; Wang C, 2016, MOL PLANT, V9, P1183, DOI 10.1016/j.molp.2016.05.015; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945	29	21	21	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8048	8055		10.1074/jbc.RA118.002324	http://dx.doi.org/10.1074/jbc.RA118.002324			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632074	hybrid, Green Published			2022-12-28	WOS:000433224600011
J	Mundy, C; Yang, E; Takano, H; Billings, PC; Pacifici, M				Mundy, Christina; Yang, Evan; Takano, Hajime; Billings, Paul C.; Pacifici, Maurizio			Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); heparan sulfate; cell-surface receptor; signaling; cell biology; hereditary multiple exostoses	TGF-BETA; SKELETAL DEVELOPMENT; PROXIMITY LIGATION; NATURAL-HISTORY; MOUSE MODEL; LONG BONES; IN-SITU; EXT1; BMP; COMPLEXES	Hereditary multiple exostoses (HME) is a pediatric disorder caused by heparan sulfate (HS) deficiency and is characterized by growth plate-associated osteochondromas. Previously, we found that osteochondroma formation in mouse models is preceded by ectopic bone morphogenetic protein (BMP) signaling in the perichondrium, but the mechanistic relationships between BMP signaling and HS deficiency remain unclear. Therefore, we used an HS antagonist (surfen) to investigate the effects of this HS interference on BMP signaling, ligand availability, cell-surface BMP receptor (BMPR) dynamics, and BMPR interactions in Ad-293 and C3H/10T1/2 cells. As observed previously, the HS interference rapidly increased phosphorylated SMAD family member 1/5/8 levels. FACS analysis and immunoblots revealed that the cells possessed appreciable levels of endogenous cell-surface BMP2/4 that were unaffected by the HS antagonist, suggesting that BMP2/4 proteins remained surface-bound but became engaged in BMPR interactions and SMAD signaling. Indeed, surface mobility of SNAP-tagged BMPRII, measured by fluorescence recovery after photobleaching (FRAP), was modulated during the drug treatment. This suggested that the receptors had transitioned to lipid rafts acting as signaling centers, confirmed for BMPRII via ultracentrifugation to separate membrane subdomains. In situ proximity ligation assays disclosed that the HS interference rapidly stimulates BMPRI-BMPRII interactions, measured by oligonucleotide-driven amplification signals. Our in vitro studies reveal that cell-associated HS controls BMP ligand availability and BMPR dynamics, interactions, and signaling, and largely restrains these processes. We propose that HS deficiency in HME may lead to extensive local BMP signaling and altered BMPR dynamics, triggering excessive cellular responses and osteochondroma formation.	[Mundy, Christina; Yang, Evan; Billings, Paul C.; Pacifici, Maurizio] Childrens Hosp Philadelphia, Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA; [Takano, Hajime] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mundy, C (corresponding author), Translat Res Program Pediat Orthopaed, ARC 904,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	matticolac@email.chop.edu	Takano, Hajime/AAD-4589-2019		NIAMS, National Institutes of Health [R01AR061758, AR071946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061758, R01AR071946] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health, Grants R01AR061758 and AR071946 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anower-E-Khuda MF, 2013, GLYCOBIOLOGY, V23, P865, DOI 10.1093/glycob/cwt024; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bandyopadhyay A, 2008, DEV BIOL, V321, P162, DOI 10.1016/j.ydbio.2008.06.012; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Bellucci A, 2014, METHODS MOL BIOL, V1174, P397, DOI 10.1007/978-1-4939-0944-5_27; Billings PC, 2015, CONNECT TISSUE RES, V56, P272, DOI 10.3109/03008207.2015.1045066; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brown A, 2013, BIOPHYS J, V104, P1720, DOI 10.1016/j.bpj.2013.02.051; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chen S, 2008, KIDNEY INT, V74, P289, DOI 10.1038/ki.2008.159; Cheung PK, 2001, AM J HUM GENET, V69, P55, DOI 10.1086/321278; Dormans J. P., 2005, PEDIAT ORTHOPAEDICS, P382; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Ehrlich M, 2012, FEBS LETT, V586, P1885, DOI 10.1016/j.febslet.2012.01.040; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Guzman A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.387639; Haas AR, 1999, DIFFERENTIATION, V64, P77, DOI 10.1046/j.1432-0436.1999.6420077.x; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Hojo H, 2013, J BIOL CHEM, V288, P9924, DOI 10.1074/jbc.M112.409342; Huegel J, 2015, AM J PATHOL, V185, P1676, DOI 10.1016/j.ajpath.2015.02.014; Huegel J, 2013, DEV DYNAM, V242, P1021, DOI 10.1002/dvdy.24010; Huegel J, 2013, DEV BIOL, V377, P100, DOI 10.1016/j.ydbio.2013.02.008; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Inubushi T, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90049; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Jones KB, 2010, P NATL ACAD SCI USA, V107, P2054, DOI 10.1073/pnas.0910875107; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Marom B, 2011, J BIOL CHEM, V286, P19287, DOI 10.1074/jbc.M110.210377; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsumoto K, 2010, P NATL ACAD SCI USA, V107, P10932, DOI 10.1073/pnas.0914642107; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Minina E, 2005, GENE EXPR PATTERNS, V6, P102, DOI 10.1016/j.modgep.2005.04.012; Mooij HL, 2015, J LIPID RES, V56, P665, DOI 10.1194/jlr.M053504; Mundy C, 2016, J CELL PHYSIOL, V231, P1033, DOI 10.1002/jcp.25192; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Pohl TLM, 2012, ACTA BIOMATER, V8, P772, DOI 10.1016/j.actbio.2011.10.019; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Sgariglia F, 2013, BONE, V57, P220, DOI 10.1016/j.bone.2013.08.012; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sinha S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006742; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; THOMAS P, 2006, FRON NEUROS, P155; Uchida K, 1997, EUR RESPIR J, V10, P735; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Whiteford JR, 2011, MOL BIOL CELL, V22, P3609, DOI 10.1091/mbc.E11-02-0099; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; Wuyts W, 2000, HUM MUTAT, V15, P220, DOI 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Zak BM, 2011, BONE, V48, P979, DOI 10.1016/j.bone.2011.02.001	67	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7703	7716		10.1074/jbc.RA117.000264	http://dx.doi.org/10.1074/jbc.RA117.000264			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29622677	Green Published, hybrid			2022-12-28	WOS:000437256500020
J	Dall, E; Hollerweger, JC; Dahms, SO; Cui, H; Haussermann, K; Brandstetter, H				Dall, Elfriede; Hollerweger, Julia C.; Dahms, Sven O.; Cui, Haissi; Haeussermann, Katharina; Brandstetter, Hans			Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASE-INHIBITOR; HUMAN STEFIN-B; CELL-PROLIFERATION; IN-VITRO; LEGUMAIN; ACTIVATION; PH; IDENTIFICATION; LOCALIZATION; DISTINCT	Protein activity is often regulated by altering the oligomerization state. One mechanism of multimerization involves domain swapping, wherein proteins exchange parts of their structures and thereby form long-lived dimers or multimers. Domain swapping has been specifically observed in amyloidogenic proteins, for example the cystatin superfamily of cysteine protease inhibitors. Cystatins are twin-headed inhibitors, simultaneously targeting the lysosomal cathepsins and legumain, with important roles in cancer progression and Alzheimer's disease. Although cystatin E is the most potent legumain inhibitor identified so far, nothing is known about its propensity to oligomerize. In this study, we show that conformational destabilization of cystatin E leads to the formation of a domain-swapped dimer with increased conformational stability. This dimer was active as a legumain inhibitor by forming a trimeric complex. By contrast, the binding sites toward papain-like proteases were buried within the cystatin E dimer. We also showed that the dimers could further convert to amyloid fibrils. Unexpectedly, cystatin E amyloid fibrils contained functional protein, which inhibited both legumain and papain-like enzymes. Fibril formation was further regulated by glycosylation. We speculate that cystatin amyloid fibrils might serve as a binding platform to stabilize the pH-sensitive legumain and cathepsins in the extracellular environment, contributing to their physiological and pathological functions.	[Dall, Elfriede; Hollerweger, Julia C.; Dahms, Sven O.; Brandstetter, Hans] Univ Salzburg, Dept Biosci, A-5020 Salzburg, Austria; [Cui, Haissi; Haeussermann, Katharina] Tech Univ Munich, Ctr Integrated Prot Sci Munich, D-85748 Munich, Germany	Salzburg University; Technical University of Munich; University of Munich	Brandstetter, H (corresponding author), Univ Salzburg, Dept Biosci, A-5020 Salzburg, Austria.	hans.brandstetter@sbg.ac.at	Brandstetter, Hans/E-6754-2011; Dall, Elfriede/F-1711-2017	Brandstetter, Hans/0000-0002-6089-3045; Dall, Elfriede/0000-0002-0823-8983; Dahms, Sven/0000-0002-0915-7579; Cui, Haissi/0000-0003-3358-8958	Austrian Science Fund (FWF) [W_01213]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF project W_01213). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMSON M, 1994, P NATL ACAD SCI USA, V91, P1416, DOI 10.1073/pnas.91.4.1416; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Briggs JJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-17; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Cheng T, 2009, J INVEST DERMATOL, V129, P1232, DOI 10.1038/jid.2008.353; Dall E, 2015, ANGEW CHEM INT EDIT, V54, P2917, DOI 10.1002/anie.201409135; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Dall E, 2012, ACTA CRYSTALLOGR F, V68, P24, DOI 10.1107/S1744309111048020; DeLano W.L., 2002, PYMOL MOL GRAPH SYST; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; GHISO J, 1986, P NATL ACAD SCI USA, V83, P2974, DOI 10.1073/pnas.83.9.2974; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Hasanbasic Samra, 2016, Mater Sociomed, V28, P235, DOI 10.5455/msm.2016.28.235-238; Haugen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052980; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Janowski R, 2004, J MOL BIOL, V341, P151, DOI 10.1016/j.jmb.2004.06.013; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kokalj SJ, 2007, J MOL BIOL, V366, P1569, DOI 10.1016/j.jmb.2006.12.025; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Liu C, 2003, CANCER RES, V63, P2957; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Lunde NN, 2017, BIOCHIMIE, V139, P27, DOI 10.1016/j.biochi.2017.05.009; Nguyen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147684; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Ni J, 1997, J BIOL CHEM, V272, P10853; Niesen F., 2010, EXCEL SCRIPT ANAL PR; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Pirchl M, 2009, NEUROPSYCHIATRIE, V23, P187; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodziewicz-Motowidlo S, 2009, BIOPOLYMERS, V91, P373, DOI 10.1002/bip.21140; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P16570, DOI 10.1074/jbc.M601033200; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Skerget K, 2010, J BIOL CHEM, V285, P3201, DOI 10.1074/jbc.M109.024620; Smith R, 2012, BIOCHIMIE, V94, P2590, DOI 10.1016/j.biochi.2012.07.026; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Turk V., BIOCH BIOPHYS ACTA, V1824, P68; Vidmar R, 2017, EMBO J, V36, P2455, DOI 10.15252/embj.201796750; Vigneswaran N, 2006, LIFE SCI, V78, P898, DOI 10.1016/j.lfs.2005.05.096; Wallin H, 2017, J BIOL CHEM, V292, P14413, DOI 10.1074/jbc.M117.776138; Williams J W, 1979, Methods Enzymol, V63, P437; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x; Yamane T, 2002, BBA-PROTEIN STRUCT M, V1596, P108, DOI 10.1016/S0167-4838(02)00209-1; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x; Zerovnik E, 2002, BIOCHEM SOC T, V30, P543; Zerovnik E, 2002, BBA-PROTEIN STRUCT M, V1594, P1, DOI 10.1016/S0167-4838(01)00295-3; Zhang ZT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14740	64	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13151	13165		10.1074/jbc.RA118.002154	http://dx.doi.org/10.1074/jbc.RA118.002154			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29967063	Green Published, hybrid			2022-12-28	WOS:000442730200015
J	Spurthi, KM; Sarikhani, M; Mishra, S; Desingu, PA; Yadav, S; Rao, S; Maity, S; Tamta, AK; Kumar, S; Majumdar, S; Jain, A; Raghuraman, A; Khan, D; Singh, I; Samuel, RJ; Ramachandra, SG; Nandi, D; Sundaresan, NR				Spurthi, Kondapalli Mrudula; Sarikhani, Mohsen; Mishra, Sneha; Desingu, Perumal Arumugam; Yadav, Shikha; Rao, Swathi; Maity, Sangeeta; Tamta, Ankit Kumar; Kumar, Shweta; Majumdar, Shamik; Jain, Aditi; Raghuraman, Aishwarya; Khan, Danish; Singh, Ishwar; Samuel, Rosa J.; Ramachandra, Subbaraya G.; Nandi, Dipankar; Sundaresan, Nagalingam R.			Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC HEART-FAILURE; NECROSIS-FACTOR-ALPHA; KAPPA-B; MYOCARDIAL-INFARCTION; ENDOGENOUS LIGANDS; STEM-CELLS; TLR2; MACROPHAGES; ACTIVATION; POLYMORPHISMS	Toll-like receptors (TLRs) are a family of pattern-recognition receptors involved in innate immunity. Previous studies have shown that TLR2 inhibition protects the heart from acute stress, including myocardial infarction and doxorubicin-induced cardiotoxicity in animal models. However, the role of TLR2 in the development of aging-associated heart failure is not known. In this work, we studied aging-associated changes in structure and function of TLR2-deficient mice hearts. Whereas young TLR2-KO mice did not develop marked cardiac dysfunction, 8- and 12-month-old TLR2-KO mice exhibited spontaneous adverse cardiac remodeling and cardiac dysfunction in an age-dependent manner. The hearts of the 8-month-old TLR2-KO mice had increased fibrosis, cell death, and reactivation of fetal genes. Moreover, TLR2-KO hearts displayed reduced infiltration by macrophages, increased numbers of myofibroblasts and atrophic cardiomyocytes, and higher levels of the atrophy-related ubiquitin ligases MuRF-1 and atrogin-1. Mechanistically, TLR2 deficiency impaired the PI3K/Akt signaling pathway, leading to hyperactivation of the transcription factor Forkhead box protein O1 (FoxO1) and, in turn, to elevated expression of FoxO1 target genes involved in the regulation of muscle wasting and cell death. AS1842856-mediated chemical inhibition of FoxO1 reduced the expression of the atrophy-related ubiquitin ligases and significantly reversed the adverse cardiac remodeling while improving the contrastile functions in the TLR2-KO mice. Interestingly, TLR2 levels decreased in hearts of older mice, and the activation of TLR1/2 signaling improved cardiac functions in these mice. These findings suggest that TLR2 signaling is essential for protecting the heart against aging-associated adverse remodeling and contractile dysfunction in mice.	[Spurthi, Kondapalli Mrudula; Sarikhani, Mohsen; Mishra, Sneha; Desingu, Perumal Arumugam; Rao, Swathi; Maity, Sangeeta; Tamta, Ankit Kumar; Kumar, Shweta; Raghuraman, Aishwarya; Khan, Danish; Singh, Ishwar; Sundaresan, Nagalingam R.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bengaluru 560012, Karnataka, India; [Yadav, Shikha; Majumdar, Shamik] Indian Inst Sci, Dept Biochem, Bengaluru 560012, Karnataka, India; [Jain, Aditi; Nandi, Dipankar] Indian Inst Sci, Ctr Biosyst Sci & Engn, Bengaluru 560012, Karnataka, India; [Samuel, Rosa J.; Ramachandra, Subbaraya G.] Indian Inst Sci, Cent Anim Facil, Bengaluru 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Sundaresan, NR (corresponding author), Indian Inst Sci, Div Biol Sci, Dept Microbiol & Cell Biol, SB-02, Bengaluru 560012, Karnataka, India.	rsundaresan@iisc.ac.in	Jain, Aditi/AAD-8922-2019; Majumdar, Shamik/ABE-2032-2021; Desingu, Perumal/AGH-9777-2022; Desingu, P./AGM-5446-2022; Nandi, Dipankar/O-1363-2019	Majumdar, Shamik/0000-0002-3458-816X; Desingu, P./0000-0003-4395-4472; Nandi, Dipankar/0000-0002-5221-9712; Maity, Sangeeta/0000-0003-4426-1715				Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Agius E, 2009, J EXP MED, V206, P1929, DOI 10.1084/jem.20090896; Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Albert EJ, 2008, J LEUKOCYTE BIOL, V83, P833, DOI 10.1189/jlb.0807557; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Balistreri CR, 2004, JAMA-J AM MED ASSOC, V292, P2339, DOI 10.1001/jama.292.19.2339; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Boehm O, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-33; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Bualeong T, 2016, J NEGAT RESULTS BIOM, V15, DOI 10.1186/s12952-016-0050-3; Calvano JE, 2006, CLIN IMMUNOL, V121, P186, DOI 10.1016/j.clim.2006.05.012; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Chen B, 2016, CIRC RES, V119, P776, DOI 10.1161/CIRCRESAHA.116.309624; Chen Q, 2017, CELL PHYSIOL BIOCHEM, V42, P427, DOI 10.1159/000477591; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Connell PS, 2012, J VET CARDIOL, V14, P31, DOI 10.1016/j.jvc.2011.11.003; Cuevas CD, 2014, J VIROL, V88, P7703, DOI 10.1128/JVI.00050-14; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Favre J, 2007, ARTERIOSCL THROM VAS, V27, P1064, DOI 10.1161/ATVBAHA.107.140723; Fernandez-Ruiz I, 2016, NAT REV CARDIOL, V13, P503, DOI [10.1038/nrcardio.2016.127, 10.1038/nrcardio.2016.58]; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Gage JR, 2004, NEUROIMMUNOMODULAT, V11, P173, DOI 10.1159/000076766; Galasso G, 2010, EUR HEART J, V31, P733; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Ha TZ, 2011, ANTIOXID REDOX SIGN, V15, P1875, DOI 10.1089/ars.2010.3723; Hattori Y, 1997, BIOCHEM MOL BIOL INT, V41, P979; Herman AC, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.45; Higashikuni Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000267; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Jain A, 2017, INT J CARDIOL, V232, P160, DOI 10.1016/j.ijcard.2017.01.036; Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999; Lin J, 2008, EXP GERONTOL, V43, P296, DOI 10.1016/j.exger.2007.12.005; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Lu L, 2017, CLIN EXP PHARMACOL P, V44, P55, DOI 10.1111/1440-1681.12753; Ma YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040763; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Marmiroli S, 1998, FEBS LETT, V438, P49, DOI 10.1016/S0014-5793(98)01270-8; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Menon R, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00196; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mishra S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23669-9; Molnar A, 2006, MOL MED, V12, P143, DOI 10.2119/2006-00043.Molnar; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08502; Pinto AR, 2014, AGING-US, V6, P399, DOI 10.18632/aging.100669; Pop-Moldovan AL, 2017, CANCER GENE THER, V24, P203, DOI 10.1038/cgt.2017.4; Pourrajab Fatemeh, 2015, Mol Cell Ther, V3, P4, DOI 10.1186/s40591-015-0041-7; Ramos GC, 2017, P NATL ACAD SCI USA, V114, pE2420, DOI 10.1073/pnas.1621047114; Richter V, 2003, GERONTOLOGY, V49, P293, DOI 10.1159/000071710; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Salvador AM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003126; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Schippers EF, 2004, CYTOKINE, V26, P16, DOI 10.1016/j.cyto.2003.12.003; Shaw AC, 2011, AGEING RES REV, V10, P346, DOI 10.1016/j.arr.2010.10.007; Shechter R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01254; Shishido T, 2003, CIRCULATION, V108, P2905, DOI 10.1161/01.CIR.0000101921.93016.1C; Sloane JA, 2010, NEUROMOL MED, V12, P149, DOI 10.1007/s12017-009-8094-x; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sussman M, 2007, TRENDS CARDIOVAS MED, V17, P235, DOI 10.1016/j.tcm.2007.08.003; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Tamura Y, 2012, CURR MOL MED, V12, P1198, DOI 10.2174/156652412803306710; Tang AH, 2007, J LEUKOCYTE BIOL, V82, P282, DOI 10.1189/jlb.1206752; Timmerman KL, 2011, J APPL PHYSIOL, V110, P869, DOI 10.1152/japplphysiol.00072.2011; Toth MJ, 2011, J APPL PHYSIOL, V110, P892, DOI 10.1152/japplphysiol.00545.2010; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; Wang L, 2014, CARDIOVASC RES, V101, P383, DOI 10.1093/cvr/cvt258; Weinberger T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00107; Yadav S, 2018, FREE RADICAL BIO MED, V116, P73, DOI 10.1016/j.freeradbiomed.2017.12.032; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x	81	18	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13073	13089		10.1074/jbc.RA118.001880	http://dx.doi.org/10.1074/jbc.RA118.001880			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29929978	Green Published, hybrid			2022-12-28	WOS:000442730200009
J	Cai, XY; Nwokonko, RM; Loktionova, NA; Abdulqadir, R; Baraniak, JH; Wang, YJ; Trebak, M; Zhou, YD; Gill, DL				Cai, Xiangyu; Nwokonko, Robert M.; Loktionova, Natalia A.; Abdulqadir, Raz; Baraniak, James H.; Wang, Youjun; Trebak, Mohamed; Zhou, Yandong; Gill, Donald L.			Pore properties of Orai1 calcium channel dimers and their activation by the STIM1 ER calcium sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calcium channel; ion channel; cell signaling; Orai1; STIM1; channel gating; selectivity filter; store-operated channel	OPERATED CA2+ CHANNELS; COILED-COIL DOMAIN; CRAC CHANNEL; ION SELECTIVITY; SUBUNIT STOICHIOMETRY; PLASMA-MEMBRANE; COMMUNICATION; MECHANISMS; PROTEINS; MUTATION	Store-operated Ca2+ entry signals are mediated by plasma membrane Orai channels activated through intermembrane coupling with Ca2+-sensing STIM proteins in the endoplasmic reticulum (ER). The nature of this elaborate Orai-gating mechanism has remained enigmatic. Based on the Drosophila Orai structure, mammalian Orai1 channels are hexamers comprising three dimeric subunit pairs. We utilized concatenated Orai1 dimers to probe the function of key domains within the channel pore and gating regions. The Orai1-E106Q selectivity-filter mutant, widely considered a dominant pore blocker, was surprisingly nondominant within concatenated heterodimers with Orai1-WT. The Orai1-E106Q/WT heterodimer formed STIM1-activated nonselective cation channels with significantly enlarged apparent pore diameter. Other Glu-106 substitutions entirely blocked the function of heterodimers with Orai1-WT. The hydrophobic pore-lining mutation V102C, which constitutively opens channels, was suppressed by Orai1-WT in the heterodimer. In contrast, the naturally occurring R91W pore-lining mutation associated with human immunodeficiency was completely dominant-negative over Orai-WT in heterodimers. Heterodimers containing the inhibitory K85E mutation extending outward from the pore helix gave an interesting partial effect on both channel activation and STIM1 binding, indicating an important allosteric link between the cytosolic Orai1 domains. The Orai1 C-terminal STIM1-binding domain mutation L273D powerfully blocked STIM1-induced channel activation. The Orai1-L273D/WT heterodimer had drastically impaired STIM1-induced channel gating but, unexpectedly, retained full STIM1 binding. This reveals the critical role of Leu-273 in transducing the STIM1-binding signal into the allosteric conformational change that initiates channel gating. Overall, our results provide important new insights into the role of key functional domains that mediate STIM1-induced gating of the Orai1 channel.	[Cai, Xiangyu; Nwokonko, Robert M.; Loktionova, Natalia A.; Abdulqadir, Raz; Baraniak, James H.; Trebak, Mohamed; Zhou, Yandong; Gill, Donald L.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Wang, Youjun] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resources & Mol Dev, Beijing 100875, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Beijing Normal University	Zhou, YD; Gill, DL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	zhouyd@psu.edu; dongill@psu.edu	zhou, Yandong/AAN-3947-2021; Nwokonko, Robert/ABH-3833-2020; Wang, Youjun/H-4016-2013	zhou, Yandong/0000-0003-3503-0296; Nwokonko, Robert/0000-0002-0793-7379; Wang, Youjun/0000-0003-0961-1716; Abdulqadir, Raz/0000-0003-4014-8213	National Institutes of Health [R01 GM120783, R01 GM109279, GM125376]; Penn State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL123364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM125376, R01GM120783, R01GM109279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in whole or part by National Institutes of Health Grants R01 GM120783 and R01 GM109279 (to D. L. G.), National Institutes of Health Predoctoral Fellowship GM125376 (to R. M. N.), and a Penn State University Junior Faculty Development Program grant (to Y. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amcheslavsky A, 2015, BIOPHYS J, V108, P237, DOI 10.1016/j.bpj.2014.11.3473; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Cai XY, 2016, J BIOL CHEM, V291, P25764, DOI 10.1074/jbc.M116.758813; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; Fahrner M, 2018, J BIOL CHEM, V293, P1271, DOI 10.1074/jbc.M117.812693; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hogan PG, 2015, CELL CALCIUM, V58, P357, DOI 10.1016/j.ceca.2015.07.001; Hou X., 2018, BIORXIV PREPRINT, DOI [10.1101/284034, DOI 10.1101/284034]; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kar P, 2013, CHANNELS, V7, P374, DOI 10.4161/chan.25298; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Mancarella S, 2011, J BIOL CHEM, V286, P44788, DOI 10.1074/jbc.M111.303081; Mancarella S, 2011, NAT CHEM BIOL, V7, P344, DOI 10.1038/nchembio.587; Maruyama Y, 2009, J BIOL CHEM, V284, P13676, DOI 10.1074/jbc.M900812200; Maus M, 2015, P NATL ACAD SCI USA, V112, P6206, DOI 10.1073/pnas.1418852112; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Palty R, 2017, CELL REP, V19, P1929, DOI 10.1016/j.celrep.2017.05.025; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Shim AHR, 2015, J MOL BIOL, V427, P77, DOI 10.1016/j.jmb.2014.09.021; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Thompson JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01961; Thompson JL, 2009, J BIOL CHEM, V284, P6620, DOI 10.1074/jbc.M808346200; Tirado-Lee L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128622; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wei-LaPierre L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3805; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yen M, 2016, BIOPHYS J, V111, P1897, DOI 10.1016/j.bpj.2016.09.020; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhou Y, 2016, APIDOLOGIE, V1, P1, DOI DOI 10.1038/ncomms13725; Zhou YD, 2018, P NATL ACAD SCI USA, V115, pE3398, DOI 10.1073/pnas.1720810115; Zhou YD, 2017, CELL CALCIUM, V63, P8, DOI 10.1016/j.ceca.2017.01.001; Zhou YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9395; Zhou YD, 2015, MOL CELL, V58, P197, DOI 10.1016/j.molcel.2015.04.003	56	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12962	12974		10.1074/jbc.RA118.003424	http://dx.doi.org/10.1074/jbc.RA118.003424			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29954946	Green Published, hybrid			2022-12-28	WOS:000442203500031
J	Sananes, A; Cohen, I; Shahar, A; Hockla, A; De Vita, E; Miller, AK; Radisky, ES; Papo, N				Sananes, Amiram; Cohen, Itay; Shahar, Anat; Hockla, Alexandra; De Vita, Elena; Miller, Aubry K.; Radisky, Evette S.; Papo, Niv			A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein engineering; directed evolution; proteolysis; protease inhibitor; X-ray crystallography; cell invasion; enzyme inhibition; selective binding; yeast surface display	MESSENGER-RNA EXPRESSION; OVARIAN-CANCER; SUBSTRATE-SPECIFICITY; CLINICAL-SIGNIFICANCE; PROTEASE INHIBITORS; ALZHEIMERS-DISEASE; SERUM BIOMARKER; EMERGING ROLES; RESIDENCE TIME; UP-REGULATION	Human tissue kallikrein (KLK) proteases are hormone-like signaling molecules with important functions in cancer pathophysiology. KLK-related peptidase 6 (KLK6), specifically, is highly up-regulated in several types of cancer, where its increased activity promotes cancer invasion and metastasis. This characteristic suggests KLK6 as an attractive target for therapeutic interventions. However, inhibitors that specifically target KLK6 have not yet been reported, possibly because KLK6 shares a high sequence homology and structural similarity with other serine proteases and resists inhibition by many polypeptide inhibitors. Here, we present an innovative combinatorial approach to engineering KLK6 inhibitors via flow cytometry-based screening of a yeast-displayed mutant library of the human amyloid precursor protein Kunitz protease inhibitor domain (APPI), an inhibitor of other serine proteases, such as anionic and cationic trypsins. On the basis of this screening, we generated APPI(M17L,I18F,S19F,F34V) (APPI-4M), an APPI variant with a KLK6 inhibition constant (K-i) of 160 pm and a turnover time of 10 days. To the best of our knowledge, APPI-4M is the most potent KLK6 inhibitor reported to date, displaying 146-fold improved affinity and 13-fold improved proteolytic stability compared with WT APPI (APPI(WT)). We further demonstrate that APPI-4M acts as a functional inhibitor in a cell-based model of KLK6-dependent breast cancer invasion. Finally, the crystal structures of the APPI(WT)/KLK6 and APPI-4M/KLK6 complexes revealed the structural and mechanistic bases for the improved KLK6 binding and proteolytic resistance of APPI-4M. We anticipate that APPI-4M will have substantial translational potential as both imaging agent and therapeutic.	[Sananes, Amiram; Cohen, Itay; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Sananes, Amiram; Cohen, Itay; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Shahar, Anat] NIBN, IL-84105 Beer Sheva, Israel; [Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [De Vita, Elena; Miller, Aubry K.] German Canc Res Ctr, Canc Drug Dev Grp, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	Ben Gurion University; Ben Gurion University; Mayo Clinic; Helmholtz Association; German Cancer Research Center (DKFZ)	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.; Papo, N (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.	papo@bgu.ac.il	Miller, Aubry/AAO-3863-2020; Radisky, Evette S/C-8526-2012; De Vita, Elena/AAV-3670-2021	Radisky, Evette S/0000-0003-3121-109X; De Vita, Elena/0000-0003-4707-8342	European Research Council [336041]; Prostate Cancer Foundation; DKFZ-MOST [GR2495]; United States-Israel Binational Science Foundation; National Institutes of Health [R01CA154387]; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Prostate Cancer Foundation; DKFZ-MOST; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the European Research Council "Ideas Program" ERC-2013-StG Contract Grant 336041, the Prostate Cancer Foundation (to N.P.), and the DKFZ-MOST Contract Grant GR2495 (to N.P. and A.K.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by United States-Israel Binational Science Foundation.; Supported by National Institutes of Health Grant R01CA154387.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Ashby EL, 2010, BRAIN RES, V1363, P1, DOI 10.1016/j.brainres.2010.09.017; Avgeris M, 2010, BIOL CHEM, V391, P505, DOI 10.1515/BC.2010.056; Bando Y, 2018, GLIA, V66, P359, DOI 10.1002/glia.23249; Bayes A, 2004, BIOL CHEM, V385, P517, DOI 10.1515/BC.2004.061; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Bradshaw JM, 2015, NAT CHEM BIOL, V11, P525, DOI [10.1038/NCHEMBIO.1817, 10.1038/nchembio.1817]; Caliendo G, 2012, J MED CHEM, V55, P6669, DOI 10.1021/jm300407t; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Christodoulou S, 2014, TUMOR BIOL, V35, P4673, DOI 10.1007/s13277-014-1612-y; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Copeland RA, 2016, NAT REV DRUG DISCOV, V15, P87, DOI 10.1038/nrd.2015.18; Copeland RA, 2010, EXPERT OPIN DRUG DIS, V5, P305, DOI 10.1517/17460441003677725; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; de Veer SJ, 2017, J INVEST DERMATOL, V137, P430, DOI 10.1016/j.jid.2016.09.017; de Veer SJ, 2016, BIOL CHEM, V397, P1237, DOI 10.1515/hsz-2016-0112; de Veer SJ, 2015, J MED CHEM, V58, P8257, DOI 10.1021/acs.jmedchem.5b01148; Diamandis EP, 2003, J CLIN ONCOL, V21, P1035, DOI 10.1200/JCO.2003.02.022; EDWARDS PR, 1995, ANAL BIOCHEM, V231, P210, DOI 10.1006/abio.1995.1522; Ehrenfeld P, 2014, ANTICANCER RES, V34, P6925; Emami N, 2007, MOL ONCOL, V1, P269, DOI 10.1016/j.molonc.2007.09.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh MC, 2004, TUMOR BIOL, V25, P193, DOI 10.1159/000081102; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Hebb Andrea L O, 2010, Curr Drug Discov Technol, V7, P137; Henkhaus RS, 2008, BIOL CHEM, V389, P757, DOI 10.1515/BC.2008.087; Heuze-Vourc'h N, 2009, J CELL MOL MED, V13, P4014, DOI 10.1111/j.1582-4934.2009.00763.x; Hoffman BR, 2002, BRIT J CANCER, V87, P763, DOI 10.1038/sj.bjc.6600533; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katz BA, 1998, NATURE, V391, P608, DOI 10.1038/35422; Katz BA, 2001, CHEM BIOL, V8, P1107, DOI 10.1016/S1074-5521(01)00084-9; Kim JT, 2011, CANCER-AM CANCER SOC, V117, P2608, DOI 10.1002/cncr.25841; KITAGUCHI N, 1990, BIOCHIM BIOPHYS ACTA, V1038, P105, DOI 10.1016/0167-4838(90)90017-A; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Kolin DL, 2014, BIOL CHEM, V395, P1087, DOI 10.1515/hsz-2014-0143; Kontos CK, 2012, CLIN CHEM LAB MED, V50, P1877, DOI 10.1515/cclm-2012-0247; Kountourakis P, 2008, CANCER SCI, V99, P2224, DOI 10.1111/j.1349-7006.2008.00942.x; Krenzer S, 2011, J INVEST DERMATOL, V131, P2281, DOI 10.1038/jid.2011.190; Krishnan R, 1998, BIOCHEMISTRY-US, V37, P12094, DOI 10.1021/bi980840e; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Liebeschuetz JW, 2002, J MED CHEM, V45, P1221, DOI 10.1021/jm010944e; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; LONGAS MO, 1980, BIOCHEM J, V189, P481, DOI 10.1042/bj1890481; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; Mange A, 2016, J PROTEOMICS, V142, P114, DOI 10.1016/j.jprot.2016.04.050; Marceau F, 2004, NAT REV DRUG DISCOV, V3, P845, DOI 10.1038/nrd1522; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnikova VO, 2008, CANCER MICROENVIRON, V1, P103, DOI 10.1007/s12307-008-0002-7; Michel N, 2014, BIOL CHEM, V395, P1015, DOI 10.1515/hsz-2014-0124; Nagahara H, 2005, CLIN CANCER RES, V11, P6800, DOI 10.1158/1078-0432.CCR-05-0943; Ogawa K, 2005, CLIN CANCER RES, V11, P2889, DOI 10.1158/1078-0432.CCR-04-2281; Oikonomopoulou K, 2010, BIOL CHEM, V391, P299, DOI 10.1515/BC.2010.038; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Patra K, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0336-4; Petraki CD, 2006, TUMOR BIOL, V27, P1, DOI 10.1159/000090150; Prassas I, 2015, NAT REV DRUG DISCOV, V14, P183, DOI 10.1038/nrd4534; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Scarisbrick IA, 2012, BRAIN PATHOL, V22, P709, DOI 10.1111/j.1750-3639.2012.00577.x; Scarisbrick IA, 2012, BIOL CHEM, V393, P355, DOI 10.1515/hsz-2011-0241; Shan SJC, 2007, BRIT J CANCER, V96, P362, DOI 10.1038/sj.bjc.6603556; Sidiropoulos KG, 2016, MOL ONCOL, V10, P993, DOI 10.1016/j.molonc.2016.03.008; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Sotiropoulou G, 2012, TRENDS PHARMACOL SCI, V33, P623, DOI 10.1016/j.tips.2012.09.005; Swedberg JE, 2010, BIOL CHEM, V391, P357, DOI 10.1515/BC.2010.037; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Vakrakou A, 2014, BIOL CHEM, V395, P1105, DOI 10.1515/hsz-2014-0166; White NMA, 2009, CANCER BIOMARK, V5, P279, DOI 10.3233/CBM-2009-0113; Wilczynska M, 1997, NAT STRUCT BIOL, V4, P354, DOI 10.1038/nsb0597-354; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang K, 2013, CHEM BIOL, V20, P92, DOI 10.1016/j.chembiol.2012.10.020	82	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12663	12680		10.1074/jbc.RA117.000871	http://dx.doi.org/10.1074/jbc.RA117.000871			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934309	hybrid, Green Published			2022-12-28	WOS:000442203500002
J	Cho, EJ; Mysliwiec, MR; Carlson, CD; Ansari, A; Schwartz, RJ; Lee, YS				Cho, Eunjin; Mysliwiec, Matthew R.; Carlson, Clayton D.; Ansari, Aseem; Schwartz, Robert J.; Lee, Youngsook			Cardiac-specific developmental and epigenetic functions of Jarid2 during embryonic development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart development; epigenetics; gene regulation; gene expression; histone modification; Congenital heart disease; Jarid2	REPRESSIVE COMPLEX 2; STEM-CELLS; HISTONE METHYLATION; GENE-EXPRESSION; TARGET GENE; JUMONJI; ISL1; DIFFERENTIATION; NKX2-5; PRC2	Epigenetic regulation is critical in normal cardiac development. We have demonstrated that the deletion of Jarid2 (Jumonji (Jmj) A/T-rich interaction domain 2) in mice results in cardiac malformations recapitulating human congenital cardiac disease and dysregulation of gene expression. However, the precise developmental and epigenetic functions of Jarid2 within the developing heart remain to be elucidated. Here, we determined the cardiac-specific functions of Jarid2 and the genetic networks regulated by Jarid2. Jarid2 was deleted using different cardiac-specific Cre mice. The deletion of Jarid2 by Nkx2.5-Cre mice (Jarid2(Nkx)) caused cardiac malformations including ventricular septal defects, thin myocardium, hypertrabeculation, and neonatal lethality. Jarid2(Nkx) mice exhibited elevated expression of neural genes, cardiac jelly, and other key factors including Isl1 and Bmp10 in the developing heart. By employing combinatorial genome-wide approaches and molecular analyses, we showed that Jarid2 in the myocardium regulates a subset of Jarid2 target gene expression and H3K27me3 enrichment during heart development. Specifically, Jarid2 was required for PRC2 occupancy and H3K27me3 at the Isl1 promoter locus, leading to the proper repression of Isl1 expression. In contrast, Jarid2 deletion in differentiated cardiomyocytes by cTnt-Cre mice caused no gross morphological defects or neonatal lethality. Thus, the early deletion of Jarid2 in cardiac progenitors, prior to the differentiation of cardiac progenitors into cardiomyocytes, results in morphogenetic defects manifested later in development. Our studies reveal that there is a critical window during early cardiac progenitor differentiation when Jarid2 is crucial to establish the epigenetic landscape at later stages of development.	[Cho, Eunjin; Mysliwiec, Matthew R.; Lee, Youngsook] Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53705 USA; [Cho, Eunjin; Lee, Youngsook] Univ Wisconsin Madison, Mol & Cellular Pharmacol Grad Program, Madison, WI 53705 USA; [Ansari, Aseem] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53705 USA; [Carlson, Clayton D.] Trinity Christian Coll, Dept Biol, Palos Hts, IL 60463 USA; [Schwartz, Robert J.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Houston System; University of Houston	Lee, YS (corresponding author), Wisconsin Inst Med Res II, 1111 Highland Ave, Madison, WI 53705 USA.	youngsooklee@wisc.edu			National Institutes of Health [HL067050]; American Heart Association [12GRNT12070021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL067050 and American Heart Association Grant 12GRNT12070021 (to Y. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Albert M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003461; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Brody MJ, 2013, J MOL CELL CARDIOL, V62, P237, DOI 10.1016/j.yjmcc.2013.05.020; Brody MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051621; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen DY, 2015, DEV BIOL, V407, P195, DOI 10.1016/j.ydbio.2015.09.016; Chen HY, 2013, DEVELOPMENT, V140, P1946, DOI 10.1242/dev.089920; Chen HY, 2009, PEDIATR CARDIOL, V30, P626, DOI 10.1007/s00246-009-9406-5; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Dimitrova E, 2015, EMBO REP, V16, P1620, DOI 10.15252/embr.201541113; Dorn T, 2015, STEM CELLS, V33, P1113, DOI 10.1002/stem.1923; FFRENCHCONSTANT C, 1988, DEVELOPMENT, V104, P369; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; Huang JH, 2012, J CLIN INVEST, V122, P3678, DOI 10.1172/JCI63635; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Jones A, 2010, PROTEIN CELL, V1, P1056, DOI 10.1007/s13238-010-0142-7; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim DH, 2013, MOL CELL BIOL, V33, P4936, DOI 10.1128/MCB.00601-13; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Leavesley DI, 2013, IUBMB LIFE, V65, P807, DOI 10.1002/iub.1203; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Li YQ, 2013, STEM CELLS, V31, P1213, DOI 10.1002/stem.1362; Liang XQ, 2015, J CLIN INVEST, V125, P3256, DOI 10.1172/JCI68257; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Lu HF, 2014, MOL CELL BIOCHEM, V391, P183, DOI 10.1007/s11010-014-2001-y; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Miller EM, 2012, AM J MED GENET A, V158A, P533, DOI 10.1002/ajmg.a.34426; Morita Y, 2016, J MOL CELL CARDIOL, V92, P158, DOI 10.1016/j.yjmcc.2016.02.008; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Mysliwiec MR, 2006, GENESIS, V44, P407, DOI 10.1002/dvg.20221; Mysliwiec MR, 2012, J BIOL CHEM, V287, P1235, DOI 10.1074/jbc.M111.315945; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Mysliwiec MR, 2007, FEBS LETT, V581, P2633, DOI 10.1016/j.febslet.2007.05.006; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Panzer AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46438; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pereira RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5540; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; Terada R, 2011, CARDIOVASC RES, V91, P289, DOI 10.1093/cvr/cvr037; Tian XY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00118-1; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Towbin JA, 2015, LANCET, V386, P813, DOI 10.1016/S0140-6736(14)61282-4; Vizan P, 2015, FEBS J, V282, P1723, DOI 10.1111/febs.13083; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhang CG, 2009, BIOCHEM BIOPH RES CO, V390, P258, DOI 10.1016/j.bbrc.2009.09.101; Zhang WJ, 2013, AM J MED GENET C, V163, P144, DOI 10.1002/ajmg.c.31369; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578	65	12	12	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11659	11673		10.1074/jbc.RA118.002482	http://dx.doi.org/10.1074/jbc.RA118.002482			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29891551	Green Published, hybrid			2022-12-28	WOS:000440134500002
J	Peruchetti, DD; Silva-Aguiar, RP; Siqueira, GM; Dias, WB; Caruso-Neves, C				Peruchetti, Diogo de Barros; Silva-Aguiar, Rodrigo Pacheco; Siqueira, Gabriela Marques; Dias, Wagner Barbosa; Caruso-Neves, Celso			High glucose reduces megalin-mediated albumin endocytosis in renal proximal tubule cells through protein kinase B O-GlcNAcylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; signal transduction; O-GlcNAcylation; mTOR complex (mTORC); Akt PKB; albumin endocytosis; diabetic nephropathy; high glucose; megalin expression; proximal tubule	LINKED N-ACETYLGLUCOSAMINE; EPITHELIAL-CELLS; ANGIOTENSIN-II; MAMMALIAN TARGET; MTOR COMPLEXES; REABSORPTION; APOPTOSIS; GLCNAC; INJURY; ROLES	The role of albumin reabsorption in proximal tubule (PT) cells has emerged as an important factor in the genesis of albuminuria observed in the early stages of diabetes. Evidence has shown that a decrease in megalin expression could be the key mechanism in this process. In the present work, we investigated the molecular mechanism underlying the modulation of albumin endocytosis in LLC-PK1 cells, a model of PT cells. High glucose concentrations (HG) inhibited megalin expression and albumin endocytosis after 48 h of incubation. This inhibitory effect involves the entrance of glucose into PT cells through SGLT located at the luminal membrane. Once inside PT cells, glucose is diverted to the hexosamine biosynthetic pathway (HBP) increasing O-GlcNAcylation of several intracellular proteins, including PKB. This process promotes the inhibition of PKB activity measured by its phosphorylation at Thr-308 and Ser-473 and phosphorylation of specific substrates, glycogen synthase kinase 3 (GSK3) and tuberous sclerosis complex 2. The decrease in PKB activity led to a decrease in megalin expression and, consequently, reducing albumin endocytosis in LLC-PK1 cells. HG did not change mammalian target of rapamycin (mTOR) C2 activity, responsible for phosphorylated PKB at Ser-473. In addition, HG activated the mTORC1/S6K pathway, but this effect was not correlated to the decrease in megalin expression or albumin endocytosis. Taken together, our data help to clarify the current understanding underlying the genesis of tubular albuminuria induced by hyperglycemia in the early stage of diabetes pathogenesis.	[Peruchetti, Diogo de Barros; Silva-Aguiar, Rodrigo Pacheco; Siqueira, Gabriela Marques; Dias, Wagner Barbosa; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ave Carlos Chagas Filho 373,Bloco C,Sala 34, BR-21941904 Rio De Janeiro, Brazil; [Caruso-Neves, Celso] INCT Regenera, Inst Nacl Ciencia & Tecnol Med Regenerat, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ave Carlos Chagas Filho 373,Bloco C,Sala 34, BR-21941904 Rio De Janeiro, Brazil.	caruso@biof.ufrj.br	Caruso-Neves, Celso/C-4014-2013; Silva-Aguiar, Rodrigo Pacheco/AAH-7924-2020; Peruchetti, Diogo B/L-3706-2017; Dias, Wagner/B-1401-2016	Caruso-Neves, Celso/0000-0002-2415-7753; Silva-Aguiar, Rodrigo Pacheco/0000-0003-1975-8033; Peruchetti, Diogo B/0000-0002-7572-9731; Dias, Wagner/0000-0002-8378-8846	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [456997/2014-8]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E-26/110.085/2014, E-26/201.197/2014, E-26/202.950/2016]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant 456997/2014-8 and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ Grants E-26/110.085/2014, E-26/201.197/2014, and E-26/202.950/2016. The authors declare that they have no conflicts of interest with the contents of this article.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Akan I, 2018, J NEUROCHEM, V144, P7, DOI 10.1111/jnc.14242; Akimoto Yoshihiro, 2011, Clin Proteomics, V8, P15, DOI 10.1186/1559-0275-8-15; Ali MAM, 2017, FUND CLIN PHARMACOL, V31, P546, DOI 10.1111/fcp.12296; Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Arnaud-Batista FJ, 2016, BBA-GEN SUBJECTS, V1860, P1431, DOI 10.1016/j.bbagen.2016.04.012; Baines RJ, 2012, AM J PHYSIOL-RENAL, V303, pF1006, DOI 10.1152/ajprenal.00021.2012; Banerjee PS, 2016, MOL ASPECTS MED, V51, P1, DOI 10.1016/j.mam.2016.05.005; Bertinat R, 2016, J CELL PHYSIOL, V231, P1635, DOI 10.1002/jcp.25286; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Brunskill NJ, 1998, J CLIN INVEST, V101, P2140, DOI 10.1172/JCI1923; Campion Carole G, 2017, Can J Kidney Health Dis, V4, p2054358117705371, DOI 10.1177/2054358117705371; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chang AS, 2016, AM J PHYSIOL-RENAL, V310, pF689, DOI 10.1152/ajprenal.00502.2015; Christensen EI, 2013, NAT REV NEPHROL, V9, P700, DOI 10.1038/nrneph.2013.212; Comper WD, 2014, NAT REV NEPHROL, V10, pE1, DOI 10.1038/nrneph.2013.58-c1; de Queirozl RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00132; Degrell P, 2009, LIFE SCI, V84, P389, DOI 10.1016/j.lfs.2009.01.007; Dias WB, 2012, BIOCHEM BIOPH RES CO, V422, P224, DOI 10.1016/j.bbrc.2012.04.124; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Doshi SM, 2017, CLIN J AM SOC NEPHRO, V12, P1366, DOI 10.2215/CJN.11111016; Fantus D, 2016, NAT REV NEPHROL, V12, P587, DOI 10.1038/nrneph.2016.108; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; Gellai R, 2016, AM J PHYSIOL-RENAL, V311, pF1172, DOI 10.1152/ajprenal.00545.2015; Gena P, 2010, ENVIRON HEALTH PERSP, V118, P1551, DOI 10.1289/ehp.0901874; Gilbert RE, 2017, DIABETES, V66, P791, DOI 10.2337/db16-0796; Gong QY, 2016, BIOCHEM BIOPH RES CO, V469, P183, DOI 10.1016/j.bbrc.2015.11.092; Grahammer F, 2017, J AM SOC NEPHROL, V28, P230, DOI 10.1681/ASN.2015111224; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Harwood SM, 2007, KIDNEY INT, V71, P655, DOI 10.1038/sj.ki.5002106; Ishibashi F, 2004, DIABETES RES CLIN PR, V65, P217, DOI 10.1016/j.diabres.2004.02.003; Ishibashi F, 2006, DIABETES RES CLIN PR, V72, P223, DOI 10.1016/j.diabres.2005.10.019; Ji S, 2011, AMINO ACIDS, V40, P809, DOI 10.1007/s00726-010-0698-9; Jiao XC, 2016, BIOCHEM BIOPH RES CO, V480, P387, DOI 10.1016/j.bbrc.2016.10.060; Kawanami D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051083; Kojima N, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12436; Koral K, 2012, AM J PHYSIOL-RENAL, V302, pF1013, DOI 10.1152/ajprenal.00289.2011; Landgraf SS, 2011, AM J PHYSIOL-RENAL, V300, pF499, DOI 10.1152/ajprenal.00384.2010; Landgraf SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107549; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF180, DOI 10.1152/ajprenal.00015.2012; Lima VV, 2016, CLIN SCI, V130, P871, DOI 10.1042/CS20150777; Lima VV, 2012, CLIN SCI, V123, P473, DOI 10.1042/CS20110638; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lungkaphin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096236; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mariappan MM, 2014, J BIOL CHEM, V289, P35363, DOI 10.1074/jbc.M114.587840; Mazzocchi LC, 2017, AM J PHYSIOL-LUNG C, V313, pL807, DOI 10.1152/ajplung.00569.2016; Moeller MJ, 2014, NAT REV NEPHROL, V10, pE2, DOI 10.1038/nrneph.2013.58-c2; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Ojima A, 2015, HORM METAB RES, V47, P686, DOI 10.1055/s-0034-1395609; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Peruchetti DB, 2014, J BIOL CHEM, V289, P16790, DOI 10.1074/jbc.M114.549717; Peruchetti DB, 2011, J BIOL CHEM, V286, P45041, DOI 10.1074/jbc.M111.260737; Peterson SB, 2016, CRIT REV BIOCHEM MOL, V51, P150, DOI 10.3109/10409238.2015.1135102; Risso G, 2015, BIOCHEM J, V468, P203, DOI 10.1042/BJ20150041; Russo LM, 2009, J AM SOC NEPHROL, V20, P489, DOI 10.1681/ASN.2008050503; Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006; Shi JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14500; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Tang SCW, 2012, NEPHROL DIAL TRANSPL, V27, P3049, DOI 10.1093/ndt/gfs260; Tang SCW, 2011, CONTRIB NEPHROL, V170, P124, DOI 10.1159/000325647; Theilig F, 2007, J AM SOC NEPHROL, V18, P1824, DOI 10.1681/ASN.2006111266; Tojo A, 2003, HYPERTENS RES, V26, P413, DOI 10.1291/hypres.26.413; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Tong YN, 2018, BIOMED PHARMACOTHER, V98, P701, DOI 10.1016/j.biopha.2017.12.112; Vallon V, 2017, DIABETOLOGIA, V60, P215, DOI 10.1007/s00125-016-4157-3; Wang JY, 2015, J DIABETES COMPLICAT, V29, P621, DOI 10.1016/j.jdiacomp.2015.04.014; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Zhou L, 2011, AM J NEPHROL, V34, P468, DOI 10.1159/000332040; Zoja C, 2015, NEPHROL DIAL TRANSPL, V30, P706, DOI 10.1093/ndt/gfu261	77	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11388	11400		10.1074/jbc.RA117.001337	http://dx.doi.org/10.1074/jbc.RA117.001337			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871929	Green Published, hybrid			2022-12-28	WOS:000439449700010
J	Podyma, B; Sun, H; Wilson, EA; Carlson, B; Pritikin, E; Gavrilova, O; Weinstein, LS; Chen, M				Podyma, Brandon; Sun, Hui; Wilson, Eric A.; Carlson, Bradley; Pritikin, Ethan; Gavrilova, Oksana; Weinstein, Lee S.; Chen, Min			The stimulatory G protein G(s) is required in melanocortin 4 receptor-expressing cells for normal energy balance, thermogenesis, and glucose metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heterotrimeric G protein; energy metabolism; mouse genetics; glucose metabolism; cyclic AMP (cAMP); metabolic regulation; neuroscience; signal transduction; G protein-coupled receptor	PSEUDOHYPOPARATHYROIDISM TYPE 1A; BROWN ADIPOSE-TISSUE; G(S)ALPHA DEFICIENCY; PEPTIDE YY; TARGETED DISRUPTION; INSULIN SENSITIVITY; HUMAN OBESITY; FOOD-INTAKE; GNAS GENE; MICE	Central melanocortin 4 receptors (MC4Rs) stimulate energy expenditure and inhibit food intake. MC4Rs activate the G protein G(s), but whether G(s) mediates all MC4R actions has not been established. Individuals with Albright hereditary osteodystrophy (AHO), who have heterozygous G(s)-inactivating mutations, only develop obesity when the G(s) mutation is present on the maternal allele because of tissue-specific genomic imprinting. Furthermore, evidence in mice implicates G(s) imprinting within the central nervous system (CNS) in this disorder. In this study, we examined the effects of G(s) in MC4R-expressing cells on metabolic regulation. Mice with homozygous G(s) deficiency in MC4R-expressing cells (MC4RGsKO) developed significant obesity with increased food intake and decreased energy expenditure, along with impaired insulin sensitivity and cold-induced thermogenesis. Moreover, the ability of the MC4R agonist melanotan-II (MTII) to stimulate energy expenditure and to inhibit food intake was impaired in MC4RGsKO mice. MTII failed to stimulate the secretion of the anorexigenic hormone peptide YY (PYY) from enteroendocrine L cells, a physiological response mediated by MC4R-G(s) signaling, even though baseline PYY levels were elevated in these mice. In G(s) heterozygotes, mild obesity and reduced energy expenditure were present only in mice with a G(s) deletion on the maternal allele in MC4R-expressing cells, whereas food intake was unaffected. These results demonstrate that G(s) signaling in MC4R-expressing cells is required for controlling energy balance, thermogenesis, and peripheral glucose metabolism. They further indicate that G(s) imprinting in MC4R-expressing cells contributes to obesity in G(s) knockout mice and probably in individuals with Albright hereditary osteodystrophy as well.	[Podyma, Brandon; Sun, Hui; Wilson, Eric A.; Carlson, Bradley; Pritikin, Ethan; Weinstein, Lee S.; Chen, Min] NIDDK, Metab Dis Branch, NIH, Bldg 10,Rm 8C101,10 Ctr Dr, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA; [Podyma, Brandon] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Pritikin, Ethan] Univ Chicago, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Virginia; University of Chicago	Weinstein, LS; Chen, M (corresponding author), NIDDK, Metab Dis Branch, NIH, Bldg 10,Rm 8C101,10 Ctr Dr, Bethesda, MD 20892 USA.	leew@mail.nih.gov; minc@niddk.nih.gov		Podyma, Brandon/0000-0002-0849-8726; Carlson, Bradley/0000-0003-3801-8890; Wilson, Eric/0000-0002-0089-2382	Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043315, ZIADK043302, ZICDK070002, ZIADK043313] Funding Source: NIH RePORTER	Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole by the Intramural Research Program of NIDDK, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Sabah S, 2016, MED PRIN PRACT, V25, P15, DOI 10.1159/000433437; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Berglund ED, 2014, NAT NEUROSCI, V17, P911, DOI 10.1038/nn.3737; Blevins JE, 2009, AM J PHYSIOL-REG I, V296, pR476, DOI 10.1152/ajpregu.90544.2008; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Cahill F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095235; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen M, 2017, J CLIN INVEST, V127, P500, DOI 10.1172/JCI88622; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 2007, BRAIN RES, V1179, P61, DOI 10.1016/j.brainres.2007.04.006; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Gautron L, 2010, J COMP NEUROL, V518, P6, DOI 10.1002/cne.22221; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Hayes MR, 2011, CELL METAB, V13, P320, DOI 10.1016/j.cmet.2011.02.001; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Holder JL, 2000, HUM MOL GENET, V9, P101; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Li YQ, 2016, P NATL ACAD SCI USA, V113, P446, DOI 10.1073/pnas.1517142113; Li YQ, 2016, J CLIN INVEST, V126, P40, DOI 10.1172/JCI76348; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Long DN, 2007, J CLIN ENDOCR METAB, V92, P1073, DOI 10.1210/jc.2006-1497; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Muniyappa R, 2013, J CLIN ENDOCR METAB, V98, pE1796, DOI 10.1210/jc.2013-1594; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; Panaro BL, 2014, CELL METAB, V20, P1018, DOI 10.1016/j.cmet.2014.10.004; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Satoh N, 1998, NEUROSCI LETT, V249, P107, DOI 10.1016/S0304-3940(98)00401-7; SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2; Sohn JW, 2013, CELL, V152, P612, DOI 10.1016/j.cell.2012.12.022; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Vaughan CH, 2011, BRAIN RES, V1411, P17, DOI 10.1016/j.brainres.2011.07.003; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Williams DL, 2003, ENDOCRINOLOGY, V144, P4692, DOI 10.1210/en.2003-0440; Xie T, 2008, ENDOCRINOLOGY, V149, P2443, DOI 10.1210/en.2007-1458; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	46	22	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10993	11005		10.1074/jbc.RA118.003450	http://dx.doi.org/10.1074/jbc.RA118.003450			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794140	hybrid, Green Published			2022-12-28	WOS:000438882800013
J	Peng, KS; Su, GQ; Ji, JM; Yang, XJ; Miao, MM; Mo, PL; Li, M; Xu, JM; Li, WG; Yu, CD				Peng, Kesong; Su, Guoqiang; Ji, Jinmeng; Yang, Xiaojia; Miao, Mengmeng; Mo, Pingli; Li, Ming; Xu, Jianming; Li, Wengang; Yu, Chundong			Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/-catenin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; colorectal cancer; transcriptional coactivator; histone demethylase; Wnt signaling	HEPATOCELLULAR-CARCINOMA PROGRESSION; INDUCIBLE FACTOR 1-ALPHA; CELL-PROLIFERATION; EXPRESSION; OVEREXPRESSION; JHDM2A; TRANSCRIPTION; COACTIVATION; STATISTICS; MARKER	The histone demethylase Jumonji domain containing 1A (JMJD1A) is overexpressed in multiple tumors and promotes cancer progression. JMJD1A has been shown to promote colorectal cancer (CRC) progression, but its molecular role in CRC is unclear. Here, we report that JMJD1A is overexpressed in CRC specimens and that its expression is positively correlated with that of proliferating cell nuclear antigen (PCNA). JMJD1A knockdown decreased the expression of proliferative genes such as c-Myc, cyclin D1, and PCNA, suppressed CRC cell proliferation, arrested cell cycle progression, and reduced xenograft tumorigenesis. Furthermore, JMJD1A knockdown inhibited CRC cell migration, invasion, and lung metastasis by decreasing matrix metallopeptidase 9 (MMP9) expression and enzymatic activity. Moreover, bioinformatics analysis of GEO profile datasets revealed that JMJD1A expression in human CRC specimens is positively correlated with the expression of Wnt/-catenin target genes, including c-Myc, cyclin D1, and MMP9. Mechanistically, JMJD1A enhanced Wnt/-catenin signaling by promoting -catenin expression and interacting with -catenin to enhance its transactivation. JMJD1A removed the methyl groups of H3K9me2 at the promoters of c-Myc and MMP9 genes. In contrast, the JMJD1A(H1120Y) variant, which lacked demethylase activity, did not demethylate H3K9me2 at these promoters, failed to assist -catenin to induce the expression of Wnt/-catenin target genes, and failed to promote CRC progression. These findings suggest that JMJD1A's demethylase activity is required for Wnt/-catenin activation. Of note, high JMJD1A levels in CRC specimens predicted poor cancer outcomes. In summary, JMJD1A promotes CRC progression by enhancing Wnt/-catenin signaling, implicating JMJD1A as a potential molecular target for CRC management.	[Peng, Kesong; Ji, Jinmeng; Yang, Xiaojia; Miao, Mengmeng; Mo, Pingli; Yu, Chundong] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China; [Su, Guoqiang] Xiamen Univ, Affiliated Hosp 1, Xiamen 361003, Fujian, Peoples R China; [Li, Ming; Li, Wengang] Xiamen Univ, Xiangan Hosp, Xiamen City Key Lab Biliary Tract Dis, Xiamen 361101, Fujian, Peoples R China; [Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Xiamen University; Xiamen University; Xiamen University; Baylor College of Medicine	Yu, CD (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China.; Li, WG (corresponding author), Xiamen Univ, Xiangan Hosp, Xiamen City Key Lab Biliary Tract Dis, Xiamen 361101, Fujian, Peoples R China.	lwg11861@163.com; cdyu@xmu.edu.cn			National Basic Research Program of China 973 Program [2015CB553800]; National Natural Science Foundation of China [81772942, U1405225]; Natural Science Foundation of Fujian Province [2015J01548]; Science and Technology Planning Projects of Xiamen Science and Technology Bureau [3502Z20154008]; Science and Technology Planning Projects of Xiamen Health and Family Planning Commission Grant [3502Z20149004]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2018KF008]; National Institutes of Health [R01 CA193455]; CPRIT [RP150197]; NATIONAL CANCER INSTITUTE [R01CA193455] Funding Source: NIH RePORTER	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Science and Technology Planning Projects of Xiamen Science and Technology Bureau; Science and Technology Planning Projects of Xiamen Health and Family Planning Commission Grant; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Basic Research Program of China 973 Program Grant 2015CB553800 (to C. Y.), National Natural Science Foundation of China Grants 81772942 (to C. Y.) and U1405225 (to C. Y.), Natural Science Foundation of Fujian Province Grant 2015J01548 (to G. S.), Science and Technology Planning Projects of Xiamen Science and Technology Bureau Grant 3502Z20154008 (to G. S.), Science and Technology Planning Projects of Xiamen Health and Family Planning Commission Grant 3502Z20149004 (to G. S.), Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University Grant SKLCSB2018KF008 (to G. S.), National Institutes of Health Grant R01 CA193455 (to J. X.), and CPRIT Grant RP150197 (to J. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Birner P, 2000, CANCER RES, V60, P4693; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dimitrova E, 2015, EMBO REP, V16, P1620, DOI 10.15252/embr.201541113; Fan L, 2016, ONCOGENE, V35, P2441, DOI 10.1038/onc.2015.309; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Goda S, 2013, J BIOL CHEM, V288, P36948, DOI 10.1074/jbc.M113.492595; Kaukonen R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12237; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Lee HY, 2013, CARCINOGENESIS, V34, P2706, DOI 10.1093/carcin/bgt256; Li J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15146; Liu YH, 2012, HEPATOLOGY, V56, P1015, DOI 10.1002/hep.25751; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mo P, 2015, ONCOGENE, V34, P3935, DOI 10.1038/onc.2014.324; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Padi SKR, 2013, GASTROENTEROLOGY, V145, P437, DOI 10.1053/j.gastro.2013.04.012; Park SJ, 2013, BIOCHEM BIOPH RES CO, V434, P722, DOI 10.1016/j.bbrc.2013.03.091; Suikki HE, 2010, PROSTATE, V70, P889, DOI 10.1002/pros.21123; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tong ZW, 2015, J BIOL CHEM, V290, P18596, DOI 10.1074/jbc.M115.640490; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uemura M, 2010, CLIN CANCER RES, V16, P4636, DOI 10.1158/1078-0432.CCR-10-0407; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Wade MA, 2015, NUCLEIC ACIDS RES, V43, P196, DOI 10.1093/nar/gku1298; Wan W, 2017, ONCOGENE, V36, P3868, DOI 10.1038/onc.2017.13; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Xu Y, 2010, ONCOGENE, V29, P3386, DOI 10.1038/onc.2010.90; Yamada D, 2012, ANN SURG ONCOL, V19, pS355, DOI 10.1245/s10434-011-1797-x; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhao W, 2014, J BIOL CHEM, V289, P11219, DOI 10.1074/jbc.M113.535989; Zhong H, 1999, CANCER RES, V59, P5830	35	32	36	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10606	10619		10.1074/jbc.RA118.001730	http://dx.doi.org/10.1074/jbc.RA118.001730			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29802196	Green Published, hybrid			2022-12-28	WOS:000437828400019
J	Feng, LF; Vujicic, S; Dietrich, ME; Litbarg, N; Setty, S; Antoni, A; Rauch, J; Levine, JS				Feng, Lanfei; Vujicic, Snezana; Dietrich, Michael E.; Litbarg, Natalia; Setty, Suman; Antoni, Angelika; Rauch, Joyce; Levine, Jerrold S.			Repeated exposure of epithelial cells to apoptotic cells induces the specific selection of an adaptive phenotype: Implications for tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; epithelial cell; innate immunity; cancer biology; B-cell lymphoma 2 (Bcl-2) family; cell death; cell proliferation; cell signaling; tumor microenvironment; directed evolution	TUMOR-ASSOCIATED MACROPHAGES; CYTOCHROME-C; SIGNALING EVENTS; BID CLEAVAGE; GRANZYME-B; IN-VITRO; DEATH; PROLIFERATION; GROWTH; CANCER	The consequences of apoptosis extend beyond the mere death of the cell. We have shown that receptor-mediated recognition of apoptotic target cells by viable kidney proximal tubular epithelial cells (PTECs) inhibits PTEC proliferation, growth, and survival. Here, we tested the hypothesis that continual exposure to apoptotic targets can induce a phenotypic change in responding PTECs, as in other instances of natural selection. In particular, we demonstrate that repeated exposure to apoptotic targets leads to emergence of a PTEC line (denoted BU.MPTSEL) resistant to apoptotic target-induced death. Resistance is exquisitely specific. Not only are BU.MPTSEL responders fully resistant to apoptotic target-induced death (approximate to 85% survival versus <10% survival of nonselected cells) but do so while retaining sensitivity to all other target-induced responses, including inhibition of proliferation and growth. Moreover, the resistance of BU.MPTSEL responders is specific to target-induced apoptosis, as apoptosis in response to other suicidal stimuli occurs normally. Comparison of the signaling events induced by apoptotic target exposure in selected versus nonselected responders indicated that the acquired resistance of BU.MPTSEL cells lies in a regulatory step affecting the generation of the pro-apoptotic protein, truncated BH3 interacting-domain death agonist (tBID), most likely at the level of BID cleavage by caspase-8. This specific adaptation has especial relevance for cancer, in which the prominence and persistence of cell death entail magnification of the post-mortem effects of apoptotic cells. Just as cancer cells acquire specific resistance to chemotherapeutic agents, we propose that cancer cells may also adapt to their ongoing exposure to apoptotic targets.	[Feng, Lanfei; Vujicic, Snezana; Dietrich, Michael E.; Litbarg, Natalia; Levine, Jerrold S.] Univ Illinois, Dept Med, Sect Nephrol, 840 South Wood St,MC-793, Chicago, IL 60612 USA; [Setty, Suman] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Feng, Lanfei; Vujicic, Snezana; Litbarg, Natalia; Levine, Jerrold S.] Jesse Brown Vet Affairs Hosp, Dept Med, Sect Nephrol, Chicago, IL 60612 USA; [Antoni, Angelika] Kutztown Univ Penn, Dept Biol, Kutztown, PA 19530 USA; [Rauch, Joyce] McGill Univ, Hlth Ctr, Res Inst, Div Rheumatol,Dept Med, Montreal, PQ H4A 3J1, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; McGill University	Levine, JS (corresponding author), Univ Illinois, Dept Med, Sect Nephrol, 840 South Wood St,MC-793, Chicago, IL 60612 USA.	jslevine@uic.edu			Section of Nephrology, University of Illinois at Chicago; Division of Rheumatology, McGill University; Department of Medicine, McGill University; Research Institute of the McGill University Health Centre	Section of Nephrology, University of Illinois at Chicago; Division of Rheumatology, McGill University; Department of Medicine, McGill University; Research Institute of the McGill University Health Centre	This work was supported, in whole or in part, by institutional funds from Dr. Jose A. Arruda and the Section of Nephrology, University of Illinois at Chicago (to J. S. L. and N. L.), and funding from the Division of Rheumatology and the Department of Medicine, McGill University, and the Research Institute of the McGill University Health Centre (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Byun JS, 2013, AM J PATHOL, V182, P1055, DOI 10.1016/j.ajpath.2013.01.009; Chaurio R, 2013, AUTOIMMUNITY, V46, P317, DOI 10.3109/08916934.2012.754433; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cristofanon S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.163; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Devitt A, 2011, J LEUKOCYTE BIOL, V90, P447, DOI 10.1189/jlb.0211095; Djudjaj S, 2016, KIDNEY INT, V89, P792, DOI 10.1016/j.kint.2015.10.015; Donato AL, 2014, J INVEST DERMATOL, V134, P1686, DOI 10.1038/jid.2014.18; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Erlanson M, 1997, ACTA ONCOL, V36, P17, DOI 10.3109/02841869709100725; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feltham R, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2016.83; Flavahan WA, 2017, SCIENCE, V357, DOI 10.1126/science.aal2380; Ford CA, 2015, CURR BIOL, V25, P577, DOI 10.1016/j.cub.2014.12.059; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gall JM, 2011, KIDNEY INT, V79, P1207, DOI 10.1038/ki.2010.532; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gregory CD, 2016, ADV EXP MED BIOL, V930, P51, DOI 10.1007/978-3-319-39406-0_3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardwick JM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008722; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Knott A, 2005, CANCER BIOL THER, V4, P532, DOI 10.4161/cbt.4.5.1658; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mao P, 2013, ONCOL LETT, V5, P1615, DOI 10.3892/ol.2013.1223; Medina CB, 2016, CELL DEATH DIFFER, V23, P979, DOI 10.1038/cdd.2016.13; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naumann I, 2011, CLIN CANCER RES, V17, P3204, DOI 10.1158/1078-0432.CCR-10-2451; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Patel VA, 2015, J BIOL CHEM, V290, P22352, DOI 10.1074/jbc.M115.667345; Patel VA, 2012, J BIOL CHEM, V287, P13761, DOI 10.1074/jbc.M112.350843; Patel VA, 2010, J BIOL CHEM, V285, P1829, DOI 10.1074/jbc.M109.018440; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Reiter I, 1999, J IMMUNOL, V163, P1730; REVESZ L, 1956, NATURE, V178, P1391, DOI 10.1038/1781391a0; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; SASAKI K, 1993, CYTOMETRY, V14, P876, DOI 10.1002/cyto.990140805; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Shoshan-Barmatz V, 2015, BBA-BIOMEMBRANES, V1848, P2547, DOI 10.1016/j.bbamem.2014.10.040; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Stanford JC, 2014, J CLIN INVEST, V124, P4737, DOI 10.1172/JCI76375; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Suzanne M, 2013, CELL DEATH DIFFER, V20, P669, DOI 10.1038/cdd.2013.11; Ucker David S., 2009, P163, DOI 10.1007/978-1-4020-9292-3_6; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Vajjhala PR, 2015, J BIOL CHEM, V290, P29217, DOI 10.1074/jbc.M115.687731; Van der Hauwaert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066750; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Voss JJLP, 2017, CELL DEATH DIFFER, V24, P971, DOI 10.1038/cdd.2016.132; Vujicic S, 2016, JOVE-J VIS EXP, DOI 10.3791/54980; Yaacoub K, 2016, CANCER LETT, V378, P150, DOI 10.1016/j.canlet.2016.05.012; Zhang WH, 2005, CANCER RES, V65, P11529, DOI 10.1158/0008-5472.CAN-05-2718; Zinkel SS, 2013, ONCOGENE, V32, P3213, DOI 10.1038/onc.2012.454; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	85	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10245	10263		10.1074/jbc.RA117.001290	http://dx.doi.org/10.1074/jbc.RA117.001290			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769319	Green Published, hybrid			2022-12-28	WOS:000437096700024
J	Persson, A; Toledo, AG; Vorontsov, E; Nasir, W; Willen, D; Noborn, F; Ellervik, U; Mani, K; Nilsson, J; Larson, G				Persson, Andrea; Toledo, Alejandro Gomez; Vorontsov, Egor; Nasir, Waqas; Willen, Daniel; Noborn, Fredrik; Ellervik, Ulf; Mani, Katrin; Nilsson, Jonas; Larson, Goran			LC-MS/MS characterization of xyloside-primed glycosaminoglycans with cytotoxic properties reveals structural diversity and novel glycan modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; chondroitin sulfate; dermatan sulfate; glycosaminoglycan; mass spectrometry (MS); glycan structure; xyloside	PROTEIN LINKAGE REGION; HEPARAN-SULFATE OLIGOSACCHARIDES; ELECTROSPRAY MASS-SPECTROMETRY; BETA-D-XYLOSIDES; CHONDROITIN SULFATE; HNK-1 SULFOTRANSFERASE; COMPOSITIONAL ANALYSIS; LIQUID-CHROMATOGRAPHY; KERATAN SULFATE; CULTURED-CELLS	Structural characterization of glycosaminoglycans remains a challenge but is essential for determining structure-function relationships between glycosaminoglycans and the biomolecules with which they interact and for gaining insight into the biosynthesis of glycosaminoglycans. We have recently reported that xyloside-primed chondroitin/dermatan sulfate derived from a human breast carcinoma cell line, HCC70, has cytotoxic effects and shown that it differs in disaccharide composition from nontoxic chondroitin/dermatan sulfate derived from a human breast fibroblast cell line, CCD-1095Sk. To further investigate the structural requirements for the cytotoxic effect, we developed a novel LC-MS/MS approach based on reversed-phase dibutylamine ion-pairing chromatography and negative-mode higher-energy collision dissociation and used it in combination with cell growth studies and disaccharide fingerprinting. This strategy enabled detailed structural characterization of linkage regions, internal oligosaccharides, and nonreducing ends, revealing not only differences between xyloside-primed chondroitin/dermatan sulfate from HCC70 cells and CCD-1095Sk cells, but also sialylation of the linkage region and previously undescribed methylation and sulfation of the nonreducing ends. Although the xyloside-primed chondroitin/dermatan sulfate from HCC70 cells was less complex in terms of presence and distribution of iduronic acid than that from CCD-1095Sk cells, both glucuronic acid and iduronic acid appeared to be essential for the cytotoxic effect. Our data have moved us one step closer to understanding the structure of the cytotoxic chondroitin/dermatan sulfate from HCC70 cells primed on xylosides and demonstrate the suitability of the LC-MS/MS approach for structural characterization of glycosaminoglycans.	[Persson, Andrea; Mani, Katrin] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Persson, Andrea; Toledo, Alejandro Gomez; Nasir, Waqas; Noborn, Fredrik; Nilsson, Jonas; Larson, Goran] Univ Gothenburg, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden; [Vorontsov, Egor] Univ Gothenburg, Sahlgrenska Acad, Prote Core Facil, SE-40530 Gothenburg, Sweden; [Willen, Daniel; Ellervik, Ulf] Lund Univ, Ctr Chem & Chem Engn, Ctr Anal & Synth, SE-22100 Lund, Sweden	Lund University; University of Gothenburg; University of Gothenburg; Lund University	Larson, G (corresponding author), Univ Gothenburg, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden.	goran.larson@clinchem.gu.se	Larson, Göran/AAF-3404-2019	Mani, Katrin/0000-0002-1821-0634	Fund of the Hedda and John Forssman Foundation, Lund University; Medical Faculty at Lund University; Swedish Cancer Society [17 0255]; Swedish Research Council [K2014-68X-08266-27-4, K2015-66X-22693-01-4]; Ahlen Foundation	Fund of the Hedda and John Forssman Foundation, Lund University; Medical Faculty at Lund University; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlen Foundation	This work was supported by Governmental grants to the Sahlgrenska University Hospital, Gothenburg, the Fund of the Hedda and John Forssman Foundation, Lund University, the Medical Faculty at Lund University, Swedish Cancer Society Grant 17 0255 (to K. M.), Swedish Research Council Grants K2014-68X-08266-27-4 (to G. L.) and K2015-66X-22693-01-4 (to K. M.), and the Ahlen Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chua JS, 2017, ACCOUNTS CHEM RES, V50, P2693, DOI 10.1021/acs.accounts.7b00289; COSTER L, 1991, BIOCHEM J, V276, P533, DOI 10.1042/bj2760533; Desaire H, 2000, J AM SOC MASS SPECTR, V11, P916, DOI 10.1016/S1044-0305(00)00168-9; DICKENSON JM, 1990, BIOCHEM J, V269, P55, DOI 10.1042/bj2690055; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; FREEZE HH, 1993, J BIOL CHEM, V268, P1618; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Hashiguchi T, 2011, J BIOL CHEM, V286, P33003, DOI 10.1074/jbc.M111.279174; HOPWOOD JJ, 1974, BIOCHEM J, V141, P57, DOI 10.1042/bj1410057; Kamhi E, 2013, BIOL REV, V88, P928, DOI 10.1111/brv.12034; Kitagawa H, 2008, J BIOL CHEM, V283, P27438, DOI 10.1074/jbc.M803279200; Koike T, 2014, J BIOL CHEM, V289, P6695, DOI 10.1074/jbc.M113.520536; Kuberan B, 2002, J AM CHEM SOC, V124, P8707, DOI 10.1021/ja0178867; Laremore TN, 2010, BIOCHEM J, V431, P199, DOI 10.1042/BJ20100788; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Li GY, 2015, ACS CHEM BIOL, V10, P1303, DOI 10.1021/acschembio.5b00011; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Mani K, 1998, CANCER RES, V58, P1099; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miller RL, 2017, ANAL CHEM, V89, P8942, DOI 10.1021/acs.analchem.7b01417; Miller RL, 2015, EUR J MASS SPECTROM, V21, P245, DOI 10.1255/ejms.1337; Nakagawa N, 2011, BIOCHEM BIOPH RES CO, V415, P109, DOI 10.1016/j.bbrc.2011.10.023; Nasir W, 2016, J PROTEOME RES, V15, P2826, DOI 10.1021/acs.jproteome.6b00417; Nilsson J, 2017, J AM SOC MASS SPECTR, V28, P229, DOI 10.1007/s13361-016-1539-1; Noborn F, 2015, MOL CELL PROTEOMICS, V14, P41, DOI 10.1074/mcp.M114.043703; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; OTSU K, 1985, BIOCHEM J, V227, P37, DOI 10.1042/bj2270037; Otsuka Y, 2018, ANAL CHEM, V90, P5201, DOI 10.1021/acs.analchem.7b05438; Palaniappan KK, 2016, CHEM REV, V116, P14277, DOI 10.1021/acs.chemrev.6b00023; Persson A, 2016, J BIOL CHEM, V291, P14871, DOI 10.1074/jbc.M116.716829; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; Prydz K, 2015, BIOMOLECULES, V5, P2003, DOI 10.3390/biom5032003; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; SALIMATH PV, 1995, J BIOL CHEM, V270, P9164, DOI 10.1074/jbc.270.16.9164; SCHWARTZ NB, 1974, P NATL ACAD SCI USA, V71, P4047, DOI 10.1073/pnas.71.10.4047; Skidmore MA, 2010, NAT PROTOC, V5, P1983, DOI 10.1038/nprot.2010.145; Stachtea XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140279; SUGAHARA K, 1991, EUR J BIOCHEM, V202, P805, DOI 10.1111/j.1432-1033.1991.tb16436.x; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Thanawiroon C, 2004, J BIOL CHEM, V279, P2608, DOI 10.1074/jbc.M304772200; Toledo AG, 2015, MOL CELL PROTEOMICS, V14, P3118, DOI 10.1074/mcp.M115.051136; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Vassal-Stermann E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047933; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Volpi N, 2014, NAT PROTOC, V9, P541, DOI 10.1038/nprot.2014.026; Wen JZ, 2014, P NATL ACAD SCI USA, V111, P15723, DOI 10.1073/pnas.1417993111; WESTERGRENTHORSSON G, 1991, J CELL PHYSIOL, V147, P523, DOI 10.1002/jcp.1041470319; Wolff JJ, 2008, J AM SOC MASS SPECTR, V19, P294, DOI 10.1016/j.jasms.2007.10.007; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yu YL, 2017, J AM CHEM SOC, V139, P16986, DOI 10.1021/jacs.7b10164; Zaia J, 2001, ANAL CHEM, V73, P233, DOI 10.1021/ac000777a; Zaia J, 2003, ANAL CHEM, V75, P2445, DOI 10.1021/ac0263418; Zhao X, 2013, J BIOL CHEM, V288, P9226, DOI 10.1074/jbc.M112.437236	60	11	11	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10202	10219		10.1074/jbc.RA118.002971	http://dx.doi.org/10.1074/jbc.RA118.002971			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29739851	Green Published, hybrid			2022-12-28	WOS:000437096700021
J	Wu, CY; Satapati, S; Gui, WJ; Wynn, RM; Sharma, G; Lou, ML; Qi, XB; Burgess, SC; Malloy, C; Khemtong, C; Sherry, AD; Chuang, DT; Merritt, ME				Wu, Cheng-Yang; Satapati, Santhosh; Gui, Wenjun; Wynn, R. Max; Sharma, Gaurav; Lou, Mingliang; Qi, Xiangbing; Burgess, Shawn C.; Malloy, Craig; Khemtong, Chalermchai; Sherry, A. Dean; Chuang, David T.; Merritt, Matthew E.			A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyruvate dehydrogenase complex (PDC); cardiomyopathy; nuclear magnetic resonance (NMR); diabetes; glucose metabolism; drug development; intermediary metabolism; fatty acid oxidation; mitochondria; hyperpolarization	CITRIC-ACID CYCLE; C-13 NMR-SPECTROSCOPY; DIABETIC CARDIOMYOPATHY; RAT-HEART; ISOTOPOMER ANALYSIS; MAGNETIC-RESONANCE; GLUCOSE-OXIDATION; CARBON FLUX; DICHLOROACETATE; METABOLISM	The pyruvate dehydrogenase complex (PDC) is a key control point of energy metabolism and is subject to regulation by multiple mechanisms, including posttranslational phosphorylation by pyruvate dehydrogenase kinase (PDK). Pharmacological modulation of PDC activity could provide a new treatment for diabetic cardiomyopathy, as dysregulated substrate selection is concomitant with decreased heart function. Dichloroacetate (DCA), a classic PDK inhibitor, has been used to treat diabetic cardiomyopathy, but the lack of specificity and side effects of DCA indicate a more specific inhibitor of PDK is needed. This study was designed to determine the effects of a novel and highly selective PDK inhibitor, 2((2,4-dihydroxyphenyl)sulfonyl) isoindoline-4,6-diol (designated PS10), on pyruvate oxidation in diet-induced obese (DIO) mouse hearts compared with DCA-treated hearts. Four groups of mice were studied: lean control, DIO, DIO + DCA, and DIO + PS10. Both DCA and PS10 improved glucose tolerance in the intact animal. Pyruvate metabolism was studied in perfused hearts supplied with physiological mixtures of long chain fatty acids, lactate, and pyruvate. Analysis was performed using conventional H-1 and C-13 isotopomer methods in combination with hyperpolarized [1-C-13]pyruvate in the same hearts. PS10 and DCA both stimulated flux through PDC as measured by the appearance of hyperpolarized [C-13]bicarbonate. DCA but not PS10 increased hyperpolarized [1-C-13]lactate production. Total carbohydrate oxidation was reduced in DIO mouse hearts but increased by DCA and PS10, the latter doing so without increasing lactate production. The present results suggest that PS10 is a more suitable PDK inhibitor for treatment of diabetic cardiomyopathy.	[Wu, Cheng-Yang; Gui, Wenjun; Wynn, R. Max; Chuang, David T.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wu, Cheng-Yang; Satapati, Santhosh; Sharma, Gaurav; Burgess, Shawn C.; Malloy, Craig; Khemtong, Chalermchai; Sherry, A. Dean] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Wynn, R. Max; Malloy, Craig; Chuang, David T.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Malloy, Craig; Khemtong, Chalermchai; Sherry, A. Dean] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75080 USA; [Merritt, Matthew E.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Lou, Mingliang; Qi, Xiangbing] Natl Inst Biol Sci, Chem Ctr, Beijing 102206, Peoples R China; [Lou, Mingliang; Qi, Xiangbing] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; State University System of Florida; University of Florida; National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chuang, DT (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Merritt, ME (corresponding author), 1200 Newell Dr,R3-266B, Gainesville, FL 32610 USA.	david.chuang@utsouthwestern.edu; matthewmerritt@ufl.edu	Sharma, Gaurav/L-3259-2018; qi, xiangbing/A-4043-2019; Sherry, Dean/P-2348-2018	Sharma, Gaurav/0000-0002-1754-7163; Wynn, Richard/0000-0002-1879-2136; qi, xiangbing/0000-0002-7139-5164; Sherry, Dean/0000-0001-7150-8301; Wu, Cheng-Yang/0000-0002-3582-083X; Merritt, Matthew/0000-0003-4617-9651; Malloy, Craig/0000-0001-5077-0642	National Institutes of Health [DK62306, R37-HL034557, P41-EB015908, R01s DK105346, HD087306, DK112865, P41122698, U24DK097209]; Welch Foundation [I-1286, I-1804]; NSF [DMR 1644779]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD087306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097209, R01DK062306, R56DK062306, R01DK105346, R01DK078184, R01DK112865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM122698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK62306, R37-HL034557, and P41-EB015908 and by Welch Foundation Grants I-1286 and I-1804. This work was also supported by National Institutes of Health Grants R01s DK105346, HD087306, DK112865, P41122698, and U24DK097209 and by NSF DMR 1644779 (to M.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Bersin RM, 1997, AM HEART J, V134, P841, DOI 10.1016/S0002-8703(97)80007-5; Bull RJ, 2000, ENVIRON HEALTH PERSP, V108, P241, DOI 10.1289/ehp.00108s2241; Chatham JC, 1999, CARDIOVASC RES, V43, P96, DOI 10.1016/S0008-6363(99)00056-5; Cunningham CH, 2016, CIRC RES, V119, P1177, DOI 10.1161/CIRCRESAHA.116.309769; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Fukushima A, 2016, BBA-MOL CELL BIOL L, V1861, P1525, DOI 10.1016/j.bbalip.2016.03.020; GARVEY WT, 1993, AM J PHYSIOL, V264, pH837, DOI 10.1152/ajpheart.1993.264.3.H837; Hall JL, 1996, AM J PHYSIOL-HEART C, V271, pH2320, DOI 10.1152/ajpheart.1996.271.6.H2320; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Jones HB, 2014, TOXICOL PATHOL, V42, P1250, DOI 10.1177/0192623314530195; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; KUO TH, 1985, DIABETES, V34, P1075, DOI 10.2337/diabetes.34.11.1075; LAPIDOT A, 1994, J BIOL CHEM, V269, P27198; Le Page LM, 2015, DIABETES, V64, P2735, DOI 10.2337/db14-1560; Lei B, 2004, J MOL CELL CARDIOL, V36, P567, DOI 10.1016/j.yjmcc.2004.02.004; Lopaschuk GD, 1997, CIRCULATION, V95, P313; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; MALLOY CR, 1990, BIOCHEMISTRY-US, V29, P6756, DOI 10.1021/bi00481a002; Malloy CR, 1996, MAGN RESON MATER PHY, V4, P35, DOI 10.1007/BF01759778; MALLOY CR, 1987, FEBS LETT, V212, P58, DOI 10.1016/0014-5793(87)81556-9; MALLOY CR, 1988, J BIOL CHEM, V263, P6964; Mayers RM, 2003, BIOCHEM SOC T, V31, P1165; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; MJOS OD, 1971, J CLIN INVEST, V50, P1386, DOI 10.1172/JCI106621; Moreno KX, 2010, AM J PHYSIOL-HEART C, V298, pH1556, DOI 10.1152/ajpheart.00656.2009; Nakayama H, 2001, JPN CIRC J, V65, P783, DOI 10.1253/jcj.65.783; Purmal C, 2014, AM J PHYSIOL-HEART C, V307, pH1134, DOI 10.1152/ajpheart.00407.2014; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843; RIBES G, 1979, DIABETES, V28, P852, DOI 10.2337/diab.28.9.852; RUSSELL RR, 1991, AM J PHYSIOL, V261, pH1756, DOI 10.1152/ajpheart.1991.261.6.H1756; Schroeder MA, 2009, FASEB J, V23, P2529, DOI 10.1096/fj.09-129171; SHERRY AD, 1992, BIOCHEMISTRY-US, V31, P4833, DOI 10.1021/bi00135a014; STACPOOLE PW, 1990, FUND APPL TOXICOL, V14, P327, DOI 10.1016/0272-0590(90)90212-3; Standl E, 2016, CIRC RES, V118, P1830, DOI 10.1161/CIRCRESAHA.116.306924; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sugden MC, 2000, J ENDOCRINOL, V167, P339, DOI 10.1677/joe.0.1670339; SUNDQVIST KE, 1989, BIOCHEM J, V257, P913, DOI 10.1042/bj2570913; Taegtmeyer H, 2013, AM J PHYSIOL-HEART C, V305, pH1693, DOI 10.1152/ajpheart.00854.2012; Tso SC, 2014, J BIOL CHEM, V289, P4432, DOI 10.1074/jbc.M113.533885; WELLS PG, 1980, DIABETOLOGIA, V19, P109, DOI 10.1007/BF00421855; WHITEHOUSE S, 1973, BIOCHEM J, V134, P651, DOI 10.1042/bj1340651; Wu CY, 2018, MOL METAB, V12, P12, DOI 10.1016/j.molmet.2018.03.014; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Yazaki Y, 1999, HEART, V81, P153, DOI 10.1136/hrt.81.2.153; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	51	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9604	9613		10.1074/jbc.RA118.002838	http://dx.doi.org/10.1074/jbc.RA118.002838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29739849	Green Published, hybrid			2022-12-28	WOS:000436102300005
J	Hong, S; Ka, D; Yoon, SJ; Suh, N; Jeong, M; Suh, JY; Bae, E				Hong, Suji; Ka, Donghyun; Yoon, Seo Jeong; Suh, Nayoung; Jeong, Migyeong; Suh, Jeong-Yong; Bae, Euiyoung			CRISPR RNA and anti-CRISPR protein binding to the Xanthomonas albilineans Csy1-Csy2 heterodimer in the type I-F CRISPR-Cas system (vol 293, pg 2744, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Hong S, 2018, J BIOL CHEM, V293, P2744, DOI 10.1074/jbc.RA117.001611	1	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9233	9233		10.1074/jbc.AAC118.004093	http://dx.doi.org/10.1074/jbc.AAC118.004093			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29907732	Green Published, hybrid			2022-12-28	WOS:000435441400010
J	Yang, JH; Yan, W; Yu, YM; Wang, YX; Yang, T; Xue, LL; Yuan, X; Long, CF; Liu, ZW; Chen, XX; Hu, MS; Zheng, L; Qiu, Q; Pei, HY; Li, D; Wang, F; Bai, P; Wen, JL; Ye, HY; Chen, LJ				Yang, Jianhong; Yan, Wei; Yu, Yamei; Wang, Yuxi; Yang, Tao; Xue, Linlin; Yuan, Xue; Long, Caofeng; Liu, Zuowei; Chen, Xiaoxin; Hu, Mengshi; Zheng, Li; Qiu, Qiang; Pei, Heying; Li, Dan; Wang, Fang; Bai, Peng; Wen, Jiaolin; Ye, Haoyu; Chen, Lijuan			The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in beta-tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule; cancer prevention; cancer; natural product; tubulin; X-ray crystallography; drug resistance; Chalcone; Colchicine; Millepachine; s-trans conformation; Tubulin	IN-VIVO; BIOLOGICAL EVALUATION; ANTICANCER AGENTS; CANCER-CELLS; RESISTANCE; MICROTUBULES; MECHANISMS; APOPTOSIS; INTERACT; POTENT	Inhibitors that bind to the paclitaxel- or vinblastine-binding sites of tubulin have been part of the pharmacopoeia of anticancer therapy for decades. However, tubulin inhibitors that bind to the colchicine-binding site are not used in clinical cancer therapy, because of their low therapeutic index. To address multidrug resistance to many conventional tubulin-binding agents, numerous efforts have attempted to clinically develop inhibitors that bind the colchicine-binding site. Previously, we have found that millepachine (MIL), a natural chalcone-type small molecule extracted from the plant Millettia pachycarpa, and its two derivatives (MDs) SKLB028 and SKLB050 have potential antitumor activities both in vitro and in vivo. However, their cellular targets and mechanisms are unclear. Here, biochemical and cellular experiments revealed that the MDs directly and irreversibly bind -tubulin. X-ray crystallography of the tubulin-MD structures disclosed that the MDs bind at the tubulin intradimer interface and to the same site as colchicine and that their binding mode is similar to that of colchicine. Of note, MDs inhibited tubulin polymerization and caused G(2)/M cell-cycle arrest. Comprehensive analysis further revealed that free MIL exhibits an s-cis conformation, whereas MIL in the colchicine-binding site in tubulin adopts an s-trans conformation. Moreover, introducing an -methyl to MDs to increase the proportion of s-trans conformations augmented MDs' tubulin inhibition activity. Our study uncovers a new class of chalcone-type tubulin inhibitors that bind the colchicine-binding site in -tubulin and suggests that the s-trans conformation of these compounds may make them more active anticancer agents.	[Yang, Jianhong; Yan, Wei; Yu, Yamei; Wang, Yuxi; Yang, Tao; Xue, Linlin; Yuan, Xue; Hu, Mengshi; Zheng, Li; Qiu, Qiang; Pei, Heying; Li, Dan; Wang, Fang; Bai, Peng; Wen, Jiaolin; Ye, Haoyu; Chen, Lijuan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Peoples R China; [Yang, Jianhong; Yan, Wei; Yu, Yamei; Wang, Yuxi; Yang, Tao; Xue, Linlin; Yuan, Xue; Hu, Mengshi; Zheng, Li; Qiu, Qiang; Pei, Heying; Li, Dan; Wang, Fang; Bai, Peng; Wen, Jiaolin; Ye, Haoyu; Chen, Lijuan] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China; [Long, Caofeng; Liu, Zuowei; Chen, Xiaoxin] Guangdong Zhongsheng Pharmaceut Co Ltd, Dongguan 523325, Guangdong, Peoples R China	Sichuan University	Chen, LJ (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Peoples R China.; Chen, LJ (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China.	chenlijuan125@163.com	Wen, Jiaolin/GZL-0162-2022	Yang, Tao/0000-0003-0186-9907	National Natural Science Foundation of China [U1402222]; Guangdong Innovative Research Team Program [2011Y073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program	This work was supported by National Natural Science Foundation of China Grant U1402222 and Guangdong Innovative Research Team Program Grant 2011Y073. The authors declare that they have no conflicts of interest with the contents of this article.	AKTULGA E, 1980, HAEMATOLOGICA, V65, P399; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Buey RM, 2007, NAT CHEM BIOL, V3, P117, DOI 10.1038/nchembio853; Cao D, 2016, J MED CHEM, V59, P5721, DOI 10.1021/acs.jmedchem.6b00158; Cao D, 2013, EUR J MED CHEM, V62, P579, DOI 10.1016/j.ejmech.2013.01.007; Chinen T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9722; Clegg A, 2002, THORAX, V57, P20, DOI 10.1136/thorax.57.1.20; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Doodhi H, 2016, CURR BIOL, V26, P1713, DOI 10.1016/j.cub.2016.04.053; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; Field JJ, 2012, CHEM BIOL, V19, P686, DOI 10.1016/j.chembiol.2012.05.008; Fojo AT, 2005, SEMIN ONCOL, V32, pS3, DOI 10.1053/j.seminoncol.2005.09.010; Imazio M, 2015, TRENDS CARDIOVAS MED, V25, P129, DOI 10.1016/j.tcm.2014.09.011; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kim JS, 2007, CLIN CANCER RES, V13, P6509, DOI 10.1158/1078-0432.CCR-07-1428; LOCKWOOD AH, 1979, P NATL ACAD SCI USA, V76, P1184, DOI 10.1073/pnas.76.3.1184; Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z; Michaud LB, 2009, ANN PHARMACOTHER, V43, P1294, DOI 10.1345/aph.1M005; MORELAND LW, 1991, ARTHRITIS RHEUM-US, V34, P782, DOI 10.1002/art.1780340622; Nakagawa-Goto K, 2015, J MED CHEM, V58, P2378, DOI 10.1021/jm501859j; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Prota AE, 2014, ANGEW CHEM INT EDIT, V53, P1621, DOI 10.1002/anie.201307749; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; SACKS S, 1981, REV MED CHILE, V109, P239; Shan B, 1999, P NATL ACAD SCI USA, V96, P5686, DOI 10.1073/pnas.96.10.5686; Swain Sandra M, 2008, Clin Adv Hematol Oncol, V6, P455; Thomas NE, 2014, MOL CANCER THER, V13, P179, DOI 10.1158/1535-7163.MCT-13-0479; Towle MJ, 2011, CANCER RES, V71, P496, DOI 10.1158/0008-5472.CAN-10-1874; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wieczorek M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1093; Wu WS, 2013, CARCINOGENESIS, V34, P1636, DOI 10.1093/carcin/bgt087; Yang JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12103; Yang Z, 2014, J MED CHEM, V57, P7977, DOI 10.1021/jm500849z; Ye HY, 2012, FITOTERAPIA, V83, P1402, DOI 10.1016/j.fitote.2012.08.001	36	29	29	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9461	9472		10.1074/jbc.RA117.001658	http://dx.doi.org/10.1074/jbc.RA117.001658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29691282	Green Published, hybrid			2022-12-28	WOS:000435441400029
J	Berteau, O				Berteau, Olivier			A missed Fe-S cluster handoff causes a metabolic shakeup	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							IRON-SULFUR PROTEINS	The general framework of pathways by which iron-sulfur (Fe-S) clusters are assembled in cells is well-known, but the cellular consequences of disruptions to that framework are not fully understood. Crooks et al. report a novel cellular system that creates an acute Fe-S cluster deficiency, using mutants of ISCU, the main scaffold protein for Fe-S cluster assembly. Surprisingly, the resultant metabolic reprogramming leads to the accumulation of lipid droplets, a situation encountered in many poorly understood pathological conditions, highlighting unanticipated links between Fe-S assembly machinery and human disease.	[Berteau, Olivier] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst,ChemSyBio, F-78350 Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Berteau, O (corresponding author), INRA, Inst Micalis, UMR 1319, F-78350 Jouy En Josas, France.	Olivier.Berteau@inra.fr	Berteau, Olivier/AAF-9080-2019	Berteau, Olivier/0000-0002-3434-5168	European Research Council (ERC) [617053]	European Research Council (ERC)(European Research Council (ERC))	Supported by European Research Council (ERC) Consolidator Grant 617053.	Benjdia A, 2016, BIOCHEM SOC T, V44, P109, DOI 10.1042/BST20150191; Berteau O, 2017, PHOTOCHEM PHOTOBIOL, V93, P67, DOI 10.1111/php.12702; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Crooks DR, 2018, J BIOL CHEM, V293, P8297, DOI 10.1074/jbc.RA118.001885; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599	10	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8312	8313		10.1074/jbc.H118.002883	http://dx.doi.org/10.1074/jbc.H118.002883			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29802141	Green Published, hybrid			2022-12-28	WOS:000433224600035
J	Sakr, M; Li, XY; Sabeh, F; Feinberg, TY; Tesmer, JJG; Tang, Y; Weiss, SJ				Sakr, Moustafa; Li, Xiao-Yan; Sabeh, Farideh; Feinberg, Tamar Y.; Tesmer, John J. G.; Tang, Yi; Weiss, Stephen J.			Tracking the Cartoon mouse phenotype: Hemopexin domain-dependent regulation of MT1-MMP pericellular collagenolytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						matrix metalloproteinase (MMP); mesenchymal stem cells (MSCs); collagen; fibroblast; intracellular trafficking; MT1-MMP; type I collagen; hemopexin domain	TYPE-1 MATRIX-METALLOPROTEINASE; CELL-SURFACE; I COLLAGEN; 1-MATRIX METALLOPROTEINASE; ENDOPLASMIC-RETICULUM; EXTRACELLULAR-MATRIX; SUCRASE-ISOMALTASE; BONE-RESORPTION; MEMBRANE; ACTIVATION	Following ENU mutagenesis, a phenodeviant line was generated, termed the Cartoon mouse, that exhibits profound defects in growth and development. Cartoon mice harbor a single S466P point mutation in the MT1-MMP hemopexin domain, a 200-amino acid segment that is thought to play a critical role in regulating MT1-MMP collagenolytic activity. Herein, we demonstrate that the MT1-MMPS466P mutation replicates the phenotypic status of Mt1-mmp-null animals as well as the functional characteristics of MT1-MMP-/- cells. However, rather than a loss-of-function mutation acquired as a consequence of defects in MT1-MMP proteolytic activity, the S466P substitution generates a misfolded, temperature-sensitive mutant that is abnormally retained in the endoplasmic reticulum (ER). By contrast, the WT hemopexin domain does not play a required role in regulating MT1-MMP trafficking, as a hemopexin domain-deletion mutant is successfully mobilized to the cell surface and displays nearly normal collagenolytic activity. Alternatively, when MT1-MMPS466P-expressing cells are cultured at a permissive temperature of 25 degrees C that depresses misfolding, the mutant successfully traffics from the ER to the trans-Golgi network (ER trans-Golgi network), where it undergoes processing to its mature form, mobilizes to the cell surface, and expresses type I collagenolytic activity. Together, these analyses define the Cartoon mouse as an unexpected gain-of-abnormal function mutation, wherein the temperature-sensitive mutant phenocopies MT1-MMP-/- mice as a consequence of eliciting a specific ER trans-Golgi network trafficking defect.	[Sakr, Moustafa] Univ Sadat City, GEBRI, Mol Diagnost & Therapeut Dept, Sadat City 32897, Egypt; [Li, Xiao-Yan; Sabeh, Farideh; Feinberg, Tamar Y.; Tang, Yi; Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Li, Xiao-Yan; Sabeh, Farideh; Feinberg, Tamar Y.; Tesmer, John J. G.; Tang, Yi; Weiss, Stephen J.] Univ Michigan, Life Sci Inst, 210 Washtenaw, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.; Weiss, Stephen J.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.; Weiss, Stephen J.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.; Weiss, Stephen J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Egyptian Knowledge Bank (EKB); University of Sadat City; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weiss, SJ (corresponding author), Univ Michigan, Life Sci Inst, 210 Washtenaw, Ann Arbor, MI 48109 USA.	sjweiss@umich.edu	Sakr, Moustafa/E-9276-2017	Sakr, Moustafa/0000-0002-5873-8468; Weiss, Stephen/0000-0002-1864-6075; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [AR065524, CA071699, HL071818, HL122416]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA071699] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122416, R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AR065524 and CA071699 (to S. J. W.), HL071818 and HL122416 (to J. J. G. T.), and the Breast Cancer Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; Atkinson SJ, 2006, BIOCHEM J, V398, P15, DOI 10.1042/BJ20060243; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Basu B, 2012, INT J BIOCHEM CELL B, V44, P393, DOI 10.1016/j.biocel.2011.11.015; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Cerofolini L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29511; Chan KM, 2012, DEV CELL, V22, P1176, DOI 10.1016/j.devcel.2012.04.014; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; El Azzouzi K, 2016, J CELL BIOL, V213, P109, DOI 10.1083/jcb.201510043; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Gutierrez-Fernandez A, 2015, EMBO J, V34, P1875, DOI 10.15252/embj.201490594; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jin GX, 2011, EMBO J, V30, P2281, DOI 10.1038/emboj.2011.136; Lafleur MA, 2006, J BIOL CHEM, V281, P6826, DOI 10.1074/jbc.M513084200; Langenfurth A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32203; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Mori H, 2013, DEVELOPMENT, V140, P343, DOI 10.1242/dev.084236; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Otani S, 2016, BIOCHEM BIOPH RES CO, V469, P1062, DOI 10.1016/j.bbrc.2015.12.105; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; Paulussen A, 2002, J BIOL CHEM, V277, P48610, DOI 10.1074/jbc.M206569200; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Propsting MJ, 2003, J BIOL CHEM, V278, P16310, DOI 10.1074/jbc.C300093200; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rowe RG, 2011, AM J PHYSIOL-LUNG C, V301, pL683, DOI 10.1152/ajplung.00187.2011; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Rozanov DV, 2002, J BIOL CHEM, V277, P9318, DOI 10.1074/jbc.M110711200; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sakamoto T, 2014, MOL CELL BIOL, V34, P30, DOI 10.1128/MCB.01169-13; Schroder HM, 2013, INT J BIOCHEM CELL B, V45, P1133, DOI 10.1016/j.biocel.2013.02.020; Shenkman M, 1997, P NATL ACAD SCI USA, V94, P11363, DOI 10.1073/pnas.94.21.11363; Shimizu-Hirota R, 2012, GENE DEV, V26, P395, DOI 10.1101/gad.178749.111; Szabova L, 2010, BLOOD, V116, P5752, DOI 10.1182/blood-2009-10-249847; Szabova L, 2009, J BONE MINER RES, V24, P1905, DOI [10.1359/JBMR.090510, 10.1359/jbmr.090510]; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Taylor SH, 2015, ELIFE, V4, DOI 10.7554/eLife.09345; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Udi Y, 2015, STRUCTURE, V23, P104, DOI 10.1016/j.str.2014.10.012; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Weaver SA, 2014, J CELL SCI, V127, P1203, DOI 10.1242/jcs.135236; Wong HLX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10824; Xu H, 2016, MATRIX BIOL, V52-54, P266, DOI 10.1016/j.matbio.2016.01.002; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zhao YC, 2015, STRUCTURE, V23, P257, DOI 10.1016/j.str.2014.11.021; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	72	2	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8113	8127		10.1074/jbc.RA117.001503	http://dx.doi.org/10.1074/jbc.RA117.001503			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29643184	hybrid, Green Published			2022-12-28	WOS:000433224600017
J	Banerjee, R				Banerjee, Ruma			Introduction to the Thematic Minireview Series: Redox metabolism and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								In this sequel to the thematic collection of Minireviews on redox metabolism and signaling published last year, five articles plumb the redox metabolic pathways relevant to cell proliferation, stress response, and survival post-detachment from the extracellular matrix. The sixth article provides unexpected insights into the hepatic NAD(P)ome, revealing that more than half of these proteins reside outside the cytoplasmic and mitochondrial compartments, pointing to the paucity of knowledge on their functions. Collectively, these articles highlight the metabolic adaptability of proliferating cells to meet redox needs, the use of lipids to mediate mitochondrial stress responses, and the need for tools to interrogate compartment-specific pool sizes and oxidized/reduced ratios of antioxidants and lipids involved in redox homeostasis.	[Banerjee, Ruma] Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			NHLBI NIH HHS [R01 HL058984] Funding Source: Medline; NIDDK NIH HHS [R01 DK045776] Funding Source: Medline; NIGMS NIH HHS [R01 GM112455] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Goodman RP, 2018, J BIOL CHEM, V293, P7508, DOI 10.1074/jbc.TM117.000258; Hawk MA, 2018, J BIOL CHEM, V293, P7531, DOI 10.1074/jbc.TM117.000260; Hosios AM, 2018, J BIOL CHEM, V293, P7490, DOI 10.1074/jbc.TM117.000239; Kong H, 2018, J BIOL CHEM, V293, P7499, DOI 10.1074/jbc.TM117.000257; Nielson JR, 2018, J BIOL CHEM, V293, P7517, DOI 10.1074/jbc.R117.001655; Solmonson A, 2018, J BIOL CHEM, V293, P7522, DOI 10.1074/jbc.TM117.000259	6	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7488	+		10.1074/jbc.TM118.003170	http://dx.doi.org/10.1074/jbc.TM118.003170			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29622674	Green Published, hybrid			2022-12-28	WOS:000437256500001
J	Muszynski, A; Heiss, C; Hjuler, CT; Sullivan, JT; Kelly, SJ; Thygesen, MB; Stougaard, J; Azadi, P; Carlson, RW; Ronson, CW				Muszynski, Artur; Heiss, Christian; Hjuler, Christian T.; Sullivan, John T.; Kelly, Simon J.; Thygesen, Mikkel B.; Stougaard, Jens; Azadi, Parastoo; Carlson, Russell W.; Ronson, Clive W.			Structures of exopolysaccharides involved in receptor-mediated perception of Mesorhizobium loti by Lotus japonicas (vol 291, pg 20946, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Heiss, Christian/GPX-7678-2022	Heiss, Christian/0000-0003-1118-8953; Stougaard, Jens/0000-0002-9312-2685				Muszynski A, 2016, J BIOL CHEM, V291, P20946, DOI 10.1074/jbc.M116.743856	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5376	5376		10.1074/jbc.AAC118.002877	http://dx.doi.org/10.1074/jbc.AAC118.002877			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29626109	hybrid, Green Published			2022-12-28	WOS:000429409300040
J	Jain, P; Malakar, B; Khan, MZ; Lochab, S; Singh, A; Nandicoori, VK				Jain, Preeti; Malakar, Basanti; Khan, Mehak Zahoor; Lochab, Savita; Singh, Archana; Nandicoori, Vinay Kumar			Delineating FtsQ-mediated regulation of cell division in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; Mycobacterium tuberculosis; phosphorylation; mycobacteria; protein kinase; FtsQ; regulation; dcw operon; divisome; septation	PENICILLIN-BINDING PROTEIN-3; ESCHERICHIA-COLI DIVISOME; OUTER-MEMBRANE PROTEINS; BACILLUS-SUBTILIS; TRIMERIC COMPLEX; IN-VITRO; Z RING; GROWTH; DIVIB; KINASE	Identifying and characterizing the individual contributors to bacterial cellular elongation and division will improve our understanding of their impact on cell growth and division. Here, we delineated the role of ftsQ, a terminal gene of the highly conserved division cell wall (dcw) operon, in growth, survival, and cell length maintenance in the human pathogen Mycobacterium tuberculosis (Mtb). We found that FtsQ overexpression significantly increases the cell length and number of multiseptate cells. FtsQ depletion in Mtb resulted in cells that were shorter than WT cells during the initial growth stages (4 days after FtsQ depletion) but were longer than WT cells at later stages (10 days after FtsQ depletion) and compromised the survival in vitro and in differentiated THP1 macrophages. Overexpression of N- and C-terminal FtsQ regions altered the cell length, and the C-terminal domain alone complemented the FtsQ depletion phenotype. MS analyses suggested robust FtsQ phosphorylation on Thr-24, and although phosphoablative and -mimetic mutants rescued the FtsQ depletion-associated cell viability defects, they failed to complement the cell length defects. MS and coimmunoprecipitation experiments identified 63 FtsQ-interacting partners, and we show that the interaction of FtsQ with the recently identified cell division protein SepIVA is independent of FtsQ phosphorylation and suggests a role of FtsQ in modulating cell division. FtsQ exhibited predominantly septal localization in both the presence and absence of SepIVA. Our results suggest a role for FtsQ in modulating the length, division, and survival of Mtb cells both in vitro and in the host.	[Jain, Preeti; Malakar, Basanti; Khan, Mehak Zahoor; Lochab, Savita; Nandicoori, Vinay Kumar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Singh, Archana] CSIR, Inst Genom & Integrat Biol, New Delhi 110025, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.ac.in		Khan, Mehak Zahoor/0000-0002-2780-4119; Singh, Archana/0000-0003-1388-9489; Nandicoori, Vinay/0000-0002-5682-4178	Department of Science and Technology, Government of India [EMR/2014/000877]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Department of Science and Technology, Government of India Grant EMR/2014/000877 (to V. K. N.). The authors declare that they have no conflicts of interest with the contents of this article. This article contains Table S1.	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Arora D, 2018, J BIOL CHEM, V293, P6497, DOI 10.1074/jbc.M117.811190; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BOTTA GA, 1981, J BACTERIOL, V145, P333, DOI 10.1128/JB.145.1.333-340.1981; Buddelmeijer N, 1998, J BACTERIOL, V180, P6107; Busiek KK, 2014, MOL MICROBIOL, V92, P1212, DOI 10.1111/mmi.12623; CARSON MJ, 1991, J BACTERIOL, V173, P2187, DOI 10.1128/JB.173.7.2187-2195.1991; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Cho H, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.172, 10.1038/nmicrobiol.2016.172]; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; DAI K, 1992, J BACTERIOL, V174, P6145, DOI 10.1128/JB.174.19.6145-6151.1992; Dai K, 1996, J BACTERIOL, V178, P1328, DOI 10.1128/jb.178.5.1328-1334.1996; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; Datta P, 2002, J BIOL CHEM, V277, P24983, DOI 10.1074/jbc.M203847200; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; DEWAR SJ, 1992, J BACTERIOL, V174, P6314, DOI 10.1128/JB.174.19.6314-6316.1992; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Du SS, 2016, P NATL ACAD SCI USA, V113, pE5052, DOI 10.1073/pnas.1606656113; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; England K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-79; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Fortuin S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00006; Gerding MA, 2009, J BACTERIOL, V191, P7383, DOI 10.1128/JB.00811-09; Ghosh J, 2009, P NATL ACAD SCI USA, V106, P10781, DOI 10.1073/pnas.0904104106; Glas M, 2015, J BIOL CHEM, V290, P21498, DOI 10.1074/jbc.M115.654756; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Gupta S, 2015, MICROBIOL-SGM, V161, P1627, DOI 10.1099/mic.0.000108; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Katis VL, 1999, J BACTERIOL, V181, P2710, DOI 10.1128/JB.181.9.2710-2718.1999; Kaval KG, 2012, VIRULENCE, V3, P406, DOI [10.4161/viru.20747, 10.1111/j.1365-2958.2012.07969.x]; Khan MZ, 2017, J BIOL CHEM, V292, P16093, DOI 10.1074/jbc.M117.797563; Kieser KJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005010; Lee JJ, 2014, NEW MICROBIOL, V37, P525; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Liu B, 2015, MOL MICROBIOL, V95, P945, DOI 10.1111/mmi.12906; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Mannik J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006638; Masson S, 2009, J BIOL CHEM, V284, P27687, DOI 10.1074/jbc.M109.019471; Mavrici D, 2014, P NATL ACAD SCI USA, V111, P8037, DOI 10.1073/pnas.1321812111; Nagarajan SN, 2015, J BIOL CHEM, V290, P9626, DOI 10.1074/jbc.M114.611822; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Ortiz C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184184; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Pichoff S, 2015, MOL MICROBIOL, V95, P971, DOI 10.1111/mmi.12907; Plocinski P, 2012, J BACTERIOL, V194, P6398, DOI 10.1128/JB.01005-12; Plocinski P, 2011, J BACTERIOL, V193, P3246, DOI 10.1128/JB.00188-11; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Priyadarshini R, 2006, J BACTERIOL, V188, P5345, DOI 10.1128/JB.00476-06; Rajanala K, 2014, J CELL SCI, V127, P3505, DOI 10.1242/jcs.149112; Ramos A, 2003, MICROBIOL-SGM, V149, P3531, DOI 10.1099/mic.0.26653-0; Rego EH, 2017, NATURE, V546, P153, DOI 10.1038/nature22361; RICARD M, 1973, J BACTERIOL, V116, P314, DOI 10.1128/JB.116.1.314-322.1973; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Robson SA, 2006, P NATL ACAD SCI USA, V103, P6700, DOI 10.1073/pnas.0601397103; Rowland SL, 2010, J BACTERIOL, V192, P6116, DOI 10.1128/JB.00783-10; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sackett MJ, 1998, MOL MICROBIOL, V28, P421, DOI 10.1046/j.1365-2958.1998.00753.x; Samten B, 2016, TUBERCULOSIS, V101, pS99, DOI 10.1016/j.tube.2016.09.017; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Sharma AK, 2016, J BIOL CHEM, V291, P24215, DOI 10.1074/jbc.M116.754531; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh B, 2013, MOL MICROBIOL, V88, P64, DOI 10.1111/mmi.12169; Soderstrom B, 2014, MOL MICROBIOL, V92, P1, DOI 10.1111/mmi.12534; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Soni V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005235; SPRATT BG, 1977, J BACTERIOL, V131, P293, DOI 10.1128/JB.131.1.293-305.1977; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Thompson LS, 2006, J BACTERIOL, V188, P7677, DOI 10.1128/JB.01072-06; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Tsang MJ, 2015, MOL MICROBIOL, V95, P925, DOI 10.1111/mmi.12905; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Verma R, 2017, J PROTEOME RES, V16, P1632, DOI 10.1021/acs.jproteome.6b00983; Wu KJ, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00649-17; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045	88	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12331	12349		10.1074/jbc.RA118.003628	http://dx.doi.org/10.1074/jbc.RA118.003628			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903917	Green Published, hybrid			2022-12-28	WOS:000441408500003
J	Seren, S; Abouzaid, MR; Eulenberg-Gustavus, C; Hirschfeld, J; Soliman, HN; Jerke, U; N'Guessan, K; Dallet-Choisy, S; Lesner, A; Lauritzen, C; Schacher, B; Eickholz, P; Nagy, N; Szell, M; Croix, C; Viaud-Massuard, MC; Aldosari, AA; Ragunatha, S; Mostafa, MI; Giampieri, F; Battino, M; Cornillier, H; Lorette, G; Stephan, JL; Goizet, C; Pedersen, J; Gauthier, F; Jenne, DE; Marchand-Adam, S; Chapple, IL; Kettritz, R; Korkmaz, B				Seren, Seda; Abouzaid, Maha Rashed; Eulenberg-Gustavus, Claudia; Hirschfeld, Josefine; Soliman, Hala Nasr; Jerke, Uwe; N'Guessan, Koffi; Dallet-Choisy, Sandrine; Lesner, Adam; Lauritzen, Conni; Schacher, Beate; Eickholz, Peter; Nagy, Nikoletta; Szell, Marta; Croix, Cecile; Viaud-Massuard, Marie-Claude; Aldosari, Abdullah Al Farraj; Ragunatha, Shivanna; Mostafa, Mostafa Ibrahim; Giampieri, Francesca; Battino, Maurizio; Cornillier, Helene; Lorette, Gerard; Stephan, Jean-Louis; Goizet, Cyril; Pedersen, John; Gauthier, Francis; Jenne, Dieter E.; Marchand-Adam, Sylvain; Chapple, Iain L.; Kettritz, Ralph; Korkmaz, Brice			Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease; protease inhibitor; neutrophil; aminopeptidase; antigen; autoimmune disease; genetic disease; proteinase 3; cathepsin C; granulomatosis with polyangiitis; Papillon-Lefevre syndrome	PAPILLON-LEFEVRE-SYNDROME; ANCA-ASSOCIATED VASCULITIDES; NEUTROPHIL SERINE PROTEASES; WEGENERS AUTOANTIGEN; MOLECULAR ANALYSIS; HUMAN-DISEASES; MUTATIONS; ELASTASE; CELLS; BINDING	Membrane-bound proteinase 3 (PR3(m)) is the main target antigen of anti-neutrophil cytoplasmic autoantibodies (ANCA) in granulomatosis with polyangiitis, a systemic small-vessel vasculitis. Binding of ANCA to PR3(m) triggers neutrophil activation with the secretion of enzymatically active PR3 and related neutrophil serine proteases, thereby contributing to vascular damage. PR3 and related proteases are activated from pro-forms by the lysosomal cysteine protease cathepsin C (CatC) during neutrophil maturation. We hypothesized that pharmacological inhibition of CatC provides an effective measure to reduce PR3(m) and therefore has implications as a novel therapeutic approach in granulomatosis with polyangiitis. We first studied neutrophilic PR3 from 24 patients with Papillon-Lefevre syndrome (PLS), a genetic form of CatC deficiency. PLS neutrophil lysates showed a largely reduced but still detectable (0.5-4%) PR3 activity when compared with healthy control cells. Despite extremely low levels of cellular PR3, the amount of constitutive PR3(m) expressed on the surface of quiescent neutrophils and the typical bimodal membrane distribution pattern were similar to what was observed in healthy neutrophils. However, following cell activation, there was no significant increase in the total amount of PR3(m) on PLS neutrophils, whereas the total amount of PR3(m) on healthy neutrophils was significantly increased. We then explored the effect of pharmacological CatC inhibition on PR3 stability in normal neutrophils using a potent cell-permeable CatC inhibitor and a CD34(+) hematopoietic stem cell model. Human CD34(+) hematopoietic stem cells were treated with the inhibitor during neutrophil differentiation over 10 days. We observed strong reductions in PR3(m), cellular PR3 protein, and proteolytic PR3 activity, whereas neutrophil differentiation was not compromised.	[Seren, Seda; N'Guessan, Koffi; Dallet-Choisy, Sandrine; Gauthier, Francis; Marchand-Adam, Sylvain; Korkmaz, Brice] INSERM, U1100, Ctr Etude Pathol Resp, F-37000 Tours, France; [Seren, Seda; N'Guessan, Koffi; Dallet-Choisy, Sandrine; Gauthier, Francis; Marchand-Adam, Sylvain; Korkmaz, Brice] Univ Tours, F-37000 Tours, France; [Abouzaid, Maha Rashed; Mostafa, Mostafa Ibrahim] Natl Res Ctr, Dept Orodent Genet, Cairo 12622, Egypt; [Soliman, Hala Nasr] Natl Res Ctr, Dept Med Mol Genet, Cairo 12622, Egypt; [Eulenberg-Gustavus, Claudia; Jerke, Uwe; Kettritz, Ralph] Charite & Max Delbruck Ctr Mol Med Helmholtz Gemi, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Hirschfeld, Josefine; Chapple, Iain L.] Univ Birmingham, Coll Med & Dent Sci, Periodontal Res Grp, Inst Clin Sci, Birmingham B5 7EG, W Midlands, England; [Hirschfeld, Josefine; Chapple, Iain L.] Birmingham Community Hlth Trust, Birmingham B5 7EG, W Midlands, England; [Lesner, Adam] Univ Gdansk, Fac Chem, PL-80309 Gdansk, Poland; [Lauritzen, Conni; Pedersen, John] Unizyme Labs AS, DK-2970 Horsholm, Denmark; [Schacher, Beate; Eickholz, Peter] Goethe Univ Frankfurt, Dept Periodontol, D-60323 Frankfurt, Germany; [Nagy, Nikoletta; Szell, Marta] Univ Szeged, Dept Med Genet, H-6720 Szeged, Hungary; [Croix, Cecile; Viaud-Massuard, Marie-Claude] CNRS, UMR Genet Immunotherapie Chim & Canc 7292, F-37000 Tours, France; [Croix, Cecile; Viaud-Massuard, Marie-Claude] Univ Tours, F-37000 Tours, France; [Aldosari, Abdullah Al Farraj] King Saud Univ, Coll Dent, Dept Prosthet Dent Sci, Riyadh 12372, Saudi Arabia; [Ragunatha, Shivanna] ESIC Med Coll, Dept Dermatol Venereol & Leprosy, Bengaluru 560010, Karnataka, India; [Ragunatha, Shivanna] PGIMSR Rajajinagar, Bengaluru 560010, Karnataka, India; [Giampieri, Francesca; Battino, Maurizio] Univ Politecn Marche, Dept Clin Sci, I-60121 Ancona, Italy; [Cornillier, Helene] Univ Tours, CHU Tours, Serv Dermatol, F-37000 Tours, France; [Lorette, Gerard] Univ Tours, INRA, UMR 1282, Lab Virol & Immunol Mol, F-37000 Tours, France; [Stephan, Jean-Louis] CHU St Etienne, Serv Hematol Immunol & Rhumatol Pediat, St Priest En Jarez, France; [Goizet, Cyril] Pellegrin Hosp, MRGM Lab, INSERM, U1211,Rare Dis Genet & Metab, F-33000 Bordeaux, France; [Goizet, Cyril] Univ Bordeaux, F-33000 Bordeaux, France; [Jenne, Dieter E.] German Ctr Lung Res DZL, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Jenne, Dieter E.] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Kettritz, Ralph] Charite, Med Dept, Div Nephrol & Intens Care Med, D-10117 Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Birmingham; Fahrenheit Universities; University of Gdansk; Goethe University Frankfurt; Szeged University; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; King Saud University; Marche Polytechnic University; CHU Tours; Universite de Tours; INRAE; Universite de Tours; CHU de St Etienne; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Korkmaz, B (corresponding author), Univ Tours, INSERM, U1100, CEPR,Fac Med, 10 Bld, F-37032 Tours, France.	brice.korkmaz@inserm.fr	GOIZET, Cyril/M-4576-2014; Giampieri, Francesca/I-1911-2015; Chapple, Iain L C/T-2986-2017; Hirschfeld, Josefine/AAD-3604-2022; Nagy, Nikoletta/AAJ-6631-2020; Battino, Maurizio/E-6103-2012; Lesner, Adam/M-2732-2019; Jenne, Dieter Erich/AAP-1414-2020; Shivanna, Ragunatha/ABD-6583-2021	GOIZET, Cyril/0000-0002-1913-889X; Giampieri, Francesca/0000-0002-8151-9132; Chapple, Iain L C/0000-0003-2697-7082; Hirschfeld, Josefine/0000-0001-8512-7411; Nagy, Nikoletta/0000-0001-8576-7953; Battino, Maurizio/0000-0002-7250-1782; Shivanna, Ragunatha/0000-0002-9774-1272; KORKMAZ, BRICE/0000-0002-5159-8706; Kettritz, Ralph/0000-0001-5821-6718; Soliman, Hala/0000-0001-8783-9869; Abouzaid, Maha/0000-0002-9986-425X; marchand-adam, sylvain/0000-0002-9522-3738; Seren, Seda/0000-0002-7263-485X; Jerke, Uwe/0000-0001-6887-8010; Lesner, Adam/0000-0001-8335-3431	European Union's Horizon 2020 research and innovation program [668036]; "Ministere de l'Enseignement Superieur et de la Recherche," the "Region Centre-Val de Loire" (Project BPCO-Lyse); "Alexandre von Humboldt Foundation" (2016, Comprehensive Pneumology Center, Munich)	European Union's Horizon 2020 research and innovation program; "Ministere de l'Enseignement Superieur et de la Recherche," the "Region Centre-Val de Loire" (Project BPCO-Lyse); "Alexandre von Humboldt Foundation" (2016, Comprehensive Pneumology Center, Munich)	This work was supported by the "Ministere de l'Enseignement Superieur et de la Recherche," the "Region Centre-Val de Loire" (Project BPCO-Lyse). This project has received funding from the European Union's Horizon 2020 research and innovation program under Grant Agreement 668036 (RELENT). The authors declare that they have no conflicts of interest with the contents of this article. Responsibility for the information and views set out in this article lies entirely with the authors.; Recipient of a short-term institutional research training grant from the "Alexandre von Humboldt Foundation" (2016, Comprehensive Pneumology Center, Munich).	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Attucci S, 2002, BIOCHEM J, V366, P965, DOI 10.1042/BJ20020321; Bullon P, 2014, J EUR ACAD DERMATOL, V28, P1049, DOI 10.1111/jdv.12265; Bullon P, 2018, J ALLERGY CLIN IMMUN, V142, P1131, DOI 10.1016/j.jaci.2018.01.018; Campbell EJ, 2000, J IMMUNOL, V165, P3366, DOI 10.4049/jimmunol.165.6.3366; Chaigne B, 2016, PRESSE MED, V45, pE171, DOI 10.1016/j.lpm.2016.05.003; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Essawi M, 1997, DIS MARKERS, V13, P99; Eulenberg-Gustavus C, 2017, J EXP MED, V214, P2089, DOI 10.1084/jem.20161093; Goldmann WH, 1999, EUR J BIOCHEM, V261, P155, DOI 10.1046/j.1432-1327.1999.00259.x; GORLIN RJ, 1964, J PEDIATR-US, V65, P895, DOI 10.1016/S0022-3476(64)80014-7; GREENE LJ, 1963, J BIOL CHEM, V238, P2054; Guarino C, 2017, BIOCHEM PHARMACOL, V131, P52, DOI 10.1016/j.bcp.2017.02.009; Guarino C, 2014, J BIOL CHEM, V289, P31777, DOI 10.1074/jbc.M114.591339; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hamon Y, 2016, J BIOL CHEM, V291, P8486, DOI 10.1074/jbc.M115.707109; Hamon Y, 2016, FEBS J, V283, P498, DOI 10.1111/febs.13605; Hart T C, 1994, Periodontol 2000, V6, P88, DOI 10.1111/j.1600-0757.1994.tb00029.x; Hart TC, 1999, J MED GENET, V36, P881; Hinkofer LC, 2013, J BIOL CHEM, V288, P26635, DOI 10.1074/jbc.M113.495770; Hong Y, 2012, J AM SOC NEPHROL, V23, P49, DOI 10.1681/ASN.2011030298; Jenne DE, 2006, CLIN NEPHROL, V66, P153; JENNE DE, 1990, NATURE, V346, P520, DOI 10.1038/346520a0; Jerke U, 2015, KIDNEY INT, V88, P764, DOI 10.1038/ki.2015.159; Kallenberg CGM, 2015, CLIN EXP RHEUMATOL, V33, pS11; Kantari C, 2011, J LEUKOCYTE BIOL, V90, P941, DOI 10.1189/jlb.1210695; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kettritz R, 2012, CLIN EXP IMMUNOL, V169, P220, DOI 10.1111/j.1365-2249.2012.04615.x; Kettritz R, 2016, IMMUNOL REV, V273, P232, DOI 10.1111/imr.12441; Korkmaz B, 2005, AM J RESP CELL MOL, V32, P553, DOI 10.1165/rcmb.2004-0374OC; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; Korkmaz B, 2018, PHARMACOL THERAPEUT, V190, P202, DOI 10.1016/j.pharmthera.2018.05.011; Korkmaz B, 2016, PHARMACOL REV, V68, P603, DOI 10.1124/pr.115.012104; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; Legowska M, 2016, ARCH BIOCHEM BIOPHYS, V612, P91, DOI 10.1016/j.abb.2016.10.007; Martin KR, 2016, J BIOL CHEM, V291, P10476, DOI 10.1074/jbc.M115.698639; Martinho S, 2017, ARCH PEDIATRIE, V24, P360, DOI 10.1016/j.arcped.2017.01.013; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Millet A, 2013, ANN RHEUM DIS, V72, P1273, DOI 10.1136/annrheumdis-2013-203255; Molgaard A, 2007, BIOCHEM J, V401, P645, DOI 10.1042/BJ20061389; Nagy N, 2014, MOL GENET GENOM MED, V2, P217, DOI 10.1002/mgg3.61; Noack B, 2008, J CLIN PERIODONTOL, V35, P311, DOI 10.1111/j.1600-051X.2008.01201.x; Pagnoux C, 2016, EUR J RHEUMATOL, V3, P122, DOI 10.5152/eurjrheum.2015.0043; Perera NC, 2013, J IMMUNOL, V191, P2700, DOI 10.4049/jimmunol.1301293; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Ragunatha S, 2015, PEDIATR DERMATOL, V32, P292, DOI 10.1111/pde.12357; Roberts H, 2016, J LEUKOCYTE BIOL, V100, P433, DOI 10.1189/jlb.5A1015-489R; Schacher B, 2006, J CLIN PERIODONTOL, V33, P829, DOI 10.1111/j.1600-051X.2006.00992.x; Schonermarck U, 2015, NEPHROL DIAL TRANSPL, V30, pi46, DOI 10.1093/ndt/gfu398; Schreiber A, 2005, J AM SOC NEPHROL, V16, P2216, DOI 10.1681/ASN.2004070609; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Schreiber A, 2017, P NATL ACAD SCI USA, V114, pE9618, DOI 10.1073/pnas.1708247114; Selvaraju Veeriah, 2003, BMC Med Genet, V4, P5, DOI 10.1186/1471-2350-4-5; Soliman H., 2015, EGYPTIAN J MED HUMAN, V16, P239, DOI [10.1016/j.ejmhg.2015.03.002, DOI 10.1016/J.EJMHG.2015.03.002]; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Thieblemont N, 2016, SEMIN IMMUNOL, V28, P159, DOI 10.1016/j.smim.2016.03.004; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Yates M, 2017, CLIN MED, V17, P60, DOI 10.7861/clinmedicine.17-1-60	61	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12415	12428		10.1074/jbc.RA118.001922	http://dx.doi.org/10.1074/jbc.RA118.001922			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29925593	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000441408500009
J	Bertalovitz, AC; Badhey, MLO; McDonald, TV				Bertalovitz, Alexander C.; Badhey, Marika L. Osterbur; McDonald, Thomas, V			Synonymous nucleotide modification of the KCNH2 gene affects both mRNA characteristics and translation of the encoded hERG ion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genetic polymorphism; genetic disease; potassium channel; protein synthesis; mRNA; transcription; translation; hERG	LONG-QT-SYNDROME; POTASSIUM CHANNEL; CIRCULAR-DICHROISM; QUALITY-CONTROL; SECONDARY STRUCTURE; CODON OPTIMALITY; CLICK CHEMISTRY; EMBL-EBI; TRAFFICKING; DECAY	Synonymous nucleotide variation is increasingly recognized as a factor than can affect protein expression, but the underlying mechanisms are incompletely understood. Here, we investigated whether synonymous changes could affect expression of the potassium voltage-gated channel subfamily H member 2 (KCNH2) gene, encoding the human ether-a-go-go-related gene (hERG) ion channel, which is linked to hereditary cardiac arrhythmia. We examined a previously described synthetic version (hERG-codon modified (CM)) with synonymous substitutions designed to reduce GC content, rare codons, and mRNA secondary structure relative to the native construct (hERG-NT). hERG-CM exhibited lower protein expression than hERG-NT in HEK293T cells. We found that the steady-state abundance of hERG-NT mRNA was greater than hERG-CM because of an enhanced transcription rate and increased mRNA stability for hERG-NT. Translation of hERG-CM was independently reduced, contributing to the overall greater synthesis of hERG-NT channel protein. This was partially offset, however, by a higher aggregation of a newly synthesized hERG-NT channel, resulting in nonfunctional protein. Regional mRNA analyses of chimeras of hERG-NT and hERG-CM revealed that synonymous changes in the 5 segments of the coding region had the greatest influence on hERG synthesis at both the mRNA and protein levels. Taken together, these results indicate that synonymous nucleotide variations within the coding region, particularly in the 5 region of the hERG mRNA, can affect both transcription and translation. These findings support the notion that greater attention should be given to the effects of synonymous genetic variation when analyzing hERG DNA sequences in the study of hereditary cardiac disease.	[Bertalovitz, Alexander C.; Badhey, Marika L. Osterbur; McDonald, Thomas, V] Albert Einstein Coll Med, Dept Mol Pharmacol, Dept Med, Div Cardiol, Bronx, NY 10461 USA; [Bertalovitz, Alexander C.; McDonald, Thomas, V] Univ S Florida, Morsani Coll Med, Dept Cardiovasc Sci, Tampa, FL 33612 USA	Yeshiva University; Albert Einstein College of Medicine; State University System of Florida; University of South Florida	McDonald, TV (corresponding author), Univ S Florida, Morsani Coll Med, Dept Cardiovasc Sci, Tampa, FL 33612 USA.	thomasmcdonald@health.usf.edu		McDonald, Thomas/0000-0002-6075-0888	National Institutes of Health from NHLBI [R01HL118437, F30HL126283]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL126283, R01HL118437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL118437 and F30HL126283 from NHLBI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badhey MLO, 2017, J CARDIOVASC ELECTR, V28, P1070, DOI 10.1111/jce.13259; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Foo B, 2016, J PHYSIOL-LONDON, V594, P2469, DOI 10.1113/JP270531; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASHIZUME H, 1967, J BIOCHEM, V61, P738, DOI 10.1093/oxfordjournals.jbchem.a128608; Huch S, 2014, WIRES RNA, V5, P747, DOI 10.1002/wrna.1244; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; JOHNSON WC, 1972, BIOPOLYMERS, V11, P225, DOI 10.1002/bip.1972.360110117; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller SH, 2005, CELL BIOCHEM BIOPHYS, V43, P365, DOI 10.1385/CBB:43:3:365; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lamothe SM, 2018, FASEB J, V32, P1933, DOI 10.1096/fj.201700832R; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Manganas LN, 2001, J BIOL CHEM, V276, P49427, DOI 10.1074/jbc.M109325200; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miller MR, 2009, NAT METHODS, V6, P439, DOI [10.1038/nmeth.1329, 10.1038/NMETH.1329]; Moric-Janiszewska E, 2012, CARDIOL J, V19, P159, DOI 10.5603/CJ.2012.0028; Newman ZR, 2016, P NATL ACAD SCI USA, V113, pE1362, DOI 10.1073/pnas.1518976113; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; PURVIS IJ, 1987, J MOL BIOL, V193, P413, DOI 10.1016/0022-2836(87)90230-0; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Radhakrishnan A, 2016, J MOL BIOL, V428, P3558, DOI 10.1016/j.jmb.2016.05.025; Roy B, 2013, TRENDS GENET, V29, P691, DOI 10.1016/j.tig.2013.09.002; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simms CL, 2017, MOL CELL, V68, P361, DOI 10.1016/j.molcel.2017.08.019; Simms CL, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1366; Smith JL, 2013, AM J PHYSIOL-CELL PH, V305, pC919, DOI 10.1152/ajpcell.00406.2012; Sroubek J, 2013, FASEB J, V27, P3039, DOI 10.1096/fj.12-227009; Tester David J, 2014, Methodist Debakey Cardiovasc J, V10, P29; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Trudeau MC, 1996, SCIENCE, V272, P1087; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tuller T, 2015, NUCLEIC ACIDS RES, V43, P13, DOI 10.1093/nar/gku1313; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Um SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000933; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang SR, 2008, BIOORG MED CHEM LETT, V18, P6505, DOI 10.1016/j.bmcl.2008.10.047; WILLIAMS AL, 1986, NUCLEIC ACIDS RES, V14, P6649, DOI 10.1093/nar/14.16.6649; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001; Zamft B, 2012, P NATL ACAD SCI USA, V109, P8948, DOI 10.1073/pnas.1205063109; Zhou T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048541; Zhou ZP, 2018, ELIFE, V7, DOI [10.7554/eLife.33569.001, 10.7554/eLife.33569]	60	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12120	12136		10.1074/jbc.RA118.001805	http://dx.doi.org/10.1074/jbc.RA118.001805			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29907571	Green Published, hybrid			2022-12-28	WOS:000440803200012
J	Bourgoint, C; Rispal, D; Berti, M; Filipuzzi, I; Helliwell, SB; Prouteau, M; Loewith, R				Bourgoint, Clelia; Rispal, Delphine; Berti, Marina; Filipuzzi, Ireos; Helliwell, Stephen B.; Prouteau, Manoel; Loewith, Robbie			Target of rapamycin complex 2-dependent phosphorylation of the coat protein Pan1 by Akl1 controls endocytosis dynamics in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						target of rapamycin (TOR); signal transduction; endocytosis; actin; membrane function; aminophospholipid flippase; Ark1; Prk1 family; Fpk1; in vitro kinase assay; Pan1	SERINE/THREONINE KINASE PRK1P; REGULATES ACTIN POLARIZATION; CELL-GROWTH CONTROL; PLASMA-MEMBRANE; PHOSPHOLIPID TRANSLOCATION; SIGNALING PATHWAY; BUDDING YEAST; CYTOSKELETON; TOR2; FLIPPASES	Target of rapamycin complex 2 (TORC2) is a widely conserved serine/threonine protein kinase. In the yeast Saccharomyces cerevisiae, TORC2 is essential, playing a key role in plasma membrane homeostasis. In this role, TORC2 regulates diverse processes, including sphingolipid synthesis, glycerol production and efflux, polarization of the actin cytoskeleton, and endocytosis. The major direct substrate of TORC2 is the AGC-family kinase Ypk1. Ypk1 connects TORC2 signaling to actin polarization and to endocytosis via the flippase kinases Fpk1 and Fpk2. Here, we report that Fpk1 mediates TORC2 signaling to control actin polarization, but not endocytosis, via aminophospholipid flippases. To search for specific targets of these flippase kinases, we exploited the fact that Fpk1 prefers to phosphorylate Ser residues within the sequence RXS(L/Y)(D/E), which is present approximate to 90 times in the yeast proteome. We observed that 25 of these sequences are phosphorylated by Fpk1 in vitro. We focused on one sequence hit, the Ark/Prk-family kinase Akl1, as this kinase previously has been implicated in endocytosis. Using a potent ATP-competitive small molecule, CMB4563, to preferentially inhibit TORC2, we found that Fpk1-mediated Akl1 phosphorylation inhibits Akl1 activity, which, in turn, reduces phosphorylation of Pan1 and of other endocytic coat proteins and ultimately contributes to a slowing of endocytosis kinetics. These results indicate that the regulation of actin polarization and endocytosis downstream of TORC2 is signaled through separate pathways that bifurcate at the level of the flippase kinases.	[Bourgoint, Clelia; Rispal, Delphine; Berti, Marina; Prouteau, Manoel; Loewith, Robbie] Univ Geneva, Dept Mol Biol, Natl Ctr Competence Res Chem Biol, CH-1211 Geneva, Switzerland; [Bourgoint, Clelia; Rispal, Delphine; Berti, Marina; Prouteau, Manoel; Loewith, Robbie] Univ Geneva, Inst Genet & Genom Geneva iGE3, Natl Ctr Competence Res Chem Biol, CH-1211 Geneva, Switzerland; [Filipuzzi, Ireos; Helliwell, Stephen B.] Novartis Inst Biomed Res, Novartis Campus, CH-4056 Basel, Switzerland	University of Geneva; University of Geneva; Novartis	Prouteau, M (corresponding author), Univ Geneva, Dept Mol Biol, Sci 3 2041, CH-1211 Geneva, Switzerland.; Loewith, R (corresponding author), Univ Geneva, Dept Mol Biol, Sci 3 2045b, CH-1211 Geneva, Switzerland.	manoel.prouteau@unige.ch; robbie.loewith@unige.ch			European Research Council (TORCH Grant); Swiss National Foundation [31003A_160023]; Canton of Geneva	European Research Council (TORCH Grant); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Canton of Geneva	Supported by the European Research Council (TORCH Grant), the Swiss National Foundation (Grant 31003A_160023), and the Canton of Geneva.	Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; Chi RJ, 2012, J CELL SCI, V125, P4728, DOI 10.1242/jcs.098871; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Das A, 2012, NAT CELL BIOL, V14, P304, DOI 10.1038/ncb2444; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Frohlich F, 2015, ELIFE, V4, DOI 10.7554/eLife.08712; Gaubitz C, 2015, MOL CELL, V58, P977, DOI 10.1016/j.molcel.2015.04.031; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goode BL, 2015, GENETICS, V199, P315, DOI 10.1534/genetics.112.145540; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Hatakeyama R, 2017, J CELL SCI, V130, P1169, DOI 10.1242/jcs.198382; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helliwell SB, 1998, GENETICS, V148, P99; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Niles BJ, 2014, MOL BIOL CELL, V25, P3962, DOI 10.1091/mbc.E14-06-1122; Noji T, 2006, BIOCHEM BIOPH RES CO, V344, P323, DOI 10.1016/j.bbrc.2006.03.095; Riggi M., 2018, NAT CELL BIOL; Rispal D, 2015, J BIOL CHEM, V290, P14963, DOI 10.1074/jbc.M114.627794; Roelants FM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00627-16; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Smythe E, 2003, EMBO REP, V4, P246, DOI 10.1038/sj.embor.embor776; Vlahakis A, 2016, J CELL BIOL, V215, P779, DOI 10.1083/jcb.201605030; Vlahakis A, 2014, AUTOPHAGY, V10, P2085, DOI 10.4161/auto.36262; Vlahakis A, 2014, P NATL ACAD SCI USA, V111, P10586, DOI 10.1073/pnas.1406305111; Watson HA, 2001, MOL BIOL CELL, V12, P3668, DOI 10.1091/mbc.12.11.3668; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759; Zeng GS, 1999, J CELL BIOL, V144, P71, DOI 10.1083/jcb.144.1.71	46	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12043	12053		10.1074/jbc.RA117.001615	http://dx.doi.org/10.1074/jbc.RA117.001615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29895620	hybrid, Green Published			2022-12-28	WOS:000440803200006
J	Patel, S; Barkell, AM; Gupta, D; Strong, SL; Bruton, S; Muskett, FW; Addis, PW; Renshaw, PS; Slocombe, PM; Doyle, C; Clargo, A; Taylor, RJ; Prosser, CE; Henry, AJ; Robinson, MK; Waters, LC; Holdsworth, G; Carr, MD				Patel, Saleha; Barkell, Alice M.; Gupta, Deepti; Strong, Sarah L.; Bruton, Shaun; Muskett, Frederick W.; Addis, Philip W.; Renshaw, Philip S.; Slocombe, Patrick M.; Doyle, Carl; Clargo, Alison; Taylor, Richard J.; Prosser, Christine E.; Henry, Alistair J.; Robinson, Martyn K.; Waters, Lorna C.; Holdsworth, Gill; Carr, Mark D.			Structural and functional analysis of Dickkopf 4 (Dkk4): New insights into Dkk evolution and regulation of Wnt signaling by Dkk and Kremen proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cooperativity; nuclear magnetic resonance (NMR); Wnt signaling; cell surface receptor; structural biology; protein structure; protein-protein interaction; Dkk4; Kremen1; LRP6	TORSION ANGLE DYNAMICS; NMR CHEMICAL-SHIFTS; N-TERMINAL DOMAIN; SECONDARY-STRUCTURE; TISSUE INHIBITOR; MATRIX-METALLOPROTEINASE; COMPLEX-FORMATION; LRP6; BINDING; FAMILY	Dickkopf (Dkk) family proteins are important regulators of Wnt signaling pathways, which play key roles in many essential biological processes. Here, we report the first detailed structural and dynamics study of a full-length mature Dkk protein (Dkk4, residues 19-224), including determination of the first atomic-resolution structure for the N-terminal cysteine-rich domain (CRD1) conserved among Dkk proteins. We discovered that CRD1 has significant structural homology to the Dkk C-terminal cysteine-rich domain (CRD2), pointing to multiple gene duplication events during Dkk family evolution. We also show that Dkk4 consists of two independent folded domains (CRD1 and CRD2) joined by a highly flexible, nonstructured linker. Similarly, the N-terminal region preceding CRD1 and containing a highly conserved NXI(R/K) sequence motif was shown to be dynamic and highly flexible. We demonstrate that Dkk4 CRD2 mediates high-affinity binding to both the E1E2 region of low-density lipoprotein receptor-related protein 6 (LRP6 E1E2) and the Kremen1 (Krm1) extracellular domain. In contrast, the N-terminal region alone bound with only moderate affinity to LRP6 E1E2, consistent with binding via the conserved NXI(R/K) motif, but did not interact with Krm proteins. We also confirmed that Dkk and Krm family proteins function synergistically to inhibit Wnt signaling. Insights provided by our integrated structural, dynamics, interaction, and functional studies have allowed us to refine the model of synergistic regulation of Wnt signaling by Dkk proteins. Our results indicate the potential for the formation of a diverse range of ternary complexes comprising Dkk, Krm, and LRP5/6 proteins, allowing fine-tuning of Wnt-dependent signaling.	[Patel, Saleha; Barkell, Alice M.; Strong, Sarah L.; Bruton, Shaun; Muskett, Frederick W.; Addis, Philip W.; Renshaw, Philip S.; Prosser, Christine E.; Waters, Lorna C.; Carr, Mark D.] Univ Leicester, Leicester Inst Struct & Chem Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England; [Patel, Saleha; Barkell, Alice M.; Strong, Sarah L.; Bruton, Shaun; Muskett, Frederick W.; Addis, Philip W.; Renshaw, Philip S.; Waters, Lorna C.; Carr, Mark D.] Univ Leicester, Dept Mol & Cell Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England; [Gupta, Deepti; Slocombe, Patrick M.; Doyle, Carl; Clargo, Alison; Taylor, Richard J.; Prosser, Christine E.; Henry, Alistair J.; Robinson, Martyn K.; Holdsworth, Gill] UCB, 208 Bath Rd, Slough SL1 3WE, Berks, England	University of Leicester; University of Leicester; UCB Pharma SA	Waters, LC; Carr, MD (corresponding author), Univ Leicester, Leicester Inst Struct & Chem Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England.; Holdsworth, G (corresponding author), 208 Bath Rd, Slough SL1 3WE, Berks, England.	lw83@le.ac.uk; gill.holdsworth@ucb.com; mdc12@le.ac.uk	Renshaw, Perry/O-1384-2018	Carr, Mark/0000-0002-3939-0996; Addis, Philip/0000-0003-1185-651X	CASE Ph.D. studentships from the Biotechnology and Biological Sciences Research Council (BBSRC); UCB; MRC [MC_U117533887] Funding Source: UKRI	CASE Ph.D. studentships from the Biotechnology and Biological Sciences Research Council (BBSRC); UCB(UCB Pharma SA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by CASE Ph.D. studentships from the Biotechnology and Biological Sciences Research Council (BBSRC) in partnership with UCB.	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Aravind L, 1998, CURR BIOL, V8, pR477, DOI 10.1016/S0960-9822(98)70309-4; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barkell AM, 2015, BIOMOL NMR ASSIGN, V9, P147, DOI 10.1007/s12104-014-9562-2; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Broadhurst RW, 1995, BIOCHEMISTRY-US, V34, P16608, DOI 10.1021/bi00051a008; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P405, DOI 10.1016/B978-012164491-8/50008-7; Chen LJ, 2008, J BIOL CHEM, V283, P23364, DOI 10.1074/jbc.M802375200; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Chouhan S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27558; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hafsa NE, 2015, NUCLEIC ACIDS RES, V43, pW370, DOI 10.1093/nar/gkv494; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holdsworth G, 2012, J BIOL CHEM, V287, P26464, DOI 10.1074/jbc.M112.350108; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mishra SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052190; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Sima J, 2016, DEVELOPMENT, V143, P4723, DOI 10.1242/dev.143909; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Sun SJ, 2015, J BIOMOL NMR, V62, P105, DOI 10.1007/s10858-015-9923-x; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Zebisch M, 2016, STRUCTURE, V24, P1599, DOI 10.1016/j.str.2016.06.020; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	44	14	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12149	12166		10.1074/jbc.RA118.002918	http://dx.doi.org/10.1074/jbc.RA118.002918			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29925589	Green Published, hybrid			2022-12-28	WOS:000440803200014
J	Pan, YC; Zhu, Y; Yang, W; Tycksen, E; Liu, SP; Palucki, J; Zhu, LJ; Sasaki, Y; Sharma, MK; Kim, AH; Zhang, B; Yano, H				Pan, Yanchun; Zhu, Ying; Yang, Wei; Tycksen, Eric; Liu, Shaopeng; Palucki, John; Zhu, Linjian; Sasaki, Yo; Sharma, Mukesh K.; Kim, Albert H.; Zhang, Bo; Yano, Hiroko			The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; DNA METHYLATION; GENE-EXPRESSION; MOUSE MODEL; BDNF GENE; CORTICOSTRIATAL PATHWAY; MOLECULAR PATHOGENESIS; DISEASE PHENOTYPES; TRANSGENIC MICE; PROTEIN	Huntington's disease (HD) is a fatal neurodegenerative disorder caused by an abnormal expansion of polyglutamine repeats in the huntingtin protein (Htt). Transcriptional dysregulation is an early event in the course of HD progression and is thought to contribute to disease pathogenesis, but how mutant Htt causes transcriptional alterations and subsequent cell death in neurons is not well understood. RNA-Seq analysis revealed that expression of a mutant Htt fragment in primary cortical neurons leads to robust gene expression changes before neuronal death. Basic helix-loop-helix transcription factor Twist1, which is essential for embryogenesis and is normally expressed at low levels in mature neurons, was substantially up-regulated in mutant Htt-expressing neurons in culture and in the brains of HD mouse models. Knockdown of Twist1 by RNAi in mutant Htt-expressing primary cortical neurons reversed the altered expression of a subset of genes involved in neuronal function and, importantly, abrogated neurotoxicity. Using brain-derived neurotrophic factor (Bdnf), which is known to be involved in HD pathogenesis, as a model gene, we found that Twist1 knockdown could reverse mutant Htt-induced DNA hypermethylation at the Bdnf regulatory region and reactivate Bdnf expression. Together, these results suggest that Twist1 is an important upstream mediator of mutant Htt-induced neuronal death and may in part operate through epigenetic mechanisms.	[Pan, Yanchun; Zhu, Ying; Palucki, John; Zhu, Linjian; Kim, Albert H.; Yano, Hiroko] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA; [Yang, Wei; Tycksen, Eric] Washington Univ, Sch Med, Genome Technol Access Ctr, St Louis, MO 63110 USA; [Yang, Wei; Sasaki, Yo; Kim, Albert H.; Yano, Hiroko] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Liu, Shaopeng; Kim, Albert H.; Zhang, Bo] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Sharma, Mukesh K.] Washington Univ, Sch Med, Ctr Biomed Informat, St Louis, MO 63110 USA; [Kim, Albert H.; Zhang, Bo; Yano, Hiroko] Washington Univ, Sch Med, Ctr Regenerat Med, St Louis, MO 63110 USA; [Kim, Albert H.; Yano, Hiroko] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Kim, Albert H.; Yano, Hiroko] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Yano, H (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg Neurol & Genet, St Louis, MO 63110 USA.	yanoh@wustl.edu	Yang, Wei/H-4749-2019; Kim, Albert H./HGF-0057-2022; Zhang, Bo/A-6874-2011	Yang, Wei/0000-0001-8162-033X; Tycksen, Eric/0000-0001-6362-0141; Zhang, Bo/0000-0003-2962-5314	National Institutes of Health [K01 AG033724, R21 NS096603, R01 NS094670]; McDonnell Center for Cellular and Molecular Neurobiology at Washington University; Hope Center for Neurological Disorders at Washington University; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS096603, R01NS094670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG033724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Cellular and Molecular Neurobiology at Washington University; Hope Center for Neurological Disorders at Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants K01 AG033724 (to H. Y.), R21 NS096603 (to H. Y.), R01 NS094670 (to A. H. K.), the McDonnell Center for Cellular and Molecular Neurobiology at Washington University, and the Hope Center for Neurological Disorders at Washington University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Apostol BL, 2008, MOL CELL NEUROSCI, V39, P8, DOI 10.1016/j.mcn.2008.04.007; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bouard C, 2016, NUCLEIC ACIDS RES, V44, P5470, DOI 10.1093/nar/gkw334; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Castanon I, 2001, DEVELOPMENT, V128, P3145; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chen EY, 2012, BIOINFORMATICS, V28, P105, DOI 10.1093/bioinformatics/btr625; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deshmukh H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-57; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dobrian Anca D, 2012, Front Endocrinol (Lausanne), V3, P108, DOI 10.3389/fendo.2012.00108; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Gujar AD, 2016, P NATL ACAD SCI USA, V113, pE8247, DOI 10.1073/pnas.1610921114; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ikegame T, 2013, J HUM GENET, V58, P434, DOI 10.1038/jhg.2013.65; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Kim Sangjune, 2014, Exp Neurobiol, V23, P36, DOI 10.5607/en.2014.23.1.36; Labadorf A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143563; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McFarland KN, 2013, J HUNTINGTONS DIS, V2, P263, DOI 10.3233/JHD-130066; McFarland KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041423; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Ng CW, 2013, P NATL ACAD SCI USA, V110, P2354, DOI 10.1073/pnas.1221292110; O'Rourke MP, 2002, INT J DEV BIOL, V46, P401; Pan YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31022; Podtelezhnikov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029610; Porcher C, 2017, BLOOD, V129, P2051, DOI 10.1182/blood-2016-12-754051; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Seredenina T, 2012, NEUROBIOL DIS, V45, P83, DOI 10.1016/j.nbd.2011.07.001; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Valor LM, 2013, J NEUROSCI, V33, P10471, DOI 10.1523/JNEUROSCI.0670-13.2013; Vashishtha M, 2013, P NATL ACAD SCI USA, V110, pE3027, DOI 10.1073/pnas.1311323110; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Villar-Menendez I, 2013, NEUROMOL MED, V15, P295, DOI 10.1007/s12017-013-8219-0; von Schimmelmann M, 2016, NAT NEUROSCI, V19, P1321, DOI 10.1038/nn.4360; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang FL, 2013, HUM MOL GENET, V22, P3641, DOI 10.1093/hmg/ddt214; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yano H, 2014, NAT NEUROSCI, V17, P822, DOI 10.1038/nn.3721; Zhao X, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.16; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	81	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11850	11866		10.1074/jbc.RA117.001211	http://dx.doi.org/10.1074/jbc.RA117.001211			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29891550	Green Published, hybrid			2022-12-28	WOS:000440134500018
J	Rijal, D; Ariana, A; Wight, A; Kim, K; Alturki, NA; Aamir, Z; Ametepe, ES; Korneluk, RG; Tiedje, C; Menon, MB; Gaestel, M; McComb, S; Sad, S				Rijal, Dikchha; Ariana, Ardeshir; Wight, Andrew; Kim, Kwangsin; Alturki, Norah A.; Aamir, Zoya; Ametepe, Emmanuelle S.; Korneluk, Robert G.; Tiedje, Christopher; Menon, Manoj B.; Gaestel, Matthias; McComb, Scott; Sad, Subash			Differentiated macrophages acquire a pro-inflammatory and cell death-resistant phenotype due to increasing XIAP and p38-mediated inhibition of RipK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MARROW-DERIVED MACROPHAGES; TNF-ALPHA; ACTIVATION; KINASE; NECROPTOSIS; APOPTOSIS; CANCER; CIAP1; RIPOPTOSOME	Monocytes differentiate into macrophages, which deactivate invading pathogens. Macrophages can be resistant to cell death mechanisms in some situations, and the mechanisms involved are not clear. Here, using mouse immune cells, we investigated whether the differentiation of macrophages affects their susceptibility to cell death by the ripoptosome/necrosome pathways. We show that treatment of macrophages with a mimetic of second mitochondrial activator of caspases (SMAC) resulted in ripoptosome-driven cell death that specifically depended on tumor necrosis factor (TNF alpha) expression and the receptor-interacting serine/threonine protein kinase 1 (RipK1)-RipK3-caspase-8 interaction in activated and cycling macrophages. Differentiation of macrophages increased the expression of pro-inflammatory cytokines but reduced RipK1-dependent cell death and the RipK3-caspase-8 interaction. The expression of the anti-apoptotic mediators, X-linked inhibitor of apoptosis protein (XIAP) and caspase-like apoptosis regulatory protein (cFLIP(L)), also increased in differentiated macrophages, which inhibited caspase activation. The resistance to cell death was abrogated in XIAP-deficient macrophages. However, even in the presence of increased XIAP expression, inhibition of the mitogen-activated protein kinase (MAPK) p38 and MAPK-activated protein kinase 2 (MK2) made differentiated macrophages susceptible to cell death. These results suggest that the p38/MK2 pathway overrides apoptosis inhibition by XIAP and that acquisition of resistance to cell death by increased expression of XIAP and cFLIP(L) may allow inflammatory macrophages to participate in pathogen control for a longer duration.	[Rijal, Dikchha; Ariana, Ardeshir; Wight, Andrew; Kim, Kwangsin; Alturki, Norah A.; Aamir, Zoya; Ametepe, Emmanuelle S.; Sad, Subash] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M8, Canada; [Korneluk, Robert G.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 5B2, Canada; [Tiedje, Christopher; Menon, Manoj B.; Gaestel, Matthias] Hannover Med Sch, Inst Cell Biochem, D-30625 Hannover, Germany; [Tiedje, Christopher] Univ Copenhagen, Dept Cellular & Mol Med, DK-1165 Copenhagen, Denmark; [McComb, Scott] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Ottawa, ON K1A 0R6, Canada; [Sad, Subash] uOttawa Ctr Infect Immun & Inflammat, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Hannover Medical School; University of Copenhagen; National Research Council Canada	Sad, S (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M8, Canada.	subash.sad@uottawa.ca	Gaestel, Matthias/A-6560-2013; Menon, Manoj B./P-1543-2015	Gaestel, Matthias/0000-0002-4944-4652; Menon, Manoj B./0000-0001-5859-0347; Tiedje, Christopher/0000-0002-3013-6967; Wight, Andrew/0000-0003-3116-8722; Ariana, Ardeshir/0000-0003-2206-9829; Sad, Subash/0000-0002-2462-7137; alturki, Norah/0000-0003-0608-4797	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Beug ST, 2012, TRENDS IMMUNOL, V33, P535, DOI 10.1016/j.it.2012.06.004; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Chamberlain LM, 2015, J BIOMED MATER RES A, V103, P2864, DOI 10.1002/jbm.a.35415; Chavez-Valdez R, 2012, NEUROSCIENCE, V219, P192, DOI 10.1016/j.neuroscience.2012.05.002; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dondelinger Y, 2017, NAT CELL BIOL, V19, P1237, DOI 10.1038/ncb3608; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jaco I, 2017, MOL CELL, V66, P698, DOI 10.1016/j.molcel.2017.05.003; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Krepler C, 2013, CLIN CANCER RES, V19, P1784, DOI 10.1158/1078-0432.CCR-12-2518; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lalaoui N, 2016, CANCER CELL, V29, P145, DOI 10.1016/j.ccell.2016.01.006; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Marsh RA, 2010, BLOOD, V116, P1079, DOI 10.1182/blood-2010-01-256099; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; McComb S, 2014, J IMMUNOL, V192, P5671, DOI 10.4049/jimmunol.1303380; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Muller-Sienerth N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021556; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; OBRIEN AD, 1982, CELL IMMUNOL, V67, P325, DOI 10.1016/0008-8749(82)90224-6; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Olayioye MA, 2005, CELL DEATH DIFFER, V12, P87, DOI 10.1038/sj.cdd.4401524; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; Schilling R, 2014, METHOD ENZYMOL, V545, P83, DOI 10.1016/B978-0-12-801430-1.00004-4; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shutinoski B, 2016, CELL DEATH DIFFER, V23, P1628, DOI 10.1038/cdd.2016.51; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Tabas I, 2007, CURR DRUG TARGETS, V8, P1288, DOI 10.2174/138945007783220623; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vogt G, 2011, J CLIN INVEST, V121, P3889, DOI 10.1172/JCI57235; WALKER EB, 1985, J LEUKOCYTE BIOL, V37, P121, DOI 10.1002/jlb.37.2.121; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WARREN MK, 1985, J IMMUNOL, V134, P982; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	73	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11913	11927		10.1074/jbc.RA118.003614	http://dx.doi.org/10.1074/jbc.RA118.003614			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29899110	Green Published, hybrid			2022-12-28	WOS:000440134500023
J	Cheng, L; Al-Owais, M; Covarrubias, ML; Koch, WJ; Manning, DR; Peers, C; Riobo-Del Galdo, NA				Cheng, Lan; Al-Owais, Moza; Covarrubias, Manuel L.; Koch, Walter J.; Manning, David. R.; Peers, Chris; Riobo-Del Galdo, Natalia A.			Coupling of Smoothened to inhibitory G proteins reduces voltage-gated K+ currents in cardiomyocytes and prolongs cardiac action potential duration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); heart; Hedgehog signaling pathway; cardiovascular; potassium channel; ion channel; action potential; arrhythmias; noncanonical; Smoothened	HEDGEHOG PATHWAY; ACTIVATION; CHANNELS; G(I)	SMO (Smoothened), the central transducer of Hedgehog signaling, is coupled to heterotrimeric G(i) proteins in many cell types, including cardiomyocytes. In this study, we report that activation of SMO with SHH (Sonic Hedgehog) or a small agonist, purmorphamine, rapidly causes a prolongation of the action potential duration that is sensitive to a SMO inhibitor. In contrast, neither of the SMO agonists prolonged the action potential in cardiomyocytes from transgenic G(i)CT/TTA mice, in which G(i) signaling is impaired, suggesting that the effect of SMO is mediated by G(i) proteins. Investigation of the mechanism underlying the change in action potential kinetics revealed that activation of SMO selectively reduces outward voltage-gated K+ repolarizing (Kv) currents in isolated cardiomyocytes and that it induces a down-regulation of membrane levels of Kv4.3 in cardiomyocytes and intact hearts from WT but not from GiCT/TTA mice. Moreover, perfusion of intact hearts with Shh or purmorphamine increased the ventricular repolarization time (QT interval) and induced ventricular arrhythmias. Our data constitute the first report that acute, noncanonical Hh signaling mediated by G(i) proteins regulates K+ currents density in cardiomyocytes and sensitizes the heart to the development of ventricular arrhythmias.	[Cheng, Lan; Riobo-Del Galdo, Natalia A.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Covarrubias, Manuel L.] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [Al-Owais, Moza; Peers, Chris] Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, Leeds LS2 9JT, W Yorkshire, England; [Riobo-Del Galdo, Natalia A.] Univ Leeds, Sch Med, Leeds Inst Canc & Pathol, Leeds LS2 9JT, W Yorkshire, England; [Koch, Walter J.] Temple Univ, Dept Pharmacol, Philadelphia, PA 19140 USA; [Koch, Walter J.] Temple Univ, Ctr Translat Med, Philadelphia, PA 19140 USA; [Manning, David. R.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA	Jefferson University; Jefferson University; University of Leeds; University of Leeds; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Riobo-Del Galdo, NA (corresponding author), Sch Mol & Cellular Biol, Miall Bldg,Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	n.a.riobo-delgaldo@leeds.ac.uk	Galdo, Natalia Riobo-Del/AAP-2938-2020	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; CHENG, LAN/0000-0002-3620-3366; Covarrubias, Manuel/0000-0002-0881-4143; Al-Owais, Moza/0000-0001-9122-7873	National Institutes of Health [2RO1GM080396]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant 2RO1GM080396 (to D. R. M. and N. R.- D. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belgacem YH, 2011, P NATL ACAD SCI USA, V108, P4482, DOI 10.1073/pnas.1018217108; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; Carbe CJ, 2014, AM J PHYSIOL-HEART C, V307, pH66, DOI 10.1152/ajpheart.00166.2014; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; Granados-Fuentes D, 2012, J NEUROSCI, V32, P10045, DOI 10.1523/JNEUROSCI.0174-12.2012; Karczewski P, 1997, BASIC RES CARDIOL, V92, P37, DOI 10.1007/BF00794066; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Lin L, 2010, MOL CELL NEUROSCI, V43, P315, DOI 10.1016/j.mcn.2009.12.005; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Martinez-Chinchilla P, 2008, METHOD ENZYMOL, V446, P189, DOI 10.1016/S0076-6879(08)01611-X; Nerbonne Jeanne M, 2016, Card Electrophysiol Clin, V8, P257, DOI 10.1016/j.ccep.2016.01.001; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Paulis L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07983; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Riobo NA, 2006, CELL CYCLE, V5, P1612, DOI 10.4161/cc.5.15.3130; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Swope David, 2012, Mol Cell Biol, V32, P1056, DOI 10.1128/MCB.06188-11; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Zhang YM, 2014, AM J PHYSIOL-HEART C, V306, pH1553, DOI 10.1152/ajpheart.00459.2013	29	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11022	11032		10.1074/jbc.RA118.001989	http://dx.doi.org/10.1074/jbc.RA118.001989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29802197	Green Published, hybrid			2022-12-28	WOS:000438882800015
J	Cheng, G; Zielonka, M; Dranka, B; Kumar, SN; Myers, CR; Bennett, B; Garces, AM; Machado, LGDD; Thiebaut, D; Ouari, O; Hardy, M; Zielonka, J; Kalyanaraman, B				Cheng, Gang; Zielonka, Monika; Dranka, Brian; Kumar, Suresh N.; Myers, Charles R.; Bennett, Brian; Garces, Alexander M.; Machado, Luiz Gabriel Dias Duarte; Thiebaut, David; Ouari, Olivier; Hardy, Micael; Zielonka, Jacek; Kalyanaraman, Balaraman			Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: Potentials, pitfalls, and the future	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; reactive oxygen species (ROS); electron paramagnetic resonance (EPR); peroxiredoxin; superoxide ion; low-temperature EPR; mitochondrial oxidants; radical scavengers; redox probes; thiol-specific antioxidant enzymes; bioenergetics	ELECTRON-PARAMAGNETIC-RESONANCE; DIAGNOSTIC MARKER PRODUCTS; IMAGING HYDROGEN-PEROXIDE; OXIDATIVE STRESS; IN-VIVO; FLUORESCENT-PROBE; NADPH OXIDASE; INTRACELLULAR SUPEROXIDE; CATIONIC ANTIOXIDANTS; ROS GENERATION	Reactive oxygen and nitrogen species (ROS/RNS) such as superoxide (O), hydrogen peroxide, lipid hydroperoxides, peroxynitrite, and hypochlorous and hypobromous acids play a key role in many pathophysiological processes. Recent studies have focused on mitochondrial ROS as redox signaling species responsible for promoting cell division, modulating and regulating kinases and phosphatases, and activating transcription factors. Many ROS also stimulate cell death and senescence. The extent to which these processes occur is attributed to ROS levels (low or high) in cells. However, the exact nature of ROS remains unknown. Investigators have used redox-active probes that, upon oxidation by ROS, yield products exhibiting fluorescence, chemiluminescence, or bioluminescence. Mitochondria-targeted probes can be used to detect ROS generated in mitochondria. However, because most of these redox-active probes (untargeted and mitochondria-targeted) are oxidized by several ROS species, attributing redox probe oxidation to specific ROS species is difficult. It is conceivable that redox-active probes are oxidized in common one-electron oxidation pathways, resulting in a radical intermediate that either reacts with another oxidant (including oxygen to produce O) and forms a stable fluorescent product or reacts with O to form a fluorescent marker product. Here, we propose the use of multiple probes and complementary techniques (HPLC, LC-MS, redox blotting, and EPR) and the measurement of intracellular probe uptake and specific marker products to identify specific ROS generated in cells. The low-temperature EPR technique developed to investigate cellular/mitochondrial oxidants can easily be extended to animal and human tissues.	[Cheng, Gang; Zielonka, Monika; Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Cheng, Gang; Zielonka, Monika; Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Kumar, Suresh N.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Myers, Charles R.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Myers, Charles R.; Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Canc Ctr, Milwaukee, WI 53226 USA; [Dranka, Brian] Agilent Technol, Cell Anal Div, Santa Clara, CA 95051 USA; [Bennett, Brian; Garces, Alexander M.; Machado, Luiz Gabriel Dias Duarte] Marquette Univ, Dept Phys, Milwaukee, WI 53233 USA; [Thiebaut, David; Ouari, Olivier; Hardy, Micael] Aix Marseille Univ, CNRS, ICR, UMR 7273, F-13013 Marseille, France	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Agilent Technologies; Marquette University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu	Zielonka, Jacek/N-9546-2014; Hardy, micael/ABF-3357-2020	Zielonka, Jacek/0000-0002-2524-0145; Hardy, micael/0000-0003-2976-7785; Ouari, Olivier/0000-0003-4320-4313; Dias Duarte Machado, Luiz Gabriel/0000-0002-0960-106X	National Science Foundation [CHE-1532168]; Bruker BioSpin; Direct For Mathematical & Physical Scien [1532168] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U01CA178960, R01CA208648] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Bruker BioSpin; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EPR was supported by National Science Foundation Major Research Instrumentation Award CHE-1532168 (to B. B.) and by Bruker BioSpin.	Abe K, 2014, J CEREBR BLOOD F MET, V34, P1907, DOI 10.1038/jcbfm.2014.160; Ahn HY, 2012, J AM CHEM SOC, V134, P4721, DOI 10.1021/ja210315x; Andreyev AY, 2015, BIOCHEMISTRY-MOSCOW+, V80, P517, DOI 10.1134/S0006297915050028; Beatty A, 2018, MOL CANCER THER, V17, P264, DOI 10.1158/1535-7163.MCT-17-0407; Beinert H, 1978, Methods Enzymol, V54, P133; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bennett B, 2016, FREE RADICAL BIO MED, V92, P141, DOI 10.1016/j.freeradbiomed.2016.01.001; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Cerrato CP, 2015, FASEB J, V29, P4589, DOI 10.1096/fj.14-269225; Chan SHH, 2009, HYPERTENSION, V53, P217, DOI 10.1161/HYPERTENSIONAHA.108.116905; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Cheng G, 2014, BRIT J CANCER, V111, P85, DOI 10.1038/bjc.2014.272; Cheng G, 2015, CANCER LETT, V365, P96, DOI 10.1016/j.canlet.2015.05.016; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Chu WH, 2014, ORG BIOMOL CHEM, V12, P4421, DOI 10.1039/c3ob42379d; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Cox AG, 2008, FREE RADICAL BIO MED, V44, P1001, DOI 10.1016/j.freeradbiomed.2007.11.017; Cunniff B, 2013, J CELL PHYSIOL, V228, P835, DOI 10.1002/jcp.24232; Davies MJ, 2016, METHODS, V109, P21, DOI 10.1016/j.ymeth.2016.05.013; Dey S, 2016, J BIOL CHEM, V291, P11185, DOI 10.1074/jbc.M116.726968; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; Dickey JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070575; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2011, CHEM BIOL, V18, P943, DOI 10.1016/j.chembiol.2011.07.005; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Esterberg R, 2016, J CLIN INVEST, V126, P3556, DOI 10.1172/JCI84939; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Ge C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03881-9; Hall DJ, 2012, J CEREBR BLOOD F MET, V32, P23, DOI 10.1038/jcbfm.2011.119; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Hu JJ, 2015, J AM CHEM SOC, V137, P6837, DOI 10.1021/jacs.5b01881; Idelchik MDS, 2017, SEMIN CANCER BIOL, V47, P57, DOI 10.1016/j.semcancer.2017.04.005; JANZEN EG, 1984, METHOD ENZYMOL, V105, P188; Jayakumar S, 2017, FREE RADICAL BIO MED, V113, P530, DOI 10.1016/j.freeradbiomed.2017.10.378; Kalyanaraman B, 2018, REDOX BIOL, V15, P347, DOI 10.1016/j.redox.2017.12.012; Kalyanaraman B, 2017, ARCH BIOCHEM BIOPHYS, V617, P38, DOI 10.1016/j.abb.2016.08.021; Kalyanaraman B, 2014, BBA-GEN SUBJECTS, V1840, P739, DOI 10.1016/j.bbagen.2013.05.008; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kotamraju S, 2004, METHOD ENZYMOL, V378, P362; Lee E, 2017, J CELL PHYSIOL, V232, P3209, DOI 10.1002/jcp.25867; Li PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22831; Logan A, 2016, CELL METAB, V23, P379, DOI 10.1016/j.cmet.2015.11.014; Ma L, 2018, INT J CANCER, V142, P1786, DOI 10.1002/ijc.31207; Maghzal GJ, 2007, FREE RADICAL BIO MED, V43, P1095, DOI 10.1016/j.freeradbiomed.2007.06.023; McCarthy C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32683; Medvedev ES, 2010, BBA-BIOENERGETICS, V1797, P1665, DOI 10.1016/j.bbabio.2010.05.011; Michalski R, 2014, J BIOL CHEM, V289, P22536, DOI 10.1074/jbc.M114.553727; Michalski R, 2014, FREE RADICAL BIO MED, V67, P278, DOI 10.1016/j.freeradbiomed.2013.10.816; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Myers CR, 2016, FREE RADICAL BIO MED, V91, P81, DOI 10.1016/j.freeradbiomed.2015.12.008; Myers CR, 2010, FREE RADICAL BIO MED, V49, P1903, DOI 10.1016/j.freeradbiomed.2010.09.020; Myers JM, 2009, FREE RADICAL BIO MED, V47, P1477, DOI 10.1016/j.freeradbiomed.2009.08.015; Ni R, 2016, FREE RADICAL BIO MED, V90, P12, DOI 10.1016/j.freeradbiomed.2015.11.013; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Oien DB, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00970; Pearson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096378; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pillai VB, 2017, ONCOTARGET, V8, P34082, DOI 10.18632/oncotarget.16133; Davila MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138777; Quinlan CL, 2013, METHOD ENZYMOL, V526, P189, DOI 10.1016/B978-0-12-405883-5.00012-0; Ren T, 2017, ONCOGENE, V36, P5897, DOI 10.1038/onc.2017.167; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Roelofs BA, 2015, FREE RADICAL BIO MED, V86, P250, DOI 10.1016/j.freeradbiomed.2015.05.032; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Shchepinova MM, 2017, CELL CHEM BIOL, V24, P1285, DOI 10.1016/j.chembiol.2017.08.003; Sikora A, 2013, CHEM RES TOXICOL, V26, P856, DOI 10.1021/tx300499c; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Skulachev VP, 2005, IUBMB LIFE, V57, P305, DOI 10.1080/15216540500092161; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Smulik R, 2014, J BIOL CHEM, V289, P35570, DOI 10.1074/jbc.M114.597740; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stein N, 2017, BIOCHEMISTRY-US, V56, P3068, DOI 10.1021/acs.biochem.6b00876; Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898; Tampo Y, 2003, CIRC RES, V92, P56, DOI 10.1161/01.RES.0000048195.15637.AC; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Torrens-Mas M, 2017, CANCERS, V9, DOI 10.3390/cancers9070090; Tortora V, 2007, FREE RADICAL BIO MED, V42, P1075, DOI 10.1016/j.freeradbiomed.2007.01.007; Tung JN, 2018, ONCOTARGET, V9, P4637, DOI 10.18632/oncotarget.23161; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Wang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02915-8; Wangpaichitr M, 2017, Cell Dev Biol, V6, DOI 10.4172/2168-9296.1000183; Wangpaichitr M, 2017, ONCOTARGET, V8, P49275, DOI 10.18632/oncotarget.17568; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Winterbourn CC, 2018, ANTIOXID REDOX SIGN, V29, P541, DOI 10.1089/ars.2017.7425; Xu J, 2016, ANAL CHEM, V88, P1455, DOI 10.1021/acs.analchem.5b04424; Yasui H, 2017, CANCER LETT, V390, P160, DOI 10.1016/j.canlet.2017.01.006; Yu W, 2016, J BIOL CHEM, V291, P3268, DOI 10.1074/jbc.M115.702076; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zielonka J, 2005, FREE RADICAL BIO MED, V39, P853, DOI 10.1016/j.freeradbiomed.2005.05.001; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042; Zielonka J, 2016, FREE RADICAL BIO MED, V99, P32, DOI 10.1016/j.freeradbiomed.2016.07.023; Zielonka J, 2016, J BIOL CHEM, V291, P7029, DOI 10.1074/jbc.M115.702787; Zielonka Jacek, 2015, Methods Mol Biol, V1264, P171, DOI 10.1007/978-1-4939-2257-4_16; Zielonka J, 2013, FREE RADICAL BIO MED, V65, P1310, DOI 10.1016/j.freeradbiomed.2013.09.017; Zielonka J, 2013, METHOD ENZYMOL, V526, P145, DOI 10.1016/B978-0-12-405883-5.00009-0; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031; Zou L, 2018, J BIOL CHEM, V293, P1666, DOI 10.1074/jbc.M117.798645	117	56	56	11	78	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10363	10380		10.1074/jbc.RA118.003044	http://dx.doi.org/10.1074/jbc.RA118.003044			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29739855	hybrid, Green Published			2022-12-28	WOS:000437096700034
J	Parikh, RY; Lin, HF; Gangaraju, VK				Parikh, Rasesh Y.; Lin, Haifan; Gangaraju, Vamsi K.			A critical role for nucleoporin 358 (Nup358) in transposon silencing and piRNA biogenesis in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear pore; RNA; RNA interference; RNAi; transposable element; TE; ovary; Piwi; Piwi-interacting RNA; ping-pong cycle; RAN-binding protein 2; RanBP2; Nup358	NUCLEAR-PORE COMPLEX; WIDE RNAI SCREEN; PROTEIN IMPORT; PIWI PROTEINS; NASCENT RNA; E3 LIGASE; GERMLINE; PATHWAY; MECHANISM; CHROMATIN	Piwi-interacting RNAs (piRNAs) are a class of small noncoding RNAs that bind Piwi proteins to silence transposons and to regulate gene expression. In Drosophila germ cells, the Aubergine (Aub)-Argonaute 3 (Ago3)-dependent ping-pong cycle generates most germline piRNAs. Loading of antisense piRNAs amplified by this cycle enables Piwi to enter the nucleus and silence transposons. Nuclear localization is crucial for Piwi function in transposon silencing, but how this process is regulated remains unknown. It is also not known whether any of the components of the nuclear pore complex (NPC) directly function in the piRNA pathway. Here, we show that nucleoporin 358 (Nup358) and Piwi interact with each other and that a germline knockdown (GLKD) of Nup358 with short hairpin RNA prevents Piwi entry into the nucleus. The Nup358 GLKD also activated transposons, increased genomic instability, and derailed piRNA biogenesis because of a combination of decreased piRNA precursor transcription and a collapse of the ping-pong cycle. Our results point to a critical role for Nup358 in the piRNA pathway, laying the foundation for future studies to fully elucidate the mechanisms by which Nup358 contributes to piRNA biogenesis and transposon silencing.	[Parikh, Rasesh Y.; Gangaraju, Vamsi K.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Parikh, Rasesh Y.; Gangaraju, Vamsi K.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Lin, Haifan] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Lin, Haifan] Yale Univ, Dept Cell Biol, New Haven, CT 06510 USA	Medical University of South Carolina; Medical University of South Carolina; Yale University; Yale University	Gangaraju, VK (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Gangaraju, VK (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.; Lin, HF (corresponding author), Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06510 USA.; Lin, HF (corresponding author), Yale Univ, Dept Cell Biol, New Haven, CT 06510 USA.	haifan.lin@yale.edu; gangaraj@musc.edu			National Institutes of Health [P30 CA138313];  [S10 OD018113]; NATIONAL CANCER INSTITUTE [P30CA138313, DP1CA174418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES021736] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Haruhiko Siomi, Mikiko Siomi, and William Theurkauf for antibodies. We thank Robert Wilson and Jennifer Schulte for preparing deep-sequencing libraries. We thank Todd Mack for generating Piwi and NNup358 expression plasmids. We acknowledge core support from the Cell and Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina (supported by National Institutes of Health Grant P30 CA138313); Shared Instrumentation Grant S10 OD018113; and the Genomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina.	Akkouche A, 2017, MOL CELL, V66, P411, DOI 10.1016/j.molcel.2017.03.017; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Forler D, 2004, MOL CELL BIOL, V24, P1155, DOI 10.1128/MCB.24.3.1155-1167.2004; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Gardini A, 2017, METHODS MOL BIOL, V1468, P111, DOI 10.1007/978-1-4939-4035-6_9; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Han BW, 2015, BIOINFORMATICS, V31, P593, DOI 10.1093/bioinformatics/btu647; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Hur JK, 2016, GENE DEV, V30, P840, DOI 10.1101/gad.276030.115; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Karam JA, 2017, J BIOL CHEM, V292, P6039, DOI 10.1074/jbc.C117.777730; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Klenov MS, 2014, NUCLEIC ACIDS RES, V42, P6208, DOI 10.1093/nar/gku268; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Ku HY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005813; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Le Thomas A, 2014, GENE DEV, V28, P1667, DOI 10.1101/gad.245514.114; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sienski G, 2015, GENE DEV, V29, P2258, DOI 10.1101/gad.271908.115; Uv AE, 2000, GENE DEV, V14, P1945; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Wang W, 2015, MOL CELL, V59, P819, DOI 10.1016/j.molcel.2015.08.007; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yamanaka S, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-22; Yu Y, 2015, SCIENCE, V350, P339, DOI 10.1126/science.aab0700; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	49	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9140	9147		10.1074/jbc.AC118.003264	http://dx.doi.org/10.1074/jbc.AC118.003264			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29735528	Green Published, hybrid			2022-12-28	WOS:000435441400001
J	Endo, H; Tanaka, S; Adegawa, S; Ichino, F; Tabunoki, H; Kikuta, S; Sato, R				Endo, Haruka; Tanaka, Shiho; Adegawa, Satomi; Ichino, Fumika; Tabunoki, Hiroko; Kikuta, Shingo; Sato, Ryoichi			Extracellular loop structures in silkworm ABCC transporters determine their specificities for Bacillus thuringiensis Cry toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; bacterial toxin; ABC transporter; insect; Bombyx mori; Bacillus thuringiensis; Cry toxin; ABC transporter C2 (ABCC2); ABC transporter C3 (ABCC3); binding affinity	RECEPTOR FUNCTION; CROSS-RESISTANCE; DOMAIN-II; BINDING; INSECT; LARVAE; MODE; C2	Bacillus thuringiensis Cry toxins are insecticidal proteins used widely for pest control. They are lethal to a restricted range of insects via specific interactions with insect receptors such as the ABC transporter subfamily members C2 (ABCC2) and C3 (ABCC3). However, it is still unclear how these different receptors contribute to insect susceptibility to Cry1A toxins. Here, we investigated the differences between the silkworm (Bombyx mori) ABCC2 (BmABCC2_S) and ABCC3 (BmABCC3) receptors in mediating Cry toxicity. Compared with BmABCC2_S, BmABCC3 exhibited 80- and 267-fold lower binding affinities to Cry1Aa and Cry1Ab, respectively, and these decreased affinities correlated well with the lower receptor activities of BmABCC3 for these Cry1A toxins. To identify the amino acid residues responsible for these differences, we constructed BmABCC3 variants containing a partial amino acid replacement with extracellular loops (ECLs) from BmABCC2_S. Replacing three amino acids from ECL 1 or 3 increased BmABCC3 activity toward Cry1Aa and enabled its activity toward Cry1Ab. Meanwhile, BmABCC2_S and BmABCC3 exhibited no receptor activities for Cry1Ca, Cry1Da, and Cry3Bb, correlating with markedly lower binding affinities for these Cry toxins. ABCC2 from a Cry1Ab-resistant B. mori strain (BmABCC2_R), which has a tyrosine insertion in ECL 2, displayed 93-fold lower binding affinity to Cry1Ab compared with BmABCC2_S but maintained high binding affinity to Cry1Aa. These results indicate that the Cry toxin-binding affinities of ABCC transporters are largely linked to the level of Cry susceptibility of ABCC-expressing cells and that the ABCC ECL structures determine the specificities to Cry toxins.	[Endo, Haruka; Tanaka, Shiho; Adegawa, Satomi; Kikuta, Shingo; Sato, Ryoichi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Ichino, Fumika; Tabunoki, Hiroko] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Sci Biol Prod, Saiwai Cho 3-5-8, Fuchu, Tokyo 1838509, Japan; [Endo, Haruka] Kashiwanoha 5-1-5, Kashiwa, Chiba 2778562, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology	Sato, R (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan.	ryoichi@cc.tuat.ac.jp	Endo, Haruka/L-2082-2019; TABUNOKI, Hiroko/H-6593-2013; Kikuta, Shingo/J-5219-2013; Adegawa, Satomi/S-7957-2018; Sato, Ryoichi/G-1074-2013	TABUNOKI, Hiroko/0000-0003-1823-9952; Kikuta, Shingo/0000-0002-3925-576X; Endo, Haruka/0000-0002-5900-7077	Japan Society for the Promotion of Science (JSPS) KAKENHI [15H02837, 15J08610]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 15H02837 (to R. S.) and 15J08610 (to H. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Adegawa S, 2017, BBA-PROTEINS PROTEOM, V1865, P220, DOI 10.1016/j.bbapap.2016.11.011; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Bretschneider A, 2016, INSECT BIOCHEM MOLEC, V76, P109, DOI 10.1016/j.ibmb.2016.07.008; Chen ZM, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1186/S12929-015-0197-0; Endo H, 2017, PEPTIDES, V98, P86, DOI 10.1016/j.peptides.2017.04.003; Endo H, 2017, FEBS LETT, V591, P56, DOI 10.1002/1873-3468.12506; Guo ZJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005124; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Masson L, 2002, BBA-PROTEIN STRUCT M, V1594, P266, DOI 10.1016/S0167-4838(01)00312-0; Obata F, 2009, FEBS J, V276, P5949, DOI 10.1111/j.1742-4658.2009.07275.x; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Suetsugu Y, 2013, G3-GENES GENOM GENET, V3, P1481, DOI 10.1534/g3.113.006239; Tabashnik BE, 1996, APPL ENVIRON MICROB, V62, P2839, DOI 10.1128/AEM.62.8.2839-2844.1996; Tanaka S, 2017, INSECT BIOCHEM MOLEC, V91, P44, DOI 10.1016/j.ibmb.2017.11.002; Tanaka S, 2016, FEBS J, V283, P4474, DOI 10.1111/febs.13952; Tanaka S, 2016, PEPTIDES, V78, P99, DOI 10.1016/j.peptides.2016.01.006; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; Zhao JZ, 2001, J ECON ENTOMOL, V94, P1547, DOI 10.1603/0022-0493-94.6.1547	21	27	30	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8569	8577		10.1074/jbc.RA118.001761	http://dx.doi.org/10.1074/jbc.RA118.001761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666188	Green Published, hybrid			2022-12-28	WOS:000434205700020
J	Goldfine, H				Goldfine, Howard			Cytochrome c takes on plasmalogen catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							IMPAIRMENT; LEVEL	Plasmalogensphospholipids containing a characteristic vinyl ether groupare precursors of lipids important for cellular signaling such as arachidonic acid. Plasmalogen catabolism involves cleavage of the vinyl ether bond, but the identity of the corresponding enzyme that cleaves the sn-1 vinyl ether bond was unknown. New research shows that cytochrome c, with some help from another lipid, catalyzes the oxidative cleavage of this bond. This discovery, and the subsequent mechanistic dissection, provides exciting new directions for lipid signaling research.	[Goldfine, Howard] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Goldfine, H (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	goldfinh@pennmedicine.upenn.edu	Goldfine, Howard/AAB-8097-2020					CADENAS E, 1980, BIOCHEM J, V187, P131, DOI 10.1042/bj1870131; Fujino T, 2017, EBIOMEDICINE, V17, P199, DOI 10.1016/j.ebiom.2017.02.012; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; Jenkins CM, 2018, J BIOL CHEM, V293, P8693, DOI 10.1074/jbc.RA117.001629; McLeod R.S., 2016, BIOCH LIPIDS LIPOPRO, V6, P259; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/NCHEM.1924, 10.1038/nchem.1924]; Weisser M, 1997, CHEM PHYS LIPIDS, V90, P135, DOI 10.1016/S0009-3084(97)00089-3; Yamashita S, 2017, LIPIDS, V52, P575, DOI 10.1007/s11745-017-4260-3; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	9	1	1	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8710	8711		10.1074/jbc.H118.003072	http://dx.doi.org/10.1074/jbc.H118.003072			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29858391	Green Published, hybrid			2022-12-28	WOS:000434205700032
J	Mondragon-Rodriguez, S; Salas-Gallardo, A; Gonzalez-Pereyra, P; Macias, M; Ordaz, B; Pena-Ortega, F; Aguilar-Vazquez, A; Orta-Salazar, E; Diaz-Cintra, S; Perry, G; Williams, S				Mondragon-Rodriguez, Siddhartha; Salas-Gallardo, Anahi; Gonzalez-Pereyra, Perla; Macias, Martin; Ordaz, Benito; Pena-Ortega, Fernando; Aguilar-Vazquez, Azucena; Orta-Salazar, Erika; Diaz-Cintra, Sofia; Perry, George; Williams, Sylvain			Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; Tau protein (Tau); tauopathy; biomarker; genetics; compensatory mechanism; epileptiform activity; hyperphosphorylation; Tau; theta activity	TRIPLE-TRANSGENIC MODEL; AMYLOID-BETA TOXICITY; A-BETA; MOUSE MODEL; DISEASE; DEPOSITION; OLIGOMERS; CURRENTS; MICE; EEG	Tau hyperphosphorylation at several sites, including those close to the microtubule domain region (MDr), is considered a key pathological event in the development of Alzheimer's disease (AD). Recent studies indicate that at the very early stage of this disease, increased phosphorylation in Tau's MDr domain correlates with reduced levels of neuronal excitability. Mechanistically, we show that pyramidal neurons and some parvalbumin-positive interneurons in 1-month-old triple-transgenic AD mice accumulate hyperphosphorylated Tau protein and that this accumulation correlates with changes in theta oscillations in hippocampal neurons. Pyramidal neurons from young triple-transgenic AD mice exhibited less spike accommodation and power increase in subthreshold membrane oscillations. Furthermore, triple-transgenic AD mice challenged with the potassium channel blocker 4-aminopyridine had reduced theta amplitude compared with 4-aminopyridine-treated control mice and, unlike these controls, displayed no seizure-like activity after this challenge. Collectively, our results provide new insights into AD pathogenesis and suggest that increases in Tau phosphorylation at the initial stages of the disease represent neuronal responses that compensate for brain circuit overexcitation.	[Mondragon-Rodriguez, Siddhartha] CONACYT Natl Council Sci & Technol, Mexico City 03940, DF, Mexico; [Mondragon-Rodriguez, Siddhartha; Salas-Gallardo, Anahi; Gonzalez-Pereyra, Perla; Macias, Martin; Ordaz, Benito; Pena-Ortega, Fernando; Aguilar-Vazquez, Azucena; Orta-Salazar, Erika; Diaz-Cintra, Sofia] Univ Nacl Autonoma Mexico, Inst Neurobiol, UNAM Dev Neurobiol & Neurophysiol, Queretaro 76230, Mexico; [Perry, George] Univ Texas San Antonio, Coll Sci, UTSA Neurosci Inst, San Antonio, TX 78284 USA; [Perry, George] Univ Texas San Antonio, Coll Sci, Dept Biol, San Antonio, TX 78284 USA; [Williams, Sylvain] McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Quebec City, PQ H4H 1R3, Canada	Universidad Nacional Autonoma de Mexico; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); McGill University	Mondragon-Rodriguez, S (corresponding author), CONACYT Natl Council Sci & Technol, Mexico City 03940, DF, Mexico.	sidmonrod@gmail.com	Miranda, Sofía/AAS-8499-2021; Mondragon-Rodriguez, Siddhartha/AAA-2452-2019; Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172; diaz cintra, sofia/0000-0002-3354-2717; Pena-Ortega, Fernando/0000-0002-0348-4392	CONACYT [612271, 770620, 269021, 117-235789]; DGAPA-UNAM [IN202018]; Fundacion Marcos Moshinsky; National Institute of Minority Health and Health Disparities from the National Institutes of Health [G12MD007591]; Semmes Foundation; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); Fundacion Marcos Moshinsky; National Institute of Minority Health and Health Disparities from the National Institutes of Health; Semmes Foundation; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported CONACYT Grants 612271 and 770620 (to P. G.-P. and A. S.-G.), CONACYT Grants 269021 and 117-235789, DGAPA-UNAM Grant IN202018, fund from the Fundacion Marcos Moshinsky, and National Institute of Minority Health and Health Disparities Grant G12MD007591 from the National Institutes of Health and by the Semmes Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amilhon B, 2015, NEURON, V86, P1277, DOI 10.1016/j.neuron.2015.05.027; Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cayzac S, 2015, NEUROBIOL AGING, V36, P3200, DOI 10.1016/j.neurobiolaging.2015.08.023; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Colgin LL, 2016, NAT REV NEUROSCI, V17, P239, DOI 10.1038/nrn.2016.21; Deacon RMJ, 2003, BEHAV BRAIN RES, V139, P139, DOI 10.1016/S0166-4328(02)00225-5; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon RMJ, 2001, NEUROREPORT, V12, P2053, DOI 10.1097/00001756-200107030-00052; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Engels MMA, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00238; García-Méndez K.M., 2017, Rev. mex. ing. bioméd, V38, P217, DOI 10.17488/rmib.38.1.16; Goedert M, 1999, NATURE, V399, P739, DOI 10.1038/21550; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Gouw AA, 2017, NEUROBIOL AGING, V57, P133, DOI 10.1016/j.neurobiolaging.2017.05.017; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kaniyappan S, 2017, ALZHEIMERS DEMENT, V13, P1270, DOI 10.1016/j.jalz.2017.04.002; Kazim SF, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00071; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lei M, 2016, NEUROBIOL DIS, V85, P111, DOI 10.1016/j.nbd.2015.10.019; Mahar I, 2017, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00327; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Mondragon-Rodriguez S, 2012, INT J ALZHEIMERS DIS, V2012; Mondragon-Rodriguez S, 2017, CURR ALZHEIMER RES, V14, P40, DOI 10.2174/1567205013666160819131336; Mondragon-Rodriguez S, 2012, J BIOL CHEM, V287, P32040, DOI 10.1074/jbc.M112.401240; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Patel J, 2012, NEURON, V75, P410, DOI 10.1016/j.neuron.2012.07.015; Salgado-Puga K, 2017, J ALZHEIMERS DIS, V57, P205, DOI 10.3233/JAD-160543; Shiri Z, 2017, J NEUROSCI, V37, P2999, DOI 10.1523/JNEUROSCI.2244-16.2017; Soler H, 2017, NEUROBIOL AGING, V49, P40, DOI 10.1016/j.neurobiolaging.2016.09.006; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang Y, 2014, NEUROBIOL AGING, V35, P88, DOI 10.1016/j.neurobiolaging.2013.07.007	38	42	42	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8462	8472		10.1074/jbc.RA117.001187	http://dx.doi.org/10.1074/jbc.RA117.001187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29632073	Green Published, hybrid			2022-12-28	WOS:000434205700011
J	Ramachandran, B; Stabley, JN; Cheng, SL; Behrmann, AS; Gay, A; Li, L; Mead, M; Kozlitina, J; Lemoff, A; Mirzaei, H; Chen, ZJ; Towler, DA				Ramachandran, Bindu; Stabley, John N.; Cheng, Su-Li; Behrmann, Abraham S.; Gay, Austin; Li, Li; Mead, Megan; Kozlitina, Julia; Lemoff, Andrew; Mirzaei, Hamid; Chen, Zhijian; Towler, Dwight A.			A GTPase-activating protein-binding protein (G3BP1)/antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt signaling; calcification; atherosclerosis; protein methylation; cardiovascular disease; vascular biology; vascular smooth muscle cells; Type 2 diabetes; metabolic syndrome; arteriosclerosis	TRANSCRIPTION FACTOR RUNX2; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; ARGININE METHYLATION; BONE BIOLOGY; IN-VIVO; KAPPA-B; RIG-I; MINERALIZATION; EXPRESSION	In aortic vascular smooth muscle (VSM), the canonical Wnt receptor LRP6 inhibits protein arginine (Arg) methylation, a new component of noncanonical Wnt signaling that stimulates nuclear factor of activated T cells (viz. NFATc4). To better understand how methylation mediates these actions, MS was performed on VSM cell extracts from control and LRP6-deficient mice. LRP6-dependent Arg methylation was regulated on >500 proteins; only 21 exhibited increased monomethylation (MMA) with concomitant reductions in dimethylation. G3BP1, a known regulator of arteriosclerosis, exhibited a >30-fold increase in MMA in its C-terminal domain. Co-transfection studies confirm that G3BP1 (G3BP is Ras-GAP SH3 domain-binding protein) methylation is inhibited by LRP6 and that G3BP1 stimulates NFATc4 transcription. NFATc4 association with VSM osteopontin (OPN) and alkaline phosphatase (TNAP) chromatin was increased with LRP6 deficiency and reduced with G3BP1 deficiency. G3BP1 activation of NFATc4 mapped to G3BP1 domains supporting interactions with RIG-I (retinoic acid inducible gene I), a stimulus for mitochondrial antiviral signaling (MAVS) that drives cardiovascular calcification in humans when mutated in Singleton-Merten syndrome (SGMRT2). Gain-of-function SGMRT2/RIG-I mutants increased G3BP1 methylation and synergized with osteogenic transcription factors (Runx2 and NFATc4). A chemical antagonist of G3BP, C108 (C108 is 2-hydroxybenzoic acid, 2-[1-(2-hydroxyphenyl)ethylidene]hydrazide CAS 15533-09-2), down-regulated RIG-I-stimulated G3BP1 methylation, Wnt/NFAT signaling, VSM TNAP activity, and calcification. G3BP1 deficiency reduced RIG-I protein levels and VSM osteogenic programs. Like G3BP1 and RIG-I deficiency, MAVS deficiency reduced VSM osteogenic signals, including TNAP activity and Wnt5-dependent nuclear NFATc4 levels. Aortic calcium accumulation is decreased in MAVS-deficient LDLR-/- mice fed arteriosclerotic diets. The G3BP1/RIG-I/MAVS relay is a component of Wnt signaling. Targeting this relay may help mitigate arteriosclerosis.	[Ramachandran, Bindu; Stabley, John N.; Cheng, Su-Li; Behrmann, Abraham S.; Gay, Austin; Li, Li; Mead, Megan; Towler, Dwight A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kozlitina, Julia] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Lemoff, Andrew; Mirzaei, Hamid] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Zhijian] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Towler, DA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Internal Med Endocrine Div, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dwight.towler@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; Lemoff, Andrew/0000-0002-4943-0170; Towler, Dwight/0000-0003-2107-7923; /0000-0002-1825-7846; Kozlitina, Julia/0000-0001-7720-2290	National Institutes of Health [HL114806, HL069229]; J. D. and Maggie E. Wilson Endowed Chair in Biomedical Research; Louis V. Avioli Professorship in Mineral Metabolism Research; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114806, R01HL069229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. D. and Maggie E. Wilson Endowed Chair in Biomedical Research; Louis V. Avioli Professorship in Mineral Metabolism Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL114806 (to D. A. T.) and HL069229 (to D. A. T.), the J. D. and Maggie E. Wilson Endowed Chair in Biomedical Research (to D. A. T.), the Louis V. Avioli Professorship in Mineral Metabolism Research (to D. A. T.), and the Howard Hughes Medical Institute (to Z. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Albanese I, 2017, ARTERIOSCL THROM VAS, V37, P543, DOI 10.1161/ATVBAHA.116.308394; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Asl HF, 2015, CIRC-CARDIOVASC GENE, V8, P305, DOI 10.1161/CIRCGENETICS.114.000640; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Bidder M, 2002, J BIOL CHEM, V277, P44485, DOI 10.1074/jbc.M206235200; Bikkavilli RK, 2012, J CELL SCI, V125, P2446, DOI 10.1242/jcs.100933; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Bostrom K, 2000, CRIT REV EUKAR GENE, V10, P151; Byon CH, 2011, ARTERIOSCL THROM VAS, V31, P1387, DOI 10.1161/ATVBAHA.110.222547; Cai X, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023580; Cai ZJ, 2016, CIRC RES, V119, P422, DOI 10.1161/CIRCRESAHA.116.308301; Can U, 2016, J PEDIATR ENDOCR MET, V29, P1277, DOI 10.1515/jpem-2016-0136; Cassola A, 2010, RNA BIOL, V7, P339, DOI 10.4161/rna.7.3.12087; Cheng SL, 2015, CIRC RES, V117, P142, DOI 10.1161/CIRCRESAHA.117.306712; Cheng SL, 2014, DIABETES, V63, P4326, DOI 10.2337/db14-0326; Cheng SL, 2010, CIRC RES, V107, P271, DOI 10.1161/CIRCRESAHA.110.219899; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Duan PP, 2016, INT J BIOCHEM CELL B, V77, P23, DOI 10.1016/j.biocel.2016.05.015; Fakhry M, 2017, BBA-MOL BASIS DIS, V1863, P643, DOI 10.1016/j.bbadis.2016.12.003; Gay A, 2017, CURR OPIN LIPIDOL, V28, P387, DOI 10.1097/MOL.0000000000000445; Glantz S. A., 2005, PRIMER BIOSTATISTICS, P64; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Gupta N, 2017, P NATL ACAD SCI USA, V114, P1033, DOI 10.1073/pnas.1525387114; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; He MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145112; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Horner SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117963; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Jang MA, 2015, AM J HUM GENET, V96, P266, DOI 10.1016/j.ajhg.2014.11.019; Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991; Karmali KN, 2016, JAMA CARDIOL, V1, P341, DOI 10.1001/jamacardio.2016.0218; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kelynack KJ, 2016, METHODS MOL BIOL, V1397, P209, DOI 10.1007/978-1-4939-3353-2_14; Komura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071271; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Lai CF, 2012, ENDOCRINOLOGY, V153, P3897, DOI 10.1210/en.2012-1216; Lawson MA, 2010, J BIOMED MATER RES B, V92B, P149, DOI 10.1002/jbm.b.31500; Lin ME, 2016, CARDIOVASC RES, V112, P606, DOI 10.1093/cvr/cvw205; Liu F, 2011, PROTEIN CELL, V2, P351, DOI 10.1007/s13238-011-1045-y; Lundgren Deborah H, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1303s28; Mackenzie NCW, 2011, INT J MOL MED, V27, P663, DOI 10.3892/ijmm.2011.631; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Martin S, 2016, J NEUROCHEM, V139, P349, DOI 10.1111/jnc.13768; Masuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000238; Milewicz DM, 2017, ARTERIOSCL THROM VAS, V37, P26, DOI 10.1161/ATVBAHA.116.303229; Morony S, 2012, CALCIFIED TISSUE INT, V91, P379, DOI 10.1007/s00223-012-9655-9; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Muhammad IF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181718; Narisawa S, 2013, J BONE MINER RES, V28, P1587, DOI 10.1002/jbmr.1901; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; New SEP, 2013, ARTERIOSCL THROM VAS, V33, P1753, DOI 10.1161/ATVBAHA.112.300128; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Pazman C, 2000, DEVELOPMENT, V127, P1715; Pockwinse SM, 2011, J CELL PHYSIOL, V226, P1383, DOI 10.1002/jcp.22465; Ptak C, 2017, ADV EXP MED BIOL, V963, P111, DOI 10.1007/978-3-319-50044-7_7; Raaz U, 2015, CIRC RES, V117, P513, DOI 10.1161/CIRCRESAHA.115.306341; Rademaker J, 2008, AM J ROENTGENOL, V191, P32, DOI 10.2214/AJR.07.3112; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Ritchey M.D., 2017, J AM HEART ASS, V6, DOI [DOI 10.1161/JAHA.117.006021, 10.1161/jaha.117.006021]; Rutsch F, 2015, AM J HUM GENET, V96, P275, DOI 10.1016/j.ajhg.2014.12.014; Sahoo PK, 2012, BIOL OPEN, V1, P109, DOI 10.1242/bio.2011023; Saito Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080858; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shafer SL, 2009, J MOL CELL CARDIOL, V46, P621, DOI 10.1016/j.yjmcc.2009.01.005; Shao JS, 2011, ARTERIOSCL THROM VAS, V31, P1821, DOI 10.1161/ATVBAHA.111.230011; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Siddique A, 2018, CAN J PHYSIOL PHARM, V96, P208, DOI 10.1139/cjpp-2017-0577; Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326; Sierra OL, 2004, J BIOL CHEM, V279, P32913, DOI 10.1074/jbc.M314098200; Sierra OL, 2010, MOL ENDOCRINOL, V24, P1478, DOI 10.1210/me.2010-0029; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Srivastava R, 2015, CELL REP, V13, P746, DOI 10.1016/j.celrep.2015.09.028; Stabley JN, 2017, ARTERIOSCL THROM VAS, V37, P205, DOI 10.1161/ATVBAHA.116.306258; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sun ST, 2016, BIOCONJUGATE CHEM, V27, P329, DOI 10.1021/acs.bioconjchem.5b00369; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Tintut Y, 2006, J INVEST MED, V54, P395, DOI 10.2310/6650.2006.06019; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Tsai WC, 2017, J BIOL CHEM, V292, P18886, DOI 10.1074/jbc.M117.800706; Tsai WC, 2016, J BIOL CHEM, V291, P22671, DOI 10.1074/jbc.M116.739573; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; Valiente-Echeverria F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5819; Vognsen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080947; Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2; Whelton SP, 2015, JACC-CARDIOVASC IMAG, V8, P1393, DOI 10.1016/j.jcmg.2015.06.019; Williams H, 2016, ARTERIOSCL THROM VAS, V36, P1417, DOI 10.1161/ATVBAHA.116.307626; Woldt E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2087; Wu XS, 2017, INT J BIOL SCI, V13, P1082, DOI 10.7150/ijbs.20905; Zhang H, 2013, CANCER GENE THER, V20, P622, DOI 10.1038/cgt.2013.62; Zhang H, 2015, ONCOTARGET, V6, P17039, DOI 10.18632/oncotarget.3636; Zhong ZD, 2012, J CELL BIOCHEM, V113, P31, DOI 10.1002/jcb.23324	106	18	18	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7942	7968		10.1074/jbc.RA118.002046	http://dx.doi.org/10.1074/jbc.RA118.002046			27	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626090	Green Published, hybrid			2022-12-28	WOS:000433224600004
J	Brown, CW; Amante, JJ; Mercurio, AM				Brown, Caitlin W.; Amante, John J.; Mercurio, Arthur M.			Cell clustering mediated by the adhesion protein PVRL4 is necessary for alpha 6 beta 4 integrin-promoted ferroptosis resistance in matrix-detached cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cell death; cell-cell interaction; extracellular matrix; integrin; ferroptosis; glutathione peroxidase 4; lipid peroxidation	EXTRACELLULAR-MATRIX; CANCER-CELLS; SURVIVAL; DEATH	Ferroptosis is an iron-dependent form of programmed cell death characterized by the accumulation of lipid-targeting reactive oxygen species that kill cells by damaging their plasma membrane. The lipid repair enzyme GSH peroxidase 4 (GPX4) protects against this oxidative damage and enables cells to resist ferroptosis. Recent work has revealed that matrix-detached carcinoma cells can be susceptible to ferroptosis and that they can evade this fate through the signaling properties of the alpha 6 beta 4 integrin, which sustains GPX4 expression. Although these findings on ferroptosis are provocative, they differ from those in previous studies indicating that matrix-detached cells are prone to apoptosis via a process referred to as anoikis. In an effort to reconcile these discrepant findings, here we observed that matrix-detached epithelial and carcinoma cells cluster spontaneously via a mechanism that involves the cell adhesion protein PVRL4 (also known as Nectin-4). We found that this clustering process allows these cells to survive by stimulating a PVRL4/alpha 6 beta 4/Src signaling axis that sustains GPX4 expression and buffers against lipid peroxidation. In the absence of alpha 6 beta 4, PVRL4-mediated clustering induced an increase in lipid peroxidation that was sufficient for triggering ferroptosis. When the clustering was inhibited, single cells did not exhibit a significant increase in lipid peroxidation in the absence of alpha 6 beta 4, and they were more susceptible to apoptosis than to ferroptosis. These results indicate that ferroptosis induction depends on cell clustering in matrix-detached cells that lack alpha 6 beta 4 and imply that the fate of matrix-detached cells can be determined by the state of their cell-cell interactions.	[Brown, Caitlin W.; Amante, John J.; Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu		Amante, John/0000-0002-8777-6551	Department of Defense [W81XWH-17-1-0009]; American Cancer Society [130451-PF-17-105-01-CSM]	Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society)	This work was supported by Department of Defense Grant W81XWH-17-1-0009. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by American Cancer Society Grant 130451-PF-17-105-01-CSM.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Brown CW, 2017, J CELL BIOL, V216, P4287, DOI 10.1083/jcb.201701136; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Hawk MA, 2018, NAT CELL BIOL, V20, P272, DOI 10.1038/s41556-018-0034-2; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rayavarapu RR, 2015, J BIOL CHEM, V290, P8722, DOI 10.1074/jbc.M114.612754; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010	18	28	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12741	12748		10.1074/jbc.RA118.003017	http://dx.doi.org/10.1074/jbc.RA118.003017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934307	hybrid, Green Published			2022-12-28	WOS:000442203500008
J	Gross, C; Saponaro, A; Santoro, B; Moroni, A; Thiel, G; Hamacher, K				Gross, Christine; Saponaro, Andrea; Santoro, Bina; Moroni, Anna; Thiel, Gerhard; Hamacher, Kay			Mechanical transduction of cytoplasmic-to-transmembrane-domain movements in a hyperpolarization-activated cyclic nucleotide-gated cation channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; protein conformation; computational biology; cyclic AMP (cAMP); protein dynamic; anisotropic network model; cAMP dependent gating; HCN1 channel; linear response theory	VOLTAGE-SENSING MECHANISM; PACEMAKER CHANNELS; STRUCTURAL BASIS; CAMP MODULATION; MOLECULAR-BASIS; HCN CHANNELS; BINDING; LINKER; PROTEINS; DYNAMICS	Hyperpolarization-activated cyclic nucleotide-gated cation (HCN) channels play a critical role in the control of pacemaking in the heart and repetitive firing in neurons. In HCN channels, the intracellular cyclic nucleotide-binding domain (CNBD) is connected to the transmembrane portion of the channel (TMPC) through a helical domain, the C-linker. Although this domain is critical for mechanical signal transduction, the conformational dynamics in the C-linker that transmit the nucleotide-binding signal to the HCN channel pore are unknown. Here, we use linear response theory to analyze conformational changes in the C-linker of the human HCN1 protein, which couple cAMP binding in the CNBD with gating in the TMPC. By applying a force to the tip of the so-called elbow of the C-linker, the coarse-grained calculations recapitulate the same conformational changes triggered by cAMP binding in experimental studies. Furthermore, in our simulations, a displacement of the C-linker parallel to the membrane plane (i.e. horizontally) induced a rotational movement resulting in a distinct tilting of the transmembrane helices. This movement, in turn, increased the distance between the voltage-sensing S4 domain and the surrounding transmembrane domains and led to a widening of the intracellular channel gate. In conclusion, our computational approach, combined with experimental data, thus provides a more detailed understanding of how cAMP binding is mechanically coupled over long distances to promote voltage-dependent opening of HCN channels.	[Gross, Christine; Hamacher, Kay] Tech Univ Darmstadt, Computat Biol & Simulat Grp, D-64287 Darmstadt, Germany; [Thiel, Gerhard] Tech Univ Darmstadt, Dept Biol, Membrane Biophys, D-64287 Darmstadt, Germany; [Saponaro, Andrea; Moroni, Anna] Univ Milan, Dept Biosci, I-20133 Milan, Italy; [Santoro, Bina] Columbia Univ, Dept Neurosci, New York, NY 10032 USA	Technical University of Darmstadt; Technical University of Darmstadt; University of Milan; Columbia University	Thiel, G (corresponding author), Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 3, D-64287 Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	moroni, anna/H-2097-2014; Saponaro, Andrea/AAD-1005-2019	moroni, anna/0000-0002-1860-406X; Saponaro, Andrea/0000-0001-5035-5174; Hamacher, Kay/0000-0002-6921-8345; Santoro, Bina/0000-0002-4277-1992; Thiel, Gerhard/0000-0002-2335-1351	Ministry of Higher Education, Research and the Arts (HMWK) of the Hessen State in LOEWE Project iNAPO; European Reseach Council (ERC) under the European Union [695078]; National Institutes of Health [R01 NS036658]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER	Ministry of Higher Education, Research and the Arts (HMWK) of the Hessen State in LOEWE Project iNAPO; European Reseach Council (ERC) under the European Union; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Ministry of Higher Education, Research and the Arts (HMWK) of the Hessen State in LOEWE Project iNAPO, by the European Reseach Council (ERC) under the European Union's Horizon 2020 Research and Innovation Program Grant 695078 noMAGIC ERC 2015AdG, and by National Institutes of Health Grant R01 NS036658 (to B. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aman TK, 2017, BIOPHYS J, V112, p249A, DOI 10.1016/j.bpj.2016.11.1362; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Biel S, 2016, PFLUG ARCH EUR J PHY, V468, P1663, DOI 10.1007/s00424-016-1870-1; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Das A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003521; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gross C, 2017, J CHEM INF MODEL, V57, P243, DOI 10.1021/acs.jcim.6b00556; Hamacher K, 2006, J CHEM THEORY COMPUT, V2, P873, DOI 10.1021/ct050247s; Hamacher K, 2006, PLOS COMPUT BIOL, V2, P80, DOI 10.1371/journal.pcbi.0020010; Hamacher K, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016703; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; Ishii TM, 2001, J PHYSIOL-LONDON, V537, P93, DOI 10.1111/j.1469-7793.2001.0093k.x; Jager S, 2016, LECT N BIOINFORMAT, V9838, P197, DOI 10.1007/978-3-319-43681-4_16; James ZM, 2018, J GEN PHYSIOL, V150, P225, DOI 10.1085/jgp.201711898; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Keskin O, 1998, PROTEIN SCI, V7, P2578, DOI 10.1002/pro.5560071211; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Li MH, 2017, NATURE, V542, P60, DOI 10.1038/nature20819; Lolicato M, 2014, NAT CHEM BIOL, V10, P457, DOI [10.1038/NCHEMBIO.1521, 10.1038/nchembio.1521]; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Moore EH, 1920, B AM MATH SOC, V26, P394, DOI 10.1090/S0002-9904-1920-03322-7; Penrose R., 1955, MATH P CAMBRIDGE PHI, V51, P406, DOI [10.1017/S0305004100030401, DOI 10.1017/S0305004100030401]; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stieber J, 2003, J BIOL CHEM, V278, P33672, DOI 10.1074/jbc.M305318200; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Thon S, 2015, BIOPHYS J, V109, P2268, DOI 10.1016/j.bpj.2015.08.054; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tsang SY, 2004, J BIOL CHEM, V279, P43752, DOI 10.1074/jbc.M408747200; Tsang SY, 2004, BIOCHEM BIOPH RES CO, V322, P652, DOI 10.1016/j.bbrc.2004.07.167; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Weissgraeber S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40168; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Wu SJ, 2012, J GEN PHYSIOL, V140, P29, DOI 10.1085/jgp.201110749; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	56	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12908	12918		10.1074/jbc.RA118.002139	http://dx.doi.org/10.1074/jbc.RA118.002139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29936413	Green Published, hybrid			2022-12-28	WOS:000442203500022
J	Hamidi, T; Singh, AK; Veland, N; Vemulapalli, V; Chen, JJ; Hardikar, S; Bao, JQ; Fry, CJ; Yang, V; Lee, KA; Guo, A; Arrowsmith, CH; Bedford, MT; Chen, TP				Hamidi, Tewfik; Singh, Anup Kumar; Veland, Nicolas; Vemulapalli, Vidyasiri; Chen, Jianji; Hardikar, Swanand; Bao, Jianqiang; Fry, Christopher J.; Yang, Vicky; Lee, Kimberly A.; Guo, Ailan; Arrowsmith, Cheryl H.; Bedford, Mark T.; Chen, Taiping			Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomarker; post-translational modification (PTM); epigenetics; histone methylation; ribosome function; Lsd1; Rpl29; Set7/9	EMBRYONIC STEM-CELLS; DNA METHYLATION; HISTONE DEMETHYLATION; NONHISTONE PROTEINS; MASS-SPECTROMETRY; IN-VIVO; INHIBITORS; TRANSCRIPTION; LSD1; MAINTENANCE	Set7/9 (also known as Set7, Set9, Setd7, and Kmt7) is a lysine methyltransferase that catalyzes the methylation of multiple substrates, including histone H3 and non-histone proteins. Although not essential for normal development and physiology, Set7/9-mediated methylation events play important roles in regulating cellular pathways involved in various human diseases, making Set7/9 a promising therapeutic target. Multiple Set7/9 inhibitors have been developed, which exhibit varying degrees of potency and selectivity in vitro. However, validation of these compounds in vivo has been hampered by the lack of a reliable cellular biomarker for Set7/9 activity. Here, we report the identification of Rpl29, a ribosomal protein abundantly expressed in all cell types, as a major substrate of Set7/9. We show that Rpl29 lysine 5 (Rpl29K5) is methylated exclusively by Set7/9 and can be demethylated by Lsd1 (also known as Kdm1a). Rpl29 is not a core component of the ribosome translational machinery and plays a regulatory role in translation efficiency. Our results indicate that Rpl29 methylation has no effect on global protein synthesis but affects Rpl29 subcellular localization. Using an Rpl29 methylation-specific antibody, we demonstrate that Rpl29K5 methylation is present ubiquitously and validate that (R)-PFI-2, a Set7/9 inhibitor, efficiently reduces Rpl29K5 methylation in cell lines. Thus, Rpl29 methylation can serve as a specific cellular biomarker for measuring Set7/9 activity.	[Hamidi, Tewfik; Singh, Anup Kumar; Veland, Nicolas; Vemulapalli, Vidyasiri; Chen, Jianji; Hardikar, Swanand; Bao, Jianqiang; Bedford, Mark T.; Chen, Taiping] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Hamidi, Tewfik; Singh, Anup Kumar; Veland, Nicolas; Vemulapalli, Vidyasiri; Chen, Jianji; Hardikar, Swanand; Bao, Jianqiang; Bedford, Mark T.; Chen, Taiping] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Smithville, TX 78957 USA; [Veland, Nicolas; Vemulapalli, Vidyasiri; Chen, Jianji; Bedford, Mark T.; Chen, Taiping] Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Program Genet & Epigenet, Houston, TX 77030 USA; [Fry, Christopher J.; Yang, Vicky; Lee, Kimberly A.; Guo, Ailan] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Guo, Ailan] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Chen, TP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.; Chen, TP (corresponding author), Bluefin Biomed Inc, 33 Tozer Rd, Beverly, MA 01915 USA.	tchen2@mdanderson.org	Chen, Jianji/GPX-4751-2022; Bao, Jianqiang/T-7299-2019	Chen, Jianji/0000-0003-4098-1811; Veland, Nicolas/0000-0002-3096-7867	National Institutes of Health NIDDK [1R01DK106418-01]; Center for Cancer Epigenetics (CCE) at MDACC; Cancer Prevention and Research Institute of Texas (CPRIT) [RP140106]; Cure on the Colorado fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106418] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Cancer Epigenetics (CCE) at MDACC; Cancer Prevention and Research Institute of Texas (CPRIT); Cure on the Colorado fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health NIDDK Grant 1R01DK106418-01 (to T. C.). C. J. F., V. Y., and K. A. L. are employees of Cell Signaling Technology Inc. (CST). A. G. was a former employee of CST and is a current employee of Bluefin Biomedicine, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipients of scholarships from the Center for Cancer Epigenetics (CCE) at MDACC.; Supported by a Research Training Award RP140106 from the Cancer Prevention and Research Institute of Texas (CPRIT).; Supported by the Cure on the Colorado fellowship.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; Campaner S, 2011, MOL CELL, V43, P681, DOI 10.1016/j.molcel.2011.08.007; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Dan JM, 2017, CELL REP, V20, P1936, DOI 10.1016/j.celrep.2017.07.070; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Elkouris M, 2016, CELL REP, V15, P2733, DOI 10.1016/j.celrep.2016.05.051; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Francis NJ, 2012, J BIOMOL SCREEN, V17, P1102, DOI 10.1177/1087057112452137; Fujiwara T, 2016, BIOORGAN MED CHEM, V24, P4318, DOI 10.1016/j.bmc.2016.07.024; Gandin V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11127; Gandin V, 2014, JOVE-J VIS EXP, DOI 10.3791/51455; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lehnertz B, 2011, MOL CELL, V43, P673, DOI 10.1016/j.molcel.2011.08.006; Maganti AV, 2015, J BIOL CHEM, V290, P9812, DOI 10.1074/jbc.M114.616219; Meng FW, 2015, J MED CHEM, V58, P8166, DOI 10.1021/acs.jmedchem.5b01154; Mori S, 2010, BIOORGAN MED CHEM, V18, P8158, DOI 10.1016/j.bmc.2010.10.022; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nicholson TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060913; Nicholson TB, 2009, EPIGENETICS-US, V4, P129, DOI 10.4161/epi.4.3.8443; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Niwa H, 2013, ACTA CRYSTALLOGR D, V69, P595, DOI 10.1107/S0907444912052092; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Oudhoff MJ, 2016, DEV CELL, V37, P47, DOI 10.1016/j.devcel.2016.03.002; Oudhoff MJ, 2013, DEV CELL, V26, P188, DOI 10.1016/j.devcel.2013.05.025; Rohde LH, 1996, J BIOL CHEM, V271, P11824, DOI 10.1074/jbc.271.20.11824; Sasaki K, 2016, J AM SOC NEPHROL, V27, P203, DOI 10.1681/ASN.2014090850; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Takemoto Y, 2016, J MED CHEM, V59, P3650, DOI 10.1021/acs.jmedchem.5b01732; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Veland N, 2017, CELL REP, V21, P3390, DOI 10.1016/j.celrep.2017.11.082; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x; Wozniak GG, 2014, BBA-GENE REGUL MECH, V1839, P1353, DOI 10.1016/j.bbagrm.2014.03.002; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4; Zheng YC, 2015, MED RES REV, V35, P1032, DOI 10.1002/med.21350	55	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12770	12780		10.1074/jbc.RA118.002890	http://dx.doi.org/10.1074/jbc.RA118.002890			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29959229	Green Published, hybrid			2022-12-28	WOS:000442203500011
J	Lemus, MR; Roussarie, E; Hammad, N; Mougeolle, A; Ransac, S; Issa, R; Mazat, JP; Uribe-Carvajal, S; Rigoulet, M; Devin, A				Lemus, Monica Rosas; Roussarie, Elodie; Hammad, Noureddine; Mougeolle, Alexis; Ransac, Stephane; Issa, Razanne; Mazat, Jean-Pierre; Uribe-Carvajal, Salvador; Rigoulet, Michel; Devin, Anne			The role of glycolysis-derived hexose phosphates in the induction of the Crabtree effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; respiration; respiratory chain; yeast; glycolysis; Crabtree effect; fructose1; 6-bisphosphate; glucose-6-phosphate; oxidative phosphorylation	SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; RESPIRATION; CELLS; PHOSPHORYLATION; OVEREXPRESSION; CARDIOMYOCYTES; MEMBRANE; KINETICS	Evidence for the Crabtree effect was first reported by H. Crabtree in 1929 and is defined as the glucose-induced decrease of cellular respiratory flux. This effect was observed in tumor cells and was not detected in most non-tumor cells. A number of hypotheses on the mechanism underlying the Crabtree effect have been formulated. However, to this day, no consensual mechanism for this effect has been described. In a previous study on isolated mitochondria, we have proposed that fructose-1,6-bisphosphate (F1,6bP), which inhibits the respiratory chain, induces the Crabtree effect. Using whole cells from the yeast Saccharomyces cerevisiae as a model, we show here not only that F1,6bP plays a key role in the process but that glucose-6-phosphate (G6P), a hexose that has an effect opposite to that of F1,6bP on the regulation of the respiratory flux, does as well. Thus, these findings reveal that the Crabtree effect strongly depends on the ratio between these two glycolysis-derived hexose phosphates. Last, in silico modeling of the Crabtree effect illustrated the requirement of an inhibition of the respiratory flux by a coordinated variation of glucose-6-phosphate and fructose-1,6-bisphosphate to fit the respiratory rate decrease observed upon glucose addition to cells. In summary, we conclude that two glycolysis-derived hexose phosphates, G6P and F1,6bP, play a key role in the induction of the Crabtree effect.	[Lemus, Monica Rosas; Roussarie, Elodie; Hammad, Noureddine; Mougeolle, Alexis; Ransac, Stephane; Issa, Razanne; Mazat, Jean-Pierre; Rigoulet, Michel; Devin, Anne] Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France; [Lemus, Monica Rosas; Roussarie, Elodie; Hammad, Noureddine; Mougeolle, Alexis; Ransac, Stephane; Issa, Razanne; Mazat, Jean-Pierre; Rigoulet, Michel; Devin, Anne] CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, 1 Rue Camille St Saens, F-33077 Bordeaux, France; [Uribe-Carvajal, Salvador] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Universidad Nacional Autonoma de Mexico	Devin, A (corresponding author), CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	anne.devin@ibgc.cnrs.fr		, Stephane Ransac/0000-0003-2597-4584	CNRS (Conseil National de la Recherche Scientifique); Comite de Dordogne and Gironde de la Ligue Nationale Contre le Cancer; Fondation ARC pour la recherche sur le Cancer; Plan Cancer 2014-2019 [BIO 2014 06]; French Association against Myopathies; European Commission	CNRS (Conseil National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Comite de Dordogne and Gironde de la Ligue Nationale Contre le Cancer; Fondation ARC pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Plan Cancer 2014-2019; French Association against Myopathies; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the CNRS (Conseil National de la Recherche Scientifique), the Comite de Dordogne and Gironde de la Ligue Nationale Contre le Cancer, The Fondation ARC pour la recherche sur le Cancer, the Plan Cancer 2014-2019 number BIO 2014 06, the French Association against Myopathies, and the European Commission (to H.N.). The authors declare that they have no conflicts of interest with the contents of this article. This publication reflects the view only of the authors and the European Commission cannot be held responsible for any use which may be made of the information contained therein.	Aiston S, 1999, J BIOL CHEM, V274, P24559, DOI 10.1074/jbc.274.35.24559; Anmann T, 2006, BBA-BIOENERGETICS, V1757, P1597, DOI 10.1016/j.bbabio.2006.09.008; Averet N, 1998, MOL CELL BIOCHEM, V184, P67, DOI 10.1023/A:1006830810440; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; Cornish-Bowden A, 2014, BIOCHIMIE, V107, P161, DOI 10.1016/j.biochi.2014.09.018; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DEWINDE JH, 1993, PROG NUCLEIC ACID RE, V46, P51, DOI 10.1016/S0079-6603(08)61018-1; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Eimre M, 2008, BBA-BIOENERGETICS, V1777, P514, DOI 10.1016/j.bbabio.2008.03.019; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; KOOBS DH, 1972, SCIENCE, V178, P127, DOI 10.1126/science.178.4057.127; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; Rodriguez-Enriquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x; SAKS V, 1995, BIOCHEM BIOPH RES CO, V208, P919, DOI 10.1006/bbrc.1995.1422; Smallbone K, 2013, FEBS LETT, V587, P2832, DOI 10.1016/j.febslet.2013.06.043; Sumner JB, 1944, SCIENCE, V100, P413, DOI 10.1126/science.100.2601.413; SUSSMAN I, 1980, BIOCHIM BIOPHYS ACTA, V591, P209, DOI 10.1016/0005-2728(80)90153-X; van Maris AJA, 2001, FEMS YEAST RES, V1, P139, DOI 10.1016/S1567-1356(01)00022-8; VEECH RL, 1979, J BIOL CHEM, V254, P6538; WEINHOUSE S, 1972, CANCER RES, V32, P2007; Wojtczak L, 1999, EUR J BIOCHEM, V263, P495, DOI 10.1046/j.1432-1327.1999.00522.x; ZIZI M, 1994, J BIOL CHEM, V269, P1614	23	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12843	12854		10.1074/jbc.RA118.003672	http://dx.doi.org/10.1074/jbc.RA118.003672			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29907566	Green Published, hybrid			2022-12-28	WOS:000442203500017
J	Andra, KK; Dorsey, S; Royer, CA; Menon, AK				Andra, Kiran K.; Dorsey, Savanna; Royer, Catherine A.; Menon, Anant K.			Structural mapping of fluorescently-tagged, functional nhTMEM16 scramblase in a lipid bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); liposome; ion channel; glycerophospholipid; membrane reconstitution; calcium; ACP tag; dithionite; fluorescence lifetime imaging (FLIM); MCP tag; scramblase	BOUND IMMUNOGLOBULIN-E; LIFETIME IMAGING MICROSCOPY; ACTIVATED CHLORIDE CHANNEL; RESONANCE ENERGY-TRANSFER; E-RECEPTOR COMPLEX; PLASMA-MEMBRANE; PHASOR APPROACH; CRYO-EM; CELLS; SURFACE	Most members of the TransMEMbrane protein 16 (TMEM16) family are Ca2+-regulated scramblases that facilitate the bidirectional movement of phospholipids across membranes necessary for diverse physiological processes. The nhTMEM16 scramblase (from the fungus Nectria hematococca) is a homodimer with a large cytoplasmic region and a hydrophilic, membrane-exposed groove in each monomer. The groove provides the transbilayer conduit for lipids, but the mechanism by which Ca2+ regulates it is not clear. Because fusion of large protein tags at either the N or C terminus abolishes nhTMEM16 activity, we hypothesized that its cytoplasmic portion containing both termini may regulate lipid translocation via a Ca2+-dependent conformational change. To test this hypothesis, here we used fluorescence methods to map key distances within the nhTMEM16 homodimer and between its termini and the membrane. To this end, we developed functional nhTMEM16 variants bearing an acyl carrier protein (ACP) tag at one or both of the termini. These constructs were fluorescently labeled by ACP synthase-mediated insertion of CoA-conjugated fluorophores and reconstituted into vesicles containing fluorescent lipids to obtain the distance of closest approach between the labeled tag and the membrane via FRET. Fluorescence lifetime measurements with phasor analysis were used to determine the distance between the N and C termini of partnering monomers in the nhTMEM16 homodimer. We now report that the measured distances do not vary significantly between Ca2+-replete and EGTA-treated samples, indicating that whereas the cytoplasmic portion of the protein is important for function, it does not appear to regulate scramblase activity via a detectable conformational change.	[Andra, Kiran K.; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA; [Dorsey, Savanna; Royer, Catherine A.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA	Cornell University; Rensselaer Polytechnic Institute	Menon, AK (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	akm2003@med.cornell.edu	Menon, Anant/AAN-8663-2021; Royer, Catherine A/E-5266-2016	Menon, Anant/0000-0001-6924-2698; Royer, Catherine A/0000-0002-2670-3391; Andra, Kiran K/0000-0003-2204-0911	National Institutes of Health [R01 GM106717]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM106717 (to A. K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAIRD B, 1985, BIOCHEMISTRY-US, V24, P6252, DOI 10.1021/bi00343a032; Bethel NP, 2016, P NATL ACAD SCI USA, V113, P14049, DOI 10.1073/pnas.1607574113; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Brunner JD, 2016, CURR OPIN STRUC BIOL, V39, P61, DOI 10.1016/j.sbi.2016.05.020; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; Day RN, 2014, METHODS, V66, P200, DOI 10.1016/j.ymeth.2013.06.017; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Gyobu S, 2017, P NATL ACAD SCI USA, V114, P6274, DOI 10.1073/pnas.1703391114; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3475, DOI 10.1021/bi00283a026; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3466, DOI 10.1021/bi00283a025; Jiang T, 2017, ELIFE, V6, DOI 10.7554/eLife.28671; Johnsson N, 2005, CHEMBIOCHEM, V6, P47, DOI 10.1002/cbic.200400290; Kobayashi T, 2018, CURR BIOL, V28, pR386, DOI 10.1016/j.cub.2018.01.007; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee BC, 2016, BIOPHYS J, V111, P1919, DOI 10.1016/j.bpj.2016.09.032; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Montigny C, 2016, BBA-MOL CELL BIOL L, V1861, P767, DOI 10.1016/j.bbalip.2015.12.020; Pandey K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16842-z; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Paulino C, 2017, ELIFE, V6, DOI 10.7554/eLife.26232; Ploier B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12832; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saha J, 2015, SPECTROCHIM ACTA A, V149, P143, DOI 10.1016/j.saa.2015.04.027; SHAKLAI N, 1977, BIOCHEMISTRY-US, V16, P5585, DOI 10.1021/bi00644a031; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Szmacinski H, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046017; Vogel SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049593; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Wielandt AG, 2015, J BIOL CHEM, V290, P16281, DOI 10.1074/jbc.M114.617746; Ziomkiewicz I, 2013, CYTOM PART A, V83, P794, DOI 10.1002/cyto.a.22311	39	6	6	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12248	12258		10.1074/jbc.RA118.003648	http://dx.doi.org/10.1074/jbc.RA118.003648			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29903908	hybrid, Green Published			2022-12-28	WOS:000440803200022
J	Li, D; Wang, L; Maziuk, BF; Yao, XD; Wolozin, B; Cho, YK				Li, Dan; Wang, Lei; Maziuk, Brandon F.; Yao, Xudong; Wolozin, Benjamin; Cho, Yong Ku			Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodegeneration; antibody; tau protein (tau); protein phosphorylation; immunochemistry; affinity; anti-PTM antibody; phospho-specific; post-translational modification; antibody specificity	SINGLE-CHAIN ANTIBODY; PAIRED HELICAL FILAMENTS; YEAST SURFACE DISPLAY; SACCHAROMYCES-CEREVISIAE; POSTTRANSLATIONAL MODIFICATIONS; ALZHEIMERS-DISEASE; MOUSE MODEL; TYROSINE PHOSPHORYLATION; POLYPEPTIDE LIBRARIES; CEREBROSPINAL-FLUID	Antibodies are essential biochemical reagents for detecting protein post-translational modifications (PTMs) in complex samples. However, recent efforts in developing PTM-targeting antibodies have reported frequent nonspecific binding and limited affinity of such antibodies. To address these challenges, we investigated whether directed evolution could be applied to improve the affinity of a high-specificity antibody targeting phosphothreonine 231 (pThr-231) of the human microtubule-associated protein tau. On the basis of existing structural information, we hypothesized that improving antibody affinity may come at the cost of loss in specificity. To test this hypothesis, we developed a novel approach using yeast surface display to quantify the specificity of PTM-targeting antibodies. When we affinity-matured the single-chain variable antibody fragment through directed evolution, we found that its affinity can be improved >20-fold over that of the WT antibody, reaching a picomolar range. We also discovered that most of the high-affinity variants exhibit cross-reactivity toward the nonphosphorylated target site but not to the phosphorylation site with a scrambled sequence. However, systematic quantification of the specificity revealed that such a tradeoff between the affinity and specificity did not apply to all variants and led to the identification of a picomolar-affinity variant that has a matching high specificity of the original phosphotau antibody. In cell- and tissue-imaging experiments, the high-affinity variant gave significantly improved signal intensity while having no detectable nonspecific binding. These results demonstrate that directed evolution is a viable approach for obtaining high-affinity PTM-specific antibodies and highlight the importance of assessing the specificity in the antibody engineering process.	[Li, Dan] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA; [Wang, Lei] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Cho, Yong Ku] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT 06269 USA; [Yao, Xudong; Cho, Yong Ku] Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA; [Maziuk, Brandon F.; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Boston University	Cho, YK (corresponding author), Univ Connecticut, Inst Syst Genom, Dept Chem & Biomol Engn, Storrs, CT 06269 USA.; Cho, YK (corresponding author), Univ Connecticut, Inst Syst Genom, Dept Biomed Engn, Storrs, CT 06269 USA.	cho@uconn.edu		Cho, Yong Ku/0000-0001-5621-521X	National Institutes of Health [NS099903, AG050471, NS089544, ES020395, NS106751]; National Science Foundation [1706743]; Brain and Behavior Research Foundation (National Alliance for Research on Schizophrenia and Depression Young Investigator); BrightFocus Foundation; Alzheimer Association; Cure Alzheimer's Fund; Edward N. and Della L. Thome Memorial Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS106751, R01NS089544, R03NS099903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050471, P30AG013846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Brain and Behavior Research Foundation (National Alliance for Research on Schizophrenia and Depression Young Investigator); BrightFocus Foundation(BrightFocus Foundation); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Cure Alzheimer's Fund; Edward N. and Della L. Thome Memorial Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant NS099903, National Science Foundation Grant 1706743, and the Brain and Behavior Research Foundation (National Alliance for Research on Schizophrenia and Depression Young Investigator) (to Y. K. C.); National Institutes of Health Grants AG050471, NS089544, and ES020395 and the BrightFocus Foundation, Alzheimer Association, Cure Alzheimer's Fund, and Edward N. and Della L. Thome Memorial Foundation (to B. W.); and National Institutes of Health Grant NS106751 (to B. M.). B. W. is cofounder and chief scientific officer of Aquinnah Pharmaceuticals Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikary R, 2015, BIOCHEMISTRY-US, V54, P2085, DOI 10.1021/bi501417q; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Arai H, 2000, EXP NEUROL, V166, P201, DOI 10.1006/exnr.2000.7501; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Baybutt H, 1997, GENE, V184, P125, DOI 10.1016/S0378-1119(96)00600-2; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bock I, 2011, EPIGENETICS-US, V6, P256, DOI 10.4161/epi.6.2.13837; Boder ET, 1998, BIOTECHNOL PROGR, V14, P55, DOI 10.1021/bp970144q; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brumbaugh K, 2011, METHODS MOL BIOL, V717, P3, DOI 10.1007/978-1-61779-024-9_1; Burns ML, 2014, APPL ENVIRON MICROB, V80, P5732, DOI 10.1128/AEM.01466-14; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cho YK, 2009, J IMMUNOL METHODS, V341, P117, DOI 10.1016/j.jim.2008.11.005; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; CZERNIK AJ, 1991, METHOD ENZYMOL, V201, P264; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Ercan E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0229-1; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hackel BJ, 2006, PHARM RES-DORDR, V23, P790, DOI 10.1007/s11095-006-9778-7; Hampel H, 2005, ARCH NEUROL-CHICAGO, V62, P770, DOI 10.1001/archneur.62.5.770; Helma J, 2015, J CELL BIOL, V209, P633, DOI 10.1083/jcb.201409074; Hoffmann NA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-82; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Huang D, 2005, BIOTECHNOL PROGR, V21, P349, DOI 10.1021/bp0497482; Irwin DJ, 2013, AM J PATHOL, V183, P344, DOI 10.1016/j.ajpath.2013.04.025; Ising C, 2017, J EXP MED, V214, P1227, DOI 10.1084/jem.20162125; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kehoe JW, 2006, MOL CELL PROTEOMICS, V5, P2350, DOI 10.1074/mcp.M600314-MCP200; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Koerber JT, 2013, NAT BIOTECHNOL, V31, P916, DOI 10.1038/nbt.2672; Kohnken R, 2000, NEUROSCI LETT, V287, P187, DOI 10.1016/S0304-3940(00)01178-2; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Krishnaswamy S, 2014, J NEUROSCI, V34, P16835, DOI 10.1523/JNEUROSCI.2755-14.2014; Kurosawa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep25174; Li CZ, 2017, NAT REV DRUG DISCOV, V16, P863, DOI 10.1038/nrd.2017.155; Liu HL, 2016, RADIOLOGY, V281, P99, DOI 10.1148/radiol.2016152444; Lothrop AP, 2013, FEBS LETT, V587, P1247, DOI 10.1016/j.febslet.2013.01.047; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Nisbet RM, 2017, BRAIN, V140, P1220, DOI 10.1093/brain/awx052; OI VT, 1982, J CELL BIOL, V93, P981, DOI 10.1083/jcb.93.3.981; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Rosseels J, 2015, J BIOL CHEM, V290, P4059, DOI 10.1074/jbc.M114.627919; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/NMETH.1855, 10.1038/nmeth.1855]; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Shih HH, 2012, J BIOL CHEM, V287, P44425, DOI 10.1074/jbc.M112.415935; Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773; Sun YL, 2017, JOVE-J VIS EXP, DOI 10.3791/56188; Swers JS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh030; Tak H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081682; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; van der Mijn JC, 2015, J PROTEOMICS, V127, P259, DOI 10.1016/j.jprot.2015.04.006; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	73	9	9	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12081	12094		10.1074/jbc.RA118.003557	http://dx.doi.org/10.1074/jbc.RA118.003557			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29899114	Green Published, hybrid			2022-12-28	WOS:000440803200009
J	Li, XY; Wang, LQ; Fang, P; Sun, Y; Jiang, XH; Wang, H; Yang, XF				Li, Xinyuan; Wang, Luqiao; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng			Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; lysophospholipid; metabolism; endothelial cell; atherosclerosis; immunometabolism; lysophosphatidylcholine; lysophosphatidylinositol; RNA-Seq; transdifferentiation	ACUTE CORONARY SYNDROME; PHOSPHOLIPASE A(2) INHIBITOR; RANDOMIZED CLINICAL-TRIAL; MESENCHYMAL TRANSITION; ATHEROSCLEROTIC PLAQUE; VASCULAR INFLAMMATION; CARDIOVASCULAR EVENTS; DISEASE; VARESPLADIB; METABOLISM	Innate immune cells express danger-associated molecular pattern (DAMP) receptors, T-cell costimulation/coinhibition receptors, and major histocompatibility complex II (MHC-II). We have recently proposed that endothelial cells can serve as innate immune cells, but the molecular mechanisms involved still await discovery. Here, we investigated whether human aortic endothelial cells (HAECs) could be transdifferentiated into innate immune cells by exposing them to hyperlipidemia-up-regulated DAMP molecules, i.e. lysophospholipids. Performing RNA-seq analysis of lysophospholipid-treated HAECs, we found that lysophosphatidylcholine (LPC) and lysophosphatidylinositol (LPI) regulate largely distinct gene programs as revealed by principal component analysis. Metabolically, LPC up-regulated genes that are involved in cholesterol biosynthesis, presumably through sterol regulatory element-binding protein 2 (SREBP2). By contrast, LPI up-regulated gene transcripts critical for the metabolism of glucose, lipids, and amino acids. Of note, we found that LPC and LPI both induce adhesion molecules, cytokines, and chemokines, which are all classic markers of endothelial cell activation, in HAECs. Moreover, LPC and LPI shared the ability to transdifferentiate HAECs into innate immune cells, including induction of potent DAMP receptors, such as CD36 molecule, T-cell costimulation/coinhibition receptors, and MHC-II proteins. The induction of these innate-immunity signatures by lysophospholipids correlated with their ability to induce up-regulation of cytosolic calcium and mitochondrial reactive oxygen species. In conclusion, lysophospholipids such as LPC and LPI induce innate immune cell transdifferentiation in HAECs. The concept of prolonged endothelial activation, discovered here, is relevant for designing new strategies for managing cardiovascular diseases.	[Li, Xinyuan; Wang, Luqiao; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Ctr Metab Dis Res, MERB 1059,3500 North Broad St, Philadelphia, PA 19140 USA; [Li, Xinyuan; Wang, Luqiao; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Ctr Cardiovasc Res, MERB 1059,3500 North Broad St, Philadelphia, PA 19140 USA; [Li, Xinyuan; Wang, Luqiao; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Ctr Thrombosis Res, Philadelphia, PA 19140 USA; [Li, Xinyuan; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Li, Xinyuan; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Microbiol, Philadelphia, PA 19140 USA; [Li, Xinyuan; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Immunol, Philadelphia, PA 19140 USA; [Wang, Luqiao] Kunming Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Kunming 650031, Yunnan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Kunming Medical University	Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Metab Dis Res, MERB 1059,3500 North Broad St, Philadelphia, PA 19140 USA.; Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Cardiovasc Res, MERB 1059,3500 North Broad St, Philadelphia, PA 19140 USA.	xfyang@temple.edu	Li, Xinyuan/Z-6299-2019; Li, Xinyuan/B-1139-2015; SUN, YU/ABE-7355-2021	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367; SUN, YU/0000-0002-0877-7186; wang, luqiao/0000-0003-0263-9492	NHLBI, National Institutes of Health [HL131460, HL132399, HL138749, HL130233, HL110764, HL117654]; NIDDK, National Institutes of Health [DK104116, DK113775]; American Heart Association Scientist Development Grant [17SDG33671051]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132399, R01HL138749, R01HL131460, R01HL130233, R01HL117654, R01HL110764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104116, R01DK113775] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grants HL131460, HL132399, HL138749, HL130233, HL110764, and HL117654 from the NHLBI, National Institutes of Health and Grants DK104116 and DK113775 from the NIDDK, National Institutes of Health (to X.-F. Y. and H. W.) and American Heart Association Scientist Development Grant 17SDG33671051 (to P. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Beiting DP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cheng JL, 2017, ADV EXP MED BIOL, V982, P359, DOI 10.1007/978-3-319-55330-6_20; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Drzazga A, 2017, BIOCHEM BIOPH RES CO, V489, P242, DOI 10.1016/j.bbrc.2017.05.145; Du FY, 2012, FRONT BIOSCI-LANDMRK, V17, P2327, DOI 10.2741/4055; Dushkin MI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P327, DOI 10.1134/S0006297912040025; Evrard SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11853; Fang P, 2014, DIABETES, V63, P4275, DOI 10.2337/db14-0809; Ferrer LM, 2016, J CARDIOVASC TRANSL, V9, P135, DOI 10.1007/s12265-016-9683-3; Filadi R, 2017, CELL CALCIUM, V62, P1, DOI 10.1016/j.ceca.2017.01.003; Fraser H, 2009, J CARDIOVASC PHARM, V53, P60, DOI 10.1097/FJC.0b013e318195bfbc; Fu HF, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0440-0; Gaber T, 2017, NAT REV RHEUMATOL, V13, P267, DOI 10.1038/nrrheum.2017.37; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jang C, 2013, NATURE, V500, P409, DOI 10.1038/nature12549; Ke XY, 2008, FRONT BIOSCI-LANDMRK, V13, P3986, DOI 10.2741/2986; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Langston PK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00061; Li XY, 2018, ARTERIOSCL THROM VAS, V38, P599, DOI 10.1161/ATVBAHA.117.310626; Li XY, 2019, CYTOKINE, V122, DOI 10.1016/j.cyto.2017.06.003; Li XY, 2017, CAN J PHYSIOL PHARM, V95, P247, DOI 10.1139/cjpp-2016-0515; Li XY, 2016, ARTERIOSCL THROM VAS, V36, P1090, DOI 10.1161/ATVBAHA.115.306964; Li YF, 2016, FRONT BIOSCI-LANDMRK, V21, P178, DOI 10.2741/4383; Li YF, 2016, FRONT BIOSCI-LANDMRK, V21, P70, DOI 10.2741/4377; Li YF, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0130-8; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Man K, 2017, CELL METAB, V25, P11, DOI 10.1016/j.cmet.2016.08.016; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Monroy MA, 2015, FRONT BIOSCI-LANDMRK, V20, P784, DOI 10.2741/4337; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; O'Donoghue ML, 2014, JAMA-J AM MED ASSOC, V312, P1006, DOI 10.1001/jama.2014.11061; Packard RRS, 2009, SEMIN IMMUNOPATHOL, V31, P5, DOI 10.1007/s00281-009-0153-8; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Rosenson RS, 2010, J AM COLL CARDIOL, V56, P1079, DOI 10.1016/j.jacc.2010.06.015; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Sha XJ, 2015, J BIOL CHEM, V290, P19307, DOI 10.1074/jbc.M115.663286; Shao Y, 2018, ANTIOXID REDOX SIGN, V28, P973, DOI 10.1089/ars.2017.7069; Shao Y, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0080-6; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Virtue A, 2017, J BIOL CHEM, V292, P1267, DOI 10.1074/jbc.M116.739839; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wang X, 2016, J CARDIOVASC TRANSL, V9, P343, DOI 10.1007/s12265-016-9700-6; White HD, 2014, NEW ENGL J MED, V370, P1702, DOI 10.1056/NEJMoa1315878; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Xi H, 2016, CIRC RES, V118, P1525, DOI 10.1161/CIRCRESAHA.116.308501; Xiao H, 2013, CIRCULATION, V128, P632, DOI 10.1161/CIRCULATIONAHA.113.002714; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Xu KM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00045; Yamashita A, 2013, PROSTAG OTH LIPID M, V107, P103, DOI 10.1016/j.prostaglandins.2013.05.004; Yang WY, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0001-0; Yang XF, 2006, INT J IMMUNOPATH PH, V19, P853, DOI 10.1177/039463200601900415; Yin Y, 2015, ARTERIOSCL THROM VAS, V35, P804, DOI 10.1161/ATVBAHA.115.305282; Yin Y, 2013, FRONT BIOSCI-LANDMRK, V18, P638, DOI 10.2741/4127	59	48	49	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11033	11045		10.1074/jbc.RA118.002752	http://dx.doi.org/10.1074/jbc.RA118.002752			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29769317	Green Published, hybrid			2022-12-28	WOS:000438882800016
J	Qin, LY; Sankaran, B; Aminzai, S; Casteel, DE; Kim, C				Qin, Liying; Sankaran, Banumathi; Aminzai, Sahar; Casteel, Darren E.; Kim, Choel			Structural basis for selective inhibition of human PKG I by the balanol-like compound N46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); protein kinase G (PKG); inhibitor; crystal structure; drug design; ATP competitive inhibitor; inhibitor specificity; nonopioid analgesics; protein-ligand complex	DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; PAIN HYPERSENSITIVITY; CATALYTIC SUBUNIT; CGMP-BINDING; NERVE INJURY; ACTIVATION; COMPLEX; SPECIFICITY; REVEALS	Activation of protein kinase G (PKG) I in nociceptive neurons induces long-term hyperexcitability that causes chronic pain. Recently, a derivative of the fungal metabolite balanol, N46, has been reported to inhibit PKG I with high potency and selectivity and attenuate thermal hyperalgesia and osteoarthritic pain. Here we determined co-crystal structures of the PKG I C-domain and cAMP-dependent protein kinase (PKA) C, each bound with N46, at 1.98 and 2.65 , respectively. N46 binds the active site with its external phenyl ring, specifically interacting with the glycine-rich loop and the C helix. Phe-371 at the PKG I glycine-rich loop is oriented parallel to the phenyl ring of N46, forming a strong -stacking interaction, whereas the analogous Phe-54 in PKA C rotates 30 degrees and forms a weaker interaction. Structural comparison revealed that steric hindrance between the preceding Ser-53 and the propoxy group of the phenyl ring may explain the weaker interaction with PKA C. The analogous Gly-370 in PKG I, however, causes little steric hindrance with Phe-371. Moreover, Ile-406 on the C helix forms a hydrophobic interaction with N46 whereas its counterpart in PKA, Thr-88, does not. Substituting these residues in PKG I with those in PKA C increases the IC50 values for N46, whereas replacing these residues in PKA C with those in PKG I reduces the IC50, consistent with our structural findings. In conclusion, our results explain the structural basis for N46-mediated selective inhibition of human PKG I and provide a starting point for structure-guided design of selective PKG I inhibitors.	[Qin, Liying; Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Aminzai, Sahar; Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Diego; Baylor College of Medicine	Kim, C (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Casteel, DE (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Kim, C (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA.	dcasteel@ucsd.edu; ckim@bcm.edu			National Institutes of Health [S10OD021832]; Howard Hughes Medical Institute; NIGMS, National Institutes of Health National [P30 GM124169-01]; Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161, P30GM124169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS, National Institutes of Health National; Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Andrey Kovalevsky and Friedrich W. Herberg for critical reading of the manuscript. We also thank Paul Leonard (MD Anderson Cancer Center) for assistance with the initial screening of the PKG I-N46 complex crystals and Ying-Ju Sung (Geisinger Commonwealth School of Medicine) for kindly providing N46. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health; the NIGMS, National Institutes of Health; and the Howard Hughes Medical Institute. The ALS-ENABLE beamlines are supported in part by NIGMS, National Institutes of Health National Grant P30 GM124169-01. The Advanced Light Source is a Department of Energy Office of Science User Facility under Contract DE-AC02-05CH11231. The Pilatus detector was funded under National Institutes of Health Grant S10OD021832.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berndt N, 2017, CURR OPIN CHEM BIOL, V39, P126, DOI 10.1016/j.cbpa.2017.06.015; Boric M, 2014, J CHEM NEUROANAT, V61-62, P140, DOI 10.1016/j.jchemneu.2014.09.004; Burkhardt M, 2000, J BIOL CHEM, V275, P33536, DOI 10.1074/jbc.M005670200; BUTT E, 1990, FEBS LETT, V263, P47, DOI 10.1016/0014-5793(90)80702-K; Butt Elke, 2009, V191, P409, DOI 10.1007/978-3-540-68964-5_17; Campbell JC, 2017, ACS CHEM BIOL, V12, P2388, DOI 10.1021/acschembio.7b00369; Campbell JC, 2017, FEBS LETT, V591, P221, DOI 10.1002/1873-3468.12505; Council of Economic Advisers, 2017, UND COST OP CRIS; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Fountas A, 2015, TRENDS ENDOCRIN MET, V26, P643, DOI 10.1016/j.tem.2015.09.003; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Gangadharan V, 2017, MOL PAIN, V13, DOI 10.1177/1744806917701743; Gustafsson AB, 1999, MOL PHARMACOL, V56, P377, DOI 10.1124/mol.56.2.377; Hedegaard Holly, 2017, NCHS Data Brief, P1; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hofmann Franz, 2013, Methods Mol Biol, V1020, P17, DOI 10.1007/978-1-62703-459-3_2; Kalyanaraman H, 2017, J BIOL CHEM, V292, P8262, DOI 10.1074/jbc.C117.787358; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; KOIDE K, 1995, CHEM BIOL, V2, P601, DOI 10.1016/1074-5521(95)90124-8; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Luo C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001283; Marsico F, 2017, J CARDIOVASC MED, V18, pe40, DOI 10.2459/JCM.0000000000000443; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Narayana N, 1999, BIOCHEMISTRY-US, V38, P2367, DOI 10.1021/bi9820659; Office of the Surgeon General, 2016, FAC ADD AM SURG GEN; Ono-Saito N, 1999, PHARMACOL THERAPEUT, V82, P123, DOI 10.1016/S0163-7258(98)00070-9; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Rummans TA, 2018, MAYO CLIN PROC, V93, P344, DOI 10.1016/j.mayocp.2017.12.020; Ryan SA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-4129; Setyawan J, 1999, MOL PHARMACOL, V56, P370, DOI 10.1124/mol.56.2.370; Sung YJ, 2006, NEUROSCIENCE, V141, P697, DOI 10.1016/j.neuroscience.2006.04.033; Sung YJ, 2017, PAIN, V158, P822, DOI 10.1097/j.pain.0000000000000832; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Wagner J, 2009, J MED CHEM, V52, P6193, DOI 10.1021/jm901108b; Walitt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138024; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Wolfertstetter S, 2013, PHARMACEUTICALS, V6, P269, DOI 10.3390/ph6020269	46	7	7	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10985	10992		10.1074/jbc.RA118.002427	http://dx.doi.org/10.1074/jbc.RA118.002427			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29769318	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000438882800012
J	Zhu, WY; Tomberg, J; Knilans, KJ; Anderson, JE; McKinnon, KP; Sempowski, GD; Nicholas, RA; Duncan, JA				Zhu, Weiyan; Tomberg, Joshua; Knilans, Kayla J.; Anderson, James E.; McKinnon, Karen P.; Sempowski, Gregory D.; Nicholas, Robert A.; Duncan, Joseph A.			Properly folded and functional PorB from Neisseria gonorrhoeae inhibits dendritic cell stimulation of CD4(+) T cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE VESICLES; IMMUNE-RESPONSES; MENINGITIDIS; ACTIVATION; TLR2; RESISTANCE; PROTEINS; INVASION; BLEBS; ROLES	Neisseria gonorrhoeae is an exclusive human pathogen that evades the host immune system through multiple mechanisms. We have shown that N. gonorrhoeae suppresses the capacity of antigen-presenting cells to induce CD4(+) T cell proliferation. In this study, we sought to determine the gonococcal factors involved in this adaptive immune suppression. We show that suppression of the capacity of antigen-pulsed dendritic cells to induce T cell proliferation is recapitulated by administration of a high-molecular-weight fraction of conditioned medium from N. gonorrhoeae cultures, which includes outer membrane vesicles that are shed during growth of the bacteria. N. gonorrhoeae PorB is the most abundant protein in N. gonorrhoeae-derived vesicles, and treatment of dendritic cells with purified recombinant PorB inhibited the capacity of the cells to stimulate T cell proliferation. This immunosuppressive feature of purified PorB depended on proper folding of the protein. PorB from N. gonorrhoeae, as well as other Neisseria species and other Gram-negative bacterial species, are known to activate host Toll-like receptor 2 (TLR2) signaling. Published studies have demonstrated that purified Neisseria PorB forms proteinacious nanoparticles, termed proteosomes, when detergent micelles are removed. Unlike folded, detergent-solubilized PorB, PorB proteosomes stimulate immune responses. We now demonstrate that the formation of PorB proteosomes from structurally intact PorB eliminates the immunosuppressive property of the protein while enhancing TLR2 stimulation. These findings suggest that gonococcal PorB present in shed outer membrane vesicles plays a role in suppression of adaptive immune responses to this immune-evasive pathogen.	[Zhu, Weiyan; Anderson, James E.; Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Tomberg, Joshua; Knilans, Kayla J.; Nicholas, Robert A.; Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, CB 7365,4046 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA; [McKinnon, Karen P.; Nicholas, Robert A.] Univ N Carolina, Dept Microbiol & Immunol, CB 7365,4046 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [McKinnon, Karen P.; Duncan, Joseph A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nicholas, RA (corresponding author), Univ N Carolina, Dept Pharmacol, CB 7365,4046 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Nicholas, RA (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, CB 7365,4046 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Duncan, JA (corresponding author), Univ N Carolina, Dept Med, CB 7030,8341B Med & Biomol Res Bldg, Chapel Hill, NC 27599 USA.; Duncan, JA (corresponding author), Univ N Carolina, Dept Pharmacol, CB 7030,8341B Med & Biomol Res Bldg, Chapel Hill, NC 27599 USA.	nicholas@med.unc.edu; jaduncan@med.unc.edu		Duncan, Joseph/0000-0002-4438-2018; Sempowski, Gregory/0000-0003-0391-6594	Burroughs Wellcome Fund Career Awards for Medical Scientists; National Institutes of Health [U19-AI031496, U19-AI113170-01, UC6-AI058607]; NIGMS [R01-GM066861]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031496, T32AI007001, UC6AI058607, U19AI113170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066861] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Awards for Medical Scientists; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the Burroughs Wellcome Fund Career Awards for Medical Scientists (to J. A. D.) and the National Institutes of Health through the following grants and contracts: U19-AI031496 (Southeastern Sexually Transmitted Infection Cooperative Research Center) (to J. A. D. and G. D. S.); U19-AI113170-01 (Atlantic Coast Sexually Transmitted Infection Cooperative Research Center) (to J. A. D., G. D. S., and R. A. N.); UC6-AI058607 (Regional Biocontainment Laboratory at Duke University Medical Center) (to G. D. S.); and NIGMS Grant R01-GM066861 (to R. A. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JE, 2003, MOL MICROBIOL, V48, P1325, DOI 10.1046/j.1365-2958.2003.03496.x; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 2001, J BIOL CHEM, V276, P17413, DOI 10.1074/jbc.M010609200; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Duluc D, 2013, MUCOSAL IMMUNOL, V6, P626, DOI 10.1038/mi.2012.104; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Faulstich M, 2015, CELL MICROBIOL, V17, P241, DOI 10.1111/cmi.12361; Fox K K, 1999, Curr Opin Urol, V9, P65, DOI 10.1097/00042307-199901000-00011; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; Jerse AE, 2013, SEX TRANSM INFECT, V89, P63, DOI 10.1136/sextrans-2013-051225; JOHNSTON KH, 1974, J BACTERIOL, V119, P250, DOI 10.1128/JB.119.1.250-257.1974; Kattner C, 2014, J STRUCT BIOL, V185, P440, DOI 10.1016/j.jsb.2013.12.006; Katz AR, 2012, CLIN INFECT DIS, V54, P841, DOI 10.1093/cid/cir929; Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629; Lappann M, 2013, J BACTERIOL, V195, P4425, DOI 10.1128/JB.00625-13; Liu XP, 2008, VACCINE, V26, P786, DOI 10.1016/j.vaccine.2007.11.080; Liu Y, 2014, MUCOSAL IMMUNOL, V7, P165, DOI 10.1038/mi.2013.36; Liu YR, 2011, MBIO, V2, DOI 10.1128/mBio.00095-11; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Massari P, 2005, PROTEIN EXPRES PURIF, V44, P136, DOI 10.1016/j.pep.2005.04.021; Massari P, 2003, CELL MICROBIOL, V5, P99, DOI 10.1046/j.1462-5822.2003.00257.x; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Mosaheb MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00225; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Murshid A, 2015, CYTOKINE, V75, P256, DOI 10.1016/j.cyto.2015.02.009; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Olesky M, 2006, J BACTERIOL, V188, P2300, DOI 10.1128/JB.188.7.2300-2308.2006; Platt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082171; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Rouquette-Loughlin CE, 2017, MBIO, V8, DOI 10.1128/mBio.00449-17; Shafer WM, 2002, J ENDOTOXIN RES, V8, P47, DOI 10.1179/096805102125000083; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Singleton TE, 2005, J IMMUNOL, V174, P3545, DOI 10.4049/jimmunol.174.6.3545; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Toussi DN, 2012, INFECT IMMUN, V80, P3417, DOI 10.1128/IAI.00683-12; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/FMB.12.117, 10.2217/fmb.12.117]; van Vliet SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000625; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x; WETZLER LM, 1992, INFECT IMMUN, V60, P39, DOI 10.1128/IAI.60.1.39-43.1992; Yu QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056705; Zhang YL, 2015, ONCOTARGET, V6, P19936, DOI 10.18632/oncotarget.4582; Zhu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041260; Zughaier S, 2006, VACCINE, V24, P1291, DOI 10.1016/j.vaccine.2005.09.039	49	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11218	11229		10.1074/jbc.RA117.001209	http://dx.doi.org/10.1074/jbc.RA117.001209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29752412	Green Published, hybrid			2022-12-28	WOS:000438882800032
J	Li, XL; Wu, CL; Shen, Y; Wang, K; Tang, L; Zhou, M; Yang, M; Pan, TY; Liu, XH; Xu, WM				Li, Xiaoliang; Wu, Chunlian; Shen, Ying; Wang, Ke; Tang, Li; Zhou, Mi; Yang, Ming; Pan, Tianying; Liu, Xinghui; Xu, Wenming			Ten-eleven translocation 2 demethylates the MMP9 promoter, and its down-regulation in preeclampsia impairs trophoblast migration and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; pregnancy; placenta; metalloprotease; DNA demethylation; preeclampsia; pregnancy complication; TET2; trophoblast; MMP9; methylation	DNA METHYLATION; HTR8/SVNEO INVASION; TET2 FUNCTION; MATRIX-METALLOPROTEINASE-9; HYPERMETHYLATION; EXPRESSION; CONTRIBUTES; PREVENTION; PLACENTA	Preeclampsia is the most common clinical disorder in pregnancy and might result from disordered uterine environments caused by epigenetic modifications, including deregulation of DNA methylation/demethylation. Recent research has indicated that 5-hydroxymethylcytosine (5hmC), a DNA base derived from 5-methylcytosine (5mC) via oxidation by ten-eleven translocation (TET) enzymes, is involved in DNA methylation-related plasticity. Here, we report that TET2 expression and 5hmC abundance are significantly altered in the placentas from preeclampsia patients. shRNA-mediated TET2 knockdown (shTET2) reduced trophoblast migration and invasion when cultured in Matrigel. Both real-time PCR of matrix metalloproteinase (MMP)-related transcripts and a human angiogenesis antibody array indicated that TET2 knockdown in trophoblasts inhibits the expression of MMP transcript, of which MMP9 represented one of the most significant TET2 downstream targets. Using an established shTET2 HTR-8/SVneo cell model, we further confirmed alterations of 5hmC levels and MMP9 expression at both mRNA and protein levels. In particular, we found that TET2 bound to and removed 5mC modifications at the MMP9 promoter region. Interestingly, in TET2 knockdown cells, both MMP9 expression and the compromised trophoblast phenotype could be rescued by vitamin C, an activator of TET enzyme activity. Finally, TET2 expression correlated with MMP9 levels in placenta samples from the preeclampsia patients, indicating that TET2 deregulation is critically involved in the pathogenesis of preeclampsia through down-regulation of MMP9 expression. Our findings highlight a critical role of TET2 in regulating trophoblast cell migration through demethylation at the MMP9 promoter, and suggest that down-regulation of the TET2-MMP9-mediated pathway contributes to preeclampsia pathogenesis.	[Li, Xiaoliang; Shen, Ying; Wang, Ke; Tang, Li; Zhou, Mi; Yang, Ming; Pan, Tianying; Xu, Wenming] Sichuan Univ, West China Univ Hosp 2, Joint Lab Reprod Med,Minist Educ, SCU CUHK,Key Lab Obstet Gynecol & Pediat Dis & Bi, Chengdu 610041, Sichuan, Peoples R China; [Li, Xiaoliang; Shen, Ying; Wang, Ke; Tang, Li; Zhou, Mi; Yang, Ming; Pan, Tianying; Liu, Xinghui; Xu, Wenming] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol Dis, Chengdu 610041, Sichuan, Peoples R China; [Li, Xiaoliang; Wu, Chunlian] China West Normal Univ, Minist Educ, Key Lab Southwest China Wildlife Resource Conserv, Nanchong 637009, Peoples R China	Sichuan University; Sichuan University; China West Normal University	Xu, WM (corresponding author), 3duan 17, Chengdu 610041, Sichuan, Peoples R China.	Xinghuiliu@163.com; xuwenming@scu.edu.cn	shen, ying/HHS-5635-2022	Xu, wenming/0000-0002-3686-229X	Natural Science Foundation of China [81300494, 81471463]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China Grants 81300494 and 81471463. The authors declare that they have no conflicts of interest with the contents of this article.	Abad C, 2012, HYPERTENS PREGNANCY, V31, P427, DOI 10.3109/10641955.2012.690058; Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; An J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.5; Anderson CM, 2014, BIOL RES NURS, V16, P409, DOI 10.1177/1099800413508645; Azami M, 2017, INT J REPROD BIOMED, V15, P273; Bowman RL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026518; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P531, DOI 10.1038/nrneph.2014.103; Chinnathambi V, 2013, HYPERTENSION, V61, P647, DOI 10.1161/HYPERTENSIONAHA.111.00486; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Duraisamy AJ, 2017, INVEST OPHTH VIS SCI, V58, P6440, DOI 10.1167/iovs.17-22706; Fan M, 2016, CELL PHYSIOL BIOCHEM, V38, P1319, DOI 10.1159/000443076; Gao WL, 2011, HYPERTENS RES, V34, P655, DOI 10.1038/hr.2011.9; Kowluru RA, 2016, LAB INVEST, V96, P1040, DOI 10.1038/labinvest.2016.78; Ling L, 2013, J MOL ENDOCRINOL, V50, P279, DOI 10.1530/JME-12-0172; Lio CW, 2016, ELIFE, V5, DOI 10.7554/eLife.18290; Liu H, 2014, PLACENTA, V35, P981, DOI 10.1016/j.placenta.2014.09.016; Logan Philip C., 2013, Frontiers in Genetics, V4, P265, DOI 10.3389/fgene.2013.00265; Lorquet S, 2010, ACTA CLIN BELG, V65, P237, DOI 10.1179/acb.2010.051; Martin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141294; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Palei ACT, 2013, CURR DRUG TARGETS, V14, P325; Peng B, 2016, MOL HUM REPROD, V22, P119, DOI 10.1093/molehr/gav070; Plaks V, 2013, P NATL ACAD SCI USA, V110, P11109, DOI 10.1073/pnas.1309561110; Pushpakumar S, 2015, FASEB J, V29, P4713, DOI 10.1096/fj.15-272443; Qu K, 2017, INT J BIOL MACROMOL, V98, P637, DOI 10.1016/j.ijbiomac.2017.02.025; Rahat B, 2016, EPIGENOMICS-UK, V8, P767, DOI 10.2217/epi.16.7; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Shorey-Kendrick LE, 2017, AM J RESP CRIT CARE, V196, P745, DOI 10.1164/rccm.201610-2141OC; Takayama K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9219; Tan Q, 2016, CLIN ENDOCRINOL, V85, P54, DOI 10.1111/cen.13047; Tanaka S, 2014, INT J DEV BIOL, V58, P231, DOI 10.1387/ijdb.140053st; Tang L, 2017, REPRODUCTION, V153, pR27, DOI 10.1530/REP-16-0287; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; White WM, 2013, HYPERTENS PREGNANCY, V32, P257, DOI 10.3109/10641955.2013.796970; Yang M, 2016, PLACENTA, V41, P62, DOI 10.1016/j.placenta.2016.03.007; Yang Y, 2015, PLACENTA, V36, P587, DOI 10.1016/j.placenta.2015.01.201; Zhang JL, 2016, WOUND REPAIR REGEN, V24, P489, DOI 10.1111/wrr.12426; Zhang YW, 2017, MOL CELL, V65, P323, DOI 10.1016/j.molcel.2016.12.013; Zhu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134119	41	32	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10059	10070		10.1074/jbc.RA117.001265	http://dx.doi.org/10.1074/jbc.RA117.001265			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29773648	hybrid, Green Published			2022-12-28	WOS:000437096700011
J	Sasaki, T; Kuboyama, A; Mita, M; Murata, S; Shimizu, M; Inoue, J; Mori, K; Sato, R				Sasaki, Takashi; Kuboyama, Ayane; Mita, Moeko; Murata, Shotaro; Shimizu, Makoto; Inoue, Jun; Mori, Kazutoshi; Sato, Ryuichiro			The exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						skeletal muscle; bile acid; muscle hypertrophy; exercise; unfolded protein response (UPR); endoplasmic reticulum stress (ER stress); transcription regulation; muscle cell differentiation; TGR5	UNFOLDED PROTEIN RESPONSE; STRESS; HYPERTROPHY; IMPACT; MASS; CHOLESTEROL; ANTIOBESITY; ACTIVATION; RESISTANCE; INHIBITION	TGR5 (also known as G protein-coupled bile acid receptor 1, GPBAR1) is a G protein-coupled bile acid receptor that is expressed in many diverse tissues. TGR5 is involved in various metabolic processes, including glucose metabolism and energy expenditure; however, TGR5's function in skeletal muscle is not fully understood. Using both gain- and loss-of-function mouse models, we demonstrate here that Tgr5 activation promotes muscle cell differentiation and muscle hypertrophy. Both young and old transgenic mice with muscle-specific Tgr5 expression exhibited increased muscle strength. Moreover, we found that Tgr5 expression is increased by the unfolded protein response (UPR), which is an adaptive response required for maintenance of endoplasmic reticulum (ER) homeostasis. Both ER stress response element (ERSE)- and unfolded protein response element (UPRE)-like sites are present in the 5 upstream region of the Tgr5 gene promoter and are essential for Tgr5 expression by Atf6 (activating transcription factor 6), a well known UPR-activated transcriptional regulator. We observed that in the skeletal muscle of mice, exercise-induced UPR increases Tgr5 expression, an effect that was abrogated in Atf6 KO mice, indicating that Atf6 is essential for this response. These findings indicate that the bile acid receptor Tgr5 contributes to improved muscle function and provide an additional explanation for the beneficial effects of exercise on skeletal muscle activity.	[Sasaki, Takashi; Kuboyama, Ayane; Mita, Moeko; Murata, Shotaro; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo 1138657, Japan; [Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutri Life Sci Lab, Tokyo 1138657, Japan; [Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Sato, Ryuichiro] Japan Agcy Med Res & Dev, CREST, AMED, Tokyo 1000004, Japan	University of Tokyo; University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo 1138657, Japan.; Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutri Life Sci Lab, Tokyo 1138657, Japan.; Sato, R (corresponding author), Japan Agcy Med Res & Dev, CREST, AMED, Tokyo 1000004, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	Mori, Kazutoshi/AAW-5449-2020	Sasaki, Takashi/0000-0002-3352-0753	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15H05781, JP16K18699]; LOTTE Foundation; Cross-ministerial Strategic Innovation Promotion Program [14533567]; Japanese Agency for Medical Research and Development (AMED-CREST) [16gm0910008h0001]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); LOTTE Foundation; Cross-ministerial Strategic Innovation Promotion Program; Japanese Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant JP15H05781 (to R. S.) and JP16K18699 (to T. S.), research grants from the LOTTE Foundation (to M. S.), Cross-ministerial Strategic Innovation Promotion Program Grant 14533567 (to R. S.), and the Japanese Agency for Medical Research and Development (AMED-CREST) Grant 16gm0910008h0001 (to R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Benoit B, 2017, NAT MED, V23, P990, DOI 10.1038/nm.4363; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Cao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28676; Chen M, 2009, AM J PHYSIOL-CELL PH, V296, pC930, DOI 10.1152/ajpcell.00443.2008; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Horiba T, 2015, BIOCHEM BIOPH RES CO, V463, P846, DOI 10.1016/j.bbrc.2015.06.022; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kim HJ, 2011, MED SCI SPORT EXER, V43, P18, DOI 10.1249/MSS.0b013e3181e4c5d1; KIM YS, 1992, LIFE SCI, V50, P397, DOI 10.1016/0024-3205(92)90374-X; Kliewer SA, 2015, DIGEST DIS, V33, P327, DOI 10.1159/000371670; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Ono E, 2011, BIOCHEM BIOPH RES CO, V410, P677, DOI 10.1016/j.bbrc.2011.06.055; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Potthoff MJ, 2013, AM J PHYSIOL-GASTR L, V304, pG371, DOI 10.1152/ajpgi.00400.2012; Rajagopal S, 2013, AM J PHYSIOL-GASTR L, V304, pG527, DOI 10.1152/ajpgi.00388.2012; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Ryall JG, 2007, J GERONTOL A-BIOL, V62, P813, DOI 10.1093/gerona/62.8.813; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sasaki T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179226; Sasaki T, 2014, AM J PHYSIOL-ENDOC M, V306, pE1085, DOI 10.1152/ajpendo.00691.2013; Sato H, 2007, BIOCHEM BIOPH RES CO, V362, P793, DOI 10.1016/j.bbrc.2007.06.130; Sato R, 2013, VITAM HORM, V91, P425, DOI 10.1016/B978-0-12-407766-9.00018-3; Stewart R, 2013, P NATL ACAD SCI USA, V110, P117, DOI 10.1073/pnas.1212676110; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tontonoz P, 2015, MOL CELL BIOL, V35, P1125, DOI 10.1128/MCB.00715-14; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Vassileva G, 2010, J ENDOCRINOL, V205, P225, DOI 10.1677/JOE-10-0009; Velazquez-Villegas LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02068-0; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Worthmann A, 2017, NAT MED, V23, P839, DOI 10.1038/nm.4357; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	49	34	35	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10322	10332		10.1074/jbc.RA118.002733	http://dx.doi.org/10.1074/jbc.RA118.002733			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29773650	Green Published, hybrid			2022-12-28	WOS:000437096700030
J	Crabtree, MD; Mendonca, CATF; Bubb, QR; Clarke, J				Crabtree, Michael D.; Mendonca, Carolina A. T. F.; Bubb, Quenton R.; Clarke, Jane			Folding and binding pathways of BH3-only proteins are encoded within their intrinsically disordered sequence, not templated by partner proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; B cell lymphoma 2 (Bcl-2) family; biophysics; kinetics; protein folding; protein-protein interaction; thermodynamics; coupled folding and binding; IDP; phi value	TRANSITION-STATE; PEPTIDES; DOMAINS; KIX; MECHANISMS; MCL-1; PUMA	Intrinsically disordered regions are present in one-third of eukaryotic proteins and are overrepresented in cellular processes such as signaling, suggesting that intrinsically disordered proteins (IDPs) may have a functional advantage over folded proteins. Upon interacting with a partner macromolecule, a subset of IDPs can fold and bind to form a well-defined three-dimensional conformation. For example, disordered BH3-only proteins bind promiscuously to a large number of homologous BCL-2 family proteins, where they fold to a helical structure in a groove on the BCL-2-like protein surface. As two protein chains are involved in the folding reaction, and the structure is only formed in the presence of the partner macromolecule, this raises the question of where the folding information is encoded. Here, we examine these coupled folding and binding reactions to determine which component determines the folding and binding pathway. Using phi value analysis to compare transition state interactions between the disordered BH3-only proteins PUMA and BID and the folded BCL-2-like proteins A1 and MCL-1, we found that, even though the BH3-only protein is disordered in isolation and requires a stabilizing partner to fold, its folding and binding pathway is encoded in the IDP itself; the reaction is not templated by the folded partner. We suggest that, by encoding both its transition state and level of residual structure, an IDP can evolve a specific kinetic profile, which could be a crucial functional advantage of disorder.	[Crabtree, Michael D.; Mendonca, Carolina A. T. F.; Bubb, Quenton R.; Clarke, Jane] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Clarke, J (corresponding author), Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.	jc162@cam.ac.uk		Crabtree, Michael/0000-0003-1466-4011; Bubb, Quenton/0000-0002-9518-0731; A T F de Mendonca, Carolina/0000-0002-7927-0120	Biotechnology and Biological Sciences Research Council studentship; Cambridge Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Science Without Borders Cambridge scholarship; Marshall scholarship	Biotechnology and Biological Sciences Research Council studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Science Without Borders Cambridge scholarship; Marshall scholarship	Supported by a Biotechnology and Biological Sciences Research Council studentship.; Supported by the Cambridge Trust and a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Science Without Borders Cambridge scholarship.; Supported by a Marshall scholarship.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Bonetti D, 2017, BIOCHEMISTRY-US, V56, P3780, DOI 10.1021/acs.biochem.7b00350; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dahal L, 2017, BIOPHYS J, V113, P2713, DOI 10.1016/j.bpj.2017.10.016; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; Harmon TS, 2016, PROTEIN ENG DES SEL, V29, P339, DOI 10.1093/protein/gzw034; Hill SA, 2014, J MOL BIOL, V426, P21, DOI 10.1016/j.jmb.2013.08.027; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kvansakul M, 2015, APOPTOSIS, V20, P136, DOI 10.1007/s10495-014-1051-7; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Lowe ED, 2002, BIOCHEMISTRY-US, V41, P15625, DOI 10.1021/bi0268910; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; Nickson AA, 2010, METHODS, V52, P38, DOI 10.1016/j.ymeth.2010.06.003; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Rogers JM, 2014, J AM CHEM SOC, V136, P5197, DOI 10.1021/ja4125065; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Toto A, 2016, BIOCHEMISTRY-US, V55, P3957, DOI 10.1021/acs.biochem.6b00505; Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002	33	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9718	9723		10.1074/jbc.RA118.002791	http://dx.doi.org/10.1074/jbc.RA118.002791			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29716994	hybrid, Green Published			2022-12-28	WOS:000436102300016
J	Sen, S; Das, C				Sen, Sabyasachi; Das, Chandrima			Managing the sugar factory: New feather in the cap for nuclear factor Y (vol 293, pg 7905, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Das, Chandrima/AAI-7398-2021					Sen S, 2018, J BIOL CHEM, V293, P7905, DOI 10.1074/jbc.H118.002885	1	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9651	9651		10.1074/jbc.AAC118.004241	http://dx.doi.org/10.1074/jbc.AAC118.004241			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29934366	Green Published, hybrid			2022-12-28	WOS:000436102300009
J	He, HL; Wang, J; Yannie, PJ; Kakiyama, G; Korzun, WJ; Ghosh, S				He, Hongliang; Wang, Jing; Yannie, Paul J.; Kakiyama, Genta; Korzun, William J.; Ghosh, Shobha			Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol-binding protein; cholesterol metabolism; atherosclerosis; dyslipidemia; diet; anti-atherogenic effect; cardiovascular disease; hepatic VLDL secretion; intracellular cholesterol transport; sterol carrier protein	CHOLESTERYL ESTER HYDROLASE; LIPID TRANSFER PROTEINS; BILE-ACID METABOLISM; TRANSGENIC EXPRESSION; L-FABP; OVEREXPRESSION; GENE; LOCALIZATION; ACCUMULATION; HEPATOCYTES	Intracellular cholesterol transport proteins move cholesterol to different subcellular compartments and thereby regulate its final metabolic fate. In hepatocytes, for example, delivery of high-density lipoprotein (HDL)-associated cholesterol for bile acid synthesis or secretion into bile facilitates cholesterol elimination from the body (anti-atherogenic effect), whereas delivery for esterification and subsequent incorporation into apolipoprotein B-containing atherogenic lipoproteins (e.g. very-low-density lipoprotein (VLDL)) enhances cholesterol secretion into the systemic circulation (pro-atherogenic effect). Intracellular cholesterol transport proteins such as sterol carrier protein-2 (SCP2) should, therefore, play a role in regulating these pro- or anti-atherosclerotic processes. Here, we sought to evaluate the effects of SCP2 deficiency on the development of diet-induced atherosclerosis. We generated LDLR-/- mice deficient in SCP2/SCPx (LS) and examined the effects of this deficiency on Western diet-induced atherosclerosis. SCP2/SCPx deficiency attenuated atherosclerosis in LS mice by >80% and significantly reduced plasma cholesterol and triglyceride levels. Investigation of the likely underlying mechanisms revealed a significant reduction in intestinal cholesterol absorption (given as an oral gavage) in SCP2/SCPx-deficient mice. Consistently, siRNA-mediated knockdown of SCP2 in intestinal cells significantly reduced cholesterol uptake. Furthermore, hepatic triglyceride/VLDL secretion from the liver or hepatocytes isolated from SCP2/SCPx-deficient mice was significantly reduced. These results indicate an important regulatory role for SCP2 deficiency in attenuating diet-induced atherosclerosis by limiting intestinal cholesterol absorption and decreasing hepatic triglyceride/VLDL secretion. These findings suggest targeted inhibition of SCP2 as a potential therapeutic strategy to reduce Western diet-induced dyslipidemia and atherosclerosis.	[He, Hongliang; Wang, Jing; Ghosh, Shobha] Virginia Commonwealth Univ, Med Ctr, Dept Internal Med, Richmond, VA 23298 USA; [Korzun, William J.] Virginia Commonwealth Univ, Med Ctr, Dept Clin & Lab Sci, Richmond, VA 23298 USA; [Yannie, Paul J.; Kakiyama, Genta; Ghosh, Shobha] Hunter Homes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA	Virginia Commonwealth University; Virginia Commonwealth University	Ghosh, S (corresponding author), VCU, Med Ctr, Div Pulm & Crit Care, Dept Internal Med, MMRB 6050,1220 E Broad St, Richmond, VA 23298 USA.	shobha@vcu.edu	He, Hongliang/Y-9779-2019	He, Hongliang/0000-0002-6099-4356	National Institutes of Health [HL097346]; VCU School of Medicine bridge grant award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VCU School of Medicine bridge grant award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL097346 and a VCU School of Medicine bridge grant award (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atshaves BP, 2009, J LIPID RES, V50, P1429, DOI 10.1194/jlr.M900020-JLR200; Basso F, 2007, J LIPID RES, V48, P114, DOI 10.1194/jlr.M600353-JLR200; Bie JH, 2012, AM J PHYSIOL-ENDOC M, V302, pE1283, DOI 10.1152/ajpendo.00511.2011; Billheimer J T, 1990, Subcell Biochem, V16, P301; CHANDERBHAN RF, 1986, ENDOCR RES, V12, P351, DOI 10.3109/07435808609035445; Coenen KR, 2007, J NUTR BIOCHEM, V18, P727, DOI 10.1016/j.jnutbio.2006.12.010; Fuchs M, 2001, J BIOL CHEM, V276, P48058, DOI 10.1074/jbc.M106732200; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Gallegos AM, 2000, CHEM PHYS LIPIDS, V105, P9, DOI 10.1016/S0009-3084(99)00128-0; Ghosh S, 2003, J LIPID RES, V44, P1833, DOI 10.1194/jlr.M300162-JLR200; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; HYLEMON PB, 1985, J BIOL CHEM, V260, P1015; Kannenberg F, 1999, J BIOL CHEM, V274, P35455, DOI 10.1074/jbc.274.50.35455; KHARROUBI A, 1988, J LIPID RES, V29, P287; Kriska T, 2006, J BIOL CHEM, V281, P23643, DOI 10.1074/jbc.M600744200; Martin GG, 2015, ARCH BIOCHEM BIOPHYS, V588, P25, DOI 10.1016/j.abb.2015.10.018; Martin GG, 2014, AM J PHYSIOL-GASTR L, V307, pG1130, DOI 10.1152/ajpgi.00209.2014; OHBA T, 1994, GENOMICS, V24, P370, DOI 10.1006/geno.1994.1630; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; ROFF CF, 1992, J BIOL CHEM, V267, P15902; SCALLEN TJ, 1985, CHEM PHYS LIPIDS, V38, P239, DOI 10.1016/0009-3084(85)90019-2; Schroeder F, 1996, P SOC EXP BIOL MED, V213, P150, DOI 10.3181/00379727-213-44047; Schroeder F, 2007, BBA-MOL CELL BIOL L, V1771, P700, DOI 10.1016/j.bbalip.2007.04.005; Seedorf U, 2000, BBA-MOL CELL BIOL L, V1486, P45, DOI 10.1016/S1388-1981(00)00047-0; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Storey SM, 2012, AM J PHYSIOL-GASTR L, V302, pG824, DOI 10.1152/ajpgi.00195.2011; Wang J, 2016, J LIPID RES, V57, P1712, DOI 10.1194/jlr.M069682; WOUTERS FS, 1995, BBA-LIPID LIPID MET, V1259, P192, DOI 10.1016/0005-2760(95)00163-7; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485; Zhao B, 2007, AM J PHYSIOL-CELL PH, V292, pC405, DOI 10.1152/ajpcell.00306.2006; ZILVERSMIT DB, 1984, J LIPID RES, V25, P1563	31	6	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9223	9231		10.1074/jbc.RA118.002290	http://dx.doi.org/10.1074/jbc.RA118.002290			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700117	hybrid, Green Published			2022-12-28	WOS:000435441400008
J	McAteer, SP; Sy, BM; Wong, JL; Tollervey, D; Gally, DL; Tree, JJ				McAteer, Sean P.; Sy, Brandon M.; Wong, Julia L.; Tollervey, David; Gally, David L.; Tree, Jai J.			Ribosome maturation by the endoribonuclease YbeY stabilizes a type 3 secretion system transcript required for virulence of enterohemorrhagic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHLY CONSERVED PROTEIN; HIGH-THROUGHPUT ANALYSIS; UV CROSS-LINKING; POSTTRANSCRIPTIONAL REGULATION; TRANSLATION INITIATION; PATHOGENICITY ISLAND; RNA REGULATION; BINDING SITES; EXPRESSION; IDENTIFICATION	Enterohemorrhagic Escherichia coli (EHEC) is a significant human pathogen that colonizes humans and its reservoir host, cattle. Colonization requires the expression of a type 3 secretion (T3S) system that injects a mixture of effector proteins into host cells to promote bacterial attachment and disease progression. The T3S system is tightly regulated by a complex network of transcriptional and post-transcriptional regulators. Using transposon mutagenesis, here we identified the ybeZYX-Int operon as being required for normal T3S levels. Deletion analyses localized the regulation to the endoribonuclease YbeY, previously linked to 16S rRNA maturation and small RNA (sRNA) function. Loss of ybeY in EHEC had pleiotropic effects on EHEC cells, including reduced motility and growth and cold sensitivity. Using UV cross-linking and RNA-Seq (CRAC) analysis, we identified YbeY-binding sites throughout the transcriptome and discovered specific binding of YbeY to the "neck" and "beak" regions of 16S rRNA but identified no significant association of YbeY with sRNA, suggesting that YbeY modulates T3S by depleting mature ribosomes. In E. coli, translation is strongly linked tomRNAstabilization, and subinhibitory concentrations of the translation-initiation inhibitor kasugamycin provoked rapid degradation of a polycistronic mRNA encoding needle filament and needle tip proteins of the T3S system. We conclude that T3S is particularly sensitive to depletion of initiating ribosomes, explaining the inhibition of T3S in the Delta ybeY strain. Accessory virulence transcripts may be preferentially degraded in cells with reduced translational capacity, potentially reflecting prioritization in protein production.	[McAteer, Sean P.; Gally, David L.] Univ Edinburgh, Roslin Inst, Div Infect & Immun, Edinburgh EH25 9RG, Midlothian, Scotland; [Sy, Brandon M.; Wong, Julia L.; Tree, Jai J.] Univ New South Wales Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2033, Australia; [Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of New South Wales Sydney; University of Edinburgh	Gally, DL (corresponding author), Univ Edinburgh, Roslin Inst, Div Infect & Immun, Edinburgh EH25 9RG, Midlothian, Scotland.; Tree, JJ (corresponding author), Univ New South Wales Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2033, Australia.	david.gally@roslin.ed.ac.uk; j.tree@unsw.edu.au	Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772; Tree, Jai/0000-0001-8233-0975; Gally, David/0000-0002-2566-0844	National Health and Medical Research Council [APP1067241, APP1139313]; Australian Government; Roslin Institute through Biotechnology and Biological Sciences Research Council [BB/J004227/1, BB/P013740/1]; Wellcome Trust [109916/Z/15/Z]; BBSRC [BBS/E/D/20231761, BBS/E/D/20002173] Funding Source: UKRI	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR); Roslin Institute through Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Health and Medical Research Council Project Grants APP1067241 and APP1139313 (to J.J.T. and J.L.W.), an Australian Government research training program scholarship (to B.M.S.), Roslin Institute strategic program research support through Biotechnology and Biological Sciences Research Council Grants BB/J004227/1 and BB/P013740/1 (to D.L.G. and S.P.M.), and Wellcome Trust Grant 109916/Z/15/Z (to D.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnold TE, 1998, RNA, V4, P319; Bhatt S, 2009, INFECT IMMUN, V77, P3552, DOI 10.1128/IAI.00418-09; Bicknell AA, 2017, BIOCHEM SOC T, V45, P339, DOI 10.1042/BST20160243; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Davies BW, 2010, MOL MICROBIOL, V78, P506, DOI 10.1111/j.1365-2958.2010.07351.x; Davis TK, 2013, INFECT DIS CLIN N AM, V27, P577, DOI 10.1016/j.idc.2013.05.010; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Dreyfus M, 2009, PROG MOL BIOL TRANSL, V85, P423, DOI 10.1016/S0079-6603(08)00811-8; Fernandez-Brando RJ, 2016, ANTIMICROB AGENTS CH, V60, P459, DOI 10.1128/AAC.02085-15; Furniss RCD, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00336-17; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Gruber CC, 2015, INFECT IMMUN, V83, P1286, DOI 10.1128/IAI.02918-14; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Jacob AI, 2013, MOL CELL, V49, P427, DOI 10.1016/j.molcel.2012.11.025; Joyce SA, 1998, J MOL BIOL, V282, P241, DOI 10.1006/jmbi.1998.2027; Kaberdin VR, 2006, FEMS MICROBIOL REV, V30, P967, DOI 10.1111/j.1574-6976.2006.00043.x; Katsowich N, 2017, SCIENCE, V355, P735, DOI 10.1126/science.aah4886; Kendall MM, 2011, J BACTERIOL, V193, P6843, DOI 10.1128/JB.06141-11; Lai YS, 2013, CELL MICROBIOL, V15, P1796, DOI 10.1111/cmi.12179; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Leskinen K, 2015, MICROBIOL-SGM, V161, P285, DOI 10.1099/mic.0.083097-0; Liu JW, 2015, PLANT PHYSIOL, V168, P205, DOI 10.1104/pp.114.255000; Merlin C, 2002, J BACTERIOL, V184, P4573, DOI 10.1128/JB.184.16.4573-4581.2002; Pandey SP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-121; Pandey SP, 2011, NUCLEIC ACIDS RES, V39, P4691, DOI 10.1093/nar/gkr060; Radhakrishnan A, 2016, J MOL BIOL, V428, P3558, DOI 10.1016/j.jmb.2016.05.025; Rahal EA, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00024; Rasouly A, 2010, J BACTERIOL, V192, P4592, DOI 10.1128/JB.00448-10; Rasouly A, 2009, J BACTERIOL, V191, P2649, DOI 10.1128/JB.01663-08; Rodgers W, 2013, ANTIMICROB AGENTS CH, V57, P1632, DOI 10.1128/AAC.02316-12; Roe AJ, 2004, MOL MICROBIOL, V54, P337, DOI 10.1111/j.1365-2958.2004.04277.x; Rutberg B., 2002, MICROBIOLOGY, V148, P1795; Santos AS, 2015, CELL MICROBIOL, V17, P318, DOI 10.1111/cmi.12412; Saramago M, 2017, NUCLEIC ACIDS RES, V45, P1371, DOI 10.1093/nar/gkw1234; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; Schuwirth BS, 2006, NAT STRUCT MOL BIOL, V13, P879, DOI 10.1038/nsmb1150; Shakhnovich EA, 2009, MOL MICROBIOL, V74, P347, DOI 10.1111/j.1365-2958.2009.06856.x; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Sharp JS, 2003, J BACTERIOL, V185, P5372, DOI 10.1128/JB.185.18.5372-5379.2003; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Sy B, 2018, METHODS MOL BIOL, V1737, P251, DOI 10.1007/978-1-4939-7634-8_15; TOLLERVEY D, 1987, EMBO J, V6, P469, DOI 10.1002/j.1460-2075.1987.tb04777.x; Tree JJ, 2014, MOL CELL, V55, P199, DOI 10.1016/j.molcel.2014.05.006; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; van Diemen PA, 2005, INFECT IMMUN, V73, P1735, DOI 10.1128/IAI.73.3.1735-1743.2005; Vercruysse M., 2016, ESCHERICHIA COLI MBI, V7; Vercruysse M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004175; WAGNER LA, 1994, J BACTERIOL, V176, P1683, DOI 10.1128/jb.176.6.1683-1688.1994; Waters SA, 2017, EMBO J, V36, P374, DOI 10.15252/embj.201694639; Webb S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r8; Xu X., 2012, ESCHERICHIA COLI PLO, V8; Zhan CY, 2005, ACTA CRYSTALLOGR F, V61, P959, DOI 10.1107/S1744309105031131	54	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9006	9016		10.1074/jbc.RA117.000300	http://dx.doi.org/10.1074/jbc.RA117.000300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29678883	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000434941900023
J	Gauthier-Kemper, A; Alonso, MS; Sundermann, F; Niewidok, B; Fernandez, MP; Bakota, L; Heinisch, JJ; Brandt, R				Gauthier-Kemper, Anne; Suarez Alonso, Maria; Suendermann, Frederik; Niewidok, Benedikt; Fernandez, Maria-Pilar; Bakota, Lidia; Heinisch, Juergen Josef; Brandt, Roland			Annexins A2 and A6 interact with the extreme N terminus of tau and thereby contribute to tau's axonal localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule-associated protein (MAP); annexin; tau protein; axon; neuron; polarity	CENTRAL-NERVOUS-SYSTEM; COLI SHUTTLE VECTORS; ALZHEIMERS-DISEASE; INITIAL SEGMENT; SACCHAROMYCES-CEREVISIAE; FRONTOTEMPORAL DEMENTIA; KLUYVEROMYCES-LACTIS; HIPPOCAMPAL-NEURONS; RESTRICTION SITES; AMYLOID-BETA	During neuronal development, the microtubule-associated protein tau becomes enriched in the axon, where it remains concentrated in the healthy brain. In tauopathies such as Alzheimer's disease, tau redistributes from the axon to the somatodendritic compartment. However, the cellular mechanism that regulates tau's localization remains unclear. We report here that tau interacts with the Ca2+-regulated plasma membrane-binding protein annexin A2 (AnxA2) via tau's extreme N terminus encoded by the first exon (E1). Bioinformatics analysis identified two conserved eight-amino-acids-long motifs within E1 in mammals. Using a heterologous yeast system, we found that disease-related mutations and pseudophosphorylation of Tyr-18, located within E1 but outside of the two conserved regions, do not influence tau's interaction with AnxA2. We further observed that tau interacts with the core domain of AnxA2 in a Ca2+-induced open conformation and interacts also with AnxA6. Moreover, lack of E1 moderately increased tau's association rate to microtubules, consistent with the supposition that the presence of the tau-annexin interaction reduces the availability of tau to interact with microtubules. Of note, intracellular competition through overexpression of E1-containing constructs reduced tau's axonal enrichment in primary neurons. Our results suggest that the E1-mediated tau-annexin interaction contributes to the enrichment of tau in the axon and is involved in its redistribution in pathological conditions.	[Gauthier-Kemper, Anne; Suendermann, Frederik; Niewidok, Benedikt; Bakota, Lidia; Brandt, Roland] Univ Osnabruck, Dept Neurobiol, Barbarastr 11, D-49076 Osnabruck, Germany; [Heinisch, Juergen Josef] Univ Osnabruck, Dept Genet, D-49076 Osnabruck, Germany; [Suarez Alonso, Maria; Fernandez, Maria-Pilar] Univ Oviedo, Dept Biochem & Mol Biol, Fac Med, E-33006 Oviedo, Spain; [Suarez Alonso, Maria] Univ Fribourg, Dept Physiol Med, Chemin Musee 5, CH-1700 Fribourg, Switzerland	University Osnabruck; University Osnabruck; University of Oviedo; University of Fribourg	Brandt, R (corresponding author), Univ Osnabruck, Dept Neurobiol, Barbarastr 11, D-49076 Osnabruck, Germany.	brandt@biologie.uni-osnabrueck.de	Heinisch, Juergen J./G-3801-2017	Bakota, Lidia/0000-0002-8777-5006; Brandt, Roland/0000-0003-0101-1257	DAAD ("Deutscher Akademischer Austauschdienst"); University of Osnabruck [SFB 944]	DAAD ("Deutscher Akademischer Austauschdienst")(Deutscher Akademischer Austausch Dienst (DAAD)); University of Osnabruck	This work was supported by the DAAD ("Deutscher Akademischer Austauschdienst") and performed as part of the IPID ("International Promovieren in Deutschland") doctoral student exchange program from the University of Osnabruck and the University of Oviedo, the FICYT ("Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia"), by computing time by the HLRN ("Norddeutscher Verbund fur Hoch-und Hochstleistungsrechnen"), the UV2000/GPU cluster at the computing center of the University of Osnabruck, and the Z-project of the SFB 944, University of Osnabruck. The authors declare that they have no conflicts of interest with the contents of this article.	Bakota L, 2012, MOL GENET GENOMICS, V287, P313, DOI 10.1007/s00438-012-0680-1; Bharadwaj A, 2013, INT J MOL SCI, V14, P6259, DOI 10.3390/ijms14036259; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; CHAPIN SJ, 1992, CELL MOTIL CYTOSKEL, V23, P236, DOI 10.1002/cm.970230403; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DOTTI CG, 1988, J NEUROSCI, V8, P1454; EBERHARD DA, 1994, AM J PATHOL, V145, P640; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fath T, 2002, J NEUROSCI, V22, P9733; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gunawardana CG, 2015, MOL CELL PROTEOMICS, V14, P3000, DOI 10.1074/mcp.M115.050724; Hall GF, 1997, P NATL ACAD SCI USA, V94, P4733, DOI 10.1073/pnas.94.9.4733; HAMRE KM, 1995, J COMP NEUROL, V352, P421, DOI 10.1002/cne.903520308; Hatch RJ, 2017, ACTA NEUROPATHOL, V133, P717, DOI 10.1007/s00401-017-1674-1; Hayashi S, 2002, ANN NEUROL, V51, P525, DOI 10.1002/ana.10163; HEINISCH J, 1991, CURR GENET, V20, P167, DOI 10.1007/BF00312781; Heinisch JJ, 2016, MICROB CELL, V3, DOI 10.15698/mic2016.04.489; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Igaev M, 2014, BIOPHYS J, V107, P2567, DOI 10.1016/j.bpj.2014.09.016; Janning D, 2014, MOL BIOL CELL, V25, P3541, DOI 10.1091/mbc.E14-06-1099; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; Kempf M, 1996, J NEUROSCI, V16, P5583; Kirchrath L, 2000, J MOL BIOL, V300, P743, DOI 10.1006/jmbi.2000.3916; Kneynsberg A, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0043-17.2017; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Lang AE, 2014, NEUROSCIENCE, V275, P322, DOI 10.1016/j.neuroscience.2014.06.017; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Leschik J, 2007, J NEUROCHEM, V101, P1303, DOI 10.1111/j.1471-4159.2006.04435.x; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Lorberg A, 2001, MOL GENET GENOMICS, V266, P514; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Mandell JW, 1996, J NEUROSCI, V16, P5727; Marin MA, 2016, EXP NEUROL, V281, P93, DOI 10.1016/j.expneurol.2016.04.018; MERCKEN M, 1995, FEBS LETT, V368, P10, DOI 10.1016/0014-5793(95)00590-6; Niewidok B, 2016, MOL BIOL CELL, V27, P3537, DOI 10.1091/mbc.E16-06-0402; Orr ME, 2015, NEUROBIOL AGING, V36, P1496, DOI 10.1016/j.neurobiolaging.2014.12.004; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Pchitskaya E, 2018, CELL CALCIUM, V70, P87, DOI 10.1016/j.ceca.2017.06.008; Poorkaj P, 2002, ANN NEUROL, V52, P511, DOI 10.1002/ana.10340; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; RABEN N, 1995, AM J HUM GENET, V56, P131; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rodicio R, 2006, MICROBIOL-SGM, V152, P2635, DOI 10.1099/mic.0.29105-0; Sanchez-Ponce D, 2011, MOL CELL NEUROSCI, V48, P104, DOI 10.1016/j.mcn.2011.06.010; Sohn PD, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0109-0; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stern JL, 2017, MOL BIOL CELL, V28, P1079, DOI 10.1091/mbc.E16-10-0728; Sundermann F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2590-9; Sun XQ, 2014, P NATL ACAD SCI USA, V111, P14271, DOI 10.1073/pnas.1411837111; Uversky VN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00018; Weissmann C, 2009, TRAFFIC, V10, P1655, DOI 10.1111/j.1600-0854.2009.00977.x; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; Xia D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29074; Yamatani H, 2010, DEV NEUROBIOL, V70, P523, DOI 10.1002/dneu.20794; Zhao WQ, 2007, J NEUROCHEM, V100, P1211, DOI 10.1111/j.1471-4159.2006.04311.x	64	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8065	8076		10.1074/jbc.RA117.000490	http://dx.doi.org/10.1074/jbc.RA117.000490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29636414	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000433224600013
J	Niehaus, TD; Folz, J; McCarty, DR; Cooper, AJL; Amador, DM; Fiehn, O; Hanson, AD				Niehaus, Thomas D.; Folz, Jacob; McCarty, Donald R.; Cooper, Arthur J. L.; Amador, David Moraga; Fiehn, Oliver; Hanson, Andrew D.			Identification of a metabolic disposal route for the oncometabolite S-(2-succino)cysteine in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; energy metabolism; respiration; metabolic disease; microbiology; cysteine; fumarate; N-acetylation; oncometabolite; protein succination; sulfhydryl group; protein modification	SMOOTH-MUSCLE TUMORS; MITOCHONDRIAL STRESS; ESCHERICHIA-COLI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; CHEMICAL-MODIFICATION; TISSUE PROTEINS; SUCCINATION; FUMARATE; INACTIVATION	Cellular thiols such as cysteine spontaneously and readily react with the respiratory intermediate fumarate, resulting in the formation of stable S-(2-succino)-adducts. Fumarate-mediated succination of thiols increases in certain tumors and in response to glucotoxicity associated with diabetes. Therefore, S-(2-succino)-adducts such as S-(2-succino)cysteine (2SC) are considered oncometabolites and biomarkers for human disease. No disposal routes for S-(2-succino)-compounds have been reported prior to this study. Here, we show that Bacillus subtilis metabolizes 2SC to cysteine using a pathway encoded by the yxe operon. The first step is N-acetylation of 2SC followed by an oxygenation that we propose results in the release of oxaloacetate and N-acetylcysteine, which is deacetylated to give cysteine. Knockouts of the genes predicted to mediate each step in the pathway lose the ability to grow on 2SC as the sulfur source and accumulate the expected upstream metabolite(s). We further show that N-acetylation of 2SC relieves toxicity. This is the first demonstration of a metabolic disposal route for any S-(2-succino)-compound, paving the way toward the identification of corresponding pathways in other species.	[Niehaus, Thomas D.; McCarty, Donald R.; Hanson, Andrew D.] Univ Florida, Dept Hort Sci, 1301 Fifield Hall,2550 Hull Rd, Gainesville, FL 32611 USA; [Amador, David Moraga] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32611 USA; [Folz, Jacob; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [Cooper, Arthur J. L.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Davis; New York Medical College	Niehaus, TD; Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, 1301 Fifield Hall,2550 Hull Rd, Gainesville, FL 32611 USA.	tomniehaus@ufl.edu; adha@ufl.edu	Folz, Jacob/HHN-6906-2022	Niehaus, Thomas/0000-0002-3575-8001	National Science Foundation [MCB-1153413]; C.V. Griffin Sr. Foundation; Div Of Molecular and Cellular Bioscience [1611711] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); C.V. Griffin Sr. Foundation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-1153413 and by an endowment from the C.V. Griffin Sr. Foundation.	Adam J, 2017, CELL REP, V20, P3135, DOI 10.1016/j.celrep.2017.08.093; Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; Bardella C, 2011, J PATHOL, V225, P4, DOI 10.1002/path.2932; Biatnik M, 2008, ANN NY ACAD SCI, V1126, P272, DOI 10.1196/annals.1433.047; Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838; BRAND B, 1991, J BIOL CHEM, V266, P14113; Burguiere P, 2005, J BACTERIOL, V187, P6019, DOI 10.1128/JB.187.17.6019-6030.2005; Chan CM, 2014, ENVIRON MICROBIOL, V16, P101, DOI 10.1111/1462-2920.12210; Danchin A, 2009, BIOESSAYS, V31, P769, DOI 10.1002/bies.200900024; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Frizzell N, 2012, BIOCHEM J, V445, P247, DOI 10.1042/BJ20112142; Frizzell N, 2011, FREE RADICAL RES, V45, P101, DOI 10.3109/10715762.2010.524643; Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257; Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228; Higashitsuji Y, 2007, FEMS MICROBIOL LETT, V274, P48, DOI 10.1111/j.1574-6968.2007.00817.x; Hoekstra AS, 2015, ONCOTARGET, V6, P38777, DOI 10.18632/oncotarget.6091; Hullo MF, 2007, J BACTERIOL, V189, P187, DOI 10.1128/JB.01273-06; Johnson CM, 2014, MOL MICROBIOL, V93, P1284, DOI 10.1111/mmi.12736; Koo BM, 2017, CELL SYST, V4, P291, DOI 10.1016/j.cels.2016.12.013; Lazinski D. W., 2015, CURR PROTOC MICROBIO, V36, P1, DOI DOI 10.1002/9780471729259.MC01E03S36; Limsuwun K, 2000, J BACTERIOL, V182, P5373, DOI 10.1128/JB.182.19.5373-5380.2000; Lin HJ, 2010, ANAL BIOCHEM, V407, P226, DOI 10.1016/j.ab.2010.07.036; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/nchembio.1141, 10.1038/NCHEMBIO.1141]; Manuel AM, 2017, ANTIOXID REDOX SIGN, V27, P1281, DOI 10.1089/ars.2016.6853; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Merkley ED, 2014, MASS SPECTROM REV, V33, P98, DOI 10.1002/mas.21382; Miglio G, 2016, BBA-PROTEINS PROTEOM, V1864, P211, DOI 10.1016/j.bbapap.2015.11.003; Nagai R, 2007, J BIOL CHEM, V282, P34219, DOI 10.1074/jbc.M703551200; Niehaus TD, 2017, J BIOL CHEM, V292, P16360, DOI 10.1074/jbc.M117.805028; Oda K, 2013, J BACTERIOL, V195, P1741, DOI 10.1128/JB.02085-12; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Piroli GG, 2016, MOL CELL PROTEOMICS, V15, P445, DOI 10.1074/mcp.M115.051516; Piroli GG, 2014, BIOCHEM J, V462, P231, DOI 10.1042/BJ20131581; Qiu JJ, 2013, INT J MOL MED, V31, P1229, DOI 10.3892/ijmm.2013.1298; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Reyes C, 2014, MODERN PATHOL, V27, P1020, DOI 10.1038/modpathol.2013.215; Ruecker N, 2017, CELL CHEM BIOL, V24, P306, DOI 10.1016/j.chembiol.2017.01.005; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; Sekowska A, 2001, GENOME BIOL, V2; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Ternette N, 2013, CELL REP, V3, P689, DOI 10.1016/j.celrep.2013.02.013; Thomas SA, 2012, OBESITY, V20, P263, DOI 10.1038/oby.2011.340; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; van der Ploeg JR, 1998, MICROBIOL-SGM, V144, P2555, DOI 10.1099/00221287-144-9-2555; Wright GD, 2005, ADV DRUG DELIVER REV, V57, P1451, DOI 10.1016/j.addr.2005.04.002; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yu ACS, 2014, APPL MICROBIOL BIOT, V98, P855, DOI 10.1007/s00253-013-5377-9; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001	51	11	11	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8255	8263		10.1074/jbc.RA118.002925	http://dx.doi.org/10.1074/jbc.RA118.002925			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626092	Green Published, hybrid			2022-12-28	WOS:000433224600029
J	Wang, LW; Wagner, LE; Alzayady, KJ; Yule, DI				Wang, Liwei; Wagner, Larry E., II; Alzayady, Kamil J.; Yule, David, I			Region-specific proteolysis differentially modulates type 2 and type 3 inositol 1,4,5-trisphosphate receptor activity in models of acute pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERULEIN-INDUCED PANCREATITIS; CA2+ RELEASE; TRISPHOSPHATE RECEPTOR; ZYMOGEN ACTIVATION; ENZYME ACTIVATION; VACUOLE FORMATION; DOWN-REGULATION; PROTEIN-KINASE; ACINAR-CELLS; INJURY	Fine-tuning of the activity of inositol 1,4,5-trisphosphate receptors (IP3R) by a diverse array of regulatory inputs results in intracellular Ca2+ signals with distinct characteristics. These events allow the activation of specific downstream effectors. We reported previously that region-specific proteolysis represents a novel regulatory event for type 1 IP3R (R1). Specifically, caspase-fragmented R1 display a marked increase in single-channel open probability. More importantly, the distinct characteristics of the Ca2+ signals elicited via fragmented R1 can activate alternate downstream effectors. In this report, we expand these studies to investigate whether all IP3R subtypes are regulated by proteolysis. We now show that type 2 and type 3 IP3R (R2 and R3, respectively) are proteolytically cleaved in rodent models of acute pancreatitis. Surprisingly, fragmented IP3R retained tetrameric architecture, remained embedded in endoplasmic reticulum membranes and were not functionally disabled. Proteolysis was associated with a marked attenuation of the frequency of Ca2+ signals in pancreatic lobules. Consistent with these data, expression of DNAs encoding complementary R2 and R3 peptides mimicking fragmented receptors at particular sites, resulted in a significant decrease in the frequency of agonist-stimulated oscillations. Further, proteolysis of R2 resulted in a marked decrease in single-channel open probability. Taken together, proteolytic fragmentation modulates R2 and R3 activity in a region-specific manner, and this event may contribute to the altered Ca2+ signals in pancreatic acinar cells during acute pancreatitis.	[Wang, Liwei; Wagner, Larry E., II; Alzayady, Kamil J.; Yule, David, I] Univ Rochester, Dept Pharmacol & Physiol, Rochester, NY 14642 USA	University of Rochester	Yule, DI (corresponding author), Univ Rochester, Dept Pharmacol & Physiol, Med Ctr, Rm 4-5320, Rochester, NY 14642 USA.	david_yule@urmc.rochester.edu			NIDCR, National Institutes of Health [R01DE014756, R01DE019245]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019245, R01DE014756] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIDCR, National Institutes of Health Grants R01DE014756 and R01DE019245. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADLER G, 1982, DIGEST DIS SCI, V27, P993, DOI 10.1007/BF01391745; Alzayady KJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6281; Alzayady KJ, 2015, MOL BIOL EVOL, V32, P2236, DOI 10.1093/molbev/msv098; Alzayady KJ, 2013, J BIOL CHEM, V288, P29772, DOI 10.1074/jbc.M113.502203; Alzayady KJ, 2013, J BIOL CHEM, V288, P11122, DOI 10.1074/jbc.M113.453241; [Anonymous], PANCREAPEDIA EXOCRIN; BALLDIN G, 1979, SURGERY, V85, P451; Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Chandrasekhar R, 2016, J BIOL CHEM, V291, P4846, DOI 10.1074/jbc.M115.705301; Chaudhuri A, 2005, AM J PHYSIOL-GASTR L, V288, pG235, DOI 10.1152/ajpgi.00334.2004; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; DeSmedt H, 1997, BIOCHEM J, V322, P575; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FUJINO I, 1995, CELL TISSUE RES, V280, P201, DOI 10.1007/s004410050345; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Huang W, 2017, GUT, V66, P301, DOI 10.1136/gutjnl-2015-309363; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Kopil CM, 2011, J BIOL CHEM, V286, P35998, DOI 10.1074/jbc.M111.254177; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Luyten T, 2017, BBA-MOL CELL RES, V1864, P947, DOI 10.1016/j.bbamcr.2017.02.013; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Muili KA, 2013, J BIOL CHEM, V288, P21065, DOI 10.1074/jbc.M113.471425; Muili KA, 2013, J BIOL CHEM, V288, P570, DOI 10.1074/jbc.M112.428896; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Sneyd J, 2017, P NATL ACAD SCI USA, V114, P1456, DOI 10.1073/pnas.1614613114; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Teos LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13953; Voronina S, 2002, J PHYSIOL-LONDON, V540, P49, DOI 10.1113/jphysiol.2002.017525; Voronina S, 2015, BIOCHEM J, V465, P405, DOI 10.1042/BJ20140398; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; Wang LW, 2017, J BIOL CHEM, V292, P11714, DOI 10.1074/jbc.M117.789917; Wang LW, 2016, J PHYSIOL-LONDON, V594, P2867, DOI 10.1113/JP271140; Ward JB, 1996, GASTROENTEROLOGY, V111, P481, DOI 10.1053/gast.1996.v111.pm8690215; Wen L, 2015, GASTROENTEROLOGY, V149, P481, DOI 10.1053/j.gastro.2015.04.015; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wright FA, 2016, PROG MOL BIOL TRANSL, V141, P141, DOI 10.1016/bs.pmbts.2016.02.004; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	63	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13112	13124		10.1074/jbc.RA118.003421	http://dx.doi.org/10.1074/jbc.RA118.003421			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29970616	Green Published, hybrid			2022-12-28	WOS:000442730200012
J	Dudakovic, A; Camilleri, ET; Paradise, CR; Samsonraj, RM; Gluscevic, M; Paggi, CA; Begun, DL; Khani, F; Pichurin, O; Ahmed, FS; Elsayed, R; Elsalanty, M; McGee-Lawrence, ME; Karperien, M; Riester, SM; Thaler, R; Westendorf, JJ; van Wijnen, AJ				Dudakovic, Amel; Camilleri, Emily T.; Paradise, Christopher R.; Samsonraj, Rebekah M.; Gluscevic, Martina; Paggi, Carlo Alberto; Begun, Dana L.; Khani, Farzaneh; Pichurin, Oksana; Ahmed, Farah S.; Elsayed, Ranya; Elsalanty, Mohammed; McGee-Lawrence, Meghan E.; Karperien, Marcel; Riester, Scott M.; Thaler, Roman; Westendorf, Jennifer J.; van Wijnen, Andre J.			Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoblast; epigenetics; histone methylation; histone; bone; chromatin regulation; bone development; enhancer of zeste homolog; methyltransferase; osteogenesis; skeleton	MESENCHYMAL STEM-CELLS; INTEGRATIVE GENOMICS VIEWER; OSTEOCALCIN GENE; EPIGENETIC CONTROL; OSTEOBLAST DIFFERENTIATION; METHYLTRANSFERASE EZH2; LINEAGE SPECIFICATION; HISTONE MODIFICATIONS; SKELETAL GROWTH; CHROMATIN	Epigenetic mechanisms control skeletal development and osteoblast differentiation. Pharmacological inhibition of the histone 3 Lys-27 (H3K27) methyltransferase enhancer of zeste homolog 2 (EZH2) in WT mice enhances osteogenesis and stimulates bone formation. However, conditional genetic loss of Ezh2 early in the mesenchymal lineage (i.e. through excision via Prrx1 promoter-driven Cre) causes skeletal abnormalities due to patterning defects. Here, we addressed the key question of whether Ezh2 controls osteoblastogenesis at later developmental stages beyond patterning. We show that Ezh2 loss in committed pre-osteoblasts by Cre expression via the osterix/Sp7 promoter yields phenotypically normal mice. These Ezh2 conditional knock-out mice (Ezh2 cKO) have normal skull bones, clavicles, and long bones but exhibit increased bone marrow adiposity and reduced male body weight. Remarkably, in vivo Ezh2 loss results in a low trabecular bone phenotype in young mice as measured by micro-computed tomography and histomorphometry. Thus, Ezh2 affects bone formation stage-dependently. We further show that Ezh2 loss in bone marrow-derived mesenchymal cells suppresses osteogenic differentiation and impedes cell cycle progression as reflected by decreased metabolic activity, reduced cell numbers, and changes in cell cycle distribution and in expression of cell cycle markers. RNA-Seq analysis of Ezh2 cKO calvaria revealed that the cyclin-dependent kinase inhibitor Cdkn2a is the most prominent cell cycle target of Ezh2. Hence, genetic loss of Ezh2 in mouse pre-osteoblasts inhibits osteogenesis in part by inducing cell cycle changes. Our results suggest that Ezh2 serves a bifunctional role during bone formation by suppressing osteogenic lineage commitment while simultaneously facilitating proliferative expansion of osteoprogenitor cells.	[Dudakovic, Amel; Camilleri, Emily T.; Samsonraj, Rebekah M.; Begun, Dana L.; Khani, Farzaneh; Pichurin, Oksana; Ahmed, Farah S.; Riester, Scott M.; Thaler, Roman; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA; [Dudakovic, Amel; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA; [Paradise, Christopher R.; Gluscevic, Martina] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN 55905 USA; [Paradise, Christopher R.] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA; [Paggi, Carlo Alberto; Karperien, Marcel] Univ Twente, Dept Dev BioEngn, NL-7522 NB Enschede, Netherlands; [Elsayed, Ranya; Elsalanty, Mohammed] Augusta Univ, Dept Oral Biol, Augusta, GA 30912 USA; [McGee-Lawrence, Meghan E.] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [McGee-Lawrence, Meghan E.] Augusta Univ, Med Coll Georgia, Dept Orthoped Surg, Augusta, GA 30912 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Twente; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.; van Wijnen, AJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu	paggi, carlo alberto/ABH-4872-2020; van Wijnen, Andre J./AAG-3578-2019; Karperien, Marcel/R-3270-2018	van Wijnen, Andre J./0000-0002-4458-0946; Camilleri, Emily/0000-0001-8982-6770; Karperien, Marcel/0000-0003-0751-0604; Dudakovic, Amel/0000-0002-8850-3977	National Institutes of Health [R01 AR049069, R01 AR68103, F32 AR066508, T32 AR056950]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950, F32AR066508, R01AR068103, R01AR049069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR049069 (to A. v. W.), R01 AR68103 (to J. J. W.), F32 AR066508 (to A. D.), and T32 AR056950 (to D. L. B.). This work was also supported by William H. and Karen J. Eby and the charitable foundation in their names. M. K. is founder and shareholder of Hy2Care B.V. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Addison WN, 2014, MOL CELL BIOL, V34, P3076, DOI 10.1128/MCB.00185-14; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carpio LR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf3273; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chen YH, 2016, STEM CELLS, V34, P2183, DOI 10.1002/stem.2400; Chen YH, 2011, J BIOL CHEM, V286, P10671, DOI 10.1074/jbc.M110.199612; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Dudakovic A., 2017, CURR MOL BIOL REP, V3, P94, DOI [10.1007/s40610-017-0064-8, DOI 10.1007/S40610-017-0064-8]; Dudakovic A, 2017, GENE, V609, P28, DOI 10.1016/j.gene.2017.01.019; Dudakovic A, 2016, J BIOL CHEM, V291, P24594, DOI 10.1074/jbc.M116.740571; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Fang C, 2016, J IMMUNOL, V196, P4452, DOI 10.4049/jimmunol.1501466; Ge K, 2012, BBA-GENE REGUL MECH, V1819, P727, DOI 10.1016/j.bbagrm.2011.12.008; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; Hemming S, 2017, FASEB J, V31, P1011, DOI 10.1096/fj.201600748R; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Khani F, 2017, J CELL BIOCHEM, V118, P1262, DOI 10.1002/jcb.25787; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01509-0; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lui JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13685; Marchesi I, 2014, CELL CYCLE, V13, P516, DOI 10.4161/cc.27921; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McGee-Lawrence ME, 2016, J BONE MINER RES, V31, P116, DOI 10.1002/jbmr.2602; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; Meyer MB, 2016, J BIOL CHEM, V291, P17829, DOI 10.1074/jbc.M116.736538; Mirzamohammadi F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12047; Montecino M, 1999, BIOCHEMISTRY-US, V38, P1338, DOI 10.1021/bi982171a; Montecino M, 1996, BIOCHEMISTRY-US, V35, P5093, DOI 10.1021/bi952489s; MONTECINO M, 1994, BIOCHEMISTRY-US, V33, P348, DOI 10.1021/bi00167a045; Pierce JL, 2019, BONE, V118, P2, DOI 10.1016/j.bone.2018.05.019; Pike JW, 2015, BONE, V81, P757, DOI 10.1016/j.bone.2015.03.012; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Samsonraj RM, 2018, STEM CELL TRANSL MED, V7, P197, DOI 10.1002/sctm.17-0086; Samsonraj RM, 2017, TISSUE ENG PART C-ME, V23, P686, DOI [10.1089/ten.tec.2017.0205, 10.1089/ten.TEC.2017.0205]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Sen B, 2017, STEM CELLS, V35, P1624, DOI 10.1002/stem.2617; Shen J, 2003, MOL ENDOCRINOL, V17, P743, DOI 10.1210/me.2002-0122; Soreide E, 2018, J CELL BIOCHEM, V119, P5715, DOI 10.1002/jcb.26755; Stein GS, 2010, CRIT REV EUKAR GENE, V20, P149, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.50; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Thaler R, 2016, J BIOL CHEM, V291, P6754, DOI 10.1074/jbc.M115.678235; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Varela N, 2016, J CELL PHYSIOL, V231, P1001, DOI 10.1002/jcp.25188; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wassef M, 2017, J MOL BIOL, V429, P1978, DOI 10.1016/j.jmb.2016.10.012; Wu H, 2017, BBA-GENE REGUL MECH, V1860, P438, DOI 10.1016/j.bbagrm.2017.01.003; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Zhong YB, 2018, NUCLEIC ACIDS RES, V46, P3382, DOI 10.1093/nar/gky101	66	41	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12894	12907		10.1074/jbc.RA118.002983	http://dx.doi.org/10.1074/jbc.RA118.002983			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29899112	hybrid, Green Published			2022-12-28	WOS:000442203500021
J	Yu, DW; Ding, XH; Liu, ZX; Wu, XY; Zhu, YM; Wei, HM; Chong, HH; Cui, S; He, YX				Yu, Danwei; Ding, Xiaohui; Liu, Zixuan; Wu, Xiyuan; Zhu, Yuanmei; Wei, Huanmian; Chong, Huihui; Cui, Sheng; He, Yuxian			Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); HIV-1; host-pathogen interaction; AIDS; antiviral agent; drug resistance; gp41; fusion inhibitor; sifuvirtide	IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 6-HELIX BUNDLE; T HOOK STRUCTURE; ENVELOPE GLYCOPROTEIN; CONFORMATIONAL-CHANGES; PHENOTYPIC RESISTANCE; PEPTIDE INHIBITORS; ATOMIC-STRUCTURE; CORE STRUCTURE; COILED-COIL	Host cell infection with HIV-1 requires fusion of viral and cell membranes. Sifuvirtide (SFT) is a peptide-based HIV-1 fusion inhibitor approved for phase III clinical trials in China. Here, we focused on characterizing HIV-1 variants highly resistant to SFT to gain insight into the molecular resistance mechanism. Three primary substitutions (V38A, A47I, and Q52R) located at the inhibitor-binding site of HIV-1's envelope protein (Env) and one secondary substitution (N126K) located at the C-terminal heptad repeat region of the viral protein gp41, which is part of the envelope, conferred high SFT resistance and cross-resistance to the anti-HIV-1 drug T20 and the template peptide C34. Interestingly, SFT's resistance profile could be dramatically improved with an M-T hook structure-modified SFT (MTSFT) and with short-peptide inhibitors that mainly target the gp41 pocket (2P23 and its lipid derivative LP-19). We found that the V38A and Q52R substitutions reduce the binding stabilities of SFT, C34, and MTSFT, but they had no effect on the binding of 2P23 and LP-19; in sharp contrast, the A47I substitution enhanced fusion inhibitor binding. Furthermore, the primary resistance substitutions impaired Env-mediated membrane fusion and cell entry and changed the conformation of the gp41 core structure. Importantly, whereas the V38A and Q52R sub-stitutions disrupted the N-terminal helix of gp41, a single A47I substitution greatly enhanced its thermostability. Taken together, our results provide crucial structural insights into the mechanism of HIV-1 resistance to gp41-dependent fusion inhibitors, which may inform the development of additional anti-HIV drugs.	[Yu, Danwei; Ding, Xiaohui; Liu, Zixuan; Wu, Xiyuan; Zhu, Yuanmei; Wei, Huanmian; Chong, Huihui; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Yu, Danwei; Ding, Xiaohui; Liu, Zixuan; Wu, Xiyuan; Zhu, Yuanmei; Wei, Huanmian; Chong, Huihui; He, Yuxian] Chinese Acad Med Sci, Ctr AIDS Res, Beijing 100730, Peoples R China; [Yu, Danwei; Ding, Xiaohui; Liu, Zixuan; Wu, Xiyuan; Zhu, Yuanmei; Wei, Huanmian; Chong, Huihui; He, Yuxian] Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, YX (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.; He, YX (corresponding author), Chinese Acad Med Sci, Ctr AIDS Res, Beijing 100730, Peoples R China.; He, YX (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.	yhe@ipbcams.ac.cn	Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020	Sheng, CUI/0000-0001-6329-3582; yu, danwei/0000-0002-2379-2210	Natural Science Foundation of China [81630061, 81473255]; CAMS Innovation Fund for Medical Sciences Grant [2017-I2M-1-014]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences Grant	This work was supported by Natural Science Foundation of China Grants 81630061 and 81473255 and CAMS Innovation Fund for Medical Sciences Grant 2017-I2M-1-014. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn KW, 2017, J BIOL CHEM, V292, P16498, DOI 10.1074/jbc.M117.791731; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chong H., 2017, J VIROL, V91; Chong HH, 2015, AIDS, V29, P13, DOI 10.1097/QAD.0000000000000498; Chong HH, 2014, J ANTIMICROB CHEMOTH, V69, P2759, DOI 10.1093/jac/dku183; Chong HH, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-40; Chong HH, 2013, FASEB J, V27, P1203, DOI 10.1096/fj.12-222547; Chong HH, 2012, J BIOL CHEM, V287, P34558, DOI 10.1074/jbc.M112.390393; Chong HH, 2012, J BIOL CHEM, V287, P20281, DOI 10.1074/jbc.M112.354126; Chong HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032599; De Feo CJ, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0086-8; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2016, J VIROL, V90, P10587, DOI 10.1128/JVI.01616-16; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2013, CURR PHARM DESIGN, V19, P1800, DOI 10.2174/1381612811319100004; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Johnson WE, 2001, J VIROL, V75, P11426, DOI 10.1128/JVI.75.23.11426-11436.2001; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Li J, 2009, IMMUNOBIOLOGY, V214, P51, DOI 10.1016/j.imbio.2008.04.005; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Poveda E, 2004, J MED VIROL, V74, P21, DOI 10.1002/jmv.20141; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Shimane K, 2013, ANTIMICROB AGENTS CH, V57, P4035, DOI 10.1128/AAC.00237-13; Shimura K, 2010, J BIOL CHEM, V285, P39471, DOI 10.1074/jbc.M110.145789; Sista PR, 2004, AIDS, V18, P1787, DOI 10.1097/00002030-200409030-00007; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Su Y, 2015, J VIROL, V89, P12467, DOI 10.1128/JVI.01741-15; Su Y, 2015, J VIROL, V89, P5801, DOI 10.1128/JVI.00373-15; Svicher V, 2009, ANTIMICROB AGENTS CH, V53, P2816, DOI 10.1128/AAC.01067-08; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wang W, 2011, J VIROL, V85, P12929, DOI 10.1128/JVI.05391-11; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu X., 2018, J VIROL, V92; Xiong SW, 2017, J VIROL, V91, DOI 10.1128/JVI.01839-16; Yao X, 2012, J BIOL CHEM, V287, P26618, DOI 10.1074/jbc.M112.381079; Yao X, 2012, J BIOL CHEM, V287, P6788, DOI 10.1074/jbc.M111.317883	57	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12703	12718		10.1074/jbc.RA118.003538	http://dx.doi.org/10.1074/jbc.RA118.003538			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29929981	Green Published, hybrid			2022-12-28	WOS:000442203500005
J	Huang, L; Liu, J; Zhang, XO; Sibley, K; Najjar, SM; Lee, MM; Wu, Q				Huang, Lei; Liu, Jehnan; Zhang, Xiao-Ou; Sibley, Katelyn; Najjar, Sonia M.; Lee, Mary M.; Wu, Qiong			Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; fatty acid oxidation; signaling; mitochondria; Akt PKB; mitochondrial biogenesis; non-alcoholic fatty liver; PGC-1; PPAR; PRMT5	CELL LUNG-CANCER; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; AKT PHOSPHORYLATION; LIPOGENIC PATHWAY; CYCLE PROGRESSION; SIGNALING CASCADE; GENE-EXPRESSION; MESSENGER-RNA	Protein arginine methyltransferase 5 (PRMT5) regulates gene expression either transcriptionally by symmetric dimethylation of arginine residues on histones H4R3, H3R8, and H2AR3 or at the posttranslational level by methylation of nonhistone target proteins. Although emerging evidence suggests that PRMT5 functions as an oncogene, its role in metabolic diseases is not well-defined. We investigated the role of PRMT5 in promoting high-fat-induced hepatic steatosis. A high-fat diet up-regulated PRMT5 levels in the liver but not in other metabolically relevant tissues such as skeletal muscle or white and brown adipose tissue. This was associated with repression of master transcription regulators involved in mitochondrial biogenesis. In contrast, lentiviral short hairpin RNA-mediated reduction of PRMT5 significantly decreased phosphatidylinositol 3-kinase/AKT signaling in mouse AML12 liver cells. PRMT5 knockdown or knockout decreased basal AKT phosphorylation but boosted the expression of peroxisome proliferator-activated receptor (PPAR) and PGC-1 with a concomitant increase in mitochondrial biogenesis. Moreover, by overexpressing an exogenous WT or enzyme-dead mutant PRMT5 or by inhibiting PRMT5 enzymatic activity with a small-molecule inhibitor, we demonstrated that the enzymatic activity of PRMT5 is required for regulation of PPAR and PGC-1 expression and mitochondrial biogenesis. Our results suggest that targeting PRMT5 may have therapeutic potential for the treatment of fatty liver.	[Huang, Lei; Lee, Mary M.; Wu, Qiong] Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA 01655 USA; [Liu, Jehnan; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res, Toledo, OH 43606 USA; [Zhang, Xiao-Ou] Univ Massachusetts, Med Sch, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Sibley, Katelyn] Worcester Polytech Inst, Dept Biochem, Worcester, MA 01609 USA; [Najjar, Sonia M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; University of Toledo; University of Massachusetts System; University of Massachusetts Worcester; Worcester Polytechnic Institute; University System of Ohio; Ohio University	Lee, MM; Wu, Q (corresponding author), Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA 01655 USA.	mary.lee@umassmemorial.org; joae.wu@umassmed.edu	Huang, Lei/H-7658-2019; Najjar, Sonia M/GXW-2217-2022; Zhang, Xiao-Ou/J-6229-2014	Lee, Mary Min-chin/0000-0003-1985-4594; Huang, Lei/0000-0002-0568-0645; Zhang, Xiao-Ou/0000-0002-2027-1313	University of Massachusetts Medical School internal funds and National Institutes of Health [R01-DK054254, R01-DK083850, R01HL112248]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083850, R01DK054254] Funding Source: NIH RePORTER	University of Massachusetts Medical School internal funds and National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by University of Massachusetts Medical School internal funds and National Institutes of Health Grants R01-DK054254, R01-DK083850, and R01HL112248. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen M, 2014, J BIOL CHEM, V289, P24325, DOI 10.1074/jbc.M114.577494; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Gulla A, 2018, LEUKEMIA, V32, P996, DOI 10.1038/leu.2017.334; Han CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0098759; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kanamaluru D, 2011, MOL CELL BIOL, V31, P1540, DOI 10.1128/MCB.01212-10; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kim SM, 2017, ONCOTARGET, V8, P46273, DOI 10.18632/oncotarget.17695; Kim SP, 2003, DIABETES, V52, P2453, DOI 10.2337/diabetes.52.10.2453; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; LeBlanc SE, 2016, NUCLEIC ACIDS RES, V44, P5133, DOI 10.1093/nar/gkw129; LeBlanc SE, 2012, MOL ENDOCRINOL, V26, P583, DOI 10.1210/me.2011-1162; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lien EC, 2016, RECENT RESULTS CANC, V207, P39, DOI 10.1007/978-3-319-42118-6_3; Liu L, 2016, CANCER RES, V76, P1260, DOI 10.1158/0008-5472.CAN-15-1766; Luyckx FH, 2000, DIABETES METAB, V26, P98; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Moussa NM, 1999, OBES RES, V7, P506, DOI 10.1002/j.1550-8528.1999.tb00440.x; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rengasamy M, 2017, NUCLEIC ACIDS RES, V45, P11106, DOI 10.1093/nar/gkx727; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Sanchis-Gomar F, 2014, CURR PHARM DESIGN, V20, P5619, DOI 10.2174/1381612820666140306095106; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Sidiropoulos KG, 2007, ARCH BIOCHEM BIOPHYS, V465, P380, DOI 10.1016/j.abb.2007.06.029; Veiga FM, 2017, BIOCHIMIE, V140, P106, DOI 10.1016/j.biochi.2017.07.003; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Soliman GA, 2011, CELL CYCLE, V10, P861, DOI 10.4161/cc.10.6.14930; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Wolff GL, 1999, PHYSIOL GENOMICS, V1, P151, DOI 10.1152/physiolgenomics.1999.1.3.151; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Yamauchi Y, 2011, CANCER RES, V71, P4989, DOI 10.1158/0008-5472.CAN-10-4108; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	72	22	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10884	10894		10.1074/jbc.RA118.002377	http://dx.doi.org/10.1074/jbc.RA118.002377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29773653	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000438882800004
J	Yu, SY; Ito, SJ; Wada, I; Hosokawa, N				Yu, Shangyu; Ito, Shinji; Wada, Ikuo; Hosokawa, Nobuko			ER-resident protein 46 (ERp46) triggers the mannose-trimming activity of ER degradation-enhancing -mannosidase-like protein 3 (EDEM3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); endoplasmic-reticulum-associated protein degradation (ERAD); ER quality control; N-linked glycosylation; protein complex; alpha-mannosidase; EDEM3; ERp46	RETICULUM-ASSOCIATED DEGRADATION; DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; PDI FAMILY; GLYCOPROTEINS; ISOMERASE; ROLES; PEROXIREDOXIN; PROTEOSTASIS	Protein folding in the cell is regulated by several quality-control mechanisms. Correct folding of glycoproteins in the endoplasmic reticulum (ER) is tightly monitored by the recognition of glycan signals by lectins in the ER-associated degradation (ERAD) pathway. In mammals, mannose trimming from N-glycans is crucial for disposal of misfolded glycoproteins. The mannosidases responsible for this process are ER mannosidase I and ER degradation-enhancing -mannosidase-like proteins (EDEMs). However, the molecular mechanism of mannose removal by EDEMs remains unclear, partly owing to the difficulty of reconstituting mannosidase activity in vitro. Here, our analysis of EDEM3-mediated mannose-trimming activity on a misfolded glycoprotein revealed that ERp46, an ER-resident oxidoreductase, associates stably with EDEM3. This interaction, which depended on the redox activity of ERp46, involved formation of a disulfide bond between the cysteine residues of the ERp46 redox-active sites and the EDEM3 -mannosidase domain. In a defined in vitro system consisting of recombinant proteins purified from HEK293 cells, the mannose-trimming activity of EDEM3 toward the model misfolded substrate, the glycoprotein T-cell receptor locus (TCR), was reconstituted only when ERp46 had established a covalent interaction with EDEM3. On the basis of these findings, we propose that disposal of misfolded glycoproteins through mannose trimming is tightly connected to redox-mediated regulation in the ER.	[Yu, Shangyu; Hosokawa, Nobuko] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Mol & Cellular Biol, Kyoto 6068507, Japan; [Ito, Shinji] Kyoto Univ, Grad Sch Med, Med Res Support Ctr, Kyoto 6068501, Japan; [Wada, Ikuo] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima 9601295, Japan	Kyoto University; Kyoto University; Fukushima Medical University	Hosokawa, N (corresponding author), Kyoto Univ, Lab Mol & Cellular Biol, Inst Frontier Life & Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto, Kyoto 6068507, Japan.	nobukoh@infront.kyoto-u.ac.jp			Institute for Molecular Science (IMS); Scientific Research C of KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mizutani Foundation for Glycosciences	Institute for Molecular Science (IMS)(National Institutes of Natural Sciences (NINS) - JapanInstitute for Molecular Science (IMS)); Scientific Research C of KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mizutani Foundation for Glycosciences	This work was supported by a Joint Research grant from the Institute for Molecular Science (IMS); Scientific Research C of KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and the Mizutani Foundation for Glycosciences (to N. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Aikawa J, 2012, GLYCOCONJUGATE J, V29, P35, DOI 10.1007/s10719-011-9362-1; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Benyair R, 2015, SEMIN CELL DEV BIOL, V41, P99, DOI 10.1016/j.semcdb.2014.11.006; Benyair R, 2015, MOL BIOL CELL, V26, P172, DOI 10.1091/mbc.E14-06-1152; Berner N, 2018, ANNU REV BIOCHEM, V87, P751, DOI 10.1146/annurev-biochem-062917-012749; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Caramelo JJ, 2015, FEBS LETT, V589, P3379, DOI 10.1016/j.febslet.2015.07.021; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Fujimori T, 2017, GENES CELLS, V22, P684, DOI 10.1111/gtc.12506; Fujimori T, 2013, FEBS J, V280, P1563, DOI 10.1111/febs.12157; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P651, DOI 10.1093/glycob/cwq013; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Liu YC, 2016, P NATL ACAD SCI USA, V113, pE4015, DOI 10.1073/pnas.1608795113; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Pfeiffer A, 2016, J BIOL CHEM, V291, P12195, DOI 10.1074/jbc.M115.703256; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Shepherd C, 2014, BIOCHEM J, V461, P107, DOI 10.1042/BJ20140234; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	43	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10663	10674		10.1074/jbc.RA118.003129	http://dx.doi.org/10.1074/jbc.RA118.003129			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29784879	Green Published, hybrid			2022-12-28	WOS:000437828400023
J	Chen, YT; Chang, IYF; Liu, H; Ma, CP; Kuo, YP; Shih, CT; Shih, YH; Kang, L; Tan, BCM				Chen, Yi-Tung; Chang, Ian Yi-Feng; Liu, Hsuan; Ma, Chung-Pei; Kuo, Yu-Ping; Shih, Chieh-Tien; Shih, Ying-Hsin; Kang, Lin; Tan, Bertrand Chin-Ming			Tumor-associated intronic editing of HNRPLL generates a novel splicing variant linked to cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA editing; alternative splicing; exonic splicing enhancer; cell proliferation; tumor cell biology	FACTOR SRSF1; RNA; GENE; ADENOSINE; TRANSCRIPTION; TRANSLATION; MUTATIONS; STABILITY; REVEALS; COMPLEX	Processing of the eukaryotic transcriptome is a dynamic regulatory mechanism that confers genetic diversity, and splicing and adenosine to inosine (A-to-I) RNA editing are well-characterized examples of such processing. Growing evidence reveals the cross-talk between the splicing and RNA editing, but there is a paucity of substantial evidence for its mechanistic details and contribution in a physiological context. Here, our findings demonstrate that tumor-associated differential RNA editing, in conjunction with splicing machinery, regulates the expression of variants of HNRPLL, a gene encoding splicing factor. We discovered an HNRPLL transcript variant containing an additional exon 12A (E12A), which is a substrate of ADAR1 and ADAR2. Adenosine deaminases acting on RNA (ADAR) direct deaminase-dependent expression of the E12A transcript, and ADAR-mediated regulation of E12A is largely splicing-based, and does not affect the stability or nucleocytoplasmic distribution of the transcript. Furthermore, ADAR-mediated modification of exon 12A generates an enhancer for the oncogenic splicing factor SRSF1 and consequently promotes the frequency of alternative splicing. Gene expression profiling by RNA-seq revealed that E12A acts distinctly from HNRPLL and regulates a set of growth-related genes, such as cyclin CCND1 and growth factor receptor TGFBR1. Accordingly, silencing E12A expression leads to impaired clonogenic ability and enhanced sensitivity to doxorubicin, thus highlighting the significance of this alternative isoform in tumor cell survival. In summary, we present the interplay of RNA editing and splicing as a regulatory mechanism of gene expression and also its physiological relevance. These findings extend our understanding of transcriptional dynamics and provide a mechanistic explanation to the link of RNA editors to tumorigenesis.	[Chen, Yi-Tung; Ma, Chung-Pei; Kuo, Yu-Ping; Shih, Chieh-Tien; Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan; [Chen, Yi-Tung; Ma, Chung-Pei; Kuo, Yu-Ping; Shih, Chieh-Tien; Shih, Ying-Hsin; Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Dept Biomed Sci, Coll Med, 259 Wen Hwa First Rd, Taoyuan 333, Taiwan; [Chang, Ian Yi-Feng; Liu, Hsuan; Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Mol Med Res Ctr, Taoyuan 333, Taiwan; [Liu, Hsuan] Chang Gung Mem Hosp, Dept Biochem, Coll Med, Taoyuan 333, Taiwan; [Liu, Hsuan] Chang Gung Mem Hosp, Div Colon & Rectal Surg, Lin Kou Med Ctr, Taoyuan 333, Taiwan; [Kang, Lin] Edward Via Coll Osteopath Med, Blacksburg, VA 24060 USA; [Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Lin Kou Med Ctr, Dept Neurosurg, Taoyuan 333, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tan, BCM (corresponding author), Chang Gung Mem Hosp, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan.; Tan, BCM (corresponding author), Chang Gung Mem Hosp, Dept Biomed Sci, Coll Med, 259 Wen Hwa First Rd, Taoyuan 333, Taiwan.	btan@mail.cgu.edu.tw	Kang, Lin/AAA-2260-2019; Chang, Ian/U-3571-2019	Kang, Lin/0000-0002-9186-9574; Chang, Ian/0000-0001-5840-2051; Tan, Bertrand/0000-0002-2218-7115; Chen, Yi-Tung/0000-0001-9715-648X	Ministry of Science and Technology of Taiwan [MOST105-2320-B-182-017, MOST104-2320-B-182-029-MY3, MOST105-2314-B-182-061-MY4, MOST103-2632-B-182-001, MOST104-2632-B-182-001, MOST105-2632-B-182-001]; Chang Gung Memorial Hospital [CMRPD1F0571, CMRPD1C0843, CMRPD3E0153, CMRPD1F0442, BMRP960]; National Health Research Institute of Taiwan [NHRI-EX105-10321SI]; Ministry of Education of Taiwan	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan); Ministry of Education of Taiwan(Ministry of Education, Taiwan)	This work was supported by Ministry of Science and Technology of Taiwan Grants MOST105-2320-B-182-017 (to H. L.), MOST104-2320-B-182-029-MY3, and MOST105-2314-B-182-061-MY4 (to B. C.-M. T.), MOST103-2632-B-182-001, MOST104-2632-B-182-001, and MOST105-2632-B-182-001, Chang Gung Memorial Hospital Grants CMRPD1F0571 (to H. L.), CMRPD1C0843, CMRPD3E0153, CMRPD1F0442, and BMRP960(to B. C-M. T.), National Health Research Institute of Taiwan Grant NHRI-EX105-10321SI, and a grant from the Ministry of Education of Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Anantharaman A, 2017, NUCLEIC ACIDS RES, V45, P4189, DOI 10.1093/nar/gkw1304; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Das S, 2012, CELL REP, V1, P110, DOI 10.1016/j.celrep.2011.12.001; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Gumireddy K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10715; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hsieh CL, 2014, CELL DEATH DIFFER, V21, P707, DOI 10.1038/cdd.2013.197; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Licht K, 2016, NUCLEIC ACIDS RES, V44, P6398, DOI 10.1093/nar/gkw325; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nakano M, 2017, J BIOL CHEM, V292, P4873, DOI 10.1074/jbc.M117.775684; Nasim MT, 2006, NAT PROTOC, V1, P1022, DOI 10.1038/nprot.2006.148; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Raitskin O, 2001, P NATL ACAD SCI USA, V98, P6571, DOI 10.1073/pnas.111153798; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Salton M, 2016, TRENDS MOL MED, V22, P28, DOI 10.1016/j.molmed.2015.11.005; Salton M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8103; Slavov D, 2000, GENE, V250, P53, DOI 10.1016/S0378-1119(00)00175-X; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang LL, 2016, CANCER CELL, V30, P750, DOI 10.1016/j.ccell.2016.10.005; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang T, 2013, NUCLEIC ACIDS RES, V41, P4743, DOI 10.1093/nar/gkt178; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Yang CC, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.12; Yang CC, 2012, EMBO J, V31, P1739, DOI 10.1038/emboj.2012.24; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zipeto MA, 2015, TRENDS MOL MED, V21, P549, DOI 10.1016/j.molmed.2015.07.001	52	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10158	10171		10.1074/jbc.RA117.001197	http://dx.doi.org/10.1074/jbc.RA117.001197			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769310	Green Published, hybrid			2022-12-28	WOS:000437096700018
J	Yan, T; Zhang, AL; Shi, FF; Chang, F; Mei, J; Liu, YJ; Zhu, YC				Yan, Ting; Zhang, Ailiang; Shi, Fangfang; Chang, Fei; Mei, Jie; Liu, Yongjian; Zhu, Yichao			Integrin v3-associated DAAM1 is essential for collagen-induced invadopodia extension and cell haptotaxis in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; actin; invadopodia; migration; integrin; DAAM1; haptotaxis; integrin v3; invadopodia; RHOA	EXTRACELLULAR-MATRIX; BETA-3 INTEGRIN; ACTIN DYNAMICS; PROTEIN DAAM1; ACTIVATION; MIGRATION; INVASION; COMPLEX; RHOA	The formin protein dishevelled-associated activator of morphogenesis 1 (DAAM1) polymerizes straight actin filaments and mediates migration of cancer cells. However, how DAAM1 governs cell haptotaxis in response to collagen remains unexplored in breast cancer cells. We hypothesized that DAAM1 mediates invadopodia extension and cell haptotaxis in response to type IV collagen in association with integrin receptors. Using Boyden chamber membranes coated with type IV collagen, we show here that type IV collagen activates both DAAM1 and Ras homolog family member A (RHOA) and promotes haptotaxis of MDA-MB-231 and MDA-MB-453 breast cancer cells, a process abolished by treatment with the integrin v3 inhibitor cyclo(-RGDfK). shRNA-mediated knockdown of DAAM1 or a dominant-negative DAAM1 mutation (N-DAAM1) significantly decreased collagen-induced RHOA activity and the assembly of stress fibers, invadopodia extension, and cell haptotaxis. Immunoprecipitation and pulldown assays revealed that integrin v3 is associated with, but only indirectly binds to, the C-terminal DAD domain of DAAM1 in mammalian cells. Blockade of RHOA activation with a specific inhibitor (CCG-1423) or via a dominant-negative RHOA mutation (RHOA-N19) suppressed collagen-induced invadopodia extension and haptotaxis of the MDA-MB-231 and MDA-MB-453 cells. Immunoblotting and immunofluorescence assays indicated high DAAM1 and RHOA expression in invadopodia, which was abolished by cyclo(-RGDfK) treatment or DAAM1 knockdown. These findings have uncovered an integrin v3/DAAM1/RHOA signaling pathway for type IV collagen-induced invadopodia extension and haptotaxis in breast cancer cells. Targeting this pathway may be a means for reducing invasiveness and metastasis of breast cancer.	[Yan, Ting] Nanjing Med Univ, Safety Assessment & Res Ctr Drug Pesticide & Vet, Nanjing 211166, Jiangsu, Peoples R China; [Chang, Fei; Mei, Jie; Liu, Yongjian; Zhu, Yichao] Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China; [Zhu, Yichao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China; [Zhang, Ailiang] Soochow Univ, Affiliated Hosp 3, Dept Spine Surg, Changzhou 213003, Peoples R China; [Shi, Fangfang] Southeast Univ, Zhongda Hosp, Dept Oncol, Nanjing 210009, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Soochow University - China; Southeast University - China	Zhu, YC (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China.; Zhu, YC (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.	zhuyichao@njmu.edu.cn	Liu, Yong/GWQ-6163-2022; Mei, Jie/W-1298-2019	Mei, Jie/0000-0001-7799-8129	National Natural Science Foundation of China [81472703]; Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents; Southeast University [2242017K3DN41]; Nanjing Medical University [2242017K3DN41]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents; Southeast University; Nanjing Medical University	This work was supported by National Natural Science Foundation of China Grant 81472703 (to Y. Z.), a sponsorship of the Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents (to Y. Z.), and Joint Research Project of Southeast University and Nanjing Medical University Grant 2242017K3DN41 (to F. S. and Y. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Debruyne PR, 2002, ONCOGENE, V21, P6740, DOI 10.1038/sj.onc.1205729; Demircioglu F, 2016, CURR OPIN CELL BIOL, V42, P121, DOI 10.1016/j.ceb.2016.07.008; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Guillabert-Gourgues A, 2016, MOL BIOL CELL, V27, P941, DOI 10.1091/mbc.E14-08-1332; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Hynes RO, 2014, NAT REV MOL CELL BIO, V15, P761, DOI 10.1038/nrm3908; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Flamini MI, 2017, HORM CANCER-US, V8, P16, DOI 10.1007/s12672-016-0280-3; Jacob A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00004; Kerkhoff E, 2011, EUR J CELL BIOL, V90, P922, DOI 10.1016/j.ejcb.2010.10.011; Kwakwa KA, 2017, CANCERS, V9, DOI 10.3390/cancers9070084; Li WT, 2016, INT J ONCOL, V48, P1155, DOI 10.3892/ijo.2016.3319; Liu JJ, 2013, CELL SIGNAL, V25, P447, DOI 10.1016/j.cellsig.2012.10.012; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Lu YY, 2016, MOL MED REP, V14, P3429, DOI 10.3892/mmr.2016.5635; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Moilanen JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45057; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nair MG, 2016, EXP CELL RES, V346, P137, DOI 10.1016/j.yexcr.2016.05.015; Nishimura T, 2016, J CELL BIOL, V215, P559, DOI 10.1083/jcb.201603107; Oudin MJ, 2016, MOL BIOL CELL, V27, P3085, DOI 10.1091/mbc.E16-04-0212; Oudin MJ, 2016, CANCER DISCOV, V6, P516, DOI 10.1158/2159-8290.CD-15-1183; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Pelaez R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181579; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Santiago-Medina M, 2016, CANCER DISCOV, V6, P474, DOI 10.1158/2159-8290.CD-16-0231; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Wang Yingchun, 2007, Sci STKE, V2007, ppl4, DOI 10.1126/stke.4002007pl4; Zeltz C, 2016, J CELL SCI, V129, P1284, DOI 10.1242/jcs.188672; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823	36	27	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10172	10185		10.1074/jbc.RA117.000327	http://dx.doi.org/10.1074/jbc.RA117.000327			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29752407	Green Published, hybrid			2022-12-28	WOS:000437096700019
J	Ahangar, MS; Furze, CM; Guy, CS; Cooper, C; Maskew, KS; Graham, B; Cameron, AD; Fullam, E				Ahangar, Mohd Syed; Furze, Christopher M.; Guy, Collette S.; Cooper, Charlotte; Maskew, Kathryn S.; Graham, Ben; Cameron, Alexander D.; Fullam, Elizabeth			Structural and functional determination of homologs of the Mycobacterium tuberculosis N-acetylglucosamine-6-phosphate deacetylase (NagA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; crystal structure; tuberculosis; Mycobacterium tuberculosis; enzyme kinetics; X-ray crystallography; peptidoglycan; bacterial cell wall; N-acetylglucosamine-6-phosphate deactylase; TB	RESUSCITATION-PROMOTING FACTORS; ACETYL-D-GLUCOSAMINE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; CELL-WALL; N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE; N-ACETYLGLUCOSAMINE; N-ACETYL-D-GLUCOSAMINE-6-PHOSPHATE DEACETYLASE; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC PRODUCTION	The Mycobacterium tuberculosis (Mtb) pathogen encodes a GlcNAc-6-phosphate deacetylase enzyme, NagA (Rv3332), that belongs to the amidohydrolase superfamily. NagA enzymes catalyze the deacetylation of GlcNAc-6-phosphate (GlcNAc6P) to glucosamine-6-phosphate (GlcN6P). NagA is a potential antitubercular drug target because it represents the key enzymatic step in the generation of essential amino-sugar precursors required for Mtb cell wall biosynthesis and also influences recycling of cell wall peptidoglycan fragments. Here, we report the structural and functional characterization of NagA from Mycobacterium smegmatis (MSNagA) and Mycobacterium marinum (MMNagA), close relatives of Mtb. Using a combination of X-ray crystallography, site-directed mutagenesis, and biochemical and biophysical assays, we show that these mycobacterial NagA enzymes are selective for GlcNAc6P. Site-directed mutagenesis studies revealed crucial roles of conserved residues in the active site that underpin stereoselective recognition, binding, and catalysis of substrates. Moreover, we report the crystal structure of MSNagA in both ligand-free form and in complex with the GlcNAc6P substrate at 2.6 and 2.0 resolutions, respectively. The GlcNAc6P complex structure disclosed the precise mode of GlcNAc6P binding and the structural framework of the active site, including two divalent metals located in the / binuclear site. Furthermore, we observed a cysteine residue located on a flexible loop region that occludes the active site. This cysteine is unique to mycobacteria and may represent a unique subsite for targeting mycobacterial NagA enzymes. Our results provide critical insights into the structural and mechanistic properties of mycobacterial NagA enzymes having an essential role in amino-sugar and nucleotide metabolism in mycobacteria.	[Ahangar, Mohd Syed; Furze, Christopher M.; Guy, Collette S.; Cooper, Charlotte; Maskew, Kathryn S.; Cameron, Alexander D.; Fullam, Elizabeth] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Guy, Collette S.; Graham, Ben] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Fullam, E (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	e.fullam@warwick.ac.uk		Cooper, Charlotte/0000-0003-4855-4187; Furze, Christopher/0000-0002-2785-4618; Ahangar, Mohd Syed/0000-0003-2251-6107; Cameron, Alexander/0000-0001-8776-3518; Guy, Collette/0000-0002-5153-0613; Maskew, Kathryn/0000-0002-5933-9186	Sir Henry Dale Fellowship - Wellcome Trust [104193/Z/14/Z]; Sir Henry Dale Fellowship - Royal Society [104193/Z/14/Z]; Wellcome Warwick Quantitative Biomedicine Programme Institution Strategic Support Fund Seed Grant [105627/Z/14/Z]; Midlands Doctoral Training Partnership Studentship [BB/M01116X/1]; Warwick Integrative Synthetic Biology research technology platform [BB/M017982/1]; Wellcome Trust Grant [201442/Z/16/Z]; Royal Society Research Grant [RG120405]; BBSRC [1790828, BB/M017982/1] Funding Source: UKRI	Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society; Wellcome Warwick Quantitative Biomedicine Programme Institution Strategic Support Fund Seed Grant; Midlands Doctoral Training Partnership Studentship; Warwick Integrative Synthetic Biology research technology platform; Wellcome Trust Grant(Wellcome Trust); Royal Society Research Grant(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Sir Henry Dale Fellowship (to E.F.) jointly funded by the Wellcome Trust and Royal Society Grant 104193/Z/14/Z, Wellcome Trust Grant 201442/Z/16/Z (to E.F.), Royal Society Research Grant RG120405 (to E.F.), and Wellcome Warwick Quantitative Biomedicine Programme Institution Strategic Support Fund Seed Grant 105627/Z/14/Z; a Midlands Doctoral Training Partnership Studentship BB/M01116X/1 (to C.C.); this work was also supported in part by Warwick Integrative Synthetic Biology research technology platform (Grant BB/M017982/1). The authors declare that they have no conflicts of interest with the contents of this article.	Abrahams KA, 2018, PARASITOLOGY, V145, P116, DOI 10.1017/S0031182016002377; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergfeld AK, 2012, J BIOL CHEM, V287, P28865, DOI 10.1074/jbc.M112.363549; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cole ST, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0430; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira FM, 2000, ACTA CRYSTALLOGR D, V56, P670, DOI 10.1107/S0907444900003668; Ferreira FM, 2006, J MOL BIOL, V359, P308, DOI 10.1016/j.jmb.2006.03.024; Fullam E, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160105; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7953, DOI 10.1021/bi700544c; IMADA A, 1977, J GEN MICROBIOL, V100, P329, DOI 10.1099/00221287-100-2-329; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Komatsuzawa H, 2004, MOL MICROBIOL, V53, P1221, DOI 10.1111/j.1365-2958.2004.04200.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042769; Li YM, 2011, CARBOHYD RES, V346, P1714, DOI 10.1016/j.carres.2011.05.024; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; MOBLEY HLT, 1982, J BACTERIOL, V150, P8, DOI 10.1128/JB.150.1.8-15.1982; Moraes GL, 2015, TUBERCULOSIS, V95, P95, DOI 10.1016/j.tube.2015.01.006; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; PLUMBRIDGE JA, 1990, J BACTERIOL, V172, P2728, DOI 10.1128/jb.172.5.2728-2735.1990; Prigozhin DM, 2013, J BIOL CHEM, V288, P31549, DOI 10.1074/jbc.M113.510792; Rosser A, 2017, CRIT REV MICROBIOL, V43, P621, DOI 10.1080/1040841X.2017.1283485; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Souza JM, 1997, ARCH BIOCHEM BIOPHYS, V340, P338, DOI 10.1006/abbi.1997.9780; Swiatek MA, 2012, BIOENGINEERED, V3, P280, DOI 10.4161/bioe.21371; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Uehara T, 2004, J BACTERIOL, V186, P7273, DOI 10.1128/JB.186.21.7273-7279.2004; Unsleber S, 2017, CARBOHYD RES, V445, P98, DOI 10.1016/j.carres.2017.04.005; Urem M, 2016, MOL MICROBIOL, V102, P183, DOI 10.1111/mmi.13464; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; WHO, 2017, GLOB TUB REP	53	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9770	9783		10.1074/jbc.RA118.002597	http://dx.doi.org/10.1074/jbc.RA118.002597			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29728457	hybrid, Green Published			2022-12-28	WOS:000436102300021
J	Drees, SL; Ernst, S; Belviso, BD; Jagmann, N; Hennecke, U; Fetzner, S				Drees, Steffen Lorenz; Ernst, Simon; Belviso, Benny Danilo; Jagmann, Nina; Hennecke, Ulrich; Fetzner, Susanne			PqsL uses reduced flavin to produce 2-hydroxylaminobenzoylacetate, a preferred PqsBC substrate in alkyl quinolone biosynthesis in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin; biosynthesis; secondary metabolism; quorum sensing; crystal structure; Pseudomonas aeruginosa; 2-alkyl-4-hydroxyquinoline-N-oxide; p-hydroxybenzoate 3-hydroxylase; monooxygenase	P-HYDROXYBENZOATE HYDROXYLASE; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; RESPIRATORY-CHAIN; BINDING-SITES; OXIDATION; ENZYME; NADPH; FLUORESCENS; COMPETITION	Alkyl hydroxyquinoline N-oxides (AQNOs) are antibiotic compounds produced by the opportunistic bacterial pathogen Pseudomonas aeruginosa. They are products of the alkyl quinolone (AQ) biosynthetic pathway, which also generates the quorum-sensing molecules 2-heptyl-4(1H)-quinolone (HHQ) and 2-heptyl-3-hydroxy-4(1H)-quinolone (PQS). Although the enzymatic synthesis of HHQ and PQS had been elucidated, the route by which AQNOs are synthesized remained elusive. Here, we report on PqsL, the key enzyme for AQNO production, which structurally resembles class A flavoprotein monooxygenases such as p-hydroxybenzoate 3-hydroxylase (pHBH) and 3-hydroxybenzoate 6-hydroxylase. However, we found that unlike related enzymes, PqsL hydroxylates a primary aromatic amine group, and it does not use NAD(P)H as cosubstrate, but unexpectedly required reduced flavin as electron donor. We also observed that PqsL is active toward 2-aminobenzoylacetate (2-ABA), the central intermediate of the AQ pathway, and forms the unstable compound 2-hydroxylaminobenzoylacetate, which was preferred over 2-ABA as substrate of the downstream enzyme PqsBC. In vitro reconstitution of the PqsL/PqsBC reaction was feasible by using the FAD reductase HpaC, and we noted that the AQ:AQNO ratio is increased in an hpaC-deletion mutant of P. aeruginosa PAO1 compared with the ratio in the WT strain. A structural comparison with pHBH, the model enzyme of class A flavoprotein monooxygenases, revealed that structural features associated with NAD(P)H binding are missing in PqsL. Our study completes the AQNO biosynthetic pathway in P. aeruginosa, indicating that PqsL produces the unstable product 2-hydroxylaminobenzoylacetate from 2-ABA and depends on free reduced flavin as electron donor instead of NAD(P)H.	[Drees, Steffen Lorenz; Ernst, Simon; Jagmann, Nina; Fetzner, Susanne] Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany; [Hennecke, Ulrich] Univ Munster, Inst Organ Chem, D-48149 Munster, Germany; [Belviso, Benny Danilo] CNR, Inst Crystallog, I-70126 Bari, Italy	University of Munster; University of Munster; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR)	Drees, SL; Fetzner, S (corresponding author), Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany.	s.drees@uni-muenster.de; fetzner@uni-muenster.de	Drees, Steffen Lorenz/Q-3510-2019; Hennecke, Ulrich/A-7723-2010	Drees, Steffen Lorenz/0000-0001-9140-0111; Hennecke, Ulrich/0000-0002-4904-6793; Fetzner, Susanne/0000-0002-7228-1871; Belviso, Benny Danilo/0000-0003-2880-1064; Ernst, Simon/0000-0002-4794-213X	Deutsche Forschungsgemeinschaft [INST 211/646-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Prof. B. Philipp (University of Munster) for access to the electrospray ionization ion trap mass spectrometer (Deutsche Forschungsgemeinschaft Grant INST 211/646-1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P150; BELAND FA, 1985, ENVIRON HEALTH PERSP, V62, P19, DOI 10.2307/3430089; Bendova L, 2007, J PHYS CHEM B, V111, P9975, DOI 10.1021/jp072859+; BORENFREUND E, 1964, J NATL CANCER I, V32, P667; Buedenbender S, 2009, J MOL BIOL, V385, P520, DOI 10.1016/j.jmb.2008.10.057; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; Cardenas ML, 2001, METHODS, V24, P175, DOI 10.1006/meth.2001.1178; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Cooley JW, 2005, BIOCHEMISTRY-US, V44, P10520, DOI 10.1021/bi050571+; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Drees SL, 2016, J BIOL CHEM, V291, P6610, DOI 10.1074/jbc.M115.708453; Drees SL, 2015, CHEM BIOL, V22, P611, DOI 10.1016/j.chembiol.2015.04.012; Dulcey CE, 2013, CHEM BIOL, V20, P1481, DOI 10.1016/j.chembiol.2013.09.021; EINARSDOTTIR GH, 1989, BIOCHEMISTRY-US, V28, P4161, DOI 10.1021/bi00436a006; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eppink MHM, 1999, J MOL BIOL, V292, P87, DOI 10.1006/jmbi.1999.3015; Eppink MHM, 1999, FEBS LETT, V443, P251, DOI 10.1016/S0014-5793(98)01726-8; Eppink MHM, 1998, EUR J BIOCHEM, V253, P194, DOI 10.1046/j.1432-1327.1998.2530194.x; Eppink MHM, 1998, J BIOL CHEM, V273, P21031, DOI 10.1074/jbc.273.33.21031; Filkins LM, 2015, J BACTERIOL, V197, P2252, DOI 10.1128/JB.00059-15; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; Green Laura K, 2013, Cancers (Basel), V5, P985, DOI 10.3390/cancers5030985; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Hazan R, 2016, CURR BIOL, V26, P195, DOI 10.1016/j.cub.2015.11.056; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; HUMPHREYS WG, 1992, P NATL ACAD SCI USA, V89, P8278, DOI 10.1073/pnas.89.17.8278; HUNTRESS EH, 1956, J AM CHEM SOC, V78, P419, DOI 10.1021/ja01583a046; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Jagmann N, 2010, ENVIRON MICROBIOL, V12, P1787, DOI 10.1111/j.1462-2920.2010.02271.x; Kamm O., 2003, ORG SYNTH, P57, DOI [10.1039/j29710002398, DOI 10.1039/J29710002398]; Kim YH, 2013, J BACTERIOL, V195, P180, DOI 10.1128/JB.02016-12; KITA K, 1984, J BIOL CHEM, V259, P3368; KRIEK E, 1974, BIOCHIM BIOPHYS ACTA, V355, P177, DOI 10.1016/0304-419X(74)90003-1; Mascotti ML, 2016, J MOL BIOL, V428, P3131, DOI 10.1016/j.jmb.2016.07.003; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lepine F, 2003, BBA-GEN SUBJECTS, V1622, P36, DOI 10.1016/S0304-4165(03)00103-X; Louie TM, 2003, BIOCHEMISTRY-US, V42, P7509, DOI 10.1021/bi034092r; Massey V., 1991, SIMPLE METHOD DETERM, P59; MILLEN MH, 1971, J CHEM SOC B, P2398, DOI 10.1039/j29710002398; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Needham ER, 1904, J CHEM SOC, V85, P148, DOI 10.1039/ct9048500148; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Palfey BA, 1997, BIOCHEMISTRY-US, V36, P15713; Palmer GC, 2013, MICROBIOL-SGM, V159, P959, DOI 10.1099/mic.0.063065-0; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; POCKLINGTON T, 1969, BIOCHEM J, V112, P331, DOI 10.1042/bj1120331; Rampioni G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006029; Schauble S, 2013, FEBS LETT, V587, P2818, DOI 10.1016/j.febslet.2013.06.025; Schnell S, 2000, J MATH CHEM, V27, P155, DOI 10.1023/A:1019139423811; SCHOPF C, 1956, CHEM BER-RECL, V89, P2877, DOI 10.1002/cber.19560891233; SCHREUDER HA, 1994, BIOCHEMISTRY-US, V33, P10161, DOI 10.1021/bi00199a044; Sena FV, 2015, MOL MICROBIOL, V98, P272, DOI 10.1111/mmi.13120; SICKER D, 1988, COLLECT CZECH CHEM C, V53, P839, DOI 10.1135/cccc19880839; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Unversucht S, 2005, ADV SYNTH CATAL, V347, P1163, DOI 10.1002/adsc.200505029; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Pee KH, 2006, APPL MICROBIOL BIOT, V70, P631, DOI 10.1007/s00253-005-0232-2; VANBERKEL WJH, 1988, EUR J BIOCHEM, V176, P449; Verna L, 1996, PHARMACOL THERAPEUT, V71, P83, DOI 10.1016/0163-7258(96)00063-0; Wang J, 2002, P NATL ACAD SCI USA, V99, P608, DOI 10.1073/pnas.022640199; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; WILLIAMSON G, 1988, BIOCHIM BIOPHYS ACTA, V953, P258, DOI 10.1016/0167-4838(88)90033-7; WIMPENNY JW, 1972, J BACTERIOL, V11, P24, DOI 10.1128/JB.111.1.24-32.1972; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000; Yap LL, 2010, BBA-BIOENERGETICS, V1797, P1924, DOI 10.1016/j.bbabio.2010.04.011; Zhang YM, 2008, J BIOL CHEM, V283, P28788, DOI 10.1074/jbc.M804555200; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	80	21	21	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9345	9357		10.1074/jbc.RA117.000789	http://dx.doi.org/10.1074/jbc.RA117.000789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29669807	Green Published, hybrid			2022-12-28	WOS:000435441400020
J	May-Zhang, LS; Yermalitsky, V; Huang, JS; Pleasent, T; Borja, MS; Oda, MN; Jerome, WG; Yancey, PG; Linton, MF; Davies, SS				May-Zhang, Linda S.; Yermalitsky, Valery; Huang, Jiansheng; Pleasent, Tiffany; Borja, Mark S.; Oda, Michael N.; Jerome, W. Gray; Yancey, Patricia G.; Linton, MacRae F.; Davies, Sean S.			Modification by isolevuglandins, highly reactive gamma-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid peroxidation; high-density lipoprotein (HDL); atherosclerosis; oxidative stress; inflammation; aldehydes; isolevuglandins; reactive lipid species	APOLIPOPROTEIN-A-I; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; PROTEIN ADDUCTS; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; MYELOPEROXIDASE; HDL; MACROPHAGES; EFFLUX; OXIDATION	Cardiovascular disease risk depends on high-density lipoprotein (HDL) function, not HDL-cholesterol. Isolevuglandins (IsoLGs) are lipid dicarbonyls that react with lysine residues of proteins and phosphatidylethanolamine. IsoLG adducts are elevated in atherosclerosis. The consequences of IsoLG modification of HDL have not been studied. We hypothesized that IsoLG modification of apoA-I deleteriously alters HDL function. We determined the effect of IsoLG on HDL structure-function and whether pentylpyridoxamine (PPM), a dicarbonyl scavenger, can preserve HDL function. IsoLG adducts in HDL derived from patients with familial hypercholesterolemia (n = 10, 233.4 +/- 158.3 ng/mg) were found to be significantly higher than in healthy controls (n = 7, 90.1 +/- 33.4 pg/mg protein). Further, HDL exposed to myeloperoxidase had elevated IsoLG-lysine adducts (5.7 ng/mg protein) compared with unexposed HDL (0.5 ng/mg protein). Preincubation with PPM reduced IsoLG-lysine adducts by 67%, whereas its inactive analogue pentylpyridoxine did not. The addition of IsoLG produced apoA-I and apoA-II cross-links beginning at 0.3 molar eq of IsoLG/mol of apoA-I (0.3 eq), whereas succinylaldehyde and 4-hydroxynonenal required 10 and 30 eq. IsoLG increased HDL size, generating a subpopulation of 16-23 nm. 1 eq of IsoLG decreased HDL-mediated [H-3]cholesterol efflux from macrophages via ABCA1, which corresponded to a decrease in HDL-apoA-I exchange from 47.4% to only 24.8%. This suggests that IsoLG inhibits apoA-I from disassociating from HDL to interact with ABCA1. The addition of 0.3 eq of IsoLG ablated HDL's ability to inhibit LPS-stimulated cytokine expression by macrophages and increased IL-1 expression by 3.5-fold. The structural-functional effects were partially rescued with PPM scavenging.	[May-Zhang, Linda S.; Yermalitsky, Valery; Linton, MacRae F.; Davies, Sean S.] Vanderbilt Univ, Dept Pharmacol, 556B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Huang, Jiansheng; Yancey, Patricia G.; Linton, MacRae F.] Vanderbilt Univ Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA; [Jerome, W. Gray] Vanderbilt Univ Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Pleasent, Tiffany] Meharry Med Coll, Nashville, TN 37208 USA; [Borja, Mark S.] Calif State Univ East Bay, Dept Chem & Biochem, Hayward, CA 94542 USA; [Oda, Michael N.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Meharry Medical College; California State University System; California State University East Bay; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Davies, SS (corresponding author), Vanderbilt Univ, Dept Pharmacol, 556B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	sean.davies@vanderbilt.edu	Yancey, Patricia/ABB-5856-2021	Davies, Sean/0000-0001-9879-8062; May-Zhang, Linda/0000-0001-9486-419X	National Institutes of Health [HL116263, HL138745]; American Heart Association [17POST33660332]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL116263, F32HL138745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants HL116263 (to M. F. L. and S. S. D.) and HL138745 (to L. S. M.) and by American Heart Association Grant 17POST33660332 (to L. S. M.). S. S. D. and M. F. L. are inventors on a patent application for the use of PPM and related dicarbonyl scavengers for the treatment of cardiovascular disease. M. N. O. is a founder of and owns a significant stake in Seer Biologics, Inc., which could stand to benefit from the research described here. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKANUMA Y, 1968, J LIPID RES, V9, P620; Akinkuolie AO, 2014, CIRC-CARDIOVASC QUAL, V7, P55, DOI 10.1161/CIRCOUTCOMES.113.000675; Amarnath V, 2005, SYNTHETIC COMMUN, V35, P397, DOI 10.1081/SCC-200048945; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Borja MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182217; Borja MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071541; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; CAVAILLON JM, 1990, INFECT IMMUN, V58, P2375, DOI 10.1128/IAI.58.7.2375-2382.1990; Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434; Colvin PL, 1999, J LIPID RES, V40, P1782; Davies SS, 2007, NAT PROTOC, V2, P2079, DOI 10.1038/nprot.2007.298; Davies SS, 2006, BIOCHEMISTRY-US, V45, P15756, DOI 10.1021/bi061860g; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Dove DE, 2005, AM J PHYSIOL-CELL PH, V288, pC586, DOI 10.1152/ajpcell.00210.2004; Enkisch C., 2009, EUR J ORG CHEM, V2009, P15; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Favari E, 2004, ARTERIOSCL THROM VAS, V24, P2345, DOI 10.1161/01.ATV.0000148706.15947.8a; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; FRANCIS GA, 1993, P NATL ACAD SCI USA, V90, P6631, DOI 10.1073/pnas.90.14.6631; Gao X, 2012, BIOCHEMISTRY-US, V51, P4633, DOI 10.1021/bi300555d; GARDNER HW, 1992, LIPIDS, V27, P686, DOI 10.1007/BF02536025; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Gauthamadasa K, 2012, J BIOL CHEM, V287, P7615, DOI 10.1074/jbc.M111.291070; Gonzalez MC, 2008, ARCH BIOCHEM BIOPHYS, V473, P34, DOI 10.1016/j.abb.2008.02.021; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guo LL, 2015, ANTIOXID REDOX SIGN, V22, P1633, DOI 10.1089/ars.2014.6078; Guo LL, 2012, FREE RADICAL BIO MED, V53, P1226, DOI 10.1016/j.freeradbiomed.2012.07.077; Guo LL, 2011, J BIOL CHEM, V286, P18170, DOI 10.1074/jbc.M110.213470; Heier M, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0570-2; Hoppe G, 1997, BBA-LIPID LIPID MET, V1344, P1, DOI 10.1016/S0005-2760(96)00160-9; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Kelesidis T, 2017, JAIDS-J ACQ IMM DEF, V75, P354, DOI 10.1097/QAI.0000000000001383; Kirabo A, 2014, J CLIN INVEST, V124, P4642, DOI 10.1172/JCI74084; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Lin CY, 1999, J LIPID RES, V40, P1618; Low H, 2012, JOVE-J VIS EXP, DOI 10.3791/3810; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; MCCALL M, 1995, ARTERIOSCL THROM VAS, V15, P1599, DOI 10.1161/01.ATV.15.10.1599; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; NAGANO Y, 1991, P NATL ACAD SCI USA, V88, P6457, DOI 10.1073/pnas.88.15.6457; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Norata GD, 2006, NUTR METAB CARDIOVAS, V16, P371, DOI 10.1016/j.numecd.2006.01.012; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Proudfoot JM, 2009, J LIPID RES, V50, P716, DOI 10.1194/jlr.M800607-JLR200; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; SALMON S, 1992, BIOCHIM BIOPHYS ACTA, V1125, P230, DOI 10.1016/0005-2760(92)90050-6; Salomon RG, 2000, BBA-MOL CELL BIOL L, V1485, P225, DOI 10.1016/S1388-1981(00)00038-X; Salomon RG, 2000, TRENDS CARDIOVAS MED, V10, P53, DOI 10.1016/S1050-1738(00)00040-2; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Solakivi T, 2005, Lipids Health Dis, V4, P25, DOI 10.1186/1476-511X-4-25; Soupene E, 2016, EXP BIOL MED, V241, P1933, DOI 10.1177/1535370216657447; Suzuki M, 2010, CIRCULATION, V122, P1919, DOI 10.1161/CIRCULATIONAHA.110.961193; Tan K, 2016, J DIABETES INVEST, V7, P445, DOI 10.1111/jdi.12487; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang WQ, 1998, J BIOL CHEM, V273, P17391, DOI 10.1074/jbc.273.28.17391; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; Yancey PG, 2007, ARTERIOSCL THROM VAS, V27, P1123, DOI 10.1161/ATVBAHA.107.139592; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yu BL, 2010, IMMUNOL CELL BIOL, V88, P285, DOI 10.1038/icb.2009.112; Zagol-Ikapitte I.A., 2010, PHARMACEUTICS, V2, P18, DOI DOI 10.3390/pharmaceutics2010018; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	79	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9176	9187		10.1074/jbc.RA117.001099	http://dx.doi.org/10.1074/jbc.RA117.001099			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29712723	hybrid, Green Published			2022-12-28	WOS:000435441400004
J	Merino, P; Diaz, A; Manrique, LG; Cheng, LH; Yepes, M				Merino, Paola; Diaz, Ariel; Manrique, Luis Guillermo; Cheng, Lihong; Yepes, Manuel			Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						urokinase receptor; plasmin; ezrin; cytoskeleton; synapse; stroke	ERM PROTEINS; CELL-ADHESION; CROSS-TALK; RECEPTOR; EXPRESSION; ACTIN; REVEALS; FAMILY; PHOSPHORYLATION; TRAFFICKING	Synaptic repair in the ischemic brain is a complex process that requires reorganization of the actin cytoskeleton. Ezrin, radixin, and moesin (ERM) are a group of evolutionarily conserved proteins that link the plasma membrane to the actin cytoskeleton and act as scaffolds for signaling transduction. Urokinase-type plasminogen activator (uPA) is a serine proteinase that upon binding to the urokinase-type plasminogen activator receptor (uPAR) catalyzes the conversion of plasminogen into plasmin on the cell surface and activates intracellular signaling pathways. Early studies indicate that uPA and uPAR expression increase during the recovery phase from an ischemic stroke and that uPA binding to uPAR promotes neurorepair in the ischemic brain. The in vitro and in vivo studies presented here show that either the release of neuronal uPA or treatment with recombinant uPA induces the local synthesis of ezrin in the synapse and the recruitment of 3-integrin to the postsynaptic density (PSD) of cerebral cortical neurons by a plasminogen-independent mechanism. We found that 3-integrin has a double effect on ezrin, inducing its recruitment to the PSD via the intercellular adhesion molecule-5 (ICAM-5) and its subsequent activation by phosphorylation at Thr-567. Finally, our data indicate that by triggering the reorganization of the actin cytoskeleton in the postsynaptic terminal, active ezrin induces the recovery of dendritic spines and synapses that have been damaged by an acute ischemic stroke. In summary, our data show that uPA-uPAR binding promotes synaptic repair in the ischemic brain via ezrin-mediated reorganization of the actin cytoskeleton in the postsynaptic terminal.	[Merino, Paola; Diaz, Ariel; Manrique, Luis Guillermo; Cheng, Lihong; Yepes, Manuel] Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Merino, Paola; Diaz, Ariel; Manrique, Luis Guillermo; Cheng, Lihong; Yepes, Manuel] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Merino, Paola; Diaz, Ariel; Manrique, Luis Guillermo; Cheng, Lihong; Yepes, Manuel] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Yepes, Manuel] Vet Affairs Med Ctr, Dept Neurol, Atlanta, GA 30033 USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yepes, M (corresponding author), Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, 954 Gatewood Rd NE, Atlanta, GA 30329 USA.	myepes@emory.edu	Díaz, Ariel/ABF-7295-2020	Díaz, Ariel/0000-0001-5677-5751; Merino, Paola/0000-0002-5203-4507; Yepes, Manuel/0000-0002-5224-9663	National Institutes of Health [NS-091201, NS-079331]; Veterans Affairs Merit Award [IO1BX003441]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079331, R01NS091201] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants NS-091201 (to M. Y.) and NS-079331 (to M. Y.) and Veterans Affairs Merit Award IO1BX003441 (to M. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfano D, 2005, THROMB HAEMOSTASIS, V93, P205, DOI 10.1160/TH04-09-0592; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Antelmi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075113; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Clucas J, 2014, J CELL SCI, V127, P267, DOI 10.1242/jcs.133108; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Dammer EB, 2015, PROTEOMICS, V15, P508, DOI 10.1002/pmic.201400189; Degryse B, 2005, J BIOL CHEM, V280, P24792, DOI 10.1074/jbc.M413954200; Degryse B, 2017, INT J BIOCHEM CELL B, V88, P14, DOI 10.1016/j.biocel.2017.04.012; DENT MAR, 1993, EUR J NEUROSCI, V5, P633, DOI 10.1111/j.1460-9568.1993.tb00529.x; Diaz A, 2017, J NEUROSCI, V37, P10310, DOI 10.1523/JNEUROSCI.1630-17.2017; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Furutani Y, 2012, J BIOL CHEM, V287, P39041, DOI 10.1074/jbc.M112.383851; Gahmberg Carl G, 2014, Adv Neurobiol, V8, P117; Ghasemi A, 2017, CELL SIGNAL, V32, P104, DOI 10.1016/j.cellsig.2017.01.020; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lavialle M, 2011, P NATL ACAD SCI USA, V108, P12915, DOI 10.1073/pnas.1100957108; Lino N, 2014, DEV DYNAM, V243, P676, DOI 10.1002/dvdy.24114; Mao J, 2013, CELL BIOCHEM BIOPHYS, V67, P1507, DOI 10.1007/s12013-013-9653-1; Marsick BM, 2011, JOVE-J VIS EXP, DOI 10.3791/2409; Marsick BM, 2012, J NEUROSCI, V32, P282, DOI 10.1523/JNEUROSCI.4794-11.2012; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Matsumoto Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105435; Merino P, 2017, J BIOL CHEM, V292, P2741, DOI 10.1074/jbc.M116.761650; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Ning L, 2013, J CELL SCI, V126, P77, DOI 10.1242/jcs.106674; OKA S, 1990, NEUROSCIENCE, V35, P93, DOI 10.1016/0306-4522(90)90124-M; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Ponuwei GA, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0246-3; RAO A, 1991, J NEUROSCI, V11, P2881; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; SUMI Y, 1992, DEVELOPMENT, V116, P625; Tian L, 2000, J CELL BIOL, V150, P243, DOI 10.1083/jcb.150.1.243; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Weingarten J, 2014, MOL CELL NEUROSCI, V59, P106, DOI 10.1016/j.mcn.2014.02.003; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Wu F, 2014, J NEUROSCI, V34, P14219, DOI 10.1523/JNEUROSCI.5309-13.2014; Wu F, 2012, J NEUROSCI, V32, P9848, DOI 10.1523/JNEUROSCI.1241-12.2012	49	17	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9234	9247		10.1074/jbc.RA118.002534	http://dx.doi.org/10.1074/jbc.RA118.002534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29720403	hybrid, Green Published			2022-12-28	WOS:000435441400011
J	AlSudais, H; Aabed, K; Nicola, W; Dixon, K; Chen, JH; Li, Q				AlSudais, Hamood; Aabed, Kawther; Nicola, William; Dixon, Katherine; Chen, Jihong; Li, Qiao			Retinoid X receptor-selective signaling in the regulation of Akt/protein kinase B isoform-specific expression (vol 291, pg 3090, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Aabed, Kawther] Princess Nourah Hint Abdulrahrnan Univ, Dept Biol, Fac Sci, Riyadh, Saudi Arabia				Aabed, Kawther/AAD-8205-2020	Aabed, Kawther/0000-0002-9927-5308				AlSudais H, 2016, J BIOL CHEM, V291, P3090, DOI 10.1074/jbc.M115.692707	1	1	1	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9139	9139		10.1074/jbc.AAC118.003993	http://dx.doi.org/10.1074/jbc.AAC118.003993			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29884764	Green Published, hybrid			2022-12-28	WOS:000434941900036
J	Griffin, C; Eter, L; Lanzetta, N; Abrishami, S; Varghese, M; McKernan, K; Muir, L; Lane, J; Lumeng, CN; Singer, K				Griffin, Cameron; Eter, Leila; Lanzetta, Nico; Abrishami, Simin; Varghese, Mita; McKernan, Kaitlin; Muir, Lindsey; Lane, Jamie; Lumeng, Carey N.; Singer, Kanakadurga			TLR4, TRIF, and MyD88 are essential for myelopoiesis and CD11c(+) adipose tissue macrophage production in obese mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						obesity; Toll-like receptor 4 (TLR4); metabolism; myeloid cell; macrophage; TIR domain-containing adapter-inducing interferon-B (TRIF); myeloid differentiation primary response gene 88 (MyD88); metabolic syndrome; insulin resistance; myelopoiesis; glucose intolerance	HEMATOPOIETIC STEM-CELLS; INSULIN-RESISTANCE; PROLIFERATION; INFLAMMATION; ACTIVATION; CONTRIBUTE; PHENOTYPE; MUTATION; LEPTIN	Obesity-induced chronic inflammation is associated with metabolic disease. Results from mouse models utilizing a high-fat diet (HFD) have indicated that an increase in activated macrophages, including CD11c(+) adipose tissue macrophages (ATMs), contributes to insulin resistance. Obesity primes myeloid cell production from hematopoietic stem cells (HSCs) and Toll-like receptor 4 (TLR4), and the downstream TIR domain-containing adapter protein-inducing interferon- (TRIF)- and MyD88-mediated pathways regulate production of similar myeloid cells after lipopolysaccharide stimulation. However, the role of these pathways in HFD-induced myelopoiesis is unknown. We hypothesized that saturated fatty acids and HFD alter myelopoiesis by activating TLR4 pathways in HSCs, differentially producing pro-inflammatory CD11c(+) myeloid cells that contribute to obesity-induced metabolic disease. Results from reciprocal bone marrow transplants (BMTs) with Tlr4(-/-) and WT mice indicated that TLR4 is required for HFD-induced myelopoiesis and production of CD11c(+) ATMs. Experiments with homozygous knockouts of Irakm (encoding a suppressor of MyD88 inactivation) and Trif in competitive BMTs revealed that MyD88 is required for HFD expansion of granulocyte macrophage progenitors and that Trif is required for pregranulocyte macrophage progenitor expansion. A comparison of WT, Tlr4(-/-), Myd88(-/-), and Trif(-/-) mice on HFD demonstrated that TLR4 plays a role in the production of CD11c(+) ATMs, and both Myd88(-/-) and Trif(-/-) mice produced fewer ATMs than WT mice. Moreover, HFD-induced TLR4 activation inhibited macrophage proliferation, leading to greater accumulation of recruited CD11c(+) ATMs. Our results indicate that HFD potentiates TLR4 and both its MyD88- and TRIF-mediated downstream pathways within progenitors and adipose tissue and leads to macrophage polarization.	[Griffin, Cameron; Eter, Leila; Lanzetta, Nico; Abrishami, Simin; Varghese, Mita; McKernan, Kaitlin; Muir, Lindsey; Lane, Jamie; Lumeng, Carey N.; Singer, Kanakadurga] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Singer, K (corresponding author), Dept Pediat & Communicable Dis, Div Pediat Endocrinol, D1205 MPB,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	ksinger@umich.edu	Muir, Lindsey/AAJ-9256-2021; Varghese, Mita/O-5860-2019	Varghese, Mita/0000-0003-4627-9396; Singer, Kanakadurga/0000-0001-8278-3800; McKernan, Kaitlin/0000-0003-3171-7218	University of Michigan Department of Pediatrics Janette Ferrantino Investigator Award; NIDDK, National Institutes of Health [K08DK101755]; Edith Briskin/SKS Foundation Taubman Emerging Scholar; National Institutes of Health [DK090262, F32DK105676]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, K08DK101755, P30DK020572, R01DK090262, F32DK105676, R01DK115190] Funding Source: NIH RePORTER	University of Michigan Department of Pediatrics Janette Ferrantino Investigator Award(University of Michigan System); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Edith Briskin/SKS Foundation Taubman Emerging Scholar; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the University of Michigan Department of Pediatrics Janette Ferrantino Investigator Award; NIDDK, National Institutes of Health, Grant K08DK101755; and Edith Briskin/SKS Foundation Taubman Emerging Scholar support (to K.S.); National Institutes of Health Grants DK090262 (to C. N. L.); and National Institutes of Health Grant F32DK105676 (to L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Boettcher S, 2012, J IMMUNOL, V188, P5824, DOI 10.4049/jimmunol.1103253; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Carvalheira JBC, 2013, BLOOD, V122, P3263, DOI 10.1182/blood-2013-04-459446; Chen J, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3336; Cho KW, 2016, J IMMUNOL, V197, P3650, DOI 10.4049/jimmunol.1600820; Coats BR, 2017, CELL REP, V20, P3149, DOI 10.1016/j.celrep.2017.08.096; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Davis JE, 2011, J NUTR BIOCHEM, V22, P136, DOI 10.1016/j.jnutbio.2009.12.008; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hosoi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012537; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li L, 2011, HEPATOLOGY, V54, P1620, DOI 10.1002/hep.24552; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liu AL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03145-8; Liu AL, 2015, J IMMUNOL, V195, P2524, DOI 10.4049/jimmunol.1501231; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Morris DL, 2012, OBESITY, V20, P1189, DOI 10.1038/oby.2012.7; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Razolli DS, 2015, ENDOCRINOLOGY, V156, P103, DOI 10.1210/en.2014-1552; Richards MR, 2013, INNATE IMMUN-LONDON, V19, P20, DOI 10.1177/1753425912447130; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Singer K, 2015, J BIOL CHEM, V290, P13250, DOI 10.1074/jbc.M114.634568; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013; Tao C, 2017, ENDOCRINOLOGY, V158, P1260, DOI 10.1210/en.2017-00024; Vila IK, 2014, CELL REP, V7, P1116, DOI 10.1016/j.celrep.2014.03.062; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013951; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yang L, 2017, CELL MOL GASTROENTER, V3, P469, DOI 10.1016/j.jcmgh.2016.12.004; Yu MJ, 2014, J EXP MED, V211, P887, DOI 10.1084/jem.20131314	58	43	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8775	8786		10.1074/jbc.RA117.001526	http://dx.doi.org/10.1074/jbc.RA117.001526			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29636416	hybrid, Green Published			2022-12-28	WOS:000434941900005
J	Noguchi, M; Hirata, N; Suizu, F				Noguchi, Masayuki; Hirata, Noriyuki; Suizu, Futoshi			AKT keeps the beat in CLOCK's circadian rhythm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ARCHITECTURE	The circadian clock plays a critical role in physiology and medicine by cyclically regulating the expression of numerous genes. The core components of the clock are thought to be controlled by several regulatory mechanisms, including post-translational modifications, but the full extent of this regulation is not known. In this issue, Sessa and co-workers demonstrate that the transcription factor CLOCK is a direct substrate of the kinase AKT. This phosphorylation controls the nuclearcytosolic translocation of CLOCK and thus its ability to regulate circadian gene expression in peripheral tissues.	[Noguchi, Masayuki; Hirata, Noriyuki; Suizu, Futoshi] Hokkaido Univ, Inst Med Genet, Div Canc Biol, Kita Ku, N15 W7, Sapporo, Hokkaido 0600815, Japan	Hokkaido University	Noguchi, M (corresponding author), Hokkaido Univ, Inst Med Genet, Div Canc Biol, Kita Ku, N15 W7, Sapporo, Hokkaido 0600815, Japan.	m_noguch@igm.hokudai.ac.jp	Suizu, Futoshi/G-3530-2019	Suizu, Futoshi/0000-0003-0206-4289				Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Luciano AK, 2018, J BIOL CHEM, V293, P9126, DOI 10.1074/jbc.RA117.000773; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Noguchi M, 2014, BBA-REV CANCER, V1846, P342, DOI 10.1016/j.bbcan.2014.07.013; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Reddy AB, 2014, ANNU REV BIOCHEM, V83, P165, DOI 10.1146/annurev-biochem-060713-035623; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zheng XZ, 2010, CURR BIOL, V20, P1203, DOI 10.1016/j.cub.2010.05.027	10	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9137	9138		10.1074/jbc.H118.003177	http://dx.doi.org/10.1074/jbc.H118.003177			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29884763	Green Published, hybrid			2022-12-28	WOS:000434941900035
J	Zhou, Q; Dong, G; Li, ZY				Zhou, Qing; Dong, Gang; Li, Ziyin			Flagellum inheritance in Trypanosoma brucei requires a kinetoplastid-specific protein phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Trypanosoma brucei; parasite; parasitology; protein phosphatase; protein kinase; basal body; flagellum; Hemoflagellate; Polo-like kinase; Trypanosomiasis	POLO-LIKE KINASE; ATTACHMENT ZONE FILAMENT; BASAL BODY DUPLICATION; CELL MORPHOGENESIS; COILED-COIL; CYTOKINESIS; SEGREGATION; BIOGENESIS; PHOSPHORYLATION; DIVISION	Trypanosoma brucei causes sleeping sickness in humans and nagana in cattle in sub-Saharan Africa and alternates between its mammalian hosts and its insect vector, the tsetse fly. T. brucei uses a flagellum for motility, cell division, and cell-cell communication. Proper positioning and attachment of the newly assembled flagellum rely on the faithful duplication and segregation of flagellum-associated cytoskeletal structures. These processes are regulated by the polo-like kinase homolog TbPLK, whose activity and abundance are under stringent control to ensure spatiotemporally regulated phosphorylation of its substrates. However, it remains unclear whether a protein phosphatase that counteracts TbPLK activity is also involved in this regulation. Here, we report that a putative kinetoplastid-specific protein phosphatase, named KPP1, has essential roles in regulating flagellum positioning and attachment in T. brucei. KPP1 localized to multiple flagellum-associated cytoskeletal structures and co-localized with TbPLK in several cytoskeletal structures at different cell-cycle stages. KPP1 depletion abolished basal body segregation, inhibited the duplication of the centrin arm and the hook complex of the bilobe structure, and disrupted the elongation of the flagellum attachment zone, leading to flagellum misplacement and detachment and cytokinesis arrest. Importantly, KPP1-depleted cells lacked dephosphorylation of TbCentrin2, a TbPLK substrate, at late cell-cycle stages. Together, these results suggest that KPP1-mediated protein dephosphorylation regulates the duplication and segregation of flagellum-associated cytoskeletal structures, thereby promoting flagellum positioning and attachment. These findings highlight the requirement of reversible protein phosphorylation, mediated by TbPLK and KPP1, in regulating flagellum inheritance in T. brucei.	[Zhou, Qing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Dong, Gang] Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria	University of Texas System; University of Texas Health Science Center Houston; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/I-6223-2019; Zhou, Qing/A-8296-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716; Dong, Gang/0000-0001-9745-8103	National Institutes of Health [AI101437, AI118736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118736, R01AI101437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01 Grants AI101437 and AI118736 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; de Graffenried CL, 2013, MOL BIOL CELL, V24, P1947, DOI 10.1091/mbc.E12-12-0911; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; Eliaz D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006245; Foley EA, 2011, NAT CELL BIOL, V13, P1265, DOI 10.1038/ncb2327; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hu HQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006146; Hu HQ, 2015, J BIOL CHEM, V290, P25012, DOI 10.1074/jbc.M115.674796; Hu HQ, 2015, EUKARYOT CELL, V14, P898, DOI 10.1128/EC.00083-15; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ikeda KN, 2012, J CELL SCI, V125, P3173, DOI 10.1242/jcs.101162; Imhof Simon, 2016, F1000Res, V5, P682, DOI 10.12688/f1000research.8249.1; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Moreira BP, 2017, J CELL SCI, V130, P1179, DOI 10.1242/jcs.194308; Morgan GW, 2005, MOL CELL BIOL, V25, P3774, DOI 10.1128/MCB.25.9.3774-3783.2005; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Perry JA, 2018, MOL MICROBIOL, V107, P344, DOI 10.1111/mmi.13885; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Szoor B, 2010, MOL BIOCHEM PARASIT, V173, P53, DOI 10.1016/j.molbiopara.2010.05.017; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Vaughan S, 2008, BIOCHEM SOC T, V36, P421, DOI 10.1042/BST0360421; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wier AD, 2013, P NATL ACAD SCI USA, V110, P17290, DOI 10.1073/pnas.1314754110; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yu ZL, 2012, J CELL SCI, V125, P1519, DOI 10.1242/jcs.094243; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660	45	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8508	8520		10.1074/jbc.RA118.002106	http://dx.doi.org/10.1074/jbc.RA118.002106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666191	Green Published, hybrid			2022-12-28	WOS:000434205700015
J	Edwards, MJ; White, GF; Lockwood, CW; Lawes, MC; Martel, A; Harris, G; Scott, DJ; Richardson, DJ; Butt, JN; Clarke, TA				Edwards, Marcus J.; White, Gaye F.; Lockwood, Colin W.; Lawes, Matthew C.; Martel, Anne; Harris, Gemma; Scott, David J.; Richardson, David J.; Butt, Julea N.; Clarke, Thomas A.			Structural modeling of an outer membrane electron conduit from a metal-reducing bacterium suggests electron transfer via periplasmic redox partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome; membrane protein; protein complex; electron transfer complex; liposome; shewanella; outer membrane; small-angle neutron scattering; MtrCAB	SHEWANELLA-ONEIDENSIS MR-1; SMALL-ANGLE SCATTERING; RESPIRATORY FLEXIBILITY; CYTOCHROME; RESOLUTION; PATHWAYS; PROTEINS; EXCHANGE; REVEALS; NETWORK	Many subsurface microorganisms couple their metabolism to the reduction or oxidation of extracellular substrates. For example, anaerobic mineral-respiring bacteria can use external metal oxides as terminal electron acceptors during respiration. Porin-cytochrome complexes facilitate the movement of electrons generated through intracellular catabolic processes across the bacterial outer membrane to these terminal electron acceptors. In the mineral-reducing model bacterium Shewanella oneidensis MR-1, this complex is composed of two decaheme cytochromes (MtrA and MtrC) and an outer-membrane -barrel (MtrB). However, the structures and mechanisms by which porin-cytochrome complexes transfer electrons are unknown. Here, we used small-angle neutron scattering (SANS) to study the molecular structure of the transmembrane complexes MtrAB and MtrCAB. Ab initio modeling of the scattering data yielded a molecular envelope with dimensions of approximate to 105 x 60 x 35 for MtrAB and approximate to 170 x 60 x 45 for MtrCAB. The shapes of these molecular envelopes suggested that MtrC interacts with the surface of MtrAB, extending approximate to 70 from the membrane surface and allowing the terminal hemes to interact with both MtrAB and an extracellular acceptor. The data also reveal that MtrA fully extends through the length of MtrB, with approximate to 30 being exposed into the periplasm. Proteoliposome models containing membrane-associated MtrCAB and internalized small tetraheme cytochrome (STC) indicate that MtrCAB could reduce Fe(III) citrate with STC as an electron donor, disclosing a direct interaction between MtrCAB and STC. Taken together, both structural and proteoliposome experiments support porin-cytochrome-mediated electron transfer via periplasmic cytochromes such as STC.	[Edwards, Marcus J.; White, Gaye F.; Lockwood, Colin W.; Lawes, Matthew C.; Richardson, David J.; Butt, Julea N.; Clarke, Thomas A.] Univ East Anglia, Ctr Mol & Struct Biochem, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Edwards, Marcus J.; White, Gaye F.; Lockwood, Colin W.; Lawes, Matthew C.; Richardson, David J.; Butt, Julea N.; Clarke, Thomas A.] Univ East Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; [Martel, Anne] Inst Laue Langevin, F-38042 Grenoble, France; [Harris, Gemma; Scott, David J.] Rutherford Appleton Lab, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Scott, David J.] Rutherford Appleton Lab, ISIS Spallat Neutron & Muon Source, Didcot OX11 0QX, Oxon, England; [Scott, David J.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Nottingham LE12 5RD, Leics, England	University of East Anglia; University of East Anglia; Institut Laue-Langevin (ILL); UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Nottingham	Clarke, TA (corresponding author), Univ East Anglia, Ctr Mol & Struct Biochem, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.; Clarke, TA (corresponding author), Univ East Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England.	tom.clarke@uea.ac.uk	clarke, tom/D-1837-2009; Butt, Julea/E-2133-2011	clarke, tom/0000-0002-6234-1914; Butt, Julea/0000-0002-9624-5226; Harris, Gemma/0000-0002-4587-4620; Scott, David/0000-0002-6726-2078; Martel, Anne/0000-0002-1232-8519; Lawes, Matt/0000-0003-1963-994X; Edwards, Marcus/0000-0002-0243-3788	Beamtime award at ISIS (Oxfordshire, UK) [RB1410125]; Beamtime award at ILL (Grenoble, France) [8-03-882]; Biotechnology and Biological Sciences Research Council [BB/K009885/1, BB/L023733/1, BB/K00929X/1]; BBSRC DTP studentship; BBSRC [BB/R013411/1, BB/K00929X/1, BB/K009885/1, BB/L023733/1, BB/P01819X/1] Funding Source: UKRI	Beamtime award at ISIS (Oxfordshire, UK); Beamtime award at ILL (Grenoble, France); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC DTP studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Beamtime awards RB1410125 at ISIS (Oxfordshire, UK) and 8-03-882 at the ILL (Grenoble, France) (to T.A.C.). This research was supported by the Biotechnology and Biological Sciences Research Council Grants BB/K009885/1, BB/L023733/1, and BB/K00929X/1 and a BBSRC DTP studentship (to M. C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alves MN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00665; Breyton C, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13071-6; Compton ELR, 2011, J BIOL CHEM, V286, P27058, DOI 10.1074/jbc.M111.244533; Coursolle D, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00056; Coursolle D, 2010, MOL MICROBIOL, V77, P995, DOI 10.1111/j.1365-2958.2010.07266.x; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; Dohnalkova AC, 2011, APPL ENVIRON MICROB, V77, P1254, DOI 10.1128/AEM.02001-10; Edwards MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11677; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Firer-Sherwood MA, 2011, J PHYS CHEM B, V115, P11208, DOI 10.1021/jp203603r; Fonseca BM, 2013, BIOCHEM J, V449, P101, DOI 10.1042/BJ20121467; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hartshorne RS, 2009, P NATL ACAD SCI USA, V106, P22169, DOI 10.1073/pnas.0900086106; Jiao Y, 2007, J BACTERIOL, V189, P1765, DOI 10.1128/JB.00776-06; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Le Roy A, 2015, METHOD ENZYMOL, V562, P257, DOI 10.1016/bs.mie.2015.06.010; Liu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00037; Liu YM, 2014, ENV MICROBIOL REP, V6, P776, DOI 10.1111/1758-2229.12204; Lower BH, 2009, APPL ENVIRON MICROB, V75, P2931, DOI 10.1128/AEM.02108-08; Marritt SJ, 2012, BIOCHEM SOC T, V40, P1217, DOI 10.1042/BST20120150; Okamoto A, 2011, ELECTROCHIM ACTA, V56, P5526, DOI 10.1016/j.electacta.2011.03.076; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Paquete CM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00318; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Richardson DJ, 2012, MOL MICROBIOL, V85, P201, DOI 10.1111/j.1365-2958.2012.08088.x; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Schicklberger M, 2011, APPL ENVIRON MICROB, V77, P1520, DOI 10.1128/AEM.01201-10; Shi L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00050; Sturm G, 2015, ISME J, V9, P1802, DOI 10.1038/ismej.2014.264; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; White GF, 2016, ADV MICROB PHYSIOL, V68, P87, DOI 10.1016/bs.ampbs.2016.02.002; White GF, 2013, P NATL ACAD SCI USA, V110, P6346, DOI 10.1073/pnas.1220074110; White GF, 2012, BIOCHEM SOC T, V40, P1257, DOI 10.1042/BST20120116	37	32	31	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8103	8112		10.1074/jbc.RA118.001850	http://dx.doi.org/10.1074/jbc.RA118.001850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29636412	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000433224600016
J	Tang, Y; Kwon, H; Neel, BA; Kasher-Meron, M; Pessin, JB; Yamada, E; Pessin, JE				Tang, Yan; Kwon, Hyokjoon; Neel, Brian A.; Kasher-Meron, Michal; Pessin, Jacob B.; Yamada, Eijiro; Pessin, Jeffrey E.			The fructose-2,6-bisphosphatase TIGAR suppresses NF-B signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS REGULATOR TIGAR; KAPPA-B; TP53-INDUCED GLYCOLYSIS; GLUCOSE-METABOLISM; CELL-DEATH; IKK-BETA; ACTIVATION; INFLAMMATION; PATHWAY; STRESS	The systems integration of whole-body metabolism and immune signaling are central homeostatic mechanisms necessary for maintenance of normal physiology, and dysregulation of these processes leads to a variety of chronic disorders. However, the intracellular mechanisms responsible for cell-autonomous cross-talk between the inflammatory signaling pathways and metabolic flux have remained enigmatic. In this study, we discovered that the fructose-2,6-bisphosphatase TIGAR (Tp53-induced glycolysis and apoptosis regulator) critically regulates NF-B activation. We found that TIGAR potently inhibits NF-B-dependent gene expression by suppressing the upstream activation of IKK phosphorylation and kinase activation. This inhibition occurred through a direct binding competition between NEMO and TIGAR for association with the linear ubiquitination assembly complex (LUBAC). This competition prevented linear ubiquitination of NEMO, which is required for activation of IKK and other downstream targets. Furthermore, a TIGAR phosphatase activity-deficient mutant was equally effective as WT TIGAR in inhibiting NEMO linear ubiquitination, IKK phosphorylation/activation, and NF-B signaling, indicating that TIGAR's effect on NF-B signaling is due to its interaction with LUBAC. Physiologically, TIGAR knockout mice displayed enhanced adipose tissue NF-B signaling, whereas adipocyte-specific overexpression of TIGAR suppressed adipose tissue NF-B signaling. Together, these results demonstrate that TIGAR has a nonenzymatic molecular function that modulates the NF-B signaling pathway by directly inhibiting the E3 ligase activity of LUBAC.	[Tang, Yan; Kasher-Meron, Michal; Pessin, Jacob B.; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Kwon, Hyokjoon] Rutgers State Univ, Rutgers Robert Wood Johnson Sch Med, Piscataway, NJ 08854 USA; [Neel, Brian A.] BGB Grp, New York, NY 10013 USA; [Yamada, Eijiro] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 3718511, Japan; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Gunma University; Yeshiva University; Albert Einstein College of Medicine	Pessin, JE (corresponding author), Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10461 USA.	Jeffrey.pessin@einstein.yu.edu		Kwon, Hyok Joon/0000-0002-3436-0608	National Institutes of Health [DK033823, DK020541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R37DK033823, P30DK020541, R01DK033823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK033823 and DK020541. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Fujita H, 2014, MOL CELL BIOL, V34, P1322, DOI 10.1128/MCB.01538-13; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Katsel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068361; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kong XX, 2017, METHODS MOL BIOL, V1566, P99, DOI 10.1007/978-1-4939-6820-6_10; Kwon H, 2014, CELL REP, V9, P1574, DOI 10.1016/j.celrep.2014.10.068; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Li H, 2009, J BIOL CHEM, V284, P1748, DOI 10.1074/jbc.M807821200; Lui VWY, 2011, ONCOGENE, V30, P1127, DOI 10.1038/onc.2010.490; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3515, DOI 10.4161/cc.9.17.12928; Meininger I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11292; Meyerovich K, 2016, J MOL ENDOCRINOL, V57, pR1, DOI 10.1530/JME-15-0306; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Nakajima S, 2013, FREE RADICAL BIO MED, V65, P162, DOI 10.1016/j.freeradbiomed.2013.06.020; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Salminen A, 2010, J CELL PHYSIOL, V224, P1, DOI 10.1002/jcp.22119; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sasaki K, 2015, IMMUNOL REV, V266, P175, DOI 10.1111/imr.12308; Schaeffer V, 2014, MOL CELL, V54, P349, DOI 10.1016/j.molcel.2014.03.016; Shimizu Y, 2015, IMMUNOL REV, V266, P190, DOI 10.1111/imr.12309; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sinha S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.128; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang SJ, 2014, CURR OPIN ONCOL, V26, P78, DOI 10.1097/CCO.0000000000000024; Wang YC, 2015, J BIOL CHEM, V290, P24772, DOI 10.1074/jbc.M115.687020; Wanka C, 2012, J BIOL CHEM, V287, P33436, DOI 10.1074/jbc.M112.384578; Yu HP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09853; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444; Zhao LQ, 2016, ONCOTARGET, V7, P31572, DOI 10.18632/oncotarget.7765	54	13	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7578	7591		10.1074/jbc.RA118.002727	http://dx.doi.org/10.1074/jbc.RA118.002727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29650758	Green Published, hybrid			2022-12-28	WOS:000437256500011
J	Zhang, HM; Yokom, AL; Cheng, S; Su, M; Hollenberg, PF; Southworth, DR; Osawa, Y				Zhang, Haoming; Yokom, Adam L.; Cheng, Shen; Su, Min; Hollenberg, Paul F.; Southworth, Daniel R.; Osawa, Yoichi			The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; dimerization; electron transfer; protein structure; electron microscopy (EM); cytochrome P450; cytochrome P450 BM3; fatty acid hydroxylase; heme domain; reductase domain	FLAVOCYTOCHROME P450 BM3; FATTY-ACID HYDROXYLASE; ELECTRON-TRANSFER; BACILLUS-MEGATERIUM; FUNCTIONAL DOMAINS; FMN; METABOLITES; MICROSCOPY; BINDING; NADPH	The cytochrome P450 enzyme CYP102A1 from Bacillus megaterium is a highly efficient hydroxylase of fatty acids, and there is a significant interest in using CYP102A1 for biotechnological applications. Here, we used size-exclusion chromatography-multiangle light scattering (SEC-MALS) analysis and negative-stain EM to investigate the molecular architecture of CYP102A1. The SEC-MALS analysis yielded a homogeneous peak with an average molecular mass of 235 +/- 5 kDa, consistent with homodimeric CYP102A1. The negative-stain EM of dimeric CYP102A1 revealed four distinct lobes, representing the two heme and two reductase domains. Two of the lobes were in close contact, whereas the other two were often observed apart and at the ends of a U-shaped configuration. The overall dimension of the dimer was approximate to 130 . To determine the identity of the lobes, we FLAG-tagged the N or C terminus of CYP102A1 to visualize additional densities in EM and found that anti-FLAG Fab could bind only the N-tagged P450. Single-particle analysis of this anti-Flag Fab-CYP102A1 complex revealed additional density in the N-terminally tagged heme domains, indicating that the heme domains appear flexible, whereas the reductase domains remain tightly associated. The effects of truncation on CYP102A1 dimerization, identification of cross-linked sites by peptide mapping, and molecular modeling results all were consistent with the dimerization of the reductase domain. We conclude that functional CYP102A1 is a compact globular protein dimerized at its reductase domains, with its heme domains exhibiting multiple conformations that likely contribute to the highly efficient catalysis of CYP102A1.	[Zhang, Haoming; Cheng, Shen; Hollenberg, Paul F.; Osawa, Yoichi] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Yokom, Adam L.; Southworth, Daniel R.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Su, Min] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zhang, HM; Osawa, Y (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	haom@umich.edu; osawa@umich.edu	Cheng, Shen/GWQ-6903-2022; Hollenberg, Paul F/A-7538-2009; Zhang, Haoming/AAE-3749-2020	Cheng, Shen/0000-0002-7493-4784; Zhang, Haoming/0000-0002-8765-4394	National Institutes of Health [GM077430, GM110001A]; University of Michigan Protein Folding Diseases Initiative; University of Michigan Mcubed fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430, R01GM110001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Protein Folding Diseases Initiative; University of Michigan Mcubed fund(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM077430 and GM110001A, the University of Michigan Protein Folding Diseases Initiative, and the University of Michigan Mcubed fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AXELSSON I, 1978, J CHROMATOGR, V152, P21, DOI 10.1016/S0021-9673(00)85330-3; BLACK SD, 1994, BIOCHEMISTRY-US, V33, P12056, DOI 10.1021/bi00206a007; Bukharina N. S., 2015, Biofizika, V60, P80; Butler CF, 2013, J BIOL CHEM, V288, P25387, DOI 10.1074/jbc.M113.479717; Carmichael AB, 2001, EUR J BIOCHEM, V268, P3117, DOI 10.1046/j.1432-1327.2001.02212.x; Chen MMY, 2012, PROTEIN ENG DES SEL, V25, P171, DOI 10.1093/protein/gzs004; Dai Y, 2017, J BIOL CHEM, V292, P6753, DOI 10.1074/jbc.M117.777219; Damsten MC, 2008, CHEM-BIOL INTERACT, V171, P96, DOI 10.1016/j.cbi.2007.09.007; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Girvan HM, 2011, ARCH BIOCHEM BIOPHYS, V507, P75, DOI 10.1016/j.abb.2010.09.014; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Joyce MG, 2012, FEBS J, V279, P1694, DOI 10.1111/j.1742-4658.2012.08544.x; Kim KH, 2011, DRUG METAB DISPOS, V39, P140, DOI 10.1124/dmd.110.036392; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kitazume T, 2007, BIOCHEMISTRY-US, V46, P11892, DOI 10.1021/bi701031r; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Lin HL, 2011, DRUG METAB DISPOS, V39, P345, DOI 10.1124/dmd.110.034074; Meinhold P, 2005, CHEMBIOCHEM, V6, P1765, DOI 10.1002/cbic.200500261; NARHI LO, 1986, J BIOL CHEM, V261, P7160; NARHI LO, 1987, J BIOL CHEM, V262, P6683; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Noble MA, 1999, BIOCHEM J, V339, P371, DOI 10.1042/0264-6021:3390371; OMURA T, 1964, J BIOL CHEM, V239, P2379; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Otey CR, 2006, BIOTECHNOL BIOENG, V93, P494, DOI 10.1002/bit.20744; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sevrioukova I, 1997, ARCH BIOCHEM BIOPHYS, V340, P231, DOI 10.1006/abbi.1997.9895; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Truan G, 1998, ARCH BIOCHEM BIOPHYS, V349, P53, DOI 10.1006/abbi.1997.0400; Venkataraman H, 2015, APPL MICROBIOL BIOT, V99, P4713, DOI 10.1007/s00253-014-6281-7; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Yokom AL, 2014, J BIOL CHEM, V289, P16855, DOI 10.1074/jbc.M114.564005; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2013, BIOCHEMISTRY-US, V52, P355, DOI 10.1021/bi301567z; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P6804, DOI 10.1021/bi030081m	39	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7727	7736		10.1074/jbc.RA117.000600	http://dx.doi.org/10.1074/jbc.RA117.000600			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618513	Green Published, hybrid			2022-12-28	WOS:000437256500022
J	Houot, L; Navarro, R; Nouailler, M; Duche, D; Guerlesquin, F; Lloubes, R				Houot, Laetitia; Navarro, Romain; Nouailler, Matthieu; Duche, Denis; Guerlesquin, Francoise; Lloubes, Roland			Electrostatic interactions between the CTX phage minor coat protein and the bacterial host receptor TolA drive the pathogenic conversion of Vibrio cholerae (vol 292, pg 13584, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Houot L, 2017, J BIOL CHEM, V292, P13584, DOI 10.1074/jbc.M117.786061	1	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7263	7263		10.1074/jbc.AAC118.003402	http://dx.doi.org/10.1074/jbc.AAC118.003402			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29752416	Green Published, hybrid			2022-12-28	WOS:000432174500017
J	Laursen, KB; Gudas, LJ				Laursen, Kristian B.; Gudas, Lorraine J.			Combinatorial knockout of RAR alpha, RAR beta, and RAR gamma completely abrogates transcriptional responses to retinoic acid in murine embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATIVE GENOMICS VIEWER; ORPHAN NUCLEAR RECEPTOR; INDUCED GROWTH ARREST; F9 CELLS; INDUCED DIFFERENTIATION; CARCINOMA-CELLS; TARGETED DISRUPTION; EPIGENETIC CHANGES; GENE; EXPRESSION	All-trans-retinoic acid (RA), a potent inducer of cellular differentiation, functions as a ligand for retinoic acid receptors (RAR alpha, beta and gamma). RARs are activated by ligand binding, which induces transcription of direct genomic targets. However, whether embryonic stem cells respond to RA through routes that do not involve RARs is unknown. Here, we used CRISPR technology to introduce biallelic frameshift mutations in RAR alpha, RAR beta, and RAR gamma, thereby abrogating all RAR functions in murine embryonic stem cells. We then evaluated RA-responsiveness of the RAR-null cells using RNA-Seq transcriptome analysis. We found that the RAR-null cells display no changes in transcripts in response to RA, demonstrating that the RARs are essential for the regulation of all transcripts in murine embryonic stem cells in response to RA. Our key finding, that in embryonic stem cells the transcriptional effects of RA all depend on RARs, addresses a long-standing topic of discussion in the field of retinoic acid signaling.	[Laursen, Kristian B.; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Cornell University; Cornell University	Gudas, LJ (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.; Gudas, LJ (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	ljgudas@med.cornell.edu			National Institutes of Health [R01CA043796, R01DE10389]; Weill Cornell funds; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants R01CA043796 and R01DE10389 (to L. J. G.) and by Weill Cornell funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bastien J, 2006, ONCOGENE, V25, P2040, DOI 10.1038/sj.onc.1209241; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; CAMPOCHIARO PA, 1991, INVEST OPHTH VIS SCI, V32, P65; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chiba H, 1997, J CELL BIOL, V139, P735, DOI 10.1083/jcb.139.3.735; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drumea K, 2008, CURR OPIN HEMATOL, V15, P37, DOI 10.1097/MOH.0b013e3282f20a9c; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Han YH, 2009, J BIOL CHEM, V284, P18503, DOI 10.1074/jbc.M109.007708; HOSLER BA, 1989, MOL CELL BIOL, V9, P5623, DOI 10.1128/MCB.9.12.5623; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Laursen KB, 2015, J BIOL CHEM, V290, P4356, DOI 10.1074/jbc.M114.613968; Laursen KB, 2013, NUCLEIC ACIDS RES, V41, P6430, DOI 10.1093/nar/gkt367; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Lee GS, 2004, CURR PHARM DESIGN, V10, P2657, DOI 10.2174/1381612043383728; Leung AYH, 2005, EXP HEMATOL, V33, P422, DOI 10.1016/j.exphem.2004.12.007; Li R, 2004, EXP CELL RES, V294, P290, DOI 10.1016/j.yexcr.2003.11.014; Marinelli A, 2009, LEUKEMIA, V23, P417, DOI 10.1038/leu.2008.205; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Mark M, 2004, CURR OPIN GENET DEV, V14, P591, DOI 10.1016/j.gde.2004.07.012; Martinez-Ceballos E, 2008, J NEUROSCI RES, V86, P2809, DOI 10.1002/jnr.21729; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Matsuo T, 1998, ONCOGENE, V16, P3337, DOI 10.1038/sj.onc.1201830; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; Perez RJ, 2013, EXP CELL RES, V319, P2196, DOI 10.1016/j.yexcr.2013.05.032; Phillips BW, 2003, PHARMACOL RES, V47, P263, DOI 10.1016/S1043-6618(03)00035-5; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ricard MJ, 2013, J BIOL CHEM, V288, P28801, DOI 10.1074/jbc.M113.474254; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva C, 2009, MOL REPROD DEV, V76, P11, DOI 10.1002/mrd.20925; Snyder JM, 2005, PEDIATR RES, V57, P384, DOI 10.1203/01.PDR.0000151315.81106.D3; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stehlin-Gaon C, 2003, NAT STRUCT BIOL, V10, P820, DOI 10.1038/nsb979; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tighe AP, 2004, J CELL PHYSIOL, V198, P223, DOI 10.1002/jcp.10424; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Urvalek A, 2014, SUBCELL BIOCHEM, V70, P129, DOI 10.1007/978-94-017-9050-5_7; Urvalek AM, 2014, J BIOL CHEM, V289, P19519, DOI 10.1074/jbc.M114.556555; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Wightman J, 2002, MOL CANCER THER, V1, P493; YANGYEN HF, 1991, NEW BIOL, V3, P1206	64	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11891	11900		10.1074/jbc.RA118.001951	http://dx.doi.org/10.1074/jbc.RA118.001951			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29848550	Green Published, hybrid			2022-12-28	WOS:000440134500021
J	Wilkening, A; Rub, C; Sylvester, M; Voos, W				Wilkening, Anne; Rueb, Cornelia; Sylvester, Marc; Voos, Wolfgang			Analysis of heat-induced protein aggregation in human mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; protein aggregation; translation; protein import; proteomics; heat stress; mitochondrial elongation factor Tu; Tufm	SYNTHESIS ELONGATION-FACTOR; FACTOR EF-TU; TRANSLATIONAL CONTROL; ESCHERICHIA-COLI; OXIDATIVE STRESS; QUALITY CONTROL; MOLECULAR CHAPERONES; SHOCK RESPONSE; HOMEOSTASIS; DEGRADATION	Proteins in mammalian cells exhibit optimal stability at physiological temperatures, and even small temperature variations may cause unfolding and nonspecific aggregation. Because this process leads to a loss of function of the affected polypeptides and to cytotoxic stress, formation of protein aggregates has been recognized as a major pathogenic factor in human diseases. In this study, we determined the impact of physiological heat stress on mitochondria isolated from HeLa cells. We found that the heat-stressed mitochondria had lower membrane potential and ATP level and exhibited a decreased production of reactive oxygen species. An analysis of the mitochondrial proteome by 2D PAGE showed that the overall solubility of endogenous proteins was only marginally affected by elevated temperatures. However, a small subset of polypeptides exhibited an high sensitivity to heat stress. The mitochondrial translation elongation factor Tu (Tufm), a protein essential for organellar protein biosynthesis, was highly aggregation-prone and lost its solubility already under mild heat-stress conditions. Moreover, mitochondrial translation and the import of cytosolic proteins were defective in the heat-stressed mitochondria. Both types of nascent polypeptides, produced by translation or imported into the mitochondria, exhibited a strong tendency to aggregate in the heat-exposed mitochondria. We propose that a fast and specific inactivation of elongation factors may prevent the accumulation of misfolded nascent polypeptides and may thereby attenuate proteotoxicity under heat stress.	[Wilkening, Anne; Rueb, Cornelia; Sylvester, Marc; Voos, Wolfgang] Friedrich Wilhelm Univ, Inst Biochem & Mol Biol, D-53115 Bonn, Germany	University of Bonn	Voos, W (corresponding author), Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	wolfgang.voos@uni-bonn.de		Sylvester, Marc/0000-0002-4275-0200	Deutsche Forschungsgemeinschaft [VO 657/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant VO 657/5-2 (to W. V.). The authors declare that they have no conflicts of interest with the contents of this article.	ARAI KI, 1974, J BIOCHEM-TOKYO, V76, P293, DOI 10.1093/oxfordjournals.jbchem.a130571; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Bender T, 2010, PROTEOMICS, V10, P1426, DOI 10.1002/pmic.200800619; Bezawork-Geleta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17397; Bhadula SK, 2001, PLANTA, V212, P359, DOI 10.1007/s004250000416; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bruderek M, 2018, MOL BIOL CELL, V29, P256, DOI 10.1091/mbc.E17-01-0027; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chang RL, 2013, SCIENCE, V340, P1220, DOI 10.1126/science.1234012; CHAPUT M, 1983, BIOCHIMIE, V65, P501, DOI 10.1016/S0300-9084(83)80132-1; Cherkasov V, 2013, CURR BIOL, V23, P2452, DOI 10.1016/j.cub.2013.09.058; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; DUNCAN R, 1984, J BIOL CHEM, V259, P1882; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Fu J, 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/835836; Germaniuk A, 2002, J BIOL CHEM, V277, P27801, DOI 10.1074/jbc.M201756200; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Huang HM, 2003, BBA-MOL BASIS DIS, V1637, P119, DOI 10.1016/S0925-4439(02)00222-3; Jovaisaite V, 2015, CURR OPIN CELL BIOL, V33, P74, DOI 10.1016/j.ceb.2014.12.003; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kudlicki W, 1997, J BIOL CHEM, V272, P32206, DOI 10.1074/jbc.272.51.32206; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lackner LL, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-35; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LUCASLENARD J, 1971, ANNU REV BIOCHEM, V40, P409, DOI 10.1146/annurev.bi.40.070171.002205; Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; Osiewacz HD, 2010, EXP GERONTOL, V45, P465, DOI 10.1016/j.exger.2010.05.001; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Rao D, 2004, EUR J BIOCHEM, V271, P3684, DOI 10.1111/j.1432-1033.2004.04309.x; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ristic Z, 2008, J PLANT PHYSIOL, V165, P192, DOI 10.1016/j.jplph.2007.03.003; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rottgers K, 2002, J BIOL CHEM, V277, P45829, DOI 10.1074/jbc.M207152200; Schmitt M, 1996, J CELL BIOL, V134, P1375, DOI 10.1083/jcb.134.6.1375; Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198	59	21	21	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11537	11552		10.1074/jbc.RA118.002122	http://dx.doi.org/10.1074/jbc.RA118.002122			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29895621	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000439449700023
J	Yuan, S; Sharma, AK; Richart, A; Lee, J; Kim, BE				Yuan, Sai; Sharma, Anuj Kumar; Richart, Alexandria; Lee, Jaekwon; Kim, Byung-Eun			CHCA-1 is a copper-regulated CTR1 homolog required for normal development, copper accumulation, and copper-sensing behavior in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans (C; elegans); copper; copper transport; intestine; metal homeostasis; CHCH-1; copper avoidance	C. ELEGANS; TRANSPORTER CTR1; AVOIDANCE-BEHAVIOR; IRON-METABOLISM; ASH NEURONS; IN-VIVO; YEAST; GENE; CELLS; HCTR1	Copper plays key roles in catalytic and regulatory biochemical reactions essential for normal growth, development, and health. Dietary copper deficiencies or mutations in copper homeostasis genes can lead to abnormal musculoskeletal development, cognitive disorders, and poor growth. In yeast and mammals, copper is acquired through the activities of the CTR1 family of high-affinity copper transporters. However, the mechanisms of systemic responses to dietary or tissue-specific copper deficiency remain unclear. Here, taking advantage of the animal model Caenorhabditis elegans for studying whole-body copper homeostasis, we investigated the role of a C. elegans CTR1 homolog, CHCA-1, in copper acquisition and in worm growth, development, and behavior. Using sequence homology searches, we identified 10 potential orthologs to mammalian CTR1. Among these genes, we found that chca-1, which is transcriptionally up-regulated in the intestine and hypodermis of C. elegans during copper deficiency, is required for normal growth, reproduction, and maintenance of systemic copper balance under copper deprivation. The intestinal copper transporter CUA-1 normally traffics to endosomes to sequester excess copper, and we found here that loss of chca-1 caused CUA-1 to mislocalize to the basolateral membrane under copper overload conditions. Moreover, animals lacking chca-1 exhibited significantly reduced copper avoidance behavior in response to toxic copper conditions compared with WT worms. These results establish that CHCA-1-mediated copper acquisition in C. elegans is crucial for normal growth, development, and copper-sensing behavior.	[Yuan, Sai; Sharma, Anuj Kumar; Richart, Alexandria; Kim, Byung-Eun] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Kim, Byung-Eun] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA; [Sharma, Anuj Kumar] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Nebraska System; University of Nebraska Lincoln; Princeton University	Kim, BE (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.; Kim, BE (corresponding author), Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA.	bekim@umd.edu	Sharma, Anuj/G-3043-2011	Sharma, Anuj/0000-0001-5061-9731; Yuan, Sai/0000-0002-4089-5780	National Institutes of Health [DK074797]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209, R01DK110195, R01DK074797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Kim laboratory for helpful suggestions, technical assistance, and critical reading of this manuscript. We thank members of Dr. Iqbal Hamza's laboratory (University of Maryland, College Park) for technical assistance and expertise in C. elegans genetics and cell biology as well as for discussions regarding the work, and Dr. Tamara Korolnek for critical reading of this manuscript. The COPAS Biosort instrument was purchased from funds supported by National Institutes of Health Grant DK074797 (to I.H.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Anderson CP, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00113; Anderson JL, 2010, J HERED, V101, pS62, DOI 10.1093/jhered/esq003; Aoki I, 2015, CURR OPIN NEUROBIOL, V34, P117, DOI 10.1016/j.conb.2015.03.011; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Block E, 2017, NAT PROD REP, V34, P529, DOI 10.1039/c7np00016b; Bousquet-Moore D, 2010, J NEUROSCI RES, V88, P2535, DOI 10.1002/jnr.22404; BRENNER S, 1974, GENETICS, V77, P71; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chen CY, 2012, J BIOL CHEM, V287, P9601, DOI 10.1074/jbc.M111.307694; Chun H, 2017, J BIOL CHEM, V292, P1, DOI 10.1074/jbc.M116.760876; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Du M, 2009, ENVIRON TOXICOL PHAR, V27, P314, DOI 10.1016/j.etap.2008.11.011; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Gaetke LM, 2014, ARCH TOXICOL, V88, P1929, DOI 10.1007/s00204-014-1355-y; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; Guo M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6655; Hao LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020995; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; IMAGAWA M, 1990, BIOCHEM J, V268, P237, DOI 10.1042/bj2680237; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mackenzie NC, 2004, GENE, V328, P113, DOI 10.1016/j.gene.2003.11.019; Mak HY, 2012, J LIPID RES, V53, P28, DOI 10.1194/jlr.R021006; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2013, J BIOL CHEM, V288, P18035, DOI 10.1074/jbc.M112.442426; Mitani S, 2009, EXP ANIM TOKYO, V58, P351, DOI 10.1538/expanim.58.351; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; Ohrvik H, 2016, J BIOL CHEM, V291, P13905, DOI 10.1074/jbc.M116.731281; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Wakabayashi T, 1998, FEBS LETT, V440, P141, DOI 10.1016/S0014-5793(98)01431-8; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	63	5	5	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10911	10925		10.1074/jbc.RA118.003503	http://dx.doi.org/10.1074/jbc.RA118.003503			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784876	Green Published, hybrid			2022-12-28	WOS:000438882800006
J	Robinson, P; Liu, X; Sparrow, A; Patel, S; Zhang, YH; Casadei, B; Watkins, H; Redwood, C				Robinson, Paul; Liu, Xing; Sparrow, Alexander; Patel, Suketu; Zhang, Yin-Hua; Casadei, Barbara; Watkins, Hugh; Redwood, Charles			Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling, and stimulate Ca2+-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyopathy; troponin; tropomyosin; Ca2+; calmodulin-dependent protein kinase II (CaMKII); extracellular-signal-regulated kinase (ERK); NFAT transcription factor; SERCA	RAT VENTRICULAR MYOCYTES; MYOSIN HEAVY-CHAIN; CARDIAC TROPONIN-C; ALPHA-TROPOMYOSIN; DILATED CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY; MOUSE MODEL; CONTRACTILITY; BINDING; HEART	Mutations in thin filament regulatory proteins that cause hypertrophic cardiomyopathy (HCM) increase myofilament Ca2+ sensitivity. Mouse models exhibit increased Ca2+ buffering and arrhythmias, and we hypothesized that these changes are primary effects of the mutations (independent of compensatory changes) and that increased Ca2+ buffering and altered Ca2+ handling contribute to HCM pathogenesis via activation of Ca2+-dependent signaling. Here, we determined the primary effects of HCM mutations on intracellular Ca2+ handling and Ca2+-dependent signaling in a model system possessing Ca2+-handling mechanisms and contractile protein isoforms closely mirroring the human environment in the absence of potentially confounding remodeling. Using adenovirus, we expressed HCM-causing variants of human troponin-T, troponin-I, and -tropomyosin (R92Q, R145G, and D175N, respectively) in isolated guinea pig left ventricular cardiomyocytes. After 48 h, each variant had localized to the I-band and comprised approximate to 50% of the total protein. HCM mutations significantly lowered the K-d of Ca2+ binding, resulting in higher Ca2+ buffering of mutant cardiomyocytes. We observed increased diastolic [Ca2+] and slowed Ca2+ reuptake, coupled with a significant decrease in basal sarcomere length and slowed relaxation. HCM mutant cells had higher sodium/calcium exchanger activity, sarcoplasmic reticulum Ca2+ load, and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) activity driven by Ca2+/calmodulin-dependent protein kinase II (CaMKII) phosphorylation of phospholamban. The ryanodine receptor (RyR) leak/load relationship was also increased, driven by CaMKII-mediated RyR phosphorylation. Altered Ca2+ homeostasis also increased signaling via both calcineurin/NFAT and extracellular signal-regulated kinase pathways. Altered myofilament Ca2+ buffering is the primary initiator of signaling cascades, indicating that directly targeting myofilament Ca2+ sensitivity provides an attractive therapeutic approach in HCM.	[Robinson, Paul; Liu, Xing; Sparrow, Alexander; Patel, Suketu; Zhang, Yin-Hua; Casadei, Barbara; Watkins, Hugh; Redwood, Charles] Univ Oxford, Radcliffe Dept Med, Cardiovasc Med Div, Oxford OX3 9DU, England; [Zhang, Yin-Hua] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Dept Physiol Biomed Sci, Seoul 110799, South Korea; [Zhang, Yin-Hua] Yanbian Univ Hosp, Yanji 133000, Jilin, Peoples R China; [Zhang, Yin-Hua] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9NT, Lancs, England	University of Oxford; Seoul National University (SNU); Yanbian University; University of Manchester	Robinson, P (corresponding author), John Radcliffe Hosp, Cardiovasc Med Div, Level 6 West Wing,Headley Way, Oxford OX3 9DU, England.	paulr@well.ox.ac.uk		Sparrow, Alexander/0000-0002-3354-3314; Casadei, Barbara/0000-0002-6801-1617	British Heart Foundation Programme Grant [RG/12/16/29939]; British Heart Foundation Centre of Research Excellence (Oxford, UK)	British Heart Foundation Programme Grant; British Heart Foundation Centre of Research Excellence (Oxford, UK)	The work is supported by British Heart Foundation Programme Grant RG/12/16/29939 and the British Heart Foundation Centre of Research Excellence (Oxford, UK). The authors declare that they have no conflicts of interest with the contents of this article.	Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bing W, 1997, BIOCHEM BIOPH RES CO, V236, P760, DOI 10.1006/bbrc.1997.7045; Bode EF, 2011, J PHYSIOL-LONDON, V589, P4723, DOI 10.1113/jphysiol.2011.211052; Burton D, 2002, BIOCHEM J, V362, P443, DOI 10.1042/0264-6021:3620443; Coppini R, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003565; Coppini R, 2013, CIRCULATION, V127, P575, DOI 10.1161/CIRCULATIONAHA.112.134932; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; Davis J, 2012, J MOL CELL CARDIOL, V53, P446, DOI 10.1016/j.yjmcc.2012.05.018; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; ELLINGSEN O, 1993, AM J PHYSIOL, V265, pH747, DOI 10.1152/ajpheart.1993.265.2.H747; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Feng W, 2012, MOL PHARMACOL, V82, P993, DOI 10.1124/mol.112.079707; Haim TE, 2007, J MOL CELL CARDIOL, V42, P1098, DOI 10.1016/j.yjmcc.2007.03.906; Hamdani N, 2013, CARDIOVASC RES, V97, P464, DOI 10.1093/cvr/cvs353; Helassa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep38276; Helms AS, 2016, CIRCULATION, V134, P1738, DOI 10.1161/CIRCULATIONAHA.115.020086; Jian Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005046; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lowey S, 2002, TRENDS CARDIOVAS MED, V12, P348, DOI 10.1016/S1050-1738(02)00181-0; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1996, CIRCULATION, V94, P588; Martins AS, 2015, CIRC-CARDIOVASC GENE, V8, P653, DOI 10.1161/CIRCGENETICS.114.000957; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; ONEILL SC, 1990, J PHYSIOL-LONDON, V430, P519, DOI 10.1113/jphysiol.1990.sp018305; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Rice R, 2010, J MOL CELL CARDIOL, V48, P979, DOI 10.1016/j.yjmcc.2009.11.018; Robertson IM, 2009, J BIOL CHEM, V284, P23012, DOI 10.1074/jbc.M109.021352; Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Smith GA, 2000, BIOCHEM J, V346, P393, DOI 10.1042/0264-6021:3460393; STEMMER P, 1989, LIFE SCI, V44, P1231, DOI 10.1016/0024-3205(89)90319-6; Tadano N, 2010, BRIT J PHARMACOL, V161, P1034, DOI 10.1111/j.1476-5381.2010.00942.x; Tardiff JC, 2016, CIRCULATION, V134, P1749, DOI 10.1161/CIRCULATIONAHA.116.025455; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Trafford AW, 1999, PFLUG ARCH EUR J PHY, V437, P501, DOI 10.1007/s004240050808; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; Witt CC, 2001, J BIOL CHEM, V276, P5353, DOI 10.1074/jbc.M008691200; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	49	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10487	10499		10.1074/jbc.RA118.002081	http://dx.doi.org/10.1074/jbc.RA118.002081			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29760186	Green Published, hybrid			2022-12-28	WOS:000437828400009
J	Gilbreth, RN; Oganesyan, VY; Amdouni, H; Novarra, S; Grinberg, L; Barnes, A; Baca, M				Gilbreth, Ryan N.; Oganesyan, Vaheh Y.; Amdouni, Hamza; Novarra, Shabazz; Grinberg, Luba; Barnes, Arnita; Baca, Manuel			Crystal structure of the human 4-1BB/4-1BBL complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; structure-function; T-cell biology; crystal structure; tumor necrosis factor (TNF); protein-protein interaction; protein structure	TNF; IMMUNOTHERAPY; 4-1BB; CANCER; LIGAND	4-1BBL is a member of the tumor necrosis factor (TNF) superfamily and is the ligand for the TNFR superfamily receptor, 4-1BB. 4-1BB plays an immunomodulatory role in T cells and NK cells, and agonists of this receptor have garnered strong attention as potential immunotherapy agents. Broadly speaking, the structural features of TNF superfamily members, their receptors, and ligand-receptor complexes are similar. However, a published crystal structure of human 4-1BBL suggests that it may be unique in this regard, exhibiting a three-bladed propeller-like trimer assembly that is distinctly different from that observed in other family members. This unusual structure also suggests that the human 4-1BB/4-1BBL complex may be structurally unique within the TNF/TNFR superfamily, but to date no structural data have been reported. Here we report the crystal structure of the human 4-1BB/4-1BBL complex at 2.4- resolution. In this structure, 4-1BBL does not adopt the unusual trimer assembly previously reported, but instead forms a canonical bell-shaped trimer typical of other TNF superfamily members. The structure of 4-1BB is also largely canonical as is the 4-1BB/4-1BBL complex. Mutational data support the 4-1BBL structure reported here as being biologically relevant, suggesting that the previously reported structure is not. Together, the data presented here offer insight into structure/function relationships in the 4-1BB/4-1BBL system and improve our structural understanding of the TNF/TNFR superfamily more broadly.	[Gilbreth, Ryan N.; Oganesyan, Vaheh Y.; Amdouni, Hamza; Novarra, Shabazz; Grinberg, Luba; Barnes, Arnita; Baca, Manuel] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune	Gilbreth, RN (corresponding author), MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.; Baca, M (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	gilbrethr@medimmune.com; Manuel.Baca@gilead.com			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, NIGMS (including Grant P41GM103393).	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Bartkowiak T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00117; Bitra A, 2018, J BIOL CHEM, V293, P1317, DOI 10.1074/jbc.M117.814905; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Chester C, 2018, BLOOD, V131, P49, DOI 10.1182/blood-2017-06-741041; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Jones T. A., 1990, CRYSTALLOGRAPHIC MOD; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leyland R, 2017, CLIN CANCER RES, V23, P3416, DOI 10.1158/1078-0432.CCR-16-2000; Li JX, 2013, ADV IMMUNOL, V119, P135, DOI 10.1016/B978-0-12-407707-2.00005-9; Liu WF, 2014, STRUCTURE, V22, P1252, DOI 10.1016/j.str.2014.06.013; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Novarra S, 2016, MABS-AUSTIN, V8, P1118, DOI 10.1080/19420862.2016.1186321; Sanmamed MF, 2015, SEMIN ONCOL, V42, P640, DOI 10.1053/j.seminoncol.2015.05.014; Schaer DA, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-7; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vanamee E. S., 2018, SCI SIGNAL, V11, P4910, DOI [10.1016/scisignal.aao4910, DOI 10.1016/SCISIGNAL.AAO4910]; Vinay DS, 2012, MOL CANCER THER, V11, P1062, DOI 10.1158/1535-7163.MCT-11-0677; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Yi L, 2017, IMMUNOL CELL BIOL, V95, P24, DOI 10.1038/icb.2016.64; Yi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086337	30	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9880	9891		10.1074/jbc.RA118.002803	http://dx.doi.org/10.1074/jbc.RA118.002803			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29720399	hybrid, Green Published			2022-12-28	WOS:000436102300029
J	Garg, N; Whiteley, M				Garg, Neha; Whiteley, Marvin			The chemical topology of a bacterial swarm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PSEUDOMONAS-AERUGINOSA	Microbes respond to antibiotics by initiating a suite of defense mechanisms, including the production of small-molecule effectors. However, it is not well-known how these defenses vary according to the particular effector or antibiotic and bacterial state, due in part to the challenges of monitoring small molecules in complex environments. A new study uses state-of-the-art imaging techniques to track the location of secreted small molecules produced by a bacterial swarm in response to different antibiotics, providing unexpected insights into the spatial heterogeneity of bacterial stress responses.	[Garg, Neha] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Whiteley, Marvin] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Garg, Neha; Whiteley, Marvin] Emory Childrens Cyst Fibrosis Ctr, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Garg, N (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	neha.garg@chemistry.gatech.edu	Garg, Neha/L-3120-2018	Garg, Neha/0000-0002-2760-7123	Georgia Institute of Technology (Georgia Tech); National Institutes of Health [R01GM116547-01A1, 1R01DE023193-01]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116547] Funding Source: NIH RePORTER	Georgia Institute of Technology (Georgia Tech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by start-up funds from the Georgia Institute of Technology (Georgia Tech) and National Institutes of Health Grants R01GM116547-01A1 and 1R01DE023193-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Davies SK, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00211-17; Garg N, 2017, CELL HOST MICROBE, V22, P705, DOI 10.1016/j.chom.2017.10.001; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Morales-Soto N, 2018, J BIOL CHEM, V293, P9544, DOI 10.1074/jbc.RA118.002605; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Quinn RA, 2016, ISME J, V10, P1483, DOI 10.1038/ismej.2015.207; Szamosvari D, 2017, ANGEW CHEM INT EDIT, V56, P7271, DOI 10.1002/anie.201702944	8	0	0	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9553	9554		10.1074/jbc.H118.003178	http://dx.doi.org/10.1074/jbc.H118.003178			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29907734	Green Published, hybrid			2022-12-28	WOS:000435441400038
J	Kumar, V; Chaudhuri, TK				Kumar, Vipul; Chaudhuri, Tapan K.			Spontaneous refolding of the large multidomain protein malate synthase G proceeds through misfolding traps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIM BARREL PROTEIN; ESCHERICHIA-COLI; FOLDING INTERMEDIATE; TRYPTOPHAN SYNTHASE; ALPHA-SUBUNIT; MYCOBACTERIUM-TUBERCULOSIS; DIHYDROFOLATE-REDUCTASE; ANGSTROM RESOLUTION; CONTACT ORDER; OFF-PATHWAY	Most protein folding studies until now focus on single domain or truncated proteins. Although great insights in the folding of such systems has been accumulated, very little is known regarding the proteins containing multiple domains. It has been shown that the high stability of domains, in conjunction with interdomain interactions, manifests as a frustrated energy landscape, causing complexity in the global folding pathway. However, multidomain proteins despite containing independently foldable, loosely cooperative sections can fold into native states with amazing speed and accuracy. To understand the complexity in mechanism, studies were conducted previously on the multidomain protein malate synthase G (MSG), an enzyme of the glyoxylate pathway with four distinct and adjacent domains. It was shown that the protein refolds to a functionally active intermediate state at a fast rate, which slowly produces the native state. Although experiments decoded the nature of the intermediate, a full description of the folding pathway was not elucidated. In this study, we use a battery of biophysical techniques to examine the protein's folding pathway. By using multiprobe kinetics studies and comparison with the equilibrium behavior of protein against urea, we demonstrate that the unfolded polypeptide undergoes conformational compaction to a misfolded intermediate within milliseconds of refolding. The misfolded product appears to be stabilized under moderate denaturant concentrations. Further folding of the protein produces a stable intermediate, which undergoes partial unfolding-assisted large segmental rearrangements to achieve the native state. This study reveals an evolved folding pathway of the multidomain protein MSG, which involves surpassing the multiple misfolding traps during refolding.	[Kumar, Vipul; Chaudhuri, Tapan K.] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Chaudhuri, TK (corresponding author), Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 110016, India.	tkchaudhuri@bioschool.iitd.ac.in			University Grants Commission, India; Indian Institute of Technology, Delhi, India	University Grants Commission, India(University Grants Commission, India); Indian Institute of Technology, Delhi, India	Recipient of a Research Fellowship from the University Grants Commission, India.; Supported by funding from the Indian Institute of Technology, Delhi, India.	Acharya N, 2016, J PHYS CHEM LETT, V7, P173, DOI 10.1021/acs.jpclett.5b02545; Andersen CB, 2010, PROTEIN SCI, V19, P279, DOI 10.1002/pro.309; Anstrom DM, 2003, PROTEIN SCI, V12, P1822, DOI 10.1110/ps.03174303; Arai M, 2011, J MOL BIOL, V410, P329, DOI 10.1016/j.jmb.2011.04.057; Batey S, 2006, P NATL ACAD SCI USA, V103, P18113, DOI 10.1073/pnas.0604580103; Borgia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9861; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; CHRUNYK BA, 1990, BIOCHEMISTRY-US, V29, P2149, DOI 10.1021/bi00460a027; Dahiya V, 2014, J BIOL CHEM, V289, P286, DOI 10.1074/jbc.M113.518373; Dahiya V, 2013, BIOCHEMISTRY-US, V52, P4517, DOI 10.1021/bi400328a; DAS BK, 1995, BIOCHEMISTRY-US, V34, P5242, DOI 10.1021/bi00015a038; Fan YX, 1998, PROTEIN SCI, V7, P2631, DOI 10.1002/pro.5560071217; Ferreiro DU, 2014, Q REV BIOPHYS, V47, P285, DOI 10.1017/S0033583514000092; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Forsyth WR, 2007, J MOL BIOL, V372, P236, DOI 10.1016/j.jmb.2007.06.018; Garcia-Manyes S, 2016, J BIOL CHEM, V291, P4226, DOI 10.1074/jbc.M115.673871; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Gu ZY, 2007, J MOL BIOL, V368, P582, DOI 10.1016/j.jmb.2007.02.027; Hagen SJ, 2010, CURR PROTEIN PEPT SC, V11, P385; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; HOLZMAN TF, 1990, BIOCHEMISTRY-US, V29, P1255, DOI 10.1021/bi00457a022; Howard BR, 2000, BIOCHEMISTRY-US, V39, P3156, DOI 10.1021/bi992519h; Huang HL, 2016, J BIOL CHEM, V291, P27421, DOI 10.1074/jbc.M116.750877; HURLE MR, 1987, PROTEINS, V2, P54, DOI 10.1002/prot.340020107; Inanami T, 2014, P NATL ACAD SCI USA, V111, P15969, DOI 10.1073/pnas.1406244111; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jacob M, 1999, BIOCHEMISTRY-US, V38, P13773, DOI 10.1021/bi991503o; JONES BE, 1994, BIOCHEMISTRY-US, V33, P15250, DOI 10.1021/bi00255a005; Kathuria SV, 2008, J MOL BIOL, V382, P467, DOI 10.1016/j.jmb.2008.06.054; Kathuria SV, 2016, PROTEIN SCI, V25, P662, DOI 10.1002/pro.2860; Krieger IV, 2012, CHEM BIOL, V19, P1556, DOI 10.1016/j.chembiol.2012.09.018; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Liu P, 2005, NATURE, V437, P159, DOI 10.1038/nature03926; MANN CJ, 1993, BIOCHEMISTRY-US, V32, P5282, DOI 10.1021/bi00071a002; Mayr EM, 1997, J MOL BIOL, V269, P260, DOI 10.1006/jmbi.1997.1033; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Saluja A, 2014, PHARM RES-DORDR, V31, P1575, DOI 10.1007/s11095-013-1263-5; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Souillac PO, 2005, J PHARM SCI-US, V94, P2069, DOI 10.1002/jps.20423; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Teichmann SA, 1999, CURR OPIN STRUC BIOL, V9, P390, DOI 10.1016/S0959-440X(99)80053-0; Tian PF, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004933; Tugarinov V, 2005, P NATL ACAD SCI USA, V102, P622, DOI 10.1073/pnas.0407792102; Vanhove M, 1998, BIOCHEMISTRY-US, V37, P1941, DOI 10.1021/bi972143c; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wani AH, 2009, J MOL BIOL, V387, P348, DOI 10.1016/j.jmb.2009.01.060; Wu Y, 2007, J MOL BIOL, V366, P1624, DOI 10.1016/j.jmb.2006.12.005; Zheng WH, 2013, P NATL ACAD SCI USA, V110, P1680, DOI 10.1073/pnas.1222130110	53	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13270	13283		10.1074/jbc.RA118.003903	http://dx.doi.org/10.1074/jbc.RA118.003903			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29959230	Green Published, hybrid			2022-12-28	WOS:000442730200025
J	Kumar, P; Smith, T; Raeman, R; Chopyk, DM; Brink, H; Liu, YS; Sulchek, T; Anania, FA				Kumar, Pradeep; Smith, Tekla; Raeman, Reben; Chopyk, Daniel M.; Brink, Hannah; Liu, Yunshan; Sulchek, Todd; Anania, Frank A.			Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatic stellate cell (HSC); fibrosis; lysyl oxidase (LOX); extracellular matrix protein; transforming growth factor beta (TGF-beta); collagen; fibronectin; inflammation; POSTN; SMAD2; 3; fibronectin; POSTN; fibrogenesis; inflammation	EPITHELIAL-MESENCHYMAL TRANSITION; MATRICELLULAR PROTEIN; PULMONARY-FIBROSIS; SERUM PERIOSTIN; KIDNEY-DISEASE; CANCER CELLS; HEPATOCYTES; EXPRESSION; COLLAGEN; MICE	Liver fibrosis arises from dysregulated wound healing due to persistent inflammatory hepatic injury. Periostin is a nonstructural extracellular matrix protein that promotes organ fibrosis in adults. Here, we sought to identify the molecular mechanisms in periostin-mediated hepatic fibrosis. Hepatic fibrosis in periostin(-/-) mice was attenuated as evidenced by significantly reduced collagen fibril density and liver stiffness compared with those in WT controls. A single dose of carbon tetrachloride caused similar acute liver injury in periostin(-/-) and WT littermates, and we did not detect significant differences in transaminases and major fibrosis-related hepatic gene expression between these two genotypes. Activated hepatic stellate cells (HSCs) are the major periostin-producing liver cell type. We found that in primary rat HSCs in vitro, periostin significantly increases the expression levels and activities of lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) isoforms 1-3. Periostin also induced expression of intra- and extracellular collagen type 1 and fibronectin in HSCs. Interestingly, periostin stimulated phosphorylation of SMAD2/3, which was sustained despite short hairpin RNA-mediated knockdown of transforming growth factor beta(TGF beta) receptor I and II, indicating that periostin-mediated SMAD2/3 phosphorylation is independent of TGF receptors. Moreover, periostin induced the phosphorylation of focal adhesion kinase (FAK) and AKT in HSCs. Notably, siRNA-mediated FAK knockdown failed to block periostin-induced SMAD2/3 phosphorylation. These results suggest that periostin promotes enhanced matrix stiffness in chronic liver disease by activating LOX and LOXL, independently of TGF receptors. Hence, targeting periostin may be of therapeutic benefit in combating hepatic fibrosis.	[Kumar, Pradeep; Smith, Tekla; Chopyk, Daniel M.; Liu, Yunshan; Anania, Frank A.] Emory Univ, Sch Med, Dept Med, Div Digest, Atlanta, GA 30322 USA; [Raeman, Reben] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Brink, Hannah; Sulchek, Todd] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Georgia Institute of Technology	Kumar, P (corresponding author), Emory Univ, Dept Med, Div Digest Dis, 615 Michael St NE,Suite 265, Atlanta, GA 30322 USA.	pkuma23@emory.edu	Raeman, Reben/AAF-7282-2021; Chopyk, Daniel/ABD-3591-2020	Raeman, Reben/0000-0002-3914-1797; Chopyk, Daniel/0000-0003-4207-1360	NIDDK, National Institutes of Health [RO1 DK062092, DK111678, DK113147]; Emory University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK110264, R01DK062092, R56DK113147, R01DK111678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Emory University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIDDK, National Institutes of Health, Grants RO1 DK062092, DK111678, and DK113147 (all to F. A. A.). A portion of this work was also supported by funds from Emory University. The authors declare that they have no conflicts of interest with the contents of this article. This article was prepared while Frank A. Anania was employed at Emory University School of Medicine. The opinions expressed in this article are the author's own and do not reflect the views of the Food and Drug Administration, the Department of Health and Human Services, or the United States government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfieri C, 2015, NEPHROL DIAL TRANSPL, V30, P1965, DOI 10.1093/ndt/gfv074; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Brown AC, 2013, J PATHOL, V229, P25, DOI 10.1002/path.4114; Carden MA, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12353; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Das SK, 2008, SCAND J CLIN LAB INV, V68, P260, DOI 10.1080/00365510701668516; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Egbert M, 2014, J DERMATOL SCI, V73, P40, DOI 10.1016/j.jdermsci.2013.08.010; Friedman SL, 2015, DIGEST DIS, V33, P504, DOI 10.1159/000374098; Gao AE, 2016, BIOCHEM BIOPH RES CO, V475, P70, DOI 10.1016/j.bbrc.2016.05.037; Hasegawa D, 2015, J CELL PHYSIOL, V230, P2647, DOI 10.1002/jcp.24950; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Hong L, 2015, J CELL MOL MED, V19, P2462, DOI 10.1111/jcmm.12636; Honsawek S, 2015, BIOMARKERS, V20, P157, DOI 10.3109/1354750X.2015.1045032; Hu QF, 2015, CELL PHYSIOL BIOCHEM, V36, P799, DOI 10.1159/000430139; Hu WW, 2017, ONCOTARGET, V8, P62248, DOI 10.18632/oncotarget.19273; Huang YM, 2015, AM J PATHOL, V185, P786, DOI 10.1016/j.ajpath.2014.11.002; Iwasaki A, 2016, J BIOL CHEM, V291, P72, DOI 10.1074/jbc.M115.691519; Kaur H, 2016, CIRC RES, V118, P1906, DOI 10.1161/CIRCRESAHA.116.308643; Khurana S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13500; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; Kong DS, 2015, LAB INVEST, V95, P1234, DOI 10.1038/labinvest.2015.107; Kumar P, 2014, FASEB J, V28, P5172, DOI 10.1096/fj.14-253229; Lee WR, 2014, BIOCHEM BIOPH RES CO, V450, P195, DOI 10.1016/j.bbrc.2014.05.089; Liu CX, 2018, CANCER SCI, V109, P688, DOI 10.1111/cas.13479; Liu SB, 2016, FASEB J, V30, P1599, DOI 10.1096/fj.14-268425; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Lv Y, 2013, EJSO-EUR J SURG ONC, V39, P1129, DOI 10.1016/j.ejso.2013.06.023; Lv Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0385-7; Martinez-Martinez E, 2016, J MOL CELL CARDIOL, V92, P96, DOI 10.1016/j.yjmcc.2016.01.012; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Matsuzawa M, 2015, J PERIODONTAL RES, V50, P855, DOI 10.1111/jre.12277; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Mesarwi OA, 2015, SLEEP, V38, P1583, DOI 10.5665/sleep.5052; Mino M, 2017, HEPATOL COMMUN, V1, P1099, DOI 10.1002/hep4.1114; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Mosher DF, 2015, CRIT REV BIOCHEM MOL, V50, P427, DOI 10.3109/10409238.2015.1069791; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Popov Y, 2011, GASTROENTEROLOGY, V140, P1642, DOI 10.1053/j.gastro.2011.01.040; Prakoura N, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00052; Romanos GE, 2014, J CELL PHYSIOL, V229, P1, DOI 10.1002/jcp.24407; Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0; Siddikuzzaman, 2011, Inflammopharmacology, V19, P117, DOI 10.1007/s10787-010-0073-1; Tajiri M, 2015, RESPIR INVESTIG, V53, P73, DOI 10.1016/j.resinv.2014.12.003; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Takeda K, 2017, MOL MED REP, V16, P5752, DOI 10.3892/mmr.2017.7356; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Terao M, 2015, DERM-ENDOCRINOL, V7, DOI 10.1080/19381980.2015.1010983; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Wallace DP, 2014, KIDNEY INT, V85, P845, DOI 10.1038/ki.2013.488; Wallace MC, 2015, SEMIN LIVER DIS, V35, P107, DOI 10.1055/s-0035-1550060; Wu SQ, 2013, MOL MED REP, V7, P875, DOI 10.3892/mmr.2013.1267; Wu TT, 2018, MATRIX BIOL, V66, P81, DOI 10.1016/j.matbio.2017.09.004; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	56	36	38	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12781	12792		10.1074/jbc.RA117.001601	http://dx.doi.org/10.1074/jbc.RA117.001601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29941453	hybrid, Green Published			2022-12-28	WOS:000442203500012
J	Liu, XJ; Xue, RY; Yang, CT; Gu, JX; Chen, S; Zhang, S				Liu, Xijun; Xue, Ruyi; Yang, Caiting; Gu, Jianxin; Chen, She; Zhang, Si			Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; cAMP response element-binding protein (CREB); estrogen receptor; bile acid; nuclear receptor	BREAST-CANCER; POSTMENOPAUSAL WOMEN; NUCLEAR RECEPTORS; LIVER-DISEASE; SEX-HORMONES; MURINE MODEL; MOUSE-LIVER; FXR; MICE; ALPHA	The liver is the main site of estrogen metabolism, and liver disease is usually associated with an abnormal estrogen status. However, little is known about the mechanism underlying this connection. Here, we investigated the effects of bile acid (BA)-activated farnesoid X receptor (FXR) on the metabolism of 17 beta-estradiol (E2) during blockage of bile flow (cholestasis). Correlations between BA levels and E2 concentrations were established in patients with cholestasis, and hepatic expression profiles of key genes involved in estrogen metabolism were investigated in both WT and FXR-/- mice. We found that the elevated E2 level positively correlated with BA concentrations in the patients with cholestasis. We further observed that bile duct ligation (BDL) increases E2 levels in mouse serum, and this elevation effect was alleviated by deleting the FXR gene. Of note, FXR down-regulated the expression of hepatic sulfotransferase SULT1E1, the primary enzyme responsible for metabolic estrogen inactivation. At the molecular level, we found that FXR competes with the protein acetylase CREB-binding protein (CBP) for binding to the transcription factor hepatocyte nuclear factor 4 alpha (HNF4 alpha). This competition decreased HNF4 alpha acetylation and nuclear retention, which, in turn, repressed HNF4 alpha-dependent SULT1E1 gene transcription. These findings suggest that cholestasis induces BA-activated FXR activity, leading to downstream inhibition of SULT1E1 and hence impeding hepatic degradation of estrogen.	[Liu, Xijun; Yang, Caiting; Gu, Jianxin; Chen, She; Zhang, Si] Fudan Univ, Zhongshan Hosp, Sch Basic Med Sci,Minist Publ Hlth, Dept Biochem & Mol Biol,Key Lab Glycoconjugate Re, Shanghai 200032, Peoples R China; [Xue, Ruyi] Fudan Univ, Zhongshan Hosp, Shanghai Inst Liver Dis, Dept Gastroenterol & Hepatol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Chen, S; Zhang, S (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, 130 Dong An Rd, Shanghai 200032, Peoples R China.	shechen@fudan.edu.cn; zhangsi@fudan.edu.cn	zhang, si/AAG-9094-2021	Xue, Ruyi/0000-0002-5710-0091; zhang, Si/0000-0002-5682-4995	National Natural Science Foundation of China [81573423, 81770137, 81371268, 81772615, 81572308, 81600309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Natural Science Foundation of China Grants 81573423, 81770137 (to S. Z.), 81371268, 81772615 (to S. C.), 81572308 (to R. Y. X.), and 81600309 (to X. J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	BECKER U, 1991, HEPATOLOGY, V13, P865, DOI 10.1016/0270-9139(91)90255-T; BECKER U, 1993, DAN MED BULL, V40, P447; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Cariou B, 2007, TRENDS PHARMACOL SCI, V28, P236, DOI 10.1016/j.tips.2007.03.002; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Costarelli V, 2002, EUR J CLIN NUTR, V56, P925, DOI 10.1038/sj.ejcn.1601396; de Ronde W, 2009, CLIN ENDOCRINOL, V71, P874, DOI 10.1111/j.1365-2265.2009.03573.x; Devine A, 2005, OSTEOPOROSIS INT, V16, P216, DOI 10.1007/s00198-004-1674-6; Fiorucci S, 2007, TRENDS MOL MED, V13, P298, DOI 10.1016/j.molmed.2007.06.001; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Gambino YP, 2012, BBA-MOL CELL RES, V1823, P900, DOI 10.1016/j.bbamcr.2012.01.015; GLUUD C, 1988, DAN MED BULL, V35, P564; Hageman J, 2010, ARTERIOSCL THROM VAS, V30, P1519, DOI 10.1161/ATVBAHA.109.197897; Hoekstra M, 2012, MOL CELL ENDOCRINOL, V362, P69, DOI 10.1016/j.mce.2012.05.010; Kakuta Y, 1998, BIOCHEM PHARMACOL, V55, P313, DOI 10.1016/S0006-2952(97)00465-6; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kodama S, 2011, NUCLEIC ACIDS RES, V39, P8392, DOI 10.1093/nar/gkr458; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; LONGCOPE C, 1969, J CLIN INVEST, V48, P2191, DOI 10.1172/JCI106185; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; McNeilly AD, 2010, J HEPATOL, V52, P705, DOI 10.1016/j.jhep.2009.10.037; Milona A, 2010, HEPATOLOGY, V52, P1341, DOI 10.1002/hep.23849; Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Stedman C, 2004, J BIOL CHEM, V279, P11336, DOI 10.1074/jbc.M310258200; Sun ZC, 2012, BIOCHEM BIOPH RES CO, V423, P775, DOI 10.1016/j.bbrc.2012.06.035; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Tong MH, 2005, NAT MED, V11, P153, DOI 10.1038/nm1184; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wu WB, 2014, BIOCHEM BIOPH RES CO, V443, P68, DOI 10.1016/j.bbrc.2013.11.057; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Xu YL, 2012, CANCER SCI, V103, P1000, DOI 10.1111/j.1349-7006.2012.02258.x; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yamamoto Y, 2006, J BIOL CHEM, V281, P16625, DOI 10.1074/jbc.M602723200; Zhang SW, 2009, J HEPATOL, V51, P380, DOI 10.1016/j.jhep.2009.03.025; Zhang SW, 2009, BIOCHEM BIOPH RES CO, V379, P476, DOI 10.1016/j.bbrc.2008.12.117	40	20	23	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12759	12769		10.1074/jbc.RA118.001789	http://dx.doi.org/10.1074/jbc.RA118.001789			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29929982	hybrid, Green Published			2022-12-28	WOS:000442203500010
J	Oerum, S; Roovers, M; Rambo, RP; Kopec, J; Bailey, HJ; Fitzpatrick, F; Newman, JA; Newman, WG; Amberger, A; Zschocke, J; Droogmans, L; Oppermann, U; Yue, WW				Oerum, Stephanie; Roovers, Martine; Rambo, Robert P.; Kopec, Jola; Bailey, Henry J.; Fitzpatrick, Fiona; Newman, Joseph A.; Newman, William G.; Amberger, Albert; Zschocke, Johannes; Droogmans, Louis; Oppermann, Udo; Yue, Wyatt W.			Structural insight into the human mitochondrial tRNA purine N1-methyltransferase and ribonuclease P complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonuclease P (RNase P); transfer RNA (tRNA); RNA methyltransferase; RNA methylation; complex; HSD10; HSD17B10; MRPP; PRORP; TRMT10C	CRYSTAL-STRUCTURE; MODIFIED NUCLEOTIDES; ALZHEIMERS-DISEASE; PROTEIN COMPLEX; METHYLTRANSFERASE; BINDING; ACID; DEHYDROGENASE; RECOGNITION; MECHANISM	Mitochondrial tRNAs are transcribed as long polycistronic transcripts of precursor tRNAs and undergo posttranscriptional modifications such as endonucleolytic processing and methylation required for their correct structure and function. Among them, 5'-end processing and purine 9 N1-methylation of mitochondrial tRNA are catalyzed by two proteinaceous complexes with overlapping subunit composition. The Mg2+-dependent RNase P complex for 5'-end cleavage comprises the methyltransferase domain-containing protein tRNA methyltransferase 10C, mitochondrial RNase P subunit (TRMT10C/MRPP1), short-chain oxidoreductase hydroxysteroid 17 beta-dehydrogenase 10 (HSD17B10/MRPP2), and metallonuclease KIAA0391/MRPP3. An MRPP1-MRPP2 subcomplex also catalyzes the formation of 1-methyladenosine/1-methylguanosine at position 9 using S-adenosyl-l-methionine as methyl donor. However, a lack of structural information has precluded insights into how these complexes methylate and process mitochondrial tRNA. Here, we used a combination of X-ray crystallography, interaction and activity assays, and small angle X-ray scattering (SAXS) to gain structural insight into the two tRNA modification complexes and their components. The MRPP1 N terminus is involved in tRNA binding and monomer-monomer self-interaction, whereas the C-terminal SPOUT fold contains key residues for S-adenosyl-l-methionine binding and N1-methylation. The entirety of MRPP1 interacts with MRPP2 to form the N1-methylation complex, whereas the MRPP1-MRPP2-MRPP3 RNase P complex only assembles in the presence of precursor tRNA. This study proposes low-resolution models of the MRPP1-MRPP2 and MRPP1-MRPP2-MRPP3 complexes that suggest the overall architecture, stoichiometry, and orientation of subunits and tRNA substrates.	[Oerum, Stephanie; Kopec, Jola; Bailey, Henry J.; Fitzpatrick, Fiona; Newman, Joseph A.; Oppermann, Udo; Yue, Wyatt W.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7BN, England; [Roovers, Martine] Inst Rech Labiris, B-1070 Anderlecht, Belgium; [Rambo, Robert P.] Harwell Sci & Innovat Ctr, Diamond Light Source, Didcot OX11 0QG, Oxon, England; [Newman, William G.] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Amberger, Albert; Zschocke, Johannes] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Droogmans, Louis] Univ Libre Bruxelles, Lab Microbiol, B-1050 Brussels, Belgium; [Oppermann, Udo] NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England	University of Oxford; Diamond Light Source; University of Manchester; Medical University of Innsbruck; Universite Libre de Bruxelles; University of Oxford	Oppermann, U; Yue, WW (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7BN, England.; Oppermann, U (corresponding author), NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England.	udo.oppermann@sgc.ox.ac.uk; wyatt.yue@sgc.ox.ac.uk	Zschocke, Johannes/C-5885-2013	Zschocke, Johannes/0000-0002-0046-8274; Oerum, Stephanie/0000-0001-9525-7295; Newman, William/0000-0002-6382-4678	AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Fonds Brachet; Fonds Van Buuren; Action Medical Research [GN2494]; MRC [1790341] Funding Source: UKRI	AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Fonds Brachet; Fonds Van Buuren; Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (Grant 092809/Z/10/Z). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Fonds Brachet and the Fonds Van Buuren.; Supported by Action Medical Research GN2494.	Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Barbas A, 2013, BIOCHEM BIOPH RES CO, V430, P218, DOI 10.1016/j.bbrc.2012.10.091; Barraud P, 2008, J MOL BIOL, V377, P535, DOI 10.1016/j.jmb.2008.01.041; Beckmann BM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10127; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Christian T, 2010, J MOL BIOL, V400, P204, DOI 10.1016/j.jmb.2010.05.003; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez MR, 2007, CELL MOL LIFE SCI, V64, P1419, DOI 10.1007/s00018-007-7091-1; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Frank R, 1996, Methods Mol Biol, V66, P149; Gillis D, 2014, J MED GENET, V51, P581, DOI 10.1136/jmedgenet-2014-102282; Gobert A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2358; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; He XY, 2005, MOL CELL ENDOCRINOL, V229, P111, DOI 10.1016/j.mce.2004.08.011; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Howard MJ, 2013, RNA BIOL, V10, P909, DOI 10.4161/rna.24513; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Igoillo-Esteve M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003888; Ito T, 2015, P NATL ACAD SCI USA, V112, pE4197, DOI 10.1073/pnas.1422981112; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kempenaers M, 2010, NUCLEIC ACIDS RES, V38, P6533, DOI 10.1093/nar/gkq451; Kissinger CR, 2004, J MOL BIOL, V342, P943, DOI 10.1016/j.jmb.2004.07.071; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09878; Liu RJ, 2013, NUCLEIC ACIDS RES, V41, P7828, DOI 10.1093/nar/gkt568; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Lv FJ, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.37; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metodiev MD, 2016, AM J HUM GENET, V98, P993, DOI 10.1016/j.ajhg.2016.03.010; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oerum S, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010020; Petoukhov MV, 2015, ACTA CRYSTALLOGR D, V71, P1051, DOI 10.1107/S1399004715002576; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Sen A, 2016, NUCLEIC ACIDS RES, V44, P6409, DOI 10.1093/nar/gkw338; Shafqat N, 2003, BIOCHEM J, V376, P49, DOI 10.1042/BJ20030877; Shao ZH, 2014, NUCLEIC ACIDS RES, V42, P509, DOI 10.1093/nar/gkt869; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Taschner A, 2012, CELL REP, V2, P19, DOI 10.1016/j.celrep.2012.05.021; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van Laer B, 2016, NUCLEIC ACIDS RES, V44, P940, DOI 10.1093/nar/gkv1369; Vilardo E, 2015, NUCLEIC ACIDS RES, V43, P5112, DOI 10.1093/nar/gkv408; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; Voigts-Hoffmann F, 2007, J AM CHEM SOC, V129, P13382, DOI 10.1021/ja075520+; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang SY, 2009, P NATL ACAD SCI USA, V106, P14820, DOI 10.1073/pnas.0902377106	66	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12862	12876		10.1074/jbc.RA117.001286	http://dx.doi.org/10.1074/jbc.RA117.001286			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29880640	Green Published, hybrid			2022-12-28	WOS:000442203500019
J	Townsend, D; Hughes, E; Akien, G; Stewart, KL; Radford, SE; Rochester, D; Middleton, DA				Townsend, David; Hughes, Eleri; Akien, Geoffrey; Stewart, Katie L.; Radford, Sheena E.; Rochester, David; Middleton, David A.			Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; apolipoprotein; solid-state NMR; circular dichroism (CD); electron microscopy (EM); polyphenol; glycosaminoglycan; amyloid	TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; ALPHA-SYNUCLEIN; ATHEROSCLEROTIC PLAQUES; SULFATE PROTEOGLYCANS; CHONDROITIN SULFATE; ALZHEIMERS-DISEASE; BETA; EGCG; GLYCOSAMINOGLYCANS; GALLATE	Amyloid deposits of WT apolipoprotein A-I (apoA-I), the main protein component of high-density lipoprotein, accumulate in atherosclerotic plaques where they may contribute to coronary artery disease by increasing plaque burden and instability. Using CD analysis, solid-state NMR spectroscopy, and transmission EM, we report here a surprising cooperative effect of heparin and the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG), a known inhibitor and modulator of amyloid formation, on apoA-I fibrils. We found that heparin, a proxy for glycosaminoglycan (GAG) polysaccharides that co-localize ubiquitously with amyloid in vivo, accelerates the rate of apoA-I formation from monomeric protein and associates with insoluble fibrils. Mature, insoluble apoA-I fibrils bound EGCG (K-D = 30 +/- 3 mu m; B-max = 40 +/- 3 mu m), but EGCG did not alter the kinetics of apoA-I amyloid assembly from monomer in the presence or absence of heparin. EGCG selectively increased the mobility of specific backbone and side-chain sites of apoA-I fibrils formed in the absence of heparin, but the fibrils largely retained their original morphology and remained insoluble. By contrast, fibrils formed in the presence of heparin were mobilized extensively by the addition of equimolar EGCG, and the fibrils were remodeled into soluble 20-nm-diameter oligomers with a largely-helical structure that were nontoxic to human umbilical artery endothelial cells. These results argue for a protective effect of EGCG on apoA-I amyloid associated with atherosclerosis and suggest that EGCG-induced remodeling of amyloid may be tightly regulated by GAGs and other amyloid co-factors in vivo, depending on EGCG bioavailability.	[Townsend, David; Hughes, Eleri; Akien, Geoffrey; Rochester, David; Middleton, David A.] Univ Lancaster, Dept Chem, Lancaster LA1 4YB, England; [Stewart, Katie L.; Radford, Sheena E.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Stewart, Katie L.] Emory Univ, Dept Phys, Atlanta, GA 30322 USA	Lancaster University; University of Leeds; Emory University	Middleton, DA (corresponding author), Univ Lancaster, Dept Chem, Lancaster LA1 4YB, England.	d.middleton@lancaster.ac.uk		Radford, Sheena/0000-0002-3079-8039; Townsend, David/0000-0003-2687-6767; Hughes, Eleri/0000-0001-5123-7524; Middleton, David/0000-0002-3227-7632	British Heart Foundation [FS/13/28/30208, PG/16/97/32567]; Biotechnology and Biological Sciences Research Council [BB/K01451X/1, BB/K015958/1]; European Research Council under European Union [322408]; Wellcome Trust [089311/Z/09/Z]	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council under European Union(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by British Heart Foundation Grants FS/13/28/30208 (to E. H.) and PG/16/97/32567 (to D. T.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Biotechnology and Biological Sciences Research Council Grants BB/K01451X/1 and BB/K015958/1.r Recipient of funding from the European Research Council under European Union's Seventh Framework Programme (FP7/2007-) ERC Grant 322408 and Wellcome Trust Grant 089311/Z/09/Z.	Ahmed R, 2017, J AM CHEM SOC, V139, P13720, DOI 10.1021/jacs.7b05012; Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Attar A, 2013, TRANSL NEUROSCI, V4, P385, DOI 10.2478/s13380-013-0137-y; Bibow S, 2017, NAT STRUCT MOL BIOL, V24, P187, DOI 10.1038/nsmb.3345; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BRATZLER RL, 1977, CIRC RES, V40, P182, DOI 10.1161/01.RES.40.2.182; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Chan GKL, 2015, J BIOL CHEM, V290, P10958, DOI 10.1074/jbc.M114.630442; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; de Pascual-Teresa S, 2010, INT J MOL SCI, V11, P1679, DOI 10.3390/ijms11041679; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; Dragicevic N, 2011, J ALZHEIMERS DIS, V26, P507, DOI 10.3233/JAD-2011-101629; Eaton JD, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170209; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Elena B, 2005, J AM CHEM SOC, V127, P17296, DOI 10.1021/ja054411x; Engel MFM, 2012, J AM CHEM SOC, V134, P14781, DOI 10.1021/ja3031664; Ferreira N, 2011, FEBS LETT, V585, P2424, DOI 10.1016/j.febslet.2011.06.030; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Galzitskaya OV, 2017, J ALZHEIMERS DIS, V59, P785, DOI 10.3233/JAD-170230; GUPTABANSAL R, 1995, J BIOL CHEM, V270, P18666, DOI 10.1074/jbc.270.31.18666; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; Hussain R, 2015, J SYNCHROTRON RADIAT, V22, P465, DOI 10.1107/S1600577514028161; Hyung SJ, 2013, P NATL ACAD SCI USA, V110, P3743, DOI 10.1073/pnas.1220326110; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Jha S, 2011, J BIOL CHEM, V286, P22894, DOI 10.1074/jbc.M110.215814; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Kisilevsky R, 2007, AMYLOID, V14, DOI 10.1080/13506120601116419; Kristen AV, 2012, CLIN RES CARDIOL, V101, P805, DOI 10.1007/s00392-012-0463-z; Li M, 2014, J AGR FOOD CHEM, V62, P3768, DOI 10.1021/jf500246m; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Madine J, 2012, ANGEW CHEM INT EDIT, V51, P13140, DOI 10.1002/anie.201204459; Malmos KG, 2016, J BIOL CHEM, V291, P16849, DOI 10.1074/jbc.M116.715466; Mamos KG, 2017, J MOL BIOL, V429, P2755, DOI 10.1016/j.jmb.2017.07.014; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; Mizooku Y, 2003, RAPID COMMUN MASS SP, V17, P1915, DOI 10.1002/rcm.1135; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Nakajima H, 2016, AMYLOID, V23, P17, DOI 10.3109/13506129.2015.1113167; Naumovski N, 2015, ANTIOXIDANTS-BASEL, V4, P373, DOI 10.3390/antiox4020373; O'Brien KD, 1998, CIRCULATION, V98, P519, DOI 10.1161/01.CIR.98.6.519; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Oda MN, 2001, BIOCHEMISTRY-US, V40, P1710, DOI 10.1021/bi001922h; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Peter B, 2017, EUR BIOPHYS J BIOPHY, V46, P1, DOI 10.1007/s00249-016-1141-2; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Ramella NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043755; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Ren RY, 2010, J BIOL CHEM, V285, P37672, DOI 10.1074/jbc.M110.149575; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; SMITH EB, 1980, ATHEROSCLEROSIS, V37, P579, DOI 10.1016/0021-9150(80)90065-9; Snow AD, 1996, EXP NEUROL, V138, P305, DOI 10.1006/exnr.1996.0069; SNOW AD, 1992, J HISTOCHEM CYTOCHEM, V40, P105, DOI 10.1177/40.1.1370306; SNOW AD, 1990, AM J PATHOL, V137, P1253; Stenvang M, 2016, BIOCHEMISTRY-US, V55, P2344, DOI 10.1021/acs.biochem.6b00063; Stewart KL, 2017, J MOL BIOL, V429, P2449, DOI 10.1016/j.jmb.2017.07.003; Stewart KL, 2016, J AM CHEM SOC, V138, P8328, DOI 10.1021/jacs.6b02816; Townsend D, 2017, BIOCHEMISTRY-US, V56, P1632, DOI 10.1021/acs.biochem.6b01120; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Vilasi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022076; VITELLO LB, 1976, J BIOL CHEM, V251, P1131; Wang H, 2013, J MOL BIOL, V425, P492, DOI 10.1016/j.jmb.2012.11.003; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.230S, 10.1093/ajcn/81.1.243S]; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Zhang Z, 2016, GLYCOBIOLOGY, V26, P1443; Zhao J, 2017, RSC ADV, V7, P32508, DOI 10.1039/c7ra03752j	83	11	11	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12877	12893		10.1074/jbc.RA118.002038	http://dx.doi.org/10.1074/jbc.RA118.002038			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29853648	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000442203500020
J	Hughey, CC; Trefts, E; Bracy, DP; James, FD; Donahue, EP; Wasserman, DH				Hughey, Curtis C.; Trefts, Elijah; Bracy, Deanna P.; James, Freyja D.; Donahue, E. Patrick; Wasserman, David H.			Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; HUMAN HEPATOCELLULAR-CARCINOMA; KNOCKOUT MOUSE MODEL; S-ADENOSYLMETHIONINE; GLUTATHIONE SYNTHESIS; PYRUVATE-CARBOXYLASE; GLUCOSE-METABOLISM; ACID SYNTHESIS; MALONYL-COA; RAT-LIVER	Glycine N-methyltransferase (GNMT) is the most abundant liver methyltransferase regulating the availability of the biological methyl donor, S-adenosylmethionine (SAM). Moreover, GNMT has been identified to be down-regulated in hepatocellular carcinoma (HCC). Despite its role in regulating SAM levels and association of its down-regulation with liver tumorigenesis, the impact of reduced GNMT on metabolic reprogramming before the manifestation of HCC has not been investigated in detail. Herein, we used H-2/C-13 metabolic flux analysis in conscious, unrestrained mice to test the hypothesis that the absence of GNMT causes metabolic reprogramming. GNMT-null (KO) mice displayed a reduction in blood glucose that was associated with a decline in both hepatic glycogenolysis and gluconeogenesis. The reduced gluconeogenesis was due to a decrease in liver gluconeogenic precursors, citric acid cycle fluxes, and anaplerosis and cataplerosis. A concurrent elevation in both hepatic SAM and metabolites of SAM utilization pathways was observed in the KO mice. Specifically, the increase in metabolites of SAM utilization pathways indicated that hepatic polyamine synthesis and catabolism, transsulfuration, and de novo lipogenesis pathways were increased in the KO mice. Of note, these pathways utilize substrates that could otherwise be used for gluconeogenesis. Also, this metabolic reprogramming occurs before the well-documented appearance of HCC in GNMT-null mice. Together, these results indicate that GNMT deletion promotes a metabolic shift whereby nutrients are channeled away from glucose formation toward pathways that utilize the elevated SAM.	[Hughey, Curtis C.; Trefts, Elijah; Bracy, Deanna P.; James, Freyja D.; Donahue, E. Patrick; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA; [Bracy, Deanna P.; James, Freyja D.; Wasserman, David H.] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Hughey, CC (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	curtis.hughey@vanderbilt.edu			NIDDK, National Institutes of Health [DK050277, DK054902]; Diabetes Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, R01DK050277, U2CDK059637, U24DK059637, R37DK050277, P60DK020593, R56DK054902, P30DK058404, R01DK054902] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants DK050277 and DK054902 (to D. H. W.) and a Diabetes Canada Postdoctoral Fellowship (to C. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; Brosnan ME, 2009, AM J CLIN NUTR, V90, p857S, DOI 10.3945/ajcn.2009.27462Z; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Chen YMA, 1998, INT J CANCER, V75, P787, DOI 10.1002/(SICI)1097-0215(19980302)75:5<787::AID-IJC20>3.0.CO;2-2; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Foster DW, 2004, ANN NY ACAD SCI, V1033, P1, DOI 10.1196/annals.1320.001; Hasenour CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170382; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; HEMS R, 1966, BIOCHEM J, V101, P284, DOI 10.1042/bj1010284; Hirata H, 2016, CANCER RES, V76, P3265, DOI 10.1158/0008-5472.CAN-15-2601; Huang ZZ, 2001, FASEB J, V15, P19, DOI 10.1096/fj.00-0445fje; Hughey CC, 2017, J BIOL CHEM, V292, P20125, DOI 10.1074/jbc.M117.811547; Jacobs RL, 2001, J BIOL CHEM, V276, P43740, DOI 10.1074/jbc.M107553200; KEECH DB, 1963, J BIOL CHEM, V238, P2609; Liao YJ, 2012, MOL MED, V18, P412, DOI 10.2119/molmed.2011.00258; Liao YJ, 2009, INT J CANCER, V124, P816, DOI 10.1002/ijc.23979; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; Liu SP, 2011, INT J CANCER, V128, P511, DOI 10.1002/ijc.25386; Long MD, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010015; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Luka Z, 2006, TRANSGENIC RES, V15, P393, DOI 10.1007/s11248-006-0008-1; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma RH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3508; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Martinez-Una M, 2015, J HEPATOL, V62, P673, DOI 10.1016/j.jhep.2014.10.019; Martinez-Una M, 2013, HEPATOLOGY, V58, P1296, DOI 10.1002/hep.26399; MCGARRY JD, 1978, J BIOL CHEM, V253, P8294; MORGAN CR, 1965, DIABETES, V14, P669, DOI 10.2337/diab.14.10.669; Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; SAVARESE TM, 1981, BIOCHEM PHARMACOL, V30, P189, DOI 10.1016/0006-2952(81)90077-0; Savic LJ, 2016, HEPAT ONCOL, V3, DOI 10.2217/hep.15.36; SCRUTTON MC, 1974, J BIOL CHEM, V249, P5405; Shang RZ, 2016, WORLD J GASTROENTERO, V22, P9933, DOI 10.3748/wjg.v22.i45.9933; Varela-Rey M, 2010, HEPATOLOGY, V52, P105, DOI 10.1002/hep.23639; VONGLUTZ G, 1976, FEBS LETT, V72, P299, DOI 10.1016/0014-5793(76)80991-X; YEO EJ, 1994, P NATL ACAD SCI USA, V91, P210, DOI 10.1073/pnas.91.1.210; Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123; Zubiete-Franco I, 2016, J HEPATOL, V64, P409, DOI 10.1016/j.jhep.2015.08.037	48	25	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11944	11954		10.1074/jbc.RA118.002568	http://dx.doi.org/10.1074/jbc.RA118.002568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29891549	hybrid, Green Published			2022-12-28	WOS:000440134500025
J	Shi, SJ; Mutchler, SM; Blobner, BM; Kashlan, OB; Kleyman, TR				Shi, Shujie; Mutchler, Stephanie M.; Blobner, Brandon M.; Kashlan, Ossama B.; Kleyman, Thomas R.			Pore-lining residues of MEC-4 and MEC-10 channel subunits tune the Caenorhabditis elegans degenerin channel's response to shear stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); shear stress; gating; mechanotransduction; acid sensing ion channel (ASIC); degenerin; pore	EPITHELIAL NA+ CHANNEL; TRANSMEMBRANE DOMAIN; SELECTIVITY FILTER; MUTATIONS; TOUCH; GENE; MECHANOTRANSDUCTION; NEURODEGENERATION; PERMEABILITY; TRANSDUCTION	The Caenorhabditis elegans MEC-4/MEC-10 channel mediates the worm's response to gentle body touch and is activated by laminar shear stress (LSS) when expressed in Xenopus oocytes. Substitutions at multiple sites within the second transmembrane domain (TM2) of MEC-4 or MEC-10 abolish the gentle touch response in worms, but the roles of these residues in mechanosensing are unclear. The present study therefore examined the role of specific MEC-4 and MEC-10 TM2 residues in the channel's response to LSS. We found that introducing mutations within the TM2 of MEC-4 or MEC-10 not only altered channel activity, but also affected the channel's response to LSS. This response was enhanced by Cys substitutions at selected MEC-4 sites (Phe(715), Gly(716), Gln(718), and Leu(719)) between the degenerin and the putative amiloride-binding sites in this subunit. In contrast, the LSS response was largely blunted in MEC-10 variants bearing single Cys substitutions in the regions preceding and following the amiloride-binding site (Gly(677)-Leu(681)), as well as with four MEC-10 touch-deficient mutations that introduced charged residues into the TM2 domain. An enhanced response to LSS was observed with a MEC-10 mutation in the putative selectivity filter. Overall, MEC-4 or MEC-10 mutants that altered the channel's LSS response are primarily clustered between the degenerin site and the selectivity filter, a region that probably forms the narrowest portion of the channel pore. Our results suggest that pore-lining residues of MEC-4 and MEC-10 have important yet different roles in tuning the channel's response to mechanical forces.	[Shi, Shujie; Mutchler, Stephanie M.; Blobner, Brandon M.; Kashlan, Ossama B.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Mutchler, Stephanie M.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Kashlan, Ossama B.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu		Mutchler, Stephanie/0000-0002-4288-4452; , Thomas/0000-0002-2413-5415	National Institutes of Health [DK103834, DK098204, DK051391, DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098204, P30DK079307, R01DK051391, R37DK051391, K01DK103834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part by National Institutes of Health Grants DK103834 (to S. S.) DK098204 (to O. B. K), DK051391 (to T. R. K.), and DK079307 (to the Pittsburgh Center for Kidney Research). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Antoun T, 2011, AM J PHYSIOL-RENAL, V300, pF1089, DOI 10.1152/ajprenal.00610.2010; Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Arnadottir J, 2011, J NEUROSCI, V31, P12695, DOI 10.1523/JNEUROSCI.4580-10.2011; Ashley Z, 2018, AM J PHYSIOL-HEART C, V314, pH1022, DOI 10.1152/ajpheart.00506.2017; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Bianchi L, 2007, MOL NEUROBIOL, V36, P254, DOI 10.1007/s12035-007-8009-5; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chatzigeorgiou M, 2010, J NEUROPHYSIOL, V104, P3334, DOI 10.1152/jn.00330.2010; Chen YS, 2016, MOL BIOL CELL, V27, P1272, DOI 10.1091/mbc.E15-08-0561; Chen YS, 2015, P NATL ACAD SCI USA, V112, P11690, DOI 10.1073/pnas.1515968112; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Drummond HA, 2008, PHYSIOLOGY, V23, P23, DOI 10.1152/physiol.00034.2007; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; Hong K, 2000, J NEUROSCI, V20, P2575; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028706; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kusche-Vihrog K, 2010, STEROIDS, V75, P544, DOI 10.1016/j.steroids.2009.09.003; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Matthewman C, 2016, AM J PHYSIOL-CELL PH, V311, pC920, DOI 10.1152/ajpcell.00247.2016; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Raouf R, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-21; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Shi SJ, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2224; Shi SJ, 2016, J BIOL CHEM, V291, P14012, DOI 10.1074/jbc.M116.718031; Shi SJ, 2013, AM J PHYSIOL-RENAL, V305, pF1585, DOI 10.1152/ajprenal.00337.2013; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781	40	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10757	10766		10.1074/jbc.RA118.002499	http://dx.doi.org/10.1074/jbc.RA118.002499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29743244	hybrid, Green Published			2022-12-28	WOS:000437828400030
J	Paradis-Isler, N; Boehm, J				Paradis-Isler, Nicolas; Boehm, Jannic			NMDA receptor-dependent dephosphorylation of serine 387 in Argonaute 2 increases its degradation and affects dendritic spine density and maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; neuron; protein turnover; protein phosphorylation; dendrite	UBIQUITIN-PROTEASOME SYSTEM; MESSENGER-RNA TRANSLATION; TERM-MEMORY FORMATION; SYNAPTIC PLASTICITY; NONCODING RNA; HIPPOCAMPAL-NEURONS; LOCAL TRANSLATION; EMERGING ROLES; MIRNA ACTIVITY; P-BODIES	Argonaute (AGO) proteins are essential components of the microRNA (miRNA) pathway. AGO proteins are loaded with miRNAs to target mRNAs and thereby regulate mRNA stability and protein translation. As such, AGO proteins are important actors in controlling local protein synthesis, for instance, at dendritic spines and synapses. Although miRNA-mediated regulation of dendritic mRNAs has become a focus of intense interest over the past years, the mechanisms regulating neuronal AGO proteins remain largely unknown. Here, using rat hippocampal neurons, we report that dendritic Ago2 is down-regulated by the proteasome upon NMDA receptor activation. We found that Ser-387 in Ago2 is dephosphorylated upon NMDA treatment and that this dephosphorylation precedes Ago2 degradation. Expressing Ser-387 phosphorylation-deficient or phosphomimetic Ago2 in neurons, we observed that this phosphorylation site is involved in modulating dendritic spine morphology and postsynaptic density protein 95 (PSD-95) expression in spines. Collectively, our results point toward a signaling pathway linking NMDA receptor-dependent Ago2 dephosphorylation and turnover to postsynaptic structural changes. They support a model in which NMDA receptor-mediated dephosphorylation of Ago2 and Ago2 turnover contributes to the de-repression of mRNAs involved in spine growth and maturation.	[Paradis-Isler, Nicolas; Boehm, Jannic] Univ Montreal, Dept Neurosci, Grp Rech Syst Nerveux Cent, Montreal, PQ H3T 1J4, Canada	Universite de Montreal	Boehm, J (corresponding author), Univ Montreal, Dept Neurosci, 2960 Chemin Tour, Montreal, PQ H3T 1J4, Canada.	jannic.boehm@umontreal.ca	Boehm, Jannic/AAK-8882-2020	Paradis-Isler, Nicolas/0000-0001-8832-0110	"Natural Sciences and Engineering Research Council of Canada" (NSERC) Discovery Grant [371858]; Natural Sciences and Engineering Research Council of Canada (NSERC) "Alexander Graham Bell" master student stipend; Quebec "Fonds de Recherche Nature et Technologies" (FQRNT); "Fonds de Recherche Sante Quebec" (FRQS)	"Natural Sciences and Engineering Research Council of Canada" (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC) "Alexander Graham Bell" master student stipend; Quebec "Fonds de Recherche Nature et Technologies" (FQRNT); "Fonds de Recherche Sante Quebec" (FRQS)	This work was supported in part by an operating grant from the "Natural Sciences and Engineering Research Council of Canada" (NSERC) Discovery Grant 371858. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Natural Sciences and Engineering Research Council of Canada (NSERC) "Alexander Graham Bell" master student stipend and a Ph.D. stipend from the Quebec "Fonds de Recherche Nature et Technologies" (FQRNT).; Supported by a salary award from the "Fonds de Recherche Sante Quebec" (FRQS). To whom correspondence should be addressed: Dept. of Neurosciences, Universite de Montreal, 2960 Chemin de la Tour, Montreal, Quebec H3T 1J4, Canada; Tel.: 514 343 6370; E-mail: jannic.boehm@umontreal.ca.	Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Alvarez-Castelao B, 2015, J BIOL CHEM, V290, P28623, DOI 10.1074/jbc.R115.657130; Antoniou A, 2014, EMBO REP, V15, P548, DOI 10.1002/embr.201337631; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Cane M, 2014, J NEUROSCI, V34, P2075, DOI 10.1523/JNEUROSCI.3353-13.2014; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dong CH, 2014, NEUROSCI LETT, V583, P199, DOI 10.1016/j.neulet.2014.09.038; Dong CH, 2014, J NEUROSCI, V34, P3171, DOI 10.1523/JNEUROSCI.3291-13.2014; Eacker SM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00136; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Filipowicz W, 2015, RNA, V21, P519, DOI 10.1261/rna.051219.115; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hanus C, 2013, NAT REV NEUROSCI, V14, P638, DOI 10.1038/nrn3546; Hauptmann J, 2013, DEV CELL, V25, P553, DOI 10.1016/j.devcel.2013.06.009; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Horman SR, 2013, MOL CELL, V50, P356, DOI 10.1016/j.molcel.2013.03.015; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; Jarome TJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00061; Jarome TJ, 2013, NEUROBIOL LEARN MEM, V105, P107, DOI 10.1016/j.nlm.2013.03.009; Jee D, 2014, TRENDS CELL BIOL, V24, P546, DOI 10.1016/j.tcb.2014.04.008; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Juvvuna PK, 2012, NUCLEIC ACIDS RES, V40, P6808, DOI 10.1093/nar/gks293; Kenny PJ, 2014, CELL REP, V9, P1729, DOI 10.1016/j.celrep.2014.10.054; Khoutorsky A, 2013, NEURON, V78, P298, DOI 10.1016/j.neuron.2013.02.025; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Leung AKL, 2015, TRENDS CELL BIOL, V25, P601, DOI 10.1016/j.tcb.2015.07.005; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Pai B, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00285; Pasquinelli AE, 2015, RNA, V21, P709, DOI 10.1261/rna.049981.115; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Patranabis S, 2016, MOL CELL BIOL, V36, P1260, DOI 10.1128/MCB.00054-16; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rosenberg T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00086; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sahin U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102957; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Siegel G, 2011, CURR OPIN GENET DEV, V21, P491, DOI 10.1016/j.gde.2011.04.008; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606; Swanger SA, 2011, CURR OPIN GENET DEV, V21, P414, DOI 10.1016/j.gde.2011.04.002; Taft CE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0134; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Valdmanis PN, 2012, NUCLEIC ACIDS RES, V40, P3704, DOI 10.1093/nar/gkr1274; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Weiss K, 2015, EUR J CELL BIOL, V94, P363, DOI 10.1016/j.ejcb.2015.05.011; Yang M, 2014, MOL CELL, V55, P782, DOI 10.1016/j.molcel.2014.07.018; Ye YQ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4959523; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008; Zeitelhofer M, 2008, RNA BIOL, V5, P244, DOI 10.4161/rna.6948; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	80	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9311	9325		10.1074/jbc.RA117.001007	http://dx.doi.org/10.1074/jbc.RA117.001007			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29735530	Green Published, hybrid			2022-12-28	WOS:000435441400017
J	Bellesis, AG; Jecrois, AM; Hayes, JA; Schiffer, CA; Royer, WE				Bellesis, Andrew G.; Jecrois, Anne M.; Hayes, Janelle A.; Schiffer, Celia A.; Royer, William E., Jr.			Assembly of human C-terminal binding protein (CtBP) into tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTIONAL COREPRESSOR CTBP; CELLULAR PHOSPHOPROTEIN; NEGATIVE MODULATION; ADENOVIRUS E1A; BREAST-CANCER; REPRESSION; DOMAIN; NADH; TRANSFORMATION	C-terminal binding protein 1 (CtBP1) and CtBP2 are transcriptional coregulators that repress numerous cellular processes, such as apoptosis, by binding transcription factors and recruiting chromatin-remodeling enzymes to gene promoters. The NAD(H)-linked oligomerization of human CtBP is coupled to its co-transcriptional activity, which is implicated in cancer progression. However, the biologically relevant level of CtBP assembly has not been firmly established; nor has the stereochemical arrangement of the subunits above that of a dimer. Here, multi-angle light scattering (MALS) data established the NAD(+)-and NADH-dependent assembly of CtBP1 and CtBP2 into tetramers. An examination of subunit interactions within CtBP1 and CtBP2 crystal lattices revealed that both share a very similar tetrameric arrangement resulting from assembly of two dimeric pairs, with specific interactions probably being sensitive to NAD(H) binding. Creating a series of mutants of both CtBP1 and CtBP2, we tested the hypothesis that the crystallographically observed interdimer pairing stabilizes the solution tetramer. MALS data confirmed that these mutants disrupt both CtBP1 and CtBP2 tetramers, with the dimer generally remaining intact, providing the first stereochemical models for tetrameric assemblies of CtBP1 and CtBP2. The crystal structure of a subtle destabilizing mutant suggested that small structural perturbations of the hinge region linking the substrate-and NAD-binding domains are sufficient to weaken the CtBP1 tetramer. These results strongly suggest that the tetramer is important in CtBP function, and the series of CtBP mutants reported here can be used to investigate the physiological role of the tetramer.	[Bellesis, Andrew G.; Jecrois, Anne M.; Hayes, Janelle A.; Schiffer, Celia A.; Royer, William E., Jr.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Bellesis, Andrew G.] Clark Univ, Carlson Sch Chem & Biochem, Worcester, MA 01610 USA; [Bellesis, Andrew G.] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Bellesis, Andrew G.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Massachusetts System; University of Massachusetts Worcester; Clark University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Royer, WE (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	William.Royer@umassmed.edu		Bellesis, Andrew/0000-0003-2853-0057	National Institutes of Health [R01 GM119014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119014] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 GM119014 (to W. E. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achouri Y, 2007, BIOCHEM BIOPH RES CO, V352, P903, DOI 10.1016/j.bbrc.2006.11.111; Balasubramanian P, 2003, FEBS LETT, V537, P157, DOI 10.1016/S0014-5793(03)00119-4; Barroilhet L, 2013, ONCOGENE, V32, P3896, DOI 10.1038/onc.2012.380; Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Bi CL, 2018, BIOCHEM BIOPH RES CO, V495, P1980, DOI 10.1016/j.bbrc.2017.12.018; Birts CN, 2011, BIOL CELL, V103, P1, DOI 10.1042/BC20100067; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Corda D, 2006, TRENDS CELL BIOL, V16, P167, DOI 10.1016/j.tcb.2006.01.007; Cubillos-Rojas M, 2017, ONCOTARGET, V8, P61824, DOI 10.18632/oncotarget.18699; Deng H, 2013, J INVEST DERMATOL, V133, P1294, DOI 10.1038/jid.2012.487; Deng Y, 2012, MOL CARCINOGEN, V51, P500, DOI 10.1002/mc.20813; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Guan CQ, 2013, J CELL BIOCHEM, V114, P1343, DOI 10.1002/jcb.24475; Hilbert BJ, 2015, ACS CHEM BIOL, V10, P1118, DOI 10.1021/cb500820b; Hilbert BJ, 2014, FEBS LETT, V588, P1743, DOI 10.1016/j.febslet.2014.03.026; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Jin W, 2007, BIOCHEM PHARMACOL, V74, P851, DOI 10.1016/j.bcp.2007.06.017; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Madison DL, 2013, J BIOL CHEM, V288, P27836, DOI 10.1074/jbc.M113.493569; Mani-Telang P, 2007, FEBS LETT, V581, P5241, DOI 10.1016/j.febslet.2007.10.011; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Nardini M, 2006, PROTEIN SCI, V15, P1042, DOI 10.1110/ps.062115406; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Nardini M, 2009, BIOCHEM BIOPH RES CO, V381, P70, DOI 10.1016/j.bbrc.2009.02.010; Paliwal Seema, 2012, Genes Cancer, V3, P481, DOI 10.1177/1947601912463695; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Payankaulam S, 2010, CURR BIOL, V20, pR764, DOI 10.1016/j.cub.2010.06.037; Ray SK, 2017, FEBS LETT, V591, P205, DOI 10.1002/1873-3468.12501; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Sumner ET, 2017, ONCOGENE, V36, P4810, DOI 10.1038/onc.2017.106; Sun LD, 2016, CELL MOL LIFE SCI, V73, P4493, DOI 10.1007/s00018-016-2303-1; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; Van Holds K. F., 1971, PHYS BIOCH, p[43, 191]; Wang R, 2012, NEOPLASIA, V14, P905, DOI 10.1593/neo.121192; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhang YW, 2011, MOL CELL BIOL, V31, P375, DOI 10.1128/MCB.00772-10; Zheng X, 2015, ONCOTARGET, V6, P3752, DOI 10.18632/oncotarget.2915	49	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9101	9112		10.1074/jbc.RA118.002514	http://dx.doi.org/10.1074/jbc.RA118.002514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29700119	Green Published, hybrid			2022-12-28	WOS:000434941900031
J	Petti, LM; Marlatt, SA; Luo, Y; Scheideman, EH; Shelar, A; DiMaio, D				Petti, Lisa M.; Marlatt, Sara A.; Luo, Yong; Scheideman, Elizabeth H.; Shelar, Ashish; DiMaio, Daniel			Regulation of C-C chemokine receptor 5 (CCR5) stability by Lys(197) and by transmembrane protein aptamers that target it for lysosomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C-C chemokine receptor type 5 (CCR5); G protein-coupled receptor (GPCR); lysosome; chemokine; human immunodeficiency virus (HIV); HIV co-receptor; CCR2b; E5 protein; proximity ligation assay; transmembrane protein; traptamer	IMMUNODEFICIENCY-VIRUS TYPE-1; AGONIST-INDUCED ENDOCYTOSIS; PHOSPHORYLATION SITES; MOLECULAR-CLONING; BETA; EXPRESSION; DOMAIN; CXCR4; INTERNALIZATION; CORECEPTOR	C-C motif chemokine receptor 5 (CCR5) is a cell surface-associated, immune-regulatory G protein-coupled receptor (GCPR) with seven transmembrane helices. We previously reported the isolation and initial characterization of short artificial transmembrane protein aptamers, named traptamers, that specifically down-regulate CCR5 expression and inhibit infection of human T cells by HIV strains that use CCR5 as a co-receptor. Here, we investigated the mechanism of traptamer-mediated CCR5 down-regulation and show that most of the traptamers (designated class 1 traptamers) form a stable complex with CCR5 and target it for lysosome-mediated degradation. The ability of these traptamers to down-regulate CCR5 depended on Lys(197) in the fifth transmembrane helix of CCR5. In the absence of traptamers, substitution of Lys(197) to an uncharged amino acid increased CCR5 stability, and introduction of a lysine at the homologous position in CCR2b, a related chemokine receptor, decreased CCR2b levels. The prototypic class 2 traptamer BY6M4 also formed a complex with CCR5, but CCR5 down-regulation caused by class 2 traptamers did not depend on the lysosome or on Lys(197). These results demonstrate that traptamers use diverse mechanisms to down-regulate CCR5 and identify a specific amino acid that plays a central role in controlling chemokine receptor stability. Further studies of these traptamers are likely to provide new insights into CCR5 metabolism and biology and may suggest new therapeutic approaches to modulate the levels of CCR5 and other GPCRs.	[Petti, Lisa M.; Marlatt, Sara A.; Luo, Yong; Scheideman, Elizabeth H.; Shelar, Ashish; DiMaio, Daniel] Yale Sch Med, Dept Genet, POB 208005, New Haven, CT 06520 USA; [DiMaio, Daniel] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA; [DiMaio, Daniel] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [DiMaio, Daniel] Yale Canc Ctr, New Haven, CT 06520 USA; [Marlatt, Sara A.] Azusa Pacific Univ, 901 E Alosta Ave, Azusa, CA 91702 USA	Yale University; Yale University; Yale University; Yale University	DiMaio, D (corresponding author), Yale Sch Med, Dept Genet, POB 208005, New Haven, CT 06520 USA.	daniel.dimaio@yale.edu	Shelar, Ashish/AAC-9295-2022		NCI, National Institutes of Health [CA037157]; NATIONAL CANCER INSTITUTE [R01CA037157, R37CA037157] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health, Grant CA037157 (to D.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arias JF, 2012, CURR HIV RES, V10, P283, DOI 10.2174/157016212800792423; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borroni EM, 2010, PHARMACOL THERAPEUT, V127, P1, DOI 10.1016/j.pharmthera.2010.04.006; Cammett TJ, 2010, P NATL ACAD SCI USA, V107, P3447, DOI 10.1073/pnas.0915057107; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Freeman-Cook LL, 2004, J MOL BIOL, V338, P907, DOI 10.1016/j.jmb.2004.03.044; Glosson NL, 2010, J BIOL CHEM, V285, P37016, DOI 10.1074/jbc.M110.125849; He L, 2017, ELIFE, V6, DOI 10.7554/eLife.27701; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Lau G, 2015, J BIOL CHEM, V290, P11041, DOI 10.1074/jbc.M115.640169; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lipovsky Alex, 2015, Methods Mol Biol, V1270, P437, DOI 10.1007/978-1-4939-2309-0_30; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Popa A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004699; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Richards R, 2011, J VIROL, V85, P8766, DOI 10.1128/JVI.05021-11; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Scheideman EH, 2012, J VIROL, V86, P10281, DOI 10.1128/JVI.00910-12; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002; Zheng Y, 2016, NATURE, V540, P458, DOI 10.1038/nature20605	41	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8787	8801		10.1074/jbc.RA117.001067	http://dx.doi.org/10.1074/jbc.RA117.001067			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29678881	Green Published, hybrid			2022-12-28	WOS:000434941900006
J	Cook, AA; Deng, W; Ren, JQ; Li, RH; Sondek, J; Bergmeier, W				Cook, Aaron A.; Deng, Wei; Ren, Jinqi; Li, Renhao; Sondek, John; Bergmeier, Wolfgang			Calcium-induced structural rearrangements release autoinhibition in the Rap-GEF CalDAG-GEFI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; guanine nucleotide exchange factor (GEF); GTPase; platelet; structural model; autoinhibition; conformational dynamics; EF hand	PLATELET DYSFUNCTION; ACTIVATION; DOMAIN; AFFINITY; RASGRP2; PARVALBUMIN; MUTATIONS; PROTEINS	Platelets are recruited to sites of vascular injury, where they are activated and aggregate to form a hemostatic plug. This process requires the activation of the small GTPase Rap1B by its cognate guanine nucleotide exchange factor CalDAG-GEFI. Studies on platelet function suggest that CalDAG-GEFI activity is regulated by changes in cytosolic calcium, but the exact molecular mechanism is poorly understood. Here we show that purified CalDAG-GEFI is autoinhibited and directly regulated by calcium. Substitutions of putative calcium-binding residues within the canonical EF hands of CalDAG-GEFI diminish its capacity to activate Rap1B. Structural differences between active (WT) and inactive (EF hand variant) CalDAG-GEFI protein were determined by hydrogen-deuterium exchange MS. The highest differential rates of deuterium uptake in WT over EF hand variant CalDAG-GEFI were observed in regions within the catalytic Cdc25 domain and a putative autoinhibitory linker connecting the Cdc25 and EF hand domains. Exchange activity in the EF hand variant was fully restored by an additional substitution, valine 406 to glutamate, which is thought to disrupt the interface between the autoinhibitory linker and the Cdc25 domain. Overall, our results suggest a model for how CalDAG-GEFI remains in an autoinhibited state when levels of cytosolic calcium in resting platelets are low. In response to cellular stimulation, calcium mobilization and binding to the EF hands causes conformational rearrangements within CalDAG-GEFI, including the autoinhibitory linker that frees the catalytic surface of CalDAG-GEFI to engage and activate Rap1B. The data from this study are the first evidence linking CalDAG-GEFI activity directly to calcium.	[Cook, Aaron A.; Sondek, John; Bergmeier, Wolfgang] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Ren, Jinqi; Sondek, John] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Deng, Wei; Sondek, John] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Deng, Wei; Li, Renhao] Emory Univ, Sch Med, Aflac Canc & Blood Disorders Ctr, Dept Pediat, Atlanta, GA 30322 USA; [Bergmeier, Wolfgang] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27516 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University; University of North Carolina; University of North Carolina Chapel Hill	Bergmeier, W (corresponding author), 120 Mason Farm Rd,3113 Genet Med Bldg, Chapel Hill, NC 27599 USA.	bergmeie@email.unc.edu	Li, Renhao/B-1257-2012; Ren, Jinqi/D-5545-2015	Li, Renhao/0000-0002-5806-5080; Ren, Jinqi/0000-0001-7461-0491	NHLBI, National Institutes of Health [R01 HL130404, R01 HL121650]; NIGMS, National Institutes of Health [P01GM103723]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121650, R01HL130404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM103723] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NHLBI, National Institutes of Health Grants R01 HL130404 and R01 HL121650 and NIGMS, National Institutes of Health Grant P01GM103723. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boudreaux MK, 2007, TRANSL RES, V150, P81, DOI 10.1016/j.trsl.2007.03.006; Busch E, 2000, J BIOL CHEM, V275, P25508, DOI 10.1074/jbc.M001770200; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Czikora A, 2016, J BIOL CHEM, V291, P11133, DOI 10.1074/jbc.M116.725333; Declercq JP, 1999, PROTEIN SCI, V8, P2194, DOI 10.1110/ps.8.10.2194; Deng W, 2017, J THROMB HAEMOST, V15, P1867, DOI 10.1111/jth.13775; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kumar S, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-15; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lozano ML, 2016, BLOOD, V128, P1282, DOI 10.1182/blood-2015-11-683102; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Morgan Christopher R, 2009, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1706s58; Ren J, 2016, BIOCHEM BIOPH RES CO, V474, P193, DOI 10.1016/j.bbrc.2016.04.100; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stefanini L, 2016, J MOL MED, V94, P13, DOI 10.1007/s00109-015-1346-3; Stefanini L, 2015, J CLIN INVEST, V125, P1419, DOI 10.1172/JCI77993; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Stolla M, 2011, BLOOD, V117, P1005, DOI 10.1182/blood-2010-07-297713; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Westbury SK, 2017, BLOOD, V130, P1026, DOI 10.1182/blood-2017-03-776773	23	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8521	8529		10.1074/jbc.RA118.002712	http://dx.doi.org/10.1074/jbc.RA118.002712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29622678	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000434205700016
J	Musselman, CA; Kutateladze, TG				Musselman, Catherine A.; Kutateladze, Tatiana G.			A histone reader becomes the readout	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEINS; TARGETS; CANCER	Chromatin signaling events are critical for the dynamic regulation of the genome. Although much has been learned about histone modification in these events, the modification of nonhistone chromatin regulators and cross-talk between these pathways is less well understood. Here, Appikonda et al. demonstrate that the transcription co-factor and oncoprotein TRIM24 (tripartite motif-containing protein 24) is SUMOylated upon association with a specific histone modification signature, which regulates the transcription of genes involved in cell adhesion. These data extend our understanding of signaling cascades in the nucleus and offer new insights for cancer drug development.	[Musselman, Catherine A.] Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Kutateladze, Tatiana G.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Iowa; University of Colorado System; University of Colorado Anschutz Medical Campus	Musselman, CA (corresponding author), Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA.; Kutateladze, TG (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	catherine-musselman@uiowa.edu; tatiana.kutateladze@ucdenver.edu		Kutateladze, Tatiana/0000-0001-7375-6990	National Science Foundation CAREER Award [1452411]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research in the Musselman group is supported by a National Science Foundation CAREER Award (1452411), and research in the Kutateladze group is supported by the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Appikonda S, 2018, J BIOL CHEM, V293, P7476, DOI 10.1074/jbc.RA118.002233; Appikonda Srikanth, 2016, Drug Discov Today Technol, V19, P57, DOI 10.1016/j.ddtec.2016.05.001; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542	10	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7486	7487		10.1074/jbc.H118.002881	http://dx.doi.org/10.1074/jbc.H118.002881			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29752422	Green Published, hybrid			2022-12-28	WOS:000432174500040
J	Martina, JA; Puertollano, R				Martina, Jose A.; Puertollano, Rosa			Protein phosphatase 2A stimulates activation of TFEB and TFE3 transcription factors in response to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription factor; phosphatase; protein phosphatase 2 (PP2A); oxidative stress; nuclear translocation; mTORC1; okadaic acid; sodium arsenite; transcription factor binding to IGHM enhancer 3; transcription factor EB	LYSOSOMAL BIOGENESIS; LINKS AUTOPHAGY; CELL-SURVIVAL; PP2A; FTY720; DEGRADATION; CALCINEURIN; MTORC1; DEPHOSPHORYLATION; METABOLISM	Adaptations and responses to stress conditions are fundamental processes that all cells must accomplish to maintain or restore cellular homeostasis. Cells have a plethora of response pathways to mitigate the effect of different environmental stressors. The transcriptional regulators transcription factor EB (TFEB) and transcription factor binding to IGHM enhancer 3 (TFE3) play a key role in the control of these stress pathways. Therefore, understanding their regulation under different stress conditions is of great interest. Here, using a range of human and murine cells, we show that TFEB and TFE3 are activated upon induction of acute oxidative stress by sodium arsenite via an mTOR complex 1 (mTORC1)-independent process. We found that the mechanism of arsenite-stimulated TFEB and TFE3 activation instead involves protein phosphatase 2A (PP2A)-mediated dephosphorylation at Ser-211 and Ser-321, respectively. Depletion of either the catalytic (PPP2CA+B) or regulatory (PPP2R2A/B55) subunits of PP2A, as well as PP2A inactivation with the specific inhibitor okadaic acid, abolished TFEB and TFE3 activation in response to sodium arsenite. Conversely, PP2A activation by ceramide or the sphingosine-like compound FTY720 was sufficient to induce TFE3 nuclear translocation. MS analysis revealed that PP2A dephosphorylates TFEB at several residues, including Ser-109, Ser-114, Ser-122, and Ser-211, thus facilitating TFEB activation. Overall, this work identifies a critical mechanism that activates TFEB and TFE3 without turning off mTORC1 activity. We propose that this mechanism may enable some cell types such as immune or cancer cells that require simultaneous TFEB/TFE3 and mTORC1 signaling to survive and achieve robust cell growth in stressful environments.	[Martina, Jose A.; Puertollano, Rosa] NHLBI, Cell Biol & Physiol Ctr, NIH, 9000 Rockville Pike,Bldg 50-3537, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Puertollano, R (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, 9000 Rockville Pike,Bldg 50-3537, Bethesda, MD 20892 USA.	puertolr@mail.nih.gov	Martina, Jose A/C-2772-2013	Martina, Jose/0000-0001-5814-8807	Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006151] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NHLBI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Campbell GR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005018; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Cianfanelli V, 2015, NAT CELL BIOL, V17, P20, DOI 10.1038/ncb3072; Di Conza G, 2017, CELL REP, V18, P1699, DOI 10.1016/j.celrep.2017.01.051; Gong XZ, 2015, ARCH TOXICOL, V89, P1057, DOI 10.1007/s00204-014-1302-y; Gray MA, 2016, CURR BIOL, V26, P1955, DOI 10.1016/j.cub.2016.05.070; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Hogan PG, 2005, CURR BIOL, V15, pR442, DOI 10.1016/j.cub.2005.06.006; Hsu CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03340-7; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Martina JA, 2016, EMBO J, V35, P479, DOI 10.15252/embj.201593428; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Nezich CL, 2015, J CELL BIOL, V210, P435, DOI 10.1083/jcb.201501002; Ouimet M, 2016, NAT IMMUNOL, V17, P677, DOI 10.1038/ni.3434; Palmieri M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14338; Pastore N, 2017, EMBO MOL MED, V9, P605, DOI 10.15252/emmm.201607204; Pastore N, 2016, AUTOPHAGY, V12, P1240, DOI 10.1080/15548627.2016.1179405; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Rahman MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37297; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sha YB, 2017, EMBO J, V36, P2544, DOI 10.15252/embj.201796699; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Sun HN, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00286; Supinski GS, 1997, J APPL PHYSIOL, V82, P1119, DOI 10.1152/jappl.1997.82.4.1119; Swingle Mark, 2007, V365, P23; Vega-Rubin-de-Celis S, 2017, AUTOPHAGY, V13, P464, DOI 10.1080/15548627.2016.1271514; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang CS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02332-3; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048; Zhang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10293; Zheng CY, 2015, INT J ONCOL, V46, P1067, DOI 10.3892/ijo.2015.2826; Zhu XX, 2014, FOOD CHEM TOXICOL, V70, P144, DOI 10.1016/j.fct.2014.05.006	48	65	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12525	12534		10.1074/jbc.RA118.003471	http://dx.doi.org/10.1074/jbc.RA118.003471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29945972	Green Published, hybrid			2022-12-28	WOS:000441408500018
J	Jain, P; Sethi, SC; Pratyusha, VA; Garai, P; Naqvi, N; Sing, S; Pawar, K; Puri, N; Komath, SS				Jain, Priyanka; Sethi, Subhash Chandra; Pratyusha, Vavilala A.; Garai, Pramita; Naqvi, Nilofer; Sing, Sonali; Pawar, Kalpana; Puri, Niti; Komath, Sneha Sudha			Ras signaling activates glycosylphosphatidylinositol (GPI) anchor biosynthesis via the GPI-N-acetylglucosaminyltransferase (GPI-GnT) in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; glycosylphosphatidylinositol (GPI anchor); macrophage; endoplasmic reticulum (ER); Saccharomyces cerevisiae; phagocytosis; plasma membrane; p38 MAPK; CaGpi2; GPI anchor biosynthesis pathway; hyphal morphogenesis; macrophage-mediated killing; Ras signaling	SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; INITIAL ENZYME; 1ST STEP; PIG-P; ERGOSTEROL BIOSYNTHESIS; MAMMALIAN-CELLS; 4TH MANNOSE; YEAST RAS; PROTEIN	The ability of Candida albicans to switch between yeast to hyphal form is a property that is primarily associated with the invasion and virulence of this human pathogenic fungus. Several glycosylphosphatidylinositol (GPI)-anchored proteins are expressed only during hyphal morphogenesis. One of the major pathways that controls hyphal morphogenesis is the Ras-signaling pathway. We examine the cross-talk between GPI anchor biosynthesis and Ras signaling in C. albicans. We show that the first step of GPI biosynthesis is activated by Ras in C. albicans. This is diametrically opposite to what is reported in Saccharomyces cerevisiae. Of the two C. albicans Ras proteins, CaRas1 alone activates GPI-GnT activity; activity is further stimulated by constitutively activated CaRas1. CaRas1 localized to the cytoplasm or endoplasmic reticulum (ER) is sufficient for GPI-GnT activation. Of the six subunits of the GPI-N-acetylglucosaminyltransferase (GPI-GnT) that catalyze the first step of GPI biosynthesis, CaGpi2 is the key player involved in activating Ras signaling and hyphal morphogenesis. Activation of Ras signaling is independent of the catalytic competence of GPI-GnT. This too is unlike what is observed in S. cerevisiae where multiple subunits were identified as inhibiting Ras2. Fluorescence resonance energy transfer (FRET) studies indicate a specific physical interaction between CaRas1 and CaGpi2 in the ER, which would explain the ability of CaRas1 to activate GPI-GnT. CaGpi2, in turn, promotes activation of the Ras-signaling pathway and hyphal morphogenesis. The Cagpi2 mutant is also more susceptible to macrophage-mediated killing, and macrophage cells show better survival when co-cultured with Cagpi2.	[Jain, Priyanka; Sethi, Subhash Chandra; Pratyusha, Vavilala A.; Garai, Pramita; Naqvi, Nilofer; Sing, Sonali; Pawar, Kalpana; Puri, Niti; Komath, Sneha Sudha] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Komath, SS (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sskomath@mail.jnu.ac.in	Pratyusha, Vavilala/AAE-6436-2021; KOMATH, SNEHA SUDHA/AAE-6359-2020	KOMATH, SNEHA SUDHA/0000-0002-0491-7102; GARAI, PRAMITA/0000-0001-7936-8921; pawar, Kalpana/0000-0002-5369-9121; Pratyusha, Vavilala/0000-0002-2048-5047	Council of Scientific and Industrial Research; University Grants Commission, India; Department of Biotechnology (DBT); DBT India [BT/PR3749/BRB/10/986/2011]; Department of Science and Technology (DST) India [SB/SO/BB-011/2014]; DST under Promotion of University Research and Scientific Excellence Grant DST-PURSE [SR/PURSE/PHASE 2/11 (C)]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, India(University Grants Commission, India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); DBT India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST) India(Department of Science & Technology (India)); DST under Promotion of University Research and Scientific Excellence Grant DST-PURSE	Supported by Senior and Junior Research Fellowships from the Council of Scientific and Industrial Research and University Grants Commission, India.; Recipient of salary through a Department of Biotechnology (DBT)-funded research grant of S. S. K.; Recipient of funding from DBT India Grant BT/PR3749/BRB/10/986/2011, Department of Science and Technology (DST) India Grant SB/SO/BB-011/2014, and an umbrella grant to the School of Life Sciences from the DST under Promotion of University Research and Scientific Excellence Grant DST-PURSE No. SR/PURSE/PHASE 2/11 (C).	Ahmad MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035305; Ashraf M, 2011, J BIOL CHEM, V286, P2543, DOI 10.1074/jbc.C110.178343; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Castillon GA, 2011, MOL BIOL CELL, V22, P2924, DOI 10.1091/mbc.E11-04-0294; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Gerami-Nejad M, 2004, YEAST, V21, P429, DOI 10.1002/yea.1080; Grimme SJ, 2001, J BIOL CHEM, V276, P27731, DOI 10.1074/jbc.M101986200; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hohn C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004314; Hong YJ, 1999, J BIOL CHEM, V274, P35099, DOI 10.1074/jbc.274.49.35099; Ihara S, 2017, J CELL SCI, V130, P602, DOI 10.1242/jcs.196717; Ikeda A, 2016, YEAST, V33, P37, DOI 10.1002/yea.3138; Inglis DO, 2013, EUKARYOT CELL, V12, P1316, DOI 10.1128/EC.00094-13; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Maeda Y, 1998, EMBO J, V17, P4920, DOI 10.1093/emboj/17.17.4920; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; Murakami Y, 2005, MOL BIOL CELL, V16, P5236, DOI 10.1091/mbc.E05-08-0743; Newman HA, 2005, EUKARYOT CELL, V4, P1801, DOI 10.1128/EC.4.11.1801-1807.2005; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Phan VT, 2010, MOL CELL BIOL, V30, P2264, DOI 10.1128/MCB.01450-08; Piispanen AE, 2013, MOL MICROBIOL, V89, P166, DOI 10.1111/mmi.12268; Piispanen AE, 2011, EUKARYOT CELL, V10, P1473, DOI 10.1128/EC.05153-11; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Pratyusha VA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23187-8; Richard M, 2002, MOL MICROBIOL, V44, P841, DOI 10.1046/j.1365-2958.2002.02926.x; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shapiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044734; Sobering AK, 2004, CELL, V117, P637, DOI 10.1016/j.cell.2004.05.003; Sobering AK, 2003, MOL CELL BIOL, V23, P4983, DOI 10.1128/MCB.23.14.4983-4990.2003; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; Uppuluri P, 2009, FUTURE MICROBIOL, V4, P1235, DOI 10.2217/FMB.09.85; Victoria GS, 2012, BIOCHEM J, V443, P619, DOI 10.1042/BJ20120143; Victoria GS, 2010, MICROBIOL-SGM, V156, P3041, DOI 10.1099/mic.0.039628-0; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yadav A, 2014, GLYCOCONJUGATE J, V31, P497, DOI 10.1007/s10719-014-9536-8; Yadav B, 2014, J BIOL CHEM, V289, P3365, DOI 10.1074/jbc.M113.528802; Zhao RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009934; Zhu Y, 2009, MOL MICROBIOL, V74, P862, DOI 10.1111/j.1365-2958.2009.06898.x	49	10	11	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12222	12238		10.1074/jbc.RA117.001225	http://dx.doi.org/10.1074/jbc.RA117.001225			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29907567	Green Published, hybrid			2022-12-28	WOS:000440803200020
J	Cogan, DP; Baraquet, C; Harwood, CS; Nair, SK				Cogan, Dillon P.; Baraquet, Claudine; Harwood, Caroline S.; Nair, Satish K.			Structural basis of transcriptional regulation by CouR, a repressor of coumarate catabolism, in Rhodopseudomonas palustris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; MULTIDRUG EFFLUX OPERON; CRYSTAL-STRUCTURE; DNA-BINDING; STRUCTURE REFINEMENT; MARR; MECHANISM; INSIGHTS; PROTEIN; IDENTIFICATION	The MarR family transcriptional regulator CouR, from the soil bacterium Rhodopseudomonas palustris CGA009, has recently been shown to negatively regulate a p-coumarate catabolic operon. Unlike most characterized MarR repressors that respond to small metabolites at concentrations in the millimolar range, repression by CouR is alleviated by the 800-Da ligand p-coumaroyl-CoA with high affinity and specificity. Here we report the crystal structures of ligand-free CouR as well as the complex with p-coumaroyl-CoA, each to 2.1-angstrom resolution, and the 2.85-angstrom resolution cocrystal structure of CouR bound to an oligonucleotide bearing the cognate DNA operator sequence. In combination with binding experiments that uncover specific residues important for ligand and DNA recognition, these structures provide glimpses of a MarR family repressor in all possible states, providing an understanding of the molecular basis of DNA binding and the conformation alterations that accompany ligand-induced dissociation for activation of the operon.	[Cogan, Dillon P.; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cogan, Dillon P.; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Baraquet, Claudine; Harwood, Caroline S.] Univ Washington, Sch Med, Dept Microbiol, Washington, DC 98195 USA; [Baraquet, Claudine] Univ Toulon & Var, Lab MAPIEM, F-83014 Toulon 9, France	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; Universite de Toulon	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Nair, SK (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.; Nair, SK (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	s-nair@life.illinois.edu	Nair, Satish/AAY-2510-2021; Claudine, Baraquet/AAY-4483-2021	Baraquet, Claudine/0000-0002-0173-7501; Harwood, Caroline/0000-0003-4450-5177; Cogan, Dillon/0000-0003-4563-2397				Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Birukou I, 2014, NUCLEIC ACIDS RES, V42, P2774, DOI 10.1093/nar/gkt1215; Chang YM, 2010, P NATL ACAD SCI USA, V107, P8617, DOI 10.1073/pnas.0913302107; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Davis JR, 2013, NUCLEIC ACIDS RES, V41, P3888, DOI 10.1093/nar/gkt009; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Duval V, 2013, J BACTERIOL, V195, P3341, DOI 10.1128/JB.02224-12; Edwards TE, 2011, ACTA CRYSTALLOGR F, V67, P1032, DOI 10.1107/S1744309111004349; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao YR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01705-4; Hao ZY, 2014, NAT CHEM BIOL, V10, P21, DOI [10.1038/NCHEMBIO.1380, 10.1038/nchembio.1380]; Haque MM, 2009, J BACTERIOL, V191, P5409, DOI 10.1128/JB.00240-09; Hirakawa H, 2012, J BACTERIOL, V194, P1960, DOI 10.1128/JB.06817-11; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Kaatz GW, 2006, ANTIMICROB AGENTS CH, V50, P1276, DOI 10.1128/AAC.50.4.1276-1281.2006; Kim Y, 2016, J BIOL CHEM, V291, P13243, DOI 10.1074/jbc.M115.712067; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Liu GJ, 2017, J AM CHEM SOC, V139, P1598, DOI 10.1021/jacs.6b11438; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Otani H, 2016, NUCLEIC ACIDS RES, V44, P595, DOI 10.1093/nar/gkv955; Perez-Rueda E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195332; Phattarasukol S, 2012, APPL ENVIRON MICROB, V78, P6812, DOI 10.1128/AEM.01418-12; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vivoli M, 2014, JOVE-J VIS EXP, DOI 10.3791/51809; Xiong Y, 2018, METHODS MOL BIOL, V1754, P223, DOI 10.1007/978-1-4939-7717-8_13	31	8	8	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11727	11735		10.1074/jbc.RA118.003561	http://dx.doi.org/10.1074/jbc.RA118.003561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29794028	Green Published, hybrid			2022-12-28	WOS:000440134500006
J	Tufail, S; Sherwani, MA; Shoaib, S; Azmi, S; Owais, M; Islam, N				Tufail, Saba; Sherwani, Mohd. Asif; Shoaib, Shoaib; Azmi, Sarfuddin; Owais, Mohammad; Islam, Najmul			Ovalbumin self-assembles into amyloid nanosheets that elicit immune responses and facilitate sustained drug release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; albumin; nanotechnology; drug delivery; drug delivery system; antigen; antigen delivery; nanosheet; ovalbumin	PEPTIDE NANOFIBERS; SECRETORY GRANULES; ENDOTHELIAL-CELLS; THIOFLAVIN T; DELIVERY; FIBRILS; AGGREGATION; NANOTUBES; PROTEINS; GRAPHENE	Amyloids are associated with many neurodegenerative diseases, motivating investigations into their structure and function. Although not linked to a specific disease, albumins have been reported to form many structural aggregates. We were interested in investigating host immune responses to amyloid fibrils assembled from the model protein ovalbumin. Surprisingly, upon subjecting ovalbumin to standard denaturing conditions, we encountered giant protein nanosheets harboring amyloid-like features and hypothesized that these nanosheets might have potential in clinical or therapeutic applications. We found that the nanosheets, without the administration of any additional adjuvant, evoked a strong antibody response in mice that was higher than that observed for native ovalbumin. This suggests that amyloid nanosheets have a self-adjuvanting property. The nanosheet-induced immune response was helper T cell 2 (Th2) biased and negligibly inflammatory. While testing whether the nanosheets might form depots for the sustained release of precursor proteins, we did observe release of ovalbumin that mimicked the conformation of native protein. Moreover, the nanosheets could load the anticancer drug doxorubicin and release it in a slow and sustained manner. Taken together, our results suggest that amyloid nanosheets should be further investigated as either an antigen delivery vehicle or a multifunctional antigen and drug co-delivery system, with potential applications in simultaneous immunotherapy and chemotherapy.	[Tufail, Saba; Shoaib, Shoaib; Azmi, Sarfuddin; Islam, Najmul] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh 202002, Uttar Pradesh, India; [Owais, Mohammad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Tufail, Saba] Aligarh Muslim Univ, Biochem Sect, Womens Coll, Aligarh 202002, Uttar Pradesh, India; [Sherwani, Mohd. Asif] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University; University of Alabama System; University of Alabama Birmingham	Tufail, S; Islam, N (corresponding author), Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.	sabatufail12@gmail.com; nxi7@hotmail.com	Sherwani, Mohammad/AAR-6089-2021; Sherwani, Mohammad Asif/AAQ-2949-2021; Azmi, Sarfuddin/AAE-7602-2022	Sherwani, Mohammad Asif/0000-0001-5317-1557; Azmi, Sarfuddin/0000-0002-1868-3458; Mohammad, Owais/0000-0001-7377-7388	University Grants Commission, Government of India	University Grants Commission, Government of India(University Grants Commission, India)	Recipient of a postdoctoral fellowship from the University Grants Commission, Government of India.	An J, 2013, MAT SCI ENG C-MATER, V33, P2827, DOI 10.1016/j.msec.2013.03.008; Ansari Mairaj Ahmed, 2012, Int J Nanomedicine, V7, P2433, DOI 10.2147/IJN.S25875; Azmi S, 2013, J MED CHEM, V56, P924, DOI 10.1021/jm301407k; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Banoczi Z, 2008, J PEPT SCI, V14, P610, DOI 10.1002/psc.950; Bemporad F, 2006, PROTEIN SCI, V15, P862, DOI 10.1110/ps.051915806; Bolisetty S, 2012, ADV FUNCT MATER, V22, P3424, DOI 10.1002/adfm.201103054; Buttstedt A, 2013, AMYLOID, V20, P86, DOI 10.3109/13506129.2013.784962; Chen WS, 2017, ADV MATER, V29, DOI 10.1002/adma.201603864; Childers WS, 2010, ANGEW CHEM INT EDIT, V49, P4104, DOI 10.1002/anie.201000212; Dai B, 2015, P NATL ACAD SCI USA, V112, P2996, DOI 10.1073/pnas.1416690112; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Dogra P, 2017, J PHYS CHEM B, V121, P412, DOI 10.1021/acs.jpcb.6b11281; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Gulseren G, 2016, J MATER CHEM B, V4, P4605, DOI 10.1039/c6tb00795c; Guo C, 2012, ACS NANO, V6, P3907, DOI 10.1021/nn300015g; Gupta S, 2010, P NATL ACAD SCI USA, V107, P13246, DOI 10.1073/pnas.1005704107; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Hu Y, 2016, ACS NANO, V10, P880, DOI 10.1021/acsnano.5b06011; Humblet-Hua NPK, 2012, J AGR FOOD CHEM, V60, P9502, DOI 10.1021/jf3024529; Jacob RS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23370; Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/nnano.2010.26, 10.1038/NNANO.2010.26]; Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106; Lakshmanan A, 2012, TRENDS BIOTECHNOL, V30, P155, DOI 10.1016/j.tibtech.2011.11.001; Lara C, 2012, BIOMACROMOLECULES, V13, P4213, DOI 10.1021/bm301481v; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li CX, 2013, NANOSCALE, V5, P6207, DOI 10.1039/c3nr01644g; Li CX, 2012, NAT NANOTECHNOL, V7, P421, DOI [10.1038/nnano.2012.62, 10.1038/NNANO.2012.62]; Li H, 2016, ACS APPL MATER INTER, V8, P1147, DOI 10.1021/acsami.5b08963; Lin YY, 2017, J AM CHEM SOC, V139, P13592, DOI 10.1021/jacs.7b06591; Liu T, 2014, ADV MATER, V26, P3433, DOI 10.1002/adma.201305256; Lu K, 2003, J AM CHEM SOC, V125, P6391, DOI 10.1021/ja0341642; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mesquida P, 2007, J MATER SCI-MATER M, V18, P1325, DOI 10.1007/s10856-006-0075-0; Min KI, 2016, ANGEW CHEM INT EDIT, V55, P6925, DOI 10.1002/anie.201601675; MINE Y, 1995, TRENDS FOOD SCI TECH, V6, P225, DOI 10.1016/S0924-2244(00)89083-4; Mitra S, 2017, J AM CHEM SOC, V139, P4513, DOI 10.1021/jacs.7b00925; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; Sanii B, 2011, J AM CHEM SOC, V133, P20808, DOI 10.1021/ja206199d; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Shojaee M, 2015, MAT SCI ENG C-MATER, V48, P158, DOI 10.1016/j.msec.2014.11.063; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Taboada P, 2006, J PHYS CHEM B, V110, P20733, DOI 10.1021/jp064861r; TAKAHASHI N, 1991, J BIOCHEM-TOKYO, V109, P846, DOI 10.1093/oxfordjournals.jbchem.a123469; Tufail S, 2015, J BIOL CHEM, V290, P4131, DOI 10.1074/jbc.M113.540989; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Udomprasert A, 2014, NAT NANOTECHNOL, V9, P537, DOI [10.1038/NNANO.2014.102, 10.1038/nnano.2014.102]; Vigneron Nathalie, 2013, Cancer Immun, V13, P15; Wang DH, 2016, ADV MATER, V28, P7414, DOI 10.1002/adma.201506476; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; You J, 2017, ADV MATER, V29, DOI 10.1002/adma.201606895; Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c	67	11	12	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11310	11324		10.1074/jbc.RA118.002550	http://dx.doi.org/10.1074/jbc.RA118.002550			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29853634	hybrid, Green Published			2022-12-28	WOS:000439449700005
J	Rege, NK; Wickramasinghe, NP; Tustan, AN; Phillips, NFB; Yee, VC; Ismail-Beigi, F; Weiss, MA				Rege, Nischay K.; Wickramasinghe, Nalinda P.; Tustan, Alisar N.; Phillips, Nelson F. B.; Yee, Vivien C.; Ismail-Beigi, Faramarz; Weiss, Michael A.			Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic-aromatic interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular pharmacology; protein design; insulin; protein self-assembly; molecular dynamics	FREE-ENERGY SIMULATIONS; MOLECULAR RECOGNITION; MONOMERIC INSULINS; RECEPTOR-BINDING; SIDE-CHAIN; DYNAMICS; HEXAMER; PROTRACTION; RESIDUES; ANALOGS	Key contributions to protein structure and stability are provided by weakly polar interactions, which arise from asymmetric electronic distributions within amino acids and peptide bonds. Of particular interest are aromatic side chains whose directional -systems commonly stabilize protein interiors and interfaces. Here, we consider aromatic-aromatic interactions within a model protein assembly: the dimer interface of insulin. Semi-classical simulations of aromatic-aromatic interactions at this interface suggested that substitution of residue Tyr(B26) by Trp would preserve native structure while enhancing dimerization (and hence hexamer stability). The crystal structure of a [Trp(B26)]insulin analog (determined as a T3R3f zinc hexamer at a resolution of 2.25 ) was observed to be essentially identical to that of WT insulin. Remarkably and yet in general accordance with theoretical expectations, spectroscopic studies demonstrated a 150-fold increase in the in vitro lifetime of the variant hexamer, a critical pharmacokinetic parameter influencing design of long-acting formulations. Functional studies in diabetic rats indeed revealed prolonged action following subcutaneous injection. The potency of the Trp(B26)-modified analog was equal to or greater than an unmodified control. Thus, exploiting a general quantum-chemical feature of protein structure and stability, our results exemplify a mechanism-based approach to the optimization of a therapeutic protein assembly.	[Rege, Nischay K.; Wickramasinghe, Nalinda P.; Phillips, Nelson F. B.; Yee, Vivien C.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Tustan, Alisar N.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Indiana Univ Sch Med, Dept Biochem, Indianapolis, IN 46202 USA	Case Western Reserve University; Case Western Reserve University; Indiana University System; Indiana University Bloomington	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.; Weiss, MA (corresponding author), Indiana Univ Sch Med, Dept Biochem, Indianapolis, IN 46202 USA.	weissma@iu.edu	Wickramasinghe, Nalinda P/F-9465-2010	Wickramasinghe, Nalinda P./0000-0002-8700-2775	United States Department of Energy (DOE), Office of Science and Office of Basic Energy Sciences [DE-AC02-76SF00515]; National Institutes of Health NIGMS [P41GM103393]; DOE Office of Biological and Environmental Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, F30DK112644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, T32GM007250] Funding Source: NIH RePORTER	United States Department of Energy (DOE), Office of Science and Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. El-Hage, M. Lawrence, M. Meuwly, and V. Pandyarajan for helpful discussion; K. Carr, R. Grabowski, P. Macklis, and M. Swain for assistance with rat studies; V. Kumar and F. van den Akker for advice regarding X-ray crystallography; J. Whittaker and L. Whittaker for advice regarding IR-binding assays; P. De Meyts (Novo Nordisk) for the gift of radiolabeled insulin; and M. C. Lawrence for assistance preparing Fig. 9. Use of the Stanford Synchrotron Radiation Lightsource at the SLAC National Accelerator Laboratory is supported by United States Department of Energy (DOE), Office of Science and Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and National Institutes of Health NIGMS Grant P41GM103393.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aleksandrov A, 2010, J MOL RECOGNIT, V23, P117, DOI 10.1002/jmr.980; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Baron R, 2013, ANNU REV PHYS CHEM, V64, P151, DOI 10.1146/annurev-physchem-040412-110047; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BENTLEY GA, 1992, J MOL BIOL, V228, P1163, DOI 10.1016/0022-2836(92)90323-C; BERGER M, 1979, DIABETOLOGIA, V17, P97, DOI 10.1007/BF01222209; Bhattacharyya R, 2002, PROTEIN ENG, V15, P91, DOI 10.1093/protein/15.2.91; Birnbaum DT, 1996, BIOCHEMISTRY-US, V35, P5366, DOI 10.1021/bi9600557; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BLUNDELL TL, 1972, DIABETES, V21, P492, DOI 10.2337/diab.21.2.S492; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1999, ADV DRUG DELIVER REV, V35, P307, DOI 10.1016/S0169-409X(98)00079-9; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; Brange J, 1997, Pharm Biotechnol, V10, P343; Brange J., 1984, U. S. Patent and Trademark Office patent full-text database, Patent No. [A61K, 61]; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; BURLEY SK, 1986, J AM CHEM SOC, V108, P7995, DOI 10.1021/ja00285a019; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; Christensen M, 2010, CURR DIABETES REP, V10, P124, DOI 10.1007/s11892-010-0102-x; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; Derewenda U., 1987, PROTEIN ENG, V222, P425; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DODSON GG, 1993, BIOCHEM SOC T, V21, P609, DOI 10.1042/bst0210609; Dong J, 2003, J MOL BIOL, V330, P431, DOI 10.1016/S0022-2836(03)00536-9; Dougherty DA, 2000, CURR OPIN CHEM BIOL, V4, P645, DOI 10.1016/S1367-5931(00)00148-4; El Hage K, 2016, J BIOL CHEM, V291, P27023, DOI 10.1074/jbc.M116.761015; El Hage K, 2016, J CHEM THEORY COMPUT, V12, P3008, DOI 10.1021/acs.jctc.6b00202; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Freire E, 2009, CHEM BIOL DRUG DES, V74, P468, DOI 10.1111/j.1747-0285.2009.00880.x; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gillies PS, 2000, DRUGS, V59, P253, DOI 10.2165/00003495-200059020-00009; Glidden MD, 2018, J BIOL CHEM, V293, P69, DOI 10.1074/jbc.M117.808667; Guvench O, 2005, J AM CHEM SOC, V127, P4668, DOI 10.1021/ja043492e; Hassiepen U, 1999, BIOPHYS J, V77, P1638, DOI 10.1016/S0006-3495(99)77012-8; HEIDENREICH KA, 1985, BIOCHEM BIOPH RES CO, V126, P1138, DOI 10.1016/0006-291X(85)90304-3; Holleman F, 1997, NEW ENGL J MED, V337, P176, DOI 10.1056/NEJM199707173370307; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; HU SQ, 1993, J PROTEIN CHEM, V12, P741, DOI 10.1007/BF01024932; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; INOUYE K, 1979, J AM CHEM SOC, V101, P751, DOI 10.1021/ja00497a051; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jekl V, 2011, J SMALL ANIM PRACT, V52, P107, DOI 10.1111/j.1748-5827.2010.01028.x; Jonassen I, 2012, PHARM RES-DORDR, V29, P2104, DOI 10.1007/s11095-012-0739-z; Joosten RP, 2009, ACTA CRYSTALLOGR D, V65, P176, DOI 10.1107/S0907444908037591; Kamerlin SCL, 2009, J PHYS CHEM B, V113, P1253, DOI 10.1021/jp8071712; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Keller D, 2001, BIOCHEMISTRY-US, V40, P10732, DOI 10.1021/bi0108150; Kramer C, 2012, J COMPUT CHEM, V33, P1673, DOI 10.1002/jcc.22996; Kurtzhals P, 1995, BIOCHEM J, V312, P725, DOI 10.1042/bj3120725; Lee LC, 2009, BBA-PROTEINS PROTEOM, V1794, P1467, DOI 10.1016/j.bbapap.2009.06.008; Lieblich SA, 2017, J AM CHEM SOC, V139, P8384, DOI 10.1021/jacs.7b00794; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; MacKerell A.D., 2002, ENCYCL COMPUT CHEM, V1, P271; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARKUSSEN J, 1987, PROTEIN ENG, V1, P205, DOI 10.1093/protein/1.3.205; MARKUSSEN J, 1987, PROTEIN ENG, V1, P215, DOI 10.1093/protein/1.3.215; Markussen J., 2003, U. S. patent, Patent No. [US 10620651, 10620651]; Marshall GR, 2013, J COMPUT AID MOL DES, V27, P107, DOI 10.1007/s10822-013-9634-x; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; O'Halloran TV, 2013, J CLIN INVEST, V123, P4136, DOI 10.1172/JCI72325; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; Reha D, 2002, J AM CHEM SOC, V124, P3366, DOI 10.1021/ja011490d; RIEMEN MW, 1983, BIOCHEMISTRY-US, V22, P1507, DOI 10.1021/bi00275a027; ROY M, 1989, J BIOL CHEM, V264, P19081; Salsali Afshin, 2006, Am J Ther, V13, P349, DOI 10.1097/00045391-200607000-00012; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; Scholfield MR, 2013, PROTEIN SCI, V22, P139, DOI 10.1002/pro.2201; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; Sikosek T, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0419; Sinnokrot MO, 2006, J PHYS CHEM A, V110, P10656, DOI 10.1021/jp0610416; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Steward LE, 1998, METH MOL B, V77, P325; SZYPERSKI T, 1993, J BIOMOL NMR, V3, P151; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; van Gunsteren WF, 2018, ANGEW CHEM INT EDIT, V57, P884, DOI 10.1002/anie.201702945; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Weiss MA, 2018, DIABETES OBES METAB, V20, P51, DOI 10.1111/dom.13402; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; Willighagen E., 2007, NATURE PREC, DOI [10.1038/npre.2007.50.1, DOI 10.1038/NPRE.2007.50.1, 10.1038/NPRE.2007.50.1]; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796	107	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10895	10910		10.1074/jbc.RA118.003650	http://dx.doi.org/10.1074/jbc.RA118.003650			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29880646	hybrid, Green Published			2022-12-28	WOS:000438882800005
J	Phatarphekar, A; Su, Q; Eun, SH; Chen, X; Rokita, SE				Phatarphekar, Abhishek; Su, Qi; Eun, Suk Ho; Chen, Xin; Rokita, Steven E.			The importance of a halotyrosine dehalogenase for Drosophila fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; reproduction; reductase; flavoprotein; tyrosine; dehalogenase; halotyrosine	IODOTYROSINE DEIODINASE; THYROID-HORMONES; TERMINAL DIFFERENTIATION; MALE GERMLINE; IN-VIVO; METABOLISM; GENE; MELANOGASTER; EVOLUTIONARY; IODINE	The ability of iodotyrosine deiodinase to salvage iodide from iodotyrosine has long been recognized as critical for iodide homeostasis and proper thyroid function in vertebrates. The significance of its additional ability to dehalogenate bromo- and chlorotyrosine is less apparent, and none of these functions could have been anticipated in invertebrates until recently. Drosophila, as most arthropods, contains a deiodinase homolog encoded by CG6279, now named condet (cdt), with a similar catalytic specificity. However, its physiological role cannot be equivalent because Drosophila lacks a thyroid and its associated hormones, and no requirement for iodide or halotyrosines has been reported for this species. We have now applied CRISPR/Cas9 technology to generate Drosophila strains in which the cdt gene has been either deleted or mutated to identify its biological function. As previously shown in larvae, expression of cdt is primarily limited to the fat body, and we now report that loss of cdt function does not enhance sensitivity of the larvae to the toxic effects of iodotyrosine. In adult flies by contrast, expression is known to occur in testes and is detected at very high levels in this tissue. The importance of cdt is most evident in the decrease in fertility observed when either males or females carry a deletion or mutation of cdt. Therefore, dehalogenation of a halotyrosine appears essential for efficient reproduction in Drosophila and likely contributes to a new pathway for controlling viability in arthropods.	[Phatarphekar, Abhishek; Su, Qi; Rokita, Steven E.] Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA; [Eun, Suk Ho; Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Rokita, SE (corresponding author), 3400 N Charles St, Baltimore, MD 21218 USA.	rokita@jhu.edu	Rokita, Steven E/C-4793-2009	Phatarphekar, Abhishek/0000-0002-2657-1157	National Institutes of Health [AI119540]; David and Lucile Packard Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant AI119540 (to S. R.), grants from the David and Lucile Packard Foundation (to X. C.), and a Faculty Scholar award from Howard Hughes Medical Institute (to X. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; Akiva E, 2017, P NATL ACAD SCI USA, V114, pE9549, DOI 10.1073/pnas.1706849114; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Bobyk KD, 2015, BIOCHEMISTRY-US, V54, P4487, DOI 10.1021/acs.biochem.5b00410; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; Chen D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004797; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Crockford SJ, 2009, INTEGR COMP BIOL, V49, P155, DOI 10.1093/icb/icp053; DICKHOFF WW, 1983, AM ZOOL, V23, P697; Eales JG, 1997, P SOC EXP BIOL MED, V214, P302; Eun SH, 2013, DEVELOPMENT, V140, P23, DOI 10.1242/dev.086397; Flatt T, 2006, INTEGR COMP BIOL, V46, P777, DOI 10.1093/icb/icl034; Forhead AJ, 2014, J ENDOCRINOL, V221, pR87, DOI 10.1530/JOE-14-0025; Friedman JE, 2006, J BIOL CHEM, V281, P2812, DOI 10.1074/jbc.M510365200; Gan QA, 2010, CELL RES, V20, P763, DOI 10.1038/cr.2010.64; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; HARTMANN N, 1950, H-S Z PHYSIOL CHEM, V285, P1, DOI 10.1515/bchm2.1950.285.1-3.1; Heifetz Y, 2010, THERIOGENOLOGY, V73, P723, DOI 10.1016/j.theriogenology.2009.11.001; Heyland A, 2005, J EXP BIOL, V208, P4355, DOI 10.1242/jeb.01877; Heyland A, 2004, EVOL DEV, V6, P382, DOI 10.1111/j.1525-142X.2004.04047.x; Heyland A, 2006, J EXP ZOOL PART B, V306B, P551, DOI 10.1002/jez.b.21113; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Hu JM, 2015, J BIOL CHEM, V290, P590, DOI 10.1074/jbc.M114.605964; HUNT S, 1984, METHOD ENZYMOL, V107, P413; Ingavat N, 2017, BIOCHEMISTRY-US, V56, P1130, DOI 10.1021/acs.biochem.6b01308; JOHNSON KS, 1992, ANAL CHEM, V64, pA1065, DOI 10.1021/ac00046a001; Mani AR, 2007, J BIOL CHEM, V282, P29114, DOI 10.1074/jbc.M704270200; Mani AR, 2016, FREE RADICAL BIO MED, V90, P243, DOI 10.1016/j.freeradbiomed.2015.11.030; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; McTamney PM, 2009, J AM CHEM SOC, V131, P14212, DOI 10.1021/ja906642n; Moreno JC, 2008, NEW ENGL J MED, V358, P1811, DOI 10.1056/NEJMoa0706819; Morris CA, 2009, NAT PROTOC, V4, P1807, DOI 10.1038/nprot.2009.192; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Phatarphekar A, 2016, PROTEIN SCI, V25, P2187, DOI 10.1002/pro.3044; Phatarphekar A, 2014, MOL BIOSYST, V10, P86, DOI 10.1039/c3mb70398c; Piper MDW, 2014, NAT METHODS, V11, P100, DOI [10.1038/NMETH.2731, 10.1038/nmeth.2731]; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; ROCHE J, 1953, BIOCHIM BIOPHYS ACTA, V12, P570, DOI 10.1016/0006-3002(53)90189-9; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ryuda M, 2008, J INSECT PHYSIOL, V54, P1440, DOI 10.1016/j.jinsphys.2008.08.006; Schulz Cordula, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4764; SILVERSTONE M, 1978, GEN COMP ENDOCR, V34, P132, DOI 10.1016/0016-6480(78)90203-4; Sun ZD, 2017, ARCH BIOCHEM BIOPHYS, V632, P77, DOI 10.1016/j.abb.2017.07.019; Tata JR, 1999, BIOCHIMIE, V81, P359, DOI 10.1016/S0300-9084(99)80082-0; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Valverde-R C, 2004, INT REV CYTOL, V234, P143, DOI 10.1016/S0074-7696(04)34004-0; Wang LS, 2014, RSC ADV, V4, P57350, DOI 10.1039/c4ra09833a; WHEELER BM, 1950, J EXP ZOOL, V115, P83, DOI 10.1002/jez.1401150106; White-Cooper H, 2000, DEVELOPMENT, V127, P5463; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Xie J, 2015, CELL, V163, P920, DOI 10.1016/j.cell.2015.10.002	54	2	3	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10314	10321		10.1074/jbc.RA118.003364	http://dx.doi.org/10.1074/jbc.RA118.003364			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764939	Green Published, hybrid			2022-12-28	WOS:000437096700029
J	Yang, J; Huang, M; Zhou, L; He, X; Jiang, XG; Zhang, Y; Xu, GQ				Yang, Jing; Huang, Min; Zhou, Liang; He, Xian; Jiang, Xiaogang; Zhang, Yang; Xu, Guoqiang			Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; AP1 transcription factor (AP-1); ubiquitylation (ubiquitination); c-Jun transcription factor; protein degradation; apoptosis; cereblon; inflammatory response	NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ACTIVATOR PROTEIN-1; GLUTAMINE-SYNTHETASE; GENE-EXPRESSION; CELL-CULTURE; AMINO-ACIDS; AP-1; THALIDOMIDE; APOPTOSIS	Chronic inflammation is associated with multiple human disorders, such as rheumatoid arthritis, metabolic diseases, and neurodegenerative diseases. Therefore, alleviation of inflammation induced by environmental stimuli is important for disease prevention or treatment. Cereblon (CRBN) functions as a substrate receptor of the cullin-4 RING E3 ligase to mediate protein ubiquitination and degradation. Although it has been reported that CRBN reduces the inflammatory response through its nonenzymatic function, its role as a substrate receptor of the E3 ligase is not explored in mediating this process. Here we used a quantitative proteomics approach to find that the major component of the activator protein 1 (AP-1) complex, c-Jun, is significantly down-regulated upon CRBN expression. Biochemical approaches further discover that CRBN interacts and partially colocalizes with c-Jun and promotes the formation of Lys(48)-linked polyubiquitin chains on c-Jun, enhancing c-Jun degradation. We further reveal that CRBN attenuates the transcriptional activity of the AP-1 complex and reduces the mRNA expression and protein level of several pro-inflammatory cytokines. Moreover, flow cytometry analyses show that CRBN attenuates lipopolysaccharide-induced apoptosis in differentiated THP-1 cells. Through genetic manipulation and pharmacological inhibition, we uncover a new molecular mechanism by which CRBN regulates the inflammatory response and apoptosis induced by lipopolysaccharide. Our work and previous studies demonstrate that CRBN suppresses the inflammatory response by promoting or inhibiting the ubiquitination of two key molecules at different levels of the inflammatory cascade through its enzymatic function as a substrate receptor and its nonenzymatic function as a protein binding partner.	[Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; Soochow Univ, Coll Pharmaceut Sci, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Xu, GQ (corresponding author), Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.	gux2002@suda.edu.cn		Xu, Guoqiang/0000-0002-4753-4769	National Natural Science Foundation of China [31670833, 81703535]; China Postdoctoral Science Foundation [2017M611895]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [17KJD180005]; Jiangsu Postdoctoral Science Foundation [1701130C]; Jiangsu Key Laboratory of Neuropsychiatric Diseases [BM2013003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Jiangsu Higher Education Institutions of China; Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Key Laboratory of Neuropsychiatric Diseases; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (31670833 and 81703535), the China Postdoctoral Science Foundation (2017M611895), the Natural Science Foundation of Jiangsu Higher Education Institutions of China (17KJD180005), the Jiangsu Postdoctoral Science Foundation (1701130C), the Jiangsu Key Laboratory of Neuropsychiatric Diseases (BM2013003), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Adcock I M, 1997, Monaldi Arch Chest Dis, V52, P178; Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772; AKIYAMA H, 1994, TOHOKU J EXP MED, V174, P295, DOI 10.1620/tjem.174.295; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Chen YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10667; Del Prete D, 2016, J BIOL CHEM, V291, P17209, DOI 10.1074/jbc.M116.733626; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Eichner R, 2016, NAT MED, V22, P735, DOI 10.1038/nm.4128; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guo C, 2014, INFLAMMATION, V37, P621, DOI 10.1007/s10753-013-9778-9; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Harrison LM, 2005, MICROB PATHOGENESIS, V38, P63, DOI 10.1016/j.micpath.2004.12.003; Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3; Hull C, 2002, J IMMUNOL, V169, P2611, DOI 10.4049/jimmunol.169.5.2611; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kang JA, 2016, P NATL ACAD SCI USA, V113, P8771, DOI 10.1073/pnas.1502166113; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee KM, 2014, J BIOL CHEM, V289, P23343, DOI 10.1074/jbc.M113.523423; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Manohar Murli, 2017, World J Gastrointest Pharmacol Ther, V8, P10, DOI 10.4292/wjgpt.v8.i1.10; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meng QH, 2011, PROTEIN CELL, V2, P889, DOI 10.1007/s13238-011-1113-3; Min Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.226; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Ren HG, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-40; Sawamura N, 2015, BIOCHEM BIOPH RES CO, V464, P1054, DOI 10.1016/j.bbrc.2015.07.068; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Nguyen TV, 2017, P NATL ACAD SCI USA, V114, P3565, DOI 10.1073/pnas.1700949114; Van Nguyen T, 2016, MOL CELL, V61, P809, DOI 10.1016/j.molcel.2016.02.032; Wu MY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102034; Xaus J, 2000, BLOOD, V95, P3823; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Xu QQ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2331-0; Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zhang Y, 2018, BIOCHEM J, V475, P1507, DOI 10.1042/BCJ20180005; Zhou L, 2018, HUM MOL GENET, V27, P667, DOI 10.1093/hmg/ddx433; Zhou YQ, 2016, J PROTEOMICS, V148, P94, DOI 10.1016/j.jprot.2016.07.015	59	24	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10141	10157		10.1074/jbc.RA118.002246	http://dx.doi.org/10.1074/jbc.RA118.002246			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29748389	Green Published, hybrid			2022-12-28	WOS:000437096700017
J	Kar, A; Jones, N; Arat, NO; Fishel, R; Griffith, JD				Kar, Anirban; Jones, Nathan; Arat, N. Ozlem; Fishel, Richard; Griffith, Jack D.			Long repeating (TTAGGG)(n) single-stranded DNA self-condenses into compact beaded filaments stabilized by G-quadruplex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						single-molecule biophysics; telomere; G-quadruplex; DNA; electron microscopy (EM)	TELOMERIC DNA; HOMOLOGOUS RECOMBINATION; MAMMALIAN TELOMERES; DISPLACEMENT ASSAY; PERSISTENCE LENGTH; MAGNETIC TWEEZERS; CRYSTAL-STRUCTURE; HUMAN-CHROMOSOMES; STRUCTURAL BASIS; PROTEIN	Conformations adopted by long stretches of single-stranded DNA (ssDNA) are of central interest in understanding the architecture of replication forks, R loops, and other structures generated during DNA metabolism in vivo. This is particularly so if the ssDNA consists of short nucleotide repeats. Such studies have been hampered by the lack of defined substrates greater than approximate to 150 nt and the absence of high-resolution biophysical approaches. Here we describe the generation of very long ssDNA consisting of the mammalian telomeric repeat (5-TTAGGG-3)(n), as well as the interrogation of its structure by EM and single-molecule magnetic tweezers (smMT). This repeat is of particular interest because it contains a run of three contiguous guanine residues capable of forming G quartets as ssDNA. Fluorescent-dye exclusion assays confirmed that this G-strand ssDNA forms ubiquitous G-quadruplex folds. EM revealed thick bead-like filaments that condensed the DNA approximate to 12-fold. The bead-like structures were 5 and 8 nm in diameter and linked by thin filaments. The G-strand ssDNA displayed initial stability to smMT force extension that ultimately released in steps that were multiples approximate to 28 nm at forces between 6 and 12 pN, well below the >20 pN required to unravel G-quadruplexes. Most smMT steps were consistent with the disruption of the beads seen by EM. Binding by RAD51 distinctively altered the force extension properties of the G-strand ssDNA, suggesting a stochastic G-quadruplex-dependent condensation model that is discussed.	[Kar, Anirban; Arat, N. Ozlem; Griffith, Jack D.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Jones, Nathan; Fishel, Richard] Ohio State Univ, Dept Canc Biol & Genet, Wexner Med Ctr, Columbus, OH 43210 USA; [Jones, Nathan; Fishel, Richard] Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA; [Arat, N. Ozlem] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Universite de Montreal	Griffith, JD (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Fishel, R (corresponding author), Ohio State Univ, Dept Canc Biol & Genet, Wexner Med Ctr, Columbus, OH 43210 USA.; Fishel, R (corresponding author), Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA.	fishel.7@osu.edu; jdg@med.unc.edu	Kar, Anirban/ABF-9178-2021	Jones, Nathan/0000-0002-2159-1394	National Institutes of Health [GM31819, ES013773, GM080176]; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013773, R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM080176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM31819 and ES013773 (to J. D. G.) and GM080176 (to R. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Brockman C, 2011, SOFT MATTER, V7, P8005, DOI 10.1039/c1sm05297g; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Campbell NH, 2008, J AM CHEM SOC, V130, P6722, DOI 10.1021/ja8016973; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chi QJ, 2013, PHYSICA A, V392, P1072, DOI 10.1016/j.physa.2012.09.022; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; de Messieres M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.058101; De Vlaminck I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041432; FELLER W, 1971, INTRO PROBABILITY TH, V1; Freedman D., 2007, STATISTICS-ABINGDON, V4th ed.; FUJIOKA K, 1993, NUCLEIC ACIDS RES, V21, P407, DOI 10.1093/nar/21.3.407; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; GLATTING G, 1995, COLLOID POLYM SCI, V273, P32; Goddard NL, 2000, PHYS REV LETT, V85, P2400, DOI 10.1103/PhysRevLett.85.2400; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hansel R, 2011, NUCLEIC ACIDS RES, V39, P5768, DOI 10.1093/nar/gkr174; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Kar A, 2016, NUCLEIC ACIDS RES, V44, P9369, DOI 10.1093/nar/gkw779; Largy E, 2012, CURR PHARM DESIGN, V18, P1992, DOI 10.2174/138161212799958350; Lee KS, 2014, J MOL BIOL, V426, P2413, DOI 10.1016/j.jmb.2014.04.023; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Lionnet Timothee, 2012, Cold Spring Harb Protoc, V2012, P133, DOI 10.1101/pdb.prot067496; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Lynch S, 2009, CHEM-EUR J, V15, P8113, DOI 10.1002/chem.200901390; Ma WJ, 2013, P NATL ACAD SCI USA, V110, pE2895, DOI 10.1073/pnas.1301676110; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; MARSH TC, 1994, BIOCHEMISTRY-US, V33, P10718, DOI 10.1021/bi00201a020; MITRA S, 1966, J GEN PHYSIOL, V49, P59, DOI 10.1085/jgp.49.6.59; Mo YQ, 2003, CANCER RES, V63, P579; Monchaud D, 2006, BIOORG MED CHEM LETT, V16, P4842, DOI 10.1016/j.bmcl.2006.06.067; Monchaud D, 2010, METHODS MOL BIOL, V608, P257, DOI 10.1007/978-1-59745-363-9_15; Nicholas J, 1998, J Natl Cancer Inst Monogr, P79; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Parkinson GN, 2007, BIOCHEMISTRY-US, V46, P2390, DOI 10.1021/bi062244n; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Petraccone L, 2013, TOP CURR CHEM, V330, P23, DOI 10.1007/128_2012_350; Qureshi MH, 2012, J PHYS CHEM B, V116, P5588, DOI 10.1021/jp300546u; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Randall A, 2009, J BIOL CHEM, V284, P13980, DOI 10.1074/jbc.M900631200; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rippe K, 2015, NAT STRUCT MOL BIOL, V22, P853, DOI 10.1038/nsmb.3078; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Senavirathne G, 2017, NUCLEIC ACIDS RES, V45, P685, DOI 10.1093/nar/gkw920; Shinohara A, 1999, MUTAT RES-DNA REPAIR, V435, P13, DOI 10.1016/S0921-8777(99)00033-6; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Taylor DJ, 2011, J MOL BIOL, V410, P10, DOI 10.1016/j.jmb.2011.04.049; Thys RG, 2015, J BIOL CHEM, V290, P28953, DOI 10.1074/jbc.M115.660324; Tombline G, 2002, J BIOL CHEM, V277, P14434, DOI 10.1074/jbc.M109917200; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Wang QA, 2010, ANAL CHEM, V82, P9469, DOI 10.1021/ac102168m; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Yu HQ, 2012, J AM CHEM SOC, V134, P20060, DOI 10.1021/ja305384c; Zhang Y, 2001, BIOPHYS J, V81, P1133, DOI 10.1016/S0006-3495(01)75770-0	68	15	15	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9473	9485		10.1074/jbc.RA118.002158	http://dx.doi.org/10.1074/jbc.RA118.002158			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29674319	Green Published, hybrid			2022-12-28	WOS:000435441400030
J	Zauner, FB; Elsasser, B; Dall, E; Cabrele, C; Brandstetter, H				Zauner, Florian B.; Elsaesser, Brigitta; Dall, Elfriede; Cabrele, Chiara; Brandstetter, Hans			Structural analyses of Arabidopsis thaliana legumain gamma reveal differential recognition and processing of proteolysis and ligation substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CASPASE-LIKE ACTIVITY; CIRCULAR PROTEINS; CRYSTAL-STRUCTURE; ASPARAGINYL ENDOPEPTIDASE; PEPTIDE MACROCYCLIZATION; DRUG DISCOVERY; CYCLOTIDES; BIOSYNTHESIS; SUNFLOWER	Legumain is a dual-function protease-peptide ligase whose activities are of great interest to researchers studying plant physiology and to biotechnological applications. However, the molecular mechanisms determining the specificities for proteolysis and ligation are unclear because structural information on the substrate recognition by a fully activated plant legumain is unavailable. Here, we present the X-ray structure of Arabidopsis thaliana legumain isoform gamma (AtLEG gamma) in complex with the covalent peptidic Ac-YVAD chloromethyl ketone (CMK) inhibitor targeting the catalytic cysteine. Mapping of the specificity pockets preceding the substrate-cleavage site explained the known substrate preference. The comparison of inhibited and free AtLEG gamma structures disclosed a substrate-induced disorder-order transition with synergistic rearrangements in the substrate-recognition sites. Docking and in vitro studies with an AtLEG gamma ligase substrate, sunflower trypsin inhibitor (SFTI), revealed a canonical, protease substrate-like binding to the active site-binding pockets preceding and following the cleavage site. We found the interaction of the second residue after the scissile bond, P2'-S2', to be critical for deciding on proteolysis versus cyclization. cis-trans-Isomerization of the cyclic peptide product triggered its release from the AtLEG gamma active site and prevented inadvertent cleavage. The presented integrative mechanisms of proteolysis and ligation (transpeptidation) explain the interdependence of legumain and its preferred substrates and provide a rational framework for engineering optimized proteases, ligases, and substrates.	[Zauner, Florian B.; Elsaesser, Brigitta; Dall, Elfriede; Cabrele, Chiara; Brandstetter, Hans] Univ Salzburg, Dept Biosci, A-5020 Salzburg, Austria	Salzburg University	Brandstetter, H (corresponding author), Univ Salzburg, Dept Mol Biol, A-5020 Salzburg, Austria.	hans.brandstetter@sbg.ac.at	Cabrele, Chiara/B-8790-2015; Brandstetter, Hans/E-6754-2011; Dall, Elfriede/F-1711-2017	Cabrele, Chiara/0000-0002-7550-6896; Brandstetter, Hans/0000-0002-6089-3045; Dall, Elfriede/0000-0002-0823-8983	Austrian Science Fund (FWF) [W_01213, M1901]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Projects W_01213 and M1901. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernath-Levin K, 2015, CHEM BIOL, V22, P571, DOI 10.1016/j.chembiol.2015.04.010; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Bosch M, 2010, PLANT MOL BIOL, V74, P381, DOI 10.1007/s11103-010-9681-9; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Chemical Computing Group Inc, 2017, MOL OPERATING ENV; Christoff AP, 2014, PLANT SCI, V215, P100, DOI 10.1016/j.plantsci.2013.11.005; Conlan BF, 2012, J BIOL CHEM, V287, P28037, DOI 10.1074/jbc.M112.347823; Conlan BF, 2011, AM J BOT, V98, P2018, DOI 10.3732/ajb.1100382; Conlan BF, 2010, BIOPOLYMERS, V94, P573, DOI 10.1002/bip.21422; Craik DJ, 2013, CURR OPIN CHEM BIOL, V17, P546, DOI 10.1016/j.cbpa.2013.05.033; Craik DJ, 2012, TOXINS, V4, P139, DOI 10.3390/toxins4020139; Dall E, 2016, BIOCHIMIE, V122, P126, DOI 10.1016/j.biochi.2015.09.022; Dall E, 2015, ANGEW CHEM INT EDIT, V54, P2917, DOI 10.1002/anie.201409135; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; Elsasser B, 2017, ACS CATAL, V7, P5585, DOI 10.1021/acscatal.7b01505; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; Harris KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10199; Hatsugai N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00234; James AM, 2018, NEW PHYTOL, V218, P923, DOI 10.1111/nph.14511; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kintzing JR, 2016, CURR OPIN CHEM BIOL, V34, P143, DOI 10.1016/j.cbpa.2016.08.022; Koehnke J, 2012, NAT STRUCT MOL BIOL, V19, P767, DOI 10.1038/nsmb.2340; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; Kroemer RT, 2004, J CHEM INF COMP SCI, V44, P871, DOI 10.1021/ci049970m; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Lesner A, 2011, CURR PHARM DESIGN, V17, P4308, DOI 10.2174/138161211798999393; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Molecular Operating Environment (MOE), 2018, MOL OP ENV MOE VERS; Mulvenna JP, 2005, J BIOL CHEM, V280, P32245, DOI 10.1074/jbc.M506060200; Muntz K, 2002, TRENDS PLANT SCI, V7, P340, DOI 10.1016/S1360-1385(02)02298-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Nguyen GKT, 2015, J AM CHEM SOC, V137, P15398, DOI 10.1021/jacs.5b11014; Nguyen GKT, 2014, NAT CHEM BIOL, V10, P732, DOI [10.1038/NCHEMBIO.1586, 10.1038/nchembio.1586]; Pelegrini PB, 2007, PEPTIDES, V28, P1475, DOI 10.1016/j.peptides.2007.04.025; Powell HR, 2017, NAT PROTOC, V12, P1310, DOI 10.1038/nprot.2017.037; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Rotari VI, 2001, BIOL CHEM, V382, P953, DOI 10.1515/BC.2001.119; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sheldon PS, 1996, BIOCHEM J, V320, P865, DOI 10.1042/bj3200865; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; Vidmar R, 2017, EMBO J, V36, P2455, DOI 10.15252/embj.201796750; Weidmann J, 2016, J EXP BOT, V67, P4801, DOI 10.1093/jxb/erw210; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Zauner FB, 2018, PLANT CELL, V30, P686, DOI 10.1105/tpc.17.00963; Zhao LX, 2014, CELL RES, V24, P344, DOI 10.1038/cr.2014.4	54	31	31	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8934	8946		10.1074/jbc.M117.817031	http://dx.doi.org/10.1074/jbc.M117.817031			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29628443	hybrid, Green Published			2022-12-28	WOS:000434941900017
J	Su, ZD; Deshpande, V; James, DE; Stockli, J				Su, Zhiduan; Deshpande, Vinita; James, David E.; Stockli, Jacqueline			Tankyrase modulates insulin sensitivity in skeletal muscle cells by regulating the stability of GLUT4 vesicle proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin resistance; glucose transport; glucose transporter type 4 (GLUT4); proteomics; skeletal muscle; GLUT4 storage vesicle; Tankyrase	3T3-L1 ADIPOCYTES; STORAGE-VESICLES; MAJOR PROTEIN; RAB-GAP; GLUT4-CONTAINING VESICLES; STIMULATED TRANSLOCATION; GLUCOSE TRANSPORTERS; PLASMA-MEMBRANE; AKT SUBSTRATE; AS160	Tankyrase 1 and 2, members of the poly(ADP-ribose) polymerase family, have previously been shown to play a role in insulin-mediated glucose uptake in adipocytes. However, their precise mechanism of action, and their role in insulin action in other cell types, such as myocytes, remains elusive. Treatment of differentiated L6 myotubes with the small molecule tankyrase inhibitor XAV939 resulted in insulin resistance as determined by impaired insulin-stimulated glucose uptake. Proteomic analysis of XAV939-treated myotubes identified down-regulation of several glucose transporter GLUT4 storage vesicle (GSV) proteins including RAB10, VAMP8, SORT1, and GLUT4. A similar effect was observed following knockdown of tankyrase 1 in L6 myotubes. Inhibition of the proteasome using MG132 rescued GSV protein levels as well as insulin-stimulated glucose uptake in XAV939-treated L6 myotubes. These studies reveal an important role for tankyrase in maintaining the stability of key GLUT4 regulatory proteins that in turn plays a role in regulating cellular insulin sensitivity.	[Su, Zhiduan; Deshpande, Vinita; James, David E.; Stockli, Jacqueline] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	James, DE; Stockli, J (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia.; James, DE (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au; jacqueline.stoeckli@sydney.edu.au	Stoeckli, Jacqueline/Z-4443-2019; Stoeckli, Jacqueline/D-7053-2016	Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350; James, David/0000-0001-5946-5257	National Health and Medical Research Council (NHMRC) [GNT1061122, GNT1068469]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council (NHMRC) project Grants GNT1061122 (to D. E. J.) and GNT1068469 (to J. S). The contents of the published material are solely the responsibility of the individual authors and do not reflect the view of NHMRC. The authors declare that they have no conflicts of interest with the contents of this article.	Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Brewer PD, 2016, J BIOL CHEM, V291, P773, DOI 10.1074/jbc.M115.694919; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Chaudhuri R, 2015, NPJ SYST BIOL APPL, V1, DOI 10.1038/npjsba.2015.10; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DaRosa PA, 2015, NATURE, V517, P223, DOI 10.1038/nature13826; Dissanayake WC, 2018, EXP CELL RES, V366, P49, DOI 10.1016/j.yexcr.2018.03.011; Fazakerley DJ, 2015, J BIOL CHEM, V290, P23528, DOI 10.1074/jbc.M115.657361; Haikarainen T, 2014, CURR PHARM DESIGN, V20, P6472, DOI 10.2174/1381612820666140630101525; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Holland A, 2013, EXPERT REV PROTEOMIC, V10, P239, DOI [10.1586/epr.13.20, 10.1586/EPR.13.20]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang GR, 2013, MOL BIOL CELL, V24, P3115, DOI 10.1091/mbc.E12-10-0765; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li N, 2015, GENE DEV, V29, P157, DOI 10.1101/gad.251785.114; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; MASTICK CC, 1994, J BIOL CHEM, V269, P6089; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Pan X, 2017, MOL BIOL CELL, V28, P1667, DOI 10.1091/mbc.E16-11-0777; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; PEDERSEN O, 1991, ENDOCRINOLOGY, V129, P771, DOI 10.1210/endo-129-2-771; PEDERSEN O, 1990, DIABETES, V39, P865, DOI 10.2337/diabetes.39.7.865; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; ROBINSON R, 1993, J BIOL CHEM, V268, P22119; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; SINHA MK, 1991, DIABETES, V40, P472, DOI 10.2337/diabetes.40.4.472; Stockli J, 2015, DIABETES, V64, P1914, DOI 10.2337/db13-1489; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Thorvaldsen TE, 2017, BASIC CLIN PHARMACOL, V121, P81, DOI 10.1111/bcpt.12786; Tsuchiya Y, 2010, J BIOL CHEM, V285, P34371, DOI 10.1074/jbc.M110.128520; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Vazirani RP, 2016, DIABETES, V65, P1577, DOI 10.2337/db15-1128; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Xie BX, 2016, DIABETES, V65, P3327, DOI 10.2337/db16-0416; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449; Zong HH, 2011, DIABETES, V60, P30, DOI 10.2337/db10-0231	62	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8578	8587		10.1074/jbc.RA117.001058	http://dx.doi.org/10.1074/jbc.RA117.001058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29669812	hybrid, Green Published			2022-12-28	WOS:000434205700021
J	Zhang, XF; Cao, SF; Barila, G; Edreira, MM; Wankhede, M; Naim, N; Buck, M; Altschuler, DL				Zhang, Xuefeng; Cao, Shufen; Barila, Guillermo; Edreira, Martin M.; Wankhede, Mamta; Naim, Nyla; Buck, Matthias; Altschuler, Daniel L.			Cyclase-associated protein 1 (CAP1) is a prenyl-binding partner of Rap1 GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE; FORCE-FIELD; NUCLEOTIDE EXCHANGE; SRV2/CAP COMPLEX; KINASE PKA; A-FACTOR; F-ACTIN; RAS; ACTIVATION; COFILIN	Rap1 proteins are members of the Ras subfamily of small GTPases involved in many biological responses, including adhesion, cell proliferation, and differentiation. Like all small GTPases, they work as molecular allosteric units that are active in signaling only when associated with the proper membrane compartment. Prenylation, occurring in the cytosol, is an enzymatic posttranslational event that anchors small GTPases at the membrane, and prenyl-binding proteins are needed to mask the cytoplasm-exposed lipid during transit to the target membrane. However, several of these proteins still await discovery. In this study, we report that cyclase-associated protein 1 (CAP1) binds Rap1. We found that this binding is GTP-independent, does not involve Rap1's effector domain, and is fully contained in its C-terminal hypervariable region (HVR). Furthermore, Rap1 prenylation was required for high-affinity interactions with CAP1 in a geranylgeranyl-specific manner. The prenyl binding specifically involved CAP1's C-terminal hydrophobic -sheet domain. We present a combination of experimental and computational approaches, yielding a model whereby the high-affinity binding between Rap1 and CAP1 involves electrostatic and nonpolar side-chain interactions between Rap1's HVR residues, lipid, and CAP1 -sheet domain. The binding was stabilized by the lipid insertion into the -solenoid whose interior was occupied by nonpolar side chains. This model was reminiscent of the recently solved structure of the PDE-K-Ras complex; accordingly, disruptors of this complex, e.g. deltarasin, blocked the Rap1-CAP1 interaction. These findings indicate that CAP1 is a geranylgeranyl-binding partner of Rap1.	[Zhang, Xuefeng; Barila, Guillermo; Edreira, Martin M.; Wankhede, Mamta; Naim, Nyla; Altschuler, Daniel L.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, W1346 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA; [Cao, Shufen; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44116 USA; [Barila, Guillermo] Univ Penn Hlth Syst, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; [Edreira, Martin M.] Univ Buenos Aires, CONICET, Consejo Nacl Invest Cient & Tecn, IQUIBICEN,Inst Dept Quim Biol,Fac Ciencias Exacta, C1428EGA, Buenos Aires, DF, Argentina	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Altschuler, DL (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, W1346 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	altschul@pitt.edu	Edreira, Martin/AAE-7816-2020	Edreira, Martin/0000-0002-9120-2649	National Institutes of Health [R01 GM099775]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099775, R01GM112491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM099775 (to D. L. A. and partially to M. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Banerjee A, 2016, CURR OPIN STRUC BIOL, V36, P10, DOI 10.1016/j.sbi.2015.11.010; Bao Z, 2016, PATHOL RES PRACT, V212, P264, DOI 10.1016/j.prp.2015.12.017; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Chaudhry F, 2013, MOL BIOL CELL, V24, P31, DOI 10.1091/mbc.E12-08-0589; Chung J, 2008, J IMMUNOL, V181, P5501, DOI 10.4049/jimmunol.181.8.5501; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Edreira MM, 2009, J BIOL CHEM, V284, P27480, DOI 10.1074/jbc.M109.011312; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fan YC, 2016, ONCOL REP, V36, P1619, DOI 10.3892/or.2016.4936; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; Flacke JP, 2013, J BIOL CHEM, V288, P3126, DOI 10.1074/jbc.M112.403279; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V45, P106, DOI 10.1002/(SICI)1097-0169(200002)45:2<106::AID-CM3>3.0.CO;2-3; Freeman SN, 2011, J IMMUNOL, V187, P5887, DOI 10.4049/jimmunol.1102233; Goitre L, 2014, METHODS MOL BIOL, V1120, P197, DOI 10.1007/978-1-62703-791-4_13; Guo XX, 2016, CELL PHYSIOL BIOCHEM, V39, P137, DOI 10.1159/000445612; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Hochbaum D, 2011, J BIOL CHEM, V286, P859, DOI 10.1074/jbc.M110.163816; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Hua MH, 2015, INT J MOL MED, V35, P941, DOI 10.3892/ijmm.2015.2089; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Iwase S, 2017, CYTOSKELETON, V74, P343, DOI 10.1002/cm.21385; Iwase S, 2016, BIOCHEM J, V473, P4427, DOI 10.1042/BCJ20160329; Jansen S, 2014, J BIOL CHEM, V289, P30732, DOI 10.1074/jbc.M114.601765; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kakurina GV, 2016, B EXP BIOL MED+, V160, P695, DOI 10.1007/s10517-016-3252-2; Khan I, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12248; Lagarrigue F, 2016, BLOOD, V128, P479, DOI 10.1182/blood-2015-12-638700; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Liu XC, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0878-7; Liu YH, 2014, PATHOL RES PRACT, V210, P169, DOI 10.1016/j.prp.2013.11.011; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makkonen M, 2013, J BIOL CHEM, V288, P984, DOI 10.1074/jbc.M112.435719; Mangmool S, 2015, MOL ENDOCRINOL, V29, P583, DOI 10.1210/me.2014-1346; Marada S, 2016, DEV BIOL, V409, P84, DOI 10.1016/j.ydbio.2015.10.020; Masugi Y, 2015, PATHOL INT, V65, P627, DOI 10.1111/pin.12351; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Moriyama K, 2002, J CELL SCI, V115, P1591; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Ono S, 2013, J CELL SCI, V126, P3249, DOI 10.1242/jcs.128231; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Papke B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11360; Pedro MP, 2017, MOL BIOL CELL, V28, P962, DOI 10.1091/mbc.E16-08-0603; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PILLINGER MH, 1994, J BIOL CHEM, V269, P1486; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Ribeiro-Neto F, 2004, J BIOL CHEM, V279, P46868, DOI 10.1074/jbc.M406858200; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; Schuld NJ, 2014, J BIOL CHEM, V289, P6862, DOI 10.1074/jbc.M113.527192; Shah B, 2017, CEREB CORTEX, V27, P1253, DOI 10.1093/cercor/bhv341; Sun W, 2017, BIOCHEM BIOPH RES CO, V485, P355, DOI 10.1016/j.bbrc.2017.02.075; Suzuki S, 2010, J BIOL CHEM, V285, P24248, DOI 10.1074/jbc.M109.094581; Takahashi M, 2017, J BIOL CHEM, V292, P1449, DOI 10.1074/jbc.M116.768986; Tan M, 2013, ONCOL REP, V30, P1639, DOI 10.3892/or.2013.2607; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Tnimov Z, 2012, J BIOL CHEM, V287, P26549, DOI 10.1074/jbc.M112.371294; van Hooren KWEM, 2012, J BIOL CHEM, V287, P24713, DOI 10.1074/jbc.M111.321976; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Wang JC, 2017, J CELL SCI, V130, P1094, DOI 10.1242/jcs.191858; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wilson JM, 2016, J MOL BIOL, V428, P4929, DOI 10.1016/j.jmb.2016.10.016; Wilson JM, 2015, CANCER BIOL THER, V16, P1364, DOI 10.1080/15384047.2015.1070988; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wu LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021929; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Wu YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143777; Xie SS, 2015, ONCOL REP, V33, P363, DOI 10.3892/or.2014.3577; Xie SS, 2017, ONCOTARGET, V8, P27216, DOI 10.18632/oncotarget.16111; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Yu XF, 2014, EXP MOL PATHOL, V96, P188, DOI 10.1016/j.yexmp.2014.02.002; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243; Zhang HB, 2012, VISION RES, V75, P19, DOI 10.1016/j.visres.2012.08.013; Zhang HouJiang, 2016, Journal of Forestry Engineering, V1, P1; Zhang YL, 2017, CANCER BIOL MED, V14, P90, DOI 10.20892/j.issn.2095-3941.2016.0086; Zhou GL, 2014, J CELL SCI, V127, P5052, DOI 10.1242/jcs.156059; Zhou M, 2016, J CELL BIOL, V214, P445, DOI 10.1083/jcb.201604061; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhu L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01822-8; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	107	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7659	7673		10.1074/jbc.RA118.001779	http://dx.doi.org/10.1074/jbc.RA118.001779			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618512	Green Published, hybrid			2022-12-28	WOS:000437256500017
J	Wang, C; Aleksandrov, AA; Yang, ZR; Forouhar, F; Proctor, EA; Kota, P; An, JL; Kaplan, A; Khazanov, N; Boel, G; Stockwell, BR; Senderowitz, H; Dokholyan, NV; Riordan, JR; Brouillette, CG; Hunt, JF				Wang, Chi; Aleksandrov, Andrei A.; Yang, Zhengrong; Forouhar, Farhad; Proctor, Elizabeth A.; Kota, Pradeep; An, Jianli; Kaplan, Anna; Khazanov, Netaly; Boel, Gregory; Stockwell, Brent R.; Senderowitz, Hanoch; Dokholyan, Nikolay V.; Riordan, John R.; Brouillette, Christie G.; Hunt, John F.			Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); thermodynamics; protein aggregation; fluorescence resonance energy transfer (FRET); high-throughput screening (HTS); calorimetry; isothermal titration calorimetry (ITC); electrophysiology; deoxythymidine; F508del mutation	DISCRETE MOLECULAR-DYNAMICS; NUCLEOTIDE-BINDING; CONFORMATIONAL MATURATION; ENDOPLASMIC-RETICULUM; DELTA-F508 MUTATION; THERMAL-STABILITY; CHLORIDE CHANNEL; WILD-TYPE; CFTR; PROTEIN	Many disease-causing mutations impair protein stability. Here, we explore a thermodynamic strategy to correct the disease-causing F508del mutation in the human cystic fibrosis transmembrane conductance regulator (hCFTR). F508del destabilizes nucleotide-binding domain 1 (hNBD1) in hCFTR relative to an aggregation-prone intermediate. We developed a fluorescence self-quenching assay for compounds that prevent aggregation of hNBD1 by stabilizing its native conformation. Unexpectedly, we found that dTTP and nucleotide analogs with exocyclic methyl groups bind to hNBD1 more strongly than ATP and preserve electrophysiological function of full-length F508del-hCFTR channels at temperatures up to 37 degrees C. Furthermore, nucleotides that increase open-channel probability, which reflects stabilization of an interdomain interface to hNBD1, thermally protect full-length F508del-hCFTR even when they do not stabilize isolated hNBD1. Therefore, stabilization of hNBD1 itself or of one of its interdomain interfaces by a small molecule indirectly offsets the destabilizing effect of the F508del mutation on full-length hCFTR. These results indicate that high-affinity binding of a small molecule to a remote site can correct a disease-causing mutation. We propose that the strategies described here should be applicable to identifying small molecules to help manage other human diseases caused by mutations that destabilize native protein conformation.	[Wang, Chi; Forouhar, Farhad; Kaplan, Anna; Boel, Gregory; Stockwell, Brent R.; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Aleksandrov, Andrei A.; Proctor, Elizabeth A.; Kota, Pradeep; Dokholyan, Nikolay V.; Riordan, John R.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Yang, Zhengrong; An, Jianli; Brouillette, Christie G.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Khazanov, Netaly; Senderowitz, Hanoch] Bar Ilan Univ, Dept Chem, IL-5290002 Ramat Gan, Israel; [Yang, Zhengrong] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Forouhar, Farhad] Columbia Univ, Irving Canc Res Ctr, New York, NY 10032 USA; [Proctor, Elizabeth A.] Penn State Univ, Dept Neurosurg, Hershey, PA 17033 USA; [Proctor, Elizabeth A.] Penn State Univ, Dept Pharmacol, Hershey, PA 17033 USA; [Kota, Pradeep] NCI Frederick, Lab Cell & Dev Signaling, NIH, Frederick, MD 21702 USA; [Boel, Gregory] Univ Paris Diderot, CNRS UMR8261, Sorbonne Paris Cite, Inst Biol Physicochim, 13 Rue Pierre & Marie Curie, F-75005 Paris, France	Columbia University; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Alabama System; University of Alabama Birmingham; Bar Ilan University; University of Alabama System; University of Alabama Birmingham; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Hunt, JF (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jfh21@columbia.edu	Boel, Gregory/N-4623-2016; Stockwell, Brent R/AAE-7200-2019; Proctor, Elizabeth A./K-2350-2012; Dokholyan, Nikolay/B-2238-2009	Boel, Gregory/0000-0001-9900-6493; Stockwell, Brent R/0000-0002-3532-3868; Proctor, Elizabeth A./0000-0002-7627-2198; Dokholyan, Nikolay/0000-0002-8225-4025	Cystic Fibrosis Foundation Therapeutics Inc. as part of the CFTR 3D Structure Consortium [HUNT13XX0]; NATIONAL CANCER INSTITUTE [P01CA087497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123247, T32GM008281, R01GM114015] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation Therapeutics Inc. as part of the CFTR 3D Structure Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Cystic Fibrosis Foundation Therapeutics Inc. to H. S., J. R. R., C. G. B., and J. F. H. as part of the CFTR 3D Structure Consortium, including grant HUNT13XX0. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alapi E.M., 2006, ANALOGUE BASED DRUG, P441, DOI [10.1002/3527608001.ch23, DOI 10.1002/3527608001.CH23]; Aleksandrov AA, 2002, FEBS LETT, V518, P183, DOI 10.1016/S0014-5793(02)02698-4; Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Aleksandrov LA, 2015, PROTEIN EXPRES PURIF, V116, P159, DOI 10.1016/j.pep.2015.09.018; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Bagdany M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00444-4; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; BALDWIN RL, 1991, CIBA F SYMP, V161, P190; BARRICK D, 1993, PROTEIN SCI, V2, P869, DOI 10.1002/pro.5560020601; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; CARSON MR, 1995, J BIOL CHEM, V270, P20466, DOI 10.1074/jbc.270.35.20466; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chung WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163615; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; Daughdrill GW, 2005, PROTEIN FOLDING HANDBOOK; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; DOBSON CM, 1994, CURR BIOL, V4, P636, DOI 10.1016/S0960-9822(00)00141-X; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dong Q, 2012, P NATL ACAD SCI USA, V109, P917, DOI 10.1073/pnas.1120065109; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Eckhardt B.J., 2017, INFECT DIS-NOR, P1293; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Freire E, 2015, THERMODYNAMICS KINET, P1, DOI 10.1002/9783527673025.ch1; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6; Hall JD, 2016, PROTEIN SCI, V25, P360, DOI 10.1002/pro.2821; Hassell AM, 2007, ACTA CRYSTALLOGR D, V63, P72, DOI 10.1107/S0907444906047020; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hudson RP, 2017, MOL PHARMACOL, V92, P124, DOI 10.1124/mol.117.108373; HUGHSON FM, 1991, BIOCHEMISTRY-US, V30, P4113, DOI 10.1021/bi00231a001; Hunt JF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009514; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Liang F, 2012, PEDIATR PULM, V47, P224; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Matsumura Y, 2013, J BIOL CHEM, V288, P31069, DOI 10.1074/jbc.M113.479345; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Meng X, 2017, J BIOL CHEM, V292, P3706, DOI 10.1074/jbc.M116.751537; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Moro WB, 2009, BIOORG MED CHEM LETT, V19, P2001, DOI 10.1016/j.bmcl.2009.02.034; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pendergast W, 2001, BIOORG MED CHEM LETT, V11, P157, DOI 10.1016/S0960-894X(00)00612-0; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; PRIVALOV PL, 1989, ANNU REV BIOPHYS BIO, V18, P47, DOI 10.1146/annurev.biophys.18.1.47; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Sampson HM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-11; Sampson HM, 2011, CHEM BIOL, V18, P231, DOI 10.1016/j.chembiol.2010.11.016; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vaccaro JA, 2000, ANTIMICROB AGENTS CH, V44, P217, DOI 10.1128/AAC.44.1.217-221.2000; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yin SY, 2010, METHODS MOL BIOL, V634, P189, DOI 10.1007/978-1-60761-652-8_14; Yin SY, 2009, P NATL ACAD SCI USA, V106, P16622, DOI 10.1073/pnas.0906146106; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083	106	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17685	17704		10.1074/jbc.RA117.000819	http://dx.doi.org/10.1074/jbc.RA117.000819			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	29903914	Green Published, hybrid			2022-12-28	WOS:000450409500003
J	Kara, E; Marks, JD; Roe, AD; Commins, C; Fan, ZY; Calvo-Rodriguez, M; Wegmann, S; Hudry, E; Hyman, BT				Kara, Eleanna; Marks, Jordan D.; Roe, Allyson D.; Commins, Caitlin; Fan, Zhanyun; Calvo-Rodriguez, Maria; Wegmann, Susanne; Hudry, Eloise; Hyman, Bradley T.			A flow cytometry-based in vitro assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC AMYLOID-BETA; ALZHEIMERS-DISEASE BRAIN; TRANSGENIC MOUSE MODEL; ENERGY-TRANSFER ASSAY; A-BETA; STABLE COMPLEXES; CULTURED-CELLS; PEPTIDE; PROTEIN; RESONANCE	Apolipoprotein E (ApoE) is a secreted apolipoprotein with three isoforms, E2, E3, and FA, that binds to lipids and facilitates their transport in the extracellular environment of the brain and the periphery. The E4 allele is a major genetic risk factor for the sporadic form of Alzheimer's disease (AD), and studies of human brain and mouse models have revealed that E4 significantly exacerbates the deposition of amyloid beta (A beta). It has been suggested that this deposition could be attributed to the formation of soluble ApoE isoform-specific ApoE-A beta complexes. However, previous studies have reported conflicting results regarding the directionality and strength of those interactions. In this study, using a series of flow cytometry assays that maintain the physiological integrity of ApoE-A beta complexes, we systematically assessed the association of A beta with ApoE2, E3, or E4. We used ApoE secreted from HEK cells or astrocytes overexpressing ApoE fused with a GFP tag. As a source of soluble A beta peptide, we used synthetic A beta 40 or A beta 42 or physiological A beta secreted from CHO cell lines overexpressing WT or V717F variant amyloid precursor protein (APP). We observed significant interactions between the different ApoE isoforms and A beta, with E4 interacting with A beta more strongly than the E2 and E3 isoforms. We also found subtle differences depending on the A beta type and the ApoE-producing cell type. In conclusion, these results indicate that the strength of the ApoE-A beta association depends on the source of A beta or ApoE.	[Kara, Eleanna; Marks, Jordan D.; Roe, Allyson D.; Commins, Caitlin; Fan, Zhanyun; Calvo-Rodriguez, Maria; Wegmann, Susanne; Hudry, Eloise; Hyman, Bradley T.] Harvard Med Sch, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Alzheimers Dis Res Lab, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), MassGen Inst Neurodegenerat Dis, Alzheimers Dis Res Lab, 114 16th St, Charlestown, MA 02129 USA.	BHYMAN@mgh.harvard.edu	Calvo-Rodriguez, Maria/B-9308-2019	Calvo-Rodriguez, Maria/0000-0001-6947-5547; Kara, Eleanna/0000-0001-5428-6743	EMBO Long-Term Fellowship [ATLF-815-2014]; Marie Curie Actions of the European Commission (LTFCOFUND2013) [GA-2013-609409]; JPB Foundation; F Prime; Abbvie; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020936, S10RR023440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG047336] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012027, S10OD016372] Funding Source: NIH RePORTER	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Actions of the European Commission (LTFCOFUND2013); JPB Foundation; F Prime; Abbvie(AbbVie); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by EMBO Long-Term Fellowship ATLF-815-2014, which is co-funded by the Marie Curie Actions of the European Commission (LTFCOFUND2013, GA-2013-609409) (to E. K.) and the JPB Foundation (to B. T. H.). This work was also supported by a grant from F Prime. Financial support was partially obtained from a sponsored research agreement from Abbvie. Abbvie was not involved in assay design, data acquisition, data analysis, preparation of the manuscript or decision to publish the results. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arbel-Ornath M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0169-9; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; Chan W, 1996, BIOCHEMISTRY-US, V35, P7123, DOI 10.1021/bi952852v; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; Golabek AA, 1996, J BIOL CHEM, V271, P10602, DOI 10.1074/jbc.271.18.10602; Grimmer T, 2010, BIOL PSYCHIAT, V68, P879, DOI 10.1016/j.biopsych.2010.05.013; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hudry E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007000; Hudry E, 2012, J NEUROSCI, V32, P3176, DOI 10.1523/JNEUROSCI.6439-11.2012; Irizarry MC, 2000, ANN NY ACAD SCI, V920, P171; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kara E, 2017, J BIOL CHEM, V292, P14720, DOI 10.1074/jbc.M117.784264; Kim J, 2012, J EXP MED, V209, P2149, DOI 10.1084/jem.20121274; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; KOO EH, 1994, J BIOL CHEM, V269, P17386; LaDu MJ, 1997, J NEUROSCI RES, V49, P9, DOI 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Liao F, 2014, J NEUROSCI, V34, P7281, DOI 10.1523/JNEUROSCI.0646-14.2014; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9; Pillot T, 1997, EUR J BIOCHEM, V243, P650, DOI 10.1111/j.1432-1033.1997.00650.x; REBECK GW, 1993, NEURON, V11, P575; Sarkar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097655; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; Shuvaev VV, 1996, FEBS LETT, V383, P9, DOI 10.1016/0014-5793(96)00206-2; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; UTERMANN G, 1984, HUM GENET, V65, P232, DOI 10.1007/BF00286508; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wellnitz S, 2005, J NEUROCHEM, V94, P1351, DOI 10.1111/j.1471-4159.2005.03295.x; Welzel AT, 2014, BIOCHEMISTRY-US, V53, P3908, DOI 10.1021/bi5003053; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; Wood SJ, 1996, BIOCHEMISTRY-US, V35, P12623, DOI 10.1021/bi961074j; Wood SJ, 1996, CHEM BIOL, V3, P949, DOI 10.1016/S1074-5521(96)90183-0; Wu HY, 2012, J NEUROSCI, V32, P5298, DOI 10.1523/JNEUROSCI.0227-12.2012	48	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13247	13256		10.1074/jbc.RA117.001388	http://dx.doi.org/10.1074/jbc.RA117.001388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29950521	Green Published, hybrid			2022-12-28	WOS:000442730200023
J	Cheng, ZS; Thomas, PW; Ju, LC; Bergstrom, A; Mason, K; Clayton, D; Miller, C; Bethel, CR; VanPelt, J; Tierney, DL; Page, RC; Bonomo, RA; Fast, W; Crowder, MW				Cheng, Zishuo; Thomas, Pei W.; Ju, Lincheng; Bergstrom, Alexander; Mason, Kelly; Clayton, Delaney; Miller, Callie; Bethel, Christopher R.; VanPelt, Jamie; Tierney, David L.; Page, Richard C.; Bonomo, Robert A.; Fast, Walter; Crowder, Michael W.			Evolution of New Delhi metallo-beta-lactamase (NDM) in the clinic: Effects of NDM mutations on stability, zinc affinity, and mono-zinc activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; antibiotics; metalloenzyme; enzyme kinetics; protein evolution; enzyme mutation; Co(II)-substituted enzyme; metallo--lactamase; NDM-1	VARIANTS REVEALS DIFFERENCES; ANTIBIOTIC-RESISTANCE; PROTEIN STABILITY; UNITED-STATES; INHIBITION; NMR	Infections by carbapenem-resistant Enterobacteriaceae are difficult to manage owing to broad antibiotic resistance profiles and because of the inability of clinically used -lactamase inhibitors to counter the activity of metallo--lactamases often harbored by these pathogens. Of particular importance is New Delhi metallo--lactamase (NDM), which requires a di-nuclear zinc ion cluster for catalytic activity. Here, we compare the structures and functions of clinical NDM variants 1-17. The impact of NDM variants on structure is probed by comparing melting temperature and refolding efficiency and also by spectroscopy (UV-visible, H-1 NMR, and EPR) of di-cobalt metalloforms. The impact of NDM variants on function is probed by determining the minimum inhibitory concentrations of various antibiotics, pre-steady-state and steady-state kinetics, inhibitor binding, and zinc dependence of resistance and activity. We observed only minor differences among the fully loaded di-zinc enzymes, but most NDM variants had more distinguishable selective advantages in experiments that mimicked zinc scarcity imposed by typical host defenses. Most NDM variants exhibited improved thermostability (up to approximate to 10 degrees C increased T-m) and improved zinc affinity (up to approximate to 10-fold decreased K-d,K- Zn2). We also provide first evidence that some NDM variants have evolved the ability to function as mono-zinc enzymes with high catalytic efficiency (NDM-15, ampicillin: k(cat)/K-m = 5 x 10(6) m(-1) s(-1)). These findings reveal the molecular mechanisms that NDM variants have evolved to overcome the combined selective pressures of -lactam antibiotics and zinc deprivation.	[Cheng, Zishuo; Bergstrom, Alexander; Mason, Kelly; Clayton, Delaney; Miller, Callie; VanPelt, Jamie; Tierney, David L.; Page, Richard C.; Crowder, Michael W.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Thomas, Pei W.; Fast, Walter] Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, Austin, TX 78712 USA; [Thomas, Pei W.; Fast, Walter] Univ Texas Austin, LaMontagne Ctr Infect Dis, Austin, TX 78712 USA; [Ju, Lincheng] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang 110004, Liaoning, Peoples R China; [Bethel, Christopher R.; Bonomo, Robert A.] Case Western Reserve Univ, Cleveland Vet Adm Med Ctr VAMC, Ctr Antimicrobial Resistance & Epidemiol CARES, Res Serv,Louis Stokes Cleveland Dept Vet Affairs, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Cleveland Vet Adm Med Ctr VAMC, Ctr Antimicrobial Resistance & Epidemiol CARES, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Cleveland Vet Adm Med Ctr VAMC, Ctr Antimicrobial Resistance & Epidemiol CARES, Dept Mol Biol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Cleveland Vet Adm Med Ctr VAMC, Ctr Antimicrobial Resistance & Epidemiol CARES, Dept Microbiol Biochem Prote & Bioinformat, Cleveland, OH 44106 USA	University System of Ohio; Miami University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; China Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Fast, W (corresponding author), Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, Austin, TX 78712 USA.; Fast, W (corresponding author), Univ Texas Austin, LaMontagne Ctr Infect Dis, Austin, TX 78712 USA.; Tierney, DL; Page, RC; Crowder, MW (corresponding author), Miami Univ, Dept Chem & Biochem, Hughes Labs 160, 651 E High St, Oxford, OH 45056 USA.; Bonomo, RA (corresponding author), Dept Med, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Dept Pharmacol, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Dept Biochem Prote & Bioinformat, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), CWRU, Cleveland VAMC, Ctr Antimicrobial Resistance & Epidemiol, Cleveland, OH 44106 USA.	dtierney@miamioh.edu; pagerc@miamioh.edu; robert.bonomo@va.gov; walt.fast@austin.utexas.edu; crowdemw@miamioh.edu	Cheng, Zishuo/AAD-6861-2020		National Institutes of Health from NIGMS [GM111926, R01AI100560, R01AI063517, R01AI072219]; NIAID, National Science Foundation [CHE-1509285]; Robert A. Welch Foundation [F-1572]; Miami University through the Robert H. and Nancy J. Blayney Professorship; Cleveland Department of Veterans Affairs Award [1I01BX001974]; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; Geriatric Research Education and Clinical Center [VISN 10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100560, R01AI072219, R01AI063517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111926] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001974] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID, National Science Foundation; Robert A. Welch Foundation(The Welch Foundation); Miami University through the Robert H. and Nancy J. Blayney Professorship; Cleveland Department of Veterans Affairs Award; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; Geriatric Research Education and Clinical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants GM111926 (to W. F., R. A. B., M. W. C., D. L. T., and R. P.), R01AI100560 (to R. A. B.), R01AI063517 (to R. A. B.), and R01AI072219 (to R. A. B.) from NIGMS and NIAID, National Science Foundation Grant CHE-1509285 (to M. W. C. and D. L. T.), Robert A. Welch Foundation Award F-1572 (to W. F.), Miami University through the Robert H. and Nancy J. Blayney Professorship (to R. C. P.), funds and/or facilities provided by the Cleveland Department of Veterans Affairs Award 1I01BX001974 (to R. A. B.), the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development, and the Geriatric Research Education and Clinical Center VISN 10 (to R. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bahr G, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01849-17; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Chen X, 2013, ANAL CHEM, V85, P7957, DOI 10.1021/ac401732d; CLSI, 2015, PERF STAND ANT SUSC; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Cunden LS, 2018, BIOCHEMISTRY-US, V57, P1673, DOI 10.1021/acs.biochem.7b01305; Goldenzweig A, 2018, ANNU REV BIOCHEM, V87, P105, DOI 10.1146/annurev-biochem-062917-012102; Gonzalez LJ, 2016, NAT CHEM BIOL, V12, P516, DOI [10.1038/nchembio.2083, 10.1038/NCHEMBIO.2083]; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Makena A, 2016, ANTIMICROB AGENTS CH, V60, P1377, DOI 10.1128/AAC.01768-15; Makena A, 2015, J ANTIMICROB CHEMOTH, V70, P463, DOI 10.1093/jac/dku403; Orellano EG, 1998, BIOCHEMISTRY-US, V37, P10173, DOI 10.1021/bi980309j; Patel MP, 2015, ANTIMICROB AGENTS CH, V59, P6741, DOI 10.1128/AAC.00618-15; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Riley EA, 2006, INORG CHEM, V45, P10016, DOI 10.1021/ic061207h; Solomon SL, 2014, AM FAM PHYSICIAN, V89, P938; Stewart AC, 2017, ACS INFECT DIS, V3, P927, DOI 10.1021/acsinfecdis.7b00128; TEALE FWJ, 1960, BIOCHEM J, V76, P381, DOI 10.1042/bj0760381; Thomas PW, 2011, BIOCHEMISTRY-US, V50, P10102, DOI 10.1021/bi201449r; Wang ZG, 1998, J AM CHEM SOC, V120, P10788, DOI 10.1021/ja982621m; Woodworth KR, 2018, MMWR-MORBID MORTAL W, V67, P396, DOI 10.15585/mmwr.mm6713e1; Yang H, 2014, BIOCHEM J, V464, P271, DOI 10.1042/BJ20140364; Yang H, 2014, J AM CHEM SOC, V136, P7273, DOI 10.1021/ja410376s; Yang H, 2012, BIOCHEMISTRY-US, V51, P3839, DOI 10.1021/bi300056y	28	60	62	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12606	12618		10.1074/jbc.RA118.003835	http://dx.doi.org/10.1074/jbc.RA118.003835			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29909397	hybrid, Green Published			2022-12-28	WOS:000441408500024
J	Bolduc, JA; Nelson, KJ; Haynes, AC; Lee, J; Reisz, JA; Graff, AH; Clodfelter, JE; Parsonage, D; Poole, LB; Furdui, CM; Lowther, WT				Bolduc, Jesalyn A.; Nelson, Kimberly J.; Haynes, Alexina C.; Lee, Jingyun; Reisz, Julie A.; Graff, Aaron H.; Clodfelter, Jill E.; Parsonage, Derek; Poole, Leslie B.; Furdui, Cristina M.; Lowther, W. Todd			Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; ANTIOXIDANT; REVEALS; INTERMEDIATE; INACTIVATION; SENSITIVITY; REDUCTASE	2-Cys peroxiredoxins (Prxs) modulate hydrogen peroxide (H2O2)-mediated cell signaling. At high H2O2 levels, eukaryotic Prxs can be inactivated by hyperoxidation and are classified as sensitive Prxs. In contrast, prokaryotic Prxs are categorized as being resistant to hyperoxidation and lack the GGLG and C-terminal YF motifs present in the sensitive Prxs. Additional molecular determinants that account for the subtle differences in the susceptibility to hyperoxidation remain to be identified. A comparison of a new, 2.15-angstrom-resolution crystal structure of Prx2 in the oxidized, disulfide-bonded state with the hyperoxidized structure of Prx2 and Prx1 in complex with sulfiredoxin revealed three structural regions that rearrange during catalysis. With these regions in hand, focused sequence analyses were performed comparing sensitive and resistant Prx groups. From this combinatorial approach, we discovered two novel hyperoxidation resistance motifs, motifs A and B, which were validated using mutagenesis of sensitive human Prxs and resistant Salmonella enterica serovar Typhimurium AhpC. Introduction and removal of these motifs, respectively, resulted in drastic changes in the sensitivity to hyperoxidation with Prx1 becoming 100-fold more resistant to hyperoxidation and AhpC becoming 800-fold more sensitive to hyperoxidation. The increased sensitivity of the latter AhpC variant was also confirmed in vivo. These results support the function of motifs A and B as primary drivers for tuning the sensitivity of Prxs to different levels of H2O2, thus enabling the initiation of variable signaling or antioxidant responses in cells.	[Bolduc, Jesalyn A.; Nelson, Kimberly J.; Haynes, Alexina C.; Graff, Aaron H.; Clodfelter, Jill E.; Parsonage, Derek; Poole, Leslie B.; Lowther, W. Todd] Wake Forest Sch Med, Struct Biol Ctr, Dept Biochem, Winston Salem, NC 27157 USA; [Reisz, Julie A.; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Lee, Jingyun; Poole, Leslie B.; Furdui, Cristina M.; Lowther, W. Todd] Wake Forest Sch Med, Wake Forest Baptist Comprehens Canc Ctr, Winston Salem, NC 27157 USA; [Poole, Leslie B.; Furdui, Cristina M.; Lowther, W. Todd] Wake Forest Sch Med, Ctr Redox Biol & Med, Winston Salem, NC 27157 USA; [Poole, Leslie B.; Furdui, Cristina M.; Lowther, W. Todd] Wake Forest Univ, Ctr Mol Signaling, Winston Salem, NC 27101 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest University	Lowther, WT (corresponding author), Wake Forest Sch Med, Struct Biol Ctr, Dept Biochem, Winston Salem, NC 27157 USA.	tlowther@wakehealth.edu		Nelson, Kimberly/0000-0003-2464-7696; Bolduc, Jesalyn/0000-0002-3950-7453; Furdui, Cristina M./0000-0003-3771-7999; Poole, Leslie/0000-0003-0334-7328	National Institutes of Health [GM072866, GM050389, GM119227]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119227, R01GM050389, R01GM072866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM072866 (to W. T. L.) and GM050389 and GM119227 (to L. B. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dvorak P, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0393-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jara M, 2008, GENES CELLS, V13, P171, DOI 10.1111/j.1365-2443.2007.01160.x; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Kim SU, 2013, J NEUROIMMUNOL, V259, P26, DOI 10.1016/j.jneuroim.2013.03.006; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Leichert LI, 2015, BIOL CHEM, V396, P389, DOI 10.1515/hsz-2014-0314; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Milev NB, 2015, TRENDS ENDOCRIN MET, V26, P430, DOI 10.1016/j.tem.2015.05.012; Morinaka A, 2011, ONCOGENE, V30, P4208, DOI 10.1038/onc.2011.139; Nelson KJ, 2013, METHOD ENZYMOL, V527, P21, DOI 10.1016/B978-0-12-405882-8.00002-7; Nelson Kimberly J, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0710s49; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Park JG, 2011, CIRC RES, V109, P739, DOI 10.1161/CIRCRESAHA.111.245530; Park MH, 2016, PHARMACOL THERAPEUT, V163, P1, DOI 10.1016/j.pharmthera.2016.03.018; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Perkins A, 2016, STRUCTURE, V24, P1668, DOI 10.1016/j.str.2016.07.012; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Perkins A, 2014, BIOCHEMISTRY-US, V53, P7693, DOI 10.1021/bi5013222; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2016, FREE RADICAL BIO MED, V99, P120, DOI 10.1016/j.freeradbiomed.2016.07.029; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Winterbourn CC, 2013, METHOD ENZYMOL, V528, P3, DOI 10.1016/B978-0-12-405881-1.00001-X; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m	54	31	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11901	11912		10.1074/jbc.RA117.001690	http://dx.doi.org/10.1074/jbc.RA117.001690			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29884768	hybrid, Green Published			2022-12-28	WOS:000440134500022
J	Kokkonen, P; Bednar, D; Dockalova, V; Prokop, Z; Damborsky, J				Kokkonen, Piia; Bednar, David; Dockalova, Veronika; Prokop, Zbynek; Damborsky, Jiri			Conformational changes allow processing of bulky substrates by a haloalkane dehalogenase with a small and buried active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; protein conformation; molecular dynamics; molecular evolution; active site; conformational change; enzyme catalysis; haloalkane dehalogenase; dichloroethane degradation; ethylene dichloride; organic halogen; organohalogen	MOLECULAR-DYNAMICS SIMULATIONS; X-RAY-STRUCTURE; HALIDE-BINDING; SPECIFICITY; TIME; MECHANISM; BOND; MUTATIONS; EVOLUTION; GEOMETRY	Haloalkane dehalogenases catalyze the hydrolysis of halogen-carbon bonds in organic halogenated compounds and as such are of great utility as biocatalysts. The crystal structures of the haloalkane dehalogenase DhlA from the bacterium from Xanthobacter autotrophicus GJ10, specifically adapted for the conversion of the small 1,2-dichloroethane (DCE) molecule, display the smallest catalytic site (110 angstrom(3)) within this enzyme family. However, during a substrate-specificity screening, we noted that DhlA can catalyze the conversion of far bulkier substrates, such as the 4-(bromomethyl)-6,7-dimethoxy-coumarin (220 angstrom(3)). This large substrate cannot bind to DhlA without conformational alterations. These conformational changes have been previously inferred from kinetic analysis, but their structural basis has not been understood. Using molecular dynamic simulations, we demonstrate here the intrinsic flexibility of part of the cap domain that allows DhlA to accommodate bulky substrates. The simulations displayed two routes for transport of substrates to the active site, one of which requires the conformational change and is likely the route for bulky substrates. These results provide insights into the structure-dynamics function relationships in enzymes with deeply buried active sites. Moreover, understanding the structural basis for the molecular adaptation of DhlA to 1,2-dichloroethane introduced into the biosphere during the industrial revolution provides a valuable lesson in enzyme design by nature.	[Kokkonen, Piia; Bednar, David; Dockalova, Veronika; Prokop, Zbynek; Damborsky, Jiri] Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, Dept Expt Biol, Loschmidt Labs, Kamenice 5-A13, Brno 62500, Czech Republic; [Kokkonen, Piia; Bednar, David; Dockalova, Veronika; Prokop, Zbynek; Damborsky, Jiri] St Annes Univ Hosp, Int Ctr Clin Res, Pekarska 53, Brno 65691, Czech Republic	Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Prokop, Z; Damborsky, J (corresponding author), Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, Dept Expt Biol, Loschmidt Labs, Kamenice 5-A13, Brno 62500, Czech Republic.; Prokop, Z; Damborsky, J (corresponding author), St Annes Univ Hosp, Int Ctr Clin Res, Pekarska 53, Brno 65691, Czech Republic.	zbynek@chemi.muni.cz; jiri@chemi.muni.cz	Damborsky, Jiri/H-3799-2012; Bednar, David/ABF-5943-2020; Prokop, Zbynek/H-5707-2012	Damborsky, Jiri/0000-0002-7848-8216; Bednar, David/0000-0002-6803-0340; Prokop, Zbynek/0000-0001-9358-4081; Brumovska, Veronika/0000-0002-6606-2058; Bartos, Piia/0000-0001-6002-1856	Ministry of Education, Youth and Sports of the Czech Republic under the Project CESNET [LM2015042]; Ministry of Education, Youth and Sports of the Czech Republic under the Project CERIT-Scientific Cloud [LM2015085]	Ministry of Education, Youth and Sports of the Czech Republic under the Project CESNET; Ministry of Education, Youth and Sports of the Czech Republic under the Project CERIT-Scientific Cloud	Computational resources were supplied by the Ministry of Education, Youth and Sports of the Czech Republic under the Projects CESNET (Project No. LM2015042) and CERIT-Scientific Cloud (Project No. LM2015085).	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; [Anonymous], PYMOL MOL GRAPH SYST; Blaha-Nelson D, 2017, J AM CHEM SOC, V139, P1155, DOI 10.1021/jacs.6b10801; Boehr DD, 2018, PROTEIN SCI, V27, P825, DOI 10.1002/pro.3379; Bohac M, 2002, BIOCHEMISTRY-US, V41, P14272, DOI 10.1021/bi026427v; Brezovsky J, 2016, ACS CATAL, V6, P7597, DOI 10.1021/acscatal.6b02081; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Case D., 2015, AMBER, V14; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Damborsky J, 1999, PROTEIN ENG, V12, P989, DOI 10.1093/protein/12.11.989; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doerr S, 2016, J CHEM THEORY COMPUT, V12, P1845, DOI 10.1021/acs.jctc.6b00049; Doerr S, 2014, J CHEM THEORY COMPUT, V10, P2064, DOI 10.1021/ct400919u; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P2371, DOI 10.1021/ct900275y; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Holloway P, 1998, BIOTECHNOL BIOENG, V59, P520, DOI 10.1002/(SICI)1097-0290(19980820)59:4<520::AID-BIT16>3.0.CO;2-D; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KENNES C, 1995, EUR J BIOCHEM, V228, P403; Koudelakova T, 2013, BIOTECHNOL J, V8, P32, DOI 10.1002/biot.201100486; Koudelakova T, 2011, BIOCHEM J, V435, P345, DOI 10.1042/BJ20101405; Krooshof GH, 1998, BIOCHEMISTRY-US, V37, P15013, DOI 10.1021/bi9815187; Krooshof GH, 1999, PROTEIN SCI, V8, P355; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liu XY, 2007, ACTA CRYSTALLOGR D, V63, P1000, DOI 10.1107/S0907444907037705; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Markwick PRL, 2011, PHYS CHEM CHEM PHYS, V13, P20053, DOI 10.1039/c1cp22100k; Marques SM, 2016, UNDERSTANDING ENZYMES: FUNCTION, DESIGN, ENGINEERING, AND ANALYSIS, P421; Nagata Y, 2015, APPL MICROBIOL BIOT, V99, P9865, DOI 10.1007/s00253-015-6954-x; Narayanan C, 2016, CATALYSTS, V6, DOI 10.3390/catal6060081; Naritomi Y, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554380; Otyepka M, 2002, PROTEIN SCI, V11, P1206, DOI 10.1110/ps.ps3830102; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Piccirillo E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196918; Pikkemaat MG, 1999, BIOCHEMISTRY-US, V38, P12052, DOI 10.1021/bi990849w; Pikkemaat MG, 2002, PROTEIN ENG, V15, P185, DOI 10.1093/protein/15.3.185; Pikkemaat MG, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.8.e35; PRIES F, 1994, J BIOL CHEM, V269, P17490; Rogne P, 2018, P NATL ACAD SCI USA, V115, P3012, DOI 10.1073/pnas.1721508115; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; ROZEBOOM HJ, 1988, J MOL BIOL, V200, P611, DOI 10.1016/0022-2836(88)90548-7; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schanstra JP, 1996, J BIOL CHEM, V271, P14747, DOI 10.1074/jbc.271.25.14747; Schanstra JP, 1996, BIOCHEMISTRY-US, V35, P5624, DOI 10.1021/bi952904g; Schanstra JP, 1996, BIOCHEMISTRY-US, V35, P13186, DOI 10.1021/bi961151a; Sharir-Ivry A, 2015, CHEM-EUR J, V21, P7159, DOI 10.1002/chem.201406236; Shek R, 2017, BIOCHEMISTRY-US, V56, P6734, DOI 10.1021/acs.biochem.7b00982; STUCKI G, 1995, ENVIRON SCI TECHNOL, V29, P2339, DOI 10.1021/es00009a028; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	60	6	7	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11505	11512		10.1074/jbc.RA117.000328	http://dx.doi.org/10.1074/jbc.RA117.000328			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858243	Green Published, hybrid			2022-12-28	WOS:000439449700020
J	Snider, SA; Margison, KD; Ghorbani, P; LeBlond, ND; O'Dwyer, C; Nunes, JRC; Nguyen, T; Xu, HB; Bennett, SAL; Fullerton, MD				Snider, Shayne A.; Margison, Kaitlyn D.; Ghorbani, Peyman; LeBlond, Nicholas D.; O'Dwyer, Conor; Nunes, Julia R. C.; Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.			Choline transport links macrophage phospholipid metabolism and inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						choline; macrophage; inflammation; phosphatidylcholine; phospholipid; choline transport; CTL1; Slc44a1; de novo lipogenesis	PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; PHOSPHATIDYLCHOLINE SYNTHESIS; FUNCTIONAL-CHARACTERIZATION; PERITONEAL-MACROPHAGES; ENDOPLASMIC-RETICULUM; CYTOKINE SECRETION; ACTIVATION; EXPRESSION	Choline is an essential nutrient that is required for synthesis of the main eukaryote phospholipid, phosphatidylcholine. Macrophages are innate immune cells that survey and respond to danger and damage signals. Although it is well-known that energy metabolism can dictate macrophage function, little is known as to the importance of choline homeostasis in macrophage biology. We hypothesized that the uptake and metabolism of choline are important for macrophage inflammation. Polarization of primary bone marrow macrophages with lipopolysaccharide (LPS) resulted in an increased rate of choline uptake and higher levels of PC synthesis. This was attributed to a substantial increase in the transcript and protein expression of the choline transporter-like protein-1 (CTL1) in polarized cells. We next sought to determine the importance of choline uptake and CTL1 for macrophage immune responsiveness. Chronic pharmacological or CTL1 antibody-mediated inhibition of choline uptake resulted in altered cytokine secretion in response to LPS, which was associated with increased levels of diacylglycerol and activation of protein kinase C. These experiments establish a previously unappreciated link between choline phospholipid metabolism and macrophage immune responsiveness, highlighting a critical and regulatory role for macrophage choline uptake via the CTL1 transporter.	[Snider, Shayne A.; Margison, Kaitlyn D.; Ghorbani, Peyman; LeBlond, Nicholas D.; O'Dwyer, Conor; Nunes, Julia R. C.; Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.] Univ Ottawa, Ctr Infect Immun & Inflammat, Fac Med, Ottawa, ON K1H 8M5, Canada; [Snider, Shayne A.; Margison, Kaitlyn D.; Ghorbani, Peyman; LeBlond, Nicholas D.; O'Dwyer, Conor; Nunes, Julia R. C.; Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.] Univ Ottawa, Ctr Catalysis Res & Innovat, Fac Med, Ottawa, ON K1H 8M5, Canada; [Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.] Univ Ottawa, Fac Med, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.] Univ Ottawa, Fac Med, Brain & Mind Inst, Ottawa, ON K1H 8M5, Canada; [Snider, Shayne A.; Margison, Kaitlyn D.; Ghorbani, Peyman; LeBlond, Nicholas D.; O'Dwyer, Conor; Nunes, Julia R. C.; Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 4109A Roger Guindon Hall,451 Smyth Rd, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Fullerton, MD (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 4109A Roger Guindon Hall,451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	morgan.fullerton@uottawa.ca	Nguyen-Tran, Thao/ABE-1326-2021; xu, hong/GSD-8903-2022	Nguyen-Tran, Thao/0000-0002-5507-618X; Nunes, Julia/0000-0003-2095-8972; Ghorbani, Peyman/0000-0002-7398-5141	Natural Science and Engineering Research Council (NSERC) of Canada [RGPIN-2015-04004, RGPIN-2015-5377]; Canadian Institutes of Health [MOP 311838]; NSERC Canadian Graduate Scholarship; Ontario Graduate Scholarship; Canadian Institutes of Health Research New Investigator Award [MSH141981]; Ontario Ministry of Research, Innovation; Science Early Researcher Award	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NSERC Canadian Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research, Innovation(Ministry of Research and Innovation, Ontario); Science Early Researcher Award	This work was supported by Natural Science and Engineering Research Council (NSERC) of Canada Discovery Grants RGPIN-2015-04004 (to M. D. F.) and RGPIN-2015-5377 (to S. A. L. B.) and Canadian Institutes of Health Research Grant MOP 311838 (to S. A. L. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an NSERC Canadian Graduate Scholarship.; Supported by an Ontario Graduate Scholarship.; Supported by Canadian Institutes of Health Research New Investigator Award MSH141981 and recipient of an Ontario Ministry of Research, Innovation, and Science Early Researcher Award.	Artyomov MN, 2016, SEMIN IMMUNOL, V28, P417, DOI 10.1016/j.smim.2016.10.004; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Balsinde J, 1997, J BIOL CHEM, V272, P20373, DOI 10.1074/jbc.272.33.20373; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHU AJ, 1992, INT J BIOCHEM, V24, P317, DOI 10.1016/0020-711X(92)90264-2; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; da Costa KA, 2014, FASEB J, V28, P2970, DOI 10.1096/fj.14-249557; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; Foey AD, 2004, IMMUNOLOGY, V112, P44, DOI 10.1111/j.1365-2567.2004.01852.x; Fujita T, 2006, NEUROSCI LETT, V393, P216, DOI 10.1016/j.neulet.2005.09.069; Fullerton MD, 2006, AM J PHYSIOL-CELL PH, V290, pC1230, DOI 10.1152/ajpcell.00255.2005; Fullerton MD, 2015, J LIPID RES, V56, P1025, DOI 10.1194/jlr.M058875; Fullerton MD, 2009, J BIOL CHEM, V284, P25704, DOI 10.1074/jbc.M109.023846; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; GROVE RI, 1990, J LEUKOCYTE BIOL, V48, P38, DOI 10.1002/jlb.48.1.38; Haga T, 2014, J BIOCHEM, V156, P181, DOI 10.1093/jb/mvu047; Huang YL, 2014, J BIOL CHEM, V289, P3001, DOI 10.1074/jbc.M113.524587; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Inazu M, 2005, J NEUROCHEM, V94, P1427, DOI 10.1111/j.1471-4159.2005.03299.x; Ishiguro N, 2008, PHARM RES-DORDR, V25, P417, DOI 10.1007/s11095-007-9362-9; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Langston PK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00061; Lennartz MR, 1999, INT J BIOCHEM CELL B, V31, P415, DOI 10.1016/S1357-2725(98)00108-3; Leonardi R, 2009, J BIOL CHEM, V284, P27077, DOI 10.1074/jbc.M109.031336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Michel V, 2009, FASEB J, V23, P2749, DOI 10.1096/fj.08-121491; Murray RZ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00538; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Norata GD, 2015, IMMUNITY, V43, P421, DOI 10.1016/j.immuni.2015.08.023; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Rowley TJ, 2010, BRIT J ANAESTH, V105, P201, DOI 10.1093/bja/aeq113; Ryan SD, 2009, P NATL ACAD SCI USA, V106, P20936, DOI 10.1073/pnas.0905654106; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Selathurai A, 2015, CELL METAB, V21, P718, DOI 10.1016/j.cmet.2015.04.001; Sweet DH, 2001, J BIOL CHEM, V276, P41611, DOI 10.1074/jbc.M108472200; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Traiffort E, 2013, MOL ASPECTS MED, V34, P646, DOI 10.1016/j.mam.2012.10.011; Treede I, 2007, J BIOL CHEM, V282, P27155, DOI 10.1074/jbc.M704408200; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Whitehead SN, 2007, ANAL CHEM, V79, P8539, DOI 10.1021/ac0712291; Wille S, 2001, J IMMUNOL, V167, P5795, DOI 10.4049/jimmunol.167.10.5795; Xu HB, 2013, FEBS J, V280, P5652, DOI 10.1111/febs.12423; Yen CLE, 1999, FASEB J, V13, P135, DOI 10.1096/fasebj.13.1.135; Yuan ZF, 2006, PHYSIOL GENOMICS, V26, P76, DOI 10.1152/physiolgenomics.00107.2005; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zhang CP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00341-2; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	59	46	48	6	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11600	11611		10.1074/jbc.RA118.003180	http://dx.doi.org/10.1074/jbc.RA118.003180			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29880645	hybrid, Green Published			2022-12-28	WOS:000439449700028
J	Bhattacharyya, S; Feferman, L; Han, XR; Ouyang, YL; Zhang, FM; Linhardt, RJ; Tobacman, JK				Bhattacharyya, Sumit; Feferman, Leo; Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.; Tobacman, Joanne K.			Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); c-Fos; c-Jun transcription factor; chondroitin sulfate; epidermal growth factor receptor (EGFR); Src homology 2 domain (SH2 domain); phosphoprotein phosphatase; arylsulfatase B; N-acetylgalactosamine-4-sulfatase; transcription factor AP-1; PTPN11; prostate; stem cells	EPIDERMAL-GROWTH-FACTOR; MUCOPOLYSACCHARIDOSIS TYPE-VI; FACTOR RECEPTOR; CHONDROITIN SULFATE; SEQUENTIAL DEGRADATION; MELANOMA-CELLS; CANCER; N-ACETYLGALACTOSAMINE-4-SULFATASE; VERSICAN; TISSUE	Epidermal growth factor receptor (EGFR) has a crucial role in cell differentiation and proliferation and cancer, and its expression appears to be up-regulated when arylsulfatase B (ARSB or GalNAc-4-sulfatase) is reduced. ARSB removes 4-sulfate groups from the nonreducing end of dermatan sulfate and chondroitin 4-sulfate (C4S), and its decreased expression has previously been reported to inhibit the activity of the ubiquitous protein-tyrosine phosphatase, nonreceptor type 11 (SHP2 or PTPN11). However, the mechanism by which decline in ARSB leads to decline in SHP2 activity is unclear. Here, we show that SHP2 binds preferentially C4S, rather than chondroitin 6-sulfate, and confirm that SHP2 activity declines when ARSB is silenced. The reduction in ARSB activity, and the resultant increase in C4S, increased the expression of EGFR (Her1/ErbB1) in human prostate stem and epithelial cells. The increased expression of EGFR occurred after 1) the decline in SHP2 activity, 2) enhanced c-Jun N-terminal kinase (JNK) activity, 3) increased nuclear DNA binding by c-Jun and c-Fos, and 4) EGFR promoter activation. In response to exogenous EGF, there was increased bromodeoxyuridine incorporation, consistent with enhanced cell proliferation. These findings indicated that ARSB and chondroitin 4-sulfation affect the activation of an important dual phosphorylation threonine-tyrosine kinase and the mRNA expression of a critical tyrosine kinase receptor in prostate cells. Restoration of ARSB activity with the associated reduction in C4S may provide a new therapeutic approach for managing malignancies in which EGFR-mediated tyrosine kinase signaling pathways are active.	[Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Univ Illinois, Dept Med, 840 S Wood St,CSN 440,M-C 718, Chicago, IL 60612 USA; [Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol & Biomed Engn, Troy, NY 12180 USA; [Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,CSN 440,M-C 718, Chicago, IL 60612 USA.	jkt@uic.edu			University of Illinois Cancer Center	University of Illinois Cancer Center	This work was supported by the University of Illinois Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article.	ANSON DS, 1992, BIOCHEM J, V284, P789, DOI 10.1042/bj2840789; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bhattacharyya S, 2014, ONCOGENE, V33, P5467, DOI 10.1038/onc.2013.483; Bhattacharyya S., 2017, ONCOTARGET, V8; Bhattacharyya S, 2008, J BIOL CHEM, V283, P9523, DOI 10.1074/jbc.M707967200; Bhattacharyya S, 2017, ONCOTARGET, V8, P4169, DOI 10.18632/oncotarget.13751; Bhattacharyya S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153463; Bhattacharyya S, 2014, J BIOL CHEM, V289, P17564, DOI 10.1074/jbc.M114.561589; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bunda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9859; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; CHING KZ, 1993, MOL CELL BIOCHEM, V126, P151, DOI 10.1007/BF00925693; Crawley A, 2004, PEDIATR RES, V55, P585, DOI 10.1203/01.PDR.0000113789.30640.5C; DESOUSA JF, 1990, J BIOL CHEM, V265, P20150; Di Lorenzo G, 2004, TUMORI J, V90, P163, DOI 10.1177/030089160409000201; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; Feferman L, 2013, PROSTATE CANCER P D, V16, P277, DOI 10.1038/pcan.2013.18; Feferman L, 2018, CANCER BIOMARK, V21, P229, DOI 10.3233/CBM-170680; Foulcer SJ, 2015, METHODS MOL BIOL, V1229, P587, DOI 10.1007/978-1-4939-1714-3_46; GLASER JH, 1979, J BIOL CHEM, V254, P2316; Grindel B, 2016, ONCOTARGET, V7, P10433, DOI 10.18632/oncotarget.7197; Gross Mitchell E, 2004, Clin Adv Hematol Oncol, V2, P53; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Guerin O, 2010, PHARMACEUTICALS, V3, P2238, DOI 10.3390/ph3072238; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hernandez D, 2011, J BIOL CHEM, V286, P1475, DOI 10.1074/jbc.M110.127522; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; INGMAR B, 1979, BIOCHEM J, V179, P7, DOI 10.1042/bj1790007; Jathal Maitreyee K., 2011, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V11, P131; Jiang CY, 2012, J CANCER RES CLIN, V138, P637, DOI 10.1007/s00432-011-1143-5; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; Kotlo K, 2013, GLYCOCONJUGATE J, V30, P667, DOI 10.1007/s10719-013-9468-8; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; LaRochelle JR, 2016, BIOCHEMISTRY-US, V55, P2269, DOI 10.1021/acs.biochem.5b01287; Liu ZL, 2010, BIOCHEMISTRY-US, V49, P9839, DOI 10.1021/bi101305b; Luo XL, 2016, CELL REP, V17, P2979, DOI 10.1016/j.celrep.2016.11.048; Manole S, 2016, CANCER RES, V76, P5219, DOI 10.1158/0008-5472.CAN-16-0123; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Qi C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010134; Reyes N, 2016, CANCER BIOMARK, V16, P191, DOI 10.3233/CBM-150555; Rivera-Colon Y, 2012, J MOL BIOL, V423, P736, DOI 10.1016/j.jmb.2012.08.020; Rogerson SJ, 1997, PARASITOL TODAY, V13, P70, DOI 10.1016/S0169-4758(96)10081-8; Serra M, 2005, INT J CANCER, V114, P879, DOI 10.1002/ijc.20813; Seth D, 1999, BRIT J CANCER, V80, P657, DOI 10.1038/sj.bjc.6690407; Sharpe B, 2017, PROSTATE, V77, P1312, DOI 10.1002/pros.23391; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; SHERWOOD ER, 1995, WORLD J UROL, V13, P290; Solit DB, 2007, J CLIN ONCOL, V25, P241, DOI 10.1200/JCO.2006.08.8187; Suhovskih Anastasia V, 2013, ISRN Oncol, V2013, P680136, DOI 10.1155/2013/680136; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; Wang QW, 2016, CANCER INVEST, V34, P255, DOI 10.1080/07357907.2016.1193745; Wight TN, 2018, MATRIX BIOL, V71-72, P396, DOI 10.1016/j.matbio.2018.02.019; Xu W, 2015, GENE THER, V22, P247, DOI 10.1038/gt.2014.110; Zhang XL, 2014, GLIA, V62, P259, DOI 10.1002/glia.22604	62	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11076	11087		10.1074/jbc.RA117.001244	http://dx.doi.org/10.1074/jbc.RA117.001244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794138	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000438882800020
J	Lasala, M; Corradi, J; Bruzzone, A; Esandi, MD; Bouzat, C				Lasala, Matias; Corradi, Jeremias; Bruzzone, Ariana; del Carmen Esandi, Maria; Bouzat, Cecilia			A human-specific, truncated 7 nicotinic receptor subunit assembles with full-length 7 and forms functional receptors with different stoichiometries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); patch clamp; Cys-loop receptor; channel activation; receptor structure-function; ion channel; 7 receptor; single-channel recording	CYS-LOOP RECEPTORS; AGONIST BINDING-SITES; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTORS; SINGLE-CHANNEL; ION-CHANNEL; ALLOSTERIC MODULATION; INFLAMMATORY-RESPONSE; DELETION POLYMORPHISM; PARTIAL DUPLICATION	The cholinergic 7 nicotinic receptor gene, CHRNA7, encodes a subunit that forms the homopentameric 7 receptor, involved in learning and memory. In humans, exons 5-10 in CHRNA7 are duplicated and fused to the FAM7A genetic element, giving rise to the hybrid gene CHRFAM7A. Its product, dup7, is a truncated subunit lacking part of the N-terminal extracellular ligand-binding domain and is associated with neurological disorders, including schizophrenia, and immunomodulation. We combined dup7 expression on mammalian cells with patch clamp recordings to understand its functional role. Transfected cells expressed dup7 protein, but they exhibited neither surface binding of the 7 antagonist -bungarotoxin nor responses to acetylcholine (ACh) or to an allosteric agonist that binds to the conserved transmembrane region. To determine whether dup7 assembles with 7, we generated receptors comprising 7 and dup7 subunits, one of which was tagged with conductance substitutions that report subunit stoichiometry and monitored ACh-elicited channel openings in the presence of a positive allosteric 7 modulator. We found that 7 and dup7 subunits co-assemble into functional heteromeric receptors, which require at least two 7 subunits for channel opening, and that dup7's presence in the pentameric arrangement does not affect the duration of the potentiated events compared with that of 7. Using an 7 subunit mutant, we found that activation of (7)(2)(dup7)(3) receptors occurs through ACh binding at the 7/7 interfacial binding site. Our study contributes to the understanding of the modulation of 7 function by the human specific, duplicated subunit, associated with human disorders.	[Lasala, Matias; Corradi, Jeremias; Bruzzone, Ariana; del Carmen Esandi, Maria; Bouzat, Cecilia] Univ Nacl Sur, CONICET, Dept Biol Bioquim & Farm, Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Bouzat, C (corresponding author), CONICET Bahia Blanca, Inst Invest Bioquim Bahia Blanca INIBIBB, Camino La Carrindanga Km 7, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	inbouzat@criba.edu.ar		Lasala, Matias/0000-0002-0085-6621	Universidad Nacional del Sur (UNS); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina	Universidad Nacional del Sur (UNS); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Universidad Nacional del Sur (UNS) (to C.B. and M.C.E.), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) (to C.B. and J.C.), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina (to C.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Andersen ND, 2016, NEUROPHARMACOLOGY, V107, P189, DOI 10.1016/j.neuropharm.2016.02.032; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Bartos M, 2009, MOL NEUROBIOL, V40, P236, DOI 10.1007/s12035-009-8084-x; Benfante R, 2011, J NEUROIMMUNOL, V230, P74, DOI 10.1016/j.jneuroim.2010.09.008; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Bouzat C, 2018, J PHYSIOL-LONDON, V596, P1847, DOI 10.1113/JP275101; Bouzat C, 2018, BRIT J PHARMACOL, V175, P1789, DOI 10.1111/bph.13770; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Chatzidaki A, 2015, BIOCHEM PHARMACOL, V97, P408, DOI 10.1016/j.bcp.2015.07.028; Chen DN, 1998, J NEUROCHEM, V70, P349; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Corradi J, 2016, MOL PHARMACOL, V90, P288, DOI 10.1124/mol.116.104240; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Costantini TW, 2015, MOL MED, V21, P323, DOI 10.2119/molmed.2015.00018; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; daCosta CJB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9057; daCosta CJB, 2013, P NATL ACAD SCI USA, V110, P6595, DOI 10.1073/pnas.1301909110; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dang XT, 2015, FASEB J, V29, P2292, DOI 10.1096/fj.14-268037; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Flomen RH, 2013, EUR J HUM GENET, V21, P76, DOI 10.1038/ejhg.2012.81; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; GOTTI C, 1995, EUR J NEUROSCI, V7, P2083, DOI 10.1111/j.1460-9568.1995.tb00630.x; Gu SY, 2016, NEURON, V89, P948, DOI 10.1016/j.neuron.2016.01.018; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Kabbani N, 2013, BIOESSAYS, V35, P1025, DOI 10.1002/bies.201300082; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lendvai B, 2013, BRAIN RES BULL, V93, P86, DOI 10.1016/j.brainresbull.2012.11.003; Locke DP, 2005, CYTOGENET GENOME RES, V108, P73, DOI 10.1159/000080804; Mazzaferro S, 2017, J BIOL CHEM, V292, P2729, DOI 10.1074/jbc.M116.764183; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Nielsen BE, 2018, CELL MOL LIFE SCI, V75, P2457, DOI 10.1007/s00018-017-2741-4; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Puskar NL, 2011, J BIOL CHEM, V286, P14618, DOI 10.1074/jbc.M110.206565; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Tsetlin V, 2007, LIFE SCI, V80, P2202, DOI 10.1016/j.lfs.2007.01.007; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	58	14	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10707	10717		10.1074/jbc.RA117.001698	http://dx.doi.org/10.1074/jbc.RA117.001698			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29784875	Green Published, hybrid			2022-12-28	WOS:000437828400026
J	Jha, B; Kumar, D; Sharma, A; Dwivedy, A; Singh, R; Biswal, BK				Jha, Bhavya; Kumar, Deepak; Sharma, Arun; Dwivedy, Abhisek; Singh, Ramandeep; Biswal, Bichitra Kumar			Identification and structural characterization of a histidinol phosphate phosphatase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; tuberculosis; histidine; phosphatase; inhibitor	IMIDAZOLEGLYCEROLPHOSPHATE DEHYDRATASE; SECONDARY-STRUCTURE; ESCHERICHIA-COLI; BIOSYNTHESIS; SEQUENCE; EXPRESSION; ALIGNMENT; CLONING; PATHWAY; FAMILY	The absence of a histidine biosynthesis pathway in humans, coupled with histidine essentiality for survival of the important human pathogen Mycobacterium tuberculosis (Mtb), underscores the importance of the bacterial enzymes of this pathway as major antituberculosis drug targets. However, the identity of the mycobacterial enzyme that functions as the histidinol phosphate phosphatase (HolPase) of this pathway remains to be established. Here, we demonstrate that the enzyme encoded by the Rv3137 gene, belonging to the inositol monophosphatase (IMPase) family, functions as the Mtb HolPase and specifically dephosphorylates histidinol phosphate. The crystal structure of Rv3137 in apo form enabled us to dissect its distinct structural features. Furthermore, the holo-complex structure revealed that a unique cocatalytic multizinc-assisted mode of substrate binding and catalysis is the hallmark of Mtb HolPase. Interestingly, the enzyme-substrate complex structure unveiled that although monomers possess individual catalytic sites they share a common product-exit channel at the dimer interface. Furthermore, target-based screening against HolPase identified several small-molecule inhibitors of this enzyme. Taken together, our study unravels the missing enzyme link in the Mtb histidine biosynthesis pathway, augments our current mechanistic understanding of histidine production in Mtb, and has helped identify potential inhibitors of this bacterial pathway.	[Jha, Bhavya; Kumar, Deepak; Dwivedy, Abhisek; Biswal, Bichitra Kumar] Natl Inst Immunol, Struct & Funct Biol Lab, Aruna Asaf Ali Marg, Delhi 110007, India; [Sharma, Arun; Singh, Ramandeep] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Faridabad 121001, Haryana, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Biswal, BK (corresponding author), Natl Inst Immunol, Struct & Funct Biol Lab, Aruna Asaf Ali Marg, Delhi 110007, India.	bbiswal@nii.ac.in	Dwivedy, Abhisek/AAV-4406-2021; Kumar, Deepak/AAB-7660-2022	Kumar, Deepak/0000-0001-5868-2057; Jha, Bhavya/0000-0002-0944-4279; Biswal, Bichitra/0000-0002-5927-3244; Singh, Ramandeep/0000-0003-2705-3826; Dwivedy, Abhisek/0000-0001-9745-8138	Department of Biotechnology (DBT), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by the Department of Biotechnology (DBT), Government of India, for X-ray data collection at synchrotron beamlines BM14 and ID30B of the European Synchrotron Radiation Facility, Grenoble, France. The authors declare that they have no conflicts of interest with the contents of this article.	Ahangar MS, 2013, ACTA CRYSTALLOGR D, V69, P2461, DOI 10.1107/S0907444913022579; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BAZZICALUPO M, 1987, MOL GEN GENET, V206, P76, DOI 10.1007/BF00326539; Castellani M, 2010, J BIOL CHEM, V285, P502, DOI 10.1074/jbc.M109.072959; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHIARIOTTI L, 1986, MOL GEN GENET, V202, P42, DOI 10.1007/BF00330514; Cho Y, 2003, J BIOL CHEM, V278, P8333, DOI 10.1074/jbc.M212124200; Cho Y, 2008, J MED CHEM, V51, P5984, DOI 10.1021/jm800328v; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Due AV, 2011, P NATL ACAD SCI USA, V108, P3554, DOI 10.1073/pnas.1015996108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Ghodge SV, 2013, BIOCHEMISTRY-US, V52, P1101, DOI 10.1021/bi301496p; Hogbom M, 2005, MOL CELL PROTEOMICS, V4, P827, DOI 10.1074/mcp.T400023-MCP200; Javid-Majd F, 2008, ACTA CRYSTALLOGR D, V64, P627, DOI 10.1107/S0907444908007105; Jiang JW, 2016, AQUAC RES, V47, P1269, DOI 10.1111/are.12586; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulis-Horn RK, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1069-4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li W., 2016, FASEB J S, V30; Lunardi J, 2013, CURR TOP MED CHEM, V13, P2866, DOI 10.2174/15680266113136660203; MANO J, 1993, PLANT PHYSIOL, V103, P733, DOI 10.1104/pp.103.3.733; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marineo S, 2008, CURR MICROBIOL, V56, P6, DOI 10.1007/s00284-007-9014-7; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mormann S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-205; Movahedzadeh F, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-50; Murima P, 2014, CHEM BIOL, V21, P1423, DOI 10.1016/j.chembiol.2014.08.020; Nasir N, 2016, SCI REP-UK, V6, DOI 10.1038/srep18880; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parish T, 2003, J BACTERIOL, V185, P6702, DOI 10.1128/JB.185.22.6702-6706.2003; PARKER AR, 1994, GENE, V145, P135, DOI 10.1016/0378-1119(94)90336-0; Petersen LN, 2010, PLANT PHYSIOL, V152, P1186, DOI 10.1104/pp.109.150805; Poon BK, 2010, ACTA CRYSTALLOGR D, V66, P503, DOI 10.1107/S0907444910001502; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruszkowski M, 2016, J BIOL CHEM, V291, P9960, DOI 10.1074/jbc.M115.708727; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SEELIG GF, 1980, J BIOL CHEM, V255, P9589; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; STAPLES MA, 1979, J BIOL CHEM, V254, P1395; Sydor AM, 2013, BIOCHEMISTRY-US, V52, P1788, DOI 10.1021/bi301600z; TADA S, 1994, PLANT PHYSIOL, V105, P579, DOI 10.1104/pp.105.2.579; VALLEE BL, 1993, P NATL ACAD SCI USA, V90, P2715, DOI 10.1073/pnas.90.7.2715; Wellington S, 2017, NAT CHEM BIOL, V13, P943, DOI [10.1038/NCHEMBIO.2420, 10.1038/nchembio.2420]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045	57	6	6	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10102	10118		10.1074/jbc.RA118.002299	http://dx.doi.org/10.1074/jbc.RA118.002299			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29752410	Green Published, hybrid			2022-12-28	WOS:000437096700014
J	Tidhar, R; Zelnik, ID; Volpert, G; Ben-Dor, S; Kelly, S; Merrill, AH; Futerman, AH				Tidhar, Rotem; Zelnik, Iris D.; Volpert, Giora; Ben-Dor, Shifra; Kelly, Samuel; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Eleven residues determine the acyl chain specificity of ceramide synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; ceramide synthase; sphingolipid; membrane; lipid	TRANSMEMBRANE PROTEIN TOPOLOGY; LONGEVITY ASSURANCE GENES; ENDOPLASMIC-RETICULUM; METABOLIC-PATHWAYS; FAMILY-MEMBERS; WEB SERVER; PREDICTION; SPHINGANINE; LAG1; DOMAINS	Lipids display large structural complexity, with approximate to 40,000 different lipids identified to date, approximate to 4000 of which are sphingolipids. A critical factor determining the biological activities of the sphingolipid, ceramide, and of more complex sphingolipids is their N-acyl chain length, which in mammals is determined by a family of six ceramide synthases (CerS). Little information is available about the CerS regions that determine specificity toward different acyl-CoA substrates. We previously demonstrated that substrate specificity resides in a region of approximate to 150 residues in the Tram-Lag-CLN8 domain. Using site-directed mutagenesis and biochemical analyses, we now narrow specificity down to an 11-residue sequence in a loop located between the last two putative transmembrane domains (TMDs) of the CerS. The specificity of a chimeric protein, CerS5((299-309CerS2)), based on the backbone of CerS5 (which generates C16-ceramide), but containing 11 residues from CerS2 (which generates C22-C24-ceramides), was altered such that it generated C22-C24 and other ceramides. Moreover, a chimeric protein, CerS4((291-301CerS2)), based on CerS4 (which normally generates C18-C22 ceramides) displayed significant activity toward C24:1-CoA. Additional data supported the notion that substitutions of these 11 residues alter the specificities of the CerS toward their cognate acyl-CoAs. Our findings may suggest that this short loop may restrict adjacent TMDs, leading to a more open conformation in the membrane, and that the CerS acting on shorter acyl-CoAs may have a longer, more flexible loop, permitting TMD flexibility. In summary, we have identified an 11-residue region that determines the acyl-CoA specificity of CerS.	[Tidhar, Rotem; Zelnik, Iris D.; Volpert, Giora; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Ben-Dor, Shifra] Weizmann Inst Sci, Life Sci Core Facil, IL-76100 Rehovot, Israel; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Tidhar, Rotem] 3PLW, IL-4250408 Netanya, Israel; [Volpert, Giora] Vens Med, IL-4250704 Netanya, Israel; [Futerman, Anthony H.] Weizmann Inst Sci, Biochem, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Weizmann Institute of Science	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	BEN-DOR, SHIFRA/M-6718-2019	BEN-DOR, SHIFRA/0000-0001-9604-1939; Futerman, Anthony/0000-0003-0013-0115	National Institutes of Health [GM076217]; Israel Science Foundation [1728/15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM076217 and Israel Science Foundation Grant 1728/15. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Ekroos K., 2012, LIPIDOMICS TECHNOLOG, V1st, P1; Futerman A. H., 2015, BIOCH LIPIDS LIPOPRO, P297; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Ikeda M, 2003, NUCLEIC ACIDS RES, V31, P406, DOI 10.1093/nar/gkg020; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Pasquier C, 1999, PROTEIN ENG, V12, P631, DOI 10.1093/protein/12.8.631; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Rost B, 1996, METHOD ENZYMOL, V266, P525; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Tidhar R, 2015, J LIPID RES, V56, P193, DOI 10.1194/jlr.D052001; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Volpert G, 2017, J CELL SCI, V130, P1486, DOI 10.1242/jcs.199968; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411	47	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9912	9921		10.1074/jbc.RA118.001936	http://dx.doi.org/10.1074/jbc.RA118.001936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29632068	Green Published, hybrid			2022-12-28	WOS:000436102300032
J	Lei, SF; Clydesdale, L; Dai, AT; Cai, XQ; Feng, Y; Yang, DH; Liang, YL; Koole, C; Zhao, PS; Coudrat, T; Christopoulos, A; Wang, MW; Wootten, D; Sexton, PM				Lei, Saifei; Clydesdale, Lachlan; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Yang, Dehua; Liang, Yi-Lynn; Koole, Cassandra; Zhao, Peishen; Coudrat, Thomas; Christopoulos, Arthur; Wang, Ming-Wei; Wootten, Denise; Sexton, Patrick M.			Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); glucagon; receptor structure-function; cell signaling; site-directed mutagenesis; biased agonism; GLP-1 receptor; glucagon-like peptide-1; class B peptide hormone; ERK kinase; arrestin; transmembrane domain	CRYO-EM STRUCTURE; GLP-1 RECEPTOR; TRANSMEMBRANE DOMAIN; LIGAND-BINDING; N-TERMINUS; ACTIVATION; COMPLEX; MECHANISM; RESIDUES; CORE	G protein-coupled receptors (GPCRs) can be differentially activated by ligands to generate multiple and distinct downstream signaling profiles, a phenomenon termed biased agonism. The glucagon-like peptide-1 receptor (GLP-1R) is a class B GPCR and a key drug target for managing metabolic disorders; however, its peptide agonists display biased signaling that affects their relative efficacies. In this study, we combined mutagenesis experiments and mapping of surface mutations onto recently described GLP-1R structures, which revealed two major domains in the GLP-1/GLP-1R/G(s) protein active structure that are differentially important for both receptor quiescence and ligand-specific initiation and propagation of biased agonism. Changes to the conformation of transmembrane helix (TM) 5 and TM 6 and reordering of extracellular loop 2 were essential for the propagation of signaling linked to cAMP formation and intracellular calcium mobilization, whereas ordering and packing of residues in TMs 1 and 7 were critical for extracellular signal-regulated kinase 1/2 (pERK) activity. On the basis of these findings, we propose a model of distinct peptide-receptor interactions that selectively control how these different signaling pathways are engaged. This work provides important structural insight into class B GPCR activation and biased agonism.	[Lei, Saifei; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Yang, Dehua; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Lei, Saifei; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Yang, Dehua; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Clydesdale, Lachlan; Liang, Yi-Lynn; Koole, Cassandra; Zhao, Peishen; Coudrat, Thomas; Christopoulos, Arthur; Wootten, Denise; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Lei, Saifei; Wang, Ming-Wei] Univ Chinese Acad Sci, Sch Pharm, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Wang, Ming-Wei; Wootten, Denise; Sexton, Patrick M.] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Monash University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University	Wang, MW (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China.; Wang, MW (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China.; Wootten, D; Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.; Wang, MW (corresponding author), Univ Chinese Acad Sci, Sch Pharm, 19A Yuquan Rd, Beijing 100049, Peoples R China.; Wang, MW; Wootten, D; Sexton, PM (corresponding author), Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China.	mwwang@simm.ac.cn; denise.wootten@monash.edu; patrick.sexton@monash.edu	Yang, Dehua/M-5789-2019; Sexton, Patrick M/B-1319-2008; Zhao, Peishen/AFQ-6840-2022; Wootten, Denise/ABD-5703-2021; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Wootten, Denise/0000-0003-4563-1642; Christopoulos, Arthur/0000-0003-4442-3294; Coudrat, Thomas/0000-0001-9197-1889	National Health and Medical Research Council of Australia [1061044, 1065410, 1126857]; National Health and Medical Research Council [1055134]; Shanghai Science and Technology Development Fund [15DZ2291600]; National Natural Science Foundation of China [81573479]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12020347, XDA12040308]; Chinese Academy of Sciences	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Shanghai Science and Technology Development Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Health and Medical Research Council of Australia Project Grants 1061044, 1065410, and 1126857; National Health and Medical Research Council Program Grant 1055134; Shanghai Science and Technology Development Fund Grant 15DZ2291600; National Natural Science Foundation of China Grant 81573479; and Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA12020347 and XDA12040308. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of the Postgraduate Overseas Study Fellowship from the Chinese Academy of Sciences.	Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Costa-Neto CM, 2016, MOL PHARMACOL, V90, P587, DOI 10.1124/mol.116.105940; Dal Maso E, 2018, BIOCHEM PHARMACOL, V150, P212, DOI 10.1016/j.bcp.2018.02.005; de Graaf C, 2016, PHARMACOL REV, V68, P954, DOI 10.1124/pr.115.011395; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Dods RL, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150253; Hager MV, 2017, BIOCHEM PHARMACOL, V136, P99, DOI 10.1016/j.bcp.2017.03.018; Hager MV, 2016, J AM CHEM SOC, V138, P14970, DOI 10.1021/jacs.6b08323; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Jazayeri A, 2017, NATURE, V546, P254, DOI 10.1038/nature22800; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Koole C, 2015, J PHARMACOL EXP THER, V353, P52, DOI 10.1124/jpet.114.220913; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koole C, 2011, MOL PHARMACOL, V80, P486, DOI 10.1124/mol.111.072884; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Mukund S, 2013, J BIOL CHEM, V288, P36168, DOI 10.1074/jbc.M113.496984; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Song GJ, 2017, NATURE, V546, P312, DOI 10.1038/nature22378; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Weston C, 2014, BRIT J PHARMACOL, V171, P3651, DOI 10.1111/bph.12716; Wootten D, 2017, CHEM REV, V117, P111, DOI 10.1021/acs.chemrev.6b00049; Wootten D, 2016, BIOCHEM PHARMACOL, V118, P68, DOI 10.1016/j.bcp.2016.08.015; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yin YT, 2017, J BIOL CHEM, V292, P9865, DOI 10.1074/jbc.M117.782987; Yin YT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.42; Zhang HN, 2018, NATURE, V553, P106, DOI 10.1038/nature25153; Zhang HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9918; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhao LH, 2016, J BIOL CHEM, V291, P15119, DOI 10.1074/jbc.M116.726620	40	31	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9370	9387		10.1074/jbc.RA118.003278	http://dx.doi.org/10.1074/jbc.RA118.003278			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29717000	hybrid, Green Published			2022-12-28	WOS:000435441400022
J	Abdulrahman, BA; Abdelaziz, DH; Schatzl, HM				Abdulrahman, Basant A.; Abdelaziz, Dalia H.; Schatzl, Hermann M.			Autophagy regulates exosomal release of prions in neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGGREGATE-PRONE PROTEINS; CELLULAR PRION; NEURODEGENERATIVE DISEASES; EXTRACELLULAR VESICLES; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; INFECTED CELLS; UNCONVENTIONAL SECRETION; MULTIVESICULAR BODIES; SELF-DIGESTION	Prions are protein-based infectious agents that autocatalytically convert the cellular prion protein PrP C to its pathological isoform PrPSc. Subsequent aggregation and accumulation of PrPSc in nervous tissues causes several invariably fatal neurodegenerative diseases in humans and animals. Prions can infect recipient cells when packaged into endosome-derived nanoparticles called exosomes, which are present in biological fluids such as blood, urine, and saliva. Autophagy is a basic cellular degradation and recycling machinery that also affects exosomal processing, but whether autophagy controls release of prions in exosomes is unclear. Our work investigated the effect of autophagy modulation on exosomal release of prions and how this interplay affects cellular prion infection. Exosomes isolated from cultured murine central neuronal cells (CAD5) and peripheral neuronal cells (N2a) contained prions as shown by immunoblotting for PrPSc, prion-conversion activity, and cell culture infection. We observed that autophagy stimulation with the mTOR inhibitor rapamycin strongly inhibited exosomal prion release. In contrast, inhibition of autophagy by wortmannin or CRISPR/ Cas9-mediated knockout of the autophagy protein Atg5 (autophagy-related 5) greatly increased the release of exosomes and exosome-associated prions. We also show that a difference in exosomal prion release between CAD5 and N2a cells is related to differences at the level of basal autophagy. Taken together, our results indicate that autophagy modulation can control lateral transfer of prions by interfering with their exosomal release. We describe a novel role of autophagy in the prion life cycle, an understanding that may provide useful targets for containing prion diseases.	[Abdulrahman, Basant A.; Abdelaziz, Dalia H.; Schatzl, Hermann M.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada; [Abdulrahman, Basant A.; Abdelaziz, Dalia H.; Schatzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB T2N 4Z6, Canada; [Abdulrahman, Basant A.; Abdelaziz, Dalia H.] Helwan Univ, Dept Biochem & Mol Biol, Fac Pharm, Cairo 11795, Egypt; [Schatzl, Hermann M.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Schatzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Helwan University; University of Wyoming; University of Wyoming	Schatzl, HM (corresponding author), Univ Calgary, Fac Vet Med, TRW 2D10,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	hschaetz@ucalgary.ca		Schatzl, Hermann/0000-0003-4972-8740; Abdulrahman, Basant/0000-0002-4970-6835	NINDS, National Institutes of Health [R01 NS076853-01A1]; Alberta Innovates-Health Solutions [201200002, 201300020, 201600010]; Canadian Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-05130]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates-Health Solutions; Canadian Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant R01 NS076853-01A1, Alberta Innovates-Health Solutions Grant 201200002, 201300020, and 201600010, and Canadian Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2015-05130. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; Cortes CJ, 2014, DRUG DISCOV TODAY, V19, P963, DOI 10.1016/j.drudis.2014.02.014; Cortes CJ, 2012, J NEUROSCI, V32, P12396, DOI 10.1523/JNEUROSCI.6189-11.2012; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Dias MVS, 2016, AUTOPHAGY, V12, P2113, DOI 10.1080/15548627.2016.1226735; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Gilch S, 2011, TOP CURR CHEM, V305, P51, DOI 10.1007/128_2011_159; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Guo BB, 2016, J BIOL CHEM, V291, P5128, DOI 10.1074/jbc.M115.684258; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Ishibashi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137958; Janas AM, 2016, BBA-BIOMEMBRANES, V1858, P1139, DOI 10.1016/j.bbamem.2016.02.011; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liberski PP, 2004, INT J BIOCHEM CELL B, V36, P2473, DOI 10.1016/j.biocel.2004.04.016; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nakagaki T, 2013, AUTOPHAGY, V9, P1386, DOI 10.4161/auto.25381; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qi YP, 1997, J NEUROSCI, V17, P1217; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Quek C, 2017, BIOCHEM BIOPH RES CO, V483, P1178, DOI 10.1016/j.bbrc.2016.09.090; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rester R, 2010, P NATL ACAD SCI USA, V107, P13147; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schatzl HM, 1997, J VIROL, V71, P8821; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shrivastava S, 2016, J VIROL, V90, P1387, DOI 10.1128/JVI.02383-15; Sikorska B, 2004, INT J BIOCHEM CELL B, V36, P2563, DOI 10.1016/j.biocel.2004.04.014; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Tang Z, 2015, BBA-MOL CELL RES, V1853, P1646, DOI 10.1016/j.bbamcr.2015.03.003; Telling GC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003090; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yun SW, 2007, J NEUROVIROL, V13, P328, DOI 10.1080/13550280701361516; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zanusso G, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2016.92; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	82	71	72	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8956	8968		10.1074/jbc.RA117.000713	http://dx.doi.org/10.1074/jbc.RA117.000713			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29700113	hybrid, Green Published			2022-12-28	WOS:000434941900019
J	Aziz, Q; Finlay, M; Montaigne, D; Ojake, L; Li, YW; Anderson, N; Ludwig, A; Tinker, A				Aziz, Qadeer; Finlay, Malcolm; Montaigne, David; Ojake, Leona; Li, Yiwen; Anderson, Naomi; Ludwig, Andreas; Tinker, Andrew			ATP-sensitive potassium channels in the sinoatrial node contribute to heart rate control and adaptation to hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY REPOLARIZATION; K+ CHANNELS; MECHANISM; MUTATION; SUBUNIT; ATRIAL; KIR6.1; GAIN	ATP-sensitive potassium channels (K-ATP) contribute to membrane currents in many tissues, are responsive to intracellular metabolism, and open as ATP falls and ADP rises. K-ATP channels are widely distributed in tissues and are prominently expressed in the heart. They have generally been observed in ventricular tissue, but they are also expressed in the atria and conduction tissues. In this study, we focused on the contribution and role of the inwardly rectifying K-ATP channel subunit, Kir6.1, in the sinoatrial node (SAN). To develop a murine, conduction-specific Kir6.1 KO model, we selectively deleted Kir6.1 in the conduction system in adult mice (cKO). Electrophysiological data in single SAN cells indicated that Kir6.1 underlies a K-ATP current in a significant proportion of cells and influences early repolarization during pacemaking, resulting in prolonged cycle length. Implanted telemetry probes to measure heart rate and electrocardiographic characteristics revealed that the cKO mice have a slow heart rate, with episodes of sinus arrest in some mice. The PR interval (time between the onset of the P wave to the beginning of QRS complex) was increased, suggesting effects on the atrioventricular node. Ex vivo studies of whole heart or dissected heart regions disclosed impaired adaptive responses of the SAN to hypoxia, and this may have had long-term pathological consequences in the cKO mice. In conclusion, Kir6.1-containing K-ATP channels in the SAN have a role in excitability, heart rate control, and the electrophysiological adaptation of the SAN to hypoxia.	[Aziz, Qadeer; Finlay, Malcolm; Ojake, Leona; Li, Yiwen; Anderson, Naomi; Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Ctr Heart, London EC1M 6BQ, England; [Ludwig, Andreas] Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, D-91054 Erlangen, Germany; [Montaigne, David] CHU Lille, Dept Clin Physiol & Echocardiog, F-59000 Lille, France; [Montaigne, David] Univ Lille, EGID, INSERM, UMR1011, F-59000 Lille, France	University of London; Queen Mary University London; University of Erlangen Nuremberg; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Tinker, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Heart, Charterhouse Sq, London EC1M 6BQ, England.	a.tinker@qmul.ac.uk	Montaigne, David/R-6066-2018	Montaigne, David/0000-0002-2346-863X; Aziz, Qadeer/0000-0002-7636-6813	British Heart Foundation [RG/15/15/31742]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grant RG/15/15/31742) and was facilitated by the National Institute of Health Research Biomedical Research Centre at Barts. The authors declare that they have no conflicts of interest with the contents of this article.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT FM, 1987, FEBS LETT, V215, P9, DOI 10.1016/0014-5793(87)80103-5; Aziz Q, 2017, J BIOL CHEM, V292, P17587, DOI 10.1074/jbc.M117.810325; Aziz Q, 2014, HYPERTENSION, V64, P523, DOI 10.1161/HYPERTENSIONAHA.114.03116; Bao L, 2011, CIRC-ARRHYTHMIA ELEC, V4, P926, DOI 10.1161/CIRCEP.111.964643; Barajas-Martinez H, 2012, HEART RHYTHM, V9, P548, DOI 10.1016/j.hrthm.2011.10.035; Boyett MR, 2003, J CARDIOVASC ELECTR, V14, P104, DOI 10.1046/j.1540-8167.2003.02307.x; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; Delaney JT, 2012, EUROPACE, V14, P1428, DOI 10.1093/europace/eus150; Fedorov VV, 2011, J MOL CELL CARDIOL, V51, P215, DOI 10.1016/j.yjmcc.2011.04.016; Flagg TP, 2008, CIRC RES, V103, P1458, DOI 10.1161/CIRCRESAHA.108.178186; Fukuzaki K, 2008, J PHYSIOL-LONDON, V586, P2767, DOI 10.1113/jphysiol.2007.148932; Giblin JP, 2002, J BIOL CHEM, V277, P13717, DOI 10.1074/jbc.M112209200; Glukhov AV, 2010, J MOL CELL CARDIOL, V48, P152, DOI 10.1016/j.yjmcc.2009.08.026; Han X, 1996, J PHYSIOL-LONDON, V490, P337, DOI 10.1113/jphysiol.1996.sp021148; Hoesl E, 2008, J MOL CELL CARDIOL, V45, P62, DOI 10.1016/j.yjmcc.2008.04.008; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lane JD, 2017, J MEMBRANE BIOL, V250, P471, DOI 10.1007/s00232-017-9973-y; Levin MD, 2016, P NATL ACAD SCI USA, V113, P6773, DOI 10.1073/pnas.1606465113; Levin MD, 2015, HEART RHYTHM, V12, P2316, DOI 10.1016/j.hrthm.2015.06.042; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Mangoni ME, 2001, CARDIOVASC RES, V52, P51, DOI 10.1016/S0008-6363(01)00370-4; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Tester DJ, 2011, CIRC-CARDIOVASC GENE, V4, P510, DOI 10.1161/CIRCGENETICS.111.960195; Tinker A, 2014, BRIT J PHARMACOL, V171, P12, DOI 10.1111/bph.12407; Unudurthi SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002865; Zingman LV, 2007, J APPL PHYSIOL, V103, P1888, DOI 10.1152/japplphysiol.00747.2007; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199; Zuberi Z, 2008, AM J PHYSIOL-REG I, V295, pR1822, DOI 10.1152/ajpregu.90625.2008	36	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8912	8921		10.1074/jbc.RA118.002775	http://dx.doi.org/10.1074/jbc.RA118.002775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29666184	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000434941900015
J	Barlow, P				Barlow, Paul			Grasping the nettle: A bacterial invasin that targets immunoglobulin variable domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								In a new paper, the protein InvD from Yersinia pseudotuberculosis, a zoonotic pathogen, is shown to assist late-stage invasion of intestinal epithelia. Remarkably, InvD acts by binding the Fab region of IgG or IgA. It straddles adjacent light-chain and heavy-chain variable domains, but its binding is different from that of antigens in that complementarity-determining regions do not participate. Structure determination revealed that its Fab-interacting domain adopts an immunoglobulin-like fold, fused to the preceding immunoglobulin-like domain and carried on a long stalk anchored to the bacterial outer membrane. Possible roles of this unusual host-pathogen interaction include avoidance of clearance from the intestine by secretory IgA.	[Barlow, Paul] Univ Edinburgh, Sch Chem, Edinburgh EH9 3FJ, Midlothian, Scotland; [Barlow, Paul] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3FJ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Barlow, P (corresponding author), Univ Edinburgh, Sch Chem, Edinburgh EH9 3FJ, Midlothian, Scotland.; Barlow, P (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3FJ, Midlothian, Scotland.							Beckingham JA, 1999, BIOCHEM J, V340, P193, DOI 10.1042/0264-6021:3400193; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Marone G., 2004, Clinical and Experimental Allergy Reviews, V4, P64, DOI 10.1111/j.1472-9725.2004.00036.x; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Sadana P, 2018, J BIOL CHEM, V293, P8672, DOI 10.1074/jbc.RA117.001068; Townsley-Fuchs J, 1997, Int Rev Immunol, V14, P325, DOI 10.3109/08830189709116523	6	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8691	8692		10.1074/jbc.H118.002949	http://dx.doi.org/10.1074/jbc.H118.002949			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29858390	Green Published, hybrid			2022-12-28	WOS:000434205700030
J	Ma, TJ; Li, BY; Wang, R; Lau, PK; Huang, Y; Jiang, LW; Schekman, R; Guo, YS				Ma, Tianji; Li, Baiying; Wang, Ryan; Lau, Pik Ki; Huang, Yan; Jiang, Liwen; Schekman, Randy; Guo, Yusong			A mechanism for differential sorting of the planar cell polarity proteins Frizzled6 and Vangl2 at the trans-Golgi network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein sorting; protein trafficking (Golgi); adaptor protein; protein secretion; vesicles	PLASMA MEMBRANE TRAFFICKING; CLATHRIN-COATED VESICLES; MOLECULAR-BASIS; RIGHT DIRECTION; EXPORT SIGNAL; ARF FAMILY; CARGO; EPSINR; ADAPTER; DROSOPHILA	In planar cell polarity (PCP), the epithelial cells are polarized along the plane of the cell surface perpendicular to the classical apical-basal axis, a process mediated by several conserved signaling receptors. Two PCP-signaling proteins, VANGL planar cell polarity protein 2 (Vangl2) and Frizzled6 (Fzd6), are located asymmetrically on opposite boundaries of the cell. Examining sorting of these two proteins at the trans-Golgi network (TGN), we demonstrated previously that the GTP-binding protein ADP-ribosylation factor-related protein 1 (Arfrp1) and the clathrin-associated adaptor protein complex 1 (AP-1) are required for Vangl2 transport from the TGN. In contrast, TGN export of Frizzled6 does not depend on Arfrp1 or AP-1. Here, to further investigate the TGN sorting process in mammalian cells, we reconstituted release of Vangl2 and Frizzled6 from the TGN into vesicles in vitro. Immunoblotting of released vesicles indicated that Vangl2 and Frizzled6 exit the TGN in separate compartments. Knockdown analysis revealed that a clathrin adaptor, epsinR, regulates TGN export of Frizzled6 but not of Vangl2. Protein interaction analysis suggested that epsinR forms a stable complex with clathrin and that this complex interacts with a conserved polybasic motif in the Frizzled6 cytosolic domain to package Frizzled6 into transport vesicles. Moreover, we found that Frizzled6-epsinR binding dissociates epsinR from AP-1, which may separate these two cargo adaptors from each other to perform distinct cargo-sorting functions. Our results suggest that Vangl2 and Frizzled6 are packaged into separate vesicles that are regulated by different clathrin adaptors at the TGN, which may contribute to their asymmetric localizations.	[Ma, Tianji; Lau, Pik Ki; Huang, Yan; Guo, Yusong] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Wang, Ryan; Schekman, Randy] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Li, Baiying; Jiang, Liwen] Chinese Univ Hong Kong, Ctr Cell & Dev Biol, State Key Lab Agrobiotechnol, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Wang, Ryan] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Schekman, Randy] Howard Hughes Med Inst, Chevy Chase, MD USA; [Schekman, Randy] Univ Calif Berkeley, Miller Inst, Berkeley, CA 94720 USA	Hong Kong University of Science & Technology; University of California System; University of California Berkeley; Chinese University of Hong Kong; Northwestern University; Feinberg School of Medicine; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Guo, YS (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	guoyusong@ust.hk	JIANG, Liwen/S-6046-2018; Guo, Yusong/AAD-7027-2019; Guo, Yusong/C-7705-2011	JIANG, Liwen/0000-0002-7829-1472; Guo, Yusong/0000-0002-5539-599X	Hong Kong Research Grants Council [26100315, 16101116, AoE/M-05/12]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported in part by Hong Kong Research Grants Council Grants 26100315, 16101116, and AoE/M-05/12 (to Y.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar RC, 2006, P NATL ACAD SCI USA, V103, P4116, DOI 10.1073/pnas.0510513103; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; Carvajal-Gonzalez JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7751; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Curwin AJ, 2012, MOL BIOL CELL, V23, P2327, DOI 10.1091/mbc.E11-09-0826; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Devenport D, 2014, J CELL BIOL, V207, P171, DOI 10.1083/jcb.201408039; Dodd ME, 2009, DEVELOPMENT, V136, P2591, DOI 10.1242/dev.038448; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Frojmark AS, 2011, AM J HUM GENET, V88, P852, DOI 10.1016/j.ajhg.2011.05.013; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Guo YS, 2013, ELIFE, V2, DOI 10.7554/eLife.00160; Harumoto T, 2010, DEV CELL, V19, P389, DOI 10.1016/j.devcel.2010.08.004; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Henderson DJ, 2006, TRENDS CARDIOVAS MED, V16, P38, DOI 10.1016/j.tcm.2005.11.005; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hirst J, 2015, MOL BIOL CELL, V26, P3085, DOI 10.1091/mbc.E15-04-0245; Horvath CAJ, 2007, INT J BIOCHEM CELL B, V39, P1765, DOI 10.1016/j.biocel.2006.12.004; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kienzle C, 2014, J CELL BIOL, V206, P635, DOI 10.1083/jcb.201311052; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046357; Lee JH, 2009, DEV BIOL, V331, P1, DOI 10.1016/j.ydbio.2009.03.029; Leventis PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025466; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Olofsson J, 2014, DEVELOPMENT, V141, P2866, DOI 10.1242/dev.105932; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Parmar HB, 2016, MOL BIOL CELL, V27, P1320, DOI 10.1091/mbc.E15-12-0845; Parmar HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094194; Parmar HB, 2014, MOL BIOL CELL, V25, P866, DOI 10.1091/mbc.E13-07-0364; Peng Y, 2012, CURR TOP DEV BIOL, V101, P33, DOI 10.1016/B978-0-12-394592-1.00002-8; Ponnambalam S, 1996, J CELL SCI, V109, P675; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wu J, 2013, NAT CELL BIOL, V15, P1045, DOI 10.1038/ncb2806; Yang YZ, 2015, ANNU REV CELL DEV BI, V31, P623, DOI 10.1146/annurev-cellbio-100814-125315	56	11	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8410	8427		10.1074/jbc.RA118.001906	http://dx.doi.org/10.1074/jbc.RA118.001906			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666182	Green Published, hybrid			2022-12-28	WOS:000434205700007
J	Motani, K; Kosako, H				Motani, Kou; Kosako, Hidetaka			Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; cell surface protein; inflammation; proteomics; post-translational modification (PTM); SEMA4D; STING	CYCLIC GMP-AMP; CYTOSOLIC-DNA; INNATE IMMUNITY; MAMMALIAN DNA; TACE; IRHOM2; DEGRADATION; TRAFFICKING; SYNTHASE; PHOSPHORYLATION	Stimulator of interferon genes (STING) is an endoplasmic reticulum-resident membrane protein that mediates cytosolic pathogen DNA-induced innate immunity and inflammatory responses in host defenses. STING is activated by cyclic di-nucleotides and is then translocated to the Golgi apparatus, an event that triggers STING assembly with the downstream enzyme TANK-binding kinase 1 (TBK1). This assembly leads to the phosphorylation of the transcription factor interferon regulatory factor 3 (IRF3), which in turn induces expression of type-I interferon (IFN) and chemokine genes. STING also mediates inflammatory responses independently of IRF3, but these molecular pathways are largely unexplored. Here, we analyzed the RAW264.7 macrophage secretome to comprehensively identify proinflammatory factors released into the extracellular medium upon STING activation. In total, we identified 1299 proteins in macrophage culture supernatants, of which 23 were significantly increased after STING activation. These proteins included IRF3-dependent cytokines, as well as previously unknown targets of STING, such as the immune semaphorin SEMA4D/CD100, which possesses proinflammatory cytokine-like activities. Unlike for canonical cytokines, the expression of the SEMA4D gene was not up-regulated. Instead, upon STING activation, membrane-bound SEMA4D was cleaved into a soluble form, suggesting the presence of a post-translational shedding machinery. Importantly, the SEMA4D shedding was blocked by TMI-1, an inhibitor of the sheddase ADAM metallopeptidase domain 17 (ADAM17) but not by the TBK1 inhibitor BX795. These results suggest that STING activates ADAM17 and that this activation produces soluble proinflammatory SEMA4D independently of the TBK1/IRF3-mediated transcriptional pathway.	[Motani, Kou; Kosako, Hidetaka] Tokushima Univ, Fujii Mem Inst Med Sci, Div Cell Signaling, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan	Tokushima University	Motani, K (corresponding author), Tokushima Univ, Fujii Mem Inst Med Sci, Div Cell Signaling, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	motani@tokushima-u.ac.jp			KAKENHI from the Japan Society for the Promotion of Science (JSPS) [15K19024, 17K08661]; Takeda Science Foundation; KAKENHI from the JSPS [17K08635]; Japan Foundation for Applied Enzymology	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); KAKENHI from the JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Foundation for Applied Enzymology	This work was supported by KAKENHI Grants-in-aid for Scientific Research characterized by interstitial lung disease, skin lesions, and 15K19024 and 17K08661 from the Japan Society for the Promotion of Science (JSPS) and by the Takeda Science Foundation (to K.M.). This work also was supported by KAKENHI Grant-in-aid for Scientific Research 17K08635 from the JSPS and by the Japan Foundation for Applied Enzymology (to H.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ablasser A, 2013, CLIN IMMUNOL, V147, P207, DOI 10.1016/j.clim.2013.01.003; Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Brifault C, 2017, J BIOL CHEM, V292, P18699, DOI 10.1074/jbc.M117.798413; Brooke MA, 2014, HUM MOL GENET, V23, P4064, DOI 10.1093/hmg/ddu120; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Cavadas M, 2017, CELL REP, V21, P745, DOI 10.1016/j.celrep.2017.09.074; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Grieve AG, 2017, ELIFE, V6, DOI 10.7554/eLife.23968; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kawane K, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016394; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Maleki KT, 2016, CLIN IMMUNOL, V163, P52, DOI 10.1016/j.clim.2015.12.012; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Motani K, 2015, J IMMUNOL, V194, P4914, DOI 10.4049/jimmunol.1402705; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Okabe Y, 2008, EUR J IMMUNOL, V38, P3150, DOI 10.1002/eji.200838559; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Rauniyar N, 2015, INT J MOL SCI, V16, P28566, DOI 10.3390/ijms161226120; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stone RC, 2016, CELL TISSUE RES, V365, P495, DOI 10.1007/s00441-016-2464-0; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tsukamoto S, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.161; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Yoshida Y, 2015, ARTHRITIS RHEUMATOL, V67, P1481, DOI 10.1002/art.39086	47	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7717	7726		10.1074/jbc.RA118.002175	http://dx.doi.org/10.1074/jbc.RA118.002175			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618514	hybrid, Green Published			2022-12-28	WOS:000437256500021
J	Coussens, NP; Kales, SC; Henderson, MJ; Lee, OW; Horiuchi, KY; Wang, YR; Chen, Q; Kuznetsova, E; Wu, J; Chakka, SH; Cheff, DM; Cheng, KCC; Shinn, P; Brimacombe, KR; Shen, M; Simeonov, A; Lal-Nag, M; Ma, HC; Jadhav, A; Hall, MD				Coussens, Nathan P.; Kales, Stephen C.; Henderson, Mark J.; Lee, Olivia W.; Horiuchi, Kurumi Y.; Wang, Yuren; Chen, Qing; Kuznetsova, Ekaterina; Wu, Jianghong; Chakka, Sirisha; Cheff, Dorian M.; Cheng, Ken Chih-Chien; Shinn, Paul; Brimacombe, Kyle R.; Shen, Min; Simeonov, Anton; Lal-Nag, Madhu; Ma, Haiching; Jadhav, Ajit; Hall, Matthew D.			High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; cancer; high-throughput screening (HTS); histone methylation; nucleosome; oncogene; small molecule; lysine methyltransferase inhibitor; MMSET; NSD2; WHSC1	ACUTE LYMPHOBLASTIC-LEUKEMIA; T(4/14) MULTIPLE-MYELOMA; PROTEIN METHYLTRANSFERASES; FGFR3 EXPRESSION; GENE-EXPRESSION; KINASE ASSAYS; CANCER-CELLS; MMSET; OVEREXPRESSION; DOMAIN	The histone lysine methyltransferase nuclear receptor-binding SET domain protein 2 (NSD2, also known as WHSC1/MMSET) is an epigenetic modifier and is thought to play a driving role in oncogenesis. Both NSD2 overexpression and point mutations that increase its catalytic activity are associated with several human cancers. Although NSD2 is an attractive therapeutic target, no potent, selective, and bioactive small molecule inhibitors of NSD2 have been reported to date, possibly due to the challenges of developing high-throughput assays for NSD2. Here, to establish a platform for the discovery and development of selective NSD2 inhibitors, we optimized and implemented multiple assays. We performed quantitative high-throughput screening with full-length WT NSD2 and a nucleosome substrate against a diverse collection of bioactive small molecules comprising 16,251 compounds. We further interrogated 174 inhibitory compounds identified in the primary screen with orthogonal and counter assays and with activity assays based on the clinically relevant NSD2 variants E1099K and T1150A. We selected five confirmed inhibitors for follow-up, which included a radiolabeled validation assay, surface plasmon resonance studies, methyltransferase profiling, and histone methylation in cells. We found that all five NSD2 inhibitors bind the catalytic SET domain and one exhibited apparent activity in cells, validating the workflow and providing a template for identifying selective NSD2 inhibitors. In summary, we have established a robust discovery pipeline for identifying potent NSD2 inhibitors from small-molecule libraries.	[Coussens, Nathan P.; Kales, Stephen C.; Henderson, Mark J.; Lee, Olivia W.; Chakka, Sirisha; Cheff, Dorian M.; Cheng, Ken Chih-Chien; Shinn, Paul; Brimacombe, Kyle R.; Shen, Min; Simeonov, Anton; Lal-Nag, Madhu; Jadhav, Ajit; Hall, Matthew D.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Horiuchi, Kurumi Y.; Wang, Yuren; Chen, Qing; Kuznetsova, Ekaterina; Wu, Jianghong; Ma, Haiching] React Biol Corp, Malvern, PA 19355 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Hall, MD (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA.	hallma@mail.nih.gov		Jadhav, Ajit/0000-0001-7955-1451; Lee, Olivia/0000-0001-5389-6267; Kales, Stephen C./0000-0002-8702-5766; Henderson, Mark/0000-0001-8590-7338	National Center for Advancing Translational Sciences (NCATS) Division of Pre-Clinical Innovation Intramural Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000252, ZICTR000041] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS) Division of Pre-Clinical Innovation Intramural Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Center for Advancing Translational Sciences (NCATS) Division of Pre-Clinical Innovation Intramural Program. K.Y.H., Y.W., Q.C., E.K., J.W., and H.M. are employed by Reaction Biology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allali-Hassani A, 2014, J BIOMOL SCREEN, V19, P928, DOI 10.1177/1087057114525854; Allali-Hassani A, 2012, J BIOMOL SCREEN, V17, P71, DOI 10.1177/1087057111422256; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Auld D, 2004, ASSAY INTERFERENCE C; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Bennett RL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026708; Benoit YD, 2013, J CELL PHYSIOL, V228, P764, DOI 10.1002/jcp.24224; Brito JLR, 2009, HAEMATOL-HEMATOL J, V94, P78, DOI 10.3324/haematol.13426; Cain C., 2013, SCIBX SCI BUSINESS E, V6, DOI 10.1038/scibx.2013.1083; Cherblanc FL, 2013, J MED CHEM, V56, P8616, DOI 10.1021/jm401063r; Cherblanc FL, 2013, NAT CHEM BIOL, V9, P136, DOI 10.1038/nchembio.1187; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Chi HF, 2014, BIOORGAN MED CHEM, V22, P1268, DOI 10.1016/j.bmc.2014.01.011; Dahlin JL, 2015, J MED CHEM, V58, P2091, DOI 10.1021/jm5019093; di Luccio Eric, 2015, J Cancer Prev, V20, P113, DOI 10.15430/JCP.2015.20.2.113; Drake KM, 2014, ASSAY DRUG DEV TECHN, V12, P258, DOI 10.1089/adt.2014.583; Ezponda T, 2013, ONCOGENE, V32, P2882, DOI 10.1038/onc.2012.297; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Giannetti AM, 2008, J MED CHEM, V51, P574, DOI 10.1021/jm700952v; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Horiuchi KY, 2013, ASSAY DRUG DEV TECHN, V11, P227, DOI 10.1089/adt.2012.480; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Huang Z, 2013, CANCER RES, V73, P6277, DOI 10.1158/0008-5472.CAN-13-1000; Hudlebusch HR, 2011, CANCER RES, V71, P4226, DOI 10.1158/0008-5472.CAN-10-3810; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Johnston PA, 2008, ASSAY DRUG DEV TECHN, V6, P505, DOI 10.1089/adt.2008.151; Kassambara A, 2009, BIOCHEM BIOPH RES CO, V379, P840, DOI 10.1016/j.bbrc.2008.12.093; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kimos M, 2016, J BIOMOL SCREEN, V21, P490, DOI 10.1177/1087057115616793; Kozian DH, 2012, BIOORG MED CHEM LETT, V22, P5239, DOI 10.1016/j.bmcl.2012.06.057; Kumar M., 2015, ASSAY DRUG DEV TECHN, V13, P200, DOI 10.1089/adt.2014.60925710335; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Lazo JS, 2001, J MED CHEM, V44, P4042, DOI 10.1021/jm0102046; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Li J, 2008, NEURO-ONCOLOGY, V10, P45, DOI 10.1215/15228517-2007-036; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Liu Q, 2016, ACTA PHARMACOL SIN, V37, P1273, DOI 10.1038/aps.2016.64; Luo MK, 2012, ACS CHEM BIOL, V7, P443, DOI 10.1021/cb200519y; Ma H., 2015, EPIGENETICS DRUG DIS, P267; Ma HC, 2008, EXPERT OPIN DRUG DIS, V3, P607, DOI 10.1517/17460441.3.6.607; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; McGrath J, 2015, PHARMACOL THERAPEUT, V150, P1, DOI 10.1016/j.pharmthera.2015.01.002; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morrison MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197082; Okabe H, 2001, CANCER RES, V61, P2129; Orena S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00115; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Qian J, 2013, ASSAY DRUG DEV TECHN, V11, P449, DOI 10.1089/adt.2013.515; Quinn AM, 2010, MOL BIOSYST, V6, P782, DOI 10.1039/b921912a; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Saloura V, 2015, MOL CANCER RES, V13, P293, DOI 10.1158/1541-7786.MCR-14-0292-T; Sankaran SM, 2016, J BIOL CHEM, V291, P8465, DOI 10.1074/jbc.M116.720748; Santra M, 2003, BLOOD, V101, P2374, DOI 10.1182/blood-2002-09-2801; Schnitzler G. R., 2001, CURR PROTOC MOL BIOL, V2001, DOI 10.1002/0471142727.mb2105s5018265197; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Soares KM, 2010, ASSAY DRUG DEV TECHN, V8, P152, DOI 10.1089/adt.2009.0247; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tanega C, 2009, ASSAY DRUG DEV TECHN, V7, P606, DOI 10.1089/adt.2009.0230; Tisi D, 2016, ACS CHEM BIOL, V11, P3093, DOI 10.1021/acschembio.6b00308; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xiao M, 2013, J SURG ONCOL, V107, P428, DOI 10.1002/jso.23234; Yang SS, 2013, BIOMARKERS, V18, P257, DOI 10.3109/1354750X.2013.773082; Zheng YP, 2016, MOL CELL PROTEOMICS, V15, P776, DOI 10.1074/mcp.M115.053819; Zheng YP, 2012, P NATL ACAD SCI USA, V109, P13549, DOI 10.1073/pnas.1205707109	84	31	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13750	13765		10.1074/jbc.RA118.004274	http://dx.doi.org/10.1074/jbc.RA118.004274			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29945974	hybrid, Green Published			2022-12-28	WOS:000443375500033
J	Zhao, WK; Liu, MJ; Ji, HJ; Zhu, YR; Wang, CC; Huang, YK; Ma, XQ; Xing, GD; Xia, Y; Jiang, Q; Qin, JZ				Zhao, Wukui; Liu, Mengjie; Ji, Haijing; Zhu, Yaru; Wang, Congcong; Huang, Yikai; Ma, Xiaoqi; Xing, Guangdong; Xia, Yin; Jiang, Qing; Qin, Jinzhong			The polycomb group protein Yaf2 regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; polycomb; phosphorylation; epigenetics; differentiation; H2AK119ub1; PRC1; Yaf2	YY1 DNA-BINDING; H2A UBIQUITYLATION; PCG RECRUITMENT; REPO DOMAIN; IN-VIVO; COMPLEX; TRANSCRIPTION; CHROMATIN; RING1B; FAMILY	The polycomb group (PcG) proteins are key epigenetic regulators in stem cell maintenance. PcG proteins have been thought to act through one of two polycomb repressive complexes (PRCs), but more recent biochemical analyses have challenged this model in the identification of noncanonical PRC1 (nc-PRC1) complexes characterized by the presence of Rybp or Yaf2 in place of the canonical Chromobox proteins. However, the biological significance of these nc-PRC1s and the potential mechanisms by which they mediate gene repression are largely unknown. Here, we explore the functional consequences of Yaf2 disruption on stem cell regulation. We show that deletion of Yaf2 results in compromised proliferation and abnormal differentiation of mouse embryonic stem cells (mESCs). Genome-wide profiling indicates Yaf2 functions primarily as a transcriptional repressor, particularly impacting genes associated with ectoderm cell fate in a manner distinct from Rybp. We confirm that Yaf2 assembles into a noncanonical PRC complex, with deletion analysis identifying the region encompassing amino acid residues 102-150 as required for this assembly. Furthermore, we identified serine 166 as a Yaf2 phosphorylation site, and we demonstrate that mutation of this site to alanine (S166A) compromises Ring1B-mediated H2A monoubiquitination and in turn its ability to repress target gene expression. We therefore propose that Yaf2 and its phosphorylation status serve as dual regulators to maintain the pluripotent state in mESCs.	[Zhao, Wukui; Liu, Mengjie; Zhu, Yaru; Wang, Congcong; Huang, Yikai; Ma, Xiaoqi; Qin, Jinzhong] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China; [Zhao, Wukui; Liu, Mengjie; Zhu, Yaru; Wang, Congcong; Huang, Yikai; Ma, Xiaoqi; Qin, Jinzhong] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China; [Ji, Haijing] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Xing, Guangdong] Jiangsu Acad Agr Sci, Inst Anim Sci, Nanjing 210014, Jiangsu, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Jiang, Qing] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Sports Med & Adult Reconstruct Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Chinese University of Hong Kong; Nanjing University	Qin, JZ (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China.; Qin, JZ (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China.	qinjz@nicemice.cn	zhao, wukui/AAI-9846-2020; Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532	National Natural Science Foundation of China [31671532, 31471387]; 2015 Shuangchuang Program of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 2015 Shuangchuang Program of Jiangsu Province	This work was supported by National Natural Science Foundation of China Grants 31671532 and 31471387 and the 2015 Shuangchuang Program of Jiangsu Province (to J. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Atlasi Y, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.57; Bannasch D, 2001, ONCOGENE, V20, P5913, DOI 10.1038/sj.onc.1204747; Basu A, 2014, NUCLEIC ACIDS RES, V42, P2208, DOI 10.1093/nar/gkt1187; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Huang YK, 2018, CELL REP, V22, P3032, DOI 10.1016/j.celrep.2018.02.072; Kalenik JL, 1997, NUCLEIC ACIDS RES, V25, P843, DOI 10.1093/nar/25.4.843; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Rose NR, 2016, ELIFE, V5, DOI [10.7554/elife.18591, 10.7554/eLife.18591]; Sawa C, 2002, J BIOL CHEM, V277, P22484, DOI 10.1074/jbc.M203060200; Schwartz YB, 2014, CELL REP, V8, P321, DOI 10.1016/j.celrep.2014.07.001; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sim YJ, 2017, STEM CELL REP, V8, P1312, DOI 10.1016/j.stemcr.2017.04.001; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Stanton SE, 2006, J BIOL CHEM, V281, P28782, DOI 10.1074/jbc.M603348200; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Turner SA, 2013, CELL STEM CELL, V12, P145, DOI 10.1016/j.stem.2013.01.014; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang RJ, 2010, STRUCTURE, V18, P966, DOI 10.1016/j.str.2010.04.013; Wilkinson F, 2010, J CELL BIOCHEM, V109, P478, DOI 10.1002/jcb.22424; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Yan Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46276; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao WK, 2017, J BIOL CHEM, V292, P21527, DOI 10.1074/jbc.M117.804054; Zhao WK, 2017, J BIOL CHEM, V292, P2773, DOI 10.1074/jbc.M116.763961	47	7	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12793	12804		10.1074/jbc.RA118.003299	http://dx.doi.org/10.1074/jbc.RA118.003299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29959227	Green Published, hybrid			2022-12-28	WOS:000442203500013
J	Shastrula, PK; Lund, PJ; Garcia, BA; Janicki, SM				Shastrula, Prashanth Krishna; Lund, Peder J.; Garcia, Benjamin A.; Janicki, Susan M.			Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin regulation; histone modification; gene regulation; glioblastoma; transcription; epigenetics; antisense RNA; histone H3; 3; RNase P; Rpp29; histone post-translational modifications (PTMs)	EMBRYONIC STEM-CELLS; RNA-POLYMERASE-III; LONG NONCODING RNAS; VARIANT H3.3; PEDIATRIC GLIOBLASTOMA; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSCRIBED GENES; MASS-SPECTROMETRY; DRIVER MUTATIONS	The histone H3 variant H3.3 is a highly conserved and dynamic regulator of chromatin organization. Therefore, fully elucidating its nucleosome incorporation mechanisms is essential to understanding its functions in epigenetic inheritance. We previously identified the RNase P protein subunit, Rpp29, as a repressor of H3.3 chromatin assembly. Here, we use a biochemical assay to show that Rpp29 interacts with H3.3 through a sequence element in its own N terminus, and we identify a novel interaction with histone H2B at an adjacent site. The fact that archaeal Rpp29 does not include this N-terminal region suggests that it evolved to regulate eukaryote-specific functions. Oncogenic H3.3 mutations alter the H3.3-Rpp29 interaction, which suggests that they could dysregulate Rpp29 function in chromatin assembly. We also used KNS42 cells, an H3.3(G34V) pediatric high-grade glioma cell line, to show that Rpp29 1) represses H3.3 incorporation into transcriptionally active protein-coding, rRNA, and tRNA genes; 2) represses mRNA, protein expression, and antisense RNA; and 3) represses euchromatic post-translational modifications (PTMs) and promotes heterochromatic PTM deposition (i.e. histone H3 Lys-9 trimethylation (H3K9me3) and H3.1/2/3K27me3). Notably, we also found that K27me2 is increased and K36me1 decreased on H3.3(G34V), which suggests that Gly-34 mutations dysregulate Lys-27 and Lys-36 methylation in cis. The fact that Rpp29 represses H3.3 chromatin assembly and sense and antisense RNA and promotes H3K9me3 and H3K27me3 suggests that Rpp29 regulates H3.3-mediated epigenetic mechanisms by processing a transcribed signal that recruits H3.3 to its incorporation sites.	[Shastrula, Prashanth Krishna; Janicki, Susan M.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Shastrula, Prashanth Krishna] Univ Sci Philadelphia, Dept Biol Sci, Philadelphia, PA 19104 USA; [Lund, Peder J.; Garcia, Benjamin A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Epigenet Inst, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Janicki, SM (corresponding author), Rowan Univ, Dept Biol Sci, 201 Mullica Hill Rd, Glassboro, NJ 08028 USA.	janicki@rowan.edu	李, 金帝/ABH-1924-2021		Wistar Cancer Center Core Facilities Grant [P30 CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815, T32CA009140, P01CA196539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174] Funding Source: NIH RePORTER	Wistar Cancer Center Core Facilities Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the Wistar Cancer Center Genomics and Molecular Screening Core Facilities (supported by Wistar Cancer Center Core Facilities Grant P30 CA10815). Wethank Sylvie Shaffer for artistic contributions to the model.	Abu-Zhayia ER, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01185-6; Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Barraza-Garcia J, 2017, CLIN GENET, V92, P91, DOI 10.1111/cge.12964; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Beltran M, 2016, GENOME RES, V26, P896, DOI 10.1101/gr.197632.115; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Davidovich C, 2015, RNA, V21, P2007, DOI 10.1261/rna.053918.115; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Elalaoui SC, 2016, AM J MED GENET A, V170, P2462, DOI 10.1002/ajmg.a.37839; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Everett RD, 2008, J VIROL, V82, P2661, DOI 10.1128/JVI.02308-07; Fang D, 2016, SCIENCE, V352, P1344, DOI 10.1126/science.aae0065; Feng WX, 2017, ARCH MED SCI, V13, P1315, DOI 10.5114/aoms.2017.66747; Ferenczy MW, 2011, J VIROL, V85, P4993, DOI 10.1128/JVI.02265-10; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Frey A, 2014, CURR BIOL, V24, P2195, DOI 10.1016/j.cub.2014.07.077; Futamura N, 2016, ONCOL LETT, V11, P2629, DOI 10.3892/ol.2016.4264; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Glazov EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002027; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Gopalan V, 2018, RNA, V24, P1, DOI 10.1261/rna.063107.117; Hennig BP, 2013, TRANSCR-AUSTIN, V4, P97, DOI 10.4161/trns.24884; Huang C, 2014, BIOESSAYS, V36, P579, DOI 10.1002/bies.201400005; Huang C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003558; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Jang CW, 2015, GENE DEV, V29, P1377, DOI 10.1101/gad.264150.115; Jarrous N, 2017, TRENDS GENET, V33, P594, DOI 10.1016/j.tig.2017.06.006; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jones JM, 2011, IMMUNOL LETT, V136, P156, DOI 10.1016/j.imlet.2011.01.005; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Kim JH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16122; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kraushaar DC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r121; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li X, 2016, ELIFE, V5, DOI 10.7554/eLife.15129; Lim JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep39669; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Lindroth AM, 2013, NAT GENET, V45, P1413, DOI 10.1038/ng.2832; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Marvin MC, 2011, RNA, V17, P1441, DOI 10.1261/rna.2737511; Meng QJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164845; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Molla-Herman A, 2015, EMBO J, V34, P3009, DOI 10.15252/embj.201591006; Natrajan R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3154; Newhart A, 2016, MOL BIOL CELL, V27, P1154, DOI 10.1091/mbc.E15-02-0099; Newhart A, 2013, J BIOL CHEM, V288, P19882, DOI 10.1074/jbc.M113.473181; Newhart A, 2013, MOL BIOL CELL, V24, P1454, DOI 10.1091/mbc.E12-09-0669; Newhart A, 2012, J CELL SCI, V125, P5489, DOI 10.1242/jcs.110148; Park J, 2015, ONCOTARGET, V6, P34658, DOI 10.18632/oncotarget.5778; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Reiner R, 2006, GENE DEV, V20, P1621, DOI 10.1101/gad.386706; Reiner R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004072; Rheinbay E, 2017, NATURE, V547, P55, DOI 10.1038/nature22992; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Rougemaille M, 2010, ADV EXP MED BIOL, V702, P122, DOI 10.1007/978-1-4419-7841-7_10; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Serruya R, 2015, NUCLEIC ACIDS RES, V43, P5442, DOI 10.1093/nar/gkv447; Shi LL, 2018, J MOL BIOL, V430, P1562, DOI 10.1016/j.jmb.2018.04.014; Sidoli S, 2017, METHODS MOL BIOL, V1528, P121, DOI 10.1007/978-1-4939-6630-1_8; Silva AC, 2012, J BIOL CHEM, V287, P1709, DOI 10.1074/jbc.M111.316489; Song HJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-225; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Talbert PB, 2017, NAT REV MOL CELL BIO, V18, P115, DOI 10.1038/nrm.2016.148; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; Venkatesh S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-16; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Venneti S, 2013, BRAIN PATHOL, V23, P558, DOI 10.1111/bpa.12042; Voon HPJ, 2016, NUCLEIC ACIDS RES, V44, P1496, DOI 10.1093/nar/gkw012; Wang XY, 2017, NAT STRUCT MOL BIOL, V24, P1028, DOI 10.1038/nsmb.3487; Weinberg DN, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026443; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yadav RK, 2017, ELIFE, V6, DOI 10.7554/eLife.27406; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011	98	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12360	12377		10.1074/jbc.RA118.001845	http://dx.doi.org/10.1074/jbc.RA118.001845			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29921582	Green Published, hybrid			2022-12-28	WOS:000441408500005
J	Svidritskiy, E; Demo, G; Korostelev, AA				Svidritskiy, Egor; Demo, Gabriel; Korostelev, Andrei A.			Mechanism of premature translation termination on a sense codon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						translation release factor; translation regulation; ribosome structure; ribosome function; RNA-protein interaction; 70S ribosome; hot-spot sense codon; hydrophobic interactions; near-stop codon; -stacking	NUCLEIC-ACID BASES; 23S RIBOSOMAL-RNA; RELEASE FACTOR; STRUCTURAL BASIS; STOP-CODON; CRYSTAL-STRUCTURES; PEPTIDE; RECOGNITION; INSIGHTS; STACKING	Accurate translation termination by release factors (RFs) is critical for the integrity of cellular proteomes. Premature termination on sense codons, for example, results in truncated proteins, whose accumulation could be detrimental to the cell. Nevertheless, some sense codons are prone to triggering premature termination, but the structural basis for this is unclear. To investigate premature termination, we determined a cryo-EM structure of the Escherichia coli 70S ribosome bound with RF1 in response to a UAU (Tyr) sense codon. The structure reveals that RF1 recognizes a UAU codon similarly to a UAG stop codon, suggesting that sense codons induce premature termination because they structurally mimic a stop codon. Hydrophobic interaction between the nucleobase of U3 (the third position of the UAU codon) and conserved Ile-196 in RF1 is important for misreading the UAU codon. Analyses of RNA binding in ribonucleoprotein complexes or by amino acids reveal that Ile-U packing is a frequent protein-RNA-binding motif with key functional implications. We discuss parallels with eukaryotic translation termination by the release factor eRF1.	[Svidritskiy, Egor; Demo, Gabriel; Korostelev, Andrei A.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, 368 Plantat St, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Korostelev, AA (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, 368 Plantat St, Worcester, MA 01605 USA.	andrei.korostelev@umassmed.edu	Demo, Gabriel/D-7261-2012	Demo, Gabriel/0000-0002-5472-9249; Korostelev, Andrei/0000-0003-1588-717X	National Institutes of Health [R01 GM107465]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM107465. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bouakaz L, 2006, J BIOL CHEM, V281, P4548, DOI 10.1074/jbc.M510433200; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; Brown RF, 2015, J CHEM THEORY COMPUT, V11, P2315, DOI 10.1021/ct501170h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; Chavatte L, 2003, J MOL BIOL, V331, P745, DOI 10.1016/S0022-2836(03)00813-1; Chavatte L, 2002, EMBO J, V21, P5302, DOI 10.1093/emboj/cdf484; CHEN L, 1995, P NATL ACAD SCI USA, V92, P5077, DOI 10.1073/pnas.92.11.5077; CULLIS PM, 1981, BIOCHEMISTRY-US, V20, P3024, DOI 10.1021/bi00514a006; de Ruiter A, 2015, NUCLEIC ACIDS RES, V43, P708, DOI 10.1093/nar/gku1344; Delano WL., 2002, PYMOL MOL GRAPHICS S; Demo G, 2017, ELIFE, V6, DOI 10.7554/eLife.23687; Dunkle JA, 2010, ANNU REV BIOPHYS, V39, P227, DOI 10.1146/annurev.biophys.37.032807.125954; Florian J, 1999, J PHYS CHEM B, V103, P884, DOI 10.1021/jp983699s; Florin T, 2017, NAT STRUCT MOL BIOL, V24, P752, DOI 10.1038/nsmb.3439; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; FRIEDMAN RA, 1995, BIOPHYS J, V69, P1528, DOI 10.1016/S0006-3495(95)80023-8; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Frolova L, 2002, RNA, V8, P129, DOI 10.1017/S1355838202013262; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Huter P, 2017, NATURE, V541, P546, DOI 10.1038/nature20821; Jafilan S, 2012, J PHYS CHEM B, V116, P3613, DOI 10.1021/jp209986y; James NR, 2016, SCIENCE, V354, P1437, DOI 10.1126/science.aai9127; Jin H, 2010, P NATL ACAD SCI USA, V107, P8593, DOI 10.1073/pnas.1003995107; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Keeling KM, 2011, WIRES RNA, V2, P837, DOI 10.1002/wrna.95; Korkmaz G, 2017, J BIOL CHEM, V292, P15134, DOI 10.1074/jbc.M117.785238; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Korostelev AA, 2011, RNA, V17, P1409, DOI 10.1261/rna.2733411; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kryuchkova P, 2013, NUCLEIC ACIDS RES, V41, P4573, DOI 10.1093/nar/gkt113; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Loveland AB, 2017, NATURE, V546, P113, DOI 10.1038/nature22397; Lozupone C, 2003, RNA, V9, P1315, DOI 10.1261/rna.5114503; Luo R, 2001, BIOPHYS J, V80, P140, DOI 10.1016/S0006-3495(01)76001-8; Ma CY, 2017, NATURE, V541, P550, DOI 10.1038/nature20822; Majerfeld I, 1998, RNA, V4, P471; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matheisl S, 2015, NUCLEIC ACIDS RES, V43, P8615, DOI 10.1093/nar/gkv909; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Moras D, 1996, CURR BIOL, V6, P530, DOI 10.1016/S0960-9822(02)00534-1; Nakamura Y, 2011, WIRES RNA, V2, P647, DOI 10.1002/wrna.81; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; Norberg J, 1998, BIOPHYS J, V74, P394, DOI 10.1016/S0006-3495(98)77796-3; Oshima K, 2018, ACTA CRYSTALLOGR F, V74, P57, DOI 10.1107/S2053230X17018039; Oshima K, 2016, BIOCHEM BIOPH RES CO, V474, P541, DOI 10.1016/j.bbrc.2016.04.118; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierson WE, 2016, CELL REP, V17, P11, DOI 10.1016/j.celrep.2016.08.085; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Polikanov YS, 2015, NAT STRUCT MOL BIOL, V22, P342, DOI 10.1038/nsmb.2992; Ramakrishnan V, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P19; Rawat U, 2006, J MOL BIOL, V357, P1144, DOI 10.1016/j.jmb.2006.01.038; Salas-Marco J, 2004, MOL CELL BIOL, V24, P7769, DOI 10.1128/MCB.24.17.7769-7778.2004; Shao SC, 2016, CELL, V167, P1229, DOI 10.1016/j.cell.2016.10.046; Shih P, 1998, J MOL BIOL, V280, P421, DOI 10.1006/jmbi.1998.1880; Sund J, 2010, NATURE, V465, P947, DOI 10.1038/nature09082; Svidritskiy E, 2018, STRUCTURE, V26, P821, DOI 10.1016/j.str.2018.04.001; Svidritskiy E, 2018, J MOL BIOL, V430, P591, DOI 10.1016/j.jmb.2018.01.007; Svidritskiy E, 2016, J MOL BIOL, V428, P2228, DOI 10.1016/j.jmb.2016.04.018; Svidritskiy E, 2014, STRUCTURE, V22, P1210, DOI 10.1016/j.str.2014.06.003; TATE WP, 1984, J BIOL CHEM, V259, P7317; TSUKADA K, 1984, CHEM PHARM BULL, V32, P1929; Van Dyke N, 2003, J MOL BIOL, V330, P9, DOI 10.1016/S0022-2836(03)00537-0; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Wilson KA, 2016, RNA, V22, P696, DOI 10.1261/rna.054924.115; WOESE CR, 1966, P NATL ACAD SCI USA, V55, P966, DOI 10.1073/pnas.55.4.966; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zeng FX, 2017, NATURE, V541, P554, DOI 10.1038/nature21053; Zhu CQ, 2016, P NATL ACAD SCI USA, V113, P12946, DOI 10.1073/pnas.1616138113	84	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12472	12479		10.1074/jbc.AW118.003232	http://dx.doi.org/10.1074/jbc.AW118.003232			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29941456	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000441408500013
J	Kuznetsov, VI; Haws, SA; Fox, CA; Denu, JM				Kuznetsov, Vyacheslav, I; Haws, Spencer A.; Fox, Catherine A.; Denu, John M.			General method for rapid purification of native chromatin fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin modification; chromatin isolation; yeast; chromatography; chromatin structure; post-translational modification (PTM); acetylation; histone; methylation; nucleosome; purification; mass spectrometry; insect cell; MCF-7; epigenetics; native chromatin fragments; oligonucleosomes	CELL-WALL INTEGRITY; YEAST; IMMUNOPRECIPITATION; NUCLEOSOMES; EXTRACTION; EXPRESSION; PROTEINS; DYNAMICS; REAGENTS; PROTEASE	Biochemical, proteomic, and epigenetic studies of chromatin rely on the ability to efficiently isolate native nucleosomes in high yield and purity. However, isolation of native chromatin suitable for many downstream experiments remains a challenging task. This is especially true for the budding yeast Saccharomyces cerevisiae, which continues to serve as an important model organism for the study of chromatin structure and function. Here, we developed a time- and cost-efficient universal protocol for isolation of native chromatin fragments from yeast, insect, and mammalian cells. The resulting protocol preserves histone posttranslational modification in the native chromatin state and is applicable for both parallel multisample spin-column purification and large-scale isolation. This protocol is based on the efficient and stable purification of polynucleosomes and features a combination of optimized cell lysis and purification conditions, three options for chromatin fragmentation, and a novel ion-exchange chromatographic purification strategy. The procedure will aid chromatin researchers interested in isolating native chromatin material for biochemical studies and serve as a mild, acid- and detergent-free sample preparation method for MS analysis.	[Kuznetsov, Vyacheslav, I; Haws, Spencer A.; Fox, Catherine A.; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA; [Kuznetsov, Vyacheslav, I; Haws, Spencer A.; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Morgridge Inst Res, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.	Fox, CA; Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA.; Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Inst Discovery, Madison, WI 53715 USA.; Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Morgridge Inst Res, Madison, WI 53715 USA.	cfox@wisc.edu; john.denu@wisc.edu		Haws, Spencer/0000-0002-2166-1858	NIGMS, National Institutes of Health [GM056890, GM059785]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056890, R01GM059785, R37GM059785] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants GM056890 (to C. A. F.) and GM059785 (to J. M. D). J. M. D. is a consultant for Bio-Techne and FORGE Life Science and is cofounder of Galilei BioSciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; ARIS JP, 1991, METHOD ENZYMOL, V194, P735; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; Fan YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054228; Fic E, 2010, ELECTROPHORESIS, V31, P3573, DOI 10.1002/elps.201000197; Fuchs SM, 2014, DRUG DISCOV TODAY DI, V12, P1, DOI DOI 10.1016/J.DDMOD.2014.04.004; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Grunstein M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017491; GUO XW, 1989, J BIOL CHEM, V264, P11653; Iwasaki W, 2013, FEBS OPEN BIO, V3, P363, DOI 10.1016/j.fob.2013.08.007; Kiseleva E, 2007, NAT PROTOC, V2, P1943, DOI 10.1038/nprot.2007.251; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Klis FM, 2007, YEAST, V24, P253, DOI 10.1002/yea.1476; KNORR D, 1979, BIOTECHNOL BIOENG, V21, P2011, DOI 10.1002/bit.260211109; Korolev N, 2012, SOFT MATTER, V8, P9322, DOI 10.1039/c2sm25662b; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lacoste N, 2017, METHODS MOL BIOL, V1528, P39, DOI 10.1007/978-1-4939-6630-1_3; Lacoste N, 2017, METHODS MOL BIOL, V1528, P53, DOI 10.1007/978-1-4939-6630-1_4; Lambert Jean-Philippe, 2009, Mol Cell Proteomics, V8, P870, DOI 10.1074/mcp.M800447-MCP200; LEE KP, 1982, CAN J BIOCHEM CELL B, V60, P379, DOI 10.1139/o82-045; Leung A, 2016, FEBS LETT, V590, P2629, DOI 10.1002/1873-3468.12266; LORCH Y, 1994, P NATL ACAD SCI USA, V91, P11032, DOI 10.1073/pnas.91.23.11032; LOWARY PT, 1989, P NATL ACAD SCI USA, V86, P8266, DOI 10.1073/pnas.86.21.8266; Nurse NP, 2013, BIOPHYS J, V104, P1081, DOI 10.1016/j.bpj.2013.01.019; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Ovalle R, 1998, YEAST, V14, P1159, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1159::AID-YEA317>3.0.CO;2-3; Palumbo JD, 2003, J BACTERIOL, V185, P4362, DOI 10.1128/JB.185.15.4362-4370.2003; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; Rodriguez-Pena JM, 2013, FEBS LETT, V587, P3675, DOI 10.1016/j.febslet.2013.09.030; RODRIGUEZCAMPOS A, 1989, J MOL BIOL, V209, P135, DOI 10.1016/0022-2836(89)90177-0; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; SHEN SH, 1991, J BIOL CHEM, V266, P1058; Sidoli S, 2017, METHODS MOL BIOL, V1528, P121, DOI 10.1007/978-1-4939-6630-1_8; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; Su Zhangli, 2015, Curr Protoc Mol Biol, V111, DOI 10.1002/0471142727.mb2132s111; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Truong DM, 2017, CELL, V171, P1508, DOI 10.1016/j.cell.2017.10.043; VALENTIN E, 1984, J GEN MICROBIOL, V130, P1419; VONHOLT C, 1989, METHOD ENZYMOL, V170, P431; Wang DX, 2009, ANAL CHEM, V81, P1893, DOI 10.1021/ac8021136; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wingfield P., 2001, CURRENT PROTOCOLS PR, pA.3F.1; Yu M.Y, 1987, WORLD J MICROB BIOT, V3, P161, DOI DOI 10.1007/BF00933616; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	48	6	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12271	12282		10.1074/jbc.RA118.002984	http://dx.doi.org/10.1074/jbc.RA118.002984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29794135	Green Published, hybrid			2022-12-28	WOS:000440803200024
J	Zou, QL; Gang, K; Yang, QF; Liu, XL; Tang, XM; Lu, HQ; He, JB; Luo, LF				Zou, Qingliang; Gang, Kai; Yang, Qifen; Liu, Xiaolin; Tang, Xuemei; Lu, Huiqiang; He, Jianbo; Luo, Lingfei			The CCCH-type zinc finger transcription factor Zc3h8 represses NF-B-mediated inflammation in digestive organs in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; inflammation; NF- B (NF-B); zebrafish; zinc finger; degeneration; digestive organ	FACTOR-KAPPA-B; LIVER FIBROSIS; MESSENGER-RNA; FETAL LIVER; TRISTETRAPROLIN; CELLS; PROTEIN; SYSTEM; ALPHA; REGENERATION	Degenerative diseases of organs lead to their impaired function. The cellular and molecular mechanisms underlying organ degeneration are therefore of great research and clinical interest but are currently incompletely characterized. Here, using a forward-genetic screen for genes regulating liver development and function in zebrafish, we identified a cq5 mutant that exhibited a liver-degeneration phenotype at 5 days postfertilization, the developmental stage at which a functional liver develops. Positional cloning revealed that the liver degeneration was caused by a single point mutation in the gene zc3h8 (zinc finger CCCH-type containing 8), changing a highly conserved histidine to glutamine at position 353 of the Zc3h8 protein. The zc3h8 mutation-induced liver degeneration in the mutant was accompanied by reduced proliferation, increased apoptosis, and macrophage phagocytosis of hepatocytes. Transcriptional profile analyses revealed up-regulation and activation of both proinflammatory cytokines and the NF-B signaling pathway in the zc3h8 mutant. Suppression of NF-B signaling activity efficiently rescued the proinflammatory cytokine response, as well as the inflammation-mediated liver degeneration phenotype of the mutant. Of note, the zc3h8 mutation-induced degeneration of several other organs, including the gut and exocrine pancreas, indicating that Zc3h8 is a general repressor of inflammation in zebrafish. Collectively, our findings demonstrate that Zc3h8 maintains organ homeostasis by inhibiting the NF-B-mediated inflammatory response in zebrafish and that Zc3h8 dysfunction causes degeneration of multiple organs, including the liver, gut, and pancreas.	[Zou, Qingliang; Gang, Kai; Yang, Qifen; Liu, Xiaolin; Tang, Xuemei; Lu, Huiqiang; He, Jianbo; Luo, Lingfei] Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China; [Zou, Qingliang; Gang, Kai; Yang, Qifen; Liu, Xiaolin; Tang, Xuemei; Lu, Huiqiang; He, Jianbo; Luo, Lingfei] Southwest Univ, Lab Mol Dev Biol, Sch Life Sci, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Luo, LF (corresponding author), Southwest Univ, Sch Life Sci, Lab Mol Dev Biol, Key Lab Freshwater Fish Reprod & Dev,Minist Educ, Chongqing 400715, Peoples R China.	lluo@swu.edu.cn			National Key Basic Research Program of China [2015CB942800]; National Natural Science Foundation of China [31330051, 31730060, 31371483, 91539201]; Natural Science Foundation Project of Chongqing [cstc2014jcyjA10062, cstc2014jcyjA10088]; Fundamental Research Funds for the Central Universities [XDJK2015B011]; 111 Program [B14037]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Program(Ministry of Education, China - 111 Project)	This work was supported by National Key Basic Research Program of China Grant 2015CB942800; National Natural Science Foundation of China Grants 31330051, 31730060, 31371483, and 91539201; Natural Science Foundation Project of Chongqing Grants cstc2014jcyjA10062 and cstc2014jcyjA10088; Fundamental Research Funds for the Central Universities Grant XDJK2015B011; and 111 Program B14037. The authors declare that they have no conflicts of interest with the contents of this article.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Cox AG, 2015, CURR OPIN GENET DEV, V32, P153, DOI 10.1016/j.gde.2015.03.002; Dahm K, 2001, GENOMICS, V73, P194, DOI 10.1006/geno.2000.6480; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Grabher C, 2004, METHOD CELL BIOL, V77, P381; He JB, 2014, GASTROENTEROLOGY, V146, P789, DOI 10.1053/j.gastro.2013.11.045; Hou YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36853; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang ES, 2002, IMMUNOLOGY, V106, P464, DOI 10.1046/j.1365-2567.2002.01455.x; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Kawamoto S, 1996, GENE, V174, P151, DOI 10.1016/0378-1119(96)00512-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Lu HQ, 2013, DEV CELL, V24, P543, DOI 10.1016/j.devcel.2013.01.021; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; O'Neill LAJ, 2006, NAT REV DRUG DISCOV, V5, P549, DOI 10.1038/nrd2070; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Pack M, 1996, DEVELOPMENT, V123, P321; Qi F, 2010, HEPATOLOGY, V52, P2158, DOI 10.1002/hep.23945; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen H, 2014, HEPATOLOGY, V60, P2065, DOI 10.1002/hep.27348; Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	52	11	13	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					11971	11983		10.1074/jbc.M117.802975	http://dx.doi.org/10.1074/jbc.M117.802975			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29871925	Green Published, hybrid			2022-12-28	WOS:000440803200001
J	Greb-Markiewicz, B; Zarebski, M; Ozyhar, A				Greb-Markiewicz, Beata; Zarebski, Miroslaw; Ozyhar, Andrzej			Multiple sequences orchestrate subcellular trafficking of neuronal PAS domain-containing protein 4 (NPAS4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basic helix-loop-helix transcription factor (bHLH); cell culture; intracellular trafficking; microscopic imaging; protein expression; bHLH-PAS; glucose concentration effect; NES; NLS; NPAS4	ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR NPAS4; NUCLEAR EXPORT SIGNALS; PANCREATIC BETA-CELLS; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; LEPTOMYCIN B; LOCALIZATION; PREDICTION; IDENTIFICATION	Neuronal Per-Arnt-Sim (PAS) domain-containing protein 4 (NPAS4) is a basic helix-loop-helix (bHLH)-PAS transcription factor first discovered in neurons in the neuronal layer of the mammalian hippocampus and later discovered in pancreatic -cells. NPAS4 has been proposed as a therapeutic target not only for depression and neurodegenerative diseases associated with synaptic dysfunction but also for type 2 diabetes and pancreas transplantation. The ability of bHLH-PAS proteins to fulfil their function depends on their intracellular trafficking, which is regulated by specific sequences, i.e. the nuclear localization signal (NLS) and the nuclear export signal (NES). However, until now, no study examining the subcellular localization signals of NPAS4 has been published. We show here that Rattus norvegicus NPAS4 was not uniformly localized in the nuclei of COS-7 and N2a cells 24 h after transfection. Additionally, cytoplasmic localization of NPAS4 was leptomycin B-sensitive. We demonstrate that NPAS4 possesses a unique arrangement of localization signals. Its bHLH domain contains an overlapping NLS and NES. We observed that its PAS-2 domain contains an NLS, an NES, and a second, proximally located, putative NLS. Moreover, the C terminus of NPAS4 contains two active NESs that overlap with a putative NLS. Our data indicate that glucose concentration could be one of the factors influencing NPAS4 localization. The presence of multiple localization signals and the differentiated localization of NPAS4 suggest a precise, multifactor-dependent regulation of NPAS4 trafficking, potentially crucial for its ability to act as a cellular stress sensor and transcription factor.	[Greb-Markiewicz, Beata; Ozyhar, Andrzej] Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland; [Zarebski, Miroslaw] Jagiellonian Univ, Dept Cell Biophys, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland	Wroclaw University of Science & Technology; Jagiellonian University	Greb-Markiewicz, B (corresponding author), Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	beata.greb-markiewicz@pwr.edu.pl	Greb-Markiewicz, Beata/AAB-5246-2020	Greb-Markiewicz, Beata/0000-0002-2831-439X; OZYHAR, Andrzej/0000-0002-5874-784X	Polish National Science Center (NCN) [2013/11/B/NZ3/00189]	Polish National Science Center (NCN)	Technical assistance from Barbara CzubaPelech, Engineer, and Miroslawa Ostrowska, Engineer, is gratefully acknowledged. Confocal fluorescence microscopy imaging was supported by Grant 2013/11/B/NZ3/00189 from the Polish National Science Center (NCN).	Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bersten DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085768; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Cartwright P, 2000, CELL MOL LIFE SCI, V57, P1193, DOI 10.1007/PL00000759; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Choy FC, 2016, J CEREBR BLOOD F MET, V36, P1449, DOI 10.1177/0271678X15606146; Choy FC, 2015, INT J MOL SCI, V16, P29011, DOI 10.3390/ijms161226144; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Davis JR, 2007, PHARM RES-DORDR, V24, P17, DOI 10.1007/s11095-006-9133-z; Dinkel H, 2007, BIOINFORMATICS, V23, P3297, DOI 10.1093/bioinformatics/btm524; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Esser JS, 2017, CARDIOVASC RES, V113, P222, DOI 10.1093/cvr/cvw248; Fan WH, 2016, J MOL NEUROSCI, V58, P401, DOI 10.1007/s12031-015-0692-5; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Fu SC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr493; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; Greb-Markiewicz B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133307; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Luo XT, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0702; Michael A.K., 2013, OA BIOCH, V1, P16, DOI [10.13172/2052-9651-1-2-1123, DOI 10.13172/2052-9651-1-2-1123]; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, BBA-GENE REGUL MECH, V1789, P192, DOI 10.1016/j.bbagrm.2009.01.003; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Rollen K, 2016, J MOL BIOL, V428, P3721, DOI 10.1016/j.jmb.2016.05.027; Sabatini PV, 2015, TRENDS ENDOCRIN MET, V26, P49, DOI 10.1016/j.tem.2014.11.002; Sabatini PV, 2013, DIABETES, V62, P2808, DOI 10.2337/db12-1527; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Shi SP, 2015, MOL BIOSYST, V11, P819, DOI 10.1039/c4mb00646a; Speckmann T, 2016, J BIOL CHEM, V291, P2682, DOI 10.1074/jbc.M115.704098; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Sullivan AE, 2016, FEBS J, V283, P3488, DOI 10.1111/febs.13824; Sun QX, 2013, P NATL ACAD SCI USA, V110, P1303, DOI 10.1073/pnas.1217203110; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu DL, 2016, ELIFE, V5, DOI 10.7554/eLife.18790; Xu DR, 2015, BIOINFORMATICS, V31, P1357, DOI 10.1093/bioinformatics/btu826; Yoshihara S, 2014, CELL REP, V8, P843, DOI 10.1016/j.celrep.2014.06.056; Zhang ZH, 2014, NEUROL SCI, V35, P277, DOI 10.1007/s10072-013-1505-7	62	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11255	11270		10.1074/jbc.RA118.001812	http://dx.doi.org/10.1074/jbc.RA118.001812			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29899116	hybrid, Green Published			2022-12-28	WOS:000439449700001
J	Bitra, A; Doukov, T; Croft, M; Zajonc, DM				Bitra, Aruna; Doukov, Tzanko; Croft, Michael; Zajonc, Dirk M.			Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); protein-protein interaction; recombinant protein expression; cell surface receptor; protein structure; X-ray crystallography	T-CELL FUNCTION; TNF SUPERFAMILY; CANCER-IMMUNOTHERAPY; MONOCLONAL-ANTIBODY; DECOY RECEPTOR; COMPLEX; ANTIGEN; GALECTIN-9; UNIQUE; OSTEOPROTEGERIN	Human (h)4-1BB (TNFRSF9 or CD137) is an inducible tumor necrosis factor receptor (TNFR) superfamily member that interacts with its cognate ligand h4-1BBL to promote T lymphocyte activation and proliferation. h4-1BB is currently being targeted with agonists in cancer immunotherapy. Here, we determined the crystal structures of unbound h4-1BBL and both WT h4-1BB and a dimerization-deficient h4-1BB mutant (C121S) in complex with h4-1BBL at resolutions between 2.7 and 3.2 angstrom. We observed that the structural arrangement of 4-1BBL, both unbound and in the complex, represents the canonical bell shape as seen in other similar TNF proteins and differs from the previously reported three-bladed propeller structure of 4-1BBL. We also found that the binding site for the receptor is at the crevice formed between two protomers of h4-1BBL, but that h4-1BB interacts predominantly with only one ligand protomer. Moreover, h4-1BBL lacked the conserved tyrosine residue in the DE loop that forms canonical interactions between other TNFR family molecules and their ligands, suggesting h4-1BBL engages h4-1BB through a distinct mechanism. Of note, we discovered that h4-1BB forms a disulfide-linked dimer because of the presence of an additional cysteine residue found in its cysteine-rich domain 4 (CRD4). As a result, h4-1BB dimerization, in addition to trimerization via h4-1BBL binding, could result in cross-linking of individual ligand-receptor complexes to form a 2D network that stimulates strong h4-1BB signaling. This work provides critical insights into the structural and functional properties of both h4-1BB and h4-1BBL and reveals that covalent receptor dimerization amplifies h4-1BB signaling.	[Bitra, Aruna; Croft, Michael; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol LJI, Div Immune Regulat, La Jolla, CA 92037 USA; [Doukov, Tzanko] SLAC, Stanford Synchrotron Radiat Light Source, Menlo Pk, CA 94025 USA; [Croft, Michael] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Diego; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, 9420 Athena Cir, La Jolla, CA 92037 USA.	dzajonc@lji.org		Zajonc, Dirk/0000-0001-7215-1981; Doukov, Tzanko/0000-0001-8625-2572	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI110929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Synchrotron Lightsource (SSRL) for access to remote data collection and the SSRL beamline scientists for support. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and National Institutes of Health, NIGMS (including Grant P41GM103393).	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bitra A, 2018, J BIOL CHEM, V293, P1317, DOI 10.1074/jbc.M117.814905; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Chattopadhyay K, 2009, IMMUNOL REV, V229, P356, DOI 10.1111/j.1600-065X.2009.00778.x; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fisher TS, 2012, CANCER IMMUNOL IMMUN, V61, P1721, DOI 10.1007/s00262-012-1237-1; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lee SW, 2009, ADV EXP MED BIOL, V647, P120, DOI 10.1007/978-0-387-89520-8_8; Liu CZ, 2010, J IMMUNOL, V184, P6910, DOI 10.4049/jimmunol.0904033; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; POLLOK KE, 1993, J IMMUNOL, V150, P771; Sanchez-Paulete AR, 2016, EUR J IMMUNOL, V46, P513, DOI 10.1002/eji.201445388; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; So T, 2008, CYTOKINE GROWTH F R, V19, P253, DOI 10.1016/j.cytogfr.2008.04.003; Sznol M, 2008, J CLIN ONCOL, V26; VANLIER RAW, 1987, J IMMUNOL, V139, P1589; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Yi L, 2017, IMMUNOL CELL BIOL, V95, P24, DOI 10.1038/icb.2016.64; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004	45	19	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9958	9969		10.1074/jbc.RA118.003176	http://dx.doi.org/10.1074/jbc.RA118.003176			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29720398	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000437096700003
J	Wang, ZQ; Huang, JL; Zhou, SR; Luo, FT; Tan, QY; Sun, XD; Ni, ZH; Chen, HG; Du, XL; Xie, YL; Chen, L				Wang, Zuqiang; Huang, Junlan; Zhou, Siru; Luo, Fengtao; Tan, Qiaoyan; Sun, Xianding; Ni, Zhenhong; Chen, Hangang; Du, Xiaolan; Xie, Yangli; Chen, Lin			Loss of Fgfr1 in chondrocytes inhibits osteoarthritis by promoting autophagic activity in temporomandibular joint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondrocyte; autophagy; fibroblast growth factor receptor (FGFR); osteoarthritis; cartilage; FGFR1; mandibular cartilage	ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; STEM-CELLS; RECEPTOR 1; GROWTH; MOUSE; DELETION; EXPRESSION; PATHOGENESIS; ACTIVATION	Temporomandibular joint osteoarthritis (TMJ OA) is a common degenerative disease with few effective disease-modifying treatments in the clinic. Fibroblast growth factor (FGF) signaling is implicated in articular cartilage homeostasis, but the functional roles of FGFR1 in TMJ OA remain largely unknown. In this study, we report that deletion of Fgfr1 in TMJ chondrocytes delayed TMJ OA progression in the age-associated spontaneous OA model and the abnormal dental occlusion OA model. Immunohistochemical staining revealed that Fgfr1 deficiency decreased the expressions of MMP13 (matrix metalloproteinase-13), ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5), and COL10A1 but increased aggrecan expression level in two TMJ OA models. Furthermore, our data show that inactivation of FGFR1 signaling may promote autophagic activity in TMJ. FGFR1 inhibitor decreased the expressions of Mmp13, Adamts5, and Runx2 in IL-1-stimulated condylar chondrocytes, whereas autophagy inhibitors abrogated the protective effects of the FGFR1 inhibitor. Thus, our study indicates inactivated FGFR1 signaling ameliorates TMJ OA progression partially by promoting autophagic activity. Manipulation of this signaling may be a potential therapeutic approach to modify TMJ OA.	[Wang, Zuqiang; Huang, Junlan; Zhou, Siru; Luo, Fengtao; Tan, Qiaoyan; Sun, Xianding; Ni, Zhenhong; Chen, Hangang; Du, Xiaolan; Xie, Yangli; Chen, Lin] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Ctr Bone Metab & Repair,Trauma Ctr, Dept Rehabil Med,Res Inst Surg,Daping Hosp, Yangzi River Rd 10, Chongqing 400042, Peoples R China	Army Medical University	Du, XL; Xie, YL; Chen, L (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Ctr Bone Metab & Repair,Trauma Ctr, Dept Rehabil Med,Res Inst Surg,Daping Hosp, Yangzi River Rd 10, Chongqing 400042, Peoples R China.	dxl_xiaolan@163.com; xieyangli841015@163.com; linchen70@163.com	Sun, Xianding/AAB-1267-2020; Luo, Fengtao/E-1236-2017	, tan/0000-0002-8534-4763; Chen, Lin/0000-0001-7764-9412; zhenhong, ni/0000-0002-7464-4074	Special Funds for Major State Basic Research Program of China (973 Program) [2014CB942904]; National Natural Science Foundation of China [81530071, 81772359]; TMMU Doctorate in Military Topics Grant [JSKT201608]; Chongqing Foundation & Advanced Research Project [cstc2017jcyjAX0148]	Special Funds for Major State Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); TMMU Doctorate in Military Topics Grant; Chongqing Foundation & Advanced Research Project	This work was supported by Special Funds for Major State Basic Research Program of China (973 Program) Grant 2014CB942904, National Natural Science Foundation of China Grants 81530071 and 81772359, TMMU Doctorate in Military Topics Grant JSKT201608, and Chongqing Foundation & Advanced Research Project Grant cstc2017jcyjAX0148. The authors declare that they have no conflicts of interest with the contents of this article.	Boileau C, 2005, ANN RHEUM DIS, V64, P891, DOI 10.1136/ard.2004.026906; Bouderlique T, 2016, ANN RHEUM DIS, V75, P627, DOI 10.1136/annrheumdis-2015-207742; Carames B, 2015, ARTHRITIS RHEUMATOL, V67, P1568, DOI 10.1002/art.39073; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Chen J, 2009, OSTEOARTHR CARTILAGE, V17, P354, DOI 10.1016/j.joca.2008.05.021; Cheng L, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34820; Cinque L, 2015, NATURE, V528, P272, DOI 10.1038/nature16063; DEBONT LGM, 1993, INT J ORAL MAX SURG, V22, P200, DOI 10.1016/S0901-5027(05)80636-8; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Ellman MB, 2008, GENE, V420, P82, DOI 10.1016/j.gene.2008.04.019; HORIO T, 1989, J ORAL REHABIL, V16, P177, DOI 10.1111/j.1365-2842.1989.tb01331.x; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Li X, 2012, J CELL BIOCHEM, V113, P2532, DOI 10.1002/jcb.24129; Liu YD, 2014, OSTEOARTHR CARTILAGE, V22, P302, DOI 10.1016/j.joca.2013.11.014; Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109; Lu L, 2014, J ORAL FACIAL PAIN H, V28, P68, DOI 10.11607/jop.1082; LUDER HU, 1988, AM J ANAT, V182, P197, DOI 10.1002/aja.1001820302; Martin G, 2003, INFLAMMATION, V27, P233, DOI 10.1023/A:1025040631514; Milam Stephen B, 2005, Odontology, V93, P7, DOI 10.1007/s10266-005-0056-7; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Sasaki H, 2012, ARTHRITIS RHEUM-US, V64, P1920, DOI 10.1002/art.34323; Schminke B, 2014, CELL MOL LIFE SCI, V71, P1081, DOI 10.1007/s00018-013-1436-8; Settembre C, 2008, GENE DEV, V22, P2645, DOI 10.1101/gad.1711308; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Sugita S, 2015, P NATL ACAD SCI USA, V112, P3080, DOI 10.1073/pnas.1419699112; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; Tang JZ, 2016, ARTHRITIS RHEUMATOL, V68, P2432, DOI 10.1002/art.39739; Wang XD, 2015, J DENT RES, V94, P666, DOI 10.1177/0022034515574770; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Wang XF, 2015, AUTOPHAGY, V11, P1998, DOI 10.1080/15548627.2015.1091551; Weng TJ, 2012, ARTHRITIS RHEUM-US, V64, P3982, DOI 10.1002/art.34645; Yan DY, 2012, J CELL BIOCHEM, V113, P2856, DOI 10.1002/jcb.24160; Yan D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3441; Yang T, 2015, J DENT RES, V94, P803, DOI 10.1177/0022034515576051; Zarb GA, 1999, J OROFAC PAIN, V13, P295; Zhang J, 2012, CIRC RES, V110, pE29, DOI 10.1161/CIRCRESAHA.111.255950; Zhang MA, 2013, APOPTOSIS, V18, P423, DOI 10.1007/s10495-013-0811-0; Zhang Y, 2015, ANN RHEUM DIS, V74, P1432, DOI 10.1136/annrheumdis-2013-204599; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zhou SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24039; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	44	19	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8761	8774		10.1074/jbc.RA118.002293	http://dx.doi.org/10.1074/jbc.RA118.002293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29691281	Green Published, hybrid			2022-12-28	WOS:000434941900004
J	Takahashi, C; Miyatake, K; Kusakabe, M; Nishida, E				Takahashi, Chika; Miyatake, Koichi; Kusakabe, Morioh; Nishida, Eisuke			The atypical mitogen-activated protein kinase ERK3 is essential for establishment of epithelial architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitogen-activated protein kinase (MAPK); cell biology; epithelial cell; epidermis; embryo; development; Xenopus	TRANSCRIPTION FACTOR AP-2; FROG XENOPUS-LAEVIS; GENE-EXPRESSION; BRANCHIOOCULOFACIAL SYNDROME; TERMINAL DIFFERENTIATION; KIDNEY DEVELOPMENT; SKIN EPIDERMIS; CANCER; PRONEPHROS; SIGNAL	Epithelia contribute to physical barriers that protect internal tissues from the external environment and also support organ structure. Accordingly, establishment and maintenance of epithelial architecture are essential for both embryonic development and adult physiology. Here, using gene knockout and knockdown techniques along with gene profiling, we show that extracellular signal-regulated kinase 3 (ERK3), a poorly characterized atypical mitogen-activated protein kinase (MAPK), regulates the epithelial architecture in vertebrates. We found that in Xenopus embryonic epidermal epithelia, ERK3 knockdown impairs adherens and tight-junction protein distribution, as well as tight-junction barrier function, resulting in epidermal breakdown. Moreover, in human epithelial breast cancer cells, inhibition of ERK3 expression induced thickened epithelia with aberrant adherens and tight junctions. Results from microarray analyses suggested that transcription factor AP-2 (TFAP2A), a transcriptional regulator important for epithelial gene expression, is involved in ERK3-dependent changes in gene expression. Of note, TFAP2A knockdown phenocopied ERK3 knockdown in both Xenopus embryos and human cells, and ERK3 was required for full activation of TFAP2A-dependent transcription. Our findings reveal that ERK3 regulates epithelial architecture, possibly together with TFAP2A.	[Takahashi, Chika; Miyatake, Koichi; Kusakabe, Morioh; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Nishida, Eisuke] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, 1-7-1 Otemachi, Tokyo 1000004, Japan; [Takahashi, Chika] RIKEN, Lab Mol Biol Aging, Ctr Biosyst Dynam Res, Chuou Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan	Kyoto University; RIKEN	Kusakabe, M; Nishida, E (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	morioh@lif.kyoto-u.ac.jp; nishida@lif.kyoto-u.ac.jp			JSPS KAKENHI [JP26221101, JP26440123]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	;This work was supported by JSPS KAKENHI Grants JP26221101 (to E.N.) and JP26440123 (to M.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Mahdi R, 2015, CELL ADHES MIGR, V9, P483, DOI 10.1080/19336918.2015.1112485; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; Bello V, 2008, DEV BIOL, V317, P106, DOI 10.1016/j.ydbio.2008.02.024; Bian K, 2016, ONCOTARGET, V7, P6665, DOI 10.18632/oncotarget.6682; BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; Brewer S, 2004, DEV BIOL, V267, P399, DOI 10.1016/j.ydbio.2003.11.021; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cizelsky W, 2014, DEVELOPMENT, V141, P2064, DOI 10.1242/dev.107938; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Decary S, 2002, MOL CELL BIOL, V22, P7877, DOI 10.1128/MCB.22.22.7877-7888.2002; Desgrange A, 2015, CELLS-BASEL, V4, P483, DOI 10.3390/cells4030483; Ding L, 2011, METHODS MOL BIOL, V762, P91, DOI 10.1007/978-1-61779-185-7_7; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Hennig G, 1996, J BIOL CHEM, V271, P595, DOI 10.1074/jbc.271.1.595; Howland RB, 1916, P NATL ACAD SCI USA, V2, P231, DOI 10.1073/pnas.2.4.231; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Kostenko Sergiy, 2012, J Mol Signal, V7, P9, DOI 10.1186/1750-2187-7-9; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; Liang B, 2005, WORLD J GASTROENTERO, V11, P623, DOI 10.3748/wjg.v11.i5.623; Lienkamp SS, 2016, SEMIN CELL DEV BIOL, V51, P117, DOI 10.1016/j.semcdb.2016.02.002; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Luo T, 2002, DEV BIOL, V245, P136, DOI 10.1006/dbio.2002.0621; Marciano DK, 2017, PEDIATR NEPHROL, V32, P7, DOI 10.1007/s00467-016-3326-4; Matsuda Y, 2015, CYTOGENET GENOME RES, V145, P187, DOI 10.1159/000381292; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Milunsky JM, 2011, AM J MED GENET A, V155A, P22, DOI 10.1002/ajmg.a.33783; MOODY SA, 1990, ANAT EMBRYOL, V182, P347, DOI 10.1007/BF02433495; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Rai R, 2004, ORAL ONCOL, V40, P705, DOI 10.1016/j.oraloncology.2004.01.010; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Sinha S, 2000, MOL CELL BIOL, V20, P2543, DOI 10.1128/MCB.20.7.2543-2555.2000; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SNAPE AM, 1991, DEVELOPMENT, V113, P283; Sun J, 2015, BIOCHEM BIOPH RES CO, V462, P178, DOI 10.1016/j.bbrc.2015.04.065; Wang X, 2006, J CELL BIOL, V172, P409, DOI 10.1083/jcb.200510002; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhang YH, 2006, GENE EXPR PATTERNS, V6, P589, DOI 10.1016/j.modgep.2005.11.011	50	1	2	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8342	8361		10.1074/jbc.RA117.000992	http://dx.doi.org/10.1074/jbc.RA117.000992			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29674317	hybrid, Green Published			2022-12-28	WOS:000434205700003
J	Engelke, AD; Gonsberg, A; Thapa, S; Jung, S; Ulbrich, S; Seidel, R; Basu, S; Multhaup, G; Baier, M; Engelhard, M; Schatzl, HM; Winklhofer, KF; Tatzelt, J				Engelke, Anna D.; Gonsberg, Anika; Thapa, Simrika; Jung, Sebastian; Ulbrich, Sarah; Seidel, Ralf; Basu, Shaon; Multhaup, Gerd; Baier, Michael; Engelhard, Martin; Schaetzl, Hermann M.; Winklhofer, Konstanze F.; Tatzelt, Joerg			Dimerization of the cellular prion protein inhibits propagation of scrapie prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodegenerative disease; prion disease; glycosylphosphatidylinositol; GPI anchor; dimerization; trafficking; neurological disease; amyloid; Creutzfeldt-Jakob disease; scrapie; PrPC; amyloid plaque	NEUROBLASTOMA-CELLS; TRANSMEMBRANE FORM; TRANSGENIC MICE; PRP; DISEASE; GLYCOSYLATION; REPLICATION; IMPAIRMENT; RESISTANT; PRECURSOR	A central step in the pathogenesis of prion diseases is the conformational transition of the cellular prion protein (PrPC) into the scrapie isoform, denoted PrPSc. Studies in transgenic mice have indicated that this conversion requires a direct interaction between PrPC and PrPSc; however, insights into the underlying mechanisms are still missing. Interestingly, only a subfraction of PrPC is converted in scrapie-infected cells, suggesting that not all PrPC species are suitable substrates for the conversion. On the basis of the observation that PrPC can form homodimers under physiological conditions with the internal hydrophobic domain (HD) serving as a putative dimerization domain, we wondered whether PrP dimerization is involved in the formation of neurotoxic and/or infectious PrP conformers. Here, we analyzed the possible impact on dimerization of pathogenic mutations in the HD that induce a spontaneous neurodegenerative disease in transgenic mice. Similarly to wildtype (WT) PrPC, the neurotoxic variant PrP(AV3) formed homodimers as well as heterodimers with WTPrPC. Notably, forced PrP dimerization via an intermolecular disulfide bond did not interfere with its maturation and intracellular trafficking. Covalently linked PrP dimers were complex glycosylated, GPI-anchored, and sorted to the outer leaflet of the plasma membrane. However, forced PrPC dimerization completely blocked its conversion into PrPSc in chronically scrapie-infected mouse neuroblastoma cells. Moreover, PrPC dimers had a dominant-negative inhibition effect on the conversion of monomeric PrPC. Our findings suggest that PrPC monomers are the major substrates for PrPSc propagation and that it may be possible to halt prion formation by stabilizing PrPC dimers.	[Engelke, Anna D.; Gonsberg, Anika; Jung, Sebastian; Ulbrich, Sarah; Tatzelt, Joerg] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Biochem Neurodegenerat Dis, D-44801 Bochum, Germany; [Winklhofer, Konstanze F.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Mol Cell Biol, D-44801 Bochum, Germany; [Thapa, Simrika; Schaetzl, Hermann M.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada; [Thapa, Simrika; Schaetzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB T2N 4Z6, Canada; [Seidel, Ralf; Engelhard, Martin] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Basu, Shaon; Multhaup, Gerd] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Baier, Michael] Robert Koch Inst, Ctr Biol Threats & Special Pathogens ZBS6, Res Grp Proteinopathies Neurodegenerat Dis, D-13353 Berlin, Germany; [Engelke, Anna D.] Heinrich Heine Univ, Med Fac, Dept Neurol, D-40225 Dusseldorf, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Calgary; University of Calgary; Max Planck Society; McGill University; Robert Koch Institute; Heinrich Heine University Dusseldorf	Tatzelt, J (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44801 Bochum, Germany.	Joerg.Tatzelt@rub.de		Winklhofer, Konstanze/0000-0002-7256-8231; Jung, Sebastian/0000-0002-0365-5710; Tatzelt, Jorg/0000-0001-5017-5528; Basu, Shaon/0000-0003-2648-4827; Schatzl, Hermann/0000-0003-4972-8740	Deutsche Forschungsgemeinschaft [TA167/6]; Ministerium fur Kultur und Wissenschaft des Landes Nordrhein-Westfalen [Az 233-1.08.03.03-031.68079]; National Institutes of Health [R01 NS076853-01A1]; Calgary Prion Research Unit, Alberta Prion Research Institute [201600010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER; Alberta Innovates [201610675] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministerium fur Kultur und Wissenschaft des Landes Nordrhein-Westfalen; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Calgary Prion Research Unit, Alberta Prion Research Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates	This work was supported in part by Deutsche Forschungsgemeinschaft Grant TA167/6 (to J.T.), Ministerium fur Kultur und Wissenschaft des Landes Nordrhein-Westfalen Grant Az 233-1.08.03.03-031.68079, National Institutes of Health Grant R01 NS076853-01A1 (to H.M.S.), and Calgary Prion Research Unit, Alberta Prion Research Institute Grant 201600010 (to H.M.S.).	Bach C, 2009, J BIOL CHEM, V284, P31260, DOI 10.1074/jbc.M109.004382; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CAO HN, 1992, J BIOL CHEM, V267, P20489; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; HARDY J, 1991, TRENDS NEUROSCI, V14, P423, DOI 10.1016/0166-2236(91)90038-V; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; Meyer RK, 2000, J BIOL CHEM, V275, P38081, DOI 10.1074/jbc.M007114200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Sakthivelu V, 2011, J BIOL CHEM, V286, P8901, DOI 10.1074/jbc.M110.185470; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Taguchi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003466; Tatzelt A, 2004, AMYLOID, V11, P162, DOI 10.1080/1350-612040000723; Warwicker J, 2000, BIOCHEM BIOPH RES CO, V278, P646, DOI 10.1006/bbrc.2000.3829; Weissmann C, 1996, COLD SPRING HARB SYM, V61, P511; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Wu B, 2017, ELIFE, V6, DOI 10.7554/eLife.23473	43	11	11	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8020	8031		10.1074/jbc.RA117.000990	http://dx.doi.org/10.1074/jbc.RA117.000990			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29636413	Green Published, hybrid			2022-12-28	WOS:000433224600009
J	Ke, HJ; Dass, S; Morrisey, JM; Mather, MW; Vaidya, AB				Ke, Hangjun; Dass, Swati; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.			The mitochondrial ribosomal protein L13 is critical for the structural and functional integrity of the mitochondrion in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						malaria; mitochondria; ribosome; plasmodium; parasitology; mitochondrial DNA (mtDNA); apicomplexan; mitochondrial ribosome; mitoribosome; mRPL13; ribosomal protein; mitochondrion; mitochondrial genome	MALARIA PARASITES; ELECTRON-TRANSPORT; COMPLEX; RNA; DNA; TRANSLATION; RESISTANCE; GENES; APICOMPLEXA; ATOVAQUONE	The phylum Apicomplexa contains a group of protozoa causing diseases in humans and livestock. Plasmodium spp., the causative agent of malaria, contains a mitochondrion that is very divergent from that of their hosts. The malarial mitochondrion is a clinically validated target for the antimalarial drug atovaquone, which specifically blocks the electron transfer activity of the bc(1) complex of the mitochondrial electron transport chain (mtETC). Most mtETC proteins are nuclear-encoded and imported from the cytosol, but three key protein subunits are encoded in the Plasmodium mitochondrial genome: cyt b, COXI, and COXIII. They are translated inside the mitochondrion by mitochondrial ribosomes (mitoribosomes). Here, we characterize the function of one large mitoribosomal protein in Plasmodium falciparum, PfmRPL13. We found that PfmRPL13 localizes to the parasite mitochondrion and is refractory to genetic knockout. Ablation of PfmRPL13 using a conditional knockdown system (TetR-DOZI-aptamer) caused a series of adverse events in the parasite, including mtETC deficiency, loss of mitochondrial membrane potential ((m)), and death. The PfmRPL13 knockdown parasite also became hypersensitive to proguanil, a drug proposed to target an alternative process for maintaining (m). Surprisingly, transmission EM revealed that PfmRPL13 disruption also resulted in an unusually elongated and branched mitochondrion. The growth arrest of the knockdown parasite could be rescued with a second copy of PfmRPL13, but not by supplementation with decylubiquinone or addition of a yeast dihydroorotate dehydrogenase gene. In summary, we provide first and direct evidence that mitoribosomes are essential for malaria parasites to maintain the structural and functional integrity of the mitochondrion.	[Ke, Hangjun; Dass, Swati; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA	Drexel University	Ke, HJ (corresponding author), 2900 Queen Lane, Philadelphia, PA 19129 USA.	hk84@drexel.edu		Mather, Michael/0000-0002-1062-0137; Dass, Swati/0000-0002-0696-3209	National Institutes of Health Career Transition Award K22 [K22AI127702]; National Institutes of Health [R01 AI028398]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI127702, R01AI028398] Funding Source: NIH RePORTER	National Institutes of Health Career Transition Award K22(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Career Transition Award K22, K22AI127702 (to H. K.) and National Institutes of Health Award R01 AI028398 (to A. B. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIKAWA M, 1966, AM J TROP MED HYG, V15, P449, DOI 10.4269/ajtmh.1966.15.449; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Camps M, 2002, MOL MICROBIOL, V43, P1309, DOI 10.1046/j.1365-2958.2002.02825.x; Chaubey S, 2005, MOL MICROBIOL, V56, P81, DOI 10.1111/j.1365-2958.2005.04538.x; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Das S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005647; FEAGIN JE, 1992, MOL BIOCHEM PARASIT, V52, P145, DOI 10.1016/0166-6851(92)90046-M; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; Feagin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038320; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Ganesan SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10727; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Goodman CD, 2016, TRENDS PARASITOL, V32, P953, DOI 10.1016/j.pt.2016.09.011; Goodman CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091178; Gray MW, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016097; Gupta A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140045; Hikosaka K, 2013, MOL BIOCHEM PARASIT, V188, P26, DOI 10.1016/j.molbiopara.2013.02.006; Hunte C, 2003, FEBS LETT, V545, P39, DOI 10.1016/S0014-5793(03)00391-0; Ke H, 2017, CURR CLIN MICROBIOL, V4, P175, DOI 10.1007/s40588-017-0075-5; Ke HJ, 2011, EUKARYOT CELL, V10, P1053, DOI 10.1128/EC.05049-11; Khaitovich P, 1999, P NATL ACAD SCI USA, V96, P85, DOI 10.1073/pnas.96.1.85; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Mather MW, 2010, MOL BIOCHEM PARASIT, V174, P150, DOI 10.1016/j.molbiopara.2010.07.006; Nina PB, 2011, J BIOL CHEM, V286, P41312, DOI 10.1074/jbc.M111.290973; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Puiu D, 2004, NUCLEIC ACIDS RES, V32, pD329, DOI 10.1093/nar/gkh050; Sharma A, 2015, BIOCHEM J, V465, P459, DOI 10.1042/BJ20140998; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Spillman NJ, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12719; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; Sun M, 2015, NUCLEIC ACIDS RES, V43, P10515, DOI 10.1093/nar/gkv991; SUPLICK K, 1988, MOL BIOCHEM PARASIT, V30, P289, DOI 10.1016/0166-6851(88)90098-9; SUPLICK K, 1990, MOL CELL BIOL, V10, P6381, DOI 10.1128/MCB.10.12.6381; Timsit Y, 2009, INT J MOL SCI, V10, P817, DOI 10.3390/ijms10030817; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; Vaidya AB, 2000, DRUG RESIST UPDATE, V3, P283, DOI 10.1054/drup.2000.0157; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; World Health Organization, 2017, DEPRESSION	47	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8128	8137		10.1074/jbc.RA118.002552	http://dx.doi.org/10.1074/jbc.RA118.002552			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626096	Green Published, hybrid			2022-12-28	WOS:000433224600018
J	Ridgway, ND				Ridgway, Neale D.			How CCT alpha puts a leash on phospholipid synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE SYNTHESIS; ENZYME	The proportion of phosphatidylcholine (PC) in the membrane is controlled by CTP:phosphocholine cytidylyltransferase (CCT), which is known to be regulated by a dual auto-inhibitory and membrane-binding domain. However, the detailed mechanism by which this domain regulates CCT activity is not clear. Ramezanpour et al. use a combined computational and biochemical approach to define new details of this mechanism, providing an elegant illustration of how the lipid-sensing domain of a phospholipid biosynthetic enzyme controls membrane homeostasis.	[Ridgway, Neale D.] Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Rm C306,CRC Bldg,5849 Univ Ave,Box 15000, Halifax, NS B3H 4R2, Canada; [Ridgway, Neale D.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Rm C306,CRC Bldg,5849 Univ Ave,Box 15000, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University	Ridgway, ND (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Rm C306,CRC Bldg,5849 Univ Ave,Box 15000, Halifax, NS B3H 4R2, Canada.; Ridgway, ND (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Rm C306,CRC Bldg,5849 Univ Ave,Box 15000, Halifax, NS B3H 4R2, Canada.	nridgway@dal.ca		Ridgway, Neale/0000-0002-0441-6228	Institute of Nutrition, Metabolism, and Diabetes (INMD), Canadian Institutes of Health Research [136809]	Institute of Nutrition, Metabolism, and Diabetes (INMD), Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Institute of Nutrition, Metabolism, and Diabetes (INMD), Canadian Institutes of Health Research Grant 136809. The author declares that he has no conflicts of interest with the contents of the article.	Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Lee J, 2014, J BIOL CHEM, V289, P1742, DOI 10.1074/jbc.M113.526970; PELECH SL, 1983, J BIOL CHEM, V258, P6782; Ramezanpour M, 2018, J BIOL CHEM, V293, P7070, DOI 10.1074/jbc.RA118.002053	5	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7085	7086		10.1074/jbc.H118.002882	http://dx.doi.org/10.1074/jbc.H118.002882			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29728535	Green Published, hybrid			2022-12-28	WOS:000431487300040
J	Herr, AB				Herr, Andrew B.			Evolution of an allosteric "off switch" in apoptotic caspases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Caspase-3 is well known as the "executioner" whose activation commits the cell to an apoptotic fate, but low levels of caspase-3 activity also play key roles in development. A new study explains how cells can balance these functions, using biophysical, structural, and computational approaches to demonstrate the mechanism by which phosphorylation of conserved sites on a distal surface loop reduces or abolishes catalytic activity. These results provide new insights into allosteric regulation mechanisms and offer new opportunities for development of caspase-3 modulators.	[Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Herr, Andrew B.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Herr, Andrew B.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Herr, AB (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.	andrew.herr@cchmc.org	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399	National Institutes of Health [U19-AI070235, R21-AI132822, R21-HD090856]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD090856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235, R21AI132822] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I thank Dr. Joe Maciag for helpful discussions and comments on the manuscript. The Herr laboratory is supported by National Institutes of Health Grants U19-AI070235, R21-AI132822, and R21-HD090856.	Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Parrish AB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008672; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Thomas ME, 2018, J BIOL CHEM, V293, P5447, DOI 10.1074/jbc.RA117.000728	8	12	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5462	5463		10.1074/jbc.H118.002379	http://dx.doi.org/10.1074/jbc.H118.002379			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29654071	Green Published, hybrid			2022-12-28	WOS:000430044100010
J	Hanna, DA; Hu, R; Kim, H; Martinez-Guzman, O; Torres, MP; Reddi, AR				Hanna, David A.; Hu, Rebecca; Kim, Hyojung; Martinez-Guzman, Osiris; Torres, Matthew P.; Reddi, Amit R.			Heme bioavailability and signaling in response to stress in yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; biosensor; metal homeostasis; metal; heme oxygenase; stress; xenobiotic; yeast; cell stress; heavy metals; heme; heme sensor; lead; Hap1; labile heme pool	LEAD TOXICITY; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISM; ESCHERICHIA-COLI; OXIDATIVE STRESS; UP-REGULATION; EXPOSURE; OVEREXPRESSION; TRAFFICKING; METABOLISM	Protoheme (hereafter referred to as heme) is an essential cellular cofactor and signaling molecule that is also potentially cytotoxic. To mitigate heme toxicity, heme synthesis and degradation are tightly coupled to heme utilization in order to limit the intracellular concentration of free heme. Such a model, however, would suggest that a readily accessible steady-state, bioavailable labile heme (LH) pool is not required for supporting heme-dependent processes. Using the yeast Saccharomyces cerevisiae as a model and fluorescent heme sensors, site-specific heme chelators, and molecular genetic approaches, we found here that 1) yeast cells preferentially use LH in heme-depleted conditions; 2) sequestration of cytosolic LH suppresses heme signaling; and 3) lead (Pb2+) stress contributes to a decrease in total heme, but an increase in LH, which correlates with increased heme signaling. We also observed that the proteasome is involved in the regulation of the LH pool and that loss of proteasomal activity sensitizes cells to Pb2+ effects on heme homeostasis. Overall, these findings suggest an important role for LH in supporting heme-dependent functions in yeast physiology.	[Hanna, David A.; Hu, Rebecca; Kim, Hyojung; Martinez-Guzman, Osiris; Reddi, Amit R.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kim, Hyojung; Torres, Matthew P.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Torres, Matthew P.; Reddi, Amit R.] Georgia Inst Technol, Parker Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Reddi, AR (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	amit.reddi@chemistry.gatech.edu		Torres, Matthew/0000-0001-7296-4536; Hanna, David/0000-0003-0726-8707	National Institutes of Health [ES025661, GM118744]; National Science Foundation [MCB-1552791]; Blanchard Professorship; Georgia Institute of Technology; Petit Institute Scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025661, R33ES025661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118744] Funding Source: NIH RePORTER; Direct For Biological Sciences [1552791] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Blanchard Professorship; Georgia Institute of Technology; Petit Institute Scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Institutes of Health Grants ES025661 (to A. R. R.) and GM118744 (to A. R. R. with a sub-award to M. P. T.), National Science Foundation Grant MCB-1552791 (to A. R. R.), the Blanchard Professorship (to A. R. R.), and start-up funding from the Georgia Institute of Technology (to A. R. R. and M. P. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Petit Institute Scholarship.	Aich A, 2015, BLOOD CELL MOL DIS, V55, P402, DOI 10.1016/j.bcmd.2015.09.003; ALAM J, 1994, J BIOL CHEM, V269, P1001; Lopes ACBA, 2016, REV ENVIRON CONTAM T, V236, P193, DOI 10.1007/978-3-319-20013-2_3; Barker PD, 1996, BIOCHEMISTRY-US, V35, P13618, DOI 10.1021/bi961127x; Baureder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036725; BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1050; Bussche JV, 2011, APPL MICROBIOL BIOT, V90, P679, DOI 10.1007/s00253-010-3056-7; Chen C, 2007, APPL MICROBIOL BIOT, V74, P683, DOI 10.1007/s00253-006-0678-x; COHEN AR, 1981, PEDIATRICS, V67, P904; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; Conant JB, 1930, J BIOL CHEM, V86, P0733; Correia MA, 2011, DRUG METAB REV, V43, P1, DOI 10.3109/03602532.2010.515222; DEMATTEIS F, 1980, BIOCHEM J, V189, P645, DOI 10.1042/bj1890645; DEMATTEIS F, 1983, FEBS LETT, V159, P127, DOI 10.1016/0014-5793(83)80430-X; Dongre NN, 2013, INDIAN J CLIN BIOCHE, V28, P65, DOI 10.1007/s12291-012-0241-8; EBERT PS, 1979, BIOCHEM BIOPH RES CO, V88, P1382, DOI 10.1016/0006-291X(79)91133-1; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Ernst WHO, 2008, PLANT CELL ENVIRON, V31, P123, DOI 10.1111/j.1365-3040.2007.01746.x; FENG YQ, 1991, BIOCHEMISTRY-US, V30, P10150, DOI 10.1021/bi00106a011; FENG YQ, 1994, NAT STRUCT BIOL, V1, P30, DOI 10.1038/nsb0194-30; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Fu X, 2014, EXP BIOL MED, V239, P202, DOI 10.1177/1535370213509213; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Gillis BS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-344; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Gruenberg-Etkovitz N, 2009, J ENVIRON PATHOL TOX, V28, P5, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i1.20; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUO GG, 1994, J BIOL CHEM, V269, P12399; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Hanna DA, 2017, BIOCHEMISTRY-US, V56, P1815, DOI 10.1021/acs.biochem.7b00007; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; ITAGAKI E, 1967, J BIOL CHEM, V242, P2272; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lanphear BP, 1998, ENVIRON RES, V76, P120, DOI 10.1006/enrs.1997.3801; Lee KH, 2009, KOREAN J PHYSIOL PHA, V13, P431, DOI 10.4196/kjpp.2009.13.6.431; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; LIU SC, 1988, BLOOD, V71, P1755; LUBRAN MM, 1980, ANN CLIN LAB SCI, V10, P402; Magyar JS, 2005, J AM CHEM SOC, V127, P9495, DOI 10.1021/ja0424530; Marques M, 2006, MICROBIOL-SGM, V152, P3595, DOI 10.1099/mic.0.29040-0; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Michener JK, 2012, P NATL ACAD SCI USA, V109, P19504, DOI 10.1073/pnas.1212287109; Ness F, 1998, J BACTERIOL, V180, P1913, DOI 10.1128/JB.180.7.1913-1919.1998; NIKKILA H, 1991, EUR J BIOCHEM, V202, P309, DOI 10.1111/j.1432-1033.1991.tb16377.x; ORTIZDEMONTELLANO PR, 1978, BIOCHEM BIOPH RES CO, V83, P132; Papinski D, 2016, J MOL BIOL, V428, P1725, DOI 10.1016/j.jmb.2016.03.030; Perez RR, 2013, CURR MICROBIOL, V67, P300, DOI 10.1007/s00284-013-0364-z; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; PIOMELLI S, 1982, P NATL ACAD SCI-BIOL, V79, P3335, DOI 10.1073/pnas.79.10.3335; POUNDS JG, 1984, NEUROTOXICOLOGY, V5, P295; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; QIAN ZM, 1990, BIOCHEM PHARMACOL, V40, P1049; Quintanar-Escorza MA, 2010, TOXICOL IN VITRO, V24, P1338, DOI 10.1016/j.tiv.2010.05.002; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Reddi AR, 2007, BIOCHEMISTRY-US, V46, P291, DOI 10.1021/bi061607g; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Robinson CR, 1997, BIOCHEMISTRY-US, V36, P16141, DOI 10.1021/bi971470h; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Sassa S, 1982, Trans Assoc Am Physicians, V95, P42; Schauder A, 2010, J ENVIRON PATHOL TOX, V29, P137, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i2.70; SCHULZE H, 1978, PLANT PHYSIOL, V62, P727, DOI 10.1104/pp.62.5.727; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Sharma B., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/640754; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith AG, 2001, TOXICOL APPL PHARM, V173, P89, DOI 10.1006/taap.2001.9167; Song YQ, 2015, ACS CHEM BIOL, V10, P1610, DOI 10.1021/cb5009734; Sousa CA, 2014, APPL MICROBIOL BIOT, V98, P5153, DOI 10.1007/s00253-014-5631-9; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2009, P NATL ACAD SCI USA, V106, P14293, DOI 10.1073/pnas.0907786106; URQUHART AJ, 1988, BIOCHEM J, V253, P357, DOI 10.1042/bj2530357; Vallelian F, 2015, CELL DEATH DIFFER, V22, P597, DOI 10.1038/cdd.2014.154; Van der Heggen M, 2010, APPL MICROBIOL BIOT, V88, P1355, DOI 10.1007/s00253-010-2799-5; Wani Ab Latif, 2015, Interdiscip Toxicol, V8, P55, DOI 10.1515/intox-2015-0009; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Yedjou CG, 2010, INT J ENV RES PUB HE, V7, P2008, DOI 10.3390/ijerph7052008; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZHANG L, 1993, P NATL ACAD SCI USA, V90, P2851, DOI 10.1073/pnas.90.7.2851; Zhang L, 1998, MOL CELL BIOL, V18, P3819, DOI 10.1128/MCB.18.7.3819; Zhang TT, 2017, J BIOL CHEM, V292, P16942, DOI 10.1074/jbc.M117.790923; Zheng G, 2014, TOXICOL LETT, V225, P110, DOI 10.1016/j.toxlet.2013.11.034	84	22	22	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12378	12393		10.1074/jbc.RA118.002125	http://dx.doi.org/10.1074/jbc.RA118.002125			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29921585	hybrid, Green Published			2022-12-28	WOS:000441408500006
J	Luck, JC; Puchkov, D; Ullrich, F; Jentsch, TJ				Lueck, Jennifer C.; Puchkov, Dmytro; Ullrich, Florian; Jentsch, Thomas J.			LRRC8/VRAC anion channels are required for late stages of spermatid development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRE RECOMBINASE ACTIVITY; MALE GERM-CELLS; VOLUME REGULATION; MALE-INFERTILITY; MOUSE MODELS; ESSENTIAL COMPONENT; MALE-FERTILITY; PROTEINS; ABNORMALITIES; TRANSPORTERS	Spermatogenesis is a highly complex developmental process that occurs primarily in seminiferous tubules of the testes and requires additional maturation steps in the epididymis and beyond. Mutations in many different genes can lead to defective spermatozoa and hence to male infertility. Some of these genes encode for ion channels and transporters that play roles in various processes such as cellular ion homeostasis, signal transduction, sperm motility, and the acrosome reaction. Here we show that germ cell-specific, but not Sertoli cell-specific, disruption of Lrrc8a leads to abnormal sperm and male infertility in mice. LRRC8A (leucine-rich repeat containing 8A) is the only obligatory subunit of heteromeric volume-regulated anion channels (VRACs). Its ablation severely compromises cell volume regulation by completely abolishing the transport of anions and osmolytes through VRACs. Consistent with impaired volume regulation, the cytoplasm of late spermatids appeared swollen. These cells failed to properly reduce their cytoplasm during further development into spermatozoa and later displayed severely disorganized mitochondrial sheaths in the midpiece region, as well as angulated or coiled flagella. These changes, which progressed in severity on the way to the epididymis, resulted in dramatically reduced sperm motility. Our work shows that VRAC, probably through its role in cell volume regulation, is required in a cell-autonomous manner for proper sperm development and explains the male infertility of Lrrc8a(-/-) mice and the spontaneous mouse mutant ebouriffe.	[Lueck, Jennifer C.; Puchkov, Dmytro; Ullrich, Florian; Jentsch, Thomas J.] Leibniz Forschungsinst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Lueck, Jennifer C.; Ullrich, Florian; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Lueck, Jennifer C.] Free Univ Berlin, Grad Program, D-14195 Berlin, Germany; [Jentsch, Thomas J.] Charite, Neurocure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Ullrich, Florian/AAA-6043-2019	Ullrich, Florian/0000-0002-1153-2040; Puchkov, Dmytro/0000-0001-8341-4847; Jentsch, Thomas/0000-0002-3509-2553	Advanced Grants for the European Research Council (ERC) Advanced Grant [294435 Cytovolion, 740537 Volsignal]; Prix Louis Jeantet de Medecine	Advanced Grants for the European Research Council (ERC) Advanced Grant; Prix Louis Jeantet de Medecine	This work was supported by Advanced Grants for the European Research Council (ERC) Advanced Grant 294435 Cytovolion and 740537 Volsignal and the Prix Louis Jeantet de Medecine (to T.J.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Avenarius MR, 2009, AM J HUM GENET, V84, P505, DOI 10.1016/j.ajhg.2009.03.004; Blanz J, 2007, J NEUROSCI, V27, P6581, DOI 10.1523/JNEUROSCI.0338-07.2007; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Bouchard MJ, 2000, MOL CELL BIOL, V20, P2865, DOI 10.1128/MCB.20.8.2865-2873.2000; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Chen H, 2012, HUM REPROD UPDATE, V18, P703, DOI 10.1093/humupd/dms027; Chung JJ, 2017, ELIFE, V6, DOI [10.7554/eLife.23082, 10.7547/elife.23082.001]; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Cooper TG, 2007, CURR PHARM DESIGN, V13, P3222, DOI 10.2174/138161207782341240; Cooper TG, 2003, MICROSC RES TECHNIQ, V61, P28, DOI 10.1002/jemt.10314; Cooper TG, 2004, MOL CELL ENDOCRINOL, V216, P55, DOI 10.1016/j.mce.2003.10.076; Cooper TG, 2011, ASIAN J ANDROL, V13, P130, DOI 10.1038/aja.2010.97; Davis FM, 2016, CELL CALCIUM, V59, P189, DOI 10.1016/j.ceca.2016.02.007; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; Deneka D, 2018, NATURE, V558, P254, DOI 10.1038/s41586-018-0134-y; Di Bella D, 2014, NEUROLOGY, V83, P1217, DOI 10.1212/WNL.0000000000000812; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; Haschek WM, 2010, FUNDAMENTALS OF TOXICOLOGIC PATHOLOGY, 2ND EDITION, P553, DOI 10.1016/B978-0-12-370469-6.00018-0; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Huynh T, 2002, HUM REPROD UPDATE, V8, P183, DOI 10.1093/humupd/8.2.183; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Joseph A, 2010, BIOL REPROD, V82, P958, DOI 10.1095/biolreprod.109.080366; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Lalouette A, 1996, BIOL REPROD, V55, P355, DOI 10.1095/biolreprod55.2.355; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lutter D, 2017, J CELL SCI, V130, P1122, DOI 10.1242/jcs.196253; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; Oberheide K, 2017, J BIOL CHEM, V292, P10845, DOI 10.1074/jbc.M117.784108; Oh S, 2008, J PHYSIOL-LONDON, V586, P2445, DOI 10.1113/jphysiol.2008.150805; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Pedersen SF, 2016, PFLUG ARCH EUR J PHY, V468, P371, DOI 10.1007/s00424-015-1781-6; Pilder SH, 1997, J ANDROL, V18, P663; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Platt CD, 2017, J ALLERGY CLIN IMMUN, V140, P1651, DOI 10.1016/j.jaci.2016.12.974; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Stuhlmann T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04353-y; Suzuki-Toyota F, 2004, ARCH HISTOL CYTOL, V67, P361, DOI 10.1679/aohc.67.361; Suzuki-Toyota F, 2007, BIOL REPROD, V77, P71, DOI 10.1095/biolreprod.106.058735; Syeda R, 2016, CELL, V164, P499, DOI 10.1016/j.cell.2015.12.031; Ullrich F, 2016, J BIOL CHEM, V291, P17040, DOI 10.1074/jbc.M116.739342; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wambergue C, 2016, HUM REPROD, V31, P1164, DOI 10.1093/humrep/dew083; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Yeung CH, 2006, MOL CELL ENDOCRINOL, V250, P98, DOI 10.1016/j.mce.2005.12.030; Yeung CH, 2004, J ANDROL, V25, P216; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036	58	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11796	11808		10.1074/jbc.RA118.003853	http://dx.doi.org/10.1074/jbc.RA118.003853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29880644	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000440134500014
J	Sankar, SB; Donegan, RK; Shah, KJ; Reddi, AR; Wood, LB				Sankar, Sitara B.; Donegan, Rebecca K.; Shah, Kajol J.; Reddi, Amit R.; Wood, Levi B.			Heme and hemoglobin suppress amyloid -mediated inflammatory activation of mouse astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (AB); astrocyte; heme; hemoglobin; Alzheimer disease	BLOOD-BRAIN-BARRIER; A-BETA CLEARANCE; ALZHEIMERS-DISEASE; CARBON-MONOXIDE; CELL-DEATH; INTRACELLULAR HEME; COGNITIVE DECLINE; PRIMARY CULTURES; LABILE HEME; PROTEIN	Glial immune activity is a key feature of Alzheimer's disease (AD). Given that the blood factors heme and hemoglobin (Hb) are both elevated in AD tissues and have immunomodulatory roles, here we sought to interrogate their roles in modulating -amyloid (A)-mediated inflammatory activation of astrocytes. We discovered that heme and Hb suppress immune activity of primary mouse astrocytes by reducing expression of several proinflammatory cytokines (e.g. RANTES (regulated on activation normal T cell expressed and secreted)) and the scavenger receptor CD36 and reducing internalization of A(1-42) by astrocytes. Moreover, we found that certain soluble (>75-kDa) A(1-42) oligomers are primarily responsible for astrocyte activation and that heme or Hb association with these oligomers reverses inflammation. We further found that heme up-regulates phosphoprotein signaling in the phosphoinositide 3-kinase (PI3K)/Akt pathway, which regulates a number of immune functions, including cytokine expression and phagocytosis. The findings in this work suggest that dysregulation of Hb and heme levels in AD brains may contribute to impaired amyloid clearance and that targeting heme homeostasis may reduce amyloid pathogenesis. Altogether, we propose heme as a critical molecular link between amyloid pathology and AD risk factors, such as aging, brain injury, and stroke, which increase Hb and heme levels in the brain.	[Sankar, Sitara B.; Shah, Kajol J.; Wood, Levi B.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Donegan, Rebecca K.; Reddi, Amit R.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Reddi, Amit R.; Wood, Levi B.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Wood, Levi B.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Reddi, AR (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Wood, LB (corresponding author), Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	amit.reddi@chemistry.gatech.edu; levi.wood@me.gatech.edu		Sankar, Sitara/0000-0002-2255-7331	Parker H. Petit Institute for Bioengineering and Bioscience; Blanchard faculty fellowship; National Science Foundation [MCB1552791]; National Institutes of Health [ES025661]; Georgia Tech President's Undergraduate Research Award; Div Of Molecular and Cellular Bioscience [1552791] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R33ES025661, R21ES025661] Funding Source: NIH RePORTER	Parker H. Petit Institute for Bioengineering and Bioscience; Blanchard faculty fellowship; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Tech President's Undergraduate Research Award; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Parker H. Petit Institute for Bioengineering and Bioscience (to A.R.R. and L.B.W.), start-up support from the George W. Woodruff School of Mechanical Engineering (to L.B.W.), start-up support from the School of Chemistry and Biochemistry (to A.R.R.), a Blanchard faculty fellowship (to A.R.R.), National Science Foundation Grant MCB1552791 (to A.R.R.), and National Institutes of Health Grant ES025661 (to A.R.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of the Georgia Tech President's Undergraduate Research Award.	Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; Abshire JR, 2017, P NATL ACAD SCI USA, V114, pE2068, DOI 10.1073/pnas.1615195114; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Atamna H, 2004, P NATL ACAD SCI USA, V101, P11153, DOI 10.1073/pnas.0404349101; Atamna H, 2009, ARCH BIOCHEM BIOPHYS, V487, P59, DOI 10.1016/j.abb.2009.05.003; Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; Bao Y, 2012, J CEREBR BLOOD F MET, V32, P1567, DOI 10.1038/jcbfm.2012.52; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Borda JT, 2008, AM J PATHOL, V172, P725, DOI 10.2353/ajpath.2008.070848; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Cao L, 2016, MOL NEUROBIOL, V53, P4417, DOI 10.1007/s12035-015-9377-x; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chuang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033120; Codeluppi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092649; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Eriksson L., 2006, MULTIAND MEGAVARIATE, P63; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fernandez PL, 2010, J BIOL CHEM, V285, P32844, DOI 10.1074/jbc.M110.146076; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Ghosh C, 2016, INORG CHEM, V55, P1748, DOI 10.1021/acs.inorgchem.5b02683; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gouveia Z, 2017, FEBS J, V284, P3278, DOI 10.1111/febs.14192; Griffin W Sue T, 2011, F1000 Med Rep, V3, P24, DOI 10.3410/M3-24; Hampton DW, 2010, J NEUROSCI, V30, P9973, DOI 10.1523/JNEUROSCI.0834-10.2010; Hanna DA, 2017, BIOCHEMISTRY-US, V56, P1815, DOI 10.1021/acs.biochem.7b00007; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Huang WC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-28; Iadecola C, 2015, NEURON, V85, P231, DOI 10.1016/j.neuron.2014.12.056; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Janes KA, 2006, CURR OPIN CHEM BIOL, V10, P73, DOI 10.1016/j.cbpa.2005.12.016; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Jiang JH, 2015, NEUROCHEM RES, V40, P1929, DOI 10.1007/s11064-015-1686-y; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kim HS, 2008, AM J PHYSIOL-GASTR L, V295, pG146, DOI 10.1152/ajpgi.00105.2007; Ko EM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-105; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Krajcovic M, 2013, MOL BIOL CELL, V24, P3736, DOI 10.1091/mbc.E13-07-0408; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; LEE SC, 1994, GLIA, V12, P309, DOI 10.1002/glia.440120407; Li CY, 2015, NEUROCHEM INT, V83-84, P9, DOI 10.1016/j.neuint.2015.03.001; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lisi L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-1; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Maresca B, 2015, J MOL NEUROSCI, V56, P35, DOI 10.1007/s12031-014-0465-6; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Michener JK, 2012, P NATL ACAD SCI USA, V109, P19504, DOI 10.1073/pnas.1212287109; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nagamoto-Combs K, 2014, J NEUROSCI METH, V233, P187, DOI 10.1016/j.jneumeth.2014.05.021; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268; Patel NS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-9; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Perry George, 1998, J Alzheimers Dis, V1, P45; Prince M., 2016, WORLD ALZHEIMER REPO; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Robinson SR, 2009, REDOX REP, V14, P228, DOI 10.1179/135100009X12525712409931; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shen J, 2014, CELL REP, V7, P180, DOI 10.1016/j.celrep.2014.02.042; Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344; Simoes RL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/946878; Snider BJ, 2009, ARCH NEUROL-CHICAGO, V66, P638, DOI 10.1001/archneurol.2009.55; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Song YQ, 2015, ACS CHEM BIOL, V10, P1610, DOI 10.1021/cb5009734; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sutton E. T., 1999, Journal of Submicroscopic Cytology and Pathology, V31, P313; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wegiel B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00047; Wood LB, 2015, SCI REP-UK, V5, DOI 10.1038/srep16622; Wu B, 2004, J NEUROCHEM, V91, P1164, DOI 10.1111/j.1471-4159.2004.02805.x; Wu CW, 2004, NEUROBIOL DIS, V17, P367, DOI 10.1016/j.nbd.2004.08.014; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xiao QL, 2014, J NEUROSCI, V34, P9607, DOI 10.1523/JNEUROSCI.3788-13.2014; Xue ZF, 2014, EUR J PHARMACOL, V741, P195, DOI 10.1016/j.ejphar.2014.08.006; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yuan XJ, 2016, P NATL ACAD SCI USA, V113, pE5144, DOI 10.1073/pnas.1609865113; Zhang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072744	105	21	22	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11358	11373		10.1074/jbc.RA117.001050	http://dx.doi.org/10.1074/jbc.RA117.001050			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871926	hybrid, Green Published			2022-12-28	WOS:000439449700008
J	Ward, DM; Chen, OS; Li, LT; Kaplan, J; Bhuiyan, SA; Natarajan, SK; Bard, M; Cox, JE				Ward, Diane M.; Chen, Opal S.; Li, Liangtao; Kaplan, Jerry; Bhuiyan, Shah Alam; Natarajan, Selvamuthu K.; Bard, Martin; Cox, James E.			Altered sterol metabolism in budding yeast affects mitochondrial iron-sulfur (Fe-S) cluster synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron; iron-sulfur protein; sterol; mitochondria; yeast; Fe-S clusters	FRATAXIN HOMOLOG YFH1; SACCHAROMYCES-CEREVISIAE; INDUCED OLIGOMERIZATION; PROTEIN BIOGENESIS; CANDIDA-ALBICANS; HEME-SYNTHESIS; ACID SYNTHESIS; ACCUMULATION; DOXORUBICIN; TRANSPORTER	Ergosterol synthesis is essential for cellular growth and viability of the budding yeast Saccharomyces cerevisiae, and intracellular sterol distribution and homeostasis are therefore highly regulated in this species. Erg25 is an iron-containing C4-methyl sterol oxidase that contributes to the conversion of 4,4-dimethylzymosterol to zymosterol, a precursor of ergosterol. The ERG29 gene encodes an endoplasmic reticulum (ER)-associated protein, and here we identified a role for Erg29 in the methyl sterol oxidase step of ergosterol synthesis. ERG29 deletion resulted in lethality in respiring cells, but respiration-incompetent (Rho(-) or Rho(0)) cells survived, suggesting that Erg29 loss leads to accumulation of oxidized sterol metabolites that affect cell viability. Down-regulation of ERG29 expression in erg29 cells indeed led to accumulation of methyl sterol metabolites, resulting in increased mitochondrial oxidants and a decreased ability of mitochondria to synthesize iron-sulfur (Fe-S) clusters due to reduced levels of Yfh1, the mammalian frataxin homolog, which is involved in mitochondrial iron metabolism. Using a high-copy genomic library, we identified suppressor genes that permitted growth of erg29 cells on respiratory substrates, and these included genes encoding the mitochondrial proteins Yfh1, Mmt1, Mmt2, and Pet20, which reversed all phenotypes associated with loss of ERG29. Of note, loss of Erg25 also resulted in accumulation of methyl sterol metabolites and also increased mitochondrial oxidants and degradation of Yfh1. We propose that accumulation of toxic intermediates of the methyl sterol oxidase reaction increases mitochondrial oxidants, which affect Yfh1 protein stability. These results indicate an interaction between sterols generated by ER proteins and mitochondrial iron metabolism.	[Ward, Diane M.; Li, Liangtao; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84132 USA; [Chen, Opal S.] Univ Utah, Sch Med, DNA Sequencing Core, Salt Lake City, UT 84132 USA; [Bhuiyan, Shah Alam; Natarajan, Selvamuthu K.; Bard, Martin] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA; [Cox, James E.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Cox, James E.] Univ Utah, Sch Med, Metabol Core Res Facil, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University-Purdue University Indianapolis; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ward, DM (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84132 USA.	diane.mcveyward@path.utah.edu			National Institutes of Health (NIH) [DK030534, DK052380]; Friedreich's Ataxia Research Alliance (FARA) [10047373]; National Center for Research Resources (NCRR) Shared Instrumentation Grant [1S10OD021505]; NIH [U54 DK110858]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, R37DK030534, U54DK110858, R01DK052380] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021505] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich's Ataxia Research Alliance (FARA); National Center for Research Resources (NCRR) Shared Instrumentation Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by National Institutes of Health (NIH) Grants DK030534 and DK052380 (to D. M. W.), Friedreich's Ataxia Research Alliance (FARA) Grant 10047373 (to D. M. W.), National Center for Research Resources (NCRR) Shared Instrumentation Grant 1S10OD021505 (to J. E. C.), and sterol analysis through NIH-sponsored Grant U54 DK110858 (to J. E. C. and D. M. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Alimardani P, 2004, BIOCHEM J, V381, P195, DOI 10.1042/BJ20040297; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bard M, 1996, P NATL ACAD SCI USA, V93, P186, DOI 10.1073/pnas.93.1.186; Baudry K, 2001, J BIOL CHEM, V276, P12702, DOI 10.1074/jbc.M100274200; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P16922, DOI 10.1073/pnas.232392299; Chen OS, 2001, FEBS LETT, V509, P131, DOI 10.1016/S0014-5793(01)03137-4; Cocco E, 2013, MOL BIOL REP, V40, P6757, DOI 10.1007/s11033-013-2792-z; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Demuyser L, 2017, MBIO, V8, DOI [10.1128/mBio.00201-17, 10.1128/mbio.00201-17]; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Gachotte D, 1998, P NATL ACAD SCI USA, V95, P13794, DOI 10.1073/pnas.95.23.13794; Gachotte D, 1997, P NATL ACAD SCI USA, V94, P11173, DOI 10.1073/pnas.94.21.11173; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109; Kalyanaraman B, 2007, CARDIOVASC TOXICOL, V7, P92, DOI 10.1007/s12012-007-0025-1; Kim MJ, 2012, BIOCHIMIE, V94, P2448, DOI 10.1016/j.biochi.2012.07.005; Kim MJ, 2010, J NEUROL SCI, V298, P64, DOI 10.1016/j.jns.2010.08.016; Kwok JC, 2004, MOL PHARMACOL, V65, P181, DOI 10.1124/mol.65.1.181; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li FY, 2001, FEBS LETT, V494, P79, DOI 10.1016/S0014-5793(01)02319-5; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li LT, 2014, J BIOL CHEM, V289, P17132, DOI 10.1074/jbc.M114.574723; Li LT, 2012, J BIOL CHEM, V287, P35709, DOI 10.1074/jbc.M112.395533; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 1997, J BIOL CHEM, V272, P28485, DOI 10.1074/jbc.272.45.28485; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; Maccarinelli F, 2014, J MOL MED, V92, P859, DOI 10.1007/s00109-014-1147-0; Melber A, 2016, ELIFE, V5, DOI 10.7554/eLife.15991; Moretti-Almeida G, 2013, FEBS LETT, V587, P3008, DOI 10.1016/j.febslet.2013.07.024; Mouli S, 2015, AM J PHYSIOL-HEART C, V309, pH844, DOI 10.1152/ajpheart.00182.2015; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Ness F, 2001, EUR J BIOCHEM, V268, P1585, DOI 10.1046/j.1432-1033.2001.02029.x; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Polevoda B, 2006, YEAST, V23, P127, DOI 10.1002/yea.1340; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Runkoa AP, 2008, FEBS LETT, V582, P715, DOI 10.1016/j.febslet.2008.01.046; Santos R, 2003, BIOCHEM J, V375, P247, DOI 10.1042/BJ20030835; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Seguin A, 2011, J BIOL CHEM, V286, P6071, DOI 10.1074/jbc.M110.163253; Seguin A, 2009, MITOCHONDRION, V9, P130, DOI 10.1016/j.mito.2009.01.007; Snoek ISI, 2006, FEMS YEAST RES, V6, P393, DOI 10.1111/j.1567-1364.2005.00007.x; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Voisine C, 2000, MOL CELL BIOL, V20, P3677, DOI 10.1128/MCB.20.10.3677-3684.2000; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	68	14	14	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10782	10795		10.1074/jbc.RA118.001781	http://dx.doi.org/10.1074/jbc.RA118.001781			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29773647	Green Published, hybrid			2022-12-28	WOS:000437828400032
J	Peng, L; Zhang, FJ; Shang, RF; Wang, XY; Chen, JY; Chou, JJ; Ma, JB; Wu, LG; Huang, Y				Peng, Ling; Zhang, Fengjuan; Shang, Renfu; Wang, Xueyan; Chen, Jiayi; Chou, James J.; Ma, Jinbiao; Wu, Ligang; Huang, Ying			Identification of substrates of the small RNA methyltransferase Hen1 in mouse spermatogonial stem cells and analysis of its methyl-transfer domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; RNA methyltransferase; spermatogenesis; RNA; RNA modification; 3'-end methylation; Hen1; methyltransferase domain; piRNA; spermatogonial stem cell	PIWI-INTERACTING RNAS; GENOME BROWSER; BIOGENESIS; SIRNAS; MIRNAS; MECHANISMS; MICRORNAS; STABILITY; INSIGHTS; DATABASE	Small noncoding RNAs (sncRNAs) regulate many genes in eukaryotic cells. Hua enhancer 1 (Hen1) is a 2-O-methyltransferase that adds a methyl group to the 2-OH of the 3-terminal nucleotide of sncRNAs. The types and properties of sncRNAs may vary among different species, and the domain composition, structure, and function of Hen1 proteins differ accordingly. In mammals, Hen1 specifically methylates sncRNAs called P-element-induced wimpy testis-interacting RNAs (piRNAs). However, other types of sncRNAs that are methylated by Hen1 have not yet been reported, and the structures and the substrates of mammalian Hen1 remain unknown. Here, we report that mouse Hen1 (mHen1) performs 3-end methylation of classical piRNAs, as well as those of most noncanonical piRNAs derived from rRNAs, small nuclear RNAs and tRNAs in murine spermatogonial stem cells. Moreover, we found that a distinct class of tRNA-derived sncRNAs are mHen1 substrates. We further determined the crystal structure of the putative methyltransferase domain of human Hen1 (HsHen1) in complex with its cofactor AdoMet at 2.0 resolution. We observed that HsHen1 has an active site similar to that of plant Hen1. We further found that the putative catalytic domain of HsHen1 alone exhibits no activity. However, an FXPP motif at its N terminus conferred full activity to this domain, and additional binding assays suggested that the FXPP motif is important for substrate binding. Our findings shed light on its methylation substrates in mouse spermatogonial stem cells and the substrate-recognition mechanism of mammalian Hen1.	[Peng, Ling; Zhang, Fengjuan; Shang, Renfu; Wang, Xueyan; Chou, James J.; Wu, Ligang; Huang, Ying] Univ Chinese Acad Sci, Chinese Acad Sci,CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, Natl Ctr Prot Sci Shanghai,Shanghai Sci Res Ctr,S, Beijing, Peoples R China; [Wang, Xueyan; Chou, James J.] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Chen, Jiayi; Ma, Jinbiao] Fudan Univ, State Key Lab Genet Engn, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci,Inst Plant Biol,Dept Biochem, Shanghai 200438, Peoples R China; [Chou, James J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Fudan University; Harvard University; Harvard Medical School	Wu, LG; Huang, Y (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci,CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, Natl Ctr Prot Sci Shanghai,Shanghai Sci Res Ctr,S, Beijing, Peoples R China.	lgwu@sibcb.ac.cn; huangy@sibcb.ac.cn	Chou, James J/N-9840-2013; Chen, Jiayi/GZM-5106-2022; Huang, Ying/AFM-0838-2022	Chou, James J/0000-0002-4442-0344; Huang, Ying/0000-0002-2806-2874	Chinese Academy of Sciences [XDB08010202, XDB19040102]; Ministry of Science and Technology of China [2014CB943100]; National Natural Science Foundation of China [91640102, 91440107, 31470781, 31230041]; Shanghai Municipal Commission for Science and Technology [12JC1409400]; Chinese Academy of Sciences; State Key Laboratory of Molecular Biology	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Molecular Biology	This work was supported by Strategic Priority Research Program Grants of the Chinese Academy of Sciences XDB08010202 (to Y. H.) and XDB19040102 (to L. W.), Ministry of Science and Technology of China Grant 2014CB943100 (to L. W.), National Natural Science Foundation of China Grants 91640102 (to Y. H.), 91440107 and 31470781 (to L. W.), and Grant 31230041 (to J. M.), Shanghai Municipal Commission for Science and Technology Grant 12JC1409400 (to L. W.), the Open Research Project on Major Infrastructure of Science and Technology of the Chinese Academy of Sciences, and the State Key Laboratory of Molecular Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan CM, 2009, P NATL ACAD SCI USA, V106, P17699, DOI 10.1073/pnas.0907540106; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chen XM, 2002, DEVELOPMENT, V129, P1085; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Ding DQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00854-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falciatori I, 2003, FASEB J, V17, P376, DOI 10.1096/fj.03-0744fje; Hayashi R, 2016, NATURE, V539, P588, DOI 10.1038/nature20162; Hirano T, 2014, RNA, V20, P1223, DOI 10.1261/rna.045310.114; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Huang Y, 2009, NATURE, V461, P823, DOI 10.1038/nature08433; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Izumi N, 2016, CELL, V164, P962, DOI 10.1016/j.cell.2016.01.008; Jain R, 2011, RNA, V17, P429, DOI 10.1261/rna.2500711; Jain R, 2010, RNA, V16, P316, DOI 10.1261/rna.1926510; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jung I, 2014, COMPUT BIOL CHEM, V50, P60, DOI 10.1016/j.compbiolchem.2014.01.008; Kamminga LM, 2010, EMBO J, V29, P3688, DOI 10.1038/emboj.2010.233; Keam SP, 2014, NUCLEIC ACIDS RES, V42, P8984, DOI 10.1093/nar/gku620; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Lim RSM, 2015, SEMIN CELL DEV BIOL, V47-48, P17, DOI 10.1016/j.semcdb.2015.10.025; Lim SL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005620; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Sun YH, 2017, ELIFE, V6, DOI [10.7554/eLife.24695, 10.7554/elife.24695]; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7876; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu B, 2010, NUCLEIC ACIDS RES, V38, P5844, DOI 10.1093/nar/gkq348; Zhai J., 2013, COLD SPRING HARB SYM, V77, P213, DOI DOI 10.1101/sqb.2013.77.014779; Zhai JX, 2013, PLANT CELL, V25, P2417, DOI 10.1105/tpc.113.114603; Zhang Y, 2017, CELL RES, V27, P1392, DOI 10.1038/cr.2017.125	53	6	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9981	9994		10.1074/jbc.RA117.000837	http://dx.doi.org/10.1074/jbc.RA117.000837			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29703750	hybrid, Green Published			2022-12-28	WOS:000437096700005
J	Pianalto, KM; Ost, KS; Brown, HE; Alspaugh, JA				Pianalto, Kaila M.; Ost, Kyla S.; Brown, Hannah E.; Alspaugh, J. Andrew			Characterization of additional components of the environmental pH-sensing complex in the pathogenic fungus Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbial pathogenesis; fungi; molecular biology; cell signaling; protein stability; environmental sensing; Nap1; pH sensing; Rim pathway	AMBIENT PH; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; MITOTIC EVENTS; SEXUAL CYCLE; RIM101; GENE; NAP1; RECEPTOR; PATHWAY	Pathogenic microorganisms must adapt to changes in their immediate surroundings, including alterations in pH, to survive the shift from the external environment to that of the infected host. In the basidiomycete fungal pathogen Cryptococcus neoformans, these pH changes are primarily sensed by the fungus-specific, alkaline pH-sensing Rim/Pal pathway. The C. neoformans Rim pathway has diverged significantly from that described in ascomycete fungi. We recently identified the C. neoformans putative pH sensor Rra1, which activates the Rim pathway in response to elevated pH. In this study, we probed the function of Rra1 by analyzing its cellular localization and performing protein co-immunoprecipitation to identify potential Rra1 interactors. We found that Rra1 does not strongly colocalize or interact with immediate downstream Rim pathway components. However, these experiments identified a novel Rra1 interactor, the previously uncharacterized C. neoformans nucleosome assembly protein 1 (Nap1), which was required for Rim pathway activation. We observed that Nap1 specifically binds to the C-terminal tail of the Rra1 sensor, probably promoting Rra1 protein stability. This function of Nap1 is conserved in fungi closely related to C. neoformans that contain Rra1 orthologs, but not in the more distantly related ascomycete fungus Saccharomyces cerevisiae. In conclusion, our findings have revealed the sophisticated, yet distinct, molecular mechanisms by which closely and distantly related microbial phyla rapidly adapt to environmental signals and changes, such as alterations in pH.	[Pianalto, Kaila M.; Ost, Kyla S.; Brown, Hannah E.; Alspaugh, J. Andrew] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Alspaugh, J. Andrew] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA; [Ost, Kyla S.] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA	Duke University; Duke University; Utah System of Higher Education; University of Utah	Alspaugh, JA (corresponding author), Duke Univ, Sch Med, Box 102359, Durham, NC 27710 USA.	andrew.alspaugh@duke.edu	Alspaugh, Andrew/AAB-1664-2019	Alspaugh, Andrew/0000-0003-3009-627X; Ost, Kyla/0000-0003-4101-2836; Brown, Hannah/0000-0002-9175-8209; Pianalto, Kaila/0000-0002-1427-0154	National Institutes of Health R01 [AI074677, AI104533]; National Defense Science and Engineering Grant - Department of Defense, Office of Scientific Research [32 CFR 168a]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074677, P01AI104533, R56AI074677] Funding Source: NIH RePORTER	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Grant - Department of Defense, Office of Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01 Grants AI074677 and AI104533 (to J.A.A.) as well as a National Defense Science and Engineering Grant (to K.M.P.) awarded by the Department of Defense, Office of Scientific Research, 32 CFR 168a. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Bertuzzi M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004413; Bignell E, 2005, MOL MICROBIOL, V55, P1072, DOI 10.1111/j.1365-2958.2004.04472.x; CADDICK MX, 1986, MOL GEN GENET, V203, P346, DOI 10.1007/BF00333978; Calvert MEK, 2008, MOL CELL BIOL, V28, P1313, DOI 10.1128/MCB.01035-07; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; Chen Y., 2014, MBIO, V5; Cornet M, 2014, EUKARYOT CELL, V13, P342, DOI 10.1128/EC.00313-13; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hervas-Aguilar A, 2010, J BIOL CHEM, V285, P18095, DOI 10.1074/jbc.M110.114371; Huang ZB, 2016, AQUAC RES, V47, P1737, DOI 10.1111/are.12628; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; KELLOGG DR, 1995, J CELL BIOL, V130, P675, DOI 10.1083/jcb.130.3.675; Kim Min Su, 2012, Methods Mol Biol, V845, P67, DOI 10.1007/978-1-61779-539-8_5; Kozubowski L, 2011, EUKARYOT CELL, V10, P1396, DOI 10.1128/EC.05087-11; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Lamb TM, 2001, J BIOL CHEM, V276, P1850, DOI 10.1074/jbc.M008381200; Li WS, 1997, GENETICS, V145, P63; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Lucena-Agell D, 2016, MOL MICROBIOL, V101, P982, DOI 10.1111/mmi.13438; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Nichols CB, 2015, EUKARYOT CELL, V14, P626, DOI 10.1128/EC.00010-15; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Nishino K, 2015, J BIOL CHEM, V290, P30797, DOI 10.1074/jbc.M115.674382; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Obara K, 2014, MOL CELL BIOL, V34, P3525, DOI 10.1128/MCB.00408-14; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Ohkuni K, 2003, BIOCHEM BIOPH RES CO, V306, P5, DOI 10.1016/S0006-291X(03)00907-0; Ost KS, 2017, MBIO, V8, DOI [10.1128/mBio.02290-16, 10.1128/mbio.02290-16]; Ost KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005159; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Penalva MA, 2014, CURR OPIN MICROBIOL, V22, P49, DOI 10.1016/j.mib.2014.09.005; Price MS, 2008, INFECT IMMUN, V76, P5729, DOI 10.1128/IAI.00896-08; Rothfels K, 2005, MOL CELL BIOL, V25, P6772, DOI 10.1128/MCB.25.15.6772-6788.2005; Selvig Kyla, 2011, Mycobiology, V39, P249, DOI 10.5941/MYCO.2011.39.4.249; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666	51	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9995	10008		10.1074/jbc.RA118.002741	http://dx.doi.org/10.1074/jbc.RA118.002741			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769315	hybrid, Green Published			2022-12-28	WOS:000437096700006
J	Tang, QY; Chakraborty, S; Xu, GZ				Tang, Qingyu; Chakraborty, Sayan; Xu, Guozhou			Mechanism of vaccinia viral protein B14-mediated inhibition of IB kinase beta activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular docking; autophosphorylation; protein kinase; virus; inhibition mechanism; B14; IKK; protein kinase; trans autophosphorylation; vaccinia virus	NF-KAPPA-B; IKK-BETA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DOCKING; TRANSCRIPTION; SERVER; CLUSPRO; COMPLEX; FRODOCK	Activation of IB kinase (IKK) is a central event in the NF-B-mediated canonical pro-inflammatory pathway. Numerous studies have reported that oligomerization-mediated trans autophosphorylation of IKK is indispensable for its phosphorylation, leading to its activation and IKK-mediated phosphorylation of substrates such as IB proteins. Moreover, IKK's interaction with the NF-B essential modifier (NEMO) is necessary for IKK activation. Interestingly, some viruses encode virulence factors that target IKK to inhibit NF-B-mediated antiviral immune responses. One of these factors is the vaccinia viral protein B14, which directly interacts with and inhibits IKK. Here we mapped the interaction interface on the B14 and IKK proteins. We observed that B14 binds to the junction of the kinase domain (KD) and scaffold and dimerization domain (SDD) of IKK. Molecular docking analyses identified key interface residues in both IKK and B14 that were further confirmed by mutational studies to promote binding of the two proteins. During trans autophosphorylation of protein kinases in the IKK complex, the activation segments of neighboring kinases need to transiently interact with each other's active sites, and we found that the B14-IKK interaction sterically hinders direct contact between the kinase domains of IKK in the IKK complex, containing IKK, IKK, and NEMO in human cells. We conclude that binding of B14 to IKK prevents IKK trans autophosphorylation and activation, thereby inhibiting NF-B signaling. Our study provides critical structural and mechanistic information for the design of potential therapeutic agents to target IKK activation for the management of inflammatory disorders.	[Tang, Qingyu; Chakraborty, Sayan; Xu, Guozhou] North Carolina State Univ, Coll Agr & Life Sci, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Xu, GZ (corresponding author), North Carolina State Univ, Coll Agr & Life Sci, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.	gxu3@ncsu.edu	Chakraborty, Sayan/AAC-4933-2021; Tang, Qingyu/W-4530-2018	Tang, Qingyu/0000-0002-5554-6540; Chakraborty, Sayan/0000-0002-2580-5097	National Institutes of Health [5R01AI118769]; North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 5R01AI118769 and new faculty startup funds from North Carolina State University (to G. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Hauenstein AV, 2017, J MOL BIOL, V429, P3793, DOI 10.1016/j.jmb.2017.10.026; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Huxford T, 2011, CURR TOP MICROBIOL, V349, P1, DOI 10.1007/82_2010_99; Garzon JI, 2009, BIOINFORMATICS, V25, P2544, DOI 10.1093/bioinformatics/btp447; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Liu SP, 2013, J BIOL CHEM, V288, P22758, DOI 10.1074/jbc.M113.482596; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Polley S, 2016, CELL REP, V17, P1907, DOI 10.1016/j.celrep.2016.10.067; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Ramirez-Aportela E, 2016, BIOINFORMATICS, V32, P2386, DOI 10.1093/bioinformatics/btw141; Rudolph D, 2000, GENE DEV, V14, P854; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Tang ED, 2003, J BIOL CHEM, V278, P38566, DOI 10.1074/jbc.M304374200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444	34	12	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10344	10352		10.1074/jbc.RA118.002817	http://dx.doi.org/10.1074/jbc.RA118.002817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29748387	Green Published, hybrid			2022-12-28	WOS:000437096700032
J	Jiang, B; Zhao, WT; Shi, MG; Zhang, J; Chen, A; Ma, HH; Suleman, M; Lin, FR; Zhou, L; Wang, JY; Zhang, Y; Liu, MJ; Wen, SX; Ouyang, C; Wang, HH; Huang, XM; Zhou, HM; Li, QX				Jiang, Bin; Zhao, Wentao; Shi, Minggang; Zhang, Jia; Chen, Ai; Ma, Huanhuan; Suleman, Muhammad; Lin, Furong; Zhou, Lin; Wang, Jinyang; Zhang, Yan; Liu, Mengjue; Wen, Shixiong; Ouyang, Cong; Wang, Huihui; Huang, Xiumin; Zhou, Huamin; Li, Qinxi			IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; hypoxia-inducible factor (HIF); brain tumor; microRNA (miRNA); cell metabolism; IDH1 mutant	ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATIONS; LEUKEMIA; ASTROCYTOMAS; RESTORATION; SUFFICIENT; INHIBITOR; MICRORNAS; SURVIVAL; PATHWAY	Resistance to apoptosis and uncontrolled proliferation are two hallmarks of cancer cells. p53 is crucial for apoptosis triggered by a broad range of stresses and a well-known gatekeeper for neoplastic transformation. Here we show that oncogenic IDH1 R132H/R132Q mutants robustly inhibit p53 expression and such an effect is attributed to 2-HG production. Mechanistically, 2-hydroxyglutarate (2-HG) stabilizes hypoxia-inducible factor-2, which in turn activates the expression of miR-380-5p, a characterized microRNA against p53 expression. Rescue expression of p53 can inhibit the proliferation rate and impair the resistance of apoptosis induced by doxorubicin in IDH1 R132Q mouse embryonic fibroblast cells. Furthermore, p53 protein levels correlates negatively with IDH1 R132H levels in human glioma samples. Our results thus shed a new light on how p53 is down-regulated by 2-HG and suggests that impairment of p53-mediated apoptosis contributes to the tumorigenesis driven by IDH1 mutants.	[Jiang, Bin; Zhao, Wentao; Zhang, Jia; Chen, Ai; Ma, Huanhuan; Suleman, Muhammad; Lin, Furong; Zhou, Lin; Wang, Jinyang; Zhang, Yan; Liu, Mengjue; Wen, Shixiong; Ouyang, Cong; Wang, Huihui; Zhou, Huamin; Li, Qinxi] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China; [Shi, Minggang] Huanhu Hosp, Dept Neurosurg, 6 Jizhao Rd, Tianjin 30050, Peoples R China; [Huang, Xiumin] Xiamen Univ, Zhongshan Hosp, Dept Gynecol & Obstet, Xiamen 361004, Peoples R China	Xiamen University; Xiamen University	Zhou, HM; Li, QX (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China.; Huang, XM (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gynecol & Obstet, Xiamen 361004, Peoples R China.	huangxmxm@163.com; huaminzhou@xmu.edu.cn; liqinxi@xmu.edu.cn	wang, huimin/HDM-8421-2022; Suleman, Muhammad/AAD-6761-2022; wang, hui/GRS-4730-2022; Ma, Huan-Huan/G-8768-2017	Zhao, Wentao/0000-0003-4787-5245; Ma, Huan-Huan/0000-0001-8029-6814; Chen, Ai/0000-0003-3481-999X; Suleman, Muhammad/0000-0003-2914-1862; Zhou, Lin/0000-0002-1958-5286	National Natural Science Foundation of China [81372702, 81402285, 31701252]; National Science Foundation of China [J1310027]; State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2018KF007]; Postdoctoral Science Foundation of China [2017M622071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cellular Stress Biology, Xiamen University; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China Grants 81372702, 81402285, and 31701252, National Science Foundation of China for Fostering Talents in Basic Research Grant J1310027, the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University Grant SKLCSB2018KF007, and Postdoctoral Science Foundation of China Grant 2017M622071. The authors declare that they have no conflicts of interest with the contents of this article.	Abbas S, 2010, BLOOD, V116, P2122, DOI 10.1182/blood-2009-11-250878; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; De Carli E, 2009, NEW ENGL J MED, V360, P2248, DOI 10.1056/NEJMc090593; Dubbink HJ, 2009, NEUROLOGY, V73, P1792, DOI 10.1212/WNL.0b013e3181c34ace; Ducray F, 2009, NEW ENGL J MED, V360, P2248; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gaal J, 2010, J CLIN ENDOCR METAB, V95, P1274, DOI 10.1210/jc.2009-2170; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Inoue S, 2016, CANCER CELL, V30, P337, DOI 10.1016/j.ccell.2016.05.018; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Tian S, 2010, BIOCHEM BIOPH RES CO, V396, P435, DOI 10.1016/j.bbrc.2010.04.112; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	46	17	18	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9747	9758		10.1074/jbc.RA117.001385	http://dx.doi.org/10.1074/jbc.RA117.001385			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743236	Green Published, hybrid			2022-12-28	WOS:000436102300019
J	Cabre, EJ; Martinez-Calle, M; Prieto, M; Fedorov, A; Olmeda, B; Loura, LMS; Perez-Gil, J				Cabre, Elisa J.; Martinez-Calle, Marta; Prieto, Manuel; Fedorov, Alexander; Olmeda, Barbara; Loura, Luis M. S.; Perez-Gil, Jesus			Homo- and hetero-oligomerization of hydrophobic pulmonary surfactant proteins SP-B and SP-C in surfactant phospholipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pulmonary surfactant; protein-protein interaction; protein complex; lung; membrane structure; fluorescence resonance energy transfer (FRET); fluorescence anisotropy	RESONANCE ENERGY-TRANSFER; AIR-WATER-INTERFACE; LUNG SURFACTANT; II PNEUMOCYTES; LIPID-BILAYER; 2 DIMENSIONS; MODEL; FLUORESCENCE; FILMS; MONOLAYERS	Pulmonary surfactant is a lipid/protein mixture that reduces surface tension at the respiratory air-water interface in lungs. Among its nonlipidic components are pulmonary surfactant-associated proteins B and C (SP-B and SP-C, respectively). These highly hydrophobic proteins are required for normal pulmonary surfactant function, and whereas past literature works have suggested possible SP-B/SP-C interactions and a reciprocal modulation effect, no direct evidence has been yet identified. In this work, we report an extensive fluorescence spectroscopy study of both intramolecular and intermolecular SP-B and SP-C interactions, using a combination of quenching and FRET steady-state and time-resolved methodologies. These proteins are compartmentalized in full surfactant membranes but not in pure 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) vesicles, in accordance with their previously described preference for liquid disordered phases. From the observed static self-quenching and homo-FRET of BODIPY-FL labeled SP-B, we conclude that this protein forms homoaggregates at low concentration (lipid:protein ratio, 1:1000). Increases in polarization of BODIPY-FL SP-B and steady-state intensity of WT SP-B were observed upon incorporation of under-stoichiometric amounts of WT SP-C. Conversely, Marina Blue-labeled SP-C is quenched by over-stoichiometric amounts of WT SP-B, whereas under-stoichiometric concentrations of the latter actually increase SP-C emission. Time-resolved hetero-FRET from Marina Blue SP-C to BODIPY-FL SP-B confirm distinct protein aggregation behaviors with varying SP-B concentration. Based on these multiple observations, we propose a model for SP-B/SP-C interactions, where SP-C might induce conformational changes on SP-B complexes, affecting its aggregation state. The conclusions inferred from the present work shed light on the synergic functionality of both proteins in the pulmonary surfactant system.	[Cabre, Elisa J.; Martinez-Calle, Marta; Olmeda, Barbara; Perez-Gil, Jesus] Univ Complutense Madrid, Dept Biochem, Fac Biol, Madrid 28040, Spain; [Martinez-Calle, Marta; Olmeda, Barbara; Perez-Gil, Jesus] Hosp 12 Octubre, Res Inst, E-28041 Madrid, Spain; [Prieto, Manuel; Fedorov, Alexander] Univ Lisbon, Inst Super Tecn, CQFM IN, P-1049001 Lisbon, Portugal; [Prieto, Manuel; Fedorov, Alexander] Univ Lisbon, Inst Super Tecn, IBB, P-1049001 Lisbon, Portugal; [Loura, Luis M. S.] Univ Coimbra, Fac Pharm, P-3000548 Coimbra, Portugal; [Loura, Luis M. S.] Univ Coimbra, Ctr Quim Coimbra, P-3004535 Coimbra, Portugal	Complutense University of Madrid; Hospital Universitario 12 de Octubre; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Coimbra; Universidade de Coimbra	Loura, LMS (corresponding author), Univ Coimbra, Fac Farm, Polo Ciencias Saude, P-3000548 Coimbra, Portugal.; Perez-Gil, J (corresponding author), Univ Complutense, Dept Bioquim, Fac Biol, Jose Antonio Novais 12, E-28040 Madrid, Spain.	lloura@ff.uc.pt; jperezgil@bio.ucm.es	Perez-Gil, Jesus/H-3102-2019; Olmeda, Bárbara/H-1440-2015; Calle, Marta Martínez/H-1451-2015; Prieto, Manuel/N-4448-2013	Perez-Gil, Jesus/0000-0003-3587-7147; Olmeda, Bárbara/0000-0001-6004-1603; Calle, Marta Martínez/0000-0003-1198-2532; fedorov, alexander/0000-0003-2454-6908; Prieto, Manuel/0000-0003-3012-6598; Jimenez-Cabre, Elisa/0000-0002-0493-6477	Spanish Ministry of Economy [BIO2015-67930-R]; Regional Government of Madrid [S2013/MIT-2807]; Fundacao para a Ciencia e a tecnologia (Portugal) [FAPESP/20107/2014, SAICTPAC/0019/2015, SFRH/BPD/111301/2015]; Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) [007630 UID/QUI/00313/2013]; COMPETE2020-UE; Portugal 2020/FEDER;  [PTDC/DTP-FTO/2784/2014]	Spanish Ministry of Economy(Spanish Government); Regional Government of Madrid; Fundacao para a Ciencia e a tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); COMPETE2020-UE; Portugal 2020/FEDER; 	This work was supported in part by Spanish Ministry of Economy Grant BIO2015-67930-R and Regional Government of Madrid Grant S2013/MIT-2807 (to J. P. G.). This work was also supported by Projects FAPESP/20107/2014 and SAICTPAC/0019/2015 from Fundacao para a Ciencia e a tecnologia (Portugal) (to M. P.); Grant SFRH/BPD/111301/2015 from Fundacao para a Ciencia e a Tecnologia (Portugal) (to A. F.); and Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) Projects 007630 UID/QUI/00313/2013, co-funded by COMPETE2020-UE, and PTDC/DTP-FTO/2784/2014, co-funded by Portugal 2020/FEDER (to L. M. S. L). The authors declare that they have no conflicts of interest with the contents of this article.	Almlen A, 2008, J APPL PHYSIOL, V104, P1101, DOI 10.1152/japplphysiol.00865.2007; BAATZ JE, 1990, BIOCHEMISTRY-US, V29, P6714, DOI 10.1021/bi00480a022; BAATZ JE, 1991, CHEM PHYS LIPIDS, V60, P163, DOI 10.1016/0009-3084(91)90039-E; de la Serna JB, 2013, FARADAY DISCUSS, V161, P535, DOI 10.1039/c2fd20096a; Brasch F, 2003, J BIOL CHEM, V278, P49006, DOI 10.1074/jbc.M306844200; Brasch F, 2002, AM J RESP CELL MOL, V26, P659, DOI 10.1165/ajrcmb.26.6.4744; Cabre EJ, 2012, BBA-BIOMEMBRANES, V1818, P1717, DOI 10.1016/j.bbamem.2012.03.008; Cabre EJ, 2009, BIOPHYS J, V97, P768, DOI 10.1016/j.bpj.2009.04.057; Castanho MARB, 1997, EUR BIOPHYS J BIOPHY, V26, P253, DOI 10.1007/s002490050078; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; CREUWELS LAJM, 1995, J BIOL CHEM, V270, P16225, DOI 10.1074/jbc.270.27.16225; Cruz A, 2004, BIOPHYS J, V86, P308, DOI 10.1016/S0006-3495(04)74106-5; Cruz A, 2000, EUR BIOPHYS J BIOPHY, V29, P204, DOI 10.1007/PL00006647; CURSTEDT T, 1987, EUR J BIOCHEM, V168, P255, DOI 10.1111/j.1432-1033.1987.tb13414.x; DAVENPORT L, 1985, BIOCHEMISTRY-US, V24, P4097, DOI 10.1021/bi00336a044; de Almeida RFM, 2009, CHEM PHYS LIPIDS, V157, P61, DOI 10.1016/j.chemphyslip.2008.07.011; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; Filipe HAL, 2015, PHYS CHEM CHEM PHYS, V17, P20066, DOI 10.1039/c5cp01596k; Gerson KD, 2008, J BIOL CHEM, V283, P10330, DOI 10.1074/jbc.M707516200; Guttentag S, 2003, AM J RESP CELL MOL, V28, P69, DOI 10.1165/rcmb.2002-0111OC; Haugland R.P., 2002, HDB FLUORESCENT PROB; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; JOHNSON ID, 1991, ANAL BIOCHEM, V198, P228, DOI 10.1016/0003-2697(91)90418-S; Klenz U, 2008, BIOPHYS J, V95, P699, DOI 10.1529/biophysj.108.131102; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; Loura LMS, 2000, J PHYS CHEM B, V104, P6920, DOI 10.1021/jp000246q; Loura LMS, 1996, BIOPHYS J, V71, P1823, DOI 10.1016/S0006-3495(96)79383-9; Loura LMS, 2001, BIOPHYS J, V80, P776, DOI 10.1016/S0006-3495(01)76057-2; Loura LMS, 2000, BBA-BIOMEMBRANES, V1467, P101, DOI 10.1016/S0005-2736(00)00211-X; Loura LMS, 2012, INT J MOL SCI, V13, P15252, DOI 10.3390/ijms131115252; Loura LMS, 2010, EUR BIOPHYS J BIOPHY, V39, P589, DOI 10.1007/s00249-009-0547-5; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MORROW MR, 1993, BIOCHEMISTRY-US, V32, P4397, DOI 10.1021/bi00067a032; Nag K, 1998, BIOPHYS J, V74, P2983, DOI 10.1016/S0006-3495(98)78005-1; Olmeda B, 2017, ANN ANAT, V209, P78, DOI 10.1016/j.aanat.2016.09.008; Olmeda B, 2015, FASEB J, V29, P4236, DOI 10.1096/fj.15-273458; Olmeda B, 2013, EUR BIOPHYS J BIOPHY, V42, P209, DOI 10.1007/s00249-012-0858-9; Parra E, 2015, CHEM PHYS LIPIDS, V185, P153, DOI 10.1016/j.chemphyslip.2014.09.002; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; PEREZGIL J, 1993, BIOCHIM BIOPHYS ACTA, V1168, P261, DOI 10.1016/0005-2760(93)90181-8; PEREZGIL J, 1995, BIOCHEMISTRY-US, V34, P3964, DOI 10.1021/bi00012a014; Plasencia I, 2004, BIOCHEM J, V377, P183, DOI 10.1042/BJ20030815; Plasencia I, 2001, BIOCHEM J, V359, P651, DOI 10.1042/0264-6021:3590651; Plasencia I, 2001, ANAL BIOCHEM, V296, P49, DOI 10.1006/abio.2001.5222; Roldan N, 2016, BIOPHYS J, V111, P1703, DOI 10.1016/j.bpj.2016.09.016; Ross M, 2002, EUR BIOPHYS J BIOPHY, V31, P52, DOI 10.1007/s002490100181; Ryan MA, 2005, BIOCHEMISTRY-US, V44, P861, DOI 10.1021/bi0485575; Schurch D, 2010, BIOPHYS J, V99, P3290, DOI 10.1016/j.bpj.2010.09.039; SNYDER B, 1982, BIOPHYS J, V40, P137, DOI 10.1016/S0006-3495(82)84468-8; Stahlman MT, 2000, LAB INVEST, V80, P395, DOI 10.1038/labinvest.3780044; Sun WC, 1998, BIOORG MED CHEM LETT, V8, P3107, DOI 10.1016/S0960-894X(98)00578-2; SUZUKI Y, 1989, AM REV RESPIR DIS, V140, P75, DOI 10.1164/ajrccm/140.1.75; TANEVA S, 1994, BIOPHYS J, V66, P1158, DOI 10.1016/S0006-3495(94)80897-5; Taneva SG, 2000, BIOPHYS J, V79, P2010, DOI 10.1016/S0006-3495(00)76449-6; UMBERGER JQ, 1945, J AM CHEM SOC, V67, P1099, DOI 10.1021/ja01223a023; VANDENBUSSCHE G, 1992, EUR J BIOCHEM, V203, P201, DOI 10.1111/j.1432-1033.1992.tb19848.x; vanderMeer B.W., 2013, FRET FORSTER RESONAN, DOI [10.1002/9783527656028.ch04, DOI 10.1002/9783527656028.CH04]; Wang GR, 2007, BBA-BIOMEMBRANES, V1768, P2060, DOI 10.1016/j.bbamem.2007.06.025; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1; Wustneck N, 2003, BIOPHYS J, V84, P1940, DOI 10.1016/S0006-3495(03)75002-4; Wustneck R, 2005, ADV COLLOID INTERFAC, V117, P33, DOI 10.1016/j.cis.2005.05.001	62	21	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9399	9411		10.1074/jbc.RA117.000222	http://dx.doi.org/10.1074/jbc.RA117.000222			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700110	hybrid, Green Published			2022-12-28	WOS:000435441400024
J	Willis, WL; Wang, LA; Wada, TT; Gardner, M; Abdouni, O; Hampton, J; Valiente, G; Young, N; Ardoin, S; Agarwal, S; Freitas, MA; Wu, LC; Jarjour, WN				Willis, William L.; Wang, Linan; Wada, Takuma Tsuzuki; Gardner, Mark; Abdouni, Omar; Hampton, Jeffrey; Valiente, Giancarlo; Young, Nicholas; Ardoin, Stacy; Agarwal, Sudha; Freitas, Michael A.; Wu, Lai-Chu; Jarjour, Wael N.			The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein cross-linking; transglutaminase; lipopolysaccharide (LPS); calcium; autoimmune disease; autoimmunity; high-mobility group box 1; systemic lupus erythematosus	SYSTEMIC-LUPUS-ERYTHEMATOSUS; TANDEM MASS-SPECTROMETRY; FACTOR-KAPPA-B; TISSUE TRANSGLUTAMINASE; IMMUNE-RESPONSES; ALPHA PRODUCTION; CROSS-LINKING; CELLS; PEPTIDES; IDENTIFICATION	High-mobility group box 1 (HMGB1) is a chromatin-associated protein that, in response to stress or injury, translocates from the nucleus to the extracellular milieu, where it functions as an alarmin. HMGB1's function is in part determined by the complexes (HMGB1c) it forms with other molecules. However, structural modifications in the HMGB1 polypeptide that may regulate HMGB1c formation have not been previously described. In this report, we observed high-molecular weight, denaturing-resistant HMGB1c in the plasma and peripheral blood mononuclear cells of individuals with systemic lupus erythematosus (SLE) and, to a much lesser extent, in healthy subjects. Differential HMGB1c levels were also detected in mouse tissues and cultured cells, in which these complexes were induced by endotoxin or the immunological adjuvant alum. Of note, we found that HMGB1c formation is catalyzed by the protein-cross-linking enzyme transglutaminase-2 (TG2). Cross-link site mapping and MS analysis revealed that HMGB1 can be cross-linked to TG2 as well as a number of additional proteins, including human autoantigens. These findings have significant functional implications for studies of cellular stress responses and innate immunity in SLE and other autoimmune disease.	[Willis, William L.; Wada, Takuma Tsuzuki; Gardner, Mark; Abdouni, Omar; Hampton, Jeffrey; Valiente, Giancarlo; Young, Nicholas; Ardoin, Stacy; Wu, Lai-Chu; Jarjour, Wael N.] Ohio State Univ, Coll Dent, Dept Internal Med, Columbus, OH 43210 USA; [Wang, Linan; Freitas, Michael A.] Ohio State Univ, Coll Dent, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Wu, Lai-Chu] Ohio State Univ, Coll Dent, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Agarwal, Sudha] Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA; [Agarwal, Sudha] Ohio State Univ, Coll Dent, Dept Orthoped, Columbus, OH 43210 USA; [Willis, William L.; Wang, Linan; Wada, Takuma Tsuzuki; Gardner, Mark; Abdouni, Omar; Hampton, Jeffrey; Valiente, Giancarlo; Young, Nicholas; Ardoin, Stacy; Freitas, Michael A.; Jarjour, Wael N.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Willis, WL; Jarjour, WN (corresponding author), Ohio State Univ, Coll Dent, Dept Internal Med, Columbus, OH 43210 USA.; Willis, WL; Jarjour, WN (corresponding author), Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA.	william.willis@osumc.edu; wael.jarjour@osumc.edu	wang, lina/HGC-1592-2022; wang, lin/HHM-2225-2022; Wu, Lai-Chu/E-4328-2011; Freitas, Michael/C-8953-2009	Wu, Lai-Chu/0000-0002-1348-269X; Freitas, Michael/0000-0002-3103-8410; Young, Nicholas/0000-0002-9323-9437	OSUWMC; CCTS from the National Center for Advancing Translational Science [UL1TR001070]; Lupus Research Alliance; NATIONAL CANCER INSTITUTE [T32CA090223, P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122436] Funding Source: NIH RePORTER	OSUWMC; CCTS from the National Center for Advancing Translational Science; Lupus Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for the participation of our patient and healthy volunteers as well as the Clinical Research Center and the Research Match Program through CCTS at OSUWMC. Funding is provided through OSUWMC and the CCTS is supported by UL1TR001070 from the National Center for Advancing Translational Science. The lupus research program at The Ohio State University is supported in part by a grant from the Lupus Research Alliance.	Abdulahad DA, 2010, AUTOIMMUN REV, V9, P661, DOI 10.1016/j.autrev.2010.05.015; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bowness JM, 1997, MOL CELL BIOCHEM, V169, P157, DOI 10.1023/A:1006846400478; Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Fagone P, 2011, GENE THER, V18, P1070, DOI 10.1038/gt.2011.59; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; FESUS L, 1989, FEBS LETT, V245, P150, DOI 10.1016/0014-5793(89)80210-8; Fleckenstein B, 2004, J BIOL CHEM, V279, P17607, DOI 10.1074/jbc.M310198200; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Gilbert D, 1996, J AUTOIMMUN, V9, P247, DOI 10.1006/jaut.1996.0031; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hreggvidsdottir HS, 2012, MOL MED, V18, P224, DOI 10.2119/molmed.2011.00327; Jiang W, 2008, ANN RHEUM DIS, V67, P727, DOI 10.1136/ard.2007.074484; Kim YH, 2016, BRIT J NEUROSURG, V2016, P1, DOI DOI 10.1155/2016/1489692; Kuo TF, 2011, FEBS J, V278, P4756, DOI 10.1111/j.1742-4658.2011.08409.x; Li J, 2010, J RHEUMATOL, V37, P766, DOI 10.3899/jrheum.090663; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Ma CY, 2012, RHEUMATOL INT, V32, P395, DOI 10.1007/s00296-010-1636-6; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Muthumani G, 2009, IMMUNOLOGY, V128, pe612, DOI 10.1111/j.1365-2567.2009.03044.x; Piredda L, 1997, CELL DEATH DIFFER, V4, P463, DOI 10.1038/sj.cdd.4400267; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; Routsias JG, 2006, ANN NY ACAD SCI, V1088, P52, DOI 10.1196/annals.1366.029; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Ruoppolo M, 2003, PROTEIN SCI, V12, P1290, DOI 10.1110/ps.0239103; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shrivastav M, 2002, CLIN RHEUMATOL, V21, P505, DOI 10.1007/s100670200124; Stamnaes J, 2008, BBA-PROTEINS PROTEOM, V1784, P1804, DOI 10.1016/j.bbapap.2008.08.011; Stamnaes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134922; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Szondy Z, 2003, P NATL ACAD SCI USA, V100, P7812, DOI 10.1073/pnas.0832466100; Tanaka M, 2007, CURR MED CHEM, V14, P2892, DOI 10.2174/092986707782360006; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Ueda T, 2010, BBA-GENE REGUL MECH, V1799, P114, DOI 10.1016/j.bbagrm.2009.11.005; Urbonaviciute V, 2007, J LEUKOCYTE BIOL, V81, P67, DOI 10.1189/jlb.0306196; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Wahamaa H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3450; Watanabe N, 1996, J BIOCHEM-TOKYO, V120, P1190; Willis WL, 2013, J CELL BIOCHEM, V114, P2753, DOI 10.1002/jcb.24624; Wu LC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-4; Xu H, 2010, J PROTEOME RES, V9, P3384, DOI 10.1021/pr100369y; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Young NA, 2013, MOL IMMUNOL, V54, P23, DOI 10.1016/j.molimm.2012.10.026	60	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8394	8409		10.1074/jbc.RA117.001078	http://dx.doi.org/10.1074/jbc.RA117.001078			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29618516	hybrid, Green Published			2022-12-28	WOS:000434205700006
J	Teran-Melo, JL; Pena-Sandoval, GR; Silva-Jimenez, H; Rodriguez, C; Alvarez, AF; Georgellis, D				Teran-Melo, Juan L.; Pena-Sandoval, Gabriela R.; Silva-Jimenez, Hortencia; Rodriguez, Claudia; Alvarez, Adrian F.; Georgellis, Dimitris			Routes of phosphoryl group transfer during signal transmission and signal decay in the dimeric sensor histidine kinase ArcB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; TRANSDUCTION SYSTEM; IN-VITRO; INTERMOLECULAR COMPLEMENTATION; REGULATOR PROTEIN; GENE-EXPRESSION; REDOX SIGNAL; PAS DOMAIN; VIVO	The Arc (anoxic redox control) two-component system of Escherichia coli, comprising ArcA as the response regulator and ArcB as the sensor histidine kinase, modulates the expression of numerous genes in response to respiratory growth conditions. Under reducing growth conditions, ArcB autophosphorylates at the expense of ATP, and transphosphorylates ArcA via a His(292) -> Asp(576) -> His(717) -> Asp(54) phosphorelay, whereas under oxidizing growth conditions, ArcB catalyzes the dephosphorylation of ArcA-P by a reverse Asp(54 )-> His(717) -> Asp(576) -> P-i phosphorelay. However, the exact phosphoryl group transfer routes and the molecular mechanisms determining their directions are unclear. Here, we show that, during signal propagation, the His(292) -> Asp(576) and Asp(576) -> His(717) phosphoryl group transfers within ArcB dimers occur intra- and intermolecularly, respectively. Moreover, we report that, during signal decay, the phosphoryl group transfer from His(717) to Asp(576) takes place intramolecularly. In conclusion, we present a mechanism that dictates the direction of the phosphoryl group transfer within ArcB dimers and that enables the discrimination of the kinase and phosphatase activities of ArcB.	[Teran-Melo, Juan L.; Rodriguez, Claudia; Alvarez, Adrian F.; Georgellis, Dimitris] Univ Nacl AutOnoma Mexico, Dept Genet Mol, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Pena-Sandoval, Gabriela R.] Univ Autonoma Nayarit, Unidad Acad Agr, Tepic 63190, Nayarit, Mexico; [Silva-Jimenez, Hortencia] Univ Autonoma Baja California, Inst Invest Oceanol, Area Oceanog Quim, Ensenada 22860, Baja California, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Baja California	Georgellis, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	dimitris@ifc.unam.mx	Alvarez, Adrian F./L-4656-2019; Silva-Jiménez, Hortencia/AAK-8730-2021; Alvarez, Adrian F./L-7575-2013; Silva-Jiménez, Hortencia/GPX-7834-2022	Alvarez, Adrian F./0000-0003-4381-5691; Silva-Jiménez, Hortencia/0000-0002-0091-7738; Alvarez, Adrian F./0000-0003-4381-5691; 	Consejo Nacional de Ciencia y Tecnologia (CONACyT); DGAPA-PAPIIT, UNAM [IN208718, IN209918]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT, UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by a doctoral fellowship from the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (to J. L. T. M.) as well as DGAPA-PAPIIT, UNAM, Grants IN208718 and IN209918 (to A. F. A. and D. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez AF, 2016, ENVIRON MICROBIOL, V18, P3210, DOI 10.1111/1462-2920.13397; Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; Alvarez AF, 2010, METHOD ENZYMOL, V471, P205, DOI 10.1016/S0076-6879(10)71012-0; Alvarez AF, 2010, J BACTERIOL, V192, P391, DOI 10.1128/JB.00881-09; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; FU HA, 1991, MOL GEN GENET, V226, P209, DOI 10.1007/BF00273605; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Georgellis D, 2001, J BACTERIOL, V183, P7206, DOI 10.1128/JB.183.24.7206-7212.2001; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Jovanovic G, 2015, MOL BIOSYST, V11, P1348, DOI 10.1039/c4mb00720d; Jung WS, 2008, FEMS MICROBIOL LETT, V284, P109, DOI 10.1111/j.1574-6968.2008.01187.x; Kinoshita-Kikuta E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148294; Kwon O, 2003, J BIOL CHEM, V278, P13192, DOI 10.1074/jbc.M210647200; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Kwon O, 2000, J BACTERIOL, V182, P2960, DOI 10.1128/JB.182.10.2960-2966.2000; Lin ECC, 1996, ESCHERICHIA COLI SAL, P1526; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; Miller J. H, 1972, EXPT MOL GENETICS; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; Oreza LAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038187; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Pena-Sandoval GR, 2005, J BACTERIOL, V187, P3267, DOI 10.1128/JB.187.9.3267-3272.2005; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Soo VWC, 2011, P NATL ACAD SCI USA, V108, P1484, DOI 10.1073/pnas.1012108108; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; SWANSON RV, 1993, MOL MICROBIOL, V8, P435, DOI 10.1111/j.1365-2958.1993.tb01588.x; Tanaka T, 1998, NATURE, V396, P88, DOI 10.1038/23968; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	48	12	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13214	13223		10.1074/jbc.RA118.003910	http://dx.doi.org/10.1074/jbc.RA118.003910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29945971	Green Published, hybrid			2022-12-28	WOS:000442730200020
J	Chiu, HC; Huang, WR; Liao, TL; Chi, PI; Nielsen, BL; Liu, JH; Liu, HJ				Chiu, Hung-Chuan; Huang, Wei-Ru; Liao, Tsai-Ling; Chi, Pei-I; Nielsen, Brent L.; Liu, Jyung-Hurng; Liu, Hung-Jen			Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell cycle; cyclin; mutagenesis; cyclin-dependent kinase 7 (CDK7); avian reovirus; CDK inhibitor; CDK-cyclin complexes; cyclin-dependent kinase (CDK); p17	DEPENDENT KINASES; NONSTRUCTURAL PROTEIN; ACTIVATION; PHOSPHORYLATION; APOPTOSIS; INHIBITORS; SEQUENCE; P21; WEB; IDENTIFICATION	The avian reovirus p17 protein is a nucleocytoplasmic shuttling protein. Although we have demonstrated that p17 causes cell growth retardation via activation of p53, the precise mechanisms remain unclear. This is the first report that avian reovirus p17 possesses broad inhibitory effects on cell cycle CDKs, cyclins, CDK-cyclin complexes, and CDK-activating kinase activity in various mammalian, avian, and cancer cell lines. Suppression of CDK activity by p17 occurs by direct binding to CDKs, cyclins, and CDK-cyclin complexes; transcriptional down-regulation of CDKs; cytoplasmic retention of CDKs and cyclins; and inhibition of CDK-activating kinase activity by promoting p53-cyclin H interaction. p17 binds to CDK-cyclin except for CDK1-cyclin B1 and CDK7-cyclin H complexes. We have determined that the negatively charged (151)LAVXDVDA(E/D)DGADPN(165) motif in cyclin B1 interacts with a positively charged region of CDK1. p17 mimics the cyclin B1 sequence to compete for CDK1 binding. The PSTAIRE motif is not required for interaction of CDK1-cyclin B1, but it is required for other CDK-cyclin complexes. p17 interacts with cyclins by its cyclin-binding motif, (RXL127)-R-125. Sequence and mutagenic analyses of p17 indicated that a (WXFD143)-W-140 motif and residues Asp-113 and Lys-122 in p17 are critical for CDK2 and CDK6 binding, leading to their sequestration in the cytoplasm. Exogenous expression of p17 significantly enhanced virus replication, whereas p17 mutants with low binding ability to cell cycle CDKs had no effect on virus yield, suggesting that p17 inhibits cell growth and the cell cycle, benefiting virus replication. An in vivo tumorigenesis assay also showed a significant reduction in tumor size.	[Chiu, Hung-Chuan; Huang, Wei-Ru; Liu, Hung-Jen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan; [Chiu, Hung-Chuan; Liu, Hung-Jen] Natl Chung Hsing Univ, iEGG & Anim Biotechnol Ctr, Taichung 402, Taiwan; [Liao, Tsai-Ling; Liu, Hung-Jen] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan; [Liu, Jyung-Hurng] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 402, Taiwan; [Liu, Hung-Jen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Liao, Tsai-Ling] Taichung Vet Gen Hosp, Dept Med Res, Taichung 407, Taiwan; [Nielsen, Brent L.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Brigham Young University	Liu, HJ (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan.	hjliu5257@nchu.edu.tw	Liu, Jyung-Hurng/C-1340-2010	Liu, Jyung-Hurng/0000-0002-7173-0372; Huang, Wei-Ru/0000-0002-2508-8374; Liu, Hung-Jen/0000-0002-1460-1494	Taichung Veterans General Hospital [TCVGH-NCHU1057603, TCVGH-NCHU1067601]; National Chung Hsing University [TCVGH-NCHU1057603, TCVGH-NCHU1067601]; Ministry of Science and Technology of Taiwan [MOST 106-2313-B-005-054-MY3, 106-2622-B-005-009-CC2]; iEGG and Animal Biotechnology Center from the Feature Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); iEGG and Animal Biotechnology Center from the Feature Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	This work was supported by Taichung Veterans General Hospital Grants TCVGH-NCHU1057603 and TCVGH-NCHU1067601, National Chung Hsing University Grants TCVGH-NCHU1057603 and TCVGH-NCHU1067601, Ministry of Science and Technology of Taiwan Grants MOST 106-2313-B-005-054-MY3 and 106-2622-B-005-009-CC2, and the iEGG and Animal Biotechnology Center from the Feature Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Boehme KW, 2013, J VIROL, V87, P12967, DOI 10.1128/JVI.02080-13; Brown NR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7769; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Chang IA, 2012, FASEB J, V26, P2401, DOI 10.1096/fj.11-199018; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Chi PI, 2013, J BIOL CHEM, V288, P3571, DOI 10.1074/jbc.M112.390245; Chiu HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153087; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W. L., 2004, PYMOL MOL GRAPH SYST; GLASS SE, 1973, AVIAN DIS, V17, P415, DOI 10.2307/1589226; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Hsu HW, 2005, AVIAN DIS, V49, P36, DOI 10.1637/7264-081904R1; Huang WR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05510-x; Huang WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133699; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Ji WT, 2009, BIOCHEM BIOPH RES CO, V384, P301, DOI 10.1016/j.bbrc.2009.04.116; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kozak R. A., 2017, VIRUSES, V9, pE90; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Liu HJ, 2003, VIROLOGY, V314, P336, DOI 10.1016/S0042-6822(03)00415-X; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MATSUOKA M, 1994, MOL CELL BIOL, V14, P7265, DOI 10.1128/MCB.14.11.7265; McGrath CF, 2005, J BIOMOL STRUCT DYN, V22, P493, DOI 10.1080/07391102.2005.10531227; Morris MC, 2002, J BIOL CHEM, V277, P23847, DOI 10.1074/jbc.M107890200; Murakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086840; NAKANISHI M, 1995, EMBO J, V14, P555, DOI 10.1002/j.1460-2075.1995.tb07031.x; Noh SJ, 1999, CANCER RES, V59, P558; NUGENT JHA, 1991, J CELL SCI, V99, P669; Petri ET, 2007, CELL CYCLE, V6, P1342, DOI 10.4161/cc.6.11.4297; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; ROSENBERGER JK, 1989, AVIAN DIS, V33, P535, DOI 10.2307/1591118; Roulstone V, 2013, GENE THER, V20, P521, DOI 10.1038/gt.2012.68; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Schneider E, 1998, ONCOGENE, V17, P2733, DOI 10.1038/sj.onc.1202504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wohlschlegel JA, 2001, MOL CELL BIOL, V21, P4868, DOI 10.1128/MCB.21.15.4868-4874.2001; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	49	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12542	12562		10.1074/jbc.RA118.002341	http://dx.doi.org/10.1074/jbc.RA118.002341			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29907572	Green Published, hybrid			2022-12-28	WOS:000441408500020
J	English, EJ; Mahn, SA; Marchese, A				English, Elizabeth J.; Mahn, Sarah A.; Marchese, Adriano			Endocytosis is required for CXC chemokine receptor type 4 (CXCR4)-mediated Akt activation and antiapoptotic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C-X-C chemokine receptor type 4 (CXCR-4); chemokine; G protein-coupled receptor (GPCR); Akt PKB; FOXO; apoptosis; anoikis; endosome; endocytosis	ARRESTIN-2 INTERACTS; BONE METASTASIS; CELL-SURVIVAL; LIGASE AIP4; ENDOSOMES; CANCER; APPL1; TRANSDUCTION; COMPLEX; UBIQUITINATION	Signaling activated by binding of the CXC motif chemokine ligand 12 (CXCL12) to its cognate G protein-coupled receptor (GPCR), chemokine CXC motif receptor 4 (CXCR4), is linked to metastatic disease. However, the mechanisms governing CXCR4 signaling remain poorly understood. Here, we show that endocytosis and early endosome antigen 1 (EEA1), which is part of the endosome fusion machinery, are required for CXCL12-mediated AKT Ser/Thr kinase (Akt) signaling selective for certain Akt substrates. Pharmacological inhibition of endocytosis partially attenuated CXCL12-induced phosphorylation of Akt, but not phosphorylation of ERK-1/2. Similarly, phosphorylation of Akt, but not ERK-1/2, stimulated by CXCL13, the cognate ligand for the chemokine receptor CXCR5, was also attenuated by inhibited endocytosis. Furthermore, siRNA-mediated depletion of the Rab5-effector EEA1, but not of adaptor protein, phosphotyrosine-interacting with PH domain and leucine zipper 1 (APPL1), partially attenuated Akt, but not ERK-1/2, phosphorylation promoted by CXCR4. Attenuation of Akt phosphorylation through inhibition of endocytosis or EEA1 depletion was associated with reduced signaling to Akt substrate forkhead box O1/3a but not the Akt substrates TSC complex subunit 2 or glycogen synthase kinase 3. This suggested that endocytosis and endosomes govern discrete aspects of CXCR4- or CXCR5-mediated Akt signaling. Consistent with this hypothesis, depletion of EEA1 reduced the ability of CXCL12 to attenuate apoptosis in suspended, but not adherent, HeLa cells. Our results suggest a mechanism whereby compartmentalized chemokine-mediated Akt signaling from endosomes suppresses the cancer-related process known as anoikis. Targeting this signaling pathway may help inhibit metastatic cancer involving receptors such as CXCR4.	[English, Elizabeth J.; Mahn, Sarah A.; Marchese, Adriano] Med Coll Wisconsin, Dept Biochem, TBRC C3850,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Marchese, A (corresponding author), Med Coll Wisconsin, Dept Biochem, TBRC C3850,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	amarchese@mcw.edu		Wedemeyer, Sarah/0000-0003-4787-4672	National Institutes of Health [GM106727, GM122889]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106727, R01GM122889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM106727 and GM122889 (to A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alanko J, 2015, NAT CELL BIOL, V17, P1412, DOI 10.1038/ncb3250; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Ebner M, 2017, J CELL BIOL, V216, P343, DOI 10.1083/jcb.201610060; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Godbole A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00357-2; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jean-Alphonse FG, 2017, NAT CHEM BIOL, V13, P259, DOI [10.1038/nchembio.2267, 10.1038/NCHEMBIO.2267]; Keppler SJ, 2015, IMMUNITY, V43, P660, DOI 10.1016/j.immuni.2015.09.004; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Lacalle RA, 2017, INT REV CEL MOL BIO, V331, P181, DOI 10.1016/bs.ircmb.2016.09.011; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schmid SL, 2017, J CELL BIOL, V216, P2623, DOI 10.1083/jcb.201705017; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Smith TH, 2017, J BIOL CHEM, V292, P13867, DOI 10.1074/jbc.M117.782359; Thomas RM, 2011, ENDOCRINOLOGY, V152, P1691, DOI 10.1210/en.2010-1353; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Varsano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049227; Verma R, 2015, J BIOL CHEM, V290, P6810, DOI 10.1074/jbc.M114.606699; Villasenor R, 2015, ELIFE, V4, DOI 10.7554/eLife.06156; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	48	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11470	11480		10.1074/jbc.RA118.001872	http://dx.doi.org/10.1074/jbc.RA118.001872			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29899118	hybrid, Green Published			2022-12-28	WOS:000439449700017
J	Noguchi, K; Dincman, TA; Dalton, AC; Howley, BV; McCall, BJ; Mohanty, BK; Howe, PH				Noguchi, Ken; Dincman, Toros A.; Dalton, Annamarie C.; Howley, Breege V.; McCall, Buckley J.; Mohanty, Bidyut K.; Howe, Philip H.			Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial-mesenchymal transition (EMT); melanoma; transcription factor; mRNA; cytokine; FAM3C; ILEI; interleukin-like EMT inducer; phenotype switching; USF-1	EPITHELIAL-MESENCHYMAL TRANSITION; MAPK PATHWAY INHIBITORS; CONFERS RESISTANCE; EXPRESSION; KINASE; MITF; BRAF; MYC; PROGRESSION; BINDING	Interleukin-like EMT inducer (ILEI, FAM3C) is a secreted factor that contributes to the epithelial-to-mesenchymal transition (EMT), a cell-biological process that confers metastatic properties to a tumor cell. However, very little is known about how ILEI is regulated. Here we demonstrate that ILEI is an in vivo regulator of melanoma invasiveness and is transcriptionally up-regulated by the upstream stimulatory factor-1 (USF-1), an E-box-binding, basic-helix-loop-helix family transcription factor. shRNA-mediated knockdown of ILEI in melanoma cell lines attenuated lung colonization but not primary tumor formation. We also identified the mechanism underlying ILEI transcriptional regulation, which was through a direct interaction of USF-1 with the ILEI promoter. Of note, stimulation of endogenous USF-1 by UV-mediated activation increased ILEI expression, whereas shRNA-mediated USF-1 knockdown decreased ILEI gene transcription. Finally, we report that knocking down USF-1 decreases tumor cell migration. In summary, our work reveals that ILEI contributes to melanoma cell invasiveness in vivo without affecting primary tumor growth and is transcriptionally up-regulated by USF-1.	[Noguchi, Ken; Dincman, Toros A.; Dalton, Annamarie C.; Howley, Breege V.; McCall, Buckley J.; Mohanty, Bidyut K.; Howe, Philip H.] Med Univ South Carolina, Coll Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Dincman, Toros A.] Med Univ South Carolina, Div Hematol & Oncol, Charleston, SC 29425 USA; [Howe, Philip H.] Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Howe, PH (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,MSC 509,Rm 501, Charleston, SC 29425 USA.	howep@musc.edu	McCall, Buckley/AAB-3828-2021	McCall, Buckley/0000-0002-0460-1124; Howe, Philip/0000-0002-1358-1313; Dincman, Toros/0000-0002-4449-0510	National Institutes of Health NCI [F30CA203269, T32CA193201, R01CA154663]; U.S. Department of Defense (DOD) [BC170301]; NATIONAL CANCER INSTITUTE [F30CA203269, T32CA193201, R01CA154663] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health NCI Grants F30CA203269, T32CA193201, and R01CA154663 and U.S. Department of Defense (DOD) Grant BC170301. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; BENDALL AJ, 1994, NUCLEIC ACIDS RES, V22, P2801, DOI 10.1093/nar/22.14.2801; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5279; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Cormier Catherine Y., 2011, Journal of Structural and Functional Genomics, V12, P55, DOI 10.1007/s10969-011-9100-8; Cormier CY, 2010, NUCLEIC ACIDS RES, V38, pD743, DOI 10.1093/nar/gkp999; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Csiszar A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0433-7; Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Gao ZH, 2014, HISTOPATHOLOGY, V65, P527, DOI 10.1111/his.12435; Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hock TD, 2004, BIOCHEM J, V383, P209, DOI 10.1042/BJ20040794; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Imagawa S, 2006, ARTERIOSCL THROM VAS, V26, P2407, DOI 10.1161/01.ATV.0000240318.61359.e3; Jansson AM, 2017, J BIOL CHEM, V292, P15501, DOI 10.1074/jbc.M117.782904; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kim M, 2015, BRIT J HAEMATOL, V168, P583, DOI 10.1111/bjh.13164; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kral M, 2017, FEBS J, V284, P3484, DOI 10.1111/febs.14207; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Laurila PP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0015; LEFRANCOISMARTINEZ AM, 1995, J BIOL CHEM, V270, P2640, DOI 10.1074/jbc.270.6.2640; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Noguchi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177830; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Ramsdale R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1111; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Richard G, 2016, EMBO MOL MED, V8, P1143, DOI 10.15252/emmm.201505971; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Smith MP, 2014, CANCER DISCOV, V4, P1214, DOI 10.1158/2159-8290.CD-13-1007; Song Q, 2014, TUMOR BIOL, V35, P1377, DOI 10.1007/s13277-013-1188-y; Steinberg SM, 2014, CANCER IMMUNOL RES, V2, P1044, DOI 10.1158/2326-6066.CIR-14-0074; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Vo BT, 2016, CANCER CELL, V29, P5, DOI 10.1016/j.ccell.2015.12.003; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Wu SL, 2010, HUM MOL GENET, V19, P597, DOI 10.1093/hmg/ddp526; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhao X, 2018, CELL BIOCHEM FUNCT, V36, P46, DOI 10.1002/cbf.3316; Zhu YH, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0424-8	61	9	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11401	11414		10.1074/jbc.RA118.003616	http://dx.doi.org/10.1074/jbc.RA118.003616			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871931	hybrid, Green Published			2022-12-28	WOS:000439449700011
J	Paredes, S; Angulo-Ibanez, M; Tasselli, L; Carlson, SM; Zheng, W; Li, TM; Chua, KF				Paredes, Silvana; Angulo-Ibanez, Maria; Tasselli, Luisa; Carlson, Scott M.; Zheng, Wei; Li, Tie-Mei; Chua, Katrin F.			The epigenetic regulator SIRT7 guards against mammalian cellular senescence induced by ribosomal DNA instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-I; DOUBLE-STRAND BREAKS; HUMAN RDNA UNITS; HETEROCHROMATIN FORMATION; HOT-SPOTS; CELLS; CHROMATIN; STRESS; GENES; DISEASE	In the yeast Saccharomyces cerevisiae, genomic instability in rDNA repeat sequences is an underlying cause of cell aging and is suppressed by the chromatin-silencing factor Sir2. In humans, rDNA instability is observed in cancers and premature aging syndromes, but its underlying mechanisms and functional consequences remain unclear. Here, we uncovered a pivotal role of sirtuin 7 (SIRT7), a mammalian Sir2 homolog, in guarding against rDNA instability and show that this function of SIRT7 protects against senescence in primary human cells. We found that, mechanistically, SIRT7 is required for association of SNF2H (also called SMARCA5, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin, subfamily A, member 5), a component of the nucleolar heterochromatin-silencing complex NoRC, with rDNA sequences. Defective rDNA-heterochromatin silencing in SIRT7-deficient cells unleashed rDNA instability, with excision and loss of rDNA gene copies, which in turn induced acute senescence. Mounting evidence indicates that accumulation of senescent cells significantly contributes to tissue dysfunction in aging-related pathologies. Our findings identify rDNA instability as a driver of mammalian cellular senescence and implicate SIRT7-dependent heterochromatin silencing in protecting against this process.	[Paredes, Silvana; Angulo-Ibanez, Maria; Tasselli, Luisa; Zheng, Wei; Li, Tie-Mei; Chua, Katrin F.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Paredes, Silvana; Angulo-Ibanez, Maria; Tasselli, Luisa; Zheng, Wei; Li, Tie-Mei; Chua, Katrin F.] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA; [Carlson, Scott M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Chua, KF (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	kfchua@stanford.edu	Tasselli, Luisa/AAM-6781-2020; Zheng, Wei/GQQ-8951-2022	Tasselli, Luisa/0000-0003-3349-1371; 	NIA, National Institutes of Health; Department of Veterans Affairs merit award; Paul F. Glenn Laboratories; NATIONAL CANCER INSTITUTE [K99CA190803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050997] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000286] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs merit award(US Department of Veterans Affairs); Paul F. Glenn Laboratories; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by a grant from the NIA, National Institutes of Health; a Department of Veterans Affairs merit award; and the Paul F. Glenn Laboratories (to K. F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chamousset D, 2010, PROTEOMICS, V10, P3045, DOI 10.1002/pmic.201000162; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; de Magalhaes JP, 2018, MECH AGEING DEV, V170, P2, DOI 10.1016/j.mad.2017.07.001; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Ganley ARD, 2014, FEMS YEAST RES, V14, P49, DOI 10.1111/1567-1364.12133; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Ianni A, 2017, BIOCHEM BIOPH RES CO, V492, P434, DOI 10.1016/j.bbrc.2017.08.081; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Killen MW, 2009, HUM MOL GENET, V18, P3417, DOI 10.1093/hmg/ddp282; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 2014, P JPN ACAD B-PHYS, V90, P119, DOI 10.2183/pjab.90.119; Lee N, 2014, PROTEOMICS, V14, P1610, DOI 10.1002/pmic.201400001; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12235; Li Z, 2017, ONCOGENE, V36, P1887, DOI 10.1038/onc.2016.359; MacLeod RAF, 2000, LEUKEMIA, V14, P1803, DOI 10.1038/sj.leu.2401894; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Paredes S, 2009, GENETICS, V181, P1661, DOI 10.1534/genetics.108.099093; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pietrzak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022585; Rieker C, 2011, J NEUROSCI, V31, P453, DOI 10.1523/JNEUROSCI.0590-10.2011; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2014, METHODS MOL BIOL, V1094, P319, DOI 10.1007/978-1-62703-706-8_25; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; Tasselli L, 2016, NAT STRUCT MOL BIOL, V23, P434, DOI 10.1038/nsmb.3202; Tchurikov NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25866; Tchurikov NA, 2015, J MOL CELL BIOL, V7, P366, DOI 10.1093/jmcb/mju038; Toiber Debra, 2011, Handb Exp Pharmacol, V206, P189, DOI 10.1007/978-3-642-21631-2_9; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499; Wronska A, 2016, GERONTOLOGY, V62, P304, DOI 10.1159/000441603; Yu J, 2017, CELL REP, V18, P1229, DOI 10.1016/j.celrep.2017.01.009; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	54	37	38	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11242	11250		10.1074/jbc.AC118.003325	http://dx.doi.org/10.1074/jbc.AC118.003325			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29728458	hybrid, Green Published			2022-12-28	WOS:000438882800035
J	Faulds, KJ; Egelston, JN; Sedivy, LJ; Mitchell, MK; Garimella, S; Kozlowski, H; D'Alessandro, A; Hansen, KC; Balsbaugh, JL; Phiel, CJ				Faulds, Kelsie J.; Egelston, Jennifer N.; Sedivy, Laura J.; Mitchell, Matthew K.; Garimella, Sanjana; Kozlowski, Hanna; D'Alessandro, Angelo; Hansen, Kirk C.; Balsbaugh, Jeremy L.; Phiel, Christopher J.			Glycogen synthase kinase-3 (GSK-3) activity regulates mRNA methylation in mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA methylation; pluripotency; stem cells; protein phosphorylation; ubiquitin	SELF-RENEWAL; BETA-CATENIN; MOLECULAR-MECHANISM; SIGNALING PATHWAYS; NUCLEAR-RNA; FTO GENE; OBESITY; INHIBITION; LITHIUM; M(6)A	Glycogen synthase kinase-3 (GSK-3) activity regulates multiple signal transduction pathways and is also a key component of the network responsible for maintaining stem cell pluripotency. Genetic deletion of Gsk-3 and Gsk-3 or inhibition of GSK-3 activity via small molecules promotes stem cell pluripotency, yet the mechanism underlying the role for GSK-3 in this process remains ambiguous. Another cellular process that has been shown to affect stem cell pluripotency is mRNA methylation (m(6)A). Here, we describe an intersection between these components, the regulation of m(6)A by GSK-3. We find that protein levels for the RNA demethylase, FTO (fat mass and obesity-associated protein), are elevated in Gsk-3;Gsk-3-deficient mouse embryonic stem cells (ESCs). FTO is normally phosphorylated by GSK-3, and MS identified the sites on FTO that are phosphorylated in a GSK-3-dependent fashion. GSK-3 phosphorylation of FTO leads to polyubiquitination, but in Gsk-3 knockout ESCs, that process is impaired, resulting in elevated levels of FTO protein. As a consequence of altered FTO protein levels, mRNAs in Gsk-3 knockout ESCs have 50% less m(6)A than WT ESCs, and m(6)A-Seq analysis reveals the specific mRNAs that have reduced m(6)A modifications. Taken together, we provide the first evidence for how m(6)A demethylation is regulated in mammalian cells and identify a putative novel mechanism by which GSK-3 activity regulates stem cell pluripotency.	[Faulds, Kelsie J.; Egelston, Jennifer N.; Sedivy, Laura J.; Mitchell, Matthew K.; Garimella, Sanjana; Kozlowski, Hanna; Phiel, Christopher J.] Univ Colorado, Dept Integrat Biol, 1150 12th St, Denver, CO 80204 USA; [D'Alessandro, Angelo; Hansen, Kirk C.] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Balsbaugh, Jeremy L.] Univ Colorado, Dept Chem & Biochem, Mass Spectrometry Core Facil, Boulder, CO 80309 USA; [Balsbaugh, Jeremy L.] Univ Connecticut, Prote & Metabol Facil, Ctr Open Res Resources & Equipment, Storrs, CT 06269 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Connecticut	Phiel, CJ (corresponding author), Univ Colorado, Dept Integrat Biol, 1150 12th St, Denver, CO 80204 USA.	christopher.phiel@ucdenver.edu	D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490; Phiel, Christopher/0000-0002-9265-2676; BALSBAUGH, JEREMY/0000-0002-1852-8749; Mitchell, Matthew/0000-0003-4099-783X	National Institutes of Health [R15GM119103-01]; University of Colorado Denver; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM119103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Denver; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R15GM119103-01 (to C. J. P.) and funding from the University of Colorado Denver. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bar-Nur O, 2014, NAT METHODS, V11, P1170, DOI [10.1038/nmeth.3142, 10.1038/NMETH.3142]; Bartman CM, 2015, EXP CELL RES, V330, P178, DOI 10.1016/j.yexcr.2014.07.020; Bartman CM, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00133; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bertero A, 2018, NATURE, V555, P256, DOI 10.1038/nature25784; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Campbell JM, 2012, STEM CELLS DEV, V21, P2430, DOI 10.1089/scd.2011.0598; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du TF, 2015, J AFFECT DISORDERS, V183, P279, DOI 10.1016/j.jad.2015.05.025; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Hishida T, 2015, STEM CELLS, V33, P713, DOI 10.1002/stem.1893; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kingham E, 2009, J CELL SCI, V122, P2311, DOI 10.1242/jcs.046557; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Lee MY, 2009, STEM CELLS, V27, P1858, DOI 10.1002/stem.124; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nam H, 2016, P NATL ACAD SCI USA, V113, P10513, DOI 10.1073/pnas.1611967113; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Sanchez-Ripoll Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060148; Schafer KN, 2013, J BIOL CHEM, V288, P32599, DOI 10.1074/jbc.M113.503474; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Tan FZ, 2015, J BIOL CHEM, V290, P4500, DOI 10.1074/jbc.M114.609016; Umehara H, 2007, STEM CELLS, V25, P2705, DOI 10.1634/stemcells.2007-0086; Voskas D, 2014, J CELL PHYSIOL, V229, P1312, DOI 10.1002/jcp.24603; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035892; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	82	17	17	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10731	10743		10.1074/jbc.RA117.001298	http://dx.doi.org/10.1074/jbc.RA117.001298			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29777057	Green Published, hybrid			2022-12-28	WOS:000437828400028
J	Li, QJ; Alsaidan, OA; Rai, S; Wu, M; Shen, HF; Beharry, Z; Almada, LL; Fernandez-Zapico, ME; Wang, LC; Cai, HJ				Li, Qianjin; Alsaidan, Omar A.; Rai, Sumit; Wu, Meng; Shen, Huifeng; Beharry, Zanna; Almada, Luciana L.; Fernandez-Zapico, Martin E.; Wang, Lianchun; Cai, Houjian			Stromal Gli signaling regulates the activity and differentiation of prostate stem and progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stromal cell; p63; sonic hedgehog (SHH); transforming growth factor (TGF-); prostate; Gli signaling	UROGENITAL SINUS MESENCHYME; SONIC-HEDGEHOG; MURINE PROSTATE; TGF-BETA; TISSUE RECOMBINANTS; ANDROGEN RECEPTOR; GROWTH-FACTOR; CANCER-CELLS; MORPHOGENESIS; BASAL	Interactions between cells in the stroma and epithelium facilitate prostate stem cell activity and tissue regeneration capacity. Numerous molecular signal transduction pathways, including the induction of sonic hedgehog (Shh) to activate the Gli transcription factors, are known to mediate the cross-talk of these two cellular compartments. However, the details of how these signaling pathways regulate prostate stem and progenitor cell activity remain elusive. Here we demonstrate that, although cell-autonomous epithelial Shh-Gli signaling is essential to determine the expression levels of basal cell markers and the renewal potential of epithelial stem and progenitor cells, stromal Gli signaling regulates prostate stem and progenitor cell activity by increasing the number and size of prostate spheroids in vitro. Blockade of stromal Gli signaling also inhibited prostate tissue regeneration in vivo. The inhibition of stromal Gli signaling suppressed the differentiation of basal and progenitor cells to luminal cells and limited prostate tubule secretory capability. Additionally, stromal cells were able to compensate for the deficiency of epithelial Shh signaling in prostate tissue regeneration. Mechanistically, suppression of Gli signaling increased the signaling factor transforming growth factor (TGF) in stromal cells. Elevation of exogenous TGF1 levels inhibited prostate spheroid formation, suggesting that a stromal Gli-TGF signaling axis regulates the activity of epithelial progenitor cells. Our study illustrates that Gli signaling regulates epithelial stem cell activity and renewal potential in both epithelial and stromal compartments.	[Li, Qianjin; Alsaidan, Omar A.; Wu, Meng; Shen, Huifeng; Cai, Houjian] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Rai, Sumit; Wang, Lianchun] Univ Georgia, Carbohydrate Res Ctr, Athens, GA 30602 USA; [Rai, Sumit; Wang, Lianchun] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Beharry, Zanna] Florida Gulf Coast Univ, Dept Chem & Phys, Ft Myers, FL 33965 USA; [Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; State University System of Florida; Florida Gulf Coast University; Mayo Clinic	Cai, HJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	caihj@uga.edu	Alsaidan, Omar/AAB-6106-2021; Cai, Houjian/AAJ-1290-2020; Wu, Meng/N-9345-2014	Alsaidan, Omar/0000-0002-2848-2932; Beharry, Zanna/0000-0002-3900-8523; Wang, Lianchun/0000-0003-1454-2719; Wu, Meng/0000-0001-8436-2209	National Institutes of Health [R01CA172495, HL-09339, GM103390]; Department of Defense [W81XWH-15-1-0507]; NATIONAL CANCER INSTITUTE [R01CA172495] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01CA172495 (to H. C.) and HL-09339 and GM103390 (to L. W.) and Department of Defense Grant W81XWH-15-1-0507 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Cai HJ, 2012, CANCER RES, V72, P4672, DOI 10.1158/0008-5472.CAN-12-0228; Callier P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004340; Chen M, 2011, EXPERT REV ENDOCRINO, V6, P453, DOI 10.1586/EEM.11.24; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; CUNHA GR, 1981, J STEROID BIOCHEM, V14, P1317, DOI 10.1016/0022-4731(81)90338-1; DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Furler RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040874; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Hager-Theodorides AL, 2005, BLOOD, V106, P1296, DOI 10.1182/blood-2005-03-0998; Hager-Theodorides AL, 2009, J IMMUNOL, V183, P3023, DOI 10.4049/jimmunol.0900152; Huang YQ, 2015, J BIOL CHEM, V290, P17745, DOI 10.1074/jbc.M115.661033; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Itoh N, 1998, ENDOCRINOLOGY, V139, P1378, DOI 10.1210/en.139.3.1378; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lim A, 2014, NAT CELL BIOL, V16, P1135, DOI 10.1038/ncb3057; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Ming JE, 1998, MOL MED TODAY, V4, P343, DOI 10.1016/S1357-4310(98)01299-4; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Peng YC, 2015, DEV BIOL, V400, P94, DOI 10.1016/j.ydbio.2015.01.019; Peng YC, 2013, P NATL ACAD SCI USA, V110, P20611, DOI 10.1073/pnas.1315729110; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Risbridger GP, 2008, ENDOCRINOLOGY, V149, P4303, DOI 10.1210/en.2008-0465; Rodgers UR, 2016, ACS CHEM BIOL, V11, P3256, DOI 10.1021/acschembio.6b00896; Salm SN, 2002, PROSTATE, V51, P175, DOI 10.1002/pros.10075; Shigemura K, 2015, CURR DRUG TARGETS, V16, P258, DOI 10.2174/1389450115666141125122643; Solanki A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146910; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Wu M, 2016, J BIOL CHEM, V291, P25749, DOI 10.1074/jbc.M116.753129; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yu M, 2013, DEV BIOL, V380, P87, DOI 10.1016/j.ydbio.2013.04.032	47	4	4	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10547	10560		10.1074/jbc.RA118.003255	http://dx.doi.org/10.1074/jbc.RA118.003255			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29773652	hybrid, Green Published			2022-12-28	WOS:000437828400015
J	Raghavan, S; Singh, NK; Mani, AM; Rao, GN				Raghavan, Somasundaram; Singh, Nikhlesh K.; Mani, Arul M.; Rao, Gadiparthi N.			Protease-activated receptor 1 inhibits cholesterol efflux and promotes atherogenesis via cullin 3-mediated degradation of the ABCA1 transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; atherosclerosis; cholesterol; macrophage; signal transduction	SMOOTH-MUSCLE-CELLS; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; THROMBIN GENERATION; ACCELERATES ATHEROSCLEROSIS; ENDOTHELIAL-CELLS; TISSUE FACTOR; IN-VITRO; KINASE 2; EXPRESSION	Although signaling of thrombin via its receptor protease-activated receptor 1 (Par1) is known to occur in atherothrombosis, its link to the actual pathogenesis of this condition is less clear. To better understand the role of thrombin-Par1 signaling in atherosclerosis, here we have studied their effects on cellular cholesterol efflux in mice. We found that by activating Par1 and cullin 3-mediated ubiquitination and degradation of ABC subfamily A member 1 (ABCA1), thrombin inhibits cholesterol efflux in both murine macrophages and smooth muscle cells. Moreover, disruption of the Par1 gene rescued ABCA1 from Western diet-induced ubiquitination and degradation and restored cholesterol efflux in apolipoprotein E-deficient (ApoE(-/-)) mice. Similarly, the Par1 deletion diminished diet-induced atherosclerotic lesions in the ApoE(-/-) mice. These observations for the first time indicate a role for thrombin-Par1 signaling in the pathogenesis of diet-induced atherosclerosis. We identify cullin 3 as a cullin-RING ubiquitin E3 ligase that mediates ABCA1 ubiquitination and degradation and thereby inhibits cholesterol efflux. Furthermore, compared with peripheral blood mononuclear cells (PBMCs) from ApoE(-/-) mice, the PBMCs from ApoE(-/-):Par1(-/-) mice exhibited decreased trafficking to inflamed arteries of Western diet-fed ApoE(-/-) mice. This finding suggested that besides inhibiting cholesterol efflux, thrombin-Par1 signaling also plays a role in the recruitment of leukocytes during diet-induced atherogenesis. Based on these findings, we conclude that thrombin-Par1 signaling appears to contribute to the pathogenesis of atherosclerosis by impairing cholesterol efflux from cells and by recruiting leukocytes to arteries.	[Raghavan, Somasundaram; Singh, Nikhlesh K.; Mani, Arul M.; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 71 S Manassas St, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 71 S Manassas St, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Raghavan, Somasundaram/M-7692-2019; Singh, Nikhlesh/AAA-4253-2020	Raghavan, Somasundaram/0000-0002-7385-7182; Singh, Nikhlesh/0000-0002-3665-6023; Mani, Arul Murugan/0000-0002-8943-7406	National Institutes of Health [HL103575]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL103575 (to G. N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleidi SM, 2015, J BIOL CHEM, V290, P24604, DOI 10.1074/jbc.M115.675579; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Austin KM, 2013, J BIOL CHEM, V288, P23105, DOI 10.1074/jbc.M113.467019; Borissoff JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055784; Borissoff JI, 2012, JACC-CARDIOVASC IMAG, V5, P1201, DOI 10.1016/j.jcmg.2012.01.023; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Camera M, 2012, THROMB RES, V129, P279, DOI 10.1016/j.thromres.2011.11.028; Chellan B, 2016, ARTERIOSCL THROM VAS, V36, P1101, DOI 10.1161/ATVBAHA.116.307306; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Crucet M, 2013, ATHEROSCLEROSIS, V229, P110, DOI 10.1016/j.atherosclerosis.2013.04.034; Dubland JA, 2016, CURR OPIN LIPIDOL, V27, P155, DOI 10.1097/MOL.0000000000000279; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Esmon CT, 2014, THROMB HAEMOSTASIS, V111, P625, DOI 10.1160/TH13-09-0730; Feng FY, 2007, ONCOGENE, V26, P3431, DOI 10.1038/sj.onc.1210129; Gadepalli R, 2013, J BIOL CHEM, V288, P30815, DOI 10.1074/jbc.M113.463414; Gadepalli R, 2012, ARTERIOSCL THROM VAS, V32, P2652, DOI 10.1161/ATVBAHA.112.253112; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Higashi Y, 2016, CIRCULATION, V133, P2263, DOI 10.1161/CIRCULATIONAHA.116.021805; Hsieh V, 2014, J BIOL CHEM, V289, P7524, DOI 10.1074/jbc.M113.515890; Jennings LK, 2009, AM J CARDIOL, V103, p4A, DOI 10.1016/j.amjcard.2008.11.017; Kalz J, 2014, J THROMB THROMBOLYS, V37, P45, DOI 10.1007/s11239-013-1026-5; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Kopec AK, 2014, J PHARMACOL EXP THER, V351, P288, DOI 10.1124/jpet.114.218545; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Maouche S, 2012, ARTERIOSCL THROM VAS, V32, P170, DOI 10.1161/ATVBAHA.111.232652; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Mitropoulos Kostas A., 1994, Current Opinion in Lipidology, V5, P227, DOI 10.1097/00041433-199405030-00011; Negre-Salvayre A, 2017, FREE RADICAL BIO MED, V106, P118, DOI 10.1016/j.freeradbiomed.2017.02.006; Nguyen KT, 2001, HYPERTENSION, V38, P1038, DOI 10.1161/hy1101.092840; Ogura M, 2011, ARTERIOSCL THROM VAS, V31, P1980, DOI 10.1161/ATVBAHA.111.228478; Pelham CJ, 2012, CELL METAB, V16, P462, DOI 10.1016/j.cmet.2012.08.011; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Sanchez C, 2012, ARTERIOSCL THROM VAS, V32, P2394, DOI 10.1161/ATVBAHA.112.250332; Sorci-Thomas MG, 2016, CIRC RES, V118, P679, DOI 10.1161/CIRCRESAHA.115.306246; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; ten Cate H, 2012, THROMB RES, V129, pS38, DOI 10.1016/j.thromres.2012.02.028; Tesauro M, 2005, CIRCULATION, V112, P2986, DOI 10.1161/CIRCULATIONAHA.105.553883; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; Westerterp M, 2016, ARTERIOSCL THROM VAS, V36, P1328, DOI 10.1161/ATVBAHA.115.306670; Wilcox JN, 2001, ANN NY ACAD SCI, V947, P433; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhou YF, 1996, J CLIN INVEST, V98, P2129, DOI 10.1172/JCI119019	55	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10574	10589		10.1074/jbc.RA118.003491	http://dx.doi.org/10.1074/jbc.RA118.003491			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29777060	Green Published, hybrid			2022-12-28	WOS:000437828400017
J	Puentes-Cala, E; Liebeke, M; Markert, S; Harder, J				Puentes-Cala, Edinson; Liebeke, Manuel; Markert, Stephanie; Harder, Jens			Limonene dehydrogenase hydroxylates the allylic methyl group of cyclic monoterpenes in the anaerobic terpene degradation by Castellaniella defragrans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin; dehydrogenase; enzyme; terpenoid; nicotinamide adenine dinucleotide (NAD); anaerobic; biodegradation; ferredoxin; limonene; monoterpene	DENITRIFYING ALCALIGENES-DEFRAGRANS; SACCHAROMYCES-CEREVISIAE; PHYTOENE DESATURASE; BIOSYNTHESIS; PROTEIN; FAD; METABOLISM; ABSORPTION; ACTIVATION; EXPRESSION	The enzymatic functionalization of hydrocarbons is a central step in the global carbon cycle initiating the mineralization of methane, isoprenes, and monoterpenes, the most abundant biologically produced hydrocarbons. Also, terpene-modifying enzymes have found many applications in the energy-economic biotechnological production of fine chemicals. Here, we describe a limonene dehydrogenase that was purified from the facultatively anaerobic betaproteobacterium Castellaniella defragrans 65Phen grown on monoterpenes under denitrifying conditions in the absence of molecular oxygen. The purified limonene:ferrocenium oxidoreductase activity hydroxylated the methyl group of limonene (1-methyl-4-(1-methylethenyl)-cyclohex-1-ene) yielding perillyl alcohol ([4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methanol). The enzyme had a DTT:perillyl alcohol oxidoreductase activity yielding limonene. Mass spectrometry and molecular size determinations revealed a heterodimeric enzyme comprising CtmA and CtmB. Recently, the two proteins had been identified by transposon mutagenesis and proteomics as part of the cyclic terpene metabolism (ctm) in C. defragrans and are annotated as FAD-dependent oxidoreductases of the protein domain family phytoene dehydrogenases and related proteins (COG1233). CtmAB is the first heterodimeric enzyme in this protein superfamily. Flavins in the purified CtmAB are oxidized by ferrocenium and are reduced by limonene. Heterologous expression of CtmA, CtmB, and CtmAB in Escherichia coli demonstrated that limonene dehydrogenase activity required both subunits, each carrying a flavin cofactor. Native CtmAB oxidized a wide range of monocyclic monoterpenes containing the allylic methyl group motif (1-methyl-cyclohex-1-ene). In conclusion, we have identified CtmAB as a hydroxylating limonene dehydrogenase and the first heteromer in a family of FAD-dependent dehydrogenases acting on allylic methylene or methyl CH-bonds. We suggest placing in Enzyme Nomenclature as new entry EC 1.17.99.8.	[Puentes-Cala, Edinson; Harder, Jens] Max Planck Inst Marine Microbiol, Dept Microbiol, Celsiusstr 1, D-28359 Bremen, Germany; [Liebeke, Manuel] Max Planck Inst Marine Microbiol, Dept Symbiosis, Celsiusstr 1, D-28359 Bremen, Germany; [Markert, Stephanie] Ernst Moritz Arndt Univ Greifswald, Pharmaceut Biotechnol, Felix Hausdorff Str, D-17489 Greifswald, Germany	Max Planck Society; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald	Harder, J (corresponding author), Max Planck Inst Marine Microbiol, Dept Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	jharder@mpi-bremen.de	Markert, Stephanie/AAL-5591-2021; Liebeke, Manuel/F-3559-2012	Markert, Stephanie/0000-0003-0923-3305; Puentes Cala, Edinson Andres/0000-0003-0587-2177; Liebeke, Manuel/0000-0002-2339-1409	Max Planck Society; DAAD in Germany; Corporacion para la Investigacion de la Corrosion in Colombia; COLCIENCIAS in Colombia	Max Planck Society(Max Planck SocietyFoundation CELLEX); DAAD in Germany(Deutscher Akademischer Austausch Dienst (DAAD)); Corporacion para la Investigacion de la Corrosion in Colombia; COLCIENCIAS in Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported in part by the Max Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a grant from the DAAD in Germany and from the Corporacion para la Investigacion de la Corrosion and COLCIENCIAS in Colombia.	Ahn JW, 2015, ENZYME MICROB TECH, V77, P29, DOI 10.1016/j.enzmictec.2015.05.005; AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x; Aliverti A, 1999, METH MOL B, V131, P9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Boll M., 2010, HDB HYDROCARBON LIPI, P1011, DOI DOI 10.1007/978-3-540-77587-4_71; Boronat A, 2015, ADV BIOCHEM ENG BIOT, V148, P3, DOI 10.1007/10_2014_285; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitenbach J, 2013, ARCH BIOCHEM BIOPHYS, V529, P86, DOI 10.1016/j.abb.2012.11.003; Brennan TCR, 2013, APPL ENVIRON MICROB, V79, P3590, DOI 10.1128/AEM.00463-13; Cheong TK, 2000, APPL BIOCHEM BIOTECH, V84-6, P903, DOI 10.1385/ABAB:84-86:1-9:903; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Cornelissen S, 2013, BIOTECHNOL BIOENG, V110, P1282, DOI 10.1002/bit.24801; Costas AMG, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00440-17; Cunane LM, 2005, BIOCHEMISTRY-US, V44, P2963, DOI 10.1021/bi048020r; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Erman W.F, 1985, CHEM MONOTERPENES EN; Gemmecker S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131717; Heider J, 2016, J MOL MICROB BIOTECH, V26, P45, DOI 10.1159/000441357; Heyen U, 2000, APPL ENVIRON MICROB, V66, P3004, DOI 10.1128/AEM.66.7.3004-3009.2000; Heyen U, 1998, FEMS MICROBIOL LETT, V169, P67, DOI 10.1111/j.1574-6968.1998.tb13300.x; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp0497839; Jongedijk E, 2015, YEAST, V32, P159, DOI 10.1002/yea.3038; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Koziol J., 1971, FLUOROMETRIC ANAL RI, P253; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMAN TC, 1990, BIOCHEMISTRY-US, V29, P10594, DOI 10.1021/bi00499a004; Marostica MR, 2007, QUIM NOVA, V30, P382, DOI 10.1590/S0100-40422007000200027; MULLER F, 1972, EUR J BIOCHEM, V25, P573, DOI 10.1111/j.1432-1033.1972.tb01730.x; Petasch J, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-164; Sakai M, 1996, J MOL STRUCT, V379, P9, DOI 10.1016/0022-2860(95)09176-9; Sandmann G, 2009, ARCH BIOCHEM BIOPHYS, V483, P169, DOI 10.1016/j.abb.2008.10.004; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Schmidt-Dannert C, 2015, ADV BIOCHEM ENG BIOT, V148, P19, DOI 10.1007/10_2014_283; Schwab W, 2013, EUR J LIPID SCI TECH, V115, P3, DOI 10.1002/ejlt.201200157; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh A, 2014, ANALYST, V139, P5747, DOI 10.1039/c4an01325e; Steiger S, 2015, MICROBIOL-SGM, V161, P194, DOI 10.1099/mic.0.083519-0; Strijkstra A, 2014, APPL ENVIRON MICROB, V80, P7592, DOI 10.1128/AEM.02385-14; Tao L, 2005, APPL ENVIRON MICROB, V71, P3294, DOI 10.1128/AEM.71.6.3294-3301.2005; Tholl D, 2015, ADV BIOCHEM ENG BIOT, V148, P63, DOI 10.1007/10_2014_295; van Beilen JB, 2005, APPL ENVIRON MICROB, V71, P1737, DOI 10.1128/AEM.71.4.1737-1744.2005; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093; Zhang ZJ, 2014, FOOD CHEM, V150, P307, DOI 10.1016/j.foodchem.2013.10.160	49	9	9	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9520	9529		10.1074/jbc.RA117.001557	http://dx.doi.org/10.1074/jbc.RA117.001557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29716998	Green Published, hybrid			2022-12-28	WOS:000435441400034
J	Halawani, D; Gogonea, V; DiDonato, JA; Pipich, V; Yao, P; China, A; Topbas, C; Vasu, K; Arif, A; Hazen, SL; Fox, PL				Halawani, Dalia; Gogonea, Valentin; DiDonato, Joseph A.; Pipich, Vitaliy; Yao, Peng; China, Arnab; Topbas, Celalettin; Vasu, Kommireddy; Arif, Abul; Hazen, Stanley L.; Fox, Paul L.			Structural control of caspase-generated glutamyl-tRNA synthetase by appended noncatalytic WHEP domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; TRANSLATIONAL CONTROL; NONCANONICAL FUNCTION; SOLUTION SCATTERING; GENE-EXPRESSION; COMPLEX; APOPTOSIS; CLEAVAGE; PHOSPHORYLATION; BINDING	Aminoacyl-tRNA synthetases are ubiquitous, evolutionarily conserved enzymes catalyzing the conjugation of amino acids onto cognate tRNAs. During eukaryotic evolution, tRNA synthetases have been the targets of persistent structural modifications. These modifications can be additive, as in the evolutionary acquisition of noncatalytic domains, or subtractive, as in the generation of truncated variants through regulated mechanisms such as proteolytic processing, alternative splicing, or coding region polyadenylation. A unique variant is the human glutamyl- prolyl-tRNA synthetase (EPRS) consisting of two fused synthetases joined by a linker containing three copies of the WHEP domain (termed by its presence in tryptophanyl-, histidyl-, and glutamyl-prolyl-tRNA synthetases). Here, we identify site-selective proteolysis as a mechanism that severs the linkage between the EPRS synthetases in vitro and in vivo. Caspase action targeted Asp-929 in the third WHEP domain, thereby separating the two synthetases. Using a neoepitope antibody directed against the newly exposed C terminus, we demonstrate EPRS cleavage at Asp-929 in vitro and in vivo. Biochemical and biophysical characterizations of the N-terminally generated EPRS proteoform containing the glutamyl-tRNA synthetase and most of the linker, including two WHEP domains, combined with structural analysis by small-angle neutron scattering, revealed a role for the WHEP domains in modulating conformations of the catalytic core and GSH-S-transferase-C-terminal-like (GST-C) domain. WHEP-driven conformational rearrangement altered GST-C domain interactions and conferred distinct oligomeric states in solution. Collectively, our results reveal long-range conformational changes imposed by the WHEP domains and illustrate how noncatalytic domains can modulate the global structure of tRNA synthetases in complex eukaryotic systems.	[Halawani, Dalia; Gogonea, Valentin; DiDonato, Joseph A.; China, Arnab; Topbas, Celalettin; Vasu, Kommireddy; Arif, Abul; Hazen, Stanley L.; Fox, Paul L.] Cleveland Clin Fdn, Dept Cellular & Mol Med, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Gogonea, Valentin; Topbas, Celalettin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Pipich, Vitaliy] Forschungszentrum Julich, Julich Ctr Neutron Sci, Outstn Maier Leibnitz Zentrum, Lichtenbergstr 1, D-85747 Garching, Germany; [Yao, Peng] Univ Rochester, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Helmholtz Association; Research Center Julich; University of Rochester	Gogonea, V (corresponding author), Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA.; Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	v.gogonea@csuohio.edu; foxp@ccf.org	Hazen, Stanley L/ABD-5845-2021; Halawani, Dalia/AAN-3261-2021; Kommireddy, Vasu/C-3928-2018; Yao, Peng/Y-8047-2019	Kommireddy, Vasu/0000-0002-7608-7566; Yao, Peng/0000-0002-1145-3967; Hazen, Stanley/0000-0001-7124-6639; Pipich, Vitaliy/0000-0002-3930-3602; Halawani, Dalia/0000-0003-4738-0656	National Institutes of Health [P01 HL029582, P01 HL076491, R01 GM086430, R01 GM115476, R01 HL128300, R01 HL128268]; American Heart Association National Center Scientist Development Grant [10SDG3930003]; Canadian Institute of Health Research Fellowship; American Heart Association [15POST22450016]; Cleveland State University through the Faculty Scholarship Initiative; Cleveland State University through Faculty Research Development Awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128268, P01HL076491, R01HL128300, P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430, R01GM115476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Center Scientist Development Grant(American Heart Association); Canadian Institute of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association); Cleveland State University through the Faculty Scholarship Initiative; Cleveland State University through Faculty Research Development Awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01 HL029582, P01 HL076491, R01 GM086430, and R01 GM115476 (to P. L. F.) Grant R01 HL128300 (to S. L. H.), and Grant R01 HL128268, by American Heart Association National Center Scientist Development Grant 10SDG3930003 (to A. A.), by a Canadian Institute of Health Research Fellowship (to D. H.), and by an American Heart Association Fellowship Award 15POST22450016 (to K. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Cleveland State University through the Faculty Scholarship Initiative and Faculty Research Development Awards.	Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Burgon P. G., 2017, SEMIN CELL DEV BIOL, V2017, p[S1084, 30111]; Chang CY, 2016, J BIOL CHEM, V291, P16567, DOI 10.1074/jbc.M116.730812; Chen J. H., 2008, NATURE, V94-97, P451; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Freist W, 1997, BIOL CHEM, V378, P1313; Grice SJ, 2015, HUM MOL GENET, V24, P4397, DOI 10.1093/hmg/ddv176; Grossmann J, 2002, AM J GASTROENTEROL, V97, P1421, DOI 10.1016/S0002-9270(02)04143-6; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Guinier A, 1938, CR HEBD ACAD SCI, V206, P1374; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Halawani D, 2010, J NEUROSCI, V30, P6132, DOI 10.1523/JNEUROSCI.5874-09.2010; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Havrylenko S, 2015, INT J MOL SCI, V16, P6571, DOI 10.3390/ijms16036571; He R, 2009, BBA-PROTEINS PROTEOM, V1794, P347, DOI 10.1016/j.bbapap.2008.11.003; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Krajewska M, 1997, CANCER RES, V57, P1605; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Lei HY, 2015, J BIOL CHEM, V290, P26314, DOI 10.1074/jbc.M115.681999; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Mort JS, 2003, BIOCHEM SOC SYMP, V70, P107, DOI 10.1042/bss0700107; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Qin XJ, 2016, J MOL BIOL, V428, P3603, DOI 10.1016/j.jmb.2016.05.018; RABEN N, 1994, J BIOL CHEM, V269, P24277; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; RATINAUD MH, 1983, EUR J BIOCHEM, V135, P471, DOI 10.1111/j.1432-1033.1983.tb07675.x; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rho SB, 1996, P NATL ACAD SCI USA, V93, P10128, DOI 10.1073/pnas.93.19.10128; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Serdyuk I. N., 2007, METHODS MOL BIOPHYSI, P423; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Stoehr G, 2013, MOL CELL PROTEOMICS, V12, P1436, DOI 10.1074/mcp.M112.024679; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THOMES JC, 1983, EUR J BIOCHEM, V135, P479, DOI 10.1111/j.1432-1033.1983.tb07676.x; Turpaev KT, 1996, EUR J BIOCHEM, V240, P732, DOI 10.1111/j.1432-1033.1996.0732h.x; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Ward JR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007051; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	66	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8843	8860		10.1074/jbc.M117.807503	http://dx.doi.org/10.1074/jbc.M117.807503			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29643180	Green Published, hybrid			2022-12-28	WOS:000434941900010
J	Arao, Y; Korach, KS				Arao, Yukitomo; Korach, Kenneth S.			The F domain of estrogen receptor is involved in species-specific, tamoxifen-mediated transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen receptor; estrogen; ligand-binding protein; mouse; human; nuclear receptor superfamily; selective estrogen receptor modulator (SERM); tamoxifen; F domain; estrogen signaling; receptor transactivation; domain swapping; estradiol	ALPHA; ANTAGONISTS; GENE; 4-HYDROXYTAMOXIFEN; IDENTIFICATION; DIMERIZATION; RESISTANCE; INHIBITOR; MUTATION; AGONISTS	Estrogen receptor (ER) is a major transducer of estrogen-mediated physiological signals. ER is a member of the nuclear receptor superfamily, which encompasses ligand-dependent transcription factors. The C terminus of nuclear receptors, termed the F domain, is the least homologous region among the members of this family. The ER F domain possesses 45 amino acids; however, its function remains unclear. We noticed that the homology of the F domains between mouse and human ERs is remarkably lower (75.6% similarity) than that between the entire proteins (94.7% similarity). To assess the functionality of the ER F domains, here we generated chimeric ER expression constructs with mouse-human-exchanged F domains. Using cell-based in vitro assays, we analyzed the transcriptional coactivator interaction and ligand-binding domain dimerization activities of these mouse-human F domain-swapped ERs. We found that the transcriptional activity of the mouse WT ER is more potent than that of the human WT ER in the human hepatoma cell line HepG2. 4-Hydroxytamoxifen (4OHT)-mediated transcriptional activity of mouse-human F domain-swapped ERs was the inverse of the WT ER activities but not estradiol-mediated transcriptional activities. Further experiments with constructs containing deletion or point mutations of a predicted -strand region within the F domain suggested that this region governs the species-specific 4OHT-mediated transcriptional activity of ER. We conclude that the ER F domain has a species-specific function in 4OHT-mediated receptor transactivation and that mouse-human F domain-swapped ER mutants enable key insights into ER F domain structure and function.	[Arao, Yukitomo; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Arao, Y; Korach, KS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	araoy@niehs.nih.gov; korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021	Arao, Yukitomo/0000-0003-1560-351X	National Institutes of Health from the Division of Intramural Research of the NIEHS [1ZIAES070065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065] Funding Source: NIH RePORTER	National Institutes of Health from the Division of Intramural Research of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant 1ZIAES070065 (to K. S. K.) from the Division of Intramural Research of the NIEHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arao Y, 2015, J BIOL CHEM, V290, P17611, DOI 10.1074/jbc.M115.638650; Arao Y, 2013, J BIOL CHEM, V288, P21105, DOI 10.1074/jbc.M113.463455; Bernard V, 2017, J CLIN ENDOCR METAB, V102, P93, DOI 10.1210/jc.2016-2749; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chatagnon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009665; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Hamilton KJ, 2014, REPROD BIOL, V14, P3, DOI 10.1016/j.repbio.2013.12.002; HART JE, 1990, PHARMACOL THERAPEUT, V47, P203, DOI 10.1016/0163-7258(90)90087-I; Jiang X, 2007, ONCOGENE, V26, P4106, DOI 10.1038/sj.onc.1210197; Kanamori H, 2000, J BIOL CHEM, V275, P5867, DOI 10.1074/jbc.275.8.5867; Koide A, 2007, MOL ENDOCRINOL, V21, P829, DOI 10.1210/me.2006-0203; MONTANO MM, 1995, MOL ENDOCRINOL, V9, P814, DOI 10.1210/me.9.7.814; Nichols M, 1998, EMBO J, V17, P765, DOI 10.1093/emboj/17.3.765; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quaynor SD, 2013, NEW ENGL J MED, V369, P164, DOI 10.1056/NEJMoa1303611; Schwartz JA, 2002, J BIOL CHEM, V277, P13202, DOI 10.1074/jbc.M112215200; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Sumida K, 2003, J STEROID BIOCHEM, V84, P33, DOI 10.1016/S0960-0760(03)00003-7; Yang J, 2008, MOL CELL ENDOCRINOL, V295, P94, DOI 10.1016/j.mce.2008.08.001	22	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8495	8507		10.1074/jbc.RA117.001212	http://dx.doi.org/10.1074/jbc.RA117.001212			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29632071	Green Published, hybrid			2022-12-28	WOS:000434205700014
J	Armstrong, JA; Cash, NJ; Ouyang, Y; Morton, JC; Chvanov, M; Latawiec, D; Awais, M; Tepikin, AV; Sutton, R; Criddle, DN				Armstrong, Jane A.; Cash, Nicole J.; Ouyang, Yulin; Morton, Jack C.; Chvanov, Michael; Latawiec, Diane; Awais, Muhammad; Tepikin, Alexei V.; Sutton, Robert; Criddle, David N.			Oxidative stress alters mitochondrial bioenergetics and modifies pancreatic cell death independently of cyclophilin D, resulting in an apoptosis-to-necrosis shift	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreas; oxidative stress; mitochondrial permeability transition (MPT); cyclophilin D; bioenergetics; reactive oxygen species (ROS); apoptosis; necrosis (necrotic death); antioxidant; Acute Pancreatitis; Seahorse	PERMEABILITY TRANSITION PORE; ACINAR-CELLS; ATP SYNTHASE; UNCOUPLING PROTEIN-2; INHIBITION; PROTECT; MODELS; LIVER; DYSFUNCTION; INDUCTION	Mitochondrial dysfunction lies at the core of acute pancreatitis (AP). Diverse AP stimuli induce Ca2+-dependent formation of the mitochondrial permeability transition pore (MPTP), a solute channel modulated by cyclophilin D (CypD), the formation of which causes ATP depletion and necrosis. Oxidative stress reportedly triggers MPTP formation and is elevated in clinical AP, but how reactive oxygen species influence cell death is unclear. Here, we assessed potential MPTP involvement in oxidant-induced effects on pancreatic acinar cell bioenergetics and fate. H2O2 application promoted acinar cell apoptosis at low concentrations (1-10 m), whereas higher levels (0.5-1 mm) elicited rapid necrosis. H2O2 also decreased the mitochondrial NADH/FAD(+) redox ratio and (m) in a concentration-dependent manner (10 m to 1 mm H2O2), with maximal effects at 500 m H2O2. H2O2 decreased the basal O-2 consumption rate of acinar cells, with no alteration of ATP turnover at <50 m H2O2. However, higher H2O2 levels (50 m) diminished spare respiratory capacity and ATP turnover, and bioenergetic collapse, ATP depletion, and cell death ensued. Menadione exerted detrimental bioenergetic effects similar to those of H2O2, which were inhibited by the antioxidant N-acetylcysteine. Oxidant-induced bioenergetic changes, loss of (m), and cell death were not ameliorated by genetic deletion of CypD or by its acute inhibition with cyclosporine A. These results indicate that oxidative stress alters mitochondrial bioenergetics and modifies pancreatic acinar cell death. A shift from apoptosis to necrosis appears to be associated with decreased mitochondrial spare respiratory capacity and ATP production, effects that are independent of CypD-sensitive MPTP formation.	[Cash, Nicole J.; Ouyang, Yulin; Morton, Jack C.; Chvanov, Michael; Tepikin, Alexei V.; Criddle, David N.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Armstrong, Jane A.; Latawiec, Diane; Awais, Muhammad; Sutton, Robert] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Criddle, DN (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	criddle@liv.ac.uk		Tepikin, Alexei/0000-0002-8172-7513; Morton, Jack/0000-0002-6571-1191	Wellcome Trust [102381/Z/13/Z]; Medical Research Council; China Scholarship Council; National Institute for Health; MRC [MR/K012967/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); China Scholarship Council(China Scholarship Council); National Institute for Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 102381/Z/13/Z (to (J.C.M.), by funds from the Medical Research Council, China Scholarship Council (to Y.O.), and by a National Institute for Health Research grant to the NIHR Liverpool Pancreas Biomedical Research Unit.	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Armstrong JA, 2013, FREE RADICAL RES, V47, P917, DOI 10.3109/10715762.2013.835046; Armstrong JS, 2004, J BIOL CHEM, V279, P50420, DOI 10.1074/jbc.M408882200; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Beger HG, 2007, WORLD J GASTROENTERO, V13, P5043, DOI 10.3748/wjg.v13.i38.5043; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bhatia M, 1998, BIOCHEM BIOPH RES CO, V246, P476, DOI 10.1006/bbrc.1998.8519; Bonora M, 2015, ONCOGENE, V34, P1475, DOI 10.1038/onc.2014.96; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Criddle DN, 2016, CELL CALCIUM, V60, P180, DOI 10.1016/j.ceca.2016.04.007; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Curran FJM, 2000, BRIT J SURG, V87, P301, DOI 10.1046/j.1365-2168.2000.01375.x; De Marchi U, 2006, MOL MEMBR BIOL, V23, P521, DOI 10.1080/09687860600907644; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Gukovsky I, 2011, ANTIOXID REDOX SIGN, V15, P2699, DOI 10.1089/ars.2011.4068; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; He LH, 2003, J BIOL CHEM, V278, P16755, DOI 10.1074/jbc.M300153200; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Huang W, 2014, GUT, V63, P1313, DOI 10.1136/gutjnl-2012-304058; Johnson PR, 2003, CELL TISSUE RES, V313, P37, DOI 10.1007/s00441-003-0741-1; Juhaszova M, 2008, ANN NY ACAD SCI, V1123, P197, DOI 10.1196/annals.1420.023; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kramer PA, 2015, BIOMED J, V38, P294, DOI 10.4103/2319-4170.155591; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Linard D, 2009, ARCH BIOCHEM BIOPHYS, V491, P39, DOI 10.1016/j.abb.2009.09.002; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mari M, 2010, ANTIOXID REDOX SIGN, V12, P1295, DOI 10.1089/ars.2009.2634; Mukherjee R, 2016, GUT, V65, P1333, DOI 10.1136/gutjnl-2014-308553; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicotera P, 1998, TOXICOL LETT, V103, P139; Ostrander JH, 2010, CANCER RES, V70, P4759, DOI 10.1158/0008-5472.CAN-09-2572; Pandol SJ, 2007, GASTROENTEROLOGY, V133, P1056; Peery AF, 2015, GASTROENTEROLOGY, V149, P1731, DOI 10.1053/j.gastro.2015.08.045; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Sata N, 1997, FREE RADICAL BIO MED, V23, P844, DOI 10.1016/S0891-5849(97)00064-6; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Segersvard R, 2005, CELL TISSUE RES, V320, P251, DOI 10.1007/s00441-004-1024-1; Shalbueva N, 2013, GASTROENTEROLOGY, V144, P437, DOI 10.1053/j.gastro.2012.10.037; Shore ER, 2016, J MED CHEM, V59, P2596, DOI 10.1021/acs.jmedchem.5b01801; Tsai K, 1998, GUT, V42, P850, DOI 10.1136/gut.42.6.850; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Zhou WC, 2017, ELIFE, V6, DOI 10.7554/eLife.23781; Zhu X, 2016, AM J PHYSIOL-GASTR L, V310, pG609, DOI 10.1152/ajpgi.00389.2015; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	60	55	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8032	8047		10.1074/jbc.RA118.003200	http://dx.doi.org/10.1074/jbc.RA118.003200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626097	hybrid, Green Published			2022-12-28	WOS:000433224600010
J	Igic, R				Igic, Rajko			An exploration of bioactive peptides: My collaboration with Ervin G. Erdos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						renin angiotensin system; kallikrein; angiotensin II; vascular biology; angiotensin; angiotensin-converting enzyme (ACE); Ervin G; Erdos; kallikrein-kinin; kinase II; retina substance P	RENIN-ANGIOTENSIN SYSTEM; BRADYKININ	This paper provides a brief historical sketch of the science of biologically active peptides. It also offers the story of how Ervin G. Erdos, a pioneer in the study of metabolism of various peptides, influenced me through collaborations that span many years. I worked in Dr. Erdos's research laboratories in Oklahoma City, Dallas, and Chicago, and we shared research interests through visits across the Atlantic between the former Yugoslavia and the United States. Among other findings, we discovered angiotensin-converting enzyme in the retina, which opened up a new research direction for many scientists interested in serious ocular diseases. This tribute to my mentor paints a portrait of a man who, in addition to his dedication to science and his seminal discoveries about the metabolism of peptides, took the time to invest in training many young scientists. His fine personal qualities explain why all of those who worked with him hold him in such high regard.	[Igic, Rajko] Univ Banja Luka, Med Sch, Dept Pharmacol, Banja Luka 78000, Bosnia & Herceg; [Igic, Rajko] Acad Arts & Sci, Banja Luka 78000, Bosnia & Herceg; [Igic, Rajko] John H Stroger Jr Hosp Cook Cty, Dept Anesthesiol & Pain Management, Chicago, IL 60612 USA; [Igic, Rajko] Citaonicka 21, Sombor 25000, Serbia	University of Banja Luka (UNIBL); John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Igic, R (corresponding author), Univ Banja Luka, Med Sch, Dept Pharmacol, Banja Luka 78000, Bosnia & Herceg.; Igic, R (corresponding author), Acad Arts & Sci, Banja Luka 78000, Bosnia & Herceg.; Igic, R (corresponding author), John H Stroger Jr Hosp Cook Cty, Dept Anesthesiol & Pain Management, Chicago, IL 60612 USA.; Igic, R (corresponding author), Citaonicka 21, Sombor 25000, Serbia.	r.igic@excite.com	Igic, Rajko/AAA-7272-2019	Igic, Rajko/0000-0001-9084-3391				CHIBA S, 1972, TOHOKU J EXP MED, V107, P381, DOI 10.1620/tjem.107.381; Choudhary R, 2017, J CURR OPHTHALMOL, V29, P7, DOI 10.1016/j.joco.2016.09.009; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; DORER FE, 1974, CIRC RES, V34, P824, DOI 10.1161/01.RES.34.6.824; DRAGOVIC T, 1993, AM REV RESPIR DIS, V147, P1491, DOI 10.1164/ajrccm/147.6_Pt_1.1491; Erdos E G, 1966, Adv Pharmacol, V4, P1, DOI 10.1016/S1054-3589(08)60097-6; Erdos E. G., 1970, HDB EXPT PHARM, V25; Erdos E. G., 1966, HYPOTENSIVE PEPTIDES; Erdos E. G., 2004, COMPREHENSIVE BIOCH, VVol. 43, P279; ERDOS EG, 1962, J APPL PHYSIOL, V17, P367, DOI 10.1152/jappl.1962.17.2.367; ERDOS EG, 1966, SCIENCE, V152, P1284, DOI 10.1126/science.152.3726.1284; ERDOS EG, 1950, NATURE, V165, P116, DOI 10.1038/165116a0; GADDUM JH, 1964, BRIT J PHARM CHEMOTH, V23, P613, DOI 10.1111/j.1476-5381.1964.tb01614.x; GAFFORD JT, 1983, BIOCHEMISTRY-US, V22, P3265, DOI 10.1021/bi00282a035; Igi R., 2017, LAZA KOSTI CHICAGO; Igi R., 2003, EINSTEIN J BIOL MED, V20, P23; Igi R., 1975, 6 INT C PHARM, P176; IGIC R, 1972, EXPERIENTIA, V28, P135, DOI 10.1007/BF01935713; IGIC R, 1972, CIRC RES, V31, pII51; IGIC R, 1980, EXP EYE RES, V30, P299, DOI 10.1016/0014-4835(80)90010-X; IGIC R, 1971, BRIT J PHARMACOL, V42, P303; Igic R, 1977, Lijec Vjesn, V99, P482; IGIC R, 1993, EXP EYE RES, V57, P415, DOI 10.1006/exer.1993.1142; Igic R, 1972, VASOPEPTIDES, P149; Igic R, 1977, CENTRAL ACTIONS ANGI, P23, DOI [DOI 10.1016/B978-0-08-020933-3.50008-8, 10.1016/B978-0-08-020933-3.50008-8]; Igic R, 2018, EXP EYE RES, V166, P74, DOI 10.1016/j.exer.2017.05.007; Kuschinsky G, 1993, KURZES LERBUCH PHARM; Michel B, 1996, CIRC RES, V78, P635; Minshall RD, 2000, PEPTIDES, V21, P1257, DOI 10.1016/S0196-9781(00)00267-9; ODYA CE, 1978, J BIOL CHEM, V253, P5927; Skidgel R.A., 1993, RENIN ANGIOTENSIN SY, V1, DOI DOI 10.1-10.10; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Szekeres L., 2003, PHARM IUGOSLAVICA, V41, P33; Taddei S, 2016, AM J CARDIOVASC DRUG, V16, P309, DOI 10.1007/s40256-016-0173-4; Tahirovic Husref, 2015, Acta Med Acad, V44, P68, DOI 10.5644/ama2006-124.128; VanHaeringen NJ, 1996, BRIT J OPHTHALMOL, V80, P99, DOI 10.1136/bjo.80.2.99; von Euler U. S., 1977, HIST NOTES, P1; WARD PE, 1979, LIFE SCI, V24, P1419, DOI 10.1016/0024-3205(79)90013-4; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6; Zizic-Borjanovic S, 2007, J BUON, V12, P181	40	2	2	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7907	7915		10.1074/jbc.X118.003433	http://dx.doi.org/10.1074/jbc.X118.003433			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29802139	hybrid, Green Published			2022-12-28	WOS:000433224600001
J	Franzmann, TM; Alberti, S				Franzmann, Titus M.; Alberti, Simon			Prion-like low-complexity sequences: Key regulators of protein solubility and phase behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein aggregation; protein misfolding; neurodegenerative disease; prion; chaperone; Prion-like protein; protein misfolding disease; protein phase separation; protein phase transition; RNA-binding protein	NUCLEAR IMPORT RECEPTOR; RNA-BINDING PROTEINS; CELL-FREE FORMATION; GENETIC-VARIATION; SEPARATION; DOMAINS; URE3; FUS; INHERITANCE; TDP-43	Many proteins, such as RNA-binding proteins, have complex folding landscapes. How cells maintain the solubility and folding state of such proteins, particularly under stress conditions, is largely unknown. Here, we argue that prion-like low-complexity regions (LCRs) are key regulators of protein solubility and folding. We discuss emerging evidence that prion-like LCRs are not, as commonly thought, autonomous aggregation modules that adopt amyloid-like conformations, but protein-specific sequences with chaperone-like functions. On the basis of recent findings, we propose that prion-like LCRs have evolved to regulate protein phase behavior and to protect proteins against proteotoxic damage.	[Franzmann, Titus M.; Alberti, Simon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Alberti, S (corresponding author), Pfotenhauerstr 108, D-01307 Dresden, Germany.	alberti@mpi-cbg.de	Alberti, Simon/ABB-8277-2021; Franzmann, Titus M/D-1962-2011; Alberti, Simon/B-2822-2017	Alberti, Simon/0000-0003-4017-6505; Franzmann, Titus/0000-0002-4281-7209	Max Planck Society; European Research Council [725836, 643417]; Bundesministerium fur Bildung und Forschung [01ED1601A, 031A359A]; Joint Programme Neurodegenerative Disease (CureALS)	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Joint Programme Neurodegenerative Disease (CureALS)	This work was supported by the Max Planck Society, European Research Council Grants 725836 and 643417, Bundesministerium fur Bildung und Forschung Grants 01ED1601A and 031A359A, and the Joint Programme Neurodegenerative Disease (CureALS). This article is part of the thematic series, Phase separation of RNA-binding proteins in physiology and disease. The authors declare that they have no conflicts of interest with the contents of this article.	Aguzzit A, 2016, TRENDS CELL BIOL, V26, P40, DOI 10.1016/j.tcb.2015.08.007; AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Al Safadi R, 2011, FEMS YEAST RES, V11, P151, DOI 10.1111/j.1567-1364.2010.00700.x; Alberti S, 2017, J CELL SCI, V130, P2789, DOI 10.1242/jcs.200295; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Baxa U, 2004, J MOL BIOL, V339, P259, DOI 10.1016/j.jmb.2004.03.033; Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Edskes HK, 2014, GENETICS, V198, P605, DOI 10.1534/genetics.114.166538; Edskes HK, 2011, GENETICS, V188, P81, DOI 10.1534/genetics.111.127217; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Feiler MS, 2015, J CELL BIOL, V211, P897, DOI 10.1083/jcb.201504057; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harvey ZH, 2018, MOL CELL, V69, P195, DOI 10.1016/j.molcel.2017.10.030; Hayden E, 2017, P NATL ACAD SCI USA, V114, P5065, DOI 10.1073/pnas.1704885114; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hughes MP, 2018, SCIENCE, V359, P698, DOI 10.1126/science.aan6398; Jarosz DF, 2014, CELL, V158, P1083, DOI 10.1016/j.cell.2014.07.025; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kato M, 2018, ANNU REV BIOCHEM, V87, P351, DOI 10.1146/annurev-biochem-061516-044700; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Khan T, 2018, MOL CELL, V71, P155, DOI 10.1016/j.molcel.2018.06.016; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; Kroschwald S, 2018, CELL REP, V23, P3327, DOI 10.1016/j.celrep.2018.05.041; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Langdon EM, 2018, SCIENCE, V360, P922, DOI 10.1126/science.aar7432; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Luo F, 2018, NAT STRUCT MOL BIOL, V25, P341, DOI 10.1038/s41594-018-0050-8; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Munder MC, 2016, ELIFE, V5, DOI 10.7554/eLife.09347; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Protter DSW, 2018, CELL REP, V22, P1401, DOI 10.1016/j.celrep.2018.01.036; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rabouille C, 2017, CURR OPIN CELL BIOL, V47, P34, DOI 10.1016/j.ceb.2017.02.006; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; TERAVANESYAN MD, 1994, GENETICS, V137, P671; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2015, MICROBIOL MOL BIOL R, V79, P1, DOI 10.1128/MMBR.00041-14; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]; Wickner Reed B., 2009, Journal of Biology (London), V8, P47, DOI 10.1186/jbiol148; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003	90	102	102	2	87	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7128	7136		10.1074/jbc.TM118.001190	http://dx.doi.org/10.1074/jbc.TM118.001190			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	29921587	Green Published, hybrid			2022-12-28	WOS:000468402900003
J	Jahan, F; Madhavan, S; Rolova, T; Viazmina, L; Gronholm, M; Gahmberg, CG				Jahan, Farhana; Madhavan, Sudarrshan; Rolova, Taisia; Viazmina, Larisa; Gronholm, Mikaela; Gahmberg, Carl G.			Phosphorylation of the alpha-chain in the integrin LFA-1 enables beta 2-chain phosphorylation and alpha-actinin binding required for cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; phosphorylation; leukocyte; adhesion; talin; 14-3-3 protein; filamin; alpha-actinin	FUNCTION-ASSOCIATED ANTIGEN-1; INSIDE-OUT ACTIVATION; CYTOPLASMIC DOMAIN; LEUKOCYTE ADHESION; LIGAND-BINDING; THREONINE PHOSPHORYLATION; T-LYMPHOCYTES; BETA-SUBUNIT; CD18; AFFINITY	The integrin leukocyte function-associated antigen-1 (LFA-1) plays a pivotal role in leukocyte adhesion and migration, but the mechanism(s) by which this integrin is regulated has remained incompletely understood. LFA-1 integrin activity requires phosphorylation of its 2-chain and interactions of its cytoplasmic tail with various cellular proteins. The -chain is constitutively phosphorylated and necessary for cellular adhesion, but how the -chain regulates adhesion has remained enigmatic. We now show that substitution of the -chain phosphorylation site (S1140A) in T cells inhibits the phosphorylation of the functionally important Thr-758 in the 2-chain, binding of -actinin and 14-3-3 protein, and expression of an integrin-activating epitope after treatment with the stromal cell-derived factor-1. The presence of this substitution resulted in a loss of cell adhesion and directional cell migration. Moreover, LFA-1 activation through the T-cell receptor in cells expressing the S1140A LFA-1 variant resulted in less Thr-758 phosphorylation, -actinin and talin binding, and cell adhesion. The finding that the LFA-1 -chain regulates adhesion through the -chain via specific phosphorylation at Ser-1140 in the -chain has not been previously reported and emphasizes that both chains are involved in the regulation of LFA-1 integrin activity.	[Jahan, Farhana; Madhavan, Sudarrshan; Rolova, Taisia; Viazmina, Larisa; Gronholm, Mikaela; Gahmberg, Carl G.] Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci Res Program, FIN-00014 Helsinki, UH, Finland	University of Helsinki	Gronholm, M; Gahmberg, CG (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci Res Program, FIN-00014 Helsinki, UH, Finland.	mikaela.gronholm@helsinki.fi; carl.gahmberg@helsinki.fi	Gahmberg, Carl/AAE-1876-2019	Gahmberg, Carl/0000-0001-9892-9296; Chernyaeva, Larisa/0000-0002-4979-381X; Jahan, Farhana/0000-0003-3607-5736; Gronholm, Mikaela/0000-0002-2378-8924; Rolova, Taisia/0000-0002-8869-593X	Academy of Finland; Sigrid Juselius Foundation; Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Wilhelm and Else Stockmann Foundation; Ruth och Nils-Erik Stenback Foundation; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Wilhelm and Else Stockmann Foundation; Ruth och Nils-Erik Stenback Foundation; Magnus Ehrnrooth Foundation	This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Medicinska Understodsforeningen Liv och Halsa, the Finska Lakaresallskapet, the Wilhelm and Else Stockmann Foundation, the Ruth och Nils-Erik Stenback Foundation, and the Magnus Ehrnrooth Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abair TD, 2008, BLOOD, V112, P3242, DOI 10.1182/blood-2007-12-126433; Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Fagerholm S, 2002, EUR J IMMUNOL, V32, P1670, DOI 10.1002/1521-4141(200206)32:6<1670::AID-IMMU1670>3.0.CO;2-M; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; FILARDO EJ, 1994, J BIOL CHEM, V269, P4641; Gahmberg CG, 2014, ADV EXP MED BIOL, V819, P85, DOI 10.1007/978-94-017-9153-3_6; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Gronholm M, 2016, BLOOD, V128, P1270, DOI 10.1182/blood-2016-03-705160; Gronholm M, 2011, J IMMUNOL, V187, P3613, DOI 10.4049/jimmunol.1100704; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; Hilden TJ, 2003, J IMMUNOL, V170, P4170, DOI 10.4049/jimmunol.170.8.4170; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones Matthew C, 2015, Curr Protoc Cell Biol, V66, DOI 10.1002/0471143030.cb0908s66; KASSNER PD, 1995, MOL BIOL CELL, V6, P661, DOI 10.1091/mbc.6.6.661; KASSNER PD, 1993, J EXP MED, V178, P649, DOI 10.1084/jem.178.2.649; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; LARSON RS, 1990, CELL REGUL, V1, P359, DOI 10.1091/mbc.1.4.359; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Li YF, 2007, J BIOL CHEM, V282, P24310, DOI 10.1074/jbc.M701860200; Liu JF, 2015, J CELL SCI, V128, P1718, DOI 10.1242/jcs.160663; Lu CF, 1997, J IMMUNOL, V159, P268; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; NORTAMO P, 1988, SCAND J IMMUNOL, V28, P537, DOI 10.1111/j.1365-3083.1988.tb01485.x; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PARDI R, 1995, J IMMUNOL, V155, P1252; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; Pouwels J, 2012, J CELL SCI, V125, P3271, DOI 10.1242/jcs.093641; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; SHAW LM, 1993, J CELL BIOL, V123, P1017, DOI 10.1083/jcb.123.4.1017; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Uotila LM, 2014, J BIOL CHEM, V289, P32230, DOI 10.1074/jbc.M114.588111; Uotila LM, 2013, J BIOL CHEM, V288, P33494, DOI 10.1074/jbc.C113.497446; Valmu L, 1999, BIOCHEM J, V339, P119, DOI 10.1042/0264-6021:3390119; VALMU L, 1995, J IMMUNOL, V155, P1175; VANKOOYK Y, 1991, J CELL BIOL, V112, P345, DOI 10.1083/jcb.112.2.345; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Weber KSC, 1997, J IMMUNOL, V158, P273; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Yauch RL, 1997, J EXP MED, V186, P1347, DOI 10.1084/jem.186.8.1347; YLANNE J, 1995, J BIOL CHEM, V270, P9550	56	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12318	12330		10.1074/jbc.RA118.004318	http://dx.doi.org/10.1074/jbc.RA118.004318			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903913	Green Published, hybrid			2022-12-28	WOS:000441408500002
J	Stopschinski, BE; Holmes, BB; Miller, GM; Manon, VA; Vaquer-Alicea, J; Prueitt, WL; Hsieh-Wilson, LC; Diamond, MI				Stopschinski, Barbara E.; Holmes, Brandon B.; Miller, Gregory M.; Manon, Victor A.; Vaquer-Alicea, Jaime; Prueitt, William L.; Hsieh-Wilson, Linda C.; Diamond, Marc I.			Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus alpha-synuclein and beta-amyloid aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tau protein (Tau); Alzheimer disease; heparan sulfate; -synuclein; amyloid- (A); neurodegeneration; neurodegenerative disease; CRISPR; Cas; proteoglycan; HSPG; tauopathies	HEPARAN-SULFATE; IN-VIVO; PROTEOGLYCANS; PROTEINS; SCRAPIE; BIOSYNTHESIS; INFUSION; DISEASES; RECEPTOR; PRIONS	Transcellular propagation of protein aggregate seeds has been proposed to mediate the progression of neurodegenerative diseases in tauopathies and -synucleinopathies. We previously reported that tau and -synuclein aggregates bind heparan sulfate proteoglycans (HSPGs) on the cell surface, promoting cellular uptake and intracellular seeding. However, the specificity and binding mode of these protein aggregates to HSPGs remain unknown. Here, we measured direct interaction with modified heparins to determine the size and sulfation requirements for tau, -synuclein, and -amyloid (A) aggregate binding to glycosaminoglycans (GAGs). Varying the GAG length and sulfation patterns, we next conducted competition studies with heparin derivatives in cell-based assays. Tau aggregates required a precise GAG architecture with defined sulfate moieties in the N- and 6-O-positions, whereas the binding of -synuclein and A aggregates was less stringent. To determine the genes required for aggregate uptake, we used CRISPR/Cas9 to individually knock out the major genes of the HSPG synthesis pathway in HEK293T cells. Knockouts of the extension enzymes exostosin 1 (EXT1), exostosin 2 (EXT2), and exostosin-like 3 (EXTL3), as well as N-sulfotransferase (NDST1) or 6-O-sulfotransferase (HS6ST2) significantly reduced tau uptake, consistent with our biochemical findings, and knockouts of EXT1, EXT2, EXTL3, or NDST1, but not HS6ST2 reduced -synuclein uptake. In summary, tau aggregates display specific interactions with HSPGs that depend on GAG length and sulfate moiety position, whereas -synuclein and A aggregates exhibit more flexible interactions with HSPGs. These principles may inform the development of mechanism-based therapies to block transcellular propagation of amyloid protein-based pathologies.	[Stopschinski, Barbara E.; Holmes, Brandon B.; Manon, Victor A.; Vaquer-Alicea, Jaime; Prueitt, William L.; Diamond, Marc I.] Univ Texas Southwestern Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Stopschinski, Barbara E.] Rhein Westfal TH Aachen, Dept Neurol, D-52074 Aachen, Germany; [Holmes, Brandon B.] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO 63110 USA; [Miller, Gregory M.; Hsieh-Wilson, Linda C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Holmes, Brandon B.] Univ Calif San Francisco, 505 Parnassus Ave,M798,Box 0114, San Francisco, CA 94143 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; RWTH Aachen University; Washington University (WUSTL); California Institute of Technology; University of California System; University of California San Francisco	Diamond, MI (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	marc.diamond@utsouthwestern.edu	Prueitt, William/GPP-1892-2022	Vaquer-Alicea, Jaime/0000-0001-8363-9579; Holmes, Brandon/0000-0002-1153-840X	RWTH University Aachen, Faculty of Medicine, Germany, through the Rotation Program for Junior Researchers; Carl and Florence E. King Foundation; National Institutes of Health [1F31NS079039]; Medical Scientist Training Program Washington University St. Louis Grant [5T32GM07200]; University of Texas Southwestern Medical Student Summer Research Fellowship; Rainwater Charitable Foundation; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS079039] Funding Source: NIH RePORTER	RWTH University Aachen, Faculty of Medicine, Germany, through the Rotation Program for Junior Researchers; Carl and Florence E. King Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program Washington University St. Louis Grant; University of Texas Southwestern Medical Student Summer Research Fellowship; Rainwater Charitable Foundation; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by RWTH University Aachen, Faculty of Medicine, Germany, through the Rotation Program for Junior Researchers (to B. E. S.), the Carl and Florence E. King Foundation (to B. E. S.), National Institutes of Health Grant 1F31NS079039 (to B. B. H.), Medical Scientist Training Program Washington University St. Louis Grant 5T32GM07200 (to B. B. H.), the University of Texas Southwestern Medical Student Summer Research Fellowship (to W. L. P.), the Rainwater Charitable Foundation (to M. I. D.), and the Cure Alzheimer's Fund (to M. I. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Busse-Wicher M, 2014, MATRIX BIOL, V35, P25, DOI 10.1016/j.matbio.2013.10.001; Castillo GM, 1997, J NEUROCHEM, V69, P2452; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; DIRINGER H, 1991, J GEN VIROL, V72, P457, DOI 10.1099/0022-1317-72-2-457; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Furman JL, 2015, JOVE-J VIS EXP, DOI 10.3791/53205; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Hsieh PH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29602; Ihse E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08720-5; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Makkonen KE, 2013, J VIROL, V87, P11148, DOI 10.1128/JVI.01919-13; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tselnicker IF, 2014, BIOCHEM SOC T, V42, P1263, DOI 10.1042/BST20140166; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang ZJ, 2017, J AM CHEM SOC, V139, P5249, DOI 10.1021/jacs.7b01923; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Zhao J, 2017, BIOPHYS J, V112, P921, DOI 10.1016/j.bpj.2017.01.024	35	91	90	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10826	10840		10.1074/jbc.RA117.000378	http://dx.doi.org/10.1074/jbc.RA117.000378			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29752409	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000437828400036
J	Waldow, F; Kohler, TP; Hess, N; Schwudke, D; Hammerschmidt, S; Gisch, N				Waldow, Franziska; Kohler, Thomas P.; Hess, Nathalie; Schwudke, Dominik; Hammerschmidt, Sven; Gisch, Nicolas			Attachment of phosphorylcholine residues to pneumococcal teichoic acids and modification of substitution patterns by the phosphorylcholine esterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); mass spectrometry (MS); glycolipid structure; bacteria; cell wall; N-acetylgalactosamine; Phosphorylcholine esterase; Phosphorylcholine transferase; Streptococcus pneumoniae; Teichoic acid	STREPTOCOCCUS-PNEUMONIAE; CRYSTAL-STRUCTURE; CELL-WALL; CHOLINE; PEPTIDOGLYCAN; LIPOPROTEINS; REEVALUATION; AUTOLYSIS; PROTEINS; INSIGHTS	The bacterial lung pathogen Streptococcus pneumoniae has a unique nutritional requirement for exogenous choline and attaches phosphorylcholine (P-Cho) residues to the GalpNAc moieties of its teichoic acids (TAs) in its cell wall. Two phosphorylcholine transferases, LicD1 and LicD2, mediate the attachment of P-Cho to the O-6 positions of the two GalpNAc residues present in each repeating unit of pneumococcal TAs (pnTAs), of which only LicD1 has been determined to be essential. At the molecular level, the specificity of the P-Cho attachment to pnTAs by LicD1 and LicD2 remains still elusive. Here, using detailed structural analyses of pnTAs from a LicD2-deficient strain, we confirmed the specificity in the attachment of P-Cho residues to pnTA. LicD1 solely transfers P-Cho to -d-GalpNAc moieties, whereas LicD2 attaches P-Cho to -d-GalpNAc. Further, we investigated the role of the pneumococcal phosphorylcholine esterase (Pce) in the modification of the P-Cho substitution pattern of pnTAs. To clarify the specificity of Pce-mediated P-Cho hydrolysis, we evaluated different concentrations and pH conditions for the treatment of pneumococcal lipoteichoic acid with purified Pce. We show that Pce can hydrolyze both P-Cho residues of the terminal repeat of the pnTA chain and almost all P-Cho residues bound to -d-GalpNAc in vitro. However, hydrolysis in vivo was restricted to the terminal repeat. In summary, our findings indicate that LicD1 and LicD2 specifically transfer P-Cho to -d-GalpNAc and -d-GalpNAc moieties, respectively, and that Pce removes distinct P-Cho substituents from pnTAs.	[Waldow, Franziska; Schwudke, Dominik; Gisch, Nicolas] Leibniz Lung Ctr, Res Ctr Borstel, Div Bioanalyt Chem, Prior Area Infect, D-23845 Borstel, Germany; [Kohler, Thomas P.; Hess, Nathalie; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Ctr Funct Genom Microbes, Dept Mol Genet & Infect Biol, Felix Hausdorff Str 8, D-17487 Greifswald, Germany	Forschungszentrum Borstel; Ernst Moritz Arndt Universitat Greifswald	Gisch, N (corresponding author), Leibniz Lung Ctr, Res Ctr Borstel, Div Bioanalyt Chem, Parkallee 4a-4c, D-23845 Borstel, Germany.	ngisch@fz-borstel.de	Schwudke, Dominik/B-3478-2013; Hammerschmidt, Sven/G-2598-2010	Schwudke, Dominik/0000-0002-1379-9451; Hammerschmidt, Sven/0000-0002-6382-6681; Gisch, Nicolas/0000-0003-3260-5269	Deutsche Forschungsgemeinschaft [GI 979/1-1, HA 3125/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants GI 979/1-1 (to N. G.) and HA 3125/5-1 (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Damjanovic M, 2007, J BACTERIOL, V189, P7105, DOI 10.1128/JB.00681-07; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; de las Rivas B, 2001, MICROB DRUG RESIST, V7, P213, DOI 10.1089/10766290152652756; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Fischer W, 1997, MICROB DRUG RESIST, V3, P309, DOI 10.1089/mdr.1997.3.309; Gisch N, 2015, STREPTOCOCCUS PNEUMO, P145; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Hermoso JA, 2005, NAT STRUCT MOL BIOL, V12, P533, DOI 10.1038/nsmb940; Hess N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01720-z; HOLTJE JV, 1974, J BIOL CHEM, V249, P7032; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; LOPEZ R, 1982, J BACTERIOL, V151, P1581, DOI 10.1128/JB.151.3.1581-1590.1982; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Saleh M, 2013, EMBO MOL MED, V5, P1852, DOI 10.1002/emmm.201202435; SANCHEZPUELLES JM, 1992, EUR J BIOCHEM, V203, P153, DOI 10.1111/j.1432-1033.1992.tb19840.x; Schenk M, 2009, IMMUNITY, V31, P847, DOI 10.1016/j.immuni.2009.11.008; Schulz C, 2014, MBIO, V5, DOI 10.1128/mBio.01858-14; Severin A, 1997, MICROB DRUG RESIST, V3, P391, DOI 10.1089/mdr.1997.3.391; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Swiatlo E, 2002, INFECT IMMUN, V70, P412, DOI 10.1128/IAI.70.1.412-415.2002; TOMASZ A, 1968, P NATL ACAD SCI USA, V59, P86, DOI 10.1073/pnas.59.1.86; Vassal-Stermann E, 2014, J IMMUNOL, V193, P5699, DOI 10.4049/jimmunol.1400127; Vollmer W, 2001, MOL MICROBIOL, V39, P1610, DOI 10.1046/j.1365-2958.2001.02349.x; Yother J, 1998, J BACTERIOL, V180, P2093, DOI 10.1128/JB.180.8.2093-2101.1998; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x	29	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10620	10629		10.1074/jbc.RA118.003360	http://dx.doi.org/10.1074/jbc.RA118.003360			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29764936	Green Published, hybrid			2022-12-28	WOS:000437828400020
J	Chen, PYT; Funk, MA; Brignole, EJ; Drennan, CL				Chen, Percival Yang-Ting; Funk, Michael A.; Brignole, Edward J.; Drennan, Catherine L.			Disruption of an oligomeric interface prevents allosteric inhibition of Escherichia coli class Ia ribonucleotide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; nucleoside; nucleotide biosynthesis; mutagenesis mechanism; ribonucleotide reductase; protein-protein interaction; 44 ring; allosteric inhibition; radical-based chemistry; tyrosyl radical cofactor	RADICAL PROPAGATION PATHWAY; DIPHOSPHATE REDUCTASE; DIFFERENTIAL EXPRESSION; MAMMALIAN-CELLS; DNA-REPLICATION; LARGE SUBUNIT; PROTEIN R1; ATP-CONE; IN-VIVO; MUTAGENESIS	Ribonucleotide reductases (RNRs) convert ribonucleotides to deoxynucleotides, a process essential for DNA biosynthesis and repair. Class Ia RNRs require two dimeric subunits for activity: an (2) subunit that houses the active site and allosteric regulatory sites and a (2) subunit that houses the diferric tyrosyl radical cofactor. Ribonucleotide reduction requires that both subunits form a compact (22) state allowing for radical transfer from (2) to (2). RNR activity is regulated allosterically by dATP, which inhibits RNR, and by ATP, which restores activity. For the well-studied Escherichia coli class Ia RNR, dATP binding to an allosteric site on promotes formation of an (44) ring-like state. Here, we investigate whether the (44) formation causes or results from RNR inhibition. We demonstrate that substitutions at the - interface (S37D/S39A-(2), S39R-(2), S39F-(2), E42K-(2), or L43Q-(2)) that disrupt the (44) oligomer abrogate dATP-mediated inhibition, consistent with the idea that (44) formation is required for dATP's allosteric inhibition of RNR. Our results further reveal that the - interface in the inhibited state is highly sensitive to manipulation, with a single substitution interfering with complex formation. We also discover that residues at the - interface whose substitution has previously been shown to cause a mutator phenotype in Escherichia coli (i.e. S39F-(2) or E42K-(2)) are impaired only in their activity regulation, thus linking this phenotype with the inability to allosterically down-regulate RNR. Whereas the cytotoxicity of RNR inhibition is well-established, these data emphasize the importance of down-regulation of RNR activity.	[Chen, Percival Yang-Ting; Funk, Michael A.; Brignole, Edward J.; Drennan, Catherine L.] MIT, Dept Chem, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA; [Brignole, Edward J.; Drennan, Catherine L.] MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA; [Brignole, Edward J.; Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Funk, Michael A.] Amer Assoc Advancement Sci, 1200 New York Ave NW, Washington, DC 20005 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Dept Chem, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.	cdrennan@mit.edu			National Science Foundation [NSF-0070319]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Deborah Pheasant for assistance in collecting analytical ultracentrifugation data and Samuel Thompson for assistance with the site-directed mutagenesis. Dr. Nozomi Ando and Dr. Christina M. Zimanyi provided valuable discussions. Analytical ultracentrifugation data were collected at the MIT Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems, supported by National Science Foundation Grant NSF-0070319. EM images were collected at the W. M. Keck Microscopy Facility (Whitehead Institute).	Abid MR, 1999, J BIOL CHEM, V274, P35991, DOI 10.1074/jbc.274.50.35991; Ahluwalia D, 2012, DNA REPAIR, V11, P480, DOI 10.1016/j.dnarep.2012.02.001; Ando N, 2016, BIOCHEMISTRY-US, V55, P373, DOI 10.1021/acs.biochem.5b01207; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Aravind L, 2000, J MOL MICROB BIOTECH, V2, P191; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Aye Y, 2012, CHEM BIOL, V19, P799, DOI 10.1016/j.chembiol.2012.05.015; Aye Y, 2011, P NATL ACAD SCI USA, V108, P9815, DOI 10.1073/pnas.1013274108; Birgander PL, 2004, J BIOL CHEM, V279, P14496, DOI 10.1074/jbc.M310142200; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BOLLINGER JM, 1991, SCIENCE, V253, P292, DOI 10.1126/science.1650033; Brignole EJ, 2018, ELIFE, V7, DOI [10.7554/eLife.3150, 10.7554/eLife.31502]; Brignole EJ, 2012, BIOCHEM SOC T, V40, P523, DOI 10.1042/BST20120081; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; CARAS IW, 1988, MOL CELL BIOL, V8, P2698, DOI 10.1128/MCB.8.7.2698; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; DOBELN UV, 1976, J BIOL CHEM, V251, P3616; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; ERIKSSON S, 1977, J BIOL CHEM, V252, P6132; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Gon S, 2011, P NATL ACAD SCI USA, V108, P19311, DOI 10.1073/pnas.1113664108; HERTEL LW, 1990, CANCER RES, V50, P4417; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Johansson R, 2016, STRUCTURE, V24, P906, DOI 10.1016/j.str.2016.03.025; Jonna VR, 2015, J BIOL CHEM, V290, P17339, DOI 10.1074/jbc.M115.649624; KARLSSON M, 1992, J BIOL CHEM, V267, P12622; Kasrayan A, 2004, J BIOL CHEM, V279, P31050, DOI 10.1074/jbc.M400693200; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; LARSSON A, 1966, J BIOL CHEM, V241, P2533; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Licht S., 1999, COMPREHENSIVE NATURA, P163; LORI F, 1994, SCIENCE, V266, P801, DOI 10.1126/science.7973634; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Minnihan EC, 2013, P NATL ACAD SCI USA, V110, P3835, DOI 10.1073/pnas.1220691110; Minnihan EC, 2011, J AM CHEM SOC, V133, P9430, DOI 10.1021/ja201640n; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; RUSSEL M, 1985, J BACTERIOL, V163, P238, DOI 10.1128/JB.163.1.238-242.1985; Rutschmann OT, 1998, AIDS, V12, pF71, DOI 10.1097/00002030-199808000-00003; SALOWE SP, 1986, J BACTERIOL, V165, P363, DOI 10.1128/jb.165.2.363-366.1986; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15748, DOI 10.1021/ja076459b; SJOBERG BM, 1978, J BIOL CHEM, V253, P6863; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; THELANDER L, 1974, J BIOL CHEM, V249, P4858; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; van der Donk WA, 1998, BIOCHEMISTRY-US, V37, P6419, DOI 10.1021/bi9729357; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Wheeler LJ, 2005, DNA REPAIR, V4, P1450, DOI 10.1016/j.dnarep.2005.09.003; Wisitpitthaya S, 2016, ACS CHEM BIOL, V11, P2021, DOI 10.1021/acschembio.6b00303; Yokoyama K, 2011, J AM CHEM SOC, V133, P18420, DOI 10.1021/ja207455k; Zimanyi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.07141; Zimanyi CM, 2012, STRUCTURE, V20, P1374, DOI 10.1016/j.str.2012.05.009	68	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10404	10412		10.1074/jbc.RA118.002569	http://dx.doi.org/10.1074/jbc.RA118.002569			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29700111	Green Published, hybrid			2022-12-28	WOS:000437096700037
J	Tsukamoto, H; Takeuchi, S; Kubota, K; Kobayashi, Y; Kozakai, S; Ukai, I; Shichiku, A; Okubo, M; Numasaki, M; Kanemitsu, Y; Matsumoto, Y; Nochi, T; Watanabe, K; Aso, H; Tomioka, Y				Tsukamoto, Hiroki; Takeuchi, Shino; Kubota, Kanae; Kobayashi, Yohei; Kozakai, Sao; Ukai, Ippo; Shichiku, Ayumi; Okubo, Misaki; Numasaki, Muneo; Kanemitsu, Yoshitomi; Matsumoto, Yotaro; Nochi, Tomonori; Watanabe, Kouichi; Aso, Hisashi; Tomioka, Yoshihisa			Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKE-IRF3 axis activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-surface receptor; endotoxin; innate immunity; lipopolysaccharide (LPS); pathogen-associated molecular pattern (PAMP); pattern recognition receptor (PRR); TIR-domain-containing adapter-inducing interferon-B (TRIF); Toll-like receptor 4 (TLR4); CD14; LPS-binding protein (LBP)	INNATE IMMUNE-RESPONSES; GRAM-NEGATIVE BACTERIA; BINDING-PROTEIN; PATTERN-RECOGNITION; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODIES; SUBCELLULAR SITES; ADAPTIVE IMMUNITY; CELL-ACTIVATION; HUMAN MONOCYTES	Toll-like receptor 4 (TLR4) is an indispensable immune receptor for lipopolysaccharide (LPS), a major component of the Gram-negative bacterial cell wall. Following LPS stimulation, TLR4 transmits the signal from the cell surface and becomes internalized in an endosome. However, the spatial regulation of TLR4 signaling is not fully understood. Here, we investigated the mechanisms of LPS-induced TLR4 internalization and clarified the roles of the extracellular LPS-binding molecules, LPS-binding protein (LBP), and glycerophosphatidylinositol-anchored protein (CD14). LPS stimulation of CD14-expressing cells induced TLR4 internalization in the presence of serum, and an inhibitory anti-LBP mAb blocked its internalization. Addition of LBP to serum-free cultures restored LPS-induced TLR4 internalization to comparable levels of serum. The secretory form of the CD14 (sCD14) induced internalization but required a much higher concentration than LBP. An inhibitory anti-sCD14 mAb was ineffective for serum-mediated internalization. LBP lacking the domain for LPS transfer to CD14 and a CD14 mutant with reduced LPS binding both attenuated TLR4 internalization. Accordingly, LBP is an essential serum molecule for TLR4 internalization, and its LPS transfer to membrane-anchored CD14 (mCD14) is a prerequisite. LBP induced the LPS-stimulated phosphorylation of TBK1, IKKE, and IRF3, leading to IFN- expression. However, LPS-stimulated late activation of NF-B or necroptosis were not affected. Collectively, our results indicate that LBP controls LPS-induced TLR4 internalization, which induces TLR adaptor molecule 1 (TRIF)-dependent activation of the TBK1-IKKE-IRF3-IFN- pathway. In summary, we showed that LBP-mediated LPS transfer to mCD14 is required for serum-dependent TLR4 internalization and activation of the TRIF pathway.	[Tsukamoto, Hiroki; Takeuchi, Shino; Kubota, Kanae; Kobayashi, Yohei; Kozakai, Sao; Ukai, Ippo; Shichiku, Ayumi; Okubo, Misaki; Kanemitsu, Yoshitomi; Matsumoto, Yotaro; Tomioka, Yoshihisa] Tohoku Univ, Lab Oncol Pharm Practice & Sci, Grad Sch Pharmaceut Sci, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Numasaki, Muneo] Tohoku Univ, Inst Dev Aging & Canc, Dept Geriatr & Gerontol, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Nochi, Tomonori; Watanabe, Kouichi; Aso, Hisashi] Tohoku Univ, Grad Sch Agr Sci, Lab Funct Morphol, 468-Aoba, Sendai, Miyagi 9800845, Japan; [Nochi, Tomonori; Watanabe, Kouichi; Aso, Hisashi] Tohoku Univ, Grad Sch Agr Sci, Int Educ & Res Ctr Food & Agr Immunol CFAI, 468-Aoba, Sendai, Miyagi 9800845, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Tsukamoto, H (corresponding author), Tohoku Univ, Lab Oncol Pharm Practice & Sci, Grad Sch Pharmaceut Sci, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	tsukamoh@m.tohoku.ac.jp	Nochi, Tomonori/U-2533-2019; matsumoto, yotaro/AAC-4539-2019	Nochi, Tomonori/0000-0003-1800-6972; Tsukamoto, Hiroki/0000-0002-4585-1656	Japan Society for the Promotion of Science KAKENHI [26460058]; Takeda Science Foundation; Ichiro Kanehara Foundation; Research Foundation for Pharmaceutical Sciences; Tokyo Biochemical Research Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ichiro Kanehara Foundation; Research Foundation for Pharmaceutical Sciences; Tokyo Biochemical Research Foundation	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 26460058 (to H. T.), grants from the Takeda Science Foundation (to H. T.), The Ichiro Kanehara Foundation (to H. T.), the Research Foundation for Pharmaceutical Sciences (to H. T.), and the Tokyo Biochemical Research Foundation (to H. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Bahrun U, 2007, HYBRIDOMA, V26, P393, DOI 10.1089/hyb.2007.0523; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Hoshino K, 1999, J IMMUNOL, V162, P3749; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Iovine NM, 1997, P NATL ACAD SCI USA, V94, P10973, DOI 10.1073/pnas.94.20.10973; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kato A, 2004, J IMMUNOL, V172, P6185, DOI 10.4049/jimmunol.172.10.6185; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prucha M, 2003, CRIT CARE, V7, pR154, DOI 10.1186/cc2386; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; RESTA R, 1994, J IMMUNOL, V153, P1046; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Stack J, 2014, J IMMUNOL, V193, P6090, DOI 10.4049/jimmunol.1401605; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; THEOFAN G, 1994, J IMMUNOL, V152, P3623; Tsukamoto H, 2017, FEBS LETT, V591, P2406, DOI 10.1002/1873-3468.12768; Tsukamoto H, 2013, BIOCHEM BIOPH RES CO, V440, P31, DOI 10.1016/j.bbrc.2013.09.004; Tsukamoto H, 2013, J IMMUNOL, V190, P195, DOI 10.4049/jimmunol.1201047; Tsukamoto H, 2012, INT IMMUNOL, V24, P495, DOI 10.1093/intimm/dxs053; Tsukamoto H, 2010, INT IMMUNOL, V22, P271, DOI 10.1093/intimm/dxq005; Vreugdenhil ACE, 2001, J CLIN INVEST, V107, P225, DOI 10.1172/JCI10832; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	50	67	75	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10186	10201		10.1074/jbc.M117.796631	http://dx.doi.org/10.1074/jbc.M117.796631			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29760187	hybrid, Green Published			2022-12-28	WOS:000437096700020
J	Bottino-Rojas, V; Talyuli, OAC; Carrara, L; Martins, AJ; James, AA; Oliveira, PL; Paiva-Silva, GO				Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Carrara, Luana; Martins, Ademir J.; James, Anthony A.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.			The redox-sensing gene Nrf2 affects intestinal homeostasis, insecticide resistance, and Zika virus susceptibility in the mosquito Aedes aegypti	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENGUE VIRUS; TRANSCRIPTION FACTORS; PYRETHROID RESISTANCE; TISSUE HOMEOSTASIS; OXIDATIVE STRESS; DUAL OXIDASE; VECTOR; ACTIVATION; MECHANISMS; EXPRESSION	Production and degradation of reactive oxygen species (ROS) are extensively regulated to ensure proper cellular responses to various environmental stimuli and stresses. Moreover, physiologically generated ROS function as secondary messengers that can influence tissue homeostasis. The cap'n'collar transcription factor known as nuclear factor erythroid-derived factor 2 (Nrf2) coordinates an evolutionarily conserved transcriptional activation pathway that mediates antioxidant and detoxification responses in many animal species, including insects and mammals. Here, we show that Nrf2-mediated signaling affects embryo survival, midgut homeostasis, and redox biology in Aedes aegypti, a mosquito species vector of dengue, Zika, and other disease-causing viruses. We observed that AeNrf2 silencing increases ROS levels and stimulates intestinal stem cell proliferation. Because ROS production is a major aspect of innate immunity in mosquito gut, we found that a decrease in Nrf2 signaling results in reduced microbiota growth and Zika virus infection. Moreover, we provide evidence that AeNrf2 signaling also controls transcriptional adaptation of A. aegypti to insecticide challenge. Therefore, we conclude that Nrf2-mediated response regulates assorted gene clusters in A. aegypti that determine cellular and midgut redox balance, affecting overall xenobiotic resistance and vectorial adaptation of the mosquito.	[Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil; [Carrara, Luana; Martins, Ademir J.] Fundacao Oswaldo Cruz, Laficave, Inst Oswaldo Cruz, BR-21040360 Rio De Janeiro, RJ, Brazil; [Martins, Ademir J.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; University of California System; University of California Irvine; University of California System; University of California Irvine	Paiva-Silva, GO (corresponding author), Univ Fed Rio de Janeiro, Predio CCS Rm DSS05,Cid Univ Ilha Fundao, BR-21902 Rio De Janeiro, RJ, Brazil.	gosilva@bioqmed.ufrj.br	Martins, Ademir/W-3251-2019; Martins, Ademir J./B-4117-2009; Bottino-Rojas, Vanessa/AAX-2172-2020; L. Oliveira, Pedro/A-9438-2010	Martins, Ademir/0000-0001-5739-1215; Bottino-Rojas, Vanessa/0000-0001-8019-9942; Talyuli Cunha, Octavio Augusto/0000-0002-7026-463X; James, Anthony/0000-0001-5577-3308; L. Oliveira, Pedro/0000-0003-0307-354X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoarnento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; National Institute of Health [AI115595, AI29746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029746, R37AI029746, U01AI115595] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoarnento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoarnento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; and National Institute of Health Grants AI115595 (to A. J. M.) and AI29746 (to A. A. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985; Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878; Carter JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139899; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cheng YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32000; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189; David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174; Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Gentile C, 2005, Mem. Inst. Oswaldo Cruz, V100, P545, DOI 10.1590/S0074-02762005000600008; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Heiss EH, 2013, REDOX BIOL, V1, P359, DOI 10.1016/j.redox.2013.06.001; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Huang HX, 2017, VIROLOGY, V503, P1, DOI 10.1016/j.virol.2016.12.019; Ingham VA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4086-7; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jin YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005634; Jones RM, 2015, CELL REP, V12, P1217, DOI 10.1016/j.celrep.2015.07.042; Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224; Kalsi M, 2017, INSECT BIOCHEM MOLEC, V83, P1, DOI 10.1016/j.ibmb.2017.02.002; Kalsi M, 2015, INSECT BIOCHEM MOLEC, V65, P47, DOI 10.1016/j.ibmb.2015.08.002; Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Kramer LD, 2016, CURR OPIN VIROL, V21, P81, DOI 10.1016/j.coviro.2016.08.008; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Lacher SE, 2015, FREE RADICAL BIO MED, V88, P452, DOI 10.1016/j.freeradbiomed.2015.06.044; Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Magalhaes T, 2008, ARCH INSECT BIOCHEM, V68, P134, DOI 10.1002/arch.20238; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Misra JR, 2013, INSECT BIOCHEM MOLEC, V43, P1116, DOI 10.1016/j.ibmb.2013.09.005; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Peng T, 2016, INSECT MOL BIOL, V25, P450, DOI 10.1111/imb.12230; Pitoniak A, 2015, FREE RADICAL BIO MED, V88, P302, DOI 10.1016/j.freeradbiomed.2015.06.020; Poupardin R, 2010, INSECT MOL BIOL, V19, P185, DOI 10.1111/j.1365-2583.2009.00967.x; Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001; Rahman MM, 2013, AGING CELL, V12, P554, DOI 10.1111/acel.12078; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Sterkel M, 2017, TRENDS PARASITOL, V33, P633, DOI 10.1016/j.pt.2017.04.008; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tromp N, 2016, LANCET, V387, P1053, DOI 10.1016/S0140-6736(16)00659-0; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Wan H, 2014, PEST MANAG SCI, V70, P1048, DOI 10.1002/ps.3645; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	88	24	25	3	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9053	9063		10.1074/jbc.RA117.001589	http://dx.doi.org/10.1074/jbc.RA117.001589			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29685890	Green Published, hybrid			2022-12-28	WOS:000434941900027
J	Petit, AP; Garcia-Petit, C; Bueren-Calabuig, JA; Vuillard, LM; Ferry, G; Boutin, JA				Petit, Alain-Pierre; Garcia-Petit, Christel; Bueren-Calabuig, Juan A.; Vuillard, Laurent M.; Ferry, Gilles; Boutin, Jean A.			A structural study of the complex between neuroepithelial cell transforming gene 1 (Net1) and RhoA reveals a potential anticancer drug hot spot	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; PROTEIN; GTPASES; ACTIVATION; CHALLENGES; INHIBITOR; PDZRHOGEF; PHENIX	The GTPase RhoA is a major player in many different regulatory pathways. RhoA catalyzes GTP hydrolysis, and its catalysis is accelerated when RhoA forms heterodimers with proteins of the guanine nucleotide exchange factor (GEF) family. Neuroepithelial cell transforming gene 1 (Net1) is a RhoA-interacting GEF implicated in cancer, but the structural features supporting the RhoA/Net1 interaction are unknown. Taking advantage of a simple production and purification process, here we solved the structure of a RhoA/Net1 heterodimer with X-ray crystallography at 2-A resolution. Using a panel of several techniques, including molecular dynamics simulations, we characterized the RhoA/Net1 interface. Moreover, deploying an extremely simple peptide-based scanning approach, we found that short peptides (penta-to nonapeptides) derived from the protein/ protein interaction region of RhoA could disrupt the RhoA/ Net1 interaction and thereby diminish the rate of nucleotide exchange. The most inhibitory peptide, EVKHF, spanning residues 102-106 in the RhoA sequence, displayed an IC50 of similar to 100 mu M without further modifications. The peptides identified here could be useful in further investigations of the RhoA/Net1 interaction region. We propose that our structural and functional insights might inform chemical approaches for transforming the pentapeptide into an optimized pseudopeptide that antagonizes Net1-mediated RhoA activation with therapeutic anticancer potential.	[Petit, Alain-Pierre; Bueren-Calabuig, Juan A.] Univ Dundee, Drug Discovery Unit, Div Biol Chem & Drug Discovery, Sch Life Sci, Dundee DD1 5EH, Scotland; [Garcia-Petit, Christel] Univ Dundee, MRC, Sch Life Sci, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Vuillard, Laurent M.; Ferry, Gilles; Boutin, Jean A.] Inst Rech SERVIER, Chim, Biol, Pole Expertise Biotechnol, F-78290 Croissy Sur Seine, France	University of Dundee; University of Dundee; Servier; Institut de Recherches Internationales Servier	Boutin, JA (corresponding author), Inst Rech SERVIER, Chim, Biol, Pole Expertise Biotechnol, F-78290 Croissy Sur Seine, France.	jean.boutin@servier.com	Boutin, Jean Albert/W-9103-2019	Boutin, Jean Albert/0000-0003-0068-7204	Tenovus Scotland; MRC [MC_PC_15036, MC_PC_17158] Funding Source: UKRI	Tenovus Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported in part by Tenovus Scotland.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Azeez KRA, 2014, BIOCHEM J, V464, P231, DOI 10.1042/BJ20140606; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biro M, 2014, BRIT J PHARMACOL, V171, P5491, DOI 10.1111/bph.12658; Blundell TL, 2006, PHILOS T R SOC B, V361, P413, DOI 10.1098/rstb.2005.1800; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Case D.A, 2014, AMBER TOOLS15; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; Cramer LP, 1999, BIOCHEM SOC SYMP, V65, P173; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Diviani D, 2016, CELL CHEM BIOL, V23, P1135, DOI 10.1016/j.chembiol.2016.07.015; Dougherty PG, 2017, BIOCHEM J, V474, P1109, DOI 10.1042/BCJ20160619; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang L, 2015, MOL MED REP, V12, P7439, DOI 10.3892/mmr.2015.4385; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koth AP, 2014, J PHYSIOL-PARIS, V108, P270, DOI 10.1016/j.jphysparis.2014.08.007; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lenoir M, 2014, J BIOL CHEM, V289, P23992, DOI 10.1074/jbc.M114.561787; Leyden J, 2006, BRIT J CANCER, V94, P1204, DOI 10.1038/sj.bjc.6603054; Loge C, 2002, J ENZYM INHIB MED CH, V17, P381, DOI 10.1080/1475636021000005659; Loirand G, 2008, CURR OPIN PHARMACOL, V8, P174, DOI 10.1016/j.coph.2007.12.006; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Ma BY, 2014, CURR PHARM DESIGN, V20, P1293, DOI 10.2174/13816128113199990073; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Murray D, 2008, BRIT J CANCER, V99, P1322, DOI 10.1038/sj.bjc.6604688; Page R, 2005, P NATL ACAD SCI USA, V102, P1901, DOI 10.1073/pnas.0408490102; Peng FF, 2008, DIABETES, V57, P1683, DOI 10.2337/db07-1149; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Renaud JP, 2016, NAT REV DRUG DISCOV, V15, P679, DOI 10.1038/nrd.2016.123; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Schaefer Antje, 2014, Small GTPases, V5, P6, DOI 10.4161/21541248.2014.968004; Smithers CC, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020026; Srougi MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017108; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tao WW, 2015, J BIOL CHEM, V290, P20086, DOI 10.1074/jbc.M115.657742; Vega Francisco M, 2018, Small GTPases, V9, P384, DOI 10.1080/21541248.2016.1253528; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ye K, 2014, TUMOR BIOL, V35, P11219, DOI 10.1007/s13277-014-2454-3; Zandvakili I, 2017, ONCOGENE, V36, P3213, DOI 10.1038/onc.2016.473; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	54	6	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9064	9077		10.1074/jbc.RA117.001123	http://dx.doi.org/10.1074/jbc.RA117.001123			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29695506	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000434941900028
J	Zwirzitz, A; Reiter, M; Skrabana, R; Ohradanova-Repic, A; Majdic, O; Gutekova, M; Cehlar, O; Petrovcikova, E; Kutejova, E; Stanek, G; Stockinger, H; Leksa, V				Zwirzitz, Alexander; Reiter, Michael; Skrabana, Rostislav; Ohradanova-Repic, Anna; Majdic, Otto; Gutekova, Marianna; Cehlar, Ondrej; Petrovcikova, Eva; Kutejova, Eva; Stanek, Gerold; Stockinger, Hannes; Leksa, Vladimir			Lactoferrin is a natural inhibitor of plasminogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease; protease inhibitor; mannose 6-phosphate (M6P); tumor; bacteria; lactoferricin; Lyme disease; M6P; IGF2R; plasmin; transferrin; fibrinolysis; plasminogen; lactoferrin; insulin-like growth factor 2 receptor; cell invasion; Borrelia	FACTOR 2 RECEPTOR; BORRELIA-BURGDORFERI; HEMOSTATIC CHANGES; ENDOTHELIAL-CELLS; CATALYTIC DOMAIN; HUMAN SERUM; BINDING; STREPTOKINASE; PROTEIN; ALPHA-2-ANTIPLASMIN	The plasminogen system is essential for dissolution of fibrin clots, and in addition, it is involved in a wide variety of other physiological processes, including proteolytic activation of growth factors, cell migration, and removal of protein aggregates. On the other hand, uncontrolled plasminogen activation contributes to many pathological processes (e.g. tumor cells' invasion in cancer progression). Moreover, some virulent bacterial species (e.g. Streptococci or Borrelia) bind human plasminogen and hijack the host's plasminogen system to penetrate tissue barriers. Thus, the conversion of plasminogen to the active serine protease plasmin must be tightly regulated. Here, we show that human lactoferrin, an iron-binding milk glycoprotein, blocks plasminogen activation on the cell surface by direct binding to human plasminogen. We mapped the mutual binding sites to the N-terminal region of lactoferrin, encompassed also in the bioactive peptide lactoferricin, and kringle 5 of plasminogen. Finally, lactoferrin blocked tumor cell invasion in vitro and also plasminogen activation driven by Borrelia. Our results explain many diverse biological properties of lactoferrin and also suggest that lactoferrin may be useful as a potential tool for therapeutic interventions to prevent both invasive malignant cells and virulent bacteria from penetrating host tissues.	[Majdic, Otto] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, A-1090 Vienna, Austria; [Skrabana, Rostislav; Cehlar, Ondrej] Slovak Acad Sci, Inst Neuroimmunol, Lab Struct Biol Neurodegenerat, Bratislava 81438, Slovakia; [Gutekova, Marianna; Petrovcikova, Eva; Kutejova, Eva; Leksa, Vladimir] Slovak Acad Sci, Inst Mol Biol, Lab Mol Immunol, Bratislava 81438, Slovakia	Medical University of Vienna; Slovak Academy of Sciences; Slovak Academy of Sciences	Leksa, V (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Lazarettgasse 19, A-1090 Vienna, Austria.	vladimir.leksa@meduniwien.ac.at	Leksa, Vladimir/ABE-7876-2020; Kutejova, Eva/K-6550-2014; Stockinger, Hannes/E-5173-2011; Ohradanova-Repic, Anna/ABG-3709-2020; Kutejova, Eva/AAI-2544-2021; Skrabana, Rostislav/T-7382-2019	Kutejova, Eva/0000-0002-0973-679X; Stockinger, Hannes/0000-0001-6404-4430; Ohradanova-Repic, Anna/0000-0002-8005-8522; Kutejova, Eva/0000-0002-0973-679X; Skrabana, Rostislav/0000-0001-8200-5275; Reiter, Michael/0000-0002-7435-7999	Austrian Science Fund [P19014-B13, P22908, I00300]; Science and Technology Assistance Agency of the Slovak Republic [APVV-16-0452]; Slovak Grant Agency VEGA Grant [2/0020/17]; European Union Seventh Framework Program (FP7) [NMP4-LA-2009-228827 NANOFOL]; EU structural funds [ITMS 26240220008]; European Union's Horizon 2020 Research and Innovation Program [683356]	Austrian Science Fund(Austrian Science Fund (FWF)); Science and Technology Assistance Agency of the Slovak Republic; Slovak Grant Agency VEGA Grant; European Union Seventh Framework Program (FP7); EU structural funds; European Union's Horizon 2020 Research and Innovation Program	This work was supported by Austrian Science Fund Grants P19014-B13, P22908, and I00300; Science and Technology Assistance Agency of the Slovak Republic Grant APVV-16-0452; Slovak Grant Agency VEGA Grant 2/0020/17; the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement NMP4-LA-2009-228827 NANOFOL; and the EU structural funds ITMS 26240220008. The research was also supported by the European Union's Horizon 2020 Research and Innovation Program under Grant Agreement 683356 (FOLSMART). The authors declare that they have no conflicts of interest with the contents of this article.	BAYNES RD, 1989, S AFR MED J, V76, P531; BENNETT RM, 1979, CLIN SCI, V57, P453, DOI 10.1042/cs0570453; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binder BR, 2008, IMMUNOL LETT, V118, P116, DOI 10.1016/j.imlet.2008.03.017; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Bremme KA, 2003, BEST PRACT RES CL HA, V16, P153, DOI 10.1016/S1521-6926(03)00021-5; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; BRUNETTI CR, 1994, J BIOL CHEM, V269, P17067; Bugge Thomas H., 2008, P183, DOI 10.1007/978-0-387-69057-5_10; Calle A, 2008, J VIROL, V82, P4762, DOI 10.1128/JVI.00077-08; CEDERHOLMWILLIAMS SA, 1981, J CLIN PATHOL, V34, P979, DOI 10.1136/jcp.34.9.979; Costello M, 1999, J CLIN ENDOCR METAB, V84, P611, DOI 10.1210/jc.84.2.611; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Degryse B, 2011, CURR PHARM DESIGN, V17, P1872, DOI 10.2174/138161211796718161; Doeuvre L, 2010, BIOCHEM J, V432, P365, DOI 10.1042/BJ20100561; Dotti CG, 2004, NEURODEGENER DIS, V1, P205, DOI 10.1159/000080987; El-Shewy HM, 2009, VITAM HORM, V80, P667, DOI 10.1016/S0083-6729(08)00624-9; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gebbia JA, 1999, J CLIN INVEST, V103, P81, DOI 10.1172/JCI5171; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Haney EF, 2009, BIOCHIMIE, V91, P141, DOI 10.1016/j.biochi.2008.04.013; HARIDAS M, 1995, ACTA CRYSTALLOGR D, V51, P629, DOI 10.1107/S0907444994013521; HASEGAWA K, 1994, JPN J MED SCI BIOL, V47, P73, DOI 10.7883/yoken1952.47.73; HU LT, 1995, INFECT IMMUN, V63, P3491, DOI 10.1128/IAI.63.9.3491-3496.1995; Kanyshkova TG, 2003, EUR J BIOCHEM, V270, P3353, DOI 10.1046/j.1432-1033.2003.03715.x; KLEMPNER MS, 1995, J INFECT DIS, V171, P1258, DOI 10.1093/infdis/171.5.1258; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Legrand D, 2005, CELL MOL LIFE SCI, V62, P2549, DOI 10.1007/s00018-005-5370-2; Legrand D, 2016, J PEDIATR-US, V173, pS10, DOI 10.1016/j.jpeds.2016.02.071; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Leksa V, 2002, J BIOL CHEM, V277, P40575, DOI 10.1074/jbc.M207979200; Leksa V, 2012, J BIOL CHEM, V287, P22450, DOI 10.1074/jbc.M112.339663; Leksa V, 2011, CIRC RES, V108, P676, DOI 10.1161/CIRCRESAHA.110.234732; LIJNEN HR, 1981, EUR J BIOCHEM, V120, P149, DOI 10.1111/j.1432-1033.1981.tb05682.x; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MAGDOLEN V, 1995, ELECTROPHORESIS, V16, P813, DOI 10.1002/elps.11501601134; Majka G, 2013, ANAL BIOANAL CHEM, V405, P5191, DOI 10.1007/s00216-013-6943-9; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; Mayeur S, 2016, ANTIOXID REDOX SIGN, V24, P813, DOI 10.1089/ars.2015.6458; McArthur JD, 2012, CURR DRUG TARGETS, V13, P297; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; NEMET K, 1987, CLIN LAB HAEMATOL, V9, P137; Persson BA, 2010, BIOPHYS CHEM, V151, P187, DOI 10.1016/j.bpc.2010.06.005; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; REED GL, 1995, BIOCHEMISTRY-US, V34, P10266, DOI 10.1021/bi00032a021; Reiter M, 2015, TICKS TICK-BORNE DIS, V6, P303, DOI 10.1016/j.ttbdis.2015.02.002; Schiller HB, 2009, MOL BIOL CELL, V20, P745, DOI 10.1091/mbc.E08-06-0569; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Sittampalam S., 2017, ASSAY GUIDANCE MANUA; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P1942, DOI 10.1074/mcp.M600030-MCP200; Sleat DE, 1997, BIOCHEM J, V324, P33, DOI 10.1042/bj3240033; Stillfried GE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1647; Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Verhamme IM, 2014, J BIOL CHEM, V289, P28006, DOI 10.1074/jbc.M114.589077; Vogel HJ, 2012, BIOCHEM CELL BIOL, V90, P233, DOI [10.1139/O2012-016, 10.1139/o2012-016]; Wally J, 2007, BIOMETALS, V20, P249, DOI 10.1007/s10534-006-9062-7; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WIMAN B, 1979, J BIOL CHEM, V254, P9291; Yang N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00999; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110	64	19	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8600	8613		10.1074/jbc.RA118.003145	http://dx.doi.org/10.1074/jbc.RA118.003145			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29669808	Green Published, hybrid			2022-12-28	WOS:000434205700023
J	Stechschulte, LA; Ge, CX; Hinds, TD; Sanchez, ER; Franceschi, RT; Lecka-Czernik, B				Stechschulte, Lance A.; Ge, Chunxi; Hinds, Terry D., Jr.; Sanchez, Edwin R.; Franceschi, Renny T.; Lecka-Czernik, Beata			RETRACTION: Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPAR gamma (peroxisome proliferator-activated receptor gamma) and RUNX2 (runt-related transcription factor 2) (Retraction of Vol 291, Pg 24475, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													FRANCESCHI, RENNY/K-3533-2019					Stechschulte LA, 2016, J BIOL CHEM, V291, P24475, DOI 10.1074/jbc.M116.752493	1	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8314	8314		10.1074/jbc.W118.003815	http://dx.doi.org/10.1074/jbc.W118.003815			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29802142	Green Published, hybrid			2022-12-28	WOS:000433224600036
J	Guengerich, FP				Guengerich, F. Peter			Cytochrome P450 research and The Journal of Biological Chemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cytochrome P450; steroid; eicosanoid; retinoid; endoplasmic reticulum (ER); mitochondria	LIVER MICROSOMAL CYTOCHROME-P-450; ARACHIDONIC-ACID EPOXYGENASE; MONOXIDE-BINDING PIGMENT; SIDE-CHAIN CLEAVAGE; 20-HYDROXYEICOSATETRAENOIC ACID; MITOCHONDRIAL CYTOCHROME-P-450; GENETIC-POLYMORPHISM; CHOLESTEROL 7-ALPHA-HYDROXYLASE; 14-ALPHA-DEMETHYLASE CYP51; MYCOBACTERIUM-TUBERCULOSIS	In honor of the 100th birthday of Dr. Herbert Tabor, JBC's Editor-in-Chief for 40 years, I will review here JBC's extensive coverage of the field of cytochrome P450 (P450) research. Research on the reactions catalyzed by these enzymes was published in JBC before it was even realized that they were P450s, i.e. they have a "pigment" with an absorption maximum at 450 nm. After the P450 pigment discovery, reported in JBC in 1962, the journal proceeded to publish the methods for measuring P450 activities and many seminal findings. Since then, the P450 field has grown extensively, with significant progress in characterizing these enzymes, including structural features, catalytic mechanisms, regulation, and many other aspects of P450 biochemistry. JBC has been the most influential journal in the P450 field. As with many other research areas, Dr. Tabor deserves a great deal of the credit for significantly advancing this burgeoning and important topic of research.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu						ANDERSSON S, 1983, J BIOL CHEM, V258, P6777; AUGUSTO O, 1982, J BIOL CHEM, V257, P1288; AXELROD JULIUS, 1955, JOUR BIOL CHEM, V214, P753; BJORKHEM I, 1980, J BIOL CHEM, V255, P5244; BREWER CB, 1988, J BIOL CHEM, V263, P791; BROWN RR, 1954, J BIOL CHEM, V209, P211; BRYSON MJ, 1968, J BIOL CHEM, V243, P2799; BURKHART BA, 1985, J BIOL CHEM, V260, P5357; CALI JJ, 1991, J BIOL CHEM, V266, P7774; CAPDEVILA JH, 1992, J BIOL CHEM, V267, P21720; CAPDEVILA JH, 1990, J BIOL CHEM, V265, P10865; Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; CHU JW, 1973, J BIOL CHEM, V248, P2089; Coon MJ, 2002, J BIOL CHEM, V277, P28351, DOI 10.1074/jbc.R200015200; COOPER DY, 1963, J BIOL CHEM, V238, P1320; de Montellano PRO, 2015, J BIOL CHEM, V290, P21833, DOI 10.1074/jbc.X115.680066; DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057; DUBOIS RN, 1981, J BIOL CHEM, V256, P700; Frank DJ, 2014, J BIOL CHEM, V289, P30417, DOI 10.1074/jbc.M114.602771; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; GHAZARIAN JG, 1974, J BIOL CHEM, V249, P3026; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; GOTOH O, 1992, J BIOL CHEM, V267, P83; GRAY RW, 1972, J BIOL CHEM, V247, P7528; Guengerich FP, 2016, TRENDS PHARMACOL SCI, V37, P625, DOI 10.1016/j.tips.2016.05.006; Guengerich FP, 2013, J BIOL CHEM, V288, P17063, DOI 10.1074/jbc.R113.466821; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; GUENGERICH FP, 1978, J BIOL CHEM, V253, P7931; Guengerich F, 2012, J BIOL CHEM, V287, P15798, DOI 10.1074/jbc.O112.000003; GUT J, 1986, J BIOL CHEM, V261, P1734; HALPERT JR, 1993, J BIOL CHEM, V268, P4453; HARA S, 1994, J BIOL CHEM, V269, P19897; HARADA N, 1984, J BIOL CHEM, V259, P3005; HARDWICK JP, 1987, J BIOL CHEM, V262, P801; Hargrove TY, 2017, J BIOL CHEM, V292, P6728, DOI 10.1074/jbc.M117.778308; HAUGEN DA, 1975, J BIOL CHEM, V250, P3567; HAURAND M, 1985, J BIOL CHEM, V260, P5059; HECKER M, 1989, J BIOL CHEM, V264, P141; HEDEGAARD J, 1965, J BIOL CHEM, V240, P4038; HOLLENBERG PF, 1973, J BIOL CHEM, V248, P2630; HONDA S, 1993, J BIOL CHEM, V268, P7494; Hsu MH, 2017, J BIOL CHEM, V292, P5610, DOI 10.1074/jbc.M117.775494; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Johnson KM, 2017, J BIOL CHEM, V292, P13672, DOI 10.1074/jbc.M116.773937; KASHIWAGI K, 1980, J BIOL CHEM, V255, P2606; KATAGIRI M, 1968, J BIOL CHEM, V243, P3543; Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Kresge N., 2006, J BIOL CHEM, V281, pe15; Kresge N, 2007, J BIOL CHEM, V282; Kresge N, 2006, J BIOL CHEM, V281; Lamb DC, 2002, J BIOL CHEM, V277, P24000, DOI 10.1074/jbc.M111109200; LAMBETH JD, 1983, J BIOL CHEM, V258, P5596; LAMBETH JD, 1982, J BIOL CHEM, V257, P1876; LARSON JR, 1991, J BIOL CHEM, V266, P7321; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lepesheva GI, 2001, J BIOL CHEM, V276, P28413, DOI 10.1074/jbc.M102767200; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; LI YC, 1991, J BIOL CHEM, V266, P19186; LIPSCOMB JD, 1976, J BIOL CHEM, V251, P1116; LU AYH, 1969, J BIOL CHEM, V244, P3714; LU AYH, 1972, J BIOL CHEM, V247, P1727; LU AYH, 1968, J BIOL CHEM, V243, P1331; MASON HS, 1957, SCIENCE, V125, P1185, DOI 10.1126/science.125.3259.1185; Masters BSS, 2009, J BIOL CHEM, V284, P19765, DOI 10.1074/jbc.X109.007518; MASUMOTO O, 1988, J BIOL CHEM, V263, P14256; MATOCHA MF, 1984, J BIOL CHEM, V259, P8672; MOMOI K, 1983, J BIOL CHEM, V258, P8855; MORGAN ET, 1985, J BIOL CHEM, V260, P1895; MORNET E, 1989, J BIOL CHEM, V264, P20961; MUELLER GC, 1948, J BIOL CHEM, V176, P535; MUERHOFF AS, 1992, J BIOL CHEM, V267, P19051; NARHI LO, 1986, J BIOL CHEM, V261, P7160; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NEBERT DW, 1968, J BIOL CHEM, V243, P6250; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1962, J BIOL CHEM, V237, P1375; PAN ZQ, 1995, J BIOL CHEM, V270, P8487, DOI 10.1074/jbc.270.15.8487; PEDERSEN JI, 1983, J BIOL CHEM, V258, P742; PERDEW GH, 1988, J BIOL CHEM, V263, P9848; POLAND A, 1976, J BIOL CHEM, V251, P4936; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; POULOS TL, 1985, J BIOL CHEM, V260, P6122; RYAN D, 1975, J BIOL CHEM, V250, P2157; RYAN KJ, 1959, J BIOL CHEM, V234, P268; Savas S, 2016, J BIOL CHEM, V291, P16904, DOI 10.1074/jbc.M116.732297; SCHLEYER H, 1972, J BIOL CHEM, V247, P6103; Sherbet DP, 2003, J BIOL CHEM, V278, P48563, DOI 10.1074/jbc.M307586200; SHIKITA M, 1973, J BIOL CHEM, V248, P5598; SHIMADA T, 1986, J BIOL CHEM, V261, P909; SHIMIZU T, 1991, J BIOL CHEM, V266, P3372; SHIRO Y, 1995, J BIOL CHEM, V270, P1617, DOI 10.1074/jbc.270.4.1617; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; SOBERMAN RJ, 1987, J BIOL CHEM, V262, P12421; SOGAWA K, 1985, J BIOL CHEM, V260, P5026; Stiles AR, 2009, J BIOL CHEM, V284, P28485, DOI 10.1074/jbc.R109.042168; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; SUWA Y, 1985, J BIOL CHEM, V260, P7980; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; THOMPSON EA, 1974, J BIOL CHEM, V249, P5373; TYSON CA, 1972, J BIOL CHEM, V247, P5777; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; VERMILION JL, 1981, J BIOL CHEM, V256, P266; Wang CX, 2017, J BIOL CHEM, V292, P10767, DOI 10.1074/jbc.M117.792465; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; Wu S, 1996, J BIOL CHEM, V271, P3460; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; ZUBER MX, 1986, J BIOL CHEM, V261, P2475	115	36	39	11	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1671	1680		10.1074/jbc.TM118.004144	http://dx.doi.org/10.1074/jbc.TM118.004144			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	29871932	hybrid, Green Published			2022-12-28	WOS:000457879200026
J	Morris, JS; Groves, RA; Hagel, JM; Facchini, PJ				Morris, Jeremy S.; Groves, Ryan A.; Hagel, Jillian M.; Facchini, Peter J.			An N-methyltransferase from Ephedra sinica catalyzing the formation of ephedrine and pseudoephedrine enables microbial phenylalkylamine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant biochemistry; plant molecular biology; secondary metabolism; genomics; synthetic biology; biochemical genomics; Ephedra sinica; N-methyltransferase; substituted phenylalkylamine; synthetic biology; natural product; secondary metabolite	CAFFEINE SYNTHASE GENE; ADENOSYL-L-METHIONINE; ESCHERICHIA-COLI; OPIUM POPPY; S-ADENOSYLMETHIONINE; MOLECULAR-CLONING; COPTIS-JAPONICA; CULTURED-CELLS; ENZYME; PLANTS	Phenylalkylamines, such as the plant compounds ephedrine and pseudoephedrine and the animal neurotransmitters dopamine and adrenaline, compose a large class of natural and synthetic molecules with important physiological functions and pharmaceutically valuable bioactivities. The final steps of ephedrine and pseudoephedrine biosynthesis in members of the plant genus Ephedra involve N-methylation of norephedrine and norpseudoephedrine, respectively. Here, using a plant transcriptome screen, we report the isolation and characterization of an N-methyltransferase (NMT) from Ephedra sinica able to catalyze the formation of (pseudo)ephedrine and other naturally occurring phenylalkylamines, including N-methylcathinone and N-methyl(pseudo)ephedrine. Phenylalkylamine N-methyltransferase (PaNMT) shares substantial amino acid sequence identity with enzymes of the NMT family involved in benzylisoquinoline alkaloid (BIA) metabolism in members of the higher plant order Ranunculales, which includes opium poppy (Papaver somniferum). PaNMT accepted a broad range of substrates with phenylalkylamine, tryptamine, -carboline, tetrahydroisoquinoline, and BIA structural scaffolds, which is in contrast to the specificity for BIA substrates of NMT enzymes within the Ranunculales. PaNMT transcript levels were highest in young shoots of E. sinica, which corresponded to the location of NMT activity yielding (pseudo)ephedrine, N-methylcathinone, and N-methyl(pseudo)ephedrine, and with in planta accumulation of phenylalkylamines. Co-expression of recombinant genes encoding PaNMT and an -transaminase (PP2799) from Pseudomonas putida in Escherichia coli enabled the conversion of exogenous (R)-phenylacetylcarbinol (PAC) and (S)-PAC to ephedrine and pseudoephedrine, respectively. Our work further demonstrates the utility of plant biochemical genomics for the isolation of key enzymes that facilitate microbial engineering for the production of medicinally important metabolites.	[Morris, Jeremy S.; Groves, Ryan A.; Hagel, Jillian M.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca						Abourashed EA, 2003, PHYTOTHER RES, V17, P703, DOI 10.1002/ptr.1337; AXELROD J, 1962, J PHARMACOL EXP THER, V138, P28; Bartlem D, 2000, PLANT PHYSIOL, V123, P101, DOI 10.1104/pp.123.1.101; Beng G. T., 2011, MALAYSIAN J ANAL SCI, V15, P54; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Brobst A., 2009, AM J UNDERGRAD RES, V8, P1; Chen YW, 2017, RSC ADV, V7, P22409, DOI 10.1039/c7ra02538f; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Choi KB, 2001, PHYTOCHEMISTRY, V56, P649, DOI 10.1016/S0031-9422(00)00481-7; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DIXON SL, 1993, J COMPUT CHEM, V14, P1460, DOI 10.1002/jcc.540141208; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Faraone SV, 2018, NEUROSCI BIOBEHAV R, V87, P255, DOI 10.1016/j.neubiorev.2018.02.001; Finberg JPM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00340; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Garcia-Moreno Bertrand, 2009, Journal of Biology (London), V8, P98, DOI 10.1186/jbiol199; Groves RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119701; GRUESORENSEN G, 1994, J AM CHEM SOC, V116, P6195, DOI 10.1021/ja00093a019; GRUNEWALD GL, 1988, J MED CHEM, V31, P1984, DOI 10.1021/jm00118a021; Hagel JM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0596-0; Hagel JM, 2012, TRENDS PLANT SCI, V17, P404, DOI 10.1016/j.tplants.2012.03.004; Hagel JM, 2012, IN VITRO CELL DEV-PL, V48, P233, DOI 10.1007/s11627-012-9426-3; HOLM S, 1979, SCAND J STAT, V6, P65; Hu Xiaoqing, 2012, Subcell Biochem, V64, P327, DOI 10.1007/978-94-007-5055-5_16; Huang RQ, 2016, P NATL ACAD SCI USA, V113, P10613, DOI 10.1073/pnas.1602575113; IMASEKI I, 1956, Pharm Bull, V4, P277; Kato M, 2000, NATURE, V406, P956, DOI 10.1038/35023072; Korte SM, 2015, EUR J PHARMACOL, V753, P88, DOI 10.1016/j.ejphar.2014.11.045; Krizevski R, 2012, PHYTOCHEMISTRY, V81, P71, DOI 10.1016/j.phytochem.2012.05.018; Krizevski R, 2010, PHYTOCHEMISTRY, V71, P895, DOI 10.1016/j.phytochem.2010.03.019; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kunjapur AM, 2014, J AM CHEM SOC, V136, P11644, DOI 10.1021/ja506664a; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liscombe DK, 2009, PLANT J, V60, P729, DOI 10.1111/j.1365-313X.2009.03980.x; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Meyer D, 2011, J AM CHEM SOC, V133, P3609, DOI 10.1021/ja110236w; Mizuno K, 2003, FEBS LETT, V534, P75, DOI 10.1016/S0014-5793(02)03781-X; Morris JS, 2016, J BIOL CHEM, V291, P23416, DOI 10.1074/jbc.M116.750893; Ng J, 2015, NAT REV NEUROL, V11, P567, DOI 10.1038/nrneurol.2015.172; O'Dowd N. A., 1998, BIOTECHNOLOGY AGR FO, V41, P154; Okada T, 2008, BIOL PHARM BULL, V31, P2194, DOI 10.1248/bpb.31.2194; OKEEFE BR, 1994, PLANT PHYSIOL, V105, P395, DOI 10.1104/pp.105.1.395; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; RETI L, 1953, ALKALOIDS-CHEM BIOL, V3, P339; RUEFFER M, 1990, PHYTOCHEMISTRY, V29, P3727, DOI 10.1016/0031-9422(90)85321-6; Satpute K., 2015, INT P CHEM BIOL ENV, V88, P65; Sehl T, 2014, GREEN CHEM, V16, P3341, DOI 10.1039/c4gc00100a; Sehl T, 2013, ANGEW CHEM INT EDIT, V52, P6772, DOI 10.1002/anie.201300718; Sehl T, 2012, J BIOTECHNOL, V159, P188, DOI 10.1016/j.jbiotec.2011.12.023; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; Thompson MA, 1998, J BIOL CHEM, V273, P34502, DOI 10.1074/jbc.273.51.34502; Torres MA, 2016, J BIOL CHEM, V291, P23403, DOI 10.1074/jbc.M116.747261; WELSH LH, 1949, J AM CHEM SOC, V71, P3500, DOI 10.1021/ja01178a071; Wu XR, 2014, APPL MICROBIOL BIOT, V98, P7399, DOI 10.1007/s00253-014-5797-1; Zhao XQ, 2010, ARCH MICROBIOL, V192, P289, DOI 10.1007/s00203-010-0548-x; ZHINGEL KY, 1991, J FORENSIC SCI, V36, P915	59	10	10	6	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13364	13376		10.1074/jbc.RA118.004067	http://dx.doi.org/10.1074/jbc.RA118.004067			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29929980	Green Published, hybrid			2022-12-28	WOS:000443375500002
J	Valegard, K; Andralojc, PJ; Haslam, RP; Pearce, FG; Eriksen, GK; Madgwickn, PJ; Kristoffersen, AK; van Lun, M; Klein, U; Eilertsen, HC; Parry, MAJ; Andersson, I				Valegard, Karin; Andralojc, P. John; Haslam, Richard P.; Pearce, F. Grant; Eriksen, Gunilla K.; Madgwickn, Pippa J.; Kristoffersen, Anne K.; van Lun, Michiel; Klein, Uwe; Eilertsen, Hans C.; Parry, Martin A. J.; Andersson, Inger			Structural and functional analyses of Rubisco from arctic diatom species reveal unusual posttranslational modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CO2 CONCENTRATING MECHANISMS; CRYSTAL-STRUCTURE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; RIBULOSEBISPHOSPHATE CARBOXYLASE; SPECIFICITY FACTOR; LARGE SUBUNIT; CELL-WALL; OXYGENASE; PROTEIN	The catalytic performance of the major CO2-assimilating enzyme, ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco), restricts photosynthetic productivity. Natural diversity in the catalytic properties of Rubisco indicates possibilities for improvement. Oceanic phytoplankton contain some of the most efficient Rubisco enzymes, and diatoms in particular are responsible for a significant proportion of total marine primary production as well as being a major source of CO2 sequestration in polar cold waters. Until now, the biochemical properties and three-dimensional structures of Rubisco from diatoms were unknown. Here, diatoms from arctic waters were collected, cultivated, and analyzed for their CO2-fixing capability. We characterized the kinetic properties of five and determined the crystal structures of four Rubiscos selected for their high CO2-fixing efficiency. The DNA sequences of the rbcL, and rbcS genes of the selected diatoms were similar, reflecting their close phylogenetic relationship. The V-max and K-m for the oxygenase and carboxylase activities at 25 degrees C and the specificity factors (S-c/o) at 15, 25, and 35 degrees C were determined. The S-c/o values were high, approaching those of mono- and dicot plants, thus exhibiting good selectivity for CO(2 )relative to O-2. Structurally, diatom Rubiscos belong to form I C/D, containing small subunits characterized by a short beta A-beta B loop and a C-terminal extension that forms a beta-hairpin structure (beta E-beta F loop). Of note, the diatom Rubiscos featured a number of posttranslational modifications of the large subunit, including 4-hydroxyproline, beta-hydroxyleucine, hydroxylated and nitrosylated cysteine, mono- and dihydroxylated lysine, and trimethylated lysine. Our studies suggest adaptation toward achieving efficient CO2 fixation in arctic diatom Rubiscos.	[Valegard, Karin; Pearce, F. Grant; van Lun, Michiel; Andersson, Inger] Uppsala Univ, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden; [Andralojc, P. John; Haslam, Richard P.; Madgwickn, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Harpenden AL5 2JQ, Herts, England; [Eriksen, Gunilla K.; Eilertsen, Hans C.] Arctic Univ Norway, Norwegian Coll Fisheries Sci, N-9037 Tromso, Norway; [Kristoffersen, Anne K.; Klein, Uwe] Univ Oslo, Dept Biosci, POB 1066, N-0316 Oslo, Norway; [Pearce, F. Grant] Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand; [Kristoffersen, Anne K.] Univ Oslo, Fac Dent, Dept Oral Biol, POB 1052, N-0316 Oslo, Norway; [Parry, Martin A. J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England	Uppsala University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UiT The Arctic University of Tromso; University of Oslo; University of Canterbury; University of Oslo; Lancaster University	Andersson, I (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.	inger.andersson@icm.uu.se		Parry, Martin/0000-0002-4477-672X; Haslam, Richard/0000-0001-6226-5643	MAX-lab (Lund, Sweden); European Union [QLK3-CT-2002-01945]; Swedish Research Council for Environment, Agricultural Sciences; Spatial Planning (FORMAS); Biotechnology and Biological Sciences Research Council, UK, through the 20:20 Wheat(R) Institute Strategic Program (BBSRC) [BB/J/00426X/1]; BBSRC [BBS/E/C/00005202] Funding Source: UKRI	MAX-lab (Lund, Sweden); European Union(European Commission); Swedish Research Council for Environment, Agricultural Sciences(Swedish Research Council Formas); Spatial Planning (FORMAS)(Swedish Research Council Formas); Biotechnology and Biological Sciences Research Council, UK, through the 20:20 Wheat(R) Institute Strategic Program (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the European Union (QLK3-CT-2002-01945) the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Biotechnology and Biological Sciences Research Council, UK, through the 20:20 Wheat (R) Institute Strategic Program (BBSRC Grant BB/J/00426X/1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Carmo-Silva AE, 2010, J EXP BOT, V61, P2355, DOI 10.1093/jxb/erq071; Carmo-Silva E, 2015, PLANT CELL ENVIRON, V38, P1817, DOI 10.1111/pce.12425; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; CHEN Z, 1988, P NATL ACAD SCI USA, V85, P4696, DOI 10.1073/pnas.85.13.4696; Chung CC, 2008, APPL ENVIRON MICROB, V74, P6521, DOI 10.1128/AEM.01481-08; Degerlund M, 2010, ESTUAR COAST, V33, P242, DOI 10.1007/s12237-009-9167-7; Delwiche CF, 1996, MOL BIOL EVOL, V13, P873, DOI 10.1093/oxfordjournals.molbev.a025647; Eilertsen HC, 2010, J PLANKTON RES, V32, P899, DOI 10.1093/plankt/fbq017; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Falkowski P, 2012, NATURE, V483, pS17, DOI 10.1038/483S17a; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Galmes J, 2005, PLANT CELL ENVIRON, V28, P571, DOI 10.1111/j.1365-3040.2005.01300.x; Galmes J, 2014, PLANT CELL ENVIRON, V37, P1989, DOI 10.1111/pce.12335; Ghiron JHL, 2008, PROTIST, V159, P91, DOI 10.1016/j.protis.2007.06.002; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Hansen S, 1999, J MOL BIOL, V288, P609, DOI 10.1006/jmbi.1999.2701; Haslam RP, 2005, PLANT RESPONSES TO AIR POLLUTION AND GLOBAL CHANGE, P157, DOI 10.1007/4-431-31014-2_18; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Heinhorst S, 2002, CURR MICROBIOL, V45, P115, DOI 10.1007/s00284-001-0094-5; HOBSON LA, 1985, PLANT PHYSIOL, V79, P833, DOI 10.1104/pp.79.3.833; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Hopkinson BM, 2016, CURR OPIN PLANT BIOL, V31, P51, DOI 10.1016/j.pbi.2016.03.013; Houtz RL, 2003, ARCH BIOCHEM BIOPHYS, V414, P150, DOI 10.1016/S0003-9861(03)00122-X; HOUTZ RL, 1992, PLANT PHYSIOL, V98, P1170, DOI 10.1104/pp.98.3.1170; HOUTZ RL, 1991, PLANT PHYSIOL, V96, P335, DOI 10.1104/pp.96.1.335; Houtz RL, 2008, J EXP BOT, V59, P1635, DOI 10.1093/jxb/erm360; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P113, DOI 10.1021/bi047928e; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; LAMPORT DTA, 1960, NATURE, V188, P665, DOI 10.1038/188665b0; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; LORIMER GH, 1976, BIOCHEMISTRY-US, V15, P529, DOI 10.1021/bi00648a012; LORIMER GH, 1980, BIOCHEMISTRY-US, V19, P5321, DOI 10.1021/bi00564a027; Losh JL, 2013, NEW PHYTOL, V198, P52, DOI 10.1111/nph.12143; Moreno J, 2008, J EXP BOT, V59, P1605, DOI 10.1093/jxb/erm310; Morin B, 1998, CHEM RES TOXICOL, V11, P1265, DOI 10.1021/tx980118h; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PARRY MAJ, 1993, PLANT PHYSIOL BIOCH, V31, P113; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; PARRY MAJ, 1989, J EXP BOT, V40, P317, DOI 10.1093/jxb/40.3.317; Quillfeldt CH, 2001, BOT MAR, V44, P375; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; SARGENT JR, 1985, MAR BIOL, V85, P109, DOI 10.1007/BF00397428; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; SMAYDA THEODORE J., 1958, OIKOS, V9, P158, DOI 10.2307/3564763; SMITH WG, 1965, J BACTERIOL, V89, P136, DOI 10.1128/JB.89.1.136-140.1965; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Stec B, 2012, P NATL ACAD SCI USA, V109, P18785, DOI 10.1073/pnas.1210754109; Sugawara H, 1999, J BIOL CHEM, V274, P15655, DOI 10.1074/jbc.274.22.15655; Syvertsen E, 1977, NOVA HEDWIGIA S, V54, P99; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Lun M, 2011, J MOL BIOL, V411, P1083, DOI 10.1016/j.jmb.2011.06.052; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YOKOTA A, 1985, PLANT PHYSIOL, V77, P735, DOI 10.1104/pp.77.3.735; Young JN, 2016, J EXP BOT, V67, P3445, DOI 10.1093/jxb/erw163	67	13	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13033	13043		10.1074/jbc.RA118.003518	http://dx.doi.org/10.1074/jbc.RA118.003518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29925588	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000442730200006
J	Chu, H; Chan, CM; Zhang, X; Wang, YX; Yuan, SF; Zhou, J; Au-Yeung, RKH; Sze, KH; Yang, D; Shuai, HP; Hou, YX; Li, C; Zhao, XY; Poon, VKM; Leung, SP; Yeung, ML; Yan, JH; Lu, GW; Jin, DY; Gao, GF; Chan, JFW; Yuen, KY				Chu, Hin; Chan, Che-Man; Zhang, Xi; Wang, Yixin; Yuan, Shuofeng; Zhou, Jie; Au-Yeung, Rex Kwok-Him; Sze, Kong-Hung; Yang, Dong; Shuai, Huiping; Hou, Yuxin; Li, Cun; Zhao, Xiaoyu; Poon, Vincent Kwok-Man; Leung, Sze Pui; Yeung, Man-Lung; Yan, Jinghua; Lu, Guangwen; Jin, Dong-Yan; Gao, George Fu; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung			Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virology; virus; infectious disease; infection; GRP78; attachment factors; bat CoV-HKU9; coronavirus; GRP78; MERS-CoV; viral infection; coronavirus spike; viral attachment; viral evolution	ENDOPLASMIC-RETICULUM STRESS; INFECTIOUS-BRONCHITIS VIRUS; CROSS-SPECIES TRANSMISSION; SPIKE PROTEIN; SIALIC-ACID; DROMEDARY CAMELS; SARS-LIKE; RECEPTOR DETERMINANT; FUNCTIONAL RECEPTOR; UNFOLDED PROTEIN	Coronavirus tropism is predominantly determined by the interaction between coronavirus spikes and the host receptors. In this regard, coronaviruses have evolved a complicated receptor-recognition system through their spike proteins. Spikes from highly related coronaviruses can recognize distinct receptors, whereas spikes of distant coronaviruses can employ the same cell-surface molecule for entry. Moreover, coronavirus spikes can recognize a broad range of cell-surface molecules in addition to the receptors and thereby can augment coronavirus attachment or entry. The receptor of Middle East respiratory syndrome coronavirus (MERS-CoV) is dipeptidyl peptidase 4 (DPP4). In this study, we identified membrane-associated 78-kDa glucose-regulated protein (GRP78) as an additional binding target of the MERS-CoV spike. Further analyses indicated that GRP78 could not independently render nonpermissive cells susceptible to MERS-CoV infection but could facilitate MERS-CoV entry into permissive cells by augmenting virus attachment. More importantly, by exploring potential interactions between GRP78 and spikes of other coronaviruses, we discovered that the highly conserved human GRP78 could interact with the spike protein of bat coronavirus HKU9 (bCoV-HKU9) and facilitate its attachment to the host cell surface. Taken together, our study has identified GRP78 as a host factor that can interact with the spike proteins of two Betacoronaviruses, the lineage C MERS-CoV and the lineage D bCoV-HKU9. The capacity of GRP78 to facilitate surface attachment of both a human coronavirus and a phylogenetically related bat coronavirus exemplifies the need for continuous surveillance of the evolution of animal coronaviruses to monitor their potential for human adaptations.	[Chu, Hin; Chan, Che-Man; Zhou, Jie; Sze, Kong-Hung; Yeung, Man-Lung; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China; [Chu, Hin; Chan, Che-Man; Zhang, Xi; Wang, Yixin; Yuan, Shuofeng; Zhou, Jie; Sze, Kong-Hung; Yang, Dong; Shuai, Huiping; Hou, Yuxin; Li, Cun; Zhao, Xiaoyu; Poon, Vincent Kwok-Man; Leung, Sze Pui; Yeung, Man-Lung; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Peoples R China; [Au-Yeung, Rex Kwok-Him] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Peoples R China; [Yeung, Man-Lung; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immunol, Hong Kong, Peoples R China; [Yeung, Man-Lung; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Carlo Yu Ctr Infect, Hong Kong, Peoples R China; [Jin, Dong-Yan] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China; [Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Peoples R China; [Yan, Jinghua; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Lu, Guangwen] Sichuan Univ, West China Hosp, West China Hosp Emergency Dept, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Lu, Guangwen] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Gao, George Fu] Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent China CDC, Beijing 1002206, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of Hong Kong; Chinese Academy of Sciences; Institute of Microbiology, CAS; Sichuan University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Carol Yu Ctr Infect, Dept Microbiol,State Key Lab Emerging Infect Dis, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	jfwchan@hku.hk; kyyuen@hku.hk	Shuai, Huiping/AAE-5585-2022; CHU, HIN/ABU-1193-2022; Yeung, Kwok Him Rex Au/A-2476-2019; Lu, Guangwen/HCH-9193-2022; Li, Cun/ABD-9346-2020; Chan, Jasper F. W./D-8007-2013; Gao, George Fu/ABD-5229-2021; Yang, Dong/ABG-1653-2020; Yeung, Man Lung/E-9903-2010	Shuai, Huiping/0000-0001-8078-4113; CHU, HIN/0000-0003-2855-9837; Yeung, Kwok Him Rex Au/0000-0002-3137-0886; Chan, Jasper F. W./0000-0001-6336-6657; zhao, xiaoyu/0000-0002-0347-9104; ZHANG, Xi/0000-0003-1340-7128; ZHOU, Jie/0000-0002-2948-3873; Yeung, Man Lung/0000-0002-6117-7884; Yuan, Shuofeng/0000-0001-7996-1119; Poon, Vincent kwok-man/0000-0002-7737-8912; Yuen, Kwok-yung/0000-0002-2083-1552	Hong Kong Health and Medical Research Fund [14131392, 15140762, 16150572]; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) Joint Research Scheme [N_HKU728/14, 81461168030]; Research Grants Council, Hong Kong Special Administrative Region [T11/707/15]; Ministry of Education of China	Hong Kong Health and Medical Research Fund; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) Joint Research Scheme; Research Grants Council, Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Ministry of Education of China(Ministry of Education, China)	This work was supported in part by the donations of Michael Seak-Kan Tong, Hui Ming, Hui Hoy and Chow Sin Lan Charity Fund Limited, Chan Yin Chuen Memorial Charitable Foundation, and the Providence Foundation Limited in memory of the late Dr. Lui Hac Minh; Hong Kong Health and Medical Research Fund Grants 14131392, 15140762, and 16150572; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) Joint Research Scheme Grants N_HKU728/14 and 81461168030; Theme-Based Research Scheme Grant T11/707/15 of the Research Grants Council, Hong Kong Special Administrative Region, and by funding from the Ministry of Education of China for the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases. The authors declare that they have no conflicts of interest with the contents of this article.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Chan CM, 2009, J VIROL, V83, P1026, DOI 10.1128/JVI.01387-08; Chan CM, 2016, J VIROL, V90, P9114, DOI 10.1128/JVI.01133-16; Chan CM, 2016, VIROLOGY, V494, P78, DOI 10.1016/j.virol.2016.04.008; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Chan JFW, 2015, CURR OPIN VIROL, V10, P63, DOI 10.1016/j.coviro.2015.01.006; Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005; Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123; Chen ZW, 2005, J VIROL, V79, P2678, DOI 10.1128/JVI.79.5.2678-2688.2005; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380; Chu H, 2014, VIROLOGY, V454, P197, DOI 10.1016/j.virol.2014.02.018; Chu H, 2012, CELL HOST MICROBE, V12, P360, DOI 10.1016/j.chom.2012.07.011; Chu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035297; Corman VM, 2016, P NATL ACAD SCI USA, V113, P9864, DOI 10.1073/pnas.1604472113; DeDiego ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002315; Earnest JT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006546; Fung TS, 2014, J VIROL, V88, P12752, DOI 10.1128/JVI.02138-14; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Honda T, 2009, J VIROL, V83, P12622, DOI 10.1128/JVI.01201-09; Huang CP, 2016, BIOCHEMISTRY-US, V55, P5977, DOI 10.1021/acs.biochem.6b00790; Huang XC, 2015, J VIROL, V89, P7202, DOI 10.1128/JVI.00854-15; Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Krempl C, 1995, Adv Exp Med Biol, V380, P371; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2013, J GEN VIROL, V94, P2679, DOI 10.1099/vir.0.055533-0; Lau SKP, 2010, J VIROL, V84, P11385, DOI 10.1128/JVI.01121-10; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liao Y, 2013, J VIROL, V87, P8124, DOI 10.1128/JVI.00626-13; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14; Nain M, 2017, J VIROL, V91, DOI [10.1128/jvi.02274-16, 10.1128/JVI.02274-16]; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Peck KM, 2015, ANNU REV VIROL, V2, P95, DOI 10.1146/annurev-virology-100114-055029; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Schultze B, 1996, J VIROL, V70, P5634, DOI 10.1128/JVI.70.8.5634-5637.1996; SCHULTZE B, 1991, J VIROL, V65, P6232, DOI 10.1128/JVI.65.11.6232-6237.1991; Tang JW, 2017, LANCET INFECT DIS, V17, pE320, DOI 10.1016/S1473-3099(17)30238-4; Tao Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01953-16; Tao Y, 2012, VIRUS RES, V167, P67, DOI 10.1016/j.virusres.2012.04.007; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Tsai YL, 2015, J BIOL CHEM, V290, P8049, DOI 10.1074/jbc.M114.618736; Versteeg GA, 2007, J VIROL, V81, P10981, DOI 10.1128/JVI.01033-07; Watanabe R, 2007, VIROLOGY, V366, P16, DOI 10.1016/j.virol.2007.06.034; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504	65	112	113	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11709	11726		10.1074/jbc.RA118.001897	http://dx.doi.org/10.1074/jbc.RA118.001897			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29887526	hybrid, Green Published			2022-12-28	WOS:000440134500005
J	Itoh, K; Adachi, Y; Yamada, T; Suzuki, TL; Otomo, T; McBride, HM; Yoshimori, T; Iijima, M; Sesaki, H				Itoh, Kie; Adachi, Yoshihiro; Yamada, Tatsuya; Suzuki, Takamichi L.; Otomo, Takanobu; McBride, Heidi M.; Yoshimori, Tamotsu; Iijima, Miho; Sesaki, Hiromi			A brain-enriched Drp1 isoform associates with lysosomes, late endosomes, and the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED PROTEIN-1; MITOCHONDRIAL FISSION FACTOR; PHOSPHATIDIC-ACID; DIVISION; FUSION; FORM; MACHINERY; MAINTAINS; AUTOPHAGY; QUALITY	Dynamin-related protein 1 (Drp1) constricts mitochondria as a mechanochemical GTPase during mitochondrial division. The Drp1 gene contains several alternative exons and produces multiple isoforms through RNA splicing. Here we performed a systematic analysis of Drp1 transcripts in different mouse tissues and identified a previously uncharacterized isoform that is highly enriched in the brain. This Drp1 isoform is termed Drp1(ABCD) because it contains four alterative exons: A, B, C, and D. Remarkably, Drp1(ABCD) is located at lysosomes, late endosomes, and the plasma membrane in addition to mitochondria. Furthermore, Drp1(ABCD) is concentrated at the interorganelle interface between mitochondria and lysosomes/late endosomes. The localizations of Drp1(ABCD) at lysosomes, late endosomes, and the plasma membrane require two exons, A and B, that are present in the GTPase domain. Drp1(ABCD) assembles onto these membranes in a manner that is regulated by its oligomerization and GTP hydrolysis. Experiments using lysosomal inhibitors show that the association of Drp1(ABCD) with lysosomes/late endosomes depends on lysosomal pH but not their protease activities. Thus, Drp1 may connect mitochondria to endosomal-lysosomal pathways in addition to mitochondrial division.	[Itoh, Kie; Adachi, Yoshihiro; Yamada, Tatsuya; Suzuki, Takamichi L.; Iijima, Miho; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Otomo, Takanobu; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; [McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 0G4, Canada	Johns Hopkins University; Osaka University	Sesaki, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	hsesaki@jhmi.edu	Otomo, Takanobu/AAD-3586-2019; McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280; Yamada, Tatsuya/0000-0002-6906-9861	NIGMS, National Institutes of Health [GM084015, GM123266]; Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University-University of Maryland Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123266, R01GM084015] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University-University of Maryland Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants GM084015 (to M. I.) and GM123266 (to H. S.), the Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins University-University of Maryland Diabetes Research Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi Yoshihiro, 2018, Small GTPases, V9, P472, DOI 10.1080/21541248.2017.1321614; Adachi Y, 2016, MOL CELL, V63, P1034, DOI 10.1016/j.molcel.2016.08.013; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Francy CA, 2015, J BIOL CHEM, V290, P11692, DOI 10.1074/jbc.M114.610881; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gajendiran P, 2018, J CELL MOL MED, V22, P2210, DOI 10.1111/jcmm.13501; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009; Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Macdonald PJ, 2016, J BIOL CHEM, V291, P493, DOI 10.1074/jbc.M115.680181; Merrill RA, 2014, INT J BIOCHEM CELL B, V48, P92, DOI 10.1016/j.biocel.2013.12.012; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Roy M, 2015, CURR OPIN CELL BIOL, V33, P111, DOI 10.1016/j.ceb.2015.02.001; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Shields LY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.94; Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Udagawa O, 2014, CURR BIOL, V24, P2451, DOI 10.1016/j.cub.2014.08.060; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wenger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071835; Yamada T, 2016, AM J PATHOL, V186, P2798, DOI 10.1016/j.ajpath.2016.06.025; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	35	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11809	11822		10.1074/jbc.RA117.001253	http://dx.doi.org/10.1074/jbc.RA117.001253			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29853636	Green Published, hybrid			2022-12-28	WOS:000440134500015
J	Miller, PW; Pokutta, S; Mitchell, JM; Chodaparambil, JV; Clarke, DN; Nelson, WJ; Weis, WI; Nichols, SA				Miller, Phillip W.; Pokutta, Sabine; Mitchell, Jennyfer M.; Chodaparambil, Jayanth V.; Clarke, D. Nathaniel; Nelson, W. James; Weis, William I.; Nichols, Scott A.			Analysis of a vinculin homolog in a sponge (phylum Porifera) reveals that vertebrate-like cell adhesions emerged early in animal evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adherens junction; focal adhesion; epithelium; protein evolution; evolution; Oscarella; Porifera; Sponge; Vinculin	ALPHA-E-CATENIN; BETA-CATENIN; ACTIN-BINDING; AGGREGATION FACTOR; CRYSTAL-STRUCTURE; DENSE-BODY; F-ACTIN; IQ-TREE; CADHERIN; COMPLEX	The evolution of cell-adhesion mechanisms in animals facilitated the assembly of organized multicellular tissues. Studies in traditional animal models have revealed two predominant adhesion structures, the adherens junction (AJ) and focal adhesions (FAs), which are involved in the attachment of neighboring cells to each other and to the secreted extracellular matrix (ECM), respectively. The AJ (containing cadherins and catenins) and FAs (comprising integrins, talin, and paxillin) differ in protein composition, but both junctions contain the actin-binding protein vinculin. The near ubiquity of these structures in animals suggests that AJ and FAs evolved early, possibly coincident with multicellularity. However, a challenge to this perspective is that previous studies of spongesa divergent animal lineageindicate that their tissues are organized primarily by an alternative, sponge-specific cell-adhesion mechanism called "aggregation factor." In this study, we examined the structure, biochemical properties, and tissue localization of a vinculin ortholog in the sponge Oscarella pearsei (Op). Our results indicate that Op vinculin localizes to both cell-cell and cell-ECM contacts and has biochemical and structural properties similar to those of vertebrate vinculin. We propose that Op vinculin played a role in cell adhesion and tissue organization in the last common ancestor of sponges and other animals. These findings provide compelling evidence that sponge tissues are indeed organized like epithelia in other animals and support the notion that AJ- and FA-like structures extend to the earliest periods of animal evolution.	[Miller, Phillip W.; Pokutta, Sabine; Chodaparambil, Jayanth V.; Nelson, W. James; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Pokutta, Sabine; Chodaparambil, Jayanth V.; Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Clarke, D. Nathaniel; Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Mitchell, Jennyfer M.; Nichols, Scott A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA	Stanford University; Stanford University; Stanford University; University of Denver	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA.; Nichols, SA (corresponding author), Univ Denver, Dept Biol Sci, Denver, CO 80208 USA.	bill.weis@stanford.edu; scott.nichols@du.edu	Clarke, Donald/A-8212-2019; Clarke, D. Nathaniel/K-7605-2019; Clarke, Nat/L-2946-2019; Weis, William/G-1437-2011	Clarke, Donald/0000-0002-9774-2582; Clarke, Nat/0000-0002-9774-2582; Chodaparambil, Jayanth/0000-0002-4217-8355; Nichols, Scott/0000-0002-4765-754X; Weis, William/0000-0002-5583-6150	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R35GM118064, R01GM114462] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Hadar Feinberg for assistance in the crystallographic analysis of Op vinculin, Betsy Steele for access to the Joseph Long Marine Laboratory (University of California Santa Cruz), and Christopher Lowe for use of confocal microscopy facilities at Hopkins Marine Station (Stanford University). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, and by NIGMS, National Institutes of Health Grant P41GM103393).	Abedin M, 2010, TRENDS CELL BIOL, V20, P734, DOI 10.1016/j.tcb.2010.08.002; Adams EDM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015040; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alatortsev VE, 1997, FEBS LETT, V413, P197, DOI 10.1016/S0014-5793(97)00901-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bays JL, 2017, CELL MOL LIFE SCI, V74, P2999, DOI 10.1007/s00018-017-2511-3; Benham-Pyle BW, 2015, SCIENCE, V348, P1024, DOI 10.1126/science.aaa4559; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Blumbach B, 1998, J CELL SCI, V111, P2635; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Boury-Esnault N, 2003, INVERTEBR BIOL, V122, P187, DOI 10.1111/j.1744-7410.2003.tb00084.x; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; BUCK CA, 1987, J CELL SCI, P231; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; CAULDWELL CB, 1973, BIOCHEMISTRY-US, V12, P3051, DOI 10.1021/bi00740a017; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Clarke DN, 2016, MOL BIOL EVOL, V33, P2016, DOI 10.1093/molbev/msw084; Collins C, 2015, CURR OPIN CELL BIOL, V36, P62, DOI 10.1016/j.ceb.2015.07.004; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dickinson DJ, 2012, BIOESSAYS, V34, P833, DOI 10.1002/bies.201100187; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Elliott GRD, 2007, J EXP BIOL, V210, P3736, DOI 10.1242/jeb.003392; Ereskovsky AV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183002; Ereskovsky AV, 2009, BIOESSAYS, V31, P89, DOI 10.1002/bies.080058; Fahey B, 2010, EVOL DEV, V12, P601, DOI 10.1111/j.1525-142X.2010.00445.x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grice LF, 2017, MOL BIOL EVOL, V34, P1083, DOI 10.1093/molbev/msx058; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Han MKL, 2016, TRENDS CELL BIOL, V26, P612, DOI 10.1016/j.tcb.2016.03.005; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Harwood A, 2004, CURR OPIN CELL BIOL, V16, P470, DOI 10.1016/j.ceb.2004.07.011; Haseley SR, 2001, P NATL ACAD SCI USA, V98, P9419, DOI 10.1073/pnas.151111298; HENKART P, 1973, BIOCHEMISTRY-US, V12, P3045, DOI 10.1021/bi00740a016; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; HUMBERTDAVID N, 1993, EUR J BIOCHEM, V216, P255, DOI 10.1111/j.1432-1033.1993.tb18140.x; HUMPHREYS T, 1963, DEV BIOL, V8, P27, DOI 10.1016/0012-1606(63)90024-1; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kang H, 2017, J BIOL CHEM, V292, P7077, DOI 10.1074/jbc.M116.769778; Keegan RM, 2008, ACTA CRYSTALLOGR D, V64, P119, DOI 10.1107/S0907444907037195; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecroisey C, 2007, J MUSCLE RES CELL M, V28, P79, DOI 10.1007/s10974-007-9104-y; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Leys SP, 2012, ADV MAR BIOL, V62, P1, DOI 10.1016/B978-0-12-394283-8.00001-1; Leys SP, 2009, INTEGR COMP BIOL, V49, P167, DOI 10.1093/icb/icp038; Maartens AP, 2016, J CELL SCI, V129, P4354, DOI 10.1242/jcs.189878; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller PW, 2013, CURR TOP MEMBR, V72, P267, DOI 10.1016/B978-0-12-417027-8.00008-8; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; MOSCONA AA, 1968, DEV BIOL, V18, P250, DOI 10.1016/0012-1606(68)90035-3; Mui KL, 2016, J CELL SCI, V129, P1093, DOI 10.1242/jcs.183699; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nichols SA, 2012, P NATL ACAD SCI USA, V109, P13046, DOI 10.1073/pnas.1120685109; Nickel M, 2011, J EXP BIOL, V214, P1692, DOI 10.1242/jeb.049148; Nielsen C, 2008, EVOL DEV, V10, P241, DOI 10.1111/j.1525-142X.2008.00231.x; Niklas KJ, 2013, EVOL DEV, V15, P41, DOI 10.1111/ede.12013; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Schippers KJ, 2018, MOL BIOL EVOL, V35, P1407, DOI 10.1093/molbev/msy033; Schuster A, 2017, DIVERGENCE TIMES DEM, DOI [10.1101/159806, DOI 10.1101/159806]; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Shao XQ, 2017, J BIOL CHEM, V292, P16477, DOI 10.1074/jbc.M117.795567; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Tyler S, 2003, INTEGR COMP BIOL, V43, P55, DOI 10.1093/icb/43.1.55; Vilanova E, 2016, J BIOL CHEM, V291, P9425, DOI 10.1074/jbc.M115.708958; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	107	12	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11674	11686		10.1074/jbc.RA117.001325	http://dx.doi.org/10.1074/jbc.RA117.001325			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29880641	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000440134500003
J	Shaw, JA; Henard, CA; Liu, L; Dieckman, LM; Vazquez-Torres, A; Bourret, TJ				Shaw, Jeff A.; Henard, Calvin A.; Liu, Lin; Dieckman, Lynne M.; Vazquez-Torres, Andres; Bourret, Travis J.			Salmonella enterica serovar Typhimurium has three transketolase enzymes contributing to the pentose phosphate pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pentose phosphate pathway (PPP); Salmonella enterica; bacterial metabolism; enzyme kinetics; enzyme purification; oxidation-reduction (redox); Transketolase	ESCHERICHIA-COLI-RPOS; SIGMA(S)-DEPENDENT GENES; STATIONARY-PHASE; CROSS-PROTECTION; IDENTIFICATION; EXPRESSION; PURIFICATION; STARVATION; RESISTANCE; PROTEINS	The genus Salmonella is responsible for many illnesses in humans and other vertebrate animals. We report here that Salmonella enterica serovar Typhimurium harbors three transketolases that support the non-oxidative branch of the pentose phosphate pathway. BLAST analysis identified two genes, STM14_2885 and STM14_2886, that together encode a putative transketolase (TktC) with 46-47% similarity to the known TktA and TktB isoforms. Assessing the mRNA and protein expression for each of the three transketolases, we determined that all are expressed in WT cells and regulated to varying extents by the alternative sigma factor RpoS. Enzyme assays with lysates from WT and transketolase-knockout strains established that TktA is responsible for >88% of the transketolase activity in WT cells. We purified recombinant forms of each isoenzyme to assess the kinetics for canonical transketolase reactions. TktA and TktB had comparable values for V-max (539-1362 m NADH consumed/s), K-m (80-739 m), and catalytic efficiency (1.02 x 10(8)-1.06 x 10(9) m(-1)/s) for each substrate tested. The recombinant form of TktC had lower K-m values (23-120 m), whereas the V-max (7.8-16 m NADH consumed/s) and catalytic efficiency (5.58 x 10(6) to 6.07 x 10(8) m(-1)/s) were 10-100-fold lower. Using a murine model of Salmonella infection, we showed that a strain lacking all three transketolases is avirulent in C57BL/6 mice. These data provide evidence that S. Typhimurium possesses three transketolases that contribute to pathogenesis.	[Shaw, Jeff A.; Bourret, Travis J.] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Henard, Calvin A.; Liu, Lin; Vazquez-Torres, Andres] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80011 USA; [Dieckman, Lynne M.] Creighton Univ, Dept Chem, Omaha, NE 68178 USA; [Vazquez-Torres, Andres] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO 80220 USA; [Henard, Calvin A.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA	Creighton University; University of Colorado System; University of Colorado Anschutz Medical Campus; Creighton University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Bourret, TJ (corresponding author), Creighton Univ, Dept Med Microbiol & Immunol, 2500 Calif Plaza, Omaha, NE 68178 USA.	TravisBourret@creighton.edu	Bourret, Travis/J-4673-2019	Shaw, Jeff/0000-0001-6064-6012; Bourret, Travis/0000-0002-4154-929X	Veterans Affairs Merit Grant [BX0002073]; National Institutes of Health (NIH) Project [AI54959]; NIH Institutional Training Grant [AI052066]; NIGMS, NIH [GM103427]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054959, T32AI052066, R01AI136520, R01AI054959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002073] Funding Source: NIH RePORTER	Veterans Affairs Merit Grant(US Department of Veterans Affairs); National Institutes of Health (NIH) Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Grant BX0002073, National Institutes of Health (NIH) Project AI54959, NIH Institutional Training Grant AI052066, and NIGMS, NIH, Grant GM103427. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Cheville AM, 1996, APPL ENVIRON MICROB, V62, P1822, DOI 10.1128/AEM.62.5.1822-1824.1996; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DATTA AG, 1961, J BIOL CHEM, V236, P617; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; EIDELS L, 1971, P NATL ACAD SCI USA, V68, P1673, DOI 10.1073/pnas.68.8.1673; Eisenstark A, 1996, FREE RADICAL BIO MED, V21, P975, DOI 10.1016/S0891-5849(96)00154-2; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Frankel D. G., 1987, ESCHERICHIA COLI SAL; GIVSKOV M, 1994, J BACTERIOL, V176, P7, DOI 10.1128/JB.176.1.7-14.1994; Henard C. A., 2013, REGULATION BACTERIAL, P425; Henard CA, 2010, J BIOL CHEM, V285, P36785, DOI 10.1074/jbc.M110.160960; Holzmeister C, 2011, PROTEOMICS, V11, P1664, DOI 10.1002/pmic.201000652; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; IIDA A, 1993, J BACTERIOL, V175, P5375, DOI 10.1128/JB.175.17.5375-5383.1993; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; JENKINS DE, 1990, J BACTERIOL, V172, P2779, DOI 10.1128/jb.172.5.2779-2781.1990; JOSEPHSON BL, 1969, J BACTERIOL, V100, P1289, DOI 10.1128/JB.100.3.1289-1295.1969; Jung IL, 2005, CURR MICROBIOL, V50, P314, DOI 10.1007/s00284-005-4501-1; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Leekitcharoenphon P, 2016, APPL ENVIRON MICROB, V82, P2516, DOI 10.1128/AEM.03821-15; Lin E. C. C., 1996, ESCHERICHIA COLI SAL, V1, P307; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; Lozano-Juste J, 2011, J EXP BOT, V62, P3501, DOI 10.1093/jxb/err042; Lundberg BE, 1999, INFECT IMMUN, V67, P436, DOI 10.1128/IAI.67.1.436-438.1999; Maeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144697; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markert B, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-7; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Saint-Ruf C, 2004, GENETICS, V168, P541, DOI 10.1534/genetics.104.028704; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Singh V., 2013, J VET SCI ANIM HUSB, V1, P301, DOI [DOI 10.15744/2348-9790.1.301, 10.15744/2348-9790.1.301]; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Sprenger GA, 1995, ARCH MICROBIOL, V164, P324, DOI 10.1007/BF02529978; SPRENGER GA, 1995, EUR J BIOCHEM, V230, P525; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; TAKEUCHI T, 1986, BIOCHIM BIOPHYS ACTA, V872, P24, DOI 10.1016/0167-4838(86)90143-3; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; WOOD T, 1986, CELL BIOCHEM FUNCT, V4, P241, DOI 10.1002/cbf.290040403; ZHAO GS, 1994, J BACTERIOL, V176, P6134, DOI 10.1128/jb.176.19.6134-6138.1994	57	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11271	11282		10.1074/jbc.RA118.003661	http://dx.doi.org/10.1074/jbc.RA118.003661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29848552	hybrid, Green Published			2022-12-28	WOS:000439449700002
J	Xue, X; Ren, JF; Sun, XL; Gui, Y; Feng, Y; Shu, BY; Wei, W; Lu, QM; Liang, Y; He, WC; Yang, JW; Dai, CS				Xue, Xian; Ren, Jiafa; Sun, Xiaoli; Gui, Yuan; Feng, Ye; Shu, Bingyan; Wei, Wei; Lu, Qingmiao; Liang, Yan; He, Weichun; Yang, Junwei; Dai, Chunsun			Protein kinase C drives fibroblast activation and kidney fibrosis by stimulating autophagic flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; fibroblast; signal transduction; cell signaling; fibrosis	MOLECULAR-MECHANISMS; LYSOSOME BIOGENESIS; MTOR; LAMP-2; PHOSPHORYLATION; TARGET; GROWTH; CELLS; AMPK	Kidney fibrosis is a histological hallmark of chronic kidney disease and arises in large part through extracellular matrix deposition by activated fibroblasts. The signaling protein complex mTOR complex 2 (mTORC2) plays a critical role in fibroblast activation and kidney fibrosis. Protein kinase C (PKC) is one of the major sub-pathways of mTORC2, but its role in fibroblast activation and kidney fibrosis remains to be determined. Here, we found that transforming growth factor 1 (TGF1) activates PKC signaling in cultured NRK-49F cells in a time-dependent manner. Blocking PKC signaling with the chemical inhibitor Go6976 or by transfection with PKC siRNA largely reduced expression of the autophagy-associated protein lysosomal-associated membrane protein 2 (LAMP2) and also inhibited autophagosome-lysosome fusion and autophagic flux in the cells. Similarly to chloroquine, Go6976 treatment and PKC siRNA transfection also markedly inhibited TGF1-induced fibroblast activation. In murine fibrotic kidneys with unilateral ureteral obstruction (UUO) nephropathy, PKC signaling is activated in the interstitial myofibroblasts. Go6976 administration largely blocked autophagic flux in fibroblasts in the fibrotic kidneys and attenuated the UUO nephropathy. Together, our findings suggest that blocking PKC activity may retard autophagic flux and thereby prevent fibroblast activation and kidney fibrosis.	[Xue, Xian; Ren, Jiafa; Sun, Xiaoli; Gui, Yuan; Feng, Ye; Shu, Bingyan; Wei, Wei; Lu, Qingmiao; Liang, Yan; He, Weichun; Yang, Junwei; Dai, Chunsun] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China; [Ren, Jiafa] Duke Univ, Div Nephrol, Dept Med, Durham, NC 27705 USA; [Ren, Jiafa] Durham Vet Affairs Med Ctr, Durham, NC 27705 USA	Nanjing Medical University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Dai, CS (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	daichunsun@njmu.edu.cn			National Science Foundation of China [81570611/H0503, 81770675/H0503]; Science Foundation of Jiangsu Province [BK20140048]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province	This work was supported by National Science Foundation of China Grants 81570611/H0503 and 81770675/H0503 and Science Foundation of Jiangsu Province Grant BK20140048 (to C.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baisantry A, 2016, J AM SOC NEPHROL, V27, P1609, DOI 10.1681/ASN.2014111059; Bernard M, 2014, AUTOPHAGY, V10, P2193, DOI 10.4161/15548627.2014.981786; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Das G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008813; De Rechter S, 2016, PEDIATR NEPHROL, V31, P737, DOI 10.1007/s00467-015-3134-2; Del Principe D, 2013, J PATHOL, V229, P208, DOI 10.1002/path.4115; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Gonnella R, 2015, BBA-MOL CELL RES, V1853, P1586, DOI 10.1016/j.bbamcr.2015.03.011; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Jiang L, 2013, J AM SOC NEPHROL, V24, P1114, DOI 10.1681/ASN.2012050476; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Kim WY, 2012, NEPHROLOGY, V17, P148, DOI 10.1111/j.1440-1797.2011.01541.x; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Li JZ, 2014, KIDNEY INT, V86, P86, DOI 10.1038/ki.2013.559; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Livingston MJ, 2016, AUTOPHAGY, V12, P976, DOI 10.1080/15548627.2016.1166317; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizunoe Y, 2017, AUTOPHAGY, V13, P642, DOI 10.1080/15548627.2016.1274850; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Pereira EM, 2014, GENE, V536, P118, DOI 10.1016/j.gene.2013.11.063; Saftig P, 2008, AUTOPHAGY, V4, P510, DOI 10.4161/auto.5724; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Wang F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15182	42	21	23	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11119	11130		10.1074/jbc.RA118.002191	http://dx.doi.org/10.1074/jbc.RA118.002191			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794026	hybrid, Green Published			2022-12-28	WOS:000438882800024
J	Taylor, IR; Ahmad, A; Wu, T; Nordhues, BA; Bhullar, A; Gestwicki, JE; Zuiderweg, ERP				Taylor, Isabelle R.; Ahmad, Atta; Wu, Taia; Nordhues, Bryce A.; Bhullar, Anup; Gestwicki, Jason E.; Zuiderweg, Erik R. P.			The disorderly conduct of Hsc70 and its interaction with the Alzheimer's-related Tau protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; microtubule-associated protein (MAP); protein conformation; protein complex; nuclear magnetic resonance (NMR)	MOLECULAR CHAPERONE DNAK; SUBSTRATE-BINDING DOMAIN; HEAT-SHOCK PROTEINS; E3 UBIQUITIN LIGASE; HSP70 CHAPERONES; HEAT-SHOCK-PROTEIN-70 HSP70; MEDIATED AUTOPHAGY; SELECTIVE UPTAKE; IN-VITRO; PEPTIDE	Hsp70 chaperones bind to various protein substrates for folding, trafficking, and degradation. Considerable structural information is available about how prokaryotic Hsp70 (DnaK) binds substrates, but less is known about mammalian Hsp70s, of which there are 13 isoforms encoded in the human genome. Here, we report the interaction between the human Hsp70 isoform heat shock cognate 71-kDa protein (Hsc70 or HSPA8) and peptides derived from the microtubule-associated protein Tau, which is linked to Alzheimer's disease. For structural studies, we used an Hsc70 construct (called BETA) comprising the substrate-binding domain but lacking the lid. Importantly, we found that truncating the lid does not significantly impair Hsc70's chaperone activity or allostery in vitro. Using NMR, we show that BETA is partially dynamically disordered in the absence of substrate and that binding of the Tau sequence GKVQIINKKG (with a K-D = 500 nm) causes dramatic rigidification of BETA. NOE distance measurements revealed that Tau binds to the canonical substrate-binding cleft, similar to the binding observed with DnaK. To further develop BETA as a tool for studying Hsc70 interactions, we also measured BETA binding in NMR and fluorescent competition assays to peptides derived from huntingtin, insulin, a second Tau-recognition sequence, and a KFERQ-like sequence linked to chaperone-mediated autophagy. We found that the insulin C-peptide binds BETA with high affinity (K-D < 100 nm), whereas the others do not (K-D > 100 m). Together, our findings reveal several similarities and differences in how prokaryotic and mammalian Hsp70 isoforms interact with different substrate peptides.	[Ahmad, Atta; Bhullar, Anup; Zuiderweg, Erik R. P.] Univ Michigan, Med Sch, Dept Biol Chem, 1500 Med Ctr Dr, Ann Arbor, MI 48109 USA; [Taylor, Isabelle R.; Wu, Taia; Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, 675 Nelson Rising Ln, San Francisco, CA 94158 USA; [Nordhues, Bryce A.] Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA; [Nordhues, Bryce A.] Univ S Florida, Byrd Alzheimers Inst, Tampa, FL 33613 USA	University of Michigan System; University of Michigan; University of California System; University of California San Francisco; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Zuiderweg, ERP (corresponding author), Univ Michigan, Med Sch, Dept Biol Chem, 1500 Med Ctr Dr, Ann Arbor, MI 48109 USA.; Gestwicki, JE (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, 675 Nelson Rising Ln, San Francisco, CA 94158 USA.	Jason.Gestwicki@ucsf.edu; zuiderwe@umich.edu		Taylor, Isabelle/0000-0003-1053-5677	National Institutes of Health [R01NS059690]; Protein Folding and Disease Program of the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Folding and Disease Program of the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS059690 (to J. E. G. and E. R. P. Z.) and the Protein Folding and Disease Program of the University of Michigan (to E. R. P. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Caballero B, 2018, AGING CELL, V17, DOI 10.1111/acel.12692; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiappori F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23474; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Goddard TD., 2000, SPARKY 3; Hyberts SG, 2014, J MAGN RESON, V241, P60, DOI 10.1016/j.jmr.2013.11.014; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; KO ASC, 1971, EUR J BIOCHEM, V20, P190, DOI 10.1111/j.1432-1033.1971.tb01378.x; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Monsellier E, 2015, J BIOL CHEM, V290, P2560, DOI 10.1074/jbc.M114.603332; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Morozova K, 2016, J BIOL CHEM, V291, P18096, DOI 10.1074/jbc.M116.736744; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Morshauser RC, 1999, J MAGN RESON, V139, P232, DOI 10.1006/jmre.1999.1802; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Young ZT, 2016, CELL CHEM BIOL, V23, P992, DOI 10.1016/j.chembiol.2016.04.014; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2015, P NATL ACAD SCI USA, V112, pE2865, DOI 10.1073/pnas.1506692112; Zuiderweg E. R., 2016, J BIOMOL NMR ASSIGNM; Zuiderweg ERP, 2013, J BIOMOL NMR, V57, P179, DOI 10.1007/s10858-013-9778-y	54	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10796	10809		10.1074/jbc.RA118.002234	http://dx.doi.org/10.1074/jbc.RA118.002234			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29764935	Green Published, hybrid			2022-12-28	WOS:000437828400033
J	Freedman, H; Winter, P; Tuszynski, J; Tyrrell, DL; Houghton, M				Freedman, Holly; Winter, Philip; Tuszynski, Jack; Tyrrell, D. Lorne; Houghton, Michael			A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computer modeling; computation; mitochondria; RNA polymerase; molecular dynamics; nucleoside; nucleotide analogue; nucleotide; molecular modeling; antiviral agent; mitochondrial RNA polymerase	EMPIRICAL FORCE-FIELD; MOLECULAR-DYNAMICS; FREE-ENERGY; NUCLEIC-ACIDS; DNA; TRANSCRIPTION; SIMULATIONS; INHIBITORS; INITIATION; FIDELITY	In the development of antiviral drugs that target viral RNA-dependent RNA polymerases, off-target toxicity caused by the inhibition of the human mitochondrial RNA polymerase (POLRMT) is a major liability. Therefore, it is essential that all new ribonucleoside analogue drugs be accurately screened for POLRMT inhibition. A computational tool that can accurately predict NTP binding to POLRMT could assist in evaluating any potential toxicity and in designing possible salvaging strategies. Using the available crystal structure of POLRMT bound to an RNA transcript, here we created a model of POLRMT with an NTP molecule bound in the active site. Furthermore, we implemented a computational screening procedure that determines the relative binding free energy of an NTP analogue to POLRMT by free energy perturbation (FEP), i.e. a simulation in which the natural NTP molecule is slowly transformed into the analogue and back. In each direction, the transformation was performed over 40 ns of simulation on our IBM Blue Gene Q supercomputer. This procedure was validated across a panel of drugs for which experimental dissociation constants were available, showing that NTP relative binding free energies could be predicted to within 0.97 kcal/mol of the experimental values on average. These results demonstrate for the first time that free-energy simulation can be a useful tool for predicting binding affinities of NTP analogues to a polymerase. We expect that our model, together with similar models of viral polymerases, will be very useful in the screening and future design of NTP inhibitors of viral polymerases that have no mitochondrial toxicity.	[Freedman, Holly; Tyrrell, D. Lorne; Houghton, Michael] Univ Alberta, Li Ka Shing Appl Virol Inst, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada; [Tuszynski, Jack] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Winter, Philip; Tuszynski, Jack] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2R7, Canada	University of Alberta; University of Alberta; University of Alberta	Freedman, H; Houghton, M (corresponding author), Univ Alberta, Li Ka Shing Appl Virol Inst, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada.	hfreedma@ualberta.ca; mhoughto@ualberta.ca	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429; Houghton, Michael/0000-0003-3762-6771	Alberta Innovates; Canadian Excellence Research Chair grant	Alberta Innovates; Canadian Excellence Research Chair grant	This work was supported by computing resources provided by the Southern Ontario Smart Computing Innovation Platform, Scinet, Compute Canada, and WestGrid. This work was also supported by funds from Alberta Innovates to the Li Ka Shing Applied Virology Institute and by a Canadian Excellence Research Chair grant (to M.H.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2008, AMBER 10; [Anonymous], 2013, MOL OP ENV MOE; Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030; Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Bren U, 2006, J PHYS CHEM B, V110, P10557, DOI 10.1021/jp060292b; Brown SP, 2009, DRUG DISCOV TODAY, V14, P420, DOI 10.1016/j.drudis.2009.01.012; Cameron CE, 2009, CURR OPIN STRUC BIOL, V19, P768, DOI 10.1016/j.sbi.2009.10.012; Case DA, 2012, AMBER 12; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Choi KH, 2012, ADV EXP MED BIOL, V726, P267, DOI 10.1007/978-1-4614-0980-9_12; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Feng JY, 2017, TOXICOL SCI, V155, P2, DOI 10.1093/toxsci/kfw224; Feng JY, 2016, ANTIMICROB AGENTS CH, V60, P806, DOI 10.1128/AAC.01922-15; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jin ZN, 2017, ANTIVIR RES, V143, P151, DOI 10.1016/j.antiviral.2017.04.005; KARPLUS M, 1980, BIOPHYS J, V32, P603, DOI 10.1016/S0006-3495(80)84993-9; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Nelms MD, 2015, CHEM RES TOXICOL, V28, P1891, DOI 10.1021/acs.chemrestox.5b00275; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saenger W., 1984, PRINCIPLES NUCL ACID, P19; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Smidansky ED, 2011, BIOCHEMISTRY-US, V50, P5016, DOI 10.1021/bi200350d; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Swails JM, 2014, J CHEM THEORY COMPUT, V10, P1341, DOI 10.1021/ct401042b; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Velazquez G, 2015, RNA BIOL, V12, P514, DOI 10.1080/15476286.2015.1014283; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang L, 2015, J AM CHEM SOC, V137, P2695, DOI 10.1021/ja512751q; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	55	7	7	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9696	9705		10.1074/jbc.RA118.002588	http://dx.doi.org/10.1074/jbc.RA118.002588			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29739852	Green Published, hybrid			2022-12-28	WOS:000436102300014
J	Wang, L; Fang, B; Fujiwara, T; Krager, K; Gorantla, A; Li, CY; Feng, JQ; Jennings, ML; Zhou, J; Aykin-Burns, N; Zhao, HB				Wang, Lei; Fang, Bin; Fujiwara, Toshifumi; Krager, Kimberly; Gorantla, Akshita; Li, Chaoyuan; Feng, Jian Q.; Jennings, Michael L.; Zhou, Jian; Aykin-Burns, Nukhet; Zhao, Haibo			Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoclast; iron metabolism; bone; mitochondrial metabolism; mitochondria; osteoporosis; bone remodeling; ferroportin; iron metabolism; iron overload; osteoclast; hemochromatosis; thalassemia; Slc40a1	AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; ESTROGEN RESPONSE ELEMENT; BONE-MINERAL DENSITY; REGULATES OSTEOCLASTOGENESIS; HEREDITARY HEMOCHROMATOSIS; GENETIC HEMOCHROMATOSIS; OXIDATIVE STRESS; SERUM FERRITIN; CRUCIAL ROLE; DIFFERENTIATION	Osteoporosis, osteopenia, and pathological bone fractures are frequent complications of iron-overload conditions such as hereditary hemochromatosis, thalassemia, and sickle cell disease. Moreover, animal models of iron overload have revealed increased bone resorption and decreased bone formation. Although systemic iron overload affects multiple organs and tissues, leading to significant changes on bone modeling and remodeling, the cell autonomous effects of excessive iron on bone cells remain unknown. Here, to elucidate the role of cellular iron homeostasis in osteoclasts, we generated two mouse strains in which solute carrier family 40 member 1 (Slc40a1), a gene encoding ferroportin (FPN), the sole iron exporter in mammalian cells, was specifically deleted in myeloid osteoclast precursors or mature cells. The FPN deletion mildly increased iron levels in both precursor and mature osteoclasts, and its loss in precursors, but not in mature cells, increased osteoclastogenesis and decreased bone mass in vivo. Of note, these phenotypes were more pronounced in female than in male mice. In vitro studies revealed that the elevated intracellular iron promoted macrophage proliferation and amplified expression of nuclear factor of activated T cells 1 (Nfatc1) and PPARG coactivator 1 (Pgc-1), two transcription factors critical for osteoclast differentiation. However, the iron excess did not affect osteoclast survival. While increased iron stimulated global mitochondrial metabolism in osteoclast precursors, it had little influence on mitochondrial mass and reactive oxygen species production. These results indicate that FPN-regulated intracellular iron levels are critical for mitochondrial metabolism, osteoclastogenesis, and skeletal homeostasis in mice.	[Wang, Lei; Zhou, Jian] Anhui Med Univ, Affiliated Hosp 1, Dept Orthoped, Hefei 230022, Anhui, Peoples R China; [Wang, Lei; Fang, Bin; Fujiwara, Toshifumi; Zhao, Haibo] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Dept Internal Med, Little Rock, AR 72205 USA; [Krager, Kimberly; Gorantla, Akshita; Aykin-Burns, Nukhet] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Jennings, Michael L.; Zhao, Haibo] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Fang, Bin] Huazhong Univ Sci & Technol, Union Hosp, Dept Hematol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Li, Chaoyuan; Feng, Jian Q.] Texas A&M Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Zhao, Haibo] Vet Affairs Long Beach Healthcare Syst, Res Dept, Tibor Rubin Vet Affairs Med Ctr, Long Beach, CA 90822 USA; [Zhao, Haibo] Univ Calif Irvine, Div Endocrinol, Dept Med, Irvine, CA 92697 USA	Anhui Medical University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Huazhong University of Science & Technology; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine	Zhou, J (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Orthoped, Hefei 230022, Anhui, Peoples R China.; Zhao, HB (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Dept Internal Med, Little Rock, AR 72205 USA.; Aykin-Burns, N (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.; Zhao, HB (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.; Zhao, HB (corresponding author), Vet Affairs Long Beach Healthcare Syst, Res Dept, Tibor Rubin Vet Affairs Med Ctr, Long Beach, CA 90822 USA.; Zhao, HB (corresponding author), Univ Calif Irvine, Div Endocrinol, Dept Med, Irvine, CA 92697 USA.	zhoujian831207@163.com; NAykinburns@uams.edu; hzhao@uams.edu		Aykin-Burns, Nukhet/0000-0001-8574-4102; ZHAO, HAIBO/0000-0003-0836-7555; Li, Chaoyuan/0000-0002-2826-8725	Chinese Natural Science Fund [81501843]; National Institutes of Health from NIAMS [AR062012, AR068509]; University of Arkansas for Medical Sciences (UAMS) Bridge Fund; UAMS Medical Research Endowment Award; National Institutes of Health [R01 DE025659]; National Institutes of Health from NIGMS [GM109005]; NIEHS [ES022781]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062012, R21AR068509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES022781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109005] Funding Source: NIH RePORTER	Chinese Natural Science Fund(National Natural Science Foundation of China (NSFC)); National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Arkansas for Medical Sciences (UAMS) Bridge Fund; UAMS Medical Research Endowment Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Chinese Natural Science Fund Grant 81501843 (to J. Z.), National Institutes of Health Grants AR062012 and AR068509 from NIAMS (to H. Z.), University of Arkansas for Medical Sciences (UAMS) Bridge Fund, UAMS Medical Research Endowment Award (to H. Z.), and by National Institutes of Health Grant R01 DE025659 (to J. Q. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant GM109005 from NIGMS and Grant ES022781 from NIEHS.	Almeida A, 2005, BRIT J HAEMATOL, V129, P482, DOI 10.1111/j.1365-2141.2005.05476.x; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Beaumont C, 2009, SEMIN HEMATOL, V46, P328, DOI 10.1053/j.seminhematol.2009.06.004; Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chang H., 1931, ANAT REC, V49, P30; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Crownover BK, 2013, AM FAM PHYSICIAN, V87, P183; Dede AD, 2016, OSTEOPOROSIS INT, V27, P3409, DOI 10.1007/s00198-016-3719-z; Dhindsa S, 2016, CLIN ENDOCRINOL, V85, P772, DOI 10.1111/cen.13130; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Ellen BF, 2008, BONE, V43, P162, DOI 10.1016/j.bone.2008.03.003; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fujiwara T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.213; Fujiwara T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86330; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; GARRICK LM, 1991, J CELL PHYSIOL, V146, P460, DOI 10.1002/jcp.1041460317; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; Gu ZM, 2015, CANCER RES, V75, P2211, DOI 10.1158/0008-5472.CAN-14-3804; Guggenbuhl P, 2005, OSTEOPOROSIS INT, V16, P1809, DOI 10.1007/s00198-005-1934-0; Guggenbuhl P, 2011, OSTEOPOROSIS INT, V22, P2313, DOI 10.1007/s00198-010-1456-2; Guggenbuhl P, 2011, BEST PRACT RES CL RH, V25, P649, DOI 10.1016/j.berh.2011.10.014; Guo JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139395; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HOLTROP ME, 1977, CLIN ORTHOP RELAT R, P177; Hou YL, 2012, GENE, V511, P398, DOI 10.1016/j.gene.2012.09.060; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Jeney V, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00077; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Kang IS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38014; Kanzaki H, 2013, J BIOL CHEM, V288, P23009, DOI 10.1074/jbc.M113.478545; Kim BJ, 2013, OSTEOPOROSIS INT, V24, P2627, DOI 10.1007/s00198-013-2363-0; Kim BJ, 2012, J BONE MINER RES, V27, P2279, DOI 10.1002/jbmr.1692; Kim H, 2017, J BONE MINER RES, V32, P397, DOI 10.1002/jbmr.2974; Kim H, 2013, CELL METAB, V17, P249, DOI 10.1016/j.cmet.2013.01.002; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Lawen A, 2013, ANTIOXID REDOX SIGN, V18, P2473, DOI 10.1089/ars.2011.4271; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee JM, 2012, J IMMUNOL, V189, P5284, DOI 10.4049/jimmunol.1003738; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Mahachoklertwattana P, 2003, J CLIN ENDOCR METAB, V88, P3966, DOI 10.1210/jc.2002-021548; MILMAN N, 1992, ANN HEMATOL, V65, P96, DOI 10.1007/BF01698138; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Qian Y, 2015, CELL SIGNAL, V27, P934, DOI 10.1016/j.cellsig.2015.01.017; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; SCOTT BL, 1956, ANAT REC, V126, P465, DOI 10.1002/ar.1091260405; Srinivasan S, 2010, ANN NY ACAD SCI, V1192, P245, DOI 10.1111/j.1749-6632.2009.05377.x; Sun L, 2014, GENE, V543, P161, DOI 10.1016/j.gene.2014.02.023; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Thongchote K, 2015, AM J PHYSIOL-ENDOC M, V309, pE936, DOI 10.1152/ajpendo.00329.2015; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Vogiatzi MG, 2009, J BONE MINER RES, V24, P543, DOI [10.1359/jbmr.080505, 10.1359/JBMR.080505]; Vogiatzi MG, 2006, BONE, V38, P571, DOI 10.1016/j.bone.2005.10.001; Voskaridou E, 2001, BRIT J HAEMATOL, V112, P36, DOI 10.1046/j.1365-2141.2001.02549.x; Wang X, 2015, J ENDOCRINOL, V226, P121, DOI 10.1530/JOE-14-0657; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Xie WJ, 2016, CALCIFIED TISSUE INT, V98, P275, DOI 10.1007/s00223-015-0087-1; Xu WJ, 2013, CELL METAB, V17, P319, DOI 10.1016/j.cmet.2013.02.004; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045; Ye SQ, 2016, INT J BIOL SCI, V12, P1488, DOI 10.7150/ijbs.15583; Ye SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027285; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang Lin-Lin, 2013, Zhonghua Wai Ke Za Zhi, V51, P518; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324; Zhao GY, 2015, INFLAMMATION, V38, P718, DOI 10.1007/s10753-014-9982-2; Zhao HB, 2006, J BONE MINER RES, V21, P456, DOI 10.1359/JBMR.051204; Zhou J, 2013, J BIOL CHEM, V288, P30064, DOI 10.1074/jbc.M113.478750; Zhou P, 2006, J IMMUNOL, V177, P8777, DOI 10.4049/jimmunol.177.12.8777; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	90	25	29	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9248	9264		10.1074/jbc.RA117.000834	http://dx.doi.org/10.1074/jbc.RA117.000834			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29724825	hybrid, Green Published			2022-12-28	WOS:000435441400012
J	Hu, Y; Fang, KH; Shen, LP; Cao, SY; Yuan, F; Su, YW; Xu, M; Pan, YF; Chen, YY; Liu, Y				Hu, Yao; Fang, Kai-Heng; Shen, Lu-Ping; Cao, Shi-Ying; Yuan, Fang; Su, Yuwen; Xu, Min; Pan, Yufeng; Chen, Yaoyu; Liu, Yan			The telomerase inhibitor AZT enhances differentiation and prevents overgrowth of human pluripotent stem cell-derived neural progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; cell therapy; induced pluripotent stem cell (iPS cell) (iPSC); telomerase; transplantation	GAMMA-SECRETASE INHIBITORS; NEURONS IN-VITRO; ALZHEIMERS-DISEASE; INTERNEURONS; DEFICITS; SPECIFICATION; TISSUE; MICE	Human pluripotent stem cell (hPSC)-based cell-replacement therapy has emerged as a promising approach for addressing numerous neurological diseases. However, hPSC transplantation has the potential to cause human cell overgrowth and cancer, which represents a major obstacle to implementing hPSC-based therapies. Inhibition of the overgrowth of transplanted cells could help reduce the risk for hPSC transplantation-induced tumorigenesis. In this study, we report that the telomerase inhibitor azidothymidine (3-azido-3-deoxythymidine; AZT) enhances the differentiation of cortical neurons and significantly suppresses the proliferation of hPSC-derived cortical progenitors. Using human embryonic stem cells and induced pluripotent stem cells in culture, we found that AZT effectively reduces the number of dividing progenitors without inducing cell death. Furthermore, AZT promoted differentiation of cortical progenitors and maturation of cortical neurons. Of note, AZT-pretreated, hPSC-derived neural progenitors exhibited decreased proliferation and increased differentiation into cortical neurons when transplanted into the mouse brain. In summary, our findings indicate that AZT prevents the overgrowth of hPSC-derived neural precursors and enhances the differentiation of cortical neurons in both cell cultures and hPSC-transplanted mouse brain. We propose that our work could inform clinical applications of hPSC-based cell therapy.	[Hu, Yao; Liu, Yan] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China; [Hu, Yao; Fang, Kai-Heng; Shen, Lu-Ping; Cao, Shi-Ying; Yuan, Fang; Su, Yuwen; Xu, Min; Liu, Yan] Nanjing Med Univ, Sch Pharm, Inst Stem Cell & Neural Regenerat, Nanjing 211166, Jiangsu, Peoples R China; [Hu, Yao; Liu, Yan] Nanjing Med Univ, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing 211166, Jiangsu, Peoples R China; [Pan, Yufeng] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Chen, Yaoyu] Jiangsu Prov Tradit Chinese Med Hosp, Div Hematol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Southeast University - China	Liu, Y (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.; Liu, Y (corresponding author), Nanjing Med Univ, Sch Pharm, Inst Stem Cell & Neural Regenerat, Nanjing 211166, Jiangsu, Peoples R China.; Liu, Y (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing 211166, Jiangsu, Peoples R China.; Chen, YY (corresponding author), Jiangsu Prov Tradit Chinese Med Hosp, Div Hematol, Nanjing 210029, Jiangsu, Peoples R China.	yaoyu.chen@njmu.edu.cn; yanliu@njmu.edu.cn			National Natural Science Foundation of China [81471301, 81301162, 81570141, 81522001]; National Key Research and Development Program of China [2016YFC1306703]; Jiangsu Outstanding Young Investigator Program [BK20160044]; Jiangsu Province Natural Science Foundation [BK20130891]; Jiangsu Province's Innovation program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Jiangsu Outstanding Young Investigator Program; Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Innovation program	This work was supported by National Natural Science Foundation of China Grants 81471301, 81301162, 81570141, and 81522001; National Key Research and Development Program of China Grant 2016YFC1306703; Jiangsu Outstanding Young Investigator Program Grant BK20160044; Jiangsu Province Natural Science Foundation Grant BK20130891; and the Jiangsu Province's Innovation program. The authors declare that they have no conflicts of interest with the contents of this article.	Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Babizhayev MA, 2015, J BIOMED MATER RES A, V103, P3993, DOI 10.1002/jbm.a.35515; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Cunningham M, 2014, CELL STEM CELL, V15, P559, DOI 10.1016/j.stem.2014.10.006; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Fao P, 2012, CLIN INFECT DIS, V55, P449, DOI 10.1093/cid/cis461; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lambert JS, 2003, SEX TRANSM INFECT, V79, P448, DOI 10.1136/sti.79.6.448; Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Ogura A, 2013, STEM CELLS DEV, V22, P374, DOI 10.1089/scd.2012.0198; Okubo T, 2016, STEM CELL REP, V7, P649, DOI 10.1016/j.stemcr.2016.08.015; Olsauskas-Kuprys R, 2013, ONCOTARGETS THER, V6, P943, DOI 10.2147/OTT.S33766; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Yuan F, 2015, SCI REP-UK, V5, DOI 10.1038/srep18550; Zhou QG, 2007, J NEUROCHEM, V103, P1843, DOI 10.1111/j.1471-4159.2007.04914.x; Zhou QG, 2011, J NEUROSCI, V31, P12258, DOI 10.1523/JNEUROSCI.0805-11.2011	29	2	2	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8722	8733		10.1074/jbc.M117.809889	http://dx.doi.org/10.1074/jbc.M117.809889			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29628445	hybrid, Green Published			2022-12-28	WOS:000434941900001
J	Wu, J; Wang, PC; Li, L; You, CJ; Wang, YS				Wu, Jun; Wang, Pengcheng; Li, Lin; You, Changjun; Wang, Yinsheng			Cytotoxic and mutagenic properties of minor-groove O-2-alkylthymidine lesions in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; DNA damage; DNA polymerase; mutagenesis; mutagenesis mechanism; alkylating agent; DNA alkylation; O2-alkylthymidine; translesion synthesis; translesion synthesis polymerase; DNA adduct; polymerase	PYRIDYLOXOBUTYL DNA-ADDUCTS; TRANSLESION SYNTHESIS; IN-VITRO; REPLICATIVE BYPASS; MASS-SPECTROMETRY; REPAIR PATHWAYS; TRANSCRIPTION; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; ALKYLTRANSFERASE; O2-ETHYLTHYMINE	Endogenous metabolism, environmental exposure, and cancer chemotherapy can lead to alkylation of DNA. It has been well documented that, among the different DNA alkylation products, minor-groove O-2-alkylthymidine (O-2-alkyldT) lesions are inefficiently repaired. In the present study, we examined how seven O-2-alkyldT lesions, with the alkyl group being a Me, Et, nPr, iPr, nBu, iBu, or sBu, are recognized by the DNA replication machinery in human cells. We found that the replication bypass efficiencies of these lesions decrease with increasing length of the alkyl chain, and that these lesions induce substantial frequencies of TA and TG mutations. Replication experiments using isogenic cells deficient in specific translesion synthesis (TLS) DNA polymerases revealed that the absence of polymerase or polymerase , but not polymerase or polymerase , significantly decreased both the bypass efficiencies and the mutation frequencies for those O-2-alkyldT lesions carrying a straight-chain alkyl group. Moreover, the mutagenic properties of the O-2-alkyldT lesions were influenced by the length and topology of the alkyl chain and by TLS polymerases. Together, our results provide important new knowledge about the cytotoxic and mutagenic properties of O-2-alkyldT lesions, and illustrate the roles of TLS polymerases in replicative bypass of these lesions in human cells.	[Wu, Jun; Li, Lin; You, Changjun; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Wang, Pengcheng; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.; Wang, YS (corresponding author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022	You, Changjun/0000-0003-4301-2098; Wang, Pengcheng/0000-0003-4581-983X	National Institutes of Health [R01 ES025121]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health Grant R01 ES025121 (to Y. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BRENT TP, 1988, P NATL ACAD SCI USA, V85, P1759, DOI 10.1073/pnas.85.6.1759; BRONSTEIN SM, 1992, CANCER RES, V52, P2008; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Chen HJC, 2012, ANAL CHEM, V84, P2521, DOI 10.1021/ac203405y; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; DENENGELSE L, 1987, CARCINOGENESIS, V8, P751; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Lao YB, 2007, CHEM RES TOXICOL, V20, P246, DOI 10.1021/tx060208j; Lao YB, 2007, CHEM RES TOXICOL, V20, P235, DOI 10.1021/tx060207r; Li L, 2009, CHEM RES TOXICOL, V22, P1464, DOI 10.1021/tx9001572; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu S, 2015, CHEM SOC REV, V44, P7829, DOI 10.1039/c5cs00316d; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; SANCHEZ JA, 1992, J CELL SCI, V103, P907; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Singer B., 1983, MOL BIOL MUTAGENS CA; Taylor ER, 2003, VIROLOGY, V315, P103, DOI 10.1016/S0042-6822(03)00588-9; Upadhyaya P, 2003, CHEM RES TOXICOL, V16, P180, DOI 10.1021/tx0256376; Upadhyaya P, 2008, CHEM RES TOXICOL, V21, P1468, DOI 10.1021/tx8001109; Wang LJ, 1997, CHEM RES TOXICOL, V10, P562, DOI 10.1021/tx9602067; Wang MY, 2003, CHEM RES TOXICOL, V16, P616, DOI 10.1021/tx034003b; Weerasooriya S, 2015, DNA REPAIR, V35, P63, DOI 10.1016/j.dnarep.2015.09.023; Williams NL, 2016, CHEM RES TOXICOL, V29, P1755, DOI 10.1021/acs.chemrestox.6b00252; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; You CJ, 2012, J BIOL CHEM, V287, P40915, DOI 10.1074/jbc.M112.418681; You CJ, 2012, NAT CHEM BIOL, V8, P817, DOI 10.1038/NCHEMBIO.1046; Zhai QQ, 2014, NUCLEIC ACIDS RES, V42, P10529, DOI 10.1093/nar/gku748; Zhai QQ, 2014, CARCINOGENESIS, V35, P2002, DOI 10.1093/carcin/bgu085; Ziegler K, 2004, J VIROL METHODS, V122, P123, DOI 10.1016/j.jviromet.2004.08.012	34	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8638	8644		10.1074/jbc.RA118.003133	http://dx.doi.org/10.1074/jbc.RA118.003133			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29685891	Green Published, hybrid			2022-12-28	WOS:000434205700026
J	Levy, Y; Ronen, D; Bershadsky, AD; Zick, Y				Levy, Yifat; Ronen, Denise; Bershadsky, Alexander D.; Zick, Yehiel			RETRACTION: Sustained induction of ERK, protein kinase B, and p70 S6 kinase regulates cell spreading and formation of F-actin microspikes upon ligation of integrins by galectin-8, a mammalian lectin. (Retraction of Vol 278, Pg 14533, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Zick, Yehiel/K-1479-2012					Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200	1	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7265	7265		10.1074/jbc.W118.003467	http://dx.doi.org/10.1074/jbc.W118.003467			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29752418	Green Published, hybrid			2022-12-28	WOS:000432174500019
J	Colineau, L; Lambertz, U; Fornes, O; Wasserman, WW; Reiner, NE				Colineau, Lucie; Lambertz, Ulrike; Fornes, Oriol; Wasserman, Wyeth W.; Reiner, Neil E.			c-Myc is a novel Leishmania virulence factor by proxy that targets the host miRNA system and is essential for survival in human macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); microRNA biogenesis; Leishmania; protozoan; infection; macrophage; Myc (c-Myc); transcription regulation; virulence factor	VIRUS-INFECTION; EXPRESSION; CANCER; GENE; TRANSCRIPTION; REPRESSION; BIOGENESIS; METABOLISM; ACTIVATION; INHIBITOR	Leishmania species are intracellular protozoan pathogens that have evolved to successfully infect and deactivate host macrophages. How this deactivation is brought about is not completely understood. Recently, microRNAs (miRNAs) have emerged as ubiquitous regulators of macrophage gene expression that contribute to shaping the immune responses to intracellular pathogens. Conversely, several pathogens have evolved the ability to exploit host miRNA expression to manipulate host-cell phenotype. However, very little is known about the mechanisms used by intracellular pathogens to drive changes in host-cell miRNA abundance. Using miRNA expression profiling of Leishmania donovani-infected human macrophages, we show here that Leishmania infection induced a genome-wide down-regulation of host miRNAs. This repression occurred at the level of miRNA gene transcription, because the synthesis rates of primary miRNAs were significantly decreased in infected cells. miRNA repression depended on the host macrophage transcription factor c-Myc. Indeed, the expression of host c-Myc was markedly up-regulated by Leishmania infection, and c-Myc silencing reversed the miRNA suppression. Furthermore, c-Myc silencing significantly reduced intracellular survival of Leishmania, demonstrating that c-Myc is essential for Leishmania pathogenesis. Taken together, these findings identify c-Myc not only as being responsible for miRNA repression in Leishmania-infected macrophages but also as a novel and essential virulence factor by proxy that promotes Leishmania survival.	[Colineau, Lucie; Lambertz, Ulrike; Reiner, Neil E.] Vancouver Coastal Hlth Res Inst, Dept Med, Div Infect Dis, Vancouver, BC V5Z 1M9, Canada; [Fornes, Oriol; Wasserman, Wyeth W.] Univ British Columbia, British Columbia Childrens Hosp, Res Inst, Ctr Mol Med & Therapeut,Dept Med Genet, Vancouver, BC V5Z 3J5, Canada	Vancouver Coastal Health Research Institute; BC Childrens Hospital; University of British Columbia	Reiner, NE (corresponding author), Univ British Columbia, Dept Med, D452-2733 Heather St, Vancouver, BC V5Z 3J5, Canada.	nreiner@mail.ubc.ca	Fornés, Oriol/L-2645-2014	Fornés, Oriol/0000-0002-5969-3054; Wasserman, Wyeth/0000-0001-6098-6412; Colineau, Lucie/0000-0001-6221-0765	Canadian Institutes for Health Research [MOP-125879]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Grant MOP-125879 from the Canadian Institutes for Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Amatori S., 2017, J CANC METASTASIS TR, V3, P90, DOI [10.20517/2394-4722.2017.22, DOI 10.20517/2394-4722.2017.22]; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheneby J, 2018, NUCLEIC ACIDS RES, V46, pD267, DOI 10.1093/nar/gkx1092; Colineau L, 2017, MED MICROBIOL IMMUN, V206, P235, DOI 10.1007/s00430-017-0500-7; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frank B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0974-3; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125429; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Huang Q, 2016, MED SCI MONITOR, V22, P1837, DOI 10.12659/MSM.895642; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Izumi H, 2001, J CELL SCI, V114, P1533; Jackstadt R, 2015, BBA-GENE REGUL MECH, V1849, P544, DOI 10.1016/j.bbagrm.2014.04.003; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee S, 2013, CELL HOST MICROBE, V13, P678, DOI 10.1016/j.chom.2013.05.007; Lemaire J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002478; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00083; Liu LL, 2016, P NATL ACAD SCI USA, V113, P1564, DOI 10.1073/pnas.1518000113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marr AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004419; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Muxel SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44141; Nothelfer K, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9076823; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Psathas JN, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014175; Qi YT, 2007, J CELL PHYSIOL, V210, P63, DOI 10.1002/jcp.20816; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; ROY AL, 1993, NATURE, V365, P359, DOI 10.1038/365359a0; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; Rzymski T, 2008, ONCOGENE, V27, P4532, DOI 10.1038/onc.2008.100; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; Singh AK, 2016, AUTOPHAGY, V12, P1817, DOI 10.1080/15548627.2016.1203500; Sun HL, 2016, CANCER CELL, V30, P723, DOI 10.1016/j.ccell.2016.10.001; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tao JC, 2014, CELL CYCLE, V13, P191, DOI 10.4161/cc.27646; Tiwari N, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.00314, 10.3389/fmicb.2017.01190]; von Brandenstein M, 2012, AM J PATHOL, V180, P1787, DOI 10.1016/j.ajpath.2012.01.014; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wang XW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01942; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Whitfield JR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00010; Wisskirchen C, 2011, J VIROL, V85, P8646, DOI 10.1128/JVI.02559-10; Wu D, 2013, RNA, V19, P876, DOI 10.1261/rna.035055.112; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Xu YM, 2015, INT J CLIN EXP MED, V8, P2024; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yim HCH, 2011, P NATL ACAD SCI USA, V108, P17749, DOI 10.1073/pnas.1104892108; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110973; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681; Zhu BB, 2016, SCI REP-UK, V6, DOI 10.1038/srep22581	67	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12805	12819		10.1074/jbc.RA118.002462	http://dx.doi.org/10.1074/jbc.RA118.002462			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934305	hybrid, Green Published			2022-12-28	WOS:000442203500014
J	Rodriguez-Acebes, S; Mouron, S; Mendez, J				Rodriguez-Acebes, Sara; Mouron, Silvana; Mendez, Juan			Uncoupling fork speed and origin activity to identify the primary cause of replicative stress phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; molecular biology; cell division cycle 7-related protein kinase (Cdc7); DNA polymerase; DNA primase; fork speed; replication origin; replicative stress; stretched DNA fibers	DNA-REPLICATION; HUMAN-CELLS; S-PHASE; CANCER DEVELOPMENT; VERTEBRATE CELLS; INITIATION; CHK1; PROGRESSION; ACTIVATION; DYNAMICS	In growing cells, DNA replication precedes mitotic cell division to transmit genetic information to the next generation. The slowing or stalling of DNA replication forks at natural or exogenous obstacles causes "replicative stress" that promotes genomic instability and affects cellular fitness. Replicative stress phenotypes can be characterized at the single-molecule level with DNA combing or stretched DNA fibers, but interpreting the results obtained with these approaches is complicated by the fact that the speed of replication forks is connected to the frequency of origin activation. Primary alterations in fork speed trigger secondary responses in origins, and, conversely, primary alterations in the number of active origins induce compensatory changes in fork speed. Here, by employing interventions that temporally restrict either fork speed or origin firing while still allowing interrogation of the other variable, we report a set of experimental conditions to separate cause and effect in any manipulation that affects DNA replication dynamics. Using HeLa cells and chemical inhibition of origin activity (through a CDC7 kinase inhibitor) and of DNA synthesis (via the DNA polymerase inhibitor aphidicolin), we found that primary effects of replicative stress on velocity of replisomes (fork rate) can be readily distinguished from primary effects on origin firing. Identifying the primary cause of replicative stress in each case as demonstrated here may facilitate the design of methods to counteract replication stress in primary cells or to enhance it in cancer cells to increase their susceptibility to therapies that target DNA repair.	[Rodriguez-Acebes, Sara; Mouron, Silvana; Mendez, Juan] Spanish Natl Canc Res Ctr, Mol Oncol Programme, DNA Replicat Grp, 3 Melchor Fernandez Almagro, Madrid 28029, Spain; [Mouron, Silvana] Spanish Natl Canc Res Ctr, Clin Res Programme, Breast Canc Clin Res Unit, 3 Melchor Fernandez Almagro, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Mendez, J (corresponding author), Spanish Natl Canc Res Ctr, Mol Oncol Programme, DNA Replicat Grp, 3 Melchor Fernandez Almagro, Madrid 28029, Spain.	jmendez@cnio.es	Mendez, Juan/K-8001-2014; Rodriguez, Sara/AAA-8972-2019; Mouron, Silvana/L-7174-2014	Mendez, Juan/0000-0002-3235-2559; Rodriguez, Sara/0000-0002-9867-7591; Mouron, Silvana/0000-0001-6287-8001	Spanish Ministry of Science and Competitiveness [BFU2013-49153-P, BFU2016-80402-R, CSD2007-00015]	Spanish Ministry of Science and Competitiveness(Spanish Government)	This work was supported by Spanish Ministry of Science and Competitiveness Grants BFU2013-49153-P, BFU2016-80402-R, and CSD2007-00015 (to J.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahuja AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10660; Alvarez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9548; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Conti C, 2007, GENE CHROMOSOME CANC, V46, P724, DOI 10.1002/gcc.20448; Dorn ES, 2009, NUCLEIC ACIDS RES, V37, P60, DOI 10.1093/nar/gkn912; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Gallo David, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot085118; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Macheret M, 2018, NATURE, V555, P112, DOI 10.1038/nature25507; Malinsky J, 2001, J CELL SCI, V114, P747; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Munoz S, 2017, CHROMOSOMA, V126, P1, DOI 10.1007/s00412-016-0573-x; Neelsen KJ, 2013, GENE DEV, V27, P2537, DOI 10.1101/gad.226373.113; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Puigvert JC, 2016, FEBS J, V283, P232, DOI 10.1111/febs.13574; Sarni D, 2016, CURR OPIN CELL BIOL, V40, P131, DOI 10.1016/j.ceb.2016.03.017; Schiavone D, 2016, MOL CELL, V61, P161, DOI 10.1016/j.molcel.2015.10.038; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Techer H, 2017, NAT REV GENET, V18, P535, DOI 10.1038/nrg.2017.46; Techer H, 2013, J MOL BIOL, V425, P4845, DOI 10.1016/j.jmb.2013.03.040; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Wheaton K, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00659-16; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060	41	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12855	12861		10.1074/jbc.RA118.003740	http://dx.doi.org/10.1074/jbc.RA118.003740			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29959228	Green Published, hybrid			2022-12-28	WOS:000442203500018
J	Tognon, CE; Rafn, B; Cetinbas, NM; Kamura, T; Trigo, G; Rotblat, B; Okumura, F; Matsumoto, M; Chow, C; Davare, M; Pollak, M; Mayor, T; Sorensen, PH				Tognon, Cristina E.; Rafn, Bo; Cetinbas, Naniye Malli; Kamura, Takumi; Trigo, Genny; Rotblat, Barak; Okumura, Fumihiko; Matsumoto, Masaki; Chow, Christine; Davare, Monika; Pollak, Michael; Mayor, Thibault; Sorensen, Poul H.			Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Non-receptor tyrosine kinase (nRTK); insulin-like growth factor (IGF); fusion protein; ubiquitylation (ubiquitination); oncogene	FACTOR-I RECEPTOR; ACUTE PROMYELOCYTIC LEUKEMIA; SMALL-MOLECULE INHIBITOR; PROTEIN-TYROSINE KINASE; GENE FUSION; CONGENITAL FIBROSARCOMA; CYCLOLIGNAN PPP; TEL ETV6; TRANSFORMATION; CELLS	Many oncogenes, including chimeric oncoproteins, require insulin-like growth factor 1 receptor (IGF1R) for promoting cell transformation. The ETS variant 6 (ETV6)-neurotrophic receptor tyrosine kinase 3 (NTRK3) (EN) chimeric tyrosine kinase is expressed in mesenchymal, epithelial, and hematopoietic cancers and requires the IGF1R axis for transformation. However, current models of IGF1R-mediated EN activation are lacking mechanistic detail. We demonstrate here that IGF-mediated IGF1R stimulation enhances EN tyrosine phosphorylation and that blocking IGF1R activity or decreasing protein levels of the adaptor protein insulin receptor substrate 1/2 (IRS1/2) results in rapid EN degradation. This was observed both in vitro and in vivo in fibroblast and breast epithelial cell line models and in MO91, an EN-expressing human leukemia cell line. Stable isotope labeling with amino acids in cell culture (SILAC)-based MS analysis identified the E3 ligase RING-finger protein 123 (Rnf123, more commonly known as KPC1) as an EN interactor upon IGF1R/insulin receptor (INSR) inhibitor treatment. KPC1/Rnf123 ubiquitylated EN in vitro, and its overexpression decreased EN protein levels. In contrast, KPC1/Rnf123 knockdown rendered EN resistant to IGF1R inhibitor-mediated degradation. These results support a critical function for IGF1R in protecting EN from KPC1/Rnf123-mediated proteasomal degradation. Attempts to therapeutically target oncogenic chimeric tyrosine kinases have traditionally focused on blocking kinase activity to restrict downstream activation of essential signaling pathways. In this study, we demonstrate that IGF1R inhibition results in rapid ubiquitylation and degradation of the EN oncoprotein through a proteasome-dependent mechanism that is reversible, highlighting a potential strategy for targeting chimeric tyrosine kinases in cancer.	[Tognon, Cristina E.; Rafn, Bo; Cetinbas, Naniye Malli; Trigo, Genny; Rotblat, Barak; Chow, Christine; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Mayor, Thibault] Univ British Columbia, Michael Smith Labs, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Kamura, Takumi; Okumura, Fumihiko; Matsumoto, Masaki] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Davare, Monika] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Pollak, Michael] Jewish Gen Hosp, Lady Davis Inst Med Res SMBD, Montreal, PQ H3T 1E2, Canada	British Columbia Cancer Agency; University of British Columbia; Kyushu University; Oregon Health & Science University; Lady Davis Institute; McGill University	Sorensen, PH (corresponding author), British Columbia Canc Res Ctr, Dept Mol Oncol, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	psor@mail.ubc.ca	Rotblat, Barak/H-5970-2019	Rotblat, Barak/0000-0003-2985-7115; Davare, Monika/0000-0003-1802-7597; Pollak, Michael/0000-0003-3047-0604	Canadian Institutes of Health Research [49520]; ReThink Breast Cancer for a Career Development Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ReThink Breast Cancer for a Career Development Award	This work was supported in part by Canadian Institutes of Health Research Grant 49520 (to P.H.S.) and a ReThink Breast Cancer for a Career Development Award (to C.E.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Cetinbas N, 2013, J BIOL CHEM, V288, P27940, DOI 10.1074/jbc.M113.475301; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; De Braekeleer E, 2014, EXPERT REV HEMATOL, V7, P347, DOI 10.1586/17474086.2014.903794; Drilon A, 2018, NEW ENGL J MED, V378, P731, DOI 10.1056/NEJMoa1714448; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Gu TL, 2007, LEUKEMIA, V21, P563, DOI 10.1038/sj.leu.2404555; Hailey J, 2002, MOL CANCER THER, V1, P1349; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Hechtman JF, 2016, MOL CANCER RES, V14, P296, DOI 10.1158/1541-7786.MCR-15-0392-T; Chi HT, 2012, BIOCHEM BIOPH RES CO, V429, P87, DOI 10.1016/j.bbrc.2012.10.087; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Knezevich SR, 1998, CANCER RES, V58, P5046; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lannon CL, 2004, J BIOL CHEM, V279, P6225, DOI 10.1074/jbc.M307388200; Leeman-Neill RJ, 2014, CANCER-AM CANCER SOC, V120, P799, DOI 10.1002/cncr.28484; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; Monni R, 2001, ONCOGENE, V20, P849, DOI 10.1038/sj.onc.1204201; Morrison KB, 2002, ONCOGENE, V21, P5684, DOI 10.1038/sj.onc.1205669; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tognon C, 2001, CANCER RES, V61, P8909; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tognon CE, 2012, ONCOGENE, V31, P1334, DOI 10.1038/onc.2011.323; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Tognon CE, 2011, CANCER RES, V71, P1060, DOI 10.1158/0008-5472.CAN-10-3096; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Wai DH, 2000, ONCOGENE, V19, P906, DOI 10.1038/sj.onc.1203396; Wang S, 2014, P NATL ACAD SCI USA, V111, P4251, DOI 10.1073/pnas.1322198111; Wang W, 1998, CANCER RES, V58, P4426; Wilde IB, 2011, J PROTEOME RES, V10, P1062, DOI 10.1021/pr1008543; Wittman M, 2005, J MED CHEM, V48, P5639, DOI 10.1021/jm050392q; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Yamamoto H, 2016, HISTOPATHOLOGY, V69, P72, DOI 10.1111/his.12910	49	9	10	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12502	12515		10.1074/jbc.RA117.000321	http://dx.doi.org/10.1074/jbc.RA117.000321			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903916	hybrid, Green Published			2022-12-28	WOS:000441408500016
J	Chen, LY; Lotz, M; Terkeltaub, R; Liu-Bryan, R				Chen, Liang-Yu; Lotz, Martin; Terkeltaub, Robert; Liu-Bryan, Ru			Modulation of matrix metabolism by ATP-citrate lyase in articular chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetylation; AMP-activated kinase (AMPK); epigenetics; chondrocyte; ATP-citrate lyase; hydroxycitric acid; nucleocytosolic acetyl-CoA	ACETYL-COENZYME; OSTEOARTHRITIS; AUTOPHAGY; CHONDROPROTECTION; PATHOGENESIS; CARTILAGE; TARGET; GROWTH; BONE	Certain dysregulated chondrocyte metabolic adaptive responses such as decreased activity of the master regulator of energy metabolism AMP-activated protein kinase (AMPK) promote osteoarthritis (OA). Metabolism intersects with epigenetic and transcriptional responses. Hence, we studied chondrocyte ATP-citrate lyase (ACLY), which generates acetyl-CoA from mitochondrial-derived citrate, and modulates acetylation of histones and transcription factors. We assessed ACLY in normal and OA human knee chondrocytes and cartilages by Western blotting and immunohistochemistry, and quantified acetyl-CoA fluorometrically. We examined histone and transcription factor lysine acetylation by Western blotting, and assessed histone H3K9 and H3K27 occupancy of iNOS, MMP3, and MMP13 promoters by chromatin immunoprecipitation (ChIP) and quantitative PCR (qPCR). We analyzed iNOS, MMP3, MMP13, aggrecan (ACAN), and Col2a1 gene expression by RT-qPCR. Glucose availability regulated ACLY expression and function, nucleocytosolic acetyl-CoA, and histone acetylation. Human knee OA chondrocytes exhibited increased ACLY activation (assessed by Ser-455 phosphorylation), associated with increased H3K9 and H3K27 acetylation. Inhibition of ACLY attenuated IL-1-induced transcription of iNOS, MMP3, and MMP13 by suppressing acetylation of p65 NF-B, H3K9, and H3K27, blunted release of NO, MMP3, and MMP13, and also reduced SOX9 acetylation that promoted SOX9 nuclear translocation, leading to increased aggrecan and Col2a1 mRNA expression. ACLY is a novel player involved in regulation of cartilage matrix metabolism. Increased ACLY activity in OA chondrocytes increased nucleocytosolic acetyl-CoA, leading to increased matrix catabolism via dysregulated histone and transcription factor acetylation. Pharmacologic ACLY inhibition in OA chondrocytes globally reverses these changes and stimulates matrix gene expression and AMPK activation, supporting translational investigation in OA.	[Chen, Liang-Yu; Terkeltaub, Robert; Liu-Bryan, Ru] Vet Affairs San Diego Healthcare Syst, 111K,3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Lotz, Martin] Scripps Res Inst, La Jolla, CA 92037 USA; [Terkeltaub, Robert; Liu-Bryan, Ru] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Scripps Research Institute; University of California System; University of California San Diego	Liu-Bryan, R (corresponding author), Vet Affairs San Diego Healthcare Syst, 111K,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ruliu@ucsd.edu		Liu-Bryan, Ru/0000-0002-9611-8163	Department of Veterans Affairs [1I01BX002234, I01BX001660]; National Institutes of Health [AG007996]; NATIONAL INSTITUTE ON AGING [P01AG007996] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002234, I01BX001660] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Department of Veterans Affairs Grants 1I01BX002234 and I01BX001660 and National Institutes of Health Grant AG007996. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bar Oz M, 2016, AGING CELL, V15, P499, DOI 10.1111/acel.12456; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Berenbaum F, 2017, ARTHRITIS RHEUMATOL, V69, P9, DOI 10.1002/art.39842; Bohensky J, 2010, PEDIATR NEPHROL, V25, P633, DOI 10.1007/s00467-009-1310-y; Burke AC, 2017, CURR OPIN LIPIDOL, V28, P193, DOI 10.1097/MOL.0000000000000390; Carames B, 2012, ARTHRITIS RHEUM-US, V64, P1182, DOI 10.1002/art.33444; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Cecil DL, 2008, J IMMUNOL, V180, P8378, DOI 10.4049/jimmunol.180.12.8378; Chang XT, 2011, INT J RHEUM DIS, V14, P217, DOI 10.1111/j.1756-185X.2011.01598.x; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Courties A, 2017, CURR OPIN RHEUMATOL, V29, P214, DOI 10.1097/BOR.0000000000000373; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Das S, 2015, CELL METAB, V21, P868, DOI 10.1016/j.cmet.2015.05.006; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Hardie David Grahame, 2017, F1000Res, V6, P1724, DOI 10.12688/f1000research.11960.1; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Infantino V, 2013, BIOCHEM BIOPH RES CO, V440, P105, DOI 10.1016/j.bbrc.2013.09.037; Keating ST, 2015, CIRC RES, V116, P715, DOI 10.1161/CIRCRESAHA.116.303936; Khwairakpam AD, 2015, CURR DRUG TARGETS, V16, P156, DOI 10.2174/1389450115666141224125117; Kim H, 2015, MOL CELLS, V38, P677, DOI 10.14348/molcells.2015.0200; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Martel-Pelletier J, 1998, INFLAMM RES, V47, P90, DOI 10.1007/s000110050288; Mobasheri A, 2017, NAT REV RHEUMATOL, V13, P302, DOI 10.1038/nrrheum.2017.50; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Phillips T, 2005, VET J, V169, P216, DOI 10.1016/j.tvjl.2004.01.026; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Rosa SC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2713; Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919; Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003; Shikhman AR, 2009, OSTEOARTHR CARTILAGE, V17, P1022, DOI 10.1016/j.joca.2009.03.004; Terkeltaub R, 2011, ARTHRITIS RHEUM-US, V63, P1928, DOI 10.1002/art.30333; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yamada K, 2002, OSTEOARTHR CARTILAGE, V10, P360, DOI 10.1053/joca.2002.0525; Zhao XL, 2014, ARTHRITIS RHEUMATOL, V66, P3073, DOI 10.1002/art.38791; Zhou S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43245	39	13	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12259	12270		10.1074/jbc.RA118.002261	http://dx.doi.org/10.1074/jbc.RA118.002261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29929979	hybrid, Green Published			2022-12-28	WOS:000440803200023
J	de Albuquerque, CP; Suhandynata, RT; Carlson, CR; Yuan, WT; Zhou, HL				de Albuquerque, Claudio Ponte; Suhandynata, Raymond T.; Carlson, Christopher R.; Yuan, Wei-Tsung; Zhou, Huilin			Binding to small ubiquitin-like modifier and the nucleolar protein Csm1 regulates substrate specificity of the Ulp2 protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SUMO-interacting motif (SIM); sumoylation; post-translational modification (PTM); protease; substrate specificity; isothermal titration calorimetry (ITC); Cdc14; Net1; Tof2; Ulp1; Ulp2	SACCHAROMYCES-CEREVISIAE; SUMO ISOPEPTIDASE; SUMOYLATED PROTEINS; MONOPOLIN COMPLEX; NUCLEAR-PORE; YEAST; PATHWAY; LIGASE; LOCALIZATION; RECOGNITION	Ulp1 and Ulp2, in the yeast Saccharomyces cerevisiae, are the founding members of deSUMOylating enzymes. These enzymes remove small ubiquitin-like modifier (SUMO) from proteins and are conserved in all eukaryotes. Previous studies have shown that Ulp1 deSUMOylates the bulk of intracellular SUMOylated proteins, whereas Ulp2 is a highly specific enzyme. However, the mechanism for Ulp2's substrate specificity has been insufficiently understood. Here we show that the C-terminal regulatory domain of Ulp2 contains three distinct, yet conserved, motifs that control its in vivo substrate specificity and cell growth. Among them, a SUMO-interacting motif (SIM) was found to coordinate with the domain of Ulp2 that binds to the nucleolar protein Csm1 to ensure maximal deSUMOylation of Ulp2's nucleolar substrates. We found that whereas the Csm1-binding domain of Ulp2 recruits this enzyme to the nucleolus, Ulp2's C-terminal SIM promotes its SUMO protease activity and plays a key role in mediating the in vivo specificity of Ulp2. Thus, the substrate specificity of Ulp2 is controlled by both its subcellular localization and the SUMOylation status of its substrates. These findings illustrate the highly coordinated and dynamic nature of the SUMO pathways in maintaining homeostasis of intracellular SUMOylation.	[de Albuquerque, Claudio Ponte; Suhandynata, Raymond T.; Carlson, Christopher R.; Yuan, Wei-Tsung; Zhou, Huilin] Univ Calif San Diego, San Diego Branch, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yuan, Wei-Tsung] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), Univ Calif San Diego, Cellular & Mol Med, 9500 Gilman Dr,CMM East 2055, La Jolla, CA 92093 USA.	huzhou@ucsd.edu		Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health NIGMS [R01 GM116897]; Ludwig Institute for Cancer Research; National Institutes of Health NCI [NCI T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116897] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023498] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ludwig Institute for Cancer Research; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health NIGMS Grant R01 GM116897 and the Ludwig Institute for Cancer Research (to H. Z.) and National Institutes of Health NCI Grant NCI T32 CA009523 (to R. T. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albuquerque CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143810; Albuquerque CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003670; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Corbett KD, 2012, CELL REPORTS, V1, P583, DOI 10.1016/j.celrep.2012.05.012; Corbett KD, 2010, CELL, V142, P556, DOI 10.1016/j.cell.2010.07.017; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; de Albuquerque CP, 2016, J BIOL CHEM, V291, P8825, DOI 10.1074/jbc.M116.716399; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Eckhoff J, 2015, J BIOL CHEM, V290, P12268, DOI 10.1074/jbc.M114.622217; Elmore ZC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-74; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gillies J, 2016, GENETICS, V202, P1377, DOI 10.1534/genetics.116.187252; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kroetz MB, 2009, MOL BIOL CELL, V20, P2196, DOI 10.1091/mbc.E08-10-1090; Lee MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001355; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liang J, 2017, GENE DEV, V31, P802, DOI 10.1101/gad.296145.117; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Rosonina E, 2010, GENE DEV, V24, P1242, DOI 10.1101/gad.1917910; Ryu HY, 2016, GENE DEV, V30, P1881, DOI 10.1101/gad.282194.116; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Srikumar T, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.23; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	45	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12105	12119		10.1074/jbc.RA118.003022	http://dx.doi.org/10.1074/jbc.RA118.003022			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29903909	Green Published, hybrid			2022-12-28	WOS:000440803200011
J	Imae, R; Manya, H; Tsumoto, H; Osumi, K; Tanaka, T; Mizuno, M; Kanagawa, M; Kobayashi, K; Toda, T; Endo, T				Imae, Rieko; Manya, Hiroshi; Tsumoto, Hiroki; Osumi, Kenji; Tanaka, Tomohiro; Mizuno, Mamoru; Kanagawa, Motoi; Kobayashi, Kazuhiro; Toda, Tatsushi; Endo, Tamao			CDP-glycerol inhibits the synthesis of the functional O-mannosyl glycan of -dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; glycosyltransferase; dystroglycan; enzyme catalysis; glycobiology; fukutin; protein glycosylation; -dystroglycanopathy; CDP-glycerol; muscular dystrophy	ALPHA-DYSTROGLYCAN; RIBITOL-PHOSPHATE; MUSCULAR-DYSTROPHY; GLYCOSYLATION; REQUIRES; MAMMALS; FKRP; ISPD	alpha-Dystroglycan (-DG) is a highly glycosylated cell-surface laminin receptor. Defects in the O-mannosyl glycan of an -DG with laminin-binding activity can cause -dystroglycanopathy, a group of congenital muscular dystrophies. In the biosynthetic pathway of functional O-mannosyl glycan, fukutin (FKTN) and fukutin-related protein (FKRP), whose mutated genes underlie -dystroglycanopathy, sequentially transfer ribitol phosphate (RboP) from CDP-Rbo to form a tandem RboP unit (RboP-RboP) required for the synthesis of the laminin-binding epitope on O-mannosyl glycan. Both RboP- and glycerol phosphate (GroP)-substituted glycoforms have recently been detected in recombinant -DG. However, it is unclear how GroP is transferred to the O-mannosyl glycan or whether GroP substitution affects the synthesis of the O-mannosyl glycan. Here, we report that, in addition to having RboP transfer activity, FKTN and FKRP can transfer GroP to O-mannosyl glycans by using CDP-glycerol (CDP-Gro) as a donor substrate. Kinetic experiments indicated that CDP-Gro is a less efficient donor substrate for FKTN than is CDP-Rbo. We also show that the GroP-substituted glycoform synthesized by FKTN does not serve as an acceptor substrate for FKRP and that therefore further elongation of the outer glycan chain cannot occur with this glycoform. Finally, CDP-Gro inhibited the RboP transfer activities of both FKTN and FKRP. These results suggest that CDP-Gro inhibits the synthesis of the functional O-mannosyl glycan of -DG by preventing further elongation of the glycan chain. This is the first report of GroP transferases in mammals.	[Imae, Rieko; Manya, Hiroshi; Endo, Tamao] Tokyo Metropolitan Geriatr Hosp & Inst Gerontol, Mol Glycobiol, Res Team Mech Aging, Tokyo 1730015, Japan; [Tsumoto, Hiroki] Tokyo Metropolitan Geriatr Hosp & Inst Gerontol, Proteome Res, Res Team Mech Aging, Tokyo 1730015, Japan; [Osumi, Kenji; Tanaka, Tomohiro; Mizuno, Mamoru] Noguchi Inst, Lab Glycoorgan Chem, Tokyo 1730003, Japan; [Kanagawa, Motoi; Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Div Neurol Mol Brain Sci, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Toda, Tatsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci, Tokyo 1138655, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Kobe University; University of Tokyo	Manya, H (corresponding author), Tokyo Metropolitan Geriatr Hosp & Inst Gerontol, Mol Glycobiol, Res Team Mech Aging, Tokyo 1730015, Japan.	manya@tmig.or.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Kanagawa, Motoi/0000-0003-0984-6398; Manya, Hiroshi/0000-0003-1573-9177	National Center of Neurology and Psychiatry Intramural Research Grant [29-4]; Japan Agency for Medical Research and Development Grants [JP18gm0810010, JP18ek0109197]; Japan Society for the Promotion of Science [JP17H03987, JP16K08262]; Ministry of Education, Culture, Sports, Science and Technology of Japan [JP17919697]	National Center of Neurology and Psychiatry Intramural Research Grant; Japan Agency for Medical Research and Development Grants(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by National Center of Neurology and Psychiatry Intramural Research Grant 29-4 (to T. Toda and T. E.), Japan Agency for Medical Research and Development Grants JP18gm0810010 and JP18ek0109197 (to H. M. and M. K.), Japan Society for the Promotion of Science Grants JP17H03987 (to H. M.) and JP16K08262 (to T. E.), and Ministry of Education, Culture, Sports, Science and Technology of Japan Grant JP17919697 (to M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhavan A, 2012, CANCER RES, V72, P2578, DOI 10.1158/0008-5472.CAN-11-3732; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; Esser AK, 2013, J BIOL CHEM, V288, P2132, DOI 10.1074/jbc.M112.432807; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2018, J BIOCHEM, V163, P359, DOI 10.1093/jb/mvy020; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2017, BBA-GEN SUBJECTS, V1861, P2462, DOI 10.1016/j.bbagen.2017.06.024; Manya H, 2016, J BIOL CHEM, V291, P24618, DOI 10.1074/jbc.M116.751917; PARK YS, 1993, J BIOL CHEM, V268, P16648; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Riemersma M, 2015, CHEM BIOL, V22, P1643, DOI 10.1016/j.chembiol.2015.10.014; Rodrigues MV, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02462-16; Sheikh MO, 2017, GLYCOBIOLOGY, V27, P806, DOI 10.1093/glycob/cwx062; Willer T, 2014, ELIFE, V3, DOI 10.7554/eLife.03941; Yagi H, 2016, MOL CELL PROTEOMICS, V15, P3424, DOI 10.1074/mcp.M116.062729; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	22	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12186	12198		10.1074/jbc.RA118.003197	http://dx.doi.org/10.1074/jbc.RA118.003197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29884773	hybrid, Green Published			2022-12-28	WOS:000440803200017
J	Xin, D; Gu, HY; Liu, EP; Sun, QM				Xin, Di; Gu, Haiyan; Liu, Enping; Sun, Qinmiao			Parkin negatively regulates the antiviral signaling pathway by targeting TRAF3 for degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; cell signaling; Parkin; interferon; ubiquitylation (ubiquitination); TRAF3	VIRAL-INFECTION; INNATE IMMUNITY; MITOFUSIN 1; DISEASE; LIGASE; UBIQUITINATION; INFLAMMATION; RECOGNITION; MITOPHAGY; PROMOTES	Chronic neuroinflammation is a characteristic of Parkinson's disease (PD). Previous investigations have shown that Parkin gene mutations are related to the early-onset recessive form of PD and isolated juvenile-onset PD. Further, Parkin plays important roles in mitochondrial quality control and cytokine-induced cell death. However, whether Parkin regulates other cellular events is still largely unknown. In this study, we performed overexpression and knockout experiments and found that Parkin negatively regulates antiviral immune responses against RNA and DNA viruses. Mechanistically, we show that Parkin interacts with tumor necrosis factor receptor-associated factor 3 (TRAF3) to regulate stability of TRAF3 protein by promoting Lys(48)-linked ubiquitination. Our findings suggest that Parkin plays a novel role in innate immune signaling by targeting TRAF3 for degradation and maintaining the balance of innate antiviral immunity.	[Xin, Di; Gu, Haiyan; Liu, Enping; Sun, Qinmiao] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Xin, Di; Gu, Haiyan; Liu, Enping; Sun, Qinmiao] Univ Chinese Acad Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, QM (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	qinmiaosun@ioz.ac.cn			Strategic Priority Research Program of Chinese Academy of Sciences [XDB13000000]; National Natural Science Foundation of China [31570916, 31370882, 31371450]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of Chinese Academy of Sciences Grant XDB13000000 and National Natural Science Foundation of China Grants 31570916, 31370882, and 31371450. The authors declare that they have no conflicts of interest with the contents of this article.	Abdullah Z, 2014, EMBO J, V33, P2283, DOI 10.15252/embj.201489055; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Baum A, 2010, AMINO ACIDS, V38, P1283, DOI 10.1007/s00726-009-0374-0; Birsa N, 2014, J BIOL CHEM, V289, P14569, DOI 10.1074/jbc.M114.563031; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Chen H, 2008, AM J EPIDEMIOL, V167, P90, DOI 10.1093/aje/kwm260; Chung JY, 2013, LAB INVEST, V93, P663, DOI 10.1038/labinvest.2013.60; Cottier F, 2012, IMMUNOL RES, V53, P127, DOI 10.1007/s12026-012-8265-y; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kazlauskaite A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130213; Khan M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005693; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Lee JK, 2009, J NEUROIMMUNE PHARM, V4, P419, DOI 10.1007/s11481-009-9176-0; Li ZX, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004783; Lin DD, 2015, P NATL ACAD SCI USA, V112, P11324, DOI 10.1073/pnas.1509968112; Lin W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11848; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; McGeer EG, 2005, NEUROBIOL AGING, V26, pS94, DOI 10.1016/j.neurobiolaging.2005.08.008; Muller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2; Sai Y, 2012, NEUROSCI BIOBEHAV R, V36, P2034, DOI 10.1016/j.neubiorev.2012.06.007; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sun LJ, 2010, CELL, V140, P436, DOI 10.1016/j.cell.2010.01.041; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086	44	13	13	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					11996	12010		10.1074/jbc.RA117.001201	http://dx.doi.org/10.1074/jbc.RA117.001201			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29903906	Green Published, hybrid			2022-12-28	WOS:000440803200003
J	Cai, N; Lou, LP; Al-Saadi, N; Tetteh, S; Runnels, LW				Cai, Na; Lou, Liping; Al-Saadi, Namariq; Tetteh, Sandra; Runnels, Loren W.			The kinase activity of the channel-kinase protein TRPM7 regulates stability and localization of the TRPM7 channel in polarized epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transient receptor potential channels (TRP channels); ion channel; protein kinase; phosphorylation; 14-3-3 protein; proteosome-mediated turnover; transient receptor potential cation channel subfamily M member 7; TRPM7	CELLULAR MG2+ HOMEOSTASIS; SECONDARY HYPOCALCEMIA; ION-CHANNEL; PHOSPHORYLATION SITES; DUAL PHOSPHORYLATION; SURFACE EXPRESSION; IDENTIFICATION; HYPOMAGNESEMIA; NEURONS; BINDING	The channel-kinase transient receptor potential melastatin 7 (TRPM7) is a bifunctional protein with ion channel and kinase domains. The kinase activity of TRPM7 has been linked to the regulation of a broad range of cellular activities, but little is understood as to how the channel itself is regulated by its own kinase activity. Here, using several mammalian cell lines expressing WT TRPM7 or kinase-inactive variants, we discovered that compared with the cells expressing WT TRPM7, cells in which TRPM7's kinase activity was inactivated had faster degradation, elevated ubiquitination, and increased intracellular retention of the channel. Mutational analysis of TRPM7 autophosphorylation sites further revealed a role for Ser-1360 of TRPM7 as a key residue mediating both TRPM7 stability and intracellular trafficking. Additional trafficking roles were uncovered for Ser-1403 and Ser-1567, whose phosphorylation by TRPM7's kinase activity mediated the interaction of the channel with the signaling protein 14-3-3. In summary, our results point to a critical role for TRPM7's kinase activity in regulating proteasome-mediated turnover of the TRPM7 channel and controlling its cellular localization in polarized epithelial cells. Overall, these findings improve our understanding of the significance of TRPM7's kinase activity for functional regulation of its channel activity.	[Cai, Na; Lou, Liping; Al-Saadi, Namariq; Tetteh, Sandra; Runnels, Loren W.] Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Al-Saadi, Namariq] Univ Misan, Amarah 62001, Iraq	Rutgers State University New Brunswick; Rutgers State University Medical Center; Misan University	Runnels, LW (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	runnellw@rwjms.rutgers.edu	Cai, Na/L-4951-2019	Cai, Na/0000-0002-7548-4359; Runnels, Loren/0000-0002-2537-7360	NIGMS, National Institutes of Health [GM080753]; New Jersey Commission on Brain Injury Research Grant [CBIR13IRG025]; American Heart Association [15PRE24890008, 17PRE33410172]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080753] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New Jersey Commission on Brain Injury Research Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant GM080753, New Jersey Commission on Brain Injury Research Grant CBIR13IRG025 (to L. W. R.), and American Heart Association Predoctoral Fellowships 15PRE24890008 (to N. C.) and 17PRE33410172 (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Abiria SA, 2017, P NATL ACAD SCI USA, V114, pE6079, DOI 10.1073/pnas.1707380114; Brandao K, 2014, CELL MOL LIFE SCI, V71, P4853, DOI 10.1007/s00018-014-1647-7; Cai N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42739; Cho CH, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0052-3; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001876; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; COURJAULT F, 1991, CELL BIOL INT REP, V15, P1225, DOI 10.1016/0309-1651(91)90094-Y; Crawley SW, 2009, BIOCHEM J, V420, P115, DOI 10.1042/BJ20081405; Deason-Towne F, 2012, CELL SIGNAL, V24, P2070, DOI 10.1016/j.cellsig.2012.06.015; Decker AR, 2014, DEV BIOL, V386, P428, DOI 10.1016/j.ydbio.2013.11.015; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Elizondo MR, 2010, ENDOCRINOLOGY, V151, P5700, DOI 10.1210/en.2010-0853; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Fernandez-Orth J, 2017, TRAFFIC, V18, P29, DOI 10.1111/tra.12455; Gabriel L, 2012, J BIOL CHEM, V287, P32354, DOI 10.1074/jbc.M112.391458; Gotru SK, 2018, ARTERIOSCL THROM VAS, V38, P344, DOI 10.1161/ATVBAHA.117.310391; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Ichimura T, 1997, FEBS LETT, V413, P273, DOI 10.1016/S0014-5793(97)00910-1; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kaitsuka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05718; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kilisch M, 2016, J CELL SCI, V129, P831, DOI 10.1242/jcs.180182; Kim TY, 2012, BIOCHEM BIOPH RES CO, V417, P1030, DOI 10.1016/j.bbrc.2011.12.085; Komiya Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15855-y; Krapivinsky G, 2014, CELL, V157, P1061, DOI 10.1016/j.cell.2014.03.046; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; LEIGHTON J, 1970, CANCER-AM CANCER SOC, V26, P1022, DOI 10.1002/1097-0142(197011)26:5<1022::AID-CNCR2820260509>3.0.CO;2-M; Liu W, 2011, DEV BIOL, V350, P348, DOI 10.1016/j.ydbio.2010.11.034; Low SE, 2011, J NEUROSCI, V31, P11633, DOI 10.1523/JNEUROSCI.4950-10.2011; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; McNeill MS, 2007, J INVEST DERMATOL, V127, P2020, DOI 10.1038/sj.jid.5700710; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; Moeller HB, 2016, J BIOL CHEM, V291, P2469, DOI 10.1074/jbc.M115.691121; Mohammad DK, 2013, MOL CELL BIOL, V33, P3214, DOI 10.1128/MCB.00247-13; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Ogata K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18291-0; Ogunrinde A, 2017, DIFFERENTIATION, V96, P15, DOI 10.1016/j.diff.2017.06.001; Overton JD, 2015, SCI REP-UK, V5, DOI 10.1038/srep18395; Perraud AL, 2011, CELL SIGNAL, V23, P586, DOI 10.1016/j.cellsig.2010.11.011; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Romagnani A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01960-z; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2014, SCI REP-UK, V4, DOI 10.1038/srep07599; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Ryazanova LV, 2001, MOL BIOL+, V35, P271, DOI 10.1023/A:1010499720185; Sahni J, 2008, CELL METAB, V8, P84, DOI 10.1016/j.cmet.2008.06.002; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Stritt S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11097; Su LT, 2011, BIOCHEM J, V434, P513, DOI 10.1042/BJ20101678; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; TRAXLER B, 1992, P NATL ACAD SCI USA, V89, P10852, DOI 10.1073/pnas.89.22.10852; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yee NS, 2011, DIS MODEL MECH, V4, P240, DOI 10.1242/dmm.004564; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zierler S, 2016, J PHYSIOL-LONDON, V594, P2957, DOI 10.1113/JP271564	72	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11491	11504		10.1074/jbc.RA118.001925	http://dx.doi.org/10.1074/jbc.RA118.001925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29866880	Green Published, hybrid			2022-12-28	WOS:000439449700019
J	Li, D; Musante, V; Zhou, WL; Picciotto, MR; Nairn, AC				Li, Daniel; Musante, Veronica; Zhou, Wenliang; Picciotto, Marina R.; Nairn, Angus C.			Striatin-1 is a B subunit of protein phosphatase PP2A that regulates dendritic arborization and spine development in striatal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING; AXONAL-TRANSPORT; ACTIN; 2A; PHOSPHORYLATION; DYNAMICS; BRAIN; DEPHOSPHORYLATION; MICROTUBULES; PLASTICITY	Striatin-1, a subunit of the serine/threonine phosphatase PP2A, is preferentially expressed in neurons in the striatum. As a member of the striatin family of B subunits, striatin-1 is a core component together with PP2A of a multiprotein complex called STRIPAK, the striatin-interacting phosphatase and kinase complex. Little is known about the function of striatin-1 or the STRIPAK complex in the mammalian striatum. Here, we identify a selective role for striatin-1 in striatal neuron maturation. Using a small hairpin RNA (shRNA) knockdown approach in primary striatal neuronal cultures, we determined that reduced expression of striatin-1 results in increased dendritic complexity and an increased density of dendritic spines, classified as stubby spines. The dendritic phenotype was rescued by co-expression of a striatin-1 mutant construct insensitive to the knockdown shRNA but was not rescued by co-expression of PP2A- or Mob3-binding deficient striatin-1 constructs. Reduction of striatin-1 did not result in deficits in neuronal connectivity in this knockdown model, as we observed no abnormalities in synapse formation or in spontaneous excitatory postsynaptic currents. Thus, this study suggests that striatin-1 is a regulator of neuronal development in striatal neurons.	[Li, Daniel; Musante, Veronica; Zhou, Wenliang; Picciotto, Marina R.; Nairn, Angus C.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	Yale University	Nairn, AC (corresponding author), Yale Univ, Dept Psychiat, New Haven, CT 06520 USA.	angus.nairn@yale.edu	Picciotto, Marina/F-8747-2012	Picciotto, Marina/0000-0002-4404-1280; Nairn, Angus/0000-0002-7075-0195; Zhou, Wenliang/0000-0001-7792-1201	National Institutes of Health Grant [DA14241]; Yale/National Institutes of Health Neuroproteomics Center from NIDA [DA018343]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044, R37DA014241, R01DA014241, P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale/National Institutes of Health Neuroproteomics Center from NIDA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Becky Carlyle and Rivka Schwarcz for their assistance with experimental procedures, Rashaun Wilson for help in data analysis, and Darren Wilson and Rich Trinko for assistance in virus production. We thank Drs. Sreeganga Chandra, Anthony Koleske, and Paul Lombroso for guidance. We thank Drs. Wang Min, Anne-Claude Gingras, and Paul Greengard for constructs and antibodies. We also thank Dr. Jean Kanyo of the Yale/NIDA Neuroproteomics Center for proteomics analysis. Electrophysiology work was supported by National Institutes of Health Grant DA14241. Proteomics analysis was supported by Yale/National Institutes of Health Neuroproteomics Center Grant DA018343 from NIDA.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Andrade EC, 2017, J NEUROSCI, V37, P2709, DOI 10.1523/JNEUROSCI.4559-15.2017; Bai SW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-54; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Berry KP, 2017, NEURON, V96, P43, DOI 10.1016/j.neuron.2017.08.008; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; CACERES A, 1983, P NATL ACAD SCI-BIOL, V80, P1738, DOI 10.1073/pnas.80.6.1738; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Chen HW, 2002, MOL CELL BIOL, V22, P1792, DOI 10.1128/MCB.22.6.1792-1803.2002; Chen YK, 2012, MOL BIOL CELL, V23, P4383, DOI 10.1091/mbc.E12-05-0365; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Falk T, 2006, J COMP NEUROL, V494, P275, DOI 10.1002/cne.20819; Fan QW, 2001, J NEUROCHEM, V76, P391, DOI 10.1046/j.1471-4159.2001.00063.x; Farah CA, 2008, CELL MOTIL CYTOSKEL, V65, P515, DOI 10.1002/cm.20284; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gaillard S, 2001, FEBS LETT, V508, P49, DOI 10.1016/S0014-5793(01)03020-4; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hiraga A, 2000, BIOCHEM J, V346, P433, DOI 10.1042/0264-6021:3460433; Hoffman A, 2017, MOL CELL NEUROSCI, V84, P119, DOI 10.1016/j.mcn.2017.01.005; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kameda H, 2008, NEUROSCI RES, V61, P79, DOI 10.1016/j.neures.2008.01.014; Khazaei MR, 2011, J NEUROCHEM, V117, P29, DOI 10.1111/j.1471-4159.2010.06971.x; Kilian P, 2008, ENDOCRINOLOGY, V149, P2923, DOI 10.1210/en.2007-0313; Lin LF, 2017, J BIOL CHEM, V292, P9451, DOI 10.1074/jbc.M116.772442; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Musante V, 2017, ELIFE, V6, DOI 10.7554/eLife.24998; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Nishi A, 2017, J BIOL CHEM, V292, P1462, DOI 10.1074/jbc.M116.752402; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Penrod RD, 2011, J NEUROSCI METH, V200, P1, DOI 10.1016/j.jneumeth.2011.05.029; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; SAITO T, 1995, BIOCHEMISTRY-US, V34, P7376, DOI 10.1021/bi00022a010; Sakuma C, 2016, CELL REP, V16, P2289, DOI 10.1016/j.celrep.2016.07.066; Sakuma C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17769; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schulte J, 2010, J NEUROSCI, V30, P5189, DOI 10.1523/JNEUROSCI.5823-09.2010; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Xiang QJ, 2002, GENETICS, V160, P169; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	61	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11179	11194		10.1074/jbc.RA117.001519	http://dx.doi.org/10.1074/jbc.RA117.001519			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29802198	Green Published, hybrid			2022-12-28	WOS:000438882800029
J	Du, JG; Wang, Q; Ziegler, SF; Zhou, BH				Du, Jianguang; Wang, Qun; Ziegler, Steven F.; Zhou, Baohua			FOXP3 interacts with hnRNPF to modulate pre-mRNA alternative splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						forkhead box P3 (FOXP3); heterogeneous nuclear ribonucleoprotein (hnRNP); RNA splicing; RNA-protein interaction; immunology; Treg; immunosuppression; alternative splicing	REGULATORY T-CELLS; BCL-X; RESPONSES; SCURFY; GENE; RECOGNITION; ENTEROPATHY; COMPLEX; PROTEIN; MOUSE	FOXP3 promotes the development and function of regulatory T cells mainly through regulating the transcription of target genes. RNA alternative splicing has been implicated in a wide range of physiological and pathophysiological processes. We report here that FOXP3 associates with heterogeneous nuclear ribonucleoprotein (hnRNP) F through the exon 2-encoded region of FOXP3 and the second quasi-RNA recognition motif (qRRM) of hnRNPF. FOXP3 represses the ability of hnRNPF to bind to its target pre-mRNA and thus modulates RNA alternative splicing. Furthermore, overexpression of mouse hnRNPF in in vitro-differentiated regulatory T cells (Tregs) reduced their suppressive function. Thus, our studies identify a novel mechanism by which FOXP3 regulates mRNA alternative splicing to modulate the function of regulatory T cells.	[Du, Jianguang; Wang, Qun; Zhou, Baohua] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Du, Jianguang; Wang, Qun; Zhou, Baohua] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Zhou, Baohua] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Ziegler, Steven F.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Wang, Qun] Femtera Labs LLC, 1800 N Capitol Ave, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Benaroya Research Institute; Virginia Mason Medical Center	Zhou, BH (corresponding author), 1044 W Walnut St, Indianapolis, IN 46202 USA.	zhoub@iu.edu			National Institutes of Health [R21 AI110773, R01 AI085046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI110773, R01AI085046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R21 AI110773 and R01 AI085046 (to B. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488; Dominguez C, 2010, NAT STRUCT MOL BIOL, V17, P853, DOI 10.1038/nsmb.1814; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Ergun A, 2013, P NATL ACAD SCI USA, V110, P14324, DOI 10.1073/pnas.1311839110; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Haque R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2983; Lei LY, 2011, J IMMUNOL, V186, P2254, DOI 10.4049/jimmunol.1002503; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Loizou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018670; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sharabi A, 2010, J AUTOIMMUN, V34, P87, DOI 10.1016/j.jaut.2009.06.002; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Xie X, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005251; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	35	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10235	10244		10.1074/jbc.RA117.001349	http://dx.doi.org/10.1074/jbc.RA117.001349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29773655	Green Published, hybrid			2022-12-28	WOS:000437096700023
J	Gonzalez-Segura, L; Mujica-Jimenez, C; Juarez-Diaz, JA; Guemez-Toro, R; Martinez-Castilla, LP; Munoz-Clares, RA				Gonzalez-Segura, Lilian; Mujica-Jimenez, Carlos; Andres Juarez-Diaz, Javier; Guemez-Toro, Rodrigo; Martinez-Castilla, Leon P.; Munoz-Clares, Rosario A.			Identification of the allosteric site for neutral amino acids in the maize C-4 isozyme of phosphoenolpyruvate carboxylase: The critical role of Ser-100	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; protein structure; enzyme kinetics; crystal structure; site-directed mutagenesis; amino acid residue conservation; monocot and eudicot PEPC-C-4 isozymes; Zea mays L	ZEA-MAYS; BINDING-SITE; LEAVES; GLUCOSE-6-PHOSPHATE; ACTIVATION; PHOTOSYNTHESIS; GLYCINE; ENZYME; KRANZ; DESENSITIZATION	The isozymes of photosynthetic phosphoenolpyruvate carboxylase from C-4 plants (PEPC-C-4) play a critical role in their atmospheric CO2 assimilation and productivity. They are allosterically activated by phosphorylated trioses or hexoses, such as d-glucose 6-phosphate, and inhibited by l-malate or l-aspartate. Additionally, PEPC-C-4 isozymes from grasses are activated by glycine, serine, or alanine, but the allosteric site for these compounds remains unknown. Here, we report a new crystal structure of the isozyme from Zea mays (ZmPEPC-C-4) with glycine bound at the monomer-monomer interfaces of the two dimers of the tetramer, making interactions with residues of both monomers. This binding site is close to, but different from, the one proposed to bind glucose 6-phosphate. Docking experiments indicated that d/l-serine or d/l-alanine could also bind to this site, which does not exist in the PEPC-C-4 isozyme from the eudicot plant Flaveria, mainly because of a lysyl residue at the equivalent position of Ser-100 in ZmPEPC-C-4. Accordingly, the ZmPEPC-C-4 S100K mutant is not activated by glycine, serine, or alanine. Amino acid sequence alignments showed that PEPC-C-4 isozymes from the monocot family Poaceae have either serine or glycine at this position, whereas those from Cyperaceae and eudicot families have lysine. The size and charge of the residue equivalent to Ser-100 are not only crucial for the activation of PEPC-C-4 isozymes by neutral amino acids but also affect their affinity for the substrate phosphoenolpyruvate and their allosteric regulation by glucose 6-phosphate and malate, accounting for the reported kinetic differences between PEPC-C-4 isozymes from monocot and eudicot plants.	[Gonzalez-Segura, Lilian; Mujica-Jimenez, Carlos; Guemez-Toro, Rodrigo; Martinez-Castilla, Leon P.; Munoz-Clares, Rosario A.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; [Andres Juarez-Diaz, Javier] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Comparada, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Munoz-Clares, RA (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico.	clares@unam.mx	Juárez-Díaz, Javier Andrés/AAD-6398-2021	Juarez-Diaz, Javier Andres/0000-0001-9238-8564; Gonzalez-Segura, Lilian/0000-0001-7736-5065; Munoz-Clares, Rosario A./0000-0002-0115-3565	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica PAPIIT [IN216911]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [252123]	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica PAPIIT; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica PAPIIT, Grant IN216911 and Consejo Nacional de Ciencia y Tecnologia (CONACYT) Grant 252123 (to R.A.M.-C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDREO CS, 1987, FEBS LETT, V213, P1, DOI 10.1016/0014-5793(87)81454-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANDARIAN V, 1992, PLANT PHYSIOL, V100, P1411, DOI 10.1104/pp.100.3.1411; Blasing OE, 2000, J BIOL CHEM, V275, P27917; Bowes G, 2002, FUNCT PLANT BIOL, V29, P379, DOI 10.1071/PP01219; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; Christin PA, 2014, J EXP BOT, V65, P3609, DOI 10.1093/jxb/eru087; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DONCASTER HD, 1987, PLANT PHYSIOL, V84, P82, DOI 10.1104/pp.84.1.82; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao Y, 1996, AUST J PLANT PHYSIOL, V23, P25, DOI 10.1071/PP9960025; GARSON L, 1991, BIOCHEM INT, V23, P299; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILLINTA J, 1995, PHOTOSYNTH RES, V45, P121, DOI 10.1007/BF00032583; GONZALEZ DH, 1984, J PLANT PHYSIOL, V116, P425, DOI 10.1016/S0176-1617(84)80134-0; Gonzalez L., 2007, FASEB J, V21; Guemez-Toro R, 2012, J MEX CHEM SOC, V56, P58; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; HEINEKE D, 1991, PLANT PHYSIOL, V95, P1131, DOI 10.1104/pp.95.4.1131; HUDSPETH RL, 1989, PLANT MOL BIOL, V12, P579, DOI 10.1007/BF00036971; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kai Y, 1999, P NATL ACAD SCI USA, V96, P823, DOI 10.1073/pnas.96.3.823; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEEGOOD RC, 1985, PLANTA, V164, P163, DOI 10.1007/BF00396078; Matsumura H, 2002, STRUCTURE, V10, P1721, DOI 10.1016/S0969-2126(02)00913-9; Matsumura H, 1999, FEBS LETT, V458, P93, DOI 10.1016/S0014-5793(99)01103-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mujica-Jimenez C, 1998, BBA-PROTEIN STRUCT M, V1386, P132, DOI 10.1016/S0167-4838(98)00093-4; NISHIKIDO T, 1973, BIOCHEM BIOPH RES CO, V53, P126, DOI 10.1016/0006-291X(73)91410-1; Paulus JK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2504; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rao SK, 2008, PLANT SCI, V174, P475, DOI 10.1016/j.plantsci.2008.01.010; RODRIGUEZSOTRES R, 1990, ARCH BIOCHEM BIOPHYS, V276, P180, DOI 10.1016/0003-9861(90)90025-T; Rosnow JJ, 2015, J EXP BOT, V66, P7347, DOI 10.1093/jxb/erv431; Rosnow JJ, 2014, J EXP BOT, V65, P3595, DOI 10.1093/jxb/eru053; Sanchez R, 2003, PLANT PHYSIOL, V132, P949, DOI 10.1104/pp.102.019653; Schlieper D, 2014, MOL PLANT, V7, P437, DOI 10.1093/mp/sst130; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; STIBOROVA M, 1985, PHOTOSYNTHETICA, V19, P177; STITT M, 1985, BIOCHIM BIOPHYS ACTA, V808, P400, DOI 10.1016/0005-2728(85)90148-3; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takahashi-Terada A, 2005, J BIOL CHEM, V280, P11798, DOI 10.1074/jbc.M408768200; Tovar-Mendez A, 1998, BIOCHEM J, V332, P633, DOI 10.1042/bj3320633; Tovar-Mendez A, 2000, PLANT PHYSIOL, V123, P149, DOI 10.1104/pp.123.1.149; TovarMendez A, 1997, BBA-PROTEIN STRUCT M, V1337, P207, DOI 10.1016/S0167-4838(96)00166-5; UEDAN K, 1976, PLANT PHYSIOL, V57, P906, DOI 10.1104/pp.57.6.906; WONG KF, 1973, BIOCHEM J, V131, P451, DOI 10.1042/bj1310451; Yuan JP, 2006, PHOTOSYNTH RES, V88, P73, DOI 10.1007/s11120-005-9032-x	52	8	9	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9945	9957		10.1074/jbc.RA118.002884	http://dx.doi.org/10.1074/jbc.RA118.002884			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29743237	Green Published, hybrid			2022-12-28	WOS:000437096700002
J	Greene, BL; Nocera, DG; Stubbe, J				Greene, Brandon L.; Nocera, Daniel G.; Stubbe, JoAnne			Basis of dATP inhibition of RNRs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HUMAN RIBONUCLEOTIDE REDUCTASE; ALLOSTERIC REGULATION	Ribonucleotide reductases (RNRs) are essential enzymes producing de novo deoxynucleotide (dNTP) building blocks for DNA replication and repair and regulating dNTP pools important for fidelity of these processes. A new study reveals that the class Ia Escherichia coli RNR is regulated by dATP via stabilization of an inactive 44 quaternary structure, slowing formation of the active 22 structure. The results support the importance of the regulatory 44 complex providing insight in design of experiments to understand RNR regulation in vivo.	[Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Greene, Brandon L.; Nocera, Daniel G.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Stubbe, J (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	stubbe@mit.edu			National Institutes of Health [GM029595, GM047274]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047274, R01GM029595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant GM029595. To whom correspondence may be addressed: Dept. of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139. Tel.: 617-253-1814; E-mail: stubbe@mit.edu.; Supported by National Institutes of Health Grant GM047274 (to D. G. N.).	Ahluwalia D, 2012, DNA REPAIR, V11, P480, DOI 10.1016/j.dnarep.2012.02.001; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Aye Y, 2012, CHEM BIOL, V19, P799, DOI 10.1016/j.chembiol.2012.05.015; Brignole EJ, 2018, ELIFE, V7, DOI [10.7554/eLife.3150, 10.7554/eLife.31502]; Chen PYT, 2018, J BIOL CHEM, V293, P10404, DOI 10.1074/jbc.RA118.002569; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Minnihan EC, 2013, P NATL ACAD SCI USA, V110, P3835, DOI 10.1073/pnas.1220691110	10	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10413	10414		10.1074/jbc.H118.003717	http://dx.doi.org/10.1074/jbc.H118.003717			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29959279	Green Published, hybrid			2022-12-28	WOS:000437096700038
J	Maun, HR; Liu, PS; Franke, Y; Eigenbrot, C; Forrest, WF; Schwartz, LB; Lazarus, RA				Maun, Henry R.; Liu, Peter S.; Franke, Yvonne; Eigenbrot, Charles; Forrest, William F.; Schwartz, Lawrence B.; Lazarus, Robert A.			Dual functionality of -tryptase protomers as both proteases and cofactors in the active tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; enzyme mechanism; heparin-binding protein; protein engineering; protein-protein interaction; serine protease; tryptase; tetramerization	MAST-CELL TRYPTASE; HUMAN BETA-TRYPTASE; SPONTANEOUS INACTIVATION; SECRETORY GRANULES; ZYMOGEN ACTIVATION; CRYSTAL-STRUCTURE; TISSUE FACTOR; HEPARIN; CONVERSION; STREPTOKINASE	Human -tryptase, a tetrameric trypsin-like serine protease, is an important mediator of the allergic inflammatory responses in asthma. During acute hypersensitivity reactions, mast cells degranulate, releasing active tetramer as a complex with proteoglycans. Extensive efforts have focused on developing therapeutic -tryptase inhibitors, but its unique activation mechanism is less well-explored. Tryptase is active only after proteolytic removal of the pro-domain followed by tetramer formation via two distinct symmetry-related interfaces. We show that the cleaved I16G mutant cannot tetramerize, likely due to impaired insertion of its N terminus into its activation pocket, indicating allosteric linkage at multiple sites on each protomer. We engineered cysteines into each of the two distinct interfaces (Y75C for small or I99C for large) to assess the activity of each tetramer and disulfide-locked dimer. Using size-exclusion chromatography and enzymatic assays, we demonstrate that the two large tetramer interfaces regulate enzymatic activity, elucidating the importance of this protein-protein interaction for allosteric regulation. Notably, the I99C large interface dimer is active, even in the absence of heparin. We show that a monomeric -tryptase mutant (I99C*/Y75A/Y37bA, where C* is cysteinylated Cys-99) cannot form a dimer or tetramer, yet it is active but only in the presence of heparin. Thus heparin both stabilizes the tetramer and allosterically conditions the active site. We hypothesize that each -tryptase protomer in the tetramer has two distinct roles, acting both as a protease and as a cofactor for its neighboring protomer, to allosterically regulate enzymatic activity, providing a rationale for direct correlation of tetramer stability with proteolytic activity.	[Maun, Henry R.; Lazarus, Robert A.] Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA; [Liu, Peter S.] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA; [Franke, Yvonne] Genentech Inc, Dept Biomol Resources, San Francisco, CA 94080 USA; [Eigenbrot, Charles] Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA; [Forrest, William F.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Div Rheumatol Allergy & Immunol, Richmond, VA 23298 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Virginia Commonwealth University	Lazarus, RA (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	lazarus.bob@gene.com			United States Department of Energy, Office of Science, and Office of Basic Energy Sciences [DE-AC02-06CH11357]	United States Department of Energy, Office of Science, and Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank Christine Tam for cloning expression constructs and Kyle Mortara and the Biomolecular Resources Department for expression of beta-tryptase in insect cells. We thank Daniel Kirchhofer and Terry Lipari for very helpful discussions and reagents. We thank Wendy Sandoval, Lawren Wu, and Tangsheng Yi for their support. We thank Jeff Holden for steered molecular dynamic simulations. We acknowledge the Antibody Production Group and Mark Ultsch for producing B12 IgG and Fab proteins. We thank Ping Wu for harvesting protein crystals and John J. Chrzas for data collection at the Advanced Photon Source. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, and Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Addington AK, 1996, BIOCHEMISTRY-US, V35, P13511, DOI 10.1021/bi960042t; ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; ALTER SC, 1990, ARCH BIOCHEM BIOPHYS, V276, P26, DOI 10.1016/0003-9861(90)90005-J; Baici A., 2015, KINETICS ENZYME MODI; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; BOTTS J, 1953, T FARADAY SOC, V49, P696, DOI 10.1039/tf9534900696; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Caughey GH, 2016, EUR J PHARMACOL, V778, P44, DOI 10.1016/j.ejphar.2015.04.045; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Copeland RA., 2000, ENZYMES PRACTICAL IN, P137; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1; DiCera E, 1996, BIOPHYS J, V70, P174, DOI 10.1016/S0006-3495(96)79558-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fajardo I, 2003, BIOCHEM J, V369, P603, DOI 10.1042/BJ20021418; Fukuoka Y, 2004, BIOCHEMISTRY-US, V43, P10757, DOI 10.1021/bi049486c; Fukuoka Y, 2007, INT IMMUNOPHARMACOL, V7, P1900, DOI 10.1016/j.intimp.2007.07.007; Fukuoka Y, 2006, J IMMUNOL, V176, P3165, DOI 10.4049/jimmunol.176.5.3165; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hallgren J, 2004, J IMMUNOL, V173, P1868, DOI 10.4049/jimmunol.173.3.1868; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henzel WJ, 2003, J AM SOC MASS SPECTR, V14, P931, DOI 10.1016/S1044-0305(03)00214-9; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan AR, 1998, PROTEIN SCI, V7, P815; MAIER M, 1983, J IMMUNOL, V130, P2352; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGrath ME, 2006, BIOCHEMISTRY-US, V45, P5964, DOI 10.1021/bi060173m; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Merdanovic M, 2013, ACS CHEM BIOL, V8, P19, DOI 10.1021/cb3005935; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mulloy B, 2017, GLYCOCONJUGATE J, V34, P351, DOI 10.1007/s10719-016-9749-0; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEMERSON Y, 1988, BLOOD, V71, P1; Paesen GC, 2007, J MOL BIOL, V368, P1172, DOI 10.1016/j.jmb.2007.03.011; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Pohlig G, 1996, EUR J BIOCHEM, V241, P619, DOI 10.1111/j.1432-1033.1996.00619.x; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; Reimer JM, 2010, IMMUNOGENETICS, V62, P369, DOI 10.1007/s00251-010-0443-2; Ren SL, 1998, J IMMUNOL, V160, P4561; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Ronnberg E, 2012, J HISTOCHEM CYTOCHEM, V60, P950, DOI 10.1369/0022155412458927; Sakai K, 1996, J CLIN INVEST, V97, P988, DOI 10.1172/JCI118523; SCHECHTER NM, 1995, BIOCHEMISTRY-US, V34, P10628, DOI 10.1021/bi00033a038; SCHECHTER NM, 1993, BIOCHEMISTRY-US, V32, P2617, DOI 10.1021/bi00061a020; Schechter NM, 2007, BIOCHEMISTRY-US, V46, P9615, DOI 10.1021/bi7004625; Schiemann F, 2009, J IMMUNOL, V183, P2223, DOI 10.4049/jimmunol.0803587; SCHWARTZ LB, 1981, J IMMUNOL, V126, P1290; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SCHWARTZ LB, 1994, J CLIN IMMUNOL, V14, P190, DOI 10.1007/BF01533368; SCHWARTZ LB, 1990, J IMMUNOL, V144, P2304; Selwood T, 1998, BIOCHEMISTRY-US, V37, P13174, DOI 10.1021/bi980780c; Sommerhoff CP, 1999, P NATL ACAD SCI USA, V96, P10984, DOI 10.1073/pnas.96.20.10984; SOMMERHOFF CP, 1994, BIOL CHEM H-S, V375, P685, DOI 10.1515/bchm3.1994.375.10.685; STACK MS, 1994, J BIOL CHEM, V269, P9416; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang Y, 2015, MOL BIOSYST, V11, P252, DOI 10.1039/c4mb00381k; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	73	9	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9614	9628		10.1074/jbc.M117.812016	http://dx.doi.org/10.1074/jbc.M117.812016			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29661938	Green Published, hybrid			2022-12-28	WOS:000436102300006
J	Treutlein, EM; Kern, K; Weigert, A; Tarighi, N; Schuh, CD; Nusing, RM; Schreiber, Y; Ferreiros, N; Brune, B; Geisslinger, G; Pierre, S; Scholich, K				Treutlein, Elsa-Marie; Kern, Katharina; Weigert, Andreas; Tarighi, Neda; Schuh, Claus-Dieter; Nuesing, Rolf M.; Schreiber, Yannick; Ferreiros, Nerea; Bruene, Bernhard; Geisslinger, Gerd; Pierre, Sandra; Scholich, Klaus			The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prostaglandin; G protein-coupled receptor (GPCR); neuroinflammation; pain; chemokine; CCL2; mast cells; neuropathic pain; peripheral neuron; Prostaglandin E2	SCIATIC-NERVE; MICE LACKING; SENSORY NEURONS; INJURED NERVE; MAST-CELLS; INFLAMMATION; MACROPHAGES; MODEL; RAT; E-2	Prostaglandin (PG) E-2 is an important lipid mediator that is involved in several pathophysiological processes contributing to fever, inflammation, and pain. Previous studies have shown that early and continuous application of nonsteroidal anti-inflammatory drugs significantly reduces pain behavior in the spared nerve injury (SNI) model for trauma-induced neuropathic pain. However, the role of PGE(2) and its receptors in the development and maintenance of neuropathic pain is incompletely understood but may help inform strategies for pain management. Here, we sought to define the nociceptive roles of the individual PGE(2) receptors (EP1-4) in the SNI model using EP knockout mice. We found that PGE(2) levels at the site of injury were increased and that the expression of the terminal synthase for PGE(2), cytosolic PGE synthase was up-regulated in resident positive macrophages located within the damaged nerve. Only genetic deletion of the EP3 receptor affected nociceptive behavior and reduced the development of late-stage mechanical allodynia as well as recruitment of immune cells to the injured nerve. Importantly, EP3 activation induced the release of CC-chemokine ligand 2 (CCL2), and antagonists against the CCL2 receptor reduced mechanical allodynia in WT but not in EP3 knockout mice. We conclude that selective inhibition of EP3 might present a potential approach for reducing chronic neuropathic pain.	[Treutlein, Elsa-Marie; Kern, Katharina; Tarighi, Neda; Schuh, Claus-Dieter; Nuesing, Rolf M.; Schreiber, Yannick; Ferreiros, Nerea; Geisslinger, Gerd; Pierre, Sandra; Scholich, Klaus] Univ Hosp Frankfurt, Pharmazentrum Frankfurt, Inst Clin Pharmacol, D-60590 Frankfurt, Germany; [Weigert, Andreas; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, D-60323 Frankfurt, Germany; [Geisslinger, Gerd] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol, D-60596 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Fraunhofer Gesellschaft	Scholich, K (corresponding author), Univ Klinikum Frankfurt, Pharmazentrum Frankfurt, Inst Clin Pharmacol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	scholich@em.uni-frankfurt.de	Schuh, Claus D/G-9032-2013; Weigert, Andreas/E-6540-2010	Weigert, Andreas/0000-0002-7529-1952	Deutsche Forschungsgemeinschaft [SCHO817/3-2, GRK2336 AVE, SFB1039]; Else Kroner Fresenius Foundation, Else Kroner Graduate School; Else Kroner Fresenius Foundation, Translational Research Innovation-Pharma Graduate School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Fresenius Foundation, Else Kroner Graduate School; Else Kroner Fresenius Foundation, Translational Research Innovation-Pharma Graduate School	This work was supported by Deutsche Forschungsgemeinschaft Grants SCHO817/3-2, GRK2336 AVE, and SFB1039 (TPA08, B04, B06, Z01) and by funds from the Else Kroner Fresenius Foundation as part of the Else Kroner Graduate School (to E.-M.T.) and as part of the Translational Research Innovation-Pharma Graduate School (to K.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Degousee N, 2012, CIRCULATION, V125, P2904, DOI 10.1161/CIRCULATIONAHA.112.099754; Duarte PC, 2012, EXP NEUROL, V234, P466, DOI 10.1016/j.expneurol.2012.01.021; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gosselin RD, 2005, J NEUROCHEM, V95, P1023, DOI 10.1111/j.1471-4159.2005.03431.x; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P1322, DOI 10.1016/j.bbi.2011.04.003; Grosch S, 2017, EXPERT OPIN INV DRUG, V26, P51, DOI 10.1080/13543784.2017.1260544; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; Ley S, 2013, ONCOGENE, V32, P631, DOI 10.1038/onc.2012.77; Linke B, 2012, PROSTAG OTH LIPID M, V99, P15, DOI 10.1016/j.prostaglandins.2012.06.002; Linke B, 2009, J PROTEOME RES, V8, P4851, DOI 10.1021/pr900106v; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Ma WY, 2005, J NEUROCHEM, V93, P664, DOI 10.1111/j.1471-4159.2005.03050.x; Ma WY, 2002, EUR J NEUROSCI, V15, P1037, DOI 10.1046/j.1460-9568.2002.01940.x; Ma WY, 2003, EXP NEUROL, V183, P581, DOI 10.1016/S0014-4886(03)00182-1; Muja N, 2004, GLIA, V46, P116, DOI 10.1002/glia.10349; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; Natura G, 2013, P NATL ACAD SCI USA, V110, P13648, DOI 10.1073/pnas.1300820110; Pierre S, 2017, J INVEST DERMATOL, V137, P686, DOI 10.1016/j.jid.2016.09.036; Pierre S, 2008, MOL CELL PROTEOMICS, V7, P2475, DOI 10.1074/mcp.M800201-MCP200; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Schafers M, 2004, EXP NEUROL, V185, P160, DOI 10.1016/j.expneurol.2003.09.015; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schuh CD, 2014, ANESTHESIOLOGY, V120, P447, DOI 10.1097/ALN.0b013e3182a76f74; Schuh CD, 2014, PAIN, V155, P545, DOI 10.1016/j.pain.2013.12.006; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; STREIT WJ, 1985, J HISTOCHEM CYTOCHEM, V33, P1042, DOI 10.1177/33.10.4045182; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Syriatowicz JP, 1999, NEUROSCIENCE, V94, P587, DOI 10.1016/S0306-4522(99)00365-6; Takahashi M, 2004, NEUROSCI LETT, V363, P203, DOI 10.1016/j.neulet.2004.03.040; Takeuchi K, 1999, J PHYSIOL PHARMACOL, V50, P155; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Van Steenwinckel J, 2015, BRAIN BEHAV IMMUN, V45, P198, DOI 10.1016/j.bbi.2014.10.016; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Woodhams PL, 2007, EUR J PAIN, V11, P605, DOI 10.1016/j.ejpain.2006.09.005	42	20	20	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9685	9695		10.1074/jbc.RA118.002492	http://dx.doi.org/10.1074/jbc.RA118.002492			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29752406	Green Published, hybrid			2022-12-28	WOS:000436102300013
J	David, DJ; Pagliuso, A; Radoshevich, L; Nahori, MA; Cossart, P				David, Daryl Jason; Pagliuso, Alessandro; Radoshevich, Lilliana; Nahori, Marie-Anne; Cossart, Pascale			Lmo1656 is a secreted virulence factor of Listeria monocytogenes that interacts with the sorting nexin 6-BAR complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						infection; host-pathogen interaction; virulence factor; sorting nexin (SNX); bacterial pathogenesis; host-pathogen interaction; Listeria monocytogenes; Lmo1656; sorting nexin 6; virulence factor	SALMONELLA-CONTAINING VACUOLE; TO-CELL SPREAD; INFECTION; RETROMER; MATURATION; PROTEINS; CLATHRIN; ENTERICA; NETWORK; TARGET	Listeria monocytogenes (Lm) is a facultative intracellular bacterial pathogen and the causative agent of listeriosis, a rare but fatal disease. During infection, Lm can traverse several physiological barriers; it can cross the intestine and placenta barrier and, in immunocompromised individuals, the blood-brain barrier. With the recent plethora of sequenced genomes available for Lm, it is clear that the complete repertoire of genes used by Lm to interact with its host remains to be fully explored. Recently, we focused on secreted Lm proteins because they are likely to interact with host cell components. Here, we investigated a putatively secreted protein of Lm, Lmo1656, that is present in most sequenced strains of Lm but absent in the nonpathogenic species Listeria innocua. lmo1656 gene is predicted to encode a small, positively charged protein. We show that Lmo1656 is secreted by Lm. Furthermore, deletion of the lmo1656 gene (lmo1656) attenuates virulence in mice infected orally but not intravenously, suggesting that Lmo1656 plays a role during oral listeriosis. We identified sorting nexin 6 (SNX6), an endosomal sorting component and BAR domain-containing protein, as a host cell interactor of Lmol656. SNX6 colocalizes with WT Lm during the early steps of infection. This colocalization depends on Lmo1656, and RNAi of SNX6 impairs infection in infected tissue culture cells, suggesting that SNX6 is utilized by Lm during infection. Our results reveal that Lmo1656 is a novel secreted virulence factor of Lm that facilitates recruitment of a specific member of the sorting nexin family in the mammalian host.	[David, Daryl Jason; Pagliuso, Alessandro; Radoshevich, Lilliana; Nahori, Marie-Anne; Cossart, Pascale] Inst Pasteur, Dept Cell Biol & Infect, Inst Natl Rech Agron,USC2020, INSERM,U604,Unite Interact Bacteries Cellules, 25 Rue Dr Roux, F-75015 Paris, France; [Radoshevich, Lilliana] Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Iowa	Cossart, P (corresponding author), Inst Pasteur, Dept Cell Biol & Infect, Inst Natl Rech Agron,USC2020, INSERM,U604,Unite Interact Bacteries Cellules, 25 Rue Dr Roux, F-75015 Paris, France.	pascale.cossart@pasteur.fr		Radoshevich, Lilliana/0000-0003-0294-9300; David, Daryl Jason Verzosa/0000-0002-9253-4805; Cossart, Pascale/0000-0001-8871-6780; Marie-Anne, Nahori/0000-0002-4066-4528	Institut Pasteur; INSERM [Unite 604]; Institut National de la Recherche Agronomique (INRA Unite Sous Contrat 2020); Universite Paris Diderot; Region Ile-de-France; Fondation Le Roch Les Mousquetaires; European Research Council Advanced Grant [670823]; European Molecular Biology Organization (EMBO) Long Term Fellowship [ALTF 140-2014]; European Commission/Marie Curie Actions EMBOCOFUND;  [GA-2012-600394]	Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National de la Recherche Agronomique (INRA Unite Sous Contrat 2020); Universite Paris Diderot; Region Ile-de-France(Region Ile-de-France); Fondation Le Roch Les Mousquetaires; European Research Council Advanced Grant(European Research Council (ERC)); European Molecular Biology Organization (EMBO) Long Term Fellowship; European Commission/Marie Curie Actions EMBOCOFUND; 	This work was supported in part by the Institut Pasteur, INSERM (Unite 604), Institut National de la Recherche Agronomique (INRA Unite Sous Contrat 2020), Universite Paris Diderot, grants from Region Ile-de-France, Fondation Le Roch Les Mousquetaires, and European Research Council Advanced Grant 670823 BacCellEpi (to P. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Molecular Biology Organization (EMBO) Long Term Fellowship ALTF 140-2014 and European Commission/Marie Curie Actions EMBOCOFUND2012 and GA-2012-600394.	Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Archambaud C, 2012, P NATL ACAD SCI USA, V109, P16684, DOI 10.1073/pnas.1212809109; Balestrino D, 2010, APPL ENVIRON MICROB, V76, P3625, DOI 10.1128/AEM.02612-09; Becavin C, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00186-16; Becavin C, 2014, MBIO, V5, DOI 10.1128/mBio.00969-14; Braun V, 2010, CELL MICROBIOL, V12, P1352, DOI 10.1111/j.1462-5822.2010.01476.x; Bujny MV, 2008, J CELL SCI, V121, P2027, DOI 10.1242/jcs.018432; David Daryl J V, 2017, F1000Res, V6, DOI 10.12688/f1000research.11363.1; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Elwell CA, 2017, ELIFE, V6, DOI [10.7554/eLife.22709, 10.7554/e.Life.22709]; Gallon M, 2015, BIOCHEM SOC T, V43, P33, DOI 10.1042/BST20140290; Gouin E, 2010, P NATL ACAD SCI USA, V107, P17333, DOI 10.1073/pnas.1007765107; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Hoffmann M., 2015, GENOME ANNOUNC, V3; Kuhbacher A, 2015, MBIO, V6, DOI 10.1128/mBio.00598-15; Kuhbacher A, 2014, METHODS MOL BIOL, V1157, P167, DOI 10.1007/978-1-4939-0703-8_14; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Liss V, 2015, CELL MICROBIOL, V17, P639, DOI 10.1111/cmi.12441; Lou J, 2017, ONCOTARGET, V8, P53935, DOI 10.18632/oncotarget.19644; Malet JK, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12682; Maury MM, 2016, NAT GENET, V48, P308, DOI 10.1038/ng.3501; McCusker MP, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01219-13; McGough IJ, 2013, J CELL SCI, V126, P45, DOI 10.1242/jcs.112904; McGourty K, 2012, SCIENCE, V338, P963, DOI 10.1126/science.1227037; MENGAUD J, 1991, MOL MICROBIOL, V5, P367, DOI 10.1111/j.1365-2958.1991.tb02118.x; Mirrashidi KM, 2015, CELL HOST MICROBE, V18, P109, DOI 10.1016/j.chom.2015.06.004; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Paul B, 2017, ELIFE, V6, DOI 10.7554/eLife.22311; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Radoshevich L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00313; Radoshevich L, 2015, ELIFE, V4, DOI 10.7554/eLife.06848; Rajabian T, 2009, NAT CELL BIOL, V11, P1212, DOI 10.1038/ncb1964; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Ribet David, 2010, Virulence, V1, P532, DOI 10.4161/viru.1.6.13449; Rigano LA, 2014, CELL MICROBIOL, V16, P1068, DOI 10.1111/cmi.12260; Roberts A, 2006, MICROBIOL-SGM, V152, P685, DOI 10.1099/mic.0.28503-0; Santos MD, 2015, CELL MICROBIOL, V17, P164, DOI 10.1111/cmi.12399; Sierecki E, 2014, MOL CELL PROTEOMICS, V13, P2233, DOI 10.1074/mcp.M113.037275; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Sun Q., 2017, PROT CONTROL MOD POW, V2, P5, DOI DOI 10.1038/sigtrans.2017.30; Van Ngo H, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12768; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Vorwerk S, 2015, MOL CELL PROTEOMICS, V14, P81, DOI 10.1074/mcp.M114.041145; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Zhou ZM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003471	52	2	3	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9265	9276		10.1074/jbc.RA117.000365	http://dx.doi.org/10.1074/jbc.RA117.000365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29666193	Green Published, hybrid			2022-12-28	WOS:000435441400013
J	Martins, A; Pfirrmann, T; Heessen, S; Sundqvist, G; Bulone, V; Andreasson, C; Ljungdahl, PO				Martins, Antonio; Pfirrmann, Thorsten; Heessen, Stijn; Sundqvist, Gustav; Bulone, Vincent; Andreasson, Claes; Ljungdahl, Per O.			Ssy5 is a signaling serine protease that exhibits atypical biogenesis and marked S1 specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Saccharomyces cerevisiae; serine protease; signal transduction; substrate specificity; yeast; enzyme structure; environmental sensing; receptor activated proteolysis; signaling protease; SPS sensor; zymogen; signaling protease	ALPHA-LYTIC PROTEASE; RECEPTOR-ACTIVATED PROTEOLYSIS; EXTRACELLULAR AMINO-ACIDS; NUCLEAR-MEMBRANE PROTEIN; CASEIN KINASE-I; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; PRO-REGION; ENDOPROTEOLYTIC ACTIVATION; SSY1P-PTR3P-SSY5P SENSOR	Ssy5 is a signaling endoprotease that plays a key role in regulating central metabolism, cellular aging, and morphological transitions important for growth and survival of yeast (Saccharomyces cerevisiae) cells. In response to extracellular amino acids, Ssy5 proteolytically activates the transcription factors Stp1 and Stp2, leading to enhanced Ssy1-Ptr3-Ssy5 (SPS) sensor-regulated gene expression. Ssy5 comprises a catalytic (Cat) domain and an extensive regulatory prodomain. Ssy5 is refractory to both broad-spectrum and serine protease-specific inhibitors, confounding its classification as a protease, and no information about Ssy5's cleavage-site preferences and its mechanism of substrate selection is available. Here, using mutational and inhibition experiments, we investigated the biogenesis and catalytic properties of Ssy5 and conclusively show that it is a serine protease. Atypical for the majority of serine proteases, Ssy5's prodomain was obligatorily required in cis during biogenesis for the maturation of the proteolytic activity of the Cat domain. Autolysis and Stp1 and Stp2 cleavage occurred between a cysteine (at the P1 site) and a serine or alanine (at the P1 site) and required residues with short side chains at the P1 site. Substitutions in the Cat domain affecting substrate specificity revealed that residues Phe-634, His-661, and Gly-671 in the S1-binding pocket of this domain are important for Ssy5 catalytic function. This study confirms that the signaling protease Ssy5 is a serine protease and provides a detailed understanding of the biogenesis and intrinsic properties of this key enzyme in yeast.	[Martins, Antonio; Pfirrmann, Thorsten; Heessen, Stijn; Andreasson, Claes; Ljungdahl, Per O.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden; [Sundqvist, Gustav; Bulone, Vincent] Royal Inst Technol KTH, AlbaNova Univ Ctr, Div Glycosci, SE-10691 Stockholm, Sweden; [Bulone, Vincent] Univ Adelaide, Sch Agr Food & Wine, ARC Ctr Excellence Plant Cell Walls, Urrbra, SA 5064, Australia; [Pfirrmann, Thorsten] Martin Luther Univ Halle Wittenberg, Inst Physiol Chem, D-06114 Halle, Germany; [Heessen, Stijn] Sanofi Aventis Deutschland GmbH, Global Business Dev & Licensing Consumer Healthca, D-65926 Frankfurt, Germany	Stockholm University; Royal Institute of Technology; University of Adelaide; Martin Luther University Halle Wittenberg; Sanofi-Aventis	Ljungdahl, PO (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden.	per.ljungdahl@su.se	Bulone, Vincent/D-7469-2013; Ljungdahl, Per O/M-5258-2013; Pfirrmann, Thorsten/AAC-5563-2019; Bulone, Vincent/C-8492-2019	Ljungdahl, Per O/0000-0002-6625-3540; Bulone, Vincent/0000-0003-2809-4160; Pfirrmann, Thorsten/0000-0002-9474-9535	Swedish Research Council [2007-3894, 2011-5925, 2015-04202]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grants 2007-3894, 2011-5925, and 2015-04202 (to P.O.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C., 2004, THESIS; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Boban M, 2007, GENETICS, V176, P2087, DOI 10.1534/genetics.107.075077; Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cunningham EL, 2004, PROTEIN SCI, V13, P325, DOI 10.1110/ps.03389704; Cunningham EL, 2003, BIOCHEMISTRY-US, V42, P13212, DOI 10.1021/bi035409q; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; FUJISHIGE A, 1992, J CELL BIOL, V118, P33, DOI 10.1083/jcb.118.1.33; GRON H, 1992, BIOCHEMISTRY-US, V31, P6011, DOI 10.1021/bi00141a008; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hooper NM, 2002, ESSAYS BIOCHEM, V38, P1; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Kelch BA, 2007, J MOL BIOL, V370, P784, DOI 10.1016/j.jmb.2007.04.078; Keller UAD, 2010, MOL CELL PROTEOMICS, V9, P912, DOI 10.1074/mcp.M000032-MCP201; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinter M., 2005, PROTEIN SEQUENCING I, P147; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Miramon P, 2016, CELL MICROBIOL, V18, P1611, DOI 10.1111/cmi.12600; NEURATH H, 1957, FED PROC, V16, P791; Ng NM, 2009, BIOL CHEM, V390, P401, DOI 10.1515/BC.2009.065; Omnus DJ, 2013, MOL BIOL CELL, V24, P1480, DOI 10.1091/mbc.E13-01-0019; Omnus DJ, 2011, MOL BIOL CELL, V22, P2754, DOI 10.1091/mbc.E11-04-0282; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Peters RJ, 1998, BIOCHEMISTRY-US, V37, P12058, DOI 10.1021/bi980883v; Pfirrmann T., 2012, HDB PROTEOLYTIC ENZY, P3103; Pfirrmann T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064870; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; PIZZI E, 1994, P NATL ACAD SCI USA, V91, P888, DOI 10.1073/pnas.91.3.888; Poulsen P, 2006, EUKARYOT CELL, V5, P601, DOI 10.1128/EC.5.3.601-608.2006; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rockwell NC, 1998, BIOCHEMISTRY-US, V37, P3386, DOI 10.1021/bi972534r; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SILEN JL, 1989, NATURE, V341, P462, DOI 10.1038/341462a0; SILVE S, 1991, MOL CELL BIOL, V11, P1114, DOI 10.1128/MCB.11.2.1114; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Tetsch L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-74; Tumusiime S, 2011, J BIOL CHEM, V286, P4620, DOI 10.1074/jbc.M110.195313; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Wielemans K, 2010, J BIOL CHEM, V285, P855, DOI 10.1074/jbc.M109.015263; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089	60	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8362	8378		10.1074/jbc.RA118.002457	http://dx.doi.org/10.1074/jbc.RA118.002457			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29661936	hybrid, Green Published			2022-12-28	WOS:000434205700004
J	Sun, H; Miao, ZQ; Zhang, X; Chan, UI; Su, SM; Guo, S; Wong, CKH; Xu, XL; Deng, CX				Sun, Heng; Miao, Zhengqiang; Zhang, Xin; Chan, Un In; Su, Sek Man; Guo, Sen; Wong, Chris Koon Ho; Xu, Xiaoling; Deng, Chu-Xia			Single-cell RNA-Seq reveals cell heterogeneity and hierarchy within mouse mammary epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammary gland; development; breast cancer; biomarker; cell differentiation; stem cells; CDH5+cell; mammary stem cells (MaSCs); single cell RNA-seq	STEM-CELLS; GENE; IDENTIFICATION; EXPRESSION; MARKERS; ALPHA; PROLIFERATION; POPULATION; QUIESCENT; RECEPTOR	The mammary gland is very intricately and well organized into distinct tissues, including epithelia, endothelia, adipocytes, and stromal and immune cells. Many mammary gland diseases, such as breast cancer, arise from abnormalities in the mammary epithelium, which is mainly composed of two distinct lineages, the basal and luminal cells. Because of the limitation of traditional transcriptome analysis of bulk mammary cells, the hierarchy and heterogeneity of mammary cells within these two lineages remain unclear. To this end, using single-cell RNA-Seq coupled with FACS analysis and principal component analysis, we determined gene expression profiles of mammary epithelial cells of virgin and pregnant mice. These analyses revealed a much higher heterogeneity among the mammary cells than has been previously reported and enabled cell classification into distinct subgroups according to signature gene markers present in each group. We also identified and verified a rare CDH5(+) cell subpopulation within a basal cell lineage as quiescent mammary stem cells (MaSCs). Moreover, using pseudo-temporal analysis, we reconstructed the developmental trajectory of mammary epithelia and uncovered distinct changes in gene expression and in biological functions of mammary cells along the developmental process. In conclusion, our work greatly refines the resolution of the cellular hierarchy in developing mammary tissues. The discovery of CDH5(+) cells as MaSCs in these tissues may have implications for our understanding of the initiation, development, and pathogenesis of mammary tumors.	[Sun, Heng; Guo, Sen; Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macau, Peoples R China; [Sun, Heng] Univ Macau, Fac Hlth Sci, Zhuhai Res Inst, Taipa, Macau, Peoples R China; [Miao, Zhengqiang; Wong, Chris Koon Ho] Univ Macau, Fac Hlth Sci, Genom & Bioinformat Core, Taipa, Macau, Peoples R China; [Zhang, Xin; Chan, Un In; Su, Sek Man; Xu, Xiaoling] Univ Macau, Fac Hlth Sci, Transgen & Knockout Core, Taipa, Macau, Peoples R China	University of Macau; University of Macau; University of Macau; University of Macau	Deng, CX (corresponding author), Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macau, Peoples R China.	cxdeng@umac.mo	Wong, Koon/AAH-3021-2020; Wong, Koon Ho/P-3685-2018; wong, chris/GSN-0962-2022	Wong, Koon/0000-0002-9264-5118; Wong, Koon Ho/0000-0002-9264-5118; Guo, Sen/0000-0002-2681-0576	University of Macau, Macau SAR, China [CPG 2017-00016-FHS, SRG 2017-00045-FHS]; Macao Science and Technology Development Fund [065/2015/A2, 094/2015/A3]; National Natural Science Foundation of China [81602587]	University of Macau, Macau SAR, China; Macao Science and Technology Development Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chair Professor Grant CPG 2017-00016-FHS and Startup Research Grant SRG 2017-00045-FHS (to C.D.), by University of Macau, Macau SAR, China, Macao Science and Technology Development Fund Grants 065/2015/A2 and 094/2015/A3 (to C.D.), and by National Natural Science Foundation of China Grant 81602587 (to H.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Brunskill EW, 2014, DEVELOPMENT, V141, P3093, DOI 10.1242/dev.110601; Cai S, 2017, CELL STEM CELL, V20, P247, DOI 10.1016/j.stem.2016.11.007; Cheng GJ, 2004, P NATL ACAD SCI USA, V101, P3739, DOI 10.1073/pnas.0307864100; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; DeLaughter DM, 2016, DEV CELL, V39, P480, DOI 10.1016/j.devcel.2016.10.001; dos Santos CO, 2013, P NATL ACAD SCI USA, V110, P7123, DOI 10.1073/pnas.1303919110; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; FINA L, 1990, BLOOD, V75, P2417; Fu NY, 2017, NAT CELL BIOL, V19, P164, DOI 10.1038/ncb3471; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009707; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Li G, 2016, DEV CELL, V39, P491, DOI 10.1016/j.devcel.2016.10.014; Li J, 2016, EMBO REP, V17, P178, DOI 10.15252/embr.201540946; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Prat A, 2009, NAT MED, V15, P842, DOI 10.1038/nm0809-842; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Soady KJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0539-6; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vassilopoulos A, 2008, INT J BIOL SCI, V4, P133, DOI 10.7150/ijbs.4.133; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Xin YR, 2016, P NATL ACAD SCI USA, V113, P3293, DOI 10.1073/pnas.1602306113; Yu QC, 2016, CELL RES, V26, P1079, DOI 10.1038/cr.2016.85; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	54	24	24	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8315	8329		10.1074/jbc.RA118.002297	http://dx.doi.org/10.1074/jbc.RA118.002297			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666189	hybrid, Green Published			2022-12-28	WOS:000434205700001
J	Wojciechowski, D; Thiemann, S; Schaal, C; Rahtz, A; de la Roche, J; Begemann, B; Becher, T; Fischer, M				Wojciechowski, Daniel; Thiemann, Stefan; Schaal, Christina; Rahtz, Alina; de la Roche, Jeanne; Begemann, Birgit; Becher, Toni; Fischer, Martin			Activation of renal ClC-K chloride channels depends on an intact N terminus of their accessory subunit barttin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; gating; intracellular trafficking; renal physiology; electrophysiology; patch clamp; confocal microscopy; protein expression; barttin; ClC-K	DISTAL NEPHRON; INNER-EAR; KIDNEY; DISEASE; GENE; MECHANISMS; EXPRESSION; MUTATIONS; SURFACE	ClC-K channels belong to the CLC family of chloride channels and chloride/proton antiporters. They contribute to sodium chloride reabsorption in Henle's loop of the kidney and to potassium secretion into the endolymph by the stria vascularis of the inner ear. Their accessory subunit barttin stabilizes the ClC-K/barttin complex, promotes its insertion into the surface membrane, and turns the pore-forming subunits into a conductive state. Barttin mutations cause Bartter syndrome type IV, a salt-wasting nephropathy with sensorineural deafness. Here, studying ClC-K/barttin channels heterologously expressed in MDCK-II and HEK293T cells with confocal imaging and patch-clamp recordings, we demonstrate that the eight-amino-acids-long barttin N terminus is required for channel trafficking and activation. Deletion of the complete N terminus (2-8 barttin) retained barttin and human hClC-Ka channels in intracellular compartments. Partial N-terminal deletions did not compromise subcellular hClC-Ka trafficking but drastically reduced current amplitudes. Sequence deletions encompassing Thr-6, Phe-7, or Arg-8 in barttin completely failed to activate hClC-Ka. Analyses of protein expression and whole-cell current noise revealed that inactive channels reside in the plasma membrane. Substituting the deleted N terminus with a polyalanine sequence was insufficient for recovering chloride currents, and single amino acid substitutions highlighted that the correct sequence is required for proper function. Fast and slow gate activation curves obtained from rat V166E rClC-K1/barttin channels indicated that mutant barttin fails to constitutively open the slow gate. Increasing expression of barttin over that of ClC-K partially recovered this insufficiency, indicating that N-terminal modifications of barttin alter both binding affinities and gating properties.	[Wojciechowski, Daniel; Thiemann, Stefan; Schaal, Christina; Rahtz, Alina; de la Roche, Jeanne; Begemann, Birgit; Becher, Toni; Fischer, Martin] Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany	Hannover Medical School	Fischer, M (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	fischer.martin@mh-hannover.de						Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; Accardi A, 2015, J PHYSIOL-LONDON, V593, P4129, DOI 10.1113/JP270575; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Embark HM, 2004, KIDNEY INT, V66, P1918, DOI 10.1111/j.1523-1755.2004.00966.x; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00155; Fischer M., 2017, NEUROFORUM S, V23, pT6; Fischer M, 2010, J AM SOC NEPHROL, V21, P1281, DOI 10.1681/ASN.2009121274; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hebert SC, 2003, CURR OPIN NEPHROL HY, V12, P527, DOI 10.1097/00041552-200309000-00008; Imbrici P, 2014, BBA-BIOMEMBRANES, V1838, P2484, DOI 10.1016/j.bbamem.2014.05.017; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Kobayashi K, 2002, J AM SOC NEPHROL, V13, P1992, DOI 10.1097/01.ASN.0000023434.47132.3D; Kramer BK, 2008, NAT CLIN PRACT NEPHR, V4, P38, DOI 10.1038/ncpneph0689; Park E, 2017, NATURE, V541, P500, DOI 10.1038/nature20812; Pinelli L, 2016, J GEN PHYSIOL, V148, P213, DOI 10.1085/jgp.201611623; Riazuddin S, 2009, AM J HUM GENET, V85, P273, DOI 10.1016/j.ajhg.2009.07.003; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Seyberth HW, 2008, NAT CLIN PRACT NEPHR, V4, P560, DOI 10.1038/ncpneph0912; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Steinke KV, 2015, J BIOL CHEM, V290, P17390, DOI 10.1074/jbc.M114.631705; Stolting G, 2017, ACTA PHYSIOL, V219, P11, DOI 10.1111/apha.12802; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Tajima M, 2007, BIOCHEM BIOPH RES CO, V362, P858, DOI 10.1016/j.bbrc.2007.08.097; Uchida S, 2000, AM J PHYSIOL-RENAL, V279, pF802, DOI 10.1152/ajprenal.2000.279.5.F802; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Wojciechowski D, 2015, J BIOL CHEM, V290, P18732, DOI 10.1074/jbc.M114.625376	30	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8626	8637		10.1074/jbc.RA117.000860	http://dx.doi.org/10.1074/jbc.RA117.000860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29674316	Green Published, hybrid			2022-12-28	WOS:000434205700025
J	Zou, A; Magee, N; Deng, FY; Lehn, S; Zhong, CC; Zhang, YX				Zou, An; Magee, Nancy; Deng, Fengyan; Lehn, Sarah; Zhong, Cuncong; Zhang, Yuxia			Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; inflammation; liver injury; fibrosis; chemokine; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; small heterodimer partner	SMALL HETERODIMER PARTNER; FATTY LIVER-DISEASE; PROTEIN-KINASE; FRUCTOSE CONSUMPTION; PROGRESSION; ACIDS; GENE; FXR; ACTIVATION; EXPRESSION	Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem worldwide, ranging from nonalcoholic fatty liver (NAFL, steatosis without hepatocellular injury) to the more aggressive nonalcoholic steatohepatitis (NASH, steatosis with ballooning, inflammation, or fibrosis). Although many studies have greatly contributed to the elucidation of NAFLD pathogenesis, the disease progression from NAFL to NASH remains incompletely understood. Nuclear receptor small heterodimer partner (Nr0b2, SHP) is a transcriptional regulator critical for the regulation of bile acid, glucose, and lipid metabolism. Here, we show that SHP levels are decreased in the livers of patients with NASH and in diet-induced mouse NASH. Exposing primary mouse hepatocytes to palmitic acid and lipopolysaccharide in vitro, we demonstrated that the suppression of Shp expression in hepatocytes is due to c-Jun N-terminal kinase (JNK) activation, which stimulates c-Jun-mediated transcriptional repression of Shp. Interestingly, in vivo induction of hepatocyte-specific SHP in steatotic mouse liver ameliorated NASH progression by attenuating liver inflammation and fibrosis, but not steatosis. Moreover, a key mechanism linking the anti-inflammatory role of hepatocyte-specific SHP expression to inflammation involved SHP-induced suppression of NF-B p65-mediated induction of chemokine (C-C motif) ligand 2 (CCL2), which activates macrophage proinflammatory polarization and migration. In summary, our results indicate that a JNK/SHP/NF-B/CCL2 regulatory network controls communications between hepatocytes and macrophages and contributes to the disease progression from NAFL to NASH. Our findings may benefit the development of new management or prevention strategies for NASH.	[Zou, An; Magee, Nancy; Deng, Fengyan; Lehn, Sarah; Zhang, Yuxia] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Zhong, Cuncong] Univ Kansas, Dept Elect Engn & Comp Sci, Lawrence, KS 66045 USA; [Zhang, Yuxia] Univ Kansas, Med Ctr, Liver Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; University of Kansas Medical Center	Zhang, YX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA.	lzhang5@kumc.edu			National Institutes of Health [NCI K22CA184146, P20GM103549, P30GM11824, P20GM103418, T32ES007079]; NATIONAL CANCER INSTITUTE [K22CA184146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118247, P20GM103418, P20GM103549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants NCI K22CA184146, P20GM103549, P30GM11824, P20GM103418, and T32ES007079. The authors declare that they have no conflicts of interest with contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Aguilar-Olivos NE, 2015, ANN HEPATOL, V14, P487, DOI 10.1016/S1665-2681(19)31170-6; Ali AH, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.06; Anakk S, 2011, J CLIN INVEST, V121, P86, DOI 10.1172/JCI42846; Ansari AW, 2011, EUR J IMMUNOL, V41, P3412, DOI 10.1002/eji.201141676; Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Baylin A, 2002, AM J CLIN NUTR, V76, P750, DOI 10.1093/ajcn/76.4.750; Bechmann LP, 2013, HEPATOLOGY, V57, P1394, DOI 10.1002/hep.26225; Benet M, 2015, MOL PHARMACOL, V87, P582, DOI 10.1124/mol.114.096313; Bettermann K, 2014, INT J MOL SCI, V15, P9924, DOI 10.3390/ijms15069924; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Ding L, 2015, ACTA PHARM SIN B, V5, P135, DOI 10.1016/j.apsb.2015.01.004; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Ganz M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0552-7; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hoeke MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088011; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Ibrahim SH, 2016, HEPATOLOGY, V63, P731, DOI 10.1002/hep.28252; Janssen AWF, 2017, J LIPID RES, V58, P1399, DOI 10.1194/jlr.M075713; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Li GD, 2013, TOXICOL APPL PHARM, V272, P299, DOI 10.1016/j.taap.2013.06.016; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Magee N, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5170402; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Park YJ, 2011, J LIPID RES, V52, P2234, DOI 10.1194/jlr.M016048; Saiman Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00213; Seok S, 2013, J BIOL CHEM, V288, P23252, DOI 10.1074/jbc.M113.452037; Smalling RV, 2013, AM J PHYSIOL-GASTR L, V305, pG364, DOI 10.1152/ajpgi.00077.2013; Suh JH, 2006, J BIOL CHEM, V281, P39169, DOI 10.1074/jbc.M605947200; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Temple JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060947; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Vrochides D, 1996, HEPATOLOGY, V23, P1650, DOI 10.1053/jhep.1996.v23.pm0008675189; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Weiskirchen Ralf, 2014, Hepatobiliary Surg Nutr, V3, P344, DOI 10.3978/j.issn.2304-3881.2014.11.03; Win S, 2015, J HEPATOL, V62, P1367, DOI 10.1016/j.jhep.2015.01.032; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Yang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7115; Yang ZH, 2016, MOL CANCER THER, V15, P2294, DOI 10.1158/1535-7163.MCT-16-0153; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20559; Zhang YX, 2014, HEPATOLOGY, V60, P919, DOI 10.1002/hep.27121; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zou An, 2015, Nucl Receptor Res, V2	66	21	21	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8656	8671		10.1074/jbc.RA117.001653	http://dx.doi.org/10.1074/jbc.RA117.001653			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666185	hybrid, Green Published			2022-12-28	WOS:000434205700028
J	Bohl, TE; Ieong, P; Lee, JK; Lee, T; Kankanala, J; Shi, K; Demir, O; Kurahashi, K; Amaro, RE; Wang, ZQ; Aihara, H				Bohl, Thomas E.; Ieong, Pek; Lee, John K.; Lee, Thomas; Kankanala, Jayakanth; Shi, Ke; Demir, Ozlem; Kurahashi, Kayo; Amaro, Rommie E.; Wang, Zhengqiang; Aihara, Hideki			The substrate-binding cap of the UDP-diacylglucosamine pyrophosphatase LpxH is highly flexible, enabling facile substrate binding and product release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; hydrogen-deuterium exchange; molecular dynamics; lipopolysaccharide (LPS); lipid A; metalloenzyme; hydrolase; molecular docking; LpxH; pyrophosphatase	SOFTWARE; DYNAMICS; SYSTEM; RESISTANCE; ACCURACY; PYTHON; AMBER	Gram-negative bacteria are surrounded by a secondary membrane of which the outer leaflet is composed of the glycolipid lipopolysaccharide (LPS), which guards against hydrophobic toxins, including many antibiotics. Therefore, LPS synthesis in bacteria is an attractive target for antibiotic development. LpxH is a pyrophosphatase involved in LPS synthesis, and previous structures revealed that LpxH has a helical cap that binds its lipid substrates. Here, crystallography and hydrogen-deuterium exchange MS provided evidence for a highly flexible substrate-binding cap in LpxH. Furthermore, molecular dynamics simulations disclosed how the helices of the cap may open to allow substrate entry. The predicted opening mechanism was supported by activity assays of LpxH variants. Finally, we confirmed biochemically that LpxH is inhibited by a previously identified antibacterial compound, determined the potency of this inhibitor, and modeled its binding mode in the LpxH active site. In summary, our work provides evidence that the substrate-binding cap of LpxH is highly dynamic, thus allowing for facile substrate binding and product release between the capping helices. Our results also pave the way for the rational design of more potent LpxH inhibitors.	[Bohl, Thomas E.; Lee, John K.; Shi, Ke; Kurahashi, Kayo; Aihara, Hideki] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Kankanala, Jayakanth; Wang, Zhengqiang] Univ Minnesota Twin Cities, Ctr Drug Design, Minneapolis, MN 55455 USA; [Ieong, Pek; Amaro, Rommie E.] Univ Calif San Diego, Natl Biomed Computat Resource, La Jolla, CA 92093 USA; [Demir, Ozlem; Amaro, Rommie E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Lee, Thomas] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Lee, John K.] Bristol Myers Squibb, Redwood City, CA 94063 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Colorado System; University of Colorado Boulder; Bristol-Myers Squibb	Bohl, TE; Aihara, H (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	bohlx031@umn.edu; aihar001@umn.edu	Wang, Zhengqiang/AAN-4363-2021	Wang, Zhengqiang/0000-0002-1326-5986; , Ke/0000-0003-4175-3714; Bohl, Heather/0000-0003-0910-7456; Demir, Ozlem/0000-0002-3317-4731; KANKANALA, JAYAKANTH/0000-0002-9581-0844	NIGMS, National Institutes of Health [P41 GM103403, P41-GM103311]; National Institutes of Health-ORIP HEI [S10OD021527]; Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118000, P41GM103403, P41GM103311, P41GM103426, R35GM118047] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007237, S10OD021527] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-ORIP HEI; Office of Science by Argonne National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Surajit Banerjee for assistance at the Advanced Photon Source. In addition, we thank Kurt Peterson of Fluorescence Innovations for help in measuring luminescence. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are supported by NIGMS, National Institutes of Health Grant P41 GM103403. The Eiger 16M detector on 24-ID-E Beamline is funded by National Institutes of Health-ORIP HEI Grant S10OD021527. This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. UCSF Chimera was utilized for protein structure analysis and to generate figures; Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, which is supported by NIGMS, National Institutes of Health Grant P41-GM103311.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beceiro A, 2014, ANTIMICROB AGENTS CH, V58, P518, DOI 10.1128/AAC.01597-13; Bohl TE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02712-9; Bojkovic J, 2016, J BACTERIOL, V198, P731, DOI 10.1128/JB.00639-15; Case DA, 2014, AMBER 14; Cho J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.154, 10.1038/nmicrobiol.2016.154]; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frisch M.J., 2016, GAUSSIAN 09; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; LOPPNOW H, 1989, J IMMUNOL, V142, P3229; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Metzger LE, 2010, BIOCHEMISTRY-US, V49, P6715, DOI 10.1021/bi1008744; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nayar AS, 2015, J BACTERIOL, V197, P1726, DOI 10.1128/JB.02552-14; Okada C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32822; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podobnik M, 2009, J BIOL CHEM, V284, P32846, DOI 10.1074/jbc.M109.049635; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rodriguez S, 2000, LIPIDS, V35, P1033, DOI 10.1007/s11745-000-0615-x; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schariter JA, 2002, J LIQ CHROMATOGR R T, V25, P1615, DOI 10.1081/JLC-120005708; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sours KM, 2010, METHODS MOL BIOL, V661, P239, DOI 10.1007/978-1-60761-795-2_14; Sutterlin HA, 2016, P NATL ACAD SCI USA, V113, pE1565, DOI 10.1073/pnas.1601375113; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ventola C Lee, 2015, P T, V40, P344; Ventola C Lee, 2015, P T, V40, P277; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Young HE, 2016, MBIO, V7, DOI 10.1128/mBio.00090-16; Young HE, 2013, J BIOL CHEM, V288, P26987, DOI 10.1074/jbc.M113.497636	45	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7969	7981		10.1074/jbc.RA118.002503	http://dx.doi.org/10.1074/jbc.RA118.002503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626094	Green Published, hybrid			2022-12-28	WOS:000433224600005
J	Taylor, AA				Taylor, Alexandra A.			Finding peroxiredoxin's reducing system in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							REDUCTASE					alexandraataylor@gmail.com						CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; KIM KW, 1988, J BIOL CHEM, V263, P4704; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296	4	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4228	4229		10.1074/jbc.CL118.002460	http://dx.doi.org/10.1074/jbc.CL118.002460			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29667929	Green Published, hybrid			2022-12-28	WOS:000427587500032
J	Pertusa, M; Rivera, B; Gonzalez, A; Ugarte, G; Madrid, R				Pertusa, Maria; Rivera, Bastian; Gonzalez, Alejandro; Ugarte, Gonzalo; Madrid, Rodolfo			Critical role of the pore domain in the cold response of TRPM8 channels identified by ortholog functional comparison	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transient receptor potential channels (TRP channels); calcium imaging; dorsal root ganglia; patch clamp; signal transduction; chicken TRPM8; cold transduction; menthol; pore domain; somatosensory system; N-terminal domain; transmembrane domains	MULTIPLE SEQUENCE ALIGNMENT; TRPV1 ION-CHANNEL; TEMPERATURE ACTIVATION; HEAT ACTIVATION; RECEPTOR; SENSITIVITY; MENTHOL; REVEALS; THERMOSENSATION; STIMULI	In mammals, the main molecular entity involved in innocuous cold transduction is TRPM8. This polymodal ion channel is activated by cold, cooling compounds such as menthol and voltage. Despite its relevance, the molecular determinants involved in its activation by cold remain elusive. In this study we explored the use of TRPM8 orthologs with different cold responses as a strategy to identify new molecular determinants related with their thermosensitivity. We focused on mouse TRPM8 (mTRPM8) and chicken TRPM8 (cTRPM8), which present complementary thermosensitive and chemosensitive phenotypes. Although mTRPM8 displays larger responses to cold than cTRPM8 does, the avian ortholog shows a higher sensitivity to menthol compared with the mouse channel, in both HEK293 cells and primary somatosensory neurons. We took advantage of these differences to build multiple functional chimeras between these orthologs, to identify the regions that account for these discrepancies. Using a combination of calcium imaging and patch clamping, we identified a region encompassing positions 526-556 in the N terminus, whose replacement by the cTRPM8 homolog sequence potentiated its response to agonists. More importantly, we found that the characteristic cold response of these orthologs is due to nonconserved residues located within the pore loop, suggesting that TRPM8 has evolved by increasing the magnitude of its cold response through changes in this region. Our results reveal that these structural domains are critically involved in cold sensitivity and functional modulation of TRPM8, and support the idea that the pore domain is a key molecular determinant in temperature responses of this thermo-transient receptor potential (TRP) channel.	[Pertusa, Maria] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9160000, Chile; Univ Santiago Chile, Millennium Nucleus Ion Channels Associated Dis Mi, Santiago 9160000, Chile	Universidad de Santiago de Chile; Universidad de Santiago de Chile	Pertusa, M (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9160000, Chile.	maria.pertusa@usach.cl	Gonzalez, Alejandro/AAG-4444-2020	Gonzalez, Alejandro/0000-0001-7513-2516; Rivera, Bastian/0000-0003-1848-8334; Madrid, Rodolfo/0000-0002-8623-5761; Pertusa, Maria/0000-0003-3856-9019	Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [11130144, 1161733]; University of Santiago de Chile through the Direccion de Investigacion, Cientifica y Tecnologica (DICYT) [021843PP]; Iniciativa Cientifica Milenio through the Nucleo Milenio de Enfermedades Asociadas a Canales Ionicos (MiNICAD); Ministry of Economy, Development and Tourism, Chile; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [21161660]	Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); University of Santiago de Chile through the Direccion de Investigacion, Cientifica y Tecnologica (DICYT); Iniciativa Cientifica Milenio through the Nucleo Milenio de Enfermedades Asociadas a Canales Ionicos (MiNICAD); Ministry of Economy, Development and Tourism, Chile; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Fondo Nacional de Ciencia y Tecnologia (FONDECYT) Grants 11130144 (to M.P.) and 1161733 (to R.M.), by the University of Santiago de Chile through the Direccion de Investigacion, Cientifica y Tecnologica (DICYT) Grant 021843PP (to M.P.), and by the Iniciativa Cientifica Milenio through the Nucleo Milenio de Enfermedades Asociadas a Canales Ionicos (MiNICAD), funded by the Ministry of Economy, Development and Tourism, Chile. This work was also supported by the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) PhD Fellowship, Grant 21161660 (to B.R.). The authors declare that they have no conflicts of interest with the contents of this article.	Almaraz L, 2014, HANDB EXP PHARMACOL, V222, P547, DOI 10.1007/978-3-642-54215-2_22; Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bavencoffe A, 2010, J BIOL CHEM, V285, P9410, DOI 10.1074/jbc.M109.069377; Bidaux G, 2015, BIOPHYS J, V109, P1840, DOI 10.1016/j.bpj.2015.09.027; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Carrasquel-Ursulaez W., 2015, TEMPERATURE, V2, P188, DOI 10.1080/23328940.2015.1047558; Chen JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2596; Chowdhury S, 2014, CELL, V158, P1148, DOI 10.1016/j.cell.2014.07.026; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; de la Pena E, 2005, J PHYSIOL-LONDON, V567, P415, DOI 10.1113/jphysiol.2005.086546; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Gonzalez A, 2015, TRP CHANNELS SENSORY, P185; Gonzalez A, 2017, J NEUROSCI, V37, P3109, DOI 10.1523/JNEUROSCI.3553-16.2017; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; HEPPELMANN B, 1990, J COMP NEUROL, V292, P103, DOI 10.1002/cne.902920107; Hirschi M, 2017, NATURE, V550, P411, DOI 10.1038/nature24055; IRIUCHIJIMA J, 1960, ACTA PHYSIOL SCAND, V49, P267, DOI 10.1111/j.1748-1716.1960.tb01952.x; Islas L. D., 2017, NEUROBIOLOGY TRP CHA, P20; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Janssens A, 2011, J PHYSIOL-LONDON, V589, P4827, DOI 10.1113/jphysiol.2011.216523; de Vega MJP, 2016, J MED CHEM, V59, P10006, DOI 10.1021/acs.jmedchem.6b00305; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kim SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059593; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laursen WJ, 2016, P NATL ACAD SCI USA, V113, P11342, DOI 10.1073/pnas.1604269113; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Madrid R, 2014, CURR TOP MEMBR, V74, P293, DOI 10.1016/B978-0-12-800181-3.00011-7; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Malkia A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-62; Matos-Cruz V, 2017, CELL REP, V21, P3329, DOI 10.1016/j.celrep.2017.11.083; McKemy DD, 2013, ACS CHEM NEUROSCI, V4, P238, DOI 10.1021/cn300193h; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morin C, 1998, PAIN, V74, P67, DOI 10.1016/S0304-3959(97)00152-8; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pertusa M., 2012, MUTAGENESIS, P221; Pertusa M, 2014, J BIOL CHEM, V289, P21828, DOI 10.1074/jbc.M114.565994; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Raddatz N, 2014, J BIOL CHEM, V289, P35438, DOI 10.1074/jbc.M114.612713; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Saito S, 2016, J BIOL CHEM, V291, P11446, DOI 10.1074/jbc.M115.702498; Saito S, 2014, MOL BIOL EVOL, V31, P708, DOI 10.1093/molbev/msu001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Stewart AP, 2010, BIOCHEM BIOPH RES CO, V394, P383, DOI 10.1016/j.bbrc.2010.03.027; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Wang H, 2013, J PHYSIOL-LONDON, V591, P185, DOI 10.1113/jphysiol.2012.242842; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamamoto A, 2016, NEUROPHARMACOLOGY, V111, P130, DOI 10.1016/j.neuropharm.2016.08.039; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002	79	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12454	12471		10.1074/jbc.RA118.002256	http://dx.doi.org/10.1074/jbc.RA118.002256			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29880642	hybrid, Green Published			2022-12-28	WOS:000441408500012
J	Stern, AL; Van der Verren, SE; Kanchugal, PS; Nasvall, J; Gutierrez-de-Teran, H; Selmer, M				Stern, Ana Laura; Van der Verren, Sander Egbert; Kanchugal, Sandesh P.; Nasvall, Joakim; Gutierrez-de-Teran, Hugo; Selmer, Maria			Structural mechanism of AadA, a dual-specificity aminoglycoside adenylyltransferase from Salmonella enterica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; enzyme structure; enzyme mechanism; X-ray crystallography; antibiotics; ATP; spectinomycin; streptomycin	RESISTANCE; SEQUENCE	Streptomycin and spectinomycin are antibiotics that bind to the bacterial ribosome and perturb protein synthesis. The clinically most prevalent bacterial resistance mechanism is their chemical modification by aminoglycoside-modifying enzymes such as aminoglycoside nucleotidyltransferases (ANTs). AadA from Salmonella enterica is an aminoglycoside (3)(9) adenylyltransferase that O-adenylates position 3 of streptomycin and position 9 of spectinomycin. We previously reported the apo-AadA structure with a closed active site. To clarify how AadA binds ATP and its two chemically distinct drug substrates, we here report crystal structures of WT AadA complexed with ATP, magnesium, and streptomycin and of an active-site mutant, E87Q, complexed with ATP and streptomycin or the closely related dihydrostreptomycin. These structures revealed that ATP binding induces a conformational change that positions the two domains for drug binding at the interdomain cleft and disclosed the interactions between both domains and the three rings of streptomycin. Spectinomycin docking followed by molecular dynamics simulations suggested that, despite the limited structural similarities with streptomycin, spectinomycin makes similar interactions around the modification site and, in agreement with mutational data, forms critical interactions with fewer residues. Using structure-guided sequence analyses of ANT(3)(9) enzymes acting on both substrates and ANT(9) enzymes active only on spectinomycin, we identified sequence determinants for activity on each substrate. We experimentally confirmed that Trp-173 and Asp-178 are essential only for streptomycin resistance. Activity assays indicated that Glu-87 is the catalytic base in AadA and that the nonadenylating E87Q mutant can hydrolyze ATP in the presence of streptomycin.	[Stern, Ana Laura; Van der Verren, Sander Egbert; Kanchugal, Sandesh P.; Gutierrez-de-Teran, Hugo; Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, SE-75124 Uppsala, Sweden; [Nasvall, Joakim] Uppsala Univ, Dept Med Biochem & Microbiol, BMC, SE-75123 Uppsala, Sweden; [Van der Verren, Sander Egbert] Vrije Univ Brussel, Struct & Mol Microbiol, VIB VUB Ctr Struct Biol, Pl Laan 2, B-1050 Brussels, Belgium; [Van der Verren, Sander Egbert] Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium	Uppsala University; Uppsala University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel	Selmer, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, SE-75124 Uppsala, Sweden.	maria.selmer@icm.uu.se	Näsvall, Joakim/F-8750-2018	Näsvall, Joakim/0000-0002-6831-3105; Kanchugal P, Sandesh/0000-0001-5127-9695; Van der Verren, Sander/0000-0002-8783-1194; Selmer, Maria/0000-0001-9079-2774	Swedish Research Council [2013-05930, 2017-03827]; Knut and Alice Wallenberg Foundation (RiboCORE); European Community's Seventh Framework Programme (FP7) under BioStruct-X Grant [283570]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation (RiboCORE); European Community's Seventh Framework Programme (FP7) under BioStruct-X Grant	This work was supported by Swedish Research Council Grants 2013-05930 and 2017-03827 and the Knut and Alice Wallenberg Foundation (RiboCORE) (to M. S.) and by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X Grant Agreement 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Azucena E, 2001, DRUG RESIST UPDATE, V4, P106, DOI 10.1054/drup.2001.0197; Bassenden AV, 2016, ACS CHEM BIOL, V11, P1339, DOI 10.1021/acschembio.5b01070; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Becker B, 2013, ACS CHEM BIOL, V8, P105, DOI 10.1021/cb3005116; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chen Y, 2015, ACTA CRYSTALLOGR D, V71, P2267, DOI 10.1107/S1399004715016429; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clark NC, 1999, ANTIMICROB AGENTS CH, V43, P157, DOI 10.1093/jac/43.1.157; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HOLLINGSHEAD S, 1985, PLASMID, V13, P17, DOI 10.1016/0147-619X(85)90052-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim C, 2006, BIOCHEMISTRY-US, V45, P8368, DOI 10.1021/bi060723g; Koskiniemi S, 2011, MOL MICROBIOL, V80, P1464, DOI 10.1111/j.1365-2958.2011.07657.x; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minkenhof J. E., 1950, NED TIJDSCHR GENEES, V94, P2129; Morar M, 2009, STRUCTURE, V17, P1649, DOI 10.1016/j.str.2009.10.013; Nasvall J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184126; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nirdnoy W, 2005, ANTIMICROB AGENTS CH, V49, P2454, DOI 10.1128/AAC.49.6.2454-2459.2005; Papadovasilaki Maria, 2015, Biochem Biophys Rep, V4, P152, DOI 10.1016/j.bbrep.2015.09.011; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	41	18	19	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11481	11490		10.1074/jbc.RA118.003989	http://dx.doi.org/10.1074/jbc.RA118.003989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871922	Green Published, hybrid			2022-12-28	WOS:000439449700018
J	Yanda, MK; Liu, QN; Cebotaru, L				Yanda, Murali K.; Liu, Qiangni; Cebotaru, Liudmila			A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; cell signaling; chaperone; drug action; fucosyltransferase; glucose metabolism; I-cell disease (mucolipidosis II); ion channel; autosomal dominant polycystic kidney disease; renal cyst growth; VX-809; cystic fibrosis transmembrane conductance regulator (CFTR); kidney disfunction; heat shock protein; Hsp90	ENDOPLASMIC-RETICULUM STRESS; EPITHELIAL-CELLS; IN-VITRO; FIBROSIS; PROTEIN; PROTEOSTASIS; CANCER; GROWTH; DELTA-F508-CFTR; INHIBITION	Autosomal dominant polycystic kidney disease (ADPKD) is associated with progressive enlargement of cysts, leading to a decline in function and renal failure that cannot be prevented by current treatments. Mutations in pkd1 and pkd2, encoding the polycystin 1 and 2 proteins, induce growth-related pathways, including heat shock proteins, as occurs in some cancers, raising the prospect that pharmacological interventions that target these pathways might alleviate or prevent ADPKD. Here, we demonstrate a role for VX-809, a corrector of cystic fibrosis transmembrane conductance regulator (CFTR), conventionally used to manage cystic fibrosis in reducing renal cyst growth. VX-809 reduced cyst growth in Pkd1-knockout mice and in proximal, tubule-derived, cultured Pkd1 knockout cells. VX-809 reduced both basal and forskolin-activated cAMP levels and also decreased the expression of the adenylyl cyclase AC3 but not of AC6. VX-809 also decreased resting levels of intracellular Ca2+ but did not affect ATP-stimulated Ca2+ release. Notably, VX-809 dramatically decreased thapsigargin-induced release of Ca2+ from the endoplasmic reticulum (ER). VX-809 also reduced the levels of heat shock proteins Hsp27, Hsp70, and Hsp90 in mice cystic kidneys, consistent with the restoration of cellular proteostasis. Moreover, VX-809 strongly decreased an ER stress marker, the GADD153 protein, and cell proliferation but had only a small effect on apoptosis. Given that administration of VX-809 is safe, this drug potentially offers a new way to treat patients with ADPKD.	[Yanda, Murali K.; Liu, Qiangni; Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Cebotaru, L (corresponding author), Johns Hopkins Univ, Sch Med, Hunterian 415,725 N Wolfe St, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu	Yanda, Murali K/N-2324-2019	Yanda, Murali K/0000-0002-4913-470X; Cebotaru, Liudmila/0000-0002-4362-8995	NIDDK NIH HHS [P30 DK089502, P30 DK090868] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868, P30DK089502] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Al-Bhalal L, 2005, ADV ANAT PATHOL, V12, P126, DOI 10.1097/01.pap.0000163959.29032.1f; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bastos AP, 2011, BRAZ J MED BIOL RES, V44, P606, DOI [10.1590/S0100-879X2011007500068, 10.1590/S0100-879X2011000700001]; Bobo LD, 2013, INFECT IMMUN, V81, P713, DOI 10.1128/IAI.00186-12; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Cebotaru L, 2016, KIDNEY INT, V90, P90, DOI 10.1016/j.kint.2016.01.026; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; El-Hariry I., 2014, U. S. Patent, Patent No. [US8906885B2, 8906885]; FULLER CM, 1992, AM J PHYSIOL, V263, pC267, DOI 10.1152/ajpcell.1992.263.2.C267; Gurlo T, 2016, MOL ENDOCRINOL, V30, P446, DOI 10.1210/me.2015-1255; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Hanaoka K, 1996, AM J PHYSIOL-CELL PH, V270, pC389, DOI 10.1152/ajpcell.1996.270.1.C389; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Ikeda M, 2006, CELL PHYSIOL BIOCHEM, V18, P9, DOI 10.1159/000095133; Joly D, 2006, J BIOL CHEM, V281, P26329, DOI 10.1074/jbc.M601373200; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Li Y, 2009, J BIOL CHEM, V284, P36431, DOI 10.1074/jbc.M109.068916; Lopes-Pacheco M, 2015, J BIOL CHEM, V290, P25636, DOI 10.1074/jbc.M115.671925; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Mangolini Alessandra, 2016, World J Nephrol, V5, P76, DOI 10.5527/wjn.v5.i1.76; Menzies RI, 2017, KIDNEY INT, V91, P315, DOI 10.1016/j.kint.2016.08.029; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Persson AEG, 2015, ACTA PHYSIOL, V213, P805, DOI 10.1111/apha.12459; Peters KW, 2011, METHODS MOL BIOL, V742, P335, DOI 10.1007/978-1-61779-120-8_20; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Proia D., 2015, U. S. Patent, Patent No. [US20150283147A1, 20150283147]; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Rieg T, 2014, AM J PHYSIOL-RENAL, V306, pF701, DOI 10.1152/ajprenal.00656.2013; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenstein BJ, 1998, LANCET, V351, P277, DOI 10.1016/S0140-6736(97)09174-5; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Santoso NG, 2011, CELL PHYSIOL BIOCHEM, V27, P715, DOI 10.1159/000330080; Seeger-Nukpezah T, 2013, P NATL ACAD SCI USA, V110, P12786, DOI 10.1073/pnas.1301904110; Shen TS, 1997, AM J PHYSIOL-CELL PH, V273, pC323, DOI 10.1152/ajpcell.1997.273.1.C323; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Southwood XC, 2016, J NEUROSCI, V36, P6803, DOI 10.1523/JNEUROSCI.1118-15.2016; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; Torres V E, 2007, Minerva Med, V98, P669; Torres VE, 2015, ANNU REV MED, V66, P195, DOI 10.1146/annurev-med-050913-022838; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Umemura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089292; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang XX, 2014, INT J ONCOL, V45, P18, DOI 10.3892/ijo.2014.2399; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wei F, 2008, KIDNEY INT, V74, P1310, DOI 10.1038/ki.2008.395; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yanda MK, 2017, J BIOL CHEM, V292, P17897, DOI 10.1074/jbc.M117.803775; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327	65	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11513	11526		10.1074/jbc.RA118.001846	http://dx.doi.org/10.1074/jbc.RA118.001846			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29875161	Green Published, hybrid			2022-12-28	WOS:000439449700021
J	AlAbdi, L; He, M; Yang, QY; Norvil, AB; Gowher, H				AlAbdi, Lama; He, Ming; Yang, Qianyi; Norvil, Allison B.; Gowher, Humaira			The transcription factor Vezf1 represses the expression of the antiangiogenic factor Cited2 in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; endothelial cell; cell differentiation; E1A-binding protein p300 (P300); gene regulation; chromatin immunoprecipitation (ChiP); DNA methylation; histone acetylation; vascular endothelial growth factor (VEGF); angiogenesis; Cited2; H3K27 acetylation; Vezf1	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; EMBRYONIC STEM-CELLS; GROWTH-FACTOR; NEGATIVE REGULATOR; DOWNSTREAM TARGET; HEART DEVELOPMENT; DNA METHYLATION; GENE-EXPRESSION; FACTOR-I; DIFFERENTIATION	Formation of the vasculature by angiogenesis is critical for proper development, but angiogenesis also contributes to the pathogenesis of various disorders, including cancer and cardiovascular diseases. Vascular endothelial zinc finger 1 (Vezf1), is a Kruppel-like zinc finger protein that plays a vital role in vascular development. However, the mechanism by which Vezf1 regulates this process is not fully understood. Here, we show that Vezf1(-/-) mouse embryonic stem cells (ESC) have significantly increased expression of a stem cell factor, Cbp/p300-interacting transactivator 2 (Cited2). Compared with WT ESCs, Vezf1(-/-) ESCs inefficiently differentiated into endothelial cells (ECs), which exhibited defects in the tube-formation assay. These defects were due to reduced activation of EC-specific genes concomitant with lower enrichment of histone 3 acetylation at Lys(27) (H3K27) at their promoters. We hypothesized that overexpression of Cited2 in Vezf1(-/-) cells sequesters P300/CBP away from the promoters of proangiogenic genes and thereby contributes to defective angiogenesis in these cells. This idea was supported by the observation that shRNA-mediated depletion of Cited2 significantly reduces the angiogenic defects in the Vezf1(-/-) ECs. In contrast to previous studies that have focused on the role of Vezf1 as a transcriptional activator of proangiogenic genes, our findings have revealed a role for Vezf1 in modulating the expression of the antiangiogenic factor Cited2. Vezf1 previously has been characterized as an insulator protein, and our results now provide insights into the mechanism, indicating that Vezf1 can block inappropriate, nonspecific interactions of promoters with cis-located enhancers, preventing aberrant promoter activation.	[AlAbdi, Lama; He, Ming; Yang, Qianyi; Norvil, Allison B.; Gowher, Humaira] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Gowher, Humaira] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Yang, Qianyi] Washington Univ, Sch Med, Dept Anesthesiol, 660 S Euclid Ave, St Louis, MO 63110 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Washington University (WUSTL)	Gowher, H (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.; Gowher, H (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	hgowher@purdue.edu	Yang, Qianyi/AAW-6730-2021; Gowher, Humaira/AAG-7112-2019	Norvil, Allison/0000-0001-8551-0269; Gowher, Humaira/0000-0002-1250-9571	American Heart Association (AHA) Scientist Development Award [17SDG33700153]; King Saud University (KSU); NCI, National Institutes of Health [P30 CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118654] Funding Source: NIH RePORTER	American Heart Association (AHA) Scientist Development Award(American Heart Association); King Saud University (KSU)(King Saud University); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association (AHA) Scientist Development Award 17SDG33700153 (to H.G.) a Graduate Student Fellowship from the King Saud University (KSU) (to L.A.) and NCI, National Institutes of Health Grant P30 CA023168. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Aitsebaomo J, 2001, J BIOL CHEM, V276, P39197, DOI 10.1074/jbc.M105166200; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Bruderer M, 2013, J VASC RES, V50, P265, DOI 10.1159/000353287; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; CLARK SP, 1990, NUCLEIC ACIDS RES, V18, P5119, DOI 10.1093/nar/18.17.5119; Deudero JJP, 2008, J BIOL CHEM, V283, P11435, DOI 10.1074/jbc.M703875200; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Du JW, 2013, CURR OPIN HEMATOL, V20, P301, DOI 10.1097/MOH.0b013e3283606022; Du JW, 2012, CELL CYCLE, V11, P2413, DOI 10.4161/cc.20803; Eccles SA, 2005, BIOTECHNOL ANN REV, V11, P391, DOI 10.1016/S1387-2656(05)11013-8; Fox SB, 2004, CANCER RES, V64, P6075, DOI 10.1158/0008-5472.CAN-04-0708; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Gerald D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3824; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Gowher H, 2008, GENE DEV, V22, P2075, DOI 10.1101/gad.1658408; Gowher H, 2012, P NATL ACAD SCI USA, V109, P2370, DOI 10.1073/pnas.1121538109; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Imanirad P, 2013, BLOOD CELL MOL DIS, V51, P256, DOI 10.1016/j.bcmd.2013.08.005; KOYANONAKAGAWA N, 1994, MOL CELL BIOL, V14, P5099, DOI 10.1128/MCB.14.8.5099; Kranc KR, 2015, STEM CELLS, V33, P699, DOI 10.1002/stem.1889; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kuhnert F, 2005, DEV BIOL, V283, P140, DOI 10.1016/j.ydbio.2005.04.003; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lebowitz PF, 1998, CELL ADHES COMMUN, V6, P277, DOI 10.3109/15419069809010787; Lee JY, 2009, BIOCHEM BIOPH RES CO, V387, P641, DOI 10.1016/j.bbrc.2009.07.029; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Miyashita H, 2005, ENDOTHELIUM-J ENDOTH, V12, P163, DOI 10.1080/10623320500227101; Miyashita H, 2004, ARTERIOSCL THROM VAS, V24, P878, DOI 10.1161/01.ATV.0000126373.52450.32; Pacheco-Leyva I, 2016, STEM CELL REP, V7, P1037, DOI 10.1016/j.stemcr.2016.10.002; Petell CJ, 2016, NUCLEIC ACIDS RES, V44, P7605, DOI 10.1093/nar/gkw426; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Xiong JW, 1999, DEV BIOL, V206, P123, DOI 10.1006/dbio.1998.9144; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yang SY, 2001, ARTERIOSCL THROM VAS, V21, P1934, DOI 10.1161/hq1201.099432; Yang Z, 2008, LIFE SCI, V82, P512, DOI 10.1016/j.lfs.2007.12.005; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zou ZM, 2010, ARTERIOSCL THROM VAS, V30, P1378, DOI 10.1161/ATVBAHA.109.200428	47	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11109	11118		10.1074/jbc.RA118.002911	http://dx.doi.org/10.1074/jbc.RA118.002911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794136	hybrid, Green Published			2022-12-28	WOS:000438882800023
J	Bishof, I; Dammer, EB; Duong, DM; Kundinger, SR; Gearing, M; Lah, JJ; Levey, AI; Seyfried, NT				Bishof, Isaac; Dammer, Eric B.; Duong, Duc M.; Kundinger, Sean R.; Gearing, Marla; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.			RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; protein aggregation; systems biology; Tau protein (Tau); neurodegeneration; mass spectrometry (MS); proteomics; RNA-binding protein; intrinsically disordered protein; RNA processing	FRONTOTEMPORAL LOBAR DEGENERATION; PRION-LIKE DOMAINS; AMYOTROPHIC-LATERAL-SCLEROSIS; INSOLUBLE BRAIN PROTEOME; LOW-COMPLEXITY DOMAINS; NEURODEGENERATIVE DISEASES; MESSENGER-RNA; NUCLEAR-LOCALIZATION; NETWORK APPROACH; TAU	The U1 small nuclear ribonucleoprotein 70 kDa (U1-70K) and other RNA-binding proteins (RBPs) are mislocalized to cytoplasmic neurofibrillary Tau aggregates in Alzheimer's disease (AD), yet the co-aggregation mechanisms are incompletely understood. U1-70K harbors two disordered low-complexity domains (LC1 and LC2) that are necessary for aggregation in AD brain extracts. The LC1 domain contains highly repetitive basic (Arg/Lys) and acidic (Asp/Glu) residues, referred to as a basic-acidic dipeptide (BAD) domain. We report here that this domain shares many of the properties of the Gln/Asn-rich LC domains in RBPs that also aggregate in neurodegenerative disease. These properties included self-assembly into oligomers and localization to nuclear granules. Co-immunoprecipitations of recombinant U1-70K and deletions lacking the LC domain(s) followed by quantitative proteomic analyses were used to resolve functional classes of U1-70K-interacting proteins that depend on the BAD domain for their interaction. Within this interaction network, we identified a class of RBPs with BAD domains nearly identical to that found in U1-70K. Two members of this class, LUC7L3 and RBM25, required their respective BAD domains for reciprocal interactions with U1-70K and nuclear granule localization. Strikingly, a significant proportion of RBPs with BAD domains had elevated insolubility in the AD brain proteome. Furthermore, we show that the BAD domain of U1-70K can interact with Tau from AD brains but not from other tauopathies. These findings highlight a mechanistic role for BAD domains in stabilizing RBP interactions and in potentially mediating co-aggregation with the pathological AD-specific Tau isoforms.	[Bishof, Isaac; Dammer, Eric B.; Duong, Duc M.; Kundinger, Sean R.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA; [Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Gearing, Marla] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Bishof, Isaac; Dammer, Eric B.; Duong, Duc M.; Kundinger, Sean R.; Gearing, Marla; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Seyfried, NT (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	nseyfri@emory.edu	Levey, Allan/F-2104-2011; Dammer, Eric B/V-8652-2019	Levey, Allan/0000-0002-3153-502X; Dammer, Eric B/0000-0003-2947-7606; Duong, Duc/0000-0001-5880-1888	National Institutes of Health, NINDS [P30NS055077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007480, P30NS055077, F31NS093859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, U01AG046161, R01AG053960, R21AG054206] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge Drs. Anita Corbett (Emory Department of Biology) and Daniel Reines (Emory Department of Biochemistry) for providing helpful comments to the manuscript. We also thank Dr. Measho Abreha for technical advice on brain homogenization and immunoprecipitation conditions. Finally, we acknowledge David S. Sanders who on Twitter created the Basic-Acidic Dipeptide (BAD) domain acronym after reading our paper on bioRxiv (https://www.biorxiv.org/). Research reported in this publication was supported in part by the Emory Neuroscience NINDS Core Facilities (Grant P30NS055077) from the National Institutes of Health, NINDS.	Allen M, 2018, ALZHEIMERS DEMENT, V14, P352, DOI 10.1016/j.jalz.2017.09.012; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Apicco DJ, 2018, NAT NEUROSCI, V21, P72, DOI 10.1038/s41593-017-0022-z; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cherry JD, 2018, J NEUROPATH EXP NEUR, V77, P40, DOI 10.1093/jnen/nlx100; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dammer EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038658; Diner I, 2014, J BIOL CHEM, V289, P35296, DOI 10.1074/jbc.M114.562959; Egloff S, 2017, EMBO J, V36, P934, DOI 10.15252/embj.201695740; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Falkenberg CV, 2017, BIOPHYS J, V113, P235, DOI 10.1016/j.bpj.2017.01.031; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; FLAMENT S, 1991, ACTA NEUROPATHOL, V81, P591, DOI 10.1007/BF00296367; Freibaum BD, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00035; Hales CM, 2016, PROTEOMICS, V16, P3042, DOI 10.1002/pmic.201600057; Hales CM, 2014, BRAIN PATHOL, V24, P344, DOI 10.1111/bpa.12133; Hales CM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-15; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Howell VM, 2007, HUM MOL GENET, V16, P2506, DOI 10.1093/hmg/ddm206; Jaiswal M, 2012, ANNU REV GENET, V46, P371, DOI 10.1146/annurev-genet-110711-155456; Karpievitch YV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S5; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36741; Liu-Yesucevitz L, 2014, J NEUROSCI, V34, P4167, DOI 10.1523/JNEUROSCI.2350-13.2014; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Maziuk B, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00089; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Raj T, 2017, BIORXIV, DOI [10.1101/174565, DOI 10.1101/174565]; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; ROMAC JMJ, 1995, GENE DEV, V9, P1400, DOI 10.1101/gad.9.11.1400; ROMAC JMJ, 1994, MOL CELL BIOL, V14, P4662, DOI 10.1128/MCB.14.7.4662; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Shaw DJ, 2010, J BIOCHEM, V147, P885, DOI 10.1093/jb/mvq025; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stejskalova E, 2014, J CELL SCI, V127, P3909, DOI 10.1242/jcs.155838; Umoh ME, 2018, EMBO MOL MED, V10, P48, DOI 10.15252/emmm.201708202; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vance C, 2013, HUM MOL GENET, V22, P2676, DOI 10.1093/hmg/ddt117; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Webb CHT, 2014, METHODS MOL BIOL, V1126, P117, DOI 10.1007/978-1-62703-980-2_8; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wolozin B, 2015, ADV EXP MED BIOL, V822, P11, DOI 10.1007/978-3-319-08927-0_3; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08	79	33	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11047	11066		10.1074/jbc.RA118.001747	http://dx.doi.org/10.1074/jbc.RA118.001747			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29802200	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000438882800018
J	Guo, Q; Grimmig, T; Gonzalez, G; Giobbie-Hurder, A; Berg, G; Carr, N; Wilson, BJ; Banerjee, P; Ma, J; Gold, JS; Nandi, B; Huang, Q; Waaga-Gasser, AM; Lian, CG; Murphy, GF; Frank, MH; Gasser, M; Frank, NY				Guo, Qin; Grimmig, Tanja; Gonzalez, Gabriel; Giobbie-Hurder, Anita; Berg, Gretchen; Carr, Nolan; Wilson, Brian J.; Banerjee, Pallavi; Ma, Jie; Gold, Jason S.; Nandi, Bisweswar; Huang, Qin; Waaga-Gasser, Ana Maria; Lian, Christine G.; Murphy, George F.; Frank, Markus H.; Gasser, Martin; Frank, Natasha Y.			ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; COLON-CANCER; DRUG-RESISTANCE; CARCINOMA-CELLS; LUNG-CANCER; MELANOMA; AXL; PROGRESSION; REGULATOR	ABC member B5 (ABCB5) mediates multidrug resistance (MDR) in diverse malignancies and confers clinically relevant 5-fluorouracil resistance to CD133-expressing cancer stem cells in human colorectal cancer (CRC). Because of its recently identified roles in normal stem cell maintenance, we hypothesized that ABCB5 might also serve MDR-independent functions in CRC. Here, in a prospective clinical study of 142 CRC patients, we found that ABCB5 mRNA transcripts previously reported not to be significantly expressed in healthy peripheral blood mononuclear cells are significantly enriched in patient peripheral blood specimens compared with non-CRC controls and correlate with CRC disease progression. In human-to-mouse CRC tumor xenotransplantation models that exhibited circulating tumor mRNA, we observed that cancer-specific ABCB5 knockdown significantly reduced detection of these transcripts, suggesting that the knockdown inhibited tumor invasiveness. Mechanistically, this effect was associated with inhibition of expression and downstream signaling of AXL receptor tyrosine kinase (AXL), a proinvasive molecule herein shown to be produced by ABCB5-positive CRC cells. Importantly, rescue of AXL expression in ABCB5-knockdown CRC tumor cells restored tumor-specific transcript detection in the peripheral blood of xenograft recipients, indicating that ABCB5 regulates CRC invasiveness, at least in part, by enhancing AXL signaling. Our results implicate ABCB5 as a critical determinant of CRC invasiveness and suggest that ABCB5 blockade might represent a strategy in CRC therapy, even independently of ABCB5's function as an MDR mediator.	[Guo, Qin; Gonzalez, Gabriel; Berg, Gretchen; Carr, Nolan; Banerjee, Pallavi; Frank, Natasha Y.] Vet Affairs Boston Healthcare Syst, Dept Med, Boston, MA 02132 USA; [Gold, Jason S.; Nandi, Bisweswar] Vet Affairs Boston Healthcare Syst, Dept Surg, Boston, MA 02132 USA; [Huang, Qin] Vet Affairs Boston Healthcare Syst, Dept Pathol, Boston, MA 02132 USA; [Guo, Qin; Gonzalez, Gabriel; Frank, Natasha Y.] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Gold, Jason S.; Nandi, Bisweswar] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Lian, Christine G.; Murphy, George F.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wilson, Brian J.; Frank, Markus H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Guo, Qin; Berg, Gretchen; Wilson, Brian J.; Banerjee, Pallavi; Ma, Jie; Frank, Markus H.; Frank, Natasha Y.] Harvard Med Sch, Boston Childrens Hosp, Transplant Res Program, Boston, MA 02115 USA; [Grimmig, Tanja; Waaga-Gasser, Ana Maria; Gasser, Martin] Univ Wurzburg, Dept Surg, D-97070 Wurzburg, Germany; [Giobbie-Hurder, Anita] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Wilson, Brian J.; Murphy, George F.; Frank, Markus H.; Frank, Natasha Y.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Wurzburg; Harvard University; Dana-Farber Cancer Institute; Harvard University	Frank, NY (corresponding author), Vet Affairs Boston Healthcare Syst, 1400 VFW Pkwy, Boston, MA 02132 USA.	nyfrank@bwh.harvard.edu	Nandi, Bisweswar/N-5815-2019; Gold, Jason S./O-5112-2014; Giobbie-Hurder, Anita/AAU-6193-2021; Frank, Markus/O-1625-2014	Gold, Jason S./0000-0002-2925-4755; Frank, Markus/0000-0002-1312-0488	Veterans Affairs Grants [BLRD 1I01BX000516, RRD 1I01RX000989]; Department of Defense translational team science award; NCI, National Institutes of Health [R01CA113796, R01CA158467, R01CA138231]; NATIONAL CANCER INSTITUTE [R01CA138231, R01CA113796, R01CA158467] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000989, I01BX000516] Funding Source: NIH RePORTER	Veterans Affairs Grants; Department of Defense translational team science award; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Grants BLR&D 1I01BX000516 and RR&D 1I01RX000989 Merit Review Awards and a Department of Defense translational team science award (to N.Y.F.) and NCI, National Institutes of Health, Grants R01CA113796, R01CA158467, and R01CA138231 (to M.H.F.). N.Y.F. and M.H.F. are co-inventors of the ABCB5-related United States patent 7,928,202 (Targeting ABCB5 for cancer therapy) assigned to Brigham and Women's Hospital (Boston, Massachusetts) and licensed to Ticeba GmbH (Heidelberg, Germany) and Rheacell GmbH & Co. KG (Heidelberg, Germany). M.H.F. serves as a scientific advisor to Ticeba GmbH and Rheacell GmbH & Co. KG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Aya-Bonilla C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-390; Bates RC, 2004, EXP CELL RES, V299, P315, DOI 10.1016/j.yexcr.2004.05.033; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Chartrain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036762; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107013; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; Cheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115339; Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dunne PD, 2014, CLIN CANCER RES, V20, P164, DOI 10.1158/1078-0432.CCR-13-1354; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Frank NY, 2006, J CELL BIOL, V175, P99, DOI 10.1083/jcb.200511036; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gray ES, 2015, J INVEST DERMATOL, V135, P2040, DOI 10.1038/jid.2015.127; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Kugimiya N, 2015, J CELL MOL MED, V19, P1569, DOI 10.1111/jcmm.12531; Liu YN, 2015, ONCOTARGET, V6, P10415, DOI 10.18632/oncotarget.3389; Ma J, 2010, BIOCHEM BIOPH RES CO, V402, P711, DOI 10.1016/j.bbrc.2010.10.091; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Quintana E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004599; Reid AL, 2013, BRIT J DERMATOL, V168, P85, DOI 10.1111/bjd.12057; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schmiegel W, 2010, Z GASTROENTEROL, V48, P65, DOI 10.1055/s-0028-1109936; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vuorte J, 2001, CYTOMETRY, V43, P290, DOI 10.1002/1097-0320(20010401)43:4<290::AID-CYTO1061>3.0.CO;2-X; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Wilson BJ, 2011, CURR COLORECT CANC R, V7, P128, DOI 10.1007/s11888-011-0093-2; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221; WOLMARK N, 1983, CANCER, V51, P1315, DOI 10.1002/1097-0142(19830401)51:7<1315::AID-CNCR2820510723>3.0.CO;2-0; Yang G, 2015, MOL MED REP, V12, P3930, DOI 10.3892/mmr.2015.3890; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	54	32	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11166	11178		10.1074/jbc.RA118.003187	http://dx.doi.org/10.1074/jbc.RA118.003187			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789423	Green Published, hybrid			2022-12-28	WOS:000438882800028
J	O'Leary, EI; Jiang, ZP; Strub, MP; Lee, JC				O'Leary, Emma I.; Jiang, Zhiping; Strub, Marie-Paule; Lee, Jennifer C.			Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated -synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; NEUTRON REFLECTOMETRY; AMPHIPATHIC HELIX; LIPID VESICLES; PHASE-BEHAVIOR; A-SYNUCLEIN; HUMAN BRAIN; IN-VITRO; BINDING	Membrane association of -synuclein (-syn), a neuronal protein associated with Parkinson's disease (PD), is involved in -syn function and pathology. Most previous studies on -syn-membrane interactions have not used the physiologically relevant N-terminally acetylated (N-acetyl) -syn form nor the most naturally abundant cellular lipid, i.e. phosphatidylcholine (PC). Here, we report on how PC membrane fluidity affects the conformation and aggregation propensity of N-acetyl -syn. It is well established that upon membrane binding, -syn adopts an -helical structure. Using CD spectroscopy, we show that N-acetyl -syn transitions from -helical to disordered at the lipid melting temperature (T-m). We found that this fluidity sensing is a robust characteristic, unaffected by acyl chain length (T-m = 34-55 degrees C) and preserved in its homologs - and -syn. Interestingly, both N-acetyl -syn membrane binding and amyloid formation trended with lipid order (1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) > 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)/sphingomyelin/cholesterol (2:2:1) DOPC), with gel-phase vesicles shortening aggregation kinetics and promoting fibril formation compared to fluid membranes. Furthermore, we found that acetylation enhances binding to PC micelles and small unilamellar vesicles with high curvature (r approximate to 16-20 nm) and that DPPC binding is reduced in the presence of cholesterol. These results confirmed that the exposure of hydrocarbon chains (i.e. packing defects) is essential for binding to zwitterionic gel membranes. Collectively, our in vitro results suggest that N-acetyl -syn localizes to highly curved, ordered membranes inside a cell. We propose that age-related changes in membrane fluidity can promote the formation of amyloid fibrils, insoluble materials associated with PD.	[O'Leary, Emma I.; Jiang, Zhiping; Lee, Jennifer C.] NHLBI, Lab Prot Conformat & Dynam, NIH, Bldg 10, Bethesda, MD 20892 USA; [Strub, Marie-Paule] NHLBI, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lee, JC (corresponding author), NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA.	leej4@mail.nih.gov	O'Leary, Emma/P-9387-2019	O'Leary, Emma/0000-0002-6437-3848	Intramural Research Program at the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001055] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program at the National Institutes of Health, NHLBI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Brisbois CA, 2016, BIOCHEMISTRY-US, V55, P4939, DOI 10.1021/acs.biochem.6b00599; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Chong SSY, 2014, BIOCHEMISTRY-US, V53, P450, DOI 10.1021/bi401457r; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fabelo N, 2011, MOL MED, V17, P1107, DOI 10.2119/molmed.2011.00119; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fujita Y, 2006, ACTA NEUROPATHOL, V112, P261, DOI 10.1007/s00401-006-0114-4; Galvagnion C, 2017, J PARKINSON DIS, V7, P433, DOI 10.3233/JPD-171103; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jiang ZP, 2017, J PHYS CHEM LETT, V8, P29, DOI 10.1021/acs.jpclett.6b02304; Jiang ZP, 2015, J PHYS CHEM B, V119, P4812, DOI 10.1021/jp512499r; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Kranenburg M, 2005, J PHYS CHEM B, V109, P6553, DOI 10.1021/jp0457646; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Leftin A, 2013, J MOL BIOL, V425, P2973, DOI 10.1016/j.jmb.2013.04.002; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; Levi M, 1997, MECH AGEING DEV, V97, P109, DOI 10.1016/S0047-6374(97)00047-X; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; McGlinchey RP, 2017, BIOCHEMISTRY-US, V56, P3881, DOI 10.1021/acs.biochem.7b00360; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Pirc K, 2015, BBA-BIOMEMBRANES, V1848, P2002, DOI 10.1016/j.bbamem.2015.06.021; Quinn PJ, 2009, BBA-BIOMEMBRANES, V1788, P33, DOI 10.1016/j.bbamem.2008.08.005; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; Vargas KJ, 2017, CELL REP, V18, P161, DOI 10.1016/j.celrep.2016.12.023; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Xu LJ, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/1720621; Yap TL, 2015, J BIOL CHEM, V290, P744, DOI 10.1074/jbc.M114.610584; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010	68	52	52	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11195	11205		10.1074/jbc.RA118.002780	http://dx.doi.org/10.1074/jbc.RA118.002780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29853639	Green Published, hybrid			2022-12-28	WOS:000438882800030
J	Teixeira, RD; Guzzo, CR; Arevalo, SJ; Andrade, MO; Abrahao, J; de Souza, RF; Farah, CS				Teixeira, Raphael D.; Guzzo, Cristiane R.; Arevalo, Santiago Justo; Andrade, Maxuel O.; Abrahao, Josielle; de Souza, Robson F.; Farah, Chuck S.			A bipartite periplasmic receptor-diguanylate cyclase pair (XAC2383-XAC2382) in the bacterium Xanthomonas citri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic di-GMP (c-di-GMP); bacterial signal transduction; structural biology; receptor; cell motility; phytopathogen; plant pathogen; Xanthomonas	CYCLIC-DI-GMP; ABC-TRANSPORTER; BINDING-PROTEIN; EXOPOLYSACCHARIDE PRODUCTION; MYCOBACTERIUM-SMEGMATIS; CATALYTIC MECHANISM; RESPONSE REGULATOR; ALLOSTERIC CONTROL; SWARMING MOTILITY; CRYSTAL-STRUCTURE	The second messenger cyclic diguanylate monophosphate (c-di-GMP) is a central regulator of bacterial lifestyle, controlling several behaviors, including the switch between sessile and motile states. The c-di-GMP levels are controlled by the interplay between diguanylate cyclases (DGCs) and phosphodiesterases, which synthesize and hydrolyze this second messenger, respectively. These enzymes often contain additional domains that regulate activity via binding of small molecules, covalent modification, or protein-protein interactions. A major challenge remains to understand how DGC activity is regulated by these additional domains or interaction partners in specific signaling pathways. Here, we identified a pair of co-transcribed genes (xac2382 and xac2383) in the phytopathogenic, Gram-negative bacterium Xanthomonas citri subsp. citri (Xac), whose mutations resulted in opposing motility phenotypes. We show that the periplasmic cache domain of XAC2382, a membrane-associated DGC, interacts with XAC2383, a periplasmic binding protein, and we provide evidence that this interaction regulates XAC2382 DGC activity. Moreover, we solved the crystal structure of XAC2383 with different ligands, indicating a preference for negatively charged phosphate-containing compounds. We propose that XAC2383 acts as a periplasmic sensor that, upon binding its ligand, inhibits the DGC activity of XAC2382. Of note, we also found that this previously uncharacterized signal transduction system is present in several other bacterial phyla, including Gram-positive bacteria. Phylogenetic analysis of homologs of the XAC2382-XAC2383 pair supports several independent origins that created new combinations of XAC2382 homologs with a conserved periplasmic cache domain with different cytoplasmic output module architectures.	[Teixeira, Raphael D.; Arevalo, Santiago Justo; Andrade, Maxuel O.; Farah, Chuck S.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil; [Guzzo, Cristiane R.; de Souza, Robson F.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508000 Sao Paulo, Brazil; [Abrahao, Josielle] Univ Estadual Campinas, Inst Quim, Dept Quim Organ, BR-13083970 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Farah, CS (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil.	chsfarah@iq.usp.br	Andrade, Maxuel/J-8426-2013; Arevalo, Santiago Justo/AAQ-2506-2021; de Souza, RF/G-9716-2011; de Oliveira Andrade, Maxuel/O-9924-2019; Carvalho, Cristiane R. G/K-2855-2016; Farah, Chuck Shaker/G-5565-2012	Andrade, Maxuel/0000-0002-4162-4341; Arevalo, Santiago Justo/0000-0001-8833-4395; de Souza, RF/0000-0002-5284-4630; de Oliveira Andrade, Maxuel/0000-0002-4162-4341; Carvalho, Cristiane R. G/0000-0002-5664-8055; Farah, Chuck Shaker/0000-0003-3110-6302; Dias Teixeira, Raphael/0000-0001-9642-7508	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/07777-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) graduate scholarship (to R. D. T.) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Research Grant 2011/07777-5 (to C. S. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Airola MV, 2013, J MOL BIOL, V425, P886, DOI 10.1016/j.jmb.2012.12.011; Alicea I, 2011, J MOL BIOL, V414, P356, DOI 10.1016/j.jmb.2011.09.047; Alkhateeb RS, 2016, J BIOTECHNOL, V225, P18, DOI 10.1016/j.jbiotec.2016.03.020; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Beyhan S, 2008, J BACTERIOL, V190, P7392, DOI 10.1128/JB.00564-08; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Borrok MJ, 2007, PROTEIN SCI, V16, P1032, DOI 10.1110/ps.062707807; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carugo O, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0019-8; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chatterjee D, 2014, ELIFE, V3, DOI 10.7554/eLife.03650; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheung J, 2009, PROTEINS, V77, P235, DOI 10.1002/prot.22485; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Cuneo MJ, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-50; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feirer N, 2015, MBIO, V6, DOI 10.1128/mBio.00156-15; Felder CB, 1999, AAPS PHARMSCI, V1; Ferreira RBR, 2012, J BACTERIOL, V194, P914, DOI 10.1128/JB.05807-11; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Gebhard S, 2008, J BACTERIOL, V190, P1335, DOI 10.1128/JB.01764-07; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Giardina G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081324; Guzzo CR, 2013, J MOL BIOL, V425, P2174, DOI 10.1016/j.jmb.2013.03.021; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; Hironaka I, 2013, APPL ENVIRON MICROB, V79, P2328, DOI 10.1128/AEM.03871-12; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0; Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Nicastro GG, 2014, ENVIRON MICROBIOL, V16, P1321, DOI 10.1111/1462-2920.12422; Nolan LM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0392-x; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oliveira MC, 2015, J MOL BIOL, V427, P415, DOI 10.1016/j.jmb.2014.11.012; Oloo EO, 2004, J BIOL CHEM, V279, P45013, DOI 10.1074/jbc.M405084200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Raterman EL, 2013, INFECT IMMUN, V81, P3089, DOI 10.1128/IAI.01396-12; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Roy Ankita Basu, 2013, Bio Protoc, V3; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schirmer T, 2016, J MOL BIOL, V428, P3683, DOI 10.1016/j.jmb.2016.07.023; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Souza DP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7453; Sundriyal A, 2014, J BIOL CHEM, V289, P6978, DOI 10.1074/jbc.M113.516195; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Trimble MJ, 2011, P NATL ACAD SCI USA, V108, P18079, DOI 10.1073/pnas.1113790108; Upadhyay AA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004862; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	77	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10767	10781		10.1074/jbc.RA118.003475	http://dx.doi.org/10.1074/jbc.RA118.003475			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29728456	Green Published, hybrid			2022-12-28	WOS:000437828400031
J	Liu, Q; Goss, DJ				Liu, Qiao; Goss, Dixie J.			The 3 mRNA I-shaped structure of maize necrotic streak virus binds to eukaryotic translation factors for eIF4F-mediated translation initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant virus; RNA-protein interaction; RNA virus; RNA structure; eukaryotic translation initiation; I-shaped RNA structure; kissing loop; maize necrotic streak virus; RNA UTR; viral protein translation	CAP-INDEPENDENT TRANSLATION; PLANT VIRAL RNAS; FACTOR 4G EIF4G; WHEAT-GERM; FAMILY TOMBUSVIRIDAE; HELICASE ACTIVITY; PROTEIN; ENHANCERS; EIFISO4F; COMPLEX	Unlike the mRNAs of their eukaryotic hosts, many RNAs of viruses lack a 5 m(7)GpppN cap and the 3 polyadenosine tail, and yet they are translated efficiently. Plant RNA viruses, in particular, have complex structures within their mRNA UTRs that allow them to bypass some cellular translation control steps. In the 3 UTR of maize necrotic streak virus (MNeSV), an I-shaped RNA structure (ISS) has been shown to bind eukaryotic initiation factor (eIF)4F and to mediate viral translation initiation. A 5-3 RNA kissing-loop interaction is required for optimal translation. However, the details of how the 3 ISS mediates translation initiation are not well understood. Here, we studied the binding of the 3 ISS with eIFs. The eIF4A-eIF4B complex was found to increase binding affinity of eIF4F with the 3 ISS by 4-fold (from K-D = 173 +/- 34 nm to K-D = 48 +/- 11 nm). Pre-steady-state analysis indicated that the eIF4A-eIF4B complex increased the RNA association rate and decreased the dissociation rate in an ATP-independent manner. Furthermore, our findings suggest that eIF4F could promote binding of the 3 ISS with the MNeSV 5UTR, enhancing the long-distance kissing-loop interaction. However, the association of the 5UTR with the 3 ISS-eIF4F complex did not increase 40S ribosomal subunit binding affinity. These quantitative results suggest a stepwise model in which the first committed step is eIF4F binding to the 3 ISS, followed by an interaction with the 5UTR and subsequent 40S ribosomal subunit binding.	[Liu, Qiao; Goss, Dixie J.] CUNY, Biochem Program, Grad Ctr, New York, NY 10065 USA; [Liu, Qiao; Goss, Dixie J.] CUNY, Chem Grad Program, Grad Ctr, New York, NY 10065 USA; [Liu, Qiao; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem & Biochem, New York, NY 10065 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem & Biochem, New York, NY 10065 USA.	dgoss@hunter.cuny.edu		Goss, Dixie/0000-0002-8500-0629	National Science Foundation [MCB 1513737]; Direct For Biological Sciences [1513737] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB 1513737 (to D.J.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Banerjee B, 2014, J BIOL CHEM, V289, P4286, DOI 10.1074/jbc.M113.530329; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; BROWNING KS, 1989, J BIOL CHEM, V264, P8491; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; Cheng SJ, 2013, TRANSLATION, V1, DOI 10.4161/trla.24038; De Stradis A, 2005, J PLANT PATHOL, V87, P213; Gao F, 2012, J VIROL, V86, P9828, DOI 10.1128/JVI.00677-12; GOSS DJ, 1988, BIOCHEMISTRY-US, V27, P3610, DOI 10.1021/bi00410a012; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Khan MA, 2005, BIOCHEMISTRY-US, V44, P4510, DOI 10.1021/bi047298g; Khan MA, 2008, BBA-GENE REGUL MECH, V1779, P622, DOI 10.1016/j.bbagrm.2008.07.004; Khan MA, 2014, NUCLEIC ACIDS RES, V42, P6567, DOI 10.1093/nar/gku248; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P369; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Louie R, 2000, PLANT DIS, V84, P1133, DOI 10.1094/PDIS.2000.84.10.1133; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Nicholson BL, 2013, J VIROL, V87, P1872, DOI 10.1128/JVI.02711-12; Nicholson BL, 2011, CURR OPIN VIROL, V1, P373, DOI 10.1016/j.coviro.2011.10.002; Nicholson BL, 2010, RNA, V16, P1402, DOI 10.1261/rna.2135210; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; RAY BK, 1985, J BIOL CHEM, V260, P7651; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Scheets K, 2006, VIROLOGY, V350, P171, DOI 10.1016/j.virol.2006.02.004; Sharma Sohani Das, 2015, J Biol Chem, V290, P11268, DOI 10.1074/jbc.M115.645002; Simon AE, 2013, ANNU REV MICROBIOL, V67, P21, DOI 10.1146/annurev-micro-092412-155609; Stuart G, 2004, ARCH VIROL, V149, P1595, DOI 10.1007/s00705-004-0298-7; Yumak H, 2010, BBA-GENE REGUL MECH, V1799, P653, DOI 10.1016/j.bbagrm.2010.08.003; Zhao P, 2017, J BIOL CHEM, V292, P5921, DOI [10.1074/jbc.M116.764902, 10.1074/jbc.m116.764902]; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9486	9495		10.1074/jbc.RA118.003377	http://dx.doi.org/10.1074/jbc.RA118.003377			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700118	hybrid, Green Published			2022-12-28	WOS:000435441400031
J	Lyman, M; Lieuw, V; Richardson, R; Timmer, A; Stewart, C; Granger, S; Woods, R; Silacci, M; Grabulovski, D; Newman, R				Lyman, Michael; Lieuw, Vincent; Richardson, Robyn; Timmer, Anjuli; Stewart, Christine; Granger, Steve; Woods, Richard; Silacci, Michela; Grabulovski, Dragan; Newman, Roland			A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; antibody engineering; autoimmune disease; cytokine; inflammation	MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; IMMUNE-RESPONSES; NECROSIS-FACTOR; ANCHOR DRUG; TOCILIZUMAB; METHOTREXATE; TRIAL; INTERLEUKIN-17A	Despite the success of current biological therapeutics for rheumatoid arthritis, these therapies, targeting individual cytokines or pathways, produce beneficial responses in only about half of patients. Therefore, better therapeutics are needed. IL-6 and IL-17A are proinflammatory cytokines in many autoimmune and inflammatory diseases, and several therapeutics have been developed to specifically inhibit them. However, targeting both of these cytokines with a bispecific therapeutic agent could account for their nonoverlapping proinflammatory functions and for the fact that IL-6 and IL-17A act in a positive feedback loop. Here, we present the development of MT-6194, a bispecific antibody targeting both IL-6R and IL-17A that was developed with the FynomAb technology. We also present data from mouse inflammatory disease experiments, indicating that simultaneous inhibition of both IL-6 and IL-17A yields enhanced efficacy compared with inhibition of each cytokine alone.	[Lyman, Michael; Lieuw, Vincent; Richardson, Robyn; Timmer, Anjuli; Stewart, Christine; Granger, Steve; Newman, Roland] Tanabe Res Labs USA Inc, 4540 Towne Ctr Ct, San Diego, CA 92121 USA; [Woods, Richard; Silacci, Michela; Grabulovski, Dragan] Covagen AG, Wagistr 25, CH-8952 Schlieren, Switzerland; [Lyman, Michael] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Richardson, Robyn] Neurocrine Biosci, 12780 El Camino Real, San Diego, CA 92130 USA; [Timmer, Anjuli] NantKwest Inc, 3530 John Hopkins Ct, San Diego, CA 92121 USA; [Granger, Steve] Salimetrics LLC, 5962 La Pl Ct,Ste 275, Carlsbad, CA 92008 USA; [Grabulovski, Dragan] Grabulovski Consulting Serv, Riedhofstr 57, CH-8049 Zurich, Switzerland	Salk Institute; Neurocrine Biosciences	Newman, R (corresponding author), Tanabe Res Labs USA Inc, 4540 Towne Ctr Ct, San Diego, CA 92121 USA.	rnewman@trlusa.com						Aletaha D, 2002, RHEUMATOLOGY, V41, P1367, DOI 10.1093/rheumatology/41.12.1367; Ben-Horin S, 2011, ALIMENT PHARM THER, V33, P987, DOI 10.1111/j.1365-2036.2011.04612.x; Brack S, 2014, MOL CANCER THER, V13, P2030, DOI 10.1158/1535-7163.MCT-14-0046-T; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Grabulovski D, 2007, J BIOL CHEM, V282, P3196, DOI 10.1074/jbc.M609211200; Hyrich KL, 2009, RHEUMATOLOGY, V48, P1323, DOI 10.1093/rheumatology/kep242; Ito H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3238; Kieseier BC, 2013, JAMA NEUROL, V70, P390, DOI 10.1001/jamaneurol.2013.668; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Nascimento MSL, 2015, J INFECT DIS, V211, P1015, DOI 10.1093/infdis/jiu531; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lubberts E, 2015, NAT REV RHEUMATOL, V11, P415, DOI 10.1038/nrrheum.2015.53; Matsuyama M, 2007, INTERNAL MED, V46, P771, DOI 10.2169/internalmedicine.46.6262; Mihara M, 2002, IMMUNOL LETT, V84, P223, DOI 10.1016/S0165-2478(02)00201-8; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Orlow S. J., 2015, DERMATOLOGY TIMES; Pieper J, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-34; Pincus T, 2003, CLIN EXP RHEUMATOL, V21, pS179; Ragab AA, 2002, AM J PHYSIOL-CELL PH, V283, pC679, DOI 10.1152/ajpcell.00421.2001; Raychaudhuri SP, 2013, CLIN REV ALLERG IMMU, V44, P183, DOI 10.1007/s12016-012-8307-1; Rubbert-Roth A, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2666; Salvarani C, 2012, CLIN EXP RHEUMATOL, V30, pS90; Sato Kojiro, 2008, Allergol Int, V57, P109, DOI 10.2332/allergolint.R-07-158; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Sheridan C, 2016, NAT BIOTECHNOL, V34, P1215, DOI 10.1038/nbt1216-1215; Sigaux J, 2017, JOINT BONE SPINE, V84, P39, DOI 10.1016/j.jbspin.2016.04.013; Silacci M, 2016, MABS-AUSTIN, V8, P141, DOI 10.1080/19420862.2015.1093266; Sokka T, 2002, J RHEUMATOL, V29, P2521; SWAAK AJG, 1989, RHEUMATOL INT, V8, P263, DOI 10.1007/BF00270982; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Teitsma XM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1108-9; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wuellner U, 2015, ANTIBODIES, V4, P426, DOI 10.3390/antib4040426; Yoshida Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698313; Zhang Y, 2013, INT IMMUNOPHARMACOL, V15, P199, DOI 10.1016/j.intimp.2012.12.010	38	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9326	9334		10.1074/jbc.M117.818559	http://dx.doi.org/10.1074/jbc.M117.818559			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29678878	Green Published, hybrid			2022-12-28	WOS:000435441400018
J	Chavez, DA; Greer, BH; Eichman, BF				Chavez, Diana A.; Greer, Briana H.; Eichman, Brandt F.			The HIRAN domain of helicase-like transcription factor positions the DNA translocase motor to drive efficient DNA fork regression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; DNA repair; DNA damage response; DNA helicase; nucleic acid enzymology; DNA damage response; DNA repair; fork reversal; replication restart; stalled replication fork	STALLED REPLICATION FORKS; CELL NUCLEAR ANTIGEN; DAMAGE TOLERANCE; HUMAN HLTF; BINDING DOMAIN; ANNEALING HELICASE; GENOME STABILITY; STRESS; REVERSAL; PROTEIN	Helicase-like transcription factor (HLTF) is a central mediator of the DNA damage response and maintains genome stability by regressing stalled replication forks. The N-terminal HIRAN domain binds specifically to the 3-end of single-stranded DNA (ssDNA), and disrupting this function interferes with fork regression in vitro as well as replication fork progression in cells under replication stress. Here, we investigated the mechanism by which the HIRAN-ssDNA interaction facilitates fork remodeling. Our results indicated that HIRAN capture of a denatured nascent leading 3-end directs specific binding of HLTF to forks. DNase footprinting revealed that HLTF binds to the parental duplex ahead of the fork and at the leading edge behind the fork. Moreover, we found that the HIRAN domain is important for initiating regression of forks when both nascent strands are at the junction, but is dispensable when forks contain ssDNA regions on either template strand. We also found that HLTF catalyzes fork restoration from a partially regressed structure in a HIRAN-dependent manner. Thus, HIRAN serves as a substrate-recognition domain to properly orient the ATPase motor domain at stalled and regressed forks and initiates fork remodeling by guiding formation of a four-way junction. We discuss how these activities compare with those of two related fork remodelers, SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A-like 1 (SMARCAL1) and zinc finger RANBP2 type-containing 3 (ZRANB3) to provide insight into their nonredundant roles in DNA damage tolerance.	[Chavez, Diana A.; Greer, Briana H.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA.; Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	brandt.eichman@vanderbilt.edu	Classen, Scott/AAY-8176-2020	Eichman, Brandt/0000-0002-0965-2297	National Institutes of Health [P01CA092584, P30CA068485]; NATIONAL CANCER INSTITUTE [P01CA092584, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117299, R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Miaw-Sheue Tsai for baculovirus production and insect cell expression of HLTF proteins (supported by Structural Cell Biology of DNA Repair Machines Grant P01CA092584 from the National Institutes of Health). We also thank Karlene Cimprich, David Cortez, and members of the Cortez laboratory for comments on the manuscript and for helpful discussions. Additional core facilities were supported by the Vanderbilt-Ingram Cancer Center, which was supported by National Institutes of Health Grant P30CA068485.	Achar YJ, 2015, NUCLEIC ACIDS RES, V43, P10277, DOI 10.1093/nar/gkv896; Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Ahuja AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10660; Ortiz-Bazan MA, 2014, CELL REP, V9, P460, DOI 10.1016/j.celrep.2014.09.005; Badu-Nkansah A, 2016, J BIOL CHEM, V291, P8251, DOI 10.1074/jbc.M115.709733; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Berti M, 2016, NAT STRUCT MOL BIOL, V23, P103, DOI 10.1038/nsmb.3163; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bhat KP, 2015, J BIOL CHEM, V290, P4110, DOI 10.1074/jbc.M114.627083; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Branzei D, 2016, CURR OPIN CELL BIOL, V40, P137, DOI 10.1016/j.ceb.2016.03.015; Burkovics P, 2014, NUCLEIC ACIDS RES, V42, P1711, DOI 10.1093/nar/gkt1040; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Choi KY, 2015, NUCLEIC ACIDS RES, V43, P2666, DOI 10.1093/nar/gkv004; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Ding L, 2014, G3-GENES GENOM GENET, V4, P1373, DOI 10.1534/g3.114.011346; Fernandez-Leiro R, 2017, NAT STRUCT MOL BIOL, V24, P140, DOI 10.1038/nsmb.3348; Follonier C, 2013, NAT STRUCT MOL BIOL, V20, P486, DOI 10.1038/nsmb.2520; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Hishiki A, 2015, J BIOL CHEM, V290, P13215, DOI 10.1074/jbc.M115.643643; Kile AC, 2015, MOL CELL, V58, P1090, DOI 10.1016/j.molcel.2015.05.013; Kobbe D, 2016, PLANT J, V88, P521, DOI 10.1111/tpj.13283; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; Mason AC, 2014, P NATL ACAD SCI USA, V111, P7618, DOI 10.1073/pnas.1324143111; Minca EC, 2010, MOL CELL, V38, P649, DOI 10.1016/j.molcel.2010.03.020; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Poole LA, 2017, CRIT REV BIOCHEM MOL, V52, P696, DOI 10.1080/10409238.2017.1380597; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2010, P NATL ACAD SCI USA, V107, P20970, DOI 10.1073/pnas.1011196107; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	43	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8484	8494		10.1074/jbc.RA118.002905	http://dx.doi.org/10.1074/jbc.RA118.002905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29643183	Green Published, hybrid			2022-12-28	WOS:000434205700013
J	Yavuz, H; Kattan, I; Hernandez, JM; Hofnagel, O; Witkowska, A; Raunser, S; Walla, PJ; Jahn, R				Yavuz, Halenur; Kattan, Iman; Hernandez, Javier M.; Hofnagel, Oliver; Witkowska, Agata; Raunser, Stefan; Walla, Peter J.; Jahn, Reinhard			Arrest of trans-SNARE zippering uncovers loosely and tightly docked intermediates in membrane fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						docking; exocytosis; membrane fusion; membrane reconstitution; SNARE proteins; soluble NSF attachment protein receptor (SNARE)	ALPHA-SNAP; NEUROTRANSMITTER RELEASE; SYNAPTIC VESICLES; CRYSTAL-STRUCTURE; COMPLEX; SYNAPTOBREVIN; PROTEINS; EXOCYTOSIS; DOCKING; RECONSTITUTION	Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins mediate intracellular membrane fusion in the secretory pathway. They contain conserved regions, termed SNARE motifs, that assemble between opposing membranes directionally from their N termini to their membrane-proximal C termini in a highly exergonic reaction. However, how this energy is utilized to overcome the energy barriers along the fusion pathway is still under debate. Here, we have used mutants of the SNARE synaptobrevin to arrest trans-SNARE zippering at defined stages. We have uncovered two distinct vesicle docking intermediates where the membranes are loosely and tightly connected, respectively. The tightly connected state is irreversible and independent of maintaining assembled SNARE complexes. Together, our results shed new light on the intermediate stages along the pathway of membrane fusion.	[Yavuz, Halenur; Witkowska, Agata; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany; [Kattan, Iman; Walla, Peter J.] Max Planck Inst Biophys Chem, Biomol Spect & Single Mol Detect Res Grp, D-37077 Gottingen, Germany; [Walla, Peter J.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany; [Hernandez, Javier M.; Hofnagel, Oliver; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany	Max Planck Society; Max Planck Society; Braunschweig University of Technology; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Raunser, Stefan/AHE-1573-2022; Witkowska, Agata/AAR-3442-2020; Witkowska, Agata/K-2637-2013	Witkowska, Agata/0000-0001-6926-4707; Raunser, Stefan/0000-0001-9373-3016; Jahn, Reinhard/0000-0003-1542-3498	Deutsche Forschungsgemeinschaft [SFB 803]; National Institutes of Health [P01 GM72694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 803 (to R. J. and P. J. W.) and National Institutes of Health Grant P01 GM72694 (to R. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Calder LJ, 2016, NAT STRUCT MOL BIOL, V23, P853, DOI 10.1038/nsmb.3271; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cypionka A, 2009, P NATL ACAD SCI USA, V106, P18575, DOI 10.1073/pnas.0906677106; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Li F, 2016, P NATL ACAD SCI USA, V113, P10536, DOI 10.1073/pnas.1604000113; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Park Y, 2014, J BIOL CHEM, V289, P16326, DOI 10.1074/jbc.M114.556803; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Ryu JK, 2015, SCIENCE, V347, P1485, DOI 10.1126/science.aaa5267; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Strop P, 2008, J BIOL CHEM, V283, P1113, DOI 10.1074/jbc.M707912200; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TOWBIN H, 1989, J CLIN CHEM CLIN BIO, V27, P495; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Vennekate W, 2012, P NATL ACAD SCI USA, V109, P11037, DOI 10.1073/pnas.1116326109; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wiederhold K, 2010, J BIOL CHEM, V285, P21549, DOI 10.1074/jbc.M110.105148; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	46	20	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8645	8655		10.1074/jbc.RA118.003313	http://dx.doi.org/10.1074/jbc.RA118.003313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666192	Green Published, hybrid			2022-12-28	WOS:000434205700027
J	McFarlane, JS; Davis, CL; Lamb, AL				McFarlane, Jeffrey S.; Davis, Cara L.; Lamb, Audrey L.			Staphylopine, pseudopaline, and yersinopine dehydrogenases: A structural and kinetic analysis of a new functional class of opine dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						siderophore; dehydrogenase; metal homeostasis; bacterial pathogenesis; protein structure; metallophore; opine; pseudopaline; staphylopine; yersinopine	PROTEIN-STRUCTURE ALIGNMENT; PSEUDOMONAS-AERUGINOSA; STEREOSELECTIVITY; BIOSYNTHESIS; METALLOPHORE; OCTOPINE; REVEALS; SYSTEM; ACIDS	Opine dehydrogenases (ODHs) from the bacterial pathogens Staphylococcus aureus, Pseudomonas aeruginosa, and Yersinia pestis perform the final enzymatic step in the biosynthesis of a new class of opine metallophores, which includes staphylopine, pseudopaline, and yersinopine, respectively. Growing evidence indicates an important role for this pathway in metal acquisition and virulence, including in lung and burn-wound infections (P. aeruginosa) and in blood and heart infections (S. aureus). Here, we present kinetic and structural characterizations of these three opine dehydrogenases. A steady-state kinetic analysis revealed that the three enzymes differ in -keto acid and NAD(P)H substrate specificity and nicotianamine-like substrate stereoselectivity. The structural basis for these differences was determined from five ODH X-ray crystal structures, ranging in resolution from 1.9 to 2.5 angstrom, with or without NADP(+) bound. Variation in hydrogen bonding with NADPH suggested an explanation for the differential recognition of this substrate by these three enzymes. Our analysis further revealed candidate residues in the active sites required for binding of the -keto acid and nicotianamine-like substrates and for catalysis. This work reports the first structural kinetic analyses of enzymes involved in opine metallophore biosynthesis in three important bacterial pathogens of humans.	[McFarlane, Jeffrey S.; Lamb, Audrey L.] Univ Kansas, Dept Mol Biosci, 5060 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA; [Davis, Cara L.; Lamb, Audrey L.] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Lamb, AL (corresponding author), Univ Kansas, Dept Mol Biosci, 5060 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.	lamb@ku.edu	McFarlane, Jeffrey/AAE-8692-2021	McFarlane, Jeffrey/0000-0002-0033-4129; Lamb, Audrey/0000-0002-2352-2130; Loomis, Cara/0000-0002-6457-4674	National Science Foundation [CHE-1403293]; National Institutes of Health [T32 GM008545, P41GM103393]; NIGMS [P20 GM103418]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; U.S. Department of Energy Office of Biological and Environmental Research; Direct For Mathematical & Physical Scien [1403293] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418, R01GM127655, T32GM008545, P41GM103393] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant CHE-1403293, by National Institutes of Health Graduate Training Program in the Dynamic Aspects of Chemical Biology Grant T32 GM008545 (to J.S.M.), and by an Institutional Development Award (IdeA) from the NIGMS via Grant P20 GM103418 (to C.L.D.). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the U.S. Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health Grant P41GM103393. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andi B, 2007, BIOCHEMISTRY-US, V46, P12512, DOI 10.1021/bi701428m; ASANO Y, 1989, J BACTERIOL, V171, P4466, DOI 10.1128/JB.171.8.4466-4471.1989; Bielecki P, 2013, ENVIRON MICROBIOL, V15, P570, DOI 10.1111/1462-2920.12024; Bielecki P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024235; BIELLMANN JF, 1973, FEBS LETT, V32, P254, DOI 10.1016/0014-5793(73)80845-2; BIELLMANN JF, 1977, BIOORG CHEM, V6, P89, DOI 10.1016/0045-2068(77)90011-6; Britton KL, 1998, NAT STRUCT BIOL, V5, P593, DOI 10.1038/854; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Damron FH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39172; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Gi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14644; Girdlestone C, 2016, J COMPUT BIOL, V23, P21, DOI 10.1089/cmb.2015.0143; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; Grim KP, 2017, MBIO, V8, DOI [10.1128/mbio.01281-17, 10.1128/mBio.01281-17]; Hanses F, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0093-3; Harrison J., 1976, P1; Holbrook JJ., 1975, ENZYMES, P191; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato Y, 1996, J MOL CATAL B-ENZYM, V1, P151, DOI 10.1016/1381-1177(95)00011-9; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lhospice S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16765-9; Mastropasqua MC, 2017, MOL MICROBIOL, V106, P543, DOI 10.1111/mmi.13834; McFarlane JS, 2017, BIOCHEMISTRY-US, V56, P5967, DOI 10.1021/acs.biochem.7b00804; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Moore LW, 1997, APPL ENVIRON MICROB, V63, P201, DOI 10.1128/AEM.63.1.201-207.1997; NAMBIAR KP, 1983, J AM CHEM SOC, V105, P5886, DOI 10.1021/ja00356a028; Remy L, 2013, MOL MICROBIOL, V87, P730, DOI 10.1111/mmi.12126; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Smitst SHJ, 2008, J MOL BIOL, V381, P200, DOI 10.1016/j.jmb.2008.06.003; THOMPSON J, 1992, ANNU REV BIOCHEM, V61, P517; THOMPSON J, 1988, J BIOL CHEM, V263, P2064; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANTHOAI N, 1959, BIOCHIM BIOPHYS ACTA, V35, P446, DOI 10.1016/0006-3002(59)90394-4; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Watanabe S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138434; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang J, 2017, J ORG CHEM, V82, P13643, DOI 10.1021/acs.joc.7b02342	42	20	24	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8009	8019		10.1074/jbc.RA118.002007	http://dx.doi.org/10.1074/jbc.RA118.002007			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29618515	Green Published, hybrid			2022-12-28	WOS:000433224600008
J	Yeh, ST; Zambrano, CM; Koch, WJ; Purcell, NH				Yeh, Szu-Tsen; Zambrano, Cristina M.; Koch, Walter J.; Purcell, Nicole H.			PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; cardiomyocyte; cell growth; cell signaling; phosphatase; GRK5; PHLPP2	NF-KAPPA-B; HEART-FAILURE; DELETION PROTECTS; AKT; ACTIVATION; CALCIUM; GRK5; OVEREXPRESSION; EXPRESSION; GROWTH	PH domain leucine-rich repeat protein phosphatase (PHLPP) is a serine/threonine phosphatase that has been shown to regulate cell growth and survival through dephosphorylation of several members of the AGC family of kinases. G-protein-coupled receptor kinase 5 (GRK5) is an AGC kinase that regulates phenylephrine (PE)-induced cardiac hypertrophy through its noncanonical function of directly targeting proteins to the nucleus to regulate transcription. Here we investigated the possibility that the PHLPP2 isoform can regulate GRK5-induced cardiomyocyte hypertrophy in neonatal rat ventricular myocytes (NRVMs). We show that removal of PHLPP2 by siRNA induces hypertrophic growth of NRVMs as measured by cell size changes at baseline, potentiated PE-induced cell size changes, and re-expression of fetal genes atrial natriuretic factor and brain natriuretic peptide. Endogenous GRK5 and PHLPP2 were found to interact in NRVMs, and PE-induced nuclear accumulation of GRK5 was enhanced upon down-regulation of PHLPP2. Conversely, overexpression of PHLPP2 blocked PE-induced hypertrophic growth, re-expression of fetal genes, and nuclear accumulation of GRK5, which depended on its phosphatase activity. Finally, using siRNA against GRK5, we found that GRK5 was necessary for the hypertrophic response induced by PHLPP2 knockdown. Our findings demonstrate for the first time a novel regulation of GRK5 by the phosphatase PHLPP2, which modulates hypertrophic growth. Understanding the signaling pathways affected by PHLPP2 has potential for new therapeutic targets in the treatment of cardiac hypertrophy and failure.	[Yeh, Szu-Tsen; Zambrano, Cristina M.; Purcell, Nicole H.] Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3032, La Jolla, CA 92093 USA; [Koch, Walter J.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA	University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Purcell, NH (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3032, La Jolla, CA 92093 USA.	npurcell@ucsd.edu			NHLBI, National Institutes of Health [HL114949, HL091799]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114949, P01HL091799] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from NHLBI, National Institutes of Health Grants HL114949 (to N. H. P.) and HL091799 (to W. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Chen B, 2013, J CEREBR BLOOD F MET, V33, P196, DOI 10.1038/jcbfm.2012.150; Cittadini A, 2006, GENE THER, V13, P8, DOI 10.1038/sj.gt.3302589; Cook SA, 2002, J BIOL CHEM, V277, P22528, DOI 10.1074/jbc.M201462200; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gold JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057324; Gold JI, 2012, CIRC RES, V111, P1048, DOI 10.1161/CIRCRESAHA.112.273367; Grzechnik AT, 2016, BIOCHEM SOC T, V44, P1675, DOI 10.1042/BST20160170; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hullmann J, 2016, PHARMACOL RES, V110, P52, DOI 10.1016/j.phrs.2016.05.008; Hullmann JE, 2014, CIRC RES, V115, P976, DOI 10.1161/CIRCRESAHA.116.304475; Islam KN, 2013, J BIOL CHEM, V288, P35683, DOI 10.1074/jbc.M113.529347; Islam KN, 2012, J BIOL CHEM, V287, P12771, DOI 10.1074/jbc.M111.324566; Johnson LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062508; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; Kim YK, 2006, BIOCHEM BIOPH RES CO, V347, P1088, DOI 10.1016/j.bbrc.2006.06.196; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liao YB, 2016, GYNECOL ONCOL, V143, P655, DOI 10.1016/j.ygyno.2016.09.010; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Lv DQ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1711-1; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Mathur A, 2017, J ENDOCRINOL, V233, pR185, DOI 10.1530/JOE-17-0081; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Miyamoto S, 2010, CIRC RES, V107, P476, DOI 10.1161/CIRCRESAHA.109.215020; Moc C, 2015, CARDIOVASC RES, V105, P160, DOI 10.1093/cvr/cvu243; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Newton AC, 2016, CLIN SCI, V130, P1499, DOI 10.1042/CS20160036; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Sallese M, 2000, BBA-MOL CELL RES, V1498, P112, DOI 10.1016/S0167-4889(00)00088-4; Schumacher SM, 2017, J CARDIOVASC PHARM, V70, P129, DOI 10.1097/FJC.0000000000000483; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Traynham CJ, 2016, J MOL CELL CARDIOL, V92, P196, DOI 10.1016/j.yjmcc.2016.01.027; Warfel NA, 2012, J BIOL CHEM, V287, P3610, DOI 10.1074/jbc.R111.318675; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563; Zhang Y, 2011, J BIOL CHEM, V286, P26943, DOI 10.1074/jbc.M111.234757	52	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8056	8064		10.1074/jbc.M117.809913	http://dx.doi.org/10.1074/jbc.M117.809913			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29628444	Green Published, hybrid			2022-12-28	WOS:000433224600012
J	Moehle, EA; Shen, K; Dillin, A				Moehle, Erica A.; Shen, Koning; Dillin, Andrew			Mitochondrial proteostasis in the context of cellular and organismal health and aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						mitochondria; proteostasis; aging; stress; unfolded protein response (UPR)	UNFOLDED PROTEIN RESPONSE; DYNAMIN-RELATED GTPASE; QUALITY-CONTROL; SUPEROXIDE-DISMUTASE; SUBSTANTIA-NIGRA; SPASTIC PARAPLEGIA; MISFOLDED PROTEINS; PARKINSONS-DISEASE; ELECTRON-TRANSPORT; STRESS-RESPONSE	As a central hub of cellular metabolism and signaling, the mitochondrion is a crucial organelle whose dysfunction can cause disease and whose activity is intimately connected to aging. We review how the mitochondrial network maintains proteomic integrity, how mitochondrial proteotoxic stress is communicated and resolved in the context of the entire cell, and how mitochondrial systems function in the context of organismal health and aging. A deeper understanding of how mitochondrial protein quality control mechanisms are coordinated across these distinct biological levels should help explain why these mechanisms fail with age and, ultimately, how routes to intervention might be attained.	[Moehle, Erica A.; Shen, Koning; Dillin, Andrew] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dillin, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dillin@berkeley.edu			Jane Coffin Childs Memorial Fund for Medical Research	Jane Coffin Childs Memorial Fund for Medical Research	Supported as postdoctoral fellows of the Jane Coffin Childs Memorial Fund for Medical Research.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Area-Gomez E, 2016, CURR OPIN GENET DEV, V38, P90, DOI 10.1016/j.gde.2016.04.006; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Berendzen KM, 2016, CELL, V166, P1553, DOI 10.1016/j.cell.2016.08.042; Bertolin G, 2013, AUTOPHAGY, V9, P1801, DOI 10.4161/auto.25884; Bhaskaran S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745009; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Brandt T, 2017, ELIFE, V6, DOI 10.7554/eLife.24662; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110; Cole A, 2015, CANCER CELL, V27, P864, DOI 10.1016/j.ccell.2015.05.004; Cookson MR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009415; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; De Leo ME, 1998, NEUROSCI LETT, V250, P173, DOI 10.1016/S0304-3940(98)00469-8; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544; Dick FD, 2006, BRIT MED BULL, V79-80, P219, DOI 10.1093/bmb/ldl018; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fiorese CJ, 2017, CRIT REV BIOCHEM MOL, V52, P304, DOI 10.1080/10409238.2017.1291577; Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002; Fitzgerald JC, 2017, BRAIN, V140, P2444, DOI 10.1093/brain/awx202; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedman JR, 2018, DEV CELL, V44, P261, DOI 10.1016/j.devcel.2017.11.023; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Hernebring M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01381; Higuchi R, 2013, CURR BIOL, V23, P2417, DOI 10.1016/j.cub.2013.10.022; Higuchi-Sanabria R, 2016, MOL BIOL CELL, V27, P776, DOI 10.1091/mbc.E15-07-0455; Hirabayahi Y, 2017, SCIENCE, V358, P623, DOI 10.1126/science.aan6009; HOHFELD J, 1994, J CELL BIOL, V126, P305, DOI 10.1083/jcb.126.2.305; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hughes AL, 2016, ELIFE, V5, DOI 10.7554/eLife.13943; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013; Jensen MB, 2017, ELIFE, V6, DOI [10.7554/eLife.26952.001, 10.7554/eLife.26952]; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; Kim HE, 2016, CELL, V166, P1539, DOI 10.1016/j.cell.2016.08.027; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Klinger H, 2010, EXP GERONTOL, V45, P533, DOI 10.1016/j.exger.2010.03.016; Kong P, 2018, NEUROSCI LETT, V662, P51, DOI 10.1016/j.neulet.2017.09.051; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Lai CY, 2002, GENETICS, V162, P73; Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70; Lee JS, 2012, J CELL PHYSIOL, V227, P2856, DOI 10.1002/jcp.23027; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Martinez BA, 2017, J NEUROSCI, V37, P11085, DOI [10.1523/JNEUROSCI.1294-17.2017, 10.1523/jneurosci.1294-17.2017]; Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x; MARTTILA RJ, 1988, J NEUROL SCI, V86, P321, DOI 10.1016/0022-510X(88)90108-6; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Munch C, 2016, NATURE, V534, P710, DOI 10.1038/nature18302; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Neutzner Albert, 2007, Novartis Found Symp, V287, P4; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Ohsawa S, 2012, NATURE, V490, P547, DOI 10.1038/nature11452; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587; Pellegrino MW, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0129-1; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Qureshi MA, 2017, J BIOL CHEM, V292, P13500, DOI 10.1074/jbc.R117.791061; Rohn JL, 2014, CURR BIOL, V24, P2598, DOI 10.1016/j.cub.2014.09.045; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Seo JH, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002507; Shao LW, 2016, CELL RES, V26, P1182, DOI 10.1038/cr.2016.118; Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Thomas RE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004279; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang Q, 2018, CELL, V174, P870, DOI 10.1016/j.cell.2018.06.029; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026	156	86	87	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5396	5407		10.1074/jbc.TM117.000893	http://dx.doi.org/10.1074/jbc.TM117.000893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	29622680	Green Published, hybrid			2022-12-28	WOS:000464517500013
J	Tang, BJ; Lummis, SCR				Tang, Bijun; Lummis, Sarah C. R.			Multiple regions in the extracellular domain of the glycine receptor determine receptor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycine receptor; electrophysiology; membrane biophysics; mutagenesis; mutant; aromatic amino acid; Cys-loop; ion channel; ligand-gated; pentameric ligand-gated ion channel; two-voltage electrode clamp	LIGAND-BINDING DOMAIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; CATION-PI INTERACTION; CYS-LOOP RECEPTORS; CRYSTAL-STRUCTURE; SUBUNIT; SITE; RESIDUES; STRYCHNINE; AGONIST	Glycine receptors (GlyRs) are Cys-loop receptors that mediate fast synaptic inhibition in the brain stem and spinal cord. They are involved in the generation of motor rhythm, reflex circuit coordination, and sensory signal processing and therefore represent targets for therapeutic interventions. The extracellular domains (ECDs) of Cys-loop receptors typically contain many aromatic amino acids, but only those in the receptor binding pocket have been extensively studied. Here, we show that many Phe residues in the ECD that are not located in the binding pocket are also involved in GlyR function. We examined these Phe residues by creating several GlyR variants, characterizing these variants with the two-electrode voltage clamp technique in Xenopus oocytes, and interpreting changes in receptor parameters by using currently available structural information on the open and closed states of the GlyR. Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss of function or significantly increased the EC50 and also altered the maximal response to the partial GlyR agonist taurine compared with glycine in those receptor variants that were functional. Substitutions with other amino acids, combined with examination of nearby residues that could potentially interact with these Phe residues, suggested interactions that could be important for GlyR function, and possibly similar interactions could contribute to the function of other members of the Cys-loop receptor family. Overall, our results suggest that many ECD regions are important for GlyR function and that these regions could inform the design of therapeutic agents targeting GlyR activity.	[Tang, Bijun; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Lummis, SCR (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England.	sl120@cam.ac.uk		Tang, Bijun/0000-0003-3689-0167	Medical Research Council [MR/L021676]; MRC [MR/L021676/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Medical Research Council Grant MR/L021676.	Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Bhattacharyya R, 2004, PROTEIN ENG DES SEL, V17, P795, DOI 10.1093/protein/gzh093; Braun N, 2016, ACS CHEM NEUROSCI, V7, P339, DOI 10.1021/acschemneuro.5b00298; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Henault CM, 2017, BBA-BIOMEMBRANES, V1859, P218, DOI 10.1016/j.bbamem.2016.11.006; Henchman RH, 2003, BIOPHYS J, V85, P3007, DOI 10.1016/S0006-3495(03)74720-1; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Huang X, 2017, NAT STRUCT MOL BIOL, V24, P108, DOI 10.1038/nsmb.3329; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Luo J, 2009, J NEUROSCI, V29, P13898, DOI 10.1523/JNEUROSCI.2833-09.2009; Lynch JW, 2006, CURR OPIN INVEST DR, V7, P48; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Mu TW, 2003, J AM CHEM SOC, V125, P6850, DOI 10.1021/ja0348086; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Pless SA, 2011, J BIOL CHEM, V286, P35129, DOI 10.1074/jbc.M111.269027; Pless SA, 2011, MOL PHARMACOL, V79, P742, DOI 10.1124/mol.110.069583; Purohit P, 2013, J GEN PHYSIOL, V141, P467, DOI 10.1085/jgp.201210946; Reeves DC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-27; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; TZARTOS SJ, 1991, MOL NEUROBIOL, V5, P1, DOI 10.1007/BF02935610; Vafa B, 1999, J NEUROCHEM, V73, P2158; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1765, DOI 10.1073/pnas.89.5.1765; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	33	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13889	13896		10.1074/jbc.RA118.003088	http://dx.doi.org/10.1074/jbc.RA118.003088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29941455	Green Published, hybrid			2022-12-28	WOS:000444070700015
J	Emendato, A; Milordini, G; Zacco, E; Sicorello, A; Dal Piaz, F; Guerrini, R; Thorogate, R; Picone, D; Pastore, A				Emendato, Alessandro; Milordini, Giulia; Zacco, Elsa; Sicorello, Alessandro; Dal Piaz, Fabrizio; Guerrini, Remo; Thorogate, Richard; Picone, Delia; Pastore, Annalisa			Glycation affects fibril formation of A beta peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID CASCADE HYPOTHESIS; HUMAN LENS PROTEINS; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; MAILLARD REACTION; END-PRODUCTS; THIOFLAVIN-T; METHYLGLYOXAL; AGGREGATION; RISK	Increasing evidence shows that beta-amyloid (A beta) peptides, which are associated with Alzheimer disease (AD), are heavily glycated in patients, suggesting a role of this irreversible nonenzymatic post-translational modification in pathology. Previous reports have shown that glycation increases the toxicity of the A beta peptides, although little is known about the mechanism. Here, we used the natural metabolic by-product methylglyoxal as a glycating agent and exploited various spectroscopic methods and atomic force microscopy to study how glycation affects the structures of the A beta 40 and A beta 42 peptides, the aggregation pathway, and the morphologies of the resulting aggregates. We found that glycation significantly slows down but does not prevent beta-conversion to mature fibers. We propose that the previously reported higher toxicity of the glycated A beta peptides could be explained by a longer persistence in an oligomeric form, usually believed to be the toxic species.	[Emendato, Alessandro; Picone, Delia] Univ Naples Federico II, Dept Chem Sci, Via Cintia, I-80126 Naples, Italy; [Milordini, Giulia; Zacco, Elsa; Sicorello, Alessandro; Pastore, Annalisa] Kings Coll London, Denmark Hill Campus, London SE5 9RT, England; [Milordini, Giulia; Zacco, Elsa; Sicorello, Alessandro; Pastore, Annalisa] Kings Coll London, UK Dementia Res Inst, Denmark Hill Campus, London SE5 9RT, England; [Dal Piaz, Fabrizio] Univ Salerno, I-84084 Fisciano, Italy; [Guerrini, Remo] Univ Ferrara, Dept Chem & Pharmaceut Sci, I-44121 Ferrara, Italy; [Thorogate, Richard] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Pastore, Annalisa] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy	University of Naples Federico II; University of London; King's College London; University of London; King's College London; University of Salerno; University of Ferrara; University of London; University College London; University of Pavia	Picone, D (corresponding author), Univ Naples Federico II, Dept Chem Sci, Via Cintia, I-80126 Naples, Italy.; Pastore, A (corresponding author), Kings Coll London, Denmark Hill Campus, London SE5 9RT, England.	delia.picone@unina.it; annalisa.pastore@crick.ac.uk	Emendato, Alessandro/GWQ-4371-2022; Zacco, Elsa/AAZ-5750-2021; Picone, Delia/L-2480-2015	Zacco, Elsa/0000-0002-3593-6023; Sicorello, Alessandro/0000-0003-1407-8039; Picone, Delia/0000-0002-7582-2581	Diabetes UK; Dementia Research Institute grant; MRC [MC_PC_13054, MC_U117584256, UKDRI-6002] Funding Source: UKRI	Diabetes UK(Diabetes UK); Dementia Research Institute grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a Diabetes UK and a Dementia Research Institute grant. To whom correspondence may be addressed: King's College London, Denmark Hill Campus, London SE5 9RT, United Kingdom. E-mail: annalisa.pastore@crick.ac.uk.	Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Baynes JW, 2000, FREE RADICAL BIO MED, V28, P1708, DOI 10.1016/S0891-5849(00)00228-8; Beisswenger PJ, 2012, DIABETES TECHNOL THE, V14, P285, DOI 10.1089/dia.2011.0108; Brion JP, 1998, EUR NEUROL, V40, P130, DOI 10.1159/000007969; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Chen K, 2006, J NEUROCHEM, V99, P1413, DOI 10.1111/j.1471-4159.2006.04181.x; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Culberson JW, 2017, PROG MOL BIOL TRANSL, V146, P1, DOI 10.1016/bs.pmbts.2016.12.011; Emendato A, 2016, FEBS LETT, V590, P582, DOI 10.1002/1873-3468.12082; Fernandez-Busquets X, 2010, CURR ALZHEIMER RES, V7, P428, DOI 10.2174/156720510791383787; Fica-Contreras SM, 2017, J BIOL INORG CHEM, V22, P1211, DOI 10.1007/s00775-017-1497-5; Frye EB, 1998, J BIOL CHEM, V273, P18714, DOI 10.1074/jbc.273.30.18714; Gandy S, 2010, ANN NEUROL, V68, P220, DOI 10.1002/ana.22052; Ganzinger KA, 2014, CHEMBIOCHEM, V15, P2515, DOI 10.1002/cbic.201402377; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Goate A M, 1990, Adv Neurol, V51, P197; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Habchi J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501244; Han WP, 2010, P NATL ACAD SCI USA, V107, P6557, DOI 10.1073/pnas.1002555107; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2017, FEBS J, V284, P1040, DOI 10.1111/febs.14004; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Iannuzzi Clara, 2014, Front Mol Biosci, V1, P9, DOI 10.3389/fmolb.2014.00009; Jana AK, 2016, PHYS CHEM CHEM PHYS, V18, P31446, DOI 10.1039/c6cp05041g; Lapolla A, 2006, MASS SPECTROM REV, V25, P775, DOI 10.1002/mas.20090; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Liao YH, 2015, PROTEIN EXPRES PURIF, V113, P63, DOI 10.1016/j.pep.2015.05.002; Luth HJ, 2005, CEREB CORTEX, V15, P211, DOI 10.1093/cercor/bhh123; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Masino L, 2011, BIOPHYS J, V100, P2033, DOI 10.1016/j.bpj.2011.02.056; MATTSON MP, 1995, NATURE, V373, P481, DOI 10.1038/373481a0; Munch G, 2000, J CHEM NEUROANAT, V20, P253, DOI 10.1016/S0891-0618(00)00096-X; Nomoto K., 2013, ANTIAGING MED, V10, P92; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pampati PK, 2011, ANAL BIOCHEM, V408, P59, DOI 10.1016/j.ab.2010.08.038; Paranjape GS, 2012, ACS CHEM NEUROSCI, V3, P302, DOI 10.1021/cn2001238; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; REICHARD GA, 1986, DIABETES, V35, P668, DOI 10.2337/diabetes.35.6.668; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549, DOI 10.1042/bst0210549; Sabate R, 2013, CHEM COMMUN, V49, P5745, DOI 10.1039/c3cc42040j; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shea TB, 2018, J ALZHEIMERS DIS, V62, P1049, DOI 10.3233/JAD-170724; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Taylor CA, 2017, MMWR-MORBID MORTAL W, V66, pS21, DOI 10.15585/mmwr.mm6620a1; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; WOLF J, 1994, J ANIM BREED GENET, V111, P209, DOI 10.1111/j.1439-0388.1994.tb00459.x; Xu WL, 2009, DIABETOLOGIA, V52, P1031, DOI 10.1007/s00125-009-1323-x; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009	52	36	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13100	13111		10.1074/jbc.RA118.002275	http://dx.doi.org/10.1074/jbc.RA118.002275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29959224	hybrid, Green Published			2022-12-28	WOS:000442730200011
J	Gisch, N; Auger, JP; Thomsen, S; Roy, D; Xu, JG; Schwudke, D; Gottschalk, M				Gisch, Nicolas; Auger, Jean-Philippe; Thomsen, Simone; Roy, David; Xu, Jianguo; Schwudke, Dominik; Gottschalk, Marcelo			Structural analysis and immunostimulatory potency of lipoteichoic acids isolated from three Streptococcus suis serotype 2 strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); mass spectrometry (MS); glycolipid structure; bacteria; cell wall; bacterial virulence; host evasion; lipoprotein; lipoteichoic acid; Streptococcus suis	CELL-WALL; IDENTIFICATION; LIPOPROTEINS; REEVALUATION; RECOGNITION; VIRULENCE	Streptococcus suis serotype 2 is an important porcine and human pathogen. Lipoteichoic acid (LTA) from S. suis has been suggested to contribute to its virulence, and absence of d-alanylation from the S. suis LTA is associated with increased susceptibility to cationic antimicrobial peptides. Here, using high-resolution NMR spectroscopy and MS analyses, we characterized the LTA structures from three S. suis serotype 2 strains differing in virulence, sequence type (ST), and geographical origin. Our analyses revealed that these strains possess-in addition to the typical type I LTA present in other streptococci-a second, mixed-type series of LTA molecules of high complexity. We observed a ST-specific difference in the incorporation of glycosyl residues into these mixed-type LTAs. We found that strains P1/7 (ST1, high virulence) and SC84 (ST7, very high virulence) can attach a 1,2-linked -d-Glcp residue as branching substituent to an -d-Glcp that is 1,3-linked to glycerol phosphate moieties and that is not present in strain 89-1591 (ST25, intermediate virulence). In contrast, the latter strain could glycosylate its LTA at the glycerol O-2 position, which was not observed in the other two strains. Using LTA preparations from WT strains and from mutants with an inactivated prolipoprotein diacylglyceryl transferase, resulting in deficient lipoprotein acylation, we show that S. suis LTAs alone do not induce Toll-like receptor 2-dependent pro-inflammatory mediator production from dendritic cells. In summary, our study reveals an unexpected complexity of LTAs present in three S. suis serotype 2 strains differing in genetic background and virulence.	[Gisch, Nicolas; Thomsen, Simone; Schwudke, Dominik] Leibniz Lung Ctr, Res Ctr Borstel, Prior Area Infect, Div Bioanalyt Chem, D-23845 Borstel, Germany; [Auger, Jean-Philippe; Roy, David; Gottschalk, Marcelo] Univ Montreal, Dept Pathol & Microbiol, Fac Vet Med, St Hyacinthe, PQ J2S 2M2, Canada; [Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China	Forschungszentrum Borstel; Universite de Montreal; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Gisch, N (corresponding author), Leibniz Lung Ctr, Res Ctr Borstel, Div Bioanalyt Chem, Parkallee 4a-4c, D-23845 Borstel, Germany.	ngisch@fz-borstel.de	Schwudke, Dominik/B-3478-2013	Schwudke, Dominik/0000-0002-1379-9451; Gisch, Nicolas/0000-0003-3260-5269	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We gratefully acknowledge B. Buske, H. Kassner, and B. Kunz (all at Research Center Borstel, Borstel, Germany) as well as S. Lacouture and C. Duquette (University of Montreal, Quebec, Canada) for excellent technical assistance. This publication made use of the Multilocus Sequence Typing Website (http://www.mlst.net) (Please note that the JBC is not responsible for the long-term archiving and maintenance of this site or any other third party hosted site.) at Imperial College London developed by D. Aanensen and funded by the Wellcome Trust.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Auger JP, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030048; Calzas C, 2013, INFECT IMMUN, V81, P3106, DOI 10.1128/IAI.00113-13; Czabanska A, 2012, CARBOHYD RES, V361, P200, DOI 10.1016/j.carres.2012.09.007; Fischer K, 2011, GLYCOBIOLOGY, V21, P1588, DOI 10.1093/glycob/cwr071; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Gisch N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16718; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; GOTTSCHALK M, 1992, VET MICROBIOL, V30, P59, DOI 10.1016/0378-1135(92)90094-A; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hess N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01720-z; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Lachance C, 2013, INFECT IMMUN, V81, P1928, DOI 10.1128/IAI.01317-12; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Percy MG, 2016, J BACTERIOL, V198, P2029, DOI 10.1128/JB.00116-16; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Rismondo J, 2018, J BIOL CHEM, V293, P3293, DOI 10.1074/jbc.RA117.001614; Roy D, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030047; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; Slater JD, 2003, VET MICROBIOL, V93, P197, DOI 10.1016/S0378-1135(03)00030-0; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	32	14	14	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12011	12025		10.1074/jbc.RA118.002174	http://dx.doi.org/10.1074/jbc.RA118.002174			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29884769	Green Published, hybrid			2022-12-28	WOS:000440803200004
J	Guhathakurta, P; Prochniewicz, E; Grant, BD; Peterson, KC; Thomas, DD				Guhathakurta, Piyali; Prochniewicz, Ewa; Grant, Benjamin D.; Peterson, Kurt C.; Thomas, David D.			High-throughput screen, using time-resolved FRET, yields actin-binding compounds that modulate actin-myosin structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; myosin; fluorescence resonance energy transfer (FRET); peptide; high-throughput screening (HTS)	ESSENTIAL LIGHT-CHAIN; VERTEBRATE STRIATED-MUSCLE; RELEASE CHANNELS; POWER STROKE; LIVING CELLS; ISOFORM; DYNAMICS; CARDIOMYOPATHY; ACTIVATION; DEPENDS	We have used a novel time-resolved FRET (TR-FRET) assay to detect small-molecule modulators of actin-myosin structure and function. Actin-myosin interactions play crucial roles in the generation of cellular force and movement. Numerous mutations and post-translational modifications of actin or myosin disrupt muscle function and cause life-threatening syndromes. Here, we used a FRET biosensor to identify modulators that bind to the actin-myosin interface and alter the structural dynamics of this complex. We attached a fluorescent donor to actin at Cys-374 and a nonfluorescent acceptor to a peptide containing the 12 N-terminal amino acids of the long isoform of skeletal muscle myosin's essential light chain. The binding site on actin of this acceptor-labeled peptide (ANT) overlaps with that of myosin, as indicated by (a) a similar distance observed in the actin-ANT complex as in the actin-myosin complex and (b) a significant decrease in actin-ANT FRET upon binding myosin. A high-throughput FRET screen of a small-molecule library (NCC, 727 compounds), using a unique fluorescence lifetime readout with unprecedented speed and precision, showed that FRET is significantly affected by 10 compounds in the micromolar range. Most of these hits alter actin-activated myosin ATPase and affect the microsecond dynamics of actin detected by transient phosphorescence anisotropy. We conclude that the actin-ANT TR-FRET assay enables detection of pharmacologically active compounds that affect actin structural dynamics and actomyosin function. This assay establishes feasibility for the discovery of allosteric modulators of the actin-myosin interaction, with the ultimate goal of developing therapies for muscle disorders.	[Guhathakurta, Piyali; Prochniewicz, Ewa; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Grant, Benjamin D.; Peterson, Kurt C.] Fluorescence Innovat Inc, Minneapolis, MN 55414 USA; [Thomas, David D.] Photon Pharma LLC, Minneapolis, MN 55410 USA	University of Minnesota System; University of Minnesota Twin Cities	Thomas, DD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	ddt@umn.edu		Thomas, David D./0000-0002-8822-2040	National Institutes of Health [R01 HL129814, R01 AR32961, R37 AG26160, R42 DA037622]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R42DA037622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01 HL129814, R01 AR32961, and R37 AG26160 (to D. D. T.) and R42 DA037622 (to Fluorescence Innovations, Inc.; subcontract to the University of Minnesota). D. D. T. holds equity in, and serves as President of, Photonic Pharma LLC. This relationship has been reviewed and managed by the University of Minnesota. Photonic Pharma had no role in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aydt EM, 2007, J STRUCT BIOL, V159, P158, DOI 10.1016/j.jsb.2007.04.002; Boneschi FM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002127.pub3; BOTTINELLI R, 1994, J PHYSIOL-LONDON, V478, P341, DOI 10.1113/jphysiol.1994.sp020254; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; Dezsi CA, 2017, AM J CARDIOVASC DRUG, V17, P361, DOI 10.1007/s40256-017-0221-8; Elzoghby AO, 2013, EUR J PHARM BIOPHARM, V85, P444, DOI 10.1016/j.ejpb.2013.07.003; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Guhathakurta P, 2017, BIOPHYS J, V113, P91, DOI 10.1016/j.bpj.2017.05.027; Guhathakurta P, 2015, P NATL ACAD SCI USA, V112, P4660, DOI 10.1073/pnas.1420101112; Haase H, 2006, FASEB J, V20, P865, DOI 10.1096/fj.05-5414com; HAYASHIBARA T, 1994, BIOCHEMISTRY-US, V33, P12821, DOI 10.1021/bi00209a013; Hernandez OM, 2007, AM J PHYSIOL-HEART C, V292, pH1643, DOI 10.1152/ajpheart.00931.2006; Jaeger MA, 2009, FASEB J, V23, P2205, DOI 10.1096/fj.09-129783; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; Layer Peter, 2007, Ther Clin Risk Manag, V3, P107, DOI 10.2147/tcrm.2007.3.1.107; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Muretta JM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480647; Petersen KJ, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4900727; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Prochniewicz E, 2013, BIOCHEMISTRY-US, V52, P1622, DOI 10.1021/bi3014467; Prochniewicz E, 2011, J MOL BIOL, V413, P584, DOI 10.1016/j.jmb.2011.08.058; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; Rebbeck RT, 2017, SLAS DISCOV, V22, P176, DOI 10.1177/1087057116674312; Schaaf TM, 2017, SLAS DISCOV, V22, P262, DOI 10.1177/1087057116680151; Sellers JR, 2003, J MUSCLE RES CELL M, V24, P579, DOI 10.1023/B:JURE.0000009969.04562.58; Stollberger C, 2005, INT CLIN PSYCHOPHARM, V20, P243; SWEENEY HL, 1995, BIOPHYS J, V68, pS112; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Thomas DD, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P226, DOI 10.1016/B978-0-12-374920-8.00415-X; THOMAS DD, 1980, BIOPHYS J, V32, P891, DOI 10.1016/S0006-3495(80)85024-7; Tickell-Painter M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006491.pub4; WAGNER PD, 1979, EUR J BIOCHEM, V99, P385, DOI 10.1111/j.1432-1033.1979.tb13267.x; Walker M, 1999, P NATL ACAD SCI USA, V96, P465, DOI 10.1073/pnas.96.2.465; Woodbury A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00130; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	41	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12288	12298		10.1074/jbc.RA118.002702	http://dx.doi.org/10.1074/jbc.RA118.002702			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29866882	Green Published, hybrid			2022-12-28	WOS:000440803200030
J	Shibata, T; Kobayashi, Y; Ikeda, Y; Kawabata, S				Shibata, Toshio; Kobayashi, Yuki; Ikeda, Yuto; Kawabata, Shun-ichiro			Intermolecular autocatalytic activation of serine protease zymogen factor C through an active transition state responding to lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endotoxin; lipopolysaccharide (LPS); protein-protein interaction; serine protease; enzyme processing; autocatalytic activation; hemolymph coagulation; proteolytic cascade; transition state	HORSESHOE-CRAB HEMOCYTES; TACHYPLEUS-TRIDENTATUS HEMOCYTES; LIMULUS FACTOR-C; INVERTEBRATE IMMUNITY; COAGULATION CASCADE; PROCLOTTING ENZYME; ALPHA-CHYMOTRYPSIN; CRYSTAL-STRUCTURE; FACTOR-B; STAPHYLOCOAGULASE	Horseshoe crab hemolymph coagulation is believed to be triggered by the autocatalytic activation of serine protease zymogen factor C to the active form, -factor C, belonging to the trypsin family, through an active transition state of factor C responding to bacterial lipopolysaccharide (LPS), designated factor C*. However, the existence of factor C* is only speculative, and its proteolytic activity has not been validated. In addition, it remains unclear whether the proteolytic cleavage of the Phe(737)-Ile(738) bond (Phe(737) site) of factor C required for the conversion to -factor C occurs intramolecularly or intermolecularly between the factor C molecules. Here we show that the Phe(737) site of a catalytic Ser-deficient mutant of factor C is LPS-dependently hydrolyzed by a Phe(737) site-uncleavable mutant, clearly indicating the existence of the active transition state of factor C without cleavage of the Phe(737) site. Moreover, we found the following facts using several mutants of factor C: the autocatalytic cleavage of factor C occurs intermolecularly between factor C* molecules on the LPS surface; factor C* does not exhibit intrinsic chymotryptic activity against the Phe(737) site, but it may recognize a three-dimensional structure around the cleavage site; and LPS is required not only to complete the substrate-binding site and oxyanion hole of factor C* by interacting with the N-terminal region but also to allow the Phe(737) site to be cleaved by inducing a conformational change around the Phe(737) site or by acting as a scaffold to induce specific protein-protein interactions between factor C* molecules.	[Shibata, Toshio; Kobayashi, Yuki; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8190395, Japan; [Shibata, Toshio; Ikeda, Yuto; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan; [Kobayashi, Yuki] Seikagaku Corp, LAL Res & Dev Dept, Tokyo 2070021, Japan	Kyushu University; Kyushu University; Seikagaku Corporation	Kawabata, S (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	skawascb@kyudai.jp			Joint Research Fund of Seikagaku Corp.	Joint Research Fund of Seikagaku Corp.	This study was supported by the Joint Research Fund of Seikagaku Corp. The authors declare that they have no conflicts of interest with the contents of this article.	Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Armstrong Peter B., 2003, P288; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Doolittle RF, 2011, J INNATE IMMUN, V3, P9, DOI 10.1159/000321005; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Fujii Y, 2016, J CELL SCI, V129, P1512, DOI 10.1242/jcs.176685; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Kato Y, 2006, BIOCHEM BIOPH RES CO, V349, P1301, DOI 10.1016/j.bbrc.2006.08.171; KAWABATA S, 1985, J BIOCHEM, V98, P1603, DOI 10.1093/oxfordjournals.jbchem.a135430; KAWABATA S, 1986, J BIOL CHEM, V261, P1427; Kawabata S., 2011, INVERTEBRATE IMMUNIT, P122; Kawabata S, 2010, J BIOCHEM, V147, P611, DOI 10.1093/jb/mvq026; Kawasaki H, 2000, J BIOL CHEM, V275, P35297, DOI 10.1074/jbc.M006856200; Kobayashi Y, 2015, J BIOL CHEM, V290, P19379, DOI 10.1074/jbc.M115.653196; Kobayashi Y, 2014, J BIOL CHEM, V289, P25987, DOI 10.1074/jbc.M114.586933; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; Le Saux A, 2008, J MOL BIOL, V377, P902, DOI 10.1016/j.jmb.2008.01.045; Levin Jack, 2003, P310; Loof TG, 2011, J INNATE IMMUN, V3, P34, DOI 10.1159/000321641; Mizumura H, 2017, INNATE IMMUN-LONDON, V23, P136, DOI 10.1177/1753425916681074; MUTA T, 1991, J BIOL CHEM, V266, P6554; MUTA T, 1993, J BIOL CHEM, V268, P21384; MUTA T, 1990, J BIOL CHEM, V265, P22426; Myamoto DT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146992; NAKAMURA T, 1988, J BIOCHEM, V103, P370, DOI 10.1093/oxfordjournals.jbchem.a122276; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1988, EUR J BIOCHEM, V176, P89, DOI 10.1111/j.1432-1033.1988.tb14254.x; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797; Tagawa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036783; TOKUNAGA F, 1991, J BIOCHEM, V109, P150, DOI 10.1093/oxfordjournals.jbchem.a123337; TOKUNAGA F, 1987, EUR J BIOCHEM, V167, P405, DOI 10.1111/j.1432-1033.1987.tb13352.x; Urbanova V, 2014, DEV COMP IMMUNOL, V46, P439, DOI 10.1016/j.dci.2014.05.016; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	42	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11589	11599		10.1074/jbc.RA118.002311	http://dx.doi.org/10.1074/jbc.RA118.002311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29866883	Green Published, hybrid			2022-12-28	WOS:000439449700027
J	Chen, HL; Yuan, CY; Cheng, HH; Chang, TC; Huang, SK; Kuo, CC; Wu, KK				Chen, Hua-Ling; Yuan, Chao-Yun; Cheng, Huei-Hsuan; Chang, Tzu-Ching; Huang, Shau-Ku; Kuo, Cheng-Chin; Wu, Kenneth K.			Restoration of hydroxyindole O-methyltransferase levels in human cancer cells induces a tryptophan-metabolic switch and attenuates cancer progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell metabolism; enzyme; metastasis; tryptophan; 5-methoxytryptophan; HIOMT; hydroxyindole O-methyltransferase; melatonin	AMINO-ACID DECARBOXYLASE; CYCLOOXYGENASE-2 PROMOTER ACTIVATION; MESSENGER-RNA; EXPRESSION; SEROTONIN; MELATONIN; 5-METHOXYTRYPTOPHAN; P300; GENE	5-Methoxytryptophan (5-MTP) is a tryptophan metabolite with recently discovered anti-inflammatory and tumor-suppressing activities. Its synthesis is catalyzed by a hydroxyindole O-methyltransferase (HIOMT)-like enzyme. However, the exact identity of this HIOMT in human cells remains unclear. Human HIOMT exists in several alternatively spliced isoforms, and we hypothesized that 5-MTP-producing HIOMT is a distinct isoform. Here, we show that human fibroblasts and cancer cells express the HIOMT298 isoform as contrasted with the expression of the HIOMT345 isoform in pineal cells. Sequencing analysis of the cloned isoforms revealed that HIOMT298 is identical to the sequence of a previously reported truncated HIOMT isoform. Of note, HIOMT298 expression was reduced in cancer cells and tissues. Stable transfection of A549 cancer cells with HIOMT298 restored HIOMT expression to normal levels, accompanied by 5-MTP production. Furthermore, HIOMT298 transfection caused a tryptophan-metabolic switch from serotonin to 5-MTP production. To determine the in vivo relevance of this alteration, we compared growth and lung metastasis of HIOMT298-transfected A549 cells with those of vector- or untransfected A549 cells as controls in a murine xenograft model. Of note, the HIOMT298-transfected A549 cells exhibited slower growth and lower metastasis than the controls. Our findings provide insight into the crucial role of HIOMT298 in 5-MTP production in cells and in inhibiting cancer progression and highlight the potential therapeutic value of 5-MTP for managing cancer.	[Chen, Hua-Ling; Yuan, Chao-Yun; Kuo, Cheng-Chin; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli 35053, Taiwan; [Chen, Hua-Ling; Huang, Shau-Ku] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli 35053, Taiwan; [Yuan, Chao-Yun; Cheng, Huei-Hsuan; Chang, Tzu-Ching; Wu, Kenneth K.] China Med Univ Hosp, Metabol Med Res Ctr, Taichung 40402, Taiwan; [Cheng, Huei-Hsuan; Chang, Tzu-Ching; Wu, Kenneth K.] China Med Univ, Grad Inst Biomed Sci, Taichung 40402, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Coll Life Sci, Dept Med Sci, Hsinchu 30013, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Coll Life Sci, Inst Biotechnol, Hsinchu 30013, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Tsing Hua University; National Tsing Hua University	Kuo, CC; Wu, KK (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	kuocc@nhri.org.tw; kkgo@nhri.org.tw			Ministry of Science and Technology Excellent Research Team Program [MOST-104-2811-B-039-010]	Ministry of Science and Technology Excellent Research Team Program	This work was supported by Ministry of Science and Technology Excellent Research Team Program MOST-104-2811-B-039-010 (to K.K.W. and C.-C.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguanno A, 1996, J BIOL CHEM, V271, P4528; Avgeris M, 2008, CLIN BIOCHEM, V41, P1140, DOI 10.1016/j.clinbiochem.2008.04.026; Botros HG, 2013, J PINEAL RES, V54, P46, DOI 10.1111/j.1600-079X.2012.01020.x; CATTANEO MG, 1995, EUR J PHARM-MOLEC PH, V291, P209, DOI 10.1016/0014-2999(95)90106-X; Cheng HH, 2016, ONCOTARGET, V7, P31243, DOI 10.18632/oncotarget.9111; Cheng HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088507; Cheng HH, 2012, P NATL ACAD SCI USA, V109, P13231, DOI 10.1073/pnas.1209919109; Chu LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152166; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; DONOHUE SJ, 1993, DNA CELL BIOL, V12, P715, DOI 10.1089/dna.1993.12.715; DONOHUE SJ, 1992, J BIOL CHEM, V267, P5184; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; Jung B, 2006, CANCER RES, V66, P9789, DOI 10.1158/0008-5472.CAN-06-1776; LOVENBERG W, 1962, J BIOL CHEM, V237, P89; Mediavilla MD, 2010, CURR MED CHEM, V17, P4462, DOI 10.2174/092986710794183015; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; RODRIGUEZ IR, 1994, J BIOL CHEM, V269, P31969; Sarrouilhe D, 2015, CURR MOL MED, V15, P62, DOI 10.2174/1566524015666150114113411; Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441; Vachtenheim J, 1997, EUR J CANCER, V33, P2411, DOI 10.1016/S0959-8049(97)00302-X; Vijayalaxmi, 2002, J CLIN ONCOL, V20, P2575, DOI 10.1200/JCO.2002.11.004; Wang YF, 2016, CIRC RES, V119, P222, DOI 10.1161/CIRCRESAHA.116.308559	24	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11131	11142		10.1074/jbc.RA117.000597	http://dx.doi.org/10.1074/jbc.RA117.000597			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794137	Green Published, hybrid			2022-12-28	WOS:000438882800025
J	Fujita, S; Sato, D; Kasai, H; Ohashi, M; Tsukue, S; Takekoshi, Y; Gomi, K; Shintani, T				Fujita, Shoki; Sato, Daichi; Kasai, Hirokazu; Ohashi, Masataka; Tsukue, Shintaro; Takekoshi, Yutaro; Gomi, Katsuya; Shintani, Takahiro			The C-terminal region of the yeast monocarboxylate transporter Jen1 acts as a glucose signal-responding degron recognized by the -arrestin Rod1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; glucose; arrestin; ubiquitylation (ubiquitination); E3 ubiquitin ligase; protein degradation; degron; monocarboxylate transporter; nutrient regulation; plasma membrane transporter; Rsp5	PERMEASE GENE JEN1; SACCHAROMYCES-CEREVISIAE; ALPHA-ARRESTIN; INDUCED UBIQUITYLATION; PHEROMONE RESPONSE; PROTEIN; ENDOCYTOSIS; SWITCH; PHOSPHORYLATION; EXPRESSION	In response to changes in nutrient conditions, cells rearrange the composition of plasma membrane (PM) transporters to optimize their metabolic flux. Not only transcriptional gene regulation, but also inactivation of specific transporters is important for fast rearrangement of the PM. In eukaryotic cells, endocytosis plays a role in transporter inactivation, which is triggered by ubiquitination of these transporters. The Nedd4 family E3 ubiquitin ligase is responsible for ubiquitination of the PM transporters and requires that a series of -arrestin proteins are targeted to these transporters. The mechanism by which an -arrestin recognizes its cognate transporters in response to environmental signals is of intense scientific interest. Excess substrates or signal transduction pathways are known to initiate recognition of transporters by -arrestins. Here, we identified an endocytic-sorting signal in the monocarboxylate transporter Jen1 from yeast (Saccharomyces cerevisiae), whose endocytic degradation depends on the Snf1-glucose signaling pathway. We found that the C-terminal 20-amino acid-long region of Jen1 contains an amino acid sequence required for association of Jen1 to the -arrestin Rod1, as well as lysine residues important for glucose-induced Jen1 ubiquitination. Notably, fusion of this region to the methionine permease, Mup1, whose endocytosis is normally induced by excess methionine, was sufficient for Mup1 to undergo glucose-induced, Rod1-mediated endocytosis. Taken together, our results demonstrate that the Jen1 C-terminal region acts as a glucose-responding degron for -arrestin-mediated endocytic degradation of Jen1.	[Fujita, Shoki; Sato, Daichi; Kasai, Hirokazu; Ohashi, Masataka; Tsukue, Shintaro; Takekoshi, Yutaro; Gomi, Katsuya; Shintani, Takahiro] Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Sendai, Miyagi 9800845, Japan	Tohoku University	Shintani, T (corresponding author), 468-1 Aramaki Aza Aoba,Aoba Ku, Sendai, Miyagi 9800845, Japan.	takahiro.shintani.d7@tohoku.ac.jp	SHINTANI, Takahiro/ABE-1267-2020; Fujita, Shoki/AAY-9793-2021	Shintani, Takahiro/0000-0001-6630-5892	Japan Society for the Promotion of Science (JSPS) Core-to-Core Program; JSPS KAKENHI [JP26450084, JP17J02369]	Japan Society for the Promotion of Science (JSPS) Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Core-to-Core Program (A. Advanced Research Networks entitled "Establishment of international agricultural immunology research-core for a quantum improvement in food safety") and JSPS KAKENHI Grants JP26450084 (to T. S.) and JP17J02369 (to S. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Akita O, 2000, BIOSCI BIOTECH BIOCH, V64, P980, DOI 10.1271/bbb.64.980; Alvaro CG, 2016, GENETICS, V203, P299, DOI 10.1534/genetics.115.186122; Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; Andrade RP, 2001, FUNGAL GENET BIOL, V32, P105, DOI 10.1006/fgbi.2001.1254; Aubry L, 2013, PROG MOL BIOL TRANSL, V118, P21, DOI 10.1016/B978-0-12-394440-5.00002-4; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; Brachmann CB, 1998, YEAST, V14, P115; Burke D., 2000, METHODS YEAST GENETI; Cain NE, 2011, MOL BIOL CELL, V22, P1919, DOI 10.1091/mbc.E10-10-0800; Chang CI, 2014, BIOL OPEN, V3, P297, DOI 10.1242/bio.20146866; Ghaddar K, 2014, MOL CELL BIOL, V34, P4447, DOI 10.1128/MCB.00699-14; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guiney EL, 2016, MOL BIOL CELL, V27, P4043, DOI 10.1091/mbc.E16-08-0570; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keener JM, 2013, TRAFFIC, V14, P412, DOI 10.1111/tra.12039; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Llopis-Torregrosa V, 2016, J BIOL CHEM, V291, P14973, DOI 10.1074/jbc.M116.733923; Lodi T, 2002, MOL GENET GENOMICS, V266, P838, DOI 10.1007/s00438-001-0604-y; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Paiva S, 2002, BIOCHEM J, V363, P737, DOI 10.1042/0264-6021:3630737; Paiva S, 2009, J BIOL CHEM, V284, P19228, DOI 10.1074/jbc.M109.008318; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Talaia G, 2017, J MOL BIOL, V429, P3678, DOI 10.1016/j.jmb.2017.09.014; Waldhart AN, 2017, CELL REP, V19, P2005, DOI 10.1016/j.celrep.2017.05.041; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035	34	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10926	10936		10.1074/jbc.RA117.001062	http://dx.doi.org/10.1074/jbc.RA117.001062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789424	Green Published, hybrid			2022-12-28	WOS:000438882800007
J	Hershberger, KA; Abraham, DM; Liu, J; Locasale, JW; Grimsrud, PA; Hirschey, MD				Hershberger, Kathleen A.; Abraham, Dennis M.; Liu, Juan; Locasale, Jason W.; Grimsrud, Paul A.; Hirschey, Matthew D.			Ablation of Sirtuin5 in the postnatal mouse heart results in protein succinylation and normal survival in response to chronic pressure overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sirtuin; protein acylation; proteomics; stress; cardiac hypertrophy	CARDIAC-HYPERTROPHY; SIRT5; MICE; IDENTIFICATION; METABOLOMICS; UNIVERSAL; TAMOXIFEN; ACYLATION; DATABASE	Mitochondrial Sirtuin 5 (SIRT5) is an NAD(+)-dependent demalonylase, desuccinylase, and deglutarylase that controls several metabolic pathways. A number of recent studies point to SIRT5 desuccinylase activity being important in maintaining cardiac function and metabolism under stress. Previously, we described a phenotype of increased mortality in whole-body SIRT5KO mice exposed to chronic pressure overload compared with their littermate WT controls. To determine whether the survival phenotype we reported was due to a cardiac-intrinsic or cardiac-extrinsic effect of SIRT5, we developed a tamoxifen-inducible, heart-specific SIRT5 knockout (SIRT5KO) mouse model. Using our new animal model, we discovered that postnatal cardiac ablation of Sirt5 resulted in persistent accumulation of protein succinylation up to 30 weeks after SIRT5 depletion. Succinyl proteomics revealed that succinylation increased on proteins of oxidative metabolism between 15 and 31 weeks after ablation. Heart-specific SIRT5KO mice were exposed to chronic pressure overload to induce cardiac hypertrophy. We found that, in contrast to whole-body SIRT5KO mice, there was no difference in survival between heart-specific SIRT5KO mice and their littermate controls. Overall, the data presented here suggest that survival of SIRT5KO mice may be dictated by a multitissue or prenatal effect of SIRT5.	[Hershberger, Kathleen A.; Liu, Juan; Locasale, Jason W.; Grimsrud, Paul A.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Hershberger, Kathleen A.; Liu, Juan; Locasale, Jason W.; Grimsrud, Paul A.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27701 USA; [Hershberger, Kathleen A.; Liu, Juan; Locasale, Jason W.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Abraham, Dennis M.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Abraham, Dennis M.] Duke Univ, Med Ctr, Duke Cardiovasc Physiol Core, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Div Endocrinol Metab & Nutr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Hirschey, MD (corresponding author), Duke Mol Physiol Inst, 300 N Duke St, Durham, NC 27701 USA.	matthew.hirschey@duke.edu	Hershberger, Kathleen/AAP-2098-2020; Locasale, Jason W/ABE-6505-2020; Grimsrud, Paul A./GWZ-9287-2022	Hershberger, Kathleen/0000-0002-3349-6140; Locasale, Jason W/0000-0002-7766-3502; Grimsrud, Paul A./0000-0002-4706-914X; Hirschey, Matthew/0000-0003-4541-5376	American Heart Association [12SDG8840004, 12IRG9010008]; NIA, National Institutes of Health [R01AG045351]; NIDDK, National Institutes of Health [P30DK096493]; Ruth L. Kirschstein National Service Research Award F31 Predoctoral Fellowship [1F31HL127959-03]; NIGMS, National Institutes of Health [5T32GM007105-40]; NHLBI, National Institutes of Health [1K08HL125905-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL125905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018164] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ruth L. Kirschstein National Service Research Award F31 Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by American Heart Association Grants 12SDG8840004 and 12IRG9010008; NIA, National Institutes of Health Grant R01AG045351; and NIDDK, National Institutes of Health Award P30DK096493. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Ruth L. Kirschstein National Service Research Award F31 Predoctoral Fellowship 1F31HL127959-03 and a NIGMS, National Institutes of Health training grant to the Duke University Pharmacological Sciences Training Program (5T32GM007105-40).; Supported by NHLBI, National Institutes of Health Grant 1K08HL125905-01.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bersell K, 2013, DIS MODEL MECH, V6, P1459, DOI 10.1242/dmm.010447; Boylston JA, 2015, J MOL CELL CARDIOL, V88, P73, DOI 10.1016/j.yjmcc.2015.09.005; Chen W, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-55; DEMARIA AN, 1979, AM J CARDIOL, V43, P1, DOI 10.1016/0002-9149(79)90036-5; Di Segni E, 1997, J AM SOC ECHOCARDIOG, V10, P926; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fernandez-Marcos PJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00425; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hershberger KA, 2017, J BIOL CHEM, V292, P19767, DOI 10.1074/jbc.M117.809897; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Horton JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84897; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Lesack Kyle, 2011, J Pathol Inform, V2, P52, DOI 10.4103/2153-3539.91130; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Martin AS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93885; McDonnell E, 2016, CELL REP, V17, P1463, DOI 10.1016/j.celrep.2016.10.012; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Samak M, 2016, MED SCI MONIT BASIC, V22, P75, DOI 10.12659/MSMBR.900437; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wagner GR, 2017, CELL METAB, V25, P823, DOI 10.1016/j.cmet.2017.03.006; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang F, 2017, CELL REP, V19, P2331, DOI 10.1016/j.celrep.2017.05.065; Winnik S, 2015, EUR HEART J, V36, P3404, DOI 10.1093/eurheartj/ehv290; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yates JR, 2015, J AM SOC MASS SPECTR, V26, P1804, DOI 10.1007/s13361-015-1220-0; Yu JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02806	42	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10630	10645		10.1074/jbc.RA118.002187	http://dx.doi.org/10.1074/jbc.RA118.002187			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29769314	hybrid, Green Published			2022-12-28	WOS:000437828400021
J	Park, SK; Herrnreiter, A; Pfister, SL; Gauthier, KM; Falck, BA; Falck, JR; Campbell, WB				Park, Sang-Kyu; Herrnreiter, Anja; Pfister, Sandra L.; Gauthier, Kathryn M.; Falck, Benjamin A.; Falck, John R.; Campbell, William B.			GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial cell; cyclooxygenase (COX); connexin; smooth muscle; fatty acid	SOLUBLE EPOXIDE HYDROLASE; GAP JUNCTIONAL COMMUNICATION; CORONARY SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; 14,15-EPOXYEICOSATRIENOIC ACID; INSULIN-SECRETION; INTERNATIONAL UNION; GLUCOSE-HOMEOSTASIS; BETA-CELLS	Endothelium-derived epoxyeicosatrienoic acids (EETs) have numerous vascular activities mediated by G protein-coupled receptors. Long-chain free fatty acids and EETs activate GPR40, prompting us to investigate the role of GPR40 in some vascular EET activities. 14,15-EET, 11,12-EET, arachidonic acid, and the GPR40 agonist GW9508 increase intracellular calcium concentrations in human GPR40-overexpressing HEK293 cells (EC50 = 0.58 +/- 0.08 m, 0.91 +/- 0.08 m, 3.9 +/- 0.06 m, and 19 +/- 0.37 nm, respectively). EETs with cis- and trans-epoxides had similar activities, whereas substitution of a thiirane sulfur for the epoxide oxygen decreased the activities. 8,9-EET, 5,6-EET, and the epoxide hydrolysis products 11,12- and 14,15-dihydroxyeicosatrienoic acids were less active than 11,12-EET. The GPR40 antagonist GW1100 and siRNA-mediated GPR40 silencing blocked the EET- and GW9508-induced calcium increases. EETs are weak GPR120 agonists. GPR40 expression was detected in human and bovine endothelial cells (ECs), smooth muscle cells, and arteries. 11,12-EET concentration-dependently relaxed preconstricted coronary arteries; however, these relaxations were not altered by GW1100. In human ECs, 11,12-EET increased MAP kinase (MAPK)-mediated ERK phosphorylation, phosphorylation and levels of connexin-43 (Cx43), and expression of cyclooxygenase-2 (COX-2), all of which were inhibited by GW1100 and the MAPK inhibitor U0126. Moreover, siRNA-mediated GPR40 silencing decreased 11,12-EET-induced ERK phosphorylation. These results indicated that GPR40 is a low-affinity EET receptor in vascular cells and arteries. We conclude that epoxidation of arachidonic acid to EETs enhances GPR40 agonist activity and that 11,12-EET stimulation of GPR40 increases Cx43 and COX-2 expression in ECs via ERK phosphorylation.	[Park, Sang-Kyu; Herrnreiter, Anja; Pfister, Sandra L.; Gauthier, Kathryn M.; Campbell, William B.] Dept Pharmacol & Toxicol Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Park, Sang-Kyu; Herrnreiter, Anja; Pfister, Sandra L.; Gauthier, Kathryn M.; Campbell, William B.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Falck, Benjamin A.; Falck, John R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Medical College of Wisconsin; University of Texas System; University of Texas Southwestern Medical Center Dallas	Campbell, WB (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	wbcamp@mcw.edu			National Institutes of Health from NHLBI [HL-83297, HL-111392]; Ralph and Marian Falk Medical Research Trust Bank of America, N.A.; Robert A. Welch Foundation [I-0011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111392, R01HL083297] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ralph and Marian Falk Medical Research Trust Bank of America, N.A.; Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL-83297 and HL-111392 from NHLBI, the Ralph and Marian Falk Medical Research Trust Bank of America, N.A., Trustee Grant, and Robert A. Welch Foundation Award I-0011. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Behm DJ, 2009, J PHARMACOL EXP THER, V328, P231, DOI 10.1124/jpet.108.145102; Bertrand R, 2016, J LABELLED COMPD RAD, V59, P604, DOI 10.1002/jlcr.3412; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Campbell W B, 2001, Med Sci Monit, V7, P578; Campbell WB, 2006, AM J PHYSIOL-HEART C, V290, pH64, DOI 10.1152/ajpheart.00516.2005; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; CAPDEVILA J, 1981, P NATL ACAD SCI-BIOL, V78, P5362, DOI 10.1073/pnas.78.9.5362; CAPDEVILA J, 1982, P NATL ACAD SCI-BIOL, V79, P767, DOI 10.1073/pnas.79.3.767; Chen JK, 2001, MOL CELL BIOL, V21, P6322, DOI 10.1128/MCB.21.18.6322-6331.2001; Chen YJ, 2016, INT S HIGH PERF COMP, P40, DOI 10.1109/HPCA.2016.7446052; Chen YM, 2011, BIOCHEMISTRY-US, V50, P3840, DOI 10.1021/bi102070w; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; de Wit C, 2000, CIRC RES, V86, P649, DOI 10.1161/01.RES.86.6.649; Dhanasekaran A, 2006, AM J PHYSIOL-HEART C, V291, pH517, DOI 10.1152/ajpheart.00953.2005; Ding YD, 2014, J PHARMACOL EXP THER, V350, P14, DOI 10.1124/jpet.114.214254; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; FALCK JR, 1990, METHOD ENZYMOL, V187, P357; Falck JR, 2003, AM J PHYSIOL-HEART C, V284, pH337, DOI 10.1152/ajpheart.00831.2001; Fang X, 1999, HYPERTENSION, V34, P1242, DOI 10.1161/01.HYP.34.6.1242; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Fleming I, 2007, PROSTAG OTH LIPID M, V82, P60, DOI 10.1016/j.prostaglandins.2006.05.003; Fredholm BB, 2014, J MOL MED, V92, P201, DOI 10.1007/s00109-013-1101-6; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Fukushima K, 2015, BIOCHEM BIOPH RES CO, V465, P512, DOI 10.1016/j.bbrc.2015.08.050; Gauthier KM, 2002, J PHYSIOL-LONDON, V545, P829, DOI 10.1113/jphysiol.2002.029843; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; HENRICH WL, 1990, AM J PHYSIOL, V258, pE269, DOI 10.1152/ajpendo.1990.258.2.E269; Honore JC, 2013, ARTERIOSCL THROM VAS, V33, P954, DOI 10.1161/ATVBAHA.112.300943; Hu H, 2009, BIOCHEM BIOPH RES CO, V390, P557, DOI 10.1016/j.bbrc.2009.10.004; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jiang HL, 2008, J PHARMACOL EXP THER, V326, P330, DOI 10.1124/jpet.107.134858; Jiang HL, 2011, AM J PHYSIOL-HEART C, V300, pH1990, DOI 10.1152/ajpheart.01267.2010; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P595, DOI 10.1161/01.ATV.0000116219.09040.8c; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen BT, 2007, TRENDS PHARMACOL SCI, V28, P32, DOI 10.1016/j.tips.2006.11.002; Larsen BT, 2006, AM J PHYSIOL-HEART C, V290, pH491, DOI 10.1152/ajpheart.00927.2005; Li PL, 1997, CIRC RES, V80, P877; Lin MT, 2015, PULM CIRC, V5, P279, DOI 10.1086/680166; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Luther JM, 2016, PROSTAG OTH LIPID M, V125, P2, DOI 10.1016/j.prostaglandins.2016.07.010; Ma SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113130; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; MARCHENKO SM, 1993, J PHYSIOL-LONDON, V462, P735, DOI 10.1113/jphysiol.1993.sp019579; Mena SJ, 2016, INNATE IMMUN-LONDON, V22, P479, DOI 10.1177/1753425916656765; Michaelis UR, 2005, ARTERIOSCL THROM VAS, V25, P321, DOI 10.1161/01.ATV.0000151648.58516.eb; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Node K, 2001, J BIOL CHEM, V276, P15983, DOI 10.1074/jbc.M100439200; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Popp R, 2002, CIRC RES, V90, P800, DOI 10.1161/01.RES.0000015328.20581.D6; Pozzi A, 2005, J BIOL CHEM, V280, P27138, DOI 10.1074/jbc.M501730200; REVTYAK GE, 1988, AM J PHYSIOL, V255, pC214, DOI 10.1152/ajpcell.1988.255.2.C214; REVTYAK GE, 1988, AM J PHYSIOL, V254, pC8, DOI 10.1152/ajpcell.1988.254.1.C8; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Siangjong L, 2013, AM J PHYSIOL-HEART C, V304, pH382, DOI 10.1152/ajpheart.00690.2012; Snyder GD, 2002, AM J PHYSIOL-HEART C, V283, pH1936, DOI 10.1152/ajpheart.00321.2002; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sun JX, 2002, CIRC RES, V90, P1020, DOI 10.1161/01.RES.0000017727.35930.33; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; van Kempen MJA, 1999, HISTOCHEM CELL BIOL, V112, P479, DOI 10.1007/s004180050432; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P165, DOI 10.1177/2042018810381066; VANVOORHIS BJ, 1993, J CLIN ENDOCR METAB, V76, P1555, DOI 10.1210/jc.76.6.1555; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Weston AH, 2005, BRIT J PHARMACOL, V145, P775, DOI 10.1038/sj.bjp.0706256; Wohlfeil ER, 1997, BBA-LIPID LIPID MET, V1345, P109, DOI 10.1016/S0005-2760(96)00170-1; WONG PYK, 1993, J LIPID MEDIATOR, V6, P199; Yamada H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25912; Yang C, 2014, PROSTAG OTH LIPID M, V112, P1, DOI 10.1016/j.prostaglandins.2014.05.001; Yang C, 2010, PROSTAG OTH LIPID M, V93, P44, DOI 10.1016/j.prostaglandins.2010.06.004; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; Yang WQ, 2007, J PHARMACOL EXP THER, V321, P1023, DOI 10.1124/jpet.107.119651; Yin GT, 2014, MOL CELL BIOCHEM, V394, P101, DOI 10.1007/s11010-014-2085-4; Zhang J, 2014, FEBS LETT, V588, P1365, DOI 10.1016/j.febslet.2014.02.003; Zhang Y, 2007, J MOL ENDOCRINOL, V38, P651, DOI 10.1677/JME-06-0048	86	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10675	10691		10.1074/jbc.RA117.001297	http://dx.doi.org/10.1074/jbc.RA117.001297			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29777058	Green Published, hybrid			2022-12-28	WOS:000437828400024
J	Wu, XZ; Gowda, NM; Kawasawa, YI; Gowda, DC				Wu, Xianzhu; Gowda, Nagaraj M.; Kawasawa, Yuka I.; Gowda, D. Channe			A malaria protein factor induces IL-4 production by dendritic cells via PI3K-Akt-NF-B signaling independent of MyD88/TRIF and promotes Th2 response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						malaria; protein complex; dendritic cell; interleukin; Toll-like receptor (TLR); PI3K-Akt-NF-kB; signaling; protein factor; dendritic cell; IL-4 production; signaling mechanism	INNATE IMMUNE-RESPONSES; PROTECTIVE-IMMUNITY; CEREBRAL MALARIA; T-CELLS; INFECTION; ACTIVATION; HEMOZOIN; HOST; PATHOGENESIS; INFLAMMATION	Dendritic cells (DC) and cytokines produced by DC play crucial roles in inducing and regulating pro-/anti-inflammatory and Th1/Th2 responses. DC are known to produce a Th1-promoting cytokine, interleukin (IL)-12, in response to malaria and other pathogenic infections, but it is thought that DC do not produce Th2-promoting cytokine, IL-4. Here, we show that a protein factor of malaria parasites induces IL-4 responses by CD11c(hi)MHCII(hi)CD3E(-)CD49b(-)CD19(-)FcERI(-) DC via PI3K-Akt-NF-B signaling independent of TLR-MyD88/TRIF. Malaria parasite-activated DC induced IL-4 responses by T cells both in vitro and in vivo, favoring Th2, and il-4-deficient DC were unable to induce IL-4 expression by T cells. Interestingly, lethal parasites, Plasmodium falciparum and Plasmodium berghei ANKA, induced IL-4 response primarily by CD8(-) DC, whereas nonlethal Plasmodium yoelii induced IL-4 by both CD8(+) and CD8(-) DC. In both P. berghei ANKA- and P. yoelii-infected mice, IL-4-expressing CD8(-) DC did not express IL-12, but a distinct CD8(-) DC subset expressed IL-12. In P. berghei ANKA infection, CD8(+) DC expressed IL-12 but not IL-4, whereas in P. yoelii infection, CD8(+) DC expressed IL-4 but not IL-12. These differential IL-4 and IL-12 responses by DC subsets may contribute to different Th1/Th2 development and clinical outcomes in lethal and nonlethal malaria. Our results for the first time demonstrate that a malaria protein factor induces IL-4 production by DC via PI3K-Akt-NF-B signaling, revealing signaling and molecular mechanisms that initiate and promote Th2 development.	[Wu, Xianzhu; Gowda, Nagaraj M.; Kawasawa, Yuka I.; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Kawasawa, Yuka I.] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Kawasawa, Yuka I.] Penn State Univ, Coll Med, Inst Personalized Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gowda, DC (corresponding author), Hershey Med Ctr, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gowda@psu.edu			NIAID, National Institutes of Health [R01 AI41139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health, Grant R01 AI41139. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baccarella A, 2013, INFECT IMMUN, V81, P4431, DOI 10.1128/IAI.00923-13; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Bernabeu M, 2017, TRENDS PARASITOL, V33, P295, DOI 10.1016/j.pt.2016.11.004; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Deroost K, 2016, FEMS MICROBIOL REV, V40, P208, DOI 10.1093/femsre/fuv046; Gallego-Delgado J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0401-8; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Gowda NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020398; Howland SW, 2015, SEMIN IMMUNOPATHOL, V37, P221, DOI 10.1007/s00281-015-0476-6; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Kelleher P, 1999, EUR J IMMUNOL, V29, P2309, DOI 10.1002/(SICI)1521-4141(199907)29:07<2309::AID-IMMU2309>3.3.CO;2-X; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Ma YL, 2015, J IMMUNOL, V195, P3769, DOI 10.4049/jimmunol.1403240; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nakahara T, 2004, INT IMMUNOL, V16, P1701, DOI 10.1093/intimm/dxh171; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Sakanaka M, 2016, IMMUNOL LETT, V174, P1, DOI 10.1016/j.imlet.2016.04.003; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 2007, IMMUNOL CELL BIOL, V85, P130, DOI 10.1038/sj.icb.7100040; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Spaulding E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005975; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Stevenson MM, 2006, PARASITE IMMUNOL, V28, P5, DOI 10.1111/j.1365-3024.2006.00772.x; Tedder Thomas F, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0732s23; Todryk SM, 2008, FUTURE MICROBIOL, V3, P279, DOI 10.2217/17460913.3.3.279; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Wu XZ, 2015, J BIOL CHEM, V290, P23135, DOI 10.1074/jbc.M115.671065; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yu X, 2016, IMMUNITY, V45, P1093, DOI 10.1016/j.immuni.2016.10.001	38	12	15	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10425	10434		10.1074/jbc.AC118.001720	http://dx.doi.org/10.1074/jbc.AC118.001720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29666186	Green Published, hybrid			2022-12-28	WOS:000437828400002
J	Aboudehen, K; Farahani, S; Kanchwala, M; Chan, SC; Avdulov, S; Mickelson, A; Lee, D; Gearhart, MD; Patel, V; Xing, C; Igarashi, P				Aboudehen, Karam; Farahani, Shayan; Kanchwala, Mohammed; Chan, Siu Chiu; Avdulov, Svetlana; Mickelson, Alan; Lee, Dayeon; Gearhart, Micah D.; Patel, Vishal; Xing, Chao; Igarashi, Peter			Long noncoding RNA Hoxb3os is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; long noncoding RNA (long ncRNA; lncRNA); mTOR complex (mTORC); CRISPR; Cas; epithelial cell	CYST FORMATION; CELL-PROLIFERATION; MAMMALIAN TARGET; GENE; CANCER; INACTIVATION; ACTIVATION; MALAT-1; PATHWAY; PROTEIN	Autosomal dominant polycystic kidney disease (ADPKD) is a debilitating disease that is characterized by the accumulation of numerous fluid-filled cysts in the kidney. ADPKD is primarily caused by mutations in two genes, PKD1 and PKD2. Long noncoding RNAs (lncRNA), defined by a length >200 nucleotides and absence of a long ORF, have recently emerged as epigenetic regulators of development and disease; however, their involvement in PKD has not been explored previously. Here, we performed deep RNA-Seq to identify lncRNAs that are dysregulated in two orthologous mouse models of ADPKD (kidney-specific Pkd1 and Pkd2 mutant mice). We identified a kidney-specific, evolutionarily conserved lncRNA called Hoxb3os that was down-regulated in cystic kidneys from Pkd1 and Pkd2 mutant mice. The human ortholog HOXB3-AS1 was down-regulated in cystic kidneys from ADPKD patients. Hoxb3os was highly expressed in renal tubules in adult WT mice, whereas its expression was lost in the cyst epithelium of mutant mice. To investigate the function of Hoxb3os, we utilized CRISPR/Cas9 to knock out its expression in mIMCD3 cells. Deletion of Hoxb3os resulted in increased phosphorylation of mTOR and its downstream targets, including p70 S6 kinase, ribosomal protein S6, and the translation repressor 4E-BP1. Consistent with activation of mTORC1 signaling, Hoxb3os mutant cells displayed increased mitochondrial respiration. The Hoxb3os mutant phenotype was partially rescued upon re-expression of Hoxb3os in knockout cells. These findings identify Hoxb3os as a novel lncRNA that is down-regulated in ADPKD and regulates mTOR signaling and mitochondrial respiration.	[Aboudehen, Karam; Farahani, Shayan; Chan, Siu Chiu; Avdulov, Svetlana; Mickelson, Alan; Lee, Dayeon; Igarashi, Peter] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Gearhart, Micah D.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Kanchwala, Mohammed; Xing, Chao] UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Xing, Chao] UT Southwestern Med Ctr, Dept Clin Sci, Dallas, TX 75390 USA; [Xing, Chao] UT Southwestern Med Ctr, Dept Bioinformat, Dallas, TX 75390 USA; [Patel, Vishal] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Aboudehen, K (corresponding author), 420 Delaware St SE,MMC 605, Minneapolis, MN 55455 USA.	karam@umn.edu	Patel, Vishal/GMW-7076-2022	Patel, Vishal/0000-0003-2875-4659; Xing, Chao/0000-0002-1838-0502; Farahani, Shayan/0000-0002-1656-5183; aboudehen, karam/0000-0003-4975-464X; Gearhart, Micah/0000-0002-9873-1930; Kanchwala, Mohammed/0000-0001-6035-2970	National Institutes of Health [R37DK042921, UL1TR001105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102572, R37DK042921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grants R37DK042921 (to P. I.) and UL1TR001105 (to C. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguiari G, 2004, FASEB J, V18, P884, DOI 10.1096/fj.03-0687fje; Audrezet MP, 2016, J AM SOC NEPHROL, V27, P722, DOI 10.1681/ASN.2014101051; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Birkenmeier K, 2016, INT J CANCER, V138, P2231, DOI 10.1002/ijc.29934; Boca M, 2006, J AM SOC NEPHROL, V17, P637, DOI 10.1681/ASN.2005050534; Braun WE, 2014, CLIN J AM SOC NEPHRO, V9, P881, DOI 10.2215/CJN.02650313; Cornec-Le Gall E, 2018, J AM SOC NEPHROL, V29, P13, DOI 10.1681/ASN.2017050483; De Kumar B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501402; Emmrich S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-171; Fatima Roshan, 2015, Mol Cell Ther, V3, P5, DOI 10.1186/s40591-015-0042-6; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Grantham J. J., 1985, PROBL DIAGN MAN POL; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Harris PC, 2002, GENEREVIEWS; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hessels D, 2009, NAT REV UROL, V6, P255, DOI 10.1038/nrurol.2009.40; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Igarashi P, 2007, J AM SOC NEPHROL, V18, P1371, DOI 10.1681/ASN.2007030299; IGLESIAS CG, 1983, AM J KIDNEY DIS, V2, P630; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; Kuntz EM, 2017, NAT MED, V23, P1234, DOI 10.1038/nm.4399; Kurbegovic A, 2014, MOL CELL BIOL, V34, P3341, DOI 10.1128/MCB.00687-14; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Long JY, 2016, J CLIN INVEST, V126, P4205, DOI 10.1172/JCI87927; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Patel V, 2009, CURR OPIN NEPHROL HY, V18, P99, DOI 10.1097/MNH.0b013e3283262ab0; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Qian P, 2016, CELL STEM CELL, V18, P1, DOI DOI 10.1016/j.stem.2015.11.001; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Wang F, 2015, ONCOTARGET, V6, P1; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang X, 2018, J CELL BIOCHEM, V119, P1567, DOI 10.1002/jcb.26317; Warner G, 2016, J AM SOC NEPHROL, V27, P1437, DOI 10.1681/ASN.2015020132; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e	53	25	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9388	9398		10.1074/jbc.RA118.001723	http://dx.doi.org/10.1074/jbc.RA118.001723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29716997	Green Published, hybrid			2022-12-28	WOS:000435441400023
J	Zuo, XL; Rong, BW; Li, L; Lv, RT; Lan, F; Tong, MH				Zuo, Xiaoli; Rong, Bowen; Li, Li; Lv, Ruitu; Lan, Fei; Tong, Ming-Han			The histone methyltransferase SETD2 is required for expression of acrosin-binding protein 1 and protamines and essential for spermiogenesis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						spermatogenesis; histone modification; histone methylation; testis; reproduction; acrosome biogenesis; histone-to-protamine transition; Setd2; spermiogenesis	GERM-CELL APOPTOSIS; LIFE-HISTORY; ZONA-PELLUCIDA; METHYLATION; SPERM; CYCLE; SPERMATOGENESIS; WAVE; DIFFERENTIATION; DEFICIENCY	Spermatogenesis is precisely controlled by complex gene expression programs and involves epigenetic reprogramming, including histone modification and DNA methylation. SET domain-containing 2 (SETD2) is the predominant histone methyltransferase catalyzing the trimethylation of histone H3 lysine 36 (H3K36me3) and plays key roles in embryonic stem cell differentiation and somatic cell development. However, its role in male germ cell development remains elusive. Here, we demonstrate an essential role of Setd2 for spermiogenesis, the final stage of spermatogenesis. Using RNA-seq, we found that, in postnatal mouse testes, Setd2 mRNA levels dramatically increase in 14-day-old mice. Using a germ cell-specific Setd2 knockout mouse model, we also found that targeted Setd2 knockout in germ cells causes aberrant spermiogenesis with acrosomal malformation before step 8 of the round-spermatid stage, resulting in complete infertility. Furthermore, we noted that the Setd2 deficiency results in complete loss of H3K36me3 and significantly decreases expression of thousands of genes, including those encoding acrosin-binding protein 1 (Acrbp1) and protamines, required for spermatogenesis. Our findings thus reveal a previously unappreciated role of the SETD2-dependent H3K36me3 modification in spermiogenesis and provide clues to the molecular mechanisms in epigenetic disorders underlying male infertility.	[Zuo, Xiaoli; Tong, Ming-Han] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China; [Rong, Bowen; Lv, Ruitu; Lan, Fei] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Shanghai Minist Educ,Key Lab Epigenet, Liver Canc Inst,Zhongshan Hosp,Minist Educ, Shanghai 200032, Peoples R China; [Rong, Bowen; Lv, Ruitu; Lan, Fei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Li, Li] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji Med Clin Stem Cell Res Ctr 10, Ren Ji Hosp,Sch Biomed Engn, Shanghai 200001, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Fudan University; Shanghai Jiao Tong University	Lan, F (corresponding author), Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Shanghai Minist Educ,Key Lab Epigenet, Liver Canc Inst,Zhongshan Hosp,Minist Educ, Shanghai 200032, Peoples R China.; Lan, F (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Tong, MH (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	fei_lan@fudan.edu.cn; minghan@sibcb.ac.cn	Lyu, Ruitu/ABG-1437-2021; Lyu, Ruitu/ABU-6220-2022	Lyu, Ruitu/0000-0003-4597-1604; Lyu, Ruitu/0000-0003-4597-1604; tong, ming han/0000-0002-1967-5927; Li, Li/0000-0003-2342-3658	National Natural Science Foundation of China [31671553, 31371303, 81772938]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]; Ministry of Science and Technology of China [2014CB943101]; National Key Research and Development Program of China [2016YFC1000600]; Science and Technology Commission of Shanghai Municipality [17JC1420102, 16140902100, 18140902700]; Shanghai Institutes for Biological Sciences foundation; State Key Development Program [2014CB943103, 2016YFA0101800]; Science and Technology Commission of Shanghai Municipality Major Project [2017SHZDZX01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Research and Development Program of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Institutes for Biological Sciences foundation; State Key Development Program; Science and Technology Commission of Shanghai Municipality Major Project	This work was supported by National Natural Science Foundation of China Grant 31671553, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19000000, Ministry of Science and Technology of China Grant 2014CB943101, National Key Research and Development Program of China Grant 2016YFC1000600, Science and Technology Commission of Shanghai Municipality Grant 17JC1420102, and the Shanghai Institutes for Biological Sciences foundation (to M.-H. T.); State Key Development Program Grants 2014CB943103 and 2016YFA0101800, National Natural Science Foundation of China Grant 31371303, and Science and Technology Commission of Shanghai Municipality Major Project 2017SHZDZX01 (to F. L.); and National Natural Science Foundation of China Grant 81772938 and Science and Technology Commission of Shanghai Municipality Grants 16140902100 and 18140902700 (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article.	An J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.171; Aviles M, 1997, HISTOCHEM J, V29, P583, DOI 10.1023/A:1026432211012; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; de Mateo S, 2014, SEMIN CELL DEV BIOL, V29, P84, DOI 10.1016/j.semcdb.2014.04.021; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dhar S, 2012, J BIOL CHEM, V287, P6387, DOI 10.1074/jbc.M111.288167; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Gaysinskaya V, 2014, CYTOM PART A, V85A, P556, DOI 10.1002/cyto.a.22463; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P409, DOI 10.1002/jemt.20786; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P364, DOI 10.1002/jemt.20785; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P320, DOI 10.1002/jemt.20784; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Iwamori N, 2016, P NATL ACAD SCI USA, V113, pE5408, DOI 10.1073/pnas.1611995113; Iwamori N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072689; Kanemori Y, 2016, P NATL ACAD SCI USA, V113, pE3696, DOI 10.1073/pnas.1522333113; Kim S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030062; Lambrot R, 2015, FASEB J, V29, P4402, DOI 10.1096/fj.14-267328; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Legrand JMD, 2018, SEMIN CELL DEV BIOL, V79, P80, DOI 10.1016/j.semcdb.2017.10.006; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; McClusky LM, 2009, J MOL HISTOL, V40, P287, DOI 10.1007/s10735-009-9240-3; MORTIMER D, 1987, J REPROD FERTIL, V81, P127; Mu WP, 2014, GENE DEV, V28, P2056, DOI 10.1101/gad.246124.114; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Powers NR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006146; Rathke C, 2014, BBA-GENE REGUL MECH, V1839, P155, DOI 10.1016/j.bbagrm.2013.08.004; Stewart KR, 2016, EPIGENOMICS-UK, V8, P1399, DOI 10.2217/epi-2016-0056; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang Yu, 2015, INT J MECHATRONICS A, V5, pl, DOI DOI 10.1021/ACS.NAN0LETT.5B00964; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Yabuta Y, 2011, J CELL BIOL, V192, P781, DOI 10.1083/jcb.201009043; Yan W, 2010, J BIOL CHEM, V285, P31418, DOI 10.1074/jbc.M110.116418; Yang KF, 2012, MOL CELL BIOL, V32, P216, DOI 10.1128/MCB.06158-11; Yuan HR, 2017, J CLIN INVEST, V127, P3381, DOI 10.1172/JCI94292; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188; Zhang YL, 2014, CELL REP, V8, P1989, DOI 10.1016/j.celrep.2014.08.031; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	56	30	31	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9188	9197		10.1074/jbc.RA118.002851	http://dx.doi.org/10.1074/jbc.RA118.002851			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29716999	Green Published, hybrid			2022-12-28	WOS:000435441400005
J	Tang, YZ; Romano, FB; Brena, M; Heuck, AP				Tang, Yuzhou; Romano, Fabian B.; Brena, Mariana; Heuck, Alejandro P.			The Pseudomonas aeruginosa type III secretion translocator PopB assists the insertion of the PopD translocator into host cell membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING ACTIVITY; MOLECULAR ARCHITECTURE; PERFRINGOLYSIN O; FLUORESCENCE; SYSTEM; DOMAIN; CHOLESTEROL; REGULATOR; EFFECTORS; REVEALS	Many Gram-negative bacterial pathogens use a type III secretion system to infect eukaryotic cells. The injection of bacterial toxins or protein effectors via this system is accomplished through a plasma membrane channel formed by two bacterial proteins, termed translocators, whose assembly and membraneinsertion mechanisms are currently unclear. Here, using purified proteins we demonstrate that the translocators PopB and PopD in Pseudomonas aeruginosa assemble heterodimers in membranes, leading to stably inserted hetero-complexes. Using site-directed fluorescence labeling with an environment-sensitive probe, we found that hydrophobic segments inPopDanchor the translocator to the membrane, but without adopting a typical transmembrane orientation. A fluorescence dual-quenching assay revealed that the presence of PopB changes the conformation adopted by PopD segments in membranes. Furthermore, analysis of PopD's interaction with human cell membranes revealed that PopD adopts a distinctive conformation when PopB is present. An N-terminal region of PopD is only exposed to the host cytosol when PopB is present. We conclude that PopB assists with the proper insertion of PopD in cell membranes, required for the formation of a functional translocon and host infection.	[Tang, Yuzhou; Romano, Fabian B.; Brena, Mariana; Heuck, Alejandro P.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Heuck, Alejandro P.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Heuck, AP (corresponding author), 710 N Pleasant St,LGRT 1228, Amherst, MA 01003 USA.	heuck@umass.edu	Romano-Chernac, Fabian B./K-9396-2019	Heuck, Alejandro/0000-0002-7786-3109; Monopoli, Kathryn/0000-0002-8615-4849	National Institutes of Health [GM097414]; National Research Service Award from the National Institutes of Health [T32 GM08515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097414, T32GM008515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM097414 (to A. P. H). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Research Service Award T32 GM08515 from the National Institutes of Health.	Alder NN, 2008, CELL, V134, P439, DOI 10.1016/j.cell.2008.06.007; Anantharajah A, 2016, TRENDS PHARMACOL SCI, V37, P734, DOI 10.1016/j.tips.2016.05.011; Armentrout EI, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005530; Boens N, 2007, ANAL CHEM, V79, P2137, DOI 10.1021/ac062160k; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Chatterjee A, 2015, J BIOL CHEM, V290, P25579, DOI 10.1074/jbc.M115.648204; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Dortet L, 2018, NAT MICROBIOL, V3, P378, DOI 10.1038/s41564-018-0109-7; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Garcia JT, 2006, INFECT IMMUN, V74, P5645, DOI 10.1128/IAI.00690-06; Ghatak C, 2015, TOXINS, V7, P1303, DOI 10.3390/toxins7041303; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Heuck AP, 2002, CELL BIOCHEM BIOPHYS, V36, P89, DOI 10.1385/CBB:36:1:89; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Howell HA, 2013, MBIO, V4, DOI 10.1128/mBio.00032-13; Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jameson DM, 2003, METHOD ENZYMOL, V360, P1; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Johnson BB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14002-x; Kaufman MR, 2000, MICROBIOL-UK, V146, P2531, DOI 10.1099/00221287-146-10-2531; Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792; Kurnikov IV, 2013, J MOL BIOL, V425, P2752, DOI 10.1016/j.jmb.2013.04.030; Ladokhin AS, 2013, TOXINS, V5, P1362, DOI 10.3390/toxins5081362; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Mounier J, 2012, CELL HOST MICROBE, V12, P381, DOI 10.1016/j.chom.2012.07.010; Ohlendieck K, 1996, Methods Mol Biol, V59, P293; Perier A, 2007, J BIOL CHEM, V282, P24239, DOI 10.1074/jbc.M703392200; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Reinhart G D, 1991, J Fluoresc, V1, P153, DOI 10.1007/BF00865362; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Romano FB, 2016, J BIOL CHEM, V291, P6304, DOI 10.1074/jbc.M115.681031; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Savinov SN, 2017, TOXINS, V9, DOI 10.3390/toxins9120381; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Senerovic L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.124; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Tomalka AG, 2012, MOL MICROBIOL, V86, P1464, DOI 10.1111/mmi.12069; Urbanowski ML, 2007, INFECT IMMUN, V75, P4432, DOI 10.1128/IAI.00664-07; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Vargas-Uribe M, 2013, BIOCHEMISTRY-US, V52, P7901, DOI 10.1021/bi400926k	51	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8982	8993		10.1074/jbc.RA118.002766	http://dx.doi.org/10.1074/jbc.RA118.002766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29685888	Green Published, hybrid			2022-12-28	WOS:000434941900021
J	Heidrich, J; Junglas, B; Grytsyk, N; Hellmann, N; Rusitzka, K; Gebauer, W; Markl, J; Hellwig, P; Schneider, D				Heidrich, Jennifer; Junglas, Benedikt; Grytsyk, Natalia; Hellmann, Nadja; Rusitzka, Kristiane; Gebauer, Wolfgang; Markl, Juergen; Hellwig, Petra; Schneider, Dirk			Mg2+ binding triggers rearrangement of the IM30 ring structure, resulting in augmented exposure of hydrophobic surfaces competent for membrane binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane fusion; cyanobacteria; plant; membrane biogenesis; membrane biophysics; membrane binding; Mg2+; PspA; thylakoid membrane; Vipp1; IM30; circular dichroism; isothermal titration calorimetry; Fourier transform IR; protein denaturation	SP PCC 6803; TRANSFORM INFRARED-SPECTROSCOPY; LIGHT-DEPENDENT CHANGES; THYLAKOID MEMBRANES; ESCHERICHIA-COLI; ABSORPTION-SPECTROSCOPY; INTACT CHLOROPLASTS; FLUORESCENT PROTEIN; CO2 FIXATION; PHAGE SHOCK	The inner membrane-associated protein of 30 kDa (IM30), also known as vesicle-inducing protein in plastids 1 (Vipp1), is found in the majority of photosynthetic organisms that use oxygen as an energy source, and its occurrence appears to be coupled to the existence of thylakoid membranes in cyanobacteria and chloroplasts. IM30 is most likely involved in thylakoid membrane biogenesis and/or maintenance, and has recently been shown to function as a membrane fusion protein in presence of Mg2+. However, the precise role of Mg2+ in this process and its impact on the structure and function of IM30 remains unknown. Here, we show that Mg2+ binds directly to IM30 with a binding affinity of approximate to 1 mm. Mg2+ binding compacts the IM30 structure coupled with an increase in the thermodynamic stability of the proteins' secondary, tertiary, and quaternary structures. Furthermore, the structural alterations trigger IM30 double ring formation in vitro because of increased exposure of hydrophobic surface regions. However, in vivo Mg2+-triggered exposure of hydrophobic surface regions most likely modulates membrane binding and induces membrane fusion.	[Heidrich, Jennifer; Junglas, Benedikt; Hellmann, Nadja; Schneider, Dirk] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55128 Mainz, Germany; [Rusitzka, Kristiane; Gebauer, Wolfgang; Markl, Juergen] Johannes Gutenberg Univ Mainz, Inst Mol Physiol, D-55128 Mainz, Germany; [Grytsyk, Natalia; Hellwig, Petra] Univ Strasbourg, CNRS, UMR 7140, Lab Bioelectrochim & Spect, 1 Rue Blaise Pascal, D-67000 Strasbourg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Schneider, D (corresponding author), Johann Joachim Becher Weg 30, D-55128 Mainz, Germany.	Dirk.Schneider@uni-mainz.de	Grytsyk, Natalia/ABG-5742-2021	Junglas, Benedikt/0000-0001-9348-3379; hellwig, petra/0000-0001-6294-5163	Max-Planck Graduate Center at the Max Planck Institutes; University of Mainz; icFRC Strasbourg	Max-Planck Graduate Center at the Max Planck Institutes; University of Mainz; icFRC Strasbourg	This work was funded by the Max-Planck Graduate Center at the Max Planck Institutes and the University of Mainz (to J.H., B.J., and D.S.) and icFRC Strasbourg (to N.G.).	Adam Z, 2011, PLANT MOL BIOL, V76, P221, DOI 10.1007/s11103-010-9693-5; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Barthel S, 2013, PLANT PHYSIOL, V163, P1037, DOI 10.1104/pp.113.224428; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; Bisicchia P, 2010, PLASMID, V64, P143, DOI 10.1016/j.plasmid.2010.06.002; BLACK CB, 1994, COORDIN CHEM REV, V135, P165, DOI 10.1016/0010-8545(94)80068-5; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Bryan SJ, 2014, MOL MICROBIOL, V94, P1179, DOI 10.1111/mmi.12826; Bultema Jelle B, 2010, Commun Integr Biol, V3, P162; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; Frain KM, 2016, BBA-BIOENERGETICS, V1857, P266, DOI 10.1016/j.bbabio.2015.08.010; Fritz H., 1984, METHODS ENZYMATIC AN; Fuhrmann E, 2009, MOL BIOL CELL, V20, P4620, DOI 10.1091/mbc.E09-04-0319; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Grytsyk N, 2017, P NATL ACAD SCI USA, V114, P1530, DOI 10.1073/pnas.1621431114; Hankamer BD, 2004, J BIOL CHEM, V279, P8862, DOI 10.1074/jbc.M307889200; Heidrich J, 2017, BBA-BIOMEMBRANES, V1859, P537, DOI 10.1016/j.bbamem.2016.09.025; Heidrich J, 2016, J BIOL CHEM, V291, P14954, DOI 10.1074/jbc.M116.722686; Hemaprabha, 2012, J PHARM SCI INNOV, V1, P22, DOI DOI 10.7897/2277-4572; Hennig R, 2017, BBA-BIOENERGETICS, V1858, P126, DOI 10.1016/j.bbabio.2016.11.004; Hennig R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8018; HIND G, 1974, P NATL ACAD SCI USA, V71, P1484, DOI 10.1073/pnas.71.4.1484; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Kriegel S, 2014, BIOCHEMISTRY-US, V53, P6340, DOI 10.1021/bi500955a; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; LaPorte D. C., 2002, BIOCHEMISTRY-US, V19, P3814; LAU SYM, 1984, J BIOL CHEM, V259, P3253; LI HM, 1994, PLANT MOL BIOL, V25, P619, DOI 10.1007/BF00029601; Liberton M, 2013, J BIOL CHEM, V288, P3632, DOI 10.1074/jbc.M112.416933; LIN DC, 1971, ARCH BIOCHEM BIOPHYS, V145, P622, DOI 10.1016/S0003-9861(71)80022-X; Martin-Molina A, 2012, BIOPHYS J, V102, P2095, DOI 10.1016/j.bpj.2012.03.009; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Myers JK, 1997, BIOCHEMISTRY-US, V36, P10923, DOI 10.1021/bi9707180; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohki SY, 1997, BIOCHEMISTRY-US, V36, P4309, DOI 10.1021/bi962759m; Osadnik H, 2015, MOL MICROBIOL, V98, P743, DOI 10.1111/mmi.13154; Otters S, 2013, PLANTA, V237, P529, DOI 10.1007/s00425-012-1772-1; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; PORTIS AR, 1976, BIOCHIM BIOPHYS ACTA, V449, P434, DOI 10.1016/0005-2728(76)90154-7; PORTIS AR, 1977, BIOCHIM BIOPHYS ACTA, V461, P313, DOI 10.1016/0005-2728(77)90181-5; PORTIS AR, 1992, ANNU REV PLANT PHYS, V43, P415, DOI 10.1146/annurev.pp.43.060192.002215; PORTIS AR, 1981, PLANT PHYSIOL, V67, P985, DOI 10.1104/pp.67.5.985; Saur M, 2017, STRUCTURE, V25, P1380, DOI 10.1016/j.str.2017.07.001; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Shcolnick S, 2006, PLANT PHYSIOL, V141, P805, DOI 10.1104/pp.106.079251; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Strambini GB, 2010, J PHYS CHEM B, V114, P1089, DOI 10.1021/jp909567q; Velazquez-Campoy Adrian, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1708s23; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; Vothknecht UC, 2012, J EXP BOT, V63, P1699, DOI 10.1093/jxb/err357; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Xie D, 1997, BIOCHEMISTRY-US, V36, P16166, DOI 10.1021/bi971550l	60	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8230	8241		10.1074/jbc.RA117.000991	http://dx.doi.org/10.1074/jbc.RA117.000991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29618510	Green Published, hybrid			2022-12-28	WOS:000433224600027
J	Bailey, DC; Alexander, E; Rice, MR; Drake, EJ; Mydy, LS; Aldrich, CC; Gulick, AM				Bailey, Daniel C.; Alexander, Evan; Rice, Matthew R.; Drake, Eric J.; Mydy, Lisa S.; Aldrich, Courtney C.; Gulick, Andrew M.			Structural and functional delineation of aerobactin biosynthesis in hypervirulent Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDEROPHORE PRODUCTION; STRUCTURE REFINEMENT; PLASMID COLV-K30; OPTIMIZATION; SYNTHETASE; SYSTEM; GENES; CRYSTALLIZATION; YERSINIABACTIN; RECONSTITUTION	Aerobactin, a citryl-hydroxamate siderophore, is produced by a number of pathogenic Gram-negative bacteria to aid in iron assimilation. Interest in this well-known siderophore was reignited by recent investigations suggesting that it plays a key role in mediating the enhanced virulence of a hypervirulent pathotype of Klebsiella pneumoniae (hvKP). In contrast to classical opportunistic strains of K. pneumoniae, hvKP causes serious life-threatening infections in previously healthy individuals in the community. Multiple contemporary reports have confirmed fears that the convergence of multidrug-resistant and hvKP pathotypes has led to the evolution of a highly transmissible, drug-resistant, and virulent super bug. Despite hvKP harboring four distinct siderophore operons, knocking out production of only aerobactin led to a significant attenuation of virulence. Herein, we continue our structural and functional studies on the biosynthesis of this crucial virulence factor. In vivo heterologous production and in vitro reconstitution of aerobactin biosynthesis from hvKP was carried out, demonstrating the specificity, stereoselectivity, and kinetic throughput of the complete pathway. Additionally, we present a steady-state kinetic analysis and the X-ray crystal structure of the second aerobactin synthetase IucC, as well as describe a surface entropy reduction strategy that was employed for structure determination. Finally, we show solution X-ray scattering data that support a unique dimeric quaternary structure for IucC. These new insights into aerobactin assembly will help inform potential antivirulence strategies and advance our understanding of siderophore biosynthesis.	[Bailey, Daniel C.; Drake, Eric J.; Mydy, Lisa S.; Gulick, Andrew M.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Struct Biol, Buffalo, NY 14203 USA; [Bailey, Daniel C.; Rice, Matthew R.; Drake, Eric J.; Mydy, Lisa S.; Gulick, Andrew M.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Alexander, Evan; Aldrich, Courtney C.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute; University of Minnesota System; University of Minnesota Twin Cities	Gulick, AM (corresponding author), 955 Main St, Buffalo, NY 14203 USA.	gulick@hwi.buffalo.edu		Mydy, Lisa/0000-0002-6976-4426; Bailey, Daniel/0000-0003-4126-8700; Rice, Matthew/0000-0003-1077-7262; Gulick, Andrew/0000-0003-4238-7453	Richard W. and Mae Stone Goode Foundation; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences Grant under Department of Energy [AGM-12006, DE-AC02-06CH11357]; National Institutes of Health Office of Research Infrastructure Program [1S10OD012289-01A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116998, T32AI007614] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012289] Funding Source: NIH RePORTER	Richard W. and Mae Stone Goode Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences Grant under Department of Energy; National Institutes of Health Office of Research Infrastructure Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Edward Snell for collecting the SAXS data on IucC, and Dr. Thomas Grant for guidance analyzing it. We thank Dr. Artem Evdokimov for invaluable assistance in SER mutant design. We thank Dr. Thomas Russo for insightful discussions regarding hvKP. The compact mass spectrometer was purchased with funds from the Richard W. and Mae Stone Goode Foundation. Diffraction data were collected at the GM/CAID-B beamline of APS, which is supported by the National Cancer Institute Grant ACB-12002, National Institute of General Medical Sciences Grant AGM-12006 under Department of Energy Contract Number DE-AC02-06CH11357 to APS, and the National Institutes of Health Office of Research Infrastructure Program Grant 1S10OD012289-01A1.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ancliff RA, 1997, TETRAHEDRON-ASYMMETR, V8, P3379, DOI 10.1016/S0957-4166(97)00435-7; Bailey DC, 2016, BIOCHEMISTRY-US, V55, P3559, DOI 10.1021/acs.biochem.6b00409; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Braykov NP, 2013, INFECT CONT HOSP EP, V34, P259, DOI 10.1086/669523; CARBONETTI NH, 1984, INFECT IMMUN, V46, P7, DOI 10.1128/IAI.46.1.7-12.1984; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Chen L, 2018, LANCET INFECT DIS, V18, P2, DOI 10.1016/S1473-3099(17)30517-0; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; COY M, 1986, BIOCHEMISTRY-US, V25, P2485, DOI 10.1021/bi00357a030; DELORENZO V, 1986, J BACTERIOL, V167, P350, DOI 10.1128/jb.167.1.350-355.1986; DELORENZO V, 1986, J BACTERIOL, V165, P570, DOI 10.1128/jb.165.2.570-578.1986; Duarte JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-334; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; GIBSON F, 1969, BIOCHIM BIOPHYS ACTA, V192, P175, DOI 10.1016/0304-4165(69)90353-5; Goldschmidt L, 2014, METHODS MOL BIOL, V1140, P201, DOI 10.1007/978-1-4939-0354-2_16; Grant TD, 2015, ACTA CRYSTALLOGR D, V71, P45, DOI 10.1107/S1399004714010876; Gu DX, 2018, LANCET INFECT DIS, V18, P37, DOI [10.1016/S1473-3099(17)30489-9, 10.1016/s1473-3099(17)30489-9]; HAYGOOD MG, 1993, LIMNOL OCEANOGR, V38, P1091, DOI 10.4319/lo.1993.38.5.1091; HU JD, 1994, J ORG CHEM, V59, P4858, DOI 10.1021/jo00096a030; Iwasaki Y, 2017, INTERNAL MED, V56, P373, DOI 10.2169/internalmedicine.56.7384; 진수신, 2013, [The Korean Journal of Medicine, 대한내과학회지], V85, P540, DOI 10.3904/kjm.2013.85.5.540; Kashani AH, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-28; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P1573, DOI 10.1001/jama.2013.2922; Kunkle CA, 2005, J BACTERIOL, V187, P422, DOI 10.1128/JB.187.2.422-433.2005; Kupper FC, 2006, INORG CHEM, V45, P6028, DOI 10.1021/ic0604967; Kwon Jang-Mi, 2013, Korean J Pediatr, V56, P407, DOI 10.3345/kjp.2013.56.9.407; Lamb AL, 2015, BBA-PROTEINS PROTEOM, V1854, P1054, DOI 10.1016/j.bbapap.2015.05.001; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li B, 2014, FUTURE MICROBIOL, V9, P1071, DOI [10.2217/FMB.14.48, 10.2217/fmb.14.48]; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P995, DOI 10.1111/j.1432-1033.1993.tb17846.x; Madsen JLH, 2015, J AM CHEM SOC, V137, P9117, DOI 10.1021/jacs.5b04557; Martel A, 2012, J SYNCHROTRON RADIAT, V19, P431, DOI 10.1107/S0909049512008072; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; Ng D, 2015, WEST J EMERG MED, V16, P165, DOI 10.5811/westjem.2014.11.23599; Nusca TD, 2012, J BIOL CHEM, V287, P16058, DOI 10.1074/jbc.M112.359349; Oves-Costales D, 2009, CHEM COMMUN, P6530, DOI 10.1039/b913092f; Oves-Costales D, 2009, CHEM COMMUN, P1389, DOI 10.1039/b823147h; Patel HM, 2001, BIOCHEMISTRY-US, V40, P9023, DOI 10.1021/bi010519n; Patel PK, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu028; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Prokesch Bonnie C, 2016, Lancet Infect Dis, V16, pe190, DOI 10.1016/S1473-3099(16)30021-4; RUSSO TA, 2013, GENOME ANNOUNCEMENTS, V0001; Russo TA, 2015, INFECT IMMUN, V83, P3325, DOI 10.1128/IAI.00430-15; Russo TA, 2014, INFECT IMMUN, V82, P2356, DOI 10.1128/IAI.01667-13; Russo TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026734; Sanchez GV, 2013, EMERG INFECT DIS, V19, P133, DOI 10.3201/eid1901.120310; Schmelz S, 2011, J MOL BIOL, V412, P495, DOI 10.1016/j.jmb.2011.07.059; Schmelz S, 2009, NAT CHEM BIOL, V5, P174, DOI 10.1038/nchembio.145; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Shon AS, 2012, FUTURE MICROBIOL, V7, P669, DOI [10.2217/FMB.12.43, 10.2217/fmb.12.43]; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Struve C, 2015, MBIO, V6, DOI 10.1128/mBio.00630-15; Takahashi K, 2015, INTERNAL MED, V54, P355, DOI 10.2169/internalmedicine.54.3485; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vandevelde A, 2014, CASE REP INFECT DIS, V2014, DOI 10.1155/2014/137248; Weaver R, 1997, TETRAHEDRON, V53, P5537, DOI 10.1016/S0040-4020(97)00210-X; WU MX, 1993, ANAL BIOCHEM, V211, P320, DOI 10.1006/abio.1993.1276; Zajdowicz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034591	69	26	28	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7841	7852		10.1074/jbc.RA118.002798	http://dx.doi.org/10.1074/jbc.RA118.002798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618511	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000437256500031
J	Fan, XZ; Zhao, J; Ren, FL; Wang, YY; Feng, YR; Ding, LD; Zhao, LP; Shang, Y; Li, J; Ni, JQ; Jia, BQ; Liu, YL; Chang, ZJ				Fan, Xuanzi; Zhao, Juan; Ren, Fangli; Wang, Yinyin; Feng, Yarui; Ding, Lidan; Zhao, Linpeng; Shang, Yu; Li, Jun; Ni, Jianquan; Jia, Baoqing; Liu, Yule; Chang, Zhijie			Dimerization of p15RS mediated by a leucine zipper-like motif is critical for its inhibitory role on Wnt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; TRANSCRIPTION FACTORS; PROTEIN; PATHWAY; DIMER; CREPT; DNA; MELANOMA; DISEASES; COMPLEX	We previously demonstrated that p15RS, a newly discovered tumor suppressor, inhibits Wnt/-catenin signaling by interrupting the formation of -catenin<bold>TCF</bold>4 complex. However, it remains unclear how p15RS helps exert such an inhibitory effect on Wnt signaling based on its molecular structure. In this study, we reported that dimerization of p15RS is required for its inhibition on the transcription regulation of Wnt-targeted genes. We found that p15RS forms a dimer through a highly conserved leucine zipper-like motif in the coiled-coil terminus domain. In particular, residues Leu-248 and Leu-255 were identified as being responsible for p15RS dimerization, as mutation of these two leucines into prolines disrupted the homodimer formation of p15RS and weakened its suppression of Wnt signaling. Functional studies further confirmed that mutations of p15RS at these residues results in diminishment of its inhibition on cell proliferation and tumor formation. We therefore concluded that dimerization of p15RS governed by the leucine zipper-like motif is critical for its inhibition of Wnt/-catenin signaling and tumorigenesis.	[Fan, Xuanzi; Zhao, Juan; Ren, Fangli; Wang, Yinyin; Feng, Yarui; Ding, Lidan; Ni, Jianquan; Chang, Zhijie] Tsinghua Univ, Sch Med, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Fan, Xuanzi; Liu, Yule] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Zhao, Linpeng; Shang, Yu] Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Dept Cell Biol,Coll Life Sci, Beijing 100875, Peoples R China; [Li, Jun] Third Mil Med Univ, PLA, Inst Immunol, Chongqing 400038, Peoples R China; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg Pathol, Beijing 100853, Peoples R China	Tsinghua University; Tsinghua University; Beijing Normal University; Army Medical University; Chinese People's Liberation Army General Hospital	Chang, ZJ (corresponding author), Tsinghua Univ, Sch Med, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	Wang, Yin/HCI-9352-2022; Liu, Yule/E-5700-2010; Chang, Zhijie/AAH-8109-2019	Liu, Yule/0000-0002-4423-6045; Chang, Zhijie/0000-0003-1567-3227	Chinese National Major Scientific Research Program [2016YFA0500301]; National Natural Science Foundation of China [81230044, 81372167, 81572729, 81572728, 81402293, 81372372]	Chinese National Major Scientific Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Major Scientific Research Program Grant 2016YFA0500301 and National Natural Science Foundation of China Grants 81230044, 81372167, 81572729, 81572728, 81402293, and 81372372. The authors declare that they have no conflicts of interest with the contents of this article.	Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Beckett D, 2001, J MOL BIOL, V314, P335, DOI 10.1006/jmbi.2001.5134; Deitrick J, 2016, PROG MOL BIOL TRANSL, V144, P49, DOI 10.1016/bs.pmbts.2016.09.010; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; He B, 2006, Ernst Schering Found Symp Proc, P27; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; Jin K, 2018, J CELL BIOCHEM, V119, P1083, DOI 10.1002/jcb.26277; Johnson ML, 2006, REV ENDOCR METAB DIS, V7, P41, DOI 10.1007/s1154-006-9003-3; Kaur A, 2016, BRIT J CANCER, V115, P1273, DOI 10.1038/bjc.2016.332; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Liu CX, 2015, J BIOL CHEM, V290, P9701, DOI 10.1074/jbc.M114.620872; Liu J, 2002, BIOCHEM BIOPH RES CO, V299, P880, DOI 10.1016/S0006-291X(02)02684-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu DD, 2012, CANCER CELL, V21, P92, DOI 10.1016/j.ccr.2011.12.016; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Matthews JM, 2012, ADV EXP MED BIOL, V747, P1, DOI 10.1007/978-1-4614-3229-6_1; Mei KR, 2014, SCI CHINA LIFE SCI, V57, P97, DOI 10.1007/s11427-013-4589-7; Neklesa TK, 2017, PHARMACOL THERAPEUT, V174, P138, DOI 10.1016/j.pharmthera.2017.02.027; Ni ZY, 2014, NAT STRUCT MOL BIOL, V21, P686, DOI 10.1038/nsmb.2853; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Poy F, 2001, NAT STRUCT BIOL, V8, P1053, DOI 10.1038/nsb720; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Togi S, 2011, J BIOL CHEM, V286, P19170, DOI 10.1074/jbc.M110.189829; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Xie WY, 2015, INTERVIROLOGY, V58, P297, DOI 10.1159/000441978; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Xue GD, 2016, CANCER TREAT REV, V49, P1, DOI 10.1016/j.ctrv.2016.06.009; Yaku H, 1997, FEBS LETT, V417, P409, DOI 10.1016/S0014-5793(97)01329-X; Zhang XC, 2012, CELL CYCLE, V11, P1988, DOI 10.4161/cc.20400; Zhang YQ, 2014, J BIOL CHEM, V289, P22589, DOI 10.1074/jbc.M114.560979	34	2	2	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7618	7628		10.1074/jbc.RA118.001969	http://dx.doi.org/10.1074/jbc.RA118.001969			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618509	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000437256500014
J	Santin, O; Moncalian, G				Santin, Omar; Moncalian, Gabriel			Loading of malonyl-CoA onto tandem acyl carrier protein domains of polyunsaturated fatty acid synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid synthase (FAS); polyketide; polyunsaturated fatty acid (PUFA); acyl carrier protein (ACP); acyltransferase	MODULAR POLYKETIDE SYNTHASES; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; SELF-ACYLATION; BIOSYNTHESIS; PREDICTION; ORGANIZATION; INTERPRO; REVEALS; ENZYMES	Omega-3 polyunsaturated fatty acids (PUFA) are produced in some unicellular organisms, such as marine gammaproteobacteria, myxobacteria, and thraustochytrids, by large enzyme complexes called PUFA synthases. These enzymatic complexes resemble bacterial antibiotic-producing proteins known as polyketide synthases (PKS). One of the PUFA synthase subunits is a conserved large protein (PfaA in marine proteobacteria) that contains three to nine tandem acyl carrier protein (ACP) domains as well as condensation and modification domains. In this work, a study of the PfaA architecture and its ability to initiate the synthesis by selecting malonyl units has been carried out. As a result, we have observed a self-acylation ability in tandem ACPs whose biochemical mechanism differ from the previously described for type II PKS. The acyltransferase domain of PfaA showed a high selectivity for malonyl-CoA that efficiently loads onto the ACPs domains. These results, together with the structural organization predicted for PfaA, suggest that this protein plays a key role at early stages of the anaerobic pathway of PUFA synthesis.	Univ Cantabria, Dept Biol Mol, Santander 39011, Spain; Univ Cantabria, Inst Biomed & Biotecnol Cantabria IBBTEC, CSIC, Santander 39011, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Moncalian, G (corresponding author), Univ Cantabria, Inst Biomed & Biotecnol Cantabria, CSIC, Santander 39011, Spain.	gabriel.moncalian@unican.es	Moncalian, Gabriel/AAI-9723-2021	Moncalian, Gabriel/0000-0002-3007-6490	Spanish Ministry of Economy and Competitiveness [BFU2014-55534-C2-2-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by Grant BFU2014-55534-C2-2-P from the Spanish Ministry of Economy and Competitiveness (to G.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Arthur CJ, 2006, CHEM BIOL, V13, P587, DOI 10.1016/j.chembiol.2006.03.010; Arthur CJ, 2005, BIOCHEMISTRY-US, V44, P15414, DOI 10.1021/bi051499i; Beld J, 2015, MOL BIOSYST, V11, P38, DOI 10.1039/c4mb00443d; Bumpus SB, 2008, J AM CHEM SOC, V130, P11614, DOI 10.1021/ja8040042; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Dunn BJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0297; Gemperlein K, 2014, CHEM SCI, V5, P1733, DOI 10.1039/c3sc53163e; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hayashi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35441; Hitchman TS, 1998, CHEM BIOL, V5, P35, DOI 10.1016/S1074-5521(98)90085-0; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jiang H, 2008, J AM CHEM SOC, V130, P6336, DOI 10.1021/ja801911t; Jiang H, 2009, METHOD ENZYMOL, V459, P79, DOI 10.1016/S0076-6879(09)04604-7; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kaulmann U, 2002, ANGEW CHEM INT EDIT, V41, P1866, DOI 10.1002/1521-3773(20020603)41:11<1866::AID-ANIE1866>3.0.CO;2-3; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lee JM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010023; Li ZX, 2007, J MOL BIOL, V371, P1075, DOI 10.1016/j.jmb.2007.06.004; Liew CW, 2012, J BIOL CHEM, V287, P23203, DOI 10.1074/jbc.M112.362210; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Matharu AL, 1998, CHEM BIOL, V5, P699, DOI 10.1016/S1074-5521(98)90663-9; Misra A, 2007, CHEM BIOL, V14, P775, DOI 10.1016/j.chembiol.2007.05.013; Misra A, 2009, MOL BIOSYST, V5, P651, DOI 10.1039/b820420a; Mulder Nicola, 2007, V396, P59; Nanson JD, 2015, SCI REP-UK, V5, DOI 10.1038/srep14797; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Orikasa Y, 2006, FEBS LETT, V580, P4423, DOI 10.1016/j.febslet.2006.07.008; Orikasa Y, 2006, BIOTECHNOL LETT, V28, P1841, DOI 10.1007/s10529-006-9168-6; Orikasa Y, 2009, FEMS MICROBIOL LETT, V295, P170, DOI 10.1111/j.1574-6968.2009.01582.x; Poust S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109421; Ray L, 2016, NAT PROD REP, V33, P150, DOI 10.1039/c5np00112a; Shulse CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020146; Szu PH, 2011, CHEM BIOL, V18, P1021, DOI 10.1016/j.chembiol.2011.07.015; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Trujillo U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057859; Tufar P, 2014, CHEM BIOL, V21, P552, DOI 10.1016/j.chembiol.2014.02.014; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Yoshida K, 2016, MAR DRUGS, V14, DOI 10.3390/md14050094; Zheng JT, 2011, J MOL BIOL, V410, P105, DOI 10.1016/j.jmb.2011.04.065	51	18	18	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12491	12501		10.1074/jbc.RA118.002443	http://dx.doi.org/10.1074/jbc.RA118.002443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29921583	Green Published, hybrid			2022-12-28	WOS:000441408500015
J	Veyel, D; Sokolowska, EM; Moreno, JC; Kierszniowska, S; Cichon, J; Wojciechowska, I; Luzarowski, M; Kosmacz, M; Szlachetko, J; Gorka, M; Meret, M; Graf, A; Meyer, EH; Willmitzer, L; Skirycz, A				Veyel, Daniel; Sokolowska, Ewelina M.; Moreno, Juan C.; Kierszniowska, Sylwia; Cichon, Justyna; Wojciechowska, Izabela; Luzarowski, Marcin; Kosmacz, Monika; Szlachetko, Jagoda; Gorka, Michal; Meret, Michael; Graf, Alexander; Meyer, Etienne H.; Willmitzer, Lothar; Skirycz, Aleksandra			PROMIS, global analysis of PROtein-metabolite interactions using size separation in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolomics; protein-protein interaction; proteomics; systems biology; chromatography; ligand-binding protein; protein-small molecule interactions; size-exclusion chromatography	MASS-SPECTROMETRY; POLYAMINE BIOSYNTHESIS; AFFINITY PURIFICATION; CRYSTAL-STRUCTURE; COMPLEXES; IDENTIFICATION; PLANTS; DRUG; PROTEASOME; KINASES	Small molecules not only represent cellular building blocks and metabolic intermediates, but also regulatory ligands and signaling molecules that interact with proteins. Although these interactions affect cellular metabolism, growth, and development, they have been largely understudied. Herein, we describe a method, which we named PROtein-Metabolite Interactions using Size separation (PROMIS), that allows simultaneous, global analysis of endogenous protein-small molecule and of protein-protein complexes. To this end, a cell-free native lysate from Arabidopsis thaliana cell cultures was fractionated by size-exclusion chromatography, followed by quantitative metabolomic and proteomic analyses. Proteins and small molecules showing similar elution behavior, across protein-containing fractions, constituted putative interactors. Applying PROMIS to an A. thaliana extract, we ascertained known protein-protein (PPIs) and protein-metabolite (PMIs) interactions and reproduced binding between small-molecule protease inhibitors and their respective proteases. More importantly, we present examples of two experimental strategies that exploit the PROMIS dataset to identify novel PMIs. By looking for similar elution behavior of metabolites and enzymes belonging to the same biochemical pathways, we identified putative feedback and feed-forward regulations in pantothenate biosynthesis and the methionine salvage cycle, respectively. By combining PROMIS with an orthogonal affinity purification approach, we identified an interaction between the dipeptide Tyr-Asp and the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase. In summary, we present proof of concept for a powerful experimental tool that enables system-wide analysis of PMIs and PPIs across all biological systems. The dataset obtained here comprises nearly 140 metabolites and 5000 proteins, which can be mined for putative interactors.	[Veyel, Daniel; Sokolowska, Ewelina M.; Moreno, Juan C.; Cichon, Justyna; Wojciechowska, Izabela; Luzarowski, Marcin; Kosmacz, Monika; Szlachetko, Jagoda; Gorka, Michal; Graf, Alexander; Meyer, Etienne H.; Willmitzer, Lothar; Skirycz, Aleksandra] Max Planck Inst Mol Plant Physiol, Dept Willmitzer, D-14476 Potsdam, Germany; [Kierszniowska, Sylwia; Meret, Michael] MetaSysX GmbH, D-14476 Potsdam, Germany	Max Planck Society	Skirycz, A (corresponding author), Max Planck Inst Mol Plant Physiol, Dept Willmitzer, D-14476 Potsdam, Germany.	skirycz@mpimp-golm.mpg.de	Meyer, Etienne H/C-1952-2008; Skirycz, Aleksandra/AAM-7911-2021	Meyer, Etienne H/0000-0003-4712-9824; Kierszniowska, Sylwia/0000-0002-4736-9222; Moreno Beltran, Juan Camilo/0000-0001-9722-5262; Skirycz, Aleksandra/0000-0002-7627-7925; Graf, Alexander/0000-0002-6696-5206				Aryal UK, 2014, PLANT CELL, V26, P3867, DOI 10.1105/tpc.114.127563; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Giavalisco P, 2011, PLANT J, V68, P364, DOI 10.1111/j.1365-313X.2011.04682.x; Han BW, 2011, PROTEINS, V79, P3236, DOI 10.1002/prot.23153; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; Henderson B, 2014, BIOCHEM SOC T, V42, P1671, DOI 10.1042/BST20140273; Hooper CM, 2017, NUCLEIC ACIDS RES, V45, pD1064, DOI 10.1093/nar/gkw1041; Huber KVM, 2015, NAT METHODS, V12, P1055, DOI [10.1038/NMETH.3590, 10.1038/nmeth.3590]; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kosmacz M, 2018, PLANT PHYSIOL, V177, P411, DOI 10.1104/pp.18.00285; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Krueger S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017806; Li XY, 2011, BIOESSAYS, V33, P485, DOI 10.1002/bies.201100026; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Luzarowski M, 2017, J EXP BOT, V68, P3487, DOI 10.1093/jxb/erx183; Maeda K, 2014, NAT PROTOC, V9, P2256, DOI 10.1038/nprot.2014.148; Mooney S, 2010, PHYTOCHEMISTRY, V71, P495, DOI 10.1016/j.phytochem.2009.12.015; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Naka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9039; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Ottenhof HH, 2004, PLANT J, V37, P61, DOI 10.1046/j.1365-313X.2003.01940.x; Pommerrenig B, 2011, PLANT CELL, V23, P1904, DOI 10.1105/tpc.110.079657; POWERS SG, 1976, J BIOL CHEM, V251, P3786; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Sauter M, 2013, BIOCHEM J, V451, P145, DOI 10.1042/BJ20121744; Scholten A, 2006, J PROTEOME RES, V5, P1435, DOI 10.1021/pr0600529; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tholl D, 2014, PLANT J, V79, P541, DOI 10.1111/tpj.12635; Tilton GB, 2006, PLANT MOL BIOL, V61, P629, DOI 10.1007/s11103-006-0037-4; Van Leene J, 2015, NAT PROTOC, V10, P169, DOI 10.1038/nprot.2014.199; Veyel D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42387; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Waduwara-Jayabahu I, 2012, PLANT PHYSIOL, V158, P1728, DOI 10.1104/pp.111.191072; Watanabe N, 2007, J MOL BIOL, V371, P685, DOI 10.1016/j.jmb.2007.05.061; Yang GX, 2012, METHODS, V57, P459, DOI 10.1016/j.ymeth.2012.06.013; Zierer W, 2016, PLANT PHYSIOL, V170, P790, DOI 10.1104/pp.15.00786	43	29	29	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12440	12453		10.1074/jbc.RA118.003351	http://dx.doi.org/10.1074/jbc.RA118.003351			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29853640	Green Published, hybrid			2022-12-28	WOS:000441408500011
J	Zheng, AJ; Shi, YJ; Shen, Z; Wang, G; Shi, JL; Xiong, QQ; Fang, LR; Xiao, SB; Fu, ZF; Peng, GQ				Zheng, Anjun; Shi, Yuejun; Shen, Zhou; Wang, Gang; Shi, Jiale; Xiong, Qiqi; Fang, Liurong; Xiao, Shaobo; Fu, Zhen F.; Peng, Guiqing			Insight into the evolution of nidovirus endoribonuclease based on the finding that nsp15 from porcine Deltacoronavirus functions as a dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral protein; endoribonuclease; protein purification; oligomerization; protein evolution; endoribonuclease; evolution; nidovirus; oligomerization; PDCoV nsp15	MOUSE HEPATITIS-VIRUS; REPLICATIVE ENDORIBONUCLEASE; CORONAVIRUS ENDORIBONUCLEASE; CRYSTAL-STRUCTURE; PROTEIN; XENDOU; INDUCTION; DISCOVERY; MURINE	Nidovirus endoribonucleases (NendoUs) include nonstructural protein 15 (nsp15) from coronaviruses and nsp11 from arteriviruses, both of which have been reported to participate in the viral replication process and in the evasion of the host immune system. Results from a previous study of coronaviruses SARS-CoV, HCoV-229E, and MHV nsp15 indicate that it mainly forms a functional hexamer, whereas nsp11 from the arterivirus PRRSV is a dimer. Here, we found that porcine Deltacoronavirus (PDCoV) nsp15 primarily exists as dimers and monomers in vitro. Biological experiments reveal that a PDCoV nsp15 mutant lacking the first 27 amino acids of the N-terminal domain (Asn-1-Asn-27) forms more monomers and displays decreased enzymatic activity, indicating that this region is important for its dimerization. Moreover, multiple sequence alignments and three-dimensional structural analysis indicated that the C-terminal region (His-251-Val-261) of PDCoV nsp15 is 10 amino acids shorter and forms a shorter loop than that formed by the equivalent sequence (Gln-259-Phe-279) of SARS-CoV nsp15. This result may explain why PDCoV nsp15 failed to form hexamers. We speculate that NendoUs may have originated from XendoU endoribonucleases (XendoUs) forming monomers in eukaryotic cells, that NendoU from arterivirus gained the ability to form dimers, and that the coronavirus variants then evolved the capacity to assemble into hexamers. We further propose that PDCoV nsp15 may be an intermediate in this evolutionary process. Our findings provide a theoretical basis for improving our understanding of NendoU evolution and offer useful clues for designing drugs and vaccines against nidoviruses.	[Zheng, Anjun; Shi, Yuejun; Shen, Zhou; Wang, Gang; Shi, Jiale; Fang, Liurong; Xiao, Shaobo; Peng, Guiqing] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China; [Zheng, Anjun; Shi, Yuejun; Shen, Zhou; Wang, Gang; Shi, Jiale; Fang, Liurong; Xiao, Shaobo; Peng, Guiqing] Huazhong Agr Univ, Key Lab Prevent Vet Med Hubei Prov, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Hubei, Peoples R China; [Shi, Yuejun; Xiong, Qiqi] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Fu, Zhen F.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; University System of Georgia; University of Georgia	Peng, GQ (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.	penggq@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188; Shen, Zhou/0000-0001-8772-2978	National Key RD Plan of China [2018YFD0500100]; National Natural Science Foundation of China [31702249, 31722056]; China Postdoctoral Science Foundation [2017M612484]; Natural Science Foundation of Hubei Province of China [2016CFA069]	National Key RD Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province)	This work was supported by National Key R&D Plan of China Grant 2018YFD0500100, National Natural Science Foundation of China Grants 31702249 and 31722056, China Postdoctoral Science Foundation Grant 2017M612484, and Natural Science Foundation of Hubei Province of China Grant 2016CFA069. The authors declare that they have no conflicts of interest with the contents of this article.	Balasuriya UBR, 2017, CURR OPIN VIROL, V27, P57, DOI 10.1016/j.coviro.2017.11.005; Bergendahl LT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05084-8; Bhardwaj K, 2004, J VIROL, V78, P12218, DOI 10.1128/JVI.78.22.12218-12224.2004; Bhardwaj K, 2006, J MOL BIOL, V361, P243, DOI 10.1016/j.jmb.2006.06.021; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; Cao JZ, 2012, VIRUS RES, V167, P247, DOI 10.1016/j.virusres.2012.05.006; Cao JZ, 2008, INTERVIROLOGY, V51, P342, DOI 10.1159/000175837; Chen QG, 2012, VIRUS RES, V163, P650, DOI 10.1016/j.virusres.2011.11.008; Cong Y., 2017, VIRUSES, V9, pE182; Deng XF, 2018, VIROLOGY, V517, P157, DOI 10.1016/j.virol.2017.12.024; Deng XF, 2017, P NATL ACAD SCI USA, V114, pE4251, DOI 10.1073/pnas.1618310114; Di H, 2018, VIROLOGY, V517, P38, DOI 10.1016/j.virol.2018.01.026; Gioia U, 2005, J BIOL CHEM, V280, P18996, DOI 10.1074/jbc.M501160200; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Guarino LA, 2005, J MOL BIOL, V353, P1106, DOI 10.1016/j.jmb.2005.09.007; Guo ZH, 2018, VIROL J, V15, DOI 10.1186/s12985-017-0910-6; Huo T, 2015, ACTA CRYSTALLOGR F, V71, P1156, DOI 10.1107/S2053230X15007359; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Joseph JS, 2007, J VIROL, V81, P6700, DOI 10.1128/JVI.02817-06; Kang H, 2007, J VIROL, V81, P13587, DOI 10.1128/JVI.00547-07; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lauber C, 2012, ARCH VIROL, V157, P1623, DOI 10.1007/s00705-012-1295-x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lorsirigool A, 2016, ARCH VIROL, V161, P2909, DOI 10.1007/s00705-016-2983-8; Ma YM, 2015, MBIO, V6, DOI 10.1128/mBio.00064-15; McCluskey BJ, 2016, PREV VET MED, V123, P185, DOI 10.1016/j.prevetmed.2015.10.018; Nedialkova DD, 2009, J VIROL, V83, P5671, DOI 10.1128/JVI.00261-09; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Posthuma CC, 2006, J VIROL, V80, P1653, DOI 10.1128/JVI.80.4.1653-1661.2006; Renzi F, 2006, P NATL ACAD SCI USA, V103, P12365, DOI 10.1073/pnas.0602426103; Ricagno S, 2006, P NATL ACAD SCI USA, V103, P11892, DOI 10.1073/pnas.0601708103; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shi XB, 2011, MOL IMMUNOL, V48, P1568, DOI 10.1016/j.molimm.2011.03.004; Shi YJ, 2016, J VIROL, V90, P4579, DOI 10.1128/JVI.03065-15; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Vasilakis N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-97; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Xu XL, 2006, J VIROL, V80, P7909, DOI 10.1128/JVI.00525-06; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	42	9	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12054	12067		10.1074/jbc.RA118.003756	http://dx.doi.org/10.1074/jbc.RA118.003756			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29887523	Green Published, hybrid			2022-12-28	WOS:000440803200007
J	Wang, ZY; Fang, LF; Zhou, ZS; Pacheco, S; Gomez, I; Song, FP; Soberon, M; Zhang, J; Bravo, A				Wang, Zeyu; Fang, Longfa; Zhou, Zishan; Pacheco, Sabino; Gomez, Isabel; Song, Fuping; Soberon, Mario; Zhang, Jie; Bravo, Alejandra			Specific binding between Bacillus thuringiensis Cry9Aa and Vip3Aa toxins synergizes their toxicity against Asiatic rice borer (Chilo suppressalis)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; toxin; Bacillus; insect; epitope mapping; pesticide; synergism; synergistic activity	BORDER MEMBRANE-VESICLES; VEGETATIVE INSECTICIDAL PROTEIN; SPODOPTERA-FRUGIPERDA MIDGUT; CRY11AA TOXIN; CRYSTAL PROTEIN; RECEPTOR; LEPIDOPTERA; DIFFERS; SITES; GENE	The bacterium Bacillus thuringiensis produces several insecticidal proteins, such as the crystal proteins (Cry) and the vegetative insecticidal proteins (Vip). In this work, we report that a specific interaction between two B. thuringiensis toxins creates insecticidal synergism and unravel the molecular basis of this interaction. When applied together, the three-domain Cry toxin Cry9Aa and the Vip Vip3Aa exhibited high insecticidal activity against an important insect pest, the Asiatic rice borer (Chilo suppressalis). We found that these two proteins bind specifically to brush border membrane vesicles of C. suppressalis and that they do not share binding sites because no binding competition was observed between them. Binding assays revealed that the Cry9Aa and Vip3Aa proteins interacted with high affinity. We mapped their specific interacting regions by analyzing binding of Cry9Aa to overlapping fragments of Vip3Aa and by analyzing binding of Vip3Aa to individual domains of Cry9Aa. Binding to peptide arrays helped narrow the binding sites to domain II loop-3 of Cry9Aa and to (TKKMKTL434)-T-428 in Vip3Aa. Site-directed mutagenesis confirmed that these binding regions participate in binding that directly correlates with the synergism between the two proteins. In summary, we show that the B. thuringiensis Cry9Aa and Vip3Aa toxins display potent synergy based on a specific interaction between them. Our results further our understanding of the complex synergistic activities among B. thuringiensis toxins and are highly relevant to the development of toxin combinations for effective insect control and for delaying development of insect resistance.	[Wang, Zeyu; Fang, Longfa; Zhou, Zishan; Song, Fuping; Zhang, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Wang, Zeyu; Pacheco, Sabino; Gomez, Isabel; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Universidad Nacional Autonoma de Mexico	Zhang, J (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.; Bravo, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Av Univ 2001 Ap Postal 510-3, Cuernavaca 62210, Morelos, Mexico.	jzhang@ippcaas.cn; bravo@ibt.unam.mx	Pacheco, Sabino/AFJ-9017-2022; de la Parra, Maria Alejandra Bravo/R-6740-2017	Pacheco, Sabino/0000-0002-0208-0046; Wang, Zeyu/0000-0003-0087-8123	National Key Research and Development Program of China [2017YFD0200400]; Consejo Nacional de Ciencia y Tecnologia (Fronteras de la Ciencia) [008]	National Key Research and Development Program of China; Consejo Nacional de Ciencia y Tecnologia (Fronteras de la Ciencia)	This work was supported by National Key Research and Development Program of China Grant 2017YFD0200400 and the Consejo Nacional de Ciencia y Tecnologia (Fronteras de la Ciencia 008). The authors declare that they have no conflicts of interest with the contents of this article.	Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Bel Y, 2017, TOXINS, V9, DOI 10.3390/toxins9040131; Ben Hamadou-Charfi D, 2013, J INVERTEBR PATHOL, V114, P139, DOI 10.1016/j.jip.2013.07.003; Bergamasco VB, 2013, J INVERTEBR PATHOL, V112, P152, DOI 10.1016/j.jip.2012.11.011; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Carriere Y, 2016, TRENDS BIOTECHNOL, V34, P291, DOI 10.1016/j.tibtech.2015.12.011; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Chakroun M, 2016, MICROBIOL MOL BIOL R, V80, P329, DOI 10.1128/MMBR.00060-15; Chakroun M, 2014, APPL ENVIRON MICROB, V80, P6258, DOI 10.1128/AEM.01521-14; CRICKMORE N., 2018, BACILLUS THURINGIENS; Fang LF, 2016, ELECTRON J BIOTECHN, V21, P54, DOI 10.1016/j.ejbt.2016.02.005; Fernandez LE, 2005, FEBS LETT, V579, P3508, DOI 10.1016/j.febslet.2005.05.032; FINNEY D J, 1971, P333; Gayen S, 2012, J PLANT BIOCHEM BIOT, V21, pS128, DOI 10.1007/s13562-012-0148-8; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; Guo SY, 2009, J STRUCT BIOL, V168, P259, DOI 10.1016/j.jsb.2009.07.004; Hernandez-Martinez P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16406-1; Hobbelen PHF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099366, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0103480, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0095422, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0095536]; Hua G, 2001, APPL ENVIRON MICROB, V67, P872, DOI 10.1128/AEM.67.2.872-879.2001; Jansens S, 1997, CROP SCI, V37, P1616, DOI 10.2135/cropsci1997.0011183X003700050035x; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang K, 2016, TOXICON, V120, P49, DOI 10.1016/j.toxicon.2016.07.019; Jiao YY, 2016, J INVERTEBR PATHOL, V136, P95, DOI 10.1016/j.jip.2016.03.010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kramer A, 1998, METH MOL B, V87, P25; Kunthic T, 2017, EUR BIOPHYS J BIOPHY, V46, P257, DOI 10.1007/s00249-016-1162-x; Kuvshinov V, 2001, PLANT SCI, V160, P341, DOI 10.1016/S0168-9452(00)00398-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert B, 1996, APPL ENVIRON MICROB, V62, P80, DOI 10.1128/AEM.62.1.80-86.1996; Lee MK, 2006, BIOCHEM BIOPH RES CO, V339, P1043, DOI 10.1016/j.bbrc.2005.11.112; Lee MK, 2003, APPL ENVIRON MICROB, V69, P4648, DOI 10.1128/AEM.69.8.4648-4657.2003; Liu JG, 2011, J INVERTEBR PATHOL, V108, P92, DOI 10.1016/j.jip.2011.07.007; Lorence A, 1997, FEBS LETT, V414, P303, DOI 10.1016/S0014-5793(97)01014-4; Lu MX, 2013, SCI REP-UK, V3, DOI 10.1038/srep03211; Marchetti E, 2009, BIOCONTROL SCI TECHN, V19, P463, DOI 10.1080/09583150902807535; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meng FX, 2003, J ECON ENTOMOL, V96, P1838, DOI 10.1603/0022-0493-96.6.1838; Naimov S, 2014, J INVERTEBR PATHOL, V115, P99, DOI 10.1016/j.jip.2013.11.003; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Palma L, 2017, TOXINS, V9, DOI 10.3390/toxins9050165; Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102; Perez C, 2007, CELL MICROBIOL, V9, P2931, DOI 10.1111/j.1462-5822.2007.01007.x; de Escudero IR, 2007, APPL ENVIRON MICROB, V73, P337, DOI 10.1128/AEM.01511-06; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; SMULEVITCH SV, 1991, FEBS LETT, V293, P25, DOI 10.1016/0014-5793(91)81144-W; Song R, 2008, APPL MICROBIOL BIOT, V80, P647, DOI 10.1007/s00253-008-1613-0; TABASHNIK BE, 1992, APPL ENVIRON MICROB, V58, P3343, DOI 10.1128/AEM.58.10.3343-3346.1992; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; vanFrankenhuyzen K, 1997, APPL ENVIRON MICROB, V63, P4132, DOI 10.1128/AEM.63.10.4132-4134.1997; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xu D, 2013, PROTEINS, V81, P229, DOI 10.1002/prot.24179; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Zack MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11702-2	57	21	22	4	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11447	11458		10.1074/jbc.RA118.003490	http://dx.doi.org/10.1074/jbc.RA118.003490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858245	Green Published, hybrid			2022-12-28	WOS:000439449700015
J	Woll, KA; Guzik-Lendrum, S; Bensel, BM; Bhanu, NV; Dailey, WP; Garcia, BA; Gilbert, SP; Eckenhoff, RG				Woll, Kellie A.; Guzik-Lendrum, Stephanie; Bensel, Brandon M.; Bhanu, Natarajan V.; Dailey, William P.; Garcia, Benjamin A.; Gilbert, Susan P.; Eckenhoff, Roderic G.			An allosteric propofol-binding site in kinesin disrupts kinesin-mediated processive movement on microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule; kinesin; anesthesia; single-molecule biophysics; photoaffinity labeling; molecular motor; tubulin; propofol; single molecule motility	HAND-OVER-HAND; AXONAL-TRANSPORT; SUPERFAMILY PROTEIN; ORGANELLE TRANSPORT; CRYSTAL-STRUCTURE; MOTOR PROTEIN; MOTILITY; MECHANISMS; VESICLES; NEURONS	Microtubule-based molecular motors mediate transport of intracellular cargo to subdomains in neurons. Previous evidence has suggested that the anesthetic propofol decreases the average run-length potential of the major anterograde transporters kinesin-1 and kinesin-2 without altering their velocity. This effect on kinesin has not been observed with other inhibitors, stimulating considerable interest in the underlying mechanism. Here, we used a photoactive derivative of propofol, meta-azipropofol (AziPm), to search for potential propofol-binding sites in kinesin. Single-molecule motility assays confirmed that AziPm and propofol similarly inhibit kinesin-1 and kinesin-2. We then applied AziPm in semiquantitative radiolabeling and MS microsequencing assays to identify propofol-binding sites within microtubule-kinesin complexes. The radiolabeling experiments suggested preferential AziPm binding to the ATP-bound microtubule-kinesin complex. The photolabeled residues were contained within the kinesin motor domain rather than at the motor domain--tubulin interface. No residues within the P-loop of kinesin were photolabeled, indicating an inhibitory mechanism that does not directly affect ATPase activity and has an effect on run length without changing velocity. Our results also indicated that when the kinesin motor interacts with the microtubule during its processive run, a site forms in kinesin to which propofol can then bind and allosterically disrupt the kinesin-microtubule interaction, resulting in kinesin detachment and run termination. The discovery of the propofol-binding allosteric site in kinesin may improve our understanding of the strict coordination of the motor heads during the processive run. We hypothesize that propofol's potent effect on intracellular transport contributes to various components of its anesthetic action.	[Woll, Kellie A.; Eckenhoff, Roderic G.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Bhanu, Natarajan V.; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Epigenet Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Guzik-Lendrum, Stephanie; Bensel, Brandon M.; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Guzik-Lendrum, Stephanie; Bensel, Brandon M.; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Dailey, William P.] Univ Penn, Dept Chem, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Pennsylvania	Eckenhoff, RG (corresponding author), 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu			National Institutes of Health [R37-GM054141, P01-GM55876, GM110174, AI118891]; National Science Foundation [DGE-1321851]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876, R37GM054141, R01GM110174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R37-GM054141 (to S.P.G.), P01-GM55876 (to R.G.E.), and GM110174 and AI118891 (to B.A.G.), and National Science Foundation Graduate Research Fellowship Program Grant DGE-1321851 (to K.A.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Bayley H., 1983, PHOTOGENERATED REAGE, DOI [10.1016/S0075-7535(08)70436-4, DOI 10.1016/S0075-7535(08)70436-4]; Bensel BM, 2017, P NATL ACAD SCI USA, V114, pE4281, DOI 10.1073/pnas.1701482114; Bentley M, 2016, NAT REV NEUROSCI, V17, P611, DOI 10.1038/nrn.2016.100; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Cao LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6364; Castle MJ, 2014, MOL THER, V22, P554, DOI 10.1038/mt.2013.237; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; LASEK RJ, 1984, J CELL BIOL, V99, pS212, DOI 10.1083/jcb.99.1.212s; LASEK RJ, 1985, NATURE, V316, P645, DOI 10.1038/316645a0; Leite LF, 2011, ACTA PHARMACOL SIN, V32, P31, DOI 10.1038/aps.2010.175; Liu DF, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.24490; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Minoura I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10058; Mintz CD, 2012, J NEUROSURG ANESTH, V24, P368, DOI 10.1097/ANA.0b013e31826a03a6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Niwa S, 2013, EMBO J, V32, P1352, DOI 10.1038/emboj.2013.59; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sardella M, 1998, GENOMICS, V47, P405, DOI 10.1006/geno.1997.5123; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Shang ZG, 2014, ELIFE, V3, DOI 10.7554/eLife.04686; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ulaganathan V, 2013, J AM CHEM SOC, V135, P2263, DOI 10.1021/ja310377d; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; VIANCOUR TA, 1993, BRAIN RES, V628, P209, DOI 10.1016/0006-8993(93)90957-O; Weiser Brian P, 2014, Curr Anesthesiol Rep, V4, P57; Woll KA, 2017, ACS CHEM BIOL, V12, P1353, DOI 10.1021/acschembio.7b00222; Woll KA, 2016, ANESTH ANALG, V123, P1253, DOI 10.1213/ANE.0000000000001365; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	63	11	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11283	11295		10.1074/jbc.RA118.002182	http://dx.doi.org/10.1074/jbc.RA118.002182			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29844014	Green Published, hybrid			2022-12-28	WOS:000439449700003
J	Yeow, J; Tan, KW; Holdbrook, DA; Chong, ZS; Marzinek, JK; Bond, PJ; Chng, SS				Yeow, Jiang; Tan, Kang Wei; Holdbrook, Daniel A.; Chong, Zhi-Soon; Marzinek, Jan K.; Bond, Peter J.; Chng, Shu-Sin			The architecture of the OmpC-MlaA complex sheds light on the maintenance of outer membrane lipid asymmetry in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						outer membrane; lipid transport; phospholipid; membrane protein; protein complex; lipid asymmetry; membrane channel; MlaA; OmpC; osmoporin	GRAM-NEGATIVE BACTERIA; SALMONELLA-TYPHIMURIUM; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; LIPOPOLYSACCHARIDE TRANSPORT; BIOLOGICAL FUNCTION; OSMOPORIN OMPC; PROTEIN; INSERTION; BARREL	A distinctive feature of the Gram-negative bacterial cell envelope is the asymmetric outer membrane (OM), where lipopolysaccharides and phospholipids (PLs) reside in the outer and inner leaflets, respectively. This unique lipid asymmetry renders the OM impermeable to external insults, including antibiotics and bile salts. In Escherichia coli, the complex comprising osmoporin OmpC and the OM lipoprotein MlaA is believed to maintain lipid asymmetry by removing mislocalized PLs from the outer leaflet of the OM. How this complex performs this function is unknown. Here, we defined the molecular architecture of the OmpC-MlaA complex to gain insights into its role in PL transport. Using in vivo photo-cross-linking and molecular dynamics simulations, we established that MlaA interacts extensively with OmpC and is located entirely within the lipid bilayer. In addition, MlaA forms a hydrophilic channel, likely enabling PL translocation across the OM. We further showed that flexibility in a hairpin loop adjacent to the channel is critical in modulating MlaA activity. Finally, we demonstrated that OmpC plays a functional role in maintaining OM lipid asymmetry together with MlaA. Our work offers glimpses into how the OmpC-MlaA complex transports PLs across the OM and has important implications for future antibacterial drug development.	[Yeow, Jiang; Tan, Kang Wei; Chong, Zhi-Soon; Chng, Shu-Sin] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Yeow, Jiang] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Holdbrook, Daniel A.; Marzinek, Jan K.; Bond, Peter J.] ASTAR, Bioinformat Inst, Singapore 138671, Singapore; [Marzinek, Jan K.; Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Chng, Shu-Sin] Natl Univ Singapore, Singapore Ctr Environm Life Sci Engn, Singapore 117456, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Chng, SS (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.; Bond, PJ (corresponding author), ASTAR, Bioinformat Inst, Singapore 138671, Singapore.	peterjb@bii.a-star.edu.sg; chmchngs@nus.edu.sg	; Chng, Shu Sin/B-1759-2018	Marzinek, Jan/0000-0002-5493-8753; Yeow, Jiang/0000-0001-5384-7211; Bond, Peter/0000-0003-2900-098X; Chng, Shu Sin/0000-0001-5466-7183	National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship; Singapore Ministry of Education Academic Research Fund Tier 3 Grant [MOE2012-T3-1-008]; National University of Singapore start-up funding; Singapore Ministry of Education Academic Research Fund Tier 1 Grant [MOE2013-T2-1-148]; Singapore Ministry of Education Academic Research Fund Tier 2 Grant [MOE2013-T2-1-148]	National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship(National University of Singapore); Singapore Ministry of Education Academic Research Fund Tier 3 Grant(Ministry of Education, Singapore); National University of Singapore start-up funding(National University of Singapore); Singapore Ministry of Education Academic Research Fund Tier 1 Grant(Ministry of Education, Singapore); Singapore Ministry of Education Academic Research Fund Tier 2 Grant(Ministry of Education, Singapore)	This work was supported by funds from the National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship (to J.Y.). Computational work was supported in part by the Singapore Ministry of Education Academic Research Fund Tier 3 Grant MOE2012-T3-1-008 (to J.K.M. and P.J.B.). All experimental work was supported by the National University of Singapore start-up funding and the Singapore Ministry of Education Academic Research Fund Tier 1 Grant and Tier 2 Grant MOE2013-T2-1-148 (to S.-S.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abellon-Ruiz J, 2017, NAT MICROBIOL, V2, P1616, DOI 10.1038/s41564-017-0046-x; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Chong ZS, 2015, MOL MICROBIOL, V98, P1133, DOI 10.1111/mmi.13202; Dalebroux ZD, 2014, P NATL ACAD SCI USA, V111, P1963, DOI 10.1073/pnas.1316901111; Dekker N, 2000, MOL MICROBIOL, V35, P711, DOI 10.1046/j.1365-2958.2000.01775.x; DeLano W. L., 2012, PYMOL MOL GRAPH SYST; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Ekiert DC, 2017, CELL, V169, P273, DOI 10.1016/j.cell.2017.03.019; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FUNAHARA Y, 1980, J BACTERIOL, V141, P1463, DOI 10.1128/JB.141.3.1463-1465.1980; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang YMM, 2016, PROTEIN SCI, V25, P1430, DOI 10.1002/pro.2939; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jia WY, 2004, J BIOL CHEM, V279, P44966, DOI 10.1074/jbc.M404963200; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; Khetrapal V, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv248; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leo JC, 2015, METHODS MOL BIOL, V1329, P157, DOI 10.1007/978-1-4939-2871-2_12; Liu NZ, 1998, PROTEIN ENG, V11, P797, DOI 10.1093/protein/11.9.797; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; NAKAMURA K, 1976, J BIOCHEM, V80, P1411, DOI 10.1093/oxfordjournals.jbchem.a131414; Naveed H, 2012, J MOL BIOL, V419, P89, DOI 10.1016/j.jmb.2012.02.043; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Okuda S, 2016, NAT REV MICROBIOL, V14, P337, DOI 10.1038/nrmicro.2016.25; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Paramo T, 2014, J CHEM THEORY COMPUT, V10, P2151, DOI 10.1021/ct401098b; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sherman DJ, 2014, P NATL ACAD SCI USA, V111, P4982, DOI 10.1073/pnas.1323516111; Shrivastava R, 2017, MOL MICROBIOL, V106, P395, DOI 10.1111/mmi.13772; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sutterlin HA, 2016, P NATL ACAD SCI USA, V113, pE1565, DOI 10.1073/pnas.1601375113; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Thong S, 2016, ELIFE, V5, DOI 10.7554/eLife.19042; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503	56	38	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11325	11340		10.1074/jbc.RA118.002441	http://dx.doi.org/10.1074/jbc.RA118.002441			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29848551	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000439449700006
J	Ball, WB; Baker, CD; Neff, JK; Apfel, GL; Lagerborg, KA; Zun, G; Petrovic, U; Jain, M; Gohil, VM				Ball, Writoban Basu; Baker, Charli D.; Neff, John K.; Apfel, Gabriel L.; Lagerborg, Kim A.; Zun, Gasper; Petrovic, Uros; Jain, Mohit; Gohil, Vishal M.			Ethanolamine ameliorates mitochondrial dysfunction in cardiolipin-deficient yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; cardiolipin; mitochondrial respiratory chain complex; cytochrome c oxidase (Complex IV); phospholipid; Barth syndrome; ethanolamine; respiratory supercomplexes	RESPIRATORY-CHAIN SUPERCOMPLEXES; MEMBRANE-PROTEIN COMPLEXES; SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; OXIDATIVE-PHOSPHORYLATION; MAMMALIAN MITOCHONDRIA; PHOSPHATIDYLETHANOLAMINE; STABILITY; METABOLISM; TRANSPORT	Cardiolipin (CL) is a signature phospholipid of the mitochondria required for the formation of mitochondrial respiratory chain (MRC) supercomplexes. The destabilization of MRC supercomplexes is the proximal cause of the pathology associated with the depletion of CL in patients with Barth syndrome. Thus, promoting supercomplex formation could ameliorate mitochondrial dysfunction associated with CL depletion. However, to date, physiologically relevant small-molecule regulators of supercomplex formation have not been identified. Here, we report that ethanolamine (Etn) supplementation rescues the MRC defects by promoting supercomplex assembly in a yeast model of Barth syndrome. We discovered this novel role of Etn while testing the hypothesis that elevating mitochondrial phosphatidylethanolamine (PE), a phospholipid suggested to overlap in function with CL, could compensate for CL deficiency. We found that the Etn supplementation rescues the respiratory growth of CL-deficient Saccharomyces cerevisiae cells in a dose-dependent manner but independently of its incorporation into PE. The rescue was specifically dependent on Etn but not choline or serine, the other phospholipid precursors. Etn improved mitochondrial function by restoring the expression of MRC proteins and promoting supercomplex assembly in CL-deficient cells. Consistent with this mechanism, overexpression of Cox4, the MRC complex IV subunit, was sufficient to promote supercomplex formation in CL-deficient cells. Taken together, our work identifies a novel role of a ubiquitous metabolite, Etn, in attenuating mitochondrial dysfunction caused by CL deficiency.	[Ball, Writoban Basu; Baker, Charli D.; Neff, John K.; Apfel, Gabriel L.; Gohil, Vishal M.] Texas A&M Univ, Dept Biochem & Biophys, 301 Old Main Dr,ILSB 2146A, College Stn, TX 77843 USA; [Lagerborg, Kim A.; Jain, Mohit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lagerborg, Kim A.; Jain, Mohit] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zun, Gasper; Petrovic, Uros] Jozef Stefan Inst, Dept Mol & Biomed Sci, Jamova 39, Ljubljana, Slovenia; [Zun, Gasper] Univ Ljubljana, Fac Chem & Chem Technol, Vecna Pot 113, Ljubljana 1000, Slovenia; [Petrovic, Uros] Univ Ljubljana, Biotech Fac, Dept Biol, Vecna Pot 111, Ljubljana 1000, Slovenia	Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Diego; University of California System; University of California San Diego; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana	Gohil, VM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 301 Old Main Dr,ILSB 2146A, College Stn, TX 77843 USA.	vgohil@tamu.edu		Petrovic, Uros/0000-0002-9743-9145; Neff, John/0000-0003-2473-6306; Basu Ball, Writoban/0000-0001-7678-126X; Gohil, Vishal/0000-0002-9920-2563	Welch Foundation [A-1810]; American Heart Association Award [16GRNT31020028]; National Institutes of Health [R01GM111672, 1R01ES027595, 1R03HL133720, 1S10OD020025]; University of California, San Diego, Frontiers of Innovation Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL133720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111672] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020025] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); American Heart Association Award(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego, Frontiers of Innovation Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Welch Foundation Grant A-1810, American Heart Association Award 16GRNT31020028, National Institutes of Health Grants R01GM111672 (to V.M.G.) and 1R01ES027595, 1R03HL133720, and 1S10OD020025 (to M.J.), and the University of California, San Diego, Frontiers of Innovation Scholars Program (to K.A.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Amberg DC., 2005, METHODS YEAST GENETI; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Baker CD, 2016, MOL BIOL CELL, V27, P2161, DOI 10.1091/mbc.E15-12-0865; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; Becker T, 2013, J BIOL CHEM, V288, P16451, DOI 10.1074/jbc.M112.442392; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; Fernandez-Murray JP, 2013, J BIOL CHEM, V288, P36106, DOI 10.1074/jbc.M113.499855; FOLCH J, 1957, J BIOL CHEM, V226, P497; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Hsu P, 2015, AUTOPHAGY, V11, P643, DOI 10.1080/15548627.2015.1023984; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; Kishi S, 2015, EBIOMEDICINE, V2, P1090, DOI 10.1016/j.ebiom.2015.07.035; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Merkel O, 2005, BBA-MOL CELL BIOL L, V1734, P215, DOI 10.1016/j.bbalip.2005.03.004; Modica-Napolitano JS, 2004, BIOL PSYCHIAT, V55, P273, DOI 10.1016/S0006-3223(03)00784-4; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Raja V, 2014, CHEM PHYS LIPIDS, V179, P49, DOI 10.1016/j.chemphyslip.2013.12.009; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; RIETVELD AG, 1993, J BIOL CHEM, V268, P12427; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schuler MH, 2016, J BIOL CHEM, V291, P18718, DOI 10.1074/jbc.M116.722694; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Su XF, 2006, MOL CELL BIOL, V26, P743, DOI 10.1128/MCB.26.3.743-753.2006; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	68	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10870	10883		10.1074/jbc.RA118.004014	http://dx.doi.org/10.1074/jbc.RA118.004014			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29866881	hybrid, Green Published			2022-12-28	WOS:000438882800003
J	Raguimova, ON; Smolin, N; Bovo, E; Bhayani, S; Autry, JM; Zima, AV; Robia, SL				Raguimova, Olga N.; Smolin, Nikolai; Bovo, Elisa; Bhayani, Siddharth; Autry, Joseph M.; Zima, Aleksey V.; Robia, Seth L.			Redistribution of SERCA calcium pump conformers during intracellular calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium ATPase; calcium imaging; calcium transport; calcium intracellular release; conformational change; membrane biophysics; membrane transport; fluorescence resonance energy transfer (FRET); sarcoplasmic reticulum (SR); endoplasmic reticulum (ER)	SARCOPLASMIC-RETICULUM CA2+-ATPASE; RESONANCE ENERGY-TRANSFER; CA2+ ATPASE; CRYSTAL-STRUCTURES; PHOSPHOLAMBAN OLIGOMERIZATION; ACTUATOR DOMAINS; HIGH-THROUGHPUT; GENE-THERAPY; TRANSPORT; BINDING	The conformational changes of a calcium transport ATPase were investigated with molecular dynamics (MD) simulations as well as fluorescence resonance energy transfer (FRET) measurements to determine the significance of a discrete structural element for regulation of the conformational dynamics of the transport cycle. Previous MD simulations indicated that a loop in the cytosolic domain of the SERCA calcium transporter facilitates an open-to-closed structural transition. To investigate the significance of this structural element, we performed additional MD simulations and new biophysical measurements of SERCA structure and function. Rationally designed in silico mutations of three acidic residues of the loop decreased SERCA domain-domain contacts and increased domain-domain separation distances. Principal component analysis of MD simulations suggested decreased sampling of compact conformations upon N-loop mutagenesis. Deficits in headpiece structural dynamics were also detected by measuring intramolecular FRET of a Cer-YFP-SERCA construct (2-color SERCA). Compared with WT, the mutated 2-color SERCA shows a partial FRET response to calcium, whereas retaining full responsiveness to the inhibitor thapsigargin. Functional measurements showed that the mutated transporter still hydrolyzes ATP and transports calcium, but that maximal enzyme activity is reduced while maintaining similar calcium affinity. In live cells, calcium elevations resulted in concomitant FRET changes as the population of WT 2-color SERCA molecules redistributed among intermediates of the transport cycle. Our results provide novel insights on how the population of SERCA pumps responds to dynamic changes in intracellular calcium.	[Raguimova, Olga N.; Smolin, Nikolai; Bovo, Elisa; Bhayani, Siddharth; Zima, Aleksey V.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Autry, Joseph M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Loyola University Chicago; University of Minnesota System; University of Minnesota Twin Cities	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.	srobia@luc.edu	Autry, Joseph M./X-6839-2019	Autry, Joseph M./0000-0002-1144-725X	National Institute of Health "Loyola Research Computing Core" [1G20RR030939]; National Science Foundation [ACI-1548562]; Stampede and Stampede2 at the Texas Advanced Computing Center (TACC) through XSEDE allocation [TG-MCB130108]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR030939] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130231, R01HL092321] Funding Source: NIH RePORTER	National Institute of Health "Loyola Research Computing Core"; National Science Foundation(National Science Foundation (NSF)); Stampede and Stampede2 at the Texas Advanced Computing Center (TACC) through XSEDE allocation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful for helpful suggestions from Howard S. Young. This work was also supported by equipment and facilities provided by National Institute of Health "Loyola Research Computing Core" Grant 1G20RR030939. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant ACI-1548562, as well as Stampede and Stampede2 at the Texas Advanced Computing Center (TACC) through XSEDE allocation TG-MCB130108.	Abrol N, 2014, J BIOL CHEM, V289, P25855, DOI 10.1074/jbc.M114.562579; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bian TF, 2016, BIOCHEM BIOPH RES CO, V481, P206, DOI 10.1016/j.bbrc.2016.10.096; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Blackwell DJ, 2016, BIOPHYS J, V111, P1192, DOI 10.1016/j.bpj.2016.08.005; Bleeker NP, 2013, MOL PHARMACEUT, V10, P4358, DOI 10.1021/mp400458u; Bovo E, 2016, AM J PHYSIOL-HEART C, V311, pH268, DOI 10.1152/ajpheart.00175.2016; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen B, 2008, BIOCHEMISTRY-US, V47, P12448, DOI 10.1021/bi8014289; Clausen JD, 2016, STRUCTURE, V24, P617, DOI 10.1016/j.str.2016.02.018; Clifford RJ, 2009, J BIOL CHEM, V284, P22905, DOI 10.1074/jbc.M109.030536; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; DHALLA NS, 1993, CAN J CARDIOL, V9, P873; Dyla M, 2017, NATURE, V551, P346, DOI 10.1038/nature24296; Fernandez-de Gortari E., 2018, BIORXIV, DOI [doi.org/10.1101/310607, DOI 10.1101/310607]; FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gadella TWJ., 2011, FRET FLIM TECHNIQUES; Gadsby DC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1673; Greenberg B, 2016, LANCET, V387, P1178, DOI 10.1016/S0140-6736(16)00082-9; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Hayward C, 2015, HUM GENE THER, V26, P293, DOI 10.1089/hum.2015.018; HENDERSON IMJ, 1994, BIOCHEM J, V297, P615, DOI 10.1042/bj2970615; HENDERSON IMJ, 1994, BIOCHEM J, V297, P625, DOI 10.1042/bj2970625; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040369; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1994, BIOPHYS J, V66, P554, DOI 10.1016/S0006-3495(94)80872-0; INESI G, 1988, METHOD ENZYMOL, V157, P154; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES LR, 1979, BIOCHIM BIOPHYS ACTA, V557, P230, DOI 10.1016/0005-2736(79)90105-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; KISS E, 1995, CIRC RES, V77, P759, DOI 10.1161/01.RES.77.4.759; Kitao A, 1998, PROTEINS, V33, P496, DOI 10.1002/(SICI)1097-0134(19981201)33:4<496::AID-PROT4>3.3.CO;2-T; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lock JT, 2015, CELL CALCIUM, V58, P638, DOI 10.1016/j.ceca.2015.10.003; Lockamy EL, 2011, BIOCHEM BIOPH RES CO, V408, P388, DOI 10.1016/j.bbrc.2011.04.023; Ma HL, 2005, BIOCHEMISTRY-US, V44, P8090, DOI 10.1021/bi050332m; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MINTZ E, 1995, J BIOL CHEM, V270, P27160, DOI 10.1074/jbc.270.45.27160; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Ritter M, 2000, AM J PHYSIOL-HEART C, V278, pH666, DOI 10.1152/ajpheart.2000.278.2.H666; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; Sato E, 2018, BIOORG MED CHEM LETT, V28, P298, DOI 10.1016/j.bmcl.2017.12.050; Savignac M, 2011, BBA-MOL CELL RES, V1813, P1111, DOI 10.1016/j.bbamcr.2010.12.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Smolin N, 2015, J PHYS CHEM B, V119, P1407, DOI 10.1021/jp511433v; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tournier AL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.208106; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Yamada H, 1996, BIOCHEM BIOPH RES CO, V225, P215, DOI 10.1006/bbrc.1996.1156; Yamasaki K, 2015, J BIOL CHEM, V290, P27868, DOI 10.1074/jbc.M115.693770; Young HS, 2001, J MOL BIOL, V308, P231, DOI 10.1006/jmbi.2001.4558	83	16	16	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10843	10856		10.1074/jbc.RA118.002472	http://dx.doi.org/10.1074/jbc.RA118.002472			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29764938	hybrid, Green Published			2022-12-28	WOS:000438882800001
J	Ambrose, RL; Liu, YC; Adams, TE; Bean, AGD; Stewart, CR				Ambrose, Rebecca L.; Liu, Yu Chih; Adams, Timothy E.; Bean, Andrew G. D.; Stewart, Cameron R.			C6orf106 is a novel inhibitor of the interferon-regulatory factor 3-dependent innate antiviral response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon-regulatory factor (IRF); innate immunity; cytokine; interferon; NF-B	NF-KAPPA-B; DOUBLE-STRANDED-RNA; RIG-I; TRANSCRIPTION FACTORS; CELL-FUNCTION; CANCER-CELLS; PROTEIN; DEGRADATION; IRF3; RECOGNITION	Host recognition of intracellular viral RNA and subsequent induction of cytokine signaling are tightly regulated at the cellular level and are a target for manipulation by viruses and therapeutics alike. Here, we characterize chromosome 6 ORF 106 (C6orf106) as an evolutionarily conserved inhibitor of the innate antiviral response. C6orf106 suppresses the synthesis of interferon (IFN)-/ and proinflammatory tumor necrosis factor (TNF) in response to the dsRNA mimic poly(I:C) and to Sendai virus infection. Unlike canonical inhibitors of antiviral signaling, C6orf106 blocks interferon-regulatory factor 3 (IRF3) and, to a lesser extent, NF-B activity without modulating their activation, nuclear translocation, cellular expression, or degradation. Instead, C6orf106 interacts with IRF3 and inhibits IRF3 recruitment to type I IFN promoter sequences while also reducing the nuclear levels of the coactivator proteins p300 and CREB-binding protein (CBP). In summary, we have defined C6orf106 as a negative regulator of antiviral immunity that blocks IRF3-dependent cytokine production via a noncanonical and poorly defined mechanism. This work presents intriguing implications for antiviral immunity, autoimmune disorders, and cancer.	[Ambrose, Rebecca L.; Bean, Andrew G. D.; Stewart, Cameron R.] Commonwealth Sci & Ind Res Org CSIRO Hlth & Biose, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Liu, Yu Chih; Adams, Timothy E.] CSIRO Mfg, Parkville, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Stewart, CR (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Hlth & Biose, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia.	Cameron.Stewart@csiro.au	Adams, Timothy E/I-6231-2012; Stewart, Cameron R/E-6823-2011; Rootes, Christina/H-4905-2013	Adams, Timothy E/0000-0003-3436-0066; Stewart, Cameron/0000-0002-3395-7859; Rootes, Christina/0000-0002-7448-8307	CSIRO; CSIRO Office of the Chief Executive postdoctoral fellowships	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Office of the Chief Executive postdoctoral fellowships	This work was supported by the CSIRO and CSIRO Office of the Chief Executive postdoctoral fellowships (to R. L. A. and Y. C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bae Y, 2010, FEBS LETT, V584, P4505, DOI 10.1016/j.febslet.2010.10.016; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Deffrasnes C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005478; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Ferrari R, 2014, CELL HOST MICROBE, V16, P663, DOI 10.1016/j.chom.2014.10.004; Francois S, 2016, J VIROL, V90, P8686, DOI 10.1128/JVI.00920-16; Gates LT, 2016, J IMMUNOL, V197, P923, DOI 10.4049/jimmunol.1502611; Gates-Tanzer LT, 2018, J BIOL CHEM, V293, P1745, DOI 10.1074/jbc.RA117.000541; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ito T, 2001, J IMMUNOL, V166, P2961, DOI 10.4049/jimmunol.166.5.2961; Jeong MJ, 2013, FEBS LETT, V587, P1373, DOI 10.1016/j.febslet.2013.03.010; Jiang GY, 2015, TUMOR BIOL, V36, P7881, DOI 10.1007/s13277-015-3500-5; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lei CQ, 2013, J BIOL CHEM, V288, P12596, DOI 10.1074/jbc.M112.444794; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Matsumoto M, 2011, REV MED VIROL, V21, P67, DOI 10.1002/rmv.680; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Monson EA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190597; Mulhern O, 2009, ADV EXP MED BIOL, V666, P49; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Oksayan S, 2012, J BIOL CHEM, V287, P28112, DOI 10.1074/jbc.M112.374694; Reimer T, 2008, J LEUKOCYTE BIOL, V83, P1249, DOI 10.1189/jlb.0607412; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Satterfield BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8483; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Song S, 2016, MOL CELL BIOL, V36, P1136, DOI 10.1128/MCB.00744-15; Suhara W, 2002, J BIOL CHEM, V277, P22304, DOI 10.1074/jbc.M200192200; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; Triantafilou K, 2012, J CELL SCI, V125, P4761, DOI 10.1242/jcs.103887; Wang L, 2000, P NATL ACAD SCI USA, V97, P430, DOI 10.1073/pnas.97.1.430; Wang P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004726; Wang SA, 2014, BBA-MOL CELL RES, V1843, P1135, DOI 10.1016/j.bbamcr.2014.02.001; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zagariya A, 1998, MOL CELL BIOL, V18, P2815, DOI 10.1128/MCB.18.5.2815; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang XP, 2015, TUMOR BIOL, V36, P5979, DOI 10.1007/s13277-015-3274-9; Zhao XJ, 2008, J IMMUNOL, V181, P3049, DOI 10.4049/jimmunol.181.5.3049	48	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10561	10573		10.1074/jbc.RA117.001491	http://dx.doi.org/10.1074/jbc.RA117.001491			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29802199	Green Published, hybrid			2022-12-28	WOS:000437828400016
J	Ro, SY; Ross, MO; Deng, YW; Batelu, S; Lawton, TJ; Hurley, JD; Stemmler, TL; Hoffman, BM; Rosenzweig, AC				Ro, Soo Y.; Ross, Matthew O.; Deng, Yue Wen; Batelu, Sharon; Lawton, Thomas J.; Hurley, Joseph D.; Stemmler, Timothy L.; Hoffman, Brian M.; Rosenzweig, Amy C.			From micelles to bicelles: Effect of the membrane on particulate methane monooxygenase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper monooxygenase; metalloenzyme; crystal structure; biofuel; biotechnology; protein-lipid interaction; membrane protein; bicelle; copper metalloenzyme; methane oxidation; methanotroph; particulate methane monooxygenase	CRYSTAL-STRUCTURE; METAL CENTERS; PROTEIN; OXIDATION; COPPER; LIPIDS; PURIFICATION; DETERGENTS; BACTERIA; COMPLEX	Particulate methane monooxygenase (pMMO) is a copper-dependent integral membrane metalloenzyme that converts methane to methanol in methanotrophic bacteria. Studies of isolated pMMO have been hindered by loss of enzymatic activity upon its removal from the native membrane. To characterize pMMO in a membrane-like environment, we reconstituted pMMOs from Methylococcus (Mcc.) capsulatus (Bath) and Methylomicrobium (Mm.) alcaliphilum 20Z into bicelles. Reconstitution into bicelles recovers methane oxidation activity lost upon detergent solubilization and purification without substantial alterations to copper content or copper electronic structure, as observed by electron paramagnetic resonance (EPR) spectroscopy. These findings suggest that loss of pMMO activity upon isolation is due to removal from the membranes rather than caused by loss of the catalytic copper ions. A 2.7 resolution crystal structure of pMMO from Mm. alcaliphilum 20Z reveals a mononuclear copper center in the PmoB subunit and indicates that the transmembrane PmoC subunit may be conformationally flexible. Finally, results from extended X-ray absorption fine structure (EXAFS) analysis of pMMO from Mm. alcaliphilum 20Z were consistent with the observed monocopper center in the PmoB subunit. These results underscore the importance of studying membrane proteins in a membrane-like environment and provide valuable insight into pMMO function.	[Ro, Soo Y.; Ross, Matthew O.; Deng, Yue Wen; Lawton, Thomas J.; Hurley, Joseph D.; Hoffman, Brian M.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Ro, Soo Y.; Ross, Matthew O.; Deng, Yue Wen; Lawton, Thomas J.; Hurley, Joseph D.; Hoffman, Brian M.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Batelu, Sharon; Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA	Northwestern University; Northwestern University; Wayne State University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.; Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	amyr@northwestern.edu		Rosenzweig, Amy/0000-0001-8472-4134; Deng, Yue Wen/0000-0003-3344-6837; Hurley, Joseph/0000-0002-3903-318X; Stemmler, Timothy/0000-0002-6298-088X	Department of Energy Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118035, R01GM111097, R01GM070473, T32GM008382, P41GM103393] Funding Source: NIH RePORTER	Department of Energy Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work used the Advanced Photon Source, a Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (grant 085P1000817). Data were collected at the LS-CAT beamline 21-ID-D. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the NIGMS, National Institutes of Health (including P41GM103393). We also thank Dr. Marina Kalyuzhnaya at San Diego State University for providing Mm. alcaliphilum 20Z cultures.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agah Sayeh, 2012, Methods Mol Biol, V914, P3, DOI 10.1007/978-1-62703-023-6_1; Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Blanchette CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11900; Cao LL, 2018, ANGEW CHEM INT EDIT, V57, P162, DOI 10.1002/anie.201708977; Chan SI, 2008, ACCOUNTS CHEM RES, V41, P969, DOI 10.1021/ar700277n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Cotelesage JJH, 2012, J INORG BIOCHEM, V115, P127, DOI 10.1016/j.jinorgbio.2012.06.019; Culpepper MA, 2014, J AM CHEM SOC, V136, P11767, DOI 10.1021/ja5053126; Czerski L, 2000, ANAL BIOCHEM, V284, P327, DOI 10.1006/abio.2000.4720; Durr UHN, 2012, CHEM REV, V112, P6054, DOI 10.1021/cr300061w; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fei Q, 2014, BIOTECHNOL ADV, V32, P596, DOI 10.1016/j.biotechadv.2014.03.011; Frandsen KEH, 2016, IUCRJ, V3, P448, DOI 10.1107/S2052252516014147; Frey L, 2017, ANGEW CHEM INT EDIT, V56, P380, DOI 10.1002/anie.201608246; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; George G. N., 2001, EXAFSPAK; Gruss F, 2015, METHODS MOL BIOL, V1329, P259, DOI 10.1007/978-1-4939-2871-2_20; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Jiang H, 2010, BIOCHEM ENG J, V49, P277, DOI 10.1016/j.bej.2010.01.003; Kaluzhnaya M, 2001, SYST APPL MICROBIOL, V24, P166, DOI 10.1078/0723-2020-00028; Kalyuzhnaya MG, 2015, METAB ENG, V29, P142, DOI 10.1016/j.ymben.2015.03.010; Khmelenina VN, 1997, CURR MICROBIOL, V35, P257, DOI 10.1007/s002849900249; Lawton TJ, 2016, J AM CHEM SOC, V138, P9327, DOI 10.1021/jacs.6b04568; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; LEE MH, 1993, PROTEIN SCI, V2, P1042, DOI 10.1002/pro.5560020617; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Liew EF, 2014, MICROBIOL-SGM, V160, P1267, DOI 10.1099/mic.0.078584-0; MAKULA RA, 1978, J BACTERIOL, V134, P771, DOI 10.1128/JB.134.3.771-777.1978; Ojala DS, 2011, METHOD ENZYMOL, P99, DOI 10.1016/B978-0-12-386905-0.00007-3; Orwick-Rydmark Marcella, 2016, Curr Protoc Protein Sci, V84, DOI 10.1002/0471140864.ps0408s84; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Puri AW, 2015, APPL ENVIRON MICROB, V81, P1766, DOI 10.1128/AEM.03795-14; RIGGSGELASCO PJ, 1995, COORDIN CHEM REV, V144, P245, DOI 10.1016/0010-8545(95)01144-E; Ross MO, 2017, J BIOL INORG CHEM, V22, P307, DOI 10.1007/s00775-016-1419-y; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shen HH, 2013, INT J MOL SCI, V14, P1589, DOI 10.3390/ijms14011589; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Sirajuddin S, 2015, BIOCHEMISTRY-US, V54, P2283, DOI 10.1021/acs.biochem.5b00198; Sirajuddin S, 2014, J BIOL CHEM, V289, P21782, DOI 10.1074/jbc.M114.581363; Smith SM, 2011, BIOCHEMISTRY-US, V50, P10231, DOI 10.1021/bi200801z; Stemmler TL, 1997, BIOCHEMISTRY-US, V36, P9847, DOI 10.1021/bi9702795; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; United States Environmental Protection Agency, 2017, 430P17001 EPA US ENV; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Wang VCC, 2017, CHEM REV, V117, P8574, DOI 10.1021/acs.chemrev.6b00624; Yang ZR, 2014, PROTEIN SCI, V23, P769, DOI 10.1002/pro.2460	55	31	31	4	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10457	10465		10.1074/jbc.RA118.003348	http://dx.doi.org/10.1074/jbc.RA118.003348			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29739854	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000437828400007
J	Sharma, S; Oot, RA; Wilkens, S				Sharma, Stuti; Oot, Rebecca A.; Wilkens, Stephan			MgATP hydrolysis destabilizes the interaction between subunit H and yeast V-1-ATPase, highlighting H's role in V-ATPase regulation by reversible disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; protein assembly; protein conformation; biophysics; isothermal titration calorimetry (ITC); biolayer interferometry; MgADP inhibition; protein-protein interaction; reversible disassembly; V-1-ATPase	VACUOLAR ATPASE; SACCHAROMYCES-CEREVISIAE; AFFINITY PURIFICATION; STRUCTURAL FEATURES; ROTATION MECHANISM; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; PROTON PUMP; CELLS; MOTOR	Vacuolar H+-ATPases (V-ATPases; V1Vo-ATPases) are rotary-motor proton pumps that acidify intracellular compartments and, in some tissues, the extracellular space. V-ATPase is regulated by reversible disassembly into autoinhibited V-1-ATPase and V-o proton channel sectors. An important player in V-ATPase regulation is subunit H, which binds at the interface of V-1 and V-o. H is required for MgATPase activity in holo-V-ATPase but also for stabilizing the MgADP-inhibited state in membrane-detached V-1. However, how H fulfills these two functions is poorly understood. To characterize the H-V-1 interaction and its role in reversible disassembly, we determined binding affinities of full-length H and its N-terminal domain (H-NT) for an isolated heterodimer of subunits E and G (EG), the N-terminal domain of subunit a (a(NT)), and V-1 lacking subunit H (V1H). Using isothermal titration calorimetry (ITC) and biolayer interferometry (BLI), we show that H-NT binds EG with moderate affinity, that full-length H binds a(NT) weakly, and that both H and H-NT bind V1H with high affinity. We also found that only one molecule of H-NT binds V1H with high affinity, suggesting conformational asymmetry of the three EG heterodimers in V1H. Moreover, MgATP hydrolysis-driven conformational changes in V-1 destabilized the interaction of H or H-NT with V1H, suggesting an interplay between MgADP inhibition and subunit H. Our observation that H binding is affected by MgATP hydrolysis in V-1 points to H's role in the mechanism of reversible disassembly.	[Sharma, Stuti; Oot, Rebecca A.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM058600]; SUNY Upstate Medical University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SUNY Upstate Medical University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM058600 and a Bridge Grant from SUNY Upstate Medical University (to S.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Brown D, 1997, J EXP BIOL, V200, P257; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Futai M, 2012, BBA-BIOENERGETICS, V1817, P1711, DOI 10.1016/j.bbabio.2012.03.015; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; HO MN, 1993, J BIOL CHEM, V268, P18286; Isaka Y, 2017, BIOPHYS J, V112, P911, DOI 10.1016/j.bpj.2017.01.029; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kishikawa J, 2014, J BIOL CHEM, V289, P403, DOI 10.1074/jbc.M113.523498; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; MacLeod KJ, 1999, J BIOL CHEM, V274, P32869, DOI 10.1074/jbc.274.46.32869; Mazhab-Jafari MT, 2016, NATURE, V539, P118, DOI 10.1038/nature19828; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Oot RA, 2017, PROTEIN SCI, V26, P896, DOI 10.1002/pro.3147; Oot RA, 2016, EMBO J, V35, P1694, DOI 10.15252/embj.201593447; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Rawson S, 2015, STRUCTURE, V23, P461, DOI 10.1016/j.str.2014.12.016; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sharma S, 2017, PROTEIN SCI, V26, P1070, DOI 10.1002/pro.3143; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Stam NJ, 2017, J BIOL CHEM, V292, P1749, DOI 10.1074/jbc.M116.766790; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; ZHANG JM, 1994, J BIOL CHEM, V269, P23518; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365; Zhou M, 2014, NAT CHEM, V6, P208, DOI [10.1038/nchem.1868, 10.1038/NCHEM.1868]	56	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10718	10730		10.1074/jbc.RA118.002951	http://dx.doi.org/10.1074/jbc.RA118.002951			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29754144	Green Published, hybrid			2022-12-28	WOS:000437828400027
J	Sung, P				Sung, Patrick			Introduction to the Thematic Minireview Series: DNA double-strand break repair and pathway choice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						DNA; DNA replication; chromosomes; cancer; chromosome rearrangements; DNA crosslink; DNA double-strand break; DNA end resection; DNA replication fork	MECHANISMS	Environmental agents and reactive metabolites induce myriad chromosomal lesions that challenge the integrity of our genome. In particular, the DNA double-strand break (DSB) has the highest potential to cause the types of chromosome aberrations and rearrangements found in transformed and cancer cells. Several conserved pathways of DSB repair exist in eukaryotes, and these have been the subject of intense studies in recent years. In this Thematic Minireview Series, four leading research groups review recent progress in deciphering DSB repair mechanisms and the intricate regulatory network that helps determine the preferential engagement of one pathway over others.	[Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Sung, P (corresponding author), Yale Univ, Sch Med, C130A Sterling Hall Med,333 Cedar St, New Haven, CT 06520 USA.	patrick.sung@yale.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [PO1 CA092584, RO1 ES007061, RO1 CA220123]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA220123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Program Project Grant PO1 CA092584 and Research Grants RO1 ES007061 and RO1 CA220123 from the National Institutes of Health. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Feng WR, 2017, COLD SH Q B, V82, P329, DOI 10.1101/sqb.2017.82.035006; Gupta R, 2018, CELL, V173, P972, DOI 10.1016/j.cell.2018.03.050; Her J, 2018, J BIOL CHEM, V293, P10502, DOI 10.1074/jbc.TM118.000371; Lieber MR, 2016, NAT REV CANCER, V16, P387, DOI 10.1038/nrc.2016.40; Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374; Sallmyr A, 2018, J BIOL CHEM, V293, P10536, DOI 10.1074/jbc.TM117.000375; Willis NA, 2015, TRENDS CANCER, V1, P217, DOI 10.1016/j.trecan.2015.10.007; Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372	8	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10500	10501		10.1074/jbc.TM118.003212	http://dx.doi.org/10.1074/jbc.TM118.003212			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29853635	Green Published, hybrid			2022-12-28	WOS:000437828400010
J	Munch, J; Billig, G; Hubner, CA; Leinders-Zufall, T; Zufall, F; Jentsch, TJ				Muench, Jonas; Billig, Gwendolyn; Huebner, Christian A.; Leinders-Zufall, Trese; Zufall, Frank; Jentsch, Thomas J.			Ca2+-activated Cl- currents in the murine vomeronasal organ enhance neuronal spiking but are dispensable for male-male aggression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; signal transduction; electrophysiology; patch clamp; neurobiology; TMEM16A; TMEM16B	ACTIVATED CHLORIDE CHANNELS; INTERSTITIAL-CELLS; EXPRESSION; TMEM16A; PROTEIN; RECEPTOR; BEHAVIOR; MICE; GENE; TRANSLATION	Ca2+-activated Cl- currents have been observed in many physiological processes, including sensory transduction in mammalian olfaction. The olfactory vomeronasal (or Jacobson's) organ (VNO) detects molecular cues originating from animals of the same species or from predators. It then triggers innate behaviors such as aggression, mating, or flight. In the VNO, Ca2+-activated Cl- channels (CaCCs) are thought to amplify the initial pheromone-evoked receptor potential by mediating a depolarizing Cl- efflux. Here, we confirmed the co-localization of the Ca2+-activated Cl- channels anoctamin 1 (Ano1, also called TMEM16A) and Ano2 (TMEM16B) in microvilli of apically and basally located vomeronasal sensory neurons (VSNs) and their absence in supporting cells of the VNO. Both channels were expressed as functional isoforms capable of giving rise to Ca2+-activated Cl- currents. Although these currents persisted in the VNOs of mice lacking Ano2, they were undetectable in olfactory neuron-specific Ano1 knockout mice irrespective of the presence of Ano2. The loss of Ca2+-activated Cl- currents resulted in diminished spontaneous and drastically reduced pheromone-evoked spiking of VSNs. Although this indicated an important role of anoctamin channels in VNO signal amplification, the lack of this amplification did not alter VNO-dependent male-male territorial aggression in olfactory Ano1/Ano2 double knockout mice. We conclude that Ano1 mediates the bulk of Ca2+-activated Cl- currents in the VNO and that Ano2 plays only a minor role. Furthermore, vomeronasal signal amplification by CaCCs appears to be dispensable for the detection of male-specific pheromones and for near-normal aggressive behavior in mice.	[Muench, Jonas; Billig, Gwendolyn; Jentsch, Thomas J.] Leibniz Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany; [Muench, Jonas; Billig, Gwendolyn; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Muench, Jonas] Free Univ Berlin, Grad Program, D-14195 Berlin, Germany; [Huebner, Christian A.] Univ Klinikum Jena, Inst Humangenet, D-07747 Jena, Germany; [Leinders-Zufall, Trese; Zufall, Frank] Univ Saarland, Ctr Integrat Physiol & Mol Med, D-66421 Homburg, Germany; [Jentsch, Thomas J.] Charite Univ Med Berlin, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Friedrich Schiller University of Jena; Saarland University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Leinders-Zufall, Trese/S-3664-2019; Billig, Gwendolyn M/A-1297-2012; Leinders-Zufall, Trese/B-4103-2009; Zufall, Frank/AAE-5290-2021	Leinders-Zufall, Trese/0000-0002-0678-362X; Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [JE164/10-1, SFB 894]; NeuroCure Cluster of Excellence grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure Cluster of Excellence grant	This work was supported in part by Deutsche Forschungsgemeinschaft Grants JE164/10-1 (to T. J. J.) and SFB 894 (to F. Z.) and a NeuroCure Cluster of Excellence grant (to T. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Amjad A, 2015, J GEN PHYSIOL, V145, P285, DOI 10.1085/jgp.201411348; BEAN NJ, 1982, PHYSIOL BEHAV, V29, P433, DOI 10.1016/0031-9384(82)90262-1; BELLRINGER JF, 1980, J REPROD FERTIL, V59, P223, DOI 10.1530/jrf.0.0590223; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chamero P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09638-8; Chamero P, 2012, TRENDS NEUROSCI, V35, P597, DOI 10.1016/j.tins.2012.04.011; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Cherkashin AP, 2016, PFLUG ARCH EUR J PHY, V468, P305, DOI 10.1007/s00424-015-1751-z; CLANCY AN, 1984, J NEUROSCI, V4, P2222; Connelly T, 2013, J NEUROPHYSIOL, V110, P55, DOI 10.1152/jn.00910.2012; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Davis AJ, 2010, AM J PHYSIOL-CELL PH, V299, pC948, DOI 10.1152/ajpcell.00018.2010; Dibattista M, 2017, CHANNELS, V11, P399, DOI 10.1080/19336950.2017.1307489; Dibattista M, 2012, J GEN PHYSIOL, V140, P3, DOI 10.1085/jgp.201210780; Ferrera L, 2011, BBA-BIOMEMBRANES, V1808, P2214, DOI 10.1016/j.bbamem.2011.05.017; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Ha GE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13791; He J, 2010, J NEUROSCI, V30, P7473, DOI 10.1523/JNEUROSCI.0825-10.2010; Heinze C, 2014, J CLIN INVEST, V124, P675, DOI 10.1172/JCI70025; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Ishii T, 2011, MOL CELL NEUROSCI, V46, P397, DOI 10.1016/j.mcn.2010.11.002; Kelliher KR, 2006, EUR J NEUROSCI, V23, P3385, DOI 10.1111/j.1460-9568.2006.04866.x; Kim S, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0230-y; Kim S, 2012, NAT NEUROSCI, V15, P1236, DOI 10.1038/nn.3173; Kim S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1368; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 2018, CELL CHEM BIOL, V25, P215, DOI 10.1016/j.chembiol.2017.11.008; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; MARUNIAK JA, 1986, PHYSIOL BEHAV, V37, P655, DOI 10.1016/0031-9384(86)90300-8; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; NEUREITHER F, 2017, PHYSL REP, V5, DOI DOI 10.14814/PHY2.13373; Norlin EM, 2003, CURR BIOL, V13, P1214, DOI 10.1016/S0960-9822(03)00452-4; Pietra G, 2016, J GEN PHYSIOL, V148, P293, DOI 10.1085/jgp.201611622; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Reisert J, 2010, J GEN PHYSIOL, V136, P529, DOI 10.1085/jgp.201010528; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schutze S, 2016, J BIOL CHEM, V291, P5566, DOI 10.1074/jbc.M115.681098; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; Sondo E, 2014, BBA-BIOMEMBRANES, V1838, P89, DOI 10.1016/j.bbamem.2013.08.010; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Ubby I, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-75; Ukhanov K, 2007, J NEUROPHYSIOL, V98, P2357, DOI 10.1152/jn.00642.2007; Untiet V, 2016, CHEM SENSES, V41, P22, DOI 10.1093/chemse/bjw077; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang C, 2010, J GEN PHYSIOL, V135, P3, DOI 10.1085/jgp.200910265; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142160; Zufall F, 2005, PFLUG ARCH EUR J PHY, V451, P61, DOI 10.1007/s00424-005-1432-4	64	8	8	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10392	10403		10.1074/jbc.RA118.003153	http://dx.doi.org/10.1074/jbc.RA118.003153			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769308	Green Published, hybrid			2022-12-28	WOS:000437096700036
J	Gurzau, AD; Chen, KL; Xue, SF; Dai, WW; Lucet, IS; Ly, TTN; Reversade, B; Blewitt, ME; Murphy, JM				Gurzau, Alexandra D.; Chen, Kelan; Xue, Shifeng; Dai, Weiwen; Lucet, Isabelle S.; Thanh Thao Nguyen Ly; Reversade, Bruno; Blewitt, Marnie E.; Murphy, James M.			FSHD2-and BAMS-associated mutations confer opposing effects on SMCHD1 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; small-angle X-ray scattering (SAXS); epigenetics; Xenopus; muscular dystrophy; craniofacial development; SMC; hinge domain	FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; ARHINIA MICROPHTHALMIA SYNDROME; EPIGENETIC REGULATOR SMCHD1; INACTIVE X-CHROMOSOME; DISEASE SEVERITY; GENE-EXPRESSION; HSP90 CHAPERONE; HINGE DOMAIN; ARCHITECTURE; BINDING	Structural maintenance of chromosomes flexible hinge domain-containing 1 (Smchd1) plays important roles in epigenetic silencing and normal mammalian development. Recently, heterozygous mutations in SMCHD1 have been reported in two disparate disorders: facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS). FSHD2-associated mutations lead to loss of function; however, whether BAMS is associated with loss- or gain-of-function mutations in SMCHD1 is unclear. Here, we have assessed the effect of SMCHD1 missense mutations from FSHD2 and BAMS patients on ATP hydrolysis activity and protein conformation and the effect of BAMS mutations on craniofacial development in a Xenopus model. These data demonstrated that FSHD2 mutations only result in decreased ATP hydrolysis, whereas many BAMS mutations can result in elevated ATPase activity and decreased eye size in Xenopus. Interestingly, a mutation reported in both an FSHD2 patient and a BAMS patient results in increased ATPase activity and a smaller Xenopus eye size. Mutations in the extended ATPase domain increased catalytic activity, suggesting critical regulatory intramolecular interactions and the possibility of targeting this region therapeutically to boost SMCHD1's activity to counter FSHD.	[Gurzau, Alexandra D.; Chen, Kelan; Dai, Weiwen; Lucet, Isabelle S.; Blewitt, Marnie E.; Murphy, James M.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Gurzau, Alexandra D.; Chen, Kelan; Lucet, Isabelle S.; Blewitt, Marnie E.; Murphy, James M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Blewitt, Marnie E.] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Xue, Shifeng; Thanh Thao Nguyen Ly; Reversade, Bruno] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Xue, Shifeng; Thanh Thao Nguyen Ly; Reversade, Bruno] ASTAR, Human Genet & Embryol Lab, Inst Med Biol, Singapore, Singapore; [Reversade, Bruno] Koc Univ, Sch Med KUSoM, Dept Med Genet, TR-34450 Sariyer, Turkey; [Reversade, Bruno] Natl Univ Singapore, Sch Med, Dept Paediat, Singapore, Singapore; [Reversade, Bruno] Acad Med Ctr, Amsterdam Reprod & Dev, NL-1105 AZ Amsterdam, Netherlands; [Reversade, Bruno] Vrije Univ Amsterdam, Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Koc University; National University of Singapore; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Blewitt, ME; Murphy, JM (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	blewitt@wehi.edu.au; jamesm@wehi.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949; Blewitt, Marnie/0000-0002-2984-1474; Gurzau, Alexandra/0000-0001-8664-0698; Xue, Shifeng/0000-0002-4668-5952; Chen, Kelan/0000-0003-1973-5405; REVERSADE, Bruno/0000-0002-4070-7997	Australian Research Training Program scholarship; Cancer Council Victoria fellowship; Bellberry-Viertel Senior Medical Research Fellowship; Australian National Health and Medical Research Council Fellowship [1105754, 1098290]; A*STAR BMRC YIG; NMRC YIRG; BMRC, A*STAR, Singapore; Victorian State Government Operational Infrastructure Support; Australian National Health and Medical Research Council IRIISS Grant [9000433]; Australian Cancer Research Foundation	Australian Research Training Program scholarship; Cancer Council Victoria fellowship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Bellberry-Viertel Senior Medical Research Fellowship; Australian National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia); A*STAR BMRC YIG(Agency for Science Technology & Research (A*STAR)); NMRC YIRG; BMRC, A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Victorian State Government Operational Infrastructure Support; Australian National Health and Medical Research Council IRIISS Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation	This study was supported by an Australian Research Training Program scholarship (to A. D. G.), a Cancer Council Victoria fellowship (to K. C.), the Bellberry-Viertel Senior Medical Research Fellowship (to M. E. B.), Australian National Health and Medical Research Council Fellowship 1105754 (to J. M. M.) and Grant 1098290 (to M. E. B. and J. M. M.), A*STAR BMRC YIG (to S. X.), NMRC YIRG (to S. X.), and a Strategic Positioning Fund on Genetic Orphan Diseases from the BMRC, A*STAR, Singapore (to B. R.). Additional support was provided by Victorian State Government Operational Infrastructure Support, Australian National Health and Medical Research Council IRIISS Grant 9000433, and the Australian Cancer Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Achilleos A, 2015, CURR TOP DEV BIOL, V115, P413, DOI 10.1016/bs.ctdb.2015.07.011; Babon Jeffrey J, 2013, Methods Mol Biol, V967, P39, DOI 10.1007/978-1-62703-242-1_3; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Brideau NJ, 2015, MOL CELL BIOL, V35, P4053, DOI 10.1128/MCB.00432-15; Chen KL, 2016, BIOCHEM J, V473, P1733, DOI 10.1042/BCJ20160189; Chen K, 2016, BIOCHEM J, V473, P733, DOI 10.1042/BJ20151049; Chen KL, 2015, P NATL ACAD SCI USA, V112, pE3535, DOI 10.1073/pnas.1504232112; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; Diebold-Durand ML, 2017, MOL CELL, V67, P334, DOI 10.1016/j.molcel.2017.06.010; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Ganji M, 2018, SCIENCE, V360, P102, DOI 10.1126/science.aar7831; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Gordon CT, 2017, NAT GENET, V49, P249, DOI 10.1038/ng.3765; Graham JM, 2006, AM J MED GENET A, V140A, P189, DOI 10.1002/ajmg.a.31039; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Jansz N, 2017, TRENDS GENET, V33, P233, DOI 10.1016/j.tig.2017.01.007; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Larsen M, 2015, EUR J HUM GENET, V23, P808, DOI 10.1038/ejhg.2014.191; Leidenroth A, 2012, EUR J HUM GENET, V20, P999, DOI 10.1038/ejhg.2012.42; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Minnen A, 2016, CELL REP, V14, P2003, DOI 10.1016/j.celrep.2016.01.066; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Piper PW, 2003, EUR J BIOCHEM, V270, P4689, DOI 10.1046/j.1432-1033.2003.03866.x; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Sacconi S, 2013, AM J HUM GENET, V93, P744, DOI 10.1016/j.ajhg.2013.08.004; Shaw ND, 2017, NAT GENET, V49, P238, DOI 10.1038/ng.3743; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tsutsumi S, 2012, P NATL ACAD SCI USA, V109, P2937, DOI 10.1073/pnas.1114414109; van der Maarel SM, 2005, AM J HUM GENET, V76, P375, DOI 10.1086/428361; Yao ZZ, 2014, HUM MOL GENET, V23, P5342, DOI 10.1093/hmg/ddu251; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	44	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9841	9853		10.1074/jbc.RA118.003104	http://dx.doi.org/10.1074/jbc.RA118.003104			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29748383	Green Published, hybrid			2022-12-28	WOS:000436102300026
J	Kasetti, RB; Maddineni, P; Patel, PD; Searby, C; Sheffield, VC; Zode, GS				Kasetti, Ramesh B.; Maddineni, Prabhavathi; Patel, Pinkal D.; Searby, Charles; Sheffield, Val C.; Zode, Gulab S.			Transforming growth factor 2 (TGF2) signaling plays a key role in glucocorticoid-induced ocular hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); glucocorticoid; growth factor; SMAD transcription factor; extracellular matrix (ECM) protein; glucocorticoids; ocular hypertension; steroid-induced glaucoma; trabecular meshwork; transforming growth factor 2 (TGF2)	TRABECULAR MESHWORK CELLS; EXTRACELLULAR-MATRIX PROTEINS; ENDOPLASMIC-RETICULUM STRESS; PLASMINOGEN-ACTIVATOR INHIBITOR-1; OPEN-ANGLE GLAUCOMA; FACTOR-BETA; INTRAOCULAR-PRESSURE; AQUEOUS-HUMOR; TISSUE TRANSGLUTAMINASE; ULTRASTRUCTURAL-CHANGES	Elevation of intraocular pressure (IOP) is a serious adverse effect of glucocorticoid (GC) therapy. Increased extracellular matrix (ECM) accumulation and endoplasmic reticulum (ER) stress in the trabecular meshwork (TM) is associated with GC-induced IOP elevation. However, the molecular mechanisms by which GCs induce ECM accumulation and ER stress in the TM have not been determined. Here, we show that a potent GC, dexamethasone (Dex), activates transforming growth factor (TGF) signaling, leading to GC-induced ECM accumulation, ER stress, and IOP elevation. Dex increased both the precursor and bioactive forms of TGF2 in conditioned medium and activated TGF-induced SMAD signaling in primary human TM cells. Dex also activated TGF2 in the aqueous humor and TM of a mouse model of Dex-induced ocular hypertension. We further show that Smad3(-/-) mice are protected from Dex-induced ocular hypertension, ER stress, and ECM accumulation. Moreover, treating WT mice with a selective TGF receptor kinase I inhibitor, LY364947, significantly decreased Dex-induced ocular hypertension. Of note, knockdown of the ER stress-induced activating transcription factor 4 (ATF4), or C/EBP homologous protein (CHOP), completely prevented Dex-induced TGF2 activation and ECM accumulation in TM cells. These observations suggested that chronic ER stress promotes Dex-induced ocular hypertension via TGF signaling. Our results indicate that TGF2 signaling plays a central role in GC-induced ocular hypertension and provides therapeutic targets for GC-induced ocular hypertension.	[Kasetti, Ramesh B.; Maddineni, Prabhavathi; Patel, Pinkal D.; Zode, Gulab S.] Univ North Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Kasetti, Ramesh B.; Maddineni, Prabhavathi; Patel, Pinkal D.; Zode, Gulab S.] Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, CBH 413,3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA; [Searby, Charles; Sheffield, Val C.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center; University of Iowa	Zode, GS (corresponding author), Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, CBH 413,3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	gulab.zode@unthsc.edu	Patel, Pinkal D./GQP-2308-2022	Patel, Pinkal D./0000-0002-7704-4381; KASETTI, RAMESH/0000-0001-7874-3988; Sheffield, Val/0000-0002-6282-0835; Maddineni, Prabhavathi/0000-0002-6928-254X	National Institutes of Health from the NEI [EY022077, EY026177, EY024259]; North Texas Eye Research Institute in Fort Worth, TX; NATIONAL EYE INSTITUTE [R01EY028616, R01EY024259, R01EY026177, K99EY022077, R00EY022077] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; North Texas Eye Research Institute in Fort Worth, TX; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY022077, EY026177, and EY024259 from the NEI and by funding from the North Texas Eye Research Institute in Fort Worth, TX. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal P, 2015, MOL VIS, V21, P612; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; ARMALY MF, 1965, FED PROC, V24, P1274; Bolkenius U, 2004, BIOCHEM BIOPH RES CO, V325, P1264, DOI 10.1016/j.bbrc.2004.10.164; Bollinger KE, 2012, MOL VIS, V18, P2001; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Clark AF, 2005, CELL MOTIL CYTOSKEL, V60, P83, DOI 10.1002/cm.20049; Clark AF, 2001, INVEST OPHTH VIS SCI, V42, P1769; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; Dickerson JE, 1998, EXP EYE RES, V66, P731, DOI 10.1006/exer.1997.0470; El-Shabrawi Y, 2000, EYE, V14, P375, DOI 10.1038/eye.2000.92; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Flugel-Koch C, 2004, EXP EYE RES, V79, P649, DOI 10.1016/j.exer.2004.07.005; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Haddadin RI, 2012, INVEST OPHTH VIS SCI, V53, P6708, DOI 10.1167/iovs.11-9013; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Jain A, 2014, J OCUL PHARMACOL TH, V30, P121, DOI 10.1089/jop.2013.0239; Johnson D, 1997, ARCH OPHTHALMOL-CHIC, V115, P375, DOI 10.1001/archopht.1997.01100150377011; Jones R, 2006, CURR OPIN OPHTHALMOL, V17, P163; Kasetti RB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14938-0; Kasetti RB, 2016, INVEST OPHTH VIS SCI, V57, P6058, DOI 10.1167/iovs.16-19610; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Kimura H, 2011, CLIN EXP NEPHROL, V15, P34, DOI 10.1007/s10157-010-0351-7; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; LUTJENDRECOLL E, 1973, INVEST OPHTH VISUAL, V12, P280; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mao WM, 2011, INVEST OPHTH VIS SCI, V52, P8068, DOI 10.1167/iovs.11-8133; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McDowell CM, 2013, EXP EYE RES, V116, P419, DOI 10.1016/j.exer.2013.10.017; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Overby DR, 2015, EXP EYE RES, V141, P15, DOI 10.1016/j.exer.2015.06.002; Overby DR, 2014, INVEST OPHTH VIS SCI, V55, P4922, DOI 10.1167/iovs.14-14429; Pan XY, 2015, MOL CELL ENDOCRINOL, V407, P37, DOI 10.1016/j.mce.2015.03.005; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398; Patel GC, 2017, AM J PATHOL, V187, P713, DOI 10.1016/j.ajpath.2016.12.003; Peters JC, 2015, INVEST OPHTH VIS SCI, V56, P3860, DOI 10.1167/iovs.14-16220; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROHEN JW, 1973, EXP EYE RES, V17, P19, DOI 10.1016/0014-4835(73)90164-4; ROSENTHAL J, 1980, J AM OPTOM ASSOC, V51, P1017; SAMPLES JR, 1993, INVEST OPHTH VIS SCI, V34, P3386; Schwartze JT, 2014, J BIOL CHEM, V289, P3262, DOI 10.1074/jbc.M113.541052; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5251, DOI 10.1167/iovs.11-7587; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; SNYDER RW, 1993, EXP EYE RES, V57, P461, DOI 10.1006/exer.1993.1148; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Stamer WD, 2017, EXP EYE RES, V158, P112, DOI 10.1016/j.exer.2016.07.009; STEELY HT, 1992, INVEST OPHTH VIS SCI, V33, P2242; Tanjore H, 2013, BBA-MOL BASIS DIS, V1832, P940, DOI 10.1016/j.bbadis.2012.11.011; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tovar-Vidales T, 2016, EXP EYE RES, V147, P156, DOI 10.1016/j.exer.2016.05.004; Tovar-Vidales T, 2013, INVEST OPHTH VIS SCI, V54, P4741, DOI 10.1167/iovs.13-12203; Tovar-Vidales T, 2011, EXP EYE RES, V93, P442, DOI 10.1016/j.exer.2011.06.011; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Wang WH, 2005, INVEST OPHTH VIS SCI, V46, P4617, DOI 10.1167/iovs.05-0781; Welge-Lussen U, 2000, INVEST OPHTH VIS SCI, V41, P2229; Wen FQ, 2003, INFLAMMATION, V27, P9, DOI 10.1023/A:1022683010976; Wickert Lucia, 2007, Comp Hepatol, V6, P5; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; YUN AJ, 1989, INVEST OPHTH VIS SCI, V30, P2012; Zhang XY, 2005, INVEST OPHTH VIS SCI, V46, P4607, DOI 10.1167/iovs.05-0571; Zhou LL, 1998, INT J MOL MED, V1, P339; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Zimmerman KA, 2013, J BIOL CHEM, V288, P14584, DOI 10.1074/jbc.M112.447243; Zode GS, 2014, J CLIN INVEST, V124, P1956, DOI 10.1172/JCI69774	70	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9854	9868		10.1074/jbc.RA118.002540	http://dx.doi.org/10.1074/jbc.RA118.002540			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743238	Green Published, hybrid			2022-12-28	WOS:000436102300027
J	Ge, JF; Burnier, L; Adamopoulou, M; Kwa, MQ; Schaks, M; Rottner, K; Brakebusch, C				Ge, Jianfeng; Burnier, Laurent; Adamopoulou, Maria; Kwa, Mei Qi; Schaks, Matthias; Rottner, Klemens; Brakebusch, Cord			RhoA, Rac1, and Cdc42 differentially regulate SMA and collagen I expression in mesenchymal stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arp2; 3 complex; cell differentiation; cell signaling; cytoskeleton; GTPase; molecular cell biology; p38; Rac (Rac GTPase); SMAD transcription factor; stem cells; mesenchymal stem cell; MRTFa; myofibroblast; Rho GTPase; TGF; SMA	C-JUN; MYOFIBROBLAST; FIBROSIS; GTPASES; INDUCTION; BINDING	Mesenchymal stem cells (MSC) are suggested to be important progenitors of myofibroblasts in fibrosis. To understand the role of Rho GTPase signaling in TGF-induced myofibroblast differentiation of MSC, we generated a novel MSC line and its descendants lacking functional Rho GTPases and Rho GTPase signaling components. Unexpectedly, our data revealed that Rho GTPase signaling is required for TGF-induced expression of -smooth muscle actin (SMA) but not of collagen I 1 (col1a1). Whereas loss of RhoA and Cdc42 reduced SMA expression, ablation of the Rac1 gene had the opposite effect. Although actin polymerization and MRTFa were crucial for TGF-induced SMA expression, neither Arp2/3-dependent actin polymerization nor cofilin-dependent severing and depolymerization of F-actin were required. Instead, F-actin levels were dependent on cell contraction, and TGF-induced actin polymerization correlated with increased cell contraction mediated by RhoA and Cdc42. Finally, we observed impaired collagen I secretion in MSC lacking RhoA or Cdc42. These data give novel molecular insights into the role of Rho GTPases in TGF signaling and have implications for our understanding of MSC function in fibrosis.	[Ge, Jianfeng; Burnier, Laurent; Adamopoulou, Maria; Kwa, Mei Qi; Brakebusch, Cord] Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark; [Schaks, Matthias; Rottner, Klemens] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Spielmannstr 8, D-38106 Braunschweig, Germany; [Schaks, Matthias; Rottner, Klemens] Helmholtz Ctr Infect Res, Dept Cell Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany	University of Copenhagen; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Brakebusch, C (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	cord.brakebusch@bric.ku.dk	Burnier, Laurent P/E-5807-2011; Rottner, Klemens/AAE-5030-2020	Burnier, Laurent P/0000-0001-7767-0334; Kwa, Mei Qi/0000-0001-8890-3391; Brakebusch, Cord/0000-0002-9342-1634; Rottner, Klemens/0000-0003-4244-4198	Novo Nordisk Foundation; Deutsche Forschungsgemeinschaft [GRK2223/1]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Novo Nordisk Foundation (to L. B.) and Grant GRK2223/1 from the Deutsche Forschungsgemeinschaft (to K. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Desai VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086865; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009; Kanellos G, 2016, J CELL SCI, V129, P3211, DOI 10.1242/jcs.187849; Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111; Knipe RS, 2015, PHARMACOL REV, V67, P103, DOI 10.1124/pr.114.009381; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Lengfeld J, 2012, MOL BIOL CELL, V23, P1955, DOI 10.1091/mbc.E11-06-0531; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Luchsinger LL, 2011, J BIOL CHEM, V286, P44116, DOI 10.1074/jbc.M111.276931; Ma FY, 2007, J AM SOC NEPHROL, V18, P472, DOI 10.1681/ASN.2006060604; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Nanthakumar CB, 2015, NAT REV DRUG DISCOV, V14, P693, DOI 10.1038/nrd4592; Ni JX, 2013, FREE RADICAL BIO MED, V61, P26, DOI 10.1016/j.freeradbiomed.2013.03.012; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rosenbloom J, 2017, METHODS MOL BIOL, V1627, P1, DOI 10.1007/978-1-4939-7113-8_1; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Tsochatzis EA, 2014, HEPATOLOGY, V60, P832, DOI 10.1002/hep.27296; Tsuchida K, 2003, KIDNEY INT, V63, P2000, DOI 10.1046/j.1523-1755.2003.00009.x; Unbekandt M, 2014, J MOL MED, V92, P217, DOI 10.1007/s00109-014-1133-6; Verrecchia F, 2001, ONCOGENE, V20, P2205, DOI 10.1038/sj.onc.1204347; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xu SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126015; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	36	14	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9358	9369		10.1074/jbc.RA117.001113	http://dx.doi.org/10.1074/jbc.RA117.001113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700112	Green Published, hybrid			2022-12-28	WOS:000435441400021
J	Nagarajan, D; Sukumaran, S; Deka, G; Krishnamurthy, K; Atreya, HS; Chandra, N				Nagarajan, Deepesh; Sukumaran, Sujeesh; Deka, Geeta; Krishnamurthy, Kiran; Atreya, Hanudatta S.; Chandra, Nagasuma			Design of a heme-binding peptide motif adopting a beta-hairpin conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein design; computational biology; heme; protein folding; protein motif; structural biology	DE-NOVO DESIGN; 4-HELIX BUNDLE; COMBINATORIAL LIBRARIES; COMPUTATIONAL DESIGN; ENZYMATIC-ACTIVITY; PROTEIN DESIGN; HIGH-AFFINITY; HEMEPROTEIN; HELICHROME; STABILITY	Heme-binding proteins constitute a large family of catalytic and transport proteins. Their widespread presence as globins and as essential oxygen and electron transporters, along with their diverse enzymatic functions, have made them targets for protein design. Most previously reported designs involved the use of -helical scaffolds, and natural peptides also exhibit a strong preference for these scaffolds. However, the reason for this preference is not well-understood, in part because alternative protein designs, such as those with -sheets or hairpins, are challenging to perform. Here, we report the computational design and experimental validation of a water-soluble heme-binding peptide, Pincer-1, composed of predominantly -scaffold secondary structures. Such heme-binding proteins are rarely observed in nature, and by designing such a scaffold, we simultaneously increase the known fold space of heme-binding proteins and expand the limits of computational design methods. For a -scaffold, two tryptophan zipper -hairpins sandwiching a heme molecule were linked through an N-terminal cysteine disulfide bond. -Hairpin orientations and residue selection were performed computationally. Heme binding was confirmed through absorbance experiments and surface plasmon resonance experiments (K-D = 730 +/- 160 nm). CD and NMR experiments validated the -hairpin topology of the designed peptide. Our results indicate that a helical scaffold is not essential for heme binding and reveal the first designed water-soluble, heme-binding -hairpin peptide. This peptide could help expand the search for and design space to cytoplasmic heme-binding proteins.	[Nagarajan, Deepesh; Chandra, Nagasuma] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Sukumaran, Sujeesh; Krishnamurthy, Kiran; Atreya, Hanudatta S.] Indian Inst Sci, NMR Res Ctr, Bangalore 560012, Karnataka, India; [Sukumaran, Sujeesh] Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India; [Deka, Geeta] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Chandra, N (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	nchandra@iisc.ac.in		Nagarajan, Deepesh/0000-0001-8468-9834; Chandra, Nagasuma/0000-0002-9939-8439	Department of Biotechnology (India)	Department of Biotechnology (India)(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology (India). The authors declare that they have no conflicts of interest with the contents of this article.	Anand Praveen, 2014, F1000Res, V3, P214, DOI 10.12688/f1000research.5165.1; Anderson JLR, 2014, CHEM SCI, V5, P507, DOI [10.1039/c3sc52019f, 10.1039/C3SC52019F]; Cherry JR, 1999, NAT BIOTECHNOL, V17, P379, DOI 10.1038/7939; CHOMA CT, 1994, J AM CHEM SOC, V116, P856, DOI 10.1021/ja00082a005; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Copeland WB, 2012, METAB ENG, V14, P270, DOI 10.1016/j.ymben.2012.03.001; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; D'Souza A, 2016, CHEM SCI, V7, P2563, DOI 10.1039/c5sc04108b; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Discher BM, 2005, BIOCHEMISTRY-US, V44, P12329, DOI 10.1021/bi050695m; Dunbar JB, 2013, J CHEM INF MODEL, V53, P1842, DOI [10.1021/ci400161J, 10.1021/ci4000486]; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Eriksen DT, 2014, J STRUCT BIOL, V185, P234, DOI 10.1016/j.jsb.2013.03.011; Faiella M, 2012, CHEM-EUR J, V18, P15960, DOI 10.1002/chem.201201404; Farid TA, 2013, NAT CHEM BIOL, V9, P826, DOI [10.1038/NCHEMBIO.1362, 10.1038/nchembio.1362]; GRAY JC, 1992, PHOTOSYNTH RES, V34, P359, DOI 10.1007/BF00029811; Hanson EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012830; Huang PS, 2016, NAT CHEM BIOL, V12, P29, DOI [10.1038/NCHEMBIO.1966, 10.1038/nchembio.1966]; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Huang SS, 2004, P NATL ACAD SCI USA, V101, P5536, DOI 10.1073/pnas.0306676101; Isogai Y, 1999, BIOCHEMISTRY-US, V38, P7431, DOI 10.1021/bi983006y; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Korendovych IV, 2010, J AM CHEM SOC, V132, P15516, DOI 10.1021/ja107487b; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/nchembio.970, 10.1038/NCHEMBIO.970]; Lin YW, 2013, CHEM-ASIAN J, V8, P2534, DOI 10.1002/asia.201300291; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mahajan M, 2014, CHEMBIOCHEM, V15, P1257, DOI 10.1002/cbic.201402142; Malisi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052505; Moffet DA, 2003, BIOPHYS CHEM, V105, P231, DOI 10.1016/S0301-4622(03)00072-3; Moretti R, 2016, METHODS MOL BIOL, V1414, P47, DOI 10.1007/978-1-4939-3569-7_4; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagarajan D, 2018, J BIOL CHEM, V293, P3492, DOI [10.1074/jbc.M117.805499, 10.1074/jbc.m117.805499]; Nagarajan D, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0047-4; Nanda V, 2010, NAT CHEM, V2, P15, DOI [10.1038/NCHEM.473, 10.1038/nchem.473]; Ouberai M, 2011, CHEM SCI, V2, P1293, DOI 10.1039/c1sc00016k; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; Patel SC, 2009, PROTEIN SCI, V18, P1388, DOI 10.1002/pro.147; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rojas NRL, 1997, PROTEIN SCI, V6, P2512; Rosenblatt MM, 2003, P NATL ACAD SCI USA, V100, P13140, DOI 10.1073/pnas.2231273100; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; SASAKI T, 1990, BIOPOLYMERS, V29, P79, DOI 10.1002/bip.360290112; SASAKI T, 1989, J AM CHEM SOC, V111, P380, DOI 10.1021/ja00183a065; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Venkatraman J, 2001, CHEM REV, V101, P3131, DOI 10.1021/cr000053z; Voet D., 2006, FUNDAMENTALS BIOCH L, P838; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	59	5	5	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9412	9422		10.1074/jbc.RA118.001768	http://dx.doi.org/10.1074/jbc.RA118.001768			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29695501	Green Published, hybrid			2022-12-28	WOS:000435441400025
J	Takala, H; Lehtivuori, HK; Berntsson, O; Hughes, A; Nanekar, R; Niebling, S; Panman, M; Henry, L; Menzel, A; Westenhoff, S; Ihalainen, JA				Takala, Heikki; Lehtivuori, Heli K.; Berntsson, Oskar; Hughes, Ashley; Nanekar, Rahul; Niebling, Stephan; Panman, Matthijs; Henry, Leocadie; Menzel, Andreas; Westenhoff, Sebastian; Ihalainen, Janne A.			On the (un)coupling of the chromophore, tongue interactions, and overall conformation in a bacterial phytochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photoreceptor; cell signaling; mutagenesis; protein structure; X-ray crystallography; structural biology; protein conformation; chromophore-binding domain; photoconversion; phytochrome	CRYSTAL-STRUCTURE; DEINOCOCCUS-RADIODURANS; PLANT PHYTOCHROME; BINDING DOMAIN; BACTERIOPHYTOCHROME; PHOTOCONVERSION; MODULE; AGP1; FTIR; REARRANGEMENTS	Phytochromes are photoreceptors in plants, fungi, and various microorganisms and cycle between metastable red light-absorbing (Pr) and far-red light-absorbing (Pfr) states. Their light responses are thought to follow a conserved structural mechanism that is triggered by isomerization of the chromophore. Downstream structural changes involve refolding of the so-called tongue extension of the phytochrome-specific GAF-related (PHY) domain of the photoreceptor. The tongue is connected to the chromophore by conserved DIP and PRXSF motifs and a conserved tyrosine, but the role of these residues in signal transduction is not clear. Here, we examine the tongue interactions and their interplay with the chromophore by substituting the conserved tyrosine (Tyr(263)) in the phytochrome from the extremophile bacterium Deinococcus radiodurans with phenylalanine. Using optical and FTIR spectroscopy, X-ray solution scattering, and crystallography of chromophore-binding domain (CBD) and CBD-PHY fragments, we show that the absence of the Tyr(263) hydroxyl destabilizes the -sheet conformation of the tongue. This allowed the phytochrome to adopt an -helical tongue conformation regardless of the chromophore state, hence distorting the activity state of the protein. Our crystal structures further revealed that water interactions are missing in the Y263F mutant, correlating with a decrease of the photoconversion yield and underpinning the functional role of Tyr(263) in phytochrome conformational changes. We propose a model in which isomerization of the chromophore, refolding of the tongue, and globular conformational changes are represented as weakly coupled equilibria. The results also suggest that the phytochromes have several redundant signaling routes.	[Takala, Heikki] Univ Helsinki, Fac Med, Dept Anat, FI-00014 Helsinki, Finland; [Takala, Heikki; Nanekar, Rahul; Ihalainen, Janne A.] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Lehtivuori, Heli K.] Univ Jyvaskyla, Dept Phys, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Berntsson, Oskar; Hughes, Ashley; Niebling, Stephan; Panman, Matthijs; Henry, Leocadie; Westenhoff, Sebastian] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden; [Menzel, Andreas] Paul Scherrer Inst, CH-5232 Villigen 15, Switzerland	University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; University of Gothenburg; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Takala, H (corresponding author), Univ Helsinki, Fac Med, FI-00014 Helsinki, Finland.	heikki.takala@helsinki.fi	Menzel, Andreas/C-4388-2012; Panman, Matthijs/N-3455-2019; Takala, Heikki/GVT-1834-2022; Takala, Heikki/ABC-9139-2020; Panman, Matthijs/D-4873-2011	Menzel, Andreas/0000-0002-0489-609X; Panman, Matthijs/0000-0003-3853-123X; Takala, Heikki/0000-0003-2518-8583; Takala, Heikki/0000-0003-2518-8583; Panman, Matthijs/0000-0003-3853-123X; Ihalainen, Janne/0000-0002-8741-1587; Berntsson, Oskar/0000-0003-1843-6278; Niebling, Stephan/0000-0001-6582-5984; Lehtivuori, Heli/0000-0002-7450-2578	Academy of Finland [285461, 277194, 296135]; Foundation of Strategic Research, Sweden [FFL09-0106]; European Research Council [279944]; Emil Aaltonen Foundation; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Foundation of Strategic Research, Sweden; European Research Council(European Research Council (ERC)European Commission); Emil Aaltonen Foundation; Jane and Aatos Erkko Foundation	This work was supported by Academy of Finland Grants 285461 (to H. T.), 277194 (to H. L.), and 296135 (to J. A. I.); the Foundation of Strategic Research, Sweden, Grant FFL09-0106, and European Research Council, Agreement 279944 (to S. W.); the Emil Aaltonen Foundation (to H. L.); and Jane and Aatos Erkko Foundation (to J. A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Auldridge ME, 2012, J BIOL CHEM, V287, P7000, DOI 10.1074/jbc.M111.295121; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Berntsson O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00300-5; Bhattacharya S, 2014, J BIOL CHEM, V289, P32144, DOI 10.1074/jbc.M114.589739; Bjorling A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600920; Bjorling A, 2015, J PHYS CHEM LETT, V6, P3379, DOI 10.1021/acs.jpclett.5b01629; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, PLANT CELL, V26, P4568, DOI 10.1105/tpc.114.131623; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Edlund P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35279; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Gourinchas G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602498; Jeong AR, 2016, PLANT PHYSIOL, V171, P2826, DOI 10.1104/pp.16.00342; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kacprzak S, 2017, J BIOL CHEM, V292, P7598, DOI 10.1074/jbc.M116.761882; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lehtivuori H, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00065; Lehtivuori H, 2013, J PHYS CHEM B, V117, P11049, DOI 10.1021/jp312061b; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2016, J BIOL CHEM, V291, P20674, DOI 10.1074/jbc.M116.739136; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Stojkovic EA, 2014, J PHYS CHEM LETT, V5, P2512, DOI 10.1021/jz501189t; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Takahashi R, 2007, BIOCHEMISTRY-US, V46, P6459, DOI 10.1021/bi7004653; Takala H, 2016, STRUCT DYNAM-US, V3, DOI 10.1063/1.4961911; Takala H, 2015, J BIOL CHEM, V290, P16383, DOI 10.1074/jbc.M115.650127; Takala H, 2014, BIOCHEMISTRY-US, V53, P7076, DOI 10.1021/bi501180s; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Tkachenko N.V., 2006, OPTICAL SPECTROSCOPY; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2015, STRUCTURE, V23, P1179, DOI 10.1016/j.str.2015.04.022; Zhang JR, 2013, PLANT PHYSIOL, V161, P1445, DOI 10.1104/pp.112.208892	41	37	38	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8161	8172		10.1074/jbc.RA118.001794	http://dx.doi.org/10.1074/jbc.RA118.001794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29622676	hybrid, Green Published			2022-12-28	WOS:000433224600021
J	Nickels, JT				Nickels, Joseph T., Jr.			New links between lipid accumulation and cancer progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						cancer; tumor cell biology; dyslipidemia; cholesterol metabolism; cell proliferation; sterol regulatory element-binding protein; tumorigenesis	SMALL-MOLECULE; SREBP; CHOLESTEROL	Individuals with elevated lipid levels are at risk for developing cardiovascular disease as well as cancer. Sterol regulatory element-binding protein transcription factors (SREBPs) are inducers of lipid synthesis. Elevated SREBPs levels are linked to cell proliferation and metastasis. Using biochemical and mouse models of cancer, Zhao et al. have discovered that nuclear SREBP-1a-dependent transcription is activated by pyruvate kinase M2 in cancer cells, which promotes tumor growth. Targeting the lipogenesis pathway may therefore be a promising avenue for cancer treatment.	[Nickels, Joseph T., Jr.] Inst Metab Disorders, Genesis Biotechnol Grp, 1000 Waterview Dr, Hamilton, NJ 08691 USA; [Nickels, Joseph T., Jr.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Nickels, JT (corresponding author), Inst Metab Disorders, Genesis Biotechnol Grp, 1000 Waterview Dr, Hamilton, NJ 08691 USA.	jnickels@venenumbiodesign.com			Genesis Biotechnology Group	Genesis Biotechnology Group	I am grateful for the financial support of Genesis Biotechnology Group.	Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Korn BS, 1998, J CLIN INVEST, V102, P2050, DOI 10.1172/JCI5341; Lewis CA, 2011, BIOCHEM SOC T, V39, P495, DOI 10.1042/BST0390495; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Ray U, 2018, FEBS J, V285, P432, DOI 10.1111/febs.14281; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Zhao XP, 2018, J BIOL CHEM, V293, P6623, DOI 10.1074/jbc.RA117.000100	9	22	22	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6635	6636		10.1074/jbc.H118.002654	http://dx.doi.org/10.1074/jbc.H118.002654			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29703762	Green Published, hybrid			2022-12-28	WOS:000431108600033
J	Hayashi, S; Nakahata, Y; Kohno, K; Matsui, T; Bessho, Y				Hayashi, Shinichi; Nakahata, Yasukazu; Kohno, Kenji; Matsui, Takaaki; Bessho, Yasumasa			Presomitic mesoderm-specific expression of the transcriptional repressor Hes7 is controlled by E-box, T-box, and Notch signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mouse; development; transcription factor; transcription regulation; Notch pathway; Hes7; mesogenin1; somitogenesis; Tbx6	SOMITE SEGMENTATION CLOCK; MOUSE EMBRYOS; TBX6; SOMITOGENESIS; MESP2; GASTRULATION; MECHANISMS; LEFTY-2; PROTEIN; XENOPUS	Somites are a pair of epithelial spheres beside a neural tube and are formed with an accurate periodicity during embryogenesis in vertebrates. It has been known that Hes7 is one of the core clock genes for somitogenesis, and its expression domain is restricted in the presomitic mesoderm (PSM). However, the molecular mechanism of how Hes7 transcription is regulated is not clear. Here, using transgenic mice and luciferase-based reporter assays and in vitro binding assays, we unravel the mechanism by which Hes7 is expressed exclusively in the PSM. We identified a Hes7 essential region residing -1.5 to -1.1 kb from the transcription start site of mouse Hes7, and this region was indispensable for PSM-specific Hes7 expression. We also present detailed analyses of cis-regulatory elements within the Hes7 essential region that directs Hes7 expression in the PSM. Hes7 expression in the PSM was up-regulated through the E-box, T-box, and RBPj-binding element in the Hes7 essential region, presumably through synergistic signaling involving mesogenin1, T-box6 (Tbx6), and Notch. Furthermore, we demonstrate that Tbx18, Ripply2, and Hes7 repress the activation of the Hes7 essential region by the aforementioned transcription factors. Our findings reveal that a unified transcriptional regulatory network involving a Hes7 essential region confers robust PSM-specific Hes7 gene expression.	[Hayashi, Shinichi; Nakahata, Yasukazu; Matsui, Takaaki; Bessho, Yasumasa] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Inst Res Initiat, Lab Gene Regulat Res, Ikoma, Nara 6300192, Japan; [Kohno, Kenji] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Inst Res Initiat, Lab Mol & Cell Genet, Ikoma, Nara 6300192, Japan; [Hayashi, Shinichi] Tokushima Univ, Embryol, Inst Adv Med Sci, Tokushima 7708503, Japan	Nara Institute of Science & Technology; Nara Institute of Science & Technology; Tokushima University	Nakahata, Y; Bessho, Y (corresponding author), Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Inst Res Initiat, Lab Gene Regulat Res, Ikoma, Nara 6300192, Japan.	yasu-nakahata@bs.naist.jp; ybessho@bs.naist.jp	Kohno, Kenji/AAZ-6573-2020	Kohno, Kenji/0000-0002-3503-6551; Nakahata, Yasukazu/0000-0003-3814-5822	Japan Society for the Promotion of Science KAKENHI Grant [JP24659086]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant [JP17H05768]; Uehara Memorial Foundation; Senri Life Science Foundation	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Senri Life Science Foundation	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant JP24659086 (to Y. N.) and by Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant JP17H05768 (to Y. B.) and in part by The Uehara Memorial Foundation and Senri Life Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Biris KK, 2007, DEV DYNAM, V236, P3167, DOI 10.1002/dvdy.21342; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garnett AT, 2009, DEVELOPMENT, V136, P749, DOI 10.1242/dev.024703; Gonzalez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053323; Hayashi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005603; Hitachi K, 2008, DEV BIOL, V313, P816, DOI 10.1016/j.ydbio.2007.10.015; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kawamura A, 2008, MOL CELL BIOL, V28, P3236, DOI 10.1128/MCB.01754-07; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kondow A, 2007, BIOCHEM BIOPH RES CO, V359, P959, DOI 10.1016/j.bbrc.2007.05.211; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lieven O, 2010, DEV BIOL, V340, P256, DOI 10.1016/j.ydbio.2010.01.037; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meno C, 2001, DEV CELL, V1, P127, DOI 10.1016/S1534-5807(01)00006-5; Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Saijoh Y, 1999, GENE DEV, V13, P259, DOI 10.1101/gad.13.3.259; Sasaki N, 2011, DEVELOPMENT, V138, P55, DOI 10.1242/dev.055533; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Takahashi J, 2010, DEV BIOL, V342, P134, DOI 10.1016/j.ydbio.2010.03.015; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144; Yoon JK, 2000, DEV BIOL, V222, P376, DOI 10.1006/dbio.2000.9717	39	9	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12167	12176		10.1074/jbc.RA118.003728	http://dx.doi.org/10.1074/jbc.RA118.003728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29895619	Green Published, hybrid			2022-12-28	WOS:000440803200015
J	Neill, T; Andreuzzi, E; Wang, ZX; Peiper, SC; Mongiat, M; Iozzo, RV				Neill, Thomas; Andreuzzi, Eva; Wang, Zi-Xuan; Peiper, Stephen C.; Mongiat, Maurizo; Iozzo, Renato, V			Endorepellin remodels the endothelial transcriptome toward a pro-autophagic and pro-mitophagic gene signature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						parkin; mitochondria; mitochondrial membrane potential; vascular endothelial growth factor (VEGF); basement membrane; mitochondrial depolarization; mitofusin 2; mitostatin; Parkin; VEGFR2	UBIQUITIN-PROTEASOME SYSTEM; GROWTH-FACTOR PROGRANULIN; BECLIN 1 PHOSPHORYLATION; BREAST-CANCER; BASEMENT-MEMBRANE; HEPARAN-SULFATE; RECEPTOR 2; ALPHA-2-BETA-1 INTEGRIN; ANGIOGENESIS INHIBITOR; EXTRACELLULAR-MATRIX	Regulation of autophagy by proteolytically cleaved fragments of heparan sulfate proteoglycans is a novel and current research focus in tumor biology. Endorepellin is the C-terminal angiostatic fragment of the heparan sulfate proteoglycan perlecan and induces autophagy in endothelial cells. To further investigate this property, we used NanoString, a digital PCR platform for measuring pre-defined transcripts in biological samples to analyze a custom subset of 95 autophagy-related genes in human umbilical vein endothelial cells treated with ultrapure human recombinant endorepellin. We discovered an endorepellin-evoked pro-autophagic and pro-mitophagic gene expression signatures, which included two coordinately up-regulated mitochondrial-associated genes encoding the E3 ubiquitin protein ligase Parkin and the tumor suppressor mitostatin. Induction of both proteins required the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2). Furthermore, we discovered that endorepellin evoked mitochondrial depolarization in endothelial cells via a specific interaction between its two proximal LG1/2 domains and VEGFR2. We also found that following loss of membrane potential, mitostatin and parkin interact and that mitostatin associates with the established Parkin receptor mitofusin-2. In conclusion, we have identified a critical role for endorepellin in remodeling the autophagic transcriptome and influencing mitochondrial homeostasis.	[Neill, Thomas; Wang, Zi-Xuan; Peiper, Stephen C.; Iozzo, Renato, V] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Neill, Thomas; Wang, Zi-Xuan; Peiper, Stephen C.; Iozzo, Renato, V] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Andreuzzi, Eva; Mongiat, Maurizo] Natl Canc Inst, CRO Aviano IRCCS, Expt Oncol Div 2, Dept Translat Res, I-33081 Aviano, Italy	Jefferson University; Jefferson University; IRCCS Aviano (CRO)	Iozzo, RV (corresponding author), Thomas Jefferson Univ, 1020 Locust St,Suite 336,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020; Andreuzzi, Eva/AAX-5692-2020; Mongiat, Maurizio/H-8297-2018	Andreuzzi, Eva/0000-0002-5925-5230; Mongiat, Maurizio/0000-0001-6509-0068	National Institutes of Health [RO1 CA39481, RO1 CA47282]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA039481, P30CA056036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants RO1 CA39481 and RO1 CA47282 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreuzzi E, 2017, MATRIX BIOL, V64, P40, DOI 10.1016/j.matbio.2017.04.002; Apte SS, 2015, MATRIX BIOL, V44-46, P1, DOI 10.1016/j.matbio.2015.04.005; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Aspinall-O'Dea M, 2007, PROTEOM CLIN APPL, V1, P1066, DOI 10.1002/prca.200700144; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chang JW, 2008, PROTEOM CLIN APPL, V2, P23, DOI 10.1002/prca.200780049; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; COHEN IR, 1994, CANCER RES, V54, P5771; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Douglass S, 2015, CONNECT TISSUE RES, V56, P381, DOI 10.3109/03008207.2015.1045297; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fassan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019771; Fong TAT, 1999, CANCER RES, V59, P99; Foster MH, 2017, MATRIX BIOL, V57-58, P149, DOI 10.1016/j.matbio.2016.07.008; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ghadiali RS, 2017, MATRIX BIOL, V59, P54, DOI 10.1016/j.matbio.2016.07.007; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Gubbiotti MA, 2017, MATRIX BIOL, V57-58, P285, DOI 10.1016/j.matbio.2016.09.003; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Jung M, 2013, J BIOL CHEM, V288, P3289, DOI 10.1074/jbc.M112.387811; Le BV, 2011, J MOL BIOL, V414, P231, DOI 10.1016/j.jmb.2011.09.048; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lord MS, 2014, MATRIX BIOL, V35, P112, DOI 10.1016/j.matbio.2014.01.016; Majek P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-64; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Mendel DB, 2000, CLIN CANCER RES, V6, P4848; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Neill T, 2016, J CELL BIOL, V215, P687, DOI 10.1083/jcb.201603079; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, AM J PATHOL, V184, P2146, DOI 10.1016/j.ajpath.2014.05.010; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; Nussenzweig SC, 2015, CIRC RES, V116, P480, DOI 10.1161/CIRCRESAHA.116.303805; Nystrom A, 2017, MATRIX BIOL, V57-58, P124, DOI 10.1016/j.matbio.2016.07.012; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; O'Riordan E, 2008, PROTEOM CLIN APPL, V2, P1025, DOI 10.1002/prca.200780137; Oda O, 1996, CLIN CHIM ACTA, V255, P119, DOI 10.1016/0009-8981(96)06395-4; Pallanck L, 2013, CURR BIOL, V23, pR570, DOI 10.1016/j.cub.2013.05.032; Parker TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033714; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Peysselon F, 2014, MATRIX BIOL, V35, P73, DOI 10.1016/j.matbio.2013.11.001; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Pozzi A, 2017, MATRIX BIOL, V57-58, P1, DOI 10.1016/j.matbio.2016.12.009; Randles MJ, 2017, MATRIX BIOL, V57-58, P12, DOI 10.1016/j.matbio.2016.08.006; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Schaefer L, 2017, FEBS J, V284, P10, DOI 10.1111/febs.13963; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Song WH, 2016, P NATL ACAD SCI USA, V113, pE5261, DOI 10.1073/pnas.1605844113; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Surin B, 2013, PROTEOMICS, V13, P142, DOI 10.1002/pmic.201200267; Tanimoto R, 2017, MATRIX BIOL, V64, P27, DOI 10.1016/j.matbio.2017.04.001; Thadikkaran L, 2005, CLIN CHIM ACTA, V360, P27, DOI 10.1016/j.cccn.2005.04.018; Tsangaris GT, 2006, PROTEOMICS, V6, P4410, DOI 10.1002/pmic.200600085; Vadon-Le Goff S, 2015, MATRIX BIOL, V44-46, P14, DOI 10.1016/j.matbio.2015.02.006; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vuadens F, 2003, PROTEOMICS, V3, P1521, DOI 10.1002/pmic.200300455; Wang H, 2015, CANCER CELL, V27, P193, DOI 10.1016/j.ccell.2014.11.017; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Wells JM, 2015, MATRIX BIOL, V44-46, P122, DOI 10.1016/j.matbio.2015.01.016; Wijeratne SS, 2016, MATRIX BIOL, V50, P27, DOI 10.1016/j.matbio.2015.11.001; Willis CD, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P171; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Wilson SE, 2017, MATRIX BIOL, V64, P17, DOI 10.1016/j.matbio.2017.06.003; Wolf SG, 2017, ELIFE, V6, DOI 10.7554/eLife.29929; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang YF, 2015, HUM GENE THER, V26, P813, DOI 10.1089/hum.2015.098; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	101	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12137	12148		10.1074/jbc.RA118.002934	http://dx.doi.org/10.1074/jbc.RA118.002934			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29921586	hybrid, Green Published			2022-12-28	WOS:000440803200013
J	Hanisch, FG; Hansman, GS; Morozov, V; Kunz, C; Schroten, H				Hanisch, Franz-Georg; Hansman, Grant S.; Morozov, Vasily; Kunz, Clemens; Schroten, Horst			Avidity of alpha-fucose on human milk oligosaccharides and blood group-unrelated oligo/polyfucoses is essential for potent norovirus-binding targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virus; carbohydrate-binding protein; glycobiology; oligosaccharide; innate immunity; anti-viral protection; food additive; human blood group antigen; milk oligosaccharide; norovirus	GROUP ANTIGENS; HELICOBACTER-PYLORI; INFECTION; GASTROENTERITIS; NOMENCLATURE; INHIBITION; DISCOVERY	There is agreement with respect to norovirus infection routes in humans regarding binding of the pathogen to gastrointestinal epithelia via recognition of blood group-active mucin-typeO-glycans as the initiating and essential event. Among food additives playing a potential role in applications to protect newborns, human milk oligosaccharides (HMOs) as competitors are of major importance. By focusing on fractions of high-molecular mass HMOs with high fucose contents, we attempted to identify the structural elements required for norovirus GII.4 (Sydney 2012, JX459908) capsid binding in neoglycolipid-based arrays. We provide evidence that HMO fractions with the strongest binding capacities contained hepta- to decasaccharides expressing branches with terminal blood group H1 or Lewis-b antigen. H2 antigen, as recognized by UEA-I lectin, is apparently not expressed in high-mass HMOs. Beyond affinity, sterical and valency effects contribute more to virus-like particle binding, as revealed for oligovalent fucose conjugates of alpha-cyclodextrin and oligofucoses from fucoidan. Accordingly, high-mass HMOs with oligovalent fucose can exhibit stronger binding capacities compared with monovalent fucose HMOs. The above features were revealed for the most clinically relevant and prevalent GII.4 strain and are distinct from other strains, like GII.10 (Vietnam 026, AF504671), which showed a preference for blood group Lewis-a positive glycans.	[Hanisch, Franz-Georg] Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany; [Hansman, Grant S.; Morozov, Vasily] Heidelberg Univ, Schaller Res Grp, Neuenheimer Feld 242, D-69120 Heidelberg, Germany; [Hansman, Grant S.; Morozov, Vasily] DKFZ, Neuenheimer Feld 242, D-69120 Heidelberg, Germany; [Hansman, Grant S.; Morozov, Vasily] Heidelberg Univ, Dept Infect Dis, Virol, Neuenheimer Feld 242, D-69120 Heidelberg, Germany; [Morozov, Vasily; Schroten, Horst] Univ Childrens Hosp Mannheim, Pediat Infect Dis Unit, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany; [Kunz, Clemens] Univ Giessen, Inst Nutr Sci, Wilhelmstr 20, D-35392 Giessen, Germany	University of Cologne; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen	Hanisch, FG (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	franz.hanisch@uni-koeln.de		Hansman, Grant/0000-0001-8735-4618	CHS Foundation; Helmholtz-Chinese Academy of Sciences [HCJRG-202]; Deutsche Forschungsgemeinschaft (DFG) [FOR2327]; Koln-Fortune Programme	CHS Foundation; Helmholtz-Chinese Academy of Sciences(Chinese Academy of Sciences); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Koln-Fortune Programme	This work was supported in part by the CHS Foundation, Helmholtz-Chinese Academy of Sciences Grant HCJRG-202, and Deutsche Forschungsgemeinschaft (DFG) Grant FOR2327 (to G. H.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Koln-Fortune Programme.	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dotz V, 2014, GLYCOBIOLOGY, V24, P185, DOI 10.1093/glycob/cwt099; EGGE H, 1983, ARCH BIOCHEM BIOPHYS, V224, P235, DOI 10.1016/0003-9861(83)90207-2; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Fiege B, 2017, GLYCOCONJUGATE J, V34, P679, DOI 10.1007/s10719-017-9792-5; Hansman GS, 2007, J CLIN MICROBIOL, V45, P1347, DOI 10.1128/JCM.01854-06; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Koromyslova A, 2017, VIROLOGY, V508, P81, DOI 10.1016/j.virol.2017.04.032; Kunz C, 1996, J CHROMATOGR B, V685, P211, DOI 10.1016/S0378-4347(96)00181-8; Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu Y, 2016, J VIROL, V90, P9983, DOI 10.1128/JVI.01494-16; Lopman BA, 2015, J INFECT DIS, V211, P1813, DOI 10.1093/infdis/jiu672; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Moonens K, 2016, CELL HOST MICROBE, V19, P55, DOI 10.1016/j.chom.2015.12.004; Nasir W, 2017, ACS CHEM BIOL, V12, P1288, DOI 10.1021/acschembio.7b00152; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Purohit S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02747-y; Rademacher C, 2011, CHEM-EUR J, V17, P7442, DOI 10.1002/chem.201003432; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; Schroten H, 2016, J VIROL, V90, P5855, DOI 10.1128/JVI.00317-16; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Singh BK, 2015, J VIROL, V89, P2024, DOI 10.1128/JVI.02968-14; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Weichert S, 2016, J VIROL, V90, P4843, DOI 10.1128/JVI.03223-15; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	30	25	26	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11955	11965		10.1074/jbc.RA117.001369	http://dx.doi.org/10.1074/jbc.RA117.001369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29858242	hybrid, Green Published			2022-12-28	WOS:000440134500026
J	Wu, GY; Yang, X; Shen, YQ				Wu, Guangyan; Yang, Xue; Shen, Yuequan			Identification of a single aspartate residue critical for both fast and slow calcium-dependent inactivation of the human TRPML1 channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOLIPIDOSIS TYPE-IV; RECEPTOR POTENTIAL CHANNEL; CA2+-DEPENDENT INACTIVATION; RELEASE CHANNEL; CALMODULIN; MECHANISMS; PROTEINS; LYSOSOME; CELLS; DISEASE	Transient receptor potential mucolipin subfamily 1 (TRPML1) is a nonselective cation channel mainly located in late endosomes and lysosomes. Mutations of the gene encoding human TRPML1 can cause severe lysosomal diseases. The activity of TRPML1 is regulated by both Ca2+ and H+, which are important for its critical physiological functions in membrane trafficking, exocytosis, autophagy, and intracellular signal transduction. However, the molecular mechanism of its dual regulation by Ca2+ and H+ remains elusive. Here, using a mutant screening method in combination with a whole-cell patch clamp technique, we identified a key TRPML1 residue, Asp-472, responsible for both fast calcium-dependent inactivation (FCDI) and slow calcium-dependent inactivation (SCDI) as well as H+ regulation. We also found that, in acidic pH, H+ can significantly delay FCDI and abolish SCDI and thereby presumably facilitate the ion conductance of the human TRPML1 channel. In summary, we have identified a key residue critical for Ca2+-induced inhibition of TRPML1 channel currents and uncovered pH-dependent regulation of this channel, providing vital information regarding the detailed mechanism of action of human TRPML1.	[Wu, Guangyan; Yang, Xue; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Wu, Guangyan; Yang, Xue; Shen, Yuequan] Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Shen, Yuequan] Synerget Innovat Ctr Chem Sci & Engn, 94 Weijin Rd, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.; Shen, YQ (corresponding author), Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.; Shen, YQ (corresponding author), Synerget Innovat Ctr Chem Sci & Engn, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yshen@nankai.edu.cn	Wu, Guangyan/P-4083-2019; Shen, Yuequan/C-8950-2013	Wu, Guang/0000-0002-7969-0192; Shen, Yuequan/0000-0002-3775-0900	National Key R&D Program of China [2017YFA0504801]; National Natural Science Foundation of China [31570750, 31370826]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China Grant 2017YFA0504801 (to Y.S.) and National Natural Science Foundation of China Grants 31570750 and 31370826 (to Y.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao Q, 2017, J BIOL CHEM, V292, P8424, DOI 10.1074/jbc.M116.772160; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Christensen KA, 2002, J CELL SCI, V115, P599; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; Di Paola S, 2018, CELL CALCIUM, V69, P112, DOI 10.1016/j.ceca.2017.06.006; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Grant L, 2008, J NEUROPHYSIOL, V99, P2183, DOI 10.1152/jn.01174.2007; Grieben M, 2017, NAT STRUCT MOL BIOL, V24, P114, DOI 10.1038/nsmb.3343; Grimm C, 2017, CELL CALCIUM, V67, P148, DOI 10.1016/j.ceca.2017.04.003; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Li MH, 2017, NAT STRUCT MOL BIOL, V24, P205, DOI 10.1038/nsmb.3362; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Li XN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01241-9; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lubensky IA, 1999, AM J SURG PATHOL, V23, P1527, DOI 10.1097/00000478-199912000-00010; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2017, CELL CALCIUM, V63, P20, DOI 10.1016/j.ceca.2016.12.003; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Schmiege P, 2017, NATURE, V550, P366, DOI 10.1038/nature24036; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Venkatachalam K, 2015, CELL CALCIUM, V58, P48, DOI 10.1016/j.ceca.2014.10.008; Wilkes M, 2017, NAT STRUCT MOL BIOL, V24, P123, DOI 10.1038/nsmb.3357; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	47	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11736	11745		10.1074/jbc.RA118.003250	http://dx.doi.org/10.1074/jbc.RA118.003250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29884771	hybrid, Green Published			2022-12-28	WOS:000440134500007
J	You, X; Qin, Z; Yan, QJ; Yang, SQ; Li, YX; Jiang, ZQ				You, Xin; Qin, Zhen; Yan, Qiaojuan; Yang, Shaoqing; Li, Yanxiao; Jiang, Zhengqiang			Structural insights into the catalytic mechanism of a novel glycoside hydrolase family 113 beta-1,4-mannanase from Amphibacillus xylanus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; BETA-MANNANASE; SUBSTRATE-RECOGNITION; ENZYMATIC CHARACTERIZATION; GENE CLONING; PROTEIN; REVEALS; BINDING; ENDO-BETA-1,4-MANNANASE; TRANSGLYCOSIDASE	beta-1,4-Mannanase degrades beta-1,4-mannan polymers into manno-oligosaccharides with a low degree of polymerization. To date, only one glycoside hydrolase (GH) family 113 beta-1,4-mannanase, from Alicyclobacillus acidocaldarius (AaManA), has been structurally characterized, and no complex structure of enzyme-manno-oligosaccharides from this family has been reported. Here, crystal structures of a GH family 113 beta-1,4-mannanase from Amphibacillus xylanus (AxMan113A) and its complexes with mannobiose, mannotriose, mannopentaose, and mannahexaose were solved. AxMan113A had higher affinity for -1 and -1 mannoses, which explains why the enzyme can hydrolyze mannobiose. At least six subsites -4 to +2) exist in the groove, but mannose units preferentially occupied subsites -4 to -1 because of steric hindrance formed by Lys-238 and Trp-239. Based on the structural information and bioinformatics, rational design was implemented to enhance hydrolysis activity. Enzyme activity of AxMan113A mutants V139C, N237W, K238A, and W239Y was improved by 93.7, 63.4, 112.9, and 36.4%, respectively, compared with the WT. In addition, previously unreported surface-binding sites were observed. Site-directed mutagenesis studies and kinetic data indicated that key residues near the surface sites play important roles in substrate binding and recognition. These first GH family 113 beta-1,4-mannanase-manno-oligosaccharide complex structures may be useful in further studying the catalytic mechanism ofGH family 113 members, and provide novel insight into protein engineering of GHs to improve their hydrolysis activity.	[You, Xin; Yan, Qiaojuan; Li, Yanxiao] China Agr Univ, Coll Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100083, Peoples R China; [Qin, Zhen] East China Univ Sci & Technol, R&D Ctr Separat & Extract Technol Fermentat Ind, Sch Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Yang, Shaoqing; Jiang, Zhengqiang] China Agr Univ, Coll Food Sci & Nutrit Engn, Beijing 100083, Peoples R China	China Agricultural University; East China University of Science & Technology; China Agricultural University	Jiang, ZQ (corresponding author), China Agr Univ, POB 294,17 Qinghua Donglu, Beijing 100083, Peoples R China.	zhqjiang@cau.edu.cn		qin, zhen/0000-0003-2133-8572	National Natural Science Foundation of China [31630096];  [T2014055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported in part by the Key Program of the National Natural Science Foundation of China Grant 31630096 and Program for Changjiang Scholars Grant T2014055. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arab-Jaziri F, 2013, NEW BIOTECHNOL, V30, P536, DOI 10.1016/j.nbt.2013.04.002; Asano I, 2003, FOOD SCI TECHNOL RES, V9, P62, DOI 10.3136/fstr.9.62; Benech RO, 2007, ENZYME MICROB TECH, V41, P740, DOI 10.1016/j.enzmictec.2007.06.012; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cockburn D, 2014, BIOLOGIA, V69, P705, DOI 10.2478/s11756-014-0373-9; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Daskiran M, 2004, POULTRY SCI, V83, P662, DOI 10.1093/ps/83.4.662; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng HY, 2005, J BIOL CHEM, V280, P37088, DOI 10.1074/jbc.M502873200; Fukamizo T, 2000, J BIOL CHEM, V275, P25633, DOI 10.1074/jbc.M002574200; Golovanov AP, 1998, J BIOMOL STRUCT DYN, V15, P673, DOI 10.1080/07391102.1998.10508984; Guo W, 2014, LANGMUIR, V30, P243, DOI 10.1021/la403494q; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Jin Y, 2016, ACS CENTRAL SCI, V2, P896, DOI 10.1021/acscentsci.6b00232; Katrolia P, 2013, J AGR FOOD CHEM, V61, P394, DOI 10.1021/jf303319h; Kim MK, 2014, PROTEINS, V82, P3217, DOI 10.1002/prot.24655; Kumagai Y, 2015, FEBS J, V282, P4001, DOI 10.1111/febs.13401; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Li JM, 2016, FOOD HYDROCOLLOID, V53, P46, DOI 10.1016/j.foodhyd.2015.01.035; Li YX, 2015, J MOL CATAL B-ENZYM, V122, P265, DOI 10.1016/j.molcatb.2015.09.018; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo ZC, 2017, APPL BIOCHEM BIOTECH, V182, P1259, DOI 10.1007/s12010-017-2397-4; Lyu QQ, 2015, BBA-GEN SUBJECTS, V1850, P1953, DOI 10.1016/j.bbagen.2015.06.011; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Murphy GS, 2012, STRUCTURE, V20, P1086, DOI 10.1016/j.str.2012.03.026; Nielsen PK, 2003, BIOCHEMISTRY-US, V42, P1478, DOI 10.1021/bi020508+; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace CN, 2001, BIOCHEMISTRY-US, V40, P310, DOI 10.1021/bi001574j; Puchart V, 2005, BBA-GEN SUBJECTS, V1726, P206, DOI 10.1016/j.bbagen.2005.07.015; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosengren A, 2014, APPL MICROBIOL BIOT, V98, P10091, DOI 10.1007/s00253-014-5871-8; Sakai K, 2017, APPL MICROBIOL BIOT, V101, P3237, DOI 10.1007/s00253-017-8107-x; Srivastava PK, 2017, BIOTECHNOL ADV, V35, P1, DOI 10.1016/j.biotechadv.2016.11.001; Takano K, 2001, BIOCHEMISTRY-US, V40, P4853, DOI 10.1021/bi002792f; Teze D, 2014, PROTEIN ENG DES SEL, V27, P13, DOI 10.1093/protein/gzt057; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; Williams RJ, 2014, ANGEW CHEM INT EDIT, V53, P1087, DOI 10.1002/anie.201308334; Wu YF, 2013, FOOD CHEM, V138, P1588, DOI 10.1016/j.foodchem.2012.11.052; Xia W, 2016, APPL ENVIRON MICROB, V82, P2718, DOI 10.1128/AEM.04071-15; Yamabhai M, 2016, CRIT REV BIOTECHNOL, V36, P32, DOI 10.3109/07388551.2014.923372; Yoon SJ, 2008, J CLIN BIOCHEM NUTR, V42, P1, DOI 10.3164/jcbn.2008001; You X, 2018, BBA-GEN SUBJECTS, V1862, P1376, DOI 10.1016/j.bbagen.2018.03.016; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200	56	7	7	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11746	11757		10.1074/jbc.RA118.002363	http://dx.doi.org/10.1074/jbc.RA118.002363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29871927	hybrid, Green Published			2022-12-28	WOS:000440134500008
J	Chen, SP; Yang, J; Zhang, Y; Duan, CY; Liu, Q; Huang, ZY; Xu, Y; Zhou, L; Xu, GQ				Chen, Suping; Yang, Jing; Zhang, Yang; Duan, Chunyan; Liu, Qing; Huang, Zhengyun; Xu, Ying; Zhou, Liang; Xu, Guoqiang			Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin-conjugating enzyme (E2 enzyme); ubiquitylation (ubiquitination); ubiquitin; clock gene; transcription factor; BMAL1; circadian function; degradation; UBE2O; polyubiquitination; transcriptional activity	CIRCADIAN CLOCK; PROTEIN BMAL1; LIGASE UBE2O; CELLS; PHOSPHORYLATION; MECHANISM; APOPTOSIS; HEALTH; PER1; ACETYLATION	Dysregulation of the circadian rhythm is associated with many diseases, including diabetes, obesity, and cancer. Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Arntl or Bmal1) is the only clock gene whose loss disrupts circadian locomotor behavior in constant darkness. BMAL1 levels are affected by proteasomal inhibition and by several enzymes in the ubiquitin-proteasome system, but the exact molecular mechanism remains unclear. Here, using immunoprecipitation and MS analyses, we discovered an interaction between BMAL1 and ubiquitin-conjugating enzyme E2 O (UBE2O), an E3-independent E2 ubiquitin-conjugating enzyme (i.e. hybrid E2/E3 enzyme). Biochemical experiments with cell lines and animal tissues validated this specific interaction and uncovered that UBE2O expression reduces BMAL1 levels by promoting its ubiquitination and degradation. Moreover, UBE2O expression/knockdown diminished/increased, respectively, BMAL1-mediated transcriptional activity but did not affect BMAL1 gene expression. Bioluminescence experiments disclosed that UBE2O knockdown elevates the amplitude of the circadian clock in human osteosarcoma U2OS cells. Furthermore, mapping of the BMAL1-interacting domain in UBE2O and analyses of BMAL1 stability and ubiquitination revealed that the conserved region 2 (CR2) in UBE2O significantly enhances BMAL1 ubiquitination and decreases BMAL1 protein levels. A Cys-to-Ser substitution experiment identified the critical Cys residue in the CR2 domain responsible for BMAL1 ubiquitination. This work identifies UBE2O as a critical regulator in the ubiquitin-proteasome system, which modulates BMAL1 transcriptional activity and circadian function by promoting BMAL1 ubiquitination and degradation under normal physiological conditions.	[Chen, Suping; Yang, Jing; Zhang, Yang; Duan, Chunyan; Liu, Qing; Zhou, Liang; Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Chen, Suping; Yang, Jing; Zhang, Yang; Duan, Chunyan; Liu, Qing; Zhou, Liang; Xu, Guoqiang] Soochow Univ, Coll Pharmaceut Sci, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Huang, Zhengyun; Xu, Ying] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Huang, Zhengyun; Xu, Ying] Soochow Univ, Cambridge Suda Genom Resource Ctr, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Zhou, L; Xu, GQ (corresponding author), Soochow Univ, Coll Pharmaceut Sci, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.	liangzhou@suda.edu.cn; gux2002@suda.edu.cn	Xu, Ying/AAF-3081-2019; Xu, Ying/A-3009-2013	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768; Xu, Guoqiang/0000-0002-4753-4769	National Basic Research Program of China (973 Program) [2012CB947602]; National Natural Science Foundation of China [31670833, 81703535]; China Postdoctoral Science Foundation [2017M611895]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [17KJD180005]; Jiangsu Postdoctoral Science Foundation [1701130C]; Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant [BM2013003]; National Center for International Research Grant [2017B01012]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Jiangsu Higher Education Institutions of China; Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant; National Center for International Research Grant; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by the National Basic Research Program of China (973 Program, 2012CB947602), National Natural Science Foundation of China (31670833 and 81703535), China Postdoctoral Science Foundation (2017M611895), Natural Science Foundation of Jiangsu Higher Education Institutions of China (17KJD180005), Jiangsu Postdoctoral Science Foundation (1701130C), Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant BM2013003, National Center for International Research Grant 2017B01012, and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Berleth ES, 1996, BIOCHEMISTRY-US, V35, P1664, DOI 10.1021/bi952105y; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Dang FB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12696; Duan WW, 2016, PROTEOMICS, V16, P60, DOI 10.1002/pmic.201500356; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gossan NC, 2014, NUCLEIC ACIDS RES, V42, P5765, DOI 10.1093/nar/gku225; Hardie DG, 2017, CANCER CELL, V31, P163, DOI 10.1016/j.ccell.2017.01.010; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano A, 2016, NAT STRUCT MOL BIOL, V23, P1053, DOI 10.1038/nsmb.3326; Hirano A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154263; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hormaechea-Agulla D, 2018, MOL CELLS, V41, P168, DOI 10.14348/molcells.2018.0008; Hou XO, 2015, ACTA PHARMACOL SIN, V36, P1300, DOI 10.1038/aps.2015.54; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Lee Y, 2015, BBA-MOL CELL RES, V1853, P2697, DOI 10.1016/j.bbamcr.2015.07.005; Liang KW, 2017, CELL, V168, P59, DOI 10.1016/j.cell.2016.12.011; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Liu ZW, 2014, CELL REP, V7, P1509, DOI 10.1016/j.celrep.2014.04.032; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Nguyen AT, 2017, SCIENCE, V357, DOI 10.1126/science.aan0218; Puram RV, 2016, CELL, V165, P303, DOI 10.1016/j.cell.2016.03.015; Ren HG, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-40; Ribas-Latre A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10954; Roenneberg T, 2016, CURR BIOL, V26, pR432, DOI 10.1016/j.cub.2016.04.011; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Scoma HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025382; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi GS, 2016, CELL REP, V14, P823, DOI 10.1016/j.celrep.2015.12.076; Stojkovic K, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00069; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tamaru T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002293; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Tang QM, 2017, CANCER RES, V77, P532, DOI 10.1158/0008-5472.CAN-16-1322; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Vila IK, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1304846; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Xu YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0499-7; Yanagitani K, 2017, SCIENCE, V357, P472, DOI 10.1126/science.aan0178; Yang YM, 2014, J BIOL RHYTHM, V29, P243, DOI 10.1177/0748730414544741; Yang YM, 2012, BIOL OPEN, V1, P789, DOI 10.1242/bio.20121990; Zhang XF, 2013, EMBO J, V32, P996, DOI 10.1038/emboj.2013.38; Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21; Zhang Y, 2018, BIOCHEM J, V475, P1507, DOI 10.1042/BCJ20180005; Zhou YQ, 2016, J PROTEOMICS, V148, P94, DOI 10.1016/j.jprot.2016.07.015	58	29	30	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11296	11309		10.1074/jbc.RA117.001432	http://dx.doi.org/10.1074/jbc.RA117.001432			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871923	Green Published, hybrid			2022-12-28	WOS:000439449700004
J	Grignaschi, E; Cereghetti, G; Grigolato, F; Kopp, MRG; Caimi, S; Faltova, L; Saad, S; Peter, M; Arosio, P				Grignaschi, Erica; Cereghetti, Gea; Grigolato, Fulvio; Kopp, Marie R. G.; Caimi, Stefano; Faltova, Lenka; Saad, Shady; Peter, Matthias; Arosio, Paolo			A hydrophobic low-complexity region regulates aggregation of the yeast pyruvate kinase Cdc19 into amyloid-like aggregates in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; protein self-assembly; protein-nucleic acid interaction; protein-protein interaction; stress granule; cell compartmentalization; A42; amyloidogenic protein; functional amyloids; hydrophobic-hydrophilic interface; stress granule	PROTEIN-MISFOLDING DISEASES; PHASE-TRANSITIONS; FIBRIL FORMATION; LAG PHASE; GRANULES; RNA; MECHANISM; KINETICS; INSULIN; DOMAIN	Cells form stress granules (SGs) upon stress stimuli to protect sensitive proteins and RNA from degradation. In the yeast Saccharomyces cerevisiae, specific stresses such as nutrient starvation and heat-shock trigger recruitment of the yeast pyruvate kinase Cdc19 into SGs. This RNA-binding protein was shown to form amyloid-like aggregates that are physiologically reversible and essential for cell cycle restart after stress. Cellular Cdc19 exists in an equilibrium between a homotetramer and monomer state. Here, we show that Cdc19 aggregation in vitro is governed by protein quaternary structure, and we investigate the physical-chemical basis of Cdc19's assembly properties. Equilibrium shift toward the monomer state exposes a hydrophobic low-complexity region (LCR), which is prone to induce intermolecular interactions with surrounding proteins. We further demonstrate that hydrophobic/hydrophilic interfaces can trigger Cdc19 aggregation in vitro. Moreover, we performed in vitro biophysical analyses to compare Cdc19 aggregates with fibrils produced by two known dysfunctional amyloidogenic peptides. We show that the Cdc19 aggregates share several structural features with pathological amyloids formed by human insulin and the Alzheimer's disease-associated A42 peptide, particularly secondary -sheet structure, thermodynamic stability, and staining by the thioflavin T dye. However, Cdc19 aggregates could not seed aggregation. These results indicate that Cdc19 adopts an amyloid-like structure in vitro that is regulated by the exposure of a hydrophobic LCR in its monomeric form. Together, our results highlight striking structural similarities between functional and dysfunctional amyloids and reveal the crucial role of hydrophobic/hydrophilic interfaces in regulating Cdc19 aggregation.	[Grignaschi, Erica; Grigolato, Fulvio; Kopp, Marie R. G.; Caimi, Stefano; Faltova, Lenka; Arosio, Paolo] Swiss Fed Inst Technol, Inst Chem & Bioengn, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Cereghetti, Gea; Saad, Shady; Peter, Matthias] Swiss Fed Inst Technol, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Arosio, P (corresponding author), Stanford Univ, Dept Chem & Syst Biol, 269 Campus Dr, Stanford, CA 94305 USA.	paolo.arosio@chem.ethz.ch	Cereghetti, Gea/GQH-3208-2022	Cereghetti, Gea/0000-0001-7732-9435; Peter, Matthias/0000-0002-2160-6824; Caimi, Stefano/0000-0003-3898-559X; Saad, Shady/0000-0003-1062-2906; Arosio, Paolo/0000-0002-2740-1205; Grigolato, Fulvio/0000-0001-5989-7260	ETH Zurich; European Research Council; Synapsis Foundation; Swiss National Science Foundation; ETH Zurich Research Grant [ETH-33 17-2]; Novartis Foundation for Biomedical and Biological Research	ETH Zurich(ETH Zurich); European Research Council(European Research Council (ERC)European Commission); Synapsis Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich Research Grant(ETH Zurich); Novartis Foundation for Biomedical and Biological Research	This work was supported by ETH Zurich, the European Research Council, the Synapsis Foundation, and Swiss National Science Foundation (to M. P.) and by ETH Zurich Research Grant ETH-33 17-2, the Synapsis Foundation, and the Novartis Foundation for Biomedical and Biological Research (to P. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Arosio P, 2014, TRENDS PHARMACOL SCI, V35, P127, DOI 10.1016/j.tips.2013.12.005; Arosio P, 2014, J AM CHEM SOC, V136, P219, DOI 10.1021/ja408765u; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00423, 10.3389/fncel.2015.00423]; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brangwynne CP, 2011, SOFT MATTER, V7, P3052, DOI 10.1039/c0sm00981d; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Grigolato F, 2017, ACS NANO, V11, P11358, DOI 10.1021/acsnano.7b05895; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Macindoe I, 2012, P NATL ACAD SCI USA, V109, pE804, DOI 10.1073/pnas.1114052109; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mateju D, 2017, EMBO J, V36, P1669, DOI 10.15252/embj.201695957; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Owczarz M, 2014, BIOPHYS J, V107, P197, DOI 10.1016/j.bpj.2014.05.030; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pham CLL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25288; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Saad S, 2017, NAT CELL BIOL, V19, P1202, DOI 10.1038/ncb3600; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Taylor JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep24656; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	44	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11424	11432		10.1074/jbc.RA117.001628	http://dx.doi.org/10.1074/jbc.RA117.001628			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29853641	hybrid, Green Published			2022-12-28	WOS:000439449700013
J	Sung, MW; Shaik, R; TerBush, AD; Osteryoung, KW; Vitha, S; Holzenburg, A				Sung, Min Woo; Shaik, Rahamthulla; TerBush, Allan D.; Osteryoung, Katherine W.; Vitha, Stanislav; Holzenburg, Andreas			The chloroplast division protein ARC6 acts to inhibit disassembly of GDP-bound FtsZ2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; cytoskeleton; GTPase; single particle analysis; structural model; Arabidopsis; chloroplast division	PLASTID DIVISION; ESCHERICHIA-COLI; ASSEMBLY DYNAMICS; FLUORESCENCE RECOVERY; GENE FAMILIES; CELL; RING; ARABIDOPSIS; GTP; IDENTIFICATION	Chloroplasts host photosynthesis and fulfill other metabolic functions that are essential to plant life. They have to divide by binary fission to maintain their numbers throughout cycles of cell division. Chloroplast division is achieved by a complex ring-shaped division machinery located on both the inner (stromal) and the outer (cytosolic) side of the chloroplast envelope. The inner division ring (termed the Z ring) is formed by the assembly of tubulin-like FtsZ1 and FtsZ2 proteins. ARC6 is a key chloroplast division protein that interacts with the Z ring. ARC6 spans the inner envelope membrane, is known to stabilize or maintain the Z ring, and anchors the Z ring to the inner membrane through interaction with FtsZ2. The underlying mechanism of Z ring stabilization is not well-understood. Here, biochemical and structural characterization of ARC6 was conducted using light scattering, sedimentation, and light and transmission EM. The recombinant protein was purified as a dimer. The results indicated that a truncated form of ARC6 (tARC6), representing the stromal portion of ARC6, affects FtsZ2 assembly without forming higher-order structures and exerts its effect via FtsZ2 dynamics. tARC6 prevented GDP-induced FtsZ2 disassembly and caused a significant net increase in FtsZ2 assembly when GDP was present. Single particle analysis and 3D reconstruction were performed to elucidate the structural basis of ARC6 activity. Together, the data reveal that a dimeric form of tARC6 binds to FtsZ2 filaments and does not increase FtsZ polymerization rates but rather inhibits GDP-associated FtsZ2 disassembly.	[Sung, Min Woo; Shaik, Rahamthulla; Holzenburg, Andreas] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [TerBush, Allan D.] Michigan State Univ, Biochem & Mol Biol Grad Program, E Lansing, MI 48824 USA; [TerBush, Allan D.; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Vitha, Stanislav; Holzenburg, Andreas] Texas A&M Univ, Microscopy & Imaging Ctr, 301 Old Main Dr, College Stn, TX 77843 USA; [Holzenburg, Andreas] Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Brownsville, TX 78550 USA; [Holzenburg, Andreas] Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Edinburg, TX 78550 USA; [Holzenburg, Andreas] Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Harlingen, TX 78550 USA	Texas A&M University System; Texas A&M University College Station; Michigan State University; Michigan State University; Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley	Vitha, S (corresponding author), Texas A&M Univ, Microscopy & Imaging Ctr, 301 Old Main Dr, College Stn, TX 77843 USA.	vitha@tamu.edu	Shaik, Rahamthulla/AAP-5107-2020	Vitha, Stanislav/0000-0003-3262-8399	National Science Foundation [MCB-1121943, MCB-1719376]	National Science Foundation(National Science Foundation (NSF))	Supported by National Science Foundation Grants MCB-1121943 and MCB-1719376 (to K. W. O.).	Ajjawi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025368; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Andreu JM, 2004, MOLECULES IN TIME AND SPACE: BACTERIAL SHAPE, DIVISON AND PHYLOGENY, P133, DOI 10.1007/0-306-48579-6_7; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03983-4; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Colletti KS, 2000, CURR BIOL, V10, P507, DOI 10.1016/S0960-9822(00)00466-8; Du SS, 2015, MOL MICROBIOL, V95, P173, DOI 10.1111/mmi.12854; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; El-Kafafi ES, 2005, BIOCHEM J, V387, P669, DOI 10.1042/BJ20041281; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Glynn JM, 2008, PLANT CELL, V20, P2460, DOI 10.1105/tpc.108.061440; Glynn JM, 2009, PLANT J, V59, P700, DOI 10.1111/j.1365-313X.2009.03905.x; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Irieda H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03698-6; Itoh R, 2001, PLANT PHYSIOL, V127, P1644, DOI 10.1104/pp.010386; Johnson CB, 2015, MICROSC MICROANAL, V21, P313, DOI 10.1017/S1431927615000082; Johnson CB, 2013, MICROSC MICROANAL, V19, P507, DOI 10.1017/S143192761300038X; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koksharova OA, 2002, J BACTERIOL, V184, P5524, DOI 10.1128/JB.184.19.5524-5528.2002; Krol E., 2013, JOVE-J VIS EXP, V2013; Kuchibhatla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028262; Li Y, 2013, SCIENCE, V341, P392, DOI 10.1126/science.1239248; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUTKENHAUS J, 1993, MOL MICROBIOL, V9, P403, DOI 10.1111/j.1365-2958.1993.tb01701.x; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Maple J, 2007, EMBO REP, V8, P293, DOI 10.1038/sj.embor.7400902; Marbouty M, 2009, MOL MICROBIOL, V74, P409, DOI 10.1111/j.1365-2958.2009.06873.x; Martin W, 1999, EUR J PHYCOL, V34, P287, DOI 10.1017/S0967026299002231; Mazouni K, 2004, MOL MICROBIOL, V52, P1145, DOI 10.1111/j.1365-2958.2004.04042.x; McAndrew RS, 2008, BIOCHEM J, V412, P367, DOI 10.1042/BJ20071354; Miyagishima S, 2003, PLANT CELL, V15, P655, DOI 10.1105/tpc.009373; Miyagishima SY, 2004, J MOL EVOL, V58, P291, DOI 10.1007/s00239-003-2551-1; Modi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115918; Nakanishi H, 2009, CURR BIOL, V19, P151, DOI 10.1016/j.cub.2008.12.018; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Okazaki K, 2010, PLANT SIGNAL BEHAV, V5, P164, DOI 10.4161/psb.5.2.10461; Olson BJSC, 2010, J BIOL CHEM, V285, P20634, DOI 10.1074/jbc.M110.122614; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Osteryoung KW, 2001, ANNU REV PLANT PHYS, V52, P315, DOI 10.1146/annurev.arplant.52.1.315; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PYKE KA, 1994, PLANT PHYSIOL, V106, P1169, DOI 10.1104/pp.106.3.1169; Rabut G., 2005, LIVE CELL IMAGING LA, P101; ROBINSON SP, 1983, PLANT PHYSIOL, V73, P238, DOI 10.1104/pp.73.2.238; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimada H, 2004, PLANT CELL PHYSIOL, V45, P960, DOI 10.1093/pcp/pch130; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Smith AG, 2011, ARCH BIOCHEM BIOPHYS, V513, P94, DOI 10.1016/j.abb.2011.07.001; Smith AG, 2010, FEBS LETT, V584, P166, DOI 10.1016/j.febslet.2009.11.044; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stokes KD, 2003, GENE, V320, P97, DOI 10.1016/S0378-1119(03)00814-X; Stokes KD, 2000, PLANT PHYSIOL, V124, P1668, DOI 10.1104/pp.124.4.1668; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; TerBush AD, 2018, PLANT PHYSIOL, V176, P295, DOI 10.1104/pp.17.00558; TerBush AD, 2016, MICROSC MICROANAL, V22, P275, DOI 10.1017/S1431927616000143; TerBush AD, 2013, CURR OPIN CELL BIOL, V25, P461, DOI 10.1016/j.ceb.2013.04.006; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; Tian L, 2014, CURR OPIN PLANT BIOL, V22, P77, DOI 10.1016/j.pbi.2014.09.007; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Wang L, 2017, J PLANT BIOL, V60, P154, DOI 10.1007/s12374-016-0418-4; Wang WH, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.11; Yoshida Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.95, 10.1038/nplants.2016.95]; Zhang M, 2016, PLANT PHYSIOL, V170, P250, DOI 10.1104/pp.15.01460; Zhang M, 2013, PLANT CELL, V25, P1787, DOI 10.1105/tpc.113.111047; Zhang M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-101	85	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10692	10706		10.1074/jbc.RA117.000999	http://dx.doi.org/10.1074/jbc.RA117.000999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29769312	Green Published, hybrid			2022-12-28	WOS:000437828400025
J	Tiedt, O; Fuchs, J; Eisenreich, W; Boll, M				Tiedt, Oliver; Fuchs, Jonathan; Eisenreich, Wolfgang; Boll, Matthias			A catalytically versatile benzoyl-CoA reductase, key enzyme in the degradation of methyl- and halobenzoates in denitrifying bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biodegradation; radical; enzyme mechanism; coenzyme A (CoA); reductase; aromatic metabolism; benzoyl-coenzyme A; Birch reduction; enzymatic dehalogenation	ANAEROBIC AROMATIC METABOLISM; ARCHAEON FERROGLOBUS-PLACIDUS; THAUERA-AROMATICA; 4-HYDROXYBENZOYL-COA REDUCTASE; CLOSTRIDIUM-DIFFICILE; ELECTRON-ACCEPTORS; COENZYME; DEHALOGENASE; DEHYDRATASE; MECHANISM	Class I benzoyl-CoA (BzCoA) reductases (BCRs) are key enzymes in the anaerobic degradation of aromatic compounds. They catalyze the ATP-dependent reduction of the central BzCoA intermediate and analogues of it to conjugated cyclic 1,5-dienoyl-CoAs probably by a radical-based, Birch-like reduction mechanism. Discovered in 1995, the enzyme from the denitrifying bacterium Thauera aromatica (BCRTar) has so far remained the only isolated and biochemically accessible BCR, mainly because BCRs are extremely labile, and their heterologous production has largely failed so far. Here, we describe a platform for the heterologous expression of the four structural genes encoding a designated 3-methylbenzoyl-CoA reductase from the related denitrifying species Thauera chlorobenzoica (MBRTcl) in Escherichia coli. This reductase represents the prototype of a distinct subclass of ATP-dependent BCRs that were proposed to be involved in the degradation of methyl-substituted BzCoA analogues. The recombinant MBRTcl had an -subunit architecture, contained three low-potential [4Fe-4S] clusters, and was highly oxygen-labile. It catalyzed the ATP-dependent reductive dearomatization of BzCoA with 2.3-2.8 ATPs hydrolyzed per two electrons transferred and preferentially dearomatized methyl- and chloro-substituted analogues in meta- and para-positions. NMR analyses revealed that 3-methylbenzoyl-CoA is regioselectively reduced to 3-methyl-1,5-dienoyl-CoA. The unprecedented reductive dechlorination of 4-chloro-BzCoA to BzCoA probably via HCl elimination from a reduced intermediate allowed for the previously unreported growth of T. chlorobenzoica on 4-chlorobenzoate. The heterologous expression platform established in this work enables the production, isolation, and characterization of bacterial and archaeal BCR and BCR-like radical enzymes, for many of which the function has remained unknown.	[Tiedt, Oliver; Fuchs, Jonathan; Boll, Matthias] Albert Ludwigs Univ Freiburg, Fak Biol Mikrobiol, D-79104 Freiburg, Germany; [Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany	University of Freiburg; Technical University of Munich	Boll, M (corresponding author), Fac Biol, Inst Biol 2, Schanzlestr 1, D-79104 Freiburg, Germany.	matthias.boll@biologie.uni-freiburg.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279	German Research Foundation, Deutsche Forschungsgemeinschaft [BO 1565/14-1]	German Research Foundation, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft Project BO 1565/14-1. The authors declare that they have no conflicts of interest with the contents of this article.	Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; BIEGERT T, 1993, EUR J BIOCHEM, V213, P555, DOI 10.1111/j.1432-1033.1993.tb17794.x; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; Boll M, 2000, J BIOL CHEM, V275, P21889, DOI 10.1074/jbc.M001833200; Boll M, 2005, BBA-BIOENERGETICS, V1707, P34, DOI 10.1016/j.bbabio.2004.01.009; Boll M, 2001, J BIOL CHEM, V276, P47853, DOI 10.1074/jbc.M106766200; Boll M, 1997, EUR J BIOCHEM, V244, P840, DOI 10.1111/j.1432-1033.1997.00840.x; Boll M, 1998, EUR J BIOCHEM, V251, P946, DOI 10.1046/j.1432-1327.1998.2510946.x; Boll M, 2000, J BIOL CHEM, V275, P31857, DOI 10.1074/jbc.M001508200; Boll M, 2014, ENVIRON MICROBIOL, V16, P612, DOI 10.1111/1462-2920.12328; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breese K, 1998, EUR J BIOCHEM, V256, P148, DOI 10.1046/j.1432-1327.1998.2560148.x; Buckel W, 2014, CHEMBIOCHEM, V15, P2188, DOI 10.1002/cbic.201402270; Buckel W, 2012, BBA-PROTEINS PROTEOM, V1824, P1278, DOI 10.1016/j.bbapap.2011.11.009; Chae JC, 2008, FEMS MICROBIOL LETT, V281, P203, DOI 10.1111/j.1574-6968.2008.01106.x; CHANG KH, 1992, BIOCHEMISTRY-US, V31, P5605, DOI 10.1021/bi00139a025; CROOKS GP, 1995, J AM CHEM SOC, V117, P10791, DOI 10.1021/ja00149a001; Dagley S, 1971, Adv Microb Physiol, V6, P1, DOI 10.1016/S0065-2911(08)60066-1; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; Dong J, 2003, BIOCHEMISTRY-US, V42, P9482, DOI 10.1021/bi0347656; Dong J, 2002, BIOCHEMISTRY-US, V41, P7453, DOI 10.1021/bi020186+; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; HAGGBLOM MM, 1993, APPL ENVIRON MICROB, V59, P1162; Haggblom MM, 1996, FEMS MICROBIOL LETT, V144, P213, DOI 10.1111/j.1574-6968.1996.tb08533.x; Jeoung JH, 2018, P NATL ACAD SCI USA, V115, P2994, DOI 10.1073/pnas.1720489115; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joshi S, 2017, J AM CHEM SOC, V139, P10952, DOI 10.1021/jacs.7b04209; Juarez JF, 2013, ENVIRON MICROBIOL, V15, P148, DOI 10.1111/j.1462-2920.2012.02818.x; KAZUMI J, 1995, APPL MICROBIOL BIOT, V43, P929, DOI 10.1007/BF02431930; Kim J, 2005, FEBS J, V272, P550, DOI 10.1111/j.1742-4658.2004.04498.x; Kim J, 2010, CHEMPHYSCHEM, V11, P1307, DOI 10.1002/cphc.200900876; Knauer SH, 2012, BIOCHEMISTRY-US, V51, P6609, DOI 10.1021/bi300571z; Knauer SH, 2011, J AM CHEM SOC, V133, P4342, DOI 10.1021/ja1076537; Kung JW, 2010, J AM CHEM SOC, V132, P9850, DOI 10.1021/ja103448u; Kung JW, 2009, P NATL ACAD SCI USA, V106, P17687, DOI 10.1073/pnas.0905073106; Kuntze K, 2011, MOL MICROBIOL, V82, P758, DOI 10.1111/j.1365-2958.2011.07856.x; Lahme S, 2012, ENVIRON MICROBIOL, V14, P1118, DOI 10.1111/j.1462-2920.2011.02693.x; Lau EY, 2001, P NATL ACAD SCI USA, V98, P9527, DOI 10.1073/pnas.161282698; Loffler C, 2011, ENVIRON MICROBIOL, V13, P696, DOI 10.1111/j.1462-2920.2010.02374.x; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Mobitz H, 2004, BIOCHEMISTRY-US, V43, P1376, DOI 10.1021/bi0358871; Mobitz H, 2002, BIOCHEMISTRY-US, V41, P1752, DOI 10.1021/bi0113770; Peters JE, 2003, J BACTERIOL, V185, P2017, DOI 10.1128/JB.185.6.2017-2021.2003; PFENNIG N, 1978, INT J SYST BACTERIOL, V28, P283, DOI 10.1099/00207713-28-2-283; Rabideau PW., 1992, ORG REACT, V48, P1, DOI DOI 10.1002/0471264180.or042.01; SCHACHTER D, 1953, J BIOL CHEM, V203, P925; Schmid G, 2016, BIOCHEMISTRY-US, V55, P5578, DOI 10.1021/acs.biochem.6b00729; Schmid G, 2015, ENVIRON MICROBIOL, V17, P3289, DOI 10.1111/1462-2920.12785; Song B, 2002, FEMS MICROBIOL LETT, V213, P183, DOI 10.1111/j.1574-6968.2002.tb11303.x; Song B, 2000, INT J SYST EVOL MICR, V50, P551, DOI 10.1099/00207713-50-2-551; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Thiele B, 2008, J AM CHEM SOC, V130, P14050, DOI 10.1021/ja805091w; Thiele B, 2008, J BIOL CHEM, V283, P20713, DOI 10.1074/jbc.M802841200; Tiedt O, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02579; Tiedt O, 2016, MBIO, V7, DOI 10.1128/mBio.00990-16; Unciuleac M, 2004, STRUCTURE, V12, P2249, DOI 10.1016/j.str.2004.10.008; Unciuleac M, 2001, P NATL ACAD SCI USA, V98, P13619, DOI 10.1073/pnas.241375598; Weinert T, 2015, NAT CHEM BIOL, V11, P586, DOI 10.1038/nchembio.1849; Yamamoto S, 2006, IUBMB LIFE, V58, P248, DOI 10.1080/15216540600719655	63	13	13	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10264	10274		10.1074/jbc.RA118.003329	http://dx.doi.org/10.1074/jbc.RA118.003329			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769313	Green Published, hybrid			2022-12-28	WOS:000437096700025
J	De, P; McNeil, M; Xia, M; Boot, CM; Hesser, DC; Denef, K; Rithner, C; Sours, T; Dobos, KM; Hoft, D; Chatterjee, D				De, Prithwiraj; McNeil, Michael; Xia, Mei; Boot, Claudia M.; Hesser, Danny C.; Denef, Karolien; Rithner, Christopher; Sours, Tyler; Dobos, Karen M.; Hoft, Daniel; Chatterjee, Delphi			Structural determinants in a glucose-containing lipopolysaccharide from Mycobacterium tuberculosis critical for inducing a subset of protective T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tuberculosis; vaccine; analytical chemistry; carbohydrate chemistry; carbohydrate function; T cells; lipoglycan; structural analysis	ADAPTIVE IMMUNE-RESPONSE; MASS-SPECTROMETRY; METHYLGLUCOSE LIPOPOLYSACCHARIDE; ELECTROSPRAY-IONIZATION; REVISED STRUCTURE; M. TUBERCULOSIS; CALMETTE-GUERIN; BIOSYNTHESIS; POLYSACCHARIDES; PURIFICATION	Mycobacteria synthesize intracellular, 6-O-methylglucose-containing lipopolysaccharides (mGLPs) proposed to modulate bacterial fatty acid metabolism. Recently, it has been shown that Mycobacterium tuberculosis mGLP specifically induces a specific subset of protective (92) T cells. Mild base treatment, which removes all the base-labile groups, reduces the specific activity of mGLP required for induction of these T cells, suggesting that acylation of the saccharide moieties is required for (92) T-cell activation. On the basis of this premise, we used analytical LC/MS and NMR methods to identify and locate the acyl functions on the mGLP saccharides. We found that mGLP is heterogeneous with respect to acyl functions and contains acetyl, isobutyryl, succinyl, and octanoyl groups and that all acylations in mGLP, except for succinyl and octanoyl residues, reside on the glucosyl residues immediately following the terminal 3-O-methylglucose. Our analyses also indicated that the octanoyl residue resides at position 2 of an internal glucose toward the reducing end. LC/MS analysis of the residual product obtained by digesting the mGLP with pancreatic -amylase revealed that the product is an oligosaccharide terminated by -(14)-linked 6-O-methyl-d-glucosyl residues. This oligosaccharide retained none of the acyl groups, except for the octanoyl group, and was unable to induce protective (92) T cells. This observation confirmed that mGLP induces (92) T cells and indicated that the acylated glucosyl residues at the nonreducing terminus of mGLP are required for this activity.	[De, Prithwiraj; McNeil, Michael; Hesser, Danny C.; Dobos, Karen M.; Chatterjee, Delphi] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Boot, Claudia M.; Denef, Karolien; Rithner, Christopher; Sours, Tyler] Colorado State Univ, Cent Instrument Facil, Dept Chem, Ft Collins, CO 80523 USA; [Xia, Mei; Hoft, Daniel] St Louis Univ, Dept Internal Med, St Louis, MO 63104 USA	Colorado State University; Colorado State University; Saint Louis University	Chatterjee, D (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Delphi.chatterjee@colostate.edu	Boot, Claudia M/C-8622-2013; McNeil, Michael/G-3325-2019; De, Prithwiraj/S-1199-2019; Dobos, Karen/D-1170-2017	Boot, Claudia M/0000-0002-1487-242X; De, Prithwiraj/0000-0003-4499-2147; Dobos, Karen/0000-0001-7115-8524	National Institutes of Health [2R01AI048391-09]; Bill and Melinda Gates Foundation [OPP1118659]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 2R01AI048391-09 (to D. H.) and Bill and Melinda Gates Foundation Grant OPP1118659 (to D. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abate G, 2016, INFECT IMMUN, V84, P580, DOI 10.1128/IAI.01262-15; Alalouf O, 2011, J BIOL CHEM, V286, P41993, DOI 10.1074/jbc.M111.301051; ANET FAL, 1992, J AM CHEM SOC, V114, P411, DOI 10.1021/ja00028a004; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Chatterjee D, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P147; Chen CY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003501; Chen ZW, 2016, CURR OPIN IMMUNOL, V42, P105, DOI 10.1016/j.coi.2016.06.005; Chen ZW, 2013, CELL MOL IMMUNOL, V10, P1, DOI 10.1038/cmi.2012.73; Chen ZW, 2013, CELL MOL IMMUNOL, V10, P58, DOI 10.1038/cmi.2012.46; Chen ZW, 2003, MICROBES INFECT, V5, P491, DOI 10.1016/S1286-4579(03)00074-1; Chen ZW, 2003, TRENDS IMMUNOL, V24, P213, DOI 10.1016/S1471-4906(03)00032-2; DELL A, 1983, CARBOHYD RES, V120, P95, DOI 10.1016/0008-6215(83)88010-0; Dinadayala P, 2004, J BIOL CHEM, V279, P12369, DOI 10.1074/jbc.M308908200; FORSBERG LS, 1982, J BIOL CHEM, V257, P3555; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gest P, 2008, ACTA CRYSTALLOGR F, V64, P1121, DOI 10.1107/S1744309108032892; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; HILL RE, 1987, J BIOL CHEM, V262, P7463; HINDSGAUL O, 1984, BIOCHEMISTRY-US, V23, P577, DOI 10.1021/bi00298a028; Hopper JTS, 2012, ANAL BIOCHEM, V421, P788, DOI 10.1016/j.ab.2011.10.034; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P466, DOI 10.1016/j.jasms.2006.10.012; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; KAMISANGO K, 1987, J BIOL CHEM, V262, P4580; Kaur D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005447; LEE YC, 1964, J BIOL CHEM, V239, P3602; LEE YC, 1966, J BIOL CHEM, V241, P1899; Maranha A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13610; Matwiejuk M, 2011, CHEM COMMUN, V47, P8379, DOI 10.1039/c1cc11690h; Meng XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep35261; Nunes-Costa D, 2017, GLYCOBIOLOGY, V27, P213, DOI 10.1093/glycob/cww132; POMMIER MT, 1986, J GEN MICROBIOL, V132, P2433; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; SAWYER DT, 1966, ANAL CHEM, V38, P192, DOI 10.1021/ac60234a011; Shen L, 2004, J INFECT DIS, V190, P1438, DOI 10.1086/423939; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; SMITH WL, 1973, J BIOL CHEM, V248, P7118; Spencer CT, 2008, J IMMUNOL, V181, P4471, DOI 10.4049/jimmunol.181.7.4471; Spencer CT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003119; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; TUFFAL G, 1995, J CARBOHYD CHEM, V14, P631, DOI 10.1080/07328309508005364; Tuffal G, 1998, GLYCOBIOLOGY, V8, P675, DOI 10.1093/glycob/8.7.675; Usui T., 2014, J AGR BIOL CHEM, V39, P1071; Worku S, 2003, INFECT IMMUN, V71, P1763, DOI 10.1128/IAI.71.4.1763-1773.2003; Xia M, 2016, INFECT IMMUN, V84, P2449, DOI 10.1128/IAI.01322-15; YABUSAKI KK, 1979, J BIOL CHEM, V254, P2314; Zhang ZQ, 2009, CURR ANAL CHEM, V5, P225, DOI 10.2174/157341109788680291	47	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9706	9717		10.1074/jbc.RA118.002582	http://dx.doi.org/10.1074/jbc.RA118.002582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29716995	hybrid, Green Published			2022-12-28	WOS:000436102300015
J	Lee, JA; Wang, ZQ; Sambo, D; Bunting, KD; Pallas, DC				Lee, Jocelyn A.; Wang, Zhengqi; Sambo, Danielle; Bunting, Kevin D.; Pallas, David C.			Global loss of leucine carboxyl methyltransferase-1 causes severe defects in fetal liver hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein serine; threonine phosphatase (PSP); protein phosphatase 2 (PP2A); hematopoiesis; development; mouse; LCMT-1; protein phosphatase methyltransferase	PROTEIN PHOSPHATASE 2A; PP2A CATALYTIC SUBUNIT; BOVINE BRAIN; METHYL ESTERIFICATION; SELF-RENEWAL; IN-VIVO; SACCHAROMYCES-CEREVISIAE; NEUROBLASTOMA-CELLS; REGULATORY SUBUNITS; ERYTHROID-CELLS	Leucine carboxyl methyltransferase-1 (LCMT-1) methylates the C-terminal leucine -carboxyl group of the catalytic subunits of the protein phosphatase 2A (PP2A) subfamily of protein phosphatases, PP2Ac, PP4c, and PP6c. LCMT-1 differentially regulates the formation and function of a subset of the heterotrimeric complexes that PP2A and PP4 form with their regulatory subunits. Global LCMT-1 knockout causes embryonic lethality in mice, but LCMT-1 function in development is unknown. In this study, we analyzed the effects of global LCMT-1 loss on embryonic development. LCMT-1 knockout causes loss of PP2Ac methylation, indicating that LCMT-1 is the sole PP2Ac methyltransferase. PP2A heterotrimers containing the B and B B-type subunits are dramatically reduced in whole embryos, and the steady-state levels of PP2Ac and the PP2A structural A subunit are also down approximate to 30%. Strikingly, global loss of LCMT-1 causes severe defects in fetal hematopoiesis and usually death by embryonic day 16.5. Fetal livers of homozygous lcmt-1 knockout embryos display hypocellularity, elevated apoptosis, and greatly reduced numbers of hematopoietic stem and progenitor cell-enriched Kit(+)Lin(-)Sca1(+) cells. The percent cycling cells and mitotic indices of WT and lcmt-1 knockout fetal liver cells are similar, suggesting that hypocellularity may be due to a combination of apoptosis and/or defects in specification, self-renewal, or survival of stem cells. Indicative of a possible intrinsic defect in stem cells, noncompetitive and competitive transplantation experiments reveal that lcmt-1 loss causes a severe multilineage hematopoietic repopulating defect. Therefore, this study reveals a novel role for LCMT-1 as a key player in fetal liver hematopoiesis.	[Lee, Jocelyn A.; Sambo, Danielle; Pallas, David C.] Emory Univ, Sch Med, Winship Canc Inst, Biochem Cell & Dev Grad Program,Dept Biochem, Atlanta, GA 30322 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Sch Med, Aflac Canc & Blood Disorders Ctr Childrens Hlth A, Dept Pediat,Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Pallas, DC (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	dpallas@emory.edu			National Institutes of Health from NCI [R01 CA57327, R01DK059380, P30CA138292]; University Research Committee at Emory University; Aflac Cancer and Blood Disorder Center; NATIONAL CANCER INSTITUTE [R01CA057327, F31CA123640, P30CA138292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059380] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University Research Committee at Emory University; Aflac Cancer and Blood Disorder Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant R01 CA57327 from NCI (to D.C.P.), National Institutes of Health Grant R01DK059380 (to K.D.B.), and National Institutes of Health P30CA138292 from NCI (Emory Winship Cancer Institute), and in part by the University Research Committee at Emory University (to D.C.P.) and the Aflac Cancer and Blood Disorder Center (to K.D.B. and Z.W.). Dr. David Pallas is entitled to royalty from the sale of products related to the research described in this paper by Millipore, Inc., Santa Cruz Biotechnologies, Inc., and Novus Biologicals, Inc. In addition, Dr. David Pallas serves as a consultant to Millipore. The terms of these arrangements have been reviewed and approved by Emory University in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Predoctoral Fellowship Grant F31CA123640 from NCI.	Baron MH, 2003, EXP HEMATOL, V31, P1160, DOI 10.1016/j.exphem.2003.08.019; Brechmann M, 2012, IMMUNITY, V37, P697, DOI 10.1016/j.immuni.2012.07.014; Chen WQ, 2011, AM J PATHOL, V178, P2333, DOI 10.1016/j.ajpath.2011.01.041; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Dudiki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141961; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; FLOER M, 1994, BIOCHEM BIOPH RES CO, V198, P372, DOI 10.1006/bbrc.1994.1052; Gentry MS, 2005, EUKARYOT CELL, V4, P1029, DOI 10.1128/EC.4.6.1029-1040.2005; Haesen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00347; Harrison DE, 1997, BLOOD, V90, P174; He QP, 2015, BLOOD, V125, P1098, DOI 10.1182/blood-2014-09-601542; Hwang J, 2016, J BIOL CHEM, V291, P21008, DOI 10.1074/jbc.M116.739920; Ikehara T, 2007, BIOCHEM BIOPH RES CO, V354, P1052, DOI 10.1016/j.bbrc.2007.01.085; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kalhor HR, 2001, ARCH BIOCHEM BIOPHYS, V395, P239, DOI 10.1006/abbi.2001.2558; Kauts ML, 2016, FEBS LETT, V590, P3975, DOI 10.1002/1873-3468.12372; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lee J. A., 2006, AFCS NATURE MOL; Lee JA, 2007, J BIOL CHEM, V282, P30974, DOI 10.1074/jbc.M704861200; LI M, 1994, BIOCHEM BIOPH RES CO, V202, P1023, DOI 10.1006/bbrc.1994.2031; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Longman MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086234; MacKay KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065967; Morioka K, 1998, EXP CELL RES, V240, P206, DOI 10.1006/excr.1997.3927; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Palis J, 2016, FEBS LETT, V590, P3965, DOI 10.1002/1873-3468.12459; Pan XY, 2015, REPRODUCTION, V149, P385, DOI 10.1530/REP-14-0231; Pontius J., 2003, NCBI HDB, P1; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sontag JM, 2013, J BIOL CHEM, V288, P27396, DOI 10.1074/jbc.M113.490102; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Tikhonova A, 2012, IMMUNITY, V37, P594, DOI 10.1016/j.immuni.2012.10.006; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu JH, 2000, J OPT COMMUN, V21, P10, DOI 10.1515/JOC.2000.21.1.10; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xiu Y, 2017, STEM CELLS, V35, P777, DOI 10.1002/stem.2523; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yoder MC, 2002, ACTA PAEDIATR, V91, P5, DOI 10.1080/080352502320764139; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhao BB, 2016, DEV CELL, V36, P498, DOI 10.1016/j.devcel.2016.02.001; Zhao C, 2012, STEM CELLS, V30, P709, DOI 10.1002/stem.1050	58	8	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9636	9650		10.1074/jbc.RA118.002012	http://dx.doi.org/10.1074/jbc.RA118.002012			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29735529	hybrid, Green Published			2022-12-28	WOS:000436102300008
J	Oganesyan, V; Peng, L; Bee, JS; Li, J; Perry, SR; Comer, F; Xu, LD; Cook, K; Senthil, K; Clarke, L; Rosenthal, K; Gao, CS; Damschroder, M; Wu, H; Dall'Acqua, W				Oganesyan, Vaheh; Peng, Li; Bee, Jared S.; Li, John; Perry, Samuel R.; Comer, Frank; Xu, Linda; Cook, Kimberly; Senthil, Kannaki; Clarke, Lori; Rosenthal, Kim; Gao, Changshou; Damschroder, Melissa; Wu, Herren; Dall'Acqua, William			Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						analytical ultracentrifugation; antibody; crystallography; epitope mapping; phosphorylation	EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER; FACTOR-RECEPTOR; LIGAND; COMBINATION; ACTIVATION; SURVIVAL; LINKERS; BINDING; DESIGN	Pathways of human epidermal growth factor (EGF) receptors are activated upon ligand-dependent or -independent homo- or heterodimerization and their subsequent transphosphorylation. Overexpression of these receptors positively correlates with transphosphorylation rates and increased tumor growth rates. MEDI4276, an anti-human epidermal growth factor receptor 2 (HER2) biparatopic antibody-drug conjugate, has two paratopes within each antibody arm. One, 39S, is aiming at the HER2 site involved in receptor dimerization and the second, single chain fragment (scFv), mimicking trastuzumab. Here we present the cocrystal structure of the 39S Fab-HER2 complex and, along with biophysical and functional assays, determine the corresponding epitope of MEDI4276 and its underlying mechanism of action. Our results reveal that MEDI4276's uniqueness is based first on the ability of its 39S paratope to block HER2 homo- or heterodimerization and second on its ability to cluster the receptors on the surface of receptor-overexpressing cells.	[Oganesyan, Vaheh; Peng, Li; Xu, Linda; Cook, Kimberly; Senthil, Kannaki; Clarke, Lori; Rosenthal, Kim; Gao, Changshou; Damschroder, Melissa; Wu, Herren; Dall'Acqua, William] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Bee, Jared S.] MedImmune, Dept Analyt Sci, Gaithersburg, MD 20878 USA; [Li, John; Perry, Samuel R.; Comer, Frank] MedImmune, Dept Biosuper, Gaithersburg, MD 20878 USA; [Peng, Li] Palleon Pharmaceut, 266 Second Ave, Waltham, MA 02451 USA; [Bee, Jared S.] MacroGenics, 9704 Med Ctr Dr, Rockville, MD 20850 USA; [Li, John] Salubris Biotherapeut Inc, 45 W Watkins Mill Rd, Gaithersburg, MD 20878 USA; [Perry, Samuel R.] Agilis Biotherapeut, 245 First St,Ste 1800, Cambridge, MA 02142 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Oganesyan, V; Dall'Acqua, W (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	oganesyanv@medimmune.com; dallacquaw@medimmune.com		Bee, Jared/0000-0002-4391-0560; Oganesyan, Vaheh/0000-0001-8910-9202	MedImmune LLC.	MedImmune LLC.(AstraZenecaMedimmune)	This work was supported by MedImmune LLC. The authors declare that they have no conflicts of interest with the contents of this article.	Adolf-Bryfogle J, 2015, NUCLEIC ACIDS RES, V43, pD432, DOI 10.1093/nar/gku1106; Arkhipov A, 2013, ELIFE, V2, DOI 10.7554/eLife.00708; Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brennan PJ, 2000, ONCOGENE, V19, P6093, DOI 10.1038/sj.onc.1203967; Brinkmann U, 2017, MABS-AUSTIN, V9, P182, DOI 10.1080/19420862.2016.1268307; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kasturirangan S, 2017, J BIOL CHEM, V292, P4361, DOI 10.1074/jbc.M116.770628; Klein JS, 2014, PROTEIN ENG DES SEL, V27, P325, DOI 10.1093/protein/gzu043; Kurata T, 2014, INVEST NEW DRUG, V32, P946, DOI 10.1007/s10637-014-0112-7; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li JY, 2016, CANCER CELL, V29, P117, DOI 10.1016/j.ccell.2015.12.008; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Maly JJ, 2014, BREAST CANCER-BASIC, V8, P81, DOI 10.4137/BCBCR.S9032; Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nahta R., 2012, MOL MECH TRASTUZUMAB, V2012, DOI [10.5402/2012/428062, DOI 10.5402/2012/428062]; Nordstrom JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3069; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel TA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0419-5; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Stein RA, 2000, J MOL EVOL, V50, P397, DOI 10.1007/s002390010043; USHIRO H, 1980, J BIOL CHEM, V255, P8363; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	36	27	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8439	8448		10.1074/jbc.M117.818013	http://dx.doi.org/10.1074/jbc.M117.818013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29669810	Green Published, hybrid			2022-12-28	WOS:000434205700009
J	Cohen, A; Habib, A; Laor, D; Yadav, S; Kupiec, M; Weisman, R				Cohen, Adiel; Habib, Aline; Laor, Dana; Yadav, Sudhanshu; Kupiec, Martin; Weisman, Ronit			TOR complex 2 in fission yeast is required for chromatin-mediated gene silencing and assembly of heterochromatic domains at subtelomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; heterochromatin; gene silencing; gene expression; Schizosaccharomyces pombe; Epe1; mating-type locus; Paf1 complex; subtelomeres; TORC2	REGULATES MITOTIC COMMITMENT; SCHIZOSACCHAROMYCES-POMBE; PAF1 COMPLEX; NITROGEN STARVATION; LYSINE-9 METHYLATION; HISTONE ACETYLATION; EPIGENETIC CONTROL; KINASE PATHWAY; PROTEIN; RNAI	The conserved serine/threonine protein kinase target of rapamycin (TOR) is a major regulator of eukaryotic cellular and organismal growth and a valuable target for drug therapy. TOR forms the core of two evolutionary conserved complexes, TOR complex 1 (TORC1) and TORC2. In the fission yeast Schizosaccharomyces pombe, TORC2 responds to glucose levels and, by activating the protein kinase Gad8 (an orthologue of human AKT), is required for well-regulated cell cycle progression, starvation responses, and cell survival. Here, we report that TORC2-Gad8 is also required for gene silencing and the formation of heterochromatin at the S. pombe mating-type locus and at subtelomeric regions. Deletion of TORC2-Gad8 resulted in loss of the heterochromatic modification of histone 3 lysine 9 dimethylation (H3K9me2) and an increase in euchromatic modifications, including histone 3 lysine 4 trimethylation (H3K4me3) and histone 4 lysine 16 acetylation (H4K16Ac). Accumulation of RNA polymerase II (Pol II) at subtelomeric genes in TORC2-Gad8 mutant cells indicated a defect in silencing at the transcriptional level. Moreover, a concurrent decrease in histone 4 lysine 20 dimethylation (H4K20me2) suggested elevated histone turnover. Loss of gene silencing in cells lacking TORC2-Gad8 is partially suppressed by loss of the anti-silencer Epe1 and fully suppressed by loss of the Pol II-associated Paf1 complex, two chromatin regulators that have been implicated in heterochromatin stability and spreading. Taken together, our findings suggest that TORC2-Gad8 signaling contributes to epigenetic stability at subtelomeric regions and the mating-type locus in S. pombe.	[Cohen, Adiel; Yadav, Sudhanshu; Weisman, Ronit] Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Ranana, Israel; [Habib, Aline; Laor, Dana; Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69977801 Tel Aviv, Israel; [Yadav, Sudhanshu] CSIC, Dept Immunol & Oncol, Natl Biotechnol Ctr, Darwin 3 Cantoblanco, Madrid 28049, Spain	Open University Israel; Tel Aviv University; Consejo Superior de Investigaciones Cientificas (CSIC)	Weisman, R (corresponding author), Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Ranana, Israel.	ronitwe@openu.ac.il		Yadav, Sudhanshu/0000-0003-0418-8058; Laor Bar-Yosef, Dana/0000-0003-1699-3839	Israel Science Foundation [688/14]; Open University of Israel [31040]	Israel Science Foundation(Israel Science Foundation); Open University of Israel	This work was supported by Israel Science Foundation Grant 688/14 and Open University of Israel Grant 31040 (to R. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Allshire RC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018770; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Atlasi Y, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.57; Aygun O, 2013, NAT STRUCT MOL BIOL, V20, P547, DOI 10.1038/nsmb.2565; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baker K, 2016, J CELL SCI, V129, P2613, DOI 10.1242/jcs.190124; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chen HF, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-29; Cohen A, 2016, J BIOL CHEM, V291, P9371, DOI 10.1074/jbc.M115.705251; Cohen A, 2014, J BIOL CHEM, V289, P21727, DOI 10.1074/jbc.M114.573824; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dheur S, 2011, MOL CELL BIOL, V31, P1088, DOI 10.1128/MCB.01290-10; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hansen KR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001268; Hatano T, 2015, CELL CYCLE, V14, P848, DOI 10.1080/15384101.2014.1000215; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Inada M, 2016, NUCLEIC ACIDS RES, V44, P9180, DOI 10.1093/nar/gkw603; Isaac S, 2007, GENETICS, V175, P1549, DOI 10.1534/genetics.106.068684; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Jih G, 2017, NATURE, V547, P463, DOI 10.1038/nature23267; Kawai M, 2001, CURR GENET, V39, P166; Kowalik KM, 2015, NATURE, V520, P248, DOI 10.1038/nature14337; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Laboucarie T, 2017, EMBO REP, V18, P2197, DOI 10.15252/embr.201744942; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laor D, 2015, MBIO, V6, DOI 10.1128/mBio.00959-15; Lee NN, 2013, CELL, V155, P1061, DOI 10.1016/j.cell.2013.10.027; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Martin R, 2017, CURR BIOL, V27, P175, DOI 10.1016/j.cub.2016.11.037; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Mbogning J, 2015, NUCLEIC ACIDS RES, V43, P9766, DOI 10.1093/nar/gkv837; Mikheyeva IV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004740; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Otsubo Y, 2008, CRIT REV BIOCHEM MOL, V43, P277, DOI [10.1080/10409230802254911, 10.1080/10409230802254911 ]; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Petersen J, 2009, BIOCHEM SOC T, V37, P273, DOI 10.1042/BST0370273; Reyes-Turcu FE, 2011, NAT STRUCT MOL BIOL, V18, P1132, DOI 10.1038/nsmb.2122; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Sadeghi L, 2015, EMBO REP, V16, P1673, DOI 10.15252/embr.201541214; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schonbrun M, 2013, J BIOL CHEM, V288, P19649, DOI 10.1074/jbc.M113.464974; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Shimada A, 2009, GENE DEV, V23, P18, DOI 10.1101/gad.1708009; Shimada Y, 2016, GENE DEV, V30, P2571, DOI 10.1101/gad.292599.116; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Sugiyama T, 2016, MOL CELL, V61, P747, DOI 10.1016/j.molcel.2016.01.029; Svensson JP, 2015, GENOME RES, V25, P872, DOI 10.1101/gr.188870.114; Tashiro S, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx780; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Thon G, 2000, GENETICS, V155, P551; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Van Oss SB, 2017, TRENDS BIOCHEM SCI, V42, P788, DOI 10.1016/j.tibs.2017.08.003; Verrier L, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150045; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JY, 2013, GENE DEV, V27, P1886, DOI 10.1101/gad.221010.113; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Weisman R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0006-2016; Workman JJ, 2016, GENETICS, V203, P1733, DOI 10.1534/genetics.116.188458; Workman JJ, 2014, CELL CYCLE, V13, P714, DOI 10.4161/cc.28112; Yi SA, 2016, MOL CELL, V62, P443, DOI 10.1016/j.molcel.2016.03.011; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	78	16	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8138	8150		10.1074/jbc.RA118.002270	http://dx.doi.org/10.1074/jbc.RA118.002270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632066	Green Published, hybrid			2022-12-28	WOS:000433224600019
J	Rohena-Rivera, K; Bhowmick, NA				Rohena-Rivera, Krizia; Bhowmick, Neil A.			Notch inhibitor screening reveals an unexpected HES1 heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROHIBITIN 2; CANCER	Notch signaling plays critical roles in cancer progression, motivating efforts to identify inhibitors of this pathway. Perron et al. report a small-molecule screen intended to discover compounds that could interfere with the downstream transcription factor HES1. Target validation of their compounds unexpectedly identified a novel HES1-interacting protein, prohibitin 2. This highlights a new mechanism to block Notch signaling and prompting further exploration of HES1 biology.	[Rohena-Rivera, Krizia; Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Bhowmick, Neil A.] Greater Los Angeles Vet Affairs Hosp, Dept Res, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	bhowmickn@cshs.org	Bhowmick, Neil/AAA-7302-2019	Bhowmick, Neil/0000-0001-8747-5989	NCI, National Institutes of Health [CA098912]; U. S. Department of Veterans Affairs [I01BX001040]; NATIONAL CANCER INSTITUTE [P01CA098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007770] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001040] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U. S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NCI, National Institutes of Health Grant CA098912 and U. S. Department of Veterans Affairs Grant I01BX001040. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bavelloni A, 2015, IUBMB LIFE, V67, P239, DOI 10.1002/iub.1366; Kumar R, 2016, J MED CHEM, V59, P7719, DOI 10.1021/acs.jmedchem.5b01516; Liu ZH, 2015, CANCER BIOL THER, V16, P353, DOI 10.1080/15384047.2015.1016662; Locatelli MA, 2017, ONCOTARGET, V8, P2320, DOI 10.18632/oncotarget.13727; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Perron A, 2018, J BIOL CHEM, V293, P8285, DOI 10.1074/jbc.RA118.002316; Schnell SA, 2015, BLOOD, V125, P2806, DOI 10.1182/blood-2014-10-608448; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Yen WC, 2015, CLIN CANCER RES, V21, P2084, DOI 10.1158/1078-0432.CCR-14-2808; Yuan X, 2015, CANCER LETT, V369, P20, DOI 10.1016/j.canlet.2015.07.048	10	2	3	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8295	8296		10.1074/jbc.H118.002880	http://dx.doi.org/10.1074/jbc.H118.002880			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29802140	Green Published, hybrid			2022-12-28	WOS:000433224600033
J	Sun, J; Hu, QW; Peng, H; Peng, C; Zhou, LH; Lu, JS; Huang, CX				Sun, Jian; Hu, Qianwen; Peng, Hong; Peng, Cheng; Zhou, Liheng; Lu, Jinsong; Huang, Chuanxin			The ubiquitin-specific protease USP8 deubiquitinates and stabilizes Cx43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin ligase; ubiquitylation (ubiquitination); autophagy; connexin; deubiquitylation (deubiquitination); USP8; Cx43; ubiquitin; degradation; autophagy	GAP-JUNCTIONS; INTERCELLULAR COMMUNICATION; PLASMA-MEMBRANE; CONNEXINS; DEGRADATION; INTERNALIZATION; AUTOPHAGY; DISEASE; CANCER; ENDOCYTOSIS	Connexin-43 (Cx43, also known as GJA1) is the most ubiquitously expressed connexin isoform in mammalian tissues. It forms intercellular gap junction (GJ) channels, enabling adjacent cells to communicate both electrically and metabolically. Cx43 is a short-lived protein which can be quickly degraded by the ubiquitin-dependent proteasomal, endolysosomal, and autophagosomal pathways. Here, we report that the ubiquitin-specific peptidase 8 (USP8) interacts with and deubiquitinates Cx43. USP8 reduces both multiple monoubiquitination and polyubiquitination of Cx43 to prevent autophagy-mediated degradation. Consistently, knockdown of USP8 results in decreased Cx43 protein levels in cultured cells and suppresses intercellular communication, revealed by the dye transfer assay. In human breast cancer specimens, the expression levels of USP8 and Cx43 proteins are positively correlated. Taken together, these results identified USP8 as a crucial and bona fide deubiquitinating enzyme involved in autophagy-mediated degradation of Cx43.	[Sun, Jian; Zhou, Liheng; Lu, Jinsong] Shanghai Jiao Tong Univ, Renji Hosp, Dept Breast Surg, Sch Med, Shanghai 200025, Peoples R China; [Hu, Qianwen; Peng, Hong; Peng, Cheng; Huang, Chuanxin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; [Hu, Qianwen; Peng, Hong; Peng, Cheng; Huang, Chuanxin] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, JS (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Breast Surg, Sch Med, Shanghai 200025, Peoples R China.; Huang, CX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China.; Huang, CX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China.	lujjss@163.com; huangcx@shsmu.edu.cn			1000 Youth Elite Program; Shanghai Jiao Tong University School of Medicine [15PJ1407400]; Science and Technology Commission of Shanghai Municipality Grant [1402700]; National Natural Science Foundation of China [81172505]; Municipality Cross Research Foundation of Shanghai Jiao Tong University [YG2017QN49]; Shanghai Municipality Commission of Health and Family Planning [201640006]; Shanghai Pujiang Scholarship [15PJ1407400]	1000 Youth Elite Program; Shanghai Jiao Tong University School of Medicine; Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipality Cross Research Foundation of Shanghai Jiao Tong University; Shanghai Municipality Commission of Health and Family Planning; Shanghai Pujiang Scholarship(Shanghai Pujiang Program)	This work was supported in part by the 1000 Youth Elite Program, the startup fund by Shanghai Jiao Tong University School of Medicine and Shanghai Pujiang Scholarship 15PJ1407400 (to C. H.); Science and Technology Commission of Shanghai Municipality Grant 1402700 (to J. L.); National Natural Science Foundation of China Grant 81172505 (to J. L.); Municipality Cross Research Foundation of Shanghai Jiao Tong University Grant YG2017QN49 (to L. Z.); and Shanghai Municipality Commission of Health and Family Planning Grant 201640006 (to J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aasen T, 2016, NAT REV CANCER, V16, P775, DOI 10.1038/nrc.2016.105; Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; Basheer WA, 2015, J MOL CELL CARDIOL, V88, P1, DOI 10.1016/j.yjmcc.2015.09.004; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Carette D, 2015, BIOL CELL, V107, P218, DOI 10.1111/boc.201400048; Chen VC, 2012, J PROTEOME RES, V11, P6134, DOI 10.1021/pr300790h; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Falk MM, 2014, FEBS LETT, V588, P1221, DOI 10.1016/j.febslet.2014.01.031; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; Funmilayo E, 2016, J BIOL CHEM, V291, P15753, DOI 10.1074/jbc.M116.718023; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Grek CL, 2016, CANCER LETT, V374, P117, DOI 10.1016/j.canlet.2016.02.008; Juul MH, 2000, CELL ADHES COMMUN, V7, P501, DOI 10.3109/15419060009040307; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2007, J MEMBRANE BIOL, V217, P43, DOI 10.1007/s00232-007-9050-z; Leithe E, 2016, BBA-REV CANCER, V1865, P133, DOI 10.1016/j.bbcan.2016.02.001; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Li S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001239; Ma ZY, 2015, CELL RES, V25, P306, DOI 10.1038/cr.2015.20; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Ribeiro-Rodrigues TM, 2014, FASEB J, V28, P4629, DOI 10.1096/fj.13-248963; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Su V, 2010, J BIOL CHEM, V285, P40979, DOI 10.1074/jbc.M110.170753; Totland MZ, 2017, J CELL SCI, V130, P2867, DOI 10.1242/jcs.202408; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754	40	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8275	8284		10.1074/jbc.RA117.001315	http://dx.doi.org/10.1074/jbc.RA117.001315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626091	Green Published, hybrid			2022-12-28	WOS:000433224600031
J	Robia, SL; Young, HS				Robia, Seth L.; Young, Howard S.			Skin cells prefer a slower calcium pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CA2+ PUMP	Naturally occurring mutations of a calcium ion transporter can cause a skin condition known as Darier's disease. In this issue of JBC, Mikkelsen et al. describe a particularly interesting Darier's mutation that alters calcium transport by disrupting a kinetic braking mechanism that is unique to the SERCA2b calcium pump isoform. The study provides new insight into the intrinsic regulation of this transporter and reveals how disruption of regulation can lead to disease in Darier's patients.	[Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada	Loyola University Chicago; University of Alberta	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.; Young, HS (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada.	srobia@luc.edu; hyoung@ualberta.ca		Young, Howard/0000-0002-5990-8422	National Institutes of Health [HL092321]; Heart and Stroke Foundation of Canada [G-16-00014670]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL092321 (to S.L.R.) and Heart and Stroke Foundation of Canada Grant G-16-00014670 (to H.S.Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Clausen JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397331; Gorski PA, 2012, J BIOL CHEM, V287, P19876, DOI 10.1074/jbc.M111.335620; Mikkelsen SA, 2018, J BIOL CHEM, V293, P3880, DOI 10.1074/jbc.RA117.000941; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106	6	1	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3890	3891		10.1074/jbc.H118.002088	http://dx.doi.org/10.1074/jbc.H118.002088			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29667928	Green Published, hybrid			2022-12-28	WOS:000427587500003
J	Emerman, AB; Blower, MD				Emerman, Amy B.; Blower, Michael D.			The RNA-binding complex ESCRT-II in Xenopus laevis eggs recognizes purine-rich sequences through its subunit, Vps25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; RNA-protein interaction; RNA; endocytosis; RNA metabolism; RNA localization; ESCRT-II; polypurine motif; endosome maturation; GA-rich sequence; membrane trafficking	MESSENGER-RNA; GLOBAL ANALYSIS; UBIQUITIN RECOGNITION; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; GENE-EXPRESSION; LOCALIZATION; PROTEINS; MECHANISM; REVEALS	RNA-binding proteins (RBP) are critical regulators of gene expression. Recent studies have uncovered hundreds of mRNA-binding proteins that do not contain annotated RNA-binding domains and have well-established roles in other cellular processes. Investigation of these nonconventional RBPs is critical for revealing novel RNA-binding domains and may disclose connections between RNA regulation and other aspects of cell biology. The endosomal sorting complex required for transport II (ESCRT-II) is a nonconventional RNA-binding complex that has a canonical role in multivesicular body formation. ESCRT-II was identified previously as an RNA-binding complex in Drosophila oocytes, but whether its RNA-binding properties extend beyond Drosophila is unknown. In this study, we found that the RNA-binding properties of ESCRT-II are conserved in Xenopus eggs, where ESCRT-II interacted with hundreds of mRNAs. Using a UV cross-linking approach, we demonstrated that ESCRT-II binds directly to RNA through its subunit, Vps25. UV cross-linking and immunoprecipitation (CLIP)-Seq revealed that Vps25 specifically recognizes a polypurine (i.e. GA-rich) motif in RNA. Using purified components, we could reconstitute the selective Vps25-mediated binding of the polypurine motif in vitro. Our results provide insight into the mechanism by which ESCRT-II selectively binds to mRNA and also suggest an unexpected link between endosome biology and RNA regulation.	[Blower, Michael D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Blower, MD (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	blower@molbio.mgh.harvard.edu		Blower, Michael/0000-0002-5037-1972	NIGMS, National Institutes of Health [RO1 GM086434]; National Science Foundation Graduate Research Fellowships Program (GRFP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086434] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Graduate Research Fellowships Program (GRFP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant RO1 GM086434 (to M. D. B.) and a grant from the National Science Foundation Graduate Research Fellowships Program (GRFP) (to A. B. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Beckmann BM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10127; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Castello A, 2016, MOL CELL, V63, P696, DOI 10.1016/j.molcel.2016.06.029; Castello A, 2015, TRENDS ENDOCRIN MET, V26, P746, DOI 10.1016/j.tem.2015.09.012; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Harami GM, 2013, TRENDS BIOCHEM SCI, V38, P364, DOI 10.1016/j.tibs.2013.04.006; He CS, 2016, MOL CELL, V64, P416, DOI 10.1016/j.molcel.2016.09.034; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P1031, DOI 10.1038/nsmb1163; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; James-Zorn C, 2015, GENESIS, V53, P486, DOI 10.1002/dvg.22873; Konig J., 2011, J VIS EXP, V30; Konopacki FA, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150218; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mardakheh FK, 2015, DEV CELL, V35, P344, DOI 10.1016/j.devcel.2015.10.005; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwarz DS, 2014, J CELL BIOL, V207, P41, DOI 10.1083/jcb.201406037; Schweidenback CTH, 2015, RNA, V21, P279, DOI 10.1261/rna.047787.114; Sharp JA, 2011, MOL BIOL CELL, V22, P4312, DOI 10.1091/mbc.E11-07-0629; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849	53	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12593	12605		10.1074/jbc.RA118.003718	http://dx.doi.org/10.1074/jbc.RA118.003718			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903915	hybrid, Green Published			2022-12-28	WOS:000441408500023
J	Arya, SB; Kumar, G; Kaur, H; Kaur, A; Tuli, A				Arya, Subhash B.; Kumar, Gaurav; Kaur, Harmeet; Kaur, Amandeep; Tuli, Amit			ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; lipopolysaccharide (LPS); GTPase; mitogen-activated protein kinase (MAPK); extracellular-signal-regulated kinase (ERK); ARL11; ARLTS1; Salmonella	TUMOR-SUPPRESSOR GENE; ARLTS1 CYS148ARG VARIANT; FAMILIAL BREAST-CANCER; COLORECTAL-CANCER; APOPTOSIS; ERK; MALIGNANCIES; INFLAMMATION; ASSOCIATION; EXPRESSION	ADP-ribosylation factor-like GTPase 11 (ARL11) is a cancer-predisposing gene that has remained functionally uncharacterized to date. In this study, we report that ARL11 is endogenously expressed in mouse and human macrophages and regulates their activation in response to lipopolysaccharide (LPS) stimulation. Accordingly, depletion of ARL11 impaired both LPS-stimulated pro-inflammatory cytokine production by macrophages and their ability to control intracellular replication of Salmonella. LPS-stimulated activation of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK) was substantially compromised in Arl11-silenced macrophages. In contrast, increased expression of ARL11 led to constitutive ERK1/2 phosphorylation, resulting in macrophage exhaustion. Finally, we found that ARL11 forms a complex with phospho-ERK in macrophages within minutes of LPS stimulation. Taken together, our findings establish ARL11 as a novel regulator of ERK signaling in macrophages, required for macrophage activation and immune function.	[Arya, Subhash B.; Kumar, Gaurav; Kaur, Harmeet; Kaur, Amandeep; Tuli, Amit] CSIR Inst Microbial Technol IMTECH, Div Cell Biol & Immunol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Arya, SB; Tuli, A (corresponding author), CSIR Inst Microbial Technol IMTECH, Div Cell Biol & Immunol, Chandigarh 160036, India.	subhasharya8@gmail.com; atuli@imtech.res.in	Arya, Subhash Babu/GPJ-9725-2022	Arya, Subhash Babu/0000-0002-5671-8666; Tuli, Amit/0000-0001-5476-4127	Wellcome Trust/Department of Biotechnology (DBT) India Alliance Intermediate Fellowship [IA/I/14/2/501543]; CSIR-IMTECH [OLP-144]; CSIR-JRF; CSIR-UGC; Wellcome Trust/DBT India Alliance; CSIR-IMTECH; DST-INSPIRE	Wellcome Trust/Department of Biotechnology (DBT) India Alliance Intermediate Fellowship(Wellcome Trust DBT India Alliance); CSIR-IMTECH; CSIR-JRF(Council of Scientific & Industrial Research (CSIR) - India); CSIR-UGC(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); Wellcome Trust/DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); CSIR-IMTECH; DST-INSPIRE(Department of Science & Technology (India))	This work was supported by Wellcome Trust/Department of Biotechnology (DBT) India Alliance Intermediate Fellowship IA/I/14/2/501543 (to A.T.).This work received infrastructure and financial support from CSIR-IMTECH (OLP-144, communication 046/2017). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the CSIR-JRF.; Supported by the CSIR-UGC.; Supported by the Wellcome Trust/DBT India Alliance and CSIR-IMTECH.; Supported by a DST-INSPIRE Fellowship.	Akisik E, 2011, MOL BIOL REP, V38, P343, DOI 10.1007/s11033-010-0113-3; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Castellvi-Bel S, 2007, CARCINOGENESIS, V28, P1687, DOI 10.1093/carcin/bgm098; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Endo M, 2005, J BIOCHEM, V138, P501, DOI 10.1093/jb/mvi143; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Frank B, 2006, INT J CANCER, V118, P2505, DOI 10.1002/ijc.21687; Frank B, 2006, CANCER LETT, V244, P172, DOI 10.1016/j.canlet.2005.12.006; Hamadou WS, 2017, B CANCER, V104, P123, DOI 10.1016/j.bulcan.2016.10.016; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; Kang HG, 2017, INT J ONCOL, V50, P545, DOI 10.3892/ijo.2017.3841; Kavanagh E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.514; Khatter Divya, 2015, Cell Logist, V5, pe1086501; La Starza R, 1998, BLOOD, V91, P231, DOI 10.1182/blood.V91.1.231.231_231_237; Lioberas J, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00028; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; Marwaha R, 2017, J CELL BIOL, V216, P1051, DOI 10.1083/jcb.201607085; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Petrocca F, 2006, CANCER RES, V66, P10287, DOI 10.1158/0008-5472.CAN-06-2289; POMERANTZ RJ, 1990, J EXP MED, V172, P253, DOI 10.1084/jem.172.1.253; Siltanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072040; Siltanen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026595; Sindhwani A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006700; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200; YANG X, 2009, J BEIJING SPORT U, V3, P6; Yendamuri S, 2008, CANCER LETT, V264, P11, DOI 10.1016/j.canlet.2008.02.021; Yendamuri S, 2007, CANCER RES, V67, P7738, DOI 10.1158/0008-5472.CAN-07-1481; Yin ZN, 1999, ONCOGENE, V18, P7576, DOI 10.1038/sj.onc.1203203; Yoo YH, 2004, FEBS LETT, V556, P39, DOI 10.1016/S0014-5793(03)01361-9	37	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9892	9909		10.1074/jbc.RA117.000727	http://dx.doi.org/10.1074/jbc.RA117.000727			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29618517	Green Published, hybrid			2022-12-28	WOS:000436102300030
J	Robb, EL; Hall, AR; Prime, TA; Eaton, S; Szibor, M; Viscomi, C; James, AM; Murphy, MP				Robb, Ellen L.; Hall, Andrew R.; Prime, Tracy A.; Eaton, Simon; Szibor, Marten; Viscomi, Carlo; James, Andrew M.; Murphy, Michael P.			Control of mitochondrial superoxide production by reverse electron transport at complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; mitochondrial membrane potential; redox signaling; reactive oxygen species (ROS); respiration; complex I; reverse electron transport; RET; coenzyme Q; superoxide	TARGETED ANTIOXIDANT MITOQ; UBIQUINONE OXIDOREDUCTASE; HYDROGEN-PEROXIDE; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; SIGNAL-TRANSDUCTION; HEART-MITOCHONDRIA; REPERFUSION INJURY; BINDING SITE; NADH	The generation of mitochondrial superoxide (O2.) by reverse electron transport (RET) at complex I causes oxidative damage in pathologies such as ischemia reperfusion injury, but also provides the precursor to H2O2 production in physiological mitochondrial redox signaling. Here, we quantified the factors that determine mitochondrial O2. production by RET in isolated heart mitochondria. Measuring mitochondrial H2O2 production at a range of proton-motive force (p) values and for several coenzyme Q (CoQ) and NADH pool redox states obtained with the uncoupler p-trifluoromethoxyphenylhydrazone, we show that O2. production by RET responds to changes in O2 concentration, the magnitude of p, and the redox states of the CoQ andNADHpools. Moreover, we determined how expressing the alternative oxidase from the tunicate Ciona intestinalis to oxidize the CoQ pool affected RET-mediated O2. production at complex I, underscoring the importance of the CoQ pool for mitochondrialO2. production by RET. An analysis ofO2. production at complex I as a function of the thermodynamic forces driving RET at complex I revealed that many molecules that affect mitochondrial reactive oxygen species production do so by altering the overall thermodynamic driving forces of RET, rather than by directly acting on complex I. These findings clarify the factors controlling RET-mediated mitochondrial O2. production in both pathological and physiological conditions. We conclude that O2. production by RET is highly responsive to small changes in p and the CoQ redox state, indicating that complex I RET represents a major mode of mitochondrial redox signaling.	[Robb, Ellen L.; Hall, Andrew R.; Prime, Tracy A.; Viscomi, Carlo; James, Andrew M.; Murphy, Michael P.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Eaton, Simon] UCL Great Ormond St Inst Child Hlth, London WC1N 1EH, England; [Szibor, Marten] Univ Tampere, Fac Med & Life Sci, FI-33014 Tampere, Finland; [Szibor, Marten] Max Planck Inst Heart & Lung Res, Ludwigstr 43, D-61231 Bad Nauheim, Germany	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of London; University College London; Tampere University; Max Planck Society	Murphy, MP (corresponding author), MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-mbu.cam.ac.uk	Eaton, Simon/C-4942-2008; viscomi, Carlo/R-1940-2016; James, Andrew M/A-2639-2015; Murphy, Michael/C-2120-2009	Eaton, Simon/0000-0003-0892-9204; James, Andrew M/0000-0002-0515-9649; Viscomi, Carlo/0000-0001-6050-0566; Murphy, Michael/0000-0003-1115-9618	Medical Research Council UK [MC_U105663142, MC_UU_00015/5]; Wellcome Trust Investigator award [110159/Z/15/Z]; Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; MRC [MC_UU_00015/8, MC_UU_00015/3, MC_U105663142, MC_UU_00015/5] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator award(Wellcome Trust); Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK (Grants MC_U105663142 (to M. P. M.) and MC_UU_00015/5 (to C. V.)) and by a Wellcome Trust Investigator award (110159/Z/15/Z) (to M. P. M). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by the Great Ormond Street Hospital Children's Charity and the NIHR Biomedical Research Centre at Great Ormond Street Hospital.	Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Fernandez-Aguera MC, 2015, CELL METAB, V22, P825, DOI 10.1016/j.cmet.2015.09.004; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; DRY IB, 1989, ARCH BIOCHEM BIOPHYS, V273, P148, DOI 10.1016/0003-9861(89)90173-2; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570; El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; HINKLE PC, 1967, J BIOL CHEM, V242, P5169; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls DG, 2013, BIOENERGETICS 4, P1; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stepanova A, 2019, J CEREBR BLOOD F MET, V39, P1790, DOI 10.1177/0271678X18770331; Szeto HH, 2011, PHARM RES-DORDR, V28, P2669, DOI 10.1007/s11095-011-0476-8; Szibor M, 2017, DIS MODEL MECH, V10, P163, DOI 10.1242/dmm.027839; Vinogradov AD, 2005, BIOCHEMISTRY-MOSCOW+, V70, P120, DOI 10.1007/s10541-005-0090-7; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wikstrom M., 1981, CYTOCHROME OXIDASE S; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Yang BX, 2006, J BIOL CHEM, V281, P16202, DOI 10.1074/jbc.M601864200; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	53	137	137	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9869	9879		10.1074/jbc.RA118.003647	http://dx.doi.org/10.1074/jbc.RA118.003647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743240	Green Published, hybrid			2022-12-28	WOS:000436102300028
J	Selvam, SP; Roth, BM; Nganga, R; Kim, J; Cooley, MA; Helke, K; Smith, CD; Ogretmen, B				Selvam, Shanmugam Panneer; Roth, Braden M.; Nganga, Rose; Kim, Jisun; Cooley, Marion A.; Helke, Kristi; Smith, Charles D.; Ogretmen, Besim			Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; signal transduction; sphingolipid; sphingosine-1-phosphate (S1P); telomerase reverse transcriptase (TERT); senescence	SPHINGOSINE KINASE 2; CERAMIDE-DEPENDENT MITOPHAGY; TERT PROMOTER MUTATIONS; CANCER-CELLS; STEM-CELLS; LIFE-SPAN; IN-VITRO; ACTIVATION; LUNG; RNA	Telomerase activation protects cells from telomere damage by delaying senescence and inducing cell immortalization, whereas telomerase inhibition mediates rapid senescence or apoptosis. However, the cellular mechanisms that determine telomere damage-dependent senescence versus apoptosis induction are largely unknown. Here, we demonstrate that telomerase instability mediated by silencing of sphingosine kinase 2 (SPHK2) and sphingosine 1-phosphate (S1P), which binds and stabilizes telomerase, induces telomere damage-dependent caspase-3 activation and apoptosis, but not senescence, in p16-deficient lung cancer cells or tumors. These outcomes were prevented by knockdown of a tumor-suppressor protein, transcription factor 21 (TCF21), or by ectopic expression of WT human telomerase reverse transcriptase (hTERT) but not mutant hTERT with altered S1P binding. Interestingly, SphK2-deficient mice exhibited accelerated aging and telomerase instability that increased telomere damage and senescence via p16 activation especially in testes tissues, but not in apoptosis. Moreover, p16 silencing in SphK2(-/-) mouse embryonic fibroblasts activated caspase-3 and apoptosis without inducing senescence. Furthermore, ectopic WT p16 expression in p16-deficient A549 lung cancer cells prevented TCF21 and caspase-3 activation and resulted in senescence in response to SphK2/S1P inhibition and telomere damage. Mechanistically, a p16 mutant with impaired caspase-3 association did not prevent telomere damage-induced apoptosis, indicating that an association between p16 and caspase-3 proteins forces senescence induction by inhibiting caspase-3 activation and apoptosis. These results suggest that p16 plays a direct role in telomere damage-dependent senescence by limiting apoptosis via binding to caspase-3, revealing a direct link between telomere damage-dependent senescence and apoptosis with regards to aging and cancer.	[Selvam, Shanmugam Panneer; Roth, Braden M.; Nganga, Rose; Kim, Jisun; Ogretmen, Besim] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 30912 USA; [Selvam, Shanmugam Panneer; Roth, Braden M.; Nganga, Rose; Kim, Jisun; Ogretmen, Besim] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 30912 USA; [Cooley, Marion A.] Med Univ South Carolina, Dept Regenerat Med, Charleston, SC 30912 USA; [Helke, Kristi] Med Univ South Carolina, Dept Comparat Med, Charleston, SC 30912 USA; [Smith, Charles D.] Penn State Univ, Dept Pharmacol, Hershey, PA 17033 USA; [Cooley, Marion A.] Augusta Univ, Dept Oral Biol, 86 Jonathan Lucas St, Augusta, GA 30912 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University System of Georgia; Augusta University	Ogretmen, B (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 30912 USA.; Ogretmen, B (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 30912 USA.	ogretmen@musc.edu	Roth, Braden/L-9386-2015	Roth, Braden/0000-0001-7559-7671; Helke, Kris/0000-0001-9746-0764; Cooley, Marion A./0000-0002-4286-745X	National Institutes of Health Grant [C06 RR015455]; Hollings Cancer Center Support Grant [P30 CA138313]; Center of Biomedical Research Excellence (Cobre) in Lipidomics and Pathobiology [P30 GM103339]; NATIONAL CANCER INSTITUTE [R01CA088932, P01CA203628, R01CA173687, P30CA138313, R01CA214461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103339] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center Support Grant; Center of Biomedical Research Excellence (Cobre) in Lipidomics and Pathobiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Richard Flavell (Yale University) for providing us with the caspase-3/7 knockout MEFs. We thank Dr. Sarah Spiegel (Virginia Commonwealth University) for providing SphK2 plasmids. We also thank Dr. Elizabeth Garrett-Mayer (Medical University of South Carolina) for assistance with statistical analyses and discussions in this study. The core facilities utilized were constructed using support from National Institutes of Health Grant C06 RR015455, Hollings Cancer Center Support Grant P30 CA138313, or Center of Biomedical Research Excellence (Cobre) in Lipidomics and Pathobiology P30 GM103339.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Arab K, 2014, MOL CELL, V55, P604, DOI 10.1016/j.molcel.2014.06.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bose K, 2003, BIOCHEMISTRY-US, V42, P12298, DOI 10.1021/bi034998x; Britten CD, 2017, CLIN CANCER RES, V23, P4642, DOI 10.1158/1078-0432.CCR-16-2363; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Dany M, 2016, BLOOD, V128, P1944, DOI 10.1182/blood-2016-04-708750; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Gencer S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7464; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hwang D, 2016, PROTEIN EXPRES PURIF, V126, P104, DOI 10.1016/j.pep.2016.06.004; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Jacobs JJL, 2005, CELL CYCLE, V4, P1364, DOI 10.4161/cc.4.10.2104; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Montero JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12534; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lewis CS, 2016, ONCOTARGET, V7, P60181, DOI 10.18632/oncotarget.11112; Li YH, 2015, NAT CELL BIOL, V17, P1327, DOI 10.1038/ncb3240; Masterson JC, 2007, ANTI-CANCER DRUG, V18, P1053, DOI 10.1097/CAD.0b013e32825209f6; McGurn LD, 2016, BIOCHEM J, V473, P4559, DOI 10.1042/BCJ20160773; Mender Ilgen, 2015, Bio Protoc, V5; Neubauer Heidi A, 2016, F1000Res, V5, P2825, DOI 10.12688/f1000research.10336.2; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Parham KA, 2015, FASEB J, V29, P3638, DOI 10.1096/fj.14-261289; Ponnusamy S, 2012, EMBO MOL MED, V4, P761, DOI 10.1002/emmm.201200244; Pont AR, 2012, MOL CELL, V47, P5, DOI 10.1016/j.molcel.2012.04.019; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rice C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14928; Richards KL, 2011, CANCER-AM CANCER SOC, V117, P606, DOI 10.1002/cncr.25472; Selvam SP, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa4998; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Thomas RJ, 2017, EMBO MOL MED, V9, P1030, DOI 10.15252/emmm.201607088; Timashev LA, 2017, GENE DEV, V31, P578, DOI 10.1101/gad.294108.116; Valentijn LJ, 2015, NAT GENET, V47, P1411, DOI 10.1038/ng.3438; Vega LR, 2003, NAT REV MOL CELL BIO, V4, P948, DOI 10.1038/nrm1256; Venant H, 2015, MOL CANCER THER, V14, P2744, DOI 10.1158/1535-7163.MCT-15-0279; Venkata JK, 2014, BLOOD, V124, P1915, DOI 10.1182/blood-2014-03559385; Walsh KM, 2014, NAT GENET, V46, P731, DOI 10.1038/ng.3004; Wang Y, 2013, J CLIN INVEST, V123, P4489, DOI 10.1172/JCI69574	60	17	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9784	9800		10.1074/jbc.RA118.003506	http://dx.doi.org/10.1074/jbc.RA118.003506			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29748384	hybrid, Green Published			2022-12-28	WOS:000436102300022
J	Dery, KJ; Silver, C; Yang, L; Shively, JE				Dery, Kenneth J.; Silver, Craig; Yang, Lu; Shively, John E.			Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin remodeling; translation regulation; alternative splicing; transcription; RNA; CEACAM1; hnRNP L; IFN-gamma; IRF1	BILIARY GLYCOPROTEIN CD66A; NF-KAPPA-B; CARCINOEMBRYONIC ANTIGEN; HNRNP-L; BREAST-CANCER; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; DNA METHYLATION; CARCINOMA CELLS; DOWN-REGULATION	The adhesion protein carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is widely expressed in epithelial cells as a short cytoplasmic isoform (S-iso) and in leukocytes as a long cytoplasmic isoform (L-iso) and is frequently silenced in cancer by unknown mechanisms. Previously, we reported that interferon response factor 1 (IRF1) biases alternative splicing (AS) to include the variable exon 7 (E7) in CEACAM1, generating long cytoplasmic isoforms. We now show that IRF1 and a variant of heterogeneous nuclear ribonucleoprotein L (Lv1) coordinately silence the CEACAM1 gene. RNAi-mediated Lv1 depletion in IRF1-treated HeLa and melanoma cells induced significant CEACAM1 protein expression, reversed by ectopic Lv1 expression. The Lv1-mediated CEACAM1 repression resided in residues Gly(71)-Gly(89) and Ala(38)-Gly(89) in Lv1's N-terminal extension. ChIP analysis of IRF1- and FLAG-tagged Lv1-treated HeLa cells and global treatment with the global epigenetic modifiers 5-aza-2-deoxycytidine and trichostatin A indicated that IRF1 and Lv1 together induce chromatin remodeling, restricting IRF1 access to the CEACAM1 promoter. In interferon -treated HeLa cells, the transcription factor SP1 did not associate with the CEACAM1 promoter, but binding by upstream transcription factor 1 (USF1), a known CEACAM1 regulator, was greatly enhanced. ChIP-sequencing revealed that Lv1 overexpression in IRF1-treated cells induces transcriptional silencing across many genes, including DCC (deleted in colorectal carcinoma), associated with CEACAM5 in colon cancer. Notably, IRF1, but not IRF3 and IRF7, affected CEACAM1 expression via translational repression. We conclude that IRF1 and Lv1 coordinately regulate CEACAM1 transcription, alternative splicing, and translation and may significantly contribute to CEACAM1 silencing in cancer.	[Dery, Kenneth J.; Shively, John E.] City Hope Natl Med Ctr, Dept Mol Immunol, Beckman Res Inst, Duarte, CA 91010 USA; [Silver, Craig] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA; [Yang, Lu] City Hope Natl Med Ctr, Integrat Genom & Bioinformat Core, Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; California State University System; California State Polytechnic University Pomona; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Dept Mol Immunol, Beckman Res Inst, Duarte, CA 91010 USA.	jshively@coh.org			NCI NIH HHS [P30 CA033572] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bieberstein NI, 2016, SCI REP-UK, V6, DOI 10.1038/srep29961; Bodaghi S, 2009, VIROLOGY, V386, P32, DOI 10.1016/j.virol.2008.12.037; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; D'Agostino L, 2010, CELL CYCLE, V9, P1131, DOI 10.4161/cc.9.6.10991; Dai P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010069; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; DANSKYULLMANN C, 1995, CYTOKINE, V7, P118, DOI 10.1006/cyto.1995.1016; Dery KJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-64; Dery KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204057; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Gencheva M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-79; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hillebrand F, 2017, BBA-GENE REGUL MECH, V1860, P205, DOI 10.1016/j.bbagrm.2016.12.001; Hu SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182771; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Jiang HW, 2015, GENET MOL RES, V14, P10273, DOI 10.4238/2015.August.28.12; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; KLINGELHUTZ AJ, 1993, ONCOGENE, V8, P95; Koren R, 2003, BREAST CANCER RES TR, V80, P215, DOI 10.1023/A:1024581508474; Lai MC, 1999, J BIOL CHEM, V274, P11832, DOI 10.1074/jbc.274.17.11832; Li JP, 2012, J PROTEOMICS, V75, P2879, DOI 10.1016/j.jprot.2011.12.040; Liu C, 2016, ONCOTARGET, V7, P71556, DOI 10.18632/oncotarget.12253; Lu RZ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002597; Lu RZ, 2011, J BIOL CHEM, V286, P27528, DOI 10.1074/jbc.M111.235762; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luo CL, 2017, CANCER RES, V77, P1168, DOI 10.1158/0008-5472.CAN-16-1919; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Mayeda A, 1998, RNA, V4, P1111, DOI 10.1017/S135583829898089X; Morales VM, 1999, J IMMUNOL, V163, P1363; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; Nishiyama A, 2016, J BIOCHEM, V159, P9, DOI 10.1093/jb/mvv113; NOLL M, 1974, NATURE, V251, P249, DOI 10.1038/251249a0; Nyati KK, 2017, NUCLEIC ACIDS RES, V45, P2687, DOI 10.1093/nar/gkx064; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Rogelj B., 2011, RNA BINDING PROTEINS, P1; Rosonina E, 2004, RNA, V10, P581, DOI 10.1261/rna.5207204; Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08; Ruan K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12720; Ruggiero T, 2003, NUCLEIC ACIDS RES, V31, P6561, DOI 10.1093/nar/gkg858; Shankarling G, 2013, BIOCHEM J, V453, P271, DOI 10.1042/BJ20130432; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Singer BB, 2000, CANCER RES, V60, P1236; TAKAHASHI H, 1993, CANCER RES, V53, P1612; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Tsompana M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-33; TURLEY H, 1995, CANCER RES, V55, P5628; Vitenshtein A, 2016, CELL REP, V15, P2331, DOI 10.1016/j.celrep.2016.05.036; Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010; Yabas M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010003; Yang CC, 2015, ACTA BIOCH BIOPH SIN, V47, P788, DOI 10.1093/abbs/gmv075; Yim JH, 2003, J INTERF CYTOK RES, V23, P501, DOI 10.1089/10799900360708623; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhou XM, 2017, ONCOTARGET, V8, P19342, DOI 10.18632/oncotarget.14258; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	69	10	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9277	9291		10.1074/jbc.RA117.001507	http://dx.doi.org/10.1074/jbc.RA117.001507			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29720400	Green Published, hybrid			2022-12-28	WOS:000435441400014
J	Agwa, AJ; Peigneur, S; Chow, CY; Lawrence, N; Craik, DJ; Tytgat, J; King, GF; Henriques, ST; Schroeder, CI				Agwa, Akello J.; Peigneur, Steve; Chow, Chun Yuen; Lawrence, Nicole; Craik, David J.; Tytgat, Jan; King, Glenn F.; Henriques, Sonia Troeira; Schroeder, Christina I.			Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; TARANTULA TOXINS; ION-CHANNEL; HAINANTOXIN-IV; MOLECULAR-BASIS; PEPTIDE TOXIN; DOMAIN-II; PROTX-II; SENSOR; BINDING	Gating modifier toxins (GMTs) are venom-derived peptides isolated from spiders and other venomous creatures and modulate activity of disease-relevant voltage-gated ion channels and are therefore being pursued as therapeutic leads. The amphipathic surface profile of GMTs has prompted the proposal that some GMTs simultaneously bind to the cell membrane and voltage-gated ion channels in a trimolecular complex. Here, we examined whether there is a relationship among spider GMT amphipathicity, membrane binding, and potency or selectivity for voltage-gated sodium (Na-V) channels. We used NMR spectroscopy and in silico calculations to examine the structures and physicochemical properties of a panel of nine GMTs and deployed surface plasmon resonance to measure GMT affinity for lipids putatively found in proximity to Na-V channels. Electrophysiology was used to quantify GMT activity on Na(V)1.7, an ion channel linked to chronic pain. Selectivity of the peptides was further examined against a panel of Na-V channel subtypes. We show that GMTs adsorb to the outer leaflet of anionic lipid bilayers through electrostatic interactions. We did not observe a direct correlation between GMT amphipathicity and affinity for lipid bilayers. Furthermore, GMT-lipid bilayer interactions did not correlate with potency or selectivity for Na(V)s. We therefore propose that increased membrane binding is unlikely to improve subtype selectivity and that the conserved amphipathic GMT surface profile is an adaptation that facilitates simultaneous modulation of multiple Na(V)s.	[Agwa, Akello J.; Chow, Chun Yuen; Lawrence, Nicole; Craik, David J.; King, Glenn F.; Henriques, Sonia Troeira; Schroeder, Christina I.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Peigneur, Steve; Tytgat, Jan] Univ Leuven KU Leuven, Lab Toxicol & Pharmacol, B-3000 Leuven, Belgium	University of Queensland; KU Leuven	Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	c.schroeder@imb.uq.edu.au	Chow, Chun Yuen/C-7941-2017; Lawrence, Nicole/A-5573-2017; Craik, David/B-1695-2010; Chow, Chun Yuen/AAS-2223-2020; Agwa, Akello/N-8633-2019; Schroeder, Christina/K-2042-2014; Troeira Henriques, Sonia/J-3500-2016	Chow, Chun Yuen/0000-0003-2861-5843; Lawrence, Nicole/0000-0002-9013-1770; Craik, David/0000-0003-0007-6796; Chow, Chun Yuen/0000-0003-2861-5843; Agwa, Akello/0000-0001-9295-5071; Schroeder, Christina/0000-0002-6737-6374; Peigneur, Steve/0000-0003-0504-5702; Tytgat, Jan/0000-0003-1778-6022; Troeira Henriques, Sonia/0000-0001-9564-9651; King, Glenn/0000-0002-2308-2200	Australian National Health and Medical Research Council [APP1080405, APP1072113, APP1044414]; Australian Research Council (ARC) [FT160100055, FT150100398]; Australian Laureate fellowship [FL150100146]; Central Europe Leuven Strategic Alliance Grant [CELSA/17/047-BOF/ISP]; University of Queensland International Postgraduate Scholarships	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Australian Laureate fellowship; Central Europe Leuven Strategic Alliance Grant; University of Queensland International Postgraduate Scholarships	This work was supported by Australian National Health and Medical Research Council Project Grant APP1080405 (to C. I. S. and S. T. H.) and Program Grant APP1072113 and Principal Research Fellowship APP1044414 (to G. F. K.); Australian Research Council (ARC) Future Fellowships FT160100055 (to C. I. S.) and FT150100398 (to S. T. H.) and Australian Laureate fellowship FL150100146 (to D. J. C.); Central Europe Leuven Strategic Alliance Grant CELSA/17/047-BOF/ISP (to J. T.); and University of Queensland International Postgraduate Scholarships (to A. J. A. and C. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agwa AJ, 2017, NEUROPHARMACOLOGY, V127, P32, DOI 10.1016/j.neuropharm.2017.04.004; Agwa AJ, 2017, TOXINS, V9, DOI 10.3390/toxins9080248; Agwa AJ, 2017, BBA-BIOMEMBRANES, V1859, P835, DOI 10.1016/j.bbamem.2017.01.020; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Cai TF, 2015, PEPTIDES, V68, P148, DOI 10.1016/j.peptides.2014.09.005; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Deplazes E, 2016, BBA-BIOMEMBRANES, V1858, P872, DOI 10.1016/j.bbamem.2016.02.002; Deuis JR, 2016, J BIOL CHEM, V291, P11829, DOI 10.1074/jbc.M116.721662; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gui JH, 2014, CURR BIOL, V24, P473, DOI 10.1016/j.cub.2014.01.013; Henriques ST, 2016, J BIOL CHEM, V291, P17049, DOI 10.1074/jbc.M116.729095; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Jung HH, 2010, BIOPHYS J, V99, P638, DOI 10.1016/j.bpj.2010.04.061; Kalia J, 2015, J MOL BIOL, V427, P158, DOI 10.1016/j.jmb.2014.07.027; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P277, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4_8]; Lau CHY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34333; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Lewis RJ, 2015, RSC DRUG DISCOV, V39, P297; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Liu Y, 2012, J PEPT SCI, V18, P643, DOI 10.1002/psc.2451; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Marvin L, 1999, EUR J BIOCHEM, V265, P572, DOI 10.1046/j.1432-1327.1999.00726.x; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; Ostrow KL, 2003, TOXICON, V42, P263, DOI 10.1016/S0041-0101(03)00141-7; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Peigneur S, 2015, NEUROPHARMACOLOGY, V95, P269, DOI 10.1016/j.neuropharm.2015.03.027; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posokhov YO, 2007, BIOPHYS J, V93, pL20, DOI 10.1529/biophysj.107.112375; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Salari A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23894; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200	63	29	29	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9041	9052		10.1074/jbc.RA118.002553	http://dx.doi.org/10.1074/jbc.RA118.002553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29703751	hybrid, Green Published			2022-12-28	WOS:000434941900026
J	Dong, K; Guo, X; Chen, WP; Hsu, AC; Shao, Q; Chen, JF; Chen, SY				Dong, Kun; Guo, Xia; Chen, Weiping; Hsu, Amanda C.; Shao, Qiang; Chen, Jian-Fu; Chen, Shi-You			Mesenchyme homeobox 1 mediates transforming growth factor-beta (TGF-beta)-induced smooth muscle cell differentiation from mouse mesenchymal progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; smooth muscle; cell differentiation; transforming growth factor beta (TGF-); SMAD transcription factor; mesenchyme homeobox 1 (Meox1); SMAD family member 3 (Smad3)	SERUM RESPONSE FACTOR; NEURAL CREST CELLS; DIVISION CYCLE 7; TGF-BETA; GENE-EXPRESSION; SMAD PROTEINS; SYSTEM; TRANSCRIPTION; PHOSPHATASES; RECRUITMENT	Differentiation of smooth muscle cells (SMCs) is critical for proper vasculogenesis and angiogenesis. However, the molecular mechanisms controlling SMC differentiation are not completely understood. During embryogenesis, the transcription factor mesenchyme homeobox 1 (Meox1) is expressed in the early developing somite, which is one of the origins of SMCs. In the present study, we identified Meox1 as a positive regulator of SMC differentiation. We found that transforming growth factor- (TGF-) induces Meox1 expression in the initial phase of SMC differentiation of pluripotent murine C3H10T1/2 cells. shRNA-mediated Meox1 knockdown suppressed TGF--induced expression of SMC early markers, whereas Meox1 overexpression increased expression of these markers. Mechanistically, Meox1 promoted SMAD family member 3 (Smad3) nuclear retention during the early stage of TGF- stimulation because Meox1 inhibited protein phosphatase Mg2+/Mn2+-dependent 1A (PPM1A) and thereby prevented PPM1A-mediated Smad3 dephosphorylation. Meox1 appears to promote PPM1A degradation, leading to sustained Smad3 phosphorylation, thus allowing Smad3 to stimulate SMC gene transcription. In vivo, Meox1 knockdown in mouse embryos impaired SMC marker expression in the descending aorta of neonatal mice, indicating that Meox1 is essential for SMC differentiation during embryonic development. In summary, the transcriptional regulator Meox1 controls TGF--induced SMC differentiation from mesenchymal progenitor cells by preventing PPM1A-mediated Smad3 dephosphorylation, thereby supporting SMC gene expression.	[Dong, Kun; Guo, Xia; Hsu, Amanda C.; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Chen, Weiping] NIDDK, Genom Core Lab, NIH, Bethesda, MD 20892 USA; [Shao, Qiang; Chen, Jian-Fu] Univ Southern Calif, Ostrow Sch Dent USC, Los Angeles, CA 90089 USA	University System of Georgia; University of Georgia; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Southern California	Chen, SY (corresponding author), 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Chen, Wei/GZK-7348-2022; Shao, Eric Qiang/I-1359-2019	Shao, Eric Qiang/0000-0001-5307-8264	National Institutes of Health [HL119053, HL123302, HL135854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL119053, R01HL135854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL119053, HL123302, and HL135854 (to S. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buckley SMK, 2008, MOL THER, V16, P819, DOI 10.1038/mt.2008.26; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Douville JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029099; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Kirilenko P, 2011, MOL CELL BIOL, V31, P1301, DOI 10.1128/MCB.00705-10; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mack CP, 2005, J THROMB HAEMOST, V3, P1976, DOI 10.1111/j.1538-7836.2005.01316.x; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Nguyen PD, 2014, NATURE, V512, P314, DOI 10.1038/nature13678; Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768; Shi N, 2013, J BIOL CHEM, V288, P34336, DOI 10.1074/jbc.M113.498238; Shi N, 2012, J BIOL CHEM, V287, P6860, DOI 10.1074/jbc.M111.306209; Shi XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093995; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Wu B, 2018, INT J CARDIOL, V251, P82, DOI 10.1016/j.ijcard.2017.10.098; Xie WB, 2013, CIRC RES, V113, pE76, DOI 10.1161/CIRCRESAHA.113.301921; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747	35	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8712	8719		10.1074/jbc.RA118.002350	http://dx.doi.org/10.1074/jbc.RA118.002350			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29678882	Green Published, hybrid			2022-12-28	WOS:000434205700033
J	Kang, XM; Yang, W; Wang, RQ; Xie, TP; Li, HX; Feng, DX; Jin, XX; Sun, HZ; Wu, SF				Kang, Xiaomin; Yang, Wei; Wang, Ruiqi; Xie, Tianping; Li, Huixia; Feng, Dongxu; Jin, Xinxin; Sun, Hongzhi; Wu, Shufang			Sirtuin-1 (SIRT1) stimulates growth-plate chondrogenesis by attenuating the PERK-eIF-2-CHOP pathway in the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondrocyte; chondrogenesis; endoplasmic reticulum stress (ER stress); growth plate; sirtuin 1 (SIRT1); unfolded protein response (UPR); PERK; bone growth	ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTORS; ARTICULAR-CARTILAGE; HUMAN CHONDROCYTES; INDUCED APOPTOSIS; GENE-EXPRESSION; BONE-FORMATION; CELL-SURVIVAL; DEACETYLATION	The NAD(+)-dependent deacetylase sirtuin-1 (SIRT1) has emerged as an important regulator of chondrogenesis and cartilage homeostasis, processes that are important for physiological skeletal growth and that are dysregulated in osteoarthritis. However, the functional role and underlying mechanism by which SIRT1 regulates chondrogenesis remain unclear. Using cultured rat metatarsal bones and chondrocytes isolated from rat metatarsal rudiments, here we studied the effects of the SIRT1 inhibitor EX527 or of SIRT1 siRNA on chondrocyte proliferation, hypertrophy, and apoptosis. We show that EX527 or SIRT1 siRNA inhibits chondrocyte proliferation and hypertrophy and induces apoptosis. We also observed that SIRT1 inhibition mainly induces the PERK-eIF-2-CHOP axis of the endoplasmic reticulum (ER) stress response in growth-plate chondrocytes. Of note, EX527- or SIRT1 siRNA-mediated inhibition of metatarsal growth and growth-plate chondrogenesis were partly neutralized by phenylbutyric acid, a chemical chaperone that attenuates ER stress. Moreover, EX527-mediated impairment of chondrocyte function (i.e. of chondrocyte proliferation, hypertrophy, and apoptosis) was partly reversed in CHOP-/- cells. We also present evidence that SIRT1 physically interacts with and deacetylates PERK. Collectively, our findings indicate that SIRT1 deacetylates PERK and attenuates the PERK-eIF-2-CHOP axis of the unfolded protein response pathway and thereby promotes growth-plate chondrogenesis and longitudinal bone growth.	[Kang, Xiaomin; Yang, Wei; Wang, Ruiqi; Xie, Tianping; Feng, Dongxu; Jin, Xinxin; Wu, Shufang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Ctr Translat Med, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Li, Huixia; Sun, Hongzhi] Xi An Jiao Tong Univ, Med Sch, Minist Educ, Key Lab Environm & Genes Related Dis, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Feng, Dongxu] Xi An Jiao Tong Univ, Sch Med, Hong Hui Hosp, Xian 710054, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wu, SF (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Ctr Translat Med, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.; Sun, HZ (corresponding author), Xi An Jiao Tong Univ, Med Sch, Minist Educ, Key Lab Environm & Genes Related Dis, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	sunhongzhi@mail.xjtu.edu.cn; shufangw@hotmail.com	jin, xin/GQZ-5811-2022		National Natural Science Foundation of China [81672221, 81472038, 81370899, 81170741]; National Excellent Young Scientist Program [81222026]; Ministry of Education of China New Century Excellent Talents Grant [NCET-11-0437]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Excellent Young Scientist Program; Ministry of Education of China New Century Excellent Talents Grant	This work was supported by National Natural Science Foundation of China Program Grants 81672221, 81472038, 81370899, and 81170741; National Excellent Young Scientist Program Grant 81222026; and Ministry of Education of China New Century Excellent Talents Grant NCET-11-0437. The authors declare that they have no conflicts of interest with the contents of this article.	AHARINEJAD S, 1995, ANAT REC, V242, P111, DOI 10.1002/ar.1092420115; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cameron TL, 2015, OSTEOARTHR CARTILAGE, V23, P661, DOI 10.1016/j.joca.2015.01.001; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Fujita N, 2011, J ORTHOP RES, V29, P511, DOI 10.1002/jor.21284; Gabay O, 2013, ARTHRITIS RHEUM-US, V65, P159, DOI 10.1002/art.37750; Gabay O, 2012, ANN RHEUM DIS, V71, P613, DOI 10.1136/ard.2011.200504; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Ghosh HS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00150; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Kang XM, 2017, J BONE MINER RES, V32, P2128, DOI 10.1002/jbmr.3134; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Liu ZJ, 2017, ONCOTARGET, V8, P9267, DOI 10.18632/oncotarget.14035; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matsuzaki T, 2014, ANN RHEUM DIS, V73, P1397, DOI 10.1136/annrheumdis-2012-202620; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Prola A, 2017, CELL DEATH DIFFER, V24, P343, DOI 10.1038/cdd.2016.138; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Sun TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10159; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Tsuchimochi K, 2010, J BIOL CHEM, V285, P8395, DOI 10.1074/jbc.M109.038638; Uehara Y, 2014, OSTEOARTHR CARTILAGE, V22, P1007, DOI 10.1016/j.joca.2014.04.025; Ushijima T, 2014, J BIOL CHEM, V289, P2852, DOI 10.1074/jbc.M113.492843; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yang W, 2016, ENDOCRINOLOGY, V157, P3096, DOI 10.1210/en.2015-2042; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	46	34	37	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8614	8625		10.1074/jbc.M117.809822	http://dx.doi.org/10.1074/jbc.M117.809822			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29653943	Green Published, hybrid			2022-12-28	WOS:000434205700024
J	Chorba, JS; Galvan, AM; Shokat, KM				Chorba, John S.; Galvan, Adri M.; Shokat, Kevan M.			Stepwise processing analyses of the single-turnover PCSK9 protease reveal its substrate sequence specificity and link clinical genotype to lipid phenotype (vol 293, pg 1875, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Chorba JS, 2018, J BIOL CHEM, V293, P1875, DOI 10.1074/jbc.RA117.000754	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6692	6692		10.1074/jbc.AAC118.003335	http://dx.doi.org/10.1074/jbc.AAC118.003335			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29728531	Green Published, hybrid			2022-12-28	WOS:000431487300006
